matchedPattern,context,lineNumber,columnNumber,publicationName
3243A > G,"...n association with other organs involvement, like 3243A > G, 3260A > G, 3303C > T in the tRNALeu (UU...",48,669,Acta_Myol_2011_Jul_30(1)_9-15.txt
3260A > G,"...on with other organs involvement, like 3243A > G, 3260A > G, 3303C > T in the tRNALeu (UUR) gene (MT...",48,680,Acta_Myol_2011_Jul_30(1)_9-15.txt
3303C > T,"...er organs involvement, like 3243A > G, 3260A > G, 3303C > T in the tRNALeu (UUR) gene (MTTL1); 4269A...",48,691,Acta_Myol_2011_Jul_30(1)_9-15.txt
4269A > G,"...> G, 3303C > T in the tRNALeu (UUR) gene (MTTL1); 4269A > G, 4295A > G, 4300A > G, 4317A > G, 4320C ...",48,736,Acta_Myol_2011_Jul_30(1)_9-15.txt
4295A > G,"...> T in the tRNALeu (UUR) gene (MTTL1); 4269A > G, 4295A > G, 4300A > G, 4317A > G, 4320C > T in the ...",48,747,Acta_Myol_2011_Jul_30(1)_9-15.txt
4300A > G,"...tRNALeu (UUR) gene (MTTL1); 4269A > G, 4295A > G, 4300A > G, 4317A > G, 4320C > T in the tRNAIle gen...",48,758,Acta_Myol_2011_Jul_30(1)_9-15.txt
4317A > G,"...R) gene (MTTL1); 4269A > G, 4295A > G, 4300A > G, 4317A > G, 4320C > T in the tRNAIle gene (MMTI); 8...",48,769,Acta_Myol_2011_Jul_30(1)_9-15.txt
4320C > T,"...TL1); 4269A > G, 4295A > G, 4300A > G, 4317A > G, 4320C > T in the tRNAIle gene (MMTI); 8348A > G in...",48,780,Acta_Myol_2011_Jul_30(1)_9-15.txt
8348A > G,"... 4317A > G, 4320C > T in the tRNAIle gene (MMTI); 8348A > G in the tRNALys gene (MTTK), 9997T > C in...",48,818,Acta_Myol_2011_Jul_30(1)_9-15.txt
9997T > C,"...ene (MMTI); 8348A > G in the tRNALys gene (MTTK), 9997T > C in the tRNAGly gene (MTTG), 12297T > C i...",48,856,Acta_Myol_2011_Jul_30(1)_9-15.txt
12297T > C,"...ene (MTTK), 9997T > C in the tRNAGly gene (MTTG), 12297T > C in the tRNA Leu(CUN)(MTTL2) and 15923A ...",48,894,Acta_Myol_2011_Jul_30(1)_9-15.txt
15923A > G,"...MTTG), 12297T > C in the tRNA Leu(CUN)(MTTL2) and 15923A > G in the tRNAThr gene (MTTT)",48,937,Acta_Myol_2011_Jul_30(1)_9-15.txt
3260 A > G,...rdiac muscles usually associated to the mutations 3260 A > G or 3303C > T in the tRNALeu (UUR) gene ...,50,212,Acta_Myol_2011_Jul_30(1)_9-15.txt
3303C > T,...usually associated to the mutations 3260 A > G or 3303C > T in the tRNALeu (UUR) gene (MTTL1),50,226,Acta_Myol_2011_Jul_30(1)_9-15.txt
3243A > G,"MTTL1 3243A > G(80%), 3271, 329",133,8,Acta_Myol_2011_Jul_30(1)_9-15.txt
3308T > C,"MT-ND1 3308T > C, various MT-ND5 gene mutations, MTCOXIII...",135,8,Acta_Myol_2011_Jul_30(1)_9-15.txt
9957T > C,"...308T > C, various MT-ND5 gene mutations, MTCOXIII 9957T >",135,59,Acta_Myol_2011_Jul_30(1)_9-15.txt
8344A > G,"MTTK 8344A > G, less frequent 8356T > C mutation",144,7,Acta_Myol_2011_Jul_30(1)_9-15.txt
8356T > C,"MTTK 8344A > G, less frequent 8356T > C mutation",144,32,Acta_Myol_2011_Jul_30(1)_9-15.txt
8993T > G,MT-ATPase 6 8993T >,155,14,Acta_Myol_2011_Jul_30(1)_9-15.txt
8993T > G,"MT-ATPase 6 8993T > G, 8993T >",174,14,Acta_Myol_2011_Jul_30(1)_9-15.txt
8993T > C,"MT-ATPase 6 8993T > G, 8993T >",174,25,Acta_Myol_2011_Jul_30(1)_9-15.txt
3243A > G,"... mutations are frequently found, especially MTTL1 3243A > G mutation (80% of the cases) (55). Conver...",193,671,Acta_Myol_2011_Jul_30(1)_9-15.txt
3308T > C,"... position 3271 and 3291 in the MTTL1 gene, MT-ND1 3308T > C mutation, various MTND5 gene mutations, ...",193,909,Acta_Myol_2011_Jul_30(1)_9-15.txt
9957T > C,"...mutation, various MTND5 gene mutations, MT-COXIII 9957T > C mutation, and large-scale deletions (56)...",193,969,Acta_Myol_2011_Jul_30(1)_9-15.txt
3243A > G,...onset hypertrophic cardiomyopathy caused by MTTL1 3243A > G mutation has been reported (57). Heart a...,195,162,Acta_Myol_2011_Jul_30(1)_9-15.txt
8344 A > G,...ested MERRF patients carry the mitochondrial MTTK 8344 A > G mutation (63). Other symptoms may inclu...,198,237,Acta_Myol_2011_Jul_30(1)_9-15.txt
8993T > G,Point mutations at position 8993 (8993T > G and 8993T > C) of the MT-ATP6 gene cause...,203,35,Acta_Myol_2011_Jul_30(1)_9-15.txt
8993T > C,Point mutations at position 8993 (8993T > G and 8993T > C) of the MT-ATP6 gene cause a neurodegene...,203,49,Acta_Myol_2011_Jul_30(1)_9-15.txt
8993T > G,... inherited point mutations in the MT-ATP6 gene (m.8993T > G/C and m.9176T > G/C) are the most common...,206,862,Acta_Myol_2011_Jul_30(1)_9-15.txt
9176T > G,...utations in the MT-ATP6 gene (m.8993T > G/C and m.9176T > G/C) are the most common changes (72). Sev...,206,880,Acta_Myol_2011_Jul_30(1)_9-15.txt
8344A > G,in patients with the m.8344A > G mutation of mitochondrial DNA Neurology ...,377,24,Acta_Myol_2011_Jul_30(1)_9-15.txt
8993 T > G,caused by 8993 T > G mitochondrial DNA mutation: a clinical,385,11,Acta_Myol_2011_Jul_30(1)_9-15.txt
14487T > C,"14487T > C (M63V, ND6) and 12297T > C (tRNA Leu) i...",398,1,Acta_Myol_2011_Jul_30(1)_9-15.txt
12297T > C,"14487T > C (M63V, ND6) and 12297T > C (tRNA Leu) in a Leig",398,28,Acta_Myol_2011_Jul_30(1)_9-15.txt
889 C>T,IL1A	2q14	-889 C>T	rs1800587	Anti-inflammation cytokine. Acti...,35,12,Acta_Naturae_2011_Jan-Mar_3(1)_116-122.txt
511 G>A,IL1B	2q14	-511 G>A	rs16944,38,12,Acta_Naturae_2011_Jan-Mar_3(1)_116-122.txt
590 C>T,IL4	5q31.1	-590 C>T	rs2243250	Decreasing the level of anti-inf...,39,13,Acta_Naturae_2011_Jan-Mar_3(1)_116-122.txt
174 G>C,IL6	7p21	-174 G>C	rs1800795	Activation of osteoclasts. Invol...,42,11,Acta_Naturae_2011_Jan-Mar_3(1)_116-122.txt
592 C>A,IL10	1q31-q32	-592 C>A	rs1800872	Inhibiting replication of T-cell...,45,16,Acta_Naturae_2011_Jan-Mar_3(1)_116-122.txt
308 G>A,TNF 	6p21.3	-308 G>A	rs1800629	Activation of osteoclasts and ma...,51,14,Acta_Naturae_2011_Jan-Mar_3(1)_116-122.txt
1799 T>A,"...hat is frequently found in cutaneous melanomas (c.1799 T>A, p.V600E), raising the question whether t...",3,2191,Acta_Neuropathol_2010_Mar_22_119(3)_317-323.txt
1799 T>A,"...is of the BRAF gene revealed one BRAF mutation (c.1799 T>A, p.V600E), in a melanoma. No HRAS or NRAS...",81,791,Acta_Neuropathol_2010_Mar_22_119(3)_317-323.txt
626 A>C,3	MC	c.626 A>C (p.Gln209Pro)	wt	wt	wt,86,8,Acta_Neuropathol_2010_Mar_22_119(3)_317-323.txt
626 A>C,7	MC	c.626 A>C (p.Gln209Pro)	wt	wt	wt,90,8,Acta_Neuropathol_2010_Mar_22_119(3)_317-323.txt
626 A>C,9	MC	c.626 A>C (p.Gln209Pro)	wt	na	wt,92,8,Acta_Neuropathol_2010_Mar_22_119(3)_317-323.txt
626 A>T,10	MM	c.626 A>T (p.Gln209Leu)	wt	wt	na,93,9,Acta_Neuropathol_2010_Mar_22_119(3)_317-323.txt
626 A>T,12	MC	c.626 A>T (p.Gln209Leu)	wt	na	na,95,9,Acta_Neuropathol_2010_Mar_22_119(3)_317-323.txt
626 A>T,13	MC	c.626 A>T (p.Gln209Leu)	wt	wt	na,96,9,Acta_Neuropathol_2010_Mar_22_119(3)_317-323.txt
626 A>T,14	MC	c.626 A>T (p.Gln209Leu)	wt	wt	wt,97,9,Acta_Neuropathol_2010_Mar_22_119(3)_317-323.txt
1799 T>A,15	MM	wt	c.1799 T>A (p.V600E)	na	wt,98,12,Acta_Neuropathol_2010_Mar_22_119(3)_317-323.txt
1799 T>A,"...our series with a BRAF point mutation (case 15; c.1799 T>A, p.V600E) might be a metastasis rather th...",114,847,Acta_Neuropathol_2010_Mar_22_119(3)_317-323.txt
1483C>T,1	14	c.1483C>T	p.R495X	34	F	9	Yes	Yes	L	No,37,8,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
1528A>G,2	14	c.1528A>G	p.K510E	39	M	15	Yes	Yes	B	No,38,8,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
1561C>T,3	15	c.1561C>T	p.R521C	33	M	10	NA	Yes	NA	No,39,8,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
1561C>T,4†	15	c.1561C>T	p.R521C	35	F	7	Yes	Yes	B	No†,40,9,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
1562G>A,5	15	c.1562G>A	p.R521H	35	F	>36	NA	Yes	L	No,41,8,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
1574C>T,15	c.1574C>T	p.P525L,43,7,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
1540A>G,7	15	c.1540A>G	p.R514G	60	M	>96	NA	Yes	B	No,45,8,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
1555A>G,9	M	52	R	Mit	3	Mt.1555A>G	PULSAR FLEX24	24	S.U.,66,19,Acta_Otolaryngol_2014_Jul_19_134(7)_717-727.txt
1555A>G,"In the present study, the responsible gene (m.1555A>G, TMPRRS3, ACTG1) was identified in 3 of 30...",182,47,Acta_Otolaryngol_2014_Jul_19_134(7)_717-727.txt
1555A>G,Patients with CDH23 mutations and the 1555A>G mitochondrial mutation are good candidates...,246,39,Acta_Otolaryngol_2014_Jul_19_134(7)_717-727.txt
172G > T,118. Lu J  Wang LE  Xiong P    172G > T variant in the 5' untranslated region of ...,565,32,Acta_Otorhinolaryngol_Ital_2012_Feb_32(1)_1-11.txt
91G > C,"In Maine Coon (MC) cats the c.91G > C mutation in the gene MYBPC3, coding for ca...",4,31,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
91G > C,...identified a disease-causing missense mutation (c.91G > C) in the feline MYBPC3 gene in a colony of ...,22,68,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
91G > C,c.91G > C: guanine substituted for a cytosine at the...,186,3,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
1237T>C,"... the risk of Hodgkin lymphoma in relation to TLR9-1237T>C, TLR9 2848A>G, MYD88-938C>A, and MYD88 194...",79,73,Adv_Hematol_2011_Nov_29_2011_736261.txt
2848A>G,"...odgkin lymphoma in relation to TLR9-1237T>C, TLR9 2848A>G, MYD88-938C>A, and MYD88 1944C>G gene poly...",79,87,Adv_Hematol_2011_Nov_29_2011_736261.txt
938C>A,"... in relation to TLR9-1237T>C, TLR9 2848A>G, MYD88-938C>A, and MYD88 1944C>G gene polymorphisms and h...",79,102,Adv_Hematol_2011_Nov_29_2011_736261.txt
1944C>G,"...R9-1237T>C, TLR9 2848A>G, MYD88-938C>A, and MYD88 1944C>G gene polymorphisms and haplotypes    [26]....",79,120,Adv_Hematol_2011_Nov_29_2011_736261.txt
4T > L,...f protection of cells from HIV-infection was 4'-Ed4T > LFD4C > DDI > D4T > 3TC > AZT > FTC > NVP. Th...,9,62,AIDS_Res_Ther_2009_Apr_22_6_5.txt
4C > D,...tion of cells from HIV-infection was 4'-Ed4T > LFD4C > DDI > D4T > 3TC > AZT > FTC > NVP. The fold-i...,9,70,AIDS_Res_Ther_2009_Apr_22_6_5.txt
4T > L,...s based on the two-component assay was DDI > 4'-Ed4T > LFD4C > FTC = D4T > 3TC > NVP > AZT,9,330,AIDS_Res_Ther_2009_Apr_22_6_5.txt
4C > F,...on the two-component assay was DDI > 4'-Ed4T > LFD4C > FTC = D4T > 3TC > NVP > AZT,9,338,AIDS_Res_Ther_2009_Apr_22_6_5.txt
4T > L,...8 h of removal of drug from cell culture was 4'-Ed4T > LFD4C > DDI > D4T > 3TC > AZT > FTC > NVP. Th...,65,1473,AIDS_Res_Ther_2009_Apr_22_6_5.txt
4C > D,...emoval of drug from cell culture was 4'-Ed4T > LFD4C > DDI > D4T > 3TC > AZT > FTC > NVP. The compos...,65,1481,AIDS_Res_Ther_2009_Apr_22_6_5.txt
4T > L,...sing persistence of anti-HIV activity: DDI > 4'-Ed4T > LFD4C > FTC = D4T > 3TC > NVP > AZT,109,475,AIDS_Res_Ther_2009_Apr_22_6_5.txt
4C > F,...sistence of anti-HIV activity: DDI > 4'-Ed4T > LFD4C > FTC = D4T > 3TC > NVP > AZT,109,483,AIDS_Res_Ther_2009_Apr_22_6_5.txt
1123G>C,"...P®. Five PTPN22 single nucleotide polymorphisms, -1123G>C, 1858C>T, 13145A>G, 14943C>T, and 20628A>G...",4,1400,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
1858C>T,"...PTPN22 single nucleotide polymorphisms, -1123G>C, 1858C>T, 13145A>G, 14943C>T, and 20628A>G, were ge...",4,1409,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
13145A>G,"...ngle nucleotide polymorphisms, -1123G>C, 1858C>T, 13145A>G, 14943C>T, and 20628A>G, were genotyped. ...",4,1418,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
14943C>T,"...otide polymorphisms, -1123G>C, 1858C>T, 13145A>G, 14943C>T, and 20628A>G, were genotyped. There were...",4,1428,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
20628A>G,"...hisms, -1123G>C, 1858C>T, 13145A>G, 14943C>T, and 20628A>G, were genotyped. There were no significan...",4,1442,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
20628A>G,...2 groups. CU patients carrying the GG genotype at 20628A>G (P=0.035) or haplotype 3 [GGG] (P=0.047) ...,4,1628,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
14943C>T,"...red to non-carriers. Similarly, CT/TT genotype at 14943C>T had a significantly higher prevalence of ...",4,1803,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
20628A>G,...ngs suggest that the PTPN22 gene polymorphisms at 20628A>G and 14943C>T may enhance serum specific I...,4,1949,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
14943C>T,...hat the PTPN22 gene polymorphisms at 20628A>G and 14943C>T may enhance serum specific IgE responses ...,4,1962,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
1858C>T,PTPN22 gene polymorphism (1858C>T) impairs T-cell signaling and may influenc...,13,27,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
1123G>C,"...d five SNPs of the PTPN22 gene, one in promoter (-1123G>C), one in exon (1858C>T) and three in intro...",22,181,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
1858C>T,"...22 gene, one in promoter (-1123G>C), one in exon (1858C>T) and three in intron (13145A>G, 14943C>T a...",22,204,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
13145A>G,"...3G>C), one in exon (1858C>T) and three in intron (13145A>G, 14943C>T and 20628A>G), based on previou...",22,234,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
14943C>T,"... in exon (1858C>T) and three in intron (13145A>G, 14943C>T and 20628A>G), based on previous reported...",22,244,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
20628A>G,"...8C>T) and three in intron (13145A>G, 14943C>T and 20628A>G), based on previous reported studies and ...",22,257,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
1123G>C,"...from the combination of the three gene variants, -1123G>C, 20628A>G and 13145A>G using Haploview 4.2...",22,655,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
20628A>G,"...combination of the three gene variants, -1123G>C, 20628A>G and 13145A>G using Haploview 4.2",22,664,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
13145A>G,"...f the three gene variants, -1123G>C, 20628A>G and 13145A>G using Haploview 4.2",22,677,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
20628A>G,"...e, CU patients with the GG homozygous genotype at 20628A>G exhibited a significantly higher prevalen...",29,114,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
14943C>T,"...=0.047; Fig. B). Similarly, the CT/TT genotype at 14943C>T was associated with a significantly highe...",29,483,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
20628A>G,"...ound significant associations of 2 intronic SNPs, 20628A>G and 14943C>T, with the prevalence of seru...",32,371,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
14943C>T,"...ant associations of 2 intronic SNPs, 20628A>G and 14943C>T, with the prevalence of serum specific Ig...",32,384,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
1123G>C,"...a et al.5 recently reported that a promoter SNP, -1123G>C, was associated with CU susceptibility in ...",34,177,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
1858C>T,... play important role in the polymorphism. The SNP 1858C>T is the most prevalent polymorphism in a Eu...,34,455,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
20628A>G,...pathogenesis.18 The present study found that both 20628A>G and 14943C>T were associated with a highe...,36,393,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
14943C>T,...18 The present study found that both 20628A>G and 14943C>T were associated with a higher prevalence ...,36,406,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
1858C>T,... It was also found that PTPN22 gene polymorphism (1858C>T) was not associated with responses to ASST...,41,451,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
20628A>G,"...n conclusion, intronic polymorphisms of PTPN22 at 20628A>G and 14943C>T enhances serum specific IgE ...",43,52,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
14943C>T,... intronic polymorphisms of PTPN22 at 20628A>G and 14943C>T enhances serum specific IgE responses to ...,43,65,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
20628A>G,... of serum specific IgE to TSST-1 according to the 20628A>G polymorphism. (B) Prevalence of serum spe...,50,186,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
14943C>T,...nce of serum specific IgE to SEA according to the 14943C>T polymorphism,50,353,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
1123G>C,-1123G>C	Forward	tcccagttttcttcaggatca,55,2,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
13145A>G,13145A>G	Forward	tcccaaatcatcctccagaa,58,1,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
14943C>T,14943C>T	Forward	gtctaacccctttgggcttc,61,1,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
20628A>G,20628A>G	Forward	ggctaggagaagggaagagc,64,1,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
1858C>T,1858C>T	Forward	gagtgcagtggcacaatcat,67,1,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
1123G>C,-1123G>C (rs2488457)	CC	175 (42.8%)	161 (41.5%)	0.3...,93,2,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
13145A>G,13145A>G (rs1217418)	AA	304 (74.3%)	293 (75.5%)	0....,96,1,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
14943C>T,14943C>T (rs11582409)	CC	276 (67.5%)	246 (63.4%)	0...,99,1,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
20628A>G,20628A>G (rs1217407)	AA	178 (43.5%)	168 (43.3%)	0....,102,1,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
939A>G,Histamine N-methyltransferase 939A>G polymorphism affects mRNA stability in pati...,149,31,Allergy_Rhinol_(Providence)_2015_Summer_6(2)_e101-e110.txt
677 C>T,"...with mild MTHFR deficiency, a model for the MTHFR 677 C>T polymorphism, the most studied variant in ...",31,199,Am_J_Clin_Nutr_2015_Mar_7_101(3)_646-658.txt
677 C>T,...tions are known to modulate disease risk in MTHFR 677 C>T individuals (31). It may be important to c...,189,1161,Am_J_Clin_Nutr_2015_Mar_7_101(3)_646-658.txt
677C->T,MTHFR 677C->T genotype is associated with folate and hom...,386,7,Am_J_Clin_Nutr_2015_Mar_7_101(3)_646-658.txt
389G > C,"...encephaly with a heterozygous mutation in SOX2 (c.389G > C, p.G130A) [Kelberman et al., 2006] makes ...",22,93,Am_J_Med_Genet_A_2010_Nov_11_152A(11)_2736-2742.txt
113G > T,"LHX2	Exon 1	Chr9: 125,814,336	rs7868184	c.-113G > T	4/97 (4)	5′-UTR",122,44,Am_J_Med_Genet_A_2010_Nov_11_152A(11)_2736-2742.txt
724G > A,"Exon 3	Chr9: 125,817,622	n/a	c.724G > A	1/97 (1)	p.A242T, conserveda",123,33,Am_J_Med_Genet_A_2010_Nov_11_152A(11)_2736-2742.txt
21G > T,"Intron 3	Chr9: 125,823,178	n/a	c.728–21G > T	5/97 (5)	Intronic, not conserved",124,39,Am_J_Med_Genet_A_2010_Nov_11_152A(11)_2736-2742.txt
765C > T,"Exon 4	Chr9: 125,823,236	rs61734362	c.765C > T	1/97 (1)	p.D255D",125,40,Am_J_Med_Genet_A_2010_Nov_11_152A(11)_2736-2742.txt
783G > C,"Exon 4	Chr9: 125,823,254	rs1042486	c.783G > C	46/97 (45)	p.P261P",126,39,Am_J_Med_Genet_A_2010_Nov_11_152A(11)_2736-2742.txt
1017C > G,"Exon 5	Chr9: 125,834,603	n/a	c.1017C > G	1/97 (1)	p.A339A",127,33,Am_J_Med_Genet_A_2010_Nov_11_152A(11)_2736-2742.txt
374A > G,"HESX1	Exon 3	Chr3: 57,207,544	rs9878928	c.374A > G	3/97 (3)	N125S",128,43,Am_J_Med_Genet_A_2010_Nov_11_152A(11)_2736-2742.txt
22 G > A,"SOX2	Exon 1	Chr3: 182,913,818	n/a	c.*22 G > A	2/97 (2)	3′-UTR, not conserved",129,38,Am_J_Med_Genet_A_2010_Nov_11_152A(11)_2736-2742.txt
724G > A,"...e of schizencephaly, we observed a heterozygous c.724G > A change, resulting in p.Ala242Thr. Though ...",135,66,Am_J_Med_Genet_A_2010_Nov_11_152A(11)_2736-2742.txt
724G > A,"...controls (574 chromosomes) and did not find the c.724G > A change, suggesting that it is not a commo...",135,466,Am_J_Med_Genet_A_2010_Nov_11_152A(11)_2736-2742.txt
1017C > G,"... One patient had a synonymous change in exon 5, c.1017C > G",137,635,Am_J_Med_Genet_A_2010_Nov_11_152A(11)_2736-2742.txt
374A > G,"...parent heterozygous missense mutation in HESX1, c.374A > G (p.Asn125Ser). However, since this polymo...",140,151,Am_J_Med_Genet_A_2010_Nov_11_152A(11)_2736-2742.txt
22 G > A,"We observed one heterozygous change in SOX2: c.*22 G > A (exon 1 + 22 bp) in two patients, includi...",143,49,Am_J_Med_Genet_A_2010_Nov_11_152A(11)_2736-2742.txt
724G > A,"...ng published SNPs. One LHX2 sequence variation, c.724G > A, had not been previously reported. Though...",148,101,Am_J_Med_Genet_A_2010_Nov_11_152A(11)_2736-2742.txt
514G > T,"...cted individuals, which can only occur when the c.514G > T and c.515C > T are present in cis. D: Ana...",35,474,Am_J_Med_Genet_A_2013_May_26_161(5)_1158-1163.txt
515C > T,"...s, which can only occur when the c.514G > T and c.515C > T are present in cis. D: Analysis of C/T SN...",35,489,Am_J_Med_Genet_A_2013_May_26_161(5)_1158-1163.txt
2C>T,...t VU1202 with biallelic mutations in DDX11 (IVS22+2C>T and c.2689_2691delAAG) and his mother (VU1203...,20,463,Anemia_2010_Jul_18_2010_565268.txt
2C>T,"... c.2689_2691delAAG) and his mother (VU1203, IVS22+2C>T) [19]. The FA-J patient EUFA1333 and FA-B pat...",20,521,Anemia_2010_Jul_18_2010_565268.txt
2C>T,WABS	VU1202	DDX11	IVS22+2C>T c.2689_2691delAAG	Compound heterozygous	[19],68,25,Anemia_2010_Jul_18_2010_565268.txt
498A>T,FA-1	EUFA1333	FANCJ	IVS11–498A>T c.2392C>T	Hematopoietic mosaicism	[25],69,27,Anemia_2010_Jul_18_2010_565268.txt
2392C>T,FA-1	EUFA1333	FANCJ	IVS11–498A>T c.2392C>T	Hematopoietic mosaicism	[25],69,36,Anemia_2010_Jul_18_2010_565268.txt
2C>T,Con-3	VU1203	DDX11	 IVS22+2C>T	Mother of VU1202	[19],73,27,Anemia_2010_Jul_18_2010_565268.txt
316G>A,(c.316G>A) was most strongly associated with WBSF in ...,653,4,Anim_Genet_2012_Dec_27_43(6)_662-673.txt
328C>T,"...‐of‐function mutations, a premature stop codon (c.328C>T, p.Arg110*) and a donor splice‐site mutatio...",42,220,Anim_Genet_2015_Dec_28_46(6)_676-682.txt
2T>A,"....Arg110*) and a donor splice‐site mutation (c.840+2T>A, p.Glu281_Leu282Ins8), both of which cause wh...",42,279,Anim_Genet_2015_Dec_28_46(6)_676-682.txt
328C>T,...ne of the SNPs constitutes a nonsense mutation (c.328C>T) causing a premature translational stop (p....,80,658,Anim_Genet_2015_Dec_28_46(6)_676-682.txt
2T>A,"...xon 3 (Fig. 2), whereas the other mutation (c.840+2T>A) introduces a donor splice‐site mutation (p.G...",80,823,Anim_Genet_2015_Dec_28_46(6)_676-682.txt
328C>T,"...01150.2) causing a premature translational stop c.328C>T, p.Arg110* at genomic position chr22: 32 32...",82,267,Anim_Genet_2015_Dec_28_46(6)_676-682.txt
328C>T,"...at cDNA level in spotted buffaloes carrying the c.328C>T mutation, suggesting nonsense‐mediated deca...",82,512,Anim_Genet_2015_Dec_28_46(6)_676-682.txt
2T>A,"...donor splice‐site mutation (NM_001001150.2) c.840+2T>A, p.Glu281_Leu282Ins8 at position chr22: 32 29...",84,280,Anim_Genet_2015_Dec_28_46(6)_676-682.txt
328C>T,"...notype frequencies of the MITF nonsense variant c.328C>T, p.Arg110* (chr22: 32 322 242a) and the spl...",88,61,Anim_Genet_2015_Dec_28_46(6)_676-682.txt
2T>A,"...2: 32 322 242a) and the splice‐site variant c.840+2T>A, p.Glu281_Leu282Ins8 (chr22: 32 297 683a) in ...",88,134,Anim_Genet_2015_Dec_28_46(6)_676-682.txt
1326T>G,"The SNP c.1326T>G in the non‐SMC condensin I complex, subuni...",1143,11,Anim_Sci_J_2016_Feb_11_87(2)_159-167.txt
1698C>T,...nce showed 2 common heterozygous polymorphisms: c.1698C>T in exon 10 and c.2095C>A in exon 12. The F...,26,291,Ann_Dermatol_2013_Nov_30_25(4)_483-488.txt
2095C>A,...ozygous polymorphisms: c.1698C>T in exon 10 and c.2095C>A in exon 12. The FACE1 (ZMPSTE24) sequence ...,26,316,Ann_Dermatol_2013_Nov_30_25(4)_483-488.txt
2249C>A,...ons comprised c.1947dupC (p.Pro649Profs*11) and c.2249C>A (p.Ser750*). The most recently reported ca...,33,505,Ann_Dermatol_2015_Dec_7_27(6)_658-666.txt
3650T> A,"... case, from Pakistan, involved homozygosity for c.3650T> A (p.Leu1217*). All pathogenic mutations we...",33,602,Ann_Dermatol_2015_Dec_7_27(6)_658-666.txt
1G>A,"... homozygous acceptor splice site mutation, c.1538-1G>A. The third case, from Pakistan, had a homozyg...",48,407,Ann_Dermatol_2015_Dec_7_27(6)_658-666.txt
1883G>C,"...m Pakistan, had a homozygous missense mutation, c.1883G>C (p.Arg628Pro) that occurred within the ext...",48,482,Ann_Dermatol_2015_Dec_7_27(6)_658-666.txt
1045G>T,"...lands) was also a homozygous missense mutation, c.1045G>T (p.Ala-349Ser)16, as was the mutation in t...",48,705,Ann_Dermatol_2015_Dec_7_27(6)_658-666.txt
1387C>T,"...9Ser)16, as was the mutation in the fifth case, c.1387C>T (p.Arg463Trp)17. Clues to the molecular pa...",48,772,Ann_Dermatol_2015_Dec_7_27(6)_658-666.txt
1G>A,"...ous effects of the mutations (p.Ala349Ser, c.1538-1G>A, and p.Arg463Trp) on α3 integrin structure, p...",51,1448,Ann_Dermatol_2015_Dec_7_27(6)_658-666.txt
109G>T,...etal hemoglobin results from a novel mutation (g.-109G>T) in the HBG2 gene promoter Chassanidis Chri...,3,240,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
109G>T,"...PFH due to a HBG2 gene promoter mutation (HBG2:g.-109G>T). This mutation, located at the 3′ end of t...",3,1663,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
109G>T,...tudies and DNA analysis revealed that the HBG2:g.-109G>T mutation is also found in the family member...,3,1980,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
158C>T,...mbers in compound heterozygosity with the HBG2:g.-158C>T single nucleotide polymorphism or the silen...,3,2076,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
101C>T,"...ngle nucleotide polymorphism or the silent HBB:g.-101C>T β-thalassemia mutation, resulting in the la...",3,2135,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
109G>T,...mobility shift analysis revealed that the HBG2:g.-109G>T mutation abolishes a transcription factor b...,3,2308,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
109G>T,...NF-E3 binding. These data suggest that the HBG2:g-109G>T mutation has a functional role in increasin...,3,2558,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
117G>A,"...most important nd-HPFH is the Greek type (HBG1:g.-117G>A [6]), whose functional role is also demonst...",13,207,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
101C>T,"...1a). Also, 31 heterozygotes for the silent HBB:g.-101C>T β-thalassemia mutation have been included (...",19,264,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
109G>T,"...llenic type of nd-HPFH, bearing the novel HBG2:g.-109G>T promoter mutation (depicted in black) and t...",20,139,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
158C>T,...oter mutation (depicted in black) and the HBG2:g.-158C>T polymorphism (depicted in light gray) or th...,20,200,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
101C>T,...ism (depicted in light gray) or the silent HBB:g.-101C>T β-thalassemia nonsense mutation (depicted i...,20,266,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
109G>T,...g the compound heterozygous for the novel HBG2:g.-109G>T mutation and the silent HBB:g.-101C>T β-tha...,22,126,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
101C>T,...vel HBG2:g.-109G>T mutation and the silent HBB:g.-101C>T β-thalassemia mutation (I-3; see also Fig. ...,22,164,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
101C>T,"...Fig. 1a), and heterozygotes for the silent HBB:g.-101C>T β-thalassemia mutation (note the markedly i...",22,259,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
101C>T,Hematological indices	HBB:g.-101C>T,24,30,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
109G>T,HBG2:g.-109G>T (I-3)	Wild-type	Wild-type,25,9,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
109G>T,...the gene’s transcription initiation site (HBG2:g.-109G>T; Fig. 2b). DNA sequencing did not reveal an...,48,521,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
158C>T,...tween positions −672 and +25. Neither the HBG2:g.-158C>T (XmnI) nor the HBG1:g.-225-222(AGCA)del pol...,48,729,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
158C>T,"...positus mother (I-2) was a carrier of the HBG2:g.-158C>T (XmnI) polymorphism, while both sisters (II...",53,141,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
158C>T,...II-3) were compound heterozygotes for the HBG2:g.-158C>T polymorphism and the novel HBG2:g.-109G>T m...,53,245,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
109G>T,"...HBG2:g.-158C>T polymorphism and the novel HBG2:g.-109G>T mutation. Surprisingly, in the latter cases...",53,287,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
109G>T,...3) was also compound heterozygous for the HBG2:g.-109G>T promoter mutation and the silent HBB:g.-101...,53,628,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
101C>T,...g.-109G>T promoter mutation and the silent HBB:g.-101C>T β-thalassemia mutation. The HBG2:g.-109G>T ...,53,675,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
109G>T,...HBB:g.-101C>T β-thalassemia mutation. The HBG2:g.-109G>T base substitution was neither identified in...,53,718,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
101C>T,"...halassemic chromosomes, bearing the silent HBB:g.-101C>T mutation nor in 209 normal (nonthalassemic)...",53,825,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
109G>T,"...c) chromosomes, suggesting that the novel HBG2:g.-109G>T variation is not a frequent polymorphism. M...",53,923,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
109G>T,"... the functional significance of the novel HBG2:g.-109G>T mutation, we measured Gγ-globin chain level...",55,69,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
101C>T,"...lassemic) individuals and carriers for the HBB:g.-101C>T mutation (79.2/20.8 versus 40/60, respectiv...",55,306,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
109G>T,"...pectively, in order to assess whether the HBG2:g.-109G>T mutation affects protein binding in vitro. ...",55,569,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
109G>T,... at position HBG2:g.-109 (G) and that the HBG2:g.-109G>T transversion inhibits protein binding in vi...,55,1630,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
109G>T,"...riments [18], these data suggest that the HBG2:g.-109G>T mutation is responsible for the resulting n...",55,1777,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
117G>A,"..., the dominant nd-HPFH is the Greek type (HBG1:g.-117G>A [6]), accounting for almost 90% of the HPFH...",61,213,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
158C>T,"...HPFH chromosomes [9]. The Cretan nd-HPFH (HBG1:g.-158C>T [9]) is the second most frequent type, foll...",61,309,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
201C>T,"...econd most frequent type, followed by the HBG1:g.-201C>T and the HBG2:g.-196C>T mutations [19]. No d...",61,379,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
196C>T,"...e, followed by the HBG1:g.-201C>T and the HBG2:g.-196C>T mutations [19]. No deletional HPFH has even...",61,402,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
109G>T,The HBG2:g.-109G>T mutation was found both in heterozygosity a...,63,13,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
158C>T,...ll as in compound heterozygosity with the HBG2:g.-158C>T (XmnI) polymorphism and the silent HBB:g.-1...,63,117,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
101C>T,"...-158C>T (XmnI) polymorphism and the silent HBB:g.-101C>T β-thalassemia mutation, the latter being on...",63,166,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
109G>T,"...ase. First of all, heterozygosity for the HBG2:g.-109G>T mutation resulted in moderately increased H...",63,428,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
101C>T,"...o, compound heterozygosity with the silent HBB:g.-101C>T β-thalassemia mutation resulted in substant...",63,568,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
109G>T,"...contrary, compound heterozygosity for the HBG2:g.-109G>T mutation and the HBG2:g.-158C>T polymorphis...",63,958,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
158C>T,...y for the HBG2:g.-109G>T mutation and the HBG2:g.-158C>T polymorphism has no effect in the observed ...,63,990,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
158C>T,...xplanations for this observation: (a) the HBG2:g.-158C>T polymorphism itself exerts a silencing effe...,63,1137,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
109G>T,...m itself exerts a silencing effect on the HBG2:g.-109G>T mutation or (b) another yet unidentified ci...,63,1205,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
109G>T,The HBG2:g.-109G>T mutation resides at the 3′ end of the dista...,65,13,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
109G>T,"...point for NF-E3 [24], suggesting that the HBG2:g.-109G>T transversion activates Hb F production most...",65,476,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
109G>T,...ur EMSA analysis data indicating that the HBG2:g.-109G>T transversion results in abolishing protein ...,65,652,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
109G>T,"...1a), these data strongly suggest that the HBG2:g.-109G>T mutation is responsible for the resulting H...",65,880,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
109G>T,"...ubstantial effect in Hb F production, the HBG2:g.-109G>T nd-HPFH mutation per se results in only mod...",67,565,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
110A>C,"... HbF levels. In addition, the neighboring HBG2:g.-110A>C mutation, leading to the Czech nd-HPFH, als...",67,682,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
117G>A,"...uction [25]. This is unexpected since the HBG1:g.-117G>A nd-HPFH mutation, residing at the 5′ end of...",67,819,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
117G>A,"... reactivation in the adult stage, (b) the HBG1:g.-117G>A and HBG2:g.-109G>T reside on different gene...",67,1205,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
109G>T,"...e adult stage, (b) the HBG1:g.-117G>A and HBG2:g.-109G>T reside on different genes, hence their rela...",67,1224,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
588 A>G,...NA polymorphism of the Agamma globin gene (Agamma-588 A>G) is linked with the XmnI polymorphism (Gga...,84,111,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
158 C>T,...A>G) is linked with the XmnI polymorphism (Ggamma-158 C>T) Hemoglobin 1995 19 419 423 10.3109/036302...,84,165,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
588 A>G,...NA polymorphism of the Agamma globin gene (Agamma-588 A>G) is linked with the XmnI polymorphism (Gga...,84,342,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
158 C>T,"...A>G) is linked with the XmnI polymorphism (Ggamma-158 C>T). Hemoglobin 19:419–423, doi:10.3109/03630...",84,396,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
158 C>T,...ereditary persistence of fetal hemoglobin [Agamma-158 C>T] results from two independent gene convers...,85,160,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
158 C>T,...ereditary persistence of fetal hemoglobin [Agamma-158 C>T] results from two independent gene convers...,85,436,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
196 C->T,"...itis G Loutradi-Anagnostou A Karababa P  (G)gamma-196 C->T, (A)gamma-201 C->T: two novel mutations i...",95,97,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
201 C->T,"...gnostou A Karababa P  (G)gamma-196 C->T, (A)gamma-201 C->T: two novel mutations in the promoter regi...",95,116,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
196 C->T,"...Loutradi-Anagnostou A, Karababa P (2008) (G)gamma-196 C->T, (A)gamma-201 C->T: two novel mutations i...",95,444,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
201 C->T,"... A, Karababa P (2008) (G)gamma-196 C->T, (A)gamma-201 C->T: two novel mutations in the promoter regi...",95,463,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
158 C>T,...Sabine confirms the functional role of the Agamma-158 C>T mutation in gamma-globin gene transcriptio...,99,298,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
158 C>T,...Sabine confirms the functional role of the Agamma-158 C>T mutation in gamma-globin gene transcriptio...,99,720,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
835 T > A,"...both of them. We described a novel homozygous, c. 835 T > A (p.Y279N) mutation in exon 6 in two pati...",3,1578,Ann_Indian_Acad_Neurol_2013_Jul-Sep_16(3)_425-427.txt
835 T > A,...ALDH gene revealed a homozygous novel mutation c. 835 T > A (p.Y279N) in exon 6,37,118,Ann_Indian_Acad_Neurol_2013_Jul-Sep_16(3)_425-427.txt
380 G > C,"...nd brain white matter disease. They identified c. 380 G > C mutation in exon 8 in two patients, and ...",48,583,Ann_Indian_Acad_Neurol_2013_Jul-Sep_16(3)_425-427.txt
228 G > A,"... G > C mutation in exon 8 in two patients, and c. 228 G > A mutation in exon 5 in one patient. We de...",48,636,Ann_Indian_Acad_Neurol_2013_Jul-Sep_16(3)_425-427.txt
835 T > A,... in one patient. We detected a novel mutation (c. 835 T > A) in exon 6 in our patient,48,714,Ann_Indian_Acad_Neurol_2013_Jul-Sep_16(3)_425-427.txt
3691C > T,"...genetic testing finally revealed a heterozygous c.3691C > T variant in the NOTCH3 gene, confirming t...",8,1409,Ann_Indian_Acad_Neurol_2016_Apr-Jun_19(2)_272-274.txt
1312C>T,"...gene was performed and the pathogenic mutation, c.1312C>T (p.Arg438Cys), was identified. Interesting...",3,1963,Ann_Lab_Med_2013_Mar_21_33(2)_150-152.txt
1312C>T,...nalysis of GDF5 revealed a missense mutation at c.1312C>T that resulted in a change in the protein l...,17,489,Ann_Lab_Med_2013_Mar_21_33(2)_150-152.txt
1312C>T,...is of the GDF5 gene. A heterozygous mutation of c.1312C>T in exon 2 is noted,30,73,Ann_Lab_Med_2013_Mar_21_33(2)_150-152.txt
763G>A,"...ice, and a missense mutation [ABL1 NM_005157.4: c.763G>A (p.Glu255Lys)] was newly detected in the se...",15,764,Ann_Lab_Med_2015_Jan_8_35(1)_159-161.txt
763G>A,...ABL1 gene was changed from G to A [NM_005157.4: c.763G>A (p.Glu255Lys)],25,493,Ann_Lab_Med_2015_Jan_8_35(1)_159-161.txt
803G>C,"...is-AB01 allele arises from a single polymorphism, 803G>C, in exon 7 of the A102 allele [6, 7]. Howev...",7,860,Ann_Lab_Med_2015_Mar_12_35(2)_279-280.txt
1142C>T,"...ations in the cis-AB01, compared to A101 alleles (1142C>T in intron 4, 163T>C and 179C>T in intron 6...",9,486,Ann_Lab_Med_2015_Mar_12_35(2)_279-280.txt
163T>C,"...1, compared to A101 alleles (1142C>T in intron 4, 163T>C and 179C>T in intron 6, 467C>T and 803G>C i...",9,507,Ann_Lab_Med_2015_Mar_12_35(2)_279-280.txt
179C>T,"... to A101 alleles (1142C>T in intron 4, 163T>C and 179C>T in intron 6, 467C>T and 803G>C in exon 7). ...",9,518,Ann_Lab_Med_2015_Mar_12_35(2)_279-280.txt
467C>T,"...42C>T in intron 4, 163T>C and 179C>T in intron 6, 467C>T and 803G>C in exon 7). We found only one nu...",9,538,Ann_Lab_Med_2015_Mar_12_35(2)_279-280.txt
803G>C,"...tron 4, 163T>C and 179C>T in intron 6, 467C>T and 803G>C in exon 7). We found only one nucleotide di...",9,549,Ann_Lab_Med_2015_Mar_12_35(2)_279-280.txt
803G>C,"... between the cis-AB01 allele and the A105 allele, 803G>C, in contrast to the three nucleotides that ...",9,657,Ann_Lab_Med_2015_Mar_12_35(2)_279-280.txt
803G>C,...le might have acquired a single point mutation at 803G>C in exon 7 and got converted to the cis-AB01...,9,978,Ann_Lab_Med_2015_Mar_12_35(2)_279-280.txt
1142C>T,"...mutations compared to the A101 allele as follows: 1142C>T in intron 4, 163T>C and 179C>T in intron 6...",15,182,Ann_Lab_Med_2015_Mar_12_35(2)_279-280.txt
163T>C,"... the A101 allele as follows: 1142C>T in intron 4, 163T>C and 179C>T in intron 6, 467C>T and 803G>C i...",15,203,Ann_Lab_Med_2015_Mar_12_35(2)_279-280.txt
179C>T,"...llele as follows: 1142C>T in intron 4, 163T>C and 179C>T in intron 6, 467C>T and 803G>C in exon 7. T...",15,214,Ann_Lab_Med_2015_Mar_12_35(2)_279-280.txt
467C>T,"...42C>T in intron 4, 163T>C and 179C>T in intron 6, 467C>T and 803G>C in exon 7. The cis-AB01 allele h...",15,234,Ann_Lab_Med_2015_Mar_12_35(2)_279-280.txt
803G>C,"...tron 4, 163T>C and 179C>T in intron 6, 467C>T and 803G>C in exon 7. The cis-AB01 allele has the only...",15,245,Ann_Lab_Med_2015_Mar_12_35(2)_279-280.txt
803G>C,... allele has the only one nucleotide difference of 803G>C compared with the A105 allele,15,325,Ann_Lab_Med_2015_Mar_12_35(2)_279-280.txt
796C>A,...HY    A novel cis-AB allele derived from a unique 796C>A mutation in exon 7 of ABO gene Transfusion ...,27,101,Ann_Lab_Med_2015_Mar_12_35(2)_279-280.txt
1178G>A,"... optic neuropathy (LHON)9 pathogenic mutations: m.1178G>A (n = 43, minimum prevalence = 2.0 × 10−5, ...",94,723,Ann_Neurol_2015_May_28_77(5)_753-759.txt
3460G>A,"...valence = 2.0 × 10−5, 95% CI = 1.5–2.7 × 10−5), m.3460G>A (n = 29, minimum prevalence = 1.4 × 10−5, ...",94,801,Ann_Neurol_2015_May_28_77(5)_753-759.txt
14484T>C,"...nce = 1.4 × 10−5, 95% CI = 0.9–2.0 × 10−5), and m.14484T>C (n = 6, minimum prevalence = 0.3 × 10−5, ...",94,883,Ann_Neurol_2015_May_28_77(5)_753-759.txt
3243A>G,"...hogenic mtDNA point mutation identified was the m.3243A>G mutation (n = 74, minimum prevalence = 3.5...",94,1029,Ann_Neurol_2015_May_28_77(5)_753-759.txt
8344A>G,"...0.1–0.5 × 10−5) were clinically affected by the m.8344A>G mutation, manifesting as myoclonic epileps...",94,1380,Ann_Neurol_2015_May_28_77(5)_753-759.txt
14709T>C,"...s harbored 1 of 10 other mtDNA point mutations: m.14709T>C (n = 3), m.5816A>G (n = 3), m.5650A>G (n ...",94,1544,Ann_Neurol_2015_May_28_77(5)_753-759.txt
5816A>G,"...ther mtDNA point mutations: m.14709T>C (n = 3), m.5816A>G (n = 3), m.5650A>G (n = 2), m.8993T>C (n =...",94,1564,Ann_Neurol_2015_May_28_77(5)_753-759.txt
5650A>G,"...tations: m.14709T>C (n = 3), m.5816A>G (n = 3), m.5650A>G (n = 2), m.8993T>C (n = 2), m.1624C>T (n =...",94,1583,Ann_Neurol_2015_May_28_77(5)_753-759.txt
8993T>C,"... (n = 3), m.5816A>G (n = 3), m.5650A>G (n = 2), m.8993T>C (n = 2), m.1624C>T (n = 1), m.12258G>A (n ...",94,1602,Ann_Neurol_2015_May_28_77(5)_753-759.txt
1624C>T,"... (n = 3), m.5650A>G (n = 2), m.8993T>C (n = 2), m.1624C>T (n = 1), m.12258G>A (n = 1), m.8993T>G (n ...",94,1621,Ann_Neurol_2015_May_28_77(5)_753-759.txt
12258G>A,"... (n = 2), m.8993T>C (n = 2), m.1624C>T (n = 1), m.12258G>A (n = 1), m.8993T>G (n = 1), m.12283G>A (n...",94,1640,Ann_Neurol_2015_May_28_77(5)_753-759.txt
8993T>G,"...(n = 2), m.1624C>T (n = 1), m.12258G>A (n = 1), m.8993T>G (n = 1), m.12283G>A (n = 1), m.12320A>G (n...",94,1660,Ann_Neurol_2015_May_28_77(5)_753-759.txt
12283G>A,"...(n = 1), m.12258G>A (n = 1), m.8993T>G (n = 1), m.12283G>A (n = 1), m.12320A>G (n = 1), and m.10010T...",94,1679,Ann_Neurol_2015_May_28_77(5)_753-759.txt
12320A>G,"...(n = 1), m.8993T>G (n = 1), m.12283G>A (n = 1), m.12320A>G (n = 1), and m.10010T>C (n = 1)",94,1699,Ann_Neurol_2015_May_28_77(5)_753-759.txt
10010T>C,"...1), m.12283G>A (n = 1), m.12320A>G (n = 1), and m.10010T>C (n = 1)",94,1723,Ann_Neurol_2015_May_28_77(5)_753-759.txt
3460G>A,"m.3460G>A, MT‐ND",103,3,Ann_Neurol_2015_May_28_77(5)_753-759.txt
11778G>A,"m.11778G>A, MT‐ND",107,3,Ann_Neurol_2015_May_28_77(5)_753-759.txt
14484T>C,"m.14484T>C, MT‐ND",111,3,Ann_Neurol_2015_May_28_77(5)_753-759.txt
1624 C>T,"m.1624 C>T, MT‐T",119,3,Ann_Neurol_2015_May_28_77(5)_753-759.txt
3243A>G,"m.3243A>G, MT‐TL",122,3,Ann_Neurol_2015_May_28_77(5)_753-759.txt
5650A>G,"m.5650A>G, MT‐T",126,3,Ann_Neurol_2015_May_28_77(5)_753-759.txt
5816A>G,"m.5816A>G, MT‐T",130,3,Ann_Neurol_2015_May_28_77(5)_753-759.txt
8344A>G,"m.8344A>G, MT‐T",133,3,Ann_Neurol_2015_May_28_77(5)_753-759.txt
10010T>C,"m.10010T>C, MT‐T",137,3,Ann_Neurol_2015_May_28_77(5)_753-759.txt
12258G>A,"m.12258G>A, MT‐TS",140,3,Ann_Neurol_2015_May_28_77(5)_753-759.txt
12283G>A,"m.12283G>A, MT‐TL",144,3,Ann_Neurol_2015_May_28_77(5)_753-759.txt
12320A>G,"m.12320A>G, MT‐TL",147,3,Ann_Neurol_2015_May_28_77(5)_753-759.txt
14709 T>C,"m.14709 T>C, MT‐T",151,3,Ann_Neurol_2015_May_28_77(5)_753-759.txt
8993T>C,"m.8993T>C, MT‐ATP",159,3,Ann_Neurol_2015_May_28_77(5)_753-759.txt
8993T>G,"m.8993T>G, MT‐ATP",162,3,Ann_Neurol_2015_May_28_77(5)_753-759.txt
3243A>G,...national figures in the intervening decade. The m.3243A>G mutation remains the most prevalent pathog...,223,509,Ann_Neurol_2015_May_28_77(5)_753-759.txt
11778G>A,"... per 100,000, with familial clustering evident, m.11778G>A: 12 pedigrees, m.3460G>A: 5 pedigrees, m....",223,1022,Ann_Neurol_2015_May_28_77(5)_753-759.txt
3460G>A,"...l clustering evident, m.11778G>A: 12 pedigrees, m.3460G>A: 5 pedigrees, m.14484T>C: single pedigree;...",223,1048,Ann_Neurol_2015_May_28_77(5)_753-759.txt
14484T>C,"...11778G>A: 12 pedigrees, m.3460G>A: 5 pedigrees, m.14484T>C: single pedigree; see Table 1). MERRF rel...",223,1072,Ann_Neurol_2015_May_28_77(5)_753-759.txt
8344A>G,...le pedigree; see Table 1). MERRF related to the m.8344A>G mutation remains a rare form of mitochondr...,223,1136,Ann_Neurol_2015_May_28_77(5)_753-759.txt
14709T>C,"...00) in this region, similar in frequency to the m.14709T>C15, 16 mutation (0.8/100,000). Thirty‐one ...",223,1258,Ann_Neurol_2015_May_28_77(5)_753-759.txt
13094T>C,"...iduals. These included 2 mtDNA point mutations, m.13094T>C and m.4300A>G, in whom the index cases we...",223,1830,Ann_Neurol_2015_May_28_77(5)_753-759.txt
4300A>G,"...ncluded 2 mtDNA point mutations, m.13094T>C and m.4300A>G, in whom the index cases were deceased at ...",223,1845,Ann_Neurol_2015_May_28_77(5)_753-759.txt
3243A>G,"...ur patient cohort, the point prevalence for the m.3243A>G mutation remains significantly lower than ...",229,427,Ann_Neurol_2015_May_28_77(5)_753-759.txt
3243A>G,...s the best predictor of clinical outcome in the m.3243A>G mtDNA mutation . Neurology,311,80,Ann_Neurol_2015_May_28_77(5)_753-759.txt
838C>A,...cleotide polymorphism in the human p27kip1 gene (-838C>A) affects basal promoter activity and the ri...,3,170,BMC_Biol_2004_Apr_2_2_5.txt
326T>G,"...leotide polymorphisms in the human p27kip1 gene (+326T>G [V109G], -79C>T, and -838C>A). The frequenc...",7,97,BMC_Biol_2004_Apr_2_2_5.txt
79C>T,"...isms in the human p27kip1 gene (+326T>G [V109G], -79C>T, and -838C>A). The frequency of -838A carrie...",7,114,BMC_Biol_2004_Apr_2_2_5.txt
838C>A,"...human p27kip1 gene (+326T>G [V109G], -79C>T, and -838C>A). The frequency of -838A carriers was signi...",7,126,BMC_Biol_2004_Apr_2_2_5.txt
326T>G,"...ymorphisms (SNPs) within the human p27kip1 gene: +326T>G (V109G), -79C>T, and -838C>A (nucleotide po...",21,486,BMC_Biol_2004_Apr_2_2_5.txt
79C>T,"... within the human p27kip1 gene: +326T>G (V109G), -79C>T, and -838C>A (nucleotide positions numbered ...",21,503,BMC_Biol_2004_Apr_2_2_5.txt
838C>A,"...human p27kip1 gene: +326T>G (V109G), -79C>T, and -838C>A (nucleotide positions numbered relative to ...",21,515,BMC_Biol_2004_Apr_2_2_5.txt
326T>G,...according to Genbank accession number AB003688). +326T>G (V109G) and -79C>T have been previously des...,21,642,BMC_Biol_2004_Apr_2_2_5.txt
79C>T,... accession number AB003688). +326T>G (V109G) and -79C>T have been previously described (rs2066827 an...,21,662,BMC_Biol_2004_Apr_2_2_5.txt
838C>A,"...ribed (rs2066827 and rs34330, respectively), and -838C>A is a novel polymorphism. +326T>G (V109G) is...",21,743,BMC_Biol_2004_Apr_2_2_5.txt
326T>G,"...pectively), and -838C>A is a novel polymorphism. +326T>G (V109G) is a missense polymorphism in exon ...",21,776,BMC_Biol_2004_Apr_2_2_5.txt
79C>T,...tion that promotes p27kip1 proteolysis [16]. The -79C>T is a polymorphism within a U-rich element in...,21,1105,BMC_Biol_2004_Apr_2_2_5.txt
79C>T,...tients and 250 controls. The frequencies for the -79C>T and +326T>G (V109G) polymorphisms did not di...,23,341,BMC_Biol_2004_Apr_2_2_5.txt
326T>G,...250 controls. The frequencies for the -79C>T and +326T>G (V109G) polymorphisms did not differ betwee...,23,352,BMC_Biol_2004_Apr_2_2_5.txt
838C>A,"...s did not differ between the two groups. For the -838C>A polymorphism, the A allele was significantl...",23,429,BMC_Biol_2004_Apr_2_2_5.txt
838C>A,Functional effect of the -838C>A polymorphism in the promoter region of the ...,25,27,BMC_Biol_2004_Apr_2_2_5.txt
838C>A,"...ated with MI, we sought to determine whether the -838C>A genetic variation has functional consequenc...",26,122,BMC_Biol_2004_Apr_2_2_5.txt
838C>A,"...of MI. Among the three SNPs described here, only -838C>A showed differences in allele frequency betw...",31,902,BMC_Biol_2004_Apr_2_2_5.txt
838C>A,"Because -838C>A lies within the promoter region of p27kip1,...",33,10,BMC_Biol_2004_Apr_2_2_5.txt
838C>A,...analysis of the promoter sequence containing the -838C>A SNP using the MatInspector v2.2 and TRANSFA...,33,603,BMC_Biol_2004_Apr_2_2_5.txt
838C>A,"Three polymorphisms of the human p27kip1 gene (-838C>A, -79C>T, and V109G) were analysed as candid...",38,49,BMC_Biol_2004_Apr_2_2_5.txt
79C>T,"...olymorphisms of the human p27kip1 gene (-838C>A, -79C>T, and V109G) were analysed as candidates to m...",38,58,BMC_Biol_2004_Apr_2_2_5.txt
838C>A,...ure 1 Single-strand conformation analysis of the -838C>A polymorphism within the human p27kip1 gene....,67,54,BMC_Biol_2004_Apr_2_2_5.txt
838C>A,-838C>A	F: TCCAGGTCCCGGCTTCCCGGt**,93,2,BMC_Biol_2004_Apr_2_2_5.txt
79C>T,-79C>T	F: TGATCAGCGGAGACTCGGCG,95,2,BMC_Biol_2004_Apr_2_2_5.txt
326T>G,+326T>G (V109G)	F: TGCGAGTGTCTAACGGGAGC,97,2,BMC_Biol_2004_Apr_2_2_5.txt
838C>A,"Table 3 Genotype frequencies for the -838C>A, -79C>T, and V109G p27kip1 single-nucleotid...",101,39,BMC_Biol_2004_Apr_2_2_5.txt
79C>T,"Table 3 Genotype frequencies for the -838C>A, -79C>T, and V109G p27kip1 single-nucleotide polymor...",101,48,BMC_Biol_2004_Apr_2_2_5.txt
838C>A,-838C>A*,103,3,BMC_Biol_2004_Apr_2_2_5.txt
79C>T,-79C>T,108,3,BMC_Biol_2004_Apr_2_2_5.txt
139C > G,...D    A functional mutation in the LDLR promoter (−139C > G) in a patient with familial hypercholeste...,286,78,Appl_Clin_Genet_2010_Aug_5_3_53-64.txt
49C > T,... Ros E  Pocoví M  Rodríguez-Rey JC   A mutation (−49C > T) in the promoter of the low density lipopr...,290,84,Appl_Clin_Genet_2010_Aug_5_3_53-64.txt
216G>A,"...a in the inner ear cohere together.21,22 The USH1C216G>A mutation, found in all Louisiana Acadian ca...",18,628,Appl_Clin_Genet_2014_Dec_4_7_245-252.txt
216G>A,...st 6 months when given to an animal model of USH1C216G>A.2,18,1236,Appl_Clin_Genet_2014_Dec_4_7_245-252.txt
3766C>T,"...rozygous mutations, c.1153dupG (p.Val385fs) and c.3766C>T (p.Arg1256X), in EIF2AK4. Unaffected paren...",18,396,Appl_Clin_Genet_2015_Aug_7_8_181-188.txt
3766C>T,"..., and the father carried the nonsense mutation, c.3766C>T).13 Ten additional sporadic PCH case patie...",18,609,Appl_Clin_Genet_2015_Aug_7_8_181-188.txt
1G>A,"...ad a compound heterozygous splice mutation (c.860-1G>A) and a nonsense mutation, c.3438C>T (p.Arg115...",18,871,Appl_Clin_Genet_2015_Aug_7_8_181-188.txt
3438C>T,"... mutation (c.860-1G>A) and a nonsense mutation, c.3438C>T (p.Arg1150X). No mutations were identified...",18,904,Appl_Clin_Genet_2015_Aug_7_8_181-188.txt
17699678 C>T,...-nucleotide polymorphism (SNP) of NLRP2: F359L (rs17699678 C>T) and NLRP3: Q705K (rs35829419 C>A) in...,10,1298,Arch_Immunol_Ther_Exp_(Warsz)_2015_Aug_8_63(6)_485-494.txt
35829419 C>A,...NLRP2: F359L (rs17699678 C>T) and NLRP3: Q705K (rs35829419 C>A) in patients with pancreatic cancer a...,10,1332,Arch_Immunol_Ther_Exp_(Warsz)_2015_Aug_8_63(6)_485-494.txt
17699678 C>T,...otyping in order to detect SNP of NLRP2 (F359L) rs17699678 C>T and NLRP3 (Q705K) rs35829419 C>A. The...,47,262,Arch_Immunol_Ther_Exp_(Warsz)_2015_Aug_8_63(6)_485-494.txt
35829419 C>A,... NLRP2 (F359L) rs17699678 C>T and NLRP3 (Q705K) rs35829419 C>A. The genotyping reactions were perfor...,47,295,Arch_Immunol_Ther_Exp_(Warsz)_2015_Aug_8_63(6)_485-494.txt
17699678 C>T,...the distribution of two polymorphisms of NLRP2 (rs17699678 C>T) and NLRP3 (rs35829419 C>A) genes in ...,53,79,Arch_Immunol_Ther_Exp_(Warsz)_2015_Aug_8_63(6)_485-494.txt
35829419 C>A,...ymorphisms of NLRP2 (rs17699678 C>T) and NLRP3 (rs35829419 C>A) genes in Polish subjects with pancre...,53,106,Arch_Immunol_Ther_Exp_(Warsz)_2015_Aug_8_63(6)_485-494.txt
17699678 C>T,Table 2 Association analysis of rs17699678 C>T polymorphism in NLRP2 with periodonti...,70,35,Arch_Immunol_Ther_Exp_(Warsz)_2015_Aug_8_63(6)_485-494.txt
1769967 C>T,Table 3 Association analysis of rs1769967 C>T polymorphism in NLRP2 with pancreatic ...,90,35,Arch_Immunol_Ther_Exp_(Warsz)_2015_Aug_8_63(6)_485-494.txt
35829419 C>A,"...ee Tables 4, 5).Table 4 Association analysis of rs35829419 C>A Q705K polymorphism in NLRP3 with peri...",123,516,Arch_Immunol_Ther_Exp_(Warsz)_2015_Aug_8_63(6)_485-494.txt
35829419 C>A,Table 5 Association analysis of rs35829419 C>A polymorphism in NLRP3 with pancreatic...,143,35,Arch_Immunol_Ther_Exp_(Warsz)_2015_Aug_8_63(6)_485-494.txt
35829419 C>A,... distinct correlation between periodontitis and rs35829419 C>A in NLRP3 polymorphism. Despite the fa...,192,271,Arch_Immunol_Ther_Exp_(Warsz)_2015_Aug_8_63(6)_485-494.txt
35829419 C>A,...trated a clear and distinct correlation between rs35829419 C>A in NLRP3 and rs17699678 C>T in NLRP2 ...,202,250,Arch_Immunol_Ther_Exp_(Warsz)_2015_Aug_8_63(6)_485-494.txt
17699678 C>T,...correlation between rs35829419 C>A in NLRP3 and rs17699678 C>T in NLRP2 polymorphism and periodontit...,202,278,Arch_Immunol_Ther_Exp_(Warsz)_2015_Aug_8_63(6)_485-494.txt
575A > G,... a glutamine-to-arginine substitution at position 575A > G (PON1 Q192R) and a leucine to-methionine ...,24,127,Arch_Med_Sci_2015_Jun_19_11(3)_513-520.txt
163T > A,... a leucine to-methionine substitution at position 163T > A (PON1 L55M). Both independently influence...,24,202,Arch_Med_Sci_2015_Jun_19_11(3)_513-520.txt
521T > C,"...linkage disequilibrium with a non-synonymous SNP, 521T > C (rs4149056). The 521T/C transition (SLCO1...",49,758,Arch_Med_Sci_2016_Jun_1_12(3)_645-658.txt
421C > A,...en PJ  Niemi M   Different effects of the ABCG2 c.421C > A SNP on the pharmacokinetics of fluvastati...,221,87,Arch_Med_Sci_2016_Jun_1_12(3)_645-658.txt
169T>Cpo,... E Førre O Kvien TK Undlien DE Lie BA  The FCRL3 -169T>Cpolymorphism is associated with rheumatoid a...,144,174,Arthritis_Res_Ther_2008_Mar_31_10(2)_205.txt
421C>A,"...C19*2 (rs4244285), CYP2C19*17 (rs12248560), ABCG2 421C>A (rs2231142), CYP1A2*1F (rs762551) and DHODH...",7,666,Arthritis_Res_Ther_2012_Jul_12_14(4)_R163.txt
19C>A,"...21C>A (rs2231142), CYP1A2*1F (rs762551) and DHODH 19C>A (rs3213422). The effects of variables on ces...",7,717,Arthritis_Res_Ther_2012_Jul_12_14(4)_R163.txt
681G>A,"...ect on leflunomide metabolism (CYP2C19*2 (CYP2C19 681G>A, rs4244285) and CYP2C19*17 (CYP2C19, 608C>T...",20,528,Arthritis_Res_Ther_2012_Jul_12_14(4)_R163.txt
608C>T,"...P2C19 681G>A, rs4244285) and CYP2C19*17 (CYP2C19, 608C>T, rs12248560) [2,3]) or biliary secretion of...",20,572,Arthritis_Res_Ther_2012_Jul_12_14(4)_R163.txt
421C>A,"...,3]) or biliary secretion of teriflunomide (ABCG2 421C>A, rs2231142) [4,5]). Polymorphisms that had ...",20,644,Arthritis_Res_Ther_2012_Jul_12_14(4)_R163.txt
163C>A,"...inked to leflunomide toxicity (CYP1A2*1F, (CYP1A2 163C>A, rs762551) and DHODH (DHODH 19C>A, rs321342...",20,750,Arthritis_Res_Ther_2012_Jul_12_14(4)_R163.txt
19C>A,"...A2*1F, (CYP1A2 163C>A, rs762551) and DHODH (DHODH 19C>A, rs3213422) [3,6,7]) were also studied. DHOD...",20,785,Arthritis_Res_Ther_2012_Jul_12_14(4)_R163.txt
421C>A,"...C19*2 (rs4244285), CYP2C19*17 (rs12248560), ABCG2 421C>A (rs2231142), CYP1A2*1F (rs762551) and DHODH...",43,208,Arthritis_Res_Ther_2012_Jul_12_14(4)_R163.txt
19C>A,"...21C>A (rs2231142), CYP1A2*1F (rs762551) and DHODH 19C>A (rs3213422). Assays were carried out accordi...",43,259,Arthritis_Res_Ther_2012_Jul_12_14(4)_R163.txt
421C>A,...ted that while 0 of 14 who had the AC genotype at 421C>A ABCG2 ceased leflunomide as a result of dia...,121,791,Arthritis_Res_Ther_2012_Jul_12_14(4)_R163.txt
421C>A,ABCG2 421C>A (rs2231142)	AC	6/14 (42.9%)	1.297 (0.527 to...,132,7,Arthritis_Res_Ther_2012_Jul_12_14(4)_R163.txt
19C>A,DHODH 19C>A (rs3213422)	AA	9/20 (45%)	1.002 (0.610 to 1....,140,7,Arthritis_Res_Ther_2012_Jul_12_14(4)_R163.txt
280A>G,"...influencing beef flavor and four types of SNPs (c.280A>G, c.388G>A, c.408G>C and c.456A>G) located a...",8,552,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
388G>A,"...g beef flavor and four types of SNPs (c.280A>G, c.388G>A, c.408G>C and c.456A>G) located at exon 2, ...",8,562,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
408G>C,"...vor and four types of SNPs (c.280A>G, c.388G>A, c.408G>C and c.456A>G) located at exon 2, 3 and 4 of...",8,572,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
456A>G,"...types of SNPs (c.280A>G, c.388G>A, c.408G>C and c.456A>G) located at exon 2, 3 and 4 of the FABP4 ge...",8,585,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
220 A>G,"..., 2006; Pannier et al., 2010). The variation of c.220 A>G (I74V) associated with palmitoleic acid in...",19,395,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
2774 G>C,"... et al., 2011). In addition, two SNPs in FABP4, g.2774 G>C (intron1) and g.3631 G>A (exon3) affect c...",19,659,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
3631 G>A,"...on, two SNPs in FABP4, g.2774 G>C (intron1) and g.3631 G>A (exon3) affect carcass weight and marblin...",19,684,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
220 A>G,...s of carcass weight and back fat thickness with c.220 A>G (I74V) and c.328 G>A (V110M) (p<0.05) (Cho...,19,861,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
328 G>A,"...nd back fat thickness with c.220 A>G (I74V) and c.328 G>A (V110M) (p<0.05) (Cho et al., 2007)",19,882,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
280A>G,"...kness, GG genotypes were the lowest at 11.91 in c.280A>G SNP (p<0.04), for marbling score, c.388G>A ...",45,578,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
388G>A,"...1 in c.280A>G SNP (p<0.04), for marbling score, c.388G>A SNPs were the highest at 5.66 in GG genotyp...",45,621,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
408G>C,"...has a high proportion of saturated fatty acids, c.408G>C SNP was the highest at 25.61, 25.79 in GG, ...",45,819,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
280A>G,...he highest at 45.08 and 54.43 in GG genotype of c.280A>G SNP (p<0.05) and 44.56 and 53.84 in GG geno...,47,187,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
388G>A,"... (p<0.05) and 44.56 and 53.84 in GG genotype of c.388G>A SNP (p<0.05). Also, they had higher content...",47,247,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
408G>C,"..., since their composition in the CC genotype of c.408G>C SNP, GG genotype of c.456A>G SNP were 45.71...",47,407,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
456A>G,"...the CC genotype of c.408G>C SNP, GG genotype of c.456A>G SNP were 45.71, 54.74 and 45.06, 54.40, res...",47,436,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
280A>G,"Haplotype block included c.280A>G in exon 2 and c.388G>A, c.408G>C in exon 3,...",51,28,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
388G>A,"Haplotype block included c.280A>G in exon 2 and c.388G>A, c.408G>C in exon 3, and c.456A>G in exon 4...",51,51,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
408G>C,"...block included c.280A>G in exon 2 and c.388G>A, c.408G>C in exon 3, and c.456A>G in exon 4. Haplotyp...",51,61,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
456A>G,"...in exon 2 and c.388G>A, c.408G>C in exon 3, and c.456A>G in exon 4. Haplotypic associations of block...",51,85,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
280A>G,"... and MUFA among the fatty acids. In particular, c.280A>G SNP had an association with back fat thickn...",54,261,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
388G>A,"...ciation with back fat thickness, and in case of c.388G>A SNP, with marbling score. Also, it has been...",54,333,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
220 A>G,"...marbling score. Also, it has been reported that c.220 A>G (I74V) SNP has an association with back fa...",54,400,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
3631 G>A,"...with back fat thickness (Cho et al., 2007), and g.3631 G>A (V110M) SNP has an association with marbl...",54,488,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
280A>G,"Among these four SNPs, c.280A>G and c.388G>A are non-synonymous SNPs that h...",58,26,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
388G>A,"Among these four SNPs, c.280A>G and c.388G>A are non-synonymous SNPs that have a change ...",58,39,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
280A>G,"... nucleotide changes. Especially, in the case of c.280A>G SNP, as ATC nucleotide into GTC, changes th...",58,179,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
388G>A,...e encoded amino acid from isoleucine to valine. c.388G>A SNP is also a non-synonymous SNP where vali...,58,279,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
408G>C,"...nucleotide changes into ATG. On the other hand, c.408G>C and c.456A>G are synonymous SNPs, which do ...",58,409,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
456A>G,"...anges into ATG. On the other hand, c.408G>C and c.456A>G are synonymous SNPs, which do not have chan...",58,422,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
408G>C,"... have nucleotide changes. These two novel SNPs (c.408G>C, c.456A>G) were not found to have an associ...",58,547,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
456A>G,"...eotide changes. These two novel SNPs (c.408G>C, c.456A>G) were not found to have an association with...",58,557,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
280A>G,"...mozygous genotypes with G, G, C and G allele at c.280A>G, c.388G>A, c.408G>C and c.456A>G had an inc...",62,73,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
388G>A,"...enotypes with G, G, C and G allele at c.280A>G, c.388G>A, c.408G>C and c.456A>G had an increased pro...",62,83,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
408G>C,"...ith G, G, C and G allele at c.280A>G, c.388G>A, c.408G>C and c.456A>G had an increased proportion of...",62,93,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
456A>G,"...nd G allele at c.280A>G, c.388G>A, c.408G>C and c.456A>G had an increased proportion of oleic acid, ...",62,106,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
280A>G,"...dingly, it is expected that haplotype blocks of c.280A>G c.388G>A, c.408G>C, and c.456A>G SNPs at ex...",66,56,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
388G>A,"...t is expected that haplotype blocks of c.280A>G c.388G>A, c.408G>C, and c.456A>G SNPs at exon 2, 3, ...",66,65,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
408G>C,"...ted that haplotype blocks of c.280A>G c.388G>A, c.408G>C, and c.456A>G SNPs at exon 2, 3, and 4 are ...",66,75,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
456A>G,"...type blocks of c.280A>G c.388G>A, c.408G>C, and c.456A>G SNPs at exon 2, 3, and 4 are able to increa...",66,89,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
181T>G,c.181T>G	2	F1	TTGACATTTTTCTTTTCCCAAC	200,99,3,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
193T>G,c.193T>G	2	F	TTGACATTTTTCTTTTCCCAAC	200,102,3,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
212C>A,c.212C>A	2	F	TATAGGCGTGGGCTTTGCTA	202,105,3,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
280A>G,c.280A>G	2	F	GGGGTGTGGTCACCATTAAA	178,108,3,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
352T>G,c.352T>G	3	F	CAAGGGCGATTGTCTATTTCTC	208,111,3,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
364T>C,c.364T>C	3	F	TTATGGGATGACCTAGCACTAAAA	201,114,3,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
388G>A,c.388G>A	3	F	ATTATCCCCACAGAGCATCG	219,117,3,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
408G>C,c.408G>C	3	F	CATCGTAAACTTAGATGAAGGTGCT	200,120,3,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
456A>G,c.456A>G	4	F	TTCCTGCTCAACATTGAAGG	190,123,3,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
181T>G,c.181T>G	2	L41V	T,135,3,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
193T>G,c.193T>G	2	L45V	T,139,3,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
212C>A,c.212C>A	2	T51N	C,143,3,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
280A>G,c.280A>G	2	I74V	A,147,3,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
352T>G,c.352T>G	3	W98G	T,151,3,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
364T>C,c.364T>C	3	S102P	T,155,3,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
388G>A,c.388G>A	3	V110M	G,159,3,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
408G>C,c.408G>C	3	L116L	G,163,3,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
456A>G,c.456A>G	4	A132A	A,167,3,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
280A>G,SNP	c.280A>G	c.388G>A	c.408G>C	c.456A>G,179,7,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
388G>A,SNP	c.280A>G	c.388G>A	c.408G>C	c.456A>G,179,16,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
408G>C,SNP	c.280A>G	c.388G>A	c.408G>C	c.456A>G,179,25,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
456A>G,SNP	c.280A>G	c.388G>A	c.408G>C	c.456A>G,179,34,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
280A>G,Block	c.280A>G	c.388G>A	c.408G>C	c.456A>G	Frequency,208,9,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
388G>A,Block	c.280A>G	c.388G>A	c.408G>C	c.456A>G	Frequency,208,18,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
408G>C,Block	c.280A>G	c.388G>A	c.408G>C	c.456A>G	Frequency,208,27,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
456A>G,Block	c.280A>G	c.388G>A	c.408G>C	c.456A>G	Frequency,208,36,Asian-Australas_J_Anim_Sci_2012_Jul_25(7)_913-920.txt
349T>C,...et al. (2011) reported that the polymorphism of c.349T>C in the CRBP II gene would be genetically ad...,47,1291,Asian-Australas_J_Anim_Sci_2014_Mar_27(3)_310-315.txt
99514A>G,"..., we detected two novel mutations (NC_010450.3:g. 99514A>G, 119846C>T) by DNA sequencing and polymer...",7,749,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
119846C>T,"...ted two novel mutations (NC_010450.3:g. 99514A>G, 119846C>T) by DNA sequencing and polymerase chain ...",7,759,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
99514A>G,...tions with teat number trait in these breeds. The 99514A>G mutation showed an extremely significant ...,7,1071,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
119846C>T,...ignificant relevance in Hanjiang (p = 0.017); the 119846C>T mutation suggested significant associati...,7,1300,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
99514A>G,... those with “TT”. Our findings suggested that the 99514A>G and 119846C>T mutations of LEF-1 affected...,7,1638,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
119846C>T,...TT”. Our findings suggested that the 99514A>G and 119846C>T mutations of LEF-1 affected porcine teat...,7,1651,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
1351T>C,"In previous studies, a 1351T>C transition and 1666A>C transversion in the...",18,24,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
1666A>C,"In previous studies, a 1351T>C transition and 1666A>C transversion in the 3′ end of LEF-1 mRNA a...",18,47,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
99514A>G,... technique was used to detect the polymorphism of 99514A>G and 119846C>T loci in porcine LEF-1 gene....,36,63,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
119846C>T,...s used to detect the polymorphism of 99514A>G and 119846C>T loci in porcine LEF-1 gene. Aliquots of ...,36,76,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
99514A>G,"...amino acids. Two novel mutations (NC_010450.3: g. 99514A>G, 119846C>T) were firstly detected by DNA ...",52,223,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
119846C>T,"...s. Two novel mutations (NC_010450.3: g. 99514A>G, 119846C>T) were firstly detected by DNA pool seque...",52,233,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
99514A>G,"...9, P11, and P12) (Table 1) of the LEF-1 gene. The 99514A>G mutation resulted in a synonymous genetic...",52,456,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
119846C>T,... (Pro)>CCG (Pro) at position 166 aa of LEF-1. The 119846C>T locus was observed in intron 9 and had n...,52,588,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
99514A>G,"...h the Hardy-Weinberg equilibrium (p>0.05). In the 99514A>G mutation, low level PIC was observed in H...",55,379,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
119846C>T,"... in HJ and median level in GZ, LW, and BM; In the 119846C>T mutation, low level PIC was observed in ...",55,474,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
99514A>G,"The frequencies of widespread allele “A” in 99514A>G mutation ranged from 0.5536 to 0.9118, an...",58,45,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
119846C>T,"...mutation ranged from 0.5536 to 0.9118, and “T” in 119846C>T mutation ranged from 0.4833 to 08824 in ...",58,104,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
99514A>G,The 99514A>G mutation revealed an extremely significan...,63,5,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
119846C>T,The 119846C>T mutation suggested significant associati...,65,5,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
99514A>G,"To further observe the correlation between the 99514A>G and the 119846C>T mutation, the haplotype...",68,48,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
119846C>T,"...erve the correlation between the 99514A>G and the 119846C>T mutation, the haplotype frequencies were...",68,65,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
1351T>C,"...ghly investigated. In previous study, there was a 1351T>C (NM_001129967.1) transition and a 1666A>C ...",81,145,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
1666A>C,...e was a 1351T>C (NM_001129967.1) transition and a 1666A>C (NM_001129967.1) transversion found in the...,81,187,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
1351T>C,...ransversion found in the 3′ end of LEF1 mRNA. The 1351T>C locus had highly significant associations ...,81,263,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
1666A>C,"...teat trait and total teat number trait, while the 1666A>C mutation was significantly associated with...",81,377,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
99514A>G,"...el single nucleotide polymorphism (NC_010450.3:g. 99514A>G, 119846C>T) located in exon 4 (P4) and in...",81,644,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
119846C>T,"...nucleotide polymorphism (NC_010450.3:g. 99514A>G, 119846C>T) located in exon 4 (P4) and intron 9 (P9...",81,654,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
99514A>G,"..., through statistical analysis, we found that the 99514A>G mutation showed extremely significant rel...",81,775,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
119846C>T,"...(p = 0.017), but no significance in BM, while the 119846C>T mutation displayed significant associati...",81,980,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
99514A>G,"...ciated with higher teat numbers. In addition, the 99514A>G mutation itself demonstrated a synonymous...",81,1378,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
99514A>G,"According to analysis of PIC, the 99514A>G mutation within porcine LEF-1 gene displa...",83,35,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
119846C>T,"...PIC in HJ and median level in GZ, LW, and BM; the 119846C>T showed low PIC in HJ and LW and median l...",83,143,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
99514A>G,"... BM, and LW. The data strongly suggested that the 99514A>G mutation showed extremely significant sta...",85,676,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
119846C>T,"...and LW and significant relevance in HJ, while the 119846C>T mutation showed significant association ...",85,832,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
99514A>G,Table 2 Genetic indexes of the 99514A>G and 119846C>T mutation within porcine LEF...,140,32,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
119846C>T,Table 2 Genetic indexes of the 99514A>G and 119846C>T mutation within porcine LEF-1 gen,140,45,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
99514A>G,99514A>G	GZ	0.3787	0.6212	2.6406	0.3537,143,1,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
119846C>T,119846C>T	GZ	0.4308	0.5692	2.3213	0.3447,147,1,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
99514A>G,Table 3 Genotypic and allelic frequencies of 99514A>G and 119846C>T mutation within porcine LEF...,153,46,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
119846C>T,...Genotypic and allelic frequencies of 99514A>G and 119846C>T mutation within porcine LEF-1 gen,153,59,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
99514A>G,99514A>G	GZ	198	69(0.3485)	123(0.6212)	6(0.0303)	0...,160,1,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
119846C>T,119846C>T	GZ	198	78(0.3939)	111(0.5606)	9(0.0455)	...,172,1,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
99514A>G,99514A>G	AA	12.36±1.16	13.52±0.87	13.35±1.16	11.81...,185,1,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
119846C>T,119846C>T	TT	12.33±1.38	13.48±0.92	13.48±1.23	12.3...,189,1,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
12669G>A,"...inal ArticleRole of the APOB Gene Polymorphism (c.12669G>A, p. Gln4154Lys) in Coronary Artery Diseas...",3,225,Balkan_J_Med_Genet_2011_Dec_8_14(2)_35-40.txt
12669G>A,".... The association of the APOB gene polymorphism c.12669G>A, p.Gln4154Lys with the risk of CAD varies...",3,1289,Balkan_J_Med_Genet_2011_Dec_8_14(2)_35-40.txt
12669G>A,"...ion. We have studied the APOB gene polymorphism c.12669G>A, p.Gln4154Lys and its relationship with l...",3,1570,Balkan_J_Med_Genet_2011_Dec_8_14(2)_35-40.txt
12669G>A,"...le variation in linking APOB gene polymorphism (c.12669G>A,p.Gln4154Lys) with CAD risk in different ...",8,1386,Balkan_J_Med_Genet_2011_Dec_8_14(2)_35-40.txt
12669G>A,"... study, the role of the APOB gene polymorphism (c.12669G>A,p.Gln4154Lys) was studied in native India...",28,65,Balkan_J_Med_Genet_2011_Dec_8_14(2)_35-40.txt
2281 C>G,"...s at nucleotide position 2281 within codon 727 (c.2281 C>G), results in the substitution of glutamic...",8,1137,Balkan_J_Med_Genet_2012_Dec_2_15(2)_67-72.txt
002T>C,"g.15,002T>C	74,168,599	T4A	0.000	-",21,6,Behav_Brain_Funct_2011_Sep_7_7_39.txt
041G>A,"g.15,041G>A	74,168,560	V17M	0.000	-",23,6,Behav_Brain_Funct_2011_Sep_7_7_39.txt
108C>G,"g.15,108C>G (rs34604640)	74,168,493	P39R	0.000	-",25,6,Behav_Brain_Funct_2011_Sep_7_7_39.txt
131C>G,"g.15,131C>G (rs17215444)	74,168,470	R47G	0.000	-",27,6,Behav_Brain_Funct_2011_Sep_7_7_39.txt
150G>A,"g.15,150G>A	74,168,451	R53H	0.000	-",29,6,Behav_Brain_Funct_2011_Sep_7_7_39.txt
190T>C,"g.15,190T>C (rs2270676)	74,168,411	F66F	0.125	5/62 (0.7...",31,6,Behav_Brain_Funct_2011_Sep_7_7_39.txt
220C>T,"g.15,220C>T (rs17221826)	74,168,381	I76I	0.000	-",33,6,Behav_Brain_Funct_2011_Sep_7_7_39.txt
240G>A,"g.15,240G>A (rs17215437)	74,168,361	R83H	0.005	0/3 (0.9...",35,6,Behav_Brain_Funct_2011_Sep_7_7_39.txt
255G>A,"g.15,255G>A (rs17221833)	74,168,346	R88H	0.000	-",37,6,Behav_Brain_Funct_2011_Sep_7_7_39.txt
288G>A,"g.15,288G>A	74,168,313	R99H	0.000	-",39,6,Behav_Brain_Funct_2011_Sep_7_7_39.txt
321C>T,"g.15,321C>T (rs11822977)	74,168,280	-	0.000	-",41,6,Behav_Brain_Funct_2011_Sep_7_7_39.txt
190T>C,"... frequencies and measures of association for g.15,190T>C (rs2270676 encoding  F66F) and g.15,240G>A ...",44,75,Behav_Brain_Funct_2011_Sep_7_7_39.txt
240G>A,"...r g.15,190T>C (rs2270676 encoding  F66F) and g.15,240G>A (rs17215437 encoding R83H), based on data f...",44,118,Behav_Brain_Funct_2011_Sep_7_7_39.txt
190T>C,"Healthy controls (Nunrelated)	study	g.15,190T>C (F66F",46,42,Behav_Brain_Funct_2011_Sep_7_7_39.txt
190T>C,"frequency in controls	g.15,190T>C (F66F",47,28,Behav_Brain_Funct_2011_Sep_7_7_39.txt
240G>A,"controls vs. tinnitus patients	g.15,240G>",48,37,Behav_Brain_Funct_2011_Sep_7_7_39.txt
240G>A,"(R83H) frequency in controls	g.15,240G>",49,35,Behav_Brain_Funct_2011_Sep_7_7_39.txt
190T>C,"... information from 46 placental mammals. Both g.15,190T>C (rs2270676 encoding F66F) and g.15,240G>A (...",76,232,Behav_Brain_Funct_2011_Sep_7_7_39.txt
240G>A,"...th g.15,190T>C (rs2270676 encoding F66F) and g.15,240G>A (rs17215437 encoding R83H) map to a highly ...",76,274,Behav_Brain_Funct_2011_Sep_7_7_39.txt
3773364 A>G,...ittal B.   Association of intronic polymorphism rs3773364 A>G in synapsin-2 gene with idiopathic epi...,158,100,Behav_Brain_Res_2013_Aug_15_251_65-74.txt
47086497C>T,"...en identified in an unrelated clinical case [chrX:47086497C>T, Q00536-2 (isoform 2): p.Arg488Ter] (h...",91,889,Biochem_J_2015_Aug_1_469(Pt_3)_409-420.txt
2S > L,as follows: E2·E3BP > L1L2S ∼ L2S > L3S′,453,32,Biochemistry_2015_Jan_13_54(1)_69-82.txt
2S > L,were as follows: E2·E3BP ∼ L1L2S > L2S > L3S,475,31,Biochemistry_2015_Jan_13_54(1)_69-82.txt
2S > L,were as follows: E2·E3BP ∼ L1L2S > L2S > L3S,475,37,Biochemistry_2015_Jan_13_54(1)_69-82.txt
2S > L,> L2S > L1L2S ∼ L3S′ > L1 = 0. With ATP present,478,4,Biochemistry_2015_Jan_13_54(1)_69-82.txt
2S > L,were as follows: E2·E3BP > L1L2S > L2S > L1 > L3S,480,31,Biochemistry_2015_Jan_13_54(1)_69-82.txt
2S > L,were as follows: E2·E3BP > L1L2S > L2S > L1 > L3S,480,37,Biochemistry_2015_Jan_13_54(1)_69-82.txt
5G > A,... Functional splicing assay supporting that c.70 + 5G > A mutation in the MPV17 gene is disease causi...,269,147,Biol_Open_2013_Jun_3_2(7)_703-710.txt
308 G>A,"...posure. For example, SNPs in the TNF-α gene (eg, −308 G>A) affected the inflammatory response of eld...",77,298,Biologics_2011_Jan_19_5_7-19.txt
825C>T,...al A  Frossard PM   G-protein beta 3 subunit gene 825C>T dimorphism is associated with left ventricu...,240,78,Biomark_Insights_2016_May_17_11_69-75.txt
2830A > T,"MB	3.5	F	c.2830A > T	c.7964A > G	Hemispheric	-	[19, 30]",30,12,Biomark_Res_2015_Jun_6_3_13.txt
7964A > G,"MB	3.5	F	c.2830A > T	c.7964A > G	Hemispheric	-	[19, 30]",30,24,Biomark_Res_2015_Jun_6_3_13.txt
9435 T > A,PFT	4.9	M	c.5946delT	9435 T > A	Midline	Ashkenazi Jewish congenital ano...,32,22,Biomark_Res_2015_Jun_6_3_13.txt
9435 T > A,MAs	2	M	c.5946delT	9435 T > A	Cerebellum	Ashkenazi Jewish Sibling of ...,33,20,Biomark_Res_2015_Jun_6_3_13.txt
7469 T > C,MB	2.5	F	5301insA	c.7469 T > C	NR	Latin American	[24],36,21,Biomark_Res_2015_Jun_6_3_13.txt
3922G > T,MB	3.5	F	c.3922G > T	c.9196C > T	NR	African American	[24],37,12,Biomark_Res_2015_Jun_6_3_13.txt
9196C > T,MB	3.5	F	c.3922G > T	c.9196C > T	NR	African American	[24],37,24,Biomark_Res_2015_Jun_6_3_13.txt
8447 T > A,MB	2.3	M	c.658_659delGT	8447 T > A	Hemispheric	Sibling of the following	[1...,38,25,Biomark_Res_2015_Jun_6_3_13.txt
8447 T > A,"MB, WT (15 mo)	4.3	M	c.658_659delGT	8447 T > A	Hemispheric	Sibling of the previous	[16...",39,37,Biomark_Res_2015_Jun_6_3_13.txt
5645C > A,"GB, WT (3.5 yrs)	9	M	c.658_659delGT	c.5645C > A	Cerebellum	Sibling of the following	[27]...",41,39,Biomark_Res_2015_Jun_6_3_13.txt
5645C > A,"...B, WT (7mo) ALL-B (10 yrs)	5.7	M	c.658_659delGT	c.5645C > A	Cerebellum	Sibling of the previous	[27]",42,52,Biomark_Res_2015_Jun_6_3_13.txt
9196C > T,MB	3.1	F	c.5946delT	c.9196C > T	Cerebellum	VACTERL syndrome	[17],44,23,Biomark_Res_2015_Jun_6_3_13.txt
3A > G,MB	2	NR	c.3264dup	c.IVS19 + 3A > G (c. 8487 + 3A > G)	NR	-	[21],47,29,Biomark_Res_2015_Jun_6_3_13.txt
3A > G,MB	2	NR	c.3264dup	c.IVS19 + 3A > G (c. 8487 + 3A > G)	NR	-	[21],47,47,Biomark_Res_2015_Jun_6_3_13.txt
1114A > C,MB	13	M	c.1114A > C	c.1114A > C	Cerebellum	Desmoplastic hist...,49,11,Biomark_Res_2015_Jun_6_3_13.txt
1114A > C,MB	13	M	c.1114A > C	c.1114A > C	Cerebellum	Desmoplastic histology	[26],49,23,Biomark_Res_2015_Jun_6_3_13.txt
1523A>T,...n a dog with a mast cell tumor carrying a c-kit c.1523A>T mutation via suppression of constitutive K...,193,131,Biomed_Res_Int_2013_Jul_11_2013_283985.txt
9C>G,"... whether there is a link between the rs2073618 (c.9C>G, G1181C) and rs3134069 (g.119964988A>C, T245G...",22,109,Biomed_Res_Int_2013_Oct_20_2013_364073.txt
119964988A>C,"...n the rs2073618 (c.9C>G, G1181C) and rs3134069 (g.119964988A>C, T245G) polymorphisms of the OPG gene...",22,140,Biomed_Res_Int_2013_Oct_20_2013_364073.txt
9C>G,rs2073618 (c.9C>G)	 	 	 ,113,14,Biomed_Res_Int_2013_Oct_20_2013_364073.txt
119964988A>C,rs3134069 (g.119964988A>C)	 	 	 ,126,14,Biomed_Res_Int_2013_Oct_20_2013_364073.txt
9C>G,(c.9C>G),143,4,Biomed_Res_Int_2013_Oct_20_2013_364073.txt
119964988A>C,(g.119964988A>C)	Dominant:	 	 	 ,159,4,Biomed_Res_Int_2013_Oct_20_2013_364073.txt
50C>T,"...o12Ala, NFKB1 -94 ins/del, NFKBIA -826C/T, COX-1 (50C>T), and COX-2 (-1195G>A) polymorphisms on pros...",7,556,Biomed_Res_Int_2015_Dec_14_2015_674039.txt
1195G>A,"...s/del, NFKBIA -826C/T, COX-1 (50C>T), and COX-2 (-1195G>A) polymorphisms on prostate cancer risk. Th...",7,576,Biomed_Res_Int_2015_Dec_14_2015_674039.txt
1195G>A,"...sms. In conclusion, NFKB1 -94 ins/del and COX-2 (-1195G>A) polymorphisms may be, respectively, assoc...",7,1382,Biomed_Res_Int_2015_Dec_14_2015_674039.txt
50C>T,"... polymorphism, NFKBIA-826C/T polymorphism, COX-1 (50C>T) polymorphism, and COX-2 (-1195G>A) polymorp...",14,1079,Biomed_Res_Int_2015_Dec_14_2015_674039.txt
1195G>A,"...morphism, COX-1 (50C>T) polymorphism, and COX-2 (-1195G>A) polymorphism. The present study aimed to ...",14,1112,Biomed_Res_Int_2015_Dec_14_2015_674039.txt
50C>T,COX-1 (50C>T) Polymorphis,36,8,Biomed_Res_Int_2015_Dec_14_2015_674039.txt
1195G>A,COX-2 (-1195G>A) Polymorphis,40,9,Biomed_Res_Int_2015_Dec_14_2015_674039.txt
1195G>A,...amplification of the region containing the COX-2 (1195G>A) polymorphism were 5′-CCC TGA GCA CTA CCC ...,41,76,Biomed_Res_Int_2015_Dec_14_2015_674039.txt
1195G>A,"...ols in the genotypic distribution was the COX-2 (-1195G>A) polymorphism. Among the cases, 71, 269, a...",54,148,Biomed_Res_Int_2015_Dec_14_2015_674039.txt
50C>T,"... 14 in controls (χ2 = 0.51, P = 0.77). For COX-1 (50C>T) polymorphism, the CC, CT, and TT genotypes ...",56,335,Biomed_Res_Int_2015_Dec_14_2015_674039.txt
1195G>A,"For COX-2 (-1195G>A) polymorphism, a significantly increased p...",64,13,Biomed_Res_Int_2015_Dec_14_2015_674039.txt
50C>T,...f significant association was observed for COX-1 (50C>T) polymorphism and PPARG Pro12Ala polymorphis...,68,68,Biomed_Res_Int_2015_Dec_14_2015_674039.txt
50C>T,"...gous and homozygous comparison models. For COX-1 (50C>T) polymorphism, the odds ratio obtained in th...",68,245,Biomed_Res_Int_2015_Dec_14_2015_674039.txt
1195G>A,"... smoking status was observed only for the COX-2 (-1195G>A) polymorphism (P < 0.01), in which a signi...",71,245,Biomed_Res_Int_2015_Dec_14_2015_674039.txt
1195G>A,"... 0.02, resp.). For the interactions between COX-2-1195G>A and COX-1 (50C>T) polymorphisms, interacti...",74,342,Biomed_Res_Int_2015_Dec_14_2015_674039.txt
50C>T,"...the interactions between COX-2-1195G>A and COX-1 (50C>T) polymorphisms, interaction between COX-2 (-...",74,361,Biomed_Res_Int_2015_Dec_14_2015_674039.txt
50C>T,"...Pro12Ala, NFKB1-94 ins/del, NFKBIA-826C/T, COX-1 (50C>T), and COX-2 (-1195G>A) polymorphisms, with p...",77,180,Biomed_Res_Int_2015_Dec_14_2015_674039.txt
1195G>A,"...ns/del, NFKBIA-826C/T, COX-1 (50C>T), and COX-2 (-1195G>A) polymorphisms, with prostate cancer risk ...",77,200,Biomed_Res_Int_2015_Dec_14_2015_674039.txt
50C>T,"...y COX-1 and COX-2 genes, respectively. The COX-1 (50C>T) polymorphism is located within the coding r...",84,362,Biomed_Res_Int_2015_Dec_14_2015_674039.txt
1195G>A,"...ced [26]. On the other hand, the promoter COX-2 (-1195G>A) polymorphism can alter the transcriptiona...",84,555,Biomed_Res_Int_2015_Dec_14_2015_674039.txt
50C>T,"...f prostate cancer risk association for the COX-1 (50C>T) polymorphism. This indicates that, despite ...",84,715,Biomed_Res_Int_2015_Dec_14_2015_674039.txt
1195G>A,...ed the presence of an association between COX-2 (-1195G>A) polymorphism and increased prostate cance...,84,959,Biomed_Res_Int_2015_Dec_14_2015_674039.txt
50C>T,"... first to evaluate the association between COX-1 (50C>T) polymorphism and prostate cancer risk, wher...",84,1614,Biomed_Res_Int_2015_Dec_14_2015_674039.txt
1195G>A,...ere available for the association between COX-2 (-1195G>A) polymorphism and prostate cancer risk. Ou...,84,1744,Biomed_Res_Int_2015_Dec_14_2015_674039.txt
1195G>A,...d the absence of risk association between COX-2 (-1195G>A) polymorphism and prostate cancer risk,84,2017,Biomed_Res_Int_2015_Dec_14_2015_674039.txt
1195G>A,"...tive prostate cancer risk association for COX-2 (-1195G>A) polymorphism, a negative risk association...",86,106,Biomed_Res_Int_2015_Dec_14_2015_674039.txt
50C>T,"...ymorphism, NFKBIA-826C/T polymorphism, and COX-1 (50C>T) polymorphism. There are several limitations...",86,291,Biomed_Res_Int_2015_Dec_14_2015_674039.txt
1195G>A,COX-2 (-1195G>A)	 	 	18.34	<0.01,124,9,Biomed_Res_Int_2015_Dec_14_2015_674039.txt
50C>T,COX-1 (50C>T)	 	 	4.05	0.13,129,8,Biomed_Res_Int_2015_Dec_14_2015_674039.txt
1195G>A,COX-2 (-1195G>A)	 	 	 	 ,170,9,Biomed_Res_Int_2015_Dec_14_2015_674039.txt
50C>T,COX-1 (50C>T)	 	 	 	 ,192,8,Biomed_Res_Int_2015_Dec_14_2015_674039.txt
1799T>A, c.1799T>A	p.V600E	56 (29.9),189,4,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
1801A>G, c.1801A>G	p.K601E	11 (5.9),192,4,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
34G>A, c.34G>A	p.G12S	1 (0.5),194,4,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
182A>G, c.182A>G	p.Q61R	34 (18.2),196,4,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
181C>A, c.181C>A	p.Q61K	5 (2.7),197,4,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
182A>G, c.182A>G	p.Q61R	7 (3.7),199,4,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
181C>A, c.181C>A	p.Q61K	6 (3.2),200,4,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
183G>T, c.183G>T	p.Q61H	1 (0.5),201,4,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
182A>G, c.182A>G	p.Q61R	8 (4.3),203,4,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
181C>A, c.181C>A	p.Q61H	1 (0.5),204,4,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
1799T>A, c.1799T>A	p.V600E	51,244,4,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
1801A>G, c.1801A>G	p.K601E	6,246,4,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
34G>A, c.34G>A	p.G12S	1,248,4,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
182A>G, c.182A>G	p.Q61R	29,250,4,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
181C>A, c.181C>A	p.Q61K	7,251,4,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
182A>G, c.182A>G	p.Q61R	4,253,4,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
181C>A, c.181C>A	p.Q61K	3,254,4,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
182A>G, c.182A>G	p.Q61R	2,256,4,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
80G>A,...n the absence of association between the common c.80G>A polymorphism (rs1051266) of the gene coding ...,19,189,Biomed_Res_Int_2015_Jan_14_2015_135931.txt
308G>A,"... potential for a biological significance of TNFA −308G>A polymorphism on the risk of obesity, M. Bar...",19,413,Biomed_Res_Int_2015_Jan_14_2015_135931.txt
12769316G>A,...nal SNPs (NFκB1: rs28362491del>ins ATTG; NFκB2: rs12769316G>A; IκBα: rs2233406C>T and rs696G>A) were...,31,787,Biomed_Res_Int_2015_Jun_16_2015_362542.txt
2233406C>T,...362491del>ins ATTG; NFκB2: rs12769316G>A; IκBα: rs2233406C>T and rs696G>A) were analyzed to evaluate...,31,808,Biomed_Res_Int_2015_Jun_16_2015_362542.txt
696G>A,...G; NFκB2: rs12769316G>A; IκBα: rs2233406C>T and rs696G>A) were analyzed to evaluate their associatio...,31,825,Biomed_Res_Int_2015_Jun_16_2015_362542.txt
696G>A,...nts in NFκB1 (rs28362491del>ins ATTG) and IκBα (rs696G>A) and their synergistic effect might contrib...,31,1597,Biomed_Res_Int_2015_Jun_16_2015_362542.txt
12769316G>A,...nctional SNPs (rs28362491del>ins ATTG in NFκB1; rs12769316G>A in NFκB2; rs2233406C>T and rs696 G>A i...,41,128,Biomed_Res_Int_2015_Jun_16_2015_362542.txt
2233406C>T,...1del>ins ATTG in NFκB1; rs12769316G>A in NFκB2; rs2233406C>T and rs696 G>A in IκBα) and NPC risk in ...,41,152,Biomed_Res_Int_2015_Jun_16_2015_362542.txt
696 G>A,...NFκB1; rs12769316G>A in NFκB2; rs2233406C>T and rs696 G>A in IκBα) and NPC risk in 906 NPC patients ...,41,169,Biomed_Res_Int_2015_Jun_16_2015_362542.txt
12769316 G>A,"...rphisms [i.e., rs28362491del>ins ATTG of NFκB1; rs12769316 G>A of NFκB2; rs2233406C>T and rs696G>A o...",48,158,Biomed_Res_Int_2015_Jun_16_2015_362542.txt
2233406C>T,...del>ins ATTG of NFκB1; rs12769316 G>A of NFκB2; rs2233406C>T and rs696G>A of IκBα] were putatively f...,48,183,Biomed_Res_Int_2015_Jun_16_2015_362542.txt
696G>A,...FκB1; rs12769316 G>A of NFκB2; rs2233406C>T and rs696G>A of IκBα] were putatively functional and rep...,48,200,Biomed_Res_Int_2015_Jun_16_2015_362542.txt
696 G>A,"...0], here we focused on the functional effect of rs696 G>A polymorphism on NPC risk",52,152,Biomed_Res_Int_2015_Jun_16_2015_362542.txt
696G>A,"... significant association was later observed for rs696G>A and NPC risk, we then constructed two repor...",55,55,Biomed_Res_Int_2015_Jun_16_2015_362542.txt
696G>A,... http://microrna.sanger.ac.uk/) showed that the rs696G>A would change the binding of the microRNA mi...,58,381,Biomed_Res_Int_2015_Jun_16_2015_362542.txt
696G>A,"...armful role of NFκB1 rs28362491del/ins and IκBα rs696G>A polymorphism for NPC risk, individuals carr...",69,138,Biomed_Res_Int_2015_Jun_16_2015_362542.txt
696G>A,...41 for rs28362491del>ins ATTG and P = 0.938 for rs696G>A). We found that the rs28362491ins variant g...,69,685,Biomed_Res_Int_2015_Jun_16_2015_362542.txt
696G>A,... gene-gene interaction of rs28362491del/ins and rs696G>A polymorphism on the risk of NPC was also in...,74,205,Biomed_Res_Int_2015_Jun_16_2015_362542.txt
696G>A,"...s for gastric cancer and CRC risk. Furthermore, rs696G>A polymorphism in the 3′-UTR of IκBα showed a...",86,665,Biomed_Res_Int_2015_Jun_16_2015_362542.txt
696G>A,"...PC susceptibility. Likewise, we also found that rs696G>A polymorphism in the 3′-UTR of IκBα gene con...",86,950,Biomed_Res_Int_2015_Jun_16_2015_362542.txt
696G>A,"... the bioinformatics analysis, we found that the rs696G>A would change the potential bindings for the...",86,1234,Biomed_Res_Int_2015_Jun_16_2015_362542.txt
696G>A,...As previous biological mechanism indicated that rs696G>A SNP in IκBα could depress its expression; i...,88,385,Biomed_Res_Int_2015_Jun_16_2015_362542.txt
696G>A,...xpression. It is reasonable about the fact that rs696G>A polymorphism might abolish the suppression ...,88,560,Biomed_Res_Int_2015_Jun_16_2015_362542.txt
12769316G>A,"... Genotyping of rs28362491del>ins ATTG in NFκB1, rs12769316G>A in NFκB2, rs2233406C>T and rs696G>A in...",96,134,Biomed_Res_Int_2015_Jun_16_2015_362542.txt
2233406C>T,"...1del>ins ATTG in NFκB1, rs12769316G>A in NFκB2, rs2233406C>T and rs696G>A in IκBα detected by the Ta...",96,158,Biomed_Res_Int_2015_Jun_16_2015_362542.txt
696G>A,"...NFκB1, rs12769316G>A in NFκB2, rs2233406C>T and rs696G>A in IκBα detected by the TaqMan allelic disc...",96,175,Biomed_Res_Int_2015_Jun_16_2015_362542.txt
696G>A,Figure 1 Effects of the rs696G>A polymorphism and treatment with microRNAs o...,107,27,Biomed_Res_Int_2015_Jun_16_2015_362542.txt
696G>A,...eam to the translation stop site TGA) including rs696G>A polymorphism and a putative target site of ...,107,283,Biomed_Res_Int_2015_Jun_16_2015_362542.txt
12769316 G>A, rs12769316 G>A	 	 	 	 	 	 	 	 	 ,160,4,Biomed_Res_Int_2015_Jun_16_2015_362542.txt
2233406 C>T, rs2233406 C>T	 	 	 	 	 	 	 	 	 ,167,4,Biomed_Res_Int_2015_Jun_16_2015_362542.txt
696 G>A, rs696 G>A	 	 	 	 	 	 	 	 	 ,174,4,Biomed_Res_Int_2015_Jun_16_2015_362542.txt
696 G>A,IκBα: rs696 G>A,334,9,Biomed_Res_Int_2015_Jun_16_2015_362542.txt
696 G>A,IκBα: rs696 G>A	Crude OR,336,9,Biomed_Res_Int_2015_Jun_16_2015_362542.txt
696 G>A,...test for the multiplicative interaction between rs696 G>A genotypes and rs28362491 del/ins genotypes...,364,62,Biomed_Res_Int_2015_Jun_16_2015_362542.txt
1304T>G,...iu B.  Chen D.  Yang L.    A functional variant (−1304T>G) in the MKK4 promoter contributes to a dec...,391,55,Biomed_Res_Int_2015_Jun_16_2015_362542.txt
3494T>C,"...s used as a template to generate point mutations, 3494T>C (L1165P), 4229C>T (T1410M), 4937T>C (M1646...",20,146,Biomed_Res_Int_2015_Mar_2_2015_678701.txt
4229C>T,"...te to generate point mutations, 3494T>C (L1165P), 4229C>T (T1410M), 4937T>C (M1646T), 6187_6191delCT...",20,164,Biomed_Res_Int_2015_Mar_2_2015_678701.txt
4937T>C,"...nt mutations, 3494T>C (L1165P), 4229C>T (T1410M), 4937T>C (M1646T), 6187_6191delCTCTA (L2063X), and ...",20,182,Biomed_Res_Int_2015_Mar_2_2015_678701.txt
6566A>G,"...4937T>C (M1646T), 6187_6191delCTCTA (L2063X), and 6566A>G (Y2189C) (Figure 1), using the QuickChange...",20,232,Biomed_Res_Int_2015_Mar_2_2015_678701.txt
3494T>C,Leucine-rich repeat (LRR)	3494T>C	L1165P	1	0	Age of onset around 47 years. S...,88,27,Biomed_Res_Int_2015_Mar_2_2015_678701.txt
4229C>T,Ras of complex proteins (ROC)	4229C>T	T1410M	19	11	Middle-age to late onset of d...,92,31,Biomed_Res_Int_2015_Mar_2_2015_678701.txt
4937T>C,C-terminal of ROC (COR)	4937T>C	M1646T	4	2	Typical PD	Jasinska-Myga et al....,97,25,Biomed_Res_Int_2015_Mar_2_2015_678701.txt
6566A>G,WD40 repeat (WD40)	6566A>G	Y2189C	14	8	Middle-age to late onset of di...,105,20,Biomed_Res_Int_2015_Mar_2_2015_678701.txt
599839 A>G,rs599839 A>G	AA	107 (48.4)	48 (56.5)	59 (43.4)	3.668...,194,3,Biomed_Res_Int_2015_Mar_8_2015_678924.txt
646776 T>C,rs646776 T>C	TT	170 (76.9)	73 (80.2)	97 (72.9)	1.568...,204,3,Biomed_Res_Int_2015_Mar_8_2015_678924.txt
4970834 C>T,rs4970834 C>T	CC	122 (54.2)	48 (53.9)	74 (54.4)	4.14...,214,3,Biomed_Res_Int_2015_Mar_8_2015_678924.txt
599839 A>G,rs599839 A>G-genotypes	 	 	 	 ,226,3,Biomed_Res_Int_2015_Mar_8_2015_678924.txt
646776 A>G,rs646776 A>G-genotypes	 	 	 	 ,237,3,Biomed_Res_Int_2015_Mar_8_2015_678924.txt
4970834 C>T,rs4970834 C>T-genotypes	 	 	 	 ,248,3,Biomed_Res_Int_2015_Mar_8_2015_678924.txt
8I>N,"...ed BV2 microglial cells in an order of efficacy: M8I>NNGH>M9I. In addition, MMP inhibitors suppresse...",3,2095,Biomol_Ther_(Seoul)_2014_Sep_30_22(5)_414-419.txt
8I>N,"...same efficacy order as that of TNF-α inhibition (M8I>NNGH>M9I), proving a direct correlation between...",3,2245,Biomol_Ther_(Seoul)_2014_Sep_30_22(5)_414-419.txt
8I>N,"... TACE activity of rhTACE in an efficacy order of M8I>NNGH>M9I. Of note, M8I and NNGH suppressed the ...",38,474,Biomol_Ther_(Seoul)_2014_Sep_30_22(5)_414-419.txt
8I>N,"...retion and TACE activity in an efficacy order of M8I>NNGH>M9I (Fig. 2, 3). Interestingly, we found t...",44,248,Biomol_Ther_(Seoul)_2014_Sep_30_22(5)_414-419.txt
13A>G,"...ng a weakened T7 promoter. Here, we introduced a -13A>G mutation into the T7 promoter (i.e., adenine...",65,108,Biotechnol_Biofuels_2016_Nov_1_9_234.txt
17T>A,"...oduced into the T7 promoter region (for example, −17T>A denotes that thymine at the −17th position i...",166,266,Biotechnol_Biofuels_2016_Nov_1_9_234.txt
13A>G,...ng the  E. coli strains carrying plasmids with a −13A>G mutation in the T7 promoter upstream of the ...,170,127,Biotechnol_Biofuels_2016_Nov_1_9_234.txt
769C>T,"A1	M	58	21OH, SCC, AADC, GAD	C, HP, A, V, Al,	c.769C>T/c.769C>T",21,49,Blood_2008_Oct_1_112(7)_2657-2666.txt
769C>T,"...	21OH, SCC, AADC, GAD	C, HP, A, V, Al,	c.769C>T/c.769C>T",21,58,Blood_2008_Oct_1_112(7)_2657-2666.txt
1G>A,"A2	M	47	AADC, GAD, TPH	HP, D, V	c.879+1G>A/c.879+1G>A",22,39,Blood_2008_Oct_1_112(7)_2657-2666.txt
1G>A,"A2	M	47	AADC, GAD, TPH	HP, D, V	c.879+1G>A/c.879+1G>A",22,50,Blood_2008_Oct_1_112(7)_2657-2666.txt
769C>T,"A3	F	54	21OH, GAD	C, A, HP, G, AT, Al, E, D	c.769C>T /c.1336T>G",23,47,Blood_2008_Oct_1_112(7)_2657-2666.txt
1336T>G,"...4	21OH, GAD	C, A, HP, G, AT, Al, E, D	c.769C>T /c.1336T>G",23,57,Blood_2008_Oct_1_112(7)_2657-2666.txt
769C>T,"A4	F	25	21OH, 17OH	A	c.769C>T / c.1242_1243insA",24,24,Blood_2008_Oct_1_112(7)_2657-2666.txt
769C>T,"A5	F	20	21OH, SCC, 17OH	C, A, V, N, G	c.769C>T/c.1242_1243insA",25,41,Blood_2008_Oct_1_112(7)_2657-2666.txt
769C>T,"A6	M	21	21OH, SCC, 17OH, AADC	C, HP, A, K	c.769C>T/c.769C>T",26,45,Blood_2008_Oct_1_112(7)_2657-2666.txt
769C>T,"...M	21	21OH, SCC, 17OH, AADC	C, HP, A, K	c.769C>T/c.769C>T",26,54,Blood_2008_Oct_1_112(7)_2657-2666.txt
2A>G,... mutation on a splice intron site (intron 9: IVS9+2A>G; no. 32),15,261,Blood_Cancer_J_2011_Feb_25_1(2)_e5.txt
2A>G,32	2	−	−	Intron 9/IVS9+2A>G,68,24,Blood_Cancer_J_2011_Feb_25_1(2)_e5.txt
1G>A,34	3	+ (87%)	−	Intron 4/IVS4+1G>A,70,30,Blood_Cancer_J_2011_Feb_25_1(2)_e5.txt
1G>T,35	3	+ (88%)	−	Intron 5/IVS5+1G>T,71,30,Blood_Cancer_J_2011_Feb_25_1(2)_e5.txt
2A>A,36	3	+ (52%)	−	Intron 6/IVS7−2A>A,72,30,Blood_Cancer_J_2011_Feb_25_1(2)_e5.txt
1273C>T,...l hemolytic uremic syndrome associated with the c.1273C>T mutation in the complement C3 gene Cho Hye...,3,339,Blood_Res_2016_Sep_23_51(3)_210-213.txt
1273C>T,"...utations are a well-known etiology of aHUS, the c.1273C>T mutation has never been reported in Caucas...",12,64,Blood_Res_2016_Sep_23_51(3)_210-213.txt
1273 C>T,"... gene revealed that she had heterozygous mutation 1273 C>T in exon 12, that affects codon 425 result...",20,714,Blood_Res_2016_Sep_23_51(3)_210-213.txt
1273C> T,... a Korean patient with aHUS associated with the c.1273C> T mutation in the complement C3 gene. Altho...,23,113,Blood_Res_2016_Sep_23_51(3)_210-213.txt
1273C>T,...that the penetrance of aHUS associated with the c.1273C>T mutation in the complement C3 gene is low....,25,867,Blood_Res_2016_Sep_23_51(3)_210-213.txt
1273C>T,...This means that a heterozygous carrier with the c.1273C>T mutation of C3 itself may not develop aHUS...,25,1191,Blood_Res_2016_Sep_23_51(3)_210-213.txt
1273C>T,The c.1273C>T mutation is located within the C3 gene dom...,27,7,Blood_Res_2016_Sep_23_51(3)_210-213.txt
1273C>T,...suspect that the pathogenesis of aHUS caused by c.1273C>T is likely to be associated with dysregulat...,27,146,Blood_Res_2016_Sep_23_51(3)_210-213.txt
1273C>T,"...e first Korean case of aHUS associated with the c.1273C>T mutation in the complement C3 gene, where ...",29,428,Blood_Res_2016_Sep_23_51(3)_210-213.txt
1273C>T,...phism analysis of our patient with heterozygote c.1273C>T mutation in C3 gene showing 250 bp product...,36,93,Blood_Res_2016_Sep_23_51(3)_210-213.txt
3C > P,...the relative differential gene expression is PPP1R3C > PPP1R3A > PPP1R6 > PPP1R3B in human skeletal ...,102,618,BMC_Biochem_2011_Nov_4_12_57.txt
3A > P,...ve differential gene expression is PPP1R3C > PPP1R3A > PPP1R6 > PPP1R3B in human skeletal muscle tis...,102,628,BMC_Biochem_2011_Nov_4_12_57.txt
3C > P,... PPP1R3B in human skeletal muscle tissue and PPP1R3C > PPP1R3B > PPP1R6 > PPP1R3A in cultured human ...,102,691,BMC_Biochem_2011_Nov_4_12_57.txt
3B > P,...n human skeletal muscle tissue and PPP1R3C > PPP1R3B > PPP1R6 > PPP1R3A in cultured human myotubes,102,701,BMC_Biochem_2011_Nov_4_12_57.txt
617V>F,...i V Fabris F  Clinical profile of homozygous JAK2 617V>F mutation in patients with polycythemia vera...,106,150,BMC_Bioinformatics_2009_Jan_30_10(Suppl_1)_S53.txt
12325489C>T,"...ong D, Hongchun W, Wei L, et al. A Polymorphism rs12325489C>T in the LincRNA-ENST00000515084 Exon Wa...",650,82,BMC_Bioinformatics_2015_May_20_16_167.txt
845G>A,...ms and liver abnormalities of homozygotes for the 845G>A(C282Y) hereditary hemochromatosis mutation ...,187,120,BMC_Blood_Disord_2005_Jul_25_5_5.txt
1081A>G,...ion screening of 101 samples (Table 2). An I361V (1081A>G) alteration in exon 5 was detected in a Fi...,37,174,BMC_Cancer_2006_Jun_1_6_145.txt
1702C>T,"...-surface binding. Another missense change, R568W (1702C>T) in exon 9, was detected in a Finnish pati...",37,800,BMC_Cancer_2006_Jun_1_6_145.txt
2581G>A,"...he protein. The third missense alteration, D861N (2581G>A) in exon 14, was detected in a UK patient ...",37,1392,BMC_Cancer_2006_Jun_1_6_145.txt
239G>A,"... kinase domain of EPHB2. The fourth change, R80H (239G>A) in exon 3, was initially observed in a Fin...",37,2003,BMC_Cancer_2006_Jun_1_6_145.txt
239G>A,"C713	3	239G>A	R80H	CRC, 73 years, FIN	brother, PC, 60 yea...",88,8,BMC_Cancer_2006_Jun_1_6_145.txt
1081A>G,"C112	5	1081A>G	I361V	CRC, 75 years and PC, 73 years, FIN	...",89,8,BMC_Cancer_2006_Jun_1_6_145.txt
1702C>T,"C809	9	1702C>T	R568W	serrated CRC, 69 years, FIN	father, ...",90,8,BMC_Cancer_2006_Jun_1_6_145.txt
2581G>A,"PAP211	14	2581G>A	D861N	HPP*, 58 years, UK	mother, CRC, 36 y...",91,11,BMC_Cancer_2006_Jun_1_6_145.txt
4446C>T,"The common French Canadian founder mutations 4446C>T and 2953delGTAinsC in BRCA1 and 8765delAG,...",72,46,BMC_Cancer_2008_May_28_8_152.txt
6085G>T,"...446C>T and 2953delGTAinsC in BRCA1 and 8765delAG, 6085G>T and 3398delAAAAG in BRCA2 were investigate...",72,97,BMC_Cancer_2008_May_28_8_152.txt
36 G>A,"TP53	EX5-36 G>A, R175H	EX8+35 C>T, R273C	EX8+35 C>T, R273C	...",167,10,BMC_Cancer_2008_May_28_8_152.txt
35 C>T,"TP53	EX5-36 G>A, R175H	EX8+35 C>T, R273C	EX8+35 C>T, R273C	EX4+62 G>A, W53X",167,28,BMC_Cancer_2008_May_28_8_152.txt
35 C>T,"TP53	EX5-36 G>A, R175H	EX8+35 C>T, R273C	EX8+35 C>T, R273C	EX4+62 G>A, W53X",167,46,BMC_Cancer_2008_May_28_8_152.txt
62 G>A,"...>A, R175H	EX8+35 C>T, R273C	EX8+35 C>T, R273C	EX4+62 G>A, W53X",167,64,BMC_Cancer_2008_May_28_8_152.txt
252A>G,...hoi D Hyun YJ Kim HJ Chae JS Lee JH Effect of the 252A>G polymorphism of the lymphotoxin-alpha gene ...,314,80,BMC_Cancer_2009_Jul_17_9_238.txt
271 G>A,...43550810.1186/1471-2407-9-144Research ArticleThe -271 G>A polymorphism of kinase insert domain-conta...,3,112,BMC_Cancer_2009_May_12_9_144.txt
271 G>A,...rapy. We investigated the characteristics of the -271 G>A polymorphism of the KDR gene to gain infor...,4,195,BMC_Cancer_2009_May_12_9_144.txt
271 G>A,The -271 G>A polymorphism of the KDR gene in 106 lung c...,7,6,BMC_Cancer_2009_May_12_9_144.txt
271 G>A,The -271 G>A polymorphism was associated with the mRNA ...,10,6,BMC_Cancer_2009_May_12_9_144.txt
271 G>A,This study is the first to show that the -271 G>A polymorphism of the KDR gene may be a func...,13,43,BMC_Cancer_2009_May_12_9_144.txt
271 G>A,The sequences of the -271 G>A polymorphism of the KDR gene were assayed ...,31,23,BMC_Cancer_2009_May_12_9_144.txt
271 G>A,Frequency of the -271 G>A polymorphism genotypes and their relations...,45,19,BMC_Cancer_2009_May_12_9_144.txt
271 G>A,"...ymorphisms in the investigated region except the -271 G>A polymorphism in the 5' UTR. Consequently, ...",46,335,BMC_Cancer_2009_May_12_9_144.txt
271 G>A,"...m in the 5' UTR. Consequently, we focused on the -271 G>A polymorphism in all of the specimens and a...",46,404,BMC_Cancer_2009_May_12_9_144.txt
271 G>A,...requency of its genotypes (Fig. 1). A search for -271 G>A polymorphisms in the single nucleotide pol...,46,517,BMC_Cancer_2009_May_12_9_144.txt
271 G>A,Figure 1 Sequence graphs of the -271 G>A polymorphism of the KDR gene (sequenced us...,48,34,BMC_Cancer_2009_May_12_9_144.txt
271 G>A,"...equencies of the AA, AG, and GG genotypes of the -271 G>A polymorphism in the NSCLC patients were 20...",50,57,BMC_Cancer_2009_May_12_9_144.txt
271 G>A,"..., the frequencies of the AA (TT) genotype of the -271 G>A polymorphism in European, Asian, and Sub-S...",50,311,BMC_Cancer_2009_May_12_9_144.txt
271 G>A,The correlations between the -271 G>A polymorphism genotype and the patients' cl...,54,31,BMC_Cancer_2009_May_12_9_144.txt
271 G>A,...able 1 Correlations between the genotypes of the -271 G>A polymorphism and clinical parameters of pa...,56,52,BMC_Cancer_2009_May_12_9_144.txt
271 G>A,The -271 G>A polymorphism affects the transcriptional l...,79,6,BMC_Cancer_2009_May_12_9_144.txt
271 G>A,"...between the KDR mRNA level and each of the three -271 G>A polymorphism genotypes, with mean values o...",80,239,BMC_Cancer_2009_May_12_9_144.txt
271 G>A,Table 2 Influence of genotypes of the -271 G>A polymorphism on KDR mRNA expression leve,82,40,BMC_Cancer_2009_May_12_9_144.txt
271 G>A,The -271 G>A polymorphism was not related to the KDR pr...,91,6,BMC_Cancer_2009_May_12_9_144.txt
271 G>A,...expression. There was no correlation between the -271 G>A genotype and KDR protein level (Table 3),92,188,BMC_Cancer_2009_May_12_9_144.txt
271 G>A,Table 3 Association of -271 G>A polymorphism genotypes with KDR protein ex...,96,25,BMC_Cancer_2009_May_12_9_144.txt
271 G>A,"...t study, the frequency of the AA genotype of the -271 G>A polymorphism was higher among cancer patie...",106,64,BMC_Cancer_2009_May_12_9_144.txt
271 G>A,...er's exact test). These results suggest that the -271 G>A polymorphism may not be associated with a ...,106,291,BMC_Cancer_2009_May_12_9_144.txt
271 G>A,"... with the AG/GG genotype, the AA genotype of the -271 G>A polymorphism was associated with a higher ...",108,59,BMC_Cancer_2009_May_12_9_144.txt
271 G>A,...r tissues. This is the first suggestion that the -271 G>A polymorphism of the KDR gene may be functi...,108,195,BMC_Cancer_2009_May_12_9_144.txt
271 G>A,...ctor-binding sites [29]. We hypothesize that the -271 G>A polymorphism is contained in a response el...,108,472,BMC_Cancer_2009_May_12_9_144.txt
271 G>A,Although the -271 G>A polymorphism was related to the KDR mRNA l...,110,15,BMC_Cancer_2009_May_12_9_144.txt
271 G>A,...mRNA and KDR protein in association with the KDR -271 G>A polymorphism genotype in tumor tissues of ...,113,106,BMC_Cancer_2009_May_12_9_144.txt
271 G>A,...rst study to assess the relationship between the -271 G>A polymorphism of KDR and KDR mRNA and prote...,113,236,BMC_Cancer_2009_May_12_9_144.txt
271 G>A,... in NSCLC patients. Our results suggest that the -271 G>A polymorphism of the KDR gene may be a func...,113,349,BMC_Cancer_2009_May_12_9_144.txt
2428C>A,BR334	26	2428C>A	S770X	3	- (0)	- (0)	-	0.658	0.091	0.748	1 ...,39,10,BMC_Cancer_2009_Oct_10_9_360.txt
1806C>T,BR386	40	1806C>T	Q563X	3	- (0)	- (0)	1+/2+	0.311	0.048	0.35...,47,10,BMC_Cancer_2009_Oct_10_9_360.txt
300T>G,BR587	38+60 CBC	300T>G	C61G	3	- (0)	- (0)	1+	0.922	0.063	0.984	2 (...,55,17,BMC_Cancer_2009_Oct_10_9_360.txt
2A>G,BR312	47	IVS16-2A>G	Exon skipping	3	+ (5)	+ (3)	1+	0.002	0.365	0....,65,16,BMC_Cancer_2009_Oct_10_9_360.txt
9106C>T,BR342	44+52 CBC	9106C>T	Q2960X	3	+ (8)	+ (3)	2+	0.006	0.182	0.187	...,67,17,BMC_Cancer_2009_Oct_10_9_360.txt
1G>T,BR360	43	IVS23+1G>T	Exon skipping	3	+ (4)	+ (6)	2+/3+	0.088	0.553...,69,16,BMC_Cancer_2009_Oct_10_9_360.txt
4450C>T,BR450	48	4450C>T	Q1408X	1	+ (7)	+ (7)	-	0.010	0.044	0.054	2...,75,10,BMC_Cancer_2009_Oct_10_9_360.txt
1186A>G,BR417	30	1186A>G	Q356R	2	+ (3)	- (0)	3+	0.015	0.040	0.055	1...,87,11,BMC_Cancer_2009_Oct_10_9_360.txt
4274A>G,BR427	48	4274A>G	L1385L	2	+ (7)	+ (7)	1+	0.000	0.010	0.011	...,89,11,BMC_Cancer_2009_Oct_10_9_360.txt
2351T>G,BR437	50	2351T>G	A744A	1	+ (5)	+ (3)	1+	0.000	0.014	0.015	3...,91,11,BMC_Cancer_2009_Oct_10_9_360.txt
5221T>C,BR570	47	5221T>C	L1701P	3	- (0)	+ (3)	3+	0.094	0.169	0.264	...,95,11,BMC_Cancer_2009_Oct_10_9_360.txt
1186A>G,BR647	49	1186A>G	Q356R	3	+ (8)	+ (7)	1+	0.005	0.010	0.015	3...,97,11,BMC_Cancer_2009_Oct_10_9_360.txt
1186A>G,BR658	43	1186A>G	Q356R	3	+ (6)	+ (6)	2+	0.001	0.069	0.070	3...,99,11,BMC_Cancer_2009_Oct_10_9_360.txt
655A>G,BR665	65 BBC	655A>G	Y179C	2	+ (5)	+ (5)	-	0.001	0.004	0.004	3 (...,101,15,BMC_Cancer_2009_Oct_10_9_360.txt
1575T>C,1575T>C	F486L,103,4,BMC_Cancer_2009_Oct_10_9_360.txt
1767A>G,1767A>G	N550H,105,4,BMC_Cancer_2009_Oct_10_9_360.txt
7T>A,"BR376	55	IVS2-7T>A		2	+ (6)	+ (3)	1+	0.000	0.008	0.008	2 (45, 90...",109,16,BMC_Cancer_2009_Oct_10_9_360.txt
6328C>T,BR390	51 OC+54 BBC	6328C>T	R2034C	2	+ (5)	+ (8)	-	0.130	0.648	0.777	3...,111,21,BMC_Cancer_2009_Oct_10_9_360.txt
5972T>C,BR458	44+49 CBC	5972T>C	T1952I	2	+ (7)	+ (5)	-	0.025	0.433	0.459	2...,113,18,BMC_Cancer_2009_Oct_10_9_360.txt
2457T>C,BR486	56	2457T>C/ 9329A>G	H743H/R3034Q	3	+ (5)	+ (8)	-	0.00...,115,11,BMC_Cancer_2009_Oct_10_9_360.txt
9329A>G,BR486	56	2457T>C/ 9329A>G	H743H/R3034Q	3	+ (5)	+ (8)	-	0.000	0.000	0...,115,20,BMC_Cancer_2009_Oct_10_9_360.txt
6751C>G,BR505	67	6751C>G	Q2175E	1	+ (7)	+ (7)	-	0.018	0.426	0.444	4...,117,11,BMC_Cancer_2009_Oct_10_9_360.txt
4236G>A,BR538	62	4236G>A	L1356L	2	+ (7)	+ (7)	-	0.001	0.025	0.026	2...,119,11,BMC_Cancer_2009_Oct_10_9_360.txt
113T>G,"BR587	38+60 CBC	IVS24-113T>G		3	- (0)	- (0)	1+	0.922	0.063	0.984	2 (40, ...",121,24,BMC_Cancer_2009_Oct_10_9_360.txt
3238G>A,BR514	57	3238G>A	S1040N	1	+ (7)	+ (8)	-	0.001	0.061	0.062	4...,125,11,BMC_Cancer_2009_Oct_10_9_360.txt
67A>C,IVS4+67A>,127,9,BMC_Cancer_2009_Oct_10_9_360.txt
1613A>G,1613A>G	E462G,128,1,BMC_Cancer_2009_Oct_10_9_360.txt
4158A>G,BR552	70	4158A>G	R1347G	3	+ (5)	+ (3)	3+	0.000	0.012	0.012	...,130,11,BMC_Cancer_2009_Oct_10_9_360.txt
6328C>T,6328C>T	R2034C,132,4,BMC_Cancer_2009_Oct_10_9_360.txt
67A>C,BR567	50	IVS4+67A>C		3	+ (6)	+ (7)	-	0.009	0.215	0.225	3 (37 BBC...,134,16,BMC_Cancer_2009_Oct_10_9_360.txt
2457T>C,2457T>C	H743H,136,4,BMC_Cancer_2009_Oct_10_9_360.txt
34T>C,"BR571	31	IVS9-34T>C		2	+ (3)	+ (6)	3+	0.001	0.037	0.038	3 (50, 5...",138,16,BMC_Cancer_2009_Oct_10_9_360.txt
5972C>T,5972C>T	T1951M,140,4,BMC_Cancer_2009_Oct_10_9_360.txt
3238G>A,BR580	43	3238G>A	S1040N	3	+ (7)	+ (5)	1+	0.001	0.030	0.031	...,142,11,BMC_Cancer_2009_Oct_10_9_360.txt
1409A>G,1409A>G	E394A,144,4,BMC_Cancer_2009_Oct_10_9_360.txt
855T>G,BR640	30	855T>G	L246V	3	+ (7)	- (0)	1+	0.117	0.261	0.378	2 ...,146,11,BMC_Cancer_2009_Oct_10_9_360.txt
4296G>A,4296G>A	L1356L,148,4,BMC_Cancer_2009_Oct_10_9_360.txt
1082 G > A,... Singh AN Dalela D Srivastava AN Mittal RD IL-10 -1082 G > A: a risk for prostate cancer but may be ...,180,84,BMC_Cancer_2010_Aug_24_10_456.txt
4446C > T,B122	239 insT	1	0	0	0	0	0	NA	c.4446C > T	45,37,32,BMC_Cancer_2010_Nov_30_10_654.txt
1G > A,B149	R273H	0	1	1	0	0	0	NA	c.IVS20+1G > A	31,47,35,BMC_Cancer_2010_Nov_30_10_654.txt
1G > A,B160	167 insA	1	0	0	0	0	0	NA	c.IVS20+1G > A	61,53,38,BMC_Cancer_2010_Nov_30_10_654.txt
1G > A,B162	NA	NA	NA	0	0	0	0	NA	c.IVS20+1G > A	27,55,34,BMC_Cancer_2010_Nov_30_10_654.txt
9C > G,B171	R306X	1	0	0	0	0	1	NA	c.IVS2-9C > G	33,58,34,BMC_Cancer_2010_Nov_30_10_654.txt
2 A > C,228	IVS5-2 A > C (splice)	1	0	0	0	0	0	0	Basal-like	39,85,10,BMC_Cancer_2010_Nov_30_10_654.txt
818G > A,...quencing product showed that the second mutation (818G > A) represented less than 30% of the observe...,72,262,BMC_Cancer_2011_Jun_13_11_243.txt
817C > T,"...wo mutations in codon 273 are visible (nucleotide 817C > T as originally described, and surprisingly...",74,142,BMC_Cancer_2011_Jun_13_11_243.txt
818 G > A,"...7C > T as originally described, and surprisingly, 818 G > A). The first mutation represents heterozy...",74,194,BMC_Cancer_2011_Jun_13_11_243.txt
35G>T,...enomic hybridization. A KRAS codon 12 mutation (c.35G>T; p.G12V) was detected in the pyloric gland a...,7,893,BMC_Cancer_2012_Dec_4_12_570.txt
35G>T,"... 2 showed a point mutation at exon 1, codon 12 (c.35G>T; p.G12V) and wildtype sequence at exon 2 in ...",55,93,BMC_Cancer_2012_Dec_4_12_570.txt
34G>C,"...nin, somatostatin, gastrin	KRAS exon 1 (p.G12R; c.34G>C)",83,182,BMC_Cancer_2012_Dec_4_12_570.txt
35G>T,"...negative: MUC2, CD10, CDX2	KRAS exon 1 (p.G12V; c.35G>T); CGH: gains at 1q, 6p11p22, 7p, 15q, 20p, a...",96,162,BMC_Cancer_2012_Dec_4_12_570.txt
54C>T,"...tion between gliomas and the LIG4 rs1805388 (Ex2 +54C>T, Thr9Ile) TT genotype (adjusted OR, 3.27; 95...",10,111,BMC_Cancer_2013_May_10_13_234.txt
1A>G,"...us variant genotype (GG) of XRCC4 rs1805377 (IVS7-1A>G, splice-site) was associated with a significa...",10,327,BMC_Cancer_2013_May_10_13_234.txt
861539 C>T,XRCC3: rs861539 C>T	nsSNP/ T241M	0.067	0.165,81,10,BMC_Cancer_2013_May_10_13_234.txt
1799794 G>A,XRCC3: rs1799794 G>A	5' UTR	0.478	0.271,82,10,BMC_Cancer_2013_May_10_13_234.txt
1799796 A>T,XRCC3: rs1799796 A>T	nsSNP/ A17893G	0.289	0.406,83,10,BMC_Cancer_2013_May_10_13_234.txt
1799943 G>A,BRCA2: rs1799943 G>A	Promoter	0.279	0.722,84,10,BMC_Cancer_2013_May_10_13_234.txt
15869 A>C,BRCA2: rs15869 A>C	3' UTR	0.244	0.375,85,10,BMC_Cancer_2013_May_10_13_234.txt
2227973 G>A,RAG1: rs2227973 G>A	nsSNP/ R820K	0.465	0.586,86,9,BMC_Cancer_2013_May_10_13_234.txt
1051685 A>G,XRCC5: rs1051685 A>G	3' UTR	0.067	0.808,87,10,BMC_Cancer_2013_May_10_13_234.txt
1805388 C>T,LIG4: rs1805388 C>T	nsSNP/T9I	0.261	0.659,88,9,BMC_Cancer_2013_May_10_13_234.txt
1805377 A>G,XRCC4: rs1805377 A>G	Splice Site	0.300	0.454,89,10,BMC_Cancer_2013_May_10_13_234.txt
189037 G>A,ATM: rs189037 G>A	Promoter	0.389	0.070,90,8,BMC_Cancer_2013_May_10_13_234.txt
4541G>A,XRCC3: rs1799794 (−4541G>A),105,20,BMC_Cancer_2013_May_10_13_234.txt
26G>A,BRCA2: rs1799943 (−26G>A),113,20,BMC_Cancer_2013_May_10_13_234.txt
1A>G,"...hat one splice-site SNP in XRCC4 (rs1805377, IVS7-1A>G, splice-site) and one non-synonymous SNP in L...",184,708,BMC_Cancer_2013_May_10_13_234.txt
54C>T,"...d one non-synonymous SNP in LIG4 (rs1805388, Ex2 +54C>T, Thr9Ile) are associated with the increased ...",184,779,BMC_Cancer_2013_May_10_13_234.txt
1A>G,"...the first evidence that the XRCC4 rs1805377 (IVS7-1A>G, splice-site) and LIG4 rs1805388 (Ex2 +54C>T,...",220,141,BMC_Cancer_2013_May_10_13_234.txt
54C>T,"...(IVS7-1A>G, splice-site) and LIG4 rs1805388 (Ex2 +54C>T, Thr9Ile) polymorphisms contribute to the ri...",220,185,BMC_Cancer_2013_May_10_13_234.txt
681G>A,...eline genotyping of CYP2C19 allele *2 (rs4244285; 681G>A) was performed. The Cox-proportional hazard...,7,92,BMC_Cardiovasc_Disord_2013_Aug_27_13_61.txt
681G>A,...sm (SNP) defining the CYP2C19*2 allele (rs4244285;681G>A) was performed with a TaqMan assay of ABI (...,34,97,BMC_Cardiovasc_Disord_2013_Aug_27_13_61.txt
1699G>A,c.1699G>A	p.Ala567Thr	rs1803274,41,4,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
6637G>A,c.6637G>A	p.Asp2213Asn	rs529038,44,4,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
238C>T,c.-238C>T		rs1800849,47,5,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
599C>T,c.599C>T	p.Pro200Leu	rs1050450,50,4,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
5723G>A,c.117–5723G>A		rs17216473,53,8,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
526C>T,c.526C>T	p.Arg176Cys	rs7412,56,4,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
1307C>A,c.1307C>A	p.Thr436Lys	rs4588,65,4,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
300C>T,c.300C>T	p.Asp100=	rs1799986,71,4,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
81C>T,c.81C>T	p.Cys27=	rs2228671,74,4,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
1699G>A,"...d that only the rs1803274 polymorphism of BCHE (c.1699G>A, p.Ala567Thr) was associated with an incre...",250,180,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
1699G>A,"Our results show that the rs1803274 (1699G>A, p.Ala567Thr) polymorphism of BCHE was als...",265,38,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
219G>T,"...cluding that some APOE polymorphisms, i.e., APOE –219G>T, 113G>C, 334T>C (APOE*4), and 472C>T (APOE*...",279,827,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
113G>C,"...that some APOE polymorphisms, i.e., APOE –219G>T, 113G>C, 334T>C (APOE*4), and 472C>T (APOE*2) eithe...",279,835,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
334T>C,"...e APOE polymorphisms, i.e., APOE –219G>T, 113G>C, 334T>C (APOE*4), and 472C>T (APOE*2) either alone ...",279,843,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
472C>T,"... i.e., APOE –219G>T, 113G>C, 334T>C (APOE*4), and 472C>T (APOE*2) either alone or in combination do ...",279,864,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
1012A>G,"...Monraats et al. Although some substitutions (the -1012A>G, −25C>A and 464G>T) of the VDR gene increa...",281,1013,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
25C>A,"...t al. Although some substitutions (the -1012A>G, −25C>A and 464G>T) of the VDR gene increased the ri...",281,1023,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
464G>T,"...ough some substitutions (the -1012A>G, −25C>A and 464G>T) of the VDR gene increased the risk of clin...",281,1033,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
46C>T,...neutral variation around the F12 gene and the F12 46C>T functional polymorphism. This extensively st...,21,175,BMC_Evol_Biol_2010_Mar_27_10_84.txt
46C>T,...ymorphism from the F7 promoter region[12] and the 46C>T polymorphism (rs1801020) from the 5'-untrans...,32,149,BMC_Evol_Biol_2010_Mar_27_10_84.txt
46C>T,"...rg. For the F12 genomic region, the single 'risk' 46C>T FST value was compared with the 95% confiden...",42,906,BMC_Evol_Biol_2010_Mar_27_10_84.txt
46C>T,...uency of the 'risk' variant T in the polymorphism 46C>T (rs1801020) ranges from 0.081 to 0.357 in th...,58,312,BMC_Evol_Biol_2010_Mar_27_10_84.txt
46C>T,...mples (0.539 in Aymara and 0.577 in Quechua). The 46C>T frequency pattern in Native Americans was cl...,58,524,BMC_Evol_Biol_2010_Mar_27_10_84.txt
46C>T,"...ase of the F7 gene,[12] the FST value for the F12 46C>T 'risk' variant decreased when the Bolivian s...",61,162,BMC_Evol_Biol_2010_Mar_27_10_84.txt
46C>T,"...Coast, second, were removed from the dataset. The 46C>T FST value was not significantly different fr...",61,291,BMC_Evol_Biol_2010_Mar_27_10_84.txt
46C>T,"...f the three datasets considered (All Populations: 46C>T FST = 0.104, neutral FST 95% CI [-0.012, 0.1...",61,425,BMC_Evol_Biol_2010_Mar_27_10_84.txt
46C>T,"...4, neutral FST 95% CI [-0.012, 0.116]; Old World: 46C>T FST = 0.047, neutral FST 95% CI [-0.015, 0.0...",61,491,BMC_Evol_Biol_2010_Mar_27_10_84.txt
46C>T,"...eutral FST 95% CI [-0.015, 0.082]; Mediterranean: 46C>T FST = 0.020, neutral FST 95% CI [-0.015, 0.0...",61,561,BMC_Evol_Biol_2010_Mar_27_10_84.txt
46C>T,... This last observation suggests that polymorphism 46C>T can be treated as a 'neutral' polymorphism i...,61,666,BMC_Evol_Biol_2010_Mar_27_10_84.txt
46C>T,46C>T	0.104	0.047	0.020,70,1,BMC_Evol_Biol_2010_Mar_27_10_84.txt
375 Arg-->Trp,...ordon R Magid MS George PM  Novel fibrinogen gamma375 Arg-->Trp mutation (fibrinogen aguadilla) caus...,81,85,BMC_Gastroenterol_2005_Nov_15_5_36.txt
634G>C,...7510.1186/1471-230X-9-77Research ArticleThe VEGF -634G>C promoter polymorphism is associated with ri...,3,132,BMC_Gastroenterol_2009_Oct_16_9_77.txt
634G>C,Our data suggested that the VEGF-634G>C SNP may be a marker for susceptibility to g...,13,34,BMC_Gastroenterol_2009_Oct_16_9_77.txt
509C>T,...ation between three TGFB1 SNPs (one promoter SNP -509C>T and two exon 1 SNPs +869T>C and +915G>C) an...,20,189,BMC_Gastroenterol_2009_Oct_16_9_77.txt
869T>C,...Ps (one promoter SNP -509C>T and two exon 1 SNPs +869T>C and +915G>C) and three VEGF SNPs (one promo...,20,217,BMC_Gastroenterol_2009_Oct_16_9_77.txt
915G>C,...oter SNP -509C>T and two exon 1 SNPs +869T>C and +915G>C) and three VEGF SNPs (one promoter SNP -149...,20,229,BMC_Gastroenterol_2009_Oct_16_9_77.txt
1498T>C,"...d +915G>C) and three VEGF SNPs (one promoter SNP -1498T>C, one 5'-untranslated region SNP -634G>C an...",20,276,BMC_Gastroenterol_2009_Oct_16_9_77.txt
634G>C,"...ter SNP -1498T>C, one 5'-untranslated region SNP -634G>C and one 3'-untranslated region SNP +936C>T)...",20,317,BMC_Gastroenterol_2009_Oct_16_9_77.txt
936C>T,...n SNP -634G>C and one 3'-untranslated region SNP +936C>T) and gastric cancer risk in a US population...,20,360,BMC_Gastroenterol_2009_Oct_16_9_77.txt
509C>T,"The selected three TGFB1 SNPs [-509C>T (rs1800469) in the promoter, +869T>C (rs180...",29,33,BMC_Gastroenterol_2009_Oct_16_9_77.txt
869T>C,"...TGFB1 SNPs [-509C>T (rs1800469) in the promoter, +869T>C (rs1800470) and +915G>C (rs1800471) in the ...",29,70,BMC_Gastroenterol_2009_Oct_16_9_77.txt
915G>C,"...800469) in the promoter, +869T>C (rs1800470) and +915G>C (rs1800471) in the exon 1] and three promot...",29,94,BMC_Gastroenterol_2009_Oct_16_9_77.txt
1498T>C,...71) in the exon 1] and three promoter VEGF SNPs [-1498T>C (rs833061) in the promoter and -634G>C (rs...,29,159,BMC_Gastroenterol_2009_Oct_16_9_77.txt
634G>C,"...GF SNPs [-1498T>C (rs833061) in the promoter and -634G>C (rs2010963) in the 5'-untranslated region, ...",29,199,BMC_Gastroenterol_2009_Oct_16_9_77.txt
936C>T,"...2010963) in the 5'-untranslated region, and VEGF +936C>T (rs3025039) in the 3'-untranslated region] ...",29,259,BMC_Gastroenterol_2009_Oct_16_9_77.txt
1498T>C,"...as previously described [24]. Assays on the VEGF -1498T>C (rs833061), -634G>C (rs2010963), and +936C...",29,603,BMC_Gastroenterol_2009_Oct_16_9_77.txt
634G>C,"...ed [24]. Assays on the VEGF -1498T>C (rs833061), -634G>C (rs2010963), and +936C>T (rs3025039) SNPs w...",29,624,BMC_Gastroenterol_2009_Oct_16_9_77.txt
936C>T,"...GF -1498T>C (rs833061), -634G>C (rs2010963), and +936C>T (rs3025039) SNPs were previously reported [...",29,649,BMC_Gastroenterol_2009_Oct_16_9_77.txt
509C>T,"...ibrium in the control subjects, except for TGFB1 -509C>T and VEGF -634G>C, indicating some possible ...",69,290,BMC_Gastroenterol_2009_Oct_16_9_77.txt
634G>C,"...trol subjects, except for TGFB1 -509C>T and VEGF -634G>C, indicating some possible selection bias in...",69,307,BMC_Gastroenterol_2009_Oct_16_9_77.txt
634G>C,"...tion between the cases and the controls, the VEGF-634G>C genotype frequencies were statistically sig...",69,506,BMC_Gastroenterol_2009_Oct_16_9_77.txt
509 C >T,TGFB1 -509 C >T (rs1800469)			0.404,77,8,BMC_Gastroenterol_2009_Oct_16_9_77.txt
869 T >C,TGFB1 869 T >C (rs1800470)			0.805,83,7,BMC_Gastroenterol_2009_Oct_16_9_77.txt
915 G >C,TGFB1 915 G >C (rs1800471)			0.447,89,7,BMC_Gastroenterol_2009_Oct_16_9_77.txt
1498T > C,VEGF -1498T > C (rs833061)			0.748,95,7,BMC_Gastroenterol_2009_Oct_16_9_77.txt
634G > C,VEGF -634G > C (rs2010963)			0.006,101,7,BMC_Gastroenterol_2009_Oct_16_9_77.txt
936C > T,VEGF +936C > T (rs3025039)			0.550,107,7,BMC_Gastroenterol_2009_Oct_16_9_77.txt
634 G>C,... of gastric cancer risk associated with the VEGF -634 G>C genotype frequencie,123,82,BMC_Gastroenterol_2009_Oct_16_9_77.txt
509C>T,"The roles of -509C>T, +869T>C and +915G>C SNPs in TGFB1 have bee...",184,15,BMC_Gastroenterol_2009_Oct_16_9_77.txt
869T>C,"The roles of -509C>T, +869T>C and +915G>C SNPs in TGFB1 have been implica...",184,24,BMC_Gastroenterol_2009_Oct_16_9_77.txt
915G>C,"The roles of -509C>T, +869T>C and +915G>C SNPs in TGFB1 have been implicated in the e...",184,36,BMC_Gastroenterol_2009_Oct_16_9_77.txt
509C>T,"...example, in high-risk Chinese populations, TGFB1 -509C>T was associated with a reduced risk of gastr...",184,174,BMC_Gastroenterol_2009_Oct_16_9_77.txt
2578C>A,"...d that none of four potentially functional SNPs (-2578C>A, -1498T>C, -634G>C, and +936C>T) of the VE...",186,492,BMC_Gastroenterol_2009_Oct_16_9_77.txt
1498T>C,"...e of four potentially functional SNPs (-2578C>A, -1498T>C, -634G>C, and +936C>T) of the VEGF gene or...",186,502,BMC_Gastroenterol_2009_Oct_16_9_77.txt
634G>C,"...potentially functional SNPs (-2578C>A, -1498T>C, -634G>C, and +936C>T) of the VEGF gene or their hap...",186,512,BMC_Gastroenterol_2009_Oct_16_9_77.txt
936C>T,"...unctional SNPs (-2578C>A, -1498T>C, -634G>C, and +936C>T) of the VEGF gene or their haplotypes achie...",186,525,BMC_Gastroenterol_2009_Oct_16_9_77.txt
634C>G,"...rts the notion that variant genotypes of the VEGF-634C>G polymorphism, but not other tested SNPs, ma...",191,138,BMC_Gastroenterol_2009_Oct_16_9_77.txt
6A>G,...le nucleotide polymorphisms (SNPs) including IVS4+6A>G (rs6957975) and L398L (rs2301629); and 2 newl...,25,499,BMC_Gastroenterol_2012_Oct_15_12_141.txt
52 A>G,"...8L (rs2301629); and 2 newly identified SNPs, IVS4-52 A>G and IVS17-12C>A were discovered (Table 1)",25,573,BMC_Gastroenterol_2012_Oct_15_12_141.txt
12C>A,"...nd 2 newly identified SNPs, IVS4-52 A>G and IVS17-12C>A were discovered (Table 1)",25,590,BMC_Gastroenterol_2012_Oct_15_12_141.txt
2T>C,Exon 1	2T>C	NA	p.M1?	unknown	1/39 (het: Pt-6) (0.013)	3/1...,32,8,BMC_Gastroenterol_2012_Oct_15_12_141.txt
6A>G,Intron 4	IVS4+6A>G	NA	none	benign	AA 17/39; AG 18/39; GG 4/39 (A...,33,15,BMC_Gastroenterol_2012_Oct_15_12_141.txt
52 A>G,Intron 4	IVS4-52 A>G	NA	none	benign	1/39 (het: Pt-8) (0.013)	NA	...,34,15,BMC_Gastroenterol_2012_Oct_15_12_141.txt
1194A>G,Exon 12	c.1194A>G	NA	p.L398L	benign	AA 9/39; AG 12/39; GG 18...,36,11,BMC_Gastroenterol_2012_Oct_15_12_141.txt
1814G>A,Exon 17	c.1814G>A	NA	p.R605Q	unknown	1/39 (het: Pt-7) (0.013...,37,11,BMC_Gastroenterol_2012_Oct_15_12_141.txt
12 C>A,Intron 17	IVS17-12 C>A	NA	none	benign	1/39 (het: Pt-9) (0.013)	NA	...,40,17,BMC_Gastroenterol_2012_Oct_15_12_141.txt
1G>A,"...-28]. Genotypes of those cases were 851del4/IVS11+1G>A [9,27], 1638ins23/S225X [26], and genotype no...",108,313,BMC_Gastroenterol_2012_Oct_15_12_141.txt
1G>A,"...escribed [25], the 851del4 (mutation I) and IVS11+1G>A (mutation II) are the most frequent mutations...",110,88,BMC_Gastroenterol_2012_Oct_15_12_141.txt
5G>A,"... common mutations were 1638ins23, S255X, and IVS6+5G>A [20]. There is no doubt about the pathogenici...",110,338,BMC_Gastroenterol_2012_Oct_15_12_141.txt
467C>T,...B expression. Sequencing of this A allele (having 467C>T and 1061delC associated with the common A2 ...,7,661,BMC_Genet_2003_Nov_17_4_17.txt
106C>T,"...ns regularly encountered in the O1v [O02] allele: 106C>T (Val36Phe), 188G>A (Arg63His), 220C>T (Pro7...",7,798,BMC_Genet_2003_Nov_17_4_17.txt
188G>A,"...tered in the O1v [O02] allele: 106C>T (Val36Phe), 188G>A (Arg63His), 220C>T (Pro74Ser) in exons 3, 4...",7,817,BMC_Genet_2003_Nov_17_4_17.txt
220C>T,"...02] allele: 106C>T (Val36Phe), 188G>A (Arg63His), 220C>T (Pro74Ser) in exons 3, 4 and 5, respectivel...",7,836,BMC_Genet_2003_Nov_17_4_17.txt
46G>A,"...4 and 5, respectively. The additional presence of 46G>A (Ala16Thr) was noted, whilst 189C>T that nor...",7,916,BMC_Genet_2003_Nov_17_4_17.txt
189C>T,"...al presence of 46G>A (Ala16Thr) was noted, whilst 189C>T that normally accompanies 188G>A in O1v was...",7,951,BMC_Genet_2003_Nov_17_4_17.txt
188G>A,"...as noted, whilst 189C>T that normally accompanies 188G>A in O1v was missing, as were all O1v-related...",7,984,BMC_Genet_2003_Nov_17_4_17.txt
297A>G,"... O1v-related mutations in exons 6 and 7 (261delG, 297A>G, 646T>A, 681G>A, 771C>T and 829G>A). On scr...",7,1072,BMC_Genet_2003_Nov_17_4_17.txt
646T>A,"...ated mutations in exons 6 and 7 (261delG, 297A>G, 646T>A, 681G>A, 771C>T and 829G>A). On screening o...",7,1080,BMC_Genet_2003_Nov_17_4_17.txt
681G>A,"...ations in exons 6 and 7 (261delG, 297A>G, 646T>A, 681G>A, 771C>T and 829G>A). On screening other sam...",7,1088,BMC_Genet_2003_Nov_17_4_17.txt
771C>T,"...n exons 6 and 7 (261delG, 297A>G, 646T>A, 681G>A, 771C>T and 829G>A). On screening other samples, 46...",7,1096,BMC_Genet_2003_Nov_17_4_17.txt
829G>A,"...nd 7 (261delG, 297A>G, 646T>A, 681G>A, 771C>T and 829G>A). On screening other samples, 46G>A was abs...",7,1107,BMC_Genet_2003_Nov_17_4_17.txt
46G>A,"..., 771C>T and 829G>A). On screening other samples, 46G>A was absent, but two new O alleles were found...",7,1144,BMC_Genet_2003_Nov_17_4_17.txt
188G>A,"..., a Jordanian O1 and an African O1v allele having 188G>A but lacking 189C>T. Sequencing of introns 2...",7,1244,BMC_Genet_2003_Nov_17_4_17.txt
189C>T,"...d an African O1v allele having 188G>A but lacking 189C>T. Sequencing of introns 2, 3, 4 and 5 in com...",7,1263,BMC_Genet_2003_Nov_17_4_17.txt
467C>T,...] allele differs from A1 by a seemingly innocuous 467C>T (Pro156Leu) substitution and a 1061delC tha...,17,635,BMC_Genet_2003_Nov_17_4_17.txt
188G>A,"...[5]), which has two mutations at these positions (188G>A and 189C>T). The indication that these five...",32,206,BMC_Genet_2003_Nov_17_4_17.txt
189C>T,... has two mutations at these positions (188G>A and 189C>T). The indication that these five individual...,32,217,BMC_Genet_2003_Nov_17_4_17.txt
467C>T,...s allele except for the characteristic mutations (467C>T and 1061delC in exon 7) found in the common...,41,134,BMC_Genet_2003_Nov_17_4_17.txt
106G>T,"... were similar to the consensus allele, except for 106G>T (exon 3), 188G>A (exon 4) and 220C>T (exon ...",43,77,BMC_Genet_2003_Nov_17_4_17.txt
188G>A,"...the consensus allele, except for 106G>T (exon 3), 188G>A (exon 4) and 220C>T (exon 5), all consisten...",43,94,BMC_Genet_2003_Nov_17_4_17.txt
220C>T,"..., except for 106G>T (exon 3), 188G>A (exon 4) and 220C>T (exon 5), all consistent with the presence ...",43,114,BMC_Genet_2003_Nov_17_4_17.txt
189C>T,"... allele. Surprisingly, the O1v-specific mutation, 189C>T, was absent, whereas a hitherto undescribed...",43,223,BMC_Genet_2003_Nov_17_4_17.txt
46G>A,...hereas a hitherto undescribed mutation in exon 2 (46G>A) was found in all five samples. As opposed t...,43,294,BMC_Genet_2003_Nov_17_4_17.txt
46G>A,"... as several weak A alleles) had the new mutation, 46G>A (Ala16Thr). Amongst all these samples one O1...",49,230,BMC_Genet_2003_Nov_17_4_17.txt
188G>A,...dividual was found to have the O1v-characteristic 188G>A (Arg63His) mutation. One O1v allele from an...,49,357,BMC_Genet_2003_Nov_17_4_17.txt
189C>T,... African individual lacked the O1v-characteristic 189C>T (silent) mutation,49,457,BMC_Genet_2003_Nov_17_4_17.txt
46G>A,...ce the new allele has a novel mutation in exon 2 (46G>A) and an unexpected lack of the O1v-specific ...,112,54,BMC_Genet_2003_Nov_17_4_17.txt
189C>T,"...cted lack of the O1v-specific mutation in exon 4 (189C>T), other introns in the A2-like allele of th...",112,124,BMC_Genet_2003_Nov_17_4_17.txt
205T>C,"... three adjacent mutations in intron 3. The first, 205T>C, caused a reversion to the consensus from O...",114,150,BMC_Genet_2003_Nov_17_4_17.txt
354G>A,"...rsion to the consensus from O1v-specific, whereas 354G>A and 399G>A were mutations not previously en...",114,221,BMC_Genet_2003_Nov_17_4_17.txt
399G>A,"...e consensus from O1v-specific, whereas 354G>A and 399G>A were mutations not previously encountered i...",114,232,BMC_Genet_2003_Nov_17_4_17.txt
277A>G,"...allele when compared to the A consensus sequence (277A>G, 286C>T, 911G>T and 952A>G). However, intro...",117,173,BMC_Genet_2003_Nov_17_4_17.txt
286C>T,"...hen compared to the A consensus sequence (277A>G, 286C>T, 911G>T and 952A>G). However, intron 6 in t...",117,181,BMC_Genet_2003_Nov_17_4_17.txt
911G>T,"...ared to the A consensus sequence (277A>G, 286C>T, 911G>T and 952A>G). However, intron 6 in three nor...",117,189,BMC_Genet_2003_Nov_17_4_17.txt
952A>G,"... A consensus sequence (277A>G, 286C>T, 911G>T and 952A>G). However, intron 6 in three normal A2 alle...",117,200,BMC_Genet_2003_Nov_17_4_17.txt
106C>T,"...veral respects. The O1v-characteristic mutations, 106C>T, 188G>A and 220C>T in exons 3, 4 and 5, res...",122,97,BMC_Genet_2003_Nov_17_4_17.txt
188G>A,"...spects. The O1v-characteristic mutations, 106C>T, 188G>A and 220C>T in exons 3, 4 and 5, respectivel...",122,105,BMC_Genet_2003_Nov_17_4_17.txt
220C>T,"... O1v-characteristic mutations, 106C>T, 188G>A and 220C>T in exons 3, 4 and 5, respectively, in combi...",122,116,BMC_Genet_2003_Nov_17_4_17.txt
46G>A,"...al interesting characteristics. The mutation, nt. 46G>A (Ala16Thr) in exon 2, has not been described...",126,87,BMC_Genet_2003_Nov_17_4_17.txt
188G>A,Few mutations have been found in exon 4. Both 188G>A and 189C>T have hitherto been exclusive cha...,128,47,BMC_Genet_2003_Nov_17_4_17.txt
189C>T,...ations have been found in exon 4. Both 188G>A and 189C>T have hitherto been exclusive characteristic...,128,58,BMC_Genet_2003_Nov_17_4_17.txt
190 G>A,...been exclusive characteristics of the O1v allele; 190 G>A has only been found in some Brazilian Blac...,128,129,BMC_Genet_2003_Nov_17_4_17.txt
203G>C,...ound in some Brazilian Black O1 alleles [29]; and 203G>C occurred in some Scandinavian Aweak alleles...,128,202,BMC_Genet_2003_Nov_17_4_17.txt
188G>A,...e Scandinavian Aweak alleles [16]. The finding of 188G>A without 189C>T in the new allele was also u...,128,274,BMC_Genet_2003_Nov_17_4_17.txt
189C>T,...Aweak alleles [16]. The finding of 188G>A without 189C>T in the new allele was also unexpected. When...,128,289,BMC_Genet_2003_Nov_17_4_17.txt
188G>A,... one otherwise normal O1v allele (African) having 188G>A but lacking 189C>T and one otherwise normal...,128,451,BMC_Genet_2003_Nov_17_4_17.txt
189C>T,...al O1v allele (African) having 188G>A but lacking 189C>T and one otherwise normal O1 allele (Jordani...,128,470,BMC_Genet_2003_Nov_17_4_17.txt
188G>A,"...one otherwise normal O1 allele (Jordanian) having 188G>A. Although infrequent, additional genetic di...",128,531,BMC_Genet_2003_Nov_17_4_17.txt
46G>A,"...he concerted effect of the mutations in exon 2 at 46G>A (Ala16Thr), exon 3 at 106G>T (Val36Phe), exo...",130,829,BMC_Genet_2003_Nov_17_4_17.txt
106G>T,"...utations in exon 2 at 46G>A (Ala16Thr), exon 3 at 106G>T (Val36Phe), exon 4 at 188G>A (Arg63His) and...",130,857,BMC_Genet_2003_Nov_17_4_17.txt
188G>A,"...Ala16Thr), exon 3 at 106G>T (Val36Phe), exon 4 at 188G>A (Arg63His) and exon 5 at 220C>T (Pro74Ser)....",130,886,BMC_Genet_2003_Nov_17_4_17.txt
220C>T,"...36Phe), exon 4 at 188G>A (Arg63His) and exon 5 at 220C>T (Pro74Ser). However, theoretically the Awea...",130,918,BMC_Genet_2003_Nov_17_4_17.txt
205C>T,"... (the consensus 205C rather than the O1v-specific 205C>T, as well as the unique 354G>A and 399G>A) a...",134,117,BMC_Genet_2003_Nov_17_4_17.txt
354G>A,"...an the O1v-specific 205C>T, as well as the unique 354G>A and 399G>A) appear to be a specific charact...",134,147,BMC_Genet_2003_Nov_17_4_17.txt
399G>A,"...specific 205C>T, as well as the unique 354G>A and 399G>A) appear to be a specific characteristic of ...",134,158,BMC_Genet_2003_Nov_17_4_17.txt
46G>A,"...o novel changes, the most important one of which (46G>A) results in an amino acid substitution in th...",141,344,BMC_Genet_2003_Nov_17_4_17.txt
189C>T,...osyltransferase). The other novel change (lack of 189C>T) led further to the identification of two n...,141,508,BMC_Genet_2003_Nov_17_4_17.txt
188G>A,... intron fragments and for screening for mutations 188G>A and 46A>G. Amplifications were performed wi...,161,219,BMC_Genet_2003_Nov_17_4_17.txt
46A>G,...gments and for screening for mutations 188G>A and 46A>G. Amplifications were performed with primer p...,161,230,BMC_Genet_2003_Nov_17_4_17.txt
46G>A,...mplification-sequencing of intron 2 /screening of 46G>A,167,92,BMC_Genet_2003_Nov_17_4_17.txt
46G>A,...A-F	F4	CCAGGAAAACCAAAATGCCACA	exon 2	screening of 46G>A,168,57,BMC_Genet_2003_Nov_17_4_17.txt
188G>A,...I-F	F9	GCTGGCCGTTACAGGGTCTG	intron 3	screening of 188G>A mutation in exon 4,178,59,BMC_Genet_2003_Nov_17_4_17.txt
488 G>A,"... and all other populations, due to the p.R163Q (c.488 G>A) polymorphism. The least amount of differe...",9,408,BMC_Genet_2008_Apr_10_9_31.txt
52 C>G,p.P18A	c.52 C>G	0	0	0	0	0.08	0	0	0,40,10,BMC_Genet_2008_Apr_10_9_31.txt
104 G>A,p.C35Y	c.104 G>A	0	0	0	0	0	0.12	0	0,41,10,BMC_Genet_2008_Apr_10_9_31.txt
112 G>A,p.V38M	c.112 G>A	0	0	0	0	0	0.06	0	0,42,10,BMC_Genet_2008_Apr_10_9_31.txt
130 C>G,p.L44V	c.130 C>G	0	0	0	0	0	0.06	0	0,43,10,BMC_Genet_2008_Apr_10_9_31.txt
133 T>C,p.F45L	c.133 T>C	0	0	0	0	0	0.24	0	0,44,10,BMC_Genet_2008_Apr_10_9_31.txt
140 G>T,p.S47I	c.140 G>T	0	0.43	0	0	0	0	0	0,45,10,BMC_Genet_2008_Apr_10_9_31.txt
150 G>A,p.L50L	c.150 G>A	0	1.28	0	0	0	0	0	0,46,10,BMC_Genet_2008_Apr_10_9_31.txt
178 G>T,p.V60L	c.178 G>T	0.10	0	0	0	10.69	15.75	13.21	0,47,10,BMC_Genet_2008_Apr_10_9_31.txt
200 G>A,p.R67Q	c.200 G>A	0	0	1.17	0	0	0.06	0	0,48,10,BMC_Genet_2008_Apr_10_9_31.txt
241 G>C,p.A81P	c.241 G>C	0	0	0	0	0.08	0	0	0,49,10,BMC_Genet_2008_Apr_10_9_31.txt
247 T>C,p.S83P	c.247 T>C	0	0	0	0	0.15	0.12	0.19	0,50,10,BMC_Genet_2008_Apr_10_9_31.txt
248 C>T,p.S83L	c.248 C>T	0	0	0	0	0	0.06	0	0,51,10,BMC_Genet_2008_Apr_10_9_31.txt
252 C>A,p.D84E	c.252 C>A	0	0	0	0	1.00	0.12	1.51	0,52,10,BMC_Genet_2008_Apr_10_9_31.txt
274 G>A,p.V92M	c.274 G>A	0.07	0	13.41	0.94	8.00	3.70	9.06	3.75,53,10,BMC_Genet_2008_Apr_10_9_31.txt
284 C>T,p.T95M	c.284 C>T	0	0	0	0	0.08	0.12	0	0,54,10,BMC_Genet_2008_Apr_10_9_31.txt
295 C>A,p.L99I	c.295 C>A	0	0.43	0	0	0	0	0	0,55,10,BMC_Genet_2008_Apr_10_9_31.txt
309 C>T,p.A103A	c.309 C>T	0	0.43	0	0	0	0	0	0,56,11,BMC_Genet_2008_Apr_10_9_31.txt
317 T>A,p.L106Q	c.317 T>A	0	0	0	0	0	0.06	0	0,57,11,BMC_Genet_2008_Apr_10_9_31.txt
318 G>A,L106L	c.318 G>A	0	1.71	0	0	0	0.12	0	0,58,9,BMC_Genet_2008_Apr_10_9_31.txt
332 C>T,p.A111V	c.332 C>T	0	0	0	0	0	0.18	0	0,59,11,BMC_Genet_2008_Apr_10_9_31.txt
359 T>C,p.I120T	c.359 T>C	0	0	1.75	0	0	0.06	0	0,60,11,BMC_Genet_2008_Apr_10_9_31.txt
364 G>A,p.V122M	c.364 G>A	0	0	0	0	0	0.24	0	0,61,11,BMC_Genet_2008_Apr_10_9_31.txt
366 G>C,p.V122V	c.366 G>C	0	0	0	0	0	0.12	0	0,62,11,BMC_Genet_2008_Apr_10_9_31.txt
425 G>A,p.R142H	c.425 G>A	0.01	0	0	0	0.62	1.31	0.75	0,63,11,BMC_Genet_2008_Apr_10_9_31.txt
451 C>T,p.R151C	c. 451 C>T	0.03	0	0	0	5.62	3.16	6.42	0,64,12,BMC_Genet_2008_Apr_10_9_31.txt
456 C>A,p.Y152X	c.456 C>A	0	0	0	0	0	0.06	0	0,65,11,BMC_Genet_2008_Apr_10_9_31.txt
464 T>C,p.I155T	c.464 T>C	0	0	0	0	0.23	0.48	1.51	0,66,11,BMC_Genet_2008_Apr_10_9_31.txt
478 C>T,p.R160W	c.478 C>T	0.04	0	0	0	8.31	1.85	7.17	0,67,11,BMC_Genet_2008_Apr_10_9_31.txt
479 G>A,p.R160Q	c.479 G>A	0	0	0	0	0	0.06	0	5,68,11,BMC_Genet_2008_Apr_10_9_31.txt
488 G>A,p.R163Q	c.488 G>A	0.14	0	75.51	4.72	4.62	1.61	4.15	0,69,11,BMC_Genet_2008_Apr_10_9_31.txt
498 G>A,p.A166A	c.498 G>A	0	0	0	0	0	0	0	11.25,70,11,BMC_Genet_2008_Apr_10_9_31.txt
504 C>T,p.I168I	c.504 C>T	0	0.43	0	0	0	0	0	0,71,11,BMC_Genet_2008_Apr_10_9_31.txt
512 C>A,p.A171D	c.512 C>A	0	0	0	0	0	0.06	0	0,72,11,BMC_Genet_2008_Apr_10_9_31.txt
520 G>A,p.V174I	c.520 G>A	0	0	0	0	0.08	0	0	0,73,11,BMC_Genet_2008_Apr_10_9_31.txt
546 C>T,p.Y182Y	c.546 C>T	0	0	0	0	0	0	0.19	0,74,11,BMC_Genet_2008_Apr_10_9_31.txt
586 T>C,p.F196L	c.586 T>C	0	2.14	0.15	0	0.08	0	0	0,75,11,BMC_Genet_2008_Apr_10_9_31.txt
637 C>T,p.R213W	c.637 C>T	0	0	0	0	0	0.06	0	0,76,11,BMC_Genet_2008_Apr_10_9_31.txt
660 C>T,p.G220G	c.660 C>T	0	0	0	0	0	0.06	0	0,77,11,BMC_Genet_2008_Apr_10_9_31.txt
684 G>A,p.Q228Q	c.684 G>A	0	0	0	0	0	0.12	0	0,78,11,BMC_Genet_2008_Apr_10_9_31.txt
689 C>T,p.P230L	c.689 C>T	0	0	0	0	0.31	0	0	0,79,11,BMC_Genet_2008_Apr_10_9_31.txt
690 G>A,p.P230P	c.690 G>A	0	0	0	0	0.08	0	0	0,80,11,BMC_Genet_2008_Apr_10_9_31.txt
699 G>A,p.Q233Q	c.699 G>A	0	0	0	0	0	0.36	0.19	0,81,11,BMC_Genet_2008_Apr_10_9_31.txt
720 T>C,p.A240A	c.720 T>C	0	0	0	0	0	0	0.19	0,82,11,BMC_Genet_2008_Apr_10_9_31.txt
726 C>T,p.T242T	c.726 C>T	0	0	0	0	0	0.12	0	0,83,11,BMC_Genet_2008_Apr_10_9_31.txt
743 G>T,p.G248V	c.743 G>T	0	0	0	0	0	0.06	0	0,84,11,BMC_Genet_2008_Apr_10_9_31.txt
779 A>C,p.H260P	c.779 A>C	0	0	0	0	0.23	0	0	0,85,11,BMC_Genet_2008_Apr_10_9_31.txt
792 C>T,p.I264I	c.792 C>T	0	0	0	0	0.15	0	0	0,86,11,BMC_Genet_2008_Apr_10_9_31.txt
795 C>G,p.V265V	c.795 C>G	0	1.28	0	0	0	0	0	0,87,11,BMC_Genet_2008_Apr_10_9_31.txt
819 C>T,p.C273C	c.819 C>T	0	0.43	0	0	0	0	0	0,88,11,BMC_Genet_2008_Apr_10_9_31.txt
832 A>G,p.K278E	c.832 A>G	0	0	0	0	0.23	0.24	0	0,89,11,BMC_Genet_2008_Apr_10_9_31.txt
837 C>A,p.N279K	c.837 C>A	0	0	0	0	0	0.06	0	0,90,11,BMC_Genet_2008_Apr_10_9_31.txt
880 G>C,p.D294H	c.880 G>C	0.01	0	0	0	1	1.43	2.45	0,91,11,BMC_Genet_2008_Apr_10_9_31.txt
900 C>T,p.F300F	c.900 C>T	0	2.99	0	0	0	0	0	0,92,11,BMC_Genet_2008_Apr_10_9_31.txt
923 C>T,p.T308M	c.923 C>T	0	0	0	0	0	0.06	0	0,93,11,BMC_Genet_2008_Apr_10_9_31.txt
942 A>G,p.T314T	c.942 A>G	0.09	44.44	13.27	13.21	7.69	2.33	10.75	18....,94,11,BMC_Genet_2008_Apr_10_9_31.txt
488 G>A,"..., most likely due to the presence of the R163Q (c.488 G>A) SNP, which was present in 75% of Asians s...",169,574,BMC_Genet_2008_Apr_10_9_31.txt
451C>T,"...t (e.g. the allele frequency of the T allele of c.451C>T, p.R151C, was 1.9% in Greece but 10.2% in B...",171,665,BMC_Genet_2008_Apr_10_9_31.txt
2T > C," VDR	c.2T > C, Met1Th",54,8,BMC_Genet_2010_Oct_21_11_95.txt
283G > A,c.1024+283G >,57,9,BMC_Genet_2010_Oct_21_11_95.txt
1056T > C,"c.1056T > C, Ile352Il",60,4,BMC_Genet_2010_Oct_21_11_95.txt
174G > C, IL6	-174G >,63,7,BMC_Genet_2010_Oct_21_11_95.txt
1377C > T," CTR	c.1377C > T, Pro463Le",66,8,BMC_Genet_2010_Oct_21_11_95.txt
1024G > T, COL1A1	c.101+1024G >,69,15,BMC_Genet_2010_Oct_21_11_95.txt
14T > C,c.1930-14T >,72,9,BMC_Genet_2010_Oct_21_11_95.txt
3261C > T,c.3261C >,75,4,BMC_Genet_2010_Oct_21_11_95.txt
68A > G, COL1A2	c.280-68A >,78,15,BMC_Genet_2010_Oct_21_11_95.txt
41G > A,c.1666-41G >,81,9,BMC_Genet_2010_Oct_21_11_95.txt
2007G > A," LRP5	c.2007G > A, E644",87,9,BMC_Genet_2010_Oct_21_11_95.txt
2074G > A,"c.2074G > A, V667",90,4,BMC_Genet_2010_Oct_21_11_95.txt
3432A > G,"c.3432A > G, V1119",93,4,BMC_Genet_2010_Oct_21_11_95.txt
4064C > T,"c.4064C > T, A1330",96,4,BMC_Genet_2010_Oct_21_11_95.txt
64G>A,"...rozen. Genotypes of the individuals for the SILV c64G>A mutation, presumably responsible for dilutio...",159,1058,BMC_Genomics_2007_Sep_24_8_335.txt
4	H > L,C-TSK	3.4	H > L > C	57	14	4,92,9,BMC_Genomics_2009_Sep_14_10_430.txt
4	H > C,"ICER	3.4	H > C, C = L, L = H	12	NS	NS",93,8,BMC_Genomics_2009_Sep_14_10_430.txt
2	H > C,"HSD17B7	3.2	H > C, H > L, C = L	14	NS	4",94,11,BMC_Genomics_2009_Sep_14_10_430.txt
3072G>A,...eorges M Buys N Indirect effect of IGF2 intron3 g.3072G>A mutation on prolificacy in sows Anim Genet...,219,147,BMC_Genomics_2014_Feb_24_15_156.txt
2881C>T,"...eptor (EGFR) inhibitors; however, a KDR p.R961W c.2881C>T mutation was noted as a variant of unknown...",9,1252,Cureus_8(2)_e478.txt
2881C>T,"...ptor (EGFR) inhibitors, however the KDR p.R961W c.2881C>T mutation that was noted as a variant of un...",26,722,Cureus_8(2)_e478.txt
2881C>T,...omarker of response to regorafenib. KDR p.R961W c.2881C>T mutation has been reported twice in COSMIC...,50,1101,Cureus_8(2)_e478.txt
964A>G,"rs153109, corresponding to position c.-964A>G of the IL-27 locus, was amplified from geno...",7,40,BMC_Infect_Dis_2014_Sep_5_14(Suppl_5)_S5.txt
964 A>G,... of IL-27p28. The genotype distribution of the c.-964 A>G polymorphism was more present in patients ...,10,225,BMC_Infect_Dis_2014_Sep_5_14(Suppl_5)_S5.txt
964A>G,"...ular, we analyzed the genotype of this SNP on c. -964A>G. Our data show a different distribution of ...",92,215,BMC_Infect_Dis_2014_Sep_5_14(Suppl_5)_S5.txt
275T>A,...ypers D Le MY van der WM Mamelok R van GT UGT1A9 -275T>A/-2152C>T polymorphisms correlate with low M...,138,116,BMC_Med_2013_Jan_11_11_9.txt
2152C>T,...Le MY van der WM Mamelok R van GT UGT1A9 -275T>A/-2152C>T polymorphisms correlate with low MPA expos...,138,124,BMC_Med_2013_Jan_11_11_9.txt
7445A>G,"...f five known mitochondrial mutations (m.A1555G, m.7445A>G, m.7472insC, m.7510T>C, m.7511T>C) was per...",36,598,BMC_Med_Genet_2005_Mar_24_6_12.txt
7510T>C,"...ial mutations (m.A1555G, m.7445A>G, m.7472insC, m.7510T>C, m.7511T>C) was performed in the GJB2 nega...",36,621,BMC_Med_Genet_2005_Mar_24_6_12.txt
7511T>C,"...ns (m.A1555G, m.7445A>G, m.7472insC, m.7510T>C, m.7511T>C) was performed in the GJB2 negative patien...",36,632,BMC_Med_Genet_2005_Mar_24_6_12.txt
27G>C,"... shown on Table 2. A new sequence variation, IVS1+27G>C, was identified in one Altaian patient with ...",47,814,BMC_Med_Genet_2005_Mar_24_6_12.txt
27G>C,...ent with severe-profound HL who had genotype IVS1+27G>C / [V27I; E114G] (Table 1) and in his non-aff...,47,905,BMC_Med_Genet_2005_Mar_24_6_12.txt
27G>C,...1) and in his non-affected mother (genotyped IVS1+27G>C/+). The IVS1+27G>C variation was not previou...,47,984,BMC_Med_Genet_2005_Mar_24_6_12.txt
27G>C,"...ffected mother (genotyped IVS1+27G>C/+). The IVS1+27G>C variation was not previously described, but ...",47,1003,BMC_Med_Genet_2005_Mar_24_6_12.txt
765C>T,"...ts non-pathogenic consequences [27]. Finally, the 765C>T polymorphism (referred to as SNP1 [9]) loca...",47,1150,BMC_Med_Genet_2005_Mar_24_6_12.txt
1555A>G,"...he Δ(GJB6-D13S1830) and mitochondrial mutations m.1555A>G, m.7445A>G, m.7472insC, m.7510T>C, m.7511T...",50,65,BMC_Med_Genet_2005_Mar_24_6_12.txt
7445A>G,"...13S1830) and mitochondrial mutations m.1555A>G, m.7445A>G, m.7472insC, m.7510T>C, m.7511T>C was nega...",50,76,BMC_Med_Genet_2005_Mar_24_6_12.txt
7510T>C,"...ial mutations m.1555A>G, m.7445A>G, m.7472insC, m.7510T>C, m.7511T>C was negative in patients who ha...",50,99,BMC_Med_Genet_2005_Mar_24_6_12.txt
7511T>C,"...ns m.1555A>G, m.7445A>G, m.7472insC, m.7510T>C, m.7511T>C was negative in patients who had no GJB2 m...",50,110,BMC_Med_Genet_2005_Mar_24_6_12.txt
224G>A,"...guage to communicate. The dominant mutation R75Q (224G>A) was found in five members, as the sole mut...",59,233,BMC_Med_Genet_2005_Mar_24_6_12.txt
516G>C,...cular phenotype. The new missense mutation W172C (516G>C) was identified in trans of the 235delC all...,59,1378,BMC_Med_Genet_2005_Mar_24_6_12.txt
27G>C,IVS1+27G>C / [V27I; E114G]	1	Altaian,107,6,BMC_Med_Genet_2005_Mar_24_6_12.txt
516G>C,W172C	516G>C,123,7,BMC_Med_Genet_2005_Mar_24_6_12.txt
224G>A,R75Q	224G>A,144,6,BMC_Med_Genet_2005_Mar_24_6_12.txt
27G>C,IVS1+27G>C,151,7,BMC_Med_Genet_2005_Mar_24_6_12.txt
79G>A,V27I	79G>A	1,156,6,BMC_Med_Genet_2005_Mar_24_6_12.txt
79G>A,[V27I; E114G]	79G>A+341A>G,163,15,BMC_Med_Genet_2005_Mar_24_6_12.txt
341A>G,[V27I; E114G]	79G>A+341A>G,163,21,BMC_Med_Genet_2005_Mar_24_6_12.txt
571T>C,F191L	571T>C,170,7,BMC_Med_Genet_2005_Mar_24_6_12.txt
457G >A,V153I	457G >A,177,7,BMC_Med_Genet_2005_Mar_24_6_12.txt
207G>C,...he OCTN2-promoter (rs2631367) is a transversion (-207G>C) disrupting a heat shock element in the pro...,24,856,BMC_Med_Genet_2006_Jun_23_7_54.txt
207G>C,"...173605_1, respectively. For the SLC22A5 promoter -207G>C (rs2631367), a TaqMan Assay by Design was p...",31,366,BMC_Med_Genet_2006_Jun_23_7_54.txt
1672G>C,"Regarding the L503F (1672G>C) polymorphism, it was described by Pelteko...",67,22,BMC_Med_Genet_2006_Jun_23_7_54.txt
207G>C,"...ohn's disease, together with the OCTN2-promoter (-207G>C) variant. In fact, the authors found that t...",67,179,BMC_Med_Genet_2006_Jun_23_7_54.txt
207G>C,...for alleles and genotypes of the OCTN2-promoter (-207G>C) and of the other SLC22A5 intronic variant ...,67,934,BMC_Med_Genet_2006_Jun_23_7_54.txt
79 C>G,"...dy, we evaluated the potential relevance of the c.79 C>G (p.Gln27Glu) polymorphism of this receptor ...",9,69,BMC_Med_Genet_2006_Mar_30_7_31.txt
79 C>G,The genotyping for the c.79 C>G (p.Gln27Glu) polymorphism of β2-AR was dete...,27,26,BMC_Med_Genet_2006_Mar_30_7_31.txt
1131T > C,... reported that in these patients carriers of the -1131T > C and S19W variants in the APOA5 gene were...,180,64,BMC_Med_Genet_2007_Aug_29_8_56.txt
1131T > C,...ld A Beil FU  The single nucleotide polymorphism -1131T > C in the apolipoprotein A5 (APOA5) gene is...,222,65,BMC_Med_Genet_2007_Aug_29_8_56.txt
948976A>G,"...sed the association of four CAPN5 gene variants(rs948976A>G, rs4945140G>A, rs2233546C>T and rs223354...",6,692,BMC_Med_Genet_2007_Jan_16_8_1.txt
4945140G>A,"...iation of four CAPN5 gene variants(rs948976A>G, rs4945140G>A, rs2233546C>T and rs2233549G>A) with se...",6,705,BMC_Med_Genet_2007_Jan_16_8_1.txt
2233546C>T,"... CAPN5 gene variants(rs948976A>G, rs4945140G>A, rs2233546C>T and rs2233549G>A) with several cardiova...",6,719,BMC_Med_Genet_2007_Jan_16_8_1.txt
2233549G>A,"...nts(rs948976A>G, rs4945140G>A, rs2233546C>T and rs2233549G>A) with several cardiovascular risk facto...",6,736,BMC_Med_Genet_2007_Jan_16_8_1.txt
948976 A>G,We have analysed two polymorphisms in intron 1 (rs948976 A>G and rs4945140 G>A) and two polymorphism...,69,51,BMC_Med_Genet_2007_Jan_16_8_1.txt
4945140 G>A,"...two polymorphisms in intron 1 (rs948976 A>G and rs4945140 G>A) and two polymorphisms located in the,...",69,68,BMC_Med_Genet_2007_Jan_16_8_1.txt
223546 C>T,"...rphisms located in the, intron 3 of CAPN5 gene (rs223546 C>T and rs223549 G>A) (Figure 1). These las...",69,145,BMC_Med_Genet_2007_Jan_16_8_1.txt
223549 G>A,"...n the, intron 3 of CAPN5 gene (rs223546 C>T and rs223549 G>A) (Figure 1). These last two SNPs are lo...",69,162,BMC_Med_Genet_2007_Jan_16_8_1.txt
948976 A>G,"...ies in our population were 0.74 for A allele in rs948976 A>G, 0.57 for G allele in rs4945140 G>A, 0....",84,163,BMC_Med_Genet_2007_Jan_16_8_1.txt
4945140 G>A,"... A allele in rs948976 A>G, 0.57 for G allele in rs4945140 G>A, 0.94 for C allele in rs223546 C>T and...",84,198,BMC_Med_Genet_2007_Jan_16_8_1.txt
223546 C>T,"...G allele in rs4945140 G>A, 0.94 for C allele in rs223546 C>T and 0.80 for G allele in rs223549G>A. T...",84,234,BMC_Med_Genet_2007_Jan_16_8_1.txt
223549G>A,...allele in rs223546 C>T and 0.80 for G allele in rs223549G>A. The rs223546 is the less informative on...,84,272,BMC_Med_Genet_2007_Jan_16_8_1.txt
948976 A>G,rs948976 A>G	0.74	0.39	AA	AG	GG,89,3,BMC_Med_Genet_2007_Jan_16_8_1.txt
4945140 G>A,rs4945140 G>A	0.57	0.40	GG	GA	AA,92,3,BMC_Med_Genet_2007_Jan_16_8_1.txt
223546 C>T,rs223546 C>T	0.94	1.0	CC	CT	TT,95,3,BMC_Med_Genet_2007_Jan_16_8_1.txt
223549 G>A,rs223549 G>A	0.80	0.13	GG	GA	AA,98,3,BMC_Med_Genet_2007_Jan_16_8_1.txt
948976 A>G,"...markers of the first cluster (table 3). For the rs948976 A>G polymorphism, wild type homozygotes hav...",102,144,BMC_Med_Genet_2007_Jan_16_8_1.txt
4945140 G>A,...the presence of the polymorphic A allele at the rs4945140 G>A locus is associated with increased BMI...,102,362,BMC_Med_Genet_2007_Jan_16_8_1.txt
4945140 G>A,"...A, 27.8 ± 4.2 kg/m2; p = 0.041, r2 = 2.0%). The rs4945140 G>A marker is also associated with DBP val...",102,547,BMC_Med_Genet_2007_Jan_16_8_1.txt
223549G>A,"....0%). Finally, HDL-c levels are associated with rs223549G>A genotypes; raised HDL-c values are relat...",102,796,BMC_Med_Genet_2007_Jan_16_8_1.txt
948976 A>G,"...ur polymorphisms analysed are in two LD blocks: rs948976 A>G and rs4945140 G>A in intron 1 (D' = -1,...",114,57,BMC_Med_Genet_2007_Jan_16_8_1.txt
4945140 G>A,"...analysed are in two LD blocks: rs948976 A>G and rs4945140 G>A in intron 1 (D' = -1, r2 = 0.26) and r...",114,74,BMC_Med_Genet_2007_Jan_16_8_1.txt
223546 C>T,"...945140 G>A in intron 1 (D' = -1, r2 = 0.26) and rs223546 C>T and rs223549G>A in intron 3 (D' = -1, r...",114,125,BMC_Med_Genet_2007_Jan_16_8_1.txt
223549G>A,"...ron 1 (D' = -1, r2 = 0.26) and rs223546 C>T and rs223549G>A in intron 3 (D' = -1, r2 = 0.02), separa...",114,142,BMC_Med_Genet_2007_Jan_16_8_1.txt
948976A>G,BASE SEQUENCE (rs948976A>G/rs4945140G>A/rs223546C>T/rs223546G>A)	PO...,118,18,BMC_Med_Genet_2007_Jan_16_8_1.txt
4945140G>A,BASE SEQUENCE (rs948976A>G/rs4945140G>A/rs223546C>T/rs223546G>A)	POPULATION FRE...,118,30,BMC_Med_Genet_2007_Jan_16_8_1.txt
223546C>T,BASE SEQUENCE (rs948976A>G/rs4945140G>A/rs223546C>T/rs223546G>A)	POPULATION FREQUENCY,118,43,BMC_Med_Genet_2007_Jan_16_8_1.txt
223546G>A,... SEQUENCE (rs948976A>G/rs4945140G>A/rs223546C>T/rs223546G>A)	POPULATION FREQUENCY,118,55,BMC_Med_Genet_2007_Jan_16_8_1.txt
330A > G,"...ns in the BRCA1 gene (c.187-188delAG [p.Q23fs], c.330A > G, [p.64-71del], c.5236G > A [p.G1706A], c....",20,147,BMC_Med_Genet_2007_Jun_29_8_40.txt
5236G > A,"...7-188delAG [p.Q23fs], c.330A > G, [p.64-71del], c.5236G > A [p.G1706A], c.5242C > A [p.A1708E], c.58...",20,173,BMC_Med_Genet_2007_Jun_29_8_40.txt
5242C > A,"...330A > G, [p.64-71del], c.5236G > A [p.G1706A], c.5242C > A [p.A1708E], c.589-590delCT [p.S157X]; nu...",20,197,BMC_Med_Genet_2007_Jun_29_8_40.txt
330A > G,"...nes identified in Spain (BRCA1: c.187-188delAG, c.330A > G, c.5236G > A, c.5242C > A, c.589-590delCT...",28,328,BMC_Med_Genet_2007_Jun_29_8_40.txt
5236G > A,"...ed in Spain (BRCA1: c.187-188delAG, c.330A > G, c.5236G > A, c.5242C > A, c.589-590delCT; numbered G...",28,340,BMC_Med_Genet_2007_Jun_29_8_40.txt
5242C > A,"...BRCA1: c.187-188delAG, c.330A > G, c.5236G > A, c.5242C > A, c.589-590delCT; numbered GeneBank U1468...",28,353,BMC_Med_Genet_2007_Jun_29_8_40.txt
5236 G > C,...ication in the same amplicon was used to detect c.5236 G > C and c.589-590delCT closely positioned i...,31,637,BMC_Med_Genet_2007_Jun_29_8_40.txt
330 A > G,BRCA1 c.330 A > G (p.64-71del)	F ggctcttaagggcagttgt,38,9,BMC_Med_Genet_2007_Jun_29_8_40.txt
5236 G > C,BRCA1 c.5236 G > C (p.G1706A,42,9,BMC_Med_Genet_2007_Jun_29_8_40.txt
5242 C > A,BRCA1 c.5242 C > A (p.A1708E)	F ggacagcacttcctgatttt,43,9,BMC_Med_Genet_2007_Jun_29_8_40.txt
5236 G > C,BRCA1 c.5236 G > C	F gacttgaacggacactgaaatattttctag	30	G/C...,59,9,BMC_Med_Genet_2007_Jun_29_8_40.txt
330 A > G,BRCA1 c.330 A > G	F gactgatgtcctttatgtaagaatgatataaccaaa	3...,60,9,BMC_Med_Genet_2007_Jun_29_8_40.txt
5242C > A,BRCA1 c.5242C > A	R acgactgactgactgactgactgactgactgactgact...,64,9,BMC_Med_Genet_2007_Jun_29_8_40.txt
5242C > A,"...ti-sense DNA strand, for the detection of BRCA1 c.5242C > A mutation we used anti-sense primer. The ...",70,181,BMC_Med_Genet_2007_Jun_29_8_40.txt
5242 G > A,"...mplicon encompassing the two exon 18 mutations: c.5242 G > A, and c.589-590delCT of BRCA1 gene. Ampl...",73,181,BMC_Med_Genet_2007_Jun_29_8_40.txt
330A > G,"...indels, as in our design (some point mutations: c.330A > G or c.5236G > A, and some indels: c.187-18...",93,1672,BMC_Med_Genet_2007_Jun_29_8_40.txt
5236G > A,"...our design (some point mutations: c.330A > G or c.5236G > A, and some indels: c.187-188delAG or c.30...",93,1686,BMC_Med_Genet_2007_Jun_29_8_40.txt
330A > G,...this is the occurrence of two Spanish mutations c.330A > G in BRCA1 and c.6857-6858delAA in BRCA2 in...,95,635,BMC_Med_Genet_2007_Jun_29_8_40.txt
406C>T,...d the presence of previously reported mutations c.406C>T (p.Arg110>Cys) in two families (family A&B)...,12,392,BMC_Med_Genet_2007_Nov_9_8_67.txt
475C>T,...(p.Arg110>Cys) in two families (family A&B) and c.475C>T (p.Arg133>Cys) mutation in family C,12,449,BMC_Med_Genet_2007_Nov_9_8_67.txt
406C>T,A	Saudi	c.406C>T	3	p.Arg110>Cys	EGF2	ND,40,11,BMC_Med_Genet_2007_Nov_9_8_67.txt
406C>T,B	Kuwait	c.406C>T	3	p.Arg110>Cys	EGF2	ND,41,12,BMC_Med_Genet_2007_Nov_9_8_67.txt
475 C>T,C	Yemen	c.475 C>T	4	p.Arg133>Cys	EGF3	ND,42,11,BMC_Med_Genet_2007_Nov_9_8_67.txt
406C>T,"...CH3 gene, revealed the presence of heterozygous c.406C>T (p.Arg110>Cys) pathogenic mutation in exon ...",55,806,BMC_Med_Genet_2007_Nov_9_8_67.txt
406C>T,...CH3 gene; revealed the presence of heterozygous c.406C>T (p.Arg110>Cys) pathogenic mutation in exon ...,58,731,BMC_Med_Genet_2007_Nov_9_8_67.txt
475C>T,...nce of a previously known heterozygous mutation c.475C>T (p.Arg133>Cys) in exon 4 [1]. This mutation...,61,701,BMC_Med_Genet_2007_Nov_9_8_67.txt
1025G>C,"...SNP upstream of the INSIG2 gene, rs7566605 (g.-10,1025G>C, Chr2:118,552,255, NT_022135.15), was repo...",6,60,BMC_Med_Genet_2008_Dec_23_9_117.txt
1025G>C,"...nce that the INSIG2 promoter SNP rs7566605 (g.-10,1025G>C, Chr2:118,552,255, NT_022135.15) was assoc...",20,282,BMC_Med_Genet_2008_Dec_23_9_117.txt
471G>A,"...es. Two of the single nucleotide substitutions, c.471G>A and c.807G>A and the insertion (c.388+3insT...",12,389,BMC_Med_Genet_2008_Jun_20_9_54.txt
807G>A,"...e single nucleotide substitutions, c.471G>A and c.807G>A and the insertion (c.388+3insT) were close ...",12,402,BMC_Med_Genet_2008_Jun_20_9_54.txt
3912G>C,"...as a transversion in the last base of intron 7, g.3912G>C (c.808-1G>C) so altering the consensus acc...",12,611,BMC_Med_Genet_2008_Jun_20_9_54.txt
1G>C,"...on in the last base of intron 7, g.3912G>C (c.808-1G>C) so altering the consensus acceptor splice si...",12,626,BMC_Med_Genet_2008_Jun_20_9_54.txt
101A>T,"...le nucleotide substitutions were transversions: c.101A>T, c.995G>C and c.670 T>G that result in p.E3...",12,839,BMC_Med_Genet_2008_Jun_20_9_54.txt
995G>C,"...ide substitutions were transversions: c.101A>T, c.995G>C and c.670 T>G that result in p.E34V, p.G332...",12,849,BMC_Med_Genet_2008_Jun_20_9_54.txt
670 T>G,"...ions were transversions: c.101A>T, c.995G>C and c.670 T>G that result in p.E34V, p.G332A and W224G a...",12,862,BMC_Med_Genet_2008_Jun_20_9_54.txt
471G>A,I	P	F	35	2.4	2.9	1212	8.80	896	+/-	c.471G>A/del exon5,47,38,BMC_Med_Genet_2008_Jun_20_9_54.txt
471G>A,M	F	64	1.2	1.1	120	1.21 (619)	70	-/-	c.471G>A/del exon5,48,41,BMC_Med_Genet_2008_Jun_20_9_54.txt
471G>A,Si	F	27	1.2	2.4	1975	9.20	371	+/-	c.471G>A/del exon5,50,38,BMC_Med_Genet_2008_Jun_20_9_54.txt
807 G>A,II	P	F	45	4.8	6.9	1510	9.71	659	+/+	c.807 G>A/r.spl?,51,39,BMC_Med_Genet_2008_Jun_20_9_54.txt
1G>C,III	P	F	35	9.2	21.6	4032	7.80	485	+/+	c.808-1G>C/r.spl?,52,45,BMC_Med_Genet_2008_Jun_20_9_54.txt
1G>C,C	F	28	1.1	0.8	97	1.70	127	-/-	c.808-1G>C/r.spl?,53,39,BMC_Med_Genet_2008_Jun_20_9_54.txt
1G>C,C	F	33	ND	ND	ND	ND	ND	-/-	c.808-1G>C/r.spl?,54,34,BMC_Med_Genet_2008_Jun_20_9_54.txt
101A>T,V	P	F	26	1.3	1.6	149	10.40	2411	+/-	c.101A>T/p.E34V,56,39,BMC_Med_Genet_2008_Jun_20_9_54.txt
101A>T,Si	F	31	1.2	2.1	539	6.00	1208	+/-	c.101A>T/p.E34V,57,38,BMC_Med_Genet_2008_Jun_20_9_54.txt
101A>T,VI	P	F	16	8.0	18.5	2619	10.12	ND	-/+	c.101A>T/p.E34V,58,40,BMC_Med_Genet_2008_Jun_20_9_54.txt
995 G>C,VII	P	F	28	2.0	1.9	948	8.00	428	-/+	c. 995 G>C/pG332A,59,40,BMC_Med_Genet_2008_Jun_20_9_54.txt
995 G>C,F	M	60	1.6	2.0	30	1.12 (619)	78	-/-	c. 995 G>C/pG332A,60,41,BMC_Med_Genet_2008_Jun_20_9_54.txt
995 G>C,Si	F	25	2.6	2.0	5	2.28	271	-/-	c. 995 G>C/pG332A,62,36,BMC_Med_Genet_2008_Jun_20_9_54.txt
995 G>C,A	F	57	1.7	2.2	52	4.27	52	-/+	c. 995 G>C/pG332A,63,35,BMC_Med_Genet_2008_Jun_20_9_54.txt
995 G>C,C	F	15	1.2	0.9	40	1.28 (619)	85	-/-	c. 995 G>C/pG332A,65,41,BMC_Med_Genet_2008_Jun_20_9_54.txt
670T>G,VIII	P	F	40	2.4	4.2	874	5.50	1030	+/+	c.670T>G/p.W224R,67,41,BMC_Med_Genet_2008_Jun_20_9_54.txt
670T>G,D	F	15	0.9	1.4	34	1.28 (619)	ND	-/-	c.670T>G/p.W224R,69,40,BMC_Med_Genet_2008_Jun_20_9_54.txt
670T>G,A	F	45	2.5	2.3	450	11.77	893	+/+	c.670T>G/p.W224R,70,37,BMC_Med_Genet_2008_Jun_20_9_54.txt
694 G>C,XI	P	F	37	1.2	3.2	801	12.6	1314	-/+	C.694 G>C/G232R,74,39,BMC_Med_Genet_2008_Jun_20_9_54.txt
503G>A,XXIII	P	F	24	6.4	8.2	1108	7.10	1529	+/+	c.503G>A/p.R168H,109,43,BMC_Med_Genet_2008_Jun_20_9_54.txt
503G>A,So	M	18	1.1	1.2	35	1.15 (619)	ND	-/-	c.503G>A/p.R168H,110,41,BMC_Med_Genet_2008_Jun_20_9_54.txt
503G>A,So	M	19	0.9	0.6	86	120	ND	-/-	c.503G>A/p.R168H,112,34,BMC_Med_Genet_2008_Jun_20_9_54.txt
503G>A,Si	F	35	ND	ND	ND	3.15	1281	+/-	c.503G>A/p.R168H,113,35,BMC_Med_Genet_2008_Jun_20_9_54.txt
532T>G,XXV	P	F	27	3.1	4.0	870	5.40	1592	+/-	c.532T>G/p.L178V,117,40,BMC_Med_Genet_2008_Jun_20_9_54.txt
317A>C,XXVI	P	F	39	4.4	6.2	307	5.33	1214	+/-	c.317A>C/p.H106P,118,41,BMC_Med_Genet_2008_Jun_20_9_54.txt
471G>A,...G to A transitions in the last bases of exon 5 (c.471G>A) (Figure 2a) and exon 7 (c.807 G>A) (Figure...,181,218,BMC_Med_Genet_2008_Jun_20_9_54.txt
807 G>A,...es of exon 5 (c.471G>A) (Figure 2a) and exon 7 (c.807 G>A) (Figure 3a) which do not lead to an amino...,181,252,BMC_Med_Genet_2008_Jun_20_9_54.txt
3912 G>C,...to C transversion in the last base of intron 7 (g.3912 G>C) (Figure 3b) which destroys the splice ac...,181,826,BMC_Med_Genet_2008_Jun_20_9_54.txt
1 G>C,... acceptor site between intron 7 and exon 8 (c 808-1 G>C) and is expected to affect normal splicing. ...,181,923,BMC_Med_Genet_2008_Jun_20_9_54.txt
471 G> A,Figure 2 a) c.471 G> A mutation in the last base of exon 5; b) 4...,183,15,BMC_Med_Genet_2008_Jun_20_9_54.txt
807G>A,...a) transition G> A in the last base of exon 7 (c: 807G>A and b) transversion G> C in the last base o...,185,60,BMC_Med_Genet_2008_Jun_20_9_54.txt
1 G>C,...version G> C in the last base of intrón 7 (c. 808-1 G>C),185,129,BMC_Med_Genet_2008_Jun_20_9_54.txt
807 G>A,II	P	16.28	43	c.807 G>A/r.spl?,192,17,BMC_Med_Genet_2008_Jun_20_9_54.txt
1G>C,III	P	13.15	39.55	c.808-1G>C/r.spl?,193,25,BMC_Med_Genet_2008_Jun_20_9_54.txt
1G>C,C	15.58	46.85	c.808-1G>C/r.spl?,194,22,BMC_Med_Genet_2008_Jun_20_9_54.txt
1G>C,C	16.85	50.67	c.808-1G>C/r.spl?,195,22,BMC_Med_Genet_2008_Jun_20_9_54.txt
101A>T,V	P	18.48	55.58	c.101A>T/p.E34V,197,19,BMC_Med_Genet_2008_Jun_20_9_54.txt
995 G>C,VII	P	15.84	47.64	c. 995 G>C/pG332A,198,22,BMC_Med_Genet_2008_Jun_20_9_54.txt
995 G>C,F	16.89	50.79	c. 995 G>C/pG332A,199,19,BMC_Med_Genet_2008_Jun_20_9_54.txt
995 G>C,C	19.21	57.77	c. 995 G>C/pG332A,200,19,BMC_Med_Genet_2008_Jun_20_9_54.txt
670T>G,VIII	P	16.95	50.98	c.670T>G/p.W224R,201,22,BMC_Med_Genet_2008_Jun_20_9_54.txt
670T>G,D	18.12	54.19	c.670T>G/p.W224R,202,18,BMC_Med_Genet_2008_Jun_20_9_54.txt
101A>T,"...A to T substitution at nucleotide position 101 (c.101A>T) (Proband V and VI, Figure 5) which results...",209,161,BMC_Med_Genet_2008_Jun_20_9_54.txt
995 G>C,"...G to C substitution at nucleotide position 995 (c.995 G>C) (Proband VII, Figure 6) which results in ...",209,378,BMC_Med_Genet_2008_Jun_20_9_54.txt
670T>G,...was a T to G change at nucleotide position 670 (c.670T>G) leading to a tryptophan to a glycine subst...,209,585,BMC_Med_Genet_2008_Jun_20_9_54.txt
471G>A,"...e of them were single nucleotide substitutions, c.471G>A, c.807 G>A and c.808-1G>C and the other was...",238,294,BMC_Med_Genet_2008_Jun_20_9_54.txt
807 G>A,"...were single nucleotide substitutions, c.471G>A, c.807 G>A and c.808-1G>C and the other was a small i...",238,304,BMC_Med_Genet_2008_Jun_20_9_54.txt
1G>C,"...tide substitutions, c.471G>A, c.807 G>A and c.808-1G>C and the other was a small insertion. In effec...",238,322,BMC_Med_Genet_2008_Jun_20_9_54.txt
471G>A,"...yptic splicing site [34]. However, only for the c.471G>A mutation (Figure 2a), which affects the don...",238,534,BMC_Med_Genet_2008_Jun_20_9_54.txt
101A>T,"...re transversions leading to missense mutations, c.101A>T, c.670 T>G and c.995G>C in exons 3, 7 and 1...",240,93,BMC_Med_Genet_2008_Jun_20_9_54.txt
670 T>G,"...rsions leading to missense mutations, c.101A>T, c.670 T>G and c.995G>C in exons 3, 7 and 10 respecti...",240,103,BMC_Med_Genet_2008_Jun_20_9_54.txt
995G>C,"... to missense mutations, c.101A>T, c.670 T>G and c.995G>C in exons 3, 7 and 10 respectively. They wer...",240,117,BMC_Med_Genet_2008_Jun_20_9_54.txt
191G>A,"...genotyped for the seven most common SNPs in NAT2 (191G>A (rs1801279), 282C>T (rs1041983, rs59855457)...",27,143,BMC_Med_Genet_2009_Dec_31_10_148.txt
282C>T,"...ven most common SNPs in NAT2 (191G>A (rs1801279), 282C>T (rs1041983, rs59855457), 341T>C (rs1801280,...",27,163,BMC_Med_Genet_2009_Dec_31_10_148.txt
341T>C,"...1G>A (rs1801279), 282C>T (rs1041983, rs59855457), 341T>C (rs1801280, rs56935242), 481C>T (rs1799929,...",27,195,BMC_Med_Genet_2009_Dec_31_10_148.txt
481C>T,"...983, rs59855457), 341T>C (rs1801280, rs56935242), 481C>T (rs1799929, rs60310310), 590G>A (rs1799930,...",27,227,BMC_Med_Genet_2009_Dec_31_10_148.txt
590G>A,"...280, rs56935242), 481C>T (rs1799929, rs60310310), 590G>A (rs1799930, rs60190029), 803A>G (rs1208, rs...",27,259,BMC_Med_Genet_2009_Dec_31_10_148.txt
803A>G,"...929, rs60310310), 590G>A (rs1799930, rs60190029), 803A>G (rs1208, rs56599719, rs58999469), and 857G>...",27,291,BMC_Med_Genet_2009_Dec_31_10_148.txt
857G>A,"...29), 803A>G (rs1208, rs56599719, rs58999469), and 857G>A (rs1799931, rs58803786)) and for which geno...",27,336,BMC_Med_Genet_2009_Dec_31_10_148.txt
191G>A,...mples that were genotyped for all SNPs except SNP 191G>A as this is rare in non-African populations....,27,522,BMC_Med_Genet_2009_Dec_31_10_148.txt
191G>A,"...ier implemented in NAT2PRED of the functional SNP 191G>A which, although monomorphic in most worldwi...",34,661,BMC_Med_Genet_2009_Dec_31_10_148.txt
191G>A,...on of origin contains a sizeable frequency of SNP 191G>A. This concerns populations of African origi...,59,900,BMC_Med_Genet_2009_Dec_31_10_148.txt
22T>C,...10.1186/1471-2350-10-29Research ArticleA novel c.-22T>C mutation in GALK1 promoter is associated wit...,3,131,BMC_Med_Genet_2009_Mar_24_10_29.txt
179A>G,"...hree nucleotide substitutions were identified: c.-179A>G, c.-27A>C, and c.-22T>C. With respect to th...",12,52,BMC_Med_Genet_2009_Mar_24_10_29.txt
27A>C,"...tide substitutions were identified: c.-179A>G, c.-27A>C, and c.-22T>C. With respect to the c.-22T>C ...",12,63,BMC_Med_Genet_2009_Mar_24_10_29.txt
22T>C,"...ions were identified: c.-179A>G, c.-27A>C, and c.-22T>C. With respect to the c.-22T>C mutation, GALK...",12,77,BMC_Med_Genet_2009_Mar_24_10_29.txt
22T>C,"...G, c.-27A>C, and c.-22T>C. With respect to the c.-22T>C mutation, GALK1 activity in 13 subjects with...",12,107,BMC_Med_Genet_2009_Mar_24_10_29.txt
22T>C,"The c.-22T>C mutation, which was observed frequently in i...",15,8,BMC_Med_Genet_2009_Mar_24_10_29.txt
22T>C,"...USA) restriction enzyme was used to confirm the c-22T>C mutation on the PCR products, using the prim...",36,193,BMC_Med_Genet_2009_Mar_24_10_29.txt
179A>G,... CAC CAT AG-3') primer was used to confirm the c.-179A>G and c.-27A>C mutations. We screened 101 hea...,36,437,BMC_Med_Genet_2009_Mar_24_10_29.txt
27A>C,...) primer was used to confirm the c.-179A>G and c.-27A>C mutations. We screened 101 healthy adults wi...,36,451,BMC_Med_Genet_2009_Mar_24_10_29.txt
179A>G,"...fied in the promoter region of the GALK1 gene: c.-179A>G, c.-27A>C, and c.-22T>C (Fig. 1), and the p...",49,422,BMC_Med_Genet_2009_Mar_24_10_29.txt
27A>C,"... promoter region of the GALK1 gene: c.-179A>G, c.-27A>C, and c.-22T>C (Fig. 1), and the presence of ...",49,433,BMC_Med_Genet_2009_Mar_24_10_29.txt
22T>C,"...on of the GALK1 gene: c.-179A>G, c.-27A>C, and c.-22T>C (Fig. 1), and the presence of these polymorp...",49,447,BMC_Med_Genet_2009_Mar_24_10_29.txt
179A>G,"...confirmed by performing PCR-RFLP (Fig. 1). For c.-179A>G, 56 subjects with A/A genotype, 5 with A/G ...",49,557,BMC_Med_Genet_2009_Mar_24_10_29.txt
27A>C,"...e and 2 with G/G genotype were identified. For c.-27A>C, 61 individuals had A/A genotype and 2 showe...",49,664,BMC_Med_Genet_2009_Mar_24_10_29.txt
179A>G,"... normal individuals, suggesting that two SNPs, c.-179A>G and c.-27A>C, are benign sequence variation...",49,899,BMC_Med_Genet_2009_Mar_24_10_29.txt
27A>C,"...duals, suggesting that two SNPs, c.-179A>G and c.-27A>C, are benign sequence variations. In terms of...",49,913,BMC_Med_Genet_2009_Mar_24_10_29.txt
22T>C,"...C, are benign sequence variations. In terms of c.-22T>C, 50 individuals with T/T, 12 with T/C, and 1...",49,967,BMC_Med_Genet_2009_Mar_24_10_29.txt
179A>G,"...an polymorphism. Genotype distributions of the c.-179A>G, c.-27A>C and c.-22T>C variations did not d...",49,1262,BMC_Med_Genet_2009_Mar_24_10_29.txt
27A>C,"...hism. Genotype distributions of the c.-179A>G, c.-27A>C and c.-22T>C variations did not deviate from...",49,1273,BMC_Med_Genet_2009_Mar_24_10_29.txt
22T>C,"...e distributions of the c.-179A>G, c.-27A>C and c.-22T>C variations did not deviate from those expect...",49,1286,BMC_Med_Genet_2009_Mar_24_10_29.txt
179A>G,c.-179A>G	A/A	56	117.2 ± 41.7	0.012	1.39 ± 2.06	0.001...,56,4,BMC_Med_Genet_2009_Mar_24_10_29.txt
27A>C,c.-27A>C	A/A	61	112.1 ± 41.7	0.173	1.34 ± 0.46	0.473,60,4,BMC_Med_Genet_2009_Mar_24_10_29.txt
22T>C,c.-22T>C	T/T	50	96.1 ± 24.3	<0.001	1.16 ± 0.25	<0.001...,64,4,BMC_Med_Genet_2009_Mar_24_10_29.txt
22T>C,...uencing revealed the presence of a mutation of c.-22T>C (A). Gel electrophoresis patterns of PCR amp...,69,131,BMC_Med_Genet_2009_Mar_24_10_29.txt
22T>C,"...nts digested with BsgI for the confirmation of c.-22T>C (B) are shown (Lane M, DNA size marker; lane...",69,248,BMC_Med_Genet_2009_Mar_24_10_29.txt
27A>C,"...f GALK1 (Table 1), which further suggests that c.-27A>C is a nonfunctional polymorphism",71,983,BMC_Med_Genet_2009_Mar_24_10_29.txt
22T>C,...e whether elevated GALK1 activity resulting from -22T>C mutation is associated with an increase of g...,77,64,BMC_Med_Genet_2009_Mar_24_10_29.txt
22T>C,"To test if c.-22T>C affected transcription, reporter analysis wa...",80,15,BMC_Med_Genet_2009_Mar_24_10_29.txt
179A>G,"...and a half fold increase (Fig. 3). In terms of c.-179A>G and c.-27A>C, the relative luciferase activ...",80,474,BMC_Med_Genet_2009_Mar_24_10_29.txt
27A>C,"...d increase (Fig. 3). In terms of c.-179A>G and c.-27A>C, the relative luciferase activity was not si...",80,488,BMC_Med_Genet_2009_Mar_24_10_29.txt
22T>C,Figure 3 c.-22T>C mutation resulted in increased reporter acti...,82,13,BMC_Med_Genet_2009_Mar_24_10_29.txt
22T>C,...termine if the elevated luciferase activity of c.-22T>C was due to alterations in the binding of a n...,84,75,BMC_Med_Genet_2009_Mar_24_10_29.txt
22T>C,...ctivities. We found that the nucleotide change c.-22T>C in the promoter region of GALK1 gene was hig...,89,837,BMC_Med_Genet_2009_Mar_24_10_29.txt
22T>C,"...promoter activity. The reporter construct with c.-22T>C enhanced luciferase activity, both in the He...",91,258,BMC_Med_Genet_2009_Mar_24_10_29.txt
22T>C,"...h the EMSA result, this data suggests that the c.-22T>C resulted in an increased abundance of the GA...",91,501,BMC_Med_Genet_2009_Mar_24_10_29.txt
22T>C,"...osphate. In the present study, we found that the -22T>C mutation was associated with increased GALK1...",95,756,BMC_Med_Genet_2009_Mar_24_10_29.txt
22T>C,... that elevated GALK1 activity resulting from the -22T>C mutation may result in transient accumulatio...,95,1160,BMC_Med_Genet_2009_Mar_24_10_29.txt
22T>C,"...proteins that bind to the GALK1 promoter, with c.-22T>C, will be necessary to elucidate the mechanis...",97,371,BMC_Med_Genet_2009_Mar_24_10_29.txt
22T>C,The c.-22T>C of GALK1 gene was frequently observed in sub...,100,8,BMC_Med_Genet_2009_Mar_24_10_29.txt
1849G>T,...ral groups have reported a somatically acquired c.1849G>T point mutation in exon 14 of JAK2 gene (JA...,18,526,BMC_Med_Genet_2010_Apr_1_11_54.txt
958G > C,"...gene SLC19A3. A pathogenic homozygous mutation (c.958G > C, [p.E320Q]) in SLC19A3 was identified in ...",10,190,BMC_Med_Genet_2010_Dec_22_11_171.txt
958G > C,"..., and then we identified a homozygous mutation (c.958G > C, [p.E320Q]) in exon 3 of SLC19A3 in all p...",97,82,BMC_Med_Genet_2010_Dec_22_11_171.txt
958G > C,"...ion and characterization of a disease mutation (c.958G > C, [p.E320Q]). (A) The sequence analyses sh...",99,71,BMC_Med_Genet_2010_Dec_22_11_171.txt
958G > C,"...on of glutamic acid at codon 320 for glutamine (c.958G > C, [p.E320Q]), indicated by an arrow. (B) R...",99,272,BMC_Med_Genet_2010_Dec_22_11_171.txt
958G > C,"...lia lesions were caused by homozygous mutation (c.958G > C, [p.E320Q]) in SLC19A3. Our cases broaden...",114,319,BMC_Med_Genet_2010_Dec_22_11_171.txt
1194T>A,"...hogenic variants (c.1740delC, c.2975_2978delAG, c.1194T>A, c.1780G>A, c.4819C > T) were identified i...",10,74,BMC_Med_Genet_2010_May_26_11_79.txt
1780G>A,"...iants (c.1740delC, c.2975_2978delAG, c.1194T>A, c.1780G>A, c.4819C > T) were identified in the group...",10,85,BMC_Med_Genet_2010_May_26_11_79.txt
4819C > T,"...40delC, c.2975_2978delAG, c.1194T>A, c.1780G>A, c.4819C > T) were identified in the group of 73 AN p...",10,96,BMC_Med_Genet_2010_May_26_11_79.txt
4819C > T,...ch two novel mutant alleles (c.2975_2978delAG + c.4819C > T) were identified in one Chinese TS-NSRAN...,10,211,BMC_Med_Genet_2010_May_26_11_79.txt
1194T > A,"...emature termination codon at position 1000; (c) c.1194T > A (p.D398E), the consequence of a transver...",35,601,BMC_Med_Genet_2010_May_26_11_79.txt
1780G > A,"...ion from aspartate to glutamate in exon 13; (d) c.1780G > A (p.E594K), a transition from G to A at n...",35,773,BMC_Med_Genet_2010_May_26_11_79.txt
4819C > T,"...on from glutamate to lysine in exon 16; and (e) c.4819C > T (p.R1607 W), a transition from C to T, w...",35,918,BMC_Med_Genet_2010_May_26_11_79.txt
4819C > T,"...) Apart from c.2975_2978delAG (p.Q994VfsX6) and c.4819C > T (p.R1607 W), which were identified in on...",35,1124,BMC_Med_Genet_2010_May_26_11_79.txt
1194 T > A,13	c.1194 T > A	p.D398 E	Missense	0501207	19	0/184,40,6,BMC_Med_Genet_2010_May_26_11_79.txt
1780 G > A,16	c.1780 G > A	p.E594K	Missense	0501768	12	0/184,42,6,BMC_Med_Genet_2010_May_26_11_79.txt
4819C > T,40	c.4819C > T	p.R1607W	Missense	0400695	1	0/184,45,6,BMC_Med_Genet_2010_May_26_11_79.txt
4819C > T,"...5, which are c.2975_2978delAG (p.Q994VfsX6) and c.4819C > T (p.R1607W), inherited from the mother an...",50,198,BMC_Med_Genet_2010_May_26_11_79.txt
1194T > A,"...Sequencing chromatograms of pathogenic variants c.1194T > A/p.D398E, c.1740delC/p.s581PfsX40 and c.1...",52,133,BMC_Med_Genet_2010_May_26_11_79.txt
1780G>A,"....1194T > A/p.D398E, c.1740delC/p.s581PfsX40 and c.1780G>A/p.E594K. Two columns are sequencing chroma...",52,182,BMC_Med_Genet_2010_May_26_11_79.txt
145C > T,"...ere identified, including 4 missense mutations: c.145C > T (p.R49W), c.157G > A (p.A53T), c.158C > T...",54,103,BMC_Med_Genet_2010_May_26_11_79.txt
157G > A,"...ding 4 missense mutations: c.145C > T (p.R49W), c.157G > A (p.A53T), c.158C > T (p.A53V) and c.244C ...",54,124,BMC_Med_Genet_2010_May_26_11_79.txt
158C > T,"...ions: c.145C > T (p.R49W), c.157G > A (p.A53T), c.158C > T (p.A53V) and c.244C > T (p.R82C). Some of...",54,145,BMC_Med_Genet_2010_May_26_11_79.txt
244C > T,"...), c.157G > A (p.A53T), c.158C > T (p.A53V) and c.244C > T (p.R82C). Some of these polymorphisms hav...",54,169,BMC_Med_Genet_2010_May_26_11_79.txt
4819C > T,"...ent, namely c.2975_2978delAG (p.Q994VfsX6), and c.4819C > T (p.R1607W). The frameshift mutation (c.2...",69,121,BMC_Med_Genet_2010_May_26_11_79.txt
4819C > T,...he patient's mother and the missense mutations (c.4819C > T) came from the patient's father. Both pa...,69,250,BMC_Med_Genet_2010_May_26_11_79.txt
4819C > T,...t alleles of c.2975_2978delAG (p.Q994VfsX6) and c.4819C > T (p.R1607W) were not found in our control...,69,434,BMC_Med_Genet_2010_May_26_11_79.txt
4819C > T,...ant alleles: c.2975_2978delAG (p.Q994VfsX6) and c.4819C > T (p.R1607W). The special mutation spectra...,81,378,BMC_Med_Genet_2010_May_26_11_79.txt
894G > T,...ariou DC Foussas SG Manolis AS Association of the 894G > T polymorphism in the endothelial nitric ox...,210,144,BMC_Med_Genet_2010_Sep_20_11_133.txt
786T > C,"...e R Gensini GF Endothelial nitric oxide synthase -786T > C, but not 894G > T and 4a4b, polymorphism ...",212,129,BMC_Med_Genet_2010_Sep_20_11_133.txt
894G > T,"...othelial nitric oxide synthase -786T > C, but not 894G > T and 4a4b, polymorphism influences plasma ...",212,147,BMC_Med_Genet_2010_Sep_20_11_133.txt
1807871	T > C,1	55553409	rs1807871	T > C	13.1	USP24	0.00	0.949	0.00	0.988	-0....,87,14,BMC_Med_Genet_2011_Jan_28_12_19.txt
2799516	G > A,1	92085352	rs2799516	G > A	9.0	TGFBR3	0.04	0.455	0.05	0.347	0.0...,88,14,BMC_Med_Genet_2011_Jan_28_12_19.txt
2046737	C > T,1	92099224	rs2046737	C > T	8.5	TGFBR3	0.06	0.231	0.06	0.240	0.0...,89,14,BMC_Med_Genet_2011_Jan_28_12_19.txt
3754032	T > A,1	111784127	rs3754032	T > A	26.0	WDR77	0.02	0.505	0.07	0.032	0.0...,90,15,BMC_Med_Genet_2011_Jan_28_12_19.txt
10496176	T > C,2	70027133	rs10496176	T > C	15.4	MXD1	0.03	0.440	0.01	0.874	0.0...,91,14,BMC_Med_Genet_2011_Jan_28_12_19.txt
10496276	T > G,2	82913481	rs10496276	T > G	19.2		0.02	0.638	0.01	0.696	0.00	0....,92,14,BMC_Med_Genet_2011_Jan_28_12_19.txt
1433527	C > A,2	118250857	rs1433527	C > A	45.3	DDX18	-0.04	0.110	-0.04	0.211	-...,93,15,BMC_Med_Genet_2011_Jan_28_12_19.txt
10496734	G > A,2	135824309	rs10496734	G > A	14.9	ZRANB3	-0.04	0.363	-0.03	0.447...,94,15,BMC_Med_Genet_2011_Jan_28_12_19.txt
2251471	T > C,2	158955976	rs2251471	T > C	6.7	CCDC148	0.09	0.123	0.12	0.027	0....,95,15,BMC_Med_Genet_2011_Jan_28_12_19.txt
1587126	A > C,3	30344099	rs1587126	A > C	33.7	TGFBR2	0.01	0.769	-0.01	0.665	-...,96,14,BMC_Med_Genet_2011_Jan_28_12_19.txt
1492053	G > A,3	99203733	rs1492053	G > A	37.0	GABRR3	0.00	0.963	0.00	0.909	0....,97,14,BMC_Med_Genet_2011_Jan_28_12_19.txt
10513577	T > C,3	163243925	rs10513577	T > C	31.0		0.00	0.991	0.01	0.773	0.02	0....,98,15,BMC_Med_Genet_2011_Jan_28_12_19.txt
1033059	A > G,3	163273126	rs1033059	A > G	31.0		0.00	0.943	0.01	0.815	0.02	0.5...,99,15,BMC_Med_Genet_2011_Jan_28_12_19.txt
951937	T > A,3	163310228	rs951937	T > A	25.6		-0.02	0.568	0.00	0.975	-0.01	0....,100,15,BMC_Med_Genet_2011_Jan_28_12_19.txt
9291683	G > A,4	9933258	rs9291683	G > A	46.8	ZNF518B	0.04	0.171	0.04	0.168	0...,101,13,BMC_Med_Genet_2011_Jan_28_12_19.txt
10517393	G > T,4	57967285	rs10517393	G > T	22.8	IGFBP7	0.01	0.795	-0.03	0.341	...,102,14,BMC_Med_Genet_2011_Jan_28_12_19.txt
2055391	C > T,4	132163115	rs2055391	C > T	8.4		-0.01	0.920	0.00	0.996	0.01	0.7...,103,15,BMC_Med_Genet_2011_Jan_28_12_19.txt
7659755	A > G,4	182246126	rs7659755	A > G	18.3		-0.02	0.534	-0.04	0.225	-0.01	...,104,15,BMC_Med_Genet_2011_Jan_28_12_19.txt
2099082	T > C,5	54231548	rs2099082	T > C	23.6	ESM1	0.00	0.903	-0.01	0.767	0.0...,105,14,BMC_Med_Genet_2011_Jan_28_12_19.txt
10515754	T > C,5	157166116	rs10515754	T > C	6.0	CLINT1	0.06	0.293	0.05	0.422	0....,106,15,BMC_Med_Genet_2011_Jan_28_12_19.txt
9294466	A > T,6	91568115	rs9294466	A > T	15.0	MAP3K7	0.04	0.301	0.05	0.211	0....,107,14,BMC_Med_Genet_2011_Jan_28_12_19.txt
6925466	C > T,6	96483564	rs6925466	C > T	38.9	FUT9	0.00	0.870	0.00	0.888	-0.0...,108,14,BMC_Med_Genet_2011_Jan_28_12_19.txt
7786503	A > C,7	14495103	rs7786503	A > C	8.0	DGKB	0.02	0.643	0.02	0.759	0.02	...,109,14,BMC_Med_Genet_2011_Jan_28_12_19.txt
10499444	C > G,7	14497256	rs10499444	C > G	7.7	DGKB	0.01	0.869	-0.01	0.898	0.0...,110,14,BMC_Med_Genet_2011_Jan_28_12_19.txt
6462230	G > C,7	30896348	rs6462230	G > C	10.7	FLJ22374	0.04	0.396	0.06	0.221	...,111,14,BMC_Med_Genet_2011_Jan_28_12_19.txt
2214681	G > A,7	147333625	rs2214681	G > A	42.5	CNTNAP2	0.00	0.950	-0.01	0.723	...,112,15,BMC_Med_Genet_2011_Jan_28_12_19.txt
1649053	T > C,10	59991493	rs1649053	T > C	38.8	BICC1	-0.02	0.583	-0.01	0.829	-...,113,15,BMC_Med_Genet_2011_Jan_28_12_19.txt
10510144	G > A,10	127169837	rs10510144	G > A	28.9	MMP21	0.05	0.127	0.06	0.048	0....,114,16,BMC_Med_Genet_2011_Jan_28_12_19.txt
1409071	G > A,13	20860773	rs1409071	G > A	41.9	ZDHHC20	0.05	0.106	0.06	0.047	0...,115,15,BMC_Med_Genet_2011_Jan_28_12_19.txt
238358	G > A,13	41736674	rs238358	G > A	9.5	AKAP11	0.03	0.536	0.03	0.516	-0.0...,116,15,BMC_Med_Genet_2011_Jan_28_12_19.txt
10492621	G > A,13	92478066	rs10492621	G > A	24.2	GPC5	-0.06	0.068	-0.07	0.042	-...,117,15,BMC_Med_Genet_2011_Jan_28_12_19.txt
10513893	C > T,14	86696500	rs10513893	C > T	7.2		0.01	0.830	-0.01	0.821	0.04	0....,118,15,BMC_Med_Genet_2011_Jan_28_12_19.txt
8049649	A > T,16	26362052	rs8049649	A > T	17.6	HS3ST4	0.06	0.080	0.05	0.197	0....,119,15,BMC_Med_Genet_2011_Jan_28_12_19.txt
10485640	A > G,20	23097739	rs10485640	A > G	9.7	CD93	-0.05	0.274	-0.05	0.334	-0...,120,15,BMC_Med_Genet_2011_Jan_28_12_19.txt
1G>A,"...ote at this gene. One of these alterations, c.574+1G>A, is located at the splice donor site of intro...",7,756,BMC_Med_Genet_2011_Jun_27_12_86.txt
2 A>G,"...intron 5. We also found a second mutation, c.2206-2 A>G, not previously reported in the literature, ...",7,851,BMC_Med_Genet_2011_Jun_27_12_86.txt
1G>A,...ing analysis. It has been proposed that the c.574+1G>A mutation would cause exon 5 skipping during N...,7,1091,BMC_Med_Genet_2011_Jun_27_12_86.txt
2A>G,"...tantly, we provide evidence that the novel c.2206-2A>G mutation also disrupts normal NTRK1 splicing,...",7,1259,BMC_Med_Genet_2011_Jun_27_12_86.txt
1G>C,... 2 Characterization of the effect of IVS 5 (c.574+1G>C) and IVS16 (c.2206-2A>G) point mutations on N...,36,57,BMC_Med_Genet_2011_Jun_27_12_86.txt
2A>G,...he effect of IVS 5 (c.574+1G>C) and IVS16 (c.2206-2A>G) point mutations on NTRK1 splicing. A. Schema...,36,81,BMC_Med_Genet_2011_Jun_27_12_86.txt
1G>C,...nge disrupting the 5' splice site of IVS 5 (c.574+1G>C). The second mutation is an A to G change tha...,38,219,BMC_Med_Genet_2011_Jun_27_12_86.txt
2A>G,...that disrupts the 3'splice site of IVS 16 (c.2206-2A>G). Both the father and sister of the patient w...,38,316,BMC_Med_Genet_2011_Jun_27_12_86.txt
2A>G,"... patient were shown to be carriers for the c.2206-2A>G mutation, whereas her mother was shown to be ...",38,406,BMC_Med_Genet_2011_Jun_27_12_86.txt
1G>C,"...er mother was shown to be a carrier for the c.574+1G>C mutation. To the best of our knowledge, these...",38,480,BMC_Med_Genet_2011_Jun_27_12_86.txt
1G>A,...ge affecting the first nucleotide of IVS 5 (c.574+1G>A) has been reported in an earlier study [12],38,700,BMC_Med_Genet_2011_Jun_27_12_86.txt
1G>C,"To assess the consequences of the c.574+1G>C and c.2206-2A>G mutations on NTRK1 splicing, ...",40,41,BMC_Med_Genet_2011_Jun_27_12_86.txt
2A>G,"...ess the consequences of the c.574+1G>C and c.2206-2A>G mutations on NTRK1 splicing, we carried out a...",40,57,BMC_Med_Genet_2011_Jun_27_12_86.txt
1G>C,"... analysis, therefore, demonstrates that the c.574+1G>C mutation causes exon 5 skipping. Skipping of ...",42,357,BMC_Med_Genet_2011_Jun_27_12_86.txt
2A>G,"...n of the first 21 bp of exon 17. Thus, the c.2206-2A>G mutation leads to the production of two diffe...",42,1023,BMC_Med_Genet_2011_Jun_27_12_86.txt
1G>C,"...er of the patient, who is a carrier for the c.574+1G>C mutation, whereas the mRNA variants with the ...",42,1704,BMC_Med_Genet_2011_Jun_27_12_86.txt
2A>G,"...r of the proband, who are carriers for the c.2206-2A>G mutation",42,1898,BMC_Med_Genet_2011_Jun_27_12_86.txt
1G>C,...licing of NTRK1 mRNA. One of the mutations (c.574+1G>C) disrupts the 5' splice site of IVS 5. Of not...,44,312,BMC_Med_Genet_2011_Jun_27_12_86.txt
1G>A,... different mutation of the same nucleotide (c.574+1G>A) was previously detected in a patient with CI...,44,416,BMC_Med_Genet_2011_Jun_27_12_86.txt
1G>C,"...effect was provided. Here, we show that the c.574+1G>C change does, in fact, lead to skipping of exo...",44,614,BMC_Med_Genet_2011_Jun_27_12_86.txt
2A>G,"...second mutation identified in our patient (c.2206-2A>G) disrupts the 3'splice site of IVS 16, and re...",44,723,BMC_Med_Genet_2011_Jun_27_12_86.txt
1G>C,"...6,14]. The skipping of exon 5 caused by the c.574+1G>C mutation introduces a frame shift that is pre...",44,1318,BMC_Med_Genet_2011_Jun_27_12_86.txt
2A>G,...-functional NTRK1 protein (Figure 2B). The c.2206-2A>G mutation is of greater interest in the contex...,44,1463,BMC_Med_Genet_2011_Jun_27_12_86.txt
1112C > T,"...e enhancement of human IL13 transcription by IL13-1112C > T, a polymorphism associated with allergic...",231,213,BMC_Med_Genet_2011_Oct_25_12_143.txt
786T>C,"...elial nitric oxide synthase Glu298Asp, 4b/a, and -786T>C gene variants with diabetic nephropathy J D...",403,81,BMC_Med_Genet_2014_Jan_16_15_9.txt
9794133G>A,"...ons are kept. For example, mutation NC_000011.8:g.9794133G>A may be located either in gene LOC283104...",29,312,BMC_Med_Genomics_2013_Jan_23_6(Suppl_1)_S16.txt
2944C>T,"...n and sequence change. For example, NM_020975.4:c.2944C>T refers a C→T substitution happened at posi...",40,295,BMC_Med_Genomics_2013_Jan_23_6(Suppl_1)_S16.txt
350G>A,"... example (Figure 1.4), the mutation NM_000492.3:c.350G>A (id: M301052)in gene CFTR is associated wit...",50,810,BMC_Med_Genomics_2013_Jan_23_6(Suppl_1)_S16.txt
2M > R,All endocrine tissues tested	NF	YWHAZ > GUSB > B2M > RPS7> HMBS > ABL > 18S > GAPDH > ACTB > HPRT,163,49,BMC_Mol_Biol_2009_Dec_11_10_106.txt
18S > G,...tested	NF	YWHAZ > GUSB > B2M > RPS7> HMBS > ABL > 18S > GAPDH > ACTB > HPRT,163,73,BMC_Mol_Biol_2009_Dec_11_10_106.txt
2M > G,gN(M)	B2M > GUSB > YWHAZ > HMBS > RPS7 > ABL > 18S > GAPD...,164,9,BMC_Mol_Biol_2009_Dec_11_10_106.txt
18S > G,gN(M)	B2M > GUSB > YWHAZ > HMBS > RPS7 > ABL > 18S > GAPDH > ACTB > HPRT,164,49,BMC_Mol_Biol_2009_Dec_11_10_106.txt
18S > G,gN	B2M = HMBS > GUSB > YWHAZ > RPS7 > ABL > 18S > GAPDH > ACTB > HPRT,165,46,BMC_Mol_Biol_2009_Dec_11_10_106.txt
2M > A,Adrenal gland	NF	HPRT > RPS7 > ABL > B2M > ACTB > GAPDH > 18S > HMBS > YWHAZ > GUSB,166,39,BMC_Mol_Biol_2009_Dec_11_10_106.txt
18S > H,...gland	NF	HPRT > RPS7 > ABL > B2M > ACTB > GAPDH > 18S > HMBS > YWHAZ > GUSB,166,59,BMC_Mol_Biol_2009_Dec_11_10_106.txt
18S > R,gN	GAPDH = 18S > RPS7 > HPRT > YWHAZ > ABL > B2M > ACTB > HMB...,168,13,BMC_Mol_Biol_2009_Dec_11_10_106.txt
2M > A,gN	GAPDH = 18S > RPS7 > HPRT > YWHAZ > ABL > B2M > ACTB > HMBS > GUSB,168,48,BMC_Mol_Biol_2009_Dec_11_10_106.txt
2M > G,Pancreas	NF	RPS7 > GUSB > YWHAZ > HMBS > B2M > GAPDH > ABL > 18S > HPRT > ACTB,169,43,BMC_Mol_Biol_2009_Dec_11_10_106.txt
18S > H,...	RPS7 > GUSB > YWHAZ > HMBS > B2M > GAPDH > ABL > 18S > HPRT > ACTB,169,62,BMC_Mol_Biol_2009_Dec_11_10_106.txt
2M > H,gN(M)	RPS7 > GUSB > YWHAZ > B2M > HMBS > ABL > GAPDH > 18S > HPRT > ACTB,170,31,BMC_Mol_Biol_2009_Dec_11_10_106.txt
18S > H,...	RPS7 > GUSB > YWHAZ > B2M > HMBS > ABL > GAPDH > 18S > HPRT > ACTB,170,57,BMC_Mol_Biol_2009_Dec_11_10_106.txt
2M > A,gN	GUSB = RPS7 > YWHAZ > HMBS > B2M > ABL > 18S > GAPDH > HPRT > ACTB,171,35,BMC_Mol_Biol_2009_Dec_11_10_106.txt
18S > G,gN	GUSB = RPS7 > YWHAZ > HMBS > B2M > ABL > 18S > GAPDH > HPRT > ACTB,171,46,BMC_Mol_Biol_2009_Dec_11_10_106.txt
2M > G,...id	NF	ACTB > RPS7 > GAPDH > HMBS > YWHAZ > ABL > B2M > GUSB > 18S > HPRT,172,60,BMC_Mol_Biol_2009_Dec_11_10_106.txt
18S > H,... RPS7 > GAPDH > HMBS > YWHAZ > ABL > B2M > GUSB > 18S > HPRT,172,72,BMC_Mol_Biol_2009_Dec_11_10_106.txt
2M > G,...gN(M)	ACTB > RPS7 > GAPDH > ABL > HMBS > YWHAZ > B2M > GUSB > 18S > HPRT,173,52,BMC_Mol_Biol_2009_Dec_11_10_106.txt
18S > H,... RPS7 > GAPDH > ABL > HMBS > YWHAZ > B2M > GUSB > 18S > HPRT,173,64,BMC_Mol_Biol_2009_Dec_11_10_106.txt
2M > G,gN	GAPDH = RPS7 > ACTB > HMBS > ABL > YWHAZ > B2M > GUSB > 18S > HPRT,174,49,BMC_Mol_Biol_2009_Dec_11_10_106.txt
18S > H,...= RPS7 > ACTB > HMBS > ABL > YWHAZ > B2M > GUSB > 18S > HPRT,174,61,BMC_Mol_Biol_2009_Dec_11_10_106.txt
2M > R,Thyroid	NF	GUSB > ACTB > YWHAZ > HMBS > B2M > RPS7 > ABL > 18S > GAPDH > HPRT,175,42,BMC_Mol_Biol_2009_Dec_11_10_106.txt
18S > G,...F	GUSB > ACTB > YWHAZ > HMBS > B2M > RPS7 > ABL > 18S > GAPDH > HPRT,175,60,BMC_Mol_Biol_2009_Dec_11_10_106.txt
2M > H,gN(M)	ACTB > GUSB > YWHAZ > B2M > HMBS > RPS7 > ABL > 18S > GAPDH > HPRT,176,31,BMC_Mol_Biol_2009_Dec_11_10_106.txt
18S > G,...)	ACTB > GUSB > YWHAZ > B2M > HMBS > RPS7 > ABL > 18S > GAPDH > HPRT,176,56,BMC_Mol_Biol_2009_Dec_11_10_106.txt
2M > Y,gN	ACTB = HMBS > GUSB > B2M > YWHAZ > RPS7 > ABL > 18S > GAPDH > HPRT,177,27,BMC_Mol_Biol_2009_Dec_11_10_106.txt
18S > G,...N	ACTB = HMBS > GUSB > B2M > YWHAZ > RPS7 > ABL > 18S > GAPDH > HPRT,177,53,BMC_Mol_Biol_2009_Dec_11_10_106.txt
2M > H,...ed	NF	RPS7 > GUSB > ACTB > YWHAZ > ABL > GAPDH > B2M > HPRT > 18S > HMBS,178,76,BMC_Mol_Biol_2009_Dec_11_10_106.txt
18S > H,... GUSB > ACTB > YWHAZ > ABL > GAPDH > B2M > HPRT > 18S > HMBS,178,88,BMC_Mol_Biol_2009_Dec_11_10_106.txt
2M > G,gN(M)	GUSB > RPS7 > ACTB > YWHAZ > ABL > B2M > GAPDH > HPRT > 18S > HMBS,179,44,BMC_Mol_Biol_2009_Dec_11_10_106.txt
18S > H,... RPS7 > ACTB > YWHAZ > ABL > B2M > GAPDH > HPRT > 18S > HMBS,179,64,BMC_Mol_Biol_2009_Dec_11_10_106.txt
2M > G,gN	GUSB = RPS7 > ACTB > YWHAZ > ABL > B2M > GAPDH > HPRT > 18S > HMBS,180,41,BMC_Mol_Biol_2009_Dec_11_10_106.txt
18S > H,... RPS7 > ACTB > YWHAZ > ABL > B2M > GAPDH > HPRT > 18S > HMBS,180,61,BMC_Mol_Biol_2009_Dec_11_10_106.txt
18S > H,...F	RPS7 > HMBS > ABL > GUSB > YWHAZ > ACTB > B2M > 18S > HPRT > GAPDH,181,64,BMC_Mol_Biol_2009_Dec_11_10_106.txt
18S > H,...)	RPS7 > HMBS > ABL > GUSB > YWHAZ > ACTB > B2M > 18S > HPRT > GAPDH,182,56,BMC_Mol_Biol_2009_Dec_11_10_106.txt
18S > H,...N	ACTB = YWHAZ > HMBS > GUSB > RPS7 > ABL > B2M > 18S > HPRT > GAPDH,183,53,BMC_Mol_Biol_2009_Dec_11_10_106.txt
2M > H,Lymph node	NF	GUSB > ACTB > B2M > HMBS > YWHAZ > ABL > RPS7 > GAPDH > 18S > HPR...,184,30,BMC_Mol_Biol_2009_Dec_11_10_106.txt
18S > H,... ACTB > B2M > HMBS > YWHAZ > ABL > RPS7 > GAPDH > 18S > HPRT,184,71,BMC_Mol_Biol_2009_Dec_11_10_106.txt
2M > A,gN(M)	GUSB > B2M > ACTB > YWHAZ > ABL > HMBS > RPS7 > GAPDH > 18...,185,16,BMC_Mol_Biol_2009_Dec_11_10_106.txt
18S > H,... B2M > ACTB > YWHAZ > ABL > HMBS > RPS7 > GAPDH > 18S > HPRT,185,64,BMC_Mol_Biol_2009_Dec_11_10_106.txt
2M > Y,gN	ABL = B2M > YWHAZ > ACTB > GUSB > HMBS > GAPDH > RPS7 > 1...,186,12,BMC_Mol_Biol_2009_Dec_11_10_106.txt
18S > H,...B2M > YWHAZ > ACTB > GUSB > HMBS > GAPDH > RPS7 > 18S > HPRT,186,61,BMC_Mol_Biol_2009_Dec_11_10_106.txt
2M > H,Spleen	NF	GUSB > RPS7 > ACTB > ABL > B2M > HMBS > YWHAZ > HPRT > GAPDH > 18S,187,39,BMC_Mol_Biol_2009_Dec_11_10_106.txt
2M > A,gN(M)	GUSB > RPS7 > ACTB > B2M > ABL > HMBS > YWHAZ > HPRT > GAPDH > 18S,188,30,BMC_Mol_Biol_2009_Dec_11_10_106.txt
2M > G,gN	ACTB = B2M > GUSB > RPS7 > ABL > HMBS > YWHAZ > HPRT > GAP...,189,13,BMC_Mol_Biol_2009_Dec_11_10_106.txt
18S > H,... HMBS > YWHAZ > RPS7 > ABL > GAPDH > GUSB > B2M > 18S > HPRT,190,96,BMC_Mol_Biol_2009_Dec_11_10_106.txt
18S > H,... HMBS > YWHAZ > RPS7 > ABL > GAPDH > GUSB > B2M > 18S > HPRT,191,64,BMC_Mol_Biol_2009_Dec_11_10_106.txt
2M > G,gN	ABL = HMBS > RPS7 > ACTB > YWHAZ > GAPDH > B2M > GUSB > 18S > HPRT,192,49,BMC_Mol_Biol_2009_Dec_11_10_106.txt
18S > H,...HMBS > RPS7 > ACTB > YWHAZ > GAPDH > B2M > GUSB > 18S > HPRT,192,61,BMC_Mol_Biol_2009_Dec_11_10_106.txt
2M > H,...otid gland	NF	ABL > ACTB > RPS7 > YWHAZ > HMBS > B2M > HPRT > GAPDH > GUSB > 18S,193,54,BMC_Mol_Biol_2009_Dec_11_10_106.txt
2M > H,gN(M)	ABL > RPS7 > ACTB > YWHAZ > HMBS > B2M > HPRT > GAPDH > GUSB > 18S,194,44,BMC_Mol_Biol_2009_Dec_11_10_106.txt
2M > H,gN	ABL = ACTB > HMBS > RPS7 > YWHAZ > B2M > HPRT > GAPDH > GUSB > 18S,195,41,BMC_Mol_Biol_2009_Dec_11_10_106.txt
18S > G,...num	NF	RPS7 > GAPDH > ACTB > HMBS > YWHAZ > ABL > 18S > GUSB > B2M > HPRT,196,56,BMC_Mol_Biol_2009_Dec_11_10_106.txt
2M > H,...GAPDH > ACTB > HMBS > YWHAZ > ABL > 18S > GUSB > B2M > HPRT,196,70,BMC_Mol_Biol_2009_Dec_11_10_106.txt
18S > G,gN(M)	RPS7 > GAPDH > ACTB > HMBS > YWHAZ > ABL > 18S > GUSB > B2M > HPRT,197,51,BMC_Mol_Biol_2009_Dec_11_10_106.txt
2M > H,...GAPDH > ACTB > HMBS > YWHAZ > ABL > 18S > GUSB > B2M > HPRT,197,65,BMC_Mol_Biol_2009_Dec_11_10_106.txt
18S > G,gN	ACTB = HMBS > RPS7 > GAPDH > YWHAZ > ABL > 18S > GUSB > B2M > HPRT,198,48,BMC_Mol_Biol_2009_Dec_11_10_106.txt
2M > H,...HMBS > RPS7 > GAPDH > YWHAZ > ABL > 18S > GUSB > B2M > HPRT,198,62,BMC_Mol_Biol_2009_Dec_11_10_106.txt
2M > H,...WHAZ > RPS7 > ABL > ACTB > HMBS > GUSB > GAPDH > B2M > HPRT > 18S,205,62,BMC_Mol_Biol_2009_Dec_11_10_106.txt
2M > H,...WHAZ > RPS7 > ABL > ACTB > HMBS > GUSB > GAPDH > B2M > HPRT > 18S,206,59,BMC_Mol_Biol_2009_Dec_11_10_106.txt
2M > H,...PS7 = YWHAZ > ABL > ACTB > HMBS > GAPDH > GUSB > B2M > HPRT > 18S,207,56,BMC_Mol_Biol_2009_Dec_11_10_106.txt
18S > H,...ACTB > RPS7 > GAPDH > HMBS > YWHAZ > ABL > GUSB > 18S > HPRT > B2M,208,65,BMC_Mol_Biol_2009_Dec_11_10_106.txt
18S > H,...RPS7 > ACTB > GAPDH > YWHAZ > HMBS > ABL > GUSB > 18S > HPRT > B2M,209,58,BMC_Mol_Biol_2009_Dec_11_10_106.txt
18S > H,...GAPDH = YWHAZ > RPS7 > ACTB > HMBS > ABL > GUSB > 18S > HPRT > B2M,210,55,BMC_Mol_Biol_2009_Dec_11_10_106.txt
2M > H,...s combined	NF	RPS7 > GUSB > YWHAZ > ABL > ACTB > B2M > HMBS > 18S > GAPDH > HPRT,214,69,BMC_Mol_Biol_2009_Dec_11_10_106.txt
18S > G,...F	RPS7 > GUSB > YWHAZ > ABL > ACTB > B2M > HMBS > 18S > GAPDH > HPRT,214,81,BMC_Mol_Biol_2009_Dec_11_10_106.txt
2M > H,gN(M)	RPS7 > GUSB > YWHAZ > ABL > ACTB > B2M > HMBS > 18S > GAPDH > HPRT,215,44,BMC_Mol_Biol_2009_Dec_11_10_106.txt
18S > G,...)	RPS7 > GUSB > YWHAZ > ABL > ACTB > B2M > HMBS > 18S > GAPDH > HPRT,215,56,BMC_Mol_Biol_2009_Dec_11_10_106.txt
2M > H,gN	GUSB = RPS7 > ABL > YWHAZ > ACTB > B2M > HMBS > 18S > GAPDH > HPRT,216,41,BMC_Mol_Biol_2009_Dec_11_10_106.txt
18S > G,...N	GUSB = RPS7 > ABL > YWHAZ > ACTB > B2M > HMBS > 18S > GAPDH > HPRT,216,53,BMC_Mol_Biol_2009_Dec_11_10_106.txt
2M > A,Blood	NF	YWHAZ > ABL > GAPDH > B2M > ACTB > GUSB > 18S > HPRT > RPS7 > HMBS,217,33,BMC_Mol_Biol_2009_Dec_11_10_106.txt
18S > H,...lood	NF	YWHAZ > ABL > GAPDH > B2M > ACTB > GUSB > 18S > HPRT > RPS7 > HMBS,217,52,BMC_Mol_Biol_2009_Dec_11_10_106.txt
2M > G,gN(M)	YWHAZ > B2M > GAPDH > ABL > ACTB > 18S > GUSB > HPRT > RPS7...,218,17,BMC_Mol_Biol_2009_Dec_11_10_106.txt
18S > G,gN(M)	YWHAZ > B2M > GAPDH > ABL > ACTB > 18S > GUSB > HPRT > RPS7 > HMBS,218,43,BMC_Mol_Biol_2009_Dec_11_10_106.txt
2M > A,gN	YWHAZ = B2M > ACTB > 18S > GAPDH > ABL > GUSB > HPRT > RPS7...,219,14,BMC_Mol_Biol_2009_Dec_11_10_106.txt
18S > G,gN	YWHAZ = B2M > ACTB > 18S > GAPDH > ABL > GUSB > HPRT > RPS7 > HMBS,219,26,BMC_Mol_Biol_2009_Dec_11_10_106.txt
2M > A,...oplastic tissues	NF	RPS7 > ACTB > HMBS > GAPDH > B2M > ABL > 18S > GUSB > YWHAZ > HPRT,220,53,BMC_Mol_Biol_2009_Dec_11_10_106.txt
18S > G,...ssues	NF	RPS7 > ACTB > HMBS > GAPDH > B2M > ABL > 18S > GUSB > YWHAZ > HPRT,220,64,BMC_Mol_Biol_2009_Dec_11_10_106.txt
18S > A,gN(M)	ACTB > RPS7 > HMBS > GAPDH > B2M > 18S > ABL > GUSB > YWHAZ > HPRT,221,43,BMC_Mol_Biol_2009_Dec_11_10_106.txt
18S > R,gN	GAPDH = HMBS > 18S > RPS7 > ACTB > B2M > ABL > GUSB > YWHAZ > HPR...,222,20,BMC_Mol_Biol_2009_Dec_11_10_106.txt
2M > A,gN	GAPDH = HMBS > 18S > RPS7 > ACTB > B2M > ABL > GUSB > YWHAZ > HPRT,222,41,BMC_Mol_Biol_2009_Dec_11_10_106.txt
2M>B,...bundance of the examined endogenous controls was B2M>BA>GAPDH>PolR2A in almost all subjects. Analysi...,70,497,BMC_Mol_Biol_2010_Apr_9_11_26.txt
634 G-->C,...suggest a potential implication of the VEGF gene -634 G-->C polymorphism in the development of sever...,67,1049,BMC_Musculoskelet_Disord_2007_Jan_4_8_1.txt
1154 G-->A,...also suggest a potential implication of the VEGF -1154 G-->A and -634 G-->C polymorphisms in the dev...,67,1970,BMC_Musculoskelet_Disord_2007_Jan_4_8_1.txt
634 G-->C,...otential implication of the VEGF -1154 G-->A and -634 G-->C polymorphisms in the development of neph...,67,1986,BMC_Musculoskelet_Disord_2007_Jan_4_8_1.txt
6055G > A,...ted that in the Portuguese population the LRRK2 c.6055G > A; p.G2019S mutation has one of the highes...,6,193,BMC_Neurol_2008_Jan_22_8_1.txt
6055G > A,"... and apparently sporadic PD. The LRRK2 mutation c.6055G > A; p.G2019S, accounts for 1–2% of typical ...",20,606,BMC_Neurol_2008_Jan_22_8_1.txt
6055G > A,We had previously shown that the c.6055G > A; p.G2019S mutation in LRRK2 is common in...,22,36,BMC_Neurol_2008_Jan_22_8_1.txt
6055G > A,...or had previously been found to carry the LRRK2 c.6055G > A; p.G2019S mutation (n = 11). This select...,25,1148,BMC_Neurol_2008_Jan_22_8_1.txt
1183G > T,...e (S4) showed data consistent with a homozygous c.1183G > T; p.E395X mutation and a duplication of e...,45,596,BMC_Neurol_2008_Jan_22_8_1.txt
6055G > A,"Two samples tested positive for the LRRK2 c.6055G > A; p.G2019S mutation, sample S12 and sampl...",67,45,BMC_Neurol_2008_Jan_22_8_1.txt
6055G > A,In our previous report [15] we showed that the c.6055G > A; p.G2019S LRRK2 mutation underlies about...,76,50,BMC_Neurol_2008_Jan_22_8_1.txt
6055G > A,...ortuguese population. While we did not find any c.6055G > A; p.G2019S carriers in the 20 late-onset ...,76,179,BMC_Neurol_2008_Jan_22_8_1.txt
6055G > A,"...te-onset patients studied here, we did identify c.6055G > A; p.G2019S in 2 of 46 early-onset cases. ...",76,270,BMC_Neurol_2008_Jan_22_8_1.txt
6055G > A,...emoval of samples previously found to carry the c.6055G > A; p.G2019S mutation we calculate that thi...,76,677,BMC_Neurol_2008_Jan_22_8_1.txt
6055G > A,...nable number of mutations: the frequency of the c.6055G > A; p.G2019S is one of the highest in Europ...,85,197,BMC_Neurol_2008_Jan_22_8_1.txt
1942 C>T,... base pair transversion in exon 15 of the gene (c.1942 C>T) resulting in a premature stop codon (p.Q...,37,279,BMC_Neurol_2011_Oct_1_11_119.txt
1313G>A,... missense mutations were identified in exon 10 (c.1313G>A; p.Arg438His) and 11 (c.1531G>A; p.Asp511A...,37,638,BMC_Neurol_2011_Oct_1_11_119.txt
1531G>A,"...ied in exon 10 (c.1313G>A; p.Arg438His) and 11 (c.1531G>A; p.Asp511Asn) in families MCP35 and MCP3, ...",37,670,BMC_Neurol_2011_Oct_1_11_119.txt
193 G>A,"1	193 G>A	Val65Met	Exon 2	Arab	[2,3]",47,3,BMC_Neurol_2011_Oct_1_11_119.txt
671 G>C,4	671 G>C	Trp224Ser	Exon 6	-	[1],53,3,BMC_Neurol_2011_Oct_1_11_119.txt
900C>A,5	c.900C>A	Cys300X	Exon 8	Indian	[4],55,5,BMC_Neurol_2011_Oct_1_11_119.txt
1 G>A,6	1043+1 G>A	Ser348RfsX63	Intron 8	Turkish	[3],57,8,BMC_Neurol_2011_Oct_1_11_119.txt
1313 G>A,"7	1313 G>A	Arg438His	Exon 10	Pakistani	[2], This stu...",59,3,BMC_Neurol_2011_Oct_1_11_119.txt
1408C>T,8	1408C>T	Gln470X	Exon 11	-	[1],61,3,BMC_Neurol_2011_Oct_1_11_119.txt
1531 G>A,"9	1531 G>A	Asp511Asn	Exon 11	Pakistani	[2], This stu...",63,3,BMC_Neurol_2011_Oct_1_11_119.txt
1576 G>T,10	1576 G>T	Glu526X	Exon 12	-	[1],65,4,BMC_Neurol_2011_Oct_1_11_119.txt
1576 G>A,11	1576 G>A	Glu526Lys	Exon 12	-	[1],67,4,BMC_Neurol_2011_Oct_1_11_119.txt
1942 C>T,12	1942 C>T	Gln648X	Exon 15	Pakistani	This study,69,4,BMC_Neurol_2011_Oct_1_11_119.txt
3232 G>A,14	3232 G>A	Ala1078Thr	Exon 27	Pakistani	[2],73,4,BMC_Neurol_2011_Oct_1_11_119.txt
1204C>T,...ses (16.66 %) of Parkin mutation (heterozygous c. 1204C>T in exon 11 and c. 458C>G in exon 4) with a...,113,98,BMC_Neurosci_2016_Feb_1_17_6.txt
458C>G,...tation (heterozygous c. 1204C>T in exon 11 and c. 458C>G in exon 4) with an age at onset of PD of 48...,113,124,BMC_Neurosci_2016_Feb_1_17_6.txt
458C>G,c. 458C>G	c. 1204C>T,119,4,BMC_Neurosci_2016_Feb_1_17_6.txt
1204C>T,c. 458C>G	c. 1204C>T,119,14,BMC_Neurosci_2016_Feb_1_17_6.txt
1204C>T,...nts with the Parkin mutations (the heterozygous c.1204C>T mutation in exon 11 and c.458C>G mutation ...,183,601,BMC_Neurosci_2016_Feb_1_17_6.txt
458C>G,... heterozygous c.1204C>T mutation in exon 11 and c.458C>G mutation in exon 4 of Parkin). In the liter...,183,635,BMC_Neurosci_2016_Feb_1_17_6.txt
985A > G,"...CADD, 15 of whom were homozygous for the common c.985A > G mutation. Infants homozygous for the comm...",10,571,BMC_Pediatr_2010_Nov_17_10_82.txt
985A > G,...2.13 uM) relative to compound heterozygotes for c.985A > G and a second detectable mutation (median ...,10,724,BMC_Pediatr_2010_Nov_17_10_82.txt
985A > G,...e to guanine transition at coding position 985 (c.985A > G); this leads to a substitution of glutama...,24,308,BMC_Pediatr_2010_Nov_17_10_82.txt
985A > G,"... revealed a more varied mutation spectrum, with c.985A > G homozygotes representing from 30% to 80% ...",24,606,BMC_Pediatr_2010_Nov_17_10_82.txt
985A > G,"...he demonstration of homozygosity for the common c.985A > G mutation, reduces the need to utilize an ...",35,741,BMC_Pediatr_2010_Nov_17_10_82.txt
985A > G,"...esting, 15 (52%) were homozygous for the common c.985A > G mutation, 5 (17%) were compound heterozyg...",67,240,BMC_Pediatr_2010_Nov_17_10_82.txt
985A > G,"...tation, 5 (17%) were compound heterozygotes for c.985A > G and a second mutation, 5 (17%) were presu...",67,301,BMC_Pediatr_2010_Nov_17_10_82.txt
985A > G,"... (17%) were presumed compound heterozygotes for c.985A > G, however a second mutation could not be i...",67,384,BMC_Pediatr_2010_Nov_17_10_82.txt
985A > G,...maining 2 infants (7%) had negative results for c.985A > G and no other mutations were reported by t...,67,633,BMC_Pediatr_2010_Nov_17_10_82.txt
985A > G,"...s; among these infants, 5 were heterozygous for c.985A > G and 3 were heterozygous for other abnorma...",67,914,BMC_Pediatr_2010_Nov_17_10_82.txt
985A > G,Homozygotes: c.985A > G	15	12.13,73,16,BMC_Pediatr_2010_Nov_17_10_82.txt
985A > G,"Compound heterozygotes: c.985A > G, detectable 2nd mutation	5	2.01",76,27,BMC_Pediatr_2010_Nov_17_10_82.txt
250C > T,"c.250C > T		(mean 2.82, range 0.84-5.94)",77,3,BMC_Pediatr_2010_Nov_17_10_82.txt
5G > A,c.388-5G > Aa,78,7,BMC_Pediatr_2010_Nov_17_10_82.txt
1073A > T,c.1073A > Ta,79,3,BMC_Pediatr_2010_Nov_17_10_82.txt
503A > C,c.503A > Ca,80,3,BMC_Pediatr_2010_Nov_17_10_82.txt
13A > G,IVS8-13A > Ga,81,6,BMC_Pediatr_2010_Nov_17_10_82.txt
985A > G,"Compound heterozygotes: c.985A > G, no detectable 2nd mutation	5	2.69",83,27,BMC_Pediatr_2010_Nov_17_10_82.txt
799G>A,"c.799G>A/c.85C > A		(mean 12.34, range 0.88-23.80)",87,3,BMC_Pediatr_2010_Nov_17_10_82.txt
85C > A,"c.799G>A/c.85C > A		(mean 12.34, range 0.88-23.80)",87,12,BMC_Pediatr_2010_Nov_17_10_82.txt
985A > G,"c.985A > G		(mean 0.52, range 0.44-0.70)",91,3,BMC_Pediatr_2010_Nov_17_10_82.txt
347G > A,c.347G > A,92,3,BMC_Pediatr_2010_Nov_17_10_82.txt
583G > A,c.583G > A,94,3,BMC_Pediatr_2010_Nov_17_10_82.txt
985A > G,...esting were homozygous for the common mutation (c.985A > G). This represents 52% of the MCADD cases ...,102,147,BMC_Pediatr_2010_Nov_17_10_82.txt
985A > G,"... those identified clinically are homozygous for c.985A > G [1,8]. The C8 screening levels for childr...",102,578,BMC_Pediatr_2010_Nov_17_10_82.txt
985A > G,...ared to compound heterozygotes with one copy of c.985A > G (both with and without a detectable secon...,102,737,BMC_Pediatr_2010_Nov_17_10_82.txt
985A > G,"...biochemical phenotype, whereby homozygosity for c.985A > G has been associated with more severe leve...",102,980,BMC_Pediatr_2010_Nov_17_10_82.txt
985A > G,...t individuals with MCADD who are homozygous for c.985A > G may be likely to experience more severe c...,102,1191,BMC_Pediatr_2010_Nov_17_10_82.txt
985A > G,"... even among children who are homozygous for the c.985A > G mutation, highlighting the imperfect rela...",102,1551,BMC_Pediatr_2010_Nov_17_10_82.txt
985A > G,"...of whom 10 were identified with one copy of the c.985A > G mutation. In 5 of those infants, there wa...",104,160,BMC_Pediatr_2010_Nov_17_10_82.txt
985A > G,"...ation severity (with severe mutations including c.985A > G as well as deletions, nonsense and splice...",104,1033,BMC_Pediatr_2010_Nov_17_10_82.txt
199T > C,"... to predict clinical symptoms. For example, the c.199T > C mutation has been widely reported in scre...",104,1423,BMC_Pediatr_2010_Nov_17_10_82.txt
985A > G,"...,12,14]. As noted above, testing for the common c.985A > G was not performed on all screen positive ...",104,1772,BMC_Pediatr_2010_Nov_17_10_82.txt
199T > C,... nor was sequencing or specific testing for the c.199T > C mutation performed consistently in all pr...,104,1881,BMC_Pediatr_2010_Nov_17_10_82.txt
199T > C,"... cohort, it is unusual that no instances of the C.199T > C mutation were detected. Environmental tri...",104,2090,BMC_Pediatr_2010_Nov_17_10_82.txt
985A > G,...5 infants found to be homozygous for the common c.985A > G mutation had qualitative urine organic ac...,108,1774,BMC_Pediatr_2010_Nov_17_10_82.txt
985A > G,...le have an increased frequency of the common MCAD 985A > G mutation J Inherit Metab Dis 2005 28 551 ...,148,142,BMC_Pediatr_2010_Nov_17_10_82.txt
003	M>E,...toms	50.32 ± 0.87	53.77 ± 0.61	51.44 ± 1.12	5.6	0.003	M>E; M >H;H = E,78,64,BMC_Public_Health_2007_Dec_5_7_347.txt
008	M>E,...anic	45.90 ± 0.87	48.59 ± 0.61	50.05 ± 1.13	4.9	0.008	M>E; M = H; H>E,81,63,BMC_Public_Health_2007_Dec_5_7_347.txt
79G > C,"...tropherogram identifying the missense mutation, c.79G > C (E27Q), is shown. (B) A genome map of the ...",89,161,BMC_Res_Notes_2014_Jul_22_7_465.txt
2555T >C,... that the three siblings share the same variant c.2555T >C (p.I852T) in the homozygous state. Accord...,57,296,BMC_Res_Notes_2016_Feb_13_9_91.txt
2555T >C,...ings revealed a homozygote state of the variant c.2555T >C (p.I852T),70,395,BMC_Res_Notes_2016_Feb_13_9_91.txt
2555T >C,"...atients who have CRB1 mutations, especially the c.2555T >C (p.I852T) homozygote variant searching fo...",83,225,BMC_Res_Notes_2016_Feb_13_9_91.txt
278C>T,3	TCA>TTA	c.278C>T	Ser93Leu	Hydrophilic to hydrophobic	In prob...,90,13,BMC_Womens_Health_2005_May_26_5_8.txt
427G>A,4	GAG> AAG	c.427G>A	Glu143Lys	Acidic to basic	Polymorphism,91,14,BMC_Womens_Health_2005_May_26_5_8.txt
531C>T,4	AGC>AGT	c.531C>T	Ser177Ser	Silent	Polymorphism,92,13,BMC_Womens_Health_2005_May_26_5_8.txt
1086C>G,4	GGC>GGG	c.1086C>G	Gly362Gly	Silent	Polymorphism,96,13,BMC_Womens_Health_2005_May_26_5_8.txt
4	Ccg>Ctg,4	Ccg>Ctg	c.1250C>T	Pro417Leu	Potential tertiary s...,97,1,BMC_Womens_Health_2005_May_26_5_8.txt
1250C>T,4	Ccg>Ctg	c.1250C>T	Pro417Leu	Potential tertiary structure cha...,97,13,BMC_Womens_Health_2005_May_26_5_8.txt
1406C>T,5	GCG>GTG	c.1406C>T	Ala469Val		Polymorphism,98,13,BMC_Womens_Health_2005_May_26_5_8.txt
1541G>A,6	GGG>GAG	c.1541G>A	Gly514Glu	Small hydrophobic to acidic	Only...,99,13,BMC_Womens_Health_2005_May_26_5_8.txt
1809T>C,9	TTC>TTT	c.1809T>C	Phe603Leu	Aromatic to aliphatic	Polymorphi...,100,13,BMC_Womens_Health_2005_May_26_5_8.txt
1998C>T,11	CAC>CAT	c.1998C>T	His666His	Silent	Polymorphism,101,14,BMC_Womens_Health_2005_May_26_5_8.txt
2621T>A,16		c.2621T>A			3' untranslated region. Polymorphism,102,7,BMC_Womens_Health_2005_May_26_5_8.txt
1541G>A,...ing brain tumors and leukemias). The underlying c.1541G>A nucleotide substitution was detected in th...,107,795,BMC_Womens_Health_2005_May_26_5_8.txt
677C-->T,"... P, Clarke R, Blom HJ, Kok FJ, Schouten EG. MTHFR 677C-->T polymorphism and risk of coronary heart d...",210,70,BMJ_2009_Nov_5_339_b4265.txt
1948 C>T,...genetic testing was performed and that showed a c.1948 C>T (p.Arg650Cys) mutation in fibrillin-1 gen...,47,77,Cureus_8(5)_e619.txt
919G>A,...h incidence of the later-onset GLA mutation c.936+919G>A (IVS4+919G>A) . Hum Mutat,491,110,BMJ_Open_2016_Apr_8_6(4)_e010422.txt
919G>A,...f the later-onset GLA mutation c.936+919G>A (IVS4+919G>A) . Hum Mutat,491,123,BMJ_Open_2016_Apr_8_6(4)_e010422.txt
27 G>A,...tigated the Kruppel-like factor 6 rs37508611 IVSI-27 G>A polymorphism on two cohorts of 306 UK and 1...,275,272,BMJ_Open_Gastroenterol_2015_Feb_17_2(1)_e000019.txt
617 G>A,...ne of juxta-membrane GS domain at position 617 (c.617 G>A) responsible for both familial and sporadi...,29,314,Bone_Res_2015_Apr_14_3_15005.txt
154A>C,"...ic telangiectasia type 2 with a novel mutation, c.154A>C (p.Thr52Pro), in the ALK1/ACVRL1 gene Neuro...",240,141,Bone_Res_2015_Apr_14_3_15005.txt
4N                                                                                     >  C,p4N                                                ...,205,2,Br_J_Cancer_1971_Sep_25(3)_458-461.txt
4 O   >  C,...                               >  C4-4 lf?  >  C4-4 O   >  C4-1,205,108,Br_J_Cancer_1971_Sep_25(3)_458-461.txt
144 T -> G,"amino acid change, 144 T -> G and 192 C -* T. One alteration",344,20,Br_J_Cancer_1997_76(12)_1550-1553.txt
3A>G,...fication of a belgian founder mutation BRCA1 IVS5+3A>G Disease Markers 1999a 15 69 73 10595255,95,203,Br_J_Cancer_2002_Dec_2_87(12)_1379-1385.txt
765G>C,...f cancer risk. A single nucleotide polymorphism (−765G>C) in the promoter region of the COX-2 gene w...,7,623,Br_J_Cancer_2004_May_4_90(9)_1760-1764.txt
765G>C,"...agen, Valencia, CA, USA). A TaqMan assay for the −765G>C COX-2 polymorphism was developed using a Ta...",16,210,Br_J_Cancer_2004_May_4_90(9)_1760-1764.txt
765G>C,...ciation between colorectal cancer risk and COX-2 −765G>C genotype or n-6 PUFA intake (Table,85,351,Br_J_Cancer_2004_May_4_90(9)_1760-1764.txt
765G>C,Table 2 COX-2 −765G>C genotype and dietary intake of n-6 PUFAs in...,86,17,Br_J_Cancer_2004_May_4_90(9)_1760-1764.txt
765G>C,Table 3 COX-2 −765G>C genotype in relation to risk of colorectal ...,104,17,Br_J_Cancer_2004_May_4_90(9)_1760-1764.txt
765G>C,... a statistically significant effect of the COX-2 −765G>C gene polymorphism on colon cancer risk amon...,122,99,Br_J_Cancer_2004_May_4_90(9)_1760-1764.txt
765G>C,"...ase activity in reporter expression studies. The −765G>C mutation lies within this region, and is al...",130,635,Br_J_Cancer_2004_May_4_90(9)_1760-1764.txt
765G>C,"...7). At present, data on the functionality of the −765G>C polymorphism and the direction/magnitude of...",130,799,Br_J_Cancer_2004_May_4_90(9)_1760-1764.txt
464 T>C,c.1-464 T>C	Promotera	44	30 (68%)	6 (14%)	8 (18%)	38	1...,103,5,Br_J_Cancer_2004_Sep_13_91(6)_1119-1130.txt
290 T>C,c.1-290 T>C	Promotera	44	29 (66%)	6 (14%)	9 (20%)	42	1...,104,5,Br_J_Cancer_2004_Sep_13_91(6)_1119-1130.txt
225 G>A,c.1-225 G>A	Promotera	44	1 (2%)	0	43 (98%)	42	0	0	42 (...,105,5,Br_J_Cancer_2004_Sep_13_91(6)_1119-1130.txt
53 C>T,c.1-53 C>T	Promotera	44	2 (5%)	0	42 (95%)	38	1 (3%)	0	...,106,5,Br_J_Cancer_2004_Sep_13_91(6)_1119-1130.txt
36 G>C,c.1-36 G>Cb	5′ UTRc	44	10 (23%)	0	34 (77%)	38	7 (18%)	...,107,5,Br_J_Cancer_2004_Sep_13_91(6)_1119-1130.txt
25 G>C,c.1-25 G>Cb	5′ UTRc	44	10 (23%)	0	34 (77%)	38	7 (18%)	...,108,5,Br_J_Cancer_2004_Sep_13_91(6)_1119-1130.txt
644 A>G,c.1-644 A>G	5′ UTRd	44	29 (66%)	8 (18%)	7 (16%)	48	12 ...,109,5,Br_J_Cancer_2004_Sep_13_91(6)_1119-1130.txt
316 A>G,c.1-316 A>G	5′ UTRd	44	10 (23%)	34 (77%)	0	46	2 (4%)	4...,110,5,Br_J_Cancer_2004_Sep_13_91(6)_1119-1130.txt
665 A>G,c.665 A>G	3′ UTRc	44	10 (23%)	33 (75%)	1 (2%)	46	7 (...,112,3,Br_J_Cancer_2004_Sep_13_91(6)_1119-1130.txt
564T>C,"...TL2 promoter DMR, heterozygosity at a DLK1 SNP (c.564T>C) (n=−2) or at closely linked microsatellite...",36,574,Br_J_Cancer_2005_Apr_25_92(8)_1574-1580.txt
980A>C,...t changes were observed (Table 1). A Pro327Pro (c.980A>C) change in exon 5 and a Pro1297Pro (c.3890C...,25,413,Br_J_Cancer_2005_Mar_28_92(6)_1126-1129.txt
3890C>G,...o (c.980A>C) change in exon 5 and a Pro1297Pro (c.3890C>G) change in exon 27 were both found in 4% (...,25,458,Br_J_Cancer_2005_Mar_28_92(6)_1126-1129.txt
4C>A,"...ntly tested in silico. One of the variants, IVS17-4C>A, gave little evidence of alternative splicing...",27,469,Br_J_Cancer_2005_Mar_28_92(6)_1126-1129.txt
4C>A,"...ittle evidence of alternative splicing. The IVS17-4C>A change was found in one PJS patient, but not ...",27,531,Br_J_Cancer_2005_Mar_28_92(6)_1126-1129.txt
1562C>T,...were associated with poor prognosis but SNP MMP-9−1562C>T was not. Tumour MMP levels were not determ...,3,1001,Br_J_Cancer_2008_Jun_3_98(11)_1820-1823.txt
1306C>T,...-nucleotide polymorphism (SNP) analysis for MMP-2−1306C>T and MMP-9−1562C>T was performed by tetra-p...,20,132,Br_J_Cancer_2008_Jun_3_98(11)_1820-1823.txt
1562C>T,"...rphism (SNP) analysis for MMP-2−1306C>T and MMP-9−1562C>T was performed by tetra-primer ARMS PCR, in...",20,150,Br_J_Cancer_2008_Jun_3_98(11)_1820-1823.txt
1306C>T,...nt association with TNM stage (Table 1) and MMP-2−1306C>T also with survival (Figure 1A). All other ...,26,319,Br_J_Cancer_2008_Jun_3_98(11)_1820-1823.txt
1306C>T,"...did not show an association with either SNP MMP-2−1306C>T or MMP-9−1562C>T, and the latter was also ...",26,450,Br_J_Cancer_2008_Jun_3_98(11)_1820-1823.txt
1562C>T,"...ssociation with either SNP MMP-2−1306C>T or MMP-9−1562C>T, and the latter was also not associated wi...",26,467,Br_J_Cancer_2008_Jun_3_98(11)_1820-1823.txt
1306C>T,"...ective SNP genotypes. The median values for MMP-2−1306C>T were 10.9, 9.5 and 11.6 ng mg−1 for genoty...",30,156,Br_J_Cancer_2008_Jun_3_98(11)_1820-1823.txt
1562C>T,...tein associated with the TT genotype of SNP MMP-9−1562C>T in tumours did not reach significance (CC/...,30,330,Br_J_Cancer_2008_Jun_3_98(11)_1820-1823.txt
1306C>T,"...e did find significant associations between MMP-2−1306C>T and TNM stage and survival, that is, worse...",37,1028,Br_J_Cancer_2008_Jun_3_98(11)_1820-1823.txt
1562C>T,"... (Sjöblom et al, 2006). Our results for SNP MMP-9−1562C>T correspond well with data from Asiatic pat...",37,1384,Br_J_Cancer_2008_Jun_3_98(11)_1820-1823.txt
1306C>T,...ce of a correlation between promoter-located SNP −1306C>T in the MMP-2 gene with tumour MMP-2 levels...,39,229,Br_J_Cancer_2008_Jun_3_98(11)_1820-1823.txt
1799T>A,"...lteration, rather than the more common p.V600E (g.1799T>A). Sequencing detected two samples with add...",74,580,Br_J_Cancer_2009_Nov_17_101(10)_1724-1730.txt
1742A>T,...ng the specific ARMS assays in this study: BRAF g.1742A>T (p.N581S) and g.1801A>G (p.K601E). Eightee...,74,733,Br_J_Cancer_2009_Nov_17_101(10)_1724-1730.txt
1801A>G,...ays in this study: BRAF g.1742A>T (p.N581S) and g.1801A>G (p.K601E). Eighteen mutations were detecte...,74,757,Br_J_Cancer_2009_Nov_17_101(10)_1724-1730.txt
1306C>T,...onding single nucleotide polymorphisms of MMP-2 (−1306C>T) and MMP-9 (−1562C>T). Multivariate analys...,10,314,Br_J_Cancer_2012_Apr_24_106(9)_1495-1498.txt
1562C>T,...ide polymorphisms of MMP-2 (−1306C>T) and MMP-9 (−1562C>T). Multivariate analyses indicated that the...,10,335,Br_J_Cancer_2012_Apr_24_106(9)_1495-1498.txt
1306C>T,"... (Miller et al, 1988). The SNP analysis for MMP-2−1306C>T and MMP-9−1562C>T was performed by restric...",30,121,Br_J_Cancer_2012_Apr_24_106(9)_1495-1498.txt
1562C>T,...88). The SNP analysis for MMP-2−1306C>T and MMP-9−1562C>T was performed by restriction fragment leng...,30,139,Br_J_Cancer_2012_Apr_24_106(9)_1495-1498.txt
1306C>T,"...ijer et al, 2006). Genotype frequencies for MMP-2-1306C>T were CC: n=108: CT: n=79 and TT: n=11, and...",30,441,Br_J_Cancer_2012_Apr_24_106(9)_1495-1498.txt
1562C>T,"...e CC: n=108: CT: n=79 and TT: n=11, and for MMP-9-1562C>T CC: n=139; CT: n=50 and TT: n=9",30,502,Br_J_Cancer_2012_Apr_24_106(9)_1495-1498.txt
1306C>T,The genotypes of the MMP-2-1306C>T and MMP-9-1562C>T polymorphism were distri...,38,28,Br_J_Cancer_2012_Apr_24_106(9)_1495-1498.txt
1562C>T,The genotypes of the MMP-2-1306C>T and MMP-9-1562C>T polymorphism were distributed according to...,38,46,Br_J_Cancer_2012_Apr_24_106(9)_1495-1498.txt
1306C>T,...ld be more likely. T allele carriers of the MMP-2−1306C>T polymorphism have lower promoter activity ...,45,483,Br_J_Cancer_2012_Apr_24_106(9)_1495-1498.txt
1562C>T,"...t al, 2001), while T allele carriers of the MMP-9−1562C>T polymorphism have increased transcriptiona...",45,633,Br_J_Cancer_2012_Apr_24_106(9)_1495-1498.txt
8672G>A,...ined kinase activity. One missense ATM mutation c.8672G>A (p.Gly2891Asp) and a c.1A>G substitution w...,10,365,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
1A>G,...nse ATM mutation c.8672G>A (p.Gly2891Asp) and a c.1A>G substitution were identified. In the modellin...,10,396,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
7271T>G,"... cancer. The presence of the missense mutation, c.7271T>G (p.Val2424Gly), further increases the risk...",21,252,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
1A>G,"...Stratagene, Amsterdam, The Netherlands). Both the 1A>G and the 8672G>A ATM mutants were sequenced in...",36,406,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
8672G>A,"...msterdam, The Netherlands). Both the 1A>G and the 8672G>A ATM mutants were sequenced in full to veri...",36,419,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
8672G>A,"Two ATM mutations, c.8672G>A. (p.Gly2891Asp) and c.1A>G (Figure 3), wer...",56,22,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
1A>G,"...wo ATM mutations, c.8672G>A. (p.Gly2891Asp) and c.1A>G (Figure 3), were identified in the cells from...",56,52,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
8672G>A,"...as carried on each allele of chromosome 11, the c.8672G>A mutation was paternal and the c.1A>G mutat...",56,393,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
1A>G,"...11, the c.8672G>A mutation was paternal and the c.1A>G mutation maternal in origin",56,433,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
1A>G,...result in expression of mutant ATM protein. The c.1A>G affects the first base in the coding sequence...,58,128,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
8672G>A,...G in the RNA was able to allow translation. The c.8672G>A (p.Gly2891Asp) is a missense mutation loca...,58,435,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
8672G>A,...ain. It was expected that at the cDNA level the c.8672G>A mutation might result in loss of exon 60. ...,58,599,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
7271T>G,"...wing a severe reaction to radiotherapy (A-T109, c.7271T>G homozygous) (Stankovic et al, 1998). Altho...",63,231,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
7271T>G,"... the level of ATM expression was highest in the c.7271T>G cells, the level of kinase activity appear...",63,334,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
2T>C,"... A-T86, carrying the initiating codon mutation, c.2T>C, on one allele and a null mutation on the sec...",66,110,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
1A>G,...a truncated protein. In translational terms the c.1A>G mutation in A-T213 would be expected to behav...,66,508,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
2T>C,... in A-T213 would be expected to behave like the c.2T>C mutation as both mutations are in the initiat...,66,571,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
1A>G,...ompromise its function. This would result in the c1A>G mutation giving a similar truncated protein t...,66,708,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
2T>C,...tation giving a similar truncated protein to the c2T>C mutation,66,765,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
2T>C,"...han that immunoprecipitated from cells from the c.2T>C patient A-T86 (Figure 5, lanes 7 and 8) but l...",68,167,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
1A>G,"...ls (Figure 5, lanes 1 and 2). Assuming that the c.1A>G and c.2T>C mutant alleles result in a similar...",68,291,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
2T>C,"...5, lanes 1 and 2). Assuming that the c.1A>G and c.2T>C mutant alleles result in a similar level of A...",68,302,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
8672G>A,...tein in cells from patient A-T213 came from the c.8672G>A (p.Gly2891Asp) allele. Truncated ATM assoc...,68,443,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
1A>G,"...uncated ATM associated with the presence of the c.1A>G mutation was not detected, probably because i...",68,526,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
8672G>A,"...it was obscured by the full-length ATM from the c.8672G>A (p.Gly2891Asp) allele (Figure 5, compare l...",68,625,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
2T>C,...finding that the ATM protein expressed from the c.2T>C mutant allele in the LCL from patient A-T187 ...,68,797,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
9139C>T,"...le that was essentially full-length p.Arg3047X (c.9139C>T) (Figure 5, lanes 9 and 10)",68,967,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
2T>C,"...ecipitated from A-T cells carrying the mutation c.2T>C, which did not demonstrate any in vitro kinas...",70,154,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
8672G>A,...activity in cells of patient A-T213 is from the c.8672G>A (p.Gly2891Asp) allele,70,318,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
1A>G,...NA. Both the mutant protein associated with the c.1A>G and the p.Gly2891Asp mutant protein are shown...,72,244,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
1A>G,"...tein are shown in Figure 6A. Interestingly, the c.1A>G protein was of lower molecular weight than wt...",72,330,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
1A>G,"...utant protein was significantly higher than the c.1A>G protein (Figure 6A, lanes 4 and 5). We were u...",72,645,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
1A>G,"...nlikely to be due to protein expressed from the c.1A>G mutation. Indeed, the mutant c.1A>G ATM clone...",74,271,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
1A>G,"...ed from the c.1A>G mutation. Indeed, the mutant c.1A>G ATM cloned into pMEP4 was expressed as a lowe...",74,307,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
2T>C,...e-inactive truncated protein expressed from the c.2T>C ATM mutant,74,459,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
8672G>A,"... this mild presentation, the two ATM mutations, c.8672G>A (p.Gly2891Asp) and c.1A>G, in patient A-T2...",77,659,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
1A>G,"...two ATM mutations, c.8672G>A (p.Gly2891Asp) and c.1A>G, in patient A-T213 are both of considerable i...",77,688,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
8672G>A,"Interestingly, the c.8672G>A missense mutation was reported in one of t...",79,22,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
1A>G,...TM protein derived from the allele carrying the c.1A>G mutation affecting the initiating methionine ...,81,56,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
2T>C,...way as a protein derived from another mutation (c.2T>C) in the same codon. Cells from a patient with...,81,182,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
2T>C,...n the same codon. Cells from a patient with the c.2T>C and an ATM-null mutation expressed a truncate...,81,239,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
1A>G,"...se activity. Therefore, it is unlikely that the c.1A>G derived protein has any activity. In both cas...",81,380,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
2T>C,... weight of ATM immunoprecipitated from both the c.2T>C mutant cells and the modelled c.1A>G is consi...,81,678,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
1A>G,...m both the c.2T>C mutant cells and the modelled c.1A>G is consistent with this,81,715,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
1A>G,...at the truncated ATM protein expressed from the c.1A>G and c.2T>C mutant alleles is the result of un...,83,142,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
2T>C,...cated ATM protein expressed from the c.1A>G and c.2T>C mutant alleles is the result of uncharacteris...,83,153,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
7271T>G,"...st cancer, were homozygous for the ATM mutation c.7271T>G (p.Val2424Gly). The mutation was also iden...",85,1043,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
1918A>T,...ations in novel premature termination mutation (c.1918A>T (Lys640Stop)) and a (c.1066-6T>G (IVS10-6T...,87,286,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
6T>G,"...n mutation (c.1918A>T (Lys640Stop)) and a (c.1066-6T>G (IVS10-6T-G)), which has previously been repo...",87,322,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
8147T>C,"...(Mandigers et al, 2011). Only one ATM mutation (c.8147T>C (p.Val2716Ala)), which also has some ATM k...",87,688,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
1A>G,"... two mutant ATM proteins, (p.Gly2891Asp and the c.1A>G derived protein) raises the possibility of a ...",89,336,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
1A>G,...vidence of a significant effect of the inactive c.1A>G derived protein in reducing the activity of t...,89,526,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
1A>G,"...s at these positions in patient A-T213; (A) the c.1A>G mutation, and (B) the c.8672G>A mutation. The...",108,207,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
8672G>A,"...nt A-T213; (A) the c.1A>G mutation, and (B) the c.8672G>A mutation. The boxed sequence triplet in (A...",108,236,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
2T>C,"..., the ATM in an LCL from patient A-T86 with the c.2T>C mutation (and also null mutation c.7665delins...",112,509,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
2T>C,... 7 and 8). It is likely that truncated ATM from c.2T>C in patient AT187 is obscured by the p.Arg3047...,112,661,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
9139C>T,...in patient AT187 is obscured by the p.Arg3047X (c.9139C>T) mutant protein (lanes 9 and 10) and the t...,112,716,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
1A>G,...ein (lanes 9 and 10) and the truncated ATM from c.1A>G in patient A-T213 is obscured by the p.Gly289...,112,786,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
8672G>A,...patient A-T213 is obscured by the p.Gly2891Asp (c.8672G>A) mutant protein (lanes 5 and 6). Immunopre...,112,844,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
2T>C,...A-T213 but not from ATM of patient A-T86 with a c.2T>C mutation and a second truncating mutation (la...,112,1316,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
2T>C,...mutation (lane 8) or from patient A-T187 with a c.2T>C mutation and c.9139C>T (p.Arg3047X). (B) Hist...,112,1404,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
9139C>T,... from patient A-T187 with a c.2T>C mutation and c.9139C>T (p.Arg3047X). (B) Histogram of relative le...,112,1424,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
1A>G,... expression than the protein expressed from the c.1A>G mutation. (A) ATM protein without tags. ATM p...,114,139,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
1A>G,"...verexposure of the western blot showed that the c.1A>G derived protein (1A>G, lane 4) is truncated a...",114,349,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
1A>G,"...tern blot showed that the c.1A>G derived protein (1A>G, lane 4) is truncated and accumulates to a lo...",114,371,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
8672G>A,"...tein (pTAM2, lane 2) or the p.Gly2891Asp protein (8672G>A, lane 5). No ATM protein was expressed fro...",114,503,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
8672G>A,"...protein (pTAM2, lane 2) and p.Gly2891Asp protein (8672G>A, lane 4) were increased when the ATM const...",114,769,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
8672G>A,... with Supplementary Figure 2A). The p.Gly2891Asp (8672G>A) protein was expressed at a similar level ...,114,908,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
8672G>A,"... transfected with pMEP4-ATM wt (pTAM2), pMEP4-ATM 8672G>A (8672G>A) or pMEP4 vector alone (pMEP4) al...",114,1133,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
8672G>A,"...ted with pMEP4-ATM wt (pTAM2), pMEP4-ATM 8672G>A (8672G>A) or pMEP4 vector alone (pMEP4) all with N-...",114,1142,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
8672G>A,... N-terminal tags. Expression of the p.Gly2891Asp (8672G>A) protein (lane 5) was comparable to that o...,114,1239,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
8672G>A,"... wt ATM (pTAM2, lanes 1 and 7). The p.Gly2891Asp (8672G>A) protein autophosphorylated Ser1981 follow...",114,1340,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
8672G>A,"...targets Smc1, KAP-1 and Nbs1 by the p.Gly2891Asp (8672G>A) protein were substantially lower than tho...",114,1564,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
7271T>G,... Gatti RA Concannon P Haile RW  2003 ATM variants 7271T>G and IVS10-6T>G among women with unilateral...,130,184,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
6T>G,...n P Haile RW  2003 ATM variants 7271T>G and IVS10-6T>G among women with unilateral and bilateral bre...,130,202,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
7271T>G,... cancer risks associated with ATM gene variants c.7271T>G and c.1066-6T>G (IVS10-6T>G) from the Brea...,131,292,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
6T>G,...iated with ATM gene variants c.7271T>G and c.1066-6T>G (IVS10-6T>G) from the Breast Cancer Family Re...,131,311,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
6T>G,...TM gene variants c.7271T>G and c.1066-6T>G (IVS10-6T>G) from the Breast Cancer Family Registry Hum M...,131,323,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
7271T-->G,"...axia telangiectasia patients, with 5762ins137 and 7271T-->G mutations, showing a less severe phenoty...",147,195,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
276G>T,...ropago G Baroni MG  2005 The adiponectin gene SNP+276G>T associates with early-onset coronary artery...,276,144,Br_J_Cancer_2013_Aug_20_109(4)_872-881.txt
45T>G,"...iations between single-nucleotide polymorphisms (+45T>G, +276G>T, -11377C>G, -11391G>A) of adiponect...",286,150,Br_J_Cancer_2013_Aug_20_109(4)_872-881.txt
276G>T,"...between single-nucleotide polymorphisms (+45T>G, +276G>T, -11377C>G, -11391G>A) of adiponectin gene ...",286,158,Br_J_Cancer_2013_Aug_20_109(4)_872-881.txt
11377C>G,"...ingle-nucleotide polymorphisms (+45T>G, +276G>T, -11377C>G, -11391G>A) of adiponectin gene and type ...",286,167,Br_J_Cancer_2013_Aug_20_109(4)_872-881.txt
11391G>A,"...otide polymorphisms (+45T>G, +276G>T, -11377C>G, -11391G>A) of adiponectin gene and type 2 diabetes ...",286,178,Br_J_Cancer_2013_Aug_20_109(4)_872-881.txt
221G>A,"...ociate with reduced enzymatic activity; UGT1A1*6 (221G>A), UGT1A1*28 ((TA)6>(TA)7), UGT1A1*60 (-3279...",36,414,Br_J_Cancer_2013_Sep_17_109(6)_1420-1427.txt
3279T>G,"...*6 (221G>A), UGT1A1*28 ((TA)6>(TA)7), UGT1A1*60 (-3279T>G), UGT1A6 (19T>G, 315A>G, 541A>G, and 552A>...",36,460,Br_J_Cancer_2013_Sep_17_109(6)_1420-1427.txt
19T>G,"...1*28 ((TA)6>(TA)7), UGT1A1*60 (-3279T>G), UGT1A6 (19T>G, 315A>G, 541A>G, and 552A>C), UGT1A7 (387T>G...",36,478,Br_J_Cancer_2013_Sep_17_109(6)_1420-1427.txt
315A>G,"...TA)6>(TA)7), UGT1A1*60 (-3279T>G), UGT1A6 (19T>G, 315A>G, 541A>G, and 552A>C), UGT1A7 (387T>G, 391C>...",36,485,Br_J_Cancer_2013_Sep_17_109(6)_1420-1427.txt
541A>G,"...)7), UGT1A1*60 (-3279T>G), UGT1A6 (19T>G, 315A>G, 541A>G, and 552A>C), UGT1A7 (387T>G, 391C>A, 392G>...",36,493,Br_J_Cancer_2013_Sep_17_109(6)_1420-1427.txt
552A>C,"...60 (-3279T>G), UGT1A6 (19T>G, 315A>G, 541A>G, and 552A>C), UGT1A7 (387T>G, 391C>A, 392G>A, and 622T>...",36,505,Br_J_Cancer_2013_Sep_17_109(6)_1420-1427.txt
387T>G,"...T1A6 (19T>G, 315A>G, 541A>G, and 552A>C), UGT1A7 (387T>G, 391C>A, 392G>A, and 622T>C), CYP2A6*4 (who...",36,522,Br_J_Cancer_2013_Sep_17_109(6)_1420-1427.txt
391C>A,"...T>G, 315A>G, 541A>G, and 552A>C), UGT1A7 (387T>G, 391C>A, 392G>A, and 622T>C), CYP2A6*4 (whole delet...",36,530,Br_J_Cancer_2013_Sep_17_109(6)_1420-1427.txt
392G>A,"...A>G, 541A>G, and 552A>C), UGT1A7 (387T>G, 391C>A, 392G>A, and 622T>C), CYP2A6*4 (whole deletion of C...",36,538,Br_J_Cancer_2013_Sep_17_109(6)_1420-1427.txt
622T>C,"... and 552A>C), UGT1A7 (387T>G, 391C>A, 392G>A, and 622T>C), CYP2A6*4 (whole deletion of CYP2A6), CYP2...",36,550,Br_J_Cancer_2013_Sep_17_109(6)_1420-1427.txt
6558T>G,"...C), CYP2A6*4 (whole deletion of CYP2A6), CYP2A6*7(6558T>G) and CYP2A6*9 (−48T>G)",36,605,Br_J_Cancer_2013_Sep_17_109(6)_1420-1427.txt
48T>G,"...tion of CYP2A6), CYP2A6*7(6558T>G) and CYP2A6*9 (−48T>G)",36,629,Br_J_Cancer_2013_Sep_17_109(6)_1420-1427.txt
19T>G,"... among single-nucleotide polymorphisms in UGT1A6 (19T>G, 315A>G, 541A>G and 552A>C) and UGT1A7 (387T...",70,113,Br_J_Cancer_2013_Sep_17_109(6)_1420-1427.txt
315A>G,"...single-nucleotide polymorphisms in UGT1A6 (19T>G, 315A>G, 541A>G and 552A>C) and UGT1A7 (387T>G, 391...",70,120,Br_J_Cancer_2013_Sep_17_109(6)_1420-1427.txt
541A>G,"...ucleotide polymorphisms in UGT1A6 (19T>G, 315A>G, 541A>G and 552A>C) and UGT1A7 (387T>G, 391C>A, 392...",70,128,Br_J_Cancer_2013_Sep_17_109(6)_1420-1427.txt
552A>C,"...olymorphisms in UGT1A6 (19T>G, 315A>G, 541A>G and 552A>C) and UGT1A7 (387T>G, 391C>A, 392G>A and 622...",70,139,Br_J_Cancer_2013_Sep_17_109(6)_1420-1427.txt
387T>G,"...A6 (19T>G, 315A>G, 541A>G and 552A>C) and UGT1A7 (387T>G, 391C>A, 392G>A and 622T>C). In particular,...",70,159,Br_J_Cancer_2013_Sep_17_109(6)_1420-1427.txt
391C>A,"...G, 315A>G, 541A>G and 552A>C) and UGT1A7 (387T>G, 391C>A, 392G>A and 622T>C). In particular, there w...",70,167,Br_J_Cancer_2013_Sep_17_109(6)_1420-1427.txt
392G>A,"...G, 541A>G and 552A>C) and UGT1A7 (387T>G, 391C>A, 392G>A and 622T>C). In particular, there was a per...",70,175,Br_J_Cancer_2013_Sep_17_109(6)_1420-1427.txt
622T>C,"...nd 552A>C) and UGT1A7 (387T>G, 391C>A, 392G>A and 622T>C). In particular, there was a perfect LD bet...",70,186,Br_J_Cancer_2013_Sep_17_109(6)_1420-1427.txt
541A>G,"...particular, there was a perfect LD between UGT1A6 541A>G and UGT1A7 622T>C. In other words, patients...",70,248,Br_J_Cancer_2013_Sep_17_109(6)_1420-1427.txt
622T>C,"...was a perfect LD between UGT1A6 541A>G and UGT1A7 622T>C. In other words, patients with UGT1A6*2 wer...",70,266,Br_J_Cancer_2013_Sep_17_109(6)_1420-1427.txt
280C>T,"...patient carrying a heterozygous RPS19 mutation (c.280C>T, p.Arg94X), and healthy control samples wer...",77,281,Br_J_Haematol_2015_Nov_25_171(4)_517-529.txt
5882G>A,ARDM-135	42	24	0.4	0.6	STGD	c.5882G>A(42)	p.Gly1961Glu	c.1029_1030insT(8)	p.Asn3...,76,31,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
5882G>A,ARDM-240	15	13	0.2	0.16	STGD	c.5882G>A(42)	p.Gly1961Glu	c.2285C>A(15)	p.Ala762Glu...,77,32,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
2285C>A,...	15	13	0.2	0.16	STGD	c.5882G>A(42)	p.Gly1961Glu	c.2285C>A(15)	p.Ala762Glu	Yes,77,59,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
5882G>A,ARDM-225	32	25	0.25	0.50	STGD	c.5882G>A(42)	p.Gly1961Glu	c.6559C>T(48)	p.Gln2187X	...,78,33,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
6559C>T,...32	25	0.25	0.50	STGD	c.5882G>A(42)	p.Gly1961Glu	c.6559C>T(48)	p.Gln2187X	Yes,78,60,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
3386G>T,ARDM-164	21	11	NA	STGD	c.3386G>T(23)	p.Arg1129Leu	c.700C>T(6)	p.Gln234X	Yes...,79,26,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
700C>T,...DM-164	21	11	NA	STGD	c.3386G>T(23)	p.Arg1129Leu	c.700C>T(6)	p.Gln234X	Yes,79,53,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
3386G>T,ARDM-162	50	16	0.1	0.1	STGD	c.3386G>T(23)	p.Arg1129Leu	ND	ND	Yes,80,31,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
3386G>T,ARDM-198	27	19	0.1	0.1	STGD	c.3386G>T(23)	p.Arg1129Leu	ND	ND	NP,81,31,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
3056C>T,ARDM-146	32	13	0.06	0.1	STGD	c.3056C>T(21)	p.Thr1019Met	c.6140T>A(44)	p.Ile2047As...,86,32,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
6140T>A,...	32	13	0.06	0.1	STGD	c.3056C>T(21)	p.Thr1019Met	c.6140T>A(44)	p.Ile2047Asn	Yes,86,59,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
3056C>T,ARDM-40	46	9	0.1	0.1	STGD	c.3056C>T(21)	p.Thr1019Met	c.3943C>T(27)	p.Gln1315X	...,87,29,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
3943C>T,...40	46	9	0.1	0.1	STGD	c.3056C>T(21)	p.Thr1019Met	c.3943C>T(27)	p.Gln1315X	Yes,87,56,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
5929G>A,ARDM-90	26	8	Hand moving	STGD	c.5929G>A (43)	p.Gly1977Ser	IVS21-2A>T		Yes,88,33,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
2A>T,...and moving	STGD	c.5929G>A (43)	p.Gly1977Ser	IVS21-2A>T		Yes,88,65,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
3323G>A,ARDM-181	57	16	0.1	0.09	STGD	c.3323G>A (22)	p.Arg1108His	IVS38+5G>A		Yes,89,32,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
5G>A,...6	0.1	0.09	STGD	c.3323G>A (22)	p.Arg1108His	IVS38+5G>A		Yes,89,64,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
4793C>A,ARDM-197	35	15	0.1	0.1	STGD	c.4793C>A(34) (false +)	p.Ala1598Asp (false +)	c.517...,90,31,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
5172G>T,...	c.4793C>A(34) (false +)	p.Ala1598Asp (false +)	c.5172G>T(36)	p.Trp1724Cys	Yes,90,78,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
6079C>T,ARDM-183	63	55	0.150	0.175	STGD	c.6079C>T(44)	p.Leu2027Phe	c.5929G>A(43) (false –)	p...,91,35,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
5929G>A,...	55	0.150	0.175	STGD	c.6079C>T(44)	p.Leu2027Phe	c.5929G>A(43) (false –)	p.Gly1977Ser (false –)	NP,91,62,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
1804C>T,ARDM-38	35	6	0.01	0.02	STGD	c.1804C>T(13)	p.Arg602Trp	c.4739delT(33)	p.Leu1580fs...,92,31,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
4457C>T,ARDM-163	48	32	0.01	0.32	STGD	c.4457C>T(30)	p.Pro1486Leu	ND	ND	Yes,93,33,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
6320G>A,ARDM-166	42	39	NA	STGD	c.6320G>A(46)	p.Arg2107His	ND	ND	Yes,94,26,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
2791G>A,ARDM-222	26	23	NA	STGD	c.2791G>A(19)	p.Val931Met	ND	ND	NP,95,26,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
4919G>A,ARDM-205	NA	NA	NA	STGD	c.4919G>A(35)	p.Arg1640Gln	ND	ND	NP,98,26,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
3386G>T,ARDM-247	30	12	0.05	0.1	CRD	c.3386G>T(23)	p.Arg1129Leu	c.6410G>A(47)	p.Cys2137Ty...,99,31,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
6410G>A,...7	30	12	0.05	0.1	CRD	c.3386G>T(23)	p.Arg1129Leu	c.6410G>A(47)	p.Cys2137Tyr	Yes,99,58,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
4297G>A,ARDM-99	59	46	0.05	0.05	CRD	c.4297G>A(29)	p.Val1433Ile	ND	ND	NP,100,31,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
2701A>G,ARDM-131	27	15	0.9	0.7	CRD	c.2701A>G(18)	p.Thr901Ala	ND	ND	Yes,101,30,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
86G>T,RP-773	38	20	0.05	0.05	RP	c.33N86G>T(23)	p.Arg1129Leu	ND	ND	NP,104,32,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
466A>G,RP-959	53	10	0.1	0.1	RP	c.466A>G(5)	p.Ile156Val	ND	ND	Yes,105,27,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
4297G>A,RP-1058	37	6	0.2	0.6	RP	c.4297G>A(29)	p.Val1433Ile	ND	ND	NP,106,27,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
264 A>T,3	c.264 A>T	p.Gly88Gly	This study,113,5,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
27G>A,IVS2-27G>A		This study,114,7,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
26 A>G,IVS3+26 A>G		91518,115,7,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
32 T>C,IVS6-32 T>C		915,116,7,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
1029T>C,8	c.1029T>C	p.Asn343Asn	This study,117,5,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
1299A>G,10	c.1299A>G	p.Glu433Glu	This study,118,6,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
1654G>A,12	c.1654G>A	p.Val552Ile	This study,119,6,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
16G>A,IVS13+16G>A		This study,120,8,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
2832A>G,19	c.2832A>G	p.Pro944Pro	This study,121,6,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
2964C>T,20	c.2964C>T	p.Leu988Leu	18,122,6,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
3507G>A,23	c.3507G>A	p.Gln1169Gln	This study,123,6,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
43G>A,IVS28+43G>A		24,124,8,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
16G>A,IVS43-16G>A		25,125,8,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
39 T>A,IVS48+39 T>A		This study,126,8,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
3T>C,IVS48-3T>C		1518,127,8,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
2A>T,...and p.Gln2187X); two splice-site mutations (IVS22-2A>T and IVS38+5G>A); three frameshift variants: t...,130,173,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
5G>A,...; two splice-site mutations (IVS22-2A>T and IVS38+5G>A); three frameshift variants: two caused by th...,130,188,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
2A>T,"...vel splice-site alterations were described, IVS21-2A>T (ARDM-90) and IVS38+5G>A (ARDM-181). Both pat...",177,57,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
5G>A,"...ns were described, IVS21-2A>T (ARDM-90) and IVS38+5G>A (ARDM-181). Both patients presented STGD phen...",177,82,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
3243A>G,"MELAS m.3243A>G	30	Randomized, placebo-controlled crossove...",49,9,Br_J_Pharmacol_2014_Apr_28_171(8)_1798-1817.txt
3243A>G,"...like episodes in MELAS patients with the common m.3243A>G mutation (Koga et al., 2005; 2006; 2010). ...",131,734,Br_J_Pharmacol_2014_Apr_28_171(8)_1798-1817.txt
3243A>G,...s the aminoacylation defect associated with the m.3243A>G mutation. Formal double-blinded randomized...,131,1268,Br_J_Pharmacol_2014_Apr_28_171(8)_1798-1817.txt
8993T>G,"... ATP synthesis defect in cybrids containing the m.8993T>G mutation, which is associated with materna...",193,314,Br_J_Pharmacol_2014_Apr_28_171(8)_1798-1817.txt
14459G>A,...minate mutant mtDNA from cybrids containing the m.14459G>A mutation associated with LHON plus dyston...,199,727,Br_J_Pharmacol_2014_Apr_28_171(8)_1798-1817.txt
8344A>G,...lli V  Comi GP    Phenotypic heterogeneity of the 8344A>G mtDNA ‘MERRF’ mutation Neurology 2013 80 2...,374,100,Br_J_Pharmacol_2014_Apr_28_171(8)_1798-1817.txt
3243A>G,... Study: clinical phenotypes associated with the m.3243A>G mutation–implications for diagnosis and ma...,389,176,Br_J_Pharmacol_2014_Apr_28_171(8)_1798-1817.txt
446C>T,4	2	Reduced	Traces	Mild reduction	Exome	Exon 2: c.446C>T; p.(Pro149Leu)	Exon 3: c.643C>T; p.(Gln215*...,98,51,Brain_2013_Jan_3_136(1)_269-281.txt
643C>T,...n	Exome	Exon 2: c.446C>T; p.(Pro149Leu)	Exon 3: c.643C>T; p.(Gln215*),98,83,Brain_2013_Jan_3_136(1)_269-281.txt
1183A>T,...on 8: c.1114_1116del; p.(Val372del)	Exon 9: Het c.1183A>T; p.(Arg395*),99,169,Brain_2013_Jan_3_136(1)_269-281.txt
2T>G,...es negative	Mild reduction	Exome/Sanger	Exon 1: c.2T>G; p.(M1_R59del)	Exon 2: c.377G>A; p.(Arg126His...,100,74,Brain_2013_Jan_3_136(1)_269-281.txt
377G>A,...me/Sanger	Exon 1: c.2T>G; p.(M1_R59del)	Exon 2: c.377G>A; p.(Arg126His),100,104,Brain_2013_Jan_3_136(1)_269-281.txt
157G>A,...d reduction on some fibres	Exome/Sanger	Exon 1: c.157G>A; p.(Ala53Thr)	Exon 9: c.1183A>T; p.(Arg395*...,101,99,Brain_2013_Jan_3_136(1)_269-281.txt
1183A>T,...e/Sanger	Exon 1: c.157G>A; p.(Ala53Thr)	Exon 9: c.1183A>T; p.(Arg395*),101,130,Brain_2013_Jan_3_136(1)_269-281.txt
677A>G,...nger	Exon 1: c.53dup; p.(Ser19Glufs*97)	Exon 3: c.677A>G; p.(Tyr226Cys),102,98,Brain_2013_Jan_3_136(1)_269-281.txt
16255759 T>A,"...ISPD mutations at the heterozygous state: g.chr7: 16255759 T>A, c.446 C>T, causing p.Pro149Leu, whic...",116,338,Brain_2013_Jan_3_136(1)_269-281.txt
446 C>T,"...t the heterozygous state: g.chr7: 16255759 T>A, c.446 C>T, causing p.Pro149Leu, which is located in ...",116,354,Brain_2013_Jan_3_136(1)_269-281.txt
16445774 G>A,"....Pro149Leu, which is located in exon 2 and g.chr7:16445774 G>A, c.643 C>T, p.Gln215* in exon 3. Exom...",116,422,Brain_2013_Jan_3_136(1)_269-281.txt
643 C>T,"...h is located in exon 2 and g.chr7:16445774 G>A, c.643 C>T, p.Gln215* in exon 3. Exome sequencing in ...",116,438,Brain_2013_Jan_3_136(1)_269-281.txt
16255759 T>A,"...s premature stop codon mutation in exon 9: g.chr7:16255759 T>A, c.1183A>T, p.Arg395* and a heterozyg...",116,565,Brain_2013_Jan_3_136(1)_269-281.txt
1183A>T,"... codon mutation in exon 9: g.chr7:16255759 T>A, c.1183A>T, p.Arg395* and a heterozygous in-frame tri...",116,581,Brain_2013_Jan_3_136(1)_269-281.txt
16445843 C>T,"... heterozygous missense mutation in exon 2: g.chr7:16445843 C>T, which is c.377G>A, leading to p.Arg1...",116,837,Brain_2013_Jan_3_136(1)_269-281.txt
377G>A,"...tation in exon 2: g.chr7:16445843 C>T, which is c.377G>A, leading to p.Arg126His. Interestingly, the...",116,862,Brain_2013_Jan_3_136(1)_269-281.txt
2T>G,"...us mutation affecting the start codon in exon 1 c.2T>G, leading to p.M1_R59del or p.M1?, was identif...",116,989,Brain_2013_Jan_3_136(1)_269-281.txt
16255759 T>A,"...ed a heterozygous stop mutation in exon 9: g.chr7:16255759 T>A, leading to c.1183 A>T and causing p....",121,84,Brain_2013_Jan_3_136(1)_269-281.txt
1183 A>T,"...tion in exon 9: g.chr7:16255759 T>A, leading to c.1183 A>T and causing p.Arg395*. The second compoun...",121,111,Brain_2013_Jan_3_136(1)_269-281.txt
157G>A,...s mutation was found by Sanger sequencing to be c.157G>A causing p.Ala53Thr located in exon 1. All I...,121,224,Brain_2013_Jan_3_136(1)_269-281.txt
677A>G,...pT) in exon 1 and a missense mutation in exon 3 c.677A>G (p.Tyr226Cys). The heterozygous carrier sta...,123,631,Brain_2013_Jan_3_136(1)_269-281.txt
284G>A,(i)	1	4 y	c.[284G>A] (M) + c.[148G> A];c.[364-1G>A]a (P)	p.R95H...,47,14,Brain_2014_May_18_137(5)_1350-1360.txt
148G> A,(i)	1	4 y	c.[284G>A] (M) + c.[148G> A];c.[364-1G>A]a (P)	p.R95H (M) + p.E50K;Spl...,47,31,Brain_2014_May_18_137(5)_1350-1360.txt
1G>A,(i)	1	4 y	c.[284G>A] (M) + c.[148G> A];c.[364-1G>A]a (P)	p.R95H (M) + p.E50K;Splice errors a (P)...,47,47,Brain_2014_May_18_137(5)_1350-1360.txt
98A>T,2	5 y 2 m	c.[98A>T] + c.[98A>T]	p.D33V + p.D33V	6 h	Hoffmann et...,48,15,Brain_2014_May_18_137(5)_1350-1360.txt
98A>T,"2	5 y 2 m	c.[98A>T] + c.[98A>T]	p.D33V + p.D33V	6 h	Hoffmann et al., 2007",48,27,Brain_2014_May_18_137(5)_1350-1360.txt
637C>T,3	2 y 7 m	c.[637C>T] + c.[637C>T]	p.P213S + p.P213S	90 min	Nove...,49,15,Brain_2014_May_18_137(5)_1350-1360.txt
637C>T,3	2 y 7 m	c.[637C>T] + c.[637C>T]	p.P213S + p.P213S	90 min	Novel,49,28,Brain_2014_May_18_137(5)_1350-1360.txt
637C>T,4*	4 m	c.[637C>T] + c.[637C>T]	p.P213S + p.P213S	None*	Novel...,50,12,Brain_2014_May_18_137(5)_1350-1360.txt
637C>T,4*	4 m	c.[637C>T] + c.[637C>T]	p.P213S + p.P213S	None*	Novel,50,25,Brain_2014_May_18_137(5)_1350-1360.txt
283C>T,5	1 y	c.[283C>T] (M) + c.[283C>T] (P)	p.R95C (M) + p.R95C (...,51,11,Brain_2014_May_18_137(5)_1350-1360.txt
283C>T,5	1 y	c.[283C>T] (M) + c.[283C>T] (P)	p.R95C (M) + p.R95C (P)	2 h	Khayat et ...,51,28,Brain_2014_May_18_137(5)_1350-1360.txt
347G>A,(ii)	7	6 y 5 m	c.[347G>A] (M) + c.[347G>A] (P)	p.R116Q (M) + p.R116Q...,53,19,Brain_2014_May_18_137(5)_1350-1360.txt
347G>A,(ii)	7	6 y 5 m	c.[347G>A] (M) + c.[347G>A] (P)	p.R116Q (M) + p.R116Q (P)	5 m	Novel,53,36,Brain_2014_May_18_137(5)_1350-1360.txt
347G>A,(iii)	8	9 y	c.[347G>A] + c.[347G>A]	p.R116Q + p.R116Q	3 h	Novel,54,16,Brain_2014_May_18_137(5)_1350-1360.txt
347G>A,(iii)	8	9 y	c.[347G>A] + c.[347G>A]	p.R116Q + p.R116Q	3 h	Novel,54,29,Brain_2014_May_18_137(5)_1350-1360.txt
98A>T,9	2 y	c.[98A>T] + c.[998A>T]	p.D33V + p.D33V	3 w	Hoffmann e...,55,11,Brain_2014_May_18_137(5)_1350-1360.txt
998A>T,"9	2 y	c.[98A>T] + c.[998A>T]	p.D33V + p.D33V	3 w	Hoffmann et al., 2007",55,23,Brain_2014_May_18_137(5)_1350-1360.txt
98A>T,10	23 y	c.[98A>T] + c.[358G>A]	p.D33V + p.E120K	2 m	Hoffmann ...,56,13,Brain_2014_May_18_137(5)_1350-1360.txt
358G>A,"10	23 y	c.[98A>T] + c.[358G>A]	p.D33V + p.E120K	2 m	Hoffmann et al., 2007...",56,25,Brain_2014_May_18_137(5)_1350-1360.txt
98A>T,11	21 y	c.[98A>T] (P) + c.264-21_ 264-1delinsC (M)	p.D33V (P)...,57,13,Brain_2014_May_18_137(5)_1350-1360.txt
98A>T,12	41 y	c.[98A>T] + c.[347G>A] + c. [673C>T]	p.D33V + p.R116Q...,58,13,Brain_2014_May_18_137(5)_1350-1360.txt
347G>A,12	41 y	c.[98A>T] + c.[347G>A] + c. [673C>T]	p.D33V + p.R116Q + p.R225Cb	...,58,25,Brain_2014_May_18_137(5)_1350-1360.txt
673C>T,12	41 y	c.[98A>T] + c.[347G>A] + c. [673C>T]	p.D33V + p.R116Q + p.R225Cb	14 d	Hoffmann ...,58,39,Brain_2014_May_18_137(5)_1350-1360.txt
674G>A,13	9 y	c.[674G>A] + c.[674G>A]	p.R225H + p.R225H	24 h	Novel,59,12,Brain_2014_May_18_137(5)_1350-1360.txt
674G>A,13	9 y	c.[674G>A] + c.[674G>A]	p.R225H + p.R225H	24 h	Novel,59,25,Brain_2014_May_18_137(5)_1350-1360.txt
347G>A,14	3 y	c.[347G>A];c.[674G>A] + c.[347G >A];c.[674G>A]	p.R116...,60,12,Brain_2014_May_18_137(5)_1350-1360.txt
674G>A,14	3 y	c.[347G>A];c.[674G>A] + c.[347G >A];c.[674G>A]	p.R116Q;p.R225H +...,60,23,Brain_2014_May_18_137(5)_1350-1360.txt
347G >A,14	3 y	c.[347G>A];c.[674G>A] + c.[347G >A];c.[674G>A]	p.R116Q;p.R225H + p.R116Q;p.R2...,60,36,Brain_2014_May_18_137(5)_1350-1360.txt
674G>A,14	3 y	c.[347G>A];c.[674G>A] + c.[347G >A];c.[674G>A]	p.R116Q;p.R225H + p.R116Q;p.R225H c	30 min...,60,48,Brain_2014_May_18_137(5)_1350-1360.txt
347G>A,15	9 y	c.[347G>A];c.[674G>A] + c.[347G >A];c.[674G>A]	p.R116...,61,12,Brain_2014_May_18_137(5)_1350-1360.txt
674G>A,15	9 y	c.[347G>A];c.[674G>A] + c.[347G >A];c.[674G>A]	p.R116Q;p.R225H +...,61,23,Brain_2014_May_18_137(5)_1350-1360.txt
347G >A,15	9 y	c.[347G>A];c.[674G>A] + c.[347G >A];c.[674G>A]	p.R116Q;p.R225H + p.R116Q;p.R2...,61,36,Brain_2014_May_18_137(5)_1350-1360.txt
674G>A,15	9 y	c.[347G>A];c.[674G>A] + c.[347G >A];c.[674G>A]	p.R116Q;p.R225H + p.R116Q;p.R225H c	10 h	N...,61,48,Brain_2014_May_18_137(5)_1350-1360.txt
148G>A,"ac.[148G>A] and c.[364-1G>A] were inherited in cis, th...",74,5,Brain_2014_May_18_137(5)_1350-1360.txt
1G>A,"ac.[148G>A] and c.[364-1G>A] were inherited in cis, this was confirmed by...",74,24,Brain_2014_May_18_137(5)_1350-1360.txt
1G>A,...ent 1) in cis with the splice site mutation c.364-1G>A (IVS3-1g>a). Previous expression studies conc...,153,951,Brain_2014_May_18_137(5)_1350-1360.txt
1G>A,"... Previous expression studies concluded that c.364-1G>A is a pathogenic mutation (Mills et al., 2005)...",153,1018,Brain_2014_May_18_137(5)_1350-1360.txt
148G>A,"ac.[148G>A] and c.[364-1G>A] were inherited in cis, th...",201,5,Brain_2014_May_18_137(5)_1350-1360.txt
1G>A,"ac.[148G>A] and c.[364-1G>A] were inherited in cis, this was confrimed by...",201,24,Brain_2014_May_18_137(5)_1350-1360.txt
1G>A,"R95H, R95C and E50K with c.[364-1G>A]: alleles associated with infertility, miscar...",222,33,Brain_2014_May_18_137(5)_1350-1360.txt
1G>A,... 1 was compound heterozygous for E50K plus c.[364-1G>A] on the paternal allele and R95H on the mater...,223,58,Brain_2014_May_18_137(5)_1350-1360.txt
1G>A,...aternal allele. Homozygosity for E50K plus c.[364-1G>A] produced a similar clinical picture (parenta...,223,154,Brain_2014_May_18_137(5)_1350-1360.txt
1G>A,"...system, PNPO enzyme activity for E50K plus c.[364-1G>A] and R95H was undetectable and 18% of wild-ty...",223,715,Brain_2014_May_18_137(5)_1350-1360.txt
432C>T,"...ces, GE Healthcare, Glatbrugg, Switzerland). The -432C>T (rs3813065) was genotyped by restriction di...",27,155,Brain_Behav_2011_Nov_1(2)_119-124.txt
432C>T,...genotype and allelic distributions of the PIK3C3 -432C>T (rs3813065) between BD patients and control...,52,272,Brain_Behav_2011_Nov_1(2)_119-124.txt
432C>T,"...modest, in allele distribution of the rs3813065 (-432C>T) with respect to BD, but not SZ. This resul...",99,285,Brain_Behav_2011_Nov_1(2)_119-124.txt
677C -> T,... Calhoun VD  Wassink TH  Weiss AP  Ho BC    MTHFR 677C -> T genotype disrupts prefrontal function in...,378,73,Brain_Imaging_Behav_2014_Jan_8_8(2)_153-182.txt
158Val -> Met,...in schizophrenia through an interaction with COMT 158Val -> Met Proceedings of the National Academy ...,378,171,Brain_Imaging_Behav_2014_Jan_8_8(2)_153-182.txt
7271T>G,... population-based study of a specific mutation (c.7271T>G) in ATM [18] and the recent report of two ...,64,782,Breast_Cancer_Res_2008_Jun_5_10(3)_208.txt
7271T>G,... cancer risks associated with ATM gene variants c.7271T>G and c.1066-6T>G (IVS10-6T>G) from the Brea...,128,287,Breast_Cancer_Res_2008_Jun_5_10(3)_208.txt
6T>G,...iated with ATM gene variants c.7271T>G and c.1066-6T>G (IVS10-6T>G) from the Breast Cancer Family Re...,128,306,Breast_Cancer_Res_2008_Jun_5_10(3)_208.txt
6T>G,...TM gene variants c.7271T>G and c.1066-6T>G (IVS10-6T>G) from the Breast Cancer Family Registry Hum M...,128,318,Breast_Cancer_Res_2008_Jun_5_10(3)_208.txt
5193G-> A,...efined population with respect to the local BRCA1 5193G-> A and BRCA2 999del5 germline mutations [21...,26,92,Breast_Cancer_Res_2009_Jul_9_11(4)_R47.txt
17	A>G,DNAH9	4	(8)	17	A>G	X	X	X	Splice intron	Transition	 	4.05	No co...,134,13,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
20	G>A,SPTLC3	1	(2)	20	G>A	X	X	X	Splice intron	Transition	 	5.91	No co...,160,14,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
1260C>A,...insufficiency. Genotypes were determined for the –1260C>A (rs10877012) and +2838T>C (rs4646536) CYP2...,3,1959,Calcif_Tissue_Int_2011_Feb_25_88(2)_109-116.txt
2838T>C,...ere determined for the –1260C>A (rs10877012) and +2838T>C (rs4646536) CYP27B1 polymorphisms. A repor...,3,1985,Calcif_Tissue_Int_2011_Feb_25_88(2)_109-116.txt
1260C>A,... was used to assess functional expression of the –1260C>A CYP27B1 variants. The association between ...,3,2099,Calcif_Tissue_Int_2011_Feb_25_88(2)_109-116.txt
1260C>A,...ream of the transcription start site of CYP27B1 (–1260C>A) and was strongly associated with either t...,24,104,Calcif_Tissue_Int_2011_Feb_25_88(2)_109-116.txt
2838T>C,"...rt for another intragenic CYP27B1 SNP rs4646536 (+2838T>C, in intron 6), which some [24], but not al...",24,845,Calcif_Tissue_Int_2011_Feb_25_88(2)_109-116.txt
1260C>A,...cteristics of participants stratified by CYP27B1 –1260C>A genotyp,68,1028,Calcif_Tissue_Int_2011_Feb_25_88(2)_109-116.txt
1260C>A,CYP27B1 –1260C>A,91,10,Calcif_Tissue_Int_2011_Feb_25_88(2)_109-116.txt
2838T>C,CYP27B1 +2838T>C,95,10,Calcif_Tissue_Int_2011_Feb_25_88(2)_109-116.txt
1260C>A,...d that the functional change associated with the –1260C>A SNP would be subtle (as any SNP associated...,117,602,Calcif_Tissue_Int_2011_Feb_25_88(2)_109-116.txt
1260C>A,"...ociation was with a SNP in the CYP27B1 promoter (–1260C>A); association with a second, intronic SNP ...",122,591,Calcif_Tissue_Int_2011_Feb_25_88(2)_109-116.txt
2838T>C,"...60C>A); association with a second, intronic SNP (+2838T>C) could be explained by tight linkage diseq...",122,643,Calcif_Tissue_Int_2011_Feb_25_88(2)_109-116.txt
24C>T,"...nse was evaluated after four cycles. MRP2 C-24T (−24C>T), MRP2 Val417Ile (1249G>A), MRP2 Ile1324Ile ...",7,167,Cancer_Chemother_Pharmacol_2010_Feb_1_65(3)_437-446.txt
1249G>A,"...four cycles. MRP2 C-24T (−24C>T), MRP2 Val417Ile (1249G>A), MRP2 Ile1324Ile (3972C>T), and GSTP1 Ile...",7,191,Cancer_Chemother_Pharmacol_2010_Feb_1_65(3)_437-446.txt
3972C>T,"...4C>T), MRP2 Val417Ile (1249G>A), MRP2 Ile1324Ile (3972C>T), and GSTP1 Ile105Val (342A>G) genotype we...",7,218,Cancer_Chemother_Pharmacol_2010_Feb_1_65(3)_437-446.txt
342A>G,"..., MRP2 Ile1324Ile (3972C>T), and GSTP1 Ile105Val (342A>G) genotype were determined by gene-chip meth...",7,249,Cancer_Chemother_Pharmacol_2010_Feb_1_65(3)_437-446.txt
497 G >A,"...een identified. Of those, EGFR intron-1 S/S, EGFR 497 G >A and EGFR R521K seem to play considerable ...",64,96,Cancer_Manag_Res_2009_Jul_23_1_79-88.txt
61A >G,"...R ligands. Variants in the ligand EGF, namely EGF 61A >G seemed to be associated with an improved OS...",66,162,Cancer_Manag_Res_2009_Jul_23_1_79-88.txt
61A >G,...phisms in KRAS wildtype tumors suggested that EGF 61A >G was significantly associated with decreased...,66,336,Cancer_Manag_Res_2009_Jul_23_1_79-88.txt
61A >G,...ussen AA  The importance of KRAS mutations and EGF61A >G polymorphism to the effect of cetuximab and...,185,90,Cancer_Manag_Res_2009_Jul_23_1_79-88.txt
1263A>G,"..., CASP9 gene polymorphisms and their haplotypes, -1263A>G (rs4645978) and -712C>T (rs4645981), have ...",23,330,Cancer_Res_Treat_2012_Mar_31_44(1)_32-36.txt
712C>T,"...s and their haplotypes, -1263A>G (rs4645978) and -712C>T (rs4645981), have been reported to both aff...",23,355,Cancer_Res_Treat_2012_Mar_31_44(1)_32-36.txt
13010627G>A,... and modulate lung cancer risk [12]. The V410I (rs13010627G>A) and I522L (rs13006529A>T) polymorphis...,23,475,Cancer_Res_Treat_2012_Mar_31_44(1)_32-36.txt
13006529A>T,...risk [12]. The V410I (rs13010627G>A) and I522L (rs13006529A>T) polymorphisms of the CASP10 gene have...,23,501,Cancer_Res_Treat_2012_Mar_31_44(1)_32-36.txt
2227310C>G,...mains to be elucidated whether or not the CASP7 rs2227310C>G polymorphism itself affects protein cha...,54,1061,Cancer_Res_Treat_2012_Mar_31_44(1)_32-36.txt
8473T>C,...aglandin synthase 2/cyclooxygenase 2 (PTGS2/COX2) 8473T>C polymorphism associated with prognosis for...,99,113,Cancer_Res_Treat_2012_Mar_31_44(1)_32-36.txt
87T>C,"...f the exon 4 (rs2016520, referred as T+294C or c.-87T>C); this polymorphism is located at the linkag...",114,643,Cardiovasc_Diabetol_2008_Jul_25_7_23.txt
87T>C,...peroxisome proliferator-activated receptor-delta -87T>C polymorphism and dietary fat in French-Canad...,153,171,Cardiovasc_Diabetol_2008_Jul_25_7_23.txt
420C > G,"...is through AMPK activation [58]. Furthermore, SNP-420C > G of the resistin gene was associated with ...",318,920,Cardiovasc_Diabetol_2011_Jan_21_10_8.txt
4719C>T,...ons. Her genotype showed a splice-site mutation c.4719C>T in exon 27 of the SCN5A gene. This rare mu...,35,781,Case_Rep_Anesthesiol_2016_Sep_7_2016_9278409.txt
1376C>G,"c.1376C>G, p.Ser459Ter",52,3,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
2691G>A,"c.2691G>A, p.Trp897Ter",55,3,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
2575C>T,c.2575C>T,61,3,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
829C>T,"c.829C>T, p.Arg277Ter",65,3,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
984C>A,"c.984C>A, p.Tyr328Ter",67,3,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
2455C>T,"c.2455C>T, p.Arg630X",68,3,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
4462C>T,"c.4462C>T, p.Arg1488X",70,3,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
5067G>A,"c5067G>A, p.Trp1689X",71,2,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
4975A>T,"c.4975A>T, p.Lys1450X",75,3,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
1126A>C,"c.1126A>C, p.K376Q",79,3,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
984C>A,"c.984C>A, p.Y328X	Ahmad et al., 2007 [15]",85,3,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
2687G>A,"c.2687G>A, p.R896Q",89,3,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
1567C>T,"c.1567C>T, p.Arg523Ter	Kurban et al., 2010 [17]",96,3,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
2697G>A,"c.2697G>A, p.Met899Ile",100,3,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
5155T>C,c.5155T>C; C1719R,106,3,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
1567C>T,"c.1567C>T, p.Arg523Ter",112,3,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
2A>G,IVS8-2A>,114,6,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
3109 G > C,...was confirmed by molecular analysis showing the c.3109 G > C mutation in the vascular endothelial gr...,16,1180,Case_Rep_Obstet_Gynecol_2013_Feb_28_2013_186173.txt
3598G>A,"...ted a heterozygous mutation in the COL2A1 gene (c.3598G>A; p.Gly1200Ser). This missense mutation, cr...",26,165,Case_Rep_Obstet_Gynecol_2015_Sep_8_2015_935204.txt
1003C>T,...ng results confirmed the presence of the R335X (c.1003C>T) mutation in the PTEN gene and the patient...,33,64,Case_Rep_Oncol_Med_2015_Sep_10_2015_546297.txt
1622T>C,"... mutation in the ABCA4 gene with complex allele c.1622T>C, p.L541P; c.3113C>T, p.A1038V in homozygou...",15,661,Case_Rep_Ophthalmol_Med_2015_Jul_2_2015_452068.txt
3113C>T,"...A4 gene with complex allele c.1622T>C, p.L541P; c.3113C>T, p.A1038V in homozygous state",15,681,Case_Rep_Ophthalmol_Med_2015_Jul_2_2015_452068.txt
1622T>C,"...mutations in exons 12 and 21 of the ABCA4 gene (c.1622T>C, p.L541P; c.3113C>T, p.A1038V), (2) a hete...",29,590,Case_Rep_Ophthalmol_Med_2015_Jul_2_2015_452068.txt
3113C>T,"...2 and 21 of the ABCA4 gene (c.1622T>C, p.L541P; c.3113C>T, p.A1038V), (2) a heterozygous variant in ...",29,610,Case_Rep_Ophthalmol_Med_2015_Jul_2_2015_452068.txt
227G>A,"...terozygous variant in exon 2 of the NR2E3 gene (c.227G>A, p.R760), and (3) a heterozygous variant in...",29,688,Case_Rep_Ophthalmol_Med_2015_Jul_2_2015_452068.txt
747A>T,...heterozygous variant in exon 6 of the RGR gene (c.747A>T p.K249N). Based on previous knowledge of th...,29,765,Case_Rep_Ophthalmol_Med_2015_Jul_2_2015_452068.txt
1622T>C,"...nes, it was concluded that the ABCA4 mutations (c.1622T>C, p.L541P; c.3113C>T, p.A1038V) were those ...",29,877,Case_Rep_Ophthalmol_Med_2015_Jul_2_2015_452068.txt
3113C>T,"...d that the ABCA4 mutations (c.1622T>C, p.L541P; c.3113C>T, p.A1038V) were those that likely caused R...",29,897,Case_Rep_Ophthalmol_Med_2015_Jul_2_2015_452068.txt
1622T>C,"...sease-causing alleles in the ABCA4 gene, L541P (c.1622T>C, p.Leu541Pro, rs61751392) and A1038V (c.31...",33,184,Case_Rep_Ophthalmol_Med_2015_Jul_2_2015_452068.txt
3113C>T,"...c.1622T>C, p.Leu541Pro, rs61751392) and A1038V (c.3113C>T, p.Ala1038Val, rs61751374), were identifie...",33,232,Case_Rep_Ophthalmol_Med_2015_Jul_2_2015_452068.txt
2588G > C,...augeri A.  Flothmann K.  Hemmrich N.    The ABCA4 2588G > C Stargardt mutation: single origin and in...,68,54,Case_Rep_Ophthalmol_Med_2015_Jul_2_2015_452068.txt
1G > T,...nsT) and a previously described mutation (c.687 + 1G > T) in the ATP6V1B1gene [10]. The c.1259 inser...,42,148,Case_Rep_Pediatr_2012_Aug_27_2012_605053.txt
34G > A,"... the patient showed the nucleotide substitution c.34G > A, resulting in p.Gly12Ser amino acid change...",91,63,Case_Rep_Pediatr_2015_Feb_28_2015_934865.txt
5234G>A,"...tation at the nucleotide position 5234 (exon 2: g.5234G>A, c.335G>A, p.Arg112His) described in the l...",46,372,Case_Rep_Transplant_2013_Apr_7_2013_905743.txt
335G>A,"...he nucleotide position 5234 (exon 2: g.5234G>A, c.335G>A, p.Arg112His) described in the literature [...",46,383,Case_Rep_Transplant_2013_Apr_7_2013_905743.txt
1299G>A,...es RAG1 or RAG2 revealed a homozygous missense (c.1299G>A) mutation in the RAG1 gene. This is the fi...,10,118,Cases_J_2009_Jul_30_2_8391.txt
1299G>A,...atient revealed a homozygous missense mutation (c.1299G>A) in the RAG1 gene leading to replacement o...,28,1733,Cases_J_2009_Jul_30_2_8391.txt
1299G>A,"...atient revealed a homozygous missense mutation (c.1299G>A) in the RAG1 gene, which led to the replac...",34,85,Cases_J_2009_Jul_30_2_8391.txt
1299G>A,...enn’s syndrome in which this missense mutation (c.1299G>A) was detectable in a patient who was heter...,34,362,Cases_J_2009_Jul_30_2_8391.txt
1565C>T,"...isingly, only 1 missense mutation (rs138651238; c.1565C>T and p.T522M) was discovered (Fig. 6). In t...",87,219,Cell_Adh_Migr_2016_Feb_6_10(1-2)_395-55.txt
142 T>C,"...ample, ERVW-1 3′-long-terminal repeat (LTR) SNPs (142 T>C and 277 A>G) are associated with syncytin-...",96,191,Cell_Adh_Migr_2016_Feb_6_10(1-2)_395-55.txt
277 A>G,...1 3′-long-terminal repeat (LTR) SNPs (142 T>C and 277 A>G) are associated with syncytin-1 overexpres...,96,203,Cell_Adh_Migr_2016_Feb_6_10(1-2)_395-55.txt
5Y>H,...order in these comparisons was HBMEC3>HBMEC3/SHSY-5Y>HBMEC3/HFA,71,60,Cell_Commun_Signal_2014_Jan_17_12_7.txt
5Y>H,".../HFA, at 4d the rank order was HBMEC3>HBMEC3/SHSY-5Y>HBMEC3/HFA",76,129,Cell_Commun_Signal_2014_Jan_17_12_7.txt
5Y>H,...k order of this experiment was HBMEC3>HBMEC3/SHSY-5Y>HBMEC3/HFA,81,58,Cell_Commun_Signal_2014_Jan_17_12_7.txt
5Y>H,"..., and the rank order at 4d was HBMEC3=HBMEC3/SHSY-5Y>HBMEC3/HFA",86,108,Cell_Commun_Signal_2014_Jan_17_12_7.txt
917A-->T,...Rufle A Tyring SK Kempf W  Homozygosity for the c.917A-->T (p.N306l) polymorphism in the EVER2/TMC8 ...,197,77,Cell_Death_Dis_2013_Feb_21_4(2)_e499.txt
917A-->T,...mis in a HIV-positive patient homozygous for the c917A-->T polymorphism in the TMC8/EVER2 gene Derma...,198,146,Cell_Death_Dis_2013_Feb_21_4(2)_e499.txt
1432A>G,"...t study, exome sequencing identified a homozygous 1432A>G DNA variant encoding the missense change N...",15,64,Cell_Death_Dis_2014_Mar_20_5(3)_e1130.txt
1432A>G,...on post-irradiation (IR). Although the homozygous 1432A>G MTPAP variant was previously associated wi...,15,399,Cell_Death_Dis_2014_Mar_20_5(3)_e1130.txt
1432A>G,"...itivity. Therefore, the association of homozygous 1432A>G with sensitivity to ionizing radiation was...",15,612,Cell_Death_Dis_2014_Mar_20_5(3)_e1130.txt
1432A>G,"... or function. The homozygous missense mutation (c.1432A>G, N478D) in the MTPAP gene was singled out ...",21,1170,Cell_Death_Dis_2014_Mar_20_5(3)_e1130.txt
1432A>G,"...redicted to be deleterious by Polyphen.38, 39 The 1432A>G MTPAP mutation, and lack of ATM mutations,...",21,1401,Cell_Death_Dis_2014_Mar_20_5(3)_e1130.txt
1 G > T,"...sion at the exon-intron junction of exon 6 (c.748+1 G > T), which segregated with the disease in the...",23,787,Cell_Rep_2014_Aug_7_8(3)_647-655.txt
1 G > T,... in all affected individuals indicated that c.748+1 G > T is a founder mutation in the Saudi populat...,23,943,Cell_Rep_2014_Aug_7_8(3)_647-655.txt
3243A>G,...pe-specific manifestations of heteroplasmic mtDNA 3243A>G mutation in human induced pluripotent stem...,245,156,Cell_Rep_2015_May_28_11(10)_1614-1624.txt
1073C>T,...as carrier of the previously identified TMEM43 c. 1073C>T (p.S358L) mutation (Merner et al. 2008; Ch...,1153,390,Cell_Tissue_Res_2012_May_25_348(2)_335-370.txt
3I > E,"...es, following the expected order of reactivity: CH3I > EtI > i-PrI.21–23 Disulphides undergo oxidati...",19,686,Chem_Commun_(Camb)_2014_Jan_16_50(13)_1533-1536.txt
3G>N,"...e enzyme. In spite of this, the ranking OGp>OTfe>O3G>NGp from the ab initio calculations is in agree...",100,329,Chembiochem_2012_Aug_13_13(12)_1785-1790.txt
2677G>T,"...y et al.[61], who in 1998 found SNPs in exons 21 (2677G>T) and 24 (2995G>A) in the MDR1 gene. Subseq...",47,752,Chin_J_Cancer_2012_Feb_31(2)_51-57.txt
2995G>A,"... in 1998 found SNPs in exons 21 (2677G>T) and 24 (2995G>A) in the MDR1 gene. Subsequently, over 50 d...",47,769,Chin_J_Cancer_2012_Feb_31(2)_51-57.txt
1236C>T,"...The most well-characterized polymorphisms include 1236C>T (rs1128503, exon 12), 2677G>T/A (rs2032582...",47,950,Chin_J_Cancer_2012_Feb_31(2)_51-57.txt
2677G>T,"...lymorphisms include 1236C>T (rs1128503, exon 12), 2677G>T/A (rs2032582, exon 21), and 3435C>T (rs104...",47,980,Chin_J_Cancer_2012_Feb_31(2)_51-57.txt
3435C>T,"...03, exon 12), 2677G>T/A (rs2032582, exon 21), and 3435C>T (rs1045642, exon 26). These SNPs have a wi...",47,1016,Chin_J_Cancer_2012_Feb_31(2)_51-57.txt
34G>A,"...nt polymorphisms of BCRP among over 50 others are 34G>A and 421C>A[66],[67]. The 421C>A SNP has been...",47,1619,Chin_J_Cancer_2012_Feb_31(2)_51-57.txt
421C>A,"...phisms of BCRP among over 50 others are 34G>A and 421C>A[66],[67]. The 421C>A SNP has been associate...",47,1629,Chin_J_Cancer_2012_Feb_31(2)_51-57.txt
421C>A,"...over 50 others are 34G>A and 421C>A[66],[67]. The 421C>A SNP has been associated with a lower protei...",47,1650,Chin_J_Cancer_2012_Feb_31(2)_51-57.txt
2292832	A>G,Has-miR-149	2q37.3	rs2292832	A>G	99.77	0.092	0.322	0.349	0.436,80,22,Chin_J_Cancer_2016_Aug_11_35_77.txt
2910164	G>C,Pre-miR-146a	5q34	rs2910164	G>C	99.81	0.468	0.429	0.558	0.558,81,21,Chin_J_Cancer_2016_Aug_11_35_77.txt
2043556	A>G,Has-miR-605	10q21.1	rs2043556	A>G	99.77	0.753	0.281,82,23,Chin_J_Cancer_2016_Aug_11_35_77.txt
4919510	G>C,Has-miR-608	10q25.1	rs4919510	G>C	99.85	0.835	0.425	0.245	0.408,87,23,Chin_J_Cancer_2016_Aug_11_35_77.txt
11614913	A>G,Pre-miR-196a	12q13.13	rs11614913	A>G	99.91	0.796	0.432,88,25,Chin_J_Cancer_2016_Aug_11_35_77.txt
542G>A,...atient was hemizygous for the nonsense mutation c.542G>A in exon 6 of the FHL1 gene. Other genes wer...,11,476,Chin_Med_J_(Engl)_2015_Aug_20_128(16)_2269-2270.txt
542G>A,"The mutation, c.542G>A, locates in exon 6 and is a novel nonsense ...",18,17,Chin_Med_J_(Engl)_2015_Aug_20_128(16)_2269-2270.txt
181W>X,"...result in a premature stop codon, p. Trp181Ter (p.181W>X), in the third LIM domain, affecting isofor...",20,121,Chin_Med_J_(Engl)_2015_Aug_20_128(16)_2269-2270.txt
542G>A,"...e of four and a half LIM domain 1 isoforms. The c.542G>A locates on exon 6, the resultant p.Trp181Te...",22,91,Chin_Med_J_(Engl)_2015_Aug_20_128(16)_2269-2270.txt
542G>A,"...e case of FHL1 mutation associated HCM, and the c.542G>A (p.181W>X) is a novel nonsense mutation. FH...",24,120,Chin_Med_J_(Engl)_2015_Aug_20_128(16)_2269-2270.txt
181W>X,"...FHL1 mutation associated HCM, and the c.542G>A (p.181W>X) is a novel nonsense mutation. FHL1 mutatio...",24,130,Chin_Med_J_(Engl)_2015_Aug_20_128(16)_2269-2270.txt
325400 G >T,"...single-nucleotide polymorphisms (SNPs), namely, rs325400 G >T and rs34851361 A >G, with CAD. These t...",36,375,Chin_Med_J_(Engl)_2015_Oct_5_128(19)_2688-2691.txt
34851361 A >G,"...polymorphisms (SNPs), namely, rs325400 G >T and rs34851361 A >G, with CAD. These two SNPs are in 11t...",36,393,Chin_Med_J_(Engl)_2015_Oct_5_128(19)_2688-2691.txt
1615G>A,"...alysis showed the girl to be homozygous for the c.1615G>A, p.(Asp539Asn) missense mutation in GPI. T...",16,729,Clin_Case_Rep_2015_Oct_7_3(10)_862-865.txt
845G>A,"...the seventh month of life. She was carrying the c.845G>A (p.C282Y) mutation in heterozygosis, confer...",27,204,Clin_Case_Rep_2016_Jun_30_4(8)_752-755.txt
742A>G,"...This study showed a missense mutation in BMPR2, c.742A>G (p.R248G) located in exon six, and another ...",33,155,Clin_Case_Rep_2016_Jun_30_4(8)_752-755.txt
760G>A,"...ed in exon six, and another mutation in ACVRL1, c.760G>A (p.D254N. These mutations are described for...",33,227,Clin_Case_Rep_2016_Jun_30_4(8)_752-755.txt
742A>G,...ese computer programs labeled it as pathogenic. c.742A>G was considered pathogenic by all but Polyph...,33,630,Clin_Case_Rep_2016_Jun_30_4(8)_752-755.txt
760G>A,...d pathogenic by all but Polyphen‐2 software and c.760G>A by all but Pmut software. The other genes s...,33,700,Clin_Case_Rep_2016_Jun_30_4(8)_752-755.txt
318C>T,...hn J  Capasso M  Lanciotti M    The polymorphism −318C>T in the promoter and 49A>G in exon 1 of CTLA...,146,57,Clin_Dev_Immunol_2012_Aug_26_2012_123789.txt
49A>G,...M    The polymorphism −318C>T in the promoter and 49A>G in exon 1 of CTLA4 and the risk of aplastic ...,146,84,Clin_Dev_Immunol_2012_Aug_26_2012_123789.txt
1082G > A,"...lationship of three SNPs in IL-10 gene promoter (−1082G > A, −824C > T, and −597C > A) with SLE susc...",65,456,Clin_Dev_Immunol_2012_Sep_20_2012_963730.txt
824C > T,"...f three SNPs in IL-10 gene promoter (−1082G > A, −824C > T, and −597C > A) with SLE susceptibility i...",65,468,Clin_Dev_Immunol_2012_Sep_20_2012_963730.txt
597C > A,"... IL-10 gene promoter (−1082G > A, −824C > T, and −597C > A) with SLE susceptibility in Malaysian pop...",65,483,Clin_Dev_Immunol_2012_Sep_20_2012_963730.txt
1947 G>A,"...mers and TaqMan probes for COMT gene Val158Met (c.1947 G>A, rs4680) were created from the Z26491 seq...",42,252,Clin_Exp_Reprod_Med_2014_Jun_30_41(2)_62-67.txt
1947 G>A,"... program. Genotypes of the COMT gene Val158Met (c.1947 G>A, rs4680) polymorphism were defined throug...",42,410,Clin_Exp_Reprod_Med_2014_Jun_30_41(2)_62-67.txt
69 C>T,...ene was sequenced and one intron variation (c.374+69 C>T in intron 4) and two exon 10 variations (c....,13,2726,Clin_Exp_Reprod_Med_2014_Sep_30_41(3)_140-145.txt
919 G>A,...69 C>T in intron 4) and two exon 10 variations (c.919 G>A Ala307Thr and c.2039 G>A Ser680Asn) were i...,13,2776,Clin_Exp_Reprod_Med_2014_Sep_30_41(3)_140-145.txt
2039 G>A,...two exon 10 variations (c.919 G>A Ala307Thr and c.2039 G>A Ser680Asn) were identified (Figure 2). Th...,13,2800,Clin_Exp_Reprod_Med_2014_Sep_30_41(3)_140-145.txt
69 T>C,"...igure 2 FSH receptor variations: (A) intron 4c374+69 T>C, (B) exon 10 Ala307Thr, and (C) exon 10 Ser...",30,52,Clin_Exp_Reprod_Med_2014_Sep_30_41(3)_140-145.txt
111720761T>G,... kit. Genotyping of SNPs rs10033464 (HGVS name: g.111720761T>G) and rs2200733 (HGVS name: g.11171016...,27,126,Clin_Med_Insights_Cardiol_2015_May_13_9_39-45.txt
111710169C>T,...name: g.111720761T>G) and rs2200733 (HGVS name: g.111710169C>T) was performed with the MassARRAY sys...,27,168,Clin_Med_Insights_Cardiol_2015_May_13_9_39-45.txt
1G>A,"... Juan Capistrano, CA), was negative for the IVS14+1G>A mutation in the DPD gene, which accounts for ...",32,475,Cureus_8(9)_e798.txt
1679 T>G,"...detected. The commonly found DPYD gene mutations (1679 T>G, 1905+1 G>A, 2846 A>T) were not detected ...",32,1129,Cureus_8(9)_e798.txt
1 G>A,"...ommonly found DPYD gene mutations (1679 T>G, 1905+1 G>A, 2846 A>T) were not detected either",32,1144,Cureus_8(9)_e798.txt
2846 A>T,"... found DPYD gene mutations (1679 T>G, 1905+1 G>A, 2846 A>T) were not detected either",32,1151,Cureus_8(9)_e798.txt
1 G>A,"...y [8]. Interestingly, DPYD*2A (also known as 1905+1 G>A) was not significantly associated with predi...",37,691,Cureus_8(9)_e798.txt
731T>C,A c.731T>C CAPN5 mutation resulted in a p.Leu244Pro su...,10,5,Clin_Ophthalmol_2013_Jul_3_7_1339-1345.txt
728G>T,"...nohistopathological features of two eyes with a c.728G>T, p.Arg243 Leu mutation in CAPN5.5 We found ...",22,722,Clin_Ophthalmol_2013_Jul_3_7_1339-1345.txt
731T>C,"...d one brother (Figure 1). This family carried a c.731T>C, p.Leu244Pro mutation in the CAPN5 gene.1 O...",28,213,Clin_Ophthalmol_2013_Jul_3_7_1339-1345.txt
731T>C,Notes: A c.731T>C mutation in CAPN5 was inherited in a domina...,61,12,Clin_Ophthalmol_2013_Jul_3_7_1339-1345.txt
1894G>T,"heterozygous nonsense mutation, c1894G>T (p.E632X), in exon 3 (Fig. 1A, B, CFig. 1....",49,34,Clin_Pediatr_Endocrinol_2016_Oct_18_25(4)_135-138.txt
1894G>T,NR3C2 mutation (c.1894G>T; p.E632X). The arrow indicates th,50,19,Clin_Pediatr_Endocrinol_2016_Oct_18_25(4)_135-138.txt
3435C-->T,...e risk of hyperbilirubinemia are predicted by the 3435C-->T polymorphism at the multidrug resistance...,225,131,Clin_Pharmacol_2013_Sep_27_5_153-159.txt
786 T->C,...common single nucleotide polymorphism (rs2070744/-786 T->C) in the gene that encodes endothelial nit...,46,402,Clin_Pharmacol_Ther_2014_Jul_17_96(1)_27-35.txt
786T>C,...ded in the analysis. They were genotyped for eNOS-786T>C SNP (rs2070744) with the Taqman® allelic di...,85,288,Clin_Pharmacol_Ther_2014_Jul_17_96(1)_27-35.txt
786T>C,...ra M  Sakamoto T  Abe K  Yamamuro M  Shono M    A-786T>C polymorphism in the endothelial nitric oxid...,224,73,Clin_Pharmacol_Ther_2014_Jul_17_96(1)_27-35.txt
1760A >G,...d the presence of a tuberous sclerosis 1 (TSC1):c.1760A >Gp.K587R mutation. Owing to the TSC1 mutati...,37,184,Clin_Sarcoma_Res_2015_Oct_19_5_22.txt
126G > T,"...nvestigation (25). For instance, the variant IVS1-126G > T in a large family with the G533C mutation...",26,2180,Clinics_(Sao_Paulo)_2012_Apr_67(Suppl_1)_91-97.txt
2830G>A,c.2830G>,50,3,Cold_Spring_Harb_Mol_Case_Stud_2016_Jul_2(4)_a000885.txt
3274C > T,bloto mutation (c.3274C > T) was introduced by site-directe,1324,19,eLife_3_e03549.txt
0G>B,"(3) H=1360[90−arctan(F3)+{0G>B180G<B],S=1−[min⁡(R,G,B)I],I=(R+G+B)3,F=2R−G−B...",127,28,Comput_Math_Methods_Med_2013_Dec_2_2013_925341.txt
4216T > C,"...efined by polymorphisms in nucleotide positions m.4216T > C/MT-ND1, m.11251A > G/MT-ND4, m.15452C > ...",222,79,Crit_Care_2012_Jan_17_16(1)_R10.txt
11251A > G,"...sms in nucleotide positions m.4216T > C/MT-ND1, m.11251A > G/MT-ND4, m.15452C > A/MT-CYB and m.16126...",222,99,Crit_Care_2012_Jan_17_16(1)_R10.txt
15452C > A,"...itions m.4216T > C/MT-ND1, m.11251A > G/MT-ND4, m.15452C > A/MT-CYB and m.16126T > C/MT-DLOOP. The l...",222,120,Crit_Care_2012_Jan_17_16(1)_R10.txt
16126T > C,"...1, m.11251A > G/MT-ND4, m.15452C > A/MT-CYB and m.16126T > C/MT-DLOOP. The last polymorphism is loca...",222,144,Crit_Care_2012_Jan_17_16(1)_R10.txt
11251A > G,...ulation of mtDNA replication and transcription. M.11251A > G is a synonymous polymorphism. Only m.42...,222,312,Crit_Care_2012_Jan_17_16(1)_R10.txt
4216T > C,...M.11251A > G is a synonymous polymorphism. Only m.4216T > C and m.15452C > A provoke amino acid subs...,222,360,Crit_Care_2012_Jan_17_16(1)_R10.txt
15452C > A,...a synonymous polymorphism. Only m.4216T > C and m.15452C > A provoke amino acid substitutions. The f...,222,376,Crit_Care_2012_Jan_17_16(1)_R10.txt
295C > T,...s apparently due to the presence of a mutation (m.295C > T) in a control region important for mtDNA ...,226,399,Crit_Care_2012_Jan_17_16(1)_R10.txt
949C>T,"... NFKB1 c.-798_-795delATTG (rs28362491), NFKBIA c.-949C>T (rs2233406), IL-8 c.-352A>T (rs4073), IL-10...",9,80,Croat_Med_J_2014_Dec_55(6)_638-646.txt
352A>T,"...s28362491), NFKBIA c.-949C>T (rs2233406), IL-8 c.-352A>T (rs4073), IL-10 c.-854T>C (rs1800871), TNF ...",9,108,Croat_Med_J_2014_Dec_55(6)_638-646.txt
854T>C,"...>T (rs2233406), IL-8 c.-352A>T (rs4073), IL-10 c.-854T>C (rs1800871), TNF c.-418G>A (rs361525), and ...",9,134,Croat_Med_J_2014_Dec_55(6)_638-646.txt
418G>A,"...A>T (rs4073), IL-10 c.-854T>C (rs1800871), TNF c.-418G>A (rs361525), and TNF c.-488G>A (rs1800629) p...",9,161,Croat_Med_J_2014_Dec_55(6)_638-646.txt
488G>A,"...(rs1800871), TNF c.-418G>A (rs361525), and TNF c.-488G>A (rs1800629) polymorphisms with breast cance...",9,191,Croat_Med_J_2014_Dec_55(6)_638-646.txt
418G>A,"... IL-8 polymorphism, GA and AA genotypes of TNF c.-418G>A polymorphism, and GA genotype of TNF c.-488...",15,407,Croat_Med_J_2014_Dec_55(6)_638-646.txt
488G>A,"...c.-418G>A polymorphism, and GA genotype of TNF c.-488G>A polymorphism significantly reduced breast c...",15,454,Croat_Med_J_2014_Dec_55(6)_638-646.txt
949C>T,"... NFKB1 c.-798_-795delATTG (rs28362491), NFKBIA c.-949C>T (rs2233406), IL-8 c.-352A>T (rs4073), IL-10...",22,622,Croat_Med_J_2014_Dec_55(6)_638-646.txt
352A>T,"...s28362491), NFKBIA c.-949C>T (rs2233406), IL-8 c.-352A>T (rs4073), IL-10 c.-854T>C (rs1800871), TNF ...",22,650,Croat_Med_J_2014_Dec_55(6)_638-646.txt
854T>C,"...>T (rs2233406), IL-8 c.-352A>T (rs4073), IL-10 c.-854T>C (rs1800871), TNF c.-418G>A (rs361525), and ...",22,676,Croat_Med_J_2014_Dec_55(6)_638-646.txt
418G>A,"...A>T (rs4073), IL-10 c.-854T>C (rs1800871), TNF c.-418G>A (rs361525), and TNF c.-488G>A (rs1800629) p...",22,703,Croat_Med_J_2014_Dec_55(6)_638-646.txt
488G>A,"...(rs1800871), TNF c.-418G>A (rs361525), and TNF c.-488G>A (rs1800629) polymorphisms with breast cance...",22,733,Croat_Med_J_2014_Dec_55(6)_638-646.txt
949C>T,"For NFKBIA c.-949C>T (rs2233406) polymorphism, the forward prime...",31,15,Croat_Med_J_2014_Dec_55(6)_638-646.txt
352A>T,"For IL-8 c.-352A>T (rs4073) polymorphism, the forward primer w...",33,13,Croat_Med_J_2014_Dec_55(6)_638-646.txt
854T>C,"For IL-10 c.-854T>C (rs1800871) polymorphism, the forward prime...",35,14,Croat_Med_J_2014_Dec_55(6)_638-646.txt
418G>A,"For TNF c.-418G>A (rs361525) polymorphism, the primers used w...",37,12,Croat_Med_J_2014_Dec_55(6)_638-646.txt
488G>A,"For TNF c.-488G>A (rs1800629) polymorphism, the primers used ...",39,12,Croat_Med_J_2014_Dec_55(6)_638-646.txt
418G>A,"... IL-8 polymorphism, GA and AA genotypes of TNF c.-418G>A polymorphism, and GA genotype of TNF c.-488...",320,241,Croat_Med_J_2014_Dec_55(6)_638-646.txt
488G>A,"...c.-418G>A polymorphism, and GA genotype of TNF c.-488G>A polymorphism significantly reduced breast c...",320,288,Croat_Med_J_2014_Dec_55(6)_638-646.txt
1555A>G,"...ne, in which the hearing loss associated with the 1555A>G mitochondrial mutation is more severe in p...",66,940,Curr_Genomics_2010_Jun_11(4)_269-278.txt
1555A>G,...3] and the deafness phenotype associated with the 1555A>G mutation in MTRNR1 was shown to be modifie...,69,425,Curr_Genomics_2010_Jun_11(4)_269-278.txt
1555A>G,... the severity of hearing loss associated with the 1555A>G mitochondrial mutation Am. J. Med. Genet 2...,173,139,Curr_Genomics_2010_Jun_11(4)_269-278.txt
256T>C,...i C Q  Parnell L D  Borecki I  Ordovas J M   The -256T>C polymorphism in the apolipoprotein A-II gen...,155,153,Curr_Genomics_2011_May_12(3)_180-189.txt
500 G>A,"...ulation, 5 missense heterozygous substitutions (c.500 G>A, c.520 C>T, c.823 C>T, c.930 G>C, c.1180 G...",216,262,Curr_Genomics_2013_Dec_14(8)_502-517.txt
520 C>T,"...missense heterozygous substitutions (c.500 G>A, c.520 C>T, c.823 C>T, c.930 G>C, c.1180 G>A) in the ...",216,273,Curr_Genomics_2013_Dec_14(8)_502-517.txt
823 C>T,"...terozygous substitutions (c.500 G>A, c.520 C>T, c.823 C>T, c.930 G>C, c.1180 G>A) in the PRKN gene w...",216,284,Curr_Genomics_2013_Dec_14(8)_502-517.txt
930 G>C,"...substitutions (c.500 G>A, c.520 C>T, c.823 C>T, c.930 G>C, c.1180 G>A) in the PRKN gene were seen in...",216,295,Curr_Genomics_2013_Dec_14(8)_502-517.txt
1180 G>A,"...ns (c.500 G>A, c.520 C>T, c.823 C>T, c.930 G>C, c.1180 G>A) in the PRKN gene were seen in 4 exons (4...",216,306,Curr_Genomics_2013_Dec_14(8)_502-517.txt
500 G>A,".... In this study, the frequency of polymorphisms c.500 G>A, c.1180 G>A and c.930 G>C was significantl...",216,418,Curr_Genomics_2013_Dec_14(8)_502-517.txt
1180 G>A,"...tudy, the frequency of polymorphisms c.500 G>A, c.1180 G>A and c.930 G>C was significantly higher in...",216,429,Curr_Genomics_2013_Dec_14(8)_502-517.txt
930 G>C,"...ency of polymorphisms c.500 G>A, c.1180 G>A and c.930 G>C was significantly higher in PD cases and i...",216,444,Curr_Genomics_2013_Dec_14(8)_502-517.txt
500 G>A,"The c.500 G>A transition, located in 4 exon in the cyste...",218,7,Curr_Genomics_2013_Dec_14(8)_502-517.txt
500 G>A,... [176]. It seems that the high frequency of the c.500 G>A polymorphism in the control group in this ...,218,450,Curr_Genomics_2013_Dec_14(8)_502-517.txt
500 G>A,...e. Our study indicates that the presence of the c.500 G>A substitution in the PRKN gene may signific...,218,672,Curr_Genomics_2013_Dec_14(8)_502-517.txt
1180 G>A,"The c.1180 G>A transition in exon 11, which is located b...",220,7,Curr_Genomics_2013_Dec_14(8)_502-517.txt
930 G>C,The c.930 G>C transversion is situated between the RING1...,222,7,Curr_Genomics_2013_Dec_14(8)_502-517.txt
930 G>C,"...ever, in the study by Bardien et al. [179], the c.930 G>C transversion was also observed in the pati...",224,167,Curr_Genomics_2013_Dec_14(8)_502-517.txt
823 C>T,"On the other hand, the c.823 C>T mutation located in exon 7 was detected in...",226,26,Curr_Genomics_2013_Dec_14(8)_502-517.txt
823 C>T,"...urrent research shows that the frequency of the c.823 C>T mutation is low. Results of our study, as ...",226,180,Curr_Genomics_2013_Dec_14(8)_502-517.txt
823 C>T,...ll as the study by Sinha [151] who detected the c.823 C>T substitution in 0.2% of the PD group but n...,226,282,Curr_Genomics_2013_Dec_14(8)_502-517.txt
823 C>T,...onstrate high penetration. It is known that the c.823 C>T mutation is located within the RING1 domai...,226,476,Curr_Genomics_2013_Dec_14(8)_502-517.txt
520 C>T,"... analyzed Polish population, the novel mutation c.520 C>T was detected [49, 123]. To date, a silent ...",228,101,Curr_Genomics_2013_Dec_14(8)_502-517.txt
522 C>T,"...To date, a silent mutation in codon 174, namely c.522 C>T, has been detected and appears to not be p...",228,183,Curr_Genomics_2013_Dec_14(8)_502-517.txt
520 C>T,...pears to not be pathogenic in nature [178]. The c.520 C>T substitution results in the amino acid cha...,228,266,Curr_Genomics_2013_Dec_14(8)_502-517.txt
520 C>T,"...ignificantly impair the activity of Parkin, the c.520 C>T transition may be one of the factors incre...",228,512,Curr_Genomics_2013_Dec_14(8)_502-517.txt
1A>T,"1	c.1A>T, c. 13G>A",288,5,Curr_Genomics_2013_Dec_14(8)_502-517.txt
13G>A,"1	c.1A>T, c. 13G>A",288,14,Curr_Genomics_2013_Dec_14(8)_502-517.txt
29G>A,"2	c.29G>A, c.34G>C, c.43G>A, c.52G>A, c.92C>A, c.95A>C...",289,5,Curr_Genomics_2013_Dec_14(8)_502-517.txt
34G>C,"2	c.29G>A, c.34G>C, c.43G>A, c.52G>A, c.92C>A, c.95A>C",289,14,Curr_Genomics_2013_Dec_14(8)_502-517.txt
43G>A,"2	c.29G>A, c.34G>C, c.43G>A, c.52G>A, c.92C>A, c.95A>C",289,23,Curr_Genomics_2013_Dec_14(8)_502-517.txt
52G>A,"2	c.29G>A, c.34G>C, c.43G>A, c.52G>A, c.92C>A, c.95A>C",289,32,Curr_Genomics_2013_Dec_14(8)_502-517.txt
92C>A,"2	c.29G>A, c.34G>C, c.43G>A, c.52G>A, c.92C>A, c.95A>C",289,41,Curr_Genomics_2013_Dec_14(8)_502-517.txt
95A>C,"2	c.29G>A, c.34G>C, c.43G>A, c.52G>A, c.92C>A, c.95A>C",289,50,Curr_Genomics_2013_Dec_14(8)_502-517.txt
97C>T,"c.97C>T, c.98G>A, c.101delA, c.101_102delAG, c.101A>...",291,3,Curr_Genomics_2013_Dec_14(8)_502-517.txt
98G>A,"c.97C>T, c.98G>A, c.101delA, c.101_102delAG, c.101A>G",291,12,Curr_Genomics_2013_Dec_14(8)_502-517.txt
101A>G,"c.97C>T, c.98G>A, c.101delA, c.101_102delAG, c.101A>G",291,48,Curr_Genomics_2013_Dec_14(8)_502-517.txt
110C>T,"c.110C>T, c.118C>T, c.124C>T, c.125G>A, c.125G>C",293,3,Curr_Genomics_2013_Dec_14(8)_502-517.txt
118C>T,"c.110C>T, c.118C>T, c.124C>T, c.125G>A, c.125G>C",293,13,Curr_Genomics_2013_Dec_14(8)_502-517.txt
124C>T,"c.110C>T, c.118C>T, c.124C>T, c.125G>A, c.125G>C",293,23,Curr_Genomics_2013_Dec_14(8)_502-517.txt
125G>A,"c.110C>T, c.118C>T, c.124C>T, c.125G>A, c.125G>C",293,33,Curr_Genomics_2013_Dec_14(8)_502-517.txt
125G>C,"c.110C>T, c.118C>T, c.124C>T, c.125G>A, c.125G>C",293,43,Curr_Genomics_2013_Dec_14(8)_502-517.txt
136G>A,"c.136G>A, c.136G>C, c.155delA, c.156_157insT, c.160T...",295,3,Curr_Genomics_2013_Dec_14(8)_502-517.txt
136G>C,"c.136G>A, c.136G>C, c.155delA, c.156_157insT, c.160T>A",295,13,Curr_Genomics_2013_Dec_14(8)_502-517.txt
160T>A,"c.136G>A, c.136G>C, c.155delA, c.156_157insT, c.160T>A",295,49,Curr_Genomics_2013_Dec_14(8)_502-517.txt
164C>T,"c.164C>T, c.167T>A",297,3,Curr_Genomics_2013_Dec_14(8)_502-517.txt
167T>A,"c.164C>T, c.167T>A",297,13,Curr_Genomics_2013_Dec_14(8)_502-517.txt
235G>T,"3	c.220_221insGT, c.235G>T, c.245C>A, c.256G>A, c.300G>C, c.310C>T, c....",298,21,Curr_Genomics_2013_Dec_14(8)_502-517.txt
245C>A,"3	c.220_221insGT, c.235G>T, c.245C>A, c.256G>A, c.300G>C, c.310C>T, c.337_376del...",298,31,Curr_Genomics_2013_Dec_14(8)_502-517.txt
256G>A,"3	c.220_221insGT, c.235G>T, c.245C>A, c.256G>A, c.300G>C, c.310C>T, c.337_376del40, c.397_...",298,41,Curr_Genomics_2013_Dec_14(8)_502-517.txt
300G>C,"3	c.220_221insGT, c.235G>T, c.245C>A, c.256G>A, c.300G>C, c.310C>T, c.337_376del40, c.397_399delCCA,...",298,51,Curr_Genomics_2013_Dec_14(8)_502-517.txt
310C>T,"...1insGT, c.235G>T, c.245C>A, c.256G>A, c.300G>C, c.310C>T, c.337_376del40, c.397_399delCCA, c.428A>G",298,61,Curr_Genomics_2013_Dec_14(8)_502-517.txt
428A>G,"...G>C, c.310C>T, c.337_376del40, c.397_399delCCA, c.428A>G",298,104,Curr_Genomics_2013_Dec_14(8)_502-517.txt
434G>A,"4	c.434G>A, c.458V>G, c.483A>T, c.497G>A",299,5,Curr_Genomics_2013_Dec_14(8)_502-517.txt
458V>G,"4	c.434G>A, c.458V>G, c.483A>T, c.497G>A",299,15,Curr_Genomics_2013_Dec_14(8)_502-517.txt
483A>T,"4	c.434G>A, c.458V>G, c.483A>T, c.497G>A",299,25,Curr_Genomics_2013_Dec_14(8)_502-517.txt
497G>A,"4	c.434G>A, c.458V>G, c.483A>T, c.497G>A",299,35,Curr_Genomics_2013_Dec_14(8)_502-517.txt
500G>A,"c.500G>A, c.511C>T, c.518C>T",301,3,Curr_Genomics_2013_Dec_14(8)_502-517.txt
511C>T,"c.500G>A, c.511C>T, c.518C>T",301,13,Curr_Genomics_2013_Dec_14(8)_502-517.txt
518C>T,"c.500G>A, c.511C>T, c.518C>T",301,23,Curr_Genomics_2013_Dec_14(8)_502-517.txt
574A>C,"5	c.536delG, c.574A>C, c.574A>G, c.600C>G",302,16,Curr_Genomics_2013_Dec_14(8)_502-517.txt
574A>G,"5	c.536delG, c.574A>C, c.574A>G, c.600C>G",302,26,Curr_Genomics_2013_Dec_14(8)_502-517.txt
600C>G,"5	c.536delG, c.574A>C, c.574A>G, c.600C>G",302,36,Curr_Genomics_2013_Dec_14(8)_502-517.txt
632A>G,"6	c.632A>G, c.633A>T, c.634delT, c.634T>G, c.635G>A",303,5,Curr_Genomics_2013_Dec_14(8)_502-517.txt
633A>T,"6	c.632A>G, c.633A>T, c.634delT, c.634T>G, c.635G>A",303,15,Curr_Genomics_2013_Dec_14(8)_502-517.txt
634T>G,"6	c.632A>G, c.633A>T, c.634delT, c.634T>G, c.635G>A",303,36,Curr_Genomics_2013_Dec_14(8)_502-517.txt
635G>A,"6	c.632A>G, c.633A>T, c.634delT, c.634T>G, c.635G>A",303,46,Curr_Genomics_2013_Dec_14(8)_502-517.txt
645C>A,"c.645C>A, c.688G>A, c.701G>A, c.714G>A, c.719C>G",305,3,Curr_Genomics_2013_Dec_14(8)_502-517.txt
688G>A,"c.645C>A, c.688G>A, c.701G>A, c.714G>A, c.719C>G",305,13,Curr_Genomics_2013_Dec_14(8)_502-517.txt
701G>A,"c.645C>A, c.688G>A, c.701G>A, c.714G>A, c.719C>G",305,23,Curr_Genomics_2013_Dec_14(8)_502-517.txt
714G>A,"c.645C>A, c.688G>A, c.701G>A, c.714G>A, c.719C>G",305,33,Curr_Genomics_2013_Dec_14(8)_502-517.txt
719C>G,"c.645C>A, c.688G>A, c.701G>A, c.714G>A, c.719C>G",305,43,Curr_Genomics_2013_Dec_14(8)_502-517.txt
719C>T,"c.719C>T, c.727G>A, c.730G>A",307,3,Curr_Genomics_2013_Dec_14(8)_502-517.txt
727G>A,"c.719C>T, c.727G>A, c.730G>A",307,13,Curr_Genomics_2013_Dec_14(8)_502-517.txt
730G>A,"c.719C>T, c.727G>A, c.730G>A",307,23,Curr_Genomics_2013_Dec_14(8)_502-517.txt
758G>A,"7	c.758G>A, c.758G>T, c.759C>G, c.766C>T, c.772G>A, c....",308,5,Curr_Genomics_2013_Dec_14(8)_502-517.txt
758G>T,"7	c.758G>A, c.758G>T, c.759C>G, c.766C>T, c.772G>A, c.794A>G",308,15,Curr_Genomics_2013_Dec_14(8)_502-517.txt
759C>G,"7	c.758G>A, c.758G>T, c.759C>G, c.766C>T, c.772G>A, c.794A>G",308,25,Curr_Genomics_2013_Dec_14(8)_502-517.txt
766C>T,"7	c.758G>A, c.758G>T, c.759C>G, c.766C>T, c.772G>A, c.794A>G",308,35,Curr_Genomics_2013_Dec_14(8)_502-517.txt
772G>A,"7	c.758G>A, c.758G>T, c.759C>G, c.766C>T, c.772G>A, c.794A>G",308,45,Curr_Genomics_2013_Dec_14(8)_502-517.txt
794A>G,"...758G>A, c.758G>T, c.759C>G, c.766C>T, c.772G>A, c.794A>G",308,55,Curr_Genomics_2013_Dec_14(8)_502-517.txt
799T>C,"c.799T>C, c.804T>A, c.813A>T, c.814C>A, c.818A>G, c....",310,3,Curr_Genomics_2013_Dec_14(8)_502-517.txt
804T>A,"c.799T>C, c.804T>A, c.813A>T, c.814C>A, c.818A>G, c.823C>T",310,13,Curr_Genomics_2013_Dec_14(8)_502-517.txt
813A>T,"c.799T>C, c.804T>A, c.813A>T, c.814C>A, c.818A>G, c.823C>T",310,23,Curr_Genomics_2013_Dec_14(8)_502-517.txt
814C>A,"c.799T>C, c.804T>A, c.813A>T, c.814C>A, c.818A>G, c.823C>T",310,33,Curr_Genomics_2013_Dec_14(8)_502-517.txt
818A>G,"c.799T>C, c.804T>A, c.813A>T, c.814C>A, c.818A>G, c.823C>T",310,43,Curr_Genomics_2013_Dec_14(8)_502-517.txt
823C>T,"...799T>C, c.804T>A, c.813A>T, c.814C>A, c.818A>G, c.823C>T",310,53,Curr_Genomics_2013_Dec_14(8)_502-517.txt
838G>A,"c.838G>A, c.848T>C, c.850G>C, c.865T>G, c.871delG",312,3,Curr_Genomics_2013_Dec_14(8)_502-517.txt
848T>C,"c.838G>A, c.848T>C, c.850G>C, c.865T>G, c.871delG",312,13,Curr_Genomics_2013_Dec_14(8)_502-517.txt
850G>C,"c.838G>A, c.848T>C, c.850G>C, c.865T>G, c.871delG",312,23,Curr_Genomics_2013_Dec_14(8)_502-517.txt
865T>G,"c.838G>A, c.848T>C, c.850G>C, c.865T>G, c.871delG",312,33,Curr_Genomics_2013_Dec_14(8)_502-517.txt
892A>C,"8	c.892A>C, c.893T>G, c.930G>C, c.931C>T, c.933G>T",313,5,Curr_Genomics_2013_Dec_14(8)_502-517.txt
893T>G,"8	c.892A>C, c.893T>G, c.930G>C, c.931C>T, c.933G>T",313,15,Curr_Genomics_2013_Dec_14(8)_502-517.txt
930G>C,"8	c.892A>C, c.893T>G, c.930G>C, c.931C>T, c.933G>T",313,25,Curr_Genomics_2013_Dec_14(8)_502-517.txt
931C>T,"8	c.892A>C, c.893T>G, c.930G>C, c.931C>T, c.933G>T",313,35,Curr_Genomics_2013_Dec_14(8)_502-517.txt
933G>T,"8	c.892A>C, c.893T>G, c.930G>C, c.931C>T, c.933G>T",313,45,Curr_Genomics_2013_Dec_14(8)_502-517.txt
983G>A,"9	c.968_973delGTGTCC, c.971delT, c.983G>A, c.1000C>T",314,36,Curr_Genomics_2013_Dec_14(8)_502-517.txt
1000C>T,"9	c.968_973delGTGTCC, c.971delT, c.983G>A, c.1000C>T",314,46,Curr_Genomics_2013_Dec_14(8)_502-517.txt
1001G>A,"c.1001G>A, c.1015G>T, c.1041_1042delGA, c.1046_1047d...",316,3,Curr_Genomics_2013_Dec_14(8)_502-517.txt
1015G>T,"c.1001G>A, c.1015G>T, c.1041_1042delGA, c.1046_1047delAA",316,14,Curr_Genomics_2013_Dec_14(8)_502-517.txt
1051A>C,"c.1051A>C, c.1076G>A",318,3,Curr_Genomics_2013_Dec_14(8)_502-517.txt
1076G>A,"c.1051A>C, c.1076G>A",318,14,Curr_Genomics_2013_Dec_14(8)_502-517.txt
1096C>T,"10	c.1096C>T, c.1097G>A, c.1138G>C",319,6,Curr_Genomics_2013_Dec_14(8)_502-517.txt
1097G>A,"10	c.1096C>T, c.1097G>A, c.1138G>C",319,17,Curr_Genomics_2013_Dec_14(8)_502-517.txt
1138G>C,"10	c.1096C>T, c.1097G>A, c.1138G>C",319,28,Curr_Genomics_2013_Dec_14(8)_502-517.txt
1180G>A,"11	c.1175_1176delGA, c.1180G>A, c.1183G>T, c.1186A>G",320,24,Curr_Genomics_2013_Dec_14(8)_502-517.txt
1183G>T,"11	c.1175_1176delGA, c.1180G>A, c.1183G>T, c.1186A>G",320,35,Curr_Genomics_2013_Dec_14(8)_502-517.txt
1186A>G,"11	c.1175_1176delGA, c.1180G>A, c.1183G>T, c.1186A>G",320,46,Curr_Genomics_2013_Dec_14(8)_502-517.txt
1192G>A,"c.1192G>A, c.1204C>T, c.1205G>A, c.1225G>T",322,3,Curr_Genomics_2013_Dec_14(8)_502-517.txt
1204C>T,"c.1192G>A, c.1204C>T, c.1205G>A, c.1225G>T",322,14,Curr_Genomics_2013_Dec_14(8)_502-517.txt
1205G>A,"c.1192G>A, c.1204C>T, c.1205G>A, c.1225G>T",322,25,Curr_Genomics_2013_Dec_14(8)_502-517.txt
1225G>T,"c.1192G>A, c.1204C>T, c.1205G>A, c.1225G>T",322,36,Curr_Genomics_2013_Dec_14(8)_502-517.txt
1244C>A,"c.1244C>A, c.1252T>C, c.1283_1284insA",324,3,Curr_Genomics_2013_Dec_14(8)_502-517.txt
1252T>C,"c.1244C>A, c.1252T>C, c.1283_1284insA",324,14,Curr_Genomics_2013_Dec_14(8)_502-517.txt
1286G>A,"12	c.1286G>A, c.1289G>A, c.1292G>T, c.1310C>T, c.1321T>...",325,6,Curr_Genomics_2013_Dec_14(8)_502-517.txt
1289G>A,"12	c.1286G>A, c.1289G>A, c.1292G>T, c.1310C>T, c.1321T>C, c.1330G>...",325,17,Curr_Genomics_2013_Dec_14(8)_502-517.txt
1292G>T,"12	c.1286G>A, c.1289G>A, c.1292G>T, c.1310C>T, c.1321T>C, c.1330G>C",325,28,Curr_Genomics_2013_Dec_14(8)_502-517.txt
1310C>T,"12	c.1286G>A, c.1289G>A, c.1292G>T, c.1310C>T, c.1321T>C, c.1330G>C",325,39,Curr_Genomics_2013_Dec_14(8)_502-517.txt
1321T>C,"12	c.1286G>A, c.1289G>A, c.1292G>T, c.1310C>T, c.1321T>C, c.1330G>C",325,50,Curr_Genomics_2013_Dec_14(8)_502-517.txt
1330G>C,"...>A, c.1289G>A, c.1292G>T, c.1310C>T, c.1321T>C, c.1330G>C",325,61,Curr_Genomics_2013_Dec_14(8)_502-517.txt
1335G>A,"c.1335G>A, c.1358G>A, c.1372A>C, c.1378_1379insG, c....",327,3,Curr_Genomics_2013_Dec_14(8)_502-517.txt
1358G>A,"c.1335G>A, c.1358G>A, c.1372A>C, c.1378_1379insG, c.1393G>A",327,14,Curr_Genomics_2013_Dec_14(8)_502-517.txt
1372A>C,"c.1335G>A, c.1358G>A, c.1372A>C, c.1378_1379insG, c.1393G>A",327,25,Curr_Genomics_2013_Dec_14(8)_502-517.txt
1393G>A,"...1335G>A, c.1358G>A, c.1372A>C, c.1378_1379insG, c.1393G>A",327,53,Curr_Genomics_2013_Dec_14(8)_502-517.txt
110C>T,"Screening for P37L and P37= (c.110C>T, c.111G>A) in exon 2 and E310D in exon 8 of...",28,32,Curr_Genomics_2015_Aug_16(4)_215-223.txt
111G>A,"Screening for P37L and P37= (c.110C>T, c.111G>A) in exon 2 and E310D in exon 8 of PRKN was ...",28,42,Curr_Genomics_2015_Aug_16(4)_215-223.txt
1331T>C,...traceptive-induced cholestasis in carriers of the 1331T>C polymorphism in the bile salt export pump ...,254,225,Curr_Med_Chem_2009_Aug_16(23)_3041-3053.txt
262C>T,...etween functional polymorphism of catalase gene (-262C>T) and recurrent depressive disorder. Neuro. ...,214,127,Curr_Neuropharmacol_2014_Mar_12(2)_108-119.txt
1562C> T,...High Serum Matrix Metalloproteinase-9 and MMP-9 (-1562C> T) Polymorphism in Patients With ST-Elevati...,158,90,Curr_Ther_Res_Clin_Exp_2015_Feb_23_77_40-45.txt
145A>G,"...)-adrenergic receptor polymorphisms: analysis of c145A>G and c1165G>C . Hum. Mutat ., 14 , 271. 1047...",252,115,Database_(Oxford)_2016_Sep_1_2016_baw124.txt
1165G>C,"... receptor polymorphisms: analysis of c145A>G and c1165G>C . Hum. Mutat ., 14 , 271. 10477438",252,127,Database_(Oxford)_2016_Sep_1_2016_baw124.txt
1120C>T,"...IPS were identified recently: missense mutation c.1120C>T in a highly conserved region of exon 8,107...",66,974,Dermatoendocrinol_2011_Apr_1_Apr-Jun_3(2)_53-61.txt
1G>A,...l heterozygous intron 1 splice site variant (c.99+1G>A) in both the index individual and the father....,5,1890,Dev_Med_Child_Neurol_2014_Nov_29_56(11)_1124-1128.txt
1G>A,... revealed a splice site variant in intron 1 (c.99+1G>A) in both the index individual and in the fath...,31,1199,Dev_Med_Child_Neurol_2014_Nov_29_56(11)_1124-1128.txt
629C>A,"...iconis X, Chew SK, Loh LM, Tan CE: The TaqIB and -629C>A polymorphisms at the cholesteryl ester tran...",74,112,Diabetes_2008_Oct_57(10)_2851-2857.txt
16861194 A>G,... shown association with type 2 diabetes (SNP1 = rs16861194 A>G; SNP3 = rs266729 C>G; in MONICA/KORA ...,24,1246,Diabetes_2009_Apr_15_58(4)_984-991.txt
266729 C>G,"... type 2 diabetes (SNP1 = rs16861194 A>G; SNP3 = rs266729 C>G; in MONICA/KORA S123, rs1648707 A>C has...",24,1269,Diabetes_2009_Apr_15_58(4)_984-991.txt
1648707 A>C,"... A>G; SNP3 = rs266729 C>G; in MONICA/KORA S123, rs1648707 A>C has served as proxy for SNP3 with link...",24,1304,Diabetes_2009_Apr_15_58(4)_984-991.txt
550 G > C,"...7096206, and rs7095891, previously classified as −550 G > C (H/l), − 221G > C (Y/X), and +4 C > T (P...",38,437,Diabetes_2010_Aug_3_59(8)_2080-2085.txt
221G > C,"...891, previously classified as −550 G > C (H/l), − 221G > C (Y/X), and +4 C > T (P/Q), respectively, ...",38,456,Diabetes_2010_Aug_3_59(8)_2080-2085.txt
4 C > T,"...ified as −550 G > C (H/l), − 221G > C (Y/X), and +4 C > T (P/Q), respectively, were also identified ...",38,477,Diabetes_2010_Aug_3_59(8)_2080-2085.txt
2T>G,... conjunction with a GK splice site mutation (IVS8+2T>G) and was associated with marked hyperglycemia...,153,1365,Diabetes_2011_Dec_13_60(12)_3175-3185.txt
128G>A,"...s in each of the three probands: R43H and G68D (c.128G>A, p.Arg43His and c.203G>A, p.Gly68Asp), E248...",34,103,Diabetes_Care_2012_Jul_12_35(7)_1482-1484.txt
203G>A,"...obands: R43H and G68D (c.128G>A, p.Arg43His and c.203G>A, p.Gly68Asp), E248 K and I225M (c.742G>A, p...",34,128,Diabetes_Care_2012_Jul_12_35(7)_1482-1484.txt
742G>A,"...is and c.203G>A, p.Gly68Asp), E248 K and I225M (c.742G>A, p.Glu248Lys and c.675C>G, p.Ile225Met), an...",34,169,Diabetes_Care_2012_Jul_12_35(7)_1482-1484.txt
675C>G,"...p), E248 K and I225M (c.742G>A, p.Glu248Lys and c.675C>G, p.Ile225Met), and G261R and D217N (c.781G>...",34,195,Diabetes_Care_2012_Jul_12_35(7)_1482-1484.txt
781G>A,"...nd c.675C>G, p.Ile225Met), and G261R and D217N (c.781G>A, p.Gly261Arg and c.649G>A, p.Asp217Asn). Of...",34,240,Diabetes_Care_2012_Jul_12_35(7)_1482-1484.txt
649G>A,"... and G261R and D217N (c.781G>A, p.Gly261Arg and c.649G>A, p.Asp217Asn). Of these six mutations, five...",34,266,Diabetes_Care_2012_Jul_12_35(7)_1482-1484.txt
276G->T,Association of the 276G->T polymorphism of the adiponectin gene with ...,184,20,Diabetes_Care_2013_Aug_11_36(8)_2408-2414.txt
948 G > T,".... However, they found an association between the -948 G > T single-nucleotide polymorphism (SNP) and...",87,448,Diabetol_Metab_Syndr_2010_Mar_26_2_21.txt
948G > T,"... three genetic polymorphisms studied (rs9770242, -948G > T, rs4730153)",87,692,Diabetol_Metab_Syndr_2010_Mar_26_2_21.txt
948C > A,...0). They found a significant association between -948C > A and T2DM (p = 0.021). In a non-diabetic p...,91,164,Diabetol_Metab_Syndr_2010_Mar_26_2_21.txt
948G > T,"... from Germany. They genotyped 3 SNPs (rs9770242, -948G > T, rs4730153). The authors did not find ass...",93,144,Diabetol_Metab_Syndr_2010_Mar_26_2_21.txt
1535C > T,"...ecently, Yan et al. [42] suggested that Visfatin -1535C > T polymorphism might be associated with re...",97,57,Diabetol_Metab_Syndr_2010_Mar_26_2_21.txt
1535C > T,...e was a significant association between Visfatin -1535C > T polymorphism and triglyceride levels in ...,97,204,Diabetol_Metab_Syndr_2010_Mar_26_2_21.txt
1535T > C,...ation may reflect linkage disequilibrium between -1535T > C and other causative variations of the vi...,97,706,Diabetol_Metab_Syndr_2010_Mar_26_2_21.txt
4478 T > G,"Robitaille, 2004 [36]	n: 217	N/D	29.6 ± 4.3	N/D	4478 T > G, 4437–4438insA and 10733G > C	No associ...",302,49,Diabetol_Metab_Syndr_2015_Apr_28_7_38.txt
10733G > C,"...	N/D	29.6 ± 4.3	N/D	4478 T > G, 4437–4438insA and 10733G > C	No association with BMI, WC, HDL-c, TG,...",302,79,Diabetol_Metab_Syndr_2015_Apr_28_7_38.txt
658G > A,"...[33]	n: 3005	N/D	22.8 ± 2.7	431 (14.3)	rs860185, −658G > A, +1930insA, rs12086634, rs2236905, rs2298...",305,66,Diabetol_Metab_Syndr_2015_Apr_28_7_38.txt
30249 T > C,"... +1932Ginsdel, xrs932335, rs13306422, rs6752 and +30249 T > C	No association with WHR, BMI, FPG, HbA...",308,130,Diabetol_Metab_Syndr_2015_Apr_28_7_38.txt
232A>G,2	c.232A>G	p.Thr78Ala	CGL2	[27],98,5,Diagn_Pathol_2013_May_9_8_78.txt
263A>G,"2	c.263A>G	p.Asn88Ser	dHMN	[16,18,28]",99,5,Diagn_Pathol_2013_May_9_8_78.txt
269C>T,"2	c.269C>T	p.Ser90Leu	dHMN, CMT2	[18,29,30]",100,5,Diagn_Pathol_2013_May_9_8_78.txt
269C>G,"2	c.269C>G	p.Ser90Trp	dHMN, CMT2	[22]",101,5,Diagn_Pathol_2013_May_9_8_78.txt
272T>C,2	c.272T>C	p.Leu91Pro	CGL2	[27],102,5,Diagn_Pathol_2013_May_9_8_78.txt
412C>T,3	c.412C>T	p.Arg138X	CGL2	[5],103,5,Diagn_Pathol_2013_May_9_8_78.txt
560A>G,4	c.560A>G	p.Tyr187Cys	CGL2	[15],104,5,Diagn_Pathol_2013_May_9_8_78.txt
565G>T,4	c.565G>T	p.Glu189X	CGL2	[14],105,5,Diagn_Pathol_2013_May_9_8_78.txt
634G>C,"5	c.634G>C	p.Ala212Pro	CGL2	[5,25]",106,5,Diagn_Pathol_2013_May_9_8_78.txt
684C>G,6	c.684C>G	p. Tyr228X	CGL2	[7],107,5,Diagn_Pathol_2013_May_9_8_78.txt
823C>T,7	c.823C>T	p.Arg275X	CGL2	[31],108,5,Diagn_Pathol_2013_May_9_8_78.txt
1171C>T,10	c.1171C>T	p.Gln391X	CGL2	[27],109,6,Diagn_Pathol_2013_May_9_8_78.txt
11A>G,IVS2 -11A>G	Exon skipping	Protein truncation	CGL2	[33],121,7,Diagn_Pathol_2013_May_9_8_78.txt
1G>A,IVS4 +1G>A	Exon skipping	Protein truncation	CGL2	[5],122,7,Diagn_Pathol_2013_May_9_8_78.txt
2A>G,IVS5 -2A>G	Exon skipping	Protein truncation	CGL2	[27],123,7,Diagn_Pathol_2013_May_9_8_78.txt
2A>C,IVS5- 2A>C	Exon skipping	Protein truncation	CGL2	[34],124,7,Diagn_Pathol_2013_May_9_8_78.txt
5G>A,IVS6 +5G>A	Exon skipping	Protein truncation	CGL2	[5],125,7,Diagn_Pathol_2013_May_9_8_78.txt
3C>G,"IVS6 -3C>G	Exon skipping	Protein truncation	CGL2	[5,25]",126,7,Diagn_Pathol_2013_May_9_8_78.txt
2A>G,IVS6 -2A>G	Exon skipping	Protein truncation	CGL2	[7],127,7,Diagn_Pathol_2013_May_9_8_78.txt
1906G->C,"Ellis, The founder mutation MSH2*1906G->C is an impor",522,34,Dis_Markers_2004_Oct_29_20(4-5)_269-276.txt
519A>G,"3.2. MMP1-1607 1G>2G, -519A>G, MMP",297,24,Dis_Markers_2010_Sep_8_29(1)_37-46.txt
181A>G,-181A>G gene polymorphisms in bladder cance,298,2,Dis_Markers_2010_Sep_8_29(1)_37-46.txt
519A>G,"MMP1 -519A>G, -1607 1G>2G, MMP7 -181A>G gene polymorphis...",303,7,Dis_Markers_2010_Sep_8_29(1)_37-46.txt
181A>G,"MMP1 -519A>G, -1607 1G>2G, MMP7 -181A>G gene polymorphisms in blad",303,34,Dis_Markers_2010_Sep_8_29(1)_37-46.txt
519A>G,"AssociationofMMP1-519A>G, -16091G>2G, MMP7-181A>G polymorphisms with...",330,19,Dis_Markers_2010_Sep_8_29(1)_37-46.txt
181A>G,"AssociationofMMP1-519A>G, -16091G>2G, MMP7-181A>G polymorphisms withtumorgrade/stagecategorie...",330,44,Dis_Markers_2010_Sep_8_29(1)_37-46.txt
519A>G,(G) of MMP1-519A>G was higher in cases as com,350,13,Dis_Markers_2010_Sep_8_29(1)_37-46.txt
519A>G,"519A>G (p, 0.347; OR, 0.79). In MMP1-1607, signif",353,1,Dis_Markers_2010_Sep_8_29(1)_37-46.txt
181 A>G,"cases. In MMP7-181 A>G, the variant G allele wa",360,16,Dis_Markers_2010_Sep_8_29(1)_37-46.txt
1555A>G,Heteroplasmy for the 1555A>G mutation in the mitochondria,502,22,Dis_Markers_2011_Jul_1_30(6)_283-289.txt
7510T>C,Spanish family with the 7510T>C mutation in the mitochon,579,25,Dis_Markers_2011_Jul_1_30(6)_283-289.txt
7510T>C,supports a pathogenic role for the 7510T>C mutation of mi,583,36,Dis_Markers_2011_Jul_1_30(6)_283-289.txt
2548G>A,"...ntel MMG   LEPR p.Q223R, β 3-AR p.W64R and LEP c.-2548G>A gene variants in obese Brazilian subjects ...",142,112,Dis_Markers_2013_Nov_6_35(6)_673-677.txt
204 A>C,...Srivastava A.  Choudhuri G.  Mittal B.   CYP7A1 (-204 A>C; rs3808607 and -469 T>C; rs3824260) promot...,232,54,Dis_Markers_2015_Apr_6_2015_185969.txt
469 T>C,... G.  Mittal B.   CYP7A1 (-204 A>C; rs3808607 and -469 T>C; rs3824260) promoter polymorphisms and ris...,232,78,Dis_Markers_2015_Apr_6_2015_185969.txt
1513A>C,"...cal region as control group. The SNP detection of 1513A>C and -762T>C was performed using PCR-RFLP, ...",8,364,Dis_Markers_2015_Dec_20_2015_671272.txt
762T>C,"... control group. The SNP detection of 1513A>C and -762T>C was performed using PCR-RFLP, and the level...",8,377,Dis_Markers_2015_Dec_20_2015_671272.txt
1513A>C,...l subjects were determined. Results. AC and CC of 1513A>C and TC and CC of -762T>C had higher freque...,8,514,Dis_Markers_2015_Dec_20_2015_671272.txt
762T>C,.... Results. AC and CC of 1513A>C and TC and CC of -762T>C had higher frequencies in case group than i...,8,540,Dis_Markers_2015_Dec_20_2015_671272.txt
762T>C,...control group. TB patients carrying TC and CC of -762T>C had higher positive rate of IgG responses t...,8,642,Dis_Markers_2015_Dec_20_2015_671272.txt
762T>C,"...TT. Additionally, patients carrying TC and CC of -762T>C had more MTB in sputum than those carrying ...",8,768,Dis_Markers_2015_Dec_20_2015_671272.txt
1513A>C,"...um than those carrying TT. Conclusion. P2X7 SNPs, 1513A>C and -762T>C, may be associated with the su...",8,845,Dis_Markers_2015_Dec_20_2015_671272.txt
762T>C,"... carrying TT. Conclusion. P2X7 SNPs, 1513A>C and -762T>C, may be associated with the susceptibility ...",8,858,Dis_Markers_2015_Dec_20_2015_671272.txt
762T>C,"...ted with the susceptibility to tuberculosis, and -762T>C SNP may contribute to the development of MT...",8,930,Dis_Markers_2015_Dec_20_2015_671272.txt
762T>C,...o the development of MTB. The mutant genotype of -762T>C (TC and CC) may lower human capability of p...,8,1007,Dis_Markers_2015_Dec_20_2015_671272.txt
1513A>C,"...or function, and the most common SNPs involve the 1513A>C and -762T>C [13, 14]. Accumulating studies...",13,807,Dis_Markers_2015_Dec_20_2015_671272.txt
762T>C,"...and the most common SNPs involve the 1513A>C and -762T>C [13, 14]. Accumulating studies suggested th...",13,820,Dis_Markers_2015_Dec_20_2015_671272.txt
762T>C,"... while there was no significant association with -762T>C polymorphism [15, 16]. However, some previo...",13,995,Dis_Markers_2015_Dec_20_2015_671272.txt
1513A>C,Two SNPs (1513A>C and -762T>C) in P2X7 gene were selected fo...,26,11,Dis_Markers_2015_Dec_20_2015_671272.txt
762T>C,Two SNPs (1513A>C and -762T>C) in P2X7 gene were selected for research ta...,26,24,Dis_Markers_2015_Dec_20_2015_671272.txt
1513A>C,...th polymorphism (PCR-RFLP) was used for analyzing 1513A>C and PCR for -762T>C SNPs. PCR primers were...,26,182,Dis_Markers_2015_Dec_20_2015_671272.txt
762T>C,...RFLP) was used for analyzing 1513A>C and PCR for -762T>C SNPs. PCR primers were designed by Premier ...,26,203,Dis_Markers_2015_Dec_20_2015_671272.txt
1513A>C,"..., and 50 ng genome DNA. The PCR amplification for 1513A>C included initial denaturation at 95°C for ...",26,808,Dis_Markers_2015_Dec_20_2015_671272.txt
762T>C,...etermine the genotype. The PCR amplification for -762T>C was as follows: initial prenaturation at 95...,26,1283,Dis_Markers_2015_Dec_20_2015_671272.txt
1513A>C,Genotype frequency distributions of 1513A>C and -762T>C in two groups were consistent ...,38,37,Dis_Markers_2015_Dec_20_2015_671272.txt
762T>C,Genotype frequency distributions of 1513A>C and -762T>C in two groups were consistent with Hardy-We...,38,50,Dis_Markers_2015_Dec_20_2015_671272.txt
1513A>C,...2 presented the comparison of allele frequency of 1513A>C and -762T>C SNPs between case and control ...,38,344,Dis_Markers_2015_Dec_20_2015_671272.txt
762T>C,...he comparison of allele frequency of 1513A>C and -762T>C SNPs between case and control groups. AC an...,38,357,Dis_Markers_2015_Dec_20_2015_671272.txt
1513A>C,...NPs between case and control groups. AC and CC of 1513A>C and TC and CC of -762T>C in case group had...,38,415,Dis_Markers_2015_Dec_20_2015_671272.txt
762T>C,...ol groups. AC and CC of 1513A>C and TC and CC of -762T>C in case group had higher frequency than con...,38,441,Dis_Markers_2015_Dec_20_2015_671272.txt
1513A>C,"...n control group (all P < 0.05). Both AC and CC of 1513A>C were risk factors of TB, and C was risk al...",38,536,Dis_Markers_2015_Dec_20_2015_671272.txt
762T>C,"... = 1.466~3.511). Additionally, both TC and CC of -762T>C were risk factors of TB, and C was risk all...",38,745,Dis_Markers_2015_Dec_20_2015_671272.txt
1513A>C,The data in Table 2 suggested that 1513A>C and -762T>C SNPs may correlate to the susc...,41,36,Dis_Markers_2015_Dec_20_2015_671272.txt
762T>C,The data in Table 2 suggested that 1513A>C and -762T>C SNPs may correlate to the susceptibility to...,41,49,Dis_Markers_2015_Dec_20_2015_671272.txt
762T>C,...wn in Table 3. TB patients carrying TC and CC of -762T>C had higher positive rate of IgG responses t...,41,259,Dis_Markers_2015_Dec_20_2015_671272.txt
1513A>C,...B antigens between patients carrying AC and CC of 1513A>C and those carrying AA (all P > 0.05),41,511,Dis_Markers_2015_Dec_20_2015_671272.txt
762T>C,"As shown in Table 3, -762T>C SNP in P2X7 gene was associated with the le...",44,23,Dis_Markers_2015_Dec_20_2015_671272.txt
762T>C,...C (Figure 2(b)) and CC (Figure 2(c)) carriers of -762T>C had greater MTB in sputum than those TT car...,44,376,Dis_Markers_2015_Dec_20_2015_671272.txt
1513A>C,...ntigen in TB patients. Our results suggested that 1513A>C and -762T>C SNPs may be a risk factor for ...,47,238,Dis_Markers_2015_Dec_20_2015_671272.txt
762T>C,...patients. Our results suggested that 1513A>C and -762T>C SNPs may be a risk factor for the developme...,47,251,Dis_Markers_2015_Dec_20_2015_671272.txt
762T>C,...nt and progression of TB. The mutant genotype of -762T>C (TC and CC) may lower human capability of p...,47,351,Dis_Markers_2015_Dec_20_2015_671272.txt
1513A>C,...howed that an increased frequency of AC and CC of 1513A>C and TC and CC of -762T>C was observed in T...,49,72,Dis_Markers_2015_Dec_20_2015_671272.txt
762T>C,"...equency of AC and CC of 1513A>C and TC and CC of -762T>C was observed in TB patients, suggesting tha...",49,98,Dis_Markers_2015_Dec_20_2015_671272.txt
1513A>C,"...on of receptor function or expression, especially 1513A>C and -762T>C SNPs [13]. A previous study pu...",51,174,Dis_Markers_2015_Dec_20_2015_671272.txt
762T>C,"...r function or expression, especially 1513A>C and -762T>C SNPs [13]. A previous study published by Ga...",51,187,Dis_Markers_2015_Dec_20_2015_671272.txt
1513A>C,"...ote [29]. Fernando et al. also suggested that the 1513A>C SNP enhances susceptibility to TB, and thi...",51,457,Dis_Markers_2015_Dec_20_2015_671272.txt
762T>C,"...ty of macrophages to kill MTB [30]. In addition, -762T>C transformation may downregulate function of...",51,610,Dis_Markers_2015_Dec_20_2015_671272.txt
762T>C,"...5]. In our study, patients carrying TC and CC of -762T>C had greater MTB in sputum than those carryi...",51,885,Dis_Markers_2015_Dec_20_2015_671272.txt
762T>C,...study was that TB patients carrying TC and CC of -762T>C had higher positive rate of IgG responses t...,53,84,Dis_Markers_2015_Dec_20_2015_671272.txt
762T>C,...ive rate of IgG responses to MTB was detected in -762T>C SNP. Hur et al. also demonstrated that sign...,53,868,Dis_Markers_2015_Dec_20_2015_671272.txt
762T>C,...ch was consistent with our study suggesting that -762T>C SNPs were correlated with the development o...,53,1038,Dis_Markers_2015_Dec_20_2015_671272.txt
1513A>C,"In conclusion, our study demonstrated that 1513A>C and -762T>C SNPs in P2X7 gene may be assoc...",55,44,Dis_Markers_2015_Dec_20_2015_671272.txt
762T>C,"...clusion, our study demonstrated that 1513A>C and -762T>C SNPs in P2X7 gene may be associated with th...",55,57,Dis_Markers_2015_Dec_20_2015_671272.txt
762T>C,"...be associated with the susceptibility to TB, and -762T>C SNP may contribute to the development of MT...",55,136,Dis_Markers_2015_Dec_20_2015_671272.txt
762T>C,...o the development of MTB. The mutant genotype of -762T>C (TC and CC) may lower human capability of p...,55,213,Dis_Markers_2015_Dec_20_2015_671272.txt
1513A>C,Figure 1 The electropherograms of 1513A>C and 762T>C SNPs in P2X7 gene after enzyme ...,66,35,Dis_Markers_2015_Dec_20_2015_671272.txt
762T>C,Figure 1 The electropherograms of 1513A>C and 762T>C SNPs in P2X7 gene after enzyme digestion an...,66,47,Dis_Markers_2015_Dec_20_2015_671272.txt
762T>C,...bacterium tuberculosis (MTB) positive samples in -762T>C single nucleotide polymorphism (SNP) of P2X...,68,91,Dis_Markers_2015_Dec_20_2015_671272.txt
1513A>C,Table 2 Genotype frequency distributions of 1513A>C and -762T>C in P2X7 gene,88,45,Dis_Markers_2015_Dec_20_2015_671272.txt
762T>C,... Genotype frequency distributions of 1513A>C and -762T>C in P2X7 gene,88,58,Dis_Markers_2015_Dec_20_2015_671272.txt
1513A>C,1513A>C	 	 	 	 	 ,93,1,Dis_Markers_2015_Dec_20_2015_671272.txt
762T>C,-762T>C	 	 	 	 	 ,106,2,Dis_Markers_2015_Dec_20_2015_671272.txt
1513A>C,...ulin G responses to Mycobacterium tuberculosis in 1513A>C and -762T>C of P2X7 gene in case group,121,86,Dis_Markers_2015_Dec_20_2015_671272.txt
762T>C,...ses to Mycobacterium tuberculosis in 1513A>C and -762T>C of P2X7 gene in case group,121,99,Dis_Markers_2015_Dec_20_2015_671272.txt
1513A>C,1513A>C	 	 	 	 	 ,127,1,Dis_Markers_2015_Dec_20_2015_671272.txt
762T>C,-762T>C	 	 	 	 	 ,131,2,Dis_Markers_2015_Dec_20_2015_671272.txt
1513A>C,...amination of sputum under the light microscope in 1513A>C and -762T>C of P2X7 gene in case group,137,61,Dis_Markers_2015_Dec_20_2015_671272.txt
762T>C,...sputum under the light microscope in 1513A>C and -762T>C of P2X7 gene in case group,137,74,Dis_Markers_2015_Dec_20_2015_671272.txt
308G>A,"... Zhang F.  Wang Y.   Tumor necrosis factor alpha -308G>A, -863C>A, -857C>T gene polymorphisms and tu...",159,87,Dis_Markers_2015_Dec_20_2015_671272.txt
863C>A,"...  Wang Y.   Tumor necrosis factor alpha -308G>A, -863C>A, -857C>T gene polymorphisms and tuberculosi...",159,96,Dis_Markers_2015_Dec_20_2015_671272.txt
857C>T,"...   Tumor necrosis factor alpha -308G>A, -863C>A, -857C>T gene polymorphisms and tuberculosis suscept...",159,105,Dis_Markers_2015_Dec_20_2015_671272.txt
677 C>T,... F.  Hasbek Z.    Increased T-allele frequency of 677 C>T polymorphism in the methylenetetrahydrofol...,239,71,Dis_Markers_2015_Jan_31_2015_681313.txt
1 G>A,"...ified a novel homozygous mutation in BEST1, c.636+1 G>A. Family members were found to carry one copy...",11,255,Doc_Ophthalmol_2014_May_24_129(1)_57-63.txt
1 G>A,"... was homozygous for a novel splice variant, c.636+1 G>A. This substitution was predicted to be patho...",45,155,Doc_Ophthalmol_2014_May_24_129(1)_57-63.txt
1 G>A,"...on, we report a novel BEST1 splice variant, c.636+1 G>A, identified homozygously in a proband clinic...",68,62,Doc_Ophthalmol_2014_May_24_129(1)_57-63.txt
422 G>A,"... before, together with known pathogenic variant c.422 G>A (R141H) for a patient clinically diagnosed...",68,306,Doc_Ophthalmol_2014_May_24_129(1)_57-63.txt
6986A>G,... was amplified and sequenced to analyze CYP3A5*3 (6986A>G) polymorphism (5′–GGCATAGGAGATACCCACGTA–3′...,27,590,Drug_Des_Devel_Ther_2014_Nov_7_8_2241-2249.txt
617V>F,...ielmelli P    Clinical profile of homozygous JAK2 617V>F mutation in patients with polycythemia vera...,178,85,Drug_Des_Devel_Ther_2015_May_18_9_2687-2694.txt
515W>L,...   Characteristics and clinical correlates of MPL 515W>L/K mutation in essential thrombocythemia Blo...,182,96,Drug_Des_Devel_Ther_2015_May_18_9_2687-2694.txt
8 C>T,...YP2D6*96 has a single-nucleotide mutation in exon 8 C>T at position 3895 in the DNA (site 1270 in cD...,64,453,Drug_Des_Devel_Ther_2016_Feb_15_10_687-696.txt
425T>C,... C substitution in site 1678 of the DNA sequence (425T>C in the cDNA) and results in one amino acid ...,68,94,Drug_Des_Devel_Ther_2016_Feb_15_10_687-696.txt
4T >A,Chronic toxicity	Lipoatrophy	d4T >AZT	Lipoatrophy is an NRTI-induced mitochondri...,29,31,Drugs_2016_Dec_16_76_75-98.txt
401T>C,...level at HRT treatment. Among these SNPs the IVS1-401T>C was most strongly related to HDL increase (...,58,856,EJIFCC_2008_Apr_3_19(1)_48-53.txt
401T>C,...tudies have also examined the effects of ER1 IVS1-401T>C polymorphism on response to HRT or bisphosp...,60,66,EJIFCC_2008_Apr_3_19(1)_48-53.txt
308 G>A,...  Faschinger C  Schmut O  Wedrich A    TNF-alpha –308 G>A and –238 G>A polymorphisms are not major r...,89,89,Electron_Physician_2016_Feb_25_8(2)_1978-1983.txt
238 G>A,...C  Schmut O  Wedrich A    TNF-alpha –308 G>A and –238 G>A polymorphisms are not major risk factors i...,89,102,Electron_Physician_2016_Feb_25_8(2)_1978-1983.txt
57C>T,"...ons in the DYF13 gene, a one-base substitution (c.57C>T) and a one-base deletion (c.59delC; Figure 3...",94,911,eLife_2014_Mar_4_3_e01566.txt
57C >T,...w places of mutations. A one-base substitution (c.57C >T) does not change amino acid. A one-base del...,95,179,eLife_2014_Mar_4_3_e01566.txt
1 G>C,"...rough RNaseP, similar to the dominant negative Nfu1 G>C mutant discussed above (Figure 3F). The grow...",163,1010,eLife_5_e15991.txt
745C>A,"...239P, R263Q, R263X, E425X, L613F, L626Q, L626V, c.745C>A, c.228-16C>G, c.228-22T>A	Antonellis & Gree...",24,168,EMBO_Mol_Med_2013_Mar_21_5(3)_332-343.txt
16C>G,"...263X, E425X, L613F, L626Q, L626V, c.745C>A, c.228-16C>G, c.228-22T>A	Antonellis & Green (2008), Laba...",24,182,EMBO_Mol_Med_2013_Mar_21_5(3)_332-343.txt
22T>A,"...L613F, L626Q, L626V, c.745C>A, c.228-16C>G, c.228-22T>A	Antonellis & Green (2008), Labauge et al (20...",24,195,EMBO_Mol_Med_2013_Mar_21_5(3)_332-343.txt
3A>T,"...hy	6: L13RfsX3, R291K, I9V, R245Q, Q12R, c.1586 + 3A>T	Cassandrini et al (2013), Edvardson et al (20...",29,107,EMBO_Mol_Med_2013_Mar_21_5(3)_332-343.txt
8344A>G,"...field. Patients with a specific mtDNA mutation, m.8344A>G, show multiple symmetric lipomas, which ha...",129,112,EMBO_Mol_Med_2014_Jun_7_6(6)_721-731.txt
673C>T,"... found a homozygous nucleotide change in XRCC4 (c.673C>T), predicted to introduce a premature stop c...",9,796,EMBO_Mol_Med_2015_Jul_14_7(7)_918-929.txt
673C>T,"...e most severe variant was the nucleotide change c.673C>T in XRCC4. Two different isoforms of XRCC4, ...",88,679,EMBO_Mol_Med_2015_Jul_14_7(7)_918-929.txt
3243A>G,... mitochondrial disorder primarily caused by the m.3243A>G mutation in the mitochondrial DNA,52,146,EMBO_Mol_Med_2016_Apr_8_8(4)_311-327.txt
3243A>G,Bezafibrate	MD (Confirmed mt.3243A>G mutation)	Open‐label phase 2 feasibility s...,182,30,EMBO_Mol_Med_2016_Apr_8_8(4)_311-327.txt
3243A>G,...eled phase 2 study on patients carrying the mtDNA 3243A>G mutation. The latter mutation is one of th...,207,572,EMBO_Mol_Med_2016_Apr_8_8(4)_311-327.txt
3243A>G,(2014 ) Serum FGF21 levels in adult m.3243A>G carriers: clinical implications . Neurolog...,1757,40,EMBO_Mol_Med_2016_Apr_8_8(4)_311-327.txt
3243A>G,"...strain, but not to disease progression in adult m.3243A>G carriers . JIMD Rep",1791,138,EMBO_Mol_Med_2016_Apr_8_8(4)_311-327.txt
3243A>G,(2011 ) Phenotypic spectrum of m.3243A>G mitochondrial DNA mutation in children . A...,2341,35,EMBO_Mol_Med_2016_Apr_8_8(4)_311-327.txt
320C>T,c.320C>T	p.Ser107Leu	Ig-like C2-type 1 domain	Diseas...,140,4,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
1342C>T,c.1342C>T	p.Arg448Trp	Juxta-membrane domain	Disease-...,144,4,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
2314C>T,c.2314C>T	p.Pro772Ser	C-terminal tail	Disease-causin...,147,4,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
2314C>T,c.2314C>T	p.Pro772Ser	C-terminal tail	Disease-causin...,150,4,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
253C>T,c.253C>T	p.Arg85Cys	First intracellular loop	Disease...,153,4,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
743G>A,c.743G>A	p.Arg248Glu	Third intracellular loop	Polymo...,156,4,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
1157C>A,...1) gene revealed two novel genetic alterations: c.1157C>A (p.Ala386Glu) in exon 7 and c.1412T>G (p.L...,57,964,Endocrinol_Diabetes_Metab_Case_Rep_2015_Aug_7_2015_150074.txt
1412T>G,...erations: c.1157C>A (p.Ala386Glu) in exon 7 and c.1412T>G (p.Leu471Arg) in exon 9 (Fig. 1) Targeted ...,57,1002,Endocrinol_Diabetes_Metab_Case_Rep_2015_Aug_7_2015_150074.txt
554G>A,"...ewborn period	18 months	Inherited, heterozygous c.554G>A (R185Q)	Saline, phosphate, and cholecalcife...",110,139,Endocrinol_Diabetes_Metab_Case_Rep_2015_Jun_18_2015_150040.txt
554G>A,"De novo heterozygous c.554G>A (R185Q)	Saline, furosemide, and pamidronate...",114,24,Endocrinol_Diabetes_Metab_Case_Rep_2015_Jun_18_2015_150040.txt
206G>A,"... mg daily	6 years	6 years	Inherited, homozygous c.206G>A (R69H)	Pamidronate, phosphate, hydration	Gr...",117,89,Endocrinol_Diabetes_Metab_Case_Rep_2015_Jun_18_2015_150040.txt
554G>A,"De novo heterozygous c.554G>A (R185Q)	Saline, low calcium formula, phosph...",119,24,Endocrinol_Diabetes_Metab_Case_Rep_2015_Jun_18_2015_150040.txt
554G>A,"De novo heterozygous c.554G>A (R185Q)	Saline, low calcium formula, and ph...",121,24,Endocrinol_Diabetes_Metab_Case_Rep_2015_Jun_18_2015_150040.txt
2753T>C,"...our case a somatic RET mutation in exon 16 (RET c.2753T>C, p.Met918Thy) was detected by targeted nex...",4,1180,Endocrinol_Diabetes_Metab_Case_Rep_2016_Jan_18_2016_150117.txt
2753T>C,"...revealed a somatic RET mutation in exon 16 (RET c.2753T>C, p.Met918Thy), further validated by Sanger...",31,237,Endocrinol_Diabetes_Metab_Case_Rep_2016_Jan_18_2016_150117.txt
444C>A,...tified two de novo heterozygous mutations (STAR c.444C>A (STAR p.N148K) and STAR c.557C>T (STAR p.R1...,4,889,Endocrinol_Diabetes_Metab_Case_Rep_2016_Mar_2_2016_150119.txt
557C>T,"...utations (STAR c.444C>A (STAR p.N148K) and STAR c.557C>T (STAR p.R193X)) in the STAR gene, causing l...",4,922,Endocrinol_Diabetes_Metab_Case_Rep_2016_Mar_2_2016_150119.txt
4154A>T,"...ovel heterozygous ABCC8 gene missense mutation (c.4154A>T/ p.Lys1385Thr), who was initially responsi...",4,564,Endocrinol_Diabetes_Metab_Case_Rep_2016_Oct_25_16-0043.txt
4154A>T,...or a novel missense mutation in the ABCC8 gene (c.4154A>T/p.Lys1385Thr). Since the lysine residue is...,31,386,Endocrinol_Diabetes_Metab_Case_Rep_2016_Oct_25_16-0043.txt
1621G>A,...g peripheral leukocytes revealed a heterozygous c.1621G>A mutation in the MEN1 gene that was previou...,10,72,Endocrinol_Metab_(Seoul)_2014_Jun_26_29(2)_146-153.txt
1621G>A,"... direct DNA sequencing, we found a heterozygous c.1621G>A (Ala541Thr) mutation at exon 10 of the MEN...",56,93,Endocrinol_Metab_(Seoul)_2014_Jun_26_29(2)_146-153.txt
1621G>A,"...identified [9]. In this patient, a heterozygous c.1621G>A (Ala541Thr) mutation was found on exon 10,...",63,588,Endocrinol_Metab_(Seoul)_2014_Jun_26_29(2)_146-153.txt
1621G>A,...yPhen-2 report indicates that the heterogeneous c.1621G>A (Ala541Thr) mutation is predicted to be be...,86,201,Endocrinol_Metab_(Seoul)_2014_Jun_26_29(2)_146-153.txt
9          C>*,"C+~~CI9          C>*,4 C         O",764,7,Environ_Health_Perspect_1977_Dec_21_285-292.txt
1       C>G,SM23.1   25H11     7.1       C>G 74a                                   ...,688,22,Environ_Health_Perspect_1993_Apr_22_101(1)_68-74.txt
4       C>G,SM54.1   77B5     16.4       C>G 74a                                   ...,689,22,Environ_Health_Perspect_1993_Apr_22_101(1)_68-74.txt
9       C>T,SM25.1   49A1      6.9       C>T 74                                    ...,690,22,Environ_Health_Perspect_1993_Apr_22_101(1)_68-74.txt
2                   T>G,SF15.1   43A8     16.2                   T>G 146                       ...,696,22,Environ_Health_Perspect_1993_Apr_22_101(1)_68-74.txt
0                   G>T,SF9.1    33A10     7.0                   G>T 197                       ...,697,22,Environ_Health_Perspect_1993_Apr_22_101(1)_68-74.txt
8                   G>A,NM28.1   24E7      3.8                   G>A 197                       ...,698,22,Environ_Health_Perspect_1993_Apr_22_101(1)_68-74.txt
1                   G>A,SM5.1    14B6      2.1                   G>A 208                       ...,699,22,Environ_Health_Perspect_1993_Apr_22_101(1)_68-74.txt
6                   C>G,NF13.1   33G8      6.6                   C>G 2228                      ...,700,22,Environ_Health_Perspect_1993_Apr_22_101(1)_68-74.txt
5                   T>C,SF6.1     14E1     7.5                   T>C 233                       ...,701,22,Environ_Health_Perspect_1993_Apr_22_101(1)_68-74.txt
6                                            G>A,NM19.1   34F5      4.6                                            G>A 4...,704,22,Environ_Health_Perspect_1993_Apr_22_101(1)_68-74.txt
9                                                       A>T,SM40.1   59F3     15.9                                                 ...,706,22,Environ_Health_Perspect_1993_Apr_22_101(1)_68-74.txt
0                                                       T>A,NM27.1   9H9       7.0                                                 ...,707,22,Environ_Health_Perspect_1993_Apr_22_101(1)_68-74.txt
8                                                       T>A,NM11.1   55G2      8.8                                                 ...,708,22,Environ_Health_Perspect_1993_Apr_22_101(1)_68-74.txt
5                                                       T>G,SM52.1   18F6     14.5                                                 ...,709,22,Environ_Health_Perspect_1993_Apr_22_101(1)_68-74.txt
1                                                                    C>G,NF9.1    34H3      5.1                                                 ...,712,22,Environ_Health_Perspect_1993_Apr_22_101(1)_68-74.txt
8                                                                    C>T,NF4.1    24F5     11.8                                                 ...,714,22,Environ_Health_Perspect_1993_Apr_22_101(1)_68-74.txt
2                                                                    G>T,NM32.1   47H11     5.2                                                 ...,715,22,Environ_Health_Perspect_1993_Apr_22_101(1)_68-74.txt
4                                                                               C>G,SM26.1   59B3     10.4                                                 ...,716,22,Environ_Health_Perspect_1993_Apr_22_101(1)_68-74.txt
2                                                                               C>G,NF14.1   48D6      3.2                                                 ...,717,22,Environ_Health_Perspect_1993_Apr_22_101(1)_68-74.txt
5                                                                               T>A,SM19.1   17B6     12.5                                                 ...,718,22,Environ_Health_Perspect_1993_Apr_22_101(1)_68-74.txt
4                                                                               G>C,NF15.1   27A7      7.4                                                 ...,719,22,Environ_Health_Perspect_1993_Apr_22_101(1)_68-74.txt
3                                                                               G>C,NM44.1   68B3     11.3                                                 ...,720,22,Environ_Health_Perspect_1993_Apr_22_101(1)_68-74.txt
4                                                                                          G>A,SF21.1   35D8      7.4                                                 ...,721,22,Environ_Health_Perspect_1993_Apr_22_101(1)_68-74.txt
1                                                                                          G>T,NF32.1   49B11     3.1                                                 ...,723,22,Environ_Health_Perspect_1993_Apr_22_101(1)_68-74.txt
299G>A,...orphism in ALAD at an Msp1 site in intron 2 (IVS2+299G>A,137,86,Environ_Health_Perspect_2003_Aug_111(10)_1335-1339.txt
299G > A,ALAD IVS2 + 299G > A 1-1 1-2 2-2 Tota,296,13,Environ_Health_Perspect_2003_Aug_111(10)_1335-1339.txt
299G > A,ALAD IVS2+299G >,308,11,Environ_Health_Perspect_2003_Aug_111(10)_1335-1339.txt
299G>A,sizes for ALAD IVS2+299G>A were 160 b,347,21,Environ_Health_Perspect_2003_Aug_111(10)_1335-1339.txt
299G>A,phism by ALAD IVS2+299G>A and its alle,356,20,Environ_Health_Perspect_2003_Aug_111(10)_1335-1339.txt
299G > A,IVS2+299G > A in either cases (p = 0.3) o,362,6,Environ_Health_Perspect_2003_Aug_111(10)_1335-1339.txt
299G>A,ALAD IVS2+299G>A genotype. W,397,11,Environ_Health_Perspect_2003_Aug_111(10)_1335-1339.txt
299G>A,equilibrium for the two ALAD IVS2+299G>,399,35,Environ_Health_Perspect_2003_Aug_111(10)_1335-1339.txt
299G > A,ALAD K59N ALAD IVS2+299G > A VD,467,21,Environ_Health_Perspect_2003_Aug_111(10)_1335-1339.txt
299G>A,"Nor is it clear why ALAD IVS2+299G>A, a",588,31,Environ_Health_Perspect_2003_Aug_111(10)_1335-1339.txt
1639G>A,"...tant polymorphic variants of the VKORC1 gene are -1639G>A (rs9923231) in the promoter region, 1173C>...",60,67,EPMA_J_2012_Sep_27_3(1)_10.txt
1173C>T,"... are -1639G>A (rs9923231) in the promoter region, 1173C>T (rs9934438), 1542G>C (rs8050894), 2255T>C ...",60,111,EPMA_J_2012_Sep_27_3(1)_10.txt
1542G>C,"...231) in the promoter region, 1173C>T (rs9934438), 1542G>C (rs8050894), 2255T>C (rs2359612), 3730G>A ...",60,132,EPMA_J_2012_Sep_27_3(1)_10.txt
2255T>C,"...region, 1173C>T (rs9934438), 1542G>C (rs8050894), 2255T>C (rs2359612), 3730G>A (rs7294) in introns, ...",60,153,EPMA_J_2012_Sep_27_3(1)_10.txt
3730G>A,"...34438), 1542G>C (rs8050894), 2255T>C (rs2359612), 3730G>A (rs7294) in introns, and 3′-untranslated r...",60,174,EPMA_J_2012_Sep_27_3(1)_10.txt
1173C>T,...73 in the VKORC1 gene. The authors concluded that 1173C>T may be in linkage disequilibrium with othe...,80,268,EPMA_J_2012_Sep_27_3(1)_10.txt
1639G>A,[20]. Yuan et al. showed that -1639G>A can be that varian,81,32,EPMA_J_2012_Sep_27_3(1)_10.txt
1639G>A,...iduals with the GG genotype of polymorphic locus -1639G>A require a higher dose of warfarin can be e...,91,70,EPMA_J_2012_Sep_27_3(1)_10.txt
1639G>A,"... of Wadelius et al., three polymorphic variants (−1639G>A (rs9923231), 1173C>T (rs9934438), and 2255...",94,63,EPMA_J_2012_Sep_27_3(1)_10.txt
1173C>T,"...three polymorphic variants (−1639G>A (rs9923231), 1173C>T (rs9934438), and 2255T>C (rs2359612)) appe...",94,84,EPMA_J_2012_Sep_27_3(1)_10.txt
2255T>C,"...s (−1639G>A (rs9923231), 1173C>T (rs9934438), and 2255T>C (rs2359612)) appeared to be the most impor...",94,109,EPMA_J_2012_Sep_27_3(1)_10.txt
1639G>A,...ion is shown to be 0.391 for polymorphic variant -1639G>A. The coefficient of determination (R2) cal...,94,344,EPMA_J_2012_Sep_27_3(1)_10.txt
12970C>G,"... < 0.05). In this study, polymorphic substitution 12970C>G explained 2% variability in warfarin dose...",140,831,EPMA_J_2012_Sep_27_3(1)_10.txt
11676382 C>G,... later study of King et al. in 2010 showed that rs11676382 C>G significantly influenced warfarin dos...,147,52,EPMA_J_2012_Sep_27_3(1)_10.txt
12714145 G>A,"...G significantly influenced warfarin dose, while rs12714145 G>A did not. Among 985 White race and Afr...",147,113,EPMA_J_2012_Sep_27_3(1)_10.txt
1799809 A>G,...re significantly associated with warfarin dose: rs1799809 A>G (MAF = 0.433) and rs2069901 T>C (MAF =...,154,158,EPMA_J_2012_Sep_27_3(1)_10.txt
2069901 T>C,... warfarin dose: rs1799809 A>G (MAF = 0.433) and rs2069901 T>C (MAF = 0.441) in the 5′-regulatory reg...,154,190,EPMA_J_2012_Sep_27_3(1)_10.txt
2069910 C>T,"...F = 0.441) in the 5′-regulatory region of PROC, rs2069910 C>T (MAF = 0.387) in intron 2, and rs20699...",154,255,EPMA_J_2012_Sep_27_3(1)_10.txt
2069919 G>A,"...C, rs2069910 C>T (MAF = 0.387) in intron 2, and rs2069919 G>A in intron 3 (MAF = 0.372). Two polymor...",154,300,EPMA_J_2012_Sep_27_3(1)_10.txt
402G>A,...ion in the FVII gene promoter in the position of -402G>A (rs570317) leads to the increase in the tra...,162,82,EPMA_J_2012_Sep_27_3(1)_10.txt
13407G>A,"...he enhanced level of FVII in plasma. Substitution 13407G>A (R353Q, rs6046) in the coding region of t...",162,203,EPMA_J_2012_Sep_27_3(1)_10.txt
1639G>A,"...l in experiments in China showed that the VKORC1 -1639G>A, alleles CYP2C9 and EPHX1 691A>G, as well ...",208,79,EPMA_J_2012_Sep_27_3(1)_10.txt
691A>G,"...hat the VKORC1 -1639G>A, alleles CYP2C9 and EPHX1 691A>G, as well as age and body mass, explained ap...",208,113,EPMA_J_2012_Sep_27_3(1)_10.txt
1639G>A,"On the whole, the combination of VKORC1 -1639G>A, CYP2C9 (*2 and *3), and clinical factors ...",211,42,EPMA_J_2012_Sep_27_3(1)_10.txt
1639G>A,"...n L Zhong QJ Wang XF Hao J Chen BC Chen JJ VKORC1-1639G>A, CYP2C9, EPHX1691A>G genotype, body weight...",320,85,EPMA_J_2012_Sep_27_3(1)_10.txt
1691A>G,"...Hao J Chen BC Chen JJ VKORC1-1639G>A, CYP2C9, EPHX1691A>G genotype, body weight, and age are importa...",320,106,EPMA_J_2012_Sep_27_3(1)_10.txt
582T>A,"...rmore, two other TMPRSS3 mutations (NM_024022.2:c.582T>A; NP_076927.1:p.C194* and NM_024022.2:c.581G...",10,979,Eur_Arch_Otorhinolaryngol_2016_Sep_25_273_1327-1328.txt
581G>T,...2:c.582T>A; NP_076927.1:p.C194* and NM_024022.2:c.581G>T; NP_076927.1:p.C194F) were detected in the ...,10,1025,Eur_Arch_Otorhinolaryngol_2016_Sep_25_273_1327-1328.txt
3243A>G,The m.3243A>G mutation is present in ∼1 in 300 of the ge...,39,7,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
3243A>G,"to the m.3243A>G mutation, while sudden death, often with a...",51,10,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
1555A>G,phenotype reported in association with the m.1555A>G mt-rRNA gene mutation is,220,46,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
3243A>G, MTTL1	m.3243A>G	++	+	++	+	+	+	−,236,10,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
4300A>G, MTTI	m.4300A>G	−	−	++	+	−	−	−,237,9,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
8344A>G, MTTK	m.8344A>G	++	+	++	++	−	−	+,238,9,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
11778G>A, MTND4	m.11778G>A	++	−	+	−	−	−	−,239,10,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
1555A>G, MTRNR1	m.1555A>G	−	−	−	−	+	−	−,242,11,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
1624C>T, MTTV	m.1624C>T	−	−	+	+	−	−	−,243,9,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
3252T>C, MTTL1	m.3252T>C	−	+	−	+	−	−	−,244,10,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
3260A>G,m.3260A>G	+	−	+	+	−	−	−,245,3,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
3303T>C,m.3303T>C	−	+	+	+	−	−	−,246,3,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
3337G>A, MTND1	m.3337G>A	−	−	+	+	−	−	−,247,10,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
3460G>A,m.3460G>A	+	−	+	−	−	+	−,248,3,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
4269A>G, MTTI	m.4269A>G	−	−	−	+	−	−	−,249,9,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
4277T>C,m.4277T>C	−	−	+	−	−	−	−,250,3,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
4284G>A,m.4284G>A	−	+	+	+	−	−	−,251,3,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
4317A>G,m.4317A>G	−	−	+	+	−	−	−,252,3,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
4320C>T,m.4320C>T	−	−	+	−	−	−	−,253,3,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
8363G>A, MTTK	m.8363G>A	−	−	+	+	−	−	−,254,9,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
8528T>C, MTATP8/MTATP6	m.8528T>C	−	−	+	−	−	−	−,255,18,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
8529G>A,m.8529G>A	−	−	+	−	−	−	−,256,3,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
8993T>G, MTATP6	m.8993T>G	−	−	+	−	−	−	−,257,11,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
9997T>C, MTTG	m.9997T>C	−	−	+	−	−	−	−,258,9,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
11778A>G, MTND4	m.11778A>G	−	−	−	+	−	−	−,259,10,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
12297T>C, MTTL2	m.12297T>C	−	−	−	+	−	−	−,260,10,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
13513G>A, MTND5	m.13513G>A	+	+	−	−	−	−	−,261,10,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
14484T>C, MTND6	m.14484T>C	−	−	−	+	−	−	−,262,10,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
14849T>C, MTCYB	m.14849T>C	−	−	+	−	−	−	−,263,10,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
15498G>A,m.15498G>A	−	−	−	−	−	−	+,264,3,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
3243A>G,m.3243A>G mutation and have revealed a correlation b...,307,3,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
8344A>G,"several mt-tRNA genes (e.g. m.8344A>G in MTTK, m.4269A>",311,31,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
4269A>G,"several mt-tRNA genes (e.g. m.8344A>G in MTTK, m.4269A>",311,50,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
4317A>G,and m.4317A>G in MTTI) and infrequent polypeptide genes ...,312,7,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
8993T>G,m.8993T>G in MTATP6 and m.8528T>C in th,313,3,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
8528T>C,m.8993T>G in MTATP6 and m.8528T>C in th,313,27,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
4300A>G,"...ients with cardiac disease.9,14 The homoplasmic m.4300A>",321,54,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
3243A>G,m.3243A>G mutation.2,333,3,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
3243A>G,reported in patients with LVH and the m.3243A>G or m.8344A>,335,41,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
8344A>G,...orted in patients with LVH and the m.3243A>G or m.8344A>,335,54,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
8344A>G,"...e, while a recent study of 18 patients with the m.8344A>",343,71,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
3243A>G,"mt-tRNA point mutations, including m.3243A>G, m.4269A>G, an",346,38,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
4269A>G,"mt-tRNA point mutations, including m.3243A>G, m.4269A>G, an",346,49,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
4317A>G,"m.4317A>G,45,46,48 and appears to be an infrequent a...",347,3,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
3243A>G,diabetes due to the m.3243A>G mutation55 and as the only clinical findin...,362,23,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
1555A>G,m.1555A>G mutation.2,363,3,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
3398T>C,m.3398T>C MTND1 variant and LVNC supports the assert...,374,3,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
8344A>G,"...mal mitochondria,61 and have been linked to the m.8344A>",379,92,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
3243A>G,"with the m.3243A>G and m.8344A>G mutations.25,2",391,12,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
8344A>G,"with the m.3243A>G and m.8344A>G mutations.25,2",391,26,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
8344A>G,...re-excitation occurring in association with the m.8344A>,412,75,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
3243A>G,"and m.3243A>G mutations, where manifest pre-excitation w...",413,7,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
3243A>G,"mutations (e.g. 3243A>G, m.4300A>G) in specific clinical scenarios...",446,17,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
4300A>G,"mutations (e.g. 3243A>G, m.4300A>G) in specific clinical scenarios. I",446,28,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
3243A>G,...rgetics have been demonstrated in patients with m.3243A>G mutation an,539,57,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
3243A>G,...Majamaa K   Causes of death in pedigrees with the 3243A>G mutation i,639,108,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
3243A>G,... 3-year clinical follow-up of adult patients with 3243A>G i,641,310,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
4277T>C,m.4277T>C mitochondrial tRNAIle mutation causing hyp...,652,3,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
8344A>G,...ac involvement is frequent in patients with the m.8344A>,671,161,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
3243A>G,3243A>G BMC Cardiovasc Disord 2002 2 12 doi:10.118...,678,1,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
3243A>G,...leijnse ML   Cardiac involvement in adults with m.3243A>G MELAS gen,705,180,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
88068052C > A,...lymorphisms (SNPs) within intron 2 at position g. 88068052C > A [Figure 3a] and intron 5 at position...,40,879,Eur_J_Dent_2014_Jan-Mar_8(1)_79-84.txt
88033661T > C,...8052C > A [Figure 3a] and intron 5 at position g. 88033661T > C [Figure 3b] in homozygous condition,40,933,Eur_J_Dent_2014_Jan-Mar_8(1)_79-84.txt
88068052C > A,...2 and intron 5. (a) SNP in intron 2 at position g.88068052C > A (indicated by a black downward arrow...,44,142,Eur_J_Dent_2014_Jan-Mar_8(1)_79-84.txt
88033661T > C,...ownward arrow); (b) SNP in intron 5 at position g.88033661T > C (indicated by a black downward arrow...,44,229,Eur_J_Dent_2014_Jan-Mar_8(1)_79-84.txt
88068052C > A,...g parent also identified SNPs within intron 2 (g. 88068052C > A) and intron 5 (g. 88033661T > C). Ac...,53,162,Eur_J_Dent_2014_Jan-Mar_8(1)_79-84.txt
88033661T > C,...thin intron 2 (g. 88068052C > A) and intron 5 (g. 88033661T > C). According to the SNP database of N...,53,194,Eur_J_Dent_2014_Jan-Mar_8(1)_79-84.txt
521T>C,...er explore the effect of ursolic acid on OATP1B1 (521T>C)-mediated transport of rosuvastatin. When t...,4,911,Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.txt
521T>C,...lymorphisms and some studies showed that OATP1B1 (521T>C) had significantly effect on the pharmacoki...,18,73,Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.txt
521T>C,...er explore the effect of ursolic acid on OATP1B1 (521T>C)-mediated transport of rosuvastatin. This s...,24,534,Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.txt
521T>C,...the SNPs were different at different races. The c.521T>C (p.Val174Ala) SNP and c.388A>G (p.Asn130Asp...,148,189,Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.txt
388A>G,...erent races. The c.521T>C (p.Val174Ala) SNP and c.388A>G (p.Asn130Asp) SNP were the common mutation ...,148,220,Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.txt
521T>C,"... found in more and more studies. Specially, the c.521T>C (p.Val174Ala) SNP has been associated with ...",150,115,Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.txt
521T>C,...icant differences between OATP1B1 mutation in the 521T>C and wild-type homozygote for rosuvastatin p...,152,342,Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.txt
521T>C,Although OATP1B1 521T>C has significant effect on the pharmacokinet...,154,18,Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.txt
521T>C,...r the same result could be presented that OATP1B1 521T>C had significant effect on the transport of ...,158,161,Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.txt
521 T>C,...*1a-HEK293T (P < 0.05). Gene mutation of OATP1B1 (521 T>C) may decrease its transport capacity. Howe...,160,806,Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.txt
388A>G,The c.388A>G and the c.521T>C variants occur in alleles ...,162,7,Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.txt
521T>C,The c.388A>G and the c.521T>C variants occur in alleles of OATP1B1*15. It...,162,24,Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.txt
521T>C,...i SM  Wen JH  Li XH  Xiong YQ   Effect of OATP1B1 521T>C heterogenesis on pharmacokinetic characteri...,202,53,Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.txt
421C>A,... Yu BN  He YJ  Fan L  Li Q  Liu ZQ   Role of BCRP 421C>A polymorphism on rosuvastatin pharmacokineti...,208,59,Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.txt
521T>C,...sly described association between the rs4149056 c.521T>C polymorphism in the solute carrier organic ...,422,229,Eur_J_Epidemiol_2015_Sep_19_30_661-708.txt
521T>C,... LE  Uitterlinden AG  Klungel OH    The SLCO1B1 c.521T>C polymorphism is associated with dose decrea...,974,98,Eur_J_Epidemiol_2015_Sep_19_30_661-708.txt
1G>T,"...(LOF) single-nucleotide polymorphisms (SNP; c.151+1G>T, c.946G>A, c.1096C>G, c.1513A>C and c.1729T>A...",3,1993,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
946G>A,"...ngle-nucleotide polymorphisms (SNP; c.151+1G>T, c.946G>A, c.1096C>G, c.1513A>C and c.1729T>A) and on...",3,2001,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
1096C>G,"...otide polymorphisms (SNP; c.151+1G>T, c.946G>A, c.1096C>G, c.1513A>C and c.1729T>A) and one gain-of-...",3,2011,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
1513A>C,"...orphisms (SNP; c.151+1G>T, c.946G>A, c.1096C>G, c.1513A>C and c.1729T>A) and one gain-of-function SN...",3,2022,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
1729T>A,"... c.151+1G>T, c.946G>A, c.1096C>G, c.1513A>C and c.1729T>A) and one gain-of-function SNP (c.489C>T). ...",3,2036,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
489C>T,...>C and c.1729T>A) and one gain-of-function SNP (c.489C>T). The purpose of this study was to determin...,3,2077,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
1513A>C,"...ts on P2X7R function.32 The most common variant c.1513A>C, produces an amino acid change at position...",18,231,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
1729T>A,"...lloproteinase-9 from macrophages.17, 33, 34 The c.1729T>A variant (p.I568N) abolishes trafficking of...",18,509,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
946G>A,"...king of the receptor to the cell surface,35 the c.946G>A variant (p.Arg307Gln) abolishes ATP binding...",18,602,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
1096C>G,"...ing to the extracellular domain of P2X7R,36 the c.1096C>G variant (p.Thr357Ser) results in reduced p...",18,699,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
1G>T,...tion of P2X7R expression32 and the intronic c.151+1G>T variant results in a null allele.37 The effec...,18,843,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
489C>T,"...variants results in ablated ATP response.37 The c.489C>T variant (p.His155Tyr), located in the extra...",18,1172,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
1G>T,"...r more minor allele for a LOF SNP at either c.151+1G>T, c.946G>A, c.1096C>G, c.1513A>C or c.1729T>A ...",34,73,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
946G>A,"...inor allele for a LOF SNP at either c.151+1G>T, c.946G>A, c.1096C>G, c.1513A>C or c.1729T>A while ha...",34,81,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
1096C>G,"...e for a LOF SNP at either c.151+1G>T, c.946G>A, c.1096C>G, c.1513A>C or c.1729T>A while having major...",34,91,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
1513A>C,"... SNP at either c.151+1G>T, c.946G>A, c.1096C>G, c.1513A>C or c.1729T>A while having major alleles at...",34,102,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
1729T>A,"...r c.151+1G>T, c.946G>A, c.1096C>G, c.1513A>C or c.1729T>A while having major alleles at the other po...",34,115,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
1G>T,"Overall, SNP call rates were 97% for c.151+1G>T (rs35933842), c.946G>A (rs28360457), c.1096C>...",41,44,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
946G>A,"...all rates were 97% for c.151+1G>T (rs35933842), c.946G>A (rs28360457), c.1096C>G (rs2230911) and c.1...",41,65,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
1096C>G,"...c.151+1G>T (rs35933842), c.946G>A (rs28360457), c.1096C>G (rs2230911) and c.1729T>A (rs1653624) and ...",41,88,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
1729T>A,"....946G>A (rs28360457), c.1096C>G (rs2230911) and c.1729T>A (rs1653624) and 95% for c.489C>T (rs208294...",41,114,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
489C>T,...s2230911) and c.1729T>A (rs1653624) and 95% for c.489C>T (rs208294) and c.1513A>C (rs3751143). Table...,41,148,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
1513A>C,...(rs1653624) and 95% for c.489C>T (rs208294) and c.1513A>C (rs3751143). Table 2 shows the predicted a...,41,172,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
946G>A,P2RX7 c.946G>A (p.Arg307Gln) SNP is associated with lower ...,43,9,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
946G>A,...x previously published P2RX7 SNPs revealed that c.946G>A (p.Arg307Gln) was significantly associated ...,44,69,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
946G>A,...hange in LS-BMD did not differ significantly by c.946G>A genotype (−0.39%/year (SEM 0.06) for GG sub...,44,737,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
946G >A,"...) for GA subjects (P=0.7)), suggesting that the c.946G >A may be exerting effects on bone mass at an...",44,868,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
1G>T,"...n=84), subjects who had a LOF SNP at either c.151+1G>T, c.G946A, c.1096C>G, c.1513A>C or c.1729T>A (...",47,141,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
1096C>G,"...ho had a LOF SNP at either c.151+1G>T, c.G946A, c.1096C>G, c.1513A>C or c.1729T>A (n=48) had almost ...",47,158,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
1513A>C,"...F SNP at either c.151+1G>T, c.G946A, c.1096C>G, c.1513A>C or c.1729T>A (n=48) had almost ninefold gr...",47,169,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
1729T>A,"...er c.151+1G>T, c.G946A, c.1096C>G, c.1513A>C or c.1729T>A (n=48) had almost ninefold greater annuali...",47,182,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
1513A>C,"...dorff et al22 demonstrated that two P2RX7 SNPs, c.1513A>C (p.Glu496Ala) and c.1729T>A (p.I568N), are...",50,862,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
1729T>A,"...hat two P2RX7 SNPs, c.1513A>C (p.Glu496Ala) and c.1729T>A (p.I568N), are associated with an increase...",50,890,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
946G>A,"...an association of a major LOF SNP in P2RX7, the c.946G>A (p.Arg307Gln), with low BMD in the LS in po...",52,80,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
946G>A,...nding effects on bone loss or baseline BMD. The c.946G>A polymorphism changes arginine to glutamine ...,52,608,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
946G>A,"...rmeability studies of subjects heterozygous for c.946G>A (Figure 1 in Gu et al, 200436) show complet...",52,981,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
946G>A,"... on function even in heterozygous dosage. Thus, c.946G>A may be classified as a dominant-negative po...",52,1175,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
946G>A,"...e turnover. Indeed, the profound effects of the c.946G>A SNP on bone are further highlighted and rep...",52,1342,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
946G>A,...und that subjects who were heterozygous for the c.946G>A (Arg307Gln variant) had >40% greater bone l...,52,1503,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
946G>A,...ith total hip replacement revision and that the c.946G>A allele increased cumulative hazard of total...,52,1877,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
1G>T,"...evision.46 In our study, heterozygosity for c.151+1G>T that leads to one null allele37 had no impact...",52,1995,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
1513A>C,"..., while neither of the most prevalent variants, c.1513A>C, nor c.1729T>A polymorphisms alone showed ...",52,2105,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
1729T>A,"... of the most prevalent variants, c.1513A>C, nor c.1729T>A polymorphisms alone showed any significant...",52,2120,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
946G>A,...acture risk. As the observed effect size of the c.946G>A is quiet large (β=0.12) compared with previ...,60,180,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
946G>A,"...mine rare genetic variants, including the P2RX7 c.946G>A, which has a population frequency of around...",60,851,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
1G>T,rs35933842	c.151+1G>T	0.01	1.00 (0.01)	0.98 (0.04)	*	0.4	−0.003,88,18,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
489C>T,rs208294	c.489C>T (p.H155Y)	0.43	0.99 (0.01)	1.01 (0.01)	1.00...,89,12,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
946G>A,rs28360457	c.946G>A (p.R307Q)	0.02	1.00 (0.01)	0.88 (0.03)	*	0....,90,14,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
1096C>G,rs2230911	c.1096C>G (p.T357S)	0.07	1.00 (0.01)	1.03 (0.02)	1.0...,91,13,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
1513A>C,rs3751143	c.1513A>C (p.E496A)	0.17	1.00 (0.01)	1.00 (0.02)	1.0...,92,13,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
1729T>A,rs1653624	c.1729T>A (p.I568N)	0.02	1.00 (0.01)	0.99 (0.03)	1.2...,93,13,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
1G>T,rs35933842	c.151+1G>T	0.01	0.97 (0.01)	0.93 (0.03)	*	0.3	−0.041,105,18,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
489C>T,rs208294	c.489C>T (p.H155Y)	0.43	0.96 (0.01)	0.98 (0.01)	0.97...,106,12,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
946G>A,rs28360457	c.946G>A (p.R307Q)	0.02	0.97 (0.01)	0.84 (0.04)	*	0....,107,14,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
1096C>G,rs2230911	c.1096C>G (p.T357S)	0.07	0.97 (0.01)	0.98 (0.02)	1.0...,108,13,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
1513A>C,rs3751143	c.1513A>C (p.E496A)	0.17	0.97 (0.01)	0.97 (0.01)	0.9...,109,13,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
1729T>A,rs1653624	c.1729T>A (p.I568N)	0.02	0.97 (0.01)	0.93 (0.02)	1.2...,110,13,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
458C>T,...pecific. The most common identified to date are c.458C>T (p.(Pro153Leu))1 and c.913G>T (p.(Glu305*))...,21,477,Eur_J_Hum_Genet_2015_Sep_22_23(9)_doi_10_1038_ejhg_2014_226.txt
913G>T,"...ified to date are c.458C>T (p.(Pro153Leu))1 and c.913G>T (p.(Glu305*)),2 in individuals of European ...",21,507,Eur_J_Hum_Genet_2015_Sep_22_23(9)_doi_10_1038_ejhg_2014_226.txt
613C>T,"...*)),2 in individuals of European ethnicity, and c.613C>T (p.(Arg205Cys))3 and c.1498C>T (p.(Arg500*)...",21,574,Eur_J_Hum_Genet_2015_Sep_22_23(9)_doi_10_1038_ejhg_2014_226.txt
1498C>T,"...an ethnicity, and c.613C>T (p.(Arg205Cys))3 and c.1498C>T (p.(Arg500*)),4 in Japanese. In one case, ...",21,604,Eur_J_Hum_Genet_2015_Sep_22_23(9)_doi_10_1038_ejhg_2014_226.txt
560T>C,...plotype in which a variant occurs is important: c.560T>C (p.(Val187Ala)) has no effect on FMO3 activ...,21,710,Eur_J_Hum_Genet_2015_Sep_22_23(9)_doi_10_1038_ejhg_2014_226.txt
472G>A,...curs in cis with the common polymorphic variant c.472G>A (p.(Glu158Lys)) it severely affects enzyme ...,21,829,Eur_J_Hum_Genet_2015_Sep_22_23(9)_doi_10_1038_ejhg_2014_226.txt
183C>A,"...MO3 have been identified.10 Of these, only one, c.183C>A (p.(Asn61Lys)), which occurs at low frequen...",21,1213,Eur_J_Hum_Genet_2015_Sep_22_23(9)_doi_10_1038_ejhg_2014_226.txt
472G>A,"...owever, some polymorphic variants, for example, c.472G>A (p.(Glu158Lys)) and c.923A>G (p.(Glu308Gly)...",21,1370,Eur_J_Hum_Genet_2015_Sep_22_23(9)_doi_10_1038_ejhg_2014_226.txt
923A>G,"...ants, for example, c.472G>A (p.(Glu158Lys)) and c.923A>G (p.(Glu308Gly)), when present in cis, can c...",21,1399,Eur_J_Hum_Genet_2015_Sep_22_23(9)_doi_10_1038_ejhg_2014_226.txt
5109G>C,"...in vitro,17 a consequence of the presence of a g.−5109G>C SNP variant. Although none of the four hap...",21,2063,Eur_J_Hum_Genet_2015_Sep_22_23(9)_doi_10_1038_ejhg_2014_226.txt
1G>A,"...ion of variants. For example, the well-known 1717-1G>A and 3120+1G>A variants (legacy names) are des...",20,1141,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1G>A,"...s. For example, the well-known 1717-1G>A and 3120+1G>A variants (legacy names) are designated as c.1...",20,1155,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1G>A,"... variants (legacy names) are designated as c.1585-1G>A and c.2988+1G>A, respectively, according to t...",20,1209,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1G>A,"...y names) are designated as c.1585-1G>A and c.2988+1G>A, respectively, according to the HGVS nomencla...",20,1225,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1624G>T, G542X	c.1624G>T	p.Gly542*,162,10,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1652G>A, G551D	c.1652G>A	p.Gly551Asp,163,10,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
3909C>G, N1303K	c.3909C>G	p.Asn1303Lys,164,11,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
3846G>A, W1282X	c.3846G>A	p.Trp1282*,165,11,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1G>T, 621+1G>T	c.489+1G>T	 ,166,6,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1G>T, 621+1G>T	c.489+1G>T	 ,166,17,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
178G>T, E60X	c.178G>T	p.Glu60*,168,9,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
254G>A, G85E	c.254G>A	p.Gly85Glu,169,9,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1G>T, 711+1G>T	c.579+1G>T	 ,171,6,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1G>T, 711+1G>T	c.579+1G>T	 ,171,17,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1040G>C, R347P	c.1040G>C	p.Arg347Pro,172,10,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1364C>A, A455E	c.1364C>A	p.Ala455Glu,173,10,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1477C>T, Q493X	c.1477C>T	p.Gln493*,174,10,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1657C>T, R553X	c.1657C>T	p.Arg553*,176,10,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1679G>C, R560T	c.1679G>C	p.Arg560Thr,177,10,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1G>A, 1898+1G>A	c.1766+1G>A	 ,178,7,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1G>A, 1898+1G>A	c.1766+1G>A	 ,178,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
5G>A, 2789+5G>A	c.2657+5G>A	 ,180,7,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
5G>A, 2789+5G>A	c.2657+5G>A	 ,180,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1G>A, 3120+1G>A	c.2988+1G>A	 ,181,7,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1G>A, 3120+1G>A	c.2988+1G>A	 ,181,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
3484C>T, R1162X	c.3484C>T	p.Arg1162*,183,11,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
115C>T, Q39X	c.115C>T	p.Gln39*,186,9,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
200C>T, P67L	c.200C>T	p.Pro67Leu,187,9,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
223C>T, R75X	c.223C>T	p.Arg75*,188,9,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1G>A, 405+1G>A	c.273+1G>A	 ,189,6,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1G>A, 405+1G>A	c.273+1G>A	 ,189,17,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1G>A, 406-1G>A	c.274-1G>A	 ,190,6,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1G>A, 406-1G>A	c.274-1G>A	 ,190,17,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
274G>T, E92X	c.274G>T	p.Glu92*,191,9,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
274G>A, E92K	c.274G>A	p.Glu92Lys,192,9,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
292C>T, Q98X	c.292C>T	p.Gln98*,193,9,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
328G>C, D110H	c.328G>C	p.Asp110His,195,10,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
349C>T, R117C	c.349C>T	p.Arg117Cys,196,10,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
532G>A, G178R	c.532G>A	p.Gly178Arg,201,10,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
5G>A, 711+5G>A	c.579+5G>A	 ,203,6,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
5G>A, 711+5G>A	c.579+5G>A	 ,203,17,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1G>T, 712-1G>T	c.580-1G>T	 ,204,6,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1G>T, 712-1G>T	c.580-1G>T	 ,204,17,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
595C>T, H199Y	c.595C>T	p.His199Tyr,205,10,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
613C>T, P205S	c.613C>T	p.Pro205Ser,206,10,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
658C>T, Q220X	c.658C>T	p.Gln220*,208,10,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
988G>T, G330X	c.988G>T	p.Gly330*,211,10,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1000C>T, R334W	c.1000C>T	p.Arg334Trp,212,10,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1013C>T, T338I	c.1013C>T	p.Thr338Ile,214,10,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1040G>A, R347H	c.1040G>A	p.Arg347His,217,10,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1G>A, 1248+1G>A	c.1116+1G>A	 ,219,7,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1G>A, 1248+1G>A	c.1116+1G>A	 ,219,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1202G>A, W401X(TAG)	c.1202G>A	p.Trp401*,221,15,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1203G>A, W401X(TGA)	c.1203G>A	p.Trp401*,222,15,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1G>A, 1341+1G>A	c.1209+1G>A	 ,223,7,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1G>A, 1341+1G>A	c.1209+1G>A	 ,223,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1G>A, 1525-1G>A	c.1393-1G>A	 ,225,7,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1G>A, 1525-1G>A	c.1393-1G>A	 ,225,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1397C>A, S466X	c.1397C>A or c.1397C>G	p.Ser466*,226,10,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1397C>G, S466X	c.1397C>A or c.1397C>G	p.Ser466*,226,23,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1466C>A, S489X	c.1466C>A	p.Ser489*,228,10,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1475C>T, S492F	c.1475C>T	p.Ser492Phe,229,10,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1558G>T, V520F	c.1558G>T	p.Val520Phe,231,10,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1G>A, 1717-1G>A	c.1585-1G>A	 ,232,7,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1G>A, 1717-1G>A	c.1585-1G>A	 ,232,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
8G>A, 1717-8G>A	c.1585-8G>A	 ,233,7,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
8G>A, 1717-8G>A	c.1585-8G>A	 ,233,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1646G>A, S549N	c.1646G>A	p.Ser549Asn,235,10,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1654C>T, Q552X	c.1654C>T	p.Gln552*,237,10,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1675G>A, A559T	c.1675G>A	p.Ala559Thr,238,10,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1G>A, 1812-1G>A	c.1680-1G>A	 ,240,7,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1G>A, 1812-1G>A	c.1680-1G>A	 ,240,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1679G>A, R560K	c.1679G>A	p.Arg560Lys,241,10,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1753G>T, E585X	c.1753G>T	p.Glu585*,242,10,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
2125C>T, R709X	c.2125C>T	p.Arg709*,247,10,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
2290C>T, R764X	c.2290C>T	p.Arg764*,252,10,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
2464G>T, E822X	c.2464G>T	p.Glu822*,254,10,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1G>A, 2622+1G>A	c.2490+1G>A	 ,255,7,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1G>A, 2622+1G>A	c.2490+1G>A	 ,255,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
2491G>T, E831X	c.2491G>T	p.Glu831*,256,10,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
2537G>A, W846X	c.2537G>A	p.Trp846*,257,10,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
2538G>A, W846X(2670TGG>TGA)	c.2538G>A	p.Trp846*,258,23,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
2551C>T, R851X	c.2551C>T	p.Arg851*,259,10,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
2834C>T, S945L	c.2834C>T	p.Ser945Leu,261,10,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
2668C>T, Q890X	c.2668C>T	p.Gln890*,263,10,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
2908G>C, G970R	c.2908G>C	p.Gly970Arg,266,10,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
3120G>A, 3120G>A	c.2988G>A	 ,267,2,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
2988G>A, 3120G>A	c.2988G>A	 ,267,12,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1G>A, 3121-1G>A	c.2989-1G>A	 ,268,7,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1G>A, 3121-1G>A	c.2989-1G>A	 ,268,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
3196C>T, R1066C	c.3196C>T	p.Arg1066Cys,272,11,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
3197G>A, R1066H	c.3197G>A	p.Arg1066His,273,11,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
3266G>A, W1089X	c.3266G>A	p.Trp1089*,275,11,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
3276C>A, Y1092X	c.3276C>A	p.Tyr1092*,276,11,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
3310G>T, E1104X	c.3310G>T	p.Glu1104*,277,11,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
3472C>T, R1158X	c.3472C>T	p.Arg1158*,278,11,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
3587C>G, S1196X	c.3587C>G	p.Ser1196*,279,11,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
3743G>A, W1204X(3743G>A)	c.3611G>A	p.Trp1204*,280,9,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
3611G>A, W1204X(3743G>A)	c.3611G>A	p.Trp1204*,280,20,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
3744G>A, W1204X(3744G>A)	c.3612G>A	p.Trp1204*,281,9,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
3612G>A, W1204X(3744G>A)	c.3612G>A	p.Trp1204*,281,20,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
2477C>T, 3849+10kbC>T	c.3718-2477C>T	p.(?),283,22,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
3731G>A, G1244E	c.3731G>A	p.Gly1244Glu,284,11,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
3752G>A, S1251N	c.3752G>A	p.Ser1251Asn,286,11,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1G>A, 4005+1G>A	c.3873+1G>A	 ,288,7,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1G>A, 4005+1G>A	c.3873+1G>A	 ,288,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
3937C>T, Q1313X	c.3937C>T	p.Gln1313*,290,11,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
350G>A, R117H	c.350G>A	p.Arg117His,296,10,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1075C>A, Q359K/T360K	c.[1075C>A;1079C>A]	p.[Gln359Lys;Thr360Lys],298,17,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1079C>A, Q359K/T360K	c.[1075C>A;1079C>A]	p.[Gln359Lys;Thr360Lys],298,25,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
2930C>T, S977F	c.2930C>T	p.Ser977Phe,303,10,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
3205G>A, G1069R	c.3205G>A	p.Gly1069Arg,305,11,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
3209G>A, R1070Q	c.3209G>A	p.Arg1070Gln,306,11,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
3454G>C, D1152H	c.3454G>C	p.Asp1152His,307,11,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
91C>T, R31C	c.91C>T	p.Arg31Cys,312,9,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
220C>T, R74W	c.220C>T	p.Arg74Trp,313,9,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
224G>A, R75Q	c.224G>A	p.Arg75Gln,314,9,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1727G>C, G576A	c.1727G>C	p.Gly576Ala,317,10,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
2002C>T, R668C	c.2002C>T	p.Arg668Cys,318,10,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
2260G>A, V754M	c.2260G>A	p.Val754Met,319,10,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
2991G>C, L997F	c.2991G>C	p.Leu997Phe,320,10,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
3208C>T, R1070W	c.3208C>T	p.Arg1070Trp,322,11,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
3485G>T, R1162L	c.3485G>T	p.Arg1162Leu,323,11,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
3808G>A, D1270N	c.3808G>A	p.Asp1270Asn,325,11,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
5G>A,"...full-length transcript such as 3849+10kbC>T, 2789+5G>A, 3272-26 A>G, 711+3 A>G",329,1270,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
26 A>G,"... transcript such as 3849+10kbC>T, 2789+5G>A, 3272-26 A>G, 711+3 A>G",329,1281,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
3 A>G,"...such as 3849+10kbC>T, 2789+5G>A, 3272-26 A>G, 711+3 A>G",329,1293,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
220C>T,[R74W;D1270N]c.[220C>T;3808G>A,337,17,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
3808G>A,[R74W;D1270N]c.[220C>T;3808G>A,337,24,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
220C>T,[R74W;V201M;D1270N]c.[220C>T;601G>A;3808G>A,339,23,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
601G>A,[R74W;V201M;D1270N]c.[220C>T;601G>A;3808G>A,339,30,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
3808G>A,[R74W;V201M;D1270N]c.[220C>T;601G>A;3808G>A,339,37,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
220C>T,[R74W;R1070W;D1270N]c.[220C>T;c.3208C>T;3808G>A,341,24,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
3208C>T,[R74W;R1070W;D1270N]c.[220C>T;c.3208C>T;3808G>A,341,33,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
3808G>A,[R74W;R1070W;D1270N]c.[220C>T;c.3208C>T;3808G>A,341,41,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1G>T,... heterozygote (two alleles in trans)a	F508del/621+1G>T	c.[1521_1523delCTT][489+1G>T],352,59,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1G>T,... trans)a	F508del/621+1G>T	c.[1521_1523delCTT][489+1G>T],352,88,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1652G>A,...example 1b	F508del and G551D	c.[1521_1523delCTT(;)1652G>A],353,79,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
2477C>T,...nknown example 2b	3849+10kbC>T and N1303K	c.[3718-2477C>T(;)3909C>G],354,72,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
3909C>G,...mple 2b	3849+10kbC>T and N1303K	c.[3718-2477C>T(;)3909C>G],354,82,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
350G>A,...ariants on one allele (in cis)	R117H-T5/normal	c.[350G>A;1210-12 T[5]][=],355,69,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
5G>A,"...; LS, large spectrum variant (p.Leu206Trp, c.2657+5G>A …); M, mild variant with variable disease pen...",396,120,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1523T>G,...08del due to the presence of the variant F508C (c.1523T>G); false homozygosity for p.Ile507del due t...,480,232,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1519A>G,...del due to the presence of p.Ile507Val (I597V) (c.1519A>G),480,323,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
55G>C,...sly reported rs11887534:G>C (NM_022437.2(ABCG8):c.55G>C (p.Asp19His). This amino-acid variant is bel...,92,773,Eur_J_Hum_Genet_2016_Jan_29_24(1)_106-112.txt
161A>G,...lecting an earlier report of NM_022437.2(ABCG8):c.161A>G (p.Tyr54Cys) (r2~0.2 between rs4299376:G>T ...,92,1071,Eur_J_Hum_Genet_2016_Jan_29_24(1)_106-112.txt
1810C>G,...n intron 10 and rs6720173:G>C NM_022436.2(ABCG5)c.1810C>G (p.Gln604Glu). The ABCG5/ABCG8 transporter...,92,1295,Eur_J_Hum_Genet_2016_Jan_29_24(1)_106-112.txt
27700742G>A,"...names of these SNPs are rs4953023 (NT_022184.16:g.27700742G>A), rs6756629 (NT_022184.16:g.27691832G>...",151,58,Eur_J_Hum_Genet_2016_Jan_29_24(1)_106-112.txt
27691832G>A,"...2184.16:g.27700742G>A), rs6756629 (NT_022184.16:g.27691832G>A), rs4299376 (NT_022184.16:g.27699318G>...",151,98,Eur_J_Hum_Genet_2016_Jan_29_24(1)_106-112.txt
27699318G>T,"...2184.16:g.27691832G>A), rs4299376 (NT_022184.16:g.27699318G>T), rs10208987 (NT_022184.16:g.27669877T...",151,138,Eur_J_Hum_Genet_2016_Jan_29_24(1)_106-112.txt
27669877T>G,"...184.16:g.27699318G>T), rs10208987 (NT_022184.16:g.27669877T>G), rs10439467 (NT_022184.16:g.27675088C...",151,179,Eur_J_Hum_Genet_2016_Jan_29_24(1)_106-112.txt
27675088C>T,"...184.16:g.27669877T>G), rs10439467 (NT_022184.16:g.27675088C>T), rs6720173 (NT_022184.16:g.27667143G>...",151,220,Eur_J_Hum_Genet_2016_Jan_29_24(1)_106-112.txt
27667143G>C,"...2184.16:g.27675088C>T), rs6720173 (NT_022184.16:g.27667143G>C), rs6709904 (NT_022184.16:g.27707066A>...",151,260,Eur_J_Hum_Genet_2016_Jan_29_24(1)_106-112.txt
27707066A>G,"...2184.16:g.27667143G>C), rs6709904 (NT_022184.16:g.27707066A>G), rs4953019 (NT_022184.16:g.27670135G>...",151,300,Eur_J_Hum_Genet_2016_Jan_29_24(1)_106-112.txt
27670135G>A,"...2184.16:g.27707066A>G), rs4953019 (NT_022184.16:g.27670135G>A), rs2278357 (NT_022184.16:g.27666581C>...",151,340,Eur_J_Hum_Genet_2016_Jan_29_24(1)_106-112.txt
27666581C>T,"...2184.16:g.27670135G>A), rs2278357 (NT_022184.16:g.27666581C>T), rs10201851 (NT_022184.16:g.27673327T...",151,380,Eur_J_Hum_Genet_2016_Jan_29_24(1)_106-112.txt
27673327T>C,"...184.16:g.27666581C>T), rs10201851 (NT_022184.16:g.27673327T>C), rs6544713 (NT_022184.16:g.27700623T>...",151,421,Eur_J_Hum_Genet_2016_Jan_29_24(1)_106-112.txt
27700623T>C,"...2184.16:g.27673327T>C), rs6544713 (NT_022184.16:g.27700623T>C), rs4148189 (NT_022184.16:g.27674272C>...",151,461,Eur_J_Hum_Genet_2016_Jan_29_24(1)_106-112.txt
27674272C>T,"...2184.16:g.27700623T>C), rs4148189 (NT_022184.16:g.27674272C>T), rs4148191 (NT_022184.16:g.27669646C>...",151,501,Eur_J_Hum_Genet_2016_Jan_29_24(1)_106-112.txt
27669646C>A,"...2184.16:g.27674272C>T), rs4148191 (NT_022184.16:g.27669646C>A), rs4148196 (NT_022184.16:g.27664656C>...",151,541,Eur_J_Hum_Genet_2016_Jan_29_24(1)_106-112.txt
27664656C>G,"...2184.16:g.27669646C>A), rs4148196 (NT_022184.16:g.27664656C>G), rs1260326 (NT_022184.16:g.11361954T>...",151,581,Eur_J_Hum_Genet_2016_Jan_29_24(1)_106-112.txt
11361954T>C,"...2184.16:g.27664656C>G), rs1260326 (NT_022184.16:g.11361954T>C), rs686030 (NT_008413.19:g.15294784C>A...",151,621,Eur_J_Hum_Genet_2016_Jan_29_24(1)_106-112.txt
15294784C>A,"...22184.16:g.11361954T>C), rs686030 (NT_008413.19:g.15294784C>A), rs661048 (NT_008413.19:g.15287631G>A...",151,660,Eur_J_Hum_Genet_2016_Jan_29_24(1)_106-112.txt
15287631G>A,"...08413.19:g.15294784C>A), rs661048 (NT_008413.19:g.15287631G>A",151,699,Eur_J_Hum_Genet_2016_Jan_29_24(1)_106-112.txt
27G>A,96 Seppälä E.H.  Autio V.  Duggal P.   KLF6  IVS1-27G>A variant and the risk of prostate cancer in F...,595,51,Eur_Urol_2014_Oct_66(4)_752-768.txt
0	M>P,"36.1 ± 57.3,  28.8 ± 39.5,  65.7 ± 31.0	M>P;.005 (at T1) and  .018 (at T2)",328,46,Evid_Based_Complement_Alternat_Med_2011_Sep_30_2011_464759.txt
9	B>P,"58.7 ± 34.6,  31.4 ± 41.8,  63.2 ± 33.9	B>P; NS (at T1) and  .044 (at T2)",330,46,Evid_Based_Complement_Alternat_Med_2011_Sep_30_2011_464759.txt
504 C>T,... from all cases. We identified five cases with C. 504 C>T heterozygous mutations of exon 6 of the MD...,3,1898,Exp_Ther_Med_2014_Nov_19_8(5)_1655-1659.txt
504 C>T,...s of exon 6 of the MDR3 gene and 14 cases with C. 504 C>T homozygous mutations in the experimental g...,3,1977,Exp_Ther_Med_2014_Nov_19_8(5)_1655-1659.txt
504 C>T,"...trol group, we identified seven cases with the C. 504 C>T homozygous mutation and six cases with the...",3,2093,Exp_Ther_Med_2014_Nov_19_8(5)_1655-1659.txt
504 C>T,...C>T homozygous mutation and six cases with the C. 504 C>T heterozygous mutation. The distribution of...,3,2147,Exp_Ther_Med_2014_Nov_19_8(5)_1655-1659.txt
485 T>A,... and control group to be 0.316. Point mutation C. 485 T>A was detected in one case in the experiment...,3,2548,Exp_Ther_Med_2014_Nov_19_8(5)_1655-1659.txt
504 C>T,...ted in one case in the experimental group. The C. 504 C>T and C. 485 T>A MDR3 mutations in exon 6 ar...,3,2615,Exp_Ther_Med_2014_Nov_19_8(5)_1655-1659.txt
485 T>A,... in the experimental group. The C. 504 C>T and C. 485 T>A MDR3 mutations in exon 6 are possibly resp...,3,2630,Exp_Ther_Med_2014_Nov_19_8(5)_1655-1659.txt
504 C>T,...nsible for the development of PNAC in infants. C. 504 C>T may not be the only risk factor of neonata...,3,2731,Exp_Ther_Med_2014_Nov_19_8(5)_1655-1659.txt
504 C>T,"...e revealed a single nucleotide substitution, a C. 504 C>T homozygous mutation in 14/41 premature inf...",39,102,Exp_Ther_Med_2014_Nov_19_8(5)_1655-1659.txt
504 C>T,...gous mutation in 14/41 premature infants and a C. 504 C>T heterozygous mutation in 5/41 premature in...,39,166,Exp_Ther_Med_2014_Nov_19_8(5)_1655-1659.txt
504 C>T,... in the experimental group. It also revealed a C. 504 C>T homozygous mutation in 7/56 premature infa...,39,271,Exp_Ther_Med_2014_Nov_19_8(5)_1655-1659.txt
504 C>T,...ygous mutation in 7/56 premature infants and a C. 504 C>T heterozygous mutation in 6/56 premature in...,39,334,Exp_Ther_Med_2014_Nov_19_8(5)_1655-1659.txt
504 C>T,"...d logistics regression analysis, SPSS 17.0) of C. 504 C>T was significantly different between the ex...",39,585,Exp_Ther_Med_2014_Nov_19_8(5)_1655-1659.txt
485 T>A,...ther single nucleotide substitution in exon 6: C. 485 T>A (P. Ile 162 Lys) in 1/41 premature infants...,41,93,Exp_Ther_Med_2014_Nov_19_8(5)_1655-1659.txt
504 C>T,...lirubin between the premature infants with the C. 504 C>T mutation and the premature infants without...,44,186,Exp_Ther_Med_2014_Nov_19_8(5)_1655-1659.txt
504 C>T,...mutation and the premature infants without the C. 504 C>T mutation in the experimental group (P>0.05...,44,244,Exp_Ther_Med_2014_Nov_19_8(5)_1655-1659.txt
504 C>T,...and r-GGT between the preterm infants with the C. 504 C>T mutation and the preterm infants without t...,44,436,Exp_Ther_Med_2014_Nov_19_8(5)_1655-1659.txt
504 C>T,...T mutation and the preterm infants without the C. 504 C>T mutation (P<0.05 for both). The results re...,44,492,Exp_Ther_Med_2014_Nov_19_8(5)_1655-1659.txt
504 C>T,...). The results revealed that the patients with C. 504 C>T in the experimental group had raised serum...,44,575,Exp_Ther_Med_2014_Nov_19_8(5)_1655-1659.txt
485 T>A,...Table V shows that the preterm infant with the C. 485 T>A mutation had raised r-GGT,44,694,Exp_Ther_Med_2014_Nov_19_8(5)_1655-1659.txt
504 C>T,...was a correlation between the MDR3 gene exon 6 C. 504 C>T synonymous mutation and PNAC in premature ...,55,89,Exp_Ther_Med_2014_Nov_19_8(5)_1655-1659.txt
504 C>T,...d total bile acid levels in the cases with the C. 504 C>T mutation were higher than those in the cas...,55,248,Exp_Ther_Med_2014_Nov_19_8(5)_1655-1659.txt
485 T>A,... in the experimental group was detected with a C. 485 T>A missense mutation and raised r-GGT. Our re...,55,381,Exp_Ther_Med_2014_Nov_19_8(5)_1655-1659.txt
504 C>T,The results reveal that C. 504 C>T and C. 485 T>A MDR3 mutations in exon 6 we...,57,28,Exp_Ther_Med_2014_Nov_19_8(5)_1655-1659.txt
485 T>A,The results reveal that C. 504 C>T and C. 485 T>A MDR3 mutations in exon 6 were detected in ...,57,43,Exp_Ther_Med_2014_Nov_19_8(5)_1655-1659.txt
504 C>T,...le for the development of PNAC in infants. The C. 504 C>T mutation in exon 6 of the MDR3 gene may be...,57,204,Exp_Ther_Med_2014_Nov_19_8(5)_1655-1659.txt
504 C>T,"...on position, ATCAATGAC; nucleic acid position, C. 504 C>T; protein position, 168 aspartic acid synon...",61,154,Exp_Ther_Med_2014_Nov_19_8(5)_1655-1659.txt
485T>A,"...on position, GAAAAAGGA; nucleic acid position, C. 485T>A; protein position, P. Ile 162 Lys, missense...",63,152,Exp_Ther_Med_2014_Nov_19_8(5)_1655-1659.txt
504 C>T,...of the distribution of genotype frequencies in C. 504 C>T in the two groups,77,71,Exp_Ther_Med_2014_Nov_19_8(5)_1655-1659.txt
504 C>T,C. 504 C>T	CC	22 (53.7%)	43 (76.8%)	7.058	0.029,80,4,Exp_Ther_Med_2014_Nov_19_8(5)_1655-1659.txt
504 C>T,...n of the distribution of allele frequencies in C. 504 C>T in the two groups,83,70,Exp_Ther_Med_2014_Nov_19_8(5)_1655-1659.txt
504 C>T,C. 504 C>T	C	49 (59.8%)	92 (82.1%)	0.316	0.164–0.609	...,86,4,Exp_Ther_Med_2014_Nov_19_8(5)_1655-1659.txt
504 C>T,...atory results between infants with and without C. 504 C>T mutation,90,79,Exp_Ther_Med_2014_Nov_19_8(5)_1655-1659.txt
504 C>T,With C. 504 C>T mutation	19	127±20.1	128.8±20.7	70.2±10.8	...,93,9,Exp_Ther_Med_2014_Nov_19_8(5)_1655-1659.txt
504 C>T,Without C. 504 C>T mutation	22	118±19.3	120.4±23.9	69.4±9.4	6...,94,12,Exp_Ther_Med_2014_Nov_19_8(5)_1655-1659.txt
485 T>A,Table V Laboratory results of infant with C. 485 T>A mutation,99,46,Exp_Ther_Med_2014_Nov_19_8(5)_1655-1659.txt
485 T>A,C. 485 T>A mutation	1	140	150.3	80.2	90.6	116,102,4,Exp_Ther_Med_2014_Nov_19_8(5)_1655-1659.txt
251A>T,...hao J  Zhou Q  Liu J  Zhu Y  Yang J  Wei M   The −251A>T polymorphism of interleukin-8 is associated...,198,63,Exp_Ther_Med_2016_Mar_18_11(3)_864-872.txt
404C>A,"HSPB1 was identified, a c.404C>A transversion resulted in p.(Ser135Tyr) amin...",83,27,F1000Res_2015_Feb_26_4_53.txt
2722G>T,11	c.2722G>T	4	11	c.5645C>G	1,60,6,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
5645C>G,11	c.2722G>T	4	11	c.5645C>G	1,60,21,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
5682C>G,11	c.1291_1292insT	1	11	c.5682C>G	1,61,27,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
191G>A,5	c.191G>A	1	6	c.516 + 1G>T	1,70,5,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
1G>T,5	c.191G>A	1	6	c.516 + 1G>T	1,70,24,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
514C>T,8	c.514C>T	1	8	c.658_659delGT	2,71,5,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
5080G>T,18	c.5080G>T	1	10	c.1813insA	1,73,6,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
1G>A,20	c.5277 + 1G>A	4	11	c.4314delC	1,74,13,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
5346G>A,22	c.5346G>A	1	15	c.7436_7437-2delAGAT	1,75,6,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
5503C>T,24	c.5503C>T	1	16	c.7734_7740del6ins9	2,76,6,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
9117G>A,23	c.9117G>A	2,80,9,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
692C>T,11	c.692C>T	1	10	c.1385A>G	1,83,6,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
1385A>G,11	c.692C>T	1	10	c.1385A>G	1,83,20,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
1258G>T,11	c.1258G>T	1	15	c.7469T>C	1,84,6,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
7469T>C,11	c.1258G>T	1	15	c.7469T>C	1,84,21,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
1486C>T,11	c.1486C>T	1	18	c.8111C>T	1,85,6,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
8111C>T,11	c.1486C>T	1	18	c.8111C>T	1,85,21,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
3C>G,17	c.4987-3C>G	1	21	c.8723T>G	1,86,11,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
8723T>G,17	c.4987-3C>G	1	21	c.8723T>G	1,86,23,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
25A>C,19(I)	c.5194-25A>C	1,87,14,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
5216A>G,20	c.5216A>G	1,88,6,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
5435C>G,23	c.5435C>G	1,89,6,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
3C>G,"...mutation probabilities below 20%. The UVs: c.4987-3C>G (putative splice variant), and c.5216A>G in B...",152,137,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
5216A>G,"...UVs: c.4987-3C>G (putative splice variant), and c.5216A>G in BRCA1 were the only two UVs with probab...",152,175,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
692C>T,11	c.692C>T	p.T231 M	1	59.9	17.8	Y	N/N	2	ND	N	Unknown	[...,156,6,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
1258G>T,11	c.1258G>T	p.D420Y	1	6.5	10.5	Y	N/Y	3	ND	N	Unknown	[3...,157,6,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
1486C>T,11	c.1486C>T	p.R496C	1	0.3	3.4	Y	N/N	43	ND	Y	Neutral	[3...,158,6,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
3C>G,17	c.4987-3C>G	NA		96.9	37.6	–	–	0	ND	ND,159,11,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
25A>C,20	c.5194-25A>C	NA	1	14.0	17.4	–	–	0	ND	ND,160,11,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
5216A>G,20	c.5216A>G	p.D1739G	1	97.3	32.5	Y	Y/Y	2	ND	ND	Cancer-...,161,6,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
5435C>G,23	c.5435C>G	p.P1812R	1	4.6	7.5	Y	Y/Y	0	ND	ND,162,6,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
1385A>G,10	c.1385A>G	p.E462G	1	37.8	17.8	Y	Y/N	35	N	Y	Neutral	[...,165,6,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
7469T>C,15	c.7469T>C	p.I2490T	1	13.6	19.9	Y	N/N	238	ND	ND,166,6,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
8111C>T,18	c.8111C>T	p.S2704F	1	11.5	7.3	Y	N/N	1	ND	ND,167,6,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
8723T>G,21	c.8723T>G	p.V2908G	1	1.2	9.8	N	Y/N	8	N	N	Neutral	[34...,168,6,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
5446G>T, 2	F11	1 (37)	Exon 2	g.5446G>T	p.Glu54X	Bil	Yes	Enucl	Epithelial	Bl (52),79,24,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
59695C>T, 5a	F31	NA	Exon 8	g.59695C>T	p.Arg255X	Bil	Yes	RT	Osteosarcoma	(12),82,21,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
64348C>T, 9a	F4	0	Exon 10	g.64348C>T	p.Arg320X	Bil	Yes	Enucl	Epithelial	C (49)...,86,20,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
64348C>T, 10a	F4		Exon 10	g.64348C>T	p.Arg320X	Bil	No	RT	Melanoma	(25),87,20,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
65386C>T," 11a	F5	2 (26, 1f)	Exon 11	g.65386C>T	p.Arg358X	Bil	Yes	RT + CH	Sarcoma	LMS (41...",88,30,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
70261C>T," 12	F6	2 (47, 41)	Exon 12	g.70261C>T	p.Gln383X	Ul	Yes	Enucl	Epithelial	Bl (62)...",89,29,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
76430C>T," 13a	F8	3 (26, 11, 49)	Exon 14	g.76430C>T	p.Arg445X	Bil	Yes	Enucl	Epithelial	L (65)...",90,34,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
76430C>T, 14a	F8		Exon 14	g.76430C>T	p.Arg445X	Bil	No	Enucl	Melanoma	(23),91,20,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
76430C>T, 15a	F8		Exon 14	g.76430C>T	p.Arg445X	Bil	No	RT	Melanoma	(37),92,20,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
76430C>T, 16a	F8		Exon 14	g.76430C>T	p.Arg445X	Bil	No	RT	Melanoma	(45),93,20,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
76430C>T, 17a	F8		Exon 14	g.76430C>T	p.Arg445X	Bil	No	RT	Melanoma	(21),94,20,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
76898C>T, 18a	F23	NA	Exon 15	g.76898C>T	p.Arg467X	Bil	No	RT + CH	Melanoma	(28),95,23,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
78238C>T, 19a	F9	1 (54)	Exon 17	g.78238C>T	p.Arg552X	Bil	Yes	RT	Sarcoma	LMS (33),96,26,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
78238C>T, 20a	F9		Exon 17	g.78238C>T	p.Arg552X	Bil	No	RT + CH	Osteosarcoma	(12...,97,20,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
150037C>T, 21a	F10	0	Exon 18	g.150037C>T	p.Arg579X	Ul	Yes	Missing	Other	(59),98,22,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
150037C>T, 22a	F10		Exon 18	g.150037C>T	p.Arg579X	Bil	No	RT	Melanoma	(35),99,21,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
150037C>T, 23a	F24	NA	Exon 18	g.150037C>T	p.Arg579X	Bil	No	RT	Osteosarcoma	(10),100,23,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
153211T>A, 24	F25	NA	Exon 19	g.153211T>A	p.Tyr606X	Bil	No	RT	Melanoma	(35),101,22,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
160832G>T," 27	F14	2 (53, 50)	Exon 21	g.160832G>T	p.Glu737X	Ul	Yes	Enucl	Epithelial	O (58)...",106,30,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
160832G>T, 28	F14		Exon 21	g.160832G>T	p.Glu737X	Bil	No	RT	Osteosarcoma	(20),107,20,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
162237C>T, 29a	F27	NA	Exon 23	g.162237C>T	p.Arg787X	Bil	No	RT + CH	Sarcoma	LMS (32...,108,23,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
162237C>T, 30a	F28	NA	Exon 23	g.162237C>T	p.Arg787X	Bil	No	RT	Sarcoma	Lipo (12),109,23,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
73869G>A, 32	F7	1 (29)	Exon 13	g.73869G>A	p.Gln444Gl,112,25,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
45867G>A, 33	F20	NA	Intron 6	g.45867G>A,114,23,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
1G>A,IVS6 + 1G>A	n.i.	Bil	No	RT	Epithelial	B (57),115,8,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
76491G>T, 34	F21	NA	Intron 14	g.76491G>T,116,24,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
5G>T,IVS14 + 5G>T	n.i.	Bil	No	RT	Melanoma	(51),117,9,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
149997G>A, 35	F19	NA	Intron 17	g.149997G>A,118,24,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
1G>A,IVS17 − 1G>A	n.i.	Bil	No	RT	Sarcoma	Rhab (8),119,9,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
160729G>C, 36	F1	0	Intron 20	g.160729G>C,120,22,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
1G>C,IVS20 − 1G>C	n.i.	Bil	Yes	RT	Epithelial	Bl (62),121,9,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
160729G>C, 37	F1		Intron 20	g.160729G>C,122,21,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
1G>C,IVS20 − 1G>C	n.i.	Bil	No	RT	Sarcoma	His (31),123,9,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
160729G>C, 38	F1		Intron 20	g.160729G>C,124,21,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
1G>C,IVS20 − 1G>C	n.i.	Bil	No	RT	Epithelial	B (43),125,9,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
59683C>T,8	g.59683C>T	Arg.251X	2	0,158,5,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
59695C>T,8	g.59695C>T	Arg.255X	1	1,159,5,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
64348C>T,10	g.64348C>T	Arg.320X	5	2,160,6,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
65386C>T,11	g.65386C>T	Arg.358X	3	1,161,6,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
76430C>T,14	g.76430C>T	Arg.445X	11	5,162,6,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
76460C>T,14	g.76460C>T	Arg.455X	8	0,163,6,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
76898C>T,15	g.76898C>T	Arg.467X	1	1,164,6,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
78238C>T,17	g.78238C>T	Arg.552X	3	2,165,6,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
78250C>T,17	g.78250C>T	Arg.556X	5	0,166,6,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
150037C>T,18	g.150037C>T	Arg.579X	7	3,167,6,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
162237C>T,23	g.162237C>T	Arg.787X	3	2,168,6,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
13T>G,"...tion among Caucasian children and adults is c.-32-13T>G (IVS1), a splicing defect which allows for t...",23,71,Front_Aging_Neurosci_2014_Jul_23_6_177.txt
1935C>A,"...irschhorn and Huie, 1999), and a common defect, c.1935C>A (p.Asp645Glu), is shared by Chinese patien...",25,151,Front_Aging_Neurosci_2014_Jul_23_6_177.txt
2560C>T,"... The most common mutation in African-Americans, c.2560C>T (p.Arg854Ter), most likely originated in t...",25,286,Front_Aging_Neurosci_2014_Jul_23_6_177.txt
5I > T,"...eATP (rapid desensitization); PAPET-ATP	NF449 > IP5I > TNP-ATP > RO 0437626 > NF279, NF023, RO1, MRS...",185,99,Front_Cell_Neurosci_2013_Nov_21_7_227.txt
404A >T,"...eotide 404 (SNP rs33977775) in the coding region (404A >T). Importantly, this polymorphism causes an...",157,126,Front_Endocrinol_(Lausanne)_2013_Mar_18_4_23.txt
455T>C,"...lipase S447X, apolipoprotein E exon 4, and apoC3 -455T>C polymorphisms on the susceptibility to diab...",322,78,Front_Endocrinol_(Lausanne)_2015_May_28_6_88.txt
262T>C,The 262T>C promoter polymorphism of the catalase gene ...,403,5,Front_Endocrinol_(Lausanne)_2015_May_28_6_88.txt
786T>C,"...elial nitric oxide synthase Glu298Asp, 4b/a, and -786T>C gene variants with diabetic nephropathy . J...",572,136,Front_Endocrinol_(Lausanne)_2015_May_28_6_88.txt
677 C>T,...ethyhlenetetrahydrofolate reductase enzyme (MTHFR 677 C>T variant genotype).	Consumption of folic ac...,67,287,Front_Genet_2014_Aug_26_5_289.txt
677 C>T,...NP) in methylenetetrahydrofolate reductase (MTHFR 677 C>T variant genotype). This enzyme catalyzes t...,98,998,Front_Genet_2014_Aug_26_5_289.txt
677 C>T,...dence of ASD in mothers and children with a MTHFR 677 C>T variant genotype that leads to inefficient...,106,363,Front_Genet_2014_Aug_26_5_289.txt
74755658G>A,"Novel: g.74755658G>A, g.74756006G>A, g.74756039T>A, g.74756...",122,12,Front_Genet_2014_Jun_4_5_167.txt
74756006G>A,"Novel: g.74755658G>A, g.74756006G>A, g.74756039T>A, g.74756176G>A, g.74756...",122,27,Front_Genet_2014_Jun_4_5_167.txt
74756039T>A,"Novel: g.74755658G>A, g.74756006G>A, g.74756039T>A, g.74756176G>A, g.74756438T>C",122,42,Front_Genet_2014_Jun_4_5_167.txt
74756176G>A,"...l: g.74755658G>A, g.74756006G>A, g.74756039T>A, g.74756176G>A, g.74756438T>C",122,57,Front_Genet_2014_Jun_4_5_167.txt
74756438T>C,"...A, g.74756006G>A, g.74756039T>A, g.74756176G>A, g.74756438T>C",122,72,Front_Genet_2014_Jun_4_5_167.txt
41016968T>A,"Novel: g.41016968T>A, g.41017103C>T, g.41017242T>C, g.41017...",124,12,Front_Genet_2014_Jun_4_5_167.txt
41017103C>T,"Novel: g.41016968T>A, g.41017103C>T, g.41017242T>C, g.41017290A>C, g.41017...",124,27,Front_Genet_2014_Jun_4_5_167.txt
41017242T>C,"Novel: g.41016968T>A, g.41017103C>T, g.41017242T>C, g.41017290A>C, g.41017450A>T, g.41017...",124,42,Front_Genet_2014_Jun_4_5_167.txt
41017290A>C,"...l: g.41016968T>A, g.41017103C>T, g.41017242T>C, g.41017290A>C, g.41017450A>T, g.41017478C>T, g.41017...",124,57,Front_Genet_2014_Jun_4_5_167.txt
41017450A>T,"...A, g.41017103C>T, g.41017242T>C, g.41017290A>C, g.41017450A>T, g.41017478C>T, g.41017486C>T, g.41017...",124,72,Front_Genet_2014_Jun_4_5_167.txt
41017478C>T,"...T, g.41017242T>C, g.41017290A>C, g.41017450A>T, g.41017478C>T, g.41017486C>T, g.41017525A>T, g.41017...",124,87,Front_Genet_2014_Jun_4_5_167.txt
41017486C>T,"...C, g.41017290A>C, g.41017450A>T, g.41017478C>T, g.41017486C>T, g.41017525A>T, g.41017749C>A, g.41017...",124,102,Front_Genet_2014_Jun_4_5_167.txt
41017525A>T,"...C, g.41017450A>T, g.41017478C>T, g.41017486C>T, g.41017525A>T, g.41017749C>A, g.41017763C>A, g.41017...",124,117,Front_Genet_2014_Jun_4_5_167.txt
41017749C>A,"...T, g.41017478C>T, g.41017486C>T, g.41017525A>T, g.41017749C>A, g.41017763C>A, g.41017847A>G",124,132,Front_Genet_2014_Jun_4_5_167.txt
41017763C>A,"...T, g.41017486C>T, g.41017525A>T, g.41017749C>A, g.41017763C>A, g.41017847A>G",124,147,Front_Genet_2014_Jun_4_5_167.txt
41017847A>G,"...T, g.41017525A>T, g.41017749C>A, g.41017763C>A, g.41017847A>G",124,162,Front_Genet_2014_Jun_4_5_167.txt
99784127T>C,Novel: g.99784127T>C,127,12,Front_Genet_2014_Jun_4_5_167.txt
4036A>G,...t M. Ren Y. Smith P. Dandara C.   (2012a ). ABCB1 4036A>G and 1236C>T polymorphisms affect plasma ef...,320,55,Front_Genet_2014_Jun_4_5_167.txt
1236C>T,...Smith P. Dandara C.   (2012a ). ABCB1 4036A>G and 1236C>T polymorphisms affect plasma efavirenz leve...,320,67,Front_Genet_2014_Jun_4_5_167.txt
45409478C>A,"NC_000019.10:g.45409478C>A		Okuda et al., 2011	90	C/C ↑ Prognosis...",45,17,Front_Genet_2014_Nov_14_5_391.txt
74351G>T,"NG_015839.2:g.74351G>T		Takenaka et al., 2010	122	C/C ↑ DFS and ...",46,16,Front_Genet_2014_Nov_14_5_391.txt
45420395A>G,"NC_000019.10:g.45420395A>G		Okuda et al., 2011	90	C/C ↑ Prognosis...",62,17,Front_Genet_2014_Nov_14_5_391.txt
63434T>C,"NG_015839.2:g.63434T>C		Ryu et al., 2004	109	C/C ↑ Survival",63,16,Front_Genet_2014_Nov_14_5_391.txt
45364001C>T,NC_000019.10:g.45364001C>T,80,17,Front_Genet_2014_Nov_14_5_391.txt
11587G>A,NG_007067.2:g.11587G>A,81,16,Front_Genet_2014_Nov_14_5_391.txt
45351661T>G,NC_000019.10:g.45351661T>G,90,17,Front_Genet_2014_Nov_14_5_391.txt
23927A>C,NG_007067.2:g.23927A>C,91,16,Front_Genet_2014_Nov_14_5_391.txt
45359191A>G,NC_000019.10:g.45359191A>G,103,17,Front_Genet_2014_Nov_14_5_391.txt
16397T>C,NG_007067.2:g.16397T>C,104,16,Front_Genet_2014_Nov_14_5_391.txt
45352266G>A,NC_000019.10:g.45352266G>A,107,17,Front_Genet_2014_Nov_14_5_391.txt
23322C>T,NG_007067.2:g.23322C>T,108,16,Front_Genet_2014_Nov_14_5_391.txt
14145949G>T,NC_000003.12:g.14145949G>T,111,17,Front_Genet_2014_Nov_14_5_391.txt
37724C>A,NG_011763.1:g.37724C>A,112,16,Front_Genet_2014_Nov_14_5_391.txt
102852167T>C,NC_000013.11:g.102852167T>C,114,17,Front_Genet_2014_Nov_14_5_391.txt
11344T>C,NG_007146.1:g.11344T>C,115,16,Front_Genet_2014_Nov_14_5_391.txt
102845848A>G,NC_000013.11:g.102845848A>G,117,17,Front_Genet_2014_Nov_14_5_391.txt
5025A>G,NG_007146.1:g.5025A>G,118,16,Front_Genet_2014_Nov_14_5_391.txt
43551574T>C,NC_000019.10:g.43551574T>C,121,17,Front_Genet_2014_Nov_14_5_391.txt
29005A>G,"NG_033799.1:g.29005A>G	NSCLC	Gurubhagavatula et al., 2004	103	A ...",122,16,Front_Genet_2014_Nov_14_5_391.txt
43553422G>A,NC_000019.10:g.43553422G>A,138,17,Front_Genet_2014_Nov_14_5_391.txt
27157C>T,NG_033799.1:g.27157C>T,139,16,Front_Genet_2014_Nov_14_5_391.txt
103699416G>A,"NC_000014.9:g.103699416G>A		Ren et al., 2012	340	C/C ↑ OS",151,16,Front_Genet_2014_Nov_14_5_391.txt
21071C>T,NG_011516.1:g.21071C>T NG_012307.1:g.75229G>A	Breast cancer	Chew...,152,16,Front_Genet_2014_Nov_14_5_391.txt
75229G>A,"NG_011516.1:g.21071C>T NG_012307.1:g.75229G>A	Breast cancer	Chew et al., 2009	136	C/C ↑...",152,39,Front_Genet_2014_Nov_14_5_391.txt
67585218A>G,"NC_000011.10:g.67585218A>G	Ovarian cancer	Khrunin et al., 2010	10...",172,17,Front_Genet_2014_Nov_14_5_391.txt
6624A>G,"NG_012075.1:g.6624A>G	Urothelial cancer	Yokomizo et al., 2007	17...",173,16,Front_Genet_2014_Nov_14_5_391.txt
52803889A>G,NC_000006.12:g.52803889A>G,185,17,Front_Genet_2014_Nov_14_5_391.txt
135T>C,NM_145740.3:c.-135T>C,186,17,Front_Genet_2014_Nov_14_5_391.txt
251A >T,...cancer in patients with polymorphisms of the IL-8-251A >T locus revealed that Caucasian populations ...,62,342,Front_Immunol_2015_May_5_6_214.txt
251A >T,... Zhu X Liang X Ling Z Li R  . Association of IL-8-251A >T polymorphisms with oral cancer risk: evide...,208,60,Front_Immunol_2015_May_5_6_214.txt
251A >T,Association between -251A >T polymorphism in the interleukin-8 gene and...,210,22,Front_Immunol_2015_May_5_6_214.txt
2A > C,...ansferase gene (chat) on chromosome 13	tf247	IVS2-2A > C	Attenuated transmission at neuromuscular ju...,120,71,Front_Mol_Neurosci_2016_Jun_29_9_50.txt
2A > G,IVS4-2A >,143,6,Front_Mol_Neurosci_2016_Jun_29_9_50.txt
1G > A,...ylase E2 (dbt) gene on chromosome 22	ti274	IVS6 + 1G > A	Abnormal output from CNS. The abnormality m...,151,94,Front_Mol_Neurosci_2016_Jun_29_9_50.txt
4580704 C > G,Polymorphism of CLOCK gene rs 4580704 C > G is associated with susceptibility of...,246,31,Front_Neurol_2015_Oct_23_6_224.txt
341C>T,...Li J.   (2013 ). The glutathione S-transferase P1 341C>T polymorphism and cancer risk: a meta-analys...,237,95,Front_Pharmacol_2014_Aug_28_5_200.txt
61 A > G,.... Xiong G. L.   (2015 ). Association between EGF +61 A > G polymorphism and gastric cancer risk: a m...,1023,76,Front_Pharmacol_2016_Sep_26_7_327.txt
29C > T,...B1*	Transforming growth factor-β 1	Association of 29C > T polymorphism in the transforming growth fa...,175,54,Front_Physiol_2012_Aug_8_3_303.txt
29C>T,...H. Tanaka M. Miyachi M.   (2012 ). Association of 29C>T polymorphism in the transforming growth fact...,401,100,Front_Physiol_2012_Aug_8_3_303.txt
2221G > T,"c.2221G > T Arg712Leu	N/A	Sakthivel et al., 2000; Wa...",55,4,Front_Physiol_2016_Oct_28_7_499.txt
2609G > A,NM_000257.3(MYH7):c.2609G > A (p.Arg870His) rs36211715	Pathogenic/Like...,57,22,Front_Physiol_2016_Oct_28_7_499.txt
1544T > C,NM_000257.3(MYH7):c.1544T > C (p.Met515Thr) rs863224900	Likely pathoge...,58,22,Front_Physiol_2016_Oct_28_7_499.txt
1816G > A,NM_000257.3(MYH7):c.1816G > A (p.Val606Met) rs121913627	Pathogenic / L...,59,22,Front_Physiol_2016_Oct_28_7_499.txt
2146G > A,NM_000257.3(MYH7):c.2146G > A (p.Gly716Arg) rs121913638	Conflicting in...,60,22,Front_Physiol_2016_Oct_28_7_499.txt
2686G > A,NM_000257.3(MYH7):c.2686G > A (p.Asp896Asn) rs606231340	Pathogenic	Ran...,61,22,Front_Physiol_2016_Oct_28_7_499.txt
3641G > A,NM_000256.3(MYBPC3):c.3641G > A (p.Trp1214Ter) rs730880597	Pathogenic	Ba...,64,24,Front_Physiol_2016_Oct_28_7_499.txt
2308G > A,NM_000256.3 (MYBPC3):c.2308G > A (p.Asp770Asn) rs36211723	Pathogenic/Like...,66,25,Front_Physiol_2016_Oct_28_7_499.txt
1G > A,NM_000256.3 (MYBPC3):c.3815-1G > A rs397516044	Pathogenic/Likely pathogenic	Wa...,67,30,Front_Physiol_2016_Oct_28_7_499.txt
430C >T,NM_001001430.2 (TNNT2):c.430C >T (p.Arg144Trp) rs483352832	Conflicting inte...,70,27,Front_Physiol_2016_Oct_28_7_499.txt
318C > G,NM_001001430.2 (TNNT2):c.318C > G (p.Ile106Met) rs3729547	Uncertain signifi...,72,27,Front_Physiol_2016_Oct_28_7_499.txt
2601 C > G,"g. 2601 C > G P82R	N/A	Rani et al., 2012b",74,5,Front_Physiol_2016_Oct_28_7_499.txt
4019 G > A,"g. 4019 G > A R98Q	N/A	Rani et al., 2012b; Ramachandr...",75,5,Front_Physiol_2016_Oct_28_7_499.txt
422G > A,NM_000363.4 (TNNI3):c.422G > A (p.Arg141Gln) rs397516347	Pathogenic/Like...,76,24,Front_Physiol_2016_Oct_28_7_499.txt
485G > A,NM_000363.4 (TNNI3):c.485G > A (p.Arg162Gln) rs397516354	Pathogenic/Like...,77,24,Front_Physiol_2016_Oct_28_7_499.txt
644C > T,NM_001018005.1 (TPM1):c.644C > T (p.Ser215Leu) rs199476316	Conflicting int...,79,26,Front_Physiol_2016_Oct_28_7_499.txt
9532494 C > T,gl187.9	Fertile	CHr1:9532494 C > T	P25 > S,73,22,Front_Plant_Sci_2015_Mar_12_6_147.txt
9532503 G > A,gl23	Sterile	CHr1:9532503 G > A	G28 > R,74,19,Front_Plant_Sci_2015_Mar_12_6_147.txt
9532608 G > A,s3pl5	Sterile	CHr1:9532608 G > A	D33 > N,75,20,Front_Plant_Sci_2015_Mar_12_6_147.txt
9532887 G > A,gl129.11	Sterile	CHr1:9532887 G > A	G70 > D,76,23,Front_Plant_Sci_2015_Mar_12_6_147.txt
9532887 G > A,gl865.6	Sterile	CHr1:9532887 G > A	G70 > D,77,22,Front_Plant_Sci_2015_Mar_12_6_147.txt
9532899 G > A,s6pl30	Sterile	CHr1:9532899 G > A	G74 > D,78,21,Front_Plant_Sci_2015_Mar_12_6_147.txt
9533395 G > A,s11pl13	Sterile	CHr1:9533395 G > A	E106 > K,79,22,Front_Plant_Sci_2015_Mar_12_6_147.txt
9533483 G > A,gl172.10	Sterile	CHr1:9533483 G > A	G135 > D,80,23,Front_Plant_Sci_2015_Mar_12_6_147.txt
9533485 G > A,s11pl33	Fertile	CHr1:9533485 G > A	G136 > R,81,22,Front_Plant_Sci_2015_Mar_12_6_147.txt
9533486 G > A,s2pl6	Fertile	CHr1:9533486 G > A	G136 > E,82,20,Front_Plant_Sci_2015_Mar_12_6_147.txt
9533599 G > A,gl392.8	Sterile	CHr1:9533599 G > A	splicing site of the 4th intron,83,22,Front_Plant_Sci_2015_Mar_12_6_147.txt
9533621 G > A,s1pl41	Sterile	CHr1:9533621 G > A	C155 > Y,84,21,Front_Plant_Sci_2015_Mar_12_6_147.txt
9533751 G > A,s10pl47	Sterile	CHr1:9533751 G > A	splicing site of the 5th intron,85,22,Front_Plant_Sci_2015_Mar_12_6_147.txt
2A> E,...se of NormFinder and GeNorm: TIP41> UBC> GAPDH> PP2A> EF-1α> CYP> ACTIN> α-TUB> β-TUB >SAMS (from th...,108,358,Front_Plant_Sci_2016_Apr_21_7_516.txt
3B > A,...expression stability is EF1-γ > IF3G1 > EF1-β > IF3B > ACT > CYC > GAPDH > ACT11 in the set of diffe...,115,1019,Front_Plant_Sci_2016_Jan_12_6_1259.txt
3B > E,...nseng tissues and IF3G1 > ACT11 > GAPDH > CYC > IF3B > EF1-γ > EF1-β > ACT in the heat-treated P. gi...,115,1129,Front_Plant_Sci_2016_Jan_12_6_1259.txt
1117C>T,Der Polymorphismus 1117C>T im Cytochrom P450 CYP1A2 beeinträchtigt di...,218,20,Front_Vet_Sci_2016_Mar_22_3_26.txt
6C > A,"...at followed by a C (AAAAAAC) would be designated A6C > A5C, whereas an insertion would be CA6 > CA7",68,1206,G3_(Bethesda)_2015_Jul_21_5(9)_1925-1935.txt
4444903 A > G,... (Table 3). The genotype frequencies of the EGF rs4444903 A > G polymorphism among the cases and con...,56,249,Gastroenterol_Hepatol_Bed_Bench_2013_Summer_6(3)_129-135.txt
61A > G,...g H-G  Choi JE  Lee WK  Kam S  Cha SI  Kim CH    +61A > G polymorphism in the EGF gene does not incr...,130,57,Gastroenterol_Hepatol_Bed_Bench_2013_Summer_6(3)_129-135.txt
61A > G,...  Genetic polymorphism of epidermal growth factor 61A > G and cancer risk: A meta-analysis Cancer Ep...,137,80,Gastroenterol_Hepatol_Bed_Bench_2013_Summer_6(3)_129-135.txt
167A>C,"...er (Foundation One) showed the MAP2K1:NM_002755:c.167A>C_p.Q56P (0.13,1125, PIK3CA:NM 006218:c.331A>...",77,148,Gastroenterology_2015_Dec_2_149(7)_1794-1803_e4.txt
331A>G,"...55:c.167A>C_p.Q56P (0.13,1125, PIK3CA:NM 006218:c.331A>G p.K111E [0.13,765]), and CTNNB1:NM_001904:c...",77,193,Gastroenterology_2015_Dec_2_149(7)_1794-1803_e4.txt
101G>A,"...31A>G p.K111E [0.13,765]), and CTNNB1:NM_001904:c.101G>A_p.G34E (0.06,851) mutational profile. TP53,...",77,244,Gastroenterology_2015_Dec_2_149(7)_1794-1803_e4.txt
786T>C,...ginal ResearchEndothelial Nitric Oxide Synthase (−786T>C) and Endothelin-1 (5665G>T) Gene Polymorphi...,3,225,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
5665G>T,...Nitric Oxide Synthase (−786T>C) and Endothelin-1 (5665G>T) Gene Polymorphisms as Vascular Dysfunctio...,3,251,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
5665G>T,...sturbance. We investigate the association of ET-1 5665G>T and eNOS −786T>C polymorphisms with solubl...,5,482,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
786T>C,...stigate the association of ET-1 5665G>T and eNOS −786T>C polymorphisms with soluble adhesion molecul...,5,500,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
786T>C,"...of microvessels.5,7 The eNOS polymorphic variant −786T>C is associated with a decreased NO productio...",16,507,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
786T>C,...he aim of this study was to investigate the eNOS −786T>C (rs2070744) and ET-1 5665G>T (rs5370) gene ...,18,52,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
5665G>T,...investigate the eNOS −786T>C (rs2070744) and ET-1 5665G>T (rs5370) gene polymorphisms in SCA individ...,18,80,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
5665G>T,The ET-1 5665G>T (rs5370) and eNOS −786T>C (rs2070744) gene...,27,10,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
786T>C,The ET-1 5665G>T (rs5370) and eNOS −786T>C (rs2070744) gene polymorphisms were investi...,27,37,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
5665G>T,"... performed to show a possible interaction of ET-1 5665G>T gene polymorphisms, sVCAM-1, and LDH level...",36,638,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
786T>C,"...evels as risk factors on ACS outcome and of eNOS −786T>C gene polymorphisms, white blood cell, LDH, ...",36,734,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
5665G>T,The ET-1 5665G>T polymorphism was analyzed in 101 SCA patie...,40,10,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
786T>C,"...ents and 108 healthy individuals, while the eNOS −786T>C was investigated in 60 SCA patients and 81 ...",40,109,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
5665G>T,...of homozygous for the variant allele (TT) of ET-1 5665G>T gene polymorphism in SCA patients (Table 1...,40,361,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
786T>C,...polymorphism in SCA patients (Table 1). The eNOS −786T>C gene polymorphism analysis showed 56.7% (34...,40,424,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
5665G>T,"...rium. In the control group, the frequency of ET-1 5665G>T gene polymorphism was 60.2% (65/108) for w...",40,730,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
786T>C,... variant allele (Table 1). The frequency of eNOS −786T>C was 54.3% (44/81) for wild-type genotype an...,40,917,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
5665G>T,...atients’ carriers of the minor allele of the ET-1 5665G>T (P < 0.001) (Fig. 1),46,334,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
5665G>T,...iation with the presence of the minor allele ET-1 5665G>T and levels of direct bilirubin and total c...,49,182,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
5665G>T,"...ch model investigates the interaction of the ET-1 5665G>T gene polymorphism, sVCAM-1, and LDH levels...",52,83,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
786T>C,"... levels on ACS outcome (Table 4) and of the eNOS −786T>C gene polymorphism, white blood cell count, ...",52,176,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
786T>C,...resting result regarding the association of eNOS −786T>C gene polymorphism and sVCAM-1 levels. SCA p...,55,78,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
786T>C,...can stimulate vascular smooth muscle.18 The eNOS −786T>C minor allele can be associated with an enha...,57,510,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
5665G>T,"Also, in the current study, the ET-1 5665G>T minor allele was associated with the occur...",59,38,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
5665G>T,"...ediators’ balance because of the presence of ET-1 5665G>T minor allele, once this gene polymorphism ...",59,998,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
5665G>T,...found the association of the minor allele of ET-1 5665G>T with ACS but not the homozygous state of t...,59,1195,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
786T>C,We suggest that eNOS −786T>C and ET-1 5665G>T gene polymorphisms may par...,68,23,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
5665G>T,We suggest that eNOS −786T>C and ET-1 5665G>T gene polymorphisms may participate in the ...,68,39,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
5665G>T,Figure 1 Presence of ET-1 5665G>T alleles and occurrence of acute chest synd...,87,27,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
5665G>T,...ing the minor allele (T) of the polymorphism ET-1 5665G>T had higher levels of direct bilirubin (≥0....,89,78,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
5665G>T,Table 1 Frequencies of ET-1 5665G>T and eNOS −786T>C gene polymorphisms among ...,93,29,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
786T>C,Table 1 Frequencies of ET-1 5665G>T and eNOS −786T>C gene polymorphisms among healthy individual...,93,47,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
5665G>T,ET-1 5665G>T	GG	60.2 (65/108)	66.3 (67/101),96,6,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
786T>C,eNOS −786T>C	TT	54.3 (44/81)	567 (34/60),99,7,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
5665G>T,...n molecules levels (sVCAM-1 and sICAM-1) and ET-1 5665G>T and eNOS −786T>C gene polymorphisms,102,89,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
786T>C,... (sVCAM-1 and sICAM-1) and ET-1 5665G>T and eNOS −786T>C gene polymorphisms,102,107,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
5665G>T,Table 3 ET-1 5665G>T and eNOS −786T>C gene polymorphisms associ...,120,14,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
786T>C,Table 3 ET-1 5665G>T and eNOS −786T>C gene polymorphisms association with clinica...,120,32,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
5665G>T,"...The multivariate model of the association of ET-1 5665G>T gene polymorphism, sVCAM-1, and lactate de...",148,59,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
5665G>T,ET-1 5665G>T	0.351	0.127	2.772	0.011,152,6,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
5665G>T,ET-1 5665G>T	0.358	0.126	2.843	0.009,155,6,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
786T>C,"...e multivariable model of the association of eNOS −786T>C gene polymorphism, white blood cell (WBC) c...",160,61,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
786T>C,eNOS −786T>C	0.420	0.187	2.249	0.037,164,7,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
786T>C,eNOS −786T>C	0.268	0.176	1.517	0.149,167,7,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
2945A>G,LR00-144	CE11A	g.-2945A>G	A/G	A/A	A/G	n/a	0/330 (0%),146,19,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
1767G>T,LR00-144	PPR	g.-1767G>T	G/T	G/G	G/T	n/a	0/518 (0%),147,17,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
1431C>A,LR03-184a1	PPR	g.-1431C>A	C/A	C/C	C/A	C/C	6/528 (1.1%),149,19,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
151T>A,LR03-184a1	Intron 1	g.151T>A	T/A	T/T	T/A	T/T	6/350 (1.7%),150,23,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
1453C>G,LR00-204	PPR	g.-1453C>G	C/G	C/C	C/G	n/a	1/528 (0.2%),151,17,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
11559C>T,LR00-204	Intron 5	g.11559C>T	C/T	C/T	C/C	n/a	2/550 (0.4%),152,21,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
21762C>A,LR03-277	3′-UTR	g.21762C>A	C/A	C/A	C/C	n/a	1/352 (0.3%),153,19,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
21796G>A,LR03-277	3′-UTR	g.21796G>A	G/A	G/G	G/A	n/a	1/352 (0.3%),154,19,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
1726C>A,LR02-304	CE12A	g.-1726C>A	C/A	C/A	C/C	n/a	0/528 (0%),155,19,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
1453C>G,LP98-052	PPR	g.-1453C>G	C/G	C/G	C/C	n/a	1/528 (0.2%),156,17,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
555C>T,CMS5151	5′-UTR	g.-555C>T	C/T	n/a	n/a	n/a	2/540 (0.4%),157,19,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
8213T>C,8348	Intron 3	g.8213T>C	T/C	n/a	n/a	n/a	0/146 (0%),158,17,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
14617A>C,12856 XS	Intron 7	g.14617A>C	A/C	n/a	n/a	n/a	1/558 (0.2%),159,21,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
14718C>T,LR01-194	Intron 7	g.14718C>T	C/T	C/C	C/T	n/a	1/558(0%),160,21,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
20765C>A,LR01-148	3′-UTR	g.20765C>A	C/A	n/a	n/a	n/a	0/362 (0%),161,19,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
1453C>G,"...00-204 both harboured identical variants (i.e. g.-1453C>G). Thus, a total of 15 novel variants were ...",162,87,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
1453C>G,...tients LR00-204 and LP98-052 both harbored the g.-1453C>G substitution,174,244,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
1453C>G,"...he two unrelated patients having the identical g.-1453C>G patient variant. In all 12 cases, at least...",176,292,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
2945A>G,"...el variants identified in the patients, seven (g.-2945A>G, g.-1767G>T, g.-1726C>A, g.8213T>C, g.1471...",178,472,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
1767G>T,"...identified in the patients, seven (g.-2945A>G, g.-1767G>T, g.-1726C>A, g.8213T>C, g.14718C>T, g.2076...",178,484,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
1726C>A,"...n the patients, seven (g.-2945A>G, g.-1767G>T, g.-1726C>A, g.8213T>C, g.14718C>T, g.20765C>A and g.2...",178,496,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
8213T>C,"...nts, seven (g.-2945A>G, g.-1767G>T, g.-1726C>A, g.8213T>C, g.14718C>T, g.20765C>A and g.21502T>C) we...",178,507,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
14718C>T,"...(g.-2945A>G, g.-1767G>T, g.-1726C>A, g.8213T>C, g.14718C>T, g.20765C>A and g.21502T>C) were not dete...",178,518,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
20765C>A,"... g.-1767G>T, g.-1726C>A, g.8213T>C, g.14718C>T, g.20765C>A and g.21502T>C) were not detected in any ...",178,530,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
21502T>C,"...-1726C>A, g.8213T>C, g.14718C>T, g.20765C>A and g.21502T>C) were not detected in any control subject...",178,545,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
2945A>G,"...ions’. Three of the seven candidate mutations (g.-2945A>G, g.-1767G>T and g.21502T>C) were identifie...",178,729,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
1767G>T,"... of the seven candidate mutations (g.-2945A>G, g.-1767G>T and g.21502T>C) were identified in patient...",178,741,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
21502T>C,"...candidate mutations (g.-2945A>G, g.-1767G>T and g.21502T>C) were identified in patient LR00-144: two...",178,755,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
2945A>G,... identified in patient LR00-144: two of these (g.-2945A>G and -1767G>T) were maternal and one (g.215...,178,819,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
1767G>T,...n patient LR00-144: two of these (g.-2945A>G and -1767G>T) were maternal and one (g.21502T>C) was pa...,178,832,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
21502T>C,"...g.-2945A>G and -1767G>T) were maternal and one (g.21502T>C) was paternal. Consequently, patient LR00...",178,866,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
2945A>G,"...ozygote for NR2E1 mutations. Importantly, both g.-2945A>G and g.-1767G>T reside within the proximal ...",178,990,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
1767G>T,"...E1 mutations. Importantly, both g.-2945A>G and g.-1767G>T reside within the proximal promoter (PPR) ...",178,1005,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
21502T>C,"...T reside within the proximal promoter (PPR) and g.21502T>C resides within the 3′-UTR, which makes ea...",178,1061,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
1726C>A,...ese reside within putative regulatory regions (g.-1726C>A in a 100-bp element in the PPR that is con...,178,1353,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
20765C>A,...that is conserved between mouse and human; and g. 20765C>A that resides in the 3′-UTR); the remainin...,178,1442,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
1453C>G,"...t variants of NR2E1. Patient LR00-204 harbored g.-1453C>G (maternal) and g.11559C>T (paternal), each...",180,113,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
11559C>T,"...ent LR00-204 harbored g.-1453C>G (maternal) and g.11559C>T (paternal), each present in the general p...",180,138,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
21762C>A,"...d 0.4%, respectively. Patient LR03-277 harbored g.21762C>A (paternal) and g.21796G>A (maternal), bot...",180,258,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
21796G>A,"...ent LR03-277 harbored g.21762C>A (paternal) and g.21796G>A (maternal), both present in the general p...",180,284,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
1453C>G,...entify a single control subject bearing either g.-1453C>G / g.11559C>T or g.21762C>A / g.21796G>A al...,180,416,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
11559C>T,...gle control subject bearing either g.-1453C>G / g.11559C>T or g.21762C>A / g.21796G>A allelic pairs....,180,428,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
21762C>A,...bject bearing either g.-1453C>G / g.11559C>T or g.21762C>A / g.21796G>A allelic pairs. We therefore ...,180,442,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
21796G>A,... either g.-1453C>G / g.11559C>T or g.21762C>A / g.21796G>A allelic pairs. We therefore consider thes...,180,455,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
1767G>T,"...brain. Of the seven candidate mutations, four (g.-1767G>T, g.-1726C>A, g.8213T>C, g.14718C>T) were p...",183,298,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
1726C>A,"...e seven candidate mutations, four (g.-1767G>T, g.-1726C>A, g.8213T>C, g.14718C>T) were predicted to ...",183,310,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
8213T>C,"...didate mutations, four (g.-1767G>T, g.-1726C>A, g.8213T>C, g.14718C>T) were predicted to create or a...",183,321,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
14718C>T,"...tions, four (g.-1767G>T, g.-1726C>A, g.8213T>C, g.14718C>T) were predicted to create or abolish bind...",183,332,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
1453C>G,"...4). Of the four functional polymorphisms, one (g.-1453C>G) was predicted to create binding of two ne...",183,598,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
1767G>T,Candidate mutation	g.-1767G>T	PPR	Created	lA-1	Regulator of neuronal dev...,189,23,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
1726C>A,Candidate mutation	g.-1726C>A	CE12A	Abolished	SP1	Regulator of neuronal ...,191,23,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
8213T>C,Candidate mutation	g.8213T>C	Intron 3	Abolished	OCT-1	Regulator of neur...,192,22,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
14718C>T,Candidate mutation	g.14718C>T	Intron 7	Created	TBX5	Regulator of eye mo...,195,22,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
2945A>G,Candidate mutation	g.2945A>G	CE11A	No effect	n/a	n/a	A	A	A	A	na,196,22,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
20765C>A,Candidate mutation	g.20765C>A	3′-UTR	No effect	n/a	n/a	C	C	C	C	na,197,22,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
21502T>C,Candidate mutation	g.21502T>C	3′-UTR	No effect	n/a	n/a	T	T	T	na	na,198,22,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
1453C>G,Functional polymorphism	g.-1453C>G	PPR	Created	EGR3	Regulator of synaptic pla...,199,28,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
11559C>T,Functional polymorphism	g.11559C>T	Intron 5	No effect	n/a	n/a	C	C	C	C	na,201,27,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
21762C>A,Functional polymorphism	g.21762C>A	3′-UTR	No effect	n/a	n/a	C	C	C	na	na,202,27,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
21796G>A,Functional polymorphism	g.21796G>A	3′-UTR	No effect	n/a	n/a	G	−	A	na	na,203,27,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
1726C>A,"...ue, mouse and Fugu. Notably, in two instances (g.-1726C>A and g.8213T>C), the major human nucleotide...",212,269,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
8213T>C,"...Fugu. Notably, in two instances (g.-1726C>A and g.8213T>C), the major human nucleotide was conserved...",212,283,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
2945A>G,"...t harboring candidate mutations is as follows: g.-2945A>G (518 chromosomes), g.-1767G>T (706 chromos...",221,630,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
1767G>T,"...s is as follows: g.-2945A>G (518 chromosomes), g.-1767G>T (706 chromosomes), g.-1726C>A (716 chromos...",221,660,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
1726C>A,"...18 chromosomes), g.-1767G>T (706 chromosomes), g.-1726C>A (716 chromosomes), g.8213T>C (334 chromoso...",221,690,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
8213T>C,"...706 chromosomes), g.-1726C>A (716 chromosomes), g.8213T>C (334 chromosomes), g.14718C>T (746 chromos...",221,719,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
14718C>T,"...(716 chromosomes), g.8213T>C (334 chromosomes), g.14718C>T (746 chromosomes), g.20765C>A (550 chromo...",221,748,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
20765C>A,"...334 chromosomes), g.14718C>T (746 chromosomes), g.20765C>A (550 chromosomes) and g.21502T>C (532 chr...",221,778,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
21502T>C,"... chromosomes), g.20765C>A (550 chromosomes) and g.21502T>C (532 chromosomes)",221,811,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
1767G>T,...date mutations/56 patients)3= 1.9 × 10−3]. The g.-1767G>T candidate mutation identified in this pati...,303,976,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
1767G>T,... Pax6 and NeuroD/β2 (Breslin et al. 2002). The g.-1767G>T substitution is also predicted to create a...,303,1454,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
1767G>T,...atient LR00-144 supports the proposal that the g.-1767G>T candidate mutation could contribute to the...,303,2152,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
8213T>C,"... 8348 and LR01-148 harbored candidate mutations g.8213T>C and g.20765C>A, respectively. Parents of b...",307,59,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
20765C>A,"...-148 harbored candidate mutations g.8213T>C and g.20765C>A, respectively. Parents of both these pati...",307,73,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
8213T>C,...esent de novo mutations. The candidate mutation g.8213T>C identified in intron 3 in patient 8348 is ...,307,286,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
1726C>A,"Finally, the two candidate mutations g.-1726C>A and g.14718C>T identified in patients LR02...",309,41,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
14718C>T,"...lly, the two candidate mutations g.-1726C>A and g.14718C>T identified in patients LR02-304 and LR01-...",309,55,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
1726C>A,"...edicted to alter neural TFBS and one of these (g.-1726C>A) resides in the promoter region, which tog...",309,567,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
1068T>C,"...8; OR= 2.06; 95% CI: 1.14–3.75) at SNP rs1718119 (1068T>C; Thr-348-Ala), and a second synonymous var...",8,724,Genes_Immun_2010_Jul_10_11(5)_374-383.txt
208293	G>A,rs208293	G>A	Intron 4	-	G (+)a	0.650	0.557	0.150,116,3,Genes_Immun_2010_Jul_10_11(5)_374-383.txt
946G>A,rs28360457	946G>A	Exon 9	Arg-307-Gln	G (+)a	-	-	-,118,12,Genes_Immun_2010_Jul_10_11(5)_374-383.txt
1068T>C,rs1718119	1068T>C	Exon 11	Thr-348-Ala	T (+)a	0.492	0.216	0.5...,120,11,Genes_Immun_2010_Jul_10_11(5)_374-383.txt
1096C>G,rs2230911	1096C>G	Exon 11	Thr-357-Ser	C (+)a	0.900	0.864	0.8...,122,11,Genes_Immun_2010_Jul_10_11(5)_374-383.txt
1405A>G,rs2230912	1405A>G	Exon 13	Gln-460-Arg	A (+)a	0.783	1	0.983,124,11,Genes_Immun_2010_Jul_10_11(5)_374-383.txt
1513T>G,rs3751143	1513T>G	Exon 13	Glu-496-Ala	T (+)a	0.864	0.761	0.9...,126,11,Genes_Immun_2010_Jul_10_11(5)_374-383.txt
1729T>A,rs1653624	1729T>A	Exon 13	Ile-568-Asn	T (+)a	0.983	1	1,128,11,Genes_Immun_2010_Jul_10_11(5)_374-383.txt
1772C>T,rs1621388b	1772C>T	Exon 13	Pro-582-Pro	C (+)b	0.625	0.875	0.6...,130,12,Genes_Immun_2010_Jul_10_11(5)_374-383.txt
11465396 G>A,"...A allelic ratios at marker SNPs for DC-SIGN (at rs11465396 G>A), SP-A2 (at rs1965708 G>T) and SP-D (...",113,72,Genes_Immun_2013_Mar_17_14(2)_99-106.txt
1965708 G>T,"...SNPs for DC-SIGN (at rs11465396 G>A), SP-A2 (at rs1965708 G>T) and SP-D (at rs721917 G>A) in lung ti...",113,99,Genes_Immun_2013_Mar_17_14(2)_99-106.txt
721917 G>A,"...396 G>A), SP-A2 (at rs1965708 G>T) and SP-D (at rs721917 G>A) in lung tissues, measured with SNaPsho...",113,127,Genes_Immun_2013_Mar_17_14(2)_99-106.txt
3435C>T,"...ug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C>T affects mRNA stability Pharmacogenet Genom...",207,111,Genes_Immun_2013_Mar_17_14(2)_99-106.txt
1155A>C,"...cating third-degree relatives; S4 and A5 (MCCC1 c.1155A>C mutation) had a PI_HAT of 0.09, indicating...",50,602,Genet_Med_2015_Aug_6_17(8)_660-667.txt
974T>G,"...ting fourth-degree relatives; A5 and S20 (MCCC1 c.974T>G mutation) have a PI_HAT of 0.09, indicating...",50,698,Genet_Med_2015_Aug_6_17(8)_660-667.txt
295G>C,...ing chromosomal region. Cases S25 and S8 (MCCC2 c.295G>C mutation) had identical genotypes at all 36...,50,1448,Genet_Med_2015_Aug_6_17(8)_660-667.txt
1065A>T,...ng identity by descent. Cases A7 and A11 (MCCC2 c.1065A>T mutation) had identical genotypes at 35 of...,50,1563,Genet_Med_2015_Aug_6_17(8)_660-667.txt
1015G>A,... and S10 (both compound heterozygotes for MCCC2 c.1015G>A mutation) had dissimilar genotypes in the ...,50,1711,Genet_Med_2015_Aug_6_17(8)_660-667.txt
1315G>A,MCCC1	1	A2	F	Homozygous	c.1315G>A	p.Val438Met	Nonsyn	This study,88,27,Genet_Med_2015_Aug_6_17(8)_660-667.txt
1750C>T,A3	F	Compound Het.	c.1750C>T*,89,22,Genet_Med_2015_Aug_6_17(8)_660-667.txt
1894C>T,c.1894C>T	p.Gln584X,90,3,Genet_Med_2015_Aug_6_17(8)_660-667.txt
4A>G,"A4	F	Homozygous	c.1731+4A>G	Intronic, splice region	UNK	This study",92,24,Genet_Med_2015_Aug_6_17(8)_660-667.txt
1155A>C,A5	F	Compound Het.	c.1155A>C*,93,22,Genet_Med_2015_Aug_6_17(8)_660-667.txt
974T>G,c.974T>G*	p.Arg385Ser,94,3,Genet_Med_2015_Aug_6_17(8)_660-667.txt
841C>T,A9	F	Compound Het.	c.841C>T; c.558delA	p.Arg281X,96,22,Genet_Med_2015_Aug_6_17(8)_660-667.txt
834A>G,c.834A>G	p.Val397Glyfs*19,99,3,Genet_Med_2015_Aug_6_17(8)_660-667.txt
539G>T,A19	F	Compound Het.	c.539G>T; c.558delA	p.Gly180Val,102,23,Genet_Med_2015_Aug_6_17(8)_660-667.txt
872C>T,A23	F	Compound Het.	c.872C>T; UND	p.Ala291Val	Nonsyn	This study,105,23,Genet_Med_2015_Aug_6_17(8)_660-667.txt
866C>T,2	S20	M	Compound Het.	c.866C>T; c.974T>G*	p.Ala289Val,107,25,Genet_Med_2015_Aug_6_17(8)_660-667.txt
974T>G,2	S20	M	Compound Het.	c.866C>T; c.974T>G*	p.Ala289Val,107,35,Genet_Med_2015_Aug_6_17(8)_660-667.txt
1155A>C,"3	S4	F	Homozygous	c.1155A>C*	p.Arg385Ser	Nonsyn	Refs. 15,16",110,21,Genet_Med_2015_Aug_6_17(8)_660-667.txt
1594G>C,S5	F	Homozygous	c.1594G>C*	p.Asp532His	Nonsyn/splicing	Ref. 15,111,19,Genet_Med_2015_Aug_6_17(8)_660-667.txt
1310T>C,"S6	M	Homozygous	c.1310T>C*	p.Leu437Pro	Nonsyn	Refs. 4,15",112,19,Genet_Med_2015_Aug_6_17(8)_660-667.txt
1114C>T,S26	F	Compound Het.	c.1114C>T,113,23,Genet_Med_2015_Aug_6_17(8)_660-667.txt
1882G>T,c.1882G>T	p.Gln372X,114,3,Genet_Med_2015_Aug_6_17(8)_660-667.txt
592C>T,MCCC2	1	A6	F	Homozygous	c.592C>T	p.Gln198X	Stop	This study,117,27,Genet_Med_2015_Aug_6_17(8)_660-667.txt
1065A>T,A7	F	Homozygous	c.1065A>T	p.Leu355Phe	Nonsyn	This study,118,19,Genet_Med_2015_Aug_6_17(8)_660-667.txt
1065A>T,A11	F	Homozygous	c.1065A>T	p.Leu355Phe	Nonsyn	This study,119,20,Genet_Med_2015_Aug_6_17(8)_660-667.txt
302C>T,A13	F	Compound Het.	c.302C>T; UND	p.Ser101Phe	Nonsyn	This study,120,23,Genet_Med_2015_Aug_6_17(8)_660-667.txt
214C>T,A14	F	Compound Het.	c.214C>T*; UND	p.Arg72X	Nonsyn	This study,121,23,Genet_Med_2015_Aug_6_17(8)_660-667.txt
1367C>T,A16	F	Homozygous	c.1367C>T	p.Ala456Val	Nonsyn	Ref. 6,122,20,Genet_Med_2015_Aug_6_17(8)_660-667.txt
599T>A,c.599T>A*	p.Ser173Phefs*25,124,3,Genet_Med_2015_Aug_6_17(8)_660-667.txt
1488G>C,A22	F	Compound Het.	c.1488G>C,126,23,Genet_Med_2015_Aug_6_17(8)_660-667.txt
994C>T,c.994C>T	p.Ser173Phefs*25,131,3,Genet_Med_2015_Aug_6_17(8)_660-667.txt
464G>A,S21	M	Compound Het.	c.464G>A*,133,23,Genet_Med_2015_Aug_6_17(8)_660-667.txt
929C>G,c.929C>G*	p.Arg155Gln,134,3,Genet_Med_2015_Aug_6_17(8)_660-667.txt
295G>C,S25	F	Homozygous	c.295G>C*	p.Glu99Gln	Nonsyn	Ref. 15,137,20,Genet_Med_2015_Aug_6_17(8)_660-667.txt
295G>C,"3	S8	M	Homozygous	c.295G>C*	p.Glu99Gln	Nonsyn	Refs. 3,15",139,21,Genet_Med_2015_Aug_6_17(8)_660-667.txt
1015G>A,"S9	M	Compound Het.	c.1015G>A*; UND	p.Val339Met	Nonsyn	Refs. 15,17",140,22,Genet_Med_2015_Aug_6_17(8)_660-667.txt
1015G>A,S10	F	Compound Het.	c.1015G>A*; UND	p.Val339Met	Nonsyn	Ref. 15,141,23,Genet_Med_2015_Aug_6_17(8)_660-667.txt
1054G>A,"S17	F	Homozygous	c.1054G>A	p.Gly352Arg	Nonsyn/splicing	Refs. 6,20",142,20,Genet_Med_2015_Aug_6_17(8)_660-667.txt
1309A>G,"S23	M	Compound Het.	c.1309A>G*; UND	p.Ile437Val	Nonsyn	Refs. 14,15",143,23,Genet_Med_2015_Aug_6_17(8)_660-667.txt
116C>T,S28	M	Homozygous	c.116C>T	p.Ser39Phe	Nonsyn	Ref. 19,144,20,Genet_Med_2015_Aug_6_17(8)_660-667.txt
6T > C,... P.E.   2003 Analysis of the polymorphism [gIVS12-6T > C] in the hMSH2 gene in lymphoma and leukemia...,70,132,Genet_Mol_Biol_2010_Dec_1_Oct-Dec_33(4)_646-649.txt
177 A > G,"...ubstitution located in exon 1 at position 177 (c.+177 A > G, GenBank accession No. NM_214379) causes...",40,281,Genet_Mol_Biol_2011_Mar_1_Jan-Mar_34(1)_56-61.txt
876 G > A,"... novel polymorphism in exon 5 at position 876 (c.+876 G > A, GenBank accession No. NM_214379) of the...",40,575,Genet_Mol_Biol_2011_Mar_1_Jan-Mar_34(1)_56-61.txt
1115T > G,"...anger sequencing of DNM2 uncovered the mutation c.1115T > G, p.F372C, in exon 8, in a heterozygous s...",42,2074,Genet_Mol_Biol_2015_May_1_38(2)_147-151.txt
1102G > A,"...nd in Patient 1. (D) heterozygous DNM2 mutation c.1102G > A, p.E368K found in Patient 2",44,320,Genet_Mol_Biol_2015_May_1_38(2)_147-151.txt
1102G > A,"...encing of DNM2 showed the heterozygous mutation c.1102G > A, p.E368K, already known to be pathogenic...",48,1006,Genet_Mol_Biol_2015_May_1_38(2)_147-151.txt
179C > T,hLIG1	179C > T	A60V	Unknown	No	Neutral (83%)	0.56 ± 0.06...,146,7,Genetics_2015_Nov_9_201(3)_1263-1274.txt
421A > G,421A > G	S141G	Heterozygous	Yes	Neutral (75%)	0.45...,147,2,Genetics_2015_Nov_9_201(3)_1263-1274.txt
454A > G,454A > G	K152E	Heterozygous	Yes	Neutral (83%)	0.52...,148,2,Genetics_2015_Nov_9_201(3)_1263-1274.txt
455A > G,455A > G	K152R	Heterozygous	Yes	Neutral (83%)	0.50...,149,2,Genetics_2015_Nov_9_201(3)_1263-1274.txt
457G > A,457G > A	E153K	Heterozygous	No	Neutral (83%)	0.60 ...,150,2,Genetics_2015_Nov_9_201(3)_1263-1274.txt
488G > A,488G > A	S163N	Unknown	No	Neutral (83%)	0.60 ± 0.1...,151,2,Genetics_2015_Nov_9_201(3)_1263-1274.txt
664C > T,664C > T	R222C	Heterozygous	No	Neutral (63%)	0.35 ...,152,2,Genetics_2015_Nov_9_201(3)_1263-1274.txt
1045G > A,1045G > A	V349M	Unknown	No	Neutral (60%)	0.47 ± 0....,153,2,Genetics_2015_Nov_9_201(3)_1263-1274.txt
1120G > A,1120G > A	A374T	Unknown	No	Neutral (83%)	0.71 ± 0....,154,2,Genetics_2015_Nov_9_201(3)_1263-1274.txt
1184C > A,1184C > A	P395Q	Unknown	No	Neutral (83%)	0.63 ± 0....,155,2,Genetics_2015_Nov_9_201(3)_1263-1274.txt
1502T > C,1502T > C	M501T	Unknown	No	Neutral (83%)	0.61 ± 0....,156,2,Genetics_2015_Nov_9_201(3)_1263-1274.txt
1835C > T,1835C > T	S612L	Heterozygous	No	Neutral (74%)	0.49...,157,2,Genetics_2015_Nov_9_201(3)_1263-1274.txt
1969T > G,1969T > G	L657V	Heterozygous	Yes	Neutral (83%)	0.7...,158,2,Genetics_2015_Nov_9_201(3)_1263-1274.txt
2290G > A,2290G > A	A764T	Unknown	Yes	Deleterious (87%)	0.73...,159,2,Genetics_2015_Nov_9_201(3)_1263-1274.txt
2353G > A,2353G > A	E785K	Unknown	No	Neutral (75%)	0.59 ± 0....,160,2,Genetics_2015_Nov_9_201(3)_1263-1274.txt
2446G > A,2446G > A	V816M	Unknown	No	Neutral (74%)	0.70 ± 0....,161,2,Genetics_2015_Nov_9_201(3)_1263-1274.txt
97A > G,hSSRP1	97A > G	K33E	Heterozygous	Yes	Deleterious (87%)	1....,162,8,Genetics_2015_Nov_9_201(3)_1263-1274.txt
566C > T,566C > T	A189V	Heterozygous	Yes	Deleterious (72%)	...,163,2,Genetics_2015_Nov_9_201(3)_1263-1274.txt
626C > T,626C > T	T209I	Unknown	Yes	Deleterious (61%)	1.09 ...,164,2,Genetics_2015_Nov_9_201(3)_1263-1274.txt
682A > G,682A > G	K228E	Heterozygous	Yes	Deleterious (87%)	...,165,2,Genetics_2015_Nov_9_201(3)_1263-1274.txt
970C > T,970C > T	R324C	Heterozygous	Yes	Neutral (60%)	1.00...,166,2,Genetics_2015_Nov_9_201(3)_1263-1274.txt
1108C > T,1108C > T	R370C	Heterozygous	No	Deleterious (65%)	...,167,2,Genetics_2015_Nov_9_201(3)_1263-1274.txt
1306C > T,1306C > T	P436S	Heterozygous	No	Neutral (83%)	0.94...,168,2,Genetics_2015_Nov_9_201(3)_1263-1274.txt
1441T > C,1441T > C	S481P	Unknown	No	Deleterious (61%)	Non-f...,169,2,Genetics_2015_Nov_9_201(3)_1263-1274.txt
1493A > G,1493A > G	N498S	Heterozygous	No	Neutral (74%)	1.05...,170,2,Genetics_2015_Nov_9_201(3)_1263-1274.txt
1723A > G,1723A > G	T575A	Heterozygous	No	Neutral (83%)	1.02...,171,2,Genetics_2015_Nov_9_201(3)_1263-1274.txt
1724C > T,1724C > T	T575M	Unknown	No	Neutral (60%)	1.02 ± 0....,172,2,Genetics_2015_Nov_9_201(3)_1263-1274.txt
1950G > T,1950G > T	K650N	Unknown	No	Neutral (83%)	1.07 ± 0....,173,2,Genetics_2015_Nov_9_201(3)_1263-1274.txt
428G > A,hPPP1CA	428G > A	R143H	Heterozygous	Yes	Deleterious (87%)	...,174,9,Genetics_2015_Nov_9_201(3)_1263-1274.txt
815A > G,815A > G	Y272C	Heterozygous	Yes	Deleterious (87%)	...,175,2,Genetics_2015_Nov_9_201(3)_1263-1274.txt
348G > T,hPPP1CC	348G > T	E116D	Unknown	Yes	Neutral (75%)	0.57 ± 0....,176,9,Genetics_2015_Nov_9_201(3)_1263-1274.txt
559C > T,559C > T	R187W	Unknown	Yes	Deleterious (87%)	0.05 ...,177,2,Genetics_2015_Nov_9_201(3)_1263-1274.txt
601C > T,601C > T	L201F	Heterozygous	Yes	Deleterious (51%)	...,178,2,Genetics_2015_Nov_9_201(3)_1263-1274.txt
610C > A,610C > A	L204I	Unknown	Yes	Neutral (63%)	0.97 ± 0....,179,2,Genetics_2015_Nov_9_201(3)_1263-1274.txt
866T > G,866T > G	L289R	Heterozygous	Yes	Deleterious (87%)	...,180,2,Genetics_2015_Nov_9_201(3)_1263-1274.txt
3435C>T,"...ug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C>T affects mRNA stability. Pharmacogenet Geno...",141,102,Genome_Med_2010_Nov_30_2(11)_85.txt
1639G>A,"...ticoagulant	A common promoter variant in VKORC1, -1639G>A (rs17878363), has significant implications...",19,60,Genome_Med_2012_May_25_4(5)_45.txt
4148981C>T,...ion were linked to reduced SLCO1A2 mRNA levels (rs4148981C>T) and methotrextate clearance (rs1104598...,23,268,Genome_Med_2012_May_25_4(5)_45.txt
11045981 T>G,...els (rs4148981C>T) and methotrextate clearance (rs11045981 T>G)	[3],23,311,Genome_Med_2012_May_25_4(5)_45.txt
829C>T,... miR-24 binding site in the 3' UTR of human DHFR (829C>T) interfered with miR-24 function and result...,27,105,Genome_Med_2012_May_25_4(5)_45.txt
1639G>A,... allele frequency 0.467) in its promoter region (-1639G>A) results in the formation of a novel E-box...,86,550,Genome_Med_2012_May_25_4(5)_45.txt
1045385 A>C,"...l lines harboring a TFAP2A 3' UTR polymorphism, rs1045385 A>C, miR-200b/200c/429 cannot bind its mRN...",88,795,Genome_Med_2012_May_25_4(5)_45.txt
1045385 A>C,...ion and MTX resistance [73]. Another example is rs1045385 A>C in the miR-200b/200c/429 binding site ...,104,457,Genome_Med_2012_May_25_4(5)_45.txt
1639G>A,...n [137]. The clinical implications of the VKORC1 -1639G>A regulatory variant and a coding variant of...,135,1057,Genome_Med_2012_May_25_4(5)_45.txt
228 C>A,"...on chromosome 5 at the following positions: 1,295,228 C>A; 1,295,248–1,295,243 CC>TT; and 1,295,161 ...",49,247,Genome_Med_2016_Jun_20_8_69.txt
161 A>C,"...295,228 C>A; 1,295,248–1,295,243 CC>TT; and 1,295,161 A>C [46]. However, when these mutations (−57 A...",49,293,Genome_Med_2016_Jun_20_8_69.txt
57 A>C,"...295,161 A>C [46]. However, when these mutations (−57 A>C, −124 C>T, −146 C>T) are introduced into tu...",49,339,Genome_Med_2016_Jun_20_8_69.txt
124 C>T,"...>C [46]. However, when these mutations (−57 A>C, −124 C>T, −146 C>T) are introduced into tumor cells...",49,348,Genome_Med_2016_Jun_20_8_69.txt
146 C>T,"...owever, when these mutations (−57 A>C, −124 C>T, −146 C>T) are introduced into tumor cells (A375 mel...",49,358,Genome_Med_2016_Jun_20_8_69.txt
57 A>C,"...ntroduced three common hTERT promoter mutations (−57 A>C, −124 C>T, −146 C>T) into isogenic human em...",51,530,Genome_Med_2016_Jun_20_8_69.txt
124 C>T,"... three common hTERT promoter mutations (−57 A>C, −124 C>T, −146 C>T) into isogenic human embryonic s...",51,539,Genome_Med_2016_Jun_20_8_69.txt
146 C>T,"...mon hTERT promoter mutations (−57 A>C, −124 C>T, −146 C>T) into isogenic human embryonic stem cells ...",51,549,Genome_Med_2016_Jun_20_8_69.txt
124 C>T,...d that in undifferentiated hESCs the presence of −124 C>T caused a 2- to 3-fold increase in hTERT mR...,51,702,Genome_Med_2016_Jun_20_8_69.txt
57 A>C,... 3-fold increase in hTERT mRNA while neither the −57 A>C nor −146 C>T mutation had any effect on hTE...,51,774,Genome_Med_2016_Jun_20_8_69.txt
146 C>T,...ease in hTERT mRNA while neither the −57 A>C nor −146 C>T mutation had any effect on hTERT transcrip...,51,786,Genome_Med_2016_Jun_20_8_69.txt
4883G>A,"...gene, at least one G allele (GG; AG) at the CD44 +4883G>A gene locus (rs187116) associated with clin...",53,638,Gut_Liver_2011_Dec_21_5(4)_397-405.txt
12A>G,"...the other was an unknown functional variant (1661+12A>G and 1551-9T>A, respectively). The polymorphi...",60,361,Hered_Cancer_Clin_Pract_2005_May_15_3(2)_65-70.txt
9T>A,"...n unknown functional variant (1661+12A>G and 1551-9T>A, respectively). The polymorphism in intron 9 ...",60,376,Hered_Cancer_Clin_Pract_2005_May_15_3(2)_65-70.txt
2642A>T,"...d. Moreover, two linked nucleotide substitutions (2642A>T, 2743T>C, Acc. U37574) in BRCA1 intron 1 w...",3,1670,Hered_Cancer_Clin_Pract_2006_Jan_15_4(1)_20-24.txt
2743T>C,"...er, two linked nucleotide substitutions (2642A>T, 2743T>C, Acc. U37574) in BRCA1 intron 1 were detec...",3,1679,Hered_Cancer_Clin_Pract_2006_Jan_15_4(1)_20-24.txt
2642A>T,...eletion 2223delAAAAA and two linked substitutions 2642A>T and 2743T>C do not significantly alter BRC...,3,2501,Hered_Cancer_Clin_Pract_2006_Jan_15_4(1)_20-24.txt
2743T>C,...delAAAAA and two linked substitutions 2642A>T and 2743T>C do not significantly alter BRCA1 expressio...,3,2513,Hered_Cancer_Clin_Pract_2006_Jan_15_4(1)_20-24.txt
2642A>T,"...de sequence alterations within the BRCA1 intron 1 2642A>T, 2743T>C (Acc. U37574) were also detected ...",35,206,Hered_Cancer_Clin_Pract_2006_Jan_15_4(1)_20-24.txt
2743T>C,"...ce alterations within the BRCA1 intron 1 2642A>T, 2743T>C (Acc. U37574) were also detected in 16 pat...",35,215,Hered_Cancer_Clin_Pract_2006_Jan_15_4(1)_20-24.txt
2642A>T,"...ragment with two linked nucleotide substitutions: 2642A>T, 2743T>",45,64,Hered_Cancer_Clin_Pract_2006_Jan_15_4(1)_20-24.txt
2743T>C,"...ith two linked nucleotide substitutions: 2642A>T, 2743T>",45,73,Hered_Cancer_Clin_Pract_2006_Jan_15_4(1)_20-24.txt
677 C>T,"...in Elmer). Two functional SNPs in the MTHFR gene, 677 C>T (rs1801133) and 1298 A>C (rs1801131), both...",11,443,Hered_Cancer_Clin_Pract_2012_Dec_10_10(Suppl_4)_A7.txt
1298 A>C,"...l SNPs in the MTHFR gene, 677 C>T (rs1801133) and 1298 A>C (rs1801131), both associated with reduced...",11,467,Hered_Cancer_Clin_Pract_2012_Dec_10_10(Suppl_4)_A7.txt
13910T>C,"...ost important for the Caucasian population is LCT-13910T>C (C/C - lactose intolerant phenotype, C/T ...",5,610,Hered_Cancer_Clin_Pract_2015_Sep_9_13(Suppl_1)_A7.txt
1537C>T,1	CH	c.1537C>,226,8,Hum_Genome_Var_2014_Nov_6_1_14020.txt
1543G>A,c.1543G>A	p.R512,228,3,Hum_Genome_Var_2014_Nov_6_1_14020.txt
1543G>A,MTI-498	1	H	c.1543G>A,238,16,Hum_Genome_Var_2014_Nov_6_1_14020.txt
1535G>A,JS_D	1	H	c.1535G>A	p.R512Q	Yes,244,13,Hum_Genome_Var_2014_Nov_6_1_14020.txt
1600T>G,JBS-011	2	CH	c.1600T>,248,17,Hum_Genome_Var_2014_Nov_6_1_14020.txt
1862G>A,c.1862G>A	p.Y534,250,3,Hum_Genome_Var_2014_Nov_6_1_14020.txt
1688G>A,MTI-008	4	H	c.1688G>A	p.R563H	Yes,258,16,Hum_Genome_Var_2014_Nov_6_1_14020.txt
1738A>G,MTI-627	3 (1 died)	H	c.1738A>G	p.K580E	Yes,264,25,Hum_Genome_Var_2014_Nov_6_1_14020.txt
1921T>C,c.1921T>,271,3,Hum_Genome_Var_2014_Nov_6_1_14020.txt
1921T>C,c.1921T>,281,3,Hum_Genome_Var_2014_Nov_6_1_14020.txt
1051C>T,c.1051C>,290,3,Hum_Genome_Var_2014_Nov_6_1_14020.txt
1051C>T,c.1051C>,300,3,Hum_Genome_Var_2014_Nov_6_1_14020.txt
1303C>T,c.1303C>T	p.R435*	Yes,308,4,Hum_Genome_Var_2014_Nov_6_1_14020.txt
1328T>A,c.1328T>,315,3,Hum_Genome_Var_2014_Nov_6_1_14020.txt
1328T>A,c.1328T>,325,3,Hum_Genome_Var_2014_Nov_6_1_14020.txt
1328T>A,c.1328T>,335,3,Hum_Genome_Var_2014_Nov_6_1_14020.txt
1328T>A,c.1328T>,345,3,Hum_Genome_Var_2014_Nov_6_1_14020.txt
1922T>A,c.1922T>,355,3,Hum_Genome_Var_2014_Nov_6_1_14020.txt
1922T>A,2	Ht	c.1922T>A,363,9,Hum_Genome_Var_2014_Nov_6_1_14020.txt
2156A>G,K8103	2	H	c.2156A>G	p.D719G	Yes,370,14,Hum_Genome_Var_2014_Nov_6_1_14020.txt
143G>A,A2229	1	H	c.143G>A	p.R48K	Yes,393,14,Hum_Genome_Var_2014_Nov_6_1_14020.txt
4714G>T,JS_3	1	H	c.4714G>T	p.E1572*	Yes,403,13,Hum_Genome_Var_2014_Nov_6_1_14020.txt
5668G>T,c.5668G>,410,3,Hum_Genome_Var_2014_Nov_6_1_14020.txt
5668G>T,c.5668G>,420,3,Hum_Genome_Var_2014_Nov_6_1_14020.txt
5668G>T,c.5668G>,431,3,Hum_Genome_Var_2014_Nov_6_1_14020.txt
5668G>T,c.5668G>,439,3,Hum_Genome_Var_2014_Nov_6_1_14020.txt
5668G>T,c.5668G>,447,3,Hum_Genome_Var_2014_Nov_6_1_14020.txt
5668G>T,c.5668G>,455,3,Hum_Genome_Var_2014_Nov_6_1_14020.txt
5932G>A,c.5932G>A,457,3,Hum_Genome_Var_2014_Nov_6_1_14020.txt
5824C>T,MTI-133	2 (2 died)	H	c.5824C>T	p.Q1942*	Yes,463,25,Hum_Genome_Var_2014_Nov_6_1_14020.txt
1888T>C,A1371	2	H	c.1888T>C	p.S630P	Yes,468,14,Hum_Genome_Var_2014_Nov_6_1_14020.txt
2461G>A,ND	Ht	c.2461G>A	p.G821S	No	digenic	Egyptian,476,10,Hum_Genome_Var_2014_Nov_6_1_14020.txt
5G>C,JS-05	1	H	c.2439+5G>C	p.I775_A813del	ND,481,19,Hum_Genome_Var_2014_Nov_6_1_14020.txt
1649A>G,JS_F1	3	H	c.1649A>G	p.Q550R	Yes,486,14,Hum_Genome_Var_2014_Nov_6_1_14020.txt
2161C>T,JBS-006	1	H	c.2161C>T	p.P721S	Yes,491,16,Hum_Genome_Var_2014_Nov_6_1_14020.txt
3055C>T,c.3055C>,500,3,Hum_Genome_Var_2014_Nov_6_1_14020.txt
3056G>A,c.3056G>,511,3,Hum_Genome_Var_2014_Nov_6_1_14020.txt
3364C>T,c.3364C>,521,3,Hum_Genome_Var_2014_Nov_6_1_14020.txt
3364C>T,c.3364C>,532,3,Hum_Genome_Var_2014_Nov_6_1_14020.txt
4652T>C,F871	1	H	c.4652T>C	p.L1551P	Yes,541,13,Hum_Genome_Var_2014_Nov_6_1_14020.txt
4582C>T,c.4582C>T	p.R1528C	Yes,548,4,Hum_Genome_Var_2014_Nov_6_1_14020.txt
4258G>A,MTI-127	1	CH	c.4258G>,554,17,Hum_Genome_Var_2014_Nov_6_1_14020.txt
2A>G,c.342-2A>,600,7,Hum_Genome_Var_2014_Nov_6_1_14020.txt
2A>G,c.342-2A>,611,7,Hum_Genome_Var_2014_Nov_6_1_14020.txt
1G>A,c.869+1G>,628,7,Hum_Genome_Var_2014_Nov_6_1_14020.txt
2T>G,MTI-429	5 (1 died)	H	c.33+2T>G	ND	Yes,637,28,Hum_Genome_Var_2014_Nov_6_1_14020.txt
376G>A,c.376G>,650,3,Hum_Genome_Var_2014_Nov_6_1_14020.txt
376G>A,c.376G>,661,3,Hum_Genome_Var_2014_Nov_6_1_14020.txt
380C>T,c.380C>T	p.A127V	Yes,671,4,Hum_Genome_Var_2014_Nov_6_1_14020.txt
389A>G,c.389A>,677,3,Hum_Genome_Var_2014_Nov_6_1_14020.txt
389A>G,c.389A>,688,3,Hum_Genome_Var_2014_Nov_6_1_14020.txt
389A>G,c.389A>,697,3,Hum_Genome_Var_2014_Nov_6_1_14020.txt
5G>A,c.128+5G>,706,7,Hum_Genome_Var_2014_Nov_6_1_14020.txt
5G>A,c.128+5G>,713,7,Hum_Genome_Var_2014_Nov_6_1_14020.txt
7978C>T,c.7978C>T	p.R2660*	Yes,717,4,Hum_Genome_Var_2014_Nov_6_1_14020.txt
1437G>C,c.1437G>C	p.R479S	No	digenic	F (Emirati,741,4,Hum_Genome_Var_2014_Nov_6_1_14020.txt
2773C>T,ND	1	H	c.2773C>T	p.R925*	Yes,753,11,Hum_Genome_Var_2014_Nov_6_1_14020.txt
875T>C,...aracterized FRMD7 missense variant (NM_194277.2:c.875T>C) detected in a Japanese family with XLCIN,17,1207,Hum_Genome_Var_2015_Feb_12_2_15002.txt
875T>C,"...s.9 Sequencing FRMD7 revealed a T>C transition (c.875T>C) in exon 9 (Figure 1b), which causes a cons...",21,729,Hum_Genome_Var_2015_Feb_12_2_15002.txt
875T>C,"...elines.10,11 We accordingly speculated that the c.875T>C variant of FRMD7 is associated with ICN in ...",21,1595,Hum_Genome_Var_2015_Feb_12_2_15002.txt
875T>C,The missense variant c.875T>C has a single-nucleotide polymorphism (SNP) ...,23,24,Hum_Genome_Var_2015_Feb_12_2_15002.txt
875T>C,The c.875T>C variant in patients with congenital nystagm...,25,7,Hum_Genome_Var_2015_Feb_12_2_15002.txt
875T>C,"...y II:1, II:2 and II:3. Arrow marks the variant, c.875T>C. (c) Cross-species multiple alignment of FR...",39,400,Hum_Genome_Var_2015_Feb_12_2_15002.txt
207C>A,"...e. Here, we report a novel hemizygous mutation, c.207C>A (Phe69 Leu), which caused a mild/late-onset...",14,1084,Hum_Genome_Var_2015_Nov_12_2_15044.txt
207C>A,"...ified one hemizygous mutation in exon 2 of GLA, c.207C>A (p. Phe69 Leu). The mutation was absent fro...",24,307,Hum_Genome_Var_2015_Nov_12_2_15044.txt
919G>A,...h incidence of the later-onset GLA mutation c.936+919G>A (IVS4+919G>A) . Hum Mutat,171,117,Hum_Genome_Var_2015_Nov_12_2_15044.txt
919G>A,...f the later-onset GLA mutation c.936+919G>A (IVS4+919G>A) . Hum Mutat,171,130,Hum_Genome_Var_2015_Nov_12_2_15044.txt
307C>T,"...it in Patient no. 19. Patient no. 12, who had a c.307C>T mutation in the paired domain (PD), exhibit...",23,1023,Hum_Genome_Var_2016_Feb_11_3_15052.txt
802G>T,"...duction of amplitude. Patient no. 19, who had a c.802G>T mutation in the proline/serine/threonine-ri...",23,1170,Hum_Genome_Var_2016_Feb_11_3_15052.txt
949C>T,"... normal ERG response. Patient no. 21, who had a c.949C>T mutation in PST, exhibited subnormal cone E...",23,1298,Hum_Genome_Var_2016_Feb_11_3_15052.txt
1G>T,"...icker amplitude. Patient no. 22, who had an IVS11+1G>T mutation, exhibited nearly negative ERG in ma...",23,1444,Hum_Genome_Var_2016_Feb_11_3_15052.txt
79C>T,"...gs (data not shown). Novel mutations, including c.79C>T (p.Gln27X), c.109_110insG (p.Ala2GlyfsX19), ...",26,698,Hum_Genome_Var_2016_Feb_11_3_15052.txt
1G>T,"... (p.Gln27X), c.109_110insG (p.Ala2GlyfsX19), IVS5+1G>T, IVS5+2T>G, c.551_552insG (p.Glu9ArgfsX15), c...",26,753,Hum_Genome_Var_2016_Feb_11_3_15052.txt
2T>G,"..., c.109_110insG (p.Ala2GlyfsX19), IVS5+1G>T, IVS5+2T>G, c.551_552insG (p.Glu9ArgfsX15), c.802G>T (p....",26,764,Hum_Genome_Var_2016_Feb_11_3_15052.txt
802G>T,"...G>T, IVS5+2T>G, c.551_552insG (p.Glu9ArgfsX15), c.802G>T (p.Glu268X) and IVS11+1G>T, were identified...",26,804,Hum_Genome_Var_2016_Feb_11_3_15052.txt
1G>T,"... (p.Glu9ArgfsX15), c.802G>T (p.Glu268X) and IVS11+1G>T, were identified in the current study. As pre...",26,833,Hum_Genome_Var_2016_Feb_11_3_15052.txt
131G>A,"...previously reported, the two missense mutations c.131G>A (p.Arg44Gln) and c.50A>G (p.Asn17Ser) were ...",26,930,Hum_Genome_Var_2016_Feb_11_3_15052.txt
50A>G,...wo missense mutations c.131G>A (p.Arg44Gln) and c.50A>G (p.Asn17Ser) were found in two sporadic pati...,26,956,Hum_Genome_Var_2016_Feb_11_3_15052.txt
1G>T,"... even in Patient no. 22–24 who had the same IVS11+1G>T mutation. However, all ocular findings were a...",29,687,Hum_Genome_Var_2016_Feb_11_3_15052.txt
50A>G,1	 	Sporadic	Exon5	c.50A>G	Missense	p.Asn17Ser	PD	No	9	F	Total/total	−/...,51,22,Hum_Genome_Var_2016_Feb_11_3_15052.txt
131G>A,2	 	Sporadic	Exon5	c.131G>A	Missense	p.Arg44Gln	PD	No	21	M	Total/total	...,52,22,Hum_Genome_Var_2016_Feb_11_3_15052.txt
79C>T,3	 	Sporadic	Exon5	c.79C>T	Nonsense	p.Gln27X	PD	Yes	9	M	Total/total	−/−...,53,22,Hum_Genome_Var_2016_Feb_11_3_15052.txt
1G>A, 	 	 	Intron6	IVS6+1G>A	Splice error	NA	PD	Yes	 	 	 	 	 	 	 	 	 	 	 	...,54,20,Hum_Genome_Var_2016_Feb_11_3_15052.txt
1G>T,7	2	Familial	Intron5	IVS5+1G>T	Splice error	NA	PD	Yes	36	F	Total/total	−/−	+...,58,27,Hum_Genome_Var_2016_Feb_11_3_15052.txt
1G>T,8	2	 	Intron5	IVS5+1G>T	Splice error	NA	PD	Yes	1	M	Total/total	+/+	+/...,59,20,Hum_Genome_Var_2016_Feb_11_3_15052.txt
2T>G,9	3	Familial	Intron5	IVS5+2T>G	Splice error	NA	PD	Yes	64	M	Total/total	−/−	+...,60,27,Hum_Genome_Var_2016_Feb_11_3_15052.txt
2T>G,10	3	 	Intron5	IVS5+2T>G	Splice error	NA	PD	Yes	38	M	Total/total	−/−	+...,61,21,Hum_Genome_Var_2016_Feb_11_3_15052.txt
2T>G,11	3	 	Intron5	IVS5+2T>G	Splice error	NA	PD	Yes	30	M	Partial/partial	−...,62,21,Hum_Genome_Var_2016_Feb_11_3_15052.txt
307C>T,12	 	Sporadic	Exon6	c.307C>T	Nonsense	p.Arg103X	PD	Yes	13	M	Total/total	...,63,23,Hum_Genome_Var_2016_Feb_11_3_15052.txt
607C>T,14	 	Sporadic	Exon8	c.607C>T	Nonsense	p.Arg203X	LNK	Yes	11	M	Total/total...,65,23,Hum_Genome_Var_2016_Feb_11_3_15052.txt
607C>T,15	 	Sporadic	Exon8	c.607C>T	Nonsense	p.Arg203X	LNK	Yes	9	F	Partial/part...,66,23,Hum_Genome_Var_2016_Feb_11_3_15052.txt
718C>T,16	 	Sporadic	Exon9	c.718C>T	Nonsense	p.Arg240X	HD	Yes	27	F	Total/total	...,67,23,Hum_Genome_Var_2016_Feb_11_3_15052.txt
718C>T,17	4	Familial	Exon9	c.718C>T	Nonsense	p.Arg240X	HD	Yes	29	M	Total/total	...,68,23,Hum_Genome_Var_2016_Feb_11_3_15052.txt
718C>T,18	4	 	Exon9	c.718C>T	Nonsense	p.Arg240X	HD	Yes	5	F	Total/total	−...,69,16,Hum_Genome_Var_2016_Feb_11_3_15052.txt
802G>T,19	 	Sporadic	Exon10	c.802G>T	Nonsense	p.Glu268X	PST	Yes	6	F	Total/total	...,70,24,Hum_Genome_Var_2016_Feb_11_3_15052.txt
829C>T,20	 	Sporadic	Exon10	c.829C>T	Nonsense	p.Gln277X	PST	Yes	13	F	Total/total...,71,24,Hum_Genome_Var_2016_Feb_11_3_15052.txt
949C>T,21	 	Sporadic	Exon11	c.949C>T	Nonsense	p.Arg317X	PST	Yes	10	M	Total/total...,72,24,Hum_Genome_Var_2016_Feb_11_3_15052.txt
1G>T,22	 	Sporadic	Intron11	IVS11+1G>T	Splice error	NA	PST	Yes	4	M	Total/total	−/−	+...,73,30,Hum_Genome_Var_2016_Feb_11_3_15052.txt
1G>T,23	5	Familial	Intron11	IVS11+1G>T	Splice error	NA	PST	Yes	7	M	Total/total	−/−	+...,74,30,Hum_Genome_Var_2016_Feb_11_3_15052.txt
1G>T,24	5	 	Intron11	IVS11+1G>T	Splice error	NA	PST	Yes	36	M	Normal/normal	−/...,75,23,Hum_Genome_Var_2016_Feb_11_3_15052.txt
607C>T,"...tified. Sporadic cases of no.14 and no.15 have c. 607C>T mutation, but exhibit different iris phenot...",80,178,Hum_Genome_Var_2016_Feb_11_3_15052.txt
718C>T,"...no. 16 and family no. 4 exhibit same genotype, c. 718C>T, while visual acuity shows variety. In addi...",80,322,Hum_Genome_Var_2016_Feb_11_3_15052.txt
1330C>T,...ient 2—c.758del [p.(Gly253Alafs*16)]; patient 3—c.1330C>T [p.(Gln444*)]. All mutations are predicate...,18,651,Hum_Genome_Var_2016_Oct_13_3_16033.txt
1858C > T,... Amundsen SS Kvien TK Association analysis of the 1858C > T polymorphism in the PTPN22 gene in juven...,213,59,Hum_Genomics_2006_Jun_1_2(6)_391-402.txt
521 T > C,"...re prospectively enrolled on the basis of SLCO1B1 521 T > C genotype. Additionally, subjects were ge...",3,1275,Hum_Genomics_2008_Sep_1_3(1)_7-16.txt
11187 G > A,"...dditionally, subjects were genotyped for SLCO1B1  11187 G > A, - 10499 A > C and 388 A > G polymorph...",3,1346,Hum_Genomics_2008_Sep_1_3(1)_7-16.txt
10499 A > C,"...bjects were genotyped for SLCO1B1  11187 G > A, - 10499 A > C and 388 A > G polymorphisms, and the C...",3,1361,Hum_Genomics_2008_Sep_1_3(1)_7-16.txt
388 A > G,"...typed for SLCO1B1  11187 G > A, - 10499 A > C and 388 A > G polymorphisms, and the CYP2C8*3 polymorp...",3,1377,Hum_Genomics_2008_Sep_1_3(1)_7-16.txt
521 T > C,...lled and stratified in the study based on SLCO1B1 521 T > C genotype. The clinical study was approve...,19,370,Hum_Genomics_2008_Sep_1_3(1)_7-16.txt
521 T > C,...otyped and enrolled in the study based on SLCO1B1 521 T > C genotype. The goal was to enrol equal nu...,25,560,Hum_Genomics_2008_Sep_1_3(1)_7-16.txt
521 T > C,...e 521 T/C and C/C genotypes). Because the SLCO1B1 521 T > C polymorphism is commonly studied in hapl...,25,732,Hum_Genomics_2008_Sep_1_3(1)_7-16.txt
11187 G > A,"...notyped for the following SLCO1B1 polymorphisms: -11187 G > A, -10499 A > C and 388 A > G (Asn130Asp...",25,865,Hum_Genomics_2008_Sep_1_3(1)_7-16.txt
10499 A > C,"...e following SLCO1B1 polymorphisms: -11187 G > A, -10499 A > C and 388 A > G (Asn130Asp). In terms of...",25,879,Hum_Genomics_2008_Sep_1_3(1)_7-16.txt
388 A > G,"...1B1 polymorphisms: -11187 G > A, -10499 A > C and 388 A > G (Asn130Asp). In terms of CYP2C8, subject...",25,895,Hum_Genomics_2008_Sep_1_3(1)_7-16.txt
11187 G > A,SLCO1B1 - 11187 G > A	PCR-forward: TGCTGCAACCATATCAACAA,30,11,Hum_Genomics_2008_Sep_1_3(1)_7-16.txt
10499 A > C,SLCO1B1 -10499 A > C	PCR-forward: Biotin-GTAAAAGCCATTCCCAAA...,33,10,Hum_Genomics_2008_Sep_1_3(1)_7-16.txt
388 A > G,SLCO1B1 388 A > G	PCR-forward: CATTTCACTTTTACCCAT,36,9,Hum_Genomics_2008_Sep_1_3(1)_7-16.txt
521 T > C,SLCO1B1 521 T > C	PCR-forward: Biotin-AGGAATCTGGGTCATACATG...,39,9,Hum_Genomics_2008_Sep_1_3(1)_7-16.txt
521 T > C,"... (range 45.7 to 93.3 kg). In terms of the SLCO1B1 521 T > C screening genotype, 13 subjects were T/T...",116,215,Hum_Genomics_2008_Sep_1_3(1)_7-16.txt
521 T > C,"...ions [34]. Polymorphisms in SLCO1B1, particularly 521 T > C, have been shown significantly to alter ...",129,660,Hum_Genomics_2008_Sep_1_3(1)_7-16.txt
521 T > C,...t al. which showed no association between SLCO1B1 521 T > C genotype and rosiglitazone or pioglitazo...,129,1309,Hum_Genomics_2008_Sep_1_3(1)_7-16.txt
11482G > A,Kang ES Cha BS Kim HJ The 11482G > A polymorphism in the perilipin gene is a...,146,27,Hum_Genomics_2008_Sep_1_3(1)_7-16.txt
786T >C,...thelial nitric oxide synthase gene polymorphisms -786T >C and 894G >T in coronary artery bypass graf...,3,193,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
894G >T,...ic oxide synthase gene polymorphisms -786T >C and 894G >T in coronary artery bypass graft surgery pa...,3,205,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
786T >C,...e endothelial nitric oxide synthase (eNOS) gene (-786T >C and 894G >T) enhance endo-thelial dysfunct...,3,927,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
894G >T,...l nitric oxide synthase (eNOS) gene (-786T >C and 894G >T) enhance endo-thelial dysfunction and have...,3,939,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
786T >C,...t (CABG) patients and 155 non-CAD controls. eNOS -786T >C and 894G >T polymorphisms were genotyped b...,3,1353,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
894G >T,...ients and 155 non-CAD controls. eNOS -786T >C and 894G >T polymorphisms were genotyped by polymerase...,3,1365,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
786T > C,"... diseasecoronary artery bypass graft surgeryeNOS -786T > C polymorphism, eNOS 894G > T polymorphisms...",5,66,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
894G > T,"...ss graft surgeryeNOS -786T > C polymorphism, eNOS 894G > T polymorphismsmokin",5,94,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
786T >C,"... 786 of the 5' flanking region of the eNOS gene (-786T >C, rs2070744) that reduces eNOS gene promote...",12,244,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
894G >T,...r activity by approximately 50 per cent [4] and a 894G >T polymorphism leading to amino acid substit...,12,344,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
786T >C,eNOS -786T >C genotypin,32,7,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
786T >C,... analysis was used for the identification of the -786T >C polymorphism in the eNOS gene. Genomic DNA...,33,130,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
894G >T,eNOS 894G >T genotypin,35,6,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
894G >T,...rotocol was designed for the analysis of the eNOS 894G >T polymorphism. Genomic DNA was amplified us...,36,69,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
786T >C,Distribution of eNOS -786T >C and 894G >T polymorphism,80,23,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
894G >T,Distribution of eNOS -786T >C and 894G >T polymorphism,80,35,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
786T >C,"...were in Hardy-Weinberg equilibrium. For the eNOS -786T >C polymorphism, the frequencies of the genot...",81,249,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
894G >T,"... p = 0.46, respectively). Similarly, for the eNOS 894G >T polymorphism, the frequencies of genotypes...",81,429,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
786T > C,Table 2 Frequencies of eNOS -786T > C and 894G > T genotypes and alleles in CAB...,83,30,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
894G > T,Table 2 Frequencies of eNOS -786T > C and 894G > T genotypes and alleles in CABG patients an...,83,43,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
786T > C,-786T > C genotypes,95,2,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
786T > C,-786T >,103,2,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
894G > T,894G > T genotypes,110,1,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
894G > T,894G > T Alleles	n = 308	n = 310,118,1,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
786T >C,"...ypertension, diabetes mel-litus and smoking, the -786T >C polymorphism did not differ among the vari...",129,119,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
894G >T,"... the various categories (data not shown). For the 894G >T polymorphism, the frequencies of the 894TT...",129,210,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
894G >T,...pe 2 diabetes) among genotypes or alleles for the 894G >T polymorphism (data not shown). The same an...,129,1440,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
894G > T,Table 3 Frequencies of the eNOS 894G > T genotypes and alleles in CABG patients ac...,131,33,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
894G > T,eNOS 894G > T genotypes	n (%)	95% CI	n (%)	95% CI,136,6,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
894G > T,*p value = 0.02 for comparison among all eNOS 894G > T genotypes in current/past smoker and neve...,153,47,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
786T >C,"...ese patients, we investigated the association of -786T >C and 894G >T polymorphisms of the eNOS gene...",192,406,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
894G >T,"..., we investigated the association of -786T >C and 894G >T polymorphisms of the eNOS gene with CAD. O...",192,418,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
786T >C,...dies have reported a lack of association of eNOS -786T >C and 894G >T polymorphisms with CAD in othe...,194,205,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
894G >T,...ported a lack of association of eNOS -786T >C and 894G >T polymorphisms with CAD in other population...,194,217,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
786T >C,... of small-study bias in studies of the G894T and -786T >C polymorphisms [19]. Our approach was to us...,194,904,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
894G >T,...e eNOS gene are not associated with CAD. The eNOS 894G >T polymorphism is associated with CAD in cur...,200,297,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
786T > C,"...helial nitric oxide synthase gene polymorphisms (-786T > C. 4a4b, 894G > T) in Korean patients with ...",215,98,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
894G > T,"...ide synthase gene polymorphisms (-786T > C. 4a4b, 894G > T) in Korean patients with coronary artery ...",215,114,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
1 G > A,(IVS5 DS -1 G > A)	CS051245	DFP	rs2076530	Sarcoidosis,152,11,Hum_Genomics_2011_Jan_1_5(2)_99-107.txt
1199G > A,ABC transporters	ABCB1	rs2229109	A	1199G > A;S400N	0.0	0.0	0.0	NA	0.0	0.03	0.0	0.0	0....,300,36,Hum_Genomics_2011_May_1_5(4)_265-282.txt
61A > G,ABCB1	rs9282564	G	61A > G; N21D	0.0	0.0	0.0	NA	NA	0.1	0.0	0.07	0.0,301,20,Hum_Genomics_2011_May_1_5(4)_265-282.txt
3435C > T,ABCB1	rs1045642	C	3435C > T	0.89	0.8	0.88	NA	0.84	0.43	0.58	0.45	0.8...,302,20,Hum_Genomics_2011_May_1_5(4)_265-282.txt
12386379A > G,ABCB1	rs4148740	G	12386379A > G	0.14	0.17	0.13	NA	NA	0.1	0.02	NA	0.1...,303,20,Hum_Genomics_2011_May_1_5(4)_265-282.txt
12391327G > A,ABCB1	rs7787082	A	12391327G > A	0.69	0.61	0.68	0.71	0.62	0.18	0.46	N...,304,20,Hum_Genomics_2011_May_1_5(4)_265-282.txt
12394837A > G,ABCB1	rs2032583	G	12394837A > G	0.14	0.18	0.25	0.25	0.23	0.16	0.03	0...,305,20,Hum_Genomics_2011_May_1_5(4)_265-282.txt
12455162A > G,ABCB1	rs3789243	G	12455162A > G	0.63	0.61	0.41	0.58	0.44	0.43	0.72	N...,306,20,Hum_Genomics_2011_May_1_5(4)_265-282.txt
1236C > T,ABCB1	rs1128503	T	1236C > T	0.13	0.23	0.12	0.11	0.14	0.39	0.68	0.54	...,307,20,Hum_Genomics_2011_May_1_5(4)_265-282.txt
12399262A > G,ABCB1	rs10248420	G	12399262A > G	0.59	0.56	0.59	0.64	0.56	0.17	0.48	0...,308,21,Hum_Genomics_2011_May_1_5(4)_265-282.txt
12400010G > A,ABCB1	rs2235041	A	12400010G > A	0.12	0.07	0.12	0.1	0.1	0.0	0.0	0.0	0...,309,20,Hum_Genomics_2011_May_1_5(4)_265-282.txt
4488C > T,ABCC2	rs8187707	T	4488C > T;H1496H	0.08	0.08	0.0	0.06	0.09	0.04	0.0	...,310,20,Hum_Genomics_2011_May_1_5(4)_265-282.txt
1249G > A,ABCC2	rs2273697	A	1249G > A;V417I	0.11	0.18	0.21	0.2	0.23	0.23	0.07	...,311,20,Hum_Genomics_2011_May_1_5(4)_265-282.txt
24C > T,ABCC2	rs717620	T	-24C > T	0.03	0.04	0.04	0.02	0.04	0.18	0.22	0.23	0....,312,20,Hum_Genomics_2011_May_1_5(4)_265-282.txt
516G > T,"Phase I	CYP2B6	rs3745274	T	516G > T;Q172H, *6	0.2	0.23	0.45	0.31	0.37	0.25	0....",313,28,Hum_Genomics_2011_May_1_5(4)_265-282.txt
983T > C,"CYP2B6	rs28399499	C	983T > C;I328T, *18	0.17	0.09	0.04	0.07	0.02	0.0	0...",314,22,Hum_Genomics_2011_May_1_5(4)_265-282.txt
593T > C,"CYP2B6	rs36079186	C	593T > C; M198T, *27	0.0	0.0	NA	NA	NA	NA	NA	NA	NA",315,22,Hum_Genomics_2011_May_1_5(4)_265-282.txt
15213256G > A,CYP2C18	rs7896133	A	15213256G > A	0.2	0.2	0.12	0.11	0.16	0.07	0.08	NA	...,316,22,Hum_Genomics_2011_May_1_5(4)_265-282.txt
15243758C > T,CYP2C18	rs2860840	T	15243758C > T	0.0	0.09	0	0.01	0.06	0.35	0.23	0.28	...,317,22,Hum_Genomics_2011_May_1_5(4)_265-282.txt
15237414G > A,CYP2C18	rs10509675	A	15237414G > A	0.15	0.09	0.27	0.18	0.17	0.21	0.02	N...,318,23,Hum_Genomics_2011_May_1_5(4)_265-282.txt
15358094T > C,CYP2C19	rs4917623	C	15358094T > C	0.11	0.2	0.18	0.16	0.29	0.49	0.6	NA	...,319,22,Hum_Genomics_2011_May_1_5(4)_265-282.txt
806C > T,"CYP2C19	rs12248560	T	-806C > T, *17	0.15	0.09	0.27	NA	NA	0.21	0.02	NA	0....",320,24,Hum_Genomics_2011_May_1_5(4)_265-282.txt
681G > A,"CYP2C19	rs4244285	A	681G > A, *2	0.22	0.2	0.16	NA	NA	0.15	0.26	0.16	0....",321,22,Hum_Genomics_2011_May_1_5(4)_265-282.txt
1846G > A,"CYP2D6	rs3892097	A	1846G > A, *4	0.0	0.01	NA	NA	NA	0.5	NA	NA	NA",322,21,Hum_Genomics_2011_May_1_5(4)_265-282.txt
1334T > C,"CYP3A4	rs4986910	C	1334T > C;M445T, *3	0.0	0.0	0.0	NA	NA	0.0	0.0	0.0	...",323,21,Hum_Genomics_2011_May_1_5(4)_265-282.txt
1247C > T,"CYP3A4	rs4986909	T	1247C > T; P416L, *13	0.0	0.0	0.0	NA	NA	0.0	0.0	NA...",324,21,Hum_Genomics_2011_May_1_5(4)_265-282.txt
878T > C,"CYP3A4	rs28371759	C	878T > C; L293P, *18	0.0	0.0	NA	NA	NA	NA	NA	NA	NA",325,22,Hum_Genomics_2011_May_1_5(4)_265-282.txt
485G > A,"CYP3A4	rs4986907	A	485G > A; R162Q, *15A	0.01	0.0	0.0	NA	NA	0.0	0.0	0...",326,21,Hum_Genomics_2011_May_1_5(4)_265-282.txt
566T > C,"CYP3A4	rs4987161	C	566T > C; F189S, *17	0.0	0.0	0.0	NA	NA	0.0	0.0	NA	...",327,21,Hum_Genomics_2011_May_1_5(4)_265-282.txt
392A > G,"CYP3A4	rs2740574	G	-392A > G, *1B	0.77	0.58	0.75	NA	NA	0.03	0.0	0.11	0...",328,22,Hum_Genomics_2011_May_1_5(4)_265-282.txt
1630 T > C,CYP3A5	rs4646450	T	-1630 T > C	0.97	0.83	1.0	0.98	0.85	0.13	0.34	NA	NA...,329,22,Hum_Genomics_2011_May_1_5(4)_265-282.txt
711G > A,"CYP3A5	rs10264272	A	711G > A;K208K, *6	0.2	0.17	0.15	0.25	0.14	0.0	0.0...",330,22,Hum_Genomics_2011_May_1_5(4)_265-282.txt
129 A > G,CYP3A7	rs10211	G	129 A > G	0.35	0.52	0.75	0.72	0.44	0.06	0.34	0.19	...,331,19,Hum_Genomics_2011_May_1_5(4)_265-282.txt
211G > A,"Phase II	UGT1A1	rs4148323	A	211G > A;G71R, *6	0.0	0.0	0.0	NA	NA	0.0	0.2	0.03	0...",332,29,Hum_Genomics_2011_May_1_5(4)_265-282.txt
601324 C > T,UGT1A1	rs887829	T	601324 C > T	0.35	0.36	0.55	NA	NA	0.28	0.08	0.35	0...,333,20,Hum_Genomics_2011_May_1_5(4)_265-282.txt
598536 G > A,"UGT1A1	rs10929302	A	598536 G > A, *93	0.25	0.29	0.36	NA	NA	0.26	0.08	N...",334,22,Hum_Genomics_2011_May_1_5(4)_265-282.txt
1236C > T,"...vidence of the clinical significance of the ABCB1 1236C > T allele, however, although it appears min...",348,408,Hum_Genomics_2011_May_1_5(4)_265-282.txt
983T > C,Mehlotra RK Bockarie MJ Zimmerman PA CYP2B6 983T > C polymorphism is prevalent in West Africa ...,387,45,Hum_Genomics_2011_May_1_5(4)_265-282.txt
2386C>T,"...ed variant predicted a premature stop mutation (c.2386C>T; p.R796X), whereas the maternally transmit...",3,2451,Hum_Mol_Genet_2015_Jul_1_24(13)_3732-3741.txt
5560G>A,...tted variant predicted a missense substitution (c.5560G>A; p.D1854N) at a conserved residue within t...,3,2550,Hum_Mol_Genet_2015_Jul_1_24(13)_3732-3741.txt
2386C>T,...tance pattern. The first variant in PI4KA was a c.2386C>T mutation in exon 20 (NM_058004.3) that is ...,46,1449,Hum_Mol_Genet_2015_Jul_1_24(13)_3732-3741.txt
5560G>A,"...of translation (p.R796X). The second variant, a c.5560G>A in exon 48 is predicted to result in a mis...",46,1594,Hum_Mol_Genet_2015_Jul_1_24(13)_3732-3741.txt
2386C>T,"...tent with autosomal recessive inheritance, with c.2386C>T inherited from the father (I-1) and c.5560...",46,2438,Hum_Mol_Genet_2015_Jul_1_24(13)_3732-3741.txt
5560G>A,...h c.2386C>T inherited from the father (I-1) and c.5560G>A from the mother (I-2) (Fig. 2B),46,2484,Hum_Mol_Genet_2015_Jul_1_24(13)_3732-3741.txt
5560G>A,... of pseudogene sequence. Reads that support the c.5560G>A variant (here shown on the +ve genomic str...,62,847,Hum_Mol_Genet_2015_Jul_1_24(13)_3732-3741.txt
5560G>A,"...arbour the dinucleotide change, indicating that c.5560G>A is unlikely to be a mismapping artefact. (...",62,980,Hum_Mol_Genet_2015_Jul_1_24(13)_3732-3741.txt
2386C>T,"...es does not extend to the region harbouring the c.2386C>T variant, when viewing the exome data for t...",67,257,Hum_Mol_Genet_2015_Jul_1_24(13)_3732-3741.txt
5560G>A,"...>T variant, when viewing the exome data for the c.5560G>A variant in IGV one sees a small percentage...",67,312,Hum_Mol_Genet_2015_Jul_1_24(13)_3732-3741.txt
5560G>A,...GT) (Fig. 2C). None of the reads supporting the c.5560G>A mutation had this dinucleotide alteration ...,67,616,Hum_Mol_Genet_2015_Jul_1_24(13)_3732-3741.txt
5560G>A,...ogene sequences at its 3′ end (Fig. 2D) and the c.5560G>A variant was still clearly visible (Supplem...,67,900,Hum_Mol_Genet_2015_Jul_1_24(13)_3732-3741.txt
5560G>A,...ther evidence (i) that the maternally inherited c.5560G>A mutation is present in the functional copy...,70,230,Hum_Mol_Genet_2015_Jul_1_24(13)_3732-3741.txt
2386C>T,...udogenes and (ii) that the paternally inherited c.2386C>T mutation is not subjected to significant l...,70,372,Hum_Mol_Genet_2015_Jul_1_24(13)_3732-3741.txt
1824C>T,...nuclei after 70 weeks of expression of the LMNA c.1824C>T mutation showed severe distortion with mul...,5,1581,Hum_Mol_Genet_2015_Mar_1_24(5)_1305-1321.txt
1824C>T,"...ous point mutation in exon 11 of the LMNA gene (c.1824C>T, p.G608G). Although this mutation does not...",10,323,Hum_Mol_Genet_2015_Mar_1_24(5)_1305-1321.txt
1824C>T,...hat specifically expresses the most common LMNA c.1824C>T HGPS mutation in neurons as well as in cel...,14,618,Hum_Mol_Genet_2015_Mar_1_24(5)_1305-1321.txt
1824C>T,Expression of the LMNA c.1824C>T mutation in mic,23,26,Hum_Mol_Genet_2015_Mar_1_24(5)_1305-1321.txt
1824C>T,HGPS animals expressed the LMNA c.1824C>T mutation from embryonic day 12.5 until pos...,32,35,Hum_Mol_Genet_2015_Mar_1_24(5)_1305-1321.txt
1824C>T,"...). In spite of long-term expression of the LMNA c.1824C>T mutation, 90-week HGPS animals did not exh...",37,439,Hum_Mol_Genet_2015_Mar_1_24(5)_1305-1321.txt
1824C>T,...als (Fig. 1P and Q). Twenty or 90 weeks of LMNA c.1824C>T mutation expression did not cause any majo...,37,1512,Hum_Mol_Genet_2015_Mar_1_24(5)_1305-1321.txt
1824C>T,...fects in the heart after 20 or 74 weeks of LMNA c.1824C>T mutation expression (Supplementary Materia...,37,2649,Hum_Mol_Genet_2015_Mar_1_24(5)_1305-1321.txt
1824C>T,"... of the common progeroid lamin A mutation, LMNA c.1824C>T; p.G608G, to test the hypothesis that neur...",87,542,Hum_Mol_Genet_2015_Mar_1_24(5)_1305-1321.txt
1732C>T,"... fibroblast lines with mutations in AP5Z1 : (i) c.1732C>T (p.Q578*), (ii) c.[412C>T];[1322G>A] (p.[R...",18,497,Hum_Mol_Genet_2015_Sep_1_24(17)_4984-4996.txt
412C>T,"...tions in AP5Z1 : (i) c.1732C>T (p.Q578*), (ii) c.[412C>T];[1322G>A] (p.[R138*];[W441*]) and (iii) c....",18,524,Hum_Mol_Genet_2015_Sep_1_24(17)_4984-4996.txt
1322G>A,"...AP5Z1 : (i) c.1732C>T (p.Q578*), (ii) c.[412C>T];[1322G>A] (p.[R138*];[W441*]) and (iii) c.[80_83del...",18,533,Hum_Mol_Genet_2015_Sep_1_24(17)_4984-4996.txt
6100C>T,"...G11 patient from Morocco carries the homozygous c.6100C>T (p.Arg2034*) nonsense variant (6), and the...",83,372,Hum_Mol_Genet_2015_Sep_1_24(17)_4984-4996.txt
2431C>T,...e originated from Latvia and has a heterozygous c.2431C>T (p.Q811*) variant in trans of a deletion a...,83,489,Hum_Mol_Genet_2015_Sep_1_24(17)_4984-4996.txt
442G>A,"Active site	p.G148R	c.442G>A	1.31	1.80	B	3	ECE: tetramer, 0–5.82%WT acti...",17,23,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
913G>A,p.G305R	c.913G>A	3.58	4.90	B	1,18,12,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
919G>A,p.G307S	c.919G>A	0.16	0.50	B	88	ECE: undetectable activity [...,19,12,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
194A>G,"Heme binding pocket	p.H65R	c.194A>G	22.01	30.30	S	3	PE: 11.5% WT activity, 75% ...",20,30,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
785C>G,p.T262R	c.785C>G	0.14	0.20	B	1,21,12,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
797G>A,"p.R266K	c.797G>A	1.76	2.90	B	10	PE: Vmax 28–114% of WT, Km[P...",22,12,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
430G>A,Other locations in active core	p.E144K	c.430G>A	0.10	0.20	B	12	ECE: <1%WT activity [Dawson ...,23,42,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
494G>A,p.C165Y	c.494G>A	1.85	3.00	B	8	ECE: 0–3%WT activity [Gordon ...,24,12,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
684C>G,"p.N228K	c.684C>G/A	0.06	0.10	B	4	ECE: aggregates, 0% WT acti...",25,12,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
833T>C,"p.I278T	c.833T>C	0.00	0.00	B	146	PE: Vmax 0.8–1.4% of WT, Km...",26,12,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
146C>T,p.P49L	c.146C>T	35.01	61.90	S	3,27,11,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
306G>C,p.K102N	c.306G>C	17.74	43.40	S	1	ECE: 21–34%WT activity [de ...,28,12,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
374G>A,p.R125Q	c.374G>A	8.57	16.60	S	13	ECE: 0–1.9%WT activity [Mar...,29,12,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
572C>T,p.T191M	c.572C>T	6.93	11.20	S	137	ECE: 1%WT activity [Kluijt...,30,12,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
904G>A,p.E302K	c.904G>A	15.03	24.50	S	6	ECE: shorter product -parti...,31,12,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
1105C>T,p.R369C	c.1105C>T	4.55	10.90	S	4	SCE: does not affect CBS fu...,32,12,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
233C>G,Dimer-dimer interface	p.P78R	c.233C>G	47.79	65.80	S	2	ECE: 13–61%WT activity [de ...,33,32,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
341C>T,p.A114V	c.341C>T	8.94	18.07	S	10	ECE: tetramer + aggregates ...,34,12,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
526G>A,"p.E176K	c.526G>A	16.35	26.60	S	2	ECE: aggregates, 0% WT acti...",35,12,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
539T>C,p.V180A	c.539T>C	5.15	15.50	S	1	ECE: 3–8% WT activity [Kluij...,36,12,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
1265C>T,"Regulatory domain-first CBS domain	p.P422L	c.1265C>T	4.89	8.70	B	1	ECE: ∼160% WT activity, 0.16...",38,46,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
1304T>C,p.I435T	c.1304T>C	16.11	38.50	S	1	ECE: tetramer [Janosik et ...,39,12,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
1316G>A,p.R439Q	c.1316G>A	36.79	71.20	S	3	ECE: 30%WT activity [Dawso...,40,12,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
1330G>A,"p.D444N	c.1330G>A	18.73	45.80	S	13	PE: 1.5 × of WTactivity, ...",41,12,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
1397C>T,"p.S466L	c.1397C>T	0.23	0.40	B	1	ECE: ∼310% WT activity, 0.05...",42,12,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
1616T>C,Regulatory domain-second CBS domain	p.L539S	c.1616T>C	1.93	5.70	B	2,43,47,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
341C>T,"...raus, 1992]. Seven mutant plasmids, namely, the c.341C>T (p.A114V), c.442G>A (p.G148R), c.526G>A (p....",58,151,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
442G>A,"...utant plasmids, namely, the c.341C>T (p.A114V), c.442G>A (p.G148R), c.526G>A (p.E176K), r.1224_1358d...",58,171,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
526G>A,"...ly, the c.341C>T (p.A114V), c.442G>A (p.G148R), c.526G>A (p.E176K), r.1224_1358del; p.W409_G453del, ...",58,191,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
1265C>T,"...6G>A (p.E176K), r.1224_1358del; p.W409_G453del, c.1265C>T (p. P422L), C.1304T>C (p.I435T), and c.139...",58,243,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
1304T>C,"..._1358del; p.W409_G453del, c.1265C>T (p. P422L), C.1304T>C (p.I435T), and c.1397C>T (p.S466L) were pr...",58,265,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
1397C>T,"... c.1265C>T (p. P422L), C.1304T>C (p.I435T), and c.1397C>T (p.S466L) were prepared using the previous...",58,290,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
4A>G,"...anti et al., 2003], and caused by the invariant c.4A>G missense change (p.Ser2Gly) in SHOC2 [Cordedd...",12,2260,Hum_Mutat_2012_Apr_17_33(4)_703-709.txt
4A>G,...ve individuals with NS/LAH due to the invariant c.4A>G missense change in SHOC2. Mutation data (loca...,18,1238,Hum_Mutat_2012_Apr_17_33(4)_703-709.txt
4A>G,"...lesion, five NS/LAH subjects with the invariant c.4A>G SHOC2 mutation, and 21 age- and sex-matched c...",28,524,Hum_Mutat_2012_Apr_17_33(4)_703-709.txt
4A>G,"...ecause of the invariant occurrence of the SHOC2 c.4A>G mutation underlying this disorder, and appear...",31,768,Hum_Mutat_2012_Apr_17_33(4)_703-709.txt
4A>G,"...1 mutation (SO-001–SO-006), and NS/LAH with the c.4A>G change (SH-001–SH-005). Four major transcript...",33,540,Hum_Mutat_2012_Apr_17_33(4)_703-709.txt
4A>G,...icular relevance is the fact that the invariant c.4A>G (p.Ser2Gly) SHOC2 mutation was observed to pr...,84,1145,Hum_Mutat_2012_Apr_17_33(4)_703-709.txt
20A>T,...tution at position 6 of the β-globin chain (HBB c.20A>T; p.Glu6-Val) and is inherited as a Mendelian...,25,163,Hum_Mutat_2013_Jul_8_34(7)_937-944.txt
19G>A,...f HbA caused by an amino acid substitution (HBB c.19G>A; p.Glu6Lys) occurring at the same position. ...,27,86,Hum_Mutat_2013_Jul_8_34(7)_937-944.txt
79G>A,... a structural variant of normal hemoglobin (HBB c.79G>A; p.Glu26Lys) affecting the production rate o...,29,57,Hum_Mutat_2013_Jul_8_34(7)_937-944.txt
28A>G,...pathogenicity of previously reported variants (c.-28A>G and c.-7C>T) within the MLH1 5′untranslated ...,8,777,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,... of previously reported variants (c.-28A>G and c.-7C>T) within the MLH1 5′untranslated region (UTR) ...,8,790,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,... at the promoter. Sequencing revealed that the c.-28A>G and c.-7C>T variants were the only potential...,8,1192,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,...ter. Sequencing revealed that the c.-28A>G and c.-7C>T variants were the only potentially pathogenic...,8,1205,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
64G>T,"...drome, namely, c.-411_-413del, c.-432_-435del, c.-64G>T, c.-53G>T, c.-42C>T, c.-28A>G, c.-28A>T, c.-...",15,148,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
53G>T,"...ely, c.-411_-413del, c.-432_-435del, c.-64G>T, c.-53G>T, c.-42C>T, c.-28A>G, c.-28A>T, c.-27C>A, c.-...",15,158,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
42C>T,"...1_-413del, c.-432_-435del, c.-64G>T, c.-53G>T, c.-42C>T, c.-28A>G, c.-28A>T, c.-27C>A, c.-11C>T, and...",15,168,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,"... c.-432_-435del, c.-64G>T, c.-53G>T, c.-42C>T, c.-28A>G, c.-28A>T, c.-27C>A, c.-11C>T, and c.-7C>T [...",15,178,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>T,"...35del, c.-64G>T, c.-53G>T, c.-42C>T, c.-28A>G, c.-28A>T, c.-27C>A, c.-11C>T, and c.-7C>T [Green et a...",15,188,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
27C>A,"...64G>T, c.-53G>T, c.-42C>T, c.-28A>G, c.-28A>T, c.-27C>A, c.-11C>T, and c.-7C>T [Green et al., 2003; ...",15,198,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
11C>T,"...53G>T, c.-42C>T, c.-28A>G, c.-28A>T, c.-27C>A, c.-11C>T, and c.-7C>T [Green et al., 2003; Hitchins e...",15,208,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,"...T, c.-28A>G, c.-28A>T, c.-27C>A, c.-11C>T, and c.-7C>T [Green et al., 2003; Hitchins et al., 2011; W...",15,222,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
27C>A,...her genetic defect within MLH1. Studies of the c.-27C>A variant provide the most compelling evidence...,15,513,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
42C>T,"... MLH1. In support of this, the c.-411_-413del, c.-42C>T, c.-27C>A, and c.-11C>T variants also signif...",15,1114,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
27C>A,"...support of this, the c.-411_-413del, c.-42C>T, c.-27C>A, and c.-11C>T variants also significantly re...",15,1124,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
11C>T,"...s, the c.-411_-413del, c.-42C>T, c.-27C>A, and c.-11C>T variants also significantly reduce the activ...",15,1138,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,"...analysis of the potential pathogenicity of the c.-28A>G or c.-7C>T variants has been undertaken, des...",15,1393,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,"...the potential pathogenicity of the c.-28A>G or c.-7C>T variants has been undertaken, despite the fac...",15,1405,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,...we aimed to determine the pathogenicity of the c.-28A>G and c.-7C>T variants within the MLH1 5′ untr...,17,66,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,...etermine the pathogenicity of the c.-28A>G and c.-7C>T variants within the MLH1 5′ untranslated regi...,17,79,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,...ds (Proband 32 and Proband N; Fig. 1) with the c.-28A>G and c.-7C>T variants (all nucleotide numberi...,21,61,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,...2 and Proband N; Fig. 1) with the c.-28A>G and c.-7C>T variants (all nucleotide numbering used throu...,21,74,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,.../169) and Norway (HREC 2014/493/REK midt). The c.-28A>G and c.-7C>T variants studied in this manuscr...,21,290,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,...way (HREC 2014/493/REK midt). The c.-28A>G and c.-7C>T variants studied in this manuscript have been...,21,303,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,...ected in the MLH1 or PMS2 genes except for the c.-28A>G and c.-7C>T heterozygous variants in the MLH...,21,1205,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,...MLH1 or PMS2 genes except for the c.-28A>G and c.-7C>T heterozygous variants in the MLH1 5′UTR. The ...,21,1218,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,...1 Identification of two probands with the MLH1 c.-28A>G and c.-7C>T variants from two unrelated canc...,23,58,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,...ion of two probands with the MLH1 c.-28A>G and c.-7C>T variants from two unrelated cancer-affected f...,23,71,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,...y cancer. Family N showed cosegregation of the c.-28A>G and c.-7C>T variants across two generations....,23,384,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,...ily N showed cosegregation of the c.-28A>G and c.-7C>T variants across two generations. See also Sup...,23,397,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
655G>A,...and allele specificity was determined using the c.655G>A site,35,821,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
655G>A,"... 1a and 9 followed by pyrosequencing across the c.655G>A site [Kwok et al., 2010]",38,834,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,"To confirm the presence of the c.-28A>G and c.-7C>T variants, we performed sequencin...",48,35,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,"To confirm the presence of the c.-28A>G and c.-7C>T variants, we performed sequencing of a 1,067-...",48,48,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
93G>A,"...dentified three heterozygous variants, namely, c.-93G>A, c.-28A>G, and c.-7C>T (Supp. Fig. S1A). No ...",48,271,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,"...three heterozygous variants, namely, c.-93G>A, c.-28A>G, and c.-7C>T (Supp. Fig. S1A). No further se...",48,281,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,"...gous variants, namely, c.-93G>A, c.-28A>G, and c.-7C>T (Supp. Fig. S1A). No further sequence variant...",48,295,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
93G>A,"...ants were identified in this region. While the c.-93G>A is a common and benign variant, the c.-28A>G...",48,392,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,"...e c.-93G>A is a common and benign variant, the c.-28A>G and c.-7C>T are described as Class 3 variant...",48,437,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,"... a common and benign variant, the c.-28A>G and c.-7C>T are described as Class 3 variants of uncertai...",48,450,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,To determine whether the c.-28A>G and c.-7C>T variants were in cis with anothe...,51,29,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,To determine whether the c.-28A>G and c.-7C>T variants were in cis with another pathogenic ...,51,42,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,...e detected across the MLH1 gene other than the c.-28A>G and c.-7C>T variants,51,948,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,...ross the MLH1 gene other than the c.-28A>G and c.-7C>T variants,51,961,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,...lterations within the MLH1 gene other than the c.-28A>G and c.-7C>T variants. A: The locations of th...,53,134,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,...thin the MLH1 gene other than the c.-28A>G and c.-7C>T variants. A: The locations of the 15 genes wi...,53,147,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
93G>A,"...ribed in Supp. Figure S2 cosegregated with the c.-93G>A, c.-28A>G, c.-7C>T, and VILL c.1164del varia...",57,1557,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,"...upp. Figure S2 cosegregated with the c.-93G>A, c.-28A>G, c.-7C>T, and VILL c.1164del variants in the...",57,1567,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,"...e S2 cosegregated with the c.-93G>A, c.-28A>G, c.-7C>T, and VILL c.1164del variants in the first-deg...",57,1577,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,...ithin or flanking the MLH1 gene other than the c.-28A>G and c.-7C>T variants prompted us to investig...,60,111,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,...king the MLH1 gene other than the c.-28A>G and c.-7C>T variants prompted us to investigate their rol...,60,124,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
655G>A,"... 1a and 9 followed by pyrosequencing across the c.655G>A site (Fig. 3A). In Proband 32, the proporti...",60,448,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
655G>A,...ontrol PBMCs that were also heterozygous at the c.655G>A site (Fig. 3D; mean normal allelic balance ...,60,1190,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,"...0001, paired t-test). These data show that the c.-28A>G and c.-7C>T variants are associated with par...",60,1352,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,...t-test). These data show that the c.-28A>G and c.-7C>T variants are associated with partial loss of ...,60,1365,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
655A>G,...rimer used to assess allelic balance across the c.655A>G site (Pyro R). B and C: Representative pyro...,62,460,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
655A>G,...rom healthy donors that were informative at the c.655A>G site. ****P < 0.0001 (paired t-test). Allel...,62,914,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,...n the MS-MLPA assay) that was abolished by the c.-7C>T variant (Fig. 4A). Bisulfite sequencing of in...,65,555,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
93G>A,...ng of individual promoter molecules across the c.-93G>A variant confirmed the lack of methylation on...,65,647,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,"...tical bars), and the sequence encompassing the c.-7C>T site. The presence of the c.-7C>T variant abo...",67,312,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,...mpassing the c.-7C>T site. The presence of the c.-7C>T variant abolishes a HhaI restriction site. B:...,67,346,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
93G>A,...g data of various tissues from Proband 32. The c.-93G>A site was used to distinguish between wild-ty...,67,482,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,"...ding to allele of origin, as determined by the c.-7C>T variant (yellow diamond). Black arrows indica...",67,1297,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
655A>G,"...3, c.-28 or c.-7 sites, we sequenced across the c.655A>G variant to determine the allele of transcri...",69,437,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,"... were located in the immediate vicinity of the c.-28A>G and c.-7C>T variants. However, comparison of...",69,1019,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,"... in the immediate vicinity of the c.-28A>G and c.-7C>T variants. However, comparison of the initiati...",69,1032,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,...s these initiation sites using the informative c.-7C>T site to distinguish between the wild-type and...,69,1341,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,"...ted Lynch syndrome families. Specifically, the c.-28A>G and c.-7C>T variants were associated with ∼5...",72,176,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,"...drome families. Specifically, the c.-28A>G and c.-7C>T variants were associated with ∼50% reduction ...",72,189,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,"...sion from the variant allele, we show that the c.-28A>G and c.-7C>T variants are not associated with...",72,788,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,"... variant allele, we show that the c.-28A>G and c.-7C>T variants are not associated with promoter hyp...",72,801,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,...ome occupancy. These findings suggest that the c.-28A>G and c.-7C>T variants may be pathogenic due t...,72,940,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,.... These findings suggest that the c.-28A>G and c.-7C>T variants may be pathogenic due to allelic imb...,72,953,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
42C>T,...d-type allele. Green et al. (2003) described a c.-42C>T variant within the MLH1 gene associated with...,74,401,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,...ective transcription. Our observation that the c.-28A>G and c.-7C>T variants are associated with par...,74,1094,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,...ription. Our observation that the c.-28A>G and c.-7C>T variants are associated with partial constitu...,74,1107,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,"...e transcriptional activity associated with the c.-28A>G and c.-7C>T variants in other tissues, inclu...",74,1760,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,"...onal activity associated with the c.-28A>G and c.-7C>T variants in other tissues, including colorect...",74,1773,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,...ble age of onset of cancer associated with the c.-28A>G and c.-7C>T variants was evident from the tw...,76,60,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,...set of cancer associated with the c.-28A>G and c.-7C>T variants was evident from the two families we...,76,73,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,...e to ascertain whether the grandfather had the c.-28A>G and c.-7C>T variants. This variable penetran...,76,441,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,...n whether the grandfather had the c.-28A>G and c.-7C>T variants. This variable penetrance may be exp...,76,454,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
42C>T,"...H1 expression, as described previously for the c.-42C>T variant, which was associated with drastical...",76,593,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
42C>T,...lyses of the tumor from an individual with the c.-42C>T variant revealed deletion of the MLH1 allele...,76,882,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,Further evidence that the c.-28A>G and c.-7C>T variants are the most likely cau...,78,30,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,Further evidence that the c.-28A>G and c.-7C>T variants are the most likely cause of cancer ...,78,43,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,"...thin or flanking the MLH1 gene, other than the c.-28A>G and c.-7C>T variants. This approach identifi...",78,516,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,"...ing the MLH1 gene, other than the c.-28A>G and c.-7C>T variants. This approach identified a frameshi...",78,529,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,"...ILL gene. The cosegregation of the c.1164del1, c.-28A>G, and c.-7C>T variants in a first-degree rela...",78,664,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,"...cosegregation of the c.1164del1, c.-28A>G, and c.-7C>T variants in a first-degree relative of Proban...",78,678,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,"...ic history of this haplotype. For example, the c.-28A>G and c.-7C>T variants have an identical MAF o...",78,921,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,"... this haplotype. For example, the c.-28A>G and c.-7C>T variants have an identical MAF of 0.0003, sho...",78,934,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,...because it was absent in Family N in which the c.-28A>G and c.-7C>T variants cosegregated. Therefore...,78,1892,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,"...s absent in Family N in which the c.-28A>G and c.-7C>T variants cosegregated. Therefore, the c.-28A>...",78,1905,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,"... c.-7C>T variants cosegregated. Therefore, the c.-28A>G and c.-7C>T variants are the most likely cau...",78,1951,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,"...ants cosegregated. Therefore, the c.-28A>G and c.-7C>T variants are the most likely cause of predisp...",78,1964,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,"...negative and BRAF wild-type. Separate from the c.-7C>T and c.-28A>G variants, no constitutional muta...",80,383,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,"... BRAF wild-type. Separate from the c.-7C>T and c.-28A>G variants, no constitutional mutations in MLH...",80,395,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,"...tion is provided. Therefore, the rarity of the c.-28A>G and c.-7C>T haplotype at the population leve...",80,687,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,"...ded. Therefore, the rarity of the c.-28A>G and c.-7C>T haplotype at the population level, but its pr...",80,700,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,...n whether both or only one are pathogenic. The c.-7C>T variant was found in a member of a hereditary...,82,121,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>T,...on of a case of CRC that was associated with a c.-28A>T variant in a 29-year-old individual from a f...,82,331,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>T,...-28A nucleotide may be pathogenic. Whether the c.-28A>T variant in this family was associated with r...,82,525,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
27C>A,"...hermore, a variant of the adjacent nucleotide (c.-27C>A) also segregates with Lynch syndrome in seve...",82,702,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
93G>A,"The presence of the c.-93G>A, c.-28A>G, c.-7C>T, and c.655A>G variants in...",84,24,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,"The presence of the c.-93G>A, c.-28A>G, c.-7C>T, and c.655A>G variants in both prob...",84,34,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,"The presence of the c.-93G>A, c.-28A>G, c.-7C>T, and c.655A>G variants in both probands allow...",84,44,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
655A>G,"...resence of the c.-93G>A, c.-28A>G, c.-7C>T, and c.655A>G variants in both probands allowed us to dis...",84,56,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,"...hypermethylation was an artifact caused by the c.-7C>T variant, which lies within a recognition site...",84,553,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,...scription factors. Due to the proximity of the c.-28A>G and c.-7C>T variants to transcription initia...,84,1865,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,"...tors. Due to the proximity of the c.-28A>G and c.-7C>T variants to transcription initiation sites, w...",84,1878,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,...f suspected Lynch syndrome associated with the c.-28A>G and c.-7C>T variants. Our analysis shows tha...,86,98,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,...ynch syndrome associated with the c.-28A>G and c.-7C>T variants. Our analysis shows that these varia...,86,111,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
93G>A,"Figure S4. Co-segregation of the c.-93G>A, c.-28A>G, c.-7C>T and VILL c.1164del1 varia...",99,37,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,"Figure S4. Co-segregation of the c.-93G>A, c.-28A>G, c.-7C>T and VILL c.1164del1 variants in a f...",99,47,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,"... S4. Co-segregation of the c.-93G>A, c.-28A>G, c.-7C>T and VILL c.1164del1 variants in a first degre...",99,57,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
27C>A,...baum U  McKinnon WC  Greenblatt MS    The MLH1 c.-27C>A and c.85G>T variants are linked to dominantl...,131,165,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
85G>T,...nnon WC  Greenblatt MS    The MLH1 c.-27C>A and c.85G>T variants are linked to dominantly inherited ...,131,177,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
188A > G,"p.Lys63Arg	ENST00000264663.5:c.188A > G	PASS	Missense	5,565	121100	196",185,32,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
1987C > T,"p.Leu663Phe	ENST00000264663.5:c.1987C > T	PASS	Missense	5,425	121298	188",186,33,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
2977A > G,"p.Ile993Val	ENST00000264663.5:c.2977A > G	PASS	Missense	1,107	120944	7",187,33,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
2192C > T,p.Thr731Met	ENST00000264663.5:c.2192C > T	PASS	Missense	897	121348	4,188,33,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
80G > A,p.Arg27His	ENST00000264663.5:c.80G > A	PASS	Missense	197	121362	2,189,32,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
1765A > T,p.Thr589Ser	ENST00000264663.5:c.1765A > T	PASS	Missense	17	121412	1,190,33,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
238 G>A,...ng G  Gao Y  Liu L  Gao T   TNF-a Gene Promoter – 238 G>A and -308 G>A Polymorphisms Alter Risk of P...,138,62,Indian_J_Dermatol_2015_Jul-Aug_60(4)_345-350.txt
308 G>A,...Liu L  Gao T   TNF-a Gene Promoter – 238 G>A and -308 G>A Polymorphisms Alter Risk of Psoriasis Vulg...,138,75,Indian_J_Dermatol_2015_Jul-Aug_60(4)_345-350.txt
2416 G > A,...on have been identified. The missense mutation (c.2416 G > A p.D806N; rs702689) was identified in ex...,40,329,Indian_J_Hum_Genet_2013_Oct-Dec_19(4)_437-442.txt
3084A > G,...four patients (2-4 and 7). The silent mutation (c.3084A > G p.Q1028Q; rs3822625) was also identified...,40,465,Indian_J_Hum_Genet_2013_Oct-Dec_19(4)_437-442.txt
1284G > A,...Figure 1b]; whereas the other silent mutation (c. 1284G > A p.T428T; rs832575) was identified in exo...,40,599,Indian_J_Hum_Genet_2013_Oct-Dec_19(4)_437-442.txt
185C>G,"...present investigation, five mutations of TFAP2B c.185C>G, c.673C>T, c.673 C>A, c.791C>A, c.821 G>A, ...",35,186,Indian_J_Med_Res_2011_Nov_134(5)_621-626.txt
673C>T,"...vestigation, five mutations of TFAP2B c.185C>G, c.673C>T, c.673 C>A, c.791C>A, c.821 G>A, c.865C>T w...",35,196,Indian_J_Med_Res_2011_Nov_134(5)_621-626.txt
673 C>A,"...n, five mutations of TFAP2B c.185C>G, c.673C>T, c.673 C>A, c.791C>A, c.821 G>A, c.865C>T were screen...",35,206,Indian_J_Med_Res_2011_Nov_134(5)_621-626.txt
791C>A,"...ations of TFAP2B c.185C>G, c.673C>T, c.673 C>A, c.791C>A, c.821 G>A, c.865C>T were screened Table II...",35,217,Indian_J_Med_Res_2011_Nov_134(5)_621-626.txt
821 G>A,"...TFAP2B c.185C>G, c.673C>T, c.673 C>A, c.791C>A, c.821 G>A, c.865C>T were screened Table IIIin 100 CH...",35,227,Indian_J_Med_Res_2011_Nov_134(5)_621-626.txt
865C>T,"...5C>G, c.673C>T, c.673 C>A, c.791C>A, c.821 G>A, c.865C>T were screened Table IIIin 100 CHD cases and...",35,238,Indian_J_Med_Res_2011_Nov_134(5)_621-626.txt
1222A>G,"...G allele. Conclusion: The presence of rs628031 (c.1222A>G, M408V) and rs2306283 (c.388A>G, N130D) po...",2391,1220,Indian_J_Pharmacol_2015_Dec_47(Suppl_1)_S57-S177.txt
388A>G,"...e of rs628031 (c.1222A>G, M408V) and rs2306283 (c.388A>G, N130D) polymorphism significantly affected...",2391,1253,Indian_J_Pharmacol_2015_Dec_47(Suppl_1)_S57-S177.txt
31 C>A,CDKN1A (p21) codon 31 C>A Ser/Arg rs1801270,83,20,Infect_Agent_Cancer_2013_May_4_8_15.txt
72 G>C,TP53 (p53) codon 72 G>C Arg/Pro rs1042522,89,18,Infect_Agent_Cancer_2013_May_4_8_15.txt
1853 G>A,ATM codon 1853 G>A Asp/Asn rs1801516,95,11,Infect_Agent_Cancer_2013_May_4_8_15.txt
309 T>C,HDM2 promoter 309 T>C rs2279744,101,15,Infect_Agent_Cancer_2013_May_4_8_15.txt
10 T>C,TGFβ1 codon 10 T>C Leu/Pro rs1982073,107,13,Infect_Agent_Cancer_2013_May_4_8_15.txt
399 G>A,XRCC1 codon 399 G>A Arg/Gln rs25487,113,13,Infect_Agent_Cancer_2013_May_4_8_15.txt
241 C>T,XRCC3 codon 241 C>T Thr/Met rs861539,119,13,Infect_Agent_Cancer_2013_May_4_8_15.txt
399 G>A,XRCC1 codon 399 G>A Arg/Gln (rs25487),132,13,Infect_Agent_Cancer_2013_May_4_8_15.txt
72 G>C,TP53 (p53) codon 72 G>C Arg/Pro (rs1042522),143,18,Infect_Agent_Cancer_2013_May_4_8_15.txt
77T->C,"... Romestaing P Gerard JP Pisani P Hall J The XRCC1–77T->C variant: haplotypes, breast cancer risk, re...",213,83,Infect_Agent_Cancer_2013_May_4_8_15.txt
9224G>A,"...polymorphisms include five SNPs (AAFC02034082.1:g.9224G>A, 9330A>C, 9367G>C, 9419A>C and 9435T>G) an...",43,373,Int_J_Biol_Sci_2006_May_18_2(4)_171-178.txt
9330A>C,"...isms include five SNPs (AAFC02034082.1:g.9224G>A, 9330A>C, 9367G>C, 9419A>C and 9435T>G) and one ins...",43,382,Int_J_Biol_Sci_2006_May_18_2(4)_171-178.txt
9367G>C,"...ude five SNPs (AAFC02034082.1:g.9224G>A, 9330A>C, 9367G>C, 9419A>C and 9435T>G) and one insertion/de...",43,391,Int_J_Biol_Sci_2006_May_18_2(4)_171-178.txt
9419A>C,"...SNPs (AAFC02034082.1:g.9224G>A, 9330A>C, 9367G>C, 9419A>C and 9435T>G) and one insertion/deletion (A...",43,400,Int_J_Biol_Sci_2006_May_18_2(4)_171-178.txt
9435T>G,"...034082.1:g.9224G>A, 9330A>C, 9367G>C, 9419A>C and 9435T>G) and one insertion/deletion (AAFC02034082....",43,412,Int_J_Biol_Sci_2006_May_18_2(4)_171-178.txt
10084T>C,"...ted, including two genomic SNPs (AAFC02034082.1:g.10084T>C and 10228G>T) and two coding SNPs (AAFC02...",43,725,Int_J_Biol_Sci_2006_May_18_2(4)_171-178.txt
10228G>T,...g two genomic SNPs (AAFC02034082.1:g.10084T>C and 10228G>T) and two coding SNPs (AAFC02034082.1:c.10...,43,738,Int_J_Biol_Sci_2006_May_18_2(4)_171-178.txt
10326C>T,...d 10228G>T) and two coding SNPs (AAFC02034082.1:c.10326C>T and 10364A>G). The latter coding SNP (AAF...,43,786,Int_J_Biol_Sci_2006_May_18_2(4)_171-178.txt
10364A>G,...nd two coding SNPs (AAFC02034082.1:c.10326C>T and 10364A>G). The latter coding SNP (AAFC02034082.1:c...,43,799,Int_J_Biol_Sci_2006_May_18_2(4)_171-178.txt
10364A>G,...0364A>G). The latter coding SNP (AAFC02034082.1:c.10364A>G) changes an amino acid from aspartic acid...,43,850,Int_J_Biol_Sci_2006_May_18_2(4)_171-178.txt
9367 G>C,...two SNPs in the promoter region (AAFC02034082.1:g.9367 G>C (P=0.0288) and 9419A>C (P=0.0397)) with B...,46,121,Int_J_Biol_Sci_2006_May_18_2(4)_171-178.txt
9419A>C,"... region (AAFC02034082.1:g.9367 G>C (P=0.0288) and 9419A>C (P=0.0397)) with BMS, and a suggestive ass...",46,145,Int_J_Biol_Sci_2006_May_18_2(4)_171-178.txt
10364A>G,... and a suggestive association of AAFC02034082.1:c.10364A>G with SFD (P=0.0739) (Table 1). Bayesian a...,46,224,Int_J_Biol_Sci_2006_May_18_2(4)_171-178.txt
9367G>C,"...heir posterior distribution. For AAFC02034082.1:g.9367G>C, only CG and GG genotypes exist in the F2 ...",46,460,Int_J_Biol_Sci_2006_May_18_2(4)_171-178.txt
9419A>C,"... in the F2 progeny. However, for AAFC02034082.1:g.9419A>C, only AC and AA genotypes were considered ...",46,549,Int_J_Biol_Sci_2006_May_18_2(4)_171-178.txt
9367G>C,"...tions between these two markers (AAFC02034082.1:g.9367G>C and 9419A>C), which were significantly ass...",48,88,Int_J_Biol_Sci_2006_May_18_2(4)_171-178.txt
9419A>C,"...n these two markers (AAFC02034082.1:g.9367G>C and 9419A>C), which were significantly associated with...",48,100,Int_J_Biol_Sci_2006_May_18_2(4)_171-178.txt
10364A>G,... significant interaction between AAFC02034082.1:c.10364A>G and these two markers for beef marbling. ...,48,290,Int_J_Biol_Sci_2006_May_18_2(4)_171-178.txt
10364A>G,...nd was also observed for markers AAFC02034082.1:c.10364A>G and g.9419A>C (P=0.0055). The marbling sc...,48,976,Int_J_Biol_Sci_2006_May_18_2(4)_171-178.txt
9419A>C,...erved for markers AAFC02034082.1:c.10364A>G and g.9419A>C (P=0.0055). The marbling score was 2.40 hi...,48,991,Int_J_Biol_Sci_2006_May_18_2(4)_171-178.txt
61450 C>A,"...onfirmed the association of obesity with the SNP +61450 C>A and +83897 T>A haplotype (χ2 = 7.637, p ...",53,957,Int_J_Biol_Sci_2006_May_18_2(4)_171-178.txt
83897 T>A,"...sociation of obesity with the SNP +61450 C>A and +83897 T>A haplotype (χ2 = 7.637, p = 0.02). Howeve...",53,972,Int_J_Biol_Sci_2006_May_18_2(4)_171-178.txt
9367G>C,...two SNPs in the promoter region (AAFC02034082.1:g.9367G>C and g.9419A>C) on beef marbling score unde...,62,126,Int_J_Biol_Sci_2006_May_18_2(4)_171-178.txt
9419A>C,...e promoter region (AAFC02034082.1:g.9367G>C and g.9419A>C) on beef marbling score under the assumpti...,62,140,Int_J_Biol_Sci_2006_May_18_2(4)_171-178.txt
10364A>G,"...tion of interaction effects between markers: A, c.10364A>G and g.9367G>C, and B, c.10364A>G and g.94...",64,75,Int_J_Biol_Sci_2006_May_18_2(4)_171-178.txt
9367G>C,"...tion effects between markers: A, c.10364A>G and g.9367G>C, and B, c.10364A>G and g.9419A>C, on beef ...",64,90,Int_J_Biol_Sci_2006_May_18_2(4)_171-178.txt
10364A>G,"...en markers: A, c.10364A>G and g.9367G>C, and B, c.10364A>G and g.9419A>C, on beef marbling scores (B...",64,108,Int_J_Biol_Sci_2006_May_18_2(4)_171-178.txt
9419A>C,"...c.10364A>G and g.9367G>C, and B, c.10364A>G and g.9419A>C, on beef marbling scores (BMS)",64,123,Int_J_Biol_Sci_2006_May_18_2(4)_171-178.txt
3435C>T,"...ug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C>T affects mRNA stability Pharmacogenet Genom...",218,110,Int_J_Biol_Sci_2013_Apr_22_9(4)_350-360.txt
653G>A,...moter element which encodes for the − 463G/A (c.− 653G>A according to the current manuscript) polymo...,90,442,Int_J_Cardiol_2014_Jun_1_174(1)_96-105.txt
822C>A,c.− 822C>A (rs2243827)	Non-coding,267,5,Int_J_Cardiol_2014_Jun_1_174(1)_96-105.txt
765T>C,c.− 765T>C (rs2243828)	Non-coding,270,5,Int_J_Cardiol_2014_Jun_1_174(1)_96-105.txt
653G>A,c.-653G>A (rs2333227)	Non-coding,273,4,Int_J_Cardiol_2014_Jun_1_174(1)_96-105.txt
287C>T,g.287C>T (rs2856857)	Non-coding,276,3,Int_J_Cardiol_2014_Jun_1_174(1)_96-105.txt
5237G>A,g.5237G>A (rs11575868)	Non-coding,279,3,Int_J_Cardiol_2014_Jun_1_174(1)_96-105.txt
9890A>C,g.9890A>C (rs2071409)	Non-coding,282,3,Int_J_Cardiol_2014_Jun_1_174(1)_96-105.txt
157G>T,c.157G>T (rs7208693)	Val53Phe,285,3,Int_J_Cardiol_2014_Jun_1_174(1)_96-105.txt
2149T>C,c.2149T>C (rs2759)	Ile717Val,288,3,Int_J_Cardiol_2014_Jun_1_174(1)_96-105.txt
822C>A,c.− 822C>A (rs2243827)	Non-coding,298,5,Int_J_Cardiol_2014_Jun_1_174(1)_96-105.txt
765T>C,c.− 765T>C (rs2243828)	Non-coding,302,5,Int_J_Cardiol_2014_Jun_1_174(1)_96-105.txt
653G>A,c.− 653G>A (rs2333227)	Non-coding,306,5,Int_J_Cardiol_2014_Jun_1_174(1)_96-105.txt
287C>T,c.287C>T (rs2856857)	Non-coding,310,3,Int_J_Cardiol_2014_Jun_1_174(1)_96-105.txt
5237G>A,g.5237G>A (rs11575868)	Non-coding,314,3,Int_J_Cardiol_2014_Jun_1_174(1)_96-105.txt
9890A>C,g.9890A>C (rs2071409)	Non-coding,318,3,Int_J_Cardiol_2014_Jun_1_174(1)_96-105.txt
157G>T,c.157G>T (rs7208693)	Val53Phe,322,3,Int_J_Cardiol_2014_Jun_1_174(1)_96-105.txt
2149T>C,c.2149T>C (rs2759)	Ile717Val,326,3,Int_J_Cardiol_2014_Jun_1_174(1)_96-105.txt
234 T>G,"...t 13 families exhibited a BRCA1 exon 3 nucleotide 234 T>G mutation (pCys39Gly), which is not previou...",123,96,Int_J_Circumpolar_Health_2012_Aug_16_71_10_3402_ijch_v71i0_19155.txt
1669T >G,...cement of the amino acid tryptophan by glycine (c.1669T >G;p.W557G) (arrow,38,1446,Int_J_Colorectal_Dis_2012_Jun_29_27(6)_689-700.txt
1502T>G,"...55/2013/987186Clinical StudyA Novel, Homozygous c.1502T>G (p.Val501Gly) Mutation in the Thyroid pero...",3,178,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
1502T>G,...hat the two sisters were homozygous for a novel c.1502T>G mutation. The mutation is predicted to sub...,17,998,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
1502T>G,"...nt, II-1, revealed a novel homozygous mutation, c.1502T>G (Figure 1). The mutation is predicted to c...",42,117,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
12A>G,"...ly). In addition, other documented polymorphisms (12A>G, c.769G>T, c.1193G>C, c.2145C>T, c.2173A>C, ...",42,282,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
769G>T,"...ddition, other documented polymorphisms (12A>G, c.769G>T, c.1193G>C, c.2145C>T, c.2173A>C, and c.254...",42,291,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
1193G>C,"...ther documented polymorphisms (12A>G, c.769G>T, c.1193G>C, c.2145C>T, c.2173A>C, and c.2540T>C) in e...",42,301,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
2145C>T,"...nted polymorphisms (12A>G, c.769G>T, c.1193G>C, c.2145C>T, c.2173A>C, and c.2540T>C) in exons 1, 7, ...",42,312,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
2173A>C,"...rphisms (12A>G, c.769G>T, c.1193G>C, c.2145C>T, c.2173A>C, and c.2540T>C) in exons 1, 7, 8, 12, and ...",42,323,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
2540T>C,"... c.769G>T, c.1193G>C, c.2145C>T, c.2173A>C, and c.2540T>C) in exons 1, 7, 8, 12, and 15, respectivel...",42,338,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
1502T>G,"..., respectively, were also detected in II-1. The c.1502T>G mutation was not found in 100 chromosomes ...",42,425,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
1502T>G,... Silico Predictions of Functional Impact of the c.1502T>G on the TPO Protei,44,58,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
1502T>G,"...resent study, we identified a novel, homozygous c.1502T>G mutation in the TPO gene in two siblings f...",51,195,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
1502T>G,...ormal unrelated individuals suggesting that the c.1502T>G alteration is not a polymorphism,51,520,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
1502T>G,"...conclusion, we demonstrated a novel, homozygous c.1502T>G mutation (p.Val501Gly) in the TPO gene whi...",58,54,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
1502T>G,"...e allele (a), II-1 who was a homozygous for the c.1502T>G (b), and I-1 who was a heterozygous for th...",66,134,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
1502T>G,"...T>G (b), and I-1 who was a heterozygous for the c.1502T>G (c). The single nucleotide transition at l...",66,188,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
1502T>G,...ngle nucleotide transition at location 1502 bp (c.1502T>G) is indicated by an arrow. The nucleotide ...,66,257,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
2A>C,"...hree mutations (p.Q36H, p.G418fsX482, and g.IVS19-2A>C) in the dual oxidase 2 gene responsible for c...",81,138,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
2482 A > G,"... the A/A and the G/A + G/G genotypes of the AMHR2 2482 A > G polymorphism (rs2002555), nor the C/C a...",3,1948,Int_J_Environ_Res_Public_Health_2016_Feb_2_13(2)_185.txt
146T > G,...hus contribute to fertility [7]. The rs10407022 c.146T > G polymorphism leads to the amino acid subs...,14,803,Int_J_Environ_Res_Public_Health_2016_Feb_2_13(2)_185.txt
482A > G,"...he AMH Ile49Ser polymorphism (rs10407022), AMHR2 -482A > G (rs2002555) and C > T rs11170547 polymorp...",70,295,Int_J_Environ_Res_Public_Health_2016_Feb_2_13(2)_185.txt
2482 A > G,"...85-t004_Table 4Table 4 The genotypes of the AMHR2 2482 A > G polymorphism (rs2002555) vs. age, BMI, ...",91,64,Int_J_Environ_Res_Public_Health_2016_Feb_2_13(2)_185.txt
763C>G,...ticleGeneticsGynecology and Female InfertilityThe 763C>G Polymorphism of The Secretory PLA2II,3,220,Int_J_Fertil_Steril_2015_Feb_7_Jan-Mar_8(4)_437-444.txt
763C>G,...s to investigate the potential association of the 763C>G polymorphism in the secretory phospholipase...,16,100,Int_J_Fertil_Steril_2015_Feb_7_Jan-Mar_8(4)_437-444.txt
763C>G,...ciation between the risk of endometriosis and the 763C>G polymorphism of PLA2G2A. Genotype distribut...,25,101,Int_J_Fertil_Steril_2015_Feb_7_Jan-Mar_8(4)_437-444.txt
763C>G,The present study suggests that the 763C>G polymorphism of PLA2G2A play,30,37,Int_J_Fertil_Steril_2015_Feb_7_Jan-Mar_8(4)_437-444.txt
763C>G,"...rabi M, Dabaghi T, Alizadeh SA, Najafipour R. The 763C>G polymorphism o",33,122,Int_J_Fertil_Steril_2015_Feb_7_Jan-Mar_8(4)_437-444.txt
763C>G,"The 763C>G polymorphism (rs11573156), in the 5´UTR whi...",60,5,Int_J_Fertil_Steril_2015_Feb_7_Jan-Mar_8(4)_437-444.txt
763C>G,...this study was to determine the prevalence of the 763C>G polymorphism of PLA2G2A in women with endom...,60,393,Int_J_Fertil_Steril_2015_Feb_7_Jan-Mar_8(4)_437-444.txt
763C>G,"...PLA2IIa gene of the amplicon, the position of the 763C>G polymorphism, the place of the restriction ...",76,79,Int_J_Fertil_Steril_2015_Feb_7_Jan-Mar_8(4)_437-444.txt
763C>G,763C>G genotypes in genomic DNA of the study subje...,79,1,Int_J_Fertil_Steril_2015_Feb_7_Jan-Mar_8(4)_437-444.txt
763C>G,...resent study examined the association between the 763C>G sPLA2IIa gene polymorphism in patients with...,152,56,Int_J_Fertil_Steril_2015_Feb_7_Jan-Mar_8(4)_437-444.txt
763C>G,"...ith Wooton et al, which reported no effect of the 763C>G polymorphism on HDL-C and TG levels in the ...",158,327,Int_J_Fertil_Steril_2015_Feb_7_Jan-Mar_8(4)_437-444.txt
763C>G,... beneficial effects of mutation in this gene. The 763C>G polymorphism of PLA2G2A is also in linkage ...,160,471,Int_J_Fertil_Steril_2015_Feb_7_Jan-Mar_8(4)_437-444.txt
763C>G,Despite the 763C>G polymorphism showing a tendency to decrease...,167,13,Int_J_Fertil_Steril_2015_Feb_7_Jan-Mar_8(4)_437-444.txt
617V> F,...ielmelli P    Clinical profile of homozygous JAK2 617V> F mutation in patients with polycythemia ver...,227,85,Int_J_Hematol_Oncol_Stem_Cell_Res_2016_Apr_1_10(2)_70-78.txt
425C>A,"...ble 1). Two non-conservative missense variants, c.425C>A (p.Pro142His",132,107,Int_J_Med_Sci_2008_Jul_8_5(4)_197-202.txt
4072G>A,"and c.4072G>A (p.Gly1358Lys), and an intronic transversi...",133,23,Int_J_Med_Sci_2008_Jul_8_5(4)_197-202.txt
10C>A,"...  potential to affect splicing of exon 24, c.5467-10C>A (IVS23-10C>A)",134,65,Int_J_Med_Sci_2008_Jul_8_5(4)_197-202.txt
10C>A,"...o affect splicing of exon 24, c.5467-10C>A (IVS23-10C>A)",134,78,Int_J_Med_Sci_2008_Jul_8_5(4)_197-202.txt
397T>C,"...striction site polymorphism involves a rs2234693 (397T>C), while the XbaI restriction site polymorph...",18,1144,Int_J_Med_Sci_2013_Mar_2_10(4)_457-466.txt
351A>G,...striction site polymorphism involves a rs9340799 (351A>G),18,1220,Int_J_Med_Sci_2013_Mar_2_10(4)_457-466.txt
1043C>T,1	IDH3B	chr20:2640199	NM_174855	Exon11	c.1043C>T	p.A348V	Damaging	Het	–	AR	RP46,70,42,Int_J_Mol_Med_2016_Jun_8_37(6)_1528-1534.txt
4405A>G,ABCA4	chr1:94495135	NM_000350	Exon30	c.4405A>G	p.N1469D	Tolerated	Het	–	AR	CORD3/STGD1/RP...,72,41,Int_J_Mol_Med_2016_Jun_8_37(6)_1528-1534.txt
6G>A,TULP1	chr6:35477095	NM_003322	Intron7	c.719-6G>A	–	–	Het	–	AR	LCA15/RP14,73,46,Int_J_Mol_Med_2016_Jun_8_37(6)_1528-1534.txt
6629G>A,CEP290	chr12:88453691	NM_025114	Exon48	c.6629G>A	p.R2210H	Probably damaging	Het	–	AR	BBS14/...,75,43,Int_J_Mol_Med_2016_Jun_8_37(6)_1528-1534.txt
50G>A,CNGB1	chr16:58001141	NM_001135639	Exon2	c.50G>A	p.R17Q	Tolerated	Het	–	AR	RP45,76,44,Int_J_Mol_Med_2016_Jun_8_37(6)_1528-1534.txt
2980C>G,EYS	chr6:65596602	NM_001142800	Exon19	c.2980C>G	p.P994A	Probably damaging	Het	0.0010	AR	RP...,77,42,Int_J_Mol_Med_2016_Jun_8_37(6)_1528-1534.txt
782G>A,HARS	chr5:140056309	NM_001289093	Exon7	c.782G>A	p.R261H	Tolerated	Het	0.0010	AD/AR	UHS3B,78,43,Int_J_Mol_Med_2016_Jun_8_37(6)_1528-1534.txt
1082A>G,NR2E3	chr15:72106440	NM_014249	Exon8	c.1082A>G	p.H361R	Tolerated	Het	0.0023	AD/AR	RP37,79,41,Int_J_Mol_Med_2016_Jun_8_37(6)_1528-1534.txt
467C>T,OPA1	chr3:193336676	NM_130831	Exon4	c.467C>T	p.A156V	Probably damaging	Het	0.0103	AD	OPA...,80,40,Int_J_Mol_Med_2016_Jun_8_37(6)_1528-1534.txt
232G>A,SEMA4A	chr1:156126297	NM_001193300	Exon3	c.232G>A	p.V78M	Probably damaging	Het	–	AD/AR	CORD10...,81,45,Int_J_Mol_Med_2016_Jun_8_37(6)_1528-1534.txt
14350G>A,USH2A	chr1:215822102	NM_206933	Exon66	c.14350G>A	p.E4784K	Probably damaging	Het	–	AR	RP39,82,42,Int_J_Mol_Med_2016_Jun_8_37(6)_1528-1534.txt
985T>A,WFS1	chr4:6302507	NM_001145853	Exon8	c.985T>A	p.F329I	Probably damaging	Het	–	AD/AR	Wolfr...,83,41,Int_J_Mol_Med_2016_Jun_8_37(6)_1528-1534.txt
126 G > T,"..., two other variants of RET were identified (IVS1–126 G > T; rs2565206) and (IVS8+82 A > G; rs302675...",79,59,Int_J_Mol_Sci_2011_Dec_27_13(1)_221-239.txt
82 A > G,"... identified (IVS1–126 G > T; rs2565206) and (IVS8+82 A > G; rs3026750 and 85–86 insC; rs3482797), an...",79,91,Int_J_Mol_Sci_2011_Dec_27_13(1)_221-239.txt
126 G > T,...authors found an association between variant IVS1–126 G > T and age at diagnosis of MTC. On the othe...,79,284,Int_J_Mol_Sci_2011_Dec_27_13(1)_221-239.txt
82 A > G,"...iagnosis of MTC. On the other hand, variant (IVS8+82 A > G; InsC 85–86) was associated with the pres...",79,356,Int_J_Mol_Sci_2011_Dec_27_13(1)_221-239.txt
82 A > G,"...abnormal splicing, postulating that variant (IVS8+82 A > G; 85–86 InsC) could interrupt and/or creat...",79,568,Int_J_Mol_Sci_2011_Dec_27_13(1)_221-239.txt
126 G>T,"...inally, in silico analysis revealed that the IVS1–126 G>T genetic variant creates a new binding site...",84,1673,Int_J_Mol_Sci_2011_Dec_27_13(1)_221-239.txt
126 G>T,IVS1–126 G>T (rs2565206)	Tamanah a (2009)	77 a	100	0.00...,113,6,Int_J_Mol_Sci_2011_Dec_27_13(1)_221-239.txt
82 A>G,IVS8+82 A>G; 85–86 insC (rs3026750)	Tamanah a (2009)	77...,115,6,Int_J_Mol_Sci_2011_Dec_27_13(1)_221-239.txt
450 K > Tcp,"...= 286 K; (B) Above the compensation point, at T = 450 K > Tcp. Note the very weak intensity of the a...",347,272,Int_J_Mol_Sci_2011_Dec_2_12(12)_8797-8835.txt
936C>T,....  Samonigg H.  Yazdani-Biuki B.  Krippl P.   The 936C>T polymorphism of the gene for vascular endot...,292,116,Int_J_Mol_Sci_2012_Nov_13_13(11)_14845-14864.txt
936C>T,86 Gu D.  Wang M.   VEGF 936C>T polymorphism and breast cancer risk: eviden...,296,26,Int_J_Mol_Sci_2012_Nov_13_13(11)_14845-14864.txt
634 G>C,....   Meta-analysis of the association between VEGF-634 G>C and risk of malignancy based on 23 case-co...,297,113,Int_J_Mol_Sci_2012_Nov_13_13(11)_14845-14864.txt
250G > A,"...eceptor (LDL-R) AvaII hepatic lipase gene (LIPC) −250G > A, endothelial lipase gene (LIPG) 584C > T,...",3,2278,Int_J_Mol_Sci_2012_Sep_24_13(9)_12062-12081.txt
584C > T,"... (LIPC) −250G > A, endothelial lipase gene (LIPG) 584C > T, methylenetetrahydrofolate reductase (MTH...",3,2319,Int_J_Mol_Sci_2012_Sep_24_13(9)_12062-12081.txt
677C > T,"... > T, methylenetetrahydrofolate reductase (MTHFR) 677C > T, the E3 ubiquitin ligase myosin regulator...",3,2373,Int_J_Mol_Sci_2012_Sep_24_13(9)_12062-12081.txt
294T > C,"...me proliferator-activated receptor delta (PPARD) +294T > C, and Scavenger receptor class B type 1 (S...",3,2600,Int_J_Mol_Sci_2012_Sep_24_13(9)_12062-12081.txt
250G > A,"...ceptor (LDL-R) AvaII, hepatic lipase gene (LIPC) −250G > A (rs2070895), endothelial lipase gene (LIP...",19,248,Int_J_Mol_Sci_2012_Sep_24_13(9)_12062-12081.txt
584C > T,"...G > A (rs2070895), endothelial lipase gene (LIPG) 584C > T (rs2000813), methylenetetrahydrofolate re...",19,301,Int_J_Mol_Sci_2012_Sep_24_13(9)_12062-12081.txt
677C > T,"...813), methylenetetrahydrofolate reductase (MTHFR) 677C > T (rs1801133), the E3 ubiquitin ligase myos...",19,367,Int_J_Mol_Sci_2012_Sep_24_13(9)_12062-12081.txt
294T > C,...me proliferator-activated receptor delta (PPARD) +294T > C (rs2016520) and Scavenger receptor class ...,19,637,Int_J_Mol_Sci_2012_Sep_24_13(9)_12062-12081.txt
294T > C,... [49] reported that the frequencies of the PPARD +294T > C genotypes were not different among the gr...,65,2331,Int_J_Mol_Sci_2012_Sep_24_13(9)_12062-12081.txt
250G > A,LIPC −250G > A (rs2070895)	GG	480 (49.1)	233 (31.0),134,7,Int_J_Mol_Sci_2012_Sep_24_13(9)_12062-12081.txt
584C > T,LIPG 584C > T (rs2000813)	CC	454 (46.4)	308 (41.0),141,6,Int_J_Mol_Sci_2012_Sep_24_13(9)_12062-12081.txt
677C > T,MTHFR 677C > T (rs1801133)	CC	471 (48.2)	354 (47.1),148,7,Int_J_Mol_Sci_2012_Sep_24_13(9)_12062-12081.txt
294T > C,PPARD +294T > C (rs2016520)	TT	559 (57.2)	396 (52.7),169,8,Int_J_Mol_Sci_2012_Sep_24_13(9)_12062-12081.txt
250G > A,LIPC −250G > A (rs2070895)	GG	117.1 ± 16.9	74.2 ± 9.3	42...,211,7,Int_J_Mol_Sci_2012_Sep_24_13(9)_12062-12081.txt
584C > T,LIPG 584C > T (rs2000813)	CC	117.8 ± 15.8	74.4 ± 9.5	43...,218,6,Int_J_Mol_Sci_2012_Sep_24_13(9)_12062-12081.txt
677C > T,MTHFR 677C > T (rs1801133)	CC	113.7 ± 11.7	72.6 ± 7.5	41...,225,7,Int_J_Mol_Sci_2012_Sep_24_13(9)_12062-12081.txt
294T > C,PPARD +294T > C (rs2016520)	TT	120.0 ± 17.5	75.7 ± 10.1	4...,245,8,Int_J_Mol_Sci_2012_Sep_24_13(9)_12062-12081.txt
250G > A,SBP	LIPC −250G > A genotype	2.211	0.587	0.081	3.764	0.000,266,11,Int_J_Mol_Sci_2012_Sep_24_13(9)_12062-12081.txt
250G > A,LIPC −250G > A allele	1.887	0.760	0.054	2.482	0.013,267,8,Int_J_Mol_Sci_2012_Sep_24_13(9)_12062-12081.txt
584C > T,LIPG 584C > T allele	1.799	0.737	0.053	2.414	0.016,268,7,Int_J_Mol_Sci_2012_Sep_24_13(9)_12062-12081.txt
584C > T,DBP	LIPG 584C > T genotype	1.396	0.403	0.077	3.460	0.001,271,10,Int_J_Mol_Sci_2012_Sep_24_13(9)_12062-12081.txt
584C > T,LIPG 584C > T allele	1.734	0.466	0.083	3.718	0.000,272,7,Int_J_Mol_Sci_2012_Sep_24_13(9)_12062-12081.txt
294T > C,PPARD +294T > C allele	−0.964	0.469	−0.046	−2.054	0.040,273,9,Int_J_Mol_Sci_2012_Sep_24_13(9)_12062-12081.txt
250G > A,LIPC −250G > A genotype	4.317	0.933	0.154	4.629	0.000,287,8,Int_J_Mol_Sci_2012_Sep_24_13(9)_12062-12081.txt
250G > A,LIPC −250G > A allele	4.415	1.267	0.117	3.484	0.001,288,8,Int_J_Mol_Sci_2012_Sep_24_13(9)_12062-12081.txt
584C > T,LIPG 584C > T allele	2.850	1.166	0.085	2.444	0.015,289,7,Int_J_Mol_Sci_2012_Sep_24_13(9)_12062-12081.txt
250G > A,DBP	LIPC −250G > A genotype	1.444	0.579	0.086	2.493	0.013,292,11,Int_J_Mol_Sci_2012_Sep_24_13(9)_12062-12081.txt
250G > A,LIPC −250G > A allele	1.938	0.782	0.085	2.478	0.013,293,8,Int_J_Mol_Sci_2012_Sep_24_13(9)_12062-12081.txt
584C > T,LIPG 584C > T genotype	2.167	0.671	0.112	3.232	0.001,294,7,Int_J_Mol_Sci_2012_Sep_24_13(9)_12062-12081.txt
584C > T,LIPG 584C > T allele	2.783	0.764	0.126	3.644	0.000,295,7,Int_J_Mol_Sci_2012_Sep_24_13(9)_12062-12081.txt
250G > A,LIPC −250G > A genotype	2.862	0.650	0.148	4.405	0.000,301,8,Int_J_Mol_Sci_2012_Sep_24_13(9)_12062-12081.txt
250G > A,LIPC −250G > A allele	2.414	0.882	0.093	2.736	0.006,302,8,Int_J_Mol_Sci_2012_Sep_24_13(9)_12062-12081.txt
1051730 G>A,"...descent (CYP2A6*2, *4, *9, *12) and for the SNP rs1051730 G>A, which tags the loci associated with b...",38,926,Int_J_Mol_Sci_2013_Apr_16_14(4)_8381-8392.txt
1051730 G>A,c CHRNA5-A3-B4 genotype represented by tag SNP rs1051730 G>A with the highest risk genotype for smo...,93,50,Int_J_Mol_Sci_2013_Apr_16_14(4)_8381-8392.txt
516 G>T,"...licing caused by single nucleotide polymorphism c.516 G>T [Q172H], a marker of CYP2B6*6 , is respons...",137,162,Int_J_Mol_Sci_2013_Apr_16_14(4)_8381-8392.txt
677C>T,...R.   Methylenetetrahydrofolate Reductase (MTHFR ) 677C>T and Methionine Synthase Reductase (MTRR ) 6...,195,102,Int_J_Mol_Sci_2013_Jan_28_14(2)_2739-2752.txt
66A>G,... 677C>T and Methionine Synthase Reductase (MTRR ) 66A>G polymorphisms: association with serum homocy...,195,151,Int_J_Mol_Sci_2013_Jan_28_14(2)_2739-2752.txt
66A>G,...van der Linde I.J.  Daniels O.  Blom H.J.   MTRR  66A>G polymorphism in relation to congenital heart...,224,113,Int_J_Mol_Sci_2013_Jan_28_14(2)_2739-2752.txt
682T>G,...erent populations. The only missense mutation 6 c.682T>G (p.Gly228Trp) was reported in an Italian fa...,14,401,Int_J_Mol_Sci_2016_Jul_12_17(7)_1106.txt
769 C>T,"c.769 C>T (p.Arg257X)	Finnish, Northern Italian	Naga...",97,3,Int_J_Mol_Sci_2016_Jul_12_17(7)_1106.txt
254A>G,"c.254A>G (A374G, p.Tyr85Cys)	Iranian Jewish	Björses ...",98,3,Int_J_Mol_Sci_2016_Jul_12_17(7)_1106.txt
415C>T,c.415C>T (p.Arg139X)	Sardinia	Meloni et al. (2012) [...,105,3,Int_J_Mol_Sci_2016_Jul_12_17(7)_1106.txt
1331T>C,...lanas J.M.    Role of chemical structures and the 1331T>C bile salt export pump polymorphism in idio...,376,194,Int_J_Mol_Sci_2016_May_12_17(5)_714.txt
183A>T,"...b.2, respectively. Two of these SNPs (apoA-Ib.2-g.183A>T and apoA-Ib.2-g.1753C>T) were significantly...",5,71,Int_J_Mol_Sci_2016_Sep_16_17(9)_1569.txt
1753C>T,...of these SNPs (apoA-Ib.2-g.183A>T and apoA-Ib.2-g.1753C>T) were significantly associated with body w...,5,94,Int_J_Mol_Sci_2016_Sep_16_17(9)_1569.txt
1746C>T,"...er Bonferroni corrections, two polymorphic loci g.1746C>T and g.2009C>G in C. carpio apoA-Ib.1 were ...",37,688,Int_J_Mol_Sci_2016_Sep_16_17(9)_1569.txt
2009C>G,"...corrections, two polymorphic loci g.1746C>T and g.2009C>G in C. carpio apoA-Ib.1 were significantly ...",37,702,Int_J_Mol_Sci_2016_Sep_16_17(9)_1569.txt
1687T>A,"...from the Hardy-Weinberg equilibrium (HWE). Loci g.1687T>A, g.1689T>C and g.1693A>C in C. carpio apoA...",37,811,Int_J_Mol_Sci_2016_Sep_16_17(9)_1569.txt
1689T>C,"...rdy-Weinberg equilibrium (HWE). Loci g.1687T>A, g.1689T>C and g.1693A>C in C. carpio apoA-Ib.1 were ...",37,822,Int_J_Mol_Sci_2016_Sep_16_17(9)_1569.txt
1693A>C,"...quilibrium (HWE). Loci g.1687T>A, g.1689T>C and g.1693A>C in C. carpio apoA-Ib.1 were completely lin...",37,836,Int_J_Mol_Sci_2016_Sep_16_17(9)_1569.txt
1961G>C,"...rpio apoA-Ib.1 were completely linked, and loci g.1961G>C and g.1966G>C in apoA-Ib.1 were linked, as...",37,902,Int_J_Mol_Sci_2016_Sep_16_17(9)_1569.txt
1966G>C,"... were completely linked, and loci g.1961G>C and g.1966G>C in apoA-Ib.1 were linked, as well",37,916,Int_J_Mol_Sci_2016_Sep_16_17(9)_1569.txt
1693A>C,"...red individuals of Yellow River carp (apoA-Ib.1-g.1693A>C, apoA-Ib.2-g.183A>T and apoA-Ib.2-g.1753C>...",40,120,Int_J_Mol_Sci_2016_Sep_16_17(9)_1569.txt
183A>T,"...llow River carp (apoA-Ib.1-g.1693A>C, apoA-Ib.2-g.183A>T and apoA-Ib.2-g.1753C>T) were additionally ...",40,141,Int_J_Mol_Sci_2016_Sep_16_17(9)_1569.txt
1753C>T,"...b.1-g.1693A>C, apoA-Ib.2-g.183A>T and apoA-Ib.2-g.1753C>T) were additionally genotyped by PCR-restri...",40,164,Int_J_Mol_Sci_2016_Sep_16_17(9)_1569.txt
1693A>C,"...d between growth traits and the locus apoA-Ib.1-g.1693A>C, while the loci g.183A>T and g.1753C>T in ...",40,434,Int_J_Mol_Sci_2016_Sep_16_17(9)_1569.txt
183A>T,"...d the locus apoA-Ib.1-g.1693A>C, while the loci g.183A>T and g.1753C>T in apoA-Ib.2 were still signi...",40,460,Int_J_Mol_Sci_2016_Sep_16_17(9)_1569.txt
1753C>T,"...poA-Ib.1-g.1693A>C, while the loci g.183A>T and g.1753C>T in apoA-Ib.2 were still significantly asso...",40,473,Int_J_Mol_Sci_2016_Sep_16_17(9)_1569.txt
183A>T,"...h growth traits (Table 2). In detail, apoA-Ib.2-g.183A>T showed highly significant association with ...",40,583,Int_J_Mol_Sci_2016_Sep_16_17(9)_1569.txt
1753C>T,"...sociations were also observed between apoA-Ib.2-g.1753C>T and BL (p < 0.05) and BW (p < 0.01), and i...",40,846,Int_J_Mol_Sci_2016_Sep_16_17(9)_1569.txt
183A>T,...her verification of growth associations at loci g.183A>T and g.1753C>T in C. carpi,42,139,Int_J_Mol_Sci_2016_Sep_16_17(9)_1569.txt
1753C>T,...ion of growth associations at loci g.183A>T and g.1753C>T in C. carpi,42,152,Int_J_Mol_Sci_2016_Sep_16_17(9)_1569.txt
183A>T,"...lso observed (Table 2). For the locus apoA-Ib.2-g.183A>T, significant association with BW (p < 0.05)...",43,172,Int_J_Mol_Sci_2016_Sep_16_17(9)_1569.txt
1753C>T,...dividuals with genotype AA. The locus apoA-Ib.2-g.1753C>T was extremely significantly associated wit...,43,355,Int_J_Mol_Sci_2016_Sep_16_17(9)_1569.txt
183A>T,"...und at two SNPs in the present study (apoA-Ib.2-g.183A>T and apoA-Ib.2-g.1753C>T), and these associa...",55,871,Int_J_Mol_Sci_2016_Sep_16_17(9)_1569.txt
1753C>T,"...present study (apoA-Ib.2-g.183A>T and apoA-Ib.2-g.1753C>T), and these associations were verified in ...",55,894,Int_J_Mol_Sci_2016_Sep_16_17(9)_1569.txt
183A>T,...er than GH itself. We speculated that apoA-Ib.2-g.183A>T in the intron of 5’-UTR may be involved in ...,55,1445,Int_J_Mol_Sci_2016_Sep_16_17(9)_1569.txt
1753C>T,"...east cancer. In this study, the locus apoA-Ib.2-g.1753C>T in exon 3 of C. carpi",56,326,Int_J_Mol_Sci_2016_Sep_16_17(9)_1569.txt
501A>T,apoA-Ib.1	g.501A>T	5′-UTR	TT	0.053	T	0.321	0.537	0.438	0.034,118,13,Int_J_Mol_Sci_2016_Sep_16_17(9)_1569.txt
1092A>T,g.1092A>T	Exon2	TT	0.325	T	0.575	0.525	0.492	0.648,136,4,Int_J_Mol_Sci_2016_Sep_16_17(9)_1569.txt
1114A>T,g.1114A>T	Exon2	TT	0.263	T	0.519	0.513	0.502	1.000,154,4,Int_J_Mol_Sci_2016_Sep_16_17(9)_1569.txt
1444G>A,g.1444G>A	Exon3	AA	0.673	A	0.811	0.276	0.308	0.323,172,4,Int_J_Mol_Sci_2016_Sep_16_17(9)_1569.txt
1500C>T,g.1500C>T	Exon3	CC	0.663	C	0.832	0.337	0.281	0.066,190,4,Int_J_Mol_Sci_2016_Sep_16_17(9)_1569.txt
1506G>A,g.1506G>A	Exon3	AA	0.490	A	0.719	0.459	0.241	0.219,199,4,Int_J_Mol_Sci_2016_Sep_16_17(9)_1569.txt
1518G>A,g.1518G>A	Exon3	AA	0.010	A	0.117	0.214	0.208	1.000,217,4,Int_J_Mol_Sci_2016_Sep_16_17(9)_1569.txt
1569A>C,g.1569A>C	Exon3	AA	0.898	A	0.949	0.102	0.097	1.000,235,4,Int_J_Mol_Sci_2016_Sep_16_17(9)_1569.txt
1687T>A,g.1687T>A	Exon3	TT	0.060	T	0.23	0.340	0.356	0.777,244,4,Int_J_Mol_Sci_2016_Sep_16_17(9)_1569.txt
1689T>C,g.1689T>C,246,4,Int_J_Mol_Sci_2016_Sep_16_17(9)_1569.txt
1693A>C,g.1693A>C,252,4,Int_J_Mol_Sci_2016_Sep_16_17(9)_1569.txt
1728C>T,g.1728C>T	Exon3	CC	0.663	C	0.832	0.337	0.281	0.067,260,4,Int_J_Mol_Sci_2016_Sep_16_17(9)_1569.txt
1746C>T,g.1746C>T	Exon3	CC	0.571	C	0.658	0.173	0.452	0.000,269,4,Int_J_Mol_Sci_2016_Sep_16_17(9)_1569.txt
1884C>T,g.1884C>T	Exon3	CC	0.837	C	0.908	0.163	0.168	0.577,287,4,Int_J_Mol_Sci_2016_Sep_16_17(9)_1569.txt
1961G>C,g.1961G>C	3′-UTR	CC	0.898	C	0.949	0.102	0.097	1.000,305,4,Int_J_Mol_Sci_2016_Sep_16_17(9)_1569.txt
1966G>C,g.1966G>C,307,4,Int_J_Mol_Sci_2016_Sep_16_17(9)_1569.txt
1985A>G,g.1985A>G	3′-UTR	GG	0.776	G	0.888	0.224	0.200	0.602,313,4,Int_J_Mol_Sci_2016_Sep_16_17(9)_1569.txt
1991C>T,g.1991C>T	3′-UTR	CC	0.133	C	0.352	0.439	0.459	0.667,322,4,Int_J_Mol_Sci_2016_Sep_16_17(9)_1569.txt
2004A>T,g.2004A>T	3′-UTR	AA	0.735	A	0.867	0.265	0.231	0.208,340,4,Int_J_Mol_Sci_2016_Sep_16_17(9)_1569.txt
2009C>G,g.2009C>G	3'-UTR	GG	0.612	G	0.694	0.163	0.427	0.000,349,4,Int_J_Mol_Sci_2016_Sep_16_17(9)_1569.txt
183A>T,apoA-Ib.2	g.183A>T	5′-UTR	TT	0.135	T	0.422	0.573	0.490	0.140,366,13,Int_J_Mol_Sci_2016_Sep_16_17(9)_1569.txt
1604C>T,g.1604C>T	Exon3	CC	0.530	C	0.725	0.390	0.401	0.805,384,4,Int_J_Mol_Sci_2016_Sep_16_17(9)_1569.txt
1753C>T,g.1753C>T	Exon3	CC	0.380	C	0.64	0.520	0.463	0.279,402,4,Int_J_Mol_Sci_2016_Sep_16_17(9)_1569.txt
1767G>C,g.1767G>C	Exon3	CC	0.900	C	0.95	0.100	0.095	1.000,420,4,Int_J_Mol_Sci_2016_Sep_16_17(9)_1569.txt
1850C>A,g.1850C>A	Exon3	CC	0.770	C	0.885	0.230	0.205	0.353,429,4,Int_J_Mol_Sci_2016_Sep_16_17(9)_1569.txt
1862G>A,g.1862G>A	Exon3	GG	0.920	G	0.955	0.070	0.183	0.171,438,4,Int_J_Mol_Sci_2016_Sep_16_17(9)_1569.txt
1949G>C,g.1949G>C	Exon3	GG	0.060	G	0.305	0.490	0.426	0.161,447,4,Int_J_Mol_Sci_2016_Sep_16_17(9)_1569.txt
2077T>G,g.2077T>G	3′-UTR	TT	0.280	T	0.565	0.570	0.494	0.155,465,4,Int_J_Mol_Sci_2016_Sep_16_17(9)_1569.txt
183 A>T,apoA-Ib.2-g.183 A>T	Yellow River carp	AA	69	17.99 ± 0.15 A	131...,485,13,Int_J_Mol_Sci_2016_Sep_16_17(9)_1569.txt
1753 C>T,apoA-Ib.2-g.1753 C>T	Yellow River carp	CC	82	18.42 ± 0.14 a	13...,497,13,Int_J_Mol_Sci_2016_Sep_16_17(9)_1569.txt
501 A>T,...TTGACGGTGTGGAGAGGATT	genotyping locus apoA-Ib.1-g.501 A>T,520,101,Int_J_Mol_Sci_2016_Sep_16_17(9)_1569.txt
1693 A>C,...TTGCGAGGATGTGTTAGTGT	genotyping locus apoA-Ib.1-g.1693 A>C,521,91,Int_J_Mol_Sci_2016_Sep_16_17(9)_1569.txt
183 A>T,...	GAGCCTTGGTTCTTACTTG	genotyping locus apoA-Ib.2-g.183 A>T,522,88,Int_J_Mol_Sci_2016_Sep_16_17(9)_1569.txt
1753 C>T,...GTGTATTGTGAGCAGGTGTG	genotyping locus apoA-Ib.2-g.1753 C>,523,91,Int_J_Mol_Sci_2016_Sep_16_17(9)_1569.txt
231C > A,"...e analysis of POMC, which revealed a homozygous c.231C > A change which is predicted to result in a ...",3,1912,Int_J_Pediatr_Endocrinol_2011_Jul_6_2011(1)_5.txt
231C > A,...iency. POMC gene sequencing showed a homozygous c.231C > A change which causes a premature terminati...,35,329,Int_J_Pediatr_Endocrinol_2011_Jul_6_2011(1)_5.txt
231C>A,...mino acid positions are not drawn to scale. The c.231C>A mutation causes a premature stop within the...,46,620,Int_J_Pediatr_Endocrinol_2011_Jul_6_2011(1)_5.txt
235Met >Thr,"...ethionine to threonine substitution at codon 235 (235Met >Thr) in the AGT gene, a mutation associate...",115,340,Int_J_Pediatr_Endocrinol_2012_May_15_2012(1)_12.txt
235Met >Thr,"... births [54]. However, the mechanism by which the 235Met >Thr mutation affects maternal-placental an...",115,693,Int_J_Pediatr_Endocrinol_2012_May_15_2012(1)_12.txt
572G>A,...umours. She was found to carry a known mutation c.572G>A (p.Cys191Tyr) in the SDHB gene. This case i...,5,1172,Int_J_Pediatr_Endocrinol_2013_Oct_3_2013(Suppl_1)_P112.txt
775G>T,...r finding of a heterozygous HNF-1α NM 000545.5: c.775G>T (p.Val259Phe) mutation. She and her mother ...,9,138,Int_J_Pediatr_Endocrinol_2015_Apr_28_2015(Suppl_1)_P19.txt
775G>T,...med MODY3 with heterozygous HNF-1α NM 000545.5: c.775G>T (p.Val259Phe) mutation. The patient was ini...,16,128,Int_J_Pediatr_Endocrinol_2015_Apr_28_2015(Suppl_1)_P19.txt
98C >T,...yzed the association between ACE I/D and GPIIIa c.98C >T polymorphisms in women with unexplained RPL...,7,73,Int_J_Reprod_Biomed_(Yazd)_2016_May_14(5)_323-328.txt
98C>T,...ed RPL and 100 controls. The ACE I/D and GPIIIa c.98C>T polymorphisms were genotyped by TETRA-ARMS P...,10,106,Int_J_Reprod_Biomed_(Yazd)_2016_May_14(5)_323-328.txt
98C>T,...ificant association was observed between GPIIIa c.98C>T polymorphism and RPL,13,260,Int_J_Reprod_Biomed_(Yazd)_2016_May_14(5)_323-328.txt
98C>T,... as a ﬁbrinogen receptor (19). The polymorphism c.98C>T in GPIIIa gene causes an amino acid substitu...,27,479,Int_J_Reprod_Biomed_(Yazd)_2016_May_14(5)_323-328.txt
98C>T,...d the association between of ACE I/D and GPIIIa c.98C>T polymorphisms in women from the northern of ...,29,200,Int_J_Reprod_Biomed_(Yazd)_2016_May_14(5)_323-328.txt
98C>T,...hism was genotyped using two primers and GPIIIa c.98C>T polymorphism was genotyped using a TETRA-ARM...,42,207,Int_J_Reprod_Biomed_(Yazd)_2016_May_14(5)_323-328.txt
98C>T,"...ng a TETRA-ARMS PCR method (27, 28). The GPIIIa c.98C>T polymorphism primers were designed by Gene R...",42,293,Int_J_Reprod_Biomed_(Yazd)_2016_May_14(5)_323-328.txt
98C>T,...and 190 bp for D allele (Figure 1A). The GPIIIa c.98C>T Alleles were also determined by bands; 395 b...,53,139,Int_J_Reprod_Biomed_(Yazd)_2016_May_14(5)_323-328.txt
98C>T,...) (Table I) (Figure 1B). The ACE I/D and GPIIIa c.98C>T genotypes in women with RPL and control grou...,53,417,Int_J_Reprod_Biomed_(Yazd)_2016_May_14(5)_323-328.txt
98C>T,...c and allelic frequencies of ACE I/D and GPIIIa c.98C>T polymorphisms in women with RPL and control ...,53,645,Int_J_Reprod_Biomed_(Yazd)_2016_May_14(5)_323-328.txt
98C>T,...e in 33% and ACE DD genotype in 44%. The GPIIIa c.98C>T wild-type genotype (TT) was observed in 84% ...,53,848,Int_J_Reprod_Biomed_(Yazd)_2016_May_14(5)_323-328.txt
98C>T,...een genotypic and allelic frequencies of GPIIIa c.98C>T polymorphism and RPL in case and control gro...,55,222,Int_J_Reprod_Biomed_(Yazd)_2016_May_14(5)_323-328.txt
98C>T,GPIIIa c.98C>T 		NG_008332.2,69,10,Int_J_Reprod_Biomed_(Yazd)_2016_May_14(5)_323-328.txt
98C>T,...e II Genotype frequencies of ACE I/D and GPIIIa c.98C>T polymorphisms in women with RPL. The risk of...,74,55,Int_J_Reprod_Biomed_(Yazd)_2016_May_14(5)_323-328.txt
98C>T,GPIIIa c.98C>T,94,10,Int_J_Reprod_Biomed_(Yazd)_2016_May_14(5)_323-328.txt
98C>T,...e III Allelic frequencies of ACE I/D and GPIIIa c.98C>T polymorphisms in women with RP,105,55,Int_J_Reprod_Biomed_(Yazd)_2016_May_14(5)_323-328.txt
98C>T,GPIIIa c.98C>T,119,10,Int_J_Reprod_Biomed_(Yazd)_2016_May_14(5)_323-328.txt
98C>T,...e IV Combination analysis of ACE I/D and GPIIIa c.98C>T polymorphisms in women with RP,130,55,Int_J_Reprod_Biomed_(Yazd)_2016_May_14(5)_323-328.txt
98C>T,...s I allele and D allele respectively. (B)GPIIIa c.98C>T polymorphism. Band of 395 bp and 200 bp are ...,152,187,Int_J_Reprod_Biomed_(Yazd)_2016_May_14(5)_323-328.txt
98C>T,"Concerning the GPIIIa c.98C>T polymorphism, it seems to increase susceptib...",159,25,Int_J_Reprod_Biomed_(Yazd)_2016_May_14(5)_323-328.txt
98C>T,... reported that heterozygous mutations of GPIIIa c.98C>T (CT) were associated with RPL (38). Goodman ...,159,394,Int_J_Reprod_Biomed_(Yazd)_2016_May_14(5)_323-328.txt
98 C>T,...ory (40). Our results indicated that the GPIIIa c.98 C>T polymorphism was not significantly correlat...,159,644,Int_J_Reprod_Biomed_(Yazd)_2016_May_14(5)_323-328.txt
149T>C,"...T  Kwack K    Association of the miR-146aC>G, miR-149T>C, miR-196a2T>C, and miR-499A>G polymorphisms...",198,92,Iran_J_Basic_Med_Sci_2014_Feb_17(2)_128-133.txt
2T>C,"...sociation of the miR-146aC>G, miR-149T>C, miR-196a2T>C, and miR-499A>G polymorphisms with gastric ca...",198,108,Iran_J_Basic_Med_Sci_2014_Feb_17(2)_128-133.txt
499A>G,"...he miR-146aC>G, miR-149T>C, miR-196a2T>C, and miR-499A>G polymorphisms with gastric cancer risk and ...",198,122,Iran_J_Basic_Med_Sci_2014_Feb_17(2)_128-133.txt
1347C > T,...ta1 expression due to the common SNP -509C-T (c. -1347C > T). Hum Genet. 2006 120 4 461 9 10.1007/s0...,188,147,Iran_J_Cancer_Prev_2016_Feb_24_9(1)_e5266.txt
80G>A,...  Dennis J  Ma Y  Xie G  Bykerk V  Pope J    RFC1 80G>A is a genetic determinant of methotrexate eff...,263,61,Iran_J_Ped_Hematol_Oncol_2016_Mar_15_6(1)_52-63.txt
2992C >T,...h weight of offspring showed association with H19 2992C >T SNP genotype of mothers (8). The small si...,71,378,Iran_J_Pediatr_2015_Apr_18_25(2)_e461.txt
604G > A,"...GA at position 202 in exon 6 of the ABCA3 gene (c.604G > A; p.G202R). Furthermore, 70 normal individ...",7,296,Iran_J_Pediatr_2016_Mar_5_26(2)_e2493.txt
420 C>G,"...ale et al showed no association between resistin -420 C>G polymorphism with PCOS, they found an asso...",306,450,Iran_J_Reprod_Med_2013_Mar_11(3)_185-194.txt
45 T>G,"...th PCOS, they found an association between ADIPOQ 45 T>G polymorphism and PCOS (18, 25, 26).",306,523,Iran_J_Reprod_Med_2013_Mar_11(3)_185-194.txt
45 G>T,The 45 G>T polymorphism has been reported to be associ...,308,5,Iran_J_Reprod_Med_2013_Mar_11(3)_185-194.txt
427A > G,"...3’ untranslated region (UTR) (HGVS NM_000681.3:c.*427A > G; dbSNP rs553668), and this SNP has been a...",23,391,Iran_Red_Crescent_Med_J_2016_Feb_13_18(2)_e22452.txt
53 G > T,33 Lasky T  Magder L   Hepatocellular carcinoma p53 G > T transversions at codon 249: the fingerpri...,205,50,ISRN_Oncol_2012_May_13_2012_421673.txt
531G>A,"...RB1 transcript revealed a heterozygous variation, 531G>A, which leads to the amino acid substitution...",17,481,Ital_J_Pediatr_2013_Feb_14_39_12.txt
467G>A,... designating the variation found in this child as 467G>A in stead of 531G>A [5]. We have analyzed R1...,19,410,Ital_J_Pediatr_2013_Feb_14_39_12.txt
531G>A,"...riation found in this child as 467G>A in stead of 531G>A [5]. We have analyzed R156H, as well as sev...",19,429,Ital_J_Pediatr_2013_Feb_14_39_12.txt
5147 G>A,"...lymorphisms (SNPs).9 For example, the mutations m.5147 G>A, m.5711 A>G, m.6257 G>A, and m.8460 A>G d...",21,245,J_Acquir_Immune_Defic_Syndr_2013_Aug_15_63(5)_647-652.txt
5711 A>G,"...(SNPs).9 For example, the mutations m.5147 G>A, m.5711 A>G, m.6257 G>A, and m.8460 A>G describe subh...",21,257,J_Acquir_Immune_Defic_Syndr_2013_Aug_15_63(5)_647-652.txt
6257 G>A,"... example, the mutations m.5147 G>A, m.5711 A>G, m.6257 G>A, and m.8460 A>G describe subhaplogroup L0...",21,269,J_Acquir_Immune_Defic_Syndr_2013_Aug_15_63(5)_647-652.txt
8460 A>G,"...tations m.5147 G>A, m.5711 A>G, m.6257 G>A, and m.8460 A>G describe subhaplogroup L0a2. Many of the ...",21,285,J_Acquir_Immune_Defic_Syndr_2013_Aug_15_63(5)_647-652.txt
3579 A>G,"...subhaplogroups before; 7 (5%) of the mutations, m.3579 A>G, m.3606 A>G, m.5090 T>C, m.10463 T>C, m.1...",51,250,J_Acquir_Immune_Defic_Syndr_2013_Aug_15_63(5)_647-652.txt
3606 A>G,"...ps before; 7 (5%) of the mutations, m.3579 A>G, m.3606 A>G, m.5090 T>C, m.10463 T>C, m.12192 G>A, m....",51,262,J_Acquir_Immune_Defic_Syndr_2013_Aug_15_63(5)_647-652.txt
5090 T>C,"... (5%) of the mutations, m.3579 A>G, m.3606 A>G, m.5090 T>C, m.10463 T>C, m.12192 G>A, m.13104 A>G, a...",51,274,J_Acquir_Immune_Defic_Syndr_2013_Aug_15_63(5)_647-652.txt
10463 T>C,"... mutations, m.3579 A>G, m.3606 A>G, m.5090 T>C, m.10463 T>C, m.12192 G>A, m.13104 A>G, and m.15038 G...",51,286,J_Acquir_Immune_Defic_Syndr_2013_Aug_15_63(5)_647-652.txt
12192 G>A,"....3579 A>G, m.3606 A>G, m.5090 T>C, m.10463 T>C, m.12192 G>A, m.13104 A>G, and m.15038 G>A, with freq...",51,299,J_Acquir_Immune_Defic_Syndr_2013_Aug_15_63(5)_647-652.txt
13104 A>G,"...3606 A>G, m.5090 T>C, m.10463 T>C, m.12192 G>A, m.13104 A>G, and m.15038 G>A, with frequencies of 2%...",51,312,J_Acquir_Immune_Defic_Syndr_2013_Aug_15_63(5)_647-652.txt
15038 G>A,"...T>C, m.10463 T>C, m.12192 G>A, m.13104 A>G, and m.15038 G>A, with frequencies of 2%, 2%, 6%, 1%, 3%,...",51,329,J_Acquir_Immune_Defic_Syndr_2013_Aug_15_63(5)_647-652.txt
12769 G>A,"...12,22,23 Of the few remaining changes, 2 (1%), m. 12769 G>A with a frequency of 2% and m.14612 G>A w...",51,580,J_Acquir_Immune_Defic_Syndr_2013_Aug_15_63(5)_647-652.txt
14612 G>A,"...2 (1%), m. 12769 G>A with a frequency of 2% and m.14612 G>A with a frequency of 4%, were novel and a...",51,619,J_Acquir_Immune_Defic_Syndr_2013_Aug_15_63(5)_647-652.txt
5147 G>A,"...erval, 0.16 to 0.94; P = 0.036). The mutations, m.5147 G>A, m.5711 A>G, m.6257 G>A, and m.8460 A>G, ...",51,1703,J_Acquir_Immune_Defic_Syndr_2013_Aug_15_63(5)_647-652.txt
5711 A>G,"...to 0.94; P = 0.036). The mutations, m.5147 G>A, m.5711 A>G, m.6257 G>A, and m.8460 A>G, described su...",51,1715,J_Acquir_Immune_Defic_Syndr_2013_Aug_15_63(5)_647-652.txt
6257 G>A,"... 0.036). The mutations, m.5147 G>A, m.5711 A>G, m.6257 G>A, and m.8460 A>G, described subhaplogroup ...",51,1727,J_Acquir_Immune_Defic_Syndr_2013_Aug_15_63(5)_647-652.txt
8460 A>G,"...ations, m.5147 G>A, m.5711 A>G, m.6257 G>A, and m.8460 A>G, described subhaplogroup L0a2",51,1743,J_Acquir_Immune_Defic_Syndr_2013_Aug_15_63(5)_647-652.txt
1757A>C,"... however, a novel de novo heterozygous missense c.1757A>C mutation in the desmoplakin gene (DSP) was...",13,88,J_Allergy_Clin_Immunol_2015_Nov_136(5)_1268-1276.txt
1757A>C,... with the exception of the novel point mutation c.1757A>C in DSP (encoding desmoplakin) predicting t...,52,727,J_Allergy_Clin_Immunol_2015_Nov_136(5)_1268-1276.txt
6208G>A,"... proband and his father were heterozygous for a c.6208G>A missense SNP in DSP, predicting the protei...",56,85,J_Allergy_Clin_Immunol_2015_Nov_136(5)_1268-1276.txt
1757A>C,"... proband has the heterozygous missense mutation c.1757A>C (indicated by the arrow), predicting the a...",98,261,J_Allergy_Clin_Immunol_2015_Nov_136(5)_1268-1276.txt
1S > E,the order E1S > E2S ≫ T4S,115,12,J_Am_Chem_Soc_2014_Aug_13_136(32)_11232-11235.txt
2T>C,"....97) canonical donor splice site of exon 4 (c.754+2T>C), which is absent from variant databases (Var...",58,695,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
2T>C,... (p.Glu216_Lys251del). This TGFB3 mutation (c.754+2T>C) segregated with the clinical phenotype and w...,58,1070,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
681G>A,Cytochrome P450 2C19 681G>A polymorphism and high on‐clopidogrel platel...,115,22,J_Am_Heart_Assoc_2013_Apr_24_2(2)_e000131.txt
1387C>T,"...tion in myosin-binding protein C (MYBPC3) gene (c.1387C>T, p.Q463X) (Figure5A) was identified in pat...",72,66,J_Am_Heart_Assoc_2015_Jul_10_4(7)_e001879.txt
1000G>A,"...2 Patient 4 carried a missense MYBPC3 mutation (c.1000G>A, p.E334K) (Figure5B), which was already de...",72,770,J_Am_Heart_Assoc_2015_Jul_10_4(7)_e001879.txt
1387C>T,"...in C gene for (A) relative III4 and her family (c.1387C>T, p. Q463X) and (B) patient 4 (c.1000G>A, p...",74,92,J_Am_Heart_Assoc_2015_Jul_10_4(7)_e001879.txt
1000G>A,"...family (c.1387C>T, p. Q463X) and (B) patient 4 (c.1000G>A, p.E334K)",74,132,J_Am_Heart_Assoc_2015_Jul_10_4(7)_e001879.txt
300T >G,"...he population frequency of 5382insC (c.5266dupC), 300T >G (p.181T >G), 185delAG (c.68_69delAG) and 3...",3,1521,J_Appl_Genet_2011_Aug_19_52(3)_325-330.txt
181T >G,"...on frequency of 5382insC (c.5266dupC), 300T >G (p.181T >G), 185delAG (c.68_69delAG) and 3819del5 (c....",3,1532,J_Appl_Genet_2011_Aug_19_52(3)_325-330.txt
300T >G,"...82insC found in 29 out of 16,849 samples (0.17%). 300T >G and 3819del5 mutations were found in respe...",3,1954,J_Appl_Genet_2011_Aug_19_52(3)_325-330.txt
300T >G,...evalence for combined Polish founder 5382insC and 300T >G mutations was 0.25% (1/400). The frequenci...,3,2133,J_Appl_Genet_2011_Aug_19_52(3)_325-330.txt
300T >G,...as 0.25% (1/400). The frequencies of 5382insC and 300T >G carriers among consecutive breast cancer c...,3,2202,J_Appl_Genet_2011_Aug_19_52(3)_325-330.txt
300T >G,"...t cancer for 5382insC mutation at OR = 17 and for 300T >G mutation at OR = 26. Our results, based on...",3,2454,J_Appl_Genet_2011_Aug_19_52(3)_325-330.txt
300T >G,"...es, show high frequencies of founder 5382insC and 300T >G BRCA1 mutations in Polish general populati...",3,2577,J_Appl_Genet_2011_Aug_19_52(3)_325-330.txt
300T >G,"... are 5382insC, originated in the Baltic area, and 300T >G, widely spread throughout Central Europe. ...",9,392,J_Appl_Genet_2011_Aug_19_52(3)_325-330.txt
300T >G,"...alysis of the frequency of 5382insC (c.5266dupC), 300T >G (p.181T >G), 185delAG (c.68_69delAG), and ...",16,53,J_Appl_Genet_2011_Aug_19_52(3)_325-330.txt
181T >G,"...he frequency of 5382insC (c.5266dupC), 300T >G (p.181T >G), 185delAG (c.68_69delAG), and 3819del5 (c...",16,64,J_Appl_Genet_2011_Aug_19_52(3)_325-330.txt
300T >G,"...82insC found in 29 out of 16,849 samples (0.17%). 300T >G and 3819del5 mutations were found in respe...",30,155,J_Appl_Genet_2011_Aug_19_52(3)_325-330.txt
300T >G,...quencies for combined Polish founder 5382insC and 300T >G mutations without the division into provin...,30,421,J_Appl_Genet_2011_Aug_19_52(3)_325-330.txt
300T >G,"...l distribution and frequencies of BRCA1 5382insC, 300T >G, 185delAG, and 3819del5 mutations. * - onl...",33,123,J_Appl_Genet_2011_Aug_19_52(3)_325-330.txt
300T >G,"...mutation was 5382insC (35/1845, 1.9%) followed by 300T >G (18/1486, 1.2%). Comparing 5382insC mutati...",37,164,J_Appl_Genet_2011_Aug_19_52(3)_325-330.txt
300T >G,...or this mutation at OR = 17 (95%CI 6.6–43.4). For 300T >G missense mutation (2 out of 4352 control s...,37,449,J_Appl_Genet_2011_Aug_19_52(3)_325-330.txt
300T >G,"...BRCA1 mutations, truncating 5382insC and missense 300T >G comprise 70–90% of all BRCA1 pathogenic al...",40,763,J_Appl_Genet_2011_Aug_19_52(3)_325-330.txt
300T >G,"... second founder mutation for Polish population is 300T >G, detected in 0.082% of the analysed sample...",46,54,J_Appl_Genet_2011_Aug_19_52(3)_325-330.txt
300T >G,...NA change was detected in 0.05% control subjects. 300T >G mutation is regarded as the founder change...,46,210,J_Appl_Genet_2011_Aug_19_52(3)_325-330.txt
300T >G,...cancer for this mutation at OR = 17. For missense 300T >G mutation (present in 18 out of 1486 breast...,50,520,J_Appl_Genet_2011_Aug_19_52(3)_325-330.txt
300T >G,"...he relative risk for 5382insC at OR = 6.2 and for 300T >G at OR = 15. In both studies, ours and thos...",50,805,J_Appl_Genet_2011_Aug_19_52(3)_325-330.txt
300T >G,"... and those provided by Gorski, the odds ratio for 300T >G BRCA1 mutation was higher than for 5382ins...",50,896,J_Appl_Genet_2011_Aug_19_52(3)_325-330.txt
300T >G,"...es, show high frequencies of founder 5382insC and 300T >G BRCA1 mutations in Polish general populati...",55,95,J_Appl_Genet_2011_Aug_19_52(3)_325-330.txt
300T >G,...evalence for combined Polish founder 5382insC and 300T >G mutations was 0.25% (1/400). Carriage of o...,55,216,J_Appl_Genet_2011_Aug_19_52(3)_325-330.txt
1G > A,"...at the splice donor sequence of intron 6, c.357 + 1G > A (IVS6 + 1G > A) (Fig. 2).Fig. 2 Forward seq...",73,931,J_Appl_Genet_2013_Aug_13_54(3)_345-351.txt
1G > A,"...onor sequence of intron 6, c.357 + 1G > A (IVS6 + 1G > A) (Fig. 2).Fig. 2 Forward sequence analysis ...",73,946,J_Appl_Genet_2013_Aug_13_54(3)_345-351.txt
1G > A,...G/A transition in intron 6 at position +1 c.357 + 1G >,73,1156,J_Appl_Genet_2013_Aug_13_54(3)_345-351.txt
581C>T,... Mostowska A  Biedziak B  Trzeciak WH   A novel c.581C>T transition localized in a highly conserved ...,98,53,J_Appl_Oral_Sci_2007_Oct_15(5)_382-386.txt
768A > S,dramatically enhanced conductances (S768A > S737A,399,39,J_Biol_Chem_2009_Feb_27_284(9)_5645-5653.txt
1202Q > V,...in the following rank order: R1202E/R4E = V1197N/R1202Q > V1197A/Q1198A/R1202A > S1199D > V1197N > V...,119,971,J_Biol_Chem_2009_Jun_5_284(23)_15573-15588.txt
1202A > S,...rder: R1202E/R4E = V1197N/R1202Q > V1197A/Q1198A/R1202A > S1199D > V1197N > V1197A/Q1198A > K1206E >...,119,994,J_Biol_Chem_2009_Jun_5_284(23)_15573-15588.txt
1199D > V,...02E/R4E = V1197N/R1202Q > V1197A/Q1198A/R1202A > S1199D > V1197N > V1197A/Q1198A > K1206E > R1202Q. ...,119,1003,J_Biol_Chem_2009_Jun_5_284(23)_15573-15588.txt
1197N > V,... V1197N/R1202Q > V1197A/Q1198A/R1202A > S1199D > V1197N > V1197A/Q1198A > K1206E > R1202Q. So not on...,119,1012,J_Biol_Chem_2009_Jun_5_284(23)_15573-15588.txt
1198A > K,... V1197A/Q1198A/R1202A > S1199D > V1197N > V1197A/Q1198A > K1206E > R1202Q. So not only does CaM teth...,119,1028,J_Biol_Chem_2009_Jun_5_284(23)_15573-15588.txt
1206E > R,...1198A/R1202A > S1199D > V1197N > V1197A/Q1198A > K1206E > R1202Q. So not only does CaM tethering adv...,119,1037,J_Biol_Chem_2009_Jun_5_284(23)_15573-15588.txt
2518 A>G,...icting evidence on the contribution of the MCP-1 −2518 A>G (rs 1024611) polymorphism to SLE incidenc...,6,380,J_Biomed_Biotechnol_2010_Apr_21_2010_130265.txt
2518 A>G,We examined the prevalence of the MCP-1 −2518 A>G polymorphism in SLE patients (n = 199) an...,7,42,J_Biomed_Biotechnol_2010_Apr_21_2010_130265.txt
2518 A>G,...nificant difference in the distribution of MCP-1 −2518 A>G polymorphic variants in patients with SLE...,7,198,J_Biomed_Biotechnol_2010_Apr_21_2010_130265.txt
2518 A>G,It has been demonstrated that the MCP-1 –2518 A>G (rs 1024611) transition in the promoter r...,18,45,J_Biomed_Biotechnol_2010_Apr_21_2010_130265.txt
2518 A>G,"...t and protein [20, 21]. Involvement of the MCP-1 –2518 A>G promoter polymorphism in SLE development ...",18,322,J_Biomed_Biotechnol_2010_Apr_21_2010_130265.txt
2518 A>G,...We analysed the distribution of functional MCP-1 –2518 A>G polymorphic variants in SLE patients (n =...,18,513,J_Biomed_Biotechnol_2010_Apr_21_2010_130265.txt
2518 A>G,...salting out procedure. The presence of the MCP-1 –2518 A>G (rs 1024611) polymorphic variant was iden...,25,123,J_Biomed_Biotechnol_2010_Apr_21_2010_130265.txt
2518 A>G,3.1. Distribution of MCP-1 –2518 A>G  Genotypes and Alleles in SLE Patients an...,31,29,J_Biomed_Biotechnol_2010_Apr_21_2010_130265.txt
2518 A>G,Genotype analysis of the MCP-1 –2518 A>G polymorphism did not reveal a significant...,32,33,J_Biomed_Biotechnol_2010_Apr_21_2010_130265.txt
2518 A>G,...ficant difference in the prevalence of the MCP-1 –2518 A>G polymorphic variant in patients with SLE ...,32,216,J_Biomed_Biotechnol_2010_Apr_21_2010_130265.txt
2518 A>G,3.2. Association of MCP-1 –2518 A>G Genotypes with Clinical Symptoms of SL,34,28,J_Biomed_Biotechnol_2010_Apr_21_2010_130265.txt
2518 A>G,"To date, the MCP-1 –2518 A>G polymorphism has been associated with cor...",40,21,J_Biomed_Biotechnol_2010_Apr_21_2010_130265.txt
2518 A>G,Reports on the contribution of the MCP-1 –2518 A>G polymorphism to SLE incidence and clinica...,42,43,J_Biomed_Biotechnol_2010_Apr_21_2010_130265.txt
2518 A>G,...rve differences in the distribution of the MCP-1 –2518 A>G polymorphic variant between patients with...,42,214,J_Biomed_Biotechnol_2010_Apr_21_2010_130265.txt
2518 A>G,...e conflicting reports on the effect of the MCP-1 –2518 A>G polymorphism to the incidence of SLE in v...,46,55,J_Biomed_Biotechnol_2010_Apr_21_2010_130265.txt
2518 A>G,"...factors, which may act in synergy with the MCP-1 –2518 A>G polymorphism to change the risk of SLE in...",46,348,J_Biomed_Biotechnol_2010_Apr_21_2010_130265.txt
2518 A>G,The  MCP-1 –2518 A>G polymorphism is located at a relatively p...,50,13,J_Biomed_Biotechnol_2010_Apr_21_2010_130265.txt
2518 A>G,"... a luciferase reporter gene, including the MCP-1 –2518 A>G polymorphic variant upstream of the repor...",50,240,J_Biomed_Biotechnol_2010_Apr_21_2010_130265.txt
2518 A>G,Table 1 Association of the MCP-1 –2518 A>G polymorphism with clinical manifestation ...,63,35,J_Biomed_Biotechnol_2010_Apr_21_2010_130265.txt
2518 A>G,Table 2 Association of the MCP-1 –2518 A>G polymorphisms in SLE patients and control...,87,35,J_Biomed_Biotechnol_2010_Apr_21_2010_130265.txt
2518 A>G,MCP-1 –2518 A>G (rs1024611)	SLE n = 199 (%)	Controls n = ...,89,8,J_Biomed_Biotechnol_2010_Apr_21_2010_130265.txt
35T > C,"...olving T to C transition at nucleotide number 35 (35T > C), which resulted in substitution of isoleu...",50,1008,J_Biomed_Biotechnol_2011_Apr_4_2011_304612.txt
35T > C,... indicating a T to C transition at nucleotide 35 (35T > C) from an affected female individual (VI-1)...,105,164,J_Biomed_Biotechnol_2011_Apr_4_2011_304612.txt
9909601 G>A,"...NA binding. Eventually, we found that two SNPs (rs9909601 G>A and rs1838149 C>T) might affect miRNA ...",26,373,J_Biomed_Res_2013_May_25_27(3)_215-219.txt
1838149 C>T,"...ally, we found that two SNPs (rs9909601 G>A and rs1838149 C>T) might affect miRNA binding",26,391,J_Biomed_Res_2013_May_25_27(3)_215-219.txt
9909601 G>A,"...ster City, CA, USA). The primers and probes for rs9909601 G>A were listed as follows: Primer: sense,...",28,351,J_Biomed_Res_2013_May_25_27(3)_215-219.txt
1838149 C>T,"...AACCAGTCACCC -TAMRA. The primers and probes for rs1838149 C>T were listed as follows: Primer: sense,...",28,597,J_Biomed_Res_2013_May_25_27(3)_215-219.txt
518C>T,"...riants. Two novel missense LRP5 HBM mutations ([c.518C>T; p.Thr173Met], [c.796C>T; p.Arg266Cys]) wer...",51,727,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
796C>T,"...e LRP5 HBM mutations ([c.518C>T; p.Thr173Met], [c.796C>T; p.Arg266Cys]) were identified, plus three ...",51,752,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
593A>G,"...e previously reported missense LRP5 mutations ([c.593A>G; p.Asn198Ser], [c.724G>A; p.Ala242Thr], [c....",51,850,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
724G>A,"...sense LRP5 mutations ([c.593A>G; p.Asn198Ser], [c.724G>A; p.Ala242Thr], [c.266A>G; p.Gln89Arg]), ass...",51,875,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
266A>G,"...593A>G; p.Asn198Ser], [c.724G>A; p.Ala242Thr], [c.266A>G; p.Gln89Arg]), associated with HBM in 11 ad...",51,900,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
530C>A,...ed a novel heterozygous nonsense SOST mutation (c.530C>A; p.Ser177X) predicted to prematurely trunca...,51,1315,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
518C>T,"... identified two novel missense LRP5 mutations ([c.518C>T; p.Thr173Met], [c.796C>T; p.Arg266Cys]) as ...",81,53,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
796C>T,"...sense LRP5 mutations ([c.518C>T; p.Thr173Met], [c.796C>T; p.Arg266Cys]) as well as three previously ...",81,78,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
593A>G,"...e previously reported missense LRP5 mutations ([c.593A>G; p.Asn198Ser], [c.724G>A; p.Ala242Thr], [c....",81,165,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
724G>A,"...sense LRP5 mutations ([c.593A>G; p.Asn198Ser], [c.724G>A; p.Ala242Thr], [c.266A>G; p.Gln89Arg]), ass...",81,190,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
266A>G,"...593A>G; p.Asn198Ser], [c.724G>A; p.Ala242Thr], [c.266A>G; p.Gln89Arg]), associated with HBM in 11 ad...",81,215,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
593A>G,593A>G	3	Asn198Ser	30	M	+12.2	+8.3	N,89,2,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
593A>G,593A>G	3	Asn198Ser	26	F	+6.8	+5.6	N,95,2,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
593A>G,593A>G	3	Asn198Ser	6,101,2,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
724G>A,724G>A	4	Ala242Thr	49	F	+7.1	+10.7	N	Y	Y	N	S	Proba...,107,2,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
724G>A,724G>A	4	Ala242Thr	21	M	+6.4	+8.2	N	N	n/a	N	F	Prob...,110,2,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
724G>A,724G>A	4	Ala242Thr	21	F	+7.1	+6.0	N,113,2,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
724G>A,724G>A	4	Ala242Thr	64	F	+5.9	+8.1	N	Y	Y,122,2,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
724G>A,724G>A	4	Ala242Thr	41	F	+3.1	+3.1	N	Y	Y	N	F	Probab...,128,2,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
796C>T,C796C>,131,3,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
266A>G,266A>G	2	Gln89Arg	6,140,2,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
518C>T,518C>,152,2,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
530C>A,530C>,167,2,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
593A>G,...pporting Information S5). He has a heterozygous c.593A>G; p.Asn198Ser mutation that is predicted to ...,350,56,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
724G>A,"...riodicals, Inc.The most frequent LRP5 mutation, c.724G>A; p.Ala242Thr, was identified in three unrel...",354,76,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
796C>T,"B, C). Interestingly, the novel mutation c.796C>T; p.Arg266Cys, was identified in a 65 year o...",355,44,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
266A>G,A heterozygous c.266A>G; p.Gln89Arg mutation was identified in an a...,357,18,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
518C>T,...osteoarthritis; he has never fractured. A novel c.518C>T; p.Thr173Met mutation was identified in a m...,357,162,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
530C>A,... novel heterozygous nonsense variant in exon 2 (c.530C>A; p.Ser177X) in a woman aged 70 years who re...,378,66,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
28G>A,"...d SNP in exon 1 in eight HBM cases (rs17882143, c.28G>A; p.Val10Ile, MAF T = 0.047%), predicted to b...",380,92,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
24G>T,...of exon 25 but not in the splice junction (c.3364‐24G>T). The common SNP rs2306033 (MAF 25% in 1000 ...,383,192,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
74Y>F,...l missense mutation in the LRP5 inhibitor DKK1 (c.74Y>F) has recently been reported to segregate wit...,405,1092,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
677 C-->T,...  Refsum H    Methylenetetrahydrofolate reductase 677 C-->T mutation and coronary heart disease risk...,152,108,J_Cardiovasc_Dis_Res_2011_Jul-Sep_2(3)_156-163.txt
5G > A,...). Sequent analysis of genomic DNA showed c.639 + 5G > A [IVS4 (+5)G > A] mutation in the α-Gal A ge...,14,2839,J_Cardiovasc_Ultrasound_2013_Mar_20_21(1)_26-29.txt
1372C>T,mutations (c.1349delT and c.1372C>T) within exon 6 of th,110,29,J_Cell_Biol_2013_May_13_201(4)_511-521.txt
1372C>T,...dentified four deleterious mutations in exon 6 (c.1372C>,286,63,J_Cell_Biol_2013_May_13_201(4)_511-521.txt
1451T>G,c.1451T>G in patients with breast cancer) compared w...,288,3,J_Cell_Biol_2013_May_13_201(4)_511-521.txt
1G>A,...ult of a splice donor mutation in intron 3 (c.471+1G>A) with the second allele being either dysfunct...,24,150,J_Cell_Mol_Med_2010_Oct_16_Jan-Feb_14(1-2)_403-416.txt
66A>G,...ueant-Rodriguez RM  Chen M    Association of MTRR 66A>G polymorphism with superoxide dismutase and d...,120,73,J_Cell_Mol_Med_2011_Nov_24_15(11)_2486-2497.txt
1G>A,...ype was associated with the splice mutation c.879+1G>A. Primary adrenocortical insufficiency and typ...,15,744,J_Clin_Endocrinol_Metab_2016_Aug_2_101(8)_2975-2983.txt
769C>T,"...9del13 found in 45% of the alleles, followed by c.769C>T, and c.879+1G>A (Figure 3 and Supplemental ...",133,274,J_Clin_Endocrinol_Metab_2016_Aug_2_101(8)_2975-2983.txt
1G>A,"...% of the alleles, followed by c.769C>T, and c.879+1G>A (Figure 3 and Supplemental Table 2). We then ...",133,292,J_Clin_Endocrinol_Metab_2016_Aug_2_101(8)_2975-2983.txt
1C>G,"... one heterozygous for the splicing mutation c.879+1C>G (patients 29, 30, 31, and 48) presented a mil...",133,1181,J_Clin_Endocrinol_Metab_2016_Aug_2_101(8)_2975-2983.txt
22C>T,"...s from childhood and was compound heterozygous (c.22C>T/c.967_979del13) for two AIRE mutations, but ...",156,828,J_Clin_Endocrinol_Metab_2016_Aug_2_101(8)_2975-2983.txt
1C>G,...PS1 cohorts. Of particular interest was the c.879+1C>G splice mutation found in three homozygous pat...,158,150,J_Clin_Endocrinol_Metab_2016_Aug_2_101(8)_2975-2983.txt
3826A >G,... Niedbal S  Jabrocka A  et al Correlation of the -3826A >G polymorphism in the promoter of the uncou...,100,133,J_Clin_Med_Res_2011_Dec_10_3(6)_319-324.txt
14590T>C,...nalysis disclosed a novel mutation in exon 101 (c.14590T>C) and confirmed a previously reported muta...,8,362,J_Clin_Neurol_2015_Jan_11_11(1)_97-101.txt
14678G>A,...med a previously reported mutation in exon 102 (c.14678G>A),8,432,J_Clin_Neurol_2015_Jan_11_11(1)_97-101.txt
14590T>C,...nalysis revealed a novel heterozygous mutation [c.14590T>C (p.Tyr4864His)] in exon 101 (Fig. 1B). Th...,26,426,J_Clin_Neurol_2015_Jan_11_11(1)_97-101.txt
14678G>A,...is for RYR1 revealed the heterozygous mutation [c.14678G>A (p.Arg4893Gln)] in exon 102 (Fig. 1B). Th...,33,152,J_Clin_Neurol_2015_Jan_11_11(1)_97-101.txt
14590T>C,...ch is slightly larger than the normal 'T' peak (c.14590T>C). The right chromatogram from case 2 show...,53,258,J_Clin_Neurol_2015_Jan_11_11(1)_97-101.txt
14678G>A,"...ak, which is larger than the aberrant 'A' peak (c.14678G>A)",53,375,J_Clin_Neurol_2015_Jan_11_11(1)_97-101.txt
7354C>T,... family with the skeletal muscle RYR1 mutation (c.7354C>T) associated with central core myopathy and...,76,111,J_Clin_Neurol_2015_Jan_11_11(1)_97-101.txt
1975T>C,"154	55	OC	Endometrioid	IA	G1	FGFR2 p.K659E, c.1975T>C	FGFR2 p.K659E, c.1975T>C (1)",38,47,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
1975T>C,"...d	IA	G1	FGFR2 p.K659E, c.1975T>C	FGFR2 p.K659E, c.1975T>C (1)",38,72,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
3140A>G,"155	45	OC	Serous	IC	G1	PIK3CA p.H1047R, c.3140A>G	PIK3CA p.H1047R, c.3140A>G (3)",39,43,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
3140A>G,"...	G1	PIK3CA p.H1047R, c.3140A>G	PIK3CA p.H1047R, c.3140A>G (3)",39,70,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
743G>A,"152	50	OC	Serous	IIC	G3	TP53 p.R248Q, c.743G>A	TP53 p.R248Q, c.743G>A (1)",40,41,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
743G>A,"...ous	IIC	G3	TP53 p.R248Q, c.743G>A	TP53 p.R248Q, c.743G>A (1)",40,64,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
503A>G,"140	44	OC	Serous	IIIA	G3	TP53 p.H168R, c.503A>G	TP53 p.H168R, c.503A>G (3)",41,42,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
503A>G,"...us	IIIA	G3	TP53 p.H168R, c.503A>G	TP53 p.H168R, c.503A>G (3)",41,65,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
815T>A,"149	57	OC	Serous	IIIA	G3	TP53 p.V272E, c.815T>A	TP53 p.V272E, c.815T>A (3)",42,42,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
815T>A,"...us	IIIA	G3	TP53 p.V272E, c.815T>A	TP53 p.V272E, c.815T>A (3)",42,65,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
646G>A,"148	71	OC	Serous	IIIB	G3	TP53 p.V216M, c.646G>A	TP53 p.V216M, c.646G>A (1)",43,42,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
646G>A,"...us	IIIB	G3	TP53 p.V216M, c.646G>A	TP53 p.V216M, c.646G>A (1)",43,65,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
404G>A,"143	52	OC	Serous	IIIC	G3	TP53 p.C135Y, c.404G>A	TP53 p.L194R, c.581T>G (3)",45,42,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
581T>G,"...us	IIIC	G3	TP53 p.C135Y, c.404G>A	TP53 p.L194R, c.581T>G (3)",45,65,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
734G>T,"158	49	OC	Serous	IIIC	G3	TP53 p.G245V, c.734G>T	TP53 p.G245V, c.734G>T (3)",46,42,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
734G>T,"...us	IIIC	G3	TP53 p.G245V, c.734G>T	TP53 p.G245V, c.734G>T (3)",46,65,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
771G>T,"130	72	OC	Serous	IIIC	G2	PPP2R1A p.W257C, c.771G>T	PPP2R1A p.W257C, c.771G>T (1)",47,45,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
771G>T,"...C	G2	PPP2R1A p.W257C, c.771G>T	PPP2R1A p.W257C, c.771G>T (1)",47,71,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
711G>C,"132	64	OC	Serous	IIIC	G2	NA	TP53 p.M237I, c.711G>C (1)",48,45,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
578A>C,"139	70	OC	Serous	IIIC	G3	TP53 p.H193P, c.578A>C	TP53 p.H193P, c.578A>C (1)",49,42,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
578A>C,"...us	IIIC	G3	TP53 p.H193P, c.578A>C	TP53 p.H193P, c.578A>C (1)",49,65,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
733G>A,"144	43	OC	Serous	IIIC	G3	TP53 p.G245S, c.733G>A	KRAS p.G12C, c.34G>T (1)",50,42,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
34G>T,"...ous	IIIC	G3	TP53 p.G245S, c.733G>A	KRAS p.G12C, c.34G>T (1)",50,64,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
818G>A,"168	58	OC	Serous	IIIC	G3	TP53 p.R273H, c.818G>A	TP53 p.R273H, c.818G>A (1)",52,42,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
818G>A,"...us	IIIC	G3	TP53 p.R273H, c.818G>A	TP53 p.R273H, c.818G>A (1)",52,65,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
35G>C,"197	73	OC	Serous	IIIC	G3	NA	KRAS p.G12A, c.35G>C (1)",53,44,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
536A>G,"137	61	OC	Serous	IIIC	G3	TP53 p.H179R, c.536A>G	TP53 p.H179R, c.536A>G (1)",54,42,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
536A>G,"...us	IIIC	G3	TP53 p.H179R, c.536A>G	TP53 p.H179R, c.536A>G (1)",54,65,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
182A>G,"...t mixed Müllerian tumor	IIIC	G3	NA	NRAS p.Q61R, c.182A>G (1)",55,69,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
3074C>A,"...Müllerian tumor	IIIA1(i)	G3	NA	PIK3CA p.T1025N, c.3074C>A (1)",56,77,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
38G>A,"...ndometrioid, partly serous	IIIC	G2	KRAS p.G13D, c.38G>A	KRAS p.G13D, c.38G>A (1)",57,62,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
38G>A,"...erous	IIIC	G2	KRAS p.G13D, c.38G>A	KRAS p.G13D, c.38G>A (1)",57,83,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
35G>A,"147	60	OC	Endometrioid	IIIC	G3	KRAS p.G12D, c.35G>A	KRAS p.G12D, c.35G>A (1)",58,47,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
35G>A,"...rioid	IIIC	G3	KRAS p.G12D, c.35G>A	KRAS p.G12D, c.35G>A (1)",58,68,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
3010A>G,"198	59	OC	Serous	IVB	G3	NA	PIK3CA p.M1004V, c.3010A>G (1)",60,47,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
785G>T,"172	55	OC	Serous	IV	G3	NA	TP53 p.G262V, c.785G>T (1)",61,43,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
49G>A,"...erous low malignant potential			NA	AKT1 p.E17K, c.49G>A (1)",62,66,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
844C>T,"...ng carcinoma, spread in ovaries			TP53 p.R282W, c.844C>T	TP53 p.R282W, c.844C>T (1)",63,75,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
844C>T,"... ovaries			TP53 p.R282W, c.844C>T	TP53 p.R282W, c.844C>T (1)",63,98,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
388C>T,"199	73	EC	EC	IA	G2	PTEN p.R130*, c.388C>T	PTEN p.R130*, c.388C>T (1)",65,36,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
388C>T,"...C	EC	IA	G2	PTEN p.R130*, c.388C>T	PTEN p.R130*, c.388C>T (1)",65,59,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
3139C>T,"200	70	EC	EC	IA	G2	PIK3CA p.H1047Y, c.3139C>T	PIK3CA p.H1047Y, c.3139C>T (1)",66,39,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
3139C>T,"...	G2	PIK3CA p.H1047Y, c.3139C>T	PIK3CA p.H1047Y, c.3139C>T (1)",66,66,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
4405C>T,"201	70	EC	EC	IA	G2	APC p.Q1469*, c.4405C>T	APC p.Q1469*, c.4405C>T (1)",67,36,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
4405C>T,"...	EC	IA	G2	APC p.Q1469*, c.4405C>T	APC p.Q1469*, c.4405C>T (1)",67,60,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
945T>A,"202	63	EC	EC	IA	G1	NA	PTEN p.Y315*, c.945T>A (1)",68,39,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
110C>T,"203	55	EC	EC	IA	G1	NA	CTNNB1 p.S37F, c.110C>T (1)",69,40,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
1513C>A,"165	61	B	Fibroma			NA	FBXW7 p.R505S, c.1513C>A (1)",70,40,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
35G>T,"...75	50	B	Ovarian cyst, teratoma			—	KRAS p.G12V, c.35G>T (1)",71,52,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
34G>T,"...77	31	B	Secondary infertility			NA	KRAS p.G12C, c.34G>T (1)",72,52,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
34G>T,"...terus myomatosus, ovarian cyst			—	KRAS p.G12C, c.34G>T (1)",73,61,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
35G>T,"...y, polyp of the cervix mucosa			NA	KRAS p.G12V, c.35G>T (1)",74,80,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
35G>T,"184	78	B	Ovarian cyst			—	KRAS p.G12V, c.35G>T (1)",75,42,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
1042C>T,"190	58	B	Teratoma			—	PIK3R1 p.R348*, c.1042C>T (1)",76,41,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
35G>A,"193	54	B	Inclusion cysts			—	KRAS p.G12D, c.35G>A (1)",77,45,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
725G>T,"...st cancer, uterine leiomyoma			NA	TP53 p.C242F, c.725G>T (1)	Germline mutation",78,66,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
715A>G,"...ma, squamous cell carcinoma)			NA	TP53 p.N239D, c.715A>G (1)	Two or more malignant tumors",79,127,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
1G>A,"129	82	OC	Serous	IIIC	G2	TP53 c.920-1G>A, g.7576927C>T (splice site)	—",80,37,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
7576927C>T,"129	82	OC	Serous	IIIC	G2	TP53 c.920-1G>A, g.7576927C>T (splice site)	—",80,45,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
527G>A,"150	51	OC	Serous	IIIC	G3	TP53 p.C176Y, c.527G>A	—",81,42,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
712T>C,"163	67	OC	Serous	IIIC	G3	TP53 p.C238R, c.712T>C	—",82,42,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
1024C>T,"174	69	OC	Serous	IV	G3	TP53 p.R342*, c.1024C>T	—",85,40,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
310C>T,"142*	58	OC	Serous	IIIC	G2	TP53 p.Q104*, c.310C>T	—	Tubal ligation",108,43,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
681G>A,"..., Ltd, Osaka, Japan). Detection of the CYP2C19*2 (681G>A, rs4244285) and *3 (636G>A, rs4986893) alle...",37,245,J_Clin_Pharmacol_2016_Apr_8_56(4)_408-413.txt
636G>A,"...tion of the CYP2C19*2 (681G>A, rs4244285) and *3 (636G>A, rs4986893) alleles was performed by polyme...",37,272,J_Clin_Pharmacol_2016_Apr_8_56(4)_408-413.txt
2674G>A,"2	36/M	Insulin-dependent DM	DM	2674G>A/2674G>A in CP, no mutation in ATP7B	aCP",50,32,J_Clin_Transl_Hepatol_2015_Jun_28_3(2)_85-92.txt
2674G>A,"2	36/M	Insulin-dependent DM	DM	2674G>A/2674G>A in CP, no mutation in ATP7B	aCP",50,40,J_Clin_Transl_Hepatol_2015_Jun_28_3(2)_85-92.txt
934C>T,"3	51/F	Insulin-dependent DM	DM, pigmentation	934C>T/934C>T in HJV, no mutation in ATP7B	HJV-HH",51,46,J_Clin_Transl_Hepatol_2015_Jun_28_3(2)_85-92.txt
934C>T,"...51/F	Insulin-dependent DM	DM, pigmentation	934C>T/934C>T in HJV, no mutation in ATP7B	HJV-HH",51,53,J_Clin_Transl_Hepatol_2015_Jun_28_3(2)_85-92.txt
745G>C,"4	48/M	Insulin-dependent DM	DM, pigmentation	745G>C/745G>C in HJV	HJV-HH",52,46,J_Clin_Transl_Hepatol_2015_Jun_28_3(2)_85-92.txt
745G>C,"...48/M	Insulin-dependent DM	DM, pigmentation	745G>C/745G>C in HJV	HJV-HH",52,53,J_Clin_Transl_Hepatol_2015_Jun_28_3(2)_85-92.txt
1100T>G,"...nsulin-dependent DM	DM, pigmentation,hypogonadism	1100T>G/2008-2009delAC in TRF2, No mutation in ATP...",54,59,J_Clin_Transl_Hepatol_2015_Jun_28_3(2)_85-92.txt
1206C>A,"...endent DM, history of alcoholism	DM, pigmentation	1206C>A/wt in TFR2	FPN-like iron overload",57,69,J_Clin_Transl_Hepatol_2015_Jun_28_3(2)_85-92.txt
187C>G,...67/F	Biochemical liver damage	Glucose-intolerance	187C>G (H63D)/wt in HFE and 714C>G/wt in TFR2	Intr...,58,54,J_Clin_Transl_Hepatol_2015_Jun_28_3(2)_85-92.txt
714C>G,...e	Glucose-intolerance	187C>G (H63D)/wt in HFE and 714C>G/wt in TFR2	Intravenousiron load,58,82,J_Clin_Transl_Hepatol_2015_Jun_28_3(2)_85-92.txt
45T>G,"...dy was to examine the associations of rs2241766 (+45T>G), rs1501299 (+276G>T), rs17300539 (−11391G>A...",9,77,J_Diabetes_Investig_2014_Mar_23_5(2)_192-198.txt
276G>T,"...e associations of rs2241766 (+45T>G), rs1501299 (+276G>T), rs17300539 (−11391G>A) and rs182052 (−100...",9,97,J_Diabetes_Investig_2014_Mar_23_5(2)_192-198.txt
11391G>A,"...41766 (+45T>G), rs1501299 (+276G>T), rs17300539 (−11391G>A) and rs182052 (−10069G>A) in the adiponec...",9,119,J_Diabetes_Investig_2014_Mar_23_5(2)_192-198.txt
10069G>A,"... (+276G>T), rs17300539 (−11391G>A) and rs182052 (−10069G>A) in the adiponectin (Ad) gene with adipon...",9,144,J_Diabetes_Investig_2014_Mar_23_5(2)_192-198.txt
45T>G,... showed that the associations between rs2241766 (+45T>G) and rs1501299 (+276G>T) in the ADIPOQ gene ...,27,575,J_Diabetes_Investig_2014_Mar_23_5(2)_192-198.txt
276G>T,...ations between rs2241766 (+45T>G) and rs1501299 (+276G>T) in the ADIPOQ gene and cardiovascular dise...,27,598,J_Diabetes_Investig_2014_Mar_23_5(2)_192-198.txt
11391G>A,"... in Caucasian patients23. Studies on rs17300539 (−11391G>A) and rs182052 (−10069G>A) are scarce, par...",27,931,J_Diabetes_Investig_2014_Mar_23_5(2)_192-198.txt
10069G>A,"... Studies on rs17300539 (−11391G>A) and rs182052 (−10069G>A) are scarce, particularly in type 2 diabe...",27,956,J_Diabetes_Investig_2014_Mar_23_5(2)_192-198.txt
45T>G,"... study to examine the associations of rs2241766 (+45T>G), rs1501299 (+276G>T), rs17300539 (−11391G>A...",29,260,J_Diabetes_Investig_2014_Mar_23_5(2)_192-198.txt
276G>T,"...e associations of rs2241766 (+45T>G), rs1501299 (+276G>T), rs17300539 (−11391G>A) and rs182052 (−100...",29,280,J_Diabetes_Investig_2014_Mar_23_5(2)_192-198.txt
11391G>A,"...41766 (+45T>G), rs1501299 (+276G>T), rs17300539 (−11391G>A) and rs182052 (−10069G>A) in the ADIPOQ g...",29,302,J_Diabetes_Investig_2014_Mar_23_5(2)_192-198.txt
10069G>A,"... (+276G>T), rs17300539 (−11391G>A) and rs182052 (−10069G>A) in the ADIPOQ gene with Ad isoforms, and...",29,327,J_Diabetes_Investig_2014_Mar_23_5(2)_192-198.txt
45T>G,"Four SNPs were genotyped rs2241766 (+45T>G), rs1501299 (+276G>T), rs17300539 (−11391G>A...",43,38,J_Diabetes_Investig_2014_Mar_23_5(2)_192-198.txt
276G>T,"...Ps were genotyped rs2241766 (+45T>G), rs1501299 (+276G>T), rs17300539 (−11391G>A) and rs182052 (−100...",43,58,J_Diabetes_Investig_2014_Mar_23_5(2)_192-198.txt
11391G>A,"...41766 (+45T>G), rs1501299 (+276G>T), rs17300539 (−11391G>A) and rs182052 (−10069G>A) of the ADIPOQ g...",43,80,J_Diabetes_Investig_2014_Mar_23_5(2)_192-198.txt
10069G>A,"... (+276G>T), rs17300539 (−11391G>A) and rs182052 (−10069G>A) of the ADIPOQ gene",43,105,J_Diabetes_Investig_2014_Mar_23_5(2)_192-198.txt
45T>G,...ferent arguments from the literature: rs2241766 (+45T>G) and rs1501299 (+276G>T) are the most cited ...,45,97,J_Diabetes_Investig_2014_Mar_23_5(2)_192-198.txt
276G>T,...he literature: rs2241766 (+45T>G) and rs1501299 (+276G>T) are the most cited regarding the cardiovas...,45,120,J_Diabetes_Investig_2014_Mar_23_5(2)_192-198.txt
11391G>A,"...garding the cardiovascular risk, the rs17300539 (−11391G>A) was highly associated with adiponectin l...",45,199,J_Diabetes_Investig_2014_Mar_23_5(2)_192-198.txt
10069G>A,"...iated with adiponectin levels, and the rs182052 (−10069G>A) seemed specially associated with disease...",45,275,J_Diabetes_Investig_2014_Mar_23_5(2)_192-198.txt
182052 G>A,rs182052 G>A (n = 189)	Genotypes	Dominant model,128,3,J_Diabetes_Investig_2014_Mar_23_5(2)_192-198.txt
2241766 T>G,rs2241766 T>G	CAD	HTGW	Triglycerides,149,3,J_Diabetes_Investig_2014_Mar_23_5(2)_192-198.txt
677C>T,"Geographical and ethnic variation of the 677C>T allele of 5,10 methylenetetrahydrofolate re...",169,42,J_Epidemiol_2008_May_29_18(3)_125-131.txt
677C-->T,Effect of the methylenetetrahydrofolate reductase 677C-->T mutation on the relations among folate in...,204,51,J_Epidemiol_2008_May_29_18(3)_125-131.txt
1747C>T,"...tinin-3, is located at 11q13-q14. This gene has a 1747C>T transition within exon 16, which results i...",20,84,J_Exerc_Nutrition_Biochem_2014_Dec_6_18(4)_347-353.txt
5557G > A,"...is to evaluate the association between ATM exon39 5557G > A (D1853N, rs1801516) polymorphism and bre...",4,330,J_Exp_Clin_Cancer_Res_2010_Aug_27_29(1)_117.txt
5557G > A,"... common single nucleotide polymorphism ATM exon39 5557G > A (D1853N, rs1801516) may be considered as...",20,93,J_Exp_Clin_Cancer_Res_2010_Aug_27_29(1)_117.txt
2841A>T,"...ly 2 (facilitated glucose transporter), member 1 -2841A>T, hypoxia-inducible factor 1 alpha Pro582Se...",7,110,J_Exp_Clin_Cancer_Res_2010_Jun_12_29(1)_69.txt
936C>T,"...p148Glu, or vascular endothelial growth factor A +936C>T and 2-[fluorine-18]-fluoro-2-deoxy-D-glucos...",7,260,J_Exp_Clin_Cancer_Res_2010_Jun_12_29(1)_69.txt
2841A>T,"...ly 2 (facilitated glucose transporter), member 1 -2841A>T polymorphism was significantly associated ...",10,74,J_Exp_Clin_Cancer_Res_2010_Jun_12_29(1)_69.txt
936C>T,...se findings suggest a potential role of the VEGFA 936C>T polymorphism for the variability of FDG upt...,20,621,J_Exp_Clin_Cancer_Res_2010_Jun_12_29(1)_69.txt
2841A>T,"...llowing SNPs were selected in this study: SLC2A1 -2841A>T (rs710218), VEGFA+936C>T (rs3025039) [NM_0...",31,222,J_Exp_Clin_Cancer_Res_2010_Jun_12_29(1)_69.txt
936C>T,"... in this study: SLC2A1 -2841A>T (rs710218), VEGFA+936C>T (rs3025039) [NM_001025366.1:c.*237C>T], APE...",31,248,J_Exp_Clin_Cancer_Res_2010_Jun_12_29(1)_69.txt
237C>T,"...218), VEGFA+936C>T (rs3025039) [NM_001025366.1:c.*237C>T], APEX1 Asp148Glu (T>G, rs1130409) [NM_0016...",31,286,J_Exp_Clin_Cancer_Res_2010_Jun_12_29(1)_69.txt
444T>G,"..., APEX1 Asp148Glu (T>G, rs1130409) [NM_001641.2:c.444T>G], HIF1A Pro582Ser (C>T, rs11549465) [NM_001...",31,343,J_Exp_Clin_Cancer_Res_2010_Jun_12_29(1)_69.txt
1744C>T,"... HIF1A Pro582Ser (C>T, rs11549465) [NM_001530.2:c.1744C>T], and HIF1A Ala588Thr (G>A, rs11549467) [N...",31,401,J_Exp_Clin_Cancer_Res_2010_Jun_12_29(1)_69.txt
1762G>A,"... HIF1A Ala588Thr (G>A, rs11549467) [NM_001530.2:c.1762G>A]",31,464,J_Exp_Clin_Cancer_Res_2010_Jun_12_29(1)_69.txt
936C>T,VEGFA	+936C>,40,8,J_Exp_Clin_Cancer_Res_2010_Jun_12_29(1)_69.txt
2841A>T,SLC2A1	-2841A>,52,9,J_Exp_Clin_Cancer_Res_2010_Jun_12_29(1)_69.txt
2841A>T,"...encies of the AA, AT, and TT genotypes of SLC2A1 -2841A>T were 51.7%, 37.7%, and 10.6%, respectively...",91,118,J_Exp_Clin_Cancer_Res_2010_Jun_12_29(1)_69.txt
2841A>T,SLC2A1 -2841A>T	AA	78	(51.7%)	A:T	0.705:0.295	0.2579,97,9,J_Exp_Clin_Cancer_Res_2010_Jun_12_29(1)_69.txt
936C>T,VEGFA +936C>T	CC	102	(67.1%)	C:T	0.819:0.181	0.2579,100,8,J_Exp_Clin_Cancer_Res_2010_Jun_12_29(1)_69.txt
2841A>T,SLC2A1 -2841A>T	AA (n = 41)	9.40 ± 2.63	0.155	AA	9.40 ± 2....,118,9,J_Exp_Clin_Cancer_Res_2010_Jun_12_29(1)_69.txt
936C>T,VEGFA +936C>T	CC (n = 54)	9.29 ± 2.66	0.816	CC	9.29 ± 2.6...,121,8,J_Exp_Clin_Cancer_Res_2010_Jun_12_29(1)_69.txt
2841A>T,...tients with squamous cell carcinomas. The SLC2A1 -2841A>T polymorphism was significantly associated ...,134,157,J_Exp_Clin_Cancer_Res_2010_Jun_12_29(1)_69.txt
2841A>T,...the mean SUVmax in the recessive model of SLC2A1 -2841A>T in combination with the APEX1 polymorphism...,134,262,J_Exp_Clin_Cancer_Res_2010_Jun_12_29(1)_69.txt
2841A>T,Table 5 Association between the SLC2A1 -2841A>T gene polymorphism and the mean SUVmax in p...,136,41,J_Exp_Clin_Cancer_Res_2010_Jun_12_29(1)_69.txt
2841A>T,TT	SLC2A1 -2841A>T	AA (n = 13)	8.68 ± 2.40	0.086	AA	8.68 ± 2....,139,12,J_Exp_Clin_Cancer_Res_2010_Jun_12_29(1)_69.txt
2841A>T,TG	SLC2A1 -2841A>T	AA (n = 20)	9.72 ± 3.00	0.984	AA	9.72 ± 3....,142,12,J_Exp_Clin_Cancer_Res_2010_Jun_12_29(1)_69.txt
2841A>T,GG	SLC2A1 -2841A>T	AA (n = 8)	9.81 ± 1.97		AA	9.81 ± 1.97	0.1...,145,12,J_Exp_Clin_Cancer_Res_2010_Jun_12_29(1)_69.txt
2841A>T,The functional effect of the SLC2A1 -2841A>T polymorphism has not been completely chara...,159,38,J_Exp_Clin_Cancer_Res_2010_Jun_12_29(1)_69.txt
936C>T,"...C [18], we did not observe an effect of the VEGFA+936C>T polymorphism on FDG-uptake. An association ...",169,296,J_Exp_Clin_Cancer_Res_2010_Jun_12_29(1)_69.txt
936C>T,...m on FDG-uptake. An association between the VEGFA+936C>T polymorphism and FDG-uptake has been rarely...,169,364,J_Exp_Clin_Cancer_Res_2010_Jun_12_29(1)_69.txt
936C>T,...h NSCLC. Wolf et al. [11] reported that the VEGFA+936C>T polymorphism is associated with FDG-uptake ...,169,490,J_Exp_Clin_Cancer_Res_2010_Jun_12_29(1)_69.txt
405G>C,".... Well-documented functional SNPs, such as VEGFA +405G>C and -460T>C, should be evaluated to identif...",169,1227,J_Exp_Clin_Cancer_Res_2010_Jun_12_29(1)_69.txt
460T>C,"...ented functional SNPs, such as VEGFA +405G>C and -460T>C, should be evaluated to identify the associ...",169,1239,J_Exp_Clin_Cancer_Res_2010_Jun_12_29(1)_69.txt
2841A>T,...ents with early stage NSCLC. Although the SLC2A1 -2841A>T polymorphism in combination with the APEX1...,171,198,J_Exp_Clin_Cancer_Res_2010_Jun_12_29(1)_69.txt
2841A>T,"In summary, the SLC2A1 -2841A>T polymorphism was associated with FDG-uptak...",173,25,J_Exp_Clin_Cancer_Res_2010_Jun_12_29(1)_69.txt
936 C>T,...phism of vascular endothelial growth factor (VEGF 936 C>T) gene and colon cancer in Korea Anticancer...,193,136,J_Exp_Clin_Cancer_Res_2010_Jun_12_29(1)_69.txt
936C>T,... Renner W Samonigg H Yazdani-Biuki B Krippl P The 936C>T polymorphism of the gene for vascular endot...,194,95,J_Exp_Clin_Cancer_Res_2010_Jun_12_29(1)_69.txt
105 C>T,"...e 7.3). Thus, we performed sensitivity tests for G105 C>T and R132C C>T with normalisation to R132S ...",75,796,J_Exp_Clin_Cancer_Res_2014_May_21_33(1)_44.txt
105 C>T,...132S C>A and for R132S C>A with normalisation to G105 C>T (Figure 8). HRM analysis showed sensitivit...,75,891,J_Exp_Clin_Cancer_Res_2014_May_21_33(1)_44.txt
105 C>T,"...h AML had IDH1 mutations. Of these 19 (8.3%) had G105 C>T, 11 (4.8%) had R132C C>T and 6 (2.6%) had ...",75,1102,J_Exp_Clin_Cancer_Res_2014_May_21_33(1)_44.txt
105 C>T,...lot for HRM analysis of serial dilutions of IDH1 G105 C>T: Undiluted mutation ratio was 51.9% (estim...,79,125,J_Exp_Clin_Cancer_Res_2014_May_21_33(1)_44.txt
105 C>T,...lse-negative. Normalisation was performed to the G105 C>T allele,79,965,J_Exp_Clin_Cancer_Res_2014_May_21_33(1)_44.txt
146C>G,...ody MM    The ATM missense mutation p.Ser49Cys (c.146C>G) and the risk of breast cancer Hum Mutat 20...,287,123,J_Exp_Clin_Cancer_Res_2016_Sep_6_35(1)_135.txt
244C>T,"...rains except the BN strain (Table I). Thus, the c.244C>T SNP in exon 1 of Vav1 is the only SNP that ...",29,1677,J_Exp_Med_2011_Oct_24_208(11)_2183-2191.txt
205 C>T,C3	Ex2/c.205 C>T	p.=	T	C	C	C	C	T	C,35,10,J_Exp_Med_2011_Oct_24_208(11)_2183-2191.txt
1018 T>C,C3	Ex9/c.1018 T>C	p.=	C	T	T	T	C	C	C,36,10,J_Exp_Med_2011_Oct_24_208(11)_2183-2191.txt
1252 C>T,C3	Ex11/c.1252 C>T	p.=	T	C	C	C	C	T	C,37,11,J_Exp_Med_2011_Oct_24_208(11)_2183-2191.txt
1339 T>C,C3	Ex12/c.1339 T>C	p.=	C	T	T	T	C	C	C,38,11,J_Exp_Med_2011_Oct_24_208(11)_2183-2191.txt
1369 T>C,C3	Ex12/c.1369 T>C	p.=	C	T	T	T	C	C	C,39,11,J_Exp_Med_2011_Oct_24_208(11)_2183-2191.txt
2929 G>A,C3	Ex23/c.2929 G>A	p.=	A	G	G	G	G	A	G,40,11,J_Exp_Med_2011_Oct_24_208(11)_2183-2191.txt
4109 A>G,C3	Ex32/c.4109 A>G	p.Thr1356Ala	G	A	A	A	A	G	A,41,11,J_Exp_Med_2011_Oct_24_208(11)_2183-2191.txt
536 G>A,Gpr108	Ex6/c.536 G>A	p.=	A	G	G	G	G	A	G,42,14,J_Exp_Med_2011_Oct_24_208(11)_2183-2191.txt
930 T>C,Gpr108	Ex8/c.930 T>C	p.=	C	T	T	T	T	C	T,43,14,J_Exp_Med_2011_Oct_24_208(11)_2183-2191.txt
935 C>T,Gpr108	Ex8/c.935 C>T	p.=	T	C	C	C	C	T	C,44,14,J_Exp_Med_2011_Oct_24_208(11)_2183-2191.txt
1397 G>A,Gpr108	Ex13/c.1397 G>A	p.=	A	G	G	G	G	A	G,45,15,J_Exp_Med_2011_Oct_24_208(11)_2183-2191.txt
1520 G>A,Gpr108	Ex15/c.1520 G>A	p.=	A	G	G	G	G	A	G,46,15,J_Exp_Med_2011_Oct_24_208(11)_2183-2191.txt
244 C>T,Vav1a	Ex1/c.244 C>Ta	p.Arg63Trpa	T	C	C	C	C	C	C,48,13,J_Exp_Med_2011_Oct_24_208(11)_2183-2191.txt
579 C>T,Vav1	Ex5/c.579 C>T	p.=	C	T	T	T	C	T	T,49,12,J_Exp_Med_2011_Oct_24_208(11)_2183-2191.txt
627 G>A,Vav1	Ex6/c.627 G>A	p.=	A	G	G	G	A	G	G,50,12,J_Exp_Med_2011_Oct_24_208(11)_2183-2191.txt
244C>T,...96). The mutation in human VAV1 at the position c.244C>T (R63W) of the sequence coding for the R63W ...,96,408,J_Exp_Med_2011_Oct_24_208(11)_2183-2191.txt
3616T>G,ATM	c.3616T>G	p.L1206V	10	Tolerated	Benign,31,7,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
3646T>C,ATM	c.3646T>C	p.Y1216H	12	Tolerated	Damaging (probably),32,7,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
2546T>C,BRCA2	c.2546T>C	p.V849A	33	Tolerated	Benign,33,9,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
9966G>T,BRCA2	c.9966G>T	p.M3322I	36	Tolerated	Damaging (probably),34,9,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
1007A>T,CHEK2	c.1007A>T	p.Q336L	54	Damaging	Benign,35,9,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
26C>G,DDB1	c.26C>G	p.A9G	86	Damaging	Damaging (possibly),37,8,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
1412A>G,EXO1	c.1412A>G	p.K471R	18	Tolerated	Benign,38,8,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
1618A>G,MSH2	c.1618A>G	p.S540G	20	Tolerated	Benign,39,8,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
2497C>G,MSH2	c.2497C>G	p.L833V	50	Damaging	Benign,40,8,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
1628A>G,MSH6	c.1628A>G	p.K543R	29	Damaging	Benign,41,8,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
10252T>C,PRKDC	c.10252T>C	p.F3418L	31	Damaging	Damaging (probably),43,9,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
400T>G,TP53	c.400T>G	p.F134V	47	Damaging	Damaging (probably),45,8,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
817C>T,TP53	c.817C>T	p.R273C	67	Damaging	Damaging (probably),46,8,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
818G>A,TP53	c.818G>A	p.R273H	38	Damaging	Damaging (probably),47,8,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
847A>G,XRCC5	c.847A>G	p.T283A	29	Damaging	Damaging (probably),48,9,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
2T>A,"...nsertion (p.D293X), a splice-site mutation (c.319+2T>A), and a missense mutation (p.I364T) located i...",61,509,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
1G>A,"...groups of controls (Table 2). Of these, the c.444+1G>A splice site mutation has been previously repo...",61,763,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
2T>A,c.319+2T>A	-	Novel	1/171	ND	Swedish	0	0	-	-,66,7,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
1007A>T,c.1007A>T	p.Q336L	Novel	1/64	Somatic	Chinese	0	0	Dam...,68,3,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
1091T>C,c.1091T>C	p.I364T	Novel	1/171	ND	Swedish	0	0	Damagin...,69,3,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
7C>T,c.7C>T	p.R3W	rs199708878	1/171	Germline	Swedish	0	0	...,70,3,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
349A>G,c.349A>G	p.R117G	rs28909982	1/171	ND	Swedish	0	0	Dam...,71,3,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
1G>A,c.444+1G>A	-	Reported	1/171	Germline	Swedish	0	0	-	-,72,7,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
1312G>T,c.1312G>T	p.D438Y	rs200050883	2/164	ND	Swedish	0	0	D...,73,3,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
1582G>A,c.1582G>A	p.E528K	rs138040612	1/64	Germline	Chinese	...,74,3,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
470T>C,c.470T>C	p.I157T	rs17879961	3/171	Germline (1)	Swedi...,75,3,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
538C>T,c.538C>T	p.R180C	rs77130927	1/171	ND	Swedish	0.006	0...,76,3,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
1111C>T,c.1111C>T	p.H371Y	Reported	2/64	Somatic/germline	Chi...,78,3,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
1897A>T,PARP1	c.1897A>T	p.K633X	Sanger	Novel	Somatic	Chinese	0	-	-...,86,9,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
2326A>G,c.2326A>G	p.S776G	Selector & Sanger	Novel	Germline	C...,88,4,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
2756T>C,c.2756T>C	p.I919T	Sanger	Novel	ND	Chinese	0	Damaging...,89,4,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
2789A>G,c.2789A>G	p.Y930C	Sanger	rs189410139	ND	Chinese	0.00...,90,4,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
3037C>A,c.3037C>A	p.L1013M	Sanger	rs138906127	ND	Swedish	0.0...,91,4,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
1316C>T,MSH2	c.1316C>T	p.P439L	Sanger	Novel	ND	Chinese	0	Damaging...,92,8,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
1619A>G,c.1619A>G	p.S540G	Selector & Sanger	Novel	Somatic	Ch...,93,4,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
2498C>G,c.2498C>G	p.L833V	Selector & Sanger	Novel	Somatic	Ch...,94,4,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
505A>G,c.505A>G	p.I169V	Sanger	rs63750716	ND	Chinese	0	Tole...,95,4,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
26C>G,DDB1	c.26C>G	p.A9G	Selector	Novel	Somatic	Chinese	0	Damag...,96,8,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
3360G>A,c.3360G>A	p.M1120I	454 amplicon	Novel	ND	Swedish	0	T...,98,4,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
536G>A,DCLRE1C	c.536G>A	p.R179Q	454 amplicon	rs150854849	ND	Swedish...,99,11,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
119G>A,MLH3	c.119G>A	p.C40Y	Selector	Novel	Germline	Chinese	0	Da...,101,8,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
365A>G,c.365A>G	p.K122R	454 amplicon	Novel	ND	Chinese	0	Dam...,102,4,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
2221G>T,c.2221G>T	p.V741I	454 amplicon	rs28756990	ND	Swedish...,103,4,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
2837C>T,c.2837C>T	p.S946F	Selector	rs201441389	Germline	Chin...,104,4,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
2964C>G,c.2964C>G	p.I988M	Selector	Novel	Germline	Chinese	0	...,105,4,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
3331C>T,c.3331C>T	p.L1111F	Selector	Novel	Germline	Chinese	0...,106,4,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
847A>G,XRCC5	c.847A>G	p.T283A	Selector	Novel	Somatic	Chinese	0	Da...,107,9,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
1046C>A,c.1046C>A	p.S349Y	454 amplicon	Novel	Germline	Chines...,108,4,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
1522A>G,c.1522A>G	p.I508V	454 amplicon	rs2287558	ND	Swedish	...,109,4,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
524G>A,"...was found to carry a homozygous point mutation (c.524G>A) in exon 6 of the AK2 gene, leading to an a...",57,490,J_Exp_Med_2015_Jul_27_212(8)_1185-1202.txt
524G>A,...s were collected from a patient with homozygous c.524G>A mutation in the human AK2 gene (Henderson e...,135,74,J_Exp_Med_2015_Jul_27_212(8)_1185-1202.txt
2T>G,"...nts with complete IL-12Rβ1 deficiency (P1, c.1791+2T>G/1791+2T>G; P2, c.1791+2T>G/p.R486X; P3, c.C12...",96,242,J_Exp_Med_2016_Apr_4_213(4)_569-583.txt
2T>G,"...omplete IL-12Rβ1 deficiency (P1, c.1791+2T>G/1791+2T>G; P2, c.1791+2T>G/p.R486X; P3, c.C1207T/C1207T...",96,252,J_Exp_Med_2016_Apr_4_213(4)_569-583.txt
2T>G,"...deficiency (P1, c.1791+2T>G/1791+2T>G; P2, c.1791+2T>G/p.R486X; P3, c.C1207T/C1207T; P4, p>R173W/R17...",96,269,J_Exp_Med_2016_Apr_4_213(4)_569-583.txt
118 A>G,...Kaasa S  Holthe M  Dale O  Borchgrevink PC    The 118 A>G polymorphism in the human mu-opioid recept...,451,78,J_Gastroenterol_2014_Feb_9_49(1)_24-45.txt
118A>G,...h J   Meta-analysis of the relevance of the OPRM1 118A>G genetic variant for pain treatment Pain 200...,452,70,J_Gastroenterol_2014_Feb_9_49(1)_24-45.txt
224Q > E,"...n the size of residue 224 in the Kir2.1 channel (E224Q > E224A > E224G) (Xie et al., 2004). Therefor...",51,1162,J_Gen_Physiol_2005_Dec_126(6)_551-562.txt
224A > E,"...ze of residue 224 in the Kir2.1 channel (E224Q > E224A > E224G) (Xie et al., 2004). Therefore, the i...",51,1170,J_Gen_Physiol_2005_Dec_126(6)_551-562.txt
38D > M,"...reas A96S LY transfer was similar to that of WT (G38D > M163V > A96S ≈ Cx40WT). In contrast, G38D ch...",7,1068,J_Gen_Physiol_2015_Nov_146(5)_387-398.txt
163V > A,"...6S LY transfer was similar to that of WT (G38D > M163V > A96S ≈ Cx40WT). In contrast, G38D channels ...",7,1075,J_Gen_Physiol_2015_Nov_146(5)_387-398.txt
163V > A,"... WT Cx40, with the following permeability order: M163V > A96S > Cx40WT > G38D. Altered conductive an...",7,1366,J_Gen_Physiol_2015_Nov_146(5)_387-398.txt
96S > C,"..., with the following permeability order: M163V > A96S > Cx40WT > G38D. Altered conductive and permea...",7,1374,J_Gen_Physiol_2015_Nov_146(5)_387-398.txt
38D > M,...p junctions to LY exhibited the following order: G38D > M163V > A96S ≈ Cx40WT,83,1132,J_Gen_Physiol_2015_Nov_146(5)_387-398.txt
163V > A,...ions to LY exhibited the following order: G38D > M163V > A96S ≈ Cx40WT,83,1139,J_Gen_Physiol_2015_Nov_146(5)_387-398.txt
163V > A,"...ed diminished permeability, relative to WT Cx40: M163V > A96S > Cx40WT > G38D",89,801,J_Gen_Physiol_2015_Nov_146(5)_387-398.txt
96S > C,"...ished permeability, relative to WT Cx40: M163V > A96S > Cx40WT > G38D",89,809,J_Gen_Physiol_2015_Nov_146(5)_387-398.txt
163V > G,... A96S LY transfer was similar to that of the WT: M163V > G38D > A96S ≈ Cx40WT,97,462,J_Gen_Physiol_2015_Nov_146(5)_387-398.txt
38D > A,... transfer was similar to that of the WT: M163V > G38D > A96S ≈ Cx40WT,97,470,J_Gen_Physiol_2015_Nov_146(5)_387-398.txt
1294C>G,Genotyping for the polymorphism c. 1294C>G (p. Leu432Val) in gene CYP1B1 was done usi...,41,36,J_Gynecol_Oncol_2011_Jun_30_22(2)_110-119.txt
472G>A,"...ylamide gels. Genotyping for the polymorphisms c. 472G>A (p. Val108/158Met) in gene COMT, c. 313A>G ...",41,427,J_Gynecol_Oncol_2011_Jun_30_22(2)_110-119.txt
313A>G,"...sms c. 472G>A (p. Val108/158Met) in gene COMT, c. 313A>G (p. Ile105Val) in gene GSTP1 and c. 47T>C (...",41,470,J_Gynecol_Oncol_2011_Jun_30_22(2)_110-119.txt
47T>C,"...MT, c. 313A>G (p. Ile105Val) in gene GSTP1 and c. 47T>C (p. Val16Ala) in gene MnSOD was performed on...",41,513,J_Gynecol_Oncol_2011_Jun_30_22(2)_110-119.txt
1294C>G,"...scordant samples were repeated. Apart from CYP1B1 1294C>G, all polymorphisms had no samples that fai...",41,1249,J_Gynecol_Oncol_2011_Jun_30_22(2)_110-119.txt
1294C>G,"...o samples that failed to be genotyped. For CYP1B1 1294C>G, 1% of the samples failed. Samples that fa...",41,1331,J_Gynecol_Oncol_2011_Jun_30_22(2)_110-119.txt
4 R>L,5 Slightly Lasting 3-4 R>L; R>L; F + Next day R Lasting +(?,445,22,J_Headache_Pain_2006_Feb_20_7(1)_9-20.txt
127C>T,"...tions and frameshift MPL mutations, such as MPL c.127C>T and c.378delT, may be responsible for this ...",43,176,J_Hematol_Oncol_2013_Jan_25_6_11.txt
305G>C,"... mutations, such as the most frequent mutation, c.305G>C, are closely associated with CAMT II. This ...",45,258,J_Hematol_Oncol_2013_Jan_25_6_11.txt
515W>L,... F Characteristics and clinical correlates of MPL 515W>L/K mutation in essential thrombocythemia Blo...,137,160,J_Hematol_Oncol_2013_Jan_25_6_11.txt
1106T>C,"...g all identified/validated common polymorphisms (−1106T>C, −906T>C, −809G>A, −616G>C, −521T>C, −376C...",3,1717,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
906T>C,"...tified/validated common polymorphisms (−1106T>C, −906T>C, −809G>A, −616G>C, −521T>C, −376C>T, −291C>...",3,1727,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
809G>A,"...lidated common polymorphisms (−1106T>C, −906T>C, −809G>A, −616G>C, −521T>C, −376C>T, −291C>T and 12-...",3,1736,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
616G>C,"...ommon polymorphisms (−1106T>C, −906T>C, −809G>A, −616G>C, −521T>C, −376C>T, −291C>T and 12-bp repeat...",3,1745,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
521T>C,"...ymorphisms (−1106T>C, −906T>C, −809G>A, −616G>C, −521T>C, −376C>T, −291C>T and 12-bp repeat) and a k...",3,1754,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
376C>T,"...s (−1106T>C, −906T>C, −809G>A, −616G>C, −521T>C, −376C>T, −291C>T and 12-bp repeat) and a known micr...",3,1763,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
291C>T,"...>C, −906T>C, −809G>A, −616G>C, −521T>C, −376C>T, −291C>T and 12-bp repeat) and a known microsatellit...",3,1772,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
809G>A,...m region. A single nucleotide polymorphism (SNP) −809G>A in the promoter region was found to be sign...,3,1916,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
809G>A,"...ed that a combination of the four polymorphisms, −809G>A, −616G>C, −291C>T and the 12-bp repeat, con...",3,2208,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
616G>C,"... combination of the four polymorphisms, −809G>A, −616G>C, −291C>T and the 12-bp repeat, conferred a ...",3,2217,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
291C>T,"...ion of the four polymorphisms, −809G>A, −616G>C, −291C>T and the 12-bp repeat, conferred a susceptib...",3,2226,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
521T>C,...lele of the single nucleotide polymorphism (SNP) −521T>C and a 120-bp tandem duplication (1.2 kb ups...,13,270,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
1106T>C,"...RD4 gene, and identified a total of eleven SNPs: −1106T>C, −930C>G, −906T>C, −873G>A, −809G>A, −616G...",41,95,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
930C>G,"...and identified a total of eleven SNPs: −1106T>C, −930C>G, −906T>C, −873G>A, −809G>A, −616G>C, −603G>...",41,105,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
906T>C,"...ified a total of eleven SNPs: −1106T>C, −930C>G, −906T>C, −873G>A, −809G>A, −616G>C, −603G>T, −595G>...",41,114,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
873G>A,"...otal of eleven SNPs: −1106T>C, −930C>G, −906T>C, −873G>A, −809G>A, −616G>C, −603G>T, −595G>del, −521...",41,123,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
809G>A,"...leven SNPs: −1106T>C, −930C>G, −906T>C, −873G>A, −809G>A, −616G>C, −603G>T, −595G>del, −521T>C, −376...",41,132,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
616G>C,"...s: −1106T>C, −930C>G, −906T>C, −873G>A, −809G>A, −616G>C, −603G>T, −595G>del, −521T>C, −376C>T, and ...",41,141,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
603G>T,"...>C, −930C>G, −906T>C, −873G>A, −809G>A, −616G>C, −603G>T, −595G>del, −521T>C, −376C>T, and −291C>T, ...",41,150,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
521T>C,"..., −873G>A, −809G>A, −616G>C, −603G>T, −595G>del, −521T>C, −376C>T, and −291C>T, and a 12-bp repeat p...",41,170,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
376C>T,"..., −809G>A, −616G>C, −603G>T, −595G>del, −521T>C, −376C>T, and −291C>T, and a 12-bp repeat polymorphi...",41,179,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
291C>T,"...16G>C, −603G>T, −595G>del, −521T>C, −376C>T, and −291C>T, and a 12-bp repeat polymorphism (Fig. 1). ...",41,192,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
930C>G,"...repeat polymorphism (Fig. 1). One novel variant, −930C>G (deposited into GenBank as ss61570833), was...",41,262,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
1106T>C,"The eight markers, −1106T>C, −906T>C, −809G>A, −616G>C, −521T>C, −376C...",43,21,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
906T>C,"The eight markers, −1106T>C, −906T>C, −809G>A, −616G>C, −521T>C, −376C>T, −291C>...",43,31,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
809G>A,"The eight markers, −1106T>C, −906T>C, −809G>A, −616G>C, −521T>C, −376C>T, −291C>T, and th...",43,40,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
616G>C,"The eight markers, −1106T>C, −906T>C, −809G>A, −616G>C, −521T>C, −376C>T, −291C>T, and the 12-bp r...",43,49,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
521T>C,"...ht markers, −1106T>C, −906T>C, −809G>A, −616G>C, −521T>C, −376C>T, −291C>T, and the 12-bp repeat pol...",43,58,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
376C>T,"...s, −1106T>C, −906T>C, −809G>A, −616G>C, −521T>C, −376C>T, −291C>T, and the 12-bp repeat polymorphism...",43,67,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
291C>T,"...>C, −906T>C, −809G>A, −616G>C, −521T>C, −376C>T, −291C>T, and the 12-bp repeat polymorphism in exon ...",43,76,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
1106 T>C,−1106 T>C	rs936460	626199			T/T	T/C	C/C,51,2,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
906 T>C,−906 T>C	rs3758653	626399			T/T	T/C	C/C,54,2,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
809 G>A,−809 G>A	rs936461	626496			A/A	A/G	G/G,57,2,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
616 G>C,−616 G>C	rs747302	626689			C/C	C/G	G/G,60,2,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
521 T>C,−521 T>C	rs1800955	626784			T/T	T/C	C/C,63,2,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
376 C>T,−376 C>T	rs916455	626929			T/T	T/C	C/C,66,2,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
291 C>T,−291 C>T	rs916457	627014			T/T	T/C	C/C,69,2,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
809G>A,... and genotypic distributions of the promoter SNP −809G>A differed significantly between cases and co...,80,58,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
1106T>C,...ere close to 1 in the distal [(120-bp repeat) − (−1106T>C) − (−906T>C)] and proximal [(−376C>T) − (−...,82,78,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
906T>C,...1 in the distal [(120-bp repeat) − (−1106T>C) − (−906T>C)] and proximal [(−376C>T) − (−291C>T) − (−1...,82,91,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
376C>T,...repeat) − (−1106T>C) − (−906T>C)] and proximal [(−376C>T) − (−291C>T) − (−12-bp)] segments of the up...,82,116,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
291C>T,...1106T>C) − (−906T>C)] and proximal [(−376C>T) − (−291C>T) − (−12-bp)] segments of the upstream regio...,82,128,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
809G>A,"...ltaneously. A combination of four polymorphisms (−809G>A, −616G>C, −219C>T and 12-bp repeat) appeare...",82,580,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
616G>C,"...y. A combination of four polymorphisms (−809G>A, −616G>C, −219C>T and 12-bp repeat) appeared to affe...",82,589,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
219C>T,"...ination of four polymorphisms (−809G>A, −616G>C, −219C>T and 12-bp repeat) appeared to affect suscep...",82,598,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
1106T>C,...erved in the discrete distal [(120-bp repeat) − (−1106T>C) − (−906T>C)] and proximal [(−376C>T) − (−...,83,495,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
906T>C,...discrete distal [(120-bp repeat) − (−1106T>C) − (−906T>C)] and proximal [(−376C>T) − (−291C>T) − (12...,83,508,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
376C>T,"...repeat) − (−1106T>C) − (−906T>C)] and proximal [(−376C>T) − (−291C>T) − (12-bp repeat)] segments, bu...",83,533,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
291C>T,"...1106T>C) − (−906T>C)] and proximal [(−376C>T) − (−291C>T) − (12-bp repeat)] segments, but not in the...",83,545,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
809G>A,−809G>A	0.346 	0.127 	7.384 	0.007 	1.414 	1.10–1.8...,88,2,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
616G>C,−616G>C	0.247 	0.125 	3.872 	0.049 	1.280 	1.00–1.6...,89,2,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
291C>T,−291C>T	1.031 	0.400 	6.649 	0.010 	2.804 	1.28–6.2...,90,2,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
809G>A,"Both upstream region variants, the single marker −809G>A and a multi-marker combination, displayed a...",99,51,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
521T>C,"...iation with schizophrenia in this study. The SNP −521T>C, which was previously reported to show asso...",99,155,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
809G>A,...s testing failed to replicate the association of −809G>A in a sample set of 80 complete schizophreni...,99,1529,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
809G>A,"...e association. Secondly, the significance of the −809G>A polymorphism in the promoter region disappe...",99,1729,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
521T>C,...usly limited and so the insignificant result for −521T>C needs to be interpreted cautiously. The sam...,99,1917,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
521C>T,...Chen N Shu BC  Dopamine D4 receptor gene and the −521C>T polymorphism of the upstream region of the ...,124,59,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
521C>T,... Shu BC (2006) Dopamine D4 receptor gene and the −521C>T polymorphism of the upstream region of the ...,124,285,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
742C>T,The mutation c.742C>T in the HOXD13 gene generates a new restrict...,29,16,J_Hum_Genet_2011_Oct_4_56(10)_701-706.txt
742C>T,"...plotype A, carry a homozygous nonsense mutation c.742C>T (p.Q248X) in exon 1 of the HOXD13 gene (Fig...",42,336,J_Hum_Genet_2011_Oct_4_56(10)_701-706.txt
742C>T,"...plotype A, carry a homozygous nonsense mutation c.742C>T (p.Q248X) in exon 1 of the HOXD13 gene. Aff...",75,114,J_Hum_Genet_2011_Oct_4_56(10)_701-706.txt
742C>T,...e heterozygous for haplotype A. b) The mutation c.742C>T in the HOXD13 gene generates a restriction ...,75,249,J_Hum_Genet_2011_Oct_4_56(10)_701-706.txt
1G>A,"...G). Seven splice site mutations were found (c.416-1G>A, c.600+1G>T, c.601-1G>A, c.919-2A>G, c.1001+1...",32,471,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1G>T,"...lice site mutations were found (c.416-1G>A, c.600+1G>T, c.601-1G>A, c.919-2A>G, c.1001+1G>A, c.1002-...",32,483,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1G>A,"...tations were found (c.416-1G>A, c.600+1G>T, c.601-1G>A, c.919-2A>G, c.1001+1G>A, c.1002-9A>G and c.1...",32,495,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
2A>G,"... found (c.416-1G>A, c.600+1G>T, c.601-1G>A, c.919-2A>G, c.1001+1G>A, c.1002-9A>G and c.1707+5G>A)",32,507,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1G>A,"...-1G>A, c.600+1G>T, c.601-1G>A, c.919-2A>G, c.1001+1G>A, c.1002-9A>G and c.1707+5G>A)",32,520,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
9A>G,"...1G>T, c.601-1G>A, c.919-2A>G, c.1001+1G>A, c.1002-9A>G and c.1707+5G>A)",32,533,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
5G>A,"..., c.919-2A>G, c.1001+1G>A, c.1002-9A>G and c.1707+5G>A)",32,549,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
2A>G,"...hat accounted for 36.0%, and the second was c.919-2A>G found in 7.0%, followed by c.1707+5G>A (4.0%)...",38,91,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
5G>A,"... was c.919-2A>G found in 7.0%, followed by c.1707+5G>A (4.0%). Frequency of the other 36 mutations w...",38,130,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
2A>G,"...utations in east Asians, namely p.H723R and c.919-2A>G. p.H723R is most prevalent in the Japanese an...",56,324,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
2A>G,"...e Japanese and Korean populations,8 whereas c.919-2A>G is most common in the Chinese.",56,411,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
266C>T,"c. 266C>T	p. P76S	2	 	1	 	0.50	Suzuki et al.5, 6",81,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
281C>T,"c. 281C>T	p. T94I	3	 	1	 	0.50	Wang et al.7, 8",82,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
367C>T,"c. 367C>T	p. P123S	4	 	1	 	0.50	Tsukamoto et al.2, 4",84,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1G>A,"c. 416-1G>A	 	Intron 4	 	2	 	1.00	Tsukamoto et al.2, 4",85,8,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
439A>G,"c. 439A>G	p. M147V	5	 	2	 	1.00	Tsukamoto et al.2, 4",86,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1G>T,c. 600+1G>T	 	Intron 5	 	1	 	0.50	This study,87,8,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1G>A,"c. 601-1G>A	 	Intron 5	 	1	 	0.50	Tsukamoto et al.2, 4",88,8,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
890C>A,c. 890C>A	p. P297Q	7	 	1	 	0.50	This study,89,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
2A>G,c. 919-2A>G	 	Intron 7	1	11	1	7.00	Coucke et al.21,91,8,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1G>A,c. 1001+1G>A	 	Intron 8	 	2	 	1.00	Coyle et al.22,92,9,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
9A>G,c. 1002-9A>Ga	 	Intron 8	 	1	 	0.50	This study,93,9,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1105A>G,"c. 1105A>G	p. K369E	9	 	1	 	0.50	Usami et al.2, 3",94,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1115C>T,"c. 1115C>T	p. A372V	9	 	1	 	0.50	Usami et al.2, 3",95,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1174A>T,"c. 1174A>T	p. N392Y	10	 	3	 	1.50	Park et al.14, 16",96,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1187G>A,c. 1187G>A	p. G396E	10	 	1	 	0.50	This study,97,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1229C>T,c. 1229C>T	p. T410M	10	1	1	 	1.50	Coyle et al.22,99,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1300G>A,c. 1300G>A	p. A434T	11	 	 	1	0.50	This study,100,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1315G>A,"c. 1315G>A	p. G439R	11	 	1	 	0.50	Suzuki et al.5, 6",101,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1343C>T,"c. 1343C>T	p. S448L	11	 	1	 	0.50	Wang et al.7, 8",102,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1579A>G,"c. 1579A>G	p. T527P	14	 	2	 	1.00	Suzuki et al.5, 6",103,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1586T>G,"c. 1586T>G	p. I529S	14	 	1	 	0.50	Wang et al.7, 8",104,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1595G>T,"c. 1595G>T	p. S532I	14	 	2	 	1.00	Usami et al.3, 17",105,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1694G>A,"c. 1694G>A	p. C565Y	15	 	1	 	0.50	Tsukamoto et al.2, ...",107,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
5G>A,"c. 1707+5G>A	 	Intron 15	1	6	 	4.00	Park et al.8, 9",108,9,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1743G>C,"c. 1743G>C	p. R581S	16	 	2	 	1.00	Iwasaki et al.5, 18...",109,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1829C>A,"c. 1829C>A	p. S610X	17	 	1	 	0.50	Tsukamoto et al.2, ...",110,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1970G>A,"c. 1970G>A	p. S657N	17	 	1	 	0.50	Tsukamoto et al.2, ...",111,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1975G>C,"c. 1975G>C	p. V659L	17	 	3	 	1.50	Wang et al.7, 8",112,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1997C>T,"c. 1997C>T	p. S666F	17	 	1	 	0.50	Tsukamoto et al.2, ...",113,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
2162C>T,"c. 2162C>T	p. T721M	19	 	1	1	1.00	Usami et al.2, 3",115,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
2168A>G,"c. 2168A>G	p. H723R	19	11	40	10	36.00	Usami et al.2, ...",116,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
2168C>T,c. 2168C>T	p. H723Y	19	1	 	 	1.00	This study,117,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
2180T>A,c. 2180T>A	p. L727X	19	 	1	 	0.50	This study,118,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
9A>G,"a c. 1002-9A>G, uncertain pathogenicity",119,11,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
2A>G,1306	3	p. [919-2A>G][H723R]	0	NA	NA	NA	NA	NA	NA	NA	NA,129,16,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1G>A,1379	10	p. [1001+1G>A][H723R]	0	+	+	−	−	NA	66.25	46.25	57.5,131,18,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
2A>G,1625	16	p. [919-2A>G][H723R]	0	+	+	NA	+	NA	100	95	88.1,133,17,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1G>A,2010	12	p. [416-1G>A][H723R]	9	+	+	−	−	+	80	91.25	81.3,138,17,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
2A>G,2498	0	p. [919-2A>G][1001+1G>A]	0	+	+	NA	−	−	86.25	86.25	83.8,143,16,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1G>A,2498	0	p. [919-2A>G][1001+1G>A]	0	+	+	NA	−	−	86.25	86.25	83.8,143,27,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
2A>G,2728	3	p. [919-2A>G][H723R]	1	+	+	−	−	−	97.5	97.5	93.8,147,16,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
5G>A,2804	2	p. [1707+5G>A][H723R]	0	+	+	−	−	−	78.75	78.75	82.5,149,17,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
2A>G,3298	6	p. [919-2A>G][H723R]	0	+	+	+	+	−	73.75	110	86.9,152,16,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1G>A,3301	4	p. [416-1G>A][H723R]	0	+	+	+	+	−	65	72.5	68.1,153,16,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
2A>G,3442	6	p. [919-2A>G][H723R]	NA	+	NA	+	+	−	81.25	50	60.0,154,16,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1G>A,3994	59	p. [601-1G>A][H723R]	10	+	+	+	+	+	96.0	94	91.3,157,17,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
9A>G,4097	3	p. [N392Y][1002-9A>G]	0	−	−	−	−	−	106.25	85	93.1,161,24,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
2A>G,4098	26	p. [N392Y][919-2A>G]	2	−	+	+	+	−	110	37.5	71.3,162,24,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
5G>A,4380	10	p. [1707+5G>A][H723R]	2	+	+	−	−	−	96.25	81.25	84.4,171,18,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
5G>A,4434	8	p. [T410M][1707+5G>A]	1	+	+	−	+	−	92.5	100	91.3,174,24,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
5G>A,4486	20	p. [1707+5G>A][1707+5G>A]	4	+	+	+	+	+	72.5	95	78.1,177,18,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
5G>A,4486	20	p. [1707+5G>A][1707+5G>A]	4	+	+	+	+	+	72.5	95	78.1,177,29,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
2A>G,4518	26	p. [H723R][919-2A>G]	0	+	+	+	+	−	105	97.5	98.1,180,24,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
2A>G,4530	5	p. [H723R][919-2A>G]	0	+	+	−	+	−	67.5	86.25	71.9,181,23,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
5G>A,4545	12	p. [1707+5G>A][H723R]	4	+	+	+	+	+	86.25	28.75	53.1,182,18,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
5G>A,4663	0	p. [1707+5G>A][H723R]	0	−	+	NA	NA	−	68.75	68.75	99.2,184,17,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
2A>G,4645	23	p. [919-2A>G] [=]	14	+	−	+	−	−	96.25	105	93.8,188,17,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
2A>G,4735	9	p. [H723R][919-2A>G]	0	+	+	+	+	−	107.5	110	103.8,194,23,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1G>T,4671	2	p. [H723R][600+1G>T]	0	+	−	−	+	−	NA	NA	NA,213,23,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
2A>G,3309	5	p. [919-2A>G][P76S]	0	+	+	+	+	−	106.25	106.25	101.3,217,16,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
2A>G,SNS5500	42	p. [919-2A>G][919-2A>G]	4	+	+	+	+	+	70	81.3	64,221,20,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
2A>G,SNS5500	42	p. [919-2A>G][919-2A>G]	4	+	+	+	+	+	70	81.3	64,221,30,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
5G>A,SNS5503	37	p. [H723R][1707+5G>A]	5	+	+	+	+	+	67.5	70	NA,222,28,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
53C>T,... in the exon 9-flanking region in intron 8 (c.832-53C>T),33,403,J_Hum_Genet_2016_Jun_25_61(6)_483-489.txt
7693C>T,5	EX53	c.7693C>T	p.Gln2565*	nonsence,89,10,J_Hum_Genet_2016_Jun_25_61(6)_483-489.txt
434G>C,6	EX6	c.434G>C	p.Arg145Pro	missense,90,9,J_Hum_Genet_2016_Jun_25_61(6)_483-489.txt
10011C>G,7	EX69	c.10011C>G	p.Cys3337Trp	missense,91,10,J_Hum_Genet_2016_Jun_25_61(6)_483-489.txt
9568C>T,8	EX66	c.9568C>T	p.Arg3190	nonsence,92,10,J_Hum_Genet_2016_Jun_25_61(6)_483-489.txt
1G>T,11	int2	c.94-1G>T	 	Splice donor variant,95,14,J_Hum_Genet_2016_Jun_25_61(6)_483-489.txt
2A>G,20	int54	c.8218-2A>G	 	Splice donor variant,104,17,J_Hum_Genet_2016_Jun_25_61(6)_483-489.txt
1732A>T,29	EX15	c.1732A>T	p.Lys578*	Nonsence,113,11,J_Hum_Genet_2016_Jun_25_61(6)_483-489.txt
2612A>C,30	EX20	c.2612A>C	p.Lys871Thr	Missense,114,11,J_Hum_Genet_2016_Jun_25_61(6)_483-489.txt
20519G > G,"g.20519G > G, p.180 Arg > Arg",31,3,J_Hum_Reprod_Sci_2009_Jan-Jun_2(1)_35-40.txt
180 Arg > Arg,"g.20519G > G, p.180 Arg > Arg",31,17,J_Hum_Reprod_Sci_2009_Jan-Jun_2(1)_35-40.txt
20422G > A,"g.20422G > A, p.Ala > Thr (Mnl1 polymorphism)",33,3,J_Hum_Reprod_Sci_2009_Jan-Jun_2(1)_35-40.txt
290A>G,"...sion analysis, in addition to the age, only RANKL 290A>G remained as an independent risk factor for ...",149,591,J_Immunol_Res_2015_Dec_21_2015_745647.txt
550G>C,"...s polymorphism [rs5030737] and DrdI for the MBL2 -550G>C [rs11003125]), so that if a polymorphism is...",42,541,J_Immunol_Res_2015_Mar_24_2015_478412.txt
221G>C,"...(for the Gly57Glu, rs1800451), and BtgI (for the -221G>C, rs7096206). The primer pairs, the conditio...",42,952,J_Immunol_Res_2015_Mar_24_2015_478412.txt
221G>C,...analyses indicating the presence of (A) the X/Y (-221G>C) and (B) the L/H (-550G>C) polymorphisms. (...,99,171,J_Immunol_Res_2015_Mar_24_2015_478412.txt
550G>C,...esence of (A) the X/Y (-221G>C) and (B) the L/H (-550G>C) polymorphisms. (C) Representative digestio...,99,197,J_Immunol_Res_2015_Mar_24_2015_478412.txt
550G>C,-550G>C (rs11003125),119,2,J_Immunol_Res_2015_Mar_24_2015_478412.txt
221G>C,-221G>C (rs7096206),122,2,J_Immunol_Res_2015_Mar_24_2015_478412.txt
215 G > A,... acid change at the position 72 of the protein (c.215 G > A) broke an Exonic Splicing Enhancer (ESE)...,83,586,J_Immunol_Res_2016_Mar_30_2016_8390356.txt
260 T>A,I.20	48	F	551	97	115	No	Yes	 	No	No	No	 	c.[260 T>A];[542 C>A,196,45,J_Immunol_Res_2016_Mar_30_2016_8390356.txt
542 C>A,...	48	F	551	97	115	No	Yes	 	No	No	No	 	c.[260 T>A];[542 C>A,196,55,J_Immunol_Res_2016_Mar_30_2016_8390356.txt
311 G>A,I.22	87	F	75	20	28	No	No	 	Yes	Yes	Yes	 	c.[311 G>A];[=,198,45,J_Immunol_Res_2016_Mar_30_2016_8390356.txt
310 T>C,I.23	29	M	486	53	59	No	Yes	IBD	Yes	Yes	Yes	 	c.[310 T>C];[=,200,50,J_Immunol_Res_2016_Mar_30_2016_8390356.txt
122 A>G,I.34	60	F	44	0	0	No	No	 	Yes	Yes	No	 	c.[122 A>G];[=,202,42,J_Immunol_Res_2016_Mar_30_2016_8390356.txt
706 G>T,...	Na	Na	Yes	No	 	No	Yes	No	Pancreatic carcinoma	c.[706 G>T];[=,204,63,J_Immunol_Res_2016_Mar_30_2016_8390356.txt
310 T>C,I.40	42	M	269	15	73	No	No	 	No	No	No	 	c.[310 T>C];[=,206,43,J_Immunol_Res_2016_Mar_30_2016_8390356.txt
579 C>A,I.45	49	M	157	7	6	Yes	No	 	Yes	No	Yes	 	c.[579 C>A];[=,208,44,J_Immunol_Res_2016_Mar_30_2016_8390356.txt
310 T>C,I.59	25	M	Na	Na 	Na	No	No	 	No	No	No	 	c.[310 T>C];[542 C>A,210,43,J_Immunol_Res_2016_Mar_30_2016_8390356.txt
542 C>A,...59	25	M	Na	Na 	Na	No	No	 	No	No	No	 	c.[310 T>C];[542 C>A,210,53,J_Immunol_Res_2016_Mar_30_2016_8390356.txt
215 G>A,...	M	208	0	33	No	No	 	No	No	No	NHL	c.[204_205insA];[215 G>A,212,58,J_Immunol_Res_2016_Mar_30_2016_8390356.txt
310 T>C,...	356	72	33	No	No	 	Yes	Yes	No	Ovaric Theratoma	c.[310 T>C];[310 T>C,214,60,J_Immunol_Res_2016_Mar_30_2016_8390356.txt
310 T>C,...	No	No	 	Yes	Yes	No	Ovaric Theratoma	c.[310 T>C];[310 T>C,214,70,J_Immunol_Res_2016_Mar_30_2016_8390356.txt
260 T>A,I.77	25	F	430	8	152	Yes	Yes	 	No	Yes	No	 	c.[260 T>A];[=,216,46,J_Immunol_Res_2016_Mar_30_2016_8390356.txt
260 T>A,I.78	19	M	983	18	169	No	Yes	 	No	No	No	 	c.[260 T>A];[=,218,45,J_Immunol_Res_2016_Mar_30_2016_8390356.txt
310 T>C,I.82	49	M	380	0	39	No	No	 	No	Yes	No	 	c.[310 T>C];[=,220,43,J_Immunol_Res_2016_Mar_30_2016_8390356.txt
492 C>G,I.86	23	F	280	5	4	No	No	 	Yes	Yes	Yes	 	c.[492 C>G];[=,222,44,J_Immunol_Res_2016_Mar_30_2016_8390356.txt
515 G>A,I.102	42	F	220	5	16	Yes	No	 	Yes	Yes	Yes	 	c.[ 515 G>A];[=,224,48,J_Immunol_Res_2016_Mar_30_2016_8390356.txt
260 T>A,...104	82	F	380	54	24	No	No	 	Yes	Yes	No	Sarcomas	c.[260 T>A];[492 C>G,226,54,J_Immunol_Res_2016_Mar_30_2016_8390356.txt
492 C>G,...80	54	24	No	No	 	Yes	Yes	No	Sarcomas	c.[260 T>A];[492 C>G,226,64,J_Immunol_Res_2016_Mar_30_2016_8390356.txt
492 C>G,I.118	54	F	240	5	140	No	Yes	RA	Yes	Yes	Yes	 	c.[492 C>G];[542 C>A,228,49,J_Immunol_Res_2016_Mar_30_2016_8390356.txt
542 C>A,...	F	240	5	140	No	Yes	RA	Yes	Yes	Yes	 	c.[492 C>G];[542 C>A,228,59,J_Immunol_Res_2016_Mar_30_2016_8390356.txt
306 C>G,"I.126	47	F	250	64	90	No	No	 	No	No	No	 	c.[306 C>G];[431 C>G,579 C>A",230,44,J_Immunol_Res_2016_Mar_30_2016_8390356.txt
431 C>G,"...26	47	F	250	64	90	No	No	 	No	No	No	 	c.[306 C>G];[431 C>G,579 C>A",230,54,J_Immunol_Res_2016_Mar_30_2016_8390356.txt
579 C>A,"...250	64	90	No	No	 	No	No	No	 	c.[306 C>G];[431 C>G,579 C>A",230,62,J_Immunol_Res_2016_Mar_30_2016_8390356.txt
542 C>A,I.138	31	M	90	5	4	No	Yes	Vitiligo	No	Yes	No	 	c.[542 C>A];[=,232,50,J_Immunol_Res_2016_Mar_30_2016_8390356.txt
310 T>C,I.152	58	F	82	25	47	No	Yes	 	Yes	Yes	No	 	c.[310 T>C];[=,234,46,J_Immunol_Res_2016_Mar_30_2016_8390356.txt
310 T>C,I.162	46	F	434	32	30	No	No	 	No	Yes	No	 	c.[310 T>C];[579 C>A,236,45,J_Immunol_Res_2016_Mar_30_2016_8390356.txt
579 C>A,...2	46	F	434	32	30	No	No	 	No	Yes	No	 	c.[310 T>C];[579 C>A,236,55,J_Immunol_Res_2016_Mar_30_2016_8390356.txt
109G>T,P1	+	c.109G>T	6.72	Casale et al. 1998,35,8,J_Inherit_Metab_Dis_2010_Aug_8_33(4)_405-410.txt
109G>T,P2	+	c.109G>T	8.49	Casale et al. 1998,36,8,J_Inherit_Metab_Dis_2010_Aug_8_33(4)_405-410.txt
109G>T,P3	+	c.109G>T/c504_5delCT	20.12a	Menao et al. 2009,37,8,J_Inherit_Metab_Dis_2010_Aug_8_33(4)_405-410.txt
144G>T,P4	+	c.144G>T/c.504_5delCT	5.61	Menao et al. 2009,39,8,J_Inherit_Metab_Dis_2010_Aug_8_33(4)_405-410.txt
575T>C,P6	+	c.575T>C	6.17	Menao et al. 2009,41,8,J_Inherit_Metab_Dis_2010_Aug_8_33(4)_405-410.txt
109G>T,P7	+	c.109G>T	5.39	Menao et al. 2009,42,8,J_Inherit_Metab_Dis_2010_Aug_8_33(4)_405-410.txt
109G>T,P8	+	c.109G>T	7.85	Menao et al. 2009,43,8,J_Inherit_Metab_Dis_2010_Aug_8_33(4)_405-410.txt
109G>T,P9	+	c.109G>T/c.825C>G	5.80a	-----,44,8,J_Inherit_Metab_Dis_2010_Aug_8_33(4)_405-410.txt
825C>G,P9	+	c.109G>T/c.825C>G	5.80a	-----,44,17,J_Inherit_Metab_Dis_2010_Aug_8_33(4)_405-410.txt
109G>T,P10	+	c.109G>T	2.13a	Menao et al. 2009,46,9,J_Inherit_Metab_Dis_2010_Aug_8_33(4)_405-410.txt
109G>T,P11	+	c.109G>T/c.504_5delCT	5.35a	-----,47,9,J_Inherit_Metab_Dis_2010_Aug_8_33(4)_405-410.txt
242G>A,P12	+	c.242G>A	5.93a	-----,48,9,J_Inherit_Metab_Dis_2010_Aug_8_33(4)_405-410.txt
8993T>G,...ate. The classical clinical picture is found in m.8993T>G/C and m.9176T>G/C mutations and covers a s...,93,191,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
9176T>G,...al clinical picture is found in m.8993T>G/C and m.9176T>G/C mutations and covers a spectrum which va...,93,207,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
8993T>G,m.8993T>G This mutation leads to NARP (typically <90...,95,3,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
8993T>G,...garbi et al. 2006; Kucharczyk et al. 2010). The m.8993T>G point mutation leads to p.Leu156Arg. Leu15...,95,850,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
8993T>C,m.8993T>C The clinical picture is similar to the m.8...,97,3,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
8993T>G,"....8993T>C The clinical picture is similar to the m.8993T>G mutation, but is generally milder (de Vrie...",97,52,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
8993T>G,"...pposite to the positive charged arginine in the m.8993T>G mutation, proline is a non-charged amino a...",97,274,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
8993T>C,...es seen in patients. It has been shown that the m.8993T>C mutation favors reactive oxygen species (R...,97,511,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
9176T>G,m.9176T>G/C The clinical picture is characterized by...,99,3,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
9176T>C,... described in a family carrying the homoplasmic m.9176T>C mutation (Verny et al. 2011). The mutation...,99,274,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
9176T>G,...rved hydrophobic leucine residue into arginine (m.9176T>G) or proline (m.9176T>C) at position 217 of...,99,402,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
9176T>C,...e residue into arginine (m.9176T>G) or proline (m.9176T>C) at position 217 of the protein. Position ...,99,425,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
9176T>G,...lls with a high degree of heteroplasmy that the m.9176T>G mutation severely decreases the rate of AT...,99,641,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
9176T>G,"...n (Carrozzo et al. 2001). In yeast carrying the m.9176T>G mutation, it has been described that that ...",99,752,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
8993T>G,"...009a, b, c). This finding is in contrast to the m.8993T>G mutation, where the assembly is not altere...",99,1070,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
9176T>G,"...d before). Taken together, the pathogenicity of m.9176T>G may not be limited to a bio-energetic defi...",99,1184,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
9176T>C,"...ology (Kucharczyk et al. 2009a, b, c). Also the m.9176T>C mutation has been studied in yeast, only s...",99,1364,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
9176T>C,...relation between genotype and phenotype for the m.9176T>C mutation (Kucharczyk et al. 2010). Additio...,99,1550,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
9035T>C,"m.9035T>C, m.9185T>C, m.9191T>C, m.8851T>C These mut...",101,3,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
9185T>C,"m.9035T>C, m.9185T>C, m.9191T>C, m.8851T>C These mutations are ...",101,14,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
9191T>C,"m.9035T>C, m.9185T>C, m.9191T>C, m.8851T>C These mutations are illustratio...",101,25,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
8851T>C,"m.9035T>C, m.9185T>C, m.9191T>C, m.8851T>C These mutations are illustrations of varia...",101,36,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
9035T>C,... earlier described NARP-MILS clinical spectrum. m.9035T>C has been found in a family with maternally...,101,146,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
9185T>C,...ve oxygen species (ROS) (Sikorska et al. 2009). m.9185T>C (p.Leu220Pro) results in a phenotype varyi...,101,473,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
9191T>C,...rome (Moslemi et al. 2005; Childs et al. 2007). m.9191T>C (p.Leu222Pro) has been described in a pati...,101,710,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
9185T>C,"...i et al. 2005). The pathogenic mechanism of the m.9185T>C and m.9191T>C mutations is unknown, but th...",101,841,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
9191T>C,".... The pathogenic mechanism of the m.9185T>C and m.9191T>C mutations is unknown, but they are situate...",101,855,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
8851T>C,...rom bilateral striatal necrosis and harboring a m.8851T>C mutation has also been described (De Meirl...,101,1169,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
8741T>G,...come (D'Aurelio et al. 2010). MT-ATP6 mutations m.8741T>G and m.8795A > G have been shown to be prot...,105,434,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
8993T>G,...ave been shown to be protective factors for the m.8993T>G MILS mutation (Mkaouar-Rebai et al. 2009)....,105,509,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
9055G>A,"...uar-Rebai et al. 2009). A MT-ATP6 polymorphism, m.9055G>A, significantly reduces the risk of Parkins...",105,586,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
8993T>G,"...he biochemical and clinical phenotype, e.g., of m.8993T>G/C and m.9176T>G mutations (D'Aurelio et al...",105,999,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
9176T>G,"...nd clinical phenotype, e.g., of m.8993T>G/C and m.9176T>G mutations (D'Aurelio et al. 2010). The ger...",105,1015,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
8932C>T,"...(D'Aurelio et al. 2010). The germ-line mutation m.8932C>T has, together with somatic mtDNA mutations...",105,1083,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
8836T>G,".... 2005; Arnold et al. 2009). The mtDNA variants m.8836T>G, m.9016A>G, m.9101T>C, m.9139G>A have been...",105,1282,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
9016A>G,"...old et al. 2009). The mtDNA variants m.8836T>G, m.9016A>G, m.9101T>C, m.9139G>A have been linked wit...",105,1293,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
9101T>C,"...2009). The mtDNA variants m.8836T>G, m.9016A>G, m.9101T>C, m.9139G>A have been linked with patients ...",105,1304,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
9139G>A,"...mtDNA variants m.8836T>G, m.9016A>G, m.9101T>C, m.9139G>A have been linked with patients who had Leb...",105,1315,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
8529G>A,m.8529G>A This homoplasmic mutation has been found i...,108,3,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
8528T>C,m.8528T>C This homoplasmic mutation has been found i...,110,3,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
8528T>C,"...tae in one patient (Ware et al. 2009). For A6L, m.8528T>C (p. Trp55Arg) is a pathogenic missense mut...",110,400,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
8529G>A,"...al. 2009).Taken together, the MT-ATP8 mutations m.8529G>A and m.8528T>C both affect the same amino a...",110,793,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
8528T>C,"...n together, the MT-ATP8 mutations m.8529G>A and m.8528T>C both affect the same amino acid (tryptopha...",110,807,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
8411A>G,m.8411A>G The de novo mutation with 97% heteroplasmy...,112,3,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
9176T>C,... two siblings with Leigh syndrome harboring the m.9176T>C mutation in MT-ATP6 (Hung and Wang 2007). ...,112,599,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
8411A>G,".... 2010), and therefore the pathogenicity of the m.8411A>G mutation has not been firmly established y...",112,803,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
35A>G,"Recently, a homozygous missense mutation c.35A>G (p.Tyr12Cys) has been described in exon 2 of...",121,44,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
8993T>G,...refore been tested in fibroblasts harboring 97% m.8993T>G mutant mtDNA. It has been shown that they ...,127,233,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
8893T>G,...nstrated that homoplasmic cybrids harboring the m.8893T>G mutation were protected from cell death an...,132,336,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
8993T>G,...mical defect in cybrid cell lines harboring the m.8993T>G mutation has been corrected successfully u...,137,488,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
8993T>G,...lso been applied to human cybrids harboring the m.8993T>G mutation by expressing the nDNA encoded AT...,139,266,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
8993T>G,"...e mtDNA (DiMauro et al. 2006). For example, the m.8993T>G mutation creates a unique cleavage site fo...",141,143,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
8993T>G,... It has been shown that culturing heteroplasmic m.8993T>G cybrid cells in medium containing oligomyc...,143,61,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
8993T>G,... mutant loads question the observation that the m.8993T>G mutation has a skewed segregation during o...,153,1497,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
9185T>C,...ariable phenotype including Leigh syndrome with a 9185T>C mutation in the MTATP6 gene Neuropediatric...,199,82,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
8993T>C,...sequences in yeast of the human mitochondrial DNA 8993T>C mutation in the ATPase6 gene found in NARP...,238,94,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
4052T>C,...ification of ataxia-associated mtDNA mutations (m.4052T>C and m.9035T>C) and evaluation of their pat...,289,87,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
9035T>C,...taxia-associated mtDNA mutations (m.4052T>C and m.9035T>C) and evaluation of their pathogenicity in ...,289,101,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
8993T->G,Steffann J Gigarel N Corcos J  Stability of the m.8993T->G mtDNA mutation load during human embryofe...,291,51,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
1156C>T,"...d to date are reported to be missense mutations c.1156C>T (p.Arg386Cys), c.901G>T (p.Gly301Cys), and...",164,727,J_Inherit_Metab_Dis_2013_Mar_1_36(2)_293-307.txt
901G>T,"... be missense mutations c.1156C>T (p.Arg386Cys), c.901G>T (p.Gly301Cys), and c.337A>T (p.Ile113Phe) (...",164,752,J_Inherit_Metab_Dis_2013_Mar_1_36(2)_293-307.txt
337A>T,"...6C>T (p.Arg386Cys), c.901G>T (p.Gly301Cys), and c.337A>T (p.Ile113Phe) (Tomatsu et al 2005a). Howeve...",164,780,J_Inherit_Metab_Dis_2013_Mar_1_36(2)_293-307.txt
337A>T,"...lso very population-dependent. For example, the c.337A>T (p.Ile113Phe) mutation was actually found t...",164,1052,J_Inherit_Metab_Dis_2013_Mar_1_36(2)_293-307.txt
3243A > G,...oy with a genetically confirmed MELAS syndrome (m.3243A > G mitochondrial DNA mutation) for 2 years ...,10,135,J_Inherit_Metab_Dis_2016_Apr_7_39_465-466.txt
983T>C,"...e polymorphisms (SNPs) CYP3A5*6, CYP3A5*3, CYP2B6 983T>C, CYP2B6 516G>T, CYP2B6 785A>G in 89/180 pat...",9,629,J_Int_AIDS_Soc_2010_Nov_8_13(Suppl_4)_P181.txt
516G>T,"... (SNPs) CYP3A5*6, CYP3A5*3, CYP2B6 983T>C, CYP2B6 516G>T, CYP2B6 785A>G in 89/180 patients obtained ...",9,644,J_Int_AIDS_Soc_2010_Nov_8_13(Suppl_4)_P181.txt
785A>G,"...6, CYP3A5*3, CYP2B6 983T>C, CYP2B6 516G>T, CYP2B6 785A>G in 89/180 patients obtained by Sequenom iPL...",9,659,J_Int_AIDS_Soc_2010_Nov_8_13(Suppl_4)_P181.txt
983T>C,...fection was observed. Of the SNPs analysed CYP2B6 983T>C and CYP3A5*3 had a significant impact on NV...,12,516,J_Int_AIDS_Soc_2010_Nov_8_13(Suppl_4)_P181.txt
34G>A,"...lementary Methods). A somatic heterozygous HRAS c.34G>A, p.G12S substitution was found in each (Figu...",15,323,J_Invest_Dermatol_2014_Apr_15_134(4)_1149-1152.txt
34G>A,"In summary, we find somatic HRAS c.34G>A, p.G12S mutation in affected tissue from two...",23,36,J_Invest_Dermatol_2014_Apr_15_134(4)_1149-1152.txt
2A>G,"...d a maternal acceptor splice site mutation g.6751-2A>G (IVS85-2A>G). Therefore, one truncated (pater...",18,332,J_Invest_Dermatol_2014_May_6_134(5)_1246-1254.txt
2A>G,"... acceptor splice site mutation g.6751-2A>G (IVS85-2A>G). Therefore, one truncated (paternal) and one...",18,344,J_Invest_Dermatol_2014_May_6_134(5)_1246-1254.txt
2A>G,...the COL7A1 region surrounding the maternal g.6751-2A>G mutation located in intron 85 indicated skipp...,18,714,J_Invest_Dermatol_2014_May_6_134(5)_1246-1254.txt
683T>G,"...t only one of the putative variants, Variant 2 (c.683T>G; p.L228R), present in a patient with defini...",16,909,J_Invest_Dermatol_2015_Jul_3_135(7)_1905-1908.txt
599G>A,"1a	72/F	47/57	20	2	rs114688446	c.599G>A, p.S200N	A: 0.8	Benign	Tolerated	Neutral	Ne...",42,34,J_Invest_Dermatol_2015_Jul_3_135(7)_1905-1908.txt
683T>G,"2	75/M	70/70	2	1	rs142246283	c.683T>G, p.L228R	no data	Probably damaging	Tolerate...",45,32,J_Invest_Dermatol_2015_Jul_3_135(7)_1905-1908.txt
2044C>T,"3	46/F	21/21	2	1	rs117918077	c.2044C>T, p.R682W	T: 1.2	Probably damaging	Damaging...",46,32,J_Invest_Dermatol_2015_Jul_3_135(7)_1905-1908.txt
2406C>A,"4	35/F	32/32	1	1	no data	c.2406C>A, p.S802R	no data	Benign	Damaging	Pathologi...",47,28,J_Invest_Dermatol_2015_Jul_3_135(7)_1905-1908.txt
64G>T,"...licing acceptor/donor site mutations. Of these, c.64G>T, c.1699C>T, c.466_467 insAC, c.1174-1G>A, an...",4,1033,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
1699C>T,"...ceptor/donor site mutations. Of these, c.64G>T, c.1699C>T, c.466_467 insAC, c.1174-1G>A, and c.1768+...",4,1042,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
1G>A,"...hese, c.64G>T, c.1699C>T, c.466_467 insAC, c.1174-1G>A, and c.1768+5G>A were novel mutations. To ana...",4,1075,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
5G>A,"...1699C>T, c.466_467 insAC, c.1174-1G>A, and c.1768+5G>A were novel mutations. To analyze the correlat...",4,1092,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
64G>T,"...e 15 unrelated Korean patients (60%). Of these, c.64G>T, c.1699C>T, c.466_467insAC, c.1174-1G>A, and...",34,130,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
1699C>T,"...lated Korean patients (60%). Of these, c.64G>T, c.1699C>T, c.466_467insAC, c.1174-1G>A, and c.1768+5...",34,139,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
1G>A,"...these, c.64G>T, c.1699C>T, c.466_467insAC, c.1174-1G>A, and c.1768+5G>A were novel mutations identif...",34,171,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
5G>A,"....1699C>T, c.466_467insAC, c.1174-1G>A, and c.1768+5G>A were novel mutations identified in this study...",34,188,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
1363G>T,Inspection of the mutations revealed that c.1363G>T (p. Glu455X) and c.1699C>T (p.Arg567X) wer...,36,45,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
1699C>T,"...ations revealed that c.1363G>T (p. Glu455X) and c.1699C>T (p.Arg567X) were nonsense mutations, and t...",36,72,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
1601C>T,"...T (p.Arg567X) were nonsense mutations, and that c.1601C>T (p.Pro534Leu) and c.64G>T (p. Ala22Ser) we...",36,128,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
64G>T,"...mutations, and that c.1601C>T (p.Pro534Leu) and c.64G>T (p. Ala22Ser) were missense mutations. One m...",36,156,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
1G>A,"... codon at amino acid 222. Three mutations, c.1174-1G>A (IVS10-1G>A), c.1768+5G>A (IVS17+5G >A), and ...",36,352,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
1G>A,"...ino acid 222. Three mutations, c.1174-1G>A (IVS10-1G>A), c.1768+5G>A (IVS17+5G >A), and c.1965+1G>A ...",36,364,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
5G>A,"...Three mutations, c.1174-1G>A (IVS10-1G>A), c.1768+5G>A (IVS17+5G >A), and c.1965+1G>A (IVS19+1G>A), ...",36,378,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
5G >A,"...ons, c.1174-1G>A (IVS10-1G>A), c.1768+5G>A (IVS17+5G >A), and c.1965+1G>A (IVS19+1G>A), occur at spl...",36,390,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
1G>A,"...VS10-1G>A), c.1768+5G>A (IVS17+5G >A), and c.1965+1G>A (IVS19+1G>A), occur at splicing acceptor/dono...",36,409,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
1G>A,"...c.1768+5G>A (IVS17+5G >A), and c.1965+1G>A (IVS19+1G>A), occur at splicing acceptor/donor sites; c.1...",36,421,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
1G>A,"...), occur at splicing acceptor/donor sites; c.1174-1G>A was detected in two unrelated Korean patients...",36,475,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
64G>T,"...n two unrelated Korean patients. Two mutations, c.64G>T and c.466_467insAC, are located in the N-ter...",36,544,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
1G>A,...icing mutation analysis predicted that the c.1174-1G>A variation decreases the binding energy of the...,36,780,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
5G> A,"... and thus abolishes the site, and that the c.1768+5G> A variation decreases the binding energy of th...",36,917,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
1601C>T,The c.1601C>T mutation has been observed in many studies...,43,7,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
64G> T,"...onserved in ECE-1 and the KELL antigen (8). The c.64G> T mutation, a new mutation detected in this s...",43,410,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
64G>T,"...sequencing results demonstrate novel mutations, c.64G>T (A), c.466insAC (B), c.1174-1G>A (C), c.1699...",57,65,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
1G>A,"...el mutations, c.64G>T (A), c.466insAC (B), c.1174-1G>A (C), c.1699C>T (D), and c.1768+5G>A (E), in t...",57,99,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
1699C>T,"..., c.64G>T (A), c.466insAC (B), c.1174-1G>A (C), c.1699C>T (D), and c.1768+5G>A (E), in the PHEX gene...",57,111,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
5G>A,"...C (B), c.1174-1G>A (C), c.1699C>T (D), and c.1768+5G>A (E), in the PHEX gene in patients with X-link...",57,135,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
679C>T,"... One was a C to T transition at nucleotide 679 (c.679C>T) in exon 7, resulting in a Pro to Ser subst...",25,106,J_Korean_Med_Sci_2010_Jan_26_25(1)_159-162.txt
907G>A,"...ther was a G to A transition at nucleotide 907 (c.907G>A) in exon 8, resulting in a Gly to Arg subst...",25,262,J_Korean_Med_Sci_2010_Jan_26_25(1)_159-162.txt
679C>T,...g of the DHCR7 gene. A novel missense mutation (c.679C>T; Pro227Ser) was identified in the patient a...,39,78,J_Korean_Med_Sci_2010_Jan_26_25(1)_159-162.txt
677 C>T,...lis D  Stefanadis C  Refsum H  Channon KM   MTHFR 677 C>T Polymorphism reveals functional importance...,68,163,J_Korean_Med_Sci_2011_Mar_25_26(3)_461-465.txt
6443T>G,...s and craniofacial abnormalities. The mutation (c.6443T>G) of the NOTCH2 gene was found. The patient...,3,1625,J_Korean_Med_Sci_2013_Nov_31_28(11)_1682-1686.txt
6443T>G,...heterogenetic mutant allele in the NOTCH2 gene (c.6443T>G) (Fig. 6) leading to an amino acid substit...,11,2519,J_Korean_Med_Sci_2013_Nov_31_28(11)_1682-1686.txt
6443T>G,"... of DNA sequencing. DNA sequencing covering the c.6443T>G mutation of (A) the patient, (B) his mothe...",32,66,J_Korean_Med_Sci_2013_Nov_31_28(11)_1682-1686.txt
896A>G,39 Chen S   Association between the TLR4 +896A>G (Asp299Gly) polymorphism and asthma: a syst...,142,43,J_Korean_Med_Sci_2014_May_25_29(5)_662-668.txt
2368392 C>T,...genotype (11.5%). The minor allele frequency of rs2368392 C>T was 0.326 and its heterozygosity was 0...,42,532,J_Korean_Med_Sci_2014_Nov_4_29(11)_1523-1527.txt
2368392 C>T,"... 1.19 odds of persistent HBV infection, and the rs2368392 C>T was found to be marginally associated ...",47,193,J_Korean_Med_Sci_2014_Nov_4_29(11)_1523-1527.txt
2368392 C>T,...o statistically significant association between rs2368392 C>T SNP and the disease progression to cir...,51,73,J_Korean_Med_Sci_2014_Nov_4_29(11)_1523-1527.txt
9101C>T,"...d to examine the relationship between the CTTN g.-9101C>T, g.-8748C>T, and g.72C>T polymorphisms and...",7,84,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
8748C>T,"... the relationship between the CTTN g.-9101C>T, g.-8748C>T, and g.72C>T polymorphisms and the risk of...",7,96,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
72C>T,"...ip between the CTTN g.-9101C>T, g.-8748C>T, and g.72C>T polymorphisms and the risk of CRC. Polymeras...",7,111,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
8748C>T,"...ction fragment length polymorphism analysis of g.-8748C>T, g.-9101C>T and Taqman analysis of g.72C>T...",7,234,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
9101C>T,"...nt length polymorphism analysis of g.-8748C>T, g.-9101C>T and Taqman analysis of g.72C>T were perfor...",7,246,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
72C>T,"...f g.-8748C>T, g.-9101C>T and Taqman analysis of g.72C>T were performed on blood samples from 218 pat...",7,279,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
9101C>T,"...ents with CRC and 533 control individuals. The g.-9101C>T, g.-8748C>T, and g.72C>T SNPs in CTTN and ...",7,380,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
8748C>T,"...C and 533 control individuals. The g.-9101C>T, g.-8748C>T, and g.72C>T SNPs in CTTN and their haplot...",7,392,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
72C>T,"...ol individuals. The g.-9101C>T, g.-8748C>T, and g.72C>T SNPs in CTTN and their haplotypes were analy...",7,407,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
9101C>T,"The genotype and allele frequencies of g.-9101C>T, g.-8748C>T, and g.72C>T did not differ be...",10,43,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
8748C>T,"...genotype and allele frequencies of g.-9101C>T, g.-8748C>T, and g.72C>T did not differ between the pa...",10,55,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
72C>T,"...lele frequencies of g.-9101C>T, g.-8748C>T, and g.72C>T did not differ between the patient group and...",10,70,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
9101C>T,"... control group. Further, the haplotype of CTTN g.-9101C>T, g.-8748C>T, and g.72C>T did not differ be...",10,174,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
8748C>T,"...up. Further, the haplotype of CTTN g.-9101C>T, g.-8748C>T, and g.72C>T did not differ between patien...",10,186,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
72C>T,"...e haplotype of CTTN g.-9101C>T, g.-8748C>T, and g.72C>T did not differ between patient group and the...",10,201,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
9101C>T,"...r, the genotype and allele frequencies of CTTN g.-9101C>T were significantly increased in the lymph ...",10,323,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
9101C>T,The CTTN g.-9101C>T polymorphism may influence lymph node posi...,13,13,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
9101C>T,"...d at investigating the association of the CTTN g.-9101C>T, g.-8748C>T, and g.72C>T polymorphisms wit...",24,1131,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
8748C>T,"...gating the association of the CTTN g.-9101C>T, g.-8748C>T, and g.72C>T polymorphisms with the risk o...",24,1143,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
72C>T,"...ciation of the CTTN g.-9101C>T, g.-8748C>T, and g.72C>T polymorphisms with the risk of CRC",24,1158,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
9101C>T,"... samples from 533 healthy volunteers. The CTTN g.-9101C>T, g.-8748C>T, and g.72C>T polymorphisms wer...",27,249,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
8748C>T,"...m 533 healthy volunteers. The CTTN g.-9101C>T, g.-8748C>T, and g.72C>T polymorphisms were analyzed i...",27,261,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
72C>T,"...olunteers. The CTTN g.-9101C>T, g.-8748C>T, and g.72C>T polymorphisms were analyzed in the 2 groups ...",27,276,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
9101C>T,"...e patient and control groups and the CTTN gene g.-9101C>T, g.-8748C>T polymorphisms were analyzed us...",30,123,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
8748C>T,"...d control groups and the CTTN gene g.-9101C>T, g.-8748C>T polymorphisms were analyzed using the poly...",30,135,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
72C>T,"...ment length polymorphism (PCR-RFLP) method, and g.72C>T was analyzed by the TaqMan method. In CRC pa...",30,273,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
9101C> T,Portions of the CTTN gene containing either the 9101C> T or -8748C>T polymorphic sites were partia...,33,49,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
8748C>T,... the CTTN gene containing either the 9101C> T or -8748C>T polymorphic sites were partially amplified...,33,62,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
9101C>T,... were partially amplified using a primer set for -9101C>T and -8748C>T (CTTN-PF1; TCCCAGGTGAGTACCCAT...,33,137,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
8748C>T,...ly amplified using a primer set for -9101C>T and -8748C>T (CTTN-PF1; TCCCAGGTGAGTACCCATGTGGT and CTT...,33,150,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
9101C>T,...10-minute extension at 72℃. The PCR products for -9101C>T and -8748C>T were digested with 2 U of Eco...,33,534,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
8748C>T,...ension at 72℃. The PCR products for -9101C>T and -8748C>T were digested with 2 U of Eco 52 I for 12 ...,33,547,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
9101C>T,...riction enzyme digestion of the PCR products for -9101C>T (630 bp) and -8748C>T (630 bp) yielded 2 f...,33,809,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
8748C>T,...on of the PCR products for -9101C>T (630 bp) and -8748C>T (630 bp) yielded 2 fragments of 490 bp and...,33,831,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
72C>T,The assay reagents for the g.72C>T (rs2298397) polymorphism in the CTTN gene we...,36,30,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
9101C>T,"The genotype frequencies of the CTTN g.-9101C>T polymorphism were 97.0% (TT), 3.0% (TC), a...",43,41,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
8748C>T,"...ol group. The genotype frequencies of the CTTN g.-8748C>T polymorphism were 97.9% (TT), 2.0% (TC), a...",43,225,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
72C>T,"...rol group. The genotype frequencies of the CTTN g.72C>T polymorphism were 78.4% (CC), 21.1% (CT), an...",43,408,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
9101C>T,"...p. The genotype and allele frequencies of CTTN g.-9101C>T, g.-8748C>T, and g.72C>T did not differ be...",43,604,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
8748C>T,"...ype and allele frequencies of CTTN g.-9101C>T, g.-8748C>T, and g.72C>T did not differ between the pa...",43,616,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
72C>T,"...frequencies of CTTN g.-9101C>T, g.-8748C>T, and g.72C>T did not differ between the patient group and...",43,631,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
9101C>T,"The genotype and allele frequencies of CTTN g.-9101C>T, g.-8748C>T, and g.72C>T did not differ be...",46,48,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
8748C>T,"...ype and allele frequencies of CTTN g.-9101C>T, g.-8748C>T, and g.72C>T did not differ between the 2 ...",46,60,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
72C>T,"...frequencies of CTTN g.-9101C>T, g.-8748C>T, and g.72C>T did not differ between the 2 CRC groups acco...",46,75,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
9101C>T,"...r, the genotype and allele frequencies of CTTN g.-9101C>T were significantly higher in the lymph nod...",46,199,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
9101 C>T,"The major haplotype of CTTN g.-9101 C>T, g.-8748C>T, and g. 72C>T was T-T-C, T-T-...",49,32,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
8748C>T,"The major haplotype of CTTN g.-9101 C>T, g.-8748C>T, and g. 72C>T was T-T-C, T-T-T. The haplot...",49,45,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
72C>T,"...haplotype of CTTN g.-9101 C>T, g.-8748C>T, and g. 72C>T was T-T-C, T-T-T. The haplotype did not diff...",49,61,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
9101C>T,"The haplotype frequencies of CTTN g.-9101C>T, g.-8748C>T, and g.72C>T did not differ be...",52,38,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
8748C>T,"The haplotype frequencies of CTTN g.-9101C>T, g.-8748C>T, and g.72C>T did not differ between CRC gr...",52,50,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
72C>T,"...frequencies of CTTN g.-9101C>T, g.-8748C>T, and g.72C>T did not differ between CRC groups and the co...",52,65,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
9101C>T,"...h the controls. Although the haplotype of CTTN g.-9101C>T, g.-8748C>T, and g.72C>T did not differ be...",67,1162,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
8748C>T,"...ls. Although the haplotype of CTTN g.-9101C>T, g.-8748C>T, and g.72C>T did not differ between CRC an...",67,1174,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
72C>T,"...e haplotype of CTTN g.-9101C>T, g.-8748C>T, and g.72C>T did not differ between CRC and the controls,...",67,1189,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
9101C>T,"...n, the genotype and allele frequencies of CTTN g.-9101C>T were significantly higher in lymph node-po...",69,63,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
8748C>T,"...owever, the genotype and allele frequencies of g.-8748C>T and g.72C>T did not differ between the CRC...",69,210,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
72C>T,...notype and allele frequencies of g.-8748C>T and g.72C>T did not differ between the CRC patient group...,69,224,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
9101C>T,"...trol group. In addition, the haplotype of CTTN g.-9101C>T, g.-8748C>T, and g.72C>T did not differ be...",69,336,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
8748C>T,"...In addition, the haplotype of CTTN g.-9101C>T, g.-8748C>T, and g.72C>T did not differ between the CR...",69,348,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
72C>T,"...e haplotype of CTTN g.-9101C>T, g.-8748C>T, and g.72C>T did not differ between the CRC patient group...",69,363,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
9101C>T,"...er studies with large populations and the CTTN g.-9101C>T, g.-8748C>T, and g.72C>T polymorphisms are...",69,606,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
8748C>T,"...ith large populations and the CTTN g.-9101C>T, g.-8748C>T, and g.72C>T polymorphisms are require to ...",69,618,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
72C>T,"...ations and the CTTN g.-9101C>T, g.-8748C>T, and g.72C>T polymorphisms are require to elucidate their...",69,633,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
9101C>T,... of the polymerase chain reaction products for g.-9101C>T (630 bp) and g.-8748C>T (630 bp) yielded 2...,73,151,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
8748C>T,... reaction products for g.-9101C>T (630 bp) and g.-8748C>T (630 bp) yielded 2 fragments of 490 bp and...,73,175,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
677 C>T,MTHFR 677 C>T Polymorphism reveals functional importance...,333,7,J_Lipid_Res_2011_Jan_52(1)_104-112.txt
3C>A,...e of the intron 9–exon 10 boundary of SCN5A (IVS9-3C>A). All of these polymorphisms are heterozygous...,80,358,J_Med_Case_Rep_2013_Mar_18_7_78.txt
3C>A,"...equencing analysis results.SCN5A (A) exon 10 IVS9-3C>A polymorphism, (B) exon 12 H558R, (C) exon 28 ...",82,83,J_Med_Case_Rep_2013_Mar_18_7_78.txt
1G>A,...this patient harbored an intronic mutation (IVS18-1G>A) that would affect ribonucleic acid (RNA) pro...,87,1118,J_Med_Case_Rep_2013_Mar_18_7_78.txt
30T>C,"...ous mutation (A155A) and one intronic variant (48-30T>C), which were not present in 220 control alle...",93,639,J_Med_Case_Rep_2013_Mar_18_7_78.txt
3C>A,"...tion close to the intron 9–exon 10 boundary, IVS9-3C>A could be directly functionally relevant becau...",97,70,J_Med_Case_Rep_2013_Mar_18_7_78.txt
3C>A,"...tially induce alternative splicing. However, IVS9-3C>A and two synonymous common polymorphisms (SCN5...",97,187,J_Med_Case_Rep_2013_Mar_18_7_78.txt
1978A>G,...ort the first germline missense mutation in BHD c.1978A>G (K508R) in a patient who presented with bi...,13,302,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
2 A>G,"...4-5delGTinsCAC), four splice site mutations (IVS4-2 A>G, IVS7+1 G>T, c.1755 G>A, IVS12+1 G>A), one m...",46,731,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
1 G>T,"...AC), four splice site mutations (IVS4-2 A>G, IVS7+1 G>T, c.1755 G>A, IVS12+1 G>A), one missense (c.1...",46,743,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
1755 G>A,"... splice site mutations (IVS4-2 A>G, IVS7+1 G>T, c.1755 G>A, IVS12+1 G>A), one missense (c.1978A>G [K...",46,752,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
1 G>A,"...ations (IVS4-2 A>G, IVS7+1 G>T, c.1755 G>A, IVS12+1 G>A), one missense (c.1978A>G [K508R]) and two n...",46,768,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
1978A>G,"...+1 G>T, c.1755 G>A, IVS12+1 G>A), one missense (c.1978A>G [K508R]) and two nonsense (c.1065-6delGCin...",46,792,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
1670C>G,"... [K508R]) and two nonsense (c.1065-6delGCinsTA, c.1670C>G) (table 1, fig 1). Splice site and missens...",46,849,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
1755 G>C,...and deletions were confirmed by subcloning. The c.1755 G>C and c.1755 G>A affect the last coding nuc...,46,1031,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
1755 G>A,...ere confirmed by subcloning. The c.1755 G>C and c.1755 G>A affect the last coding nucleotide of exon...,46,1046,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
2A>G,253	4		IVS4-2A>G		Splice site	1	1		0	1	1 (n = 1),54,13,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
2A>G,"240	4		IVS4-2A>G		Splice site	10	9	TD, PFF	1	4	0",55,13,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
2A>G,254	4		IVS4-2A>G		Splice site	1	1	TD	1	1	0,56,13,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
2A>G,255	4		IVS4-2A>G		Splice site	1	1	PFF	0	1	1 (n = 2),57,13,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
1 G>T,261	7		IVS7+1 G>T		Splice site	1	1	L	1	1	1 (n = 3),65,13,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
1 G>T,"262	7		IVS7+1 G>T		Splice site	5	4	AF, DFSP, LS, TD	4	5	1 (n =...",66,13,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
1 G>T,263*	7		IVS7+1 G>T		Splice site	1	1		1	1	1 (n = 1),67,14,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
2 T>G,267	9		IVS9+2 T>G		Splice site	1	1		0	1	0,71,13,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
1670C>G,268		11	c.1670C>G	Y405X	Nonsense	1	1	DF	1	1	0,72,11,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
1755G>C,290*		11	c.1755G>C	E434Q	Splice site	1	1		1	0	0,94,12,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
1755G>A,291*		11	c.1755G>A	E434K	Splice site	2	1	PFF	1	2	1 (n = 4),95,12,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
1844C>G,293		12	c.1844C>G	Y463X	Nonsense	2	2	AF	0	2	1 (n = 2),97,11,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
1844C>G,"294		12	c.1844C>G	Y463X	Nonsense	1	0	PFF, AF	0	0	0",98,11,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
1844C>G,295		12	c.1844C>G	Y463X	Nonsense	1	1	AF	1	1	1 (n = 4),99,11,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
1G>A,"296	12		IVS12+1G>A		Splice site	1	1	TD, PFF	0	1	1",100,15,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
1978A>G,297*		13	c.1978A>G	K508R	Missense	1	0	0	1	0	0,101,12,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
1844C>G,... mutations in exon 12 shared a common mutation (c.1844C>G). Four families had a BHD mutation in exon...,110,544,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
1G>T,"...d to cause exon skipping: three in intron 7 (IVS7+1G>T), four in intron 4 (IVS4-2 A>G), one in intro...",110,951,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
2 A>G,"...e in intron 7 (IVS7+1G>T), four in intron 4 (IVS4-2 A>G), one in intron 9 (IVS9+2 T>G) and one in in...",110,981,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
2 T>G,"...r in intron 4 (IVS4-2 A>G), one in intron 9 (IVS9+2 T>G) and one in intron 12 (IVS12+1 G>A) (table 1...",110,1011,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
1 G>A,...intron 9 (IVS9+2 T>G) and one in intron 12 (IVS12+1 G>A) (table 1). The most 5′ mutation (c.514delT)...,110,1046,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
1978A>G,.... (B) Genomic sequence of BHDS patient with the c.1978A>G (K508R) mutation. (C) Multiple sequence al...,114,128,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
1755G>C,"Ukn 1	1 Unk	c.1755G>C, c. 875delC,",156,19,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
2 A>G,"c.1733insC, IVS10-2 A>G",157,25,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
1 G>A,c.IVS 6-1 G>A,161,15,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
1398G>T,"... 200510	11	Ukn 11/11	No 11/11	Pos 6/6	Yes 10/10	c.1398G>T, c.1884C>T",165,63,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
1884C>T,"...Ukn 11/11	No 11/11	Pos 6/6	Yes 10/10	c.1398G>T, c.1884C>T",165,74,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
1884C>T,"...(c.1065-6delGCinsTA, c. 1733insC, c. 1733delC and 1884C>T) were reported by both the NCI BHDS group ...",180,376,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
1755G>C,"...requent site of mutations (c.1733insC/1733delC, c.1755G>C) present in 125 individuals from 40 unrela...",180,723,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
2034 C>T,... mutation reported occurred at nucleotide 2034 (c.2034 C>T) in exon 14 and was predicted to produce ...,182,421,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
2 A>G,"...te mutation in the BHD gene within intron 4 (IVS4-2 A>G) (table 1). However, we did not identify seq...",213,519,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
1436A>C,"...r MYH7 gene. All five pathogenic variants (MYH7 c.1436A>C, MYH7 c.1207C>T, MYBPC3 c.2373_2374dup, MY...",103,428,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
1207C>T,"... five pathogenic variants (MYH7 c.1436A>C, MYH7 c.1207C>T, MYBPC3 c.2373_2374dup, MYBPC3 c.676_701du...",103,444,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
24C>T,...were variants at the same position (MYBPC3 c.1093-24C>T) and were not in the HCDiff list due to low ...,103,1267,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
415G>T,".... Two variants, the PLN c.40_42del and the MYH7 c.415G>T, were both observed twice in unrelated pati...",113,323,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
415G>T,"...nts, with one patient having two variants (MYH7 c.415G>T+LAMP2 c.661G>A). All the other variants wer...",113,424,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
661G>A,...atient having two variants (MYH7 c.415G>T+LAMP2 c.661G>A). All the other variants were present solit...,113,439,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
4859C>T,...One of the two variants in SCN5A (NM_198056.2 : c.4859C>T) has been reported previously.12–16 The va...,114,111,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
55665408 A>G,Patient 1	F	64	?	TNNI3	55665408 A>G	NM_000363.4	539A>G	p.Asp180Gly	Probab...,119,24,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
539A>G,Patient 1	F	64	?	TNNI3	55665408 A>G	NM_000363.4	539A>G	p.Asp180Gly	Probably damaging	Possibly dama...,119,49,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
153609246 C>T,Patient 3	M	44	?	EMD	153609246 C>T	NM_000117.2	454C>T	p.Arg152Cys	Benig...,122,22,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
454C>T,Patient 3	M	44	?	EMD	153609246 C>T	NM_000117.2	454C>T	p.Arg152Cys	Benign	Benign	180	0.00	C55	Not ...,122,48,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
4628T>C,...atient 7†	F	22	51	SCN5A	38595955  T>C	NM_198056.2	4628T>C	p.Val1543Ala	Benign	Benign	64	0.00	C65	Not...,126,52,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
23901935 G>T,Patient 10	F	27	30	MYH7	23901935 G>T	NM_000257.2	415G>T	p.Val139Leu	Probab...,129,25,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
415G>T,Patient 10	F	27	30	MYH7	23901935 G>T	NM_000257.2	415G>T	p.Val139Leu	Probably damaging	Probably dama...,129,50,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
119581776 G>A,F	–	–	LAMP2	119581776 G>A	NM_002294.2	661G>A	p.Gly221Arg	Proba...,130,14,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
661G>A,F	–	–	LAMP2	119581776 G>A	NM_002294.2	661G>A	p.Gly221Arg	Probably damaging	Probably dama...,130,40,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
415G>T,Patient 12	F	52	38	MYH7	23901935  G>T	NM_000257.2	415G>T	p.Val139Leu	Probably damaging	Probably dama...,132,51,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
4859C>T,...atient 14	M	35	21	SCN5A	38593004  C>T	NM_198056.2	4859C>T	p.Thr1620Met	Probably damaging	Probably da...,134,52,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
88451727 A>G,Patient 16	F	73	?	LDB3	88451727 A>G	NM_007078.2	764A>G	p.Lys255Arg	Benign...,136,24,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
764A>G,Patient 16	F	73	?	LDB3	88451727 A>G	NM_007078.2	764A>G	p.Lys255Arg	Benign	Benign	26	0.00	C25	Not f...,136,49,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
1976T>C,Patient 19§	V	?	?	MYH7	23896054  T>C	NM_000257.2	1976T>C	p.Met659Thr	Probably damaging	Probably dam...,139,50,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
877C>T,"...riants of unknown clinical significance (TNNT2, c.877C>T,2",151,658,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
755A>G,"TPM1, c.755A>G and MYBPC3, c.3392T>C22), while the others ...",153,9,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
3392T>C,"TPM1, c.755A>G and MYBPC3, c.3392T>C22), while the others were non-pathogenic c...",153,30,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
1543G>A,...d before. These variants are VCL: NM_014000.2:  c.1543G>A (amino acid change and loss of splice site...,155,241,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
566C>T,"...ge and loss of splice site), LDB3: NM_007078.2: c.566C>T.  We classified them as VUS2 (see table 3)",155,315,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
63356265 A>G,Patient 20	M	?	?	?	TPM1	63356265 A>G	NM_001018020.1	775A>G	p.Lys259Glu	Not...,160,25,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
775A>G,...tient 20	M	?	?	?	TPM1	63356265 A>G	NM_001018020.1	775A>G	p.Lys259Glu	Not reliable	Not reliable	56	0....,160,53,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
75854219 G>A,Patient 22	F	58	16	Yes	VCL	75854219 G>A	NM_014000.2	1543G>A	p.Gly515Ser	Proba...,162,28,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
1543G>A,...tient 22	F	58	16	Yes	VCL	75854219 G>A	NM_014000.2	1543G>A	p.Gly515Ser	Probably damaging	Probably dam...,162,53,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
88441437 C>T,Patient 25	M	44	20	?	LDB3	88441437 C>T	NM_007078.2	566C>T	p.Ser189Leu	Benign...,165,27,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
566C>T,...atient 25	M	44	20	?	LDB3	88441437 C>T	NM_007078.2	566C>T	p.Ser189Leu	Benign	Benign	145	0.1	C0	2/10 8...,165,52,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
47354463 T>C,MYBPC3	47354463 T>C	NM_000256.3	3392T>C	p.Ile1131Thr	Beni...,167,13,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
3392T>C,MYBPC3	47354463 T>C	NM_000256.3	3392T>C	p.Ile1131Thr	Benign	Possibly damaging	89	0...,167,38,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
201328349 C>T,Patient 28	M	67	28	?	TNNT2	201328349 C>T	NM_000364.2	877C>T	p.Arg293Cys	Proba...,170,28,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
877C>T,...ient 28	M	67	28	?	TNNT2	201328349 C>T	NM_000364.2	877C>T	p.Arg293Cys	Probably damaging	Probably dama...,170,54,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
1231G>A,...ected with Sanger sequencing (MYH7: NM_000257.2 c.1231G>A and MYH7: NM_000257.2: c.2967T>C). Re-exam...,181,571,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
2967T>C,...7: NM_000257.2 c.1231G>A and MYH7: NM_000257.2: c.2967T>C). Re-examination of these two variants by ...,181,604,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
1178C>T,"...h Sanger sequencing—that is, MYH7: NM_000257.2: c.1178C>T,26–28 c.1231G>A,29–32 c.2002C>A, c.5135G>A...",183,264,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
1231G>A,"...ing—that is, MYH7: NM_000257.2: c.1178C>T,26–28 c.1231G>A,29–32 c.2002C>A, c.5135G>A, c.1987C>T, c.1...",183,280,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
2002C>A,"...7: NM_000257.2: c.1178C>T,26–28 c.1231G>A,29–32 c.2002C>A, c.5135G>A, c.1987C>T, c.121G>A and MYBPC3...",183,296,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
5135G>A,"...7.2: c.1178C>T,26–28 c.1231G>A,29–32 c.2002C>A, c.5135G>A, c.1987C>T, c.121G>A and MYBPC3: NM_000256...",183,307,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
1987C>T,"...C>T,26–28 c.1231G>A,29–32 c.2002C>A, c.5135G>A, c.1987C>T, c.121G>A and MYBPC3: NM_000256.3: c.2827C...",183,318,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
121G>A,"....1231G>A,29–32 c.2002C>A, c.5135G>A, c.1987C>T, c.121G>A and MYBPC3: NM_000256.3: c.2827C>T,33 c.300...",183,329,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
2827C>T,"...A, c.1987C>T, c.121G>A and MYBPC3: NM_000256.3: c.2827C>T,33 c.3004C>T (twice), c.2864_2865del, MYL2...",183,363,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
3004C>T,"... c.121G>A and MYBPC3: NM_000256.3: c.2827C>T,33 c.3004C>T (twice), c.2864_2865del, MYL2: NM_000432.3...",183,376,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
37G>A,"...C>T (twice), c.2864_2865del, MYL2: NM_000432.3: c.37G>A34–37 and TPM1: NM_000366.5: c.618A>G, but al...",183,430,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
618A>G,"...M_000432.3: c.37G>A34–37 and TPM1: NM_000366.5: c.618A>G, but also in genes that are part of the add...",183,466,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
3157G>A,"...rdiomyopathy panel—that is, SCN5A: NM_198056.2: c.3157G>A3",183,592,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
253C>T,"39, PRKAG2: NM_016203.3: c.253C>T, TCAP: NM_003673.2: c.37_39del,4",184,28,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
10T>C,CSRP3: NM_003476.3: c.10T>C4,186,23,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
1804G>A,"43, LMNA: NM_170707.2: c.1804G>A,4",187,26,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
935A>C,DES: NM_001927.3: c.935A>C (table 4). Ten patients had a single varian...,189,21,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
1178C>T,...ients had two variants each (MYH7: NM_000257.2: c.1178C>T combined with SCN5A: NM_198056.2: c.3157G>...,189,131,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
3157G>A,"....2: c.1178C>T combined with SCN5A: NM_198056.2: c.3157G>A, and MYBPC3: NM_000256.3: c.3004C>T combin...",189,175,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
3004C>T,"...M_198056.2: c.3157G>A, and MYBPC3: NM_000256.3: c.3004C>T combined with LMNA: NM_170707.2: c.1804G>A...",189,211,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
1804G>A,"...6.3: c.3004C>T combined with LMNA: NM_170707.2: c.1804G>A), and one patient had three variants (MYH7...",189,254,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
121G>A,"... patient had three variants (MYH7: NM_000257.2: c.121G>A, MYBPC3: NM_000256.3: c.3004C>T, and DES: N...",189,321,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
3004C>T,"...H7: NM_000257.2: c.121G>A, MYBPC3: NM_000256.3: c.3004C>T, and DES: NM_001927.3: c.935A>C). All vari...",189,352,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
935A>C,"...: NM_000256.3: c.3004C>T, and DES: NM_001927.3: c.935A>C). All variants were confirmed with Sanger s...",189,385,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
38622493 G>A,Patient 29	M	24	17	?	SCN5A	38622493 G>A	NM_198056.2	3157G>A	Glu1053Lys	Probab...,194,28,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
3157G>A,...tient 29	M	24	17	?	SCN5A	38622493 G>A	NM_198056.2	3157G>A	Glu1053Lys	Probably damaging	Possibly dama...,194,53,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
23898517 C>T,MYH7	23898517 C>T	NM_000257.2	1178C>T	Ala393Val	Possibl...,195,11,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
1178C>T,MYH7	23898517 C>T	NM_000257.2	1178C>T	Ala393Val	Possibly damaging	Possibly damag...,195,36,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
111356964G>A,Patient 31†	M	65	11	No	MYL2	111356964G>A	NM_000432.3	37G>A	Ala13Thr	Possibly d...,197,29,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
37G>A,...ient 31†	M	65	11	No	MYL2	111356964G>A	NM_000432.3	37G>A	Ala13Thr	Possibly damaging	Benign	58	0.08	C0...,197,54,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
151478451C>T,Patient 32	M	?	?	?	PRKAG2	151478451C>T	NM_016203.3	253C>T	Pro85Ser	Possibly ...,198,27,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
253C>T,...atient 32	M	?	?	?	PRKAG2	151478451C>T	NM_016203.3	253C>T	Pro85Ser	Possibly damaging	Benign	74	0.12	C...,198,52,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
47356671 C>T,Patient 35	M	16	18	Yes	MYBPC3	47356671 C>T	NM_000256.3	2827C>T	Arg943X	–	–	–	–	–...,201,31,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
2827C>T,...nt 35	M	16	18	Yes	MYBPC3	47356671 C>T	NM_000256.3	2827C>T	Arg943X	–	–	–	–	–	Not found	Pathogenic	Dut...,201,56,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
23898464 G>A,Patient 38	F	58	15	No	MYH7	23898464 G>A	NM_000257.2	1231G>A	Val411Ile	Possibl...,204,28,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
1231G>A,...tient 38	F	58	15	No	MYH7	23898464 G>A	NM_000257.2	1231G>A	Val411Ile	Possibly damaging	Probably damag...,204,53,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
23896028 C>A,Patient 39	M	31	?	Yes	MYH7	23896028 C>A	NM_000257.2	2002C>A	His668Asn	Probabl...,205,28,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
2002C>A,...tient 39	M	31	?	Yes	MYH7	23896028 C>A	NM_000257.2	2002C>A	His668Asn	Probably damaging	Probably damag...,205,53,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
23884860 G>A,Patient 44	F	74	21	No	MYH7	23884860 G>A	NM_000257.2	5135G>A	Arg1712Gln	Possib...,210,28,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
5135G>A,...tient 44	F	74	21	No	MYH7	23884860 G>A	NM_000257.2	5135G>A	Arg1712Gln	Possibly damaging	Probably dama...,210,53,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
19213986 T>C,Patient 47	F	71	?	Yes	CSRP3	19213986 T>C	NM_003476.3	10T>C	Trp4Arg	Possibly da...,213,29,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
10T>C,...ient 47	F	71	?	Yes	CSRP3	19213986 T>C	NM_003476.3	10T>C	Trp4Arg	Possibly damaging	Possibly damaging	...,213,54,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
156108384G>A,Patient 48	F	56	15	Yes	LMNA	156108384G>A	NM_170707.2	1804G>A	Gly602Ser	Benign	...,214,29,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
1804G>A,...ient 48	F	56	15	Yes	LMNA	156108384G>A	NM_170707.2	1804G>A	Gly602Ser	Benign	Benign	56	1.00	C0	12/12 9...,214,54,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
47355294 C>T,MYBPC3	47355294 C>T	NM_000256.3	3004C>T	Arg1002Trp	Probab...,215,13,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
3004C>T,MYBPC3	47355294 C>T	NM_000256.3	3004C>T	Arg1002Trp	Probably damaging	Probably dama...,215,38,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
23896043C>T,Patient 52	F	38	26	No	MYH7	23896043C>T	NM_000257.2	1987C>T	Arg663Cys	Probably...,219,28,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
1987C>T,...atient 52	F	38	26	No	MYH7	23896043C>T	NM_000257.2	1987C>T	Arg663Cys	Probably damaging	Possibly damag...,219,52,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
220285587A>C,Patient 53	F	32	20	Yes	DES	220285587A>C	NM_001927.3	935A>C	Asp312Ala	Probably...,220,28,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
935A>C,...tient 53	F	32	20	Yes	DES	220285587A>C	NM_001927.3	935A>C	Asp312Ala	Probably damaging	Probably damagi...,220,53,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
47355294C>T,MYBPC3	47355294C>T	NM_000256.3	3004C>T	Arg1002Trp	Probabl...,221,13,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
3004C>T,MYBPC3	47355294C>T	NM_000256.3	3004C>T	Arg1002Trp	Probably damaging	Probably dama...,221,37,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
23902821G>A,MYH7	23902821G>A	NM_000257.2	121G>A	Asp41Asn	Benign	Pos...,222,11,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
121G>A,MYH7	23902821G>A	NM_000257.2	121G>A	Asp41Asn	Benign	Possibly damaging	23	0.13	C...,222,35,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
24C>T,"...ticular variants (eg, MYBPC3: NM_000256.3: c.1093-24C>T). A balanced representation of all targeted ...",255,815,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
182A>G,"...Hypoplastic, hypomineralised	WDR72	NM_182758.3	c.[182A>G];[815G>A]	p.[H61R];[W272*]	Compound heteroz...",97,65,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
815G>A,"...ic, hypomineralised	WDR72	NM_182758.3	c.[182A>G];[815G>A]	p.[H61R];[W272*]	Compound heterozygous	Nov...",97,74,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
1495G>A, V2.05	M	6	AR	N/A	CNNM4	NM_020184.3	c.[1495G>A];[1495G>A]	p.[V499M];[V499M]	Homozygous (C...,98,40,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
1495G>A, V2.05	M	6	AR	N/A	CNNM4	NM_020184.3	c.[1495G>A];[1495G>A]	p.[V499M];[V499M]	Homozygous (C)	Novel	S2...,98,50,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
2407G>T, V2.09	F	16	AD	Hypoplastic	COL17A1	NM_000494.3	c.[2407G>T]; [=]	p.[G803*];[=]	Maternal	73	S4,100,51,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
124C>T, V2.18	M	13	?	Hypoplastic	LAMB3	NM_000228.2	c.[124C>T]; [=]	p.[R42*];[=]	?	74	S5,101,48,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
1289C>A, V2.20	F	18	?	Hypomature	FAM83H	NM_198488.3	c.[1289C>A];[=]	p.[S430*];[=]	?	75	S6,102,48,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
1282C>T,....26	M	13	AD	Hypomineralised	FAM83H	NM_198488.3	c.[1282C>T];[=]	p.[Q428*];[=]	Paternal	Novel	S7,103,54,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
155C>T, V2.28	M	14	?	Hypoplastic	AMELX	NM_182680.1	c.[155C>T];[=]	p.[P52L];[=]	De novo	Novel	S8,104,48,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
1G>A, V2.29	M	14	AD	N/A	ENAM	NM_031889.2	c.[123+1G>A];[=]	p.[0?];[=]	Paternal	Novel	S9,105,44,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
1646G>A, V2.48	F	20	AD	Hypoplastic	COL17A1	NM_000494.3	c.[1646G>A];[=]	p.[W549*];[=]	Maternal	Novel	S10,106,51,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
1G>C, V2.53	F	19	?	Hypoplastic	AMBN	NM_016519.5	c.[532-1G>C];[532-1G>C]	p.[0?];[(0?)]	Homozygous	Novel	S1...,107,51,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
1G>C,...	?	Hypoplastic	AMBN	NM_016519.5	c.[532-1G>C];[532-1G>C]	p.[0?];[(0?)]	Homozygous	Novel	S11,107,62,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
2029C>T, V2.63	M	10	?	N/A	FAM83H	NM_198488.3	c.[2029C>T];[=]	p.[Q677*];[=]	?	76	S12,108,41,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
1873C>T,"...	?	Hypoplastic, hypomature	COL17A1	NM_000494.3	c.[1873C>T];[=]	p.[R625*];[=]	?	Novel	S13",109,62,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
1G>A,...A; LAMA3	NM_000494.3; NM_198129.1	COL17A1:c.[1141+1G>A]; LAMA3:c.[6477_6486del]	COL17A1:p.[0?]; LAMA...,110,83,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
383G>A,"... 31, 34, 35, 38, 44, 45, 48	WNT10A	NM_025216.2	c.[383G>A];[=]	p.[R128Q];[=]	Maternal	77	S15",114,107,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
343A>C,"... 37, 38, 41, 44, 45, 47, 48	WNT10A	NM_025216.2	c.[343A>C](;)[682T>A]	p.[K115Q](;)[F228I]	?	Novel and...",115,103,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
682T>A,"..., 44, 45, 47, 48	WNT10A	NM_025216.2	c.[343A>C](;)[682T>A]	p.[K115Q](;)[F228I]	?	Novel and 78	S16",115,114,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
321C>A,"... 41, 42, 43, 44, 45, 47, 48	WNT10A	NM_025216.2	c.[321C>A];[321C>A]	p.[C107*];[C107*]	Homozygous	78	S...",116,143,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
321C>A,"...43, 44, 45, 47, 48	WNT10A	NM_025216.2	c.[321C>A];[321C>A]	p.[C107*];[C107*]	Homozygous	78	S17",116,152,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
682T>A,"... 35, 37, 38, 41, 42, 45, 48	WNT10A	NM_025216.2	c.[682T>A];[682T>A]	p.[F228I];[F228I]	Homozygous	78	S...",117,115,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
682T>A,"...38, 41, 42, 45, 48	WNT10A	NM_025216.2	c.[682T>A];[682T>A]	p.[F228I];[F228I]	Homozygous	78	S18",117,124,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
682T>A,"... 32, 37, 38, 41, 42, 47, 48	WNT10A	NM_025216.2	c.[682T>A];[682T>A]	p.[F228I];[F228I]	Homozygous	78	S...",118,91,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
682T>A,"...38, 41, 42, 47, 48	WNT10A	NM_025216.2	c.[682T>A];[682T>A]	p.[F228I];[F228I]	Homozygous	78	S19",118,100,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
637G>A,"... 22, 23, 24, 28, 31, 41, 45	WNT10A	NM_025216.2	c.[637G>A];[=]	p.[G213S];[=]	?	79	S21",120,79,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
682T>A,"... 41, 42, 43, 44, 45, 47, 48	WNT10A	NM_025216.2	c.[682T>A];[321C>A]	p.[F228I];[C107*]	Compound hetero...",121,135,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
321C>A,"...43, 44, 45, 47, 48	WNT10A	NM_025216.2	c.[682T>A];[321C>A]	p.[F228I];[C107*]	Compound heterozygous	78...",121,144,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
682T>A,"... 32, 37, 38, 41, 42, 47, 48	WNT10A	NM_025216.2	c.[682T>A ](;)[321C>A]	p.[F228I](;)[C107*]	?	78	S23",122,87,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
321C>A,"... 41, 42, 47, 48	WNT10A	NM_025216.2	c.[682T>A ](;)[321C>A]	p.[F228I](;)[C107*]	?	78	S23",122,99,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
682T>A,"... 41, 42, 43, 44, 45, 47, 48	WNT10A	NM_025216.2	c.[682T>A];[682T>A]	p.[F228I];[F228I]	Homozygous	78	S...",123,119,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
682T>A,"...43, 44, 45, 47, 48	WNT10A	NM_025216.2	c.[682T>A];[682T>A]	p.[F228I];[F228I]	Homozygous	78	S24",123,128,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
682T>A,"... 41, 42, 43, 44, 45, 47, 48	WNT10A	NM_025216.2	c.[682T>A];[682T>A]	p.[F228I];[F228I]	Homozygous	78	S...",124,119,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
682T>A,"...43, 44, 45, 47, 48	WNT10A	NM_025216.2	c.[682T>A];[682T>A]	p.[F228I];[F228I]	Homozygous	78	S25",124,128,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
467G>A,"...	Ag 12, 14, 22, 31, 32, 35, 41	EDA	NM_001399.4	c.[467G>A];[=]	p.[R156H];[=]	De novo	17	S26",125,63,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
682T>A,"... 37, 33, 31, 41, 43, 45, 47	WNT10A	NM_025216.2	c.[682T>A];[=]	p.[F228I];[=]	Maternal	78	S28",127,98,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
682T>A,"... 35, 37, 38, 44, 45, 47, 48	WNT10A	NM_025216.2	c.[682T>A];[682T>A]	p.[F228I];[F228I]	Homozygous	78	S...",128,99,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
682T>A,"...38, 44, 45, 47, 48	WNT10A	NM_025216.2	c.[682T>A];[682T>A]	p.[F228I];[F228I]	Homozygous	78	S29",128,108,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
682T>A, V2.54	F	49	?	ED	WNT10A	NM_025216.2	c.[682T>A];[c.416C>T]	p.[F228I];[p.A139V]	Compound he...,130,40,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
416C>T, V2.54	F	49	?	ED	WNT10A	NM_025216.2	c.[682T>A];[c.416C>T]	p.[F228I];[p.A139V]	Compound heterozygous	...,130,51,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
52G>T, V2.55	F	12	AD	DGI	DSPP	NM_014208.3	c.[52G>T];[=]	p.[V18F];[=]	Maternal	80	S34,136,40,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
5G>A,...	11	?	Ectodermal dysplasia	EDA	NM_001399.4	c.[396+5G>A];[=]	p.[0?];[=]	Maternal	Novel	S39,151,59,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
2A>T,"...mineralised, hypoplastic	MMP20	NM_004771.3	c.[954-2A>T];[126+6T>G]	p.[0?];[0?]	Compound heterozygous...",152,72,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
6T>G,"..., hypoplastic	MMP20	NM_004771.3	c.[954-2A>T];[126+6T>G]	p.[0?];[0?]	Compound heterozygous	25 and nov...",152,83,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
2A>T,"... hypoplastic, hypomature	MMP20	NM_004771.3	c.[954-2A>T](;)[c.103A>C]	p.[0?](;)[R35R]	?	25 and novel	...",153,67,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
103A>C,"...c, hypomature	MMP20	NM_004771.3	c.[954-2A>T](;)[c.103A>C]	p.[0?](;)[R35R]	?	25 and novel	S41",153,78,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
935C>G,...piphyseal dysplasia	GALNS	NM_000512.4	c.[121-31];[935C>G]	p.[0?];[T312S]	Compound heterozygous	Novel...,154,74,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
2A>G,"...ineralised, hypoplastic	FAM20A	NM_017565.3	c.[590-2A>G;590-3C>A](;) [1294G>A]	p.[0?](;)[A432T]	Mater...",155,73,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
3C>A,"...d, hypoplastic	FAM20A	NM_017565.3	c.[590-2A>G;590-3C>A](;) [1294G>A]	p.[0?](;)[A432T]	Maternal and d...",155,82,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
1294G>A,...stic	FAM20A	NM_017565.3	c.[590-2A>G;590-3C>A](;) [1294G>A]	p.[0?](;)[A432T]	Maternal and de novo	82 ...,155,92,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
1903C>T," V2.86	F	6	?	AI hypoplastic	LAMB3	NM_000228.2	c.[1903C>T];[=]	p.[R635*];[=]	Maternal, asymptomatic	...",156,50,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
1156C>T,...	?	Mucopolysaccharidosis IVA	GALNS	NM_000512.4	c.[1156C>T];[?]	p.[R386C];[?]	de novo	84	S45,158,61,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
1G>A,...y inherited novel COL17A1 splice mutation (c.1141+1G>A) and a novel LAMA3 frameshift-inducing deleti...,166,548,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
1G>A,...affected at the time of ascertainment. The c.1141+1G>A mutation is predicted to cause either in-fram...,166,786,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
1G>C,"...th a novel homozygous splice-site mutation (c.532–1G>C) in AMBN. To date, only a single family has b...",172,81,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
1849 G>T,...ned sequences showing mutation in JAK2 exon 14 - c1849 G>T (V617F). Prevalence of this mutation in t...,43,62,J_Med_Life_2015_Jan-Mar_8(1)_55-61.txt
1849 G>T,...ned sequences showing mutation in JAK2 exon 14 - c1849 G>T (V617F). Prevalence of this mutation in t...,109,63,J_Med_Life_2015_Jan-Mar_8(1)_55-61.txt
589G>T,"...nt is homozygous for a novel nonsense mutation, c.589G>T; p.E197X, in exon 3 of the UMOD gene (Figur...",30,344,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
589G>T,"... analysis revealed a heterozygote substitution, c.589G>T; p.E197X. Glutamic acid 197 resides in a hi...",45,119,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
2T>C,"..., which mostly affect mRNA splicing (such as IVS1+2T>C and g.IVS1+2_3insT) [28,29]. Recently, in a f...",47,486,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
943T>C,2	c.943T>C (p.Cys315Arg)	Pathogeni,100,5,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
898T>G,3	c.898T>G (p.Cys300Gly)	Pathogeni,102,5,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
817G>T,4	c.817G>T (p.Val273Phe)	Pathogeni,104,5,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
764G>A,5	c.764G>A (p.Cys255Tyr)	Pathogeni,106,5,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
743G>C,6	c.743G>C (p.Cys248Ser)	Pathogeni,108,5,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
649T>G,7	c.649T>G (p.Cys217Gly)	Pathogeni,110,5,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
649T>C,8	c.649T>C (p.Cys217Arg)	Pathogeni,112,5,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
443G>A,9	c.443G>A (p.Cys148Tyr)	Pathogeni,114,5,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
383A>G,10	c.383A>G (p.Asn128Ser)	Pathogeni,116,6,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
376T>C,11	c.376T>C (p.Cys126Arg)	Pathogeni,118,6,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
307G>T,12	c.307G>T (p.Gly103Cys)	Pathogeni,120,6,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
230G>A,13	c.230G>A (p.Cys77Tyr)	Pathogeni,122,6,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
1746T>C,14	c.-1746T>C	associatio,124,7,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
5G>C,...an FTLD founder pedigree segregating the GRN IVS1+5G>C splice donor site mutation (Cruts et al. 2006...,43,2022,J_Mol_Neurosci_2011_Nov_26_45(3)_516-521.txt
3291T>C,...10.1016/j.jns.2012.12.003Short CommunicationThe m.3291T>C mt-tRNALeu(UUR) mutation is definitely pat...,3,161,J_Neurol_Sci_2013_Feb_15_325(1-2)_165-169.txt
3291T>C,"...Despite several independent reports linking the m.3291T>C mutation to disease in humans, albeit in a...",3,1639,J_Neurol_Sci_2013_Feb_15_325(1-2)_165-169.txt
3291T>C,A heteroplasmic m.3291T>C variant in the MTTL1 gene has previously b...,11,19,J_Neurol_Sci_2013_Feb_15_325(1-2)_165-169.txt
3291T>C,... These reports provided strong evidence linking m.3291T>C to disease through genetic analysis and mo...,11,322,J_Neurol_Sci_2013_Feb_15_325(1-2)_165-169.txt
3291T>C,...ecent publication questioned the description of m.3291T>C as ‘pathogenic’ [8]. The primary concern o...,11,649,J_Neurol_Sci_2013_Feb_15_325(1-2)_165-169.txt
3291T>C,3.3 Assessment of m.3291T>C mutation load by quantitative pyrosequenci...,29,21,J_Neurol_Sci_2013_Feb_15_325(1-2)_165-169.txt
3291T>C,... Pyromark Q24 software was used to quantify the m.3291T>C heteroplasmy levels by directly comparing ...,32,245,J_Neurol_Sci_2013_Feb_15_325(1-2)_165-169.txt
3291T>C,...ondrial genome identified a previously reported m.3291T>C mutation in the MTTL1 gene which was clear...,39,175,J_Neurol_Sci_2013_Feb_15_325(1-2)_165-169.txt
3291T>C,"... patient into haplogroup K1b1a1, with which the m.3291T>C mutation has not been associated, whilst s...",39,334,J_Neurol_Sci_2013_Feb_15_325(1-2)_165-169.txt
3291T>C,The m.3291T>C mutation was shown by pyrosequencing to be...,41,7,J_Neurol_Sci_2013_Feb_15_325(1-2)_165-169.txt
3291T>C,4.3 Single-fibre segregation studies of the m.3291T>C mutatio,43,47,J_Neurol_Sci_2013_Feb_15_325(1-2)_165-169.txt
3291T>C,...COX-deficient fibres to investigate whether the m.3291T>C mutation segregated with respiratory chain...,44,124,J_Neurol_Sci_2013_Feb_15_325(1-2)_165-169.txt
3291T>C,"...ineural deafness, in whom a previously reported m.3291T>C mutation in mt-tRNALeu(UUR) was identified...",47,131,J_Neurol_Sci_2013_Feb_15_325(1-2)_165-169.txt
3291T>C,"...RNA point mutations, through the association of m.3291T>C with a new disease phenotype",47,604,J_Neurol_Sci_2013_Feb_15_325(1-2)_165-169.txt
8344A>G,...lipomas have been associated primarily with the m.8344A>G mutation in mt-tRNALy,49,364,J_Neurol_Sci_2013_Feb_15_325(1-2)_165-169.txt
3271T>C,"[16–18], although the m.3271T>C mutation has also been linked to lipoma fo...",50,25,J_Neurol_Sci_2013_Feb_15_325(1-2)_165-169.txt
3291T>C,The heteroplasmic m.3291T>C mutation in the T-Loop of mt-tRNALeu(UUR) ...,54,21,J_Neurol_Sci_2013_Feb_15_325(1-2)_165-169.txt
8344A>G,"...ed in a number of cases, including most notably m.8344A>G [20], pathogenicity is not dependent upon ...",56,69,J_Neurol_Sci_2013_Feb_15_325(1-2)_165-169.txt
3291T>C,...he data presented here confirms the role of the m.3291T>C mutation in mitochondrial pathogenesis bas...,58,52,J_Neurol_Sci_2013_Feb_15_325(1-2)_165-169.txt
3291T>C,... the pathogenic role of the previously reported m.3291T>C mutation in human mitochondrial disease. F...,60,116,J_Neurol_Sci_2013_Feb_15_325(1-2)_165-169.txt
3291T>C,"...ar, genetic and functional investigation of the m.3291T>C mutation. The identified m.3291T>C mutatio...",72,65,J_Neurol_Sci_2013_Feb_15_325(1-2)_165-169.txt
3291T>C,...ation of the m.3291T>C mutation. The identified m.3291T>C mutation is shown in a sequencing chromato...,72,100,J_Neurol_Sci_2013_Feb_15_325(1-2)_165-169.txt
3291T>C,...e mutation with biochemical deficiency (B). The m.3291T>C mutation is located in the T-loop of mt-tR...,72,318,J_Neurol_Sci_2013_Feb_15_325(1-2)_165-169.txt
3291T>C,...i M.   Neuromuscular syndrome associated with the 3291T>C mutation of mitochondrial DNA: a second ca...,79,115,J_Neurol_Sci_2013_Feb_15_325(1-2)_165-169.txt
3291T>C,...ioral decline with hearing loss due to the rare m.3291T>C MELAS mutation J Neurol Sci 300 2011 165 1...,80,210,J_Neurol_Sci_2013_Feb_15_325(1-2)_165-169.txt
3291T>C,... with mitochondrial encephalomyopathy harboring a 3291T>C mutation in mitochondrial DNA Neurol Sci 3...,81,142,J_Neurol_Sci_2013_Feb_15_325(1-2)_165-169.txt
3291T>C,...ng Y.  Leng J.H.   Is mitochondrial tRNALeu(UUR)  3291T>C mutation pathogenic? Mitochondrial DNA 23 ...,82,55,J_Neurol_Sci_2013_Feb_15_325(1-2)_165-169.txt
3435C>T,"...ug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C>T affects mRNA stability Pharmacogenetics an...",131,110,J_Nucleic_Acids_2012_Sep_3_2012_985260.txt
6N > C,"... weight between strains differed (C3H/HeJ > C57BL/6N > C57BL/6J); however, no differences existed wi...",68,68,J_Nutr_Metab_2015_Jun_3_2015_758080.txt
1G>T,"...ic mutation database, with the exception of c.672+1G>T, c.783‐1G>A and R333C. There is no apparent d...",161,203,J_Pathol_Clin_Res_2015_Mar_30_1(3)_125-133.txt
1G>A,"...database, with the exception of c.672+1G>T, c.783‐1G>A and R333C. There is no apparent difference in...",161,215,J_Pathol_Clin_Res_2015_Mar_30_1(3)_125-133.txt
18S>M,"...ce (1/Ct) of the genes covered in this study, was 18S>MT-ATP6>B2M>GAPDH>ACTB>CDKN1A in all experimen...",40,1580,J_Radiat_Res_2015_Jan_30_56(1)_177-185.txt
2M>G,"...the genes covered in this study, was 18S>MT-ATP6>B2M>GAPDH>ACTB>CDKN1A in all experimental groups co...",40,1593,J_Radiat_Res_2015_Jan_30_56(1)_177-185.txt
18S>A,"...ion level. In males, the order of variability was 18S>ACTB>B2M>GAPDH>CDKN1A>MT-ATP6 at 0 h and ACTB>...",40,2219,J_Radiat_Res_2015_Jan_30_56(1)_177-185.txt
2M>G,"... In males, the order of variability was 18S>ACTB>B2M>GAPDH>CDKN1A>MT-ATP6 at 0 h and ACTB>B2M>18S>GA...",40,2229,J_Radiat_Res_2015_Jan_30_56(1)_177-185.txt
1A>M,...e order of variability was 18S>ACTB>B2M>GAPDH>CDKN1A>MT-ATP6 at 0 h and ACTB>B2M>18S>GAPDH>MT-ATP6>C...,40,2242,J_Radiat_Res_2015_Jan_30_56(1)_177-185.txt
18S>G,...ACTB>B2M>GAPDH>CDKN1A>MT-ATP6 at 0 h and ACTB>B2M>18S>GAPDH>MT-ATP6>CDKN1A at 24 h post-irradiation ...,40,2273,J_Radiat_Res_2015_Jan_30_56(1)_177-185.txt
1A>A,"...while in the case of females, the orders were CDKN1A>ACTB>18S>MT-ATP6>B2M>GAPDH at 0 h and ACTB>18S>...",40,2395,J_Radiat_Res_2015_Jan_30_56(1)_177-185.txt
18S>M,"... the case of females, the orders were CDKN1A>ACTB>18S>MT-ATP6>B2M>GAPDH at 0 h and ACTB>18S>B2M>CDKN...",40,2403,J_Radiat_Res_2015_Jan_30_56(1)_177-185.txt
2M>G,"...females, the orders were CDKN1A>ACTB>18S>MT-ATP6>B2M>GAPDH at 0 h and ACTB>18S>B2M>CDKN1A>MT-ATP6>GA...",40,2416,J_Radiat_Res_2015_Jan_30_56(1)_177-185.txt
18S>B,...CDKN1A>ACTB>18S>MT-ATP6>B2M>GAPDH at 0 h and ACTB>18S>B2M>CDKN1A>MT-ATP6>GAPDH at 24 h post-irradiat...,40,2441,J_Radiat_Res_2015_Jan_30_56(1)_177-185.txt
2M>C,...A>ACTB>18S>MT-ATP6>B2M>GAPDH at 0 h and ACTB>18S>B2M>CDKN1A>MT-ATP6>GAPDH at 24 h post-irradiation (...,40,2446,J_Radiat_Res_2015_Jan_30_56(1)_177-185.txt
1A>M,"...18S>MT-ATP6>B2M>GAPDH at 0 h and ACTB>18S>B2M>CDKN1A>MT-ATP6>GAPDH at 24 h post-irradiation (Fig. 2,...",40,2453,J_Radiat_Res_2015_Jan_30_56(1)_177-185.txt
1A>B,"...is study, therefore, emerged as GAPDH>MT-ATP6>CDKN1A>B2M>18S>ACTB. This result showed that expressio...",48,1164,J_Radiat_Res_2015_Jan_30_56(1)_177-185.txt
18S>A,"...y, therefore, emerged as GAPDH>MT-ATP6>CDKN1A>B2M>18S>ACTB. This result showed that expression of th...",48,1171,J_Radiat_Res_2015_Jan_30_56(1)_177-185.txt
430C>T,"...warfarin dose. We tested SNPs in CYP2C9 (3 sites: 430C>T (rs1799853), 1075A>C (rs1057910), 1076T>C) ...",7,345,J_Stroke_2013_May_31_15(2)_115-121.txt
1075A>C,"...sted SNPs in CYP2C9 (3 sites: 430C>T (rs1799853), 1075A>C (rs1057910), 1076T>C) and VKORC1 (14 sites...",7,365,J_Stroke_2013_May_31_15(2)_115-121.txt
1076T>C,"...3 sites: 430C>T (rs1799853), 1075A>C (rs1057910), 1076T>C) and VKORC1 (14 sites: 381C>T, 861C>A (rs1...",7,386,J_Stroke_2013_May_31_15(2)_115-121.txt
381C>T,"...75A>C (rs1057910), 1076T>C) and VKORC1 (14 sites: 381C>T, 861C>A (rs17880887), 2653G>C, 3673A>G, 549...",7,417,J_Stroke_2013_May_31_15(2)_115-121.txt
861C>A,"...s1057910), 1076T>C) and VKORC1 (14 sites: 381C>T, 861C>A (rs17880887), 2653G>C, 3673A>G, 5496G>T, 58...",7,425,J_Stroke_2013_May_31_15(2)_115-121.txt
2653G>C,"...nd VKORC1 (14 sites: 381C>T, 861C>A (rs17880887), 2653G>C, 3673A>G, 5496G>T, 5808T>G (r17882154), 60...",7,446,J_Stroke_2013_May_31_15(2)_115-121.txt
3673A>G,"... (14 sites: 381C>T, 861C>A (rs17880887), 2653G>C, 3673A>G, 5496G>T, 5808T>G (r17882154), 6009C>T, 64...",7,455,J_Stroke_2013_May_31_15(2)_115-121.txt
5496G>T,"...s: 381C>T, 861C>A (rs17880887), 2653G>C, 3673A>G, 5496G>T, 5808T>G (r17882154), 6009C>T, 6484T>C (rs...",7,464,J_Stroke_2013_May_31_15(2)_115-121.txt
5808T>G,"..., 861C>A (rs17880887), 2653G>C, 3673A>G, 5496G>T, 5808T>G (r17882154), 6009C>T, 6484T>C (rs9934438),...",7,473,J_Stroke_2013_May_31_15(2)_115-121.txt
6009C>T,"..., 2653G>C, 3673A>G, 5496G>T, 5808T>G (r17882154), 6009C>T, 6484T>C (rs9934438), 6853C>T (rs17886369)...",7,494,J_Stroke_2013_May_31_15(2)_115-121.txt
6484T>C,"..., 3673A>G, 5496G>T, 5808T>G (r17882154), 6009C>T, 6484T>C (rs9934438), 6853C>T (rs17886369), 7566T>C...",7,503,J_Stroke_2013_May_31_15(2)_115-121.txt
6853C>T,"...808T>G (r17882154), 6009C>T, 6484T>C (rs9934438), 6853C>T (rs17886369), 7566T>C, 8767G>C, 8814T>C, 9...",7,524,J_Stroke_2013_May_31_15(2)_115-121.txt
7566T>C,"...09C>T, 6484T>C (rs9934438), 6853C>T (rs17886369), 7566T>C, 8767G>C, 8814T>C, 9041G>A (rs17880624), a...",7,546,J_Stroke_2013_May_31_15(2)_115-121.txt
8767G>C,"...84T>C (rs9934438), 6853C>T (rs17886369), 7566T>C, 8767G>C, 8814T>C, 9041G>A (rs17880624), and 9071G>...",7,555,J_Stroke_2013_May_31_15(2)_115-121.txt
8814T>C,"...9934438), 6853C>T (rs17886369), 7566T>C, 8767G>C, 8814T>C, 9041G>A (rs17880624), and 9071G>T) using ...",7,564,J_Stroke_2013_May_31_15(2)_115-121.txt
9041G>A,"... 6853C>T (rs17886369), 7566T>C, 8767G>C, 8814T>C, 9041G>A (rs17880624), and 9071G>T) using a standar...",7,573,J_Stroke_2013_May_31_15(2)_115-121.txt
9071G>T,"...6T>C, 8767G>C, 8814T>C, 9041G>A (rs17880624), and 9071G>T) using a standard sequencing method. Multi...",7,599,J_Stroke_2013_May_31_15(2)_115-121.txt
1075A>C,"...high prevalence of wild-type CYP2C9 polymorphism (1075A>C, P<0.001), and six heterozygote SNPs in VR...",10,276,J_Stroke_2013_May_31_15(2)_115-121.txt
381T>C,"...VRORC1 (P<0.001), which were tightly interlinked (381T>C, 3673G>A, 6484T>C, 6853C>G. 7566C>T, 9041G>...",10,374,J_Stroke_2013_May_31_15(2)_115-121.txt
3673G>A,"...P<0.001), which were tightly interlinked (381T>C, 3673G>A, 6484T>C, 6853C>G. 7566C>T, 9041G>A) (r2=1...",10,382,J_Stroke_2013_May_31_15(2)_115-121.txt
6484T>C,"... which were tightly interlinked (381T>C, 3673G>A, 6484T>C, 6853C>G. 7566C>T, 9041G>A) (r2=1). Based ...",10,391,J_Stroke_2013_May_31_15(2)_115-121.txt
6853C>G,"...re tightly interlinked (381T>C, 3673G>A, 6484T>C, 6853C>G. 7566C>T, 9041G>A) (r2=1). Based on these ...",10,400,J_Stroke_2013_May_31_15(2)_115-121.txt
7566C>T,"...y interlinked (381T>C, 3673G>A, 6484T>C, 6853C>G. 7566C>T, 9041G>A) (r2=1). Based on these data, a w...",10,409,J_Stroke_2013_May_31_15(2)_115-121.txt
9041G>A,"...nked (381T>C, 3673G>A, 6484T>C, 6853C>G. 7566C>T, 9041G>A) (r2=1). Based on these data, a warfarin d...",10,418,J_Stroke_2013_May_31_15(2)_115-121.txt
430C>T,"...oups. We selected 26 SNPs in CYP2C9 (three sites; 430C>T (rs1799853), 1075A>C (rs10 57910), 1076T>C)...",36,310,J_Stroke_2013_May_31_15(2)_115-121.txt
1075A>C,"... SNPs in CYP2C9 (three sites; 430C>T (rs1799853), 1075A>C (rs10 57910), 1076T>C), VKORC1 (14 sites; ...",36,330,J_Stroke_2013_May_31_15(2)_115-121.txt
1076T>C,"... sites; 430C>T (rs1799853), 1075A>C (rs10 57910), 1076T>C), VKORC1 (14 sites; 381C>T, 861C>A (rs1788...",36,352,J_Stroke_2013_May_31_15(2)_115-121.txt
381C>T,"...1075A>C (rs10 57910), 1076T>C), VKORC1 (14 sites; 381C>T, 861C>A (rs17880887), 2653G>C, 3673A>G, 549...",36,380,J_Stroke_2013_May_31_15(2)_115-121.txt
861C>A,"...(rs10 57910), 1076T>C), VKORC1 (14 sites; 381C>T, 861C>A (rs17880887), 2653G>C, 3673A>G, 5496G>T, 58...",36,388,J_Stroke_2013_May_31_15(2)_115-121.txt
2653G>C,"...), VKORC1 (14 sites; 381C>T, 861C>A (rs17880887), 2653G>C, 3673A>G, 5496G>T, 5808T>G (r17882154), 60...",36,409,J_Stroke_2013_May_31_15(2)_115-121.txt
3673A>G,"... (14 sites; 381C>T, 861C>A (rs17880887), 2653G>C, 3673A>G, 5496G>T, 5808T>G (r17882154), 6009C>T, 64...",36,418,J_Stroke_2013_May_31_15(2)_115-121.txt
5496G>T,"...s; 381C>T, 861C>A (rs17880887), 2653G>C, 3673A>G, 5496G>T, 5808T>G (r17882154), 6009C>T, 6484T>C (rs...",36,427,J_Stroke_2013_May_31_15(2)_115-121.txt
5808T>G,"..., 861C>A (rs17880887), 2653G>C, 3673A>G, 5496G>T, 5808T>G (r17882154), 6009C>T, 6484T>C (rs9934438),...",36,436,J_Stroke_2013_May_31_15(2)_115-121.txt
6009C>T,"..., 2653G>C, 3673A>G, 5496G>T, 5808T>G (r17882154), 6009C>T, 6484T>C (rs9934438), 6853C>T (rs17886369)...",36,457,J_Stroke_2013_May_31_15(2)_115-121.txt
6484T>C,"..., 3673A>G, 5496G>T, 5808T>G (r17882154), 6009C>T, 6484T>C (rs9934438), 6853C>T (rs17886369), 7566T>C...",36,466,J_Stroke_2013_May_31_15(2)_115-121.txt
6853C>T,"...808T>G (r17882154), 6009C>T, 6484T>C (rs9934438), 6853C>T (rs17886369), 7566T>C, 8767G>C, 8814T>C, 9...",36,487,J_Stroke_2013_May_31_15(2)_115-121.txt
7566T>C,"...09C>T, 6484T>C (rs9934438), 6853C>T (rs17886369), 7566T>C, 8767G>C, 8814T>C, 9041G>A (rs17880624), 9...",36,509,J_Stroke_2013_May_31_15(2)_115-121.txt
8767G>C,"...84T>C (rs9934438), 6853C>T (rs17886369), 7566T>C, 8767G>C, 8814T>C, 9041G>A (rs17880624), 9071G>T), ...",36,518,J_Stroke_2013_May_31_15(2)_115-121.txt
8814T>C,"...9934438), 6853C>T (rs17886369), 7566T>C, 8767G>C, 8814T>C, 9041G>A (rs17880624), 9071G>T), gamma-glu...",36,527,J_Stroke_2013_May_31_15(2)_115-121.txt
9041G>A,"... 6853C>T (rs17886369), 7566T>C, 8767G>C, 8814T>C, 9041G>A (rs17880624), 9071G>T), gamma-glutamyl car...",36,536,J_Stroke_2013_May_31_15(2)_115-121.txt
9071G>T,"... 7566T>C, 8767G>C, 8814T>C, 9041G>A (rs17880624), 9071G>T), gamma-glutamyl carboxylase (GGCX, nine s...",36,558,J_Stroke_2013_May_31_15(2)_115-121.txt
268A>T,"...X, nine sites; eight SNPs and one microsatellite; 268A>T, 412G>A, 6258A>G, 8015C>T, 8016G>A, 8240A>G...",36,649,J_Stroke_2013_May_31_15(2)_115-121.txt
412G>A,"...sites; eight SNPs and one microsatellite; 268A>T, 412G>A, 6258A>G, 8015C>T, 8016G>A, 8240A>G, 8445C>...",36,657,J_Stroke_2013_May_31_15(2)_115-121.txt
6258A>G,"...ight SNPs and one microsatellite; 268A>T, 412G>A, 6258A>G, 8015C>T, 8016G>A, 8240A>G, 8445C> T, 1387...",36,665,J_Stroke_2013_May_31_15(2)_115-121.txt
8015C>T,"... and one microsatellite; 268A>T, 412G>A, 6258A>G, 8015C>T, 8016G>A, 8240A>G, 8445C> T, 13875A>G, CAA...",36,674,J_Stroke_2013_May_31_15(2)_115-121.txt
8016G>A,"...microsatellite; 268A>T, 412G>A, 6258A>G, 8015C>T, 8016G>A, 8240A>G, 8445C> T, 13875A>G, CAA repeat)",36,683,J_Stroke_2013_May_31_15(2)_115-121.txt
8240A>G,"...llite; 268A>T, 412G>A, 6258A>G, 8015C>T, 8016G>A, 8240A>G, 8445C> T, 13875A>G, CAA repeat)",36,692,J_Stroke_2013_May_31_15(2)_115-121.txt
8445C> T,"...8A>T, 412G>A, 6258A>G, 8015C>T, 8016G>A, 8240A>G, 8445C> T, 13875A>G, CAA repeat)",36,701,J_Stroke_2013_May_31_15(2)_115-121.txt
13875A>G,"...>A, 6258A>G, 8015C>T, 8016G>A, 8240A>G, 8445C> T, 13875A>G, CAA repeat)",36,711,J_Stroke_2013_May_31_15(2)_115-121.txt
381T>C,"...cant difference of WRI (6 SNPs located in VKORC1 (381T>C, 3673G>A, 6484T>C [rs9934438], 6853C>G [rs1...",50,158,J_Stroke_2013_May_31_15(2)_115-121.txt
3673G>A,"...ference of WRI (6 SNPs located in VKORC1 (381T>C, 3673G>A, 6484T>C [rs9934438], 6853C>G [rs17886369]...",50,166,J_Stroke_2013_May_31_15(2)_115-121.txt
6484T>C,"...f WRI (6 SNPs located in VKORC1 (381T>C, 3673G>A, 6484T>C [rs9934438], 6853C>G [rs17886369]. 7566C>T...",50,175,J_Stroke_2013_May_31_15(2)_115-121.txt
6853C>G,"... in VKORC1 (381T>C, 3673G>A, 6484T>C [rs9934438], 6853C>G [rs17886369]. 7566C>T, 9041G>A [rs17880624...",50,196,J_Stroke_2013_May_31_15(2)_115-121.txt
7566C>T,"...73G>A, 6484T>C [rs9934438], 6853C>G [rs17886369]. 7566C>T, 9041G>A [rs17880624]) and one in CYP2C9 [...",50,218,J_Stroke_2013_May_31_15(2)_115-121.txt
9041G>A,"...84T>C [rs9934438], 6853C>G [rs17886369]. 7566C>T, 9041G>A [rs17880624]) and one in CYP2C9 [1075A>C])...",50,227,J_Stroke_2013_May_31_15(2)_115-121.txt
1075A>C,"...7566C>T, 9041G>A [rs17880624]) and one in CYP2C9 [1075A>C]). In terms of genotype prevalence, 24 pat...",50,268,J_Stroke_2013_May_31_15(2)_115-121.txt
9041 G>A,...% interlinked (r2=1). In view of the finding that 9041 G>A (rs17880624) displayed the most consisten...,50,520,J_Stroke_2013_May_31_15(2)_115-121.txt
9041 G>A,The high prevalence of heterozygotic VKORC1 9041 G>A (rs17880624) was closely associated with ...,52,45,J_Stroke_2013_May_31_15(2)_115-121.txt
1075A>C,"... (P<0.001), and prevalence of heterozygote CYP2C9 1075A>C (rs1057910) with high WRI (P<0.001) (Figur...",52,152,J_Stroke_2013_May_31_15(2)_115-121.txt
9041G>A,"...tients. Young age, high BMI, heterozygote VKORC1 (9041G>A, rs17880624), and/or homozygote CYP2C9 (10...",55,175,J_Stroke_2013_May_31_15(2)_115-121.txt
1075A>C,"... (9041G>A, rs17880624), and/or homozygote CYP2C9 (1075A>C, rs1057910) contributed to low WRI, indica...",55,223,J_Stroke_2013_May_31_15(2)_115-121.txt
9041G>A,"...riability and prevalence of selected SNPs (VKORC1 9041G>A and CYP2C9 1075A>C). However, the linkage ...",57,348,J_Stroke_2013_May_31_15(2)_115-121.txt
1075A>C,"...lence of selected SNPs (VKORC1 9041G>A and CYP2C9 1075A>C). However, the linkage in VKORC1 SNPs has ...",57,367,J_Stroke_2013_May_31_15(2)_115-121.txt
1075A>C,...heterozygote in several SNPs in VKORC1 and CYP2C9 1075A>C require a high warfarin dose. While 9041G>...,59,188,J_Stroke_2013_May_31_15(2)_115-121.txt
9041G>A,...YP2C9 1075A>C require a high warfarin dose. While 9041G>A was not linked with other SNPs (at positio...,59,232,J_Stroke_2013_May_31_15(2)_115-121.txt
1076T>C,...e could not find significant influence of CYP2C9 (1076T>C or 430C>T) on warfarin dose although this ...,59,483,J_Stroke_2013_May_31_15(2)_115-121.txt
430C>T,... find significant influence of CYP2C9 (1076T>C or 430C>T) on warfarin dose although this position wa...,59,494,J_Stroke_2013_May_31_15(2)_115-121.txt
1639 G>A,"...kawa S  Moriwaki H  Akimoto T    Effect of VKORC1-1639 G>A; a polymorphism, body weight, age, and se...",94,91,J_Stroke_2013_May_31_15(2)_115-121.txt
1639 G>A,"...kawa S  Moriwaki H  Akimoto T    Effect of VKORC1-1639 G>A polymorphism, body weight, age, and serum...",107,91,J_Stroke_2013_May_31_15(2)_115-121.txt
1639 G>A,...on of warfarin maintenance dose based on VKORC1 (-1639 G>A) and CYP2C9 genotypes Clin Chem 2007 53 1...,128,136,J_Stroke_2013_May_31_15(2)_115-121.txt
2T>C,c.286+2T>,158,7,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
2T>G,c.286+2T>G,160,7,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
175C>T,c.175C>T; p.Arg59X	0.56	0.04	0.5	49	1	2	0,167,4,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
470G>A,c.470G>A;p.Cys157Tyr	0.92,172,4,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
470G>A,c.470G>A;p.Cys157Tyr	1.31	0.27	0.58	62	2	1	2,176,4,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
191G>T,c.191G>T; p.Cys64Phe	1.17	0.17	0.78	84	2	1	0,179,4,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
5T>C,c.3134‐5T>C	0.87	0.23	0.62	53	2	0	2,184,9,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
3643C>T,c.3643C>T p.Arg1215X	0.85	0.31	0.42	73	2	2	1,187,4,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
1112A>G,c.1112A>G p.Asp371Gly	0.91	0.3	0.67	77	1	1	0,192,4,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
3023C>T,c.3023C>T; p.Ser1008Leu	1.15,195,4,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
331C>T,"... described. Genotyping of the following SNPs CFH −331C>T (rs3753394), CFH c.184G>A; p.Val62Ile (rs80...",220,106,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
184G>A,"...the following SNPs CFH −331C>T (rs3753394), CFH c.184G>A; p.Val62Ile (rs800292), CFH c.1204T>C; p.Ty...",220,132,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
1204T>C,"...3394), CFH c.184G>A; p.Val62Ile (rs800292), CFH c.1204T>C; p.Tyr402His (rs1061170), CFH c.2016A>G; p...",220,169,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
2016A>G,"...2), CFH c.1204T>C; p.Tyr402His (rs1061170), CFH c.2016A>G; p.Gln672Gln (rs3753396), CFH IVS15 −543G>...",220,209,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
543G>A,"...FH c.2016A>G; p.Gln672Gln (rs3753396), CFH IVS15 −543G>A intron 15 (rs1410996), CFH c.2808G>T; p.Glu...",220,254,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
2808G>T,"...), CFH IVS15 −543G>A intron 15 (rs1410996), CFH c.2808G>T; p.Glu936Asp (rs1065489), CD46 −652A>G (rs...",220,290,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
652A>G,"...6), CFH c.2808G>T; p.Glu936Asp (rs1065489), CD46 −652A>G (rs2796267), CD46 −366A>G (rs2796268), CD46...",220,330,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
366A>G,"...6Asp (rs1065489), CD46 −652A>G (rs2796267), CD46 −366A>G (rs2796268), CD46 IVS9 −78G>A (rs1962149), ...",220,356,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
78G>A,"...(rs2796267), CD46 −366A>G (rs2796268), CD46 IVS9 −78G>A (rs1962149), CD46 IVS12 +638G>A (rs859705), ...",220,387,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
638G>A,"...96268), CD46 IVS9 −78G>A (rs1962149), CD46 IVS12 +638G>A (rs859705), and CD46 c.4070T>C (rs7144) was...",220,418,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
4070T>C,"...62149), CD46 IVS12 +638G>A (rs859705), and CD46 c.4070T>C (rs7144) was used to determine CFH and CD4...",220,448,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
5T>C,Analysis of CFH c.3134‐5T>C varian,225,24,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
5T>C,... serum arising as a consequence of the CFH c.3134‐5T>C variant was undertaken by Western blotting. S...,229,102,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
2T>C,"...owed a compound heterozygote CD46 mutation (c.286+2T>C, c.286+2T>G), which resulted in complete CD46...",246,102,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
2T>G,"...und heterozygote CD46 mutation (c.286+2T>C, c.286+2T>G), which resulted in complete CD46 deficiency....",246,114,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
2T>C,"...h resulted in complete CD46 deficiency. The c.286+2T>C variant was of maternal origin, while the c.2...",246,175,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
2T>G,"...C variant was of maternal origin, while the c.286+2T>G was paternal. Flow cytometry analysis confirm...",246,228,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
5T>C,...ysis of cDNA from the patient with the CFH c.3134‐5T>C genetic variant (patient 6) did not detect an...,248,157,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
5T>C,...1. FH analysis from the patient with a CFH c.3134‐5T>C genetic variant. Western blot using a polyclo...,298,57,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
5T>C,...oncentration from the patient with the CFH c.3134‐5T>C is > 2× the control sample in an attempt to e...,298,238,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
538C > T,"...ding 35delG, 176-191del16, 235delC, 299-300delAT, 538C > T, 1555A > G, 1494C > T, 2168A > G, and IVS...",7,444,J_Transl_Med_2011_Sep_14_9_154.txt
1555A > G,"...G, 176-191del16, 235delC, 299-300delAT, 538C > T, 1555A > G, 1494C > T, 2168A > G, and IVS7-2A > G. ...",7,454,J_Transl_Med_2011_Sep_14_9_154.txt
1494C > T,"...el16, 235delC, 299-300delAT, 538C > T, 1555A > G, 1494C > T, 2168A > G, and IVS7-2A > G. The samples...",7,465,J_Transl_Med_2011_Sep_14_9_154.txt
2168A > G,"...lC, 299-300delAT, 538C > T, 1555A > G, 1494C > T, 2168A > G, and IVS7-2A > G. The samples that showe...",7,476,J_Transl_Med_2011_Sep_14_9_154.txt
2A > G,"...8C > T, 1555A > G, 1494C > T, 2168A > G, and IVS7-2A > G. The samples that showed the absence of bot...",7,496,J_Transl_Med_2011_Sep_14_9_154.txt
538C > T,"...191del16, 235delC and 299-300delAT for GJB2 gene, 538C > T for GJB3 gene, 1555A > G and 1494C > T fo...",18,1155,J_Transl_Med_2011_Sep_14_9_154.txt
1555A > G,"...9-300delAT for GJB2 gene, 538C > T for GJB3 gene, 1555A > G and 1494C > T for mtDNA 12S rRNA gene, a...",18,1179,J_Transl_Med_2011_Sep_14_9_154.txt
1494C > T,"... GJB2 gene, 538C > T for GJB3 gene, 1555A > G and 1494C > T for mtDNA 12S rRNA gene, and 2168A > G (...",18,1193,J_Transl_Med_2011_Sep_14_9_154.txt
2168A > G,"...5A > G and 1494C > T for mtDNA 12S rRNA gene, and 2168A > G (H723R) and IVS7-2A > G for SLC26A4 gene...",18,1232,J_Transl_Med_2011_Sep_14_9_154.txt
2A > G,"...DNA 12S rRNA gene, and 2168A > G (H723R) and IVS7-2A > G for SLC26A4 gene",18,1259,J_Transl_Med_2011_Sep_14_9_154.txt
538C > T,"..., 176-191del16, 235delC, and 299-300delAT), GJB3 (538C > T), SLC26A4 (IVS7-2A > G and 2168A > G), an...",27,621,J_Transl_Med_2011_Sep_14_9_154.txt
2A > G,"...and 299-300delAT), GJB3 (538C > T), SLC26A4 (IVS7-2A > G and 2168A > G), and mitochondrial 12S rRNA ...",27,646,J_Transl_Med_2011_Sep_14_9_154.txt
2168A > G,"...delAT), GJB3 (538C > T), SLC26A4 (IVS7-2A > G and 2168A > G), and mitochondrial 12S rRNA (1555A > G ...",27,657,J_Transl_Med_2011_Sep_14_9_154.txt
1555A > G,"...A > G and 2168A > G), and mitochondrial 12S rRNA (1555A > G and 1494C > T). The test results were de...",27,697,J_Transl_Med_2011_Sep_14_9_154.txt
1494C > T,"...A > G), and mitochondrial 12S rRNA (1555A > G and 1494C > T). The test results were determined based...",27,711,J_Transl_Med_2011_Sep_14_9_154.txt
1503G > A,"...7delG for GJB2 in three patients (Figure 1A), and 1503G > A for mtDNA 12S rRNA in one patient (Figur...",36,440,J_Transl_Med_2011_Sep_14_9_154.txt
1503G > A,...s with nonsyndromic deafness: (A) 187delG and (B) 1503G > A,38,121,J_Transl_Med_2011_Sep_14_9_154.txt
1494C > T,1494C > T (12S rRNA)	1503G > A	1,44,1,J_Transl_Med_2011_Sep_14_9_154.txt
1503G > A,1494C > T (12S rRNA)	1503G > A	1,44,22,J_Transl_Med_2011_Sep_14_9_154.txt
1555A > G,1555A > G	3	3	0	0,73,1,J_Transl_Med_2011_Sep_14_9_154.txt
1494C > T,1494C > T	0	1	0	0,74,1,J_Transl_Med_2011_Sep_14_9_154.txt
2A > G,IVS7-2A > G/-	0	7	0	0,75,6,J_Transl_Med_2011_Sep_14_9_154.txt
2A > G,IVS7-2A > G/IVS7-2A > G	2	7	0	0,76,6,J_Transl_Med_2011_Sep_14_9_154.txt
2A > G,IVS7-2A > G/IVS7-2A > G	2	7	0	0,76,18,J_Transl_Med_2011_Sep_14_9_154.txt
2168A > G,2168A > G/-	1	3	1	0,77,1,J_Transl_Med_2011_Sep_14_9_154.txt
2168A > G,2168A > G/IVS7-2A > G	1	1	0	0,78,1,J_Transl_Med_2011_Sep_14_9_154.txt
2A > G,2168A > G/IVS7-2A > G	1	1	0	0,78,16,J_Transl_Med_2011_Sep_14_9_154.txt
2A > G,235delC/IVS7-2A > G	0	1	0	0,82,14,J_Transl_Med_2011_Sep_14_9_154.txt
2168A > G,235delC/2168A > G	0	1	0	0,83,9,J_Transl_Med_2011_Sep_14_9_154.txt
2A > G,IVS7-2A > G	0	1	0	0,85,6,J_Transl_Med_2011_Sep_14_9_154.txt
2A > G,IVS7-2A > G/538C > T	0	1	0	0,86,6,J_Transl_Med_2011_Sep_14_9_154.txt
538C > T,IVS7-2A > G/538C > T	0	1	0	0,86,13,J_Transl_Med_2011_Sep_14_9_154.txt
538C > T,538C > T/-	0	1	0	0,88,1,J_Transl_Med_2011_Sep_14_9_154.txt
1503G > A,1503G > A	1	0	0	0,90,1,J_Transl_Med_2011_Sep_14_9_154.txt
2168A > G,"The frequencies of SLC26A4 mutation, including 2168A > G (H723R) and IVS7-2A > G, were 2.01% (4/1...",94,48,J_Transl_Med_2011_Sep_14_9_154.txt
2A > G,"...A4 mutation, including 2168A > G (H723R) and IVS7-2A > G, were 2.01% (4/199) in Uyghur patients and ...",94,75,J_Transl_Med_2011_Sep_14_9_154.txt
2A > G,"...Han Chinese patients, respectively. Of note, IVS7-2A > G mutant alleles accounted for 83.33% (25/30)...",94,194,J_Transl_Med_2011_Sep_14_9_154.txt
1555A > G,"...requencies of mtDNA 12S rRNA mutations, including 1555A > G and 1494C > T, were 2.01% (4/199) in Uyg...",96,56,J_Transl_Med_2011_Sep_14_9_154.txt
1494C > T,"...mtDNA 12S rRNA mutations, including 1555A > G and 1494C > T, were 2.01% (4/199) in Uyghur patients a...",96,70,J_Transl_Med_2011_Sep_14_9_154.txt
1503 G > A,"...atients, respectively. The homozygous mutation of 1503 G > A was an unreported gene mutation. The mu...",96,203,J_Transl_Med_2011_Sep_14_9_154.txt
538C > T,...ported gene mutation. The mutation frequencies of 538C > T for GJB3 were 0.0% (0/199) in Uyghur pati...,96,275,J_Transl_Med_2011_Sep_14_9_154.txt
1G > A,"...rn deaf population, L236P, T416P, E384G, and IVS8+1G > A are common mutant loci of SLC26A4 [21], whe...",106,309,J_Transl_Med_2011_Sep_14_9_154.txt
2168A > G,"...A are common mutant loci of SLC26A4 [21], whereas 2168A > G is the primary mutant locus in Japanese ...",106,364,J_Transl_Med_2011_Sep_14_9_154.txt
2 A > G,"...n Japanese and Korean deaf patients [27,28]. IVS7-2 A > G is reported to be the major mutant locus o...",106,453,J_Transl_Med_2011_Sep_14_9_154.txt
2A > G,"... the two locus mutations of SLC26A4, namely, IVS7-2A > G and 2168A > G (H723R), are less frequently ...",106,624,J_Transl_Med_2011_Sep_14_9_154.txt
2168A > G,"...cus mutations of SLC26A4, namely, IVS7-2A > G and 2168A > G (H723R), are less frequently found in Uy...",106,635,J_Transl_Med_2011_Sep_14_9_154.txt
2A > G,"...uently found in Uyghur NSD patients, whereas IVS7-2A > G is the primary mutation in Uyghur patients....",106,717,J_Transl_Med_2011_Sep_14_9_154.txt
2A > G,...et al. [15] reported the complete absence of IVS7-2A > G mutation in 60 Uyghur patients. Li et al. [...,106,822,J_Transl_Med_2011_Sep_14_9_154.txt
2A > G,"...yghur patients. Li et al. [30] reported that IVS7-2A > G, a major mutant locus of SLC26A4 exhibited ...",106,895,J_Transl_Med_2011_Sep_14_9_154.txt
2A > G,"...(22/151) in Han Chinese NSD patients, whilst IVS7-2A > G mutant alleles account for 83.33% (25/30) a...",106,1231,J_Transl_Med_2011_Sep_14_9_154.txt
2A > G,...ion. This is consistent with the report that IVS7-2A > G is the primary mutation of SLC26A4 in Han C...,106,1349,J_Transl_Med_2011_Sep_14_9_154.txt
1555A > G,"...ted with aminoglycoside-induced deafness [31,32]. 1555A > G and 1494C > T are the most important and...",108,113,J_Transl_Med_2011_Sep_14_9_154.txt
1494C > T,"...glycoside-induced deafness [31,32]. 1555A > G and 1494C > T are the most important and common mutati...",108,127,J_Transl_Med_2011_Sep_14_9_154.txt
1555A > G,"... > T are the most important and common mutations. 1555A > G is more frequently detected, but shows a...",108,182,J_Transl_Med_2011_Sep_14_9_154.txt
1555A > G,"... deaf populations show a relatively low-frequency 1555A > G mutation [34,35], in comparison with a f...",108,439,J_Transl_Med_2011_Sep_14_9_154.txt
1494C > T,...rted by Li et al. [11]. The mutation frequency of 1494C > T is even lower than that of 1555A > G. 14...,108,565,J_Transl_Med_2011_Sep_14_9_154.txt
1555A > G,...frequency of 1494C > T is even lower than that of 1555A > G. 1494C > T mutation is detected in only ...,108,602,J_Transl_Med_2011_Sep_14_9_154.txt
1494C > T,...f 1494C > T is even lower than that of 1555A > G. 1494C > T mutation is detected in only one Han Chi...,108,613,J_Transl_Med_2011_Sep_14_9_154.txt
1503G > A,...rable between the two ethnicities. The unreported 1503G > A homogenous mutation that is found in one...,108,843,J_Transl_Med_2011_Sep_14_9_154.txt
538C > T,... in European and North American populations [38]. 538C > T mutation of GJB3 is detected in two of Ha...,110,298,J_Transl_Med_2011_Sep_14_9_154.txt
2A > G,...X Han B Yuan H Platt OS Han D Wu BL SLC26A4 c.919-2A > G varies among Chinese ethnic groups as a cau...,140,121,J_Transl_Med_2011_Sep_14_9_154.txt
2A > G,...Y Zhang X Xue DD Jin ZC Frequency of SLC26A4 IVS7-2A > G mutation in patients with severe to profoun...,155,109,J_Transl_Med_2011_Sep_14_9_154.txt
1277 T>C,... bp respectively) surrounding the polymorphisms c.1277 T>C of CFH (rs1061170) and c.205 G>T of ARMS2...,88,113,J_Transl_Med_2013_Sep_25_11_228.txt
205 G>T,...polymorphisms c.1277 T>C of CFH (rs1061170) and c.205 G>T of ARMS2 (rs10490924): CFH-forward (CFHf) ...,88,147,J_Transl_Med_2013_Sep_25_11_228.txt
17058639 C>T,...P polymorphisms. Table S3. Association of SLMAP rs17058639 C>T genotypes with clinical phenotypes (o...,366,185,J_Transl_Med_2015_Feb_15_13_61.txt
17058639 C>T,...ANOVA analysis). Table S4. Association of SLMAP rs17058639 C>T genotypes with progression of diabeti...,366,292,J_Transl_Med_2015_Feb_15_13_61.txt
1979C>T,"We identified a novel TMC1 mutation in exon 20, c.1979C>T, p.P660L, which segregated with prelingual...",11,51,J_Transl_Med_2016_Jan_28_14_29.txt
1979C>T,"...homozygous mutation in TMC1 located in exon 20, c.1979C>T, p.P660L in a three-generation, 14-member ...",29,88,J_Transl_Med_2016_Jan_28_14_29.txt
1979C>T,"...Sanger sequencing and found a missense variant, c.1979C>T, p.P660L, in exon 20 of TMC1 [NM_138691, (...",66,119,J_Transl_Med_2016_Jan_28_14_29.txt
1979C>T,...y SH-02. a DNA sequences of homozygous missense c.1979C>T mutations and the wild-type control. b The...,66,806,J_Transl_Med_2016_Jan_28_14_29.txt
1979C>T,"... The structure of TMC1A depicts the position of c.1979C>T, a mutation in exon 20 and p.P660L in TM2 ...",66,902,J_Transl_Med_2016_Jan_28_14_29.txt
1979C>T,138691	c.1979C>T	p.P660L	Hom	SIFT	Polyphen2	MutationTaster,76,11,J_Transl_Med_2016_Jan_28_14_29.txt
1979C>T,"...fied a novel TMC1 missense mutation in exon 20, c.1979C>T, p.P660L",81,1021,J_Transl_Med_2016_Jan_28_14_29.txt
1979C>T,"...6 appears to confer channel function [18]. TMC1 c.1979C>T, p.P660L is located in a predicted third e...",91,730,J_Transl_Med_2016_Jan_28_14_29.txt
129467A>G,...in the 3′ untranslated region as follows: PDE5A:g.129467A>G; g.129281T>C; g.129858C>A; g.130270T>C; ...,104,120,J_Vet_Intern_Med_2014_Dec_16_Jan-Feb_28(1)_78-83.txt
129281T>C,...ranslated region as follows: PDE5A:g.129467A>G; g.129281T>C; g.129858C>A; g.130270T>C; g.130311G>C; ...,104,133,J_Vet_Intern_Med_2014_Dec_16_Jan-Feb_28(1)_78-83.txt
129858C>A,...ion as follows: PDE5A:g.129467A>G; g.129281T>C; g.129858C>A; g.130270T>C; g.130311G>C; g.130515A>C. ...,104,146,J_Vet_Intern_Med_2014_Dec_16_Jan-Feb_28(1)_78-83.txt
130270T>C,...s: PDE5A:g.129467A>G; g.129281T>C; g.129858C>A; g.130270T>C; g.130311G>C; g.130515A>C. Although SNPs...,104,159,J_Vet_Intern_Med_2014_Dec_16_Jan-Feb_28(1)_78-83.txt
130311G>C,...9467A>G; g.129281T>C; g.129858C>A; g.130270T>C; g.130311G>C; g.130515A>C. Although SNPs within the 3...,104,172,J_Vet_Intern_Med_2014_Dec_16_Jan-Feb_28(1)_78-83.txt
130515A>C,...9281T>C; g.129858C>A; g.130270T>C; g.130311G>C; g.130515A>C. Although SNPs within the 3′ UTR of huma...,104,185,J_Vet_Intern_Med_2014_Dec_16_Jan-Feb_28(1)_78-83.txt
1G > C,"...ozygous mutation in 9%. These abnormalities (IVS3-1G > C, R228X) represent XPA gene mutation hot spo...",46,1108,Jpn_Clin_Med_2013_Apr_16_4_29-35.txt
1236C > T,"...2℃ extension for 10 minutes. The genotype of MDR1 1236C > T (assay ID: C__7586662_10), ABCG2 421C > ...",33,639,Korean_J_Anesthesiol_2012_Apr_23_62(4)_332-336.txt
421C > A,"...f MDR1 1236C > T (assay ID: C__7586662_10), ABCG2 421C > A (assay ID: C__15854163_70) and ABCC2 1249...",33,682,Korean_J_Anesthesiol_2012_Apr_23_62(4)_332-336.txt
1249G > A,...CG2 421C > A (assay ID: C__15854163_70) and ABCC2 1249G > A (assay ID: C__22272980_20) SNPs was anal...,33,728,Korean_J_Anesthesiol_2012_Apr_23_62(4)_332-336.txt
1236C > T,"...r estimation of a haplotype in three genotypes of 1236C > T, 2677G > T/A, 3435C > T in MDR-1 gene, T...",49,259,Korean_J_Anesthesiol_2012_Apr_23_62(4)_332-336.txt
2677G > T,"...n of a haplotype in three genotypes of 1236C > T, 2677G > T/A, 3435C > T in MDR-1 gene, TGC, CAC, CG...",49,270,Korean_J_Anesthesiol_2012_Apr_23_62(4)_332-336.txt
3435C > T,"...ype in three genotypes of 1236C > T, 2677G > T/A, 3435C > T in MDR-1 gene, TGC, CAC, CGC, TTT were m...",49,283,Korean_J_Anesthesiol_2012_Apr_23_62(4)_332-336.txt
2677G > T,"Table 3 Primer and Probe Sequences for MDR1 2677G > T, 2677G > A, 3435C >",75,45,Korean_J_Anesthesiol_2012_Apr_23_62(4)_332-336.txt
2677G > A,"... 3 Primer and Probe Sequences for MDR1 2677G > T, 2677G > A, 3435C >",75,56,Korean_J_Anesthesiol_2012_Apr_23_62(4)_332-336.txt
3435C > T,"...nd Probe Sequences for MDR1 2677G > T, 2677G > A, 3435C >",75,67,Korean_J_Anesthesiol_2012_Apr_23_62(4)_332-336.txt
118A>G,...morphism of the micro-opioid receptor gene (OPRM1 118A>G) affects fentanyl-induced analgesia during ...,78,91,Korean_J_Pain_2016_Jan_4_29(1)_34-39.txt
118A>G,...tsch J   The mu-opioid receptor gene polymorphism 118A>G depletes alfentanil-induced analgesia and p...,79,105,Korean_J_Pain_2016_Jan_4_29(1)_34-39.txt
556C>G,"...ated on chromosome 11p15.1 and encoding Kir6.2, c.556C>G (p.His186Asp), was found (Fig. 1). Genetic ...",17,228,Korean_J_Pediatr_2015_Aug_21_58(8)_309-312.txt
1875T>A,"... that NF-Y could bind to the region containing g.-1875T>A, a variant present in H3, and that the bin...",4,1745,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
207G>C,...the haplotype consisting of L503F of OCTN1 and g.-207G>C of OCTN2 was significantly associated with ...,11,510,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
1875T>A,...mpare the effects of NF-Y on the reference and g.-1875T>A variant OCTN1 promoters. p<0.05 was consid...,33,307,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
1745A>G,"...e major alleles except for one minor allele at g.-1745A>G, was the most common haplotype in the stud...",37,421,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
1145A>G,"...plotype 2 (H2) includes three minor alleles at g.-1145A>G, g.-538C>G, and g.-248C>G, and contains a ...",37,537,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
538C>G,"...2) includes three minor alleles at g.-1145A>G, g.-538C>G, and g.-248C>G, and contains a reference se...",37,549,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
248C>G,"...ee minor alleles at g.-1145A>G, g.-538C>G, and g.-248C>G, and contains a reference sequence accordin...",37,564,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
1875T>A,...t in the haplotypes. Two of the five variants (g.-1875T>A and g.-1745A>G) showed increased promoter ...,40,1202,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
1745A>G,"...ypes. Two of the five variants (g.-1875T>A and g.-1745A>G) showed increased promoter activities, whe...",40,1217,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
1145A>G,"...ed increased promoter activities, whereas two (g.-1145A>G and g.-248C>G) had decreased promoter acti...",40,1280,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
248C>G,"...omoter activities, whereas two (g.-1145A>G and g.-248C>G) had decreased promoter activities; the act...",40,1295,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
538C>G,...decreased promoter activities; the activity of g.-538C>G was comparable with the reference (Fig. 1b)...,40,1357,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
1145A>G,"...ibited decreased promoter activities contained g.-1145A>G and g.-248C>G. However, H1 and H3 also had...",40,1637,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
248C>G,"...d promoter activities contained g.-1145A>G and g.-248C>G. However, H1 and H3 also had the variants g...",40,1652,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
1745A>G,"...8C>G. However, H1 and H3 also had the variants g.-1745A>G and g.-1875T>A, respectively, which showed...",40,1704,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
1875T>A,"...H1 and H3 also had the variants g.-1745A>G and g.-1875T>A, respectively, which showed increased prom...",40,1719,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
1875T>A,Effect of the variant g.-1875T>A on the binding affinity of NF-Y to the OCT...,42,26,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
1875T>A,".... The results predicted that only one variant, g.-1875T>A, might affect the binding affinity of the ...",43,417,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
1875T>A,"...y results obtained using OCTN1 variants, where g.-1875T>A showed significantly increased promoter ac...",48,454,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
256C>G,"...CTN1 promoter, and only two of these variants, g.-256C>G and g.-248C>G, were found in Chinese indivi...",51,512,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
248C>G,"... and only two of these variants, g.-256C>G and g.-248C>G, were found in Chinese individuals. The min...",51,526,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
248C>G,...ese individuals. The minor allele frequency of g.-248C>G in the Tahara et al. study was similar to t...,51,602,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
256C>G,"...n the current study. However, the rare variant g.-256C>G, which had a frequency of 1.5% in the Tahar...",51,707,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
2063A>C,"...tart site), and identified two novel variants, g.-2063A>C and g.-510C>T. The region from -104 bp to ...",51,986,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
510C>T,"... identified two novel variants, g.-2063A>C and g.-510C>T. The region from -104 bp to -1 bp upstream ...",51,1001,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
1145A>G,"... These three haplotypes contained the variants g.-1145A>G, g.-538C>G, and g.-248C>G. Of these varian...",53,195,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
538C>G,"... haplotypes contained the variants g.-1145A>G, g.-538C>G, and g.-248C>G. Of these variants, g.-1145A...",53,207,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
248C>G,"...tained the variants g.-1145A>G, g.-538C>G, and g.-248C>G. Of these variants, g.-1145A>G and g.-248C>...",53,222,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
1145A>G,"..., g.-538C>G, and g.-248C>G. Of these variants, g.-1145A>G and g.-248C>G showed significantly decreas...",53,252,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
248C>G,"...d g.-248C>G. Of these variants, g.-1145A>G and g.-248C>G showed significantly decreased promoter act...",53,267,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
538C>G,"...ter activities, while the promoter activity of g.-538C>G was similar to that of the reference. The p...",53,360,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
1745A>G,"...hat of H4, possibly because of the presence of g.-1745A>G and g.-1875T>A, respectively, which showed...",53,510,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
1875T>A,"...ibly because of the presence of g.-1745A>G and g.-1875T>A, respectively, which showed increased prom...",53,525,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
1875T>A,"...d bind to the OCTN1 promoter region containing g.-1875T>A, a variant present in haplotype 3, and tha...",55,89,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
1875T>A,"...sequence TCGCCAATAAC. In contrast, the variant g.-1875T>A has the sequence TCGCCAAAAAC, which is a p...",57,329,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
1875T>A,"...omplex was decreased by 70% in the presence of g.-1875T>A (Fig. 2a). In addition, NF-Y repressed OCT...",57,573,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
207G>C,... the OCTN1 variant L503F and the OCTN2 variant g.-207G>C was significantly associated with susceptib...,59,116,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
1875T>A,"...TN1 regulate promoter activity was determined: g.-1875T>A, a variant present in H3, was associated w...",61,316,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
1875T>A,...lity shift analysis of the OCTN1 reference and g.-1875T>A variant sequences. (a) Labeled oligonucleo...,87,78,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
1298A>C,"...s been studied extensively. Along with C677T, the 1298A>C and 1793G>A polymorphism were associated w...",252,421,Lipids_Health_Dis_2006_Jan_23_5_1.txt
1793G>A,"...ed extensively. Along with C677T, the 1298A>C and 1793G>A polymorphism were associated with the plas...",252,433,Lipids_Health_Dis_2006_Jan_23_5_1.txt
1793G>A,"...lassmann G Fodinger M  Associations between MTHFR 1793G>A and plasma total homocysteine, folate, and...",453,100,Lipids_Health_Dis_2006_Jan_23_5_1.txt
80G->A,...ister M Rosenblatt DS Nicolas JP  A Polymorphism (80G->A) in the Reduced Folate Carrier Gene and Its...,464,100,Lipids_Health_Dis_2006_Jan_23_5_1.txt
1793G>A,"...lassmann G Fodinger M  Associations between MTHFR 1793G>A and plasma total homocysteine, folate, and...",475,100,Lipids_Health_Dis_2006_Jan_23_5_1.txt
677C > T,...peats and the methylenetetrahydrofolate reductase 677C > T polymorphism on homocysteine levels and r...,476,224,Lipids_Health_Dis_2006_Jan_23_5_1.txt
786T>C,"... R Gensini GF  Endothelial nitric oxide synthase -786T>C, but not 894G>T and 4a4b, polymorphism infl...",487,130,Lipids_Health_Dis_2006_Jan_23_5_1.txt
894G>T,"...ndothelial nitric oxide synthase -786T>C, but not 894G>T and 4a4b, polymorphism influences plasma ho...",487,146,Lipids_Health_Dis_2006_Jan_23_5_1.txt
3238C>G,...6ResearchInteractions of the apolipoprotein C-III 3238C>G polymorphism and alcohol consumption on se...,3,163,Lipids_Health_Dis_2010_Aug_17_9_86.txt
3238C>G,...rtaken to detect the interactions of the ApoC-III 3238C>G (rs5128) polymorphism and alcohol consumpt...,4,281,Lipids_Health_Dis_2010_Aug_17_9_86.txt
3238C>G,...mized cluster samples. Genotyping of the ApoC-III 3238C>G was performed by polymerase chain reaction...,7,173,Lipids_Health_Dis_2010_Aug_17_9_86.txt
3238C>G,...y direct sequencing. Interactions of the ApoC-III 3238C>G genotype and alcohol consumption was asses...,7,374,Lipids_Health_Dis_2010_Aug_17_9_86.txt
3238C>G,...was to determine the interactions of the ApoC-III 3238C>G (rs5128) polymorphism and alcohol consumpt...,18,1508,Lipids_Health_Dis_2010_Aug_17_9_86.txt
3238C>G,...at 4°C until analysis. Genotyping of the ApoC-III 3238C>G was performed by polymerase chain reaction...,31,180,Lipids_Health_Dis_2010_Aug_17_9_86.txt
3238C>G,...ed t test. The allele frequencies of the ApoC-III 3238C>G were determined by gene counting. A chi-sq...,40,392,Lipids_Health_Dis_2010_Aug_17_9_86.txt
3238C>G,...rg expectations. Interaction between the ApoC-III 3238C>G genotype and alcohol consumption was asses...,40,647,Lipids_Health_Dis_2010_Aug_17_9_86.txt
3238C>G,...A part of the nucleotide sequence of the ApoC-III 3238C>G. (A) CC genotype; (B) CG genotype; (C) GG ...,85,60,Lipids_Health_Dis_2010_Aug_17_9_86.txt
3238C>G,...genotypic and allelic frequencies of the ApoC-III 3238C>G are shown in Table 2. The frequencies of C...,88,55,Lipids_Health_Dis_2010_Aug_17_9_86.txt
3238C>G,ApoC-III 3238C>G genotype	1.324	6.542	0.011	1.068-1.642,137,11,Lipids_Health_Dis_2010_Aug_17_9_86.txt
3238C>G,ApoC-III 3238C>G genotype	1.517	8.448	0.004	1.145-2.009,142,11,Lipids_Health_Dis_2010_Aug_17_9_86.txt
3238C>G,ApoC-III 3238C>G genotype	1.709	9.600	0.002	1.218-2.400,147,11,Lipids_Health_Dis_2010_Aug_17_9_86.txt
3238C>G,ApoC-III 3238C>G genotype	1.678	15.923	0.000	1.301-2.163,155,11,Lipids_Health_Dis_2010_Aug_17_9_86.txt
3238C>G,ApoC-III 3238C>G genotype	1.324	6.542	0.011	1.068-1.642,160,11,Lipids_Health_Dis_2010_Aug_17_9_86.txt
3238C>G,ApoC-III 3238C>G genotype	2.200	12.048	0.044	1.410-3.434,165,11,Lipids_Health_Dis_2010_Aug_17_9_86.txt
3238C>G,ApoC-III 3238C>G genotype	1.574	6.223	0.013	1.102-2.248,175,11,Lipids_Health_Dis_2010_Aug_17_9_86.txt
3238C>G,ApoC-III 3238C>G genotype	1.874	16.157	0.000	1.380-2.545,179,11,Lipids_Health_Dis_2010_Aug_17_9_86.txt
3238C>G,ApoC-III 3238C>G genotype	2.319	10.577	0.001	1.397-3.849,183,11,Lipids_Health_Dis_2010_Aug_17_9_86.txt
3238C>G,ApoC-III 3238C>G genotype	1.863	11.039	0.001	1.291-2.689,190,11,Lipids_Health_Dis_2010_Aug_17_9_86.txt
3238C>G,...allelic and genotypic frequencies of the ApoC-III 3238C>G between the nondrinkers and drinkers. The ...,196,123,Lipids_Health_Dis_2010_Aug_17_9_86.txt
3238C>G,The relationship between the ApoC-III 3238C>G polymorphism and plasma or serum lipid lev...,198,39,Lipids_Health_Dis_2010_Aug_17_9_86.txt
3238C>G,The interactions of the ApoC-III 3238C>G polymorphism and alcohol consumption on se...,200,34,Lipids_Health_Dis_2010_Aug_17_9_86.txt
3238C>G,...hesize that the interactions between the ApoC-III 3238C>G polymorphism and different kinds of alcoho...,200,1422,Lipids_Health_Dis_2010_Aug_17_9_86.txt
3238C>G,...genotypic and allelic frequencies of the ApoC-III 3238C>G polymorphism between the nondrinkers and d...,203,133,Lipids_Health_Dis_2010_Aug_17_9_86.txt
3238C>G,...nd drinkers. But the interactions of the ApoC-III 3238C>G polymorphism and alcohol consumption on se...,203,229,Lipids_Health_Dis_2010_Aug_17_9_86.txt
482C > T,"...ook DG Cappuccio FP Variable effects of the APOC3-482C > T variant on insulin, glucose and triglycer...",237,134,Lipids_Health_Dis_2010_Aug_17_9_86.txt
2854T>G,...gh-Firbank EC Williams CM Influence of the APOC3 -2854T>G polymorphism on plasma lipid levels: effec...,242,87,Lipids_Health_Dis_2010_Aug_17_9_86.txt
455T>C,...lly PW Huff MW Hegele RA Association between the -455T>C promoter polymorphism of the APOC3 gene and...,258,142,Lipids_Health_Dis_2010_Aug_17_9_86.txt
482 C>T,"...ransfer protein TaqIB, and the apolipoprotein C3 -482 C>T polymorphisms on their association with co...",273,224,Lipids_Health_Dis_2010_Aug_17_9_86.txt
214C>A,...76-511X-13-124ResearchMTLRP genetic polymorphism (214C>A) was associated with Type 2 diabetes in Cau...,3,171,Lipids_Health_Dis_2014_Aug_5_13_124.txt
214C>A,"...ibed within this gene. One missense polymorphism, 214C>A at codon 72 with Met replacing Leu, is outs...",27,320,Lipids_Health_Dis_2014_Aug_5_13_124.txt
214C>A,"...n\" and \"polymorphism\" or \"SNP\" or \"Leu72Met \" or \"214C>A\" and \"type 2 diabetes\"",33,217,Lipids_Health_Dis_2014_Aug_5_13_124.txt
214C>A,...gure 2 Forest plot of MTLRP genetic polymorphism (214C>A) and Type 2 diabetes (CC genotype vs CA + A...,87,53,Lipids_Health_Dis_2014_Aug_5_13_124.txt
214C>A,...gure 3 Forest plot of MTLRP genetic polymorphism (214C>A) and Type 2 diabetes (A allele vs C allele)...,89,53,Lipids_Health_Dis_2014_Aug_5_13_124.txt
214C>A,...und an association of MTLRP genetic polymorphism (214C>A) with Type 2 diabetes in Caucasian populati...,101,78,Lipids_Health_Dis_2014_Aug_5_13_124.txt
214C>A,Several previous studies suggested that MTLRP 214C>A polymorphism was associated with the risk f...,103,47,Lipids_Health_Dis_2014_Aug_5_13_124.txt
214C>A,Our study suggested that 214C>A polymorphism in the MTLRP gene was associat...,114,26,Lipids_Health_Dis_2014_Aug_5_13_124.txt
34383331 T>A,... of promoter variant -794CATT and ncRNA variant rs34383331 T>A show that the diplotype 5 T is signif...,128,88,Malar_J_2013_Sep_25_12_345.txt
202 G>A,"A− (202 G>A, 376 A>G)	GTGGCTGTTCCGGGATGGCCTTCTG AGGGCA...",78,5,Malar_J_2015_Aug_7_14_308.txt
376 A>G,"A− (202 G>A, 376 A>G)	GTGGCTGTTCCGGGATGGCCTTCTG AGGGCAACGGCAAGC...",78,14,Malar_J_2015_Aug_7_14_308.txt
376 A>G,A+ (376 A>G)	CTGCGTTTTCTCCGCCAATC AGGGCAACGGCAAGCCTTAC...,79,5,Malar_J_2015_Aug_7_14_308.txt
202 G>A,"A− (202 G>A, 376 A>G)	898	423, 184, 169, 106, 32	423, ...",89,5,Malar_J_2015_Aug_7_14_308.txt
376 A>G,"A− (202 G>A, 376 A>G)	898	423, 184, 169, 106, 32	423, 184, 127,...",89,14,Malar_J_2015_Aug_7_14_308.txt
376 A>G,"A+ (376 A>G)	585	402, 187	289, 187, 117	[22, 35]",90,5,Malar_J_2015_Aug_7_14_308.txt
714T>G,... Genetic association analysis of the functional c.714T>G polymorphism and mucosal expression of dect...,104,137,Mamm_Genome_2011_Feb_11_22(1-2)_55-65.txt
504T>C,...zeli S  Traeger-Synodinos J  Giannatou E    The c.504T>C (p.Asn168Asn) polymorphism in the ABCB4 gen...,176,63,Med_Sci_Monit_2011_May_1_17(5)_CR265-CR271.txt
1112C>T,"...e enhancement of human IL13 transcription by IL13–1112C>T, a polymorphism associated with allergic i...",183,109,Med_Sci_Monit_2014_Dec_11_20_2617-2623.txt
896 A>G,...D  Prodromou ML  El Khoury J    The role of TLR4  896 A>G and 1196 C>T in susceptibility to infectio...,120,62,Med_Sci_Monit_2015_Feb_27_21_625-629.txt
1196 C>T,... ML  El Khoury J    The role of TLR4  896 A>G and 1196 C>T in susceptibility to infections: a review...,120,74,Med_Sci_Monit_2015_Feb_27_21_625-629.txt
894G > T,19 Ferlazzo N  Gorgone G  Caccamo D    The 894G > T (Glu298Asp) Variant in the Endothelial NO...,171,44,Med_Sci_Monit_2015_Jan_27_21_326-332.txt
1486T>C,"...har L    Association of TLR4 (D299G, T399I), TLR9–1486T>C, TIRAP S180L and TNF-alpha promoter (–1031...",220,85,Med_Sci_Monit_2015_Nov_20_21_3591-3599.txt
896A>G,47 Chen S   Association between the TLR4 +896A>G (Asp299Gly) polymorphism and asthma: a syst...,222,43,Med_Sci_Monit_2015_Nov_20_21_3591-3599.txt
896A>G,48 Yao Y  Ren X  He L    TLR4 +896A>G (Asp299Gly) polymorphism is not associated ...,223,32,Med_Sci_Monit_2015_Nov_20_21_3591-3599.txt
677C>T,...tetrahydrofolate reductase polymorphism (MTHFR  c.677C>T) and elevated plasma homocysteine levels in...,154,107,Med_Sci_Monit_2016_Jan_12_22_127-133.txt
677C-->T,13 Klerk M  Verhoef P  Clarke R    MTHFR  677C-->T polymorphism and risk of coronary heart d...,156,43,Med_Sci_Monit_2016_Jan_12_22_127-133.txt
677C>T,...oke in relation to plasma homocysteine and MTHFR  677C>T and 1298A>C genotypes and haplotypes – evid...,186,124,Med_Sci_Monit_2016_Jan_12_22_127-133.txt
1298A>C,...tion to plasma homocysteine and MTHFR  677C>T and 1298A>C genotypes and haplotypes – evidence for an...,186,135,Med_Sci_Monit_2016_Jan_12_22_127-133.txt
2241766 T>G,"... the SNPs in adiponectin gene (including ADIPOQ rs2241766 T>G, rs1501299 G>T, and rs266729 C>G SNPs)...",37,455,Med_Sci_Monit_2016_Sep_26_22_3419-3425.txt
1501299 G>T,"...iponectin gene (including ADIPOQ rs2241766 T>G, rs1501299 G>T, and rs266729 C>G SNPs) are correlated...",37,470,Med_Sci_Monit_2016_Sep_26_22_3419-3425.txt
266729 C>G,"...luding ADIPOQ rs2241766 T>G, rs1501299 G>T, and rs266729 C>G SNPs) are correlated with an increased ...",37,489,Med_Sci_Monit_2016_Sep_26_22_3419-3425.txt
786T>C,...A −2.5 kb (CCTTT)n as well as Ser608Leu and NOS3 −786T>C variants and their correlation with nitrite...,25,718,Mediators_Inflamm_2015_Mar_24_2015_245308.txt
786T>C,"...imilar distributions of NOS2A Ser608Leu and NOS3 −786T>C polymorphisms. Interestingly, the NOS3 −786...",25,962,Mediators_Inflamm_2015_Mar_24_2015_245308.txt
786T>C,"...s/nitrates. Here, we first demonstrate that NOS3 −786T>C variant affects nitrite/nitrate levels in I...",25,1523,Mediators_Inflamm_2015_Mar_24_2015_245308.txt
786T>C,...the Ser608Leu polymorphisms in NOS2 gene and the −786T>C polymorphism in NOS3 promoter with differen...,36,200,Mediators_Inflamm_2015_Mar_24_2015_245308.txt
786T>C,...ucleotide Polymorphisms NOS2A Ser608Leu and NOS3 −786T>,52,79,Mediators_Inflamm_2015_Mar_24_2015_245308.txt
786T>C,"...Ps) NOS2A Ser608Leu (C2087T, rs2297518) and NOS3 −786T>C (rs2070744) was performed by real-time PCR ...",53,228,Mediators_Inflamm_2015_Mar_24_2015_245308.txt
786T>C,...nalysis of the distribution of NOS3 gene variant −786T>C showed that allele and genotype frequencies...,81,56,Mediators_Inflamm_2015_Mar_24_2015_245308.txt
786T>C,"...zed in patients and controls with different NOS3 −786T>C genotypes, some statistically significant d...",129,89,Mediators_Inflamm_2015_Mar_24_2015_245308.txt
786T>C,"...ide microsatellite −2.5 kb (CCTTT)n and the NOS3 −786T>C, were associated with either increased nitr...",140,441,Mediators_Inflamm_2015_Mar_24_2015_245308.txt
786T>C,...nts NOS2 −2.5 kb (CCTTT)n and Ser608Leu and NOS3 −786T>C in IEI patients,142,344,Mediators_Inflamm_2015_Mar_24_2015_245308.txt
786T>C,...rphic variants NOS2A C2087T (Ser608Leu) and NOS3 −786T>C when patient groups were compared with cont...,144,123,Mediators_Inflamm_2015_Mar_24_2015_245308.txt
786T>C,Figure 2 Effects of different NOS3 −786T>C genotypes on nitrite/nitrate plasma levels ...,169,37,Mediators_Inflamm_2015_Mar_24_2015_245308.txt
786T>C,"...ents and healthy subjects, having different NOS3 −786T>C genotypes, through their quartiles. The bot...",169,345,Mediators_Inflamm_2015_Mar_24_2015_245308.txt
786T>C,−786T>C NOS3	 	 	 	 ,189,2,Mediators_Inflamm_2015_Mar_24_2015_245308.txt
1434C>G,...ous work revealed that variant allele of rs705382-1434C>G was independently associated with higher l...,21,1259,Medicine_(Baltimore)_2015_Dec_7_94(48)_e2179.txt
684G>A,We found that the 684G>A polymorphism affects the tumor NOTCH3 expre...,8,19,Medicine_(Baltimore)_2015_Mar_6_94(9)_e482.txt
684G>A,"...e in these glioma patients. More importantly, the 684G>A polymorphism is significantly associated wi...",8,244,Medicine_(Baltimore)_2015_Mar_6_94(9)_e482.txt
684G>A,Our study indicates that the NOTCH3 gene 684G>A polymorphism may be used as a prognosis mar...,10,42,Medicine_(Baltimore)_2015_Mar_6_94(9)_e482.txt
381C>T,...ed on their NOTCH3 genotypes. The distribution of 381C>T and 474C>A polymorphisms did not have a sig...,36,114,Medicine_(Baltimore)_2015_Mar_6_94(9)_e482.txt
474C>A,... NOTCH3 genotypes. The distribution of 381C>T and 474C>A polymorphisms did not have a significantly ...,36,125,Medicine_(Baltimore)_2015_Mar_6_94(9)_e482.txt
684G>A,"...les 1a and 1b). However, we found that the NOTCH3 684G>A polymorphism was significantly associated w...",36,284,Medicine_(Baltimore)_2015_Mar_6_94(9)_e482.txt
474C>A,...eristics of glioma patients based on their NOTCH3 474C>A genotype,40,80,Medicine_(Baltimore)_2015_Mar_6_94(9)_e482.txt
684G>A,...ed by western blot assay. Figure 1 shows only the 684G>A polymorphism significantly affected the tum...,45,126,Medicine_(Baltimore)_2015_Mar_6_94(9)_e482.txt
381C>T,"...l than 684GA and 684AA carriers. In contrast, the 381C>T and 474C>A did not affect the NOTCH3 expres...",45,309,Medicine_(Baltimore)_2015_Mar_6_94(9)_e482.txt
474C>A,"...A and 684AA carriers. In contrast, the 381C>T and 474C>A did not affect the NOTCH3 expression levels...",45,320,Medicine_(Baltimore)_2015_Mar_6_94(9)_e482.txt
684G>A,...ffect the NOTCH3 expression levels. Meanwhile the 684G>A polymorphism also dramatically affect tumor...,45,386,Medicine_(Baltimore)_2015_Mar_6_94(9)_e482.txt
684G>A,...enotypes by western blot assay. We found that the 684G>A polymorphism significantly affected the tum...,47,97,Medicine_(Baltimore)_2015_Mar_6_94(9)_e482.txt
684G>A,... from the 684GA and 684AA carriers. Meanwhile the 684G>A polymorphism also dramatically affects tumo...,47,323,Medicine_(Baltimore)_2015_Mar_6_94(9)_e482.txt
381C>T,...els were similar among the tumor samples from the 381C>T and 474C>A genotype carriers,47,488,Medicine_(Baltimore)_2015_Mar_6_94(9)_e482.txt
474C>A,...milar among the tumor samples from the 381C>T and 474C>A genotype carriers,47,499,Medicine_(Baltimore)_2015_Mar_6_94(9)_e482.txt
684G>A,...ism on the patient survival. We found that NOTCH3 684G>A polymorphism is the only one that affected ...,50,189,Medicine_(Baltimore)_2015_Mar_6_94(9)_e482.txt
684G>A,"...nalysis of all glioma patients, stratified by the 684G>A polymorphism. We next subgrouped all patien...",50,520,Medicine_(Baltimore)_2015_Mar_6_94(9)_e482.txt
684G>A,... survival curves for glioma patients based on the 684G>A polymorphism in patients receiving differen...,52,76,Medicine_(Baltimore)_2015_Mar_6_94(9)_e482.txt
684G>A,...rphism in patients receiving different treatment. 684G>A polymorphism was the only one which can aff...,52,139,Medicine_(Baltimore)_2015_Mar_6_94(9)_e482.txt
684G>A,...0.001) in overall patients. (B) The effect of the 684G>A polymorphism on the survival rate in glioma...,52,394,Medicine_(Baltimore)_2015_Mar_6_94(9)_e482.txt
684G>A,...ith surgery + chemothreapy. (C) The effect of the 684G>A polymorphism on the survival rate in glioma...,52,513,Medicine_(Baltimore)_2015_Mar_6_94(9)_e482.txt
684G>A,"...stology, size, WHO grade, and therapy status. The 684G>A polymorphism is a predictor for unfavorable...",54,268,Medicine_(Baltimore)_2015_Mar_6_94(9)_e482.txt
684G>A,...of gliomas in Chinese patients. We found that the 684G>A polymorphism affects the tumor NOTCH3 expre...,57,176,Medicine_(Baltimore)_2015_Mar_6_94(9)_e482.txt
684G>A,"... in these gliomas patients. More importantly, the 684G>A polymorphism is significantly associated wi...",57,385,Medicine_(Baltimore)_2015_Mar_6_94(9)_e482.txt
684G>A,...ir treatment manner. Our study indicates that the 684G>A polymorphism may be used as a molecular mar...,57,537,Medicine_(Baltimore)_2015_Mar_6_94(9)_e482.txt
684 G>A,"... amd migraine.20,21 As a synonymous polymorphism, 684 G>A is thought to be non functional and does n...",63,186,Medicine_(Baltimore)_2015_Mar_6_94(9)_e482.txt
684 G>A,"... the seemingly non-functional polymorphisms, like 684 G>A, could affect transcription, splicing, mRN...",63,348,Medicine_(Baltimore)_2015_Mar_6_94(9)_e482.txt
684G>A,"...with this finding, we found in our study that the 684G>A polymorphism can affect the NOTCH3 expressi...",63,540,Medicine_(Baltimore)_2015_Mar_6_94(9)_e482.txt
381C>T,"...significantly associated with migraine, while the 381C>T does not affect the migraine risk.21 A rece...",63,726,Medicine_(Baltimore)_2015_Mar_6_94(9)_e482.txt
381C>T,...etween one of the known NOTCH3 gene polymorphism (381C>T) with 2 other genes (MTHFR C677T and ALOX5A...,63,861,Medicine_(Baltimore)_2015_Mar_6_94(9)_e482.txt
684G>A,...d with human cancers.24 Our study showed that the 684G>A polymorphism affects the tumor NOTCH3 expre...,65,586,Medicine_(Baltimore)_2015_Mar_6_94(9)_e482.txt
684G>A,"... in these gliomas patients. More importantly, the 684G>A polymorphism is significantly associated wi...",65,794,Medicine_(Baltimore)_2015_Mar_6_94(9)_e482.txt
684G>A,...ir treatment manner. Our study indicates that the 684G>A polymorphism may be used as a molecular mar...,65,946,Medicine_(Baltimore)_2015_Mar_6_94(9)_e482.txt
684G>A,...did not have in vitor study to show the effect of 684G>A polymorphism of NOTCH3 on the biological be...,67,307,Medicine_(Baltimore)_2015_Mar_6_94(9)_e482.txt
684G>A,"... Thirdly, the molecular mechanism under which the 684G>A polymorphism affect the gloimas risk and th...",67,436,Medicine_(Baltimore)_2015_Mar_6_94(9)_e482.txt
3460G>A,"... female ratio varies between mutations: 3:1 for m.3460G>A, 6:1 for m.11778G>A and 8:1 for m.14484T>C...",10,532,Middle_East_Afr_J_Ophthalmol_2011_Jan-Mar_18(1)_17-23.txt
11778G>A,"...s between mutations: 3:1 for m.3460G>A, 6:1 for m.11778G>A and 8:1 for m.14484T>C. The reason for th...",10,551,Middle_East_Afr_J_Ophthalmol_2011_Jan-Mar_18(1)_17-23.txt
14484T>C,"...1 for m.3460G>A, 6:1 for m.11778G>A and 8:1 for m.14484T>C. The reason for the predominance remains ...",10,574,Middle_East_Afr_J_Ophthalmol_2011_Jan-Mar_18(1)_17-23.txt
11778G>A,"...ery are mutation-specific, being least with the m.11778G>A mutation that generally causes the most s...",14,240,Middle_East_Afr_J_Ophthalmol_2011_Jan-Mar_18(1)_17-23.txt
14484T>C,"...t severe visual phenotype, and highest with the m.14484T>C mutation; the m.3460G>A mutation carries ...",14,337,Middle_East_Afr_J_Ophthalmol_2011_Jan-Mar_18(1)_17-23.txt
3460G>A,"..., and highest with the m.14484T>C mutation; the m.3460G>A mutation carries an intermediate prognosis...",14,362,Middle_East_Afr_J_Ophthalmol_2011_Jan-Mar_18(1)_17-23.txt
11778G>A,"...like syndrome, particularly in females with the m.11778G>A mutation (Harding’s disease).12 Additiona...",14,943,Middle_East_Afr_J_Ophthalmol_2011_Jan-Mar_18(1)_17-23.txt
11778G>A,"...hrome C).28 Second, studies of cybrids with the m.11778G>A and m.3460G>A mitochondrial DNA mutations...",25,322,Middle_East_Afr_J_Ophthalmol_2011_Jan-Mar_18(1)_17-23.txt
3460G>A,"...ond, studies of cybrids with the m.11778G>A and m.3460G>A mitochondrial DNA mutations show a higher ...",25,337,Middle_East_Afr_J_Ophthalmol_2011_Jan-Mar_18(1)_17-23.txt
3460G>A,"...f apoptosis, particularly if they harbor either m.3460G>A or m.14484T>C. 2-deoxy-d-ribose-induced ap...",31,373,Middle_East_Afr_J_Ophthalmol_2011_Jan-Mar_18(1)_17-23.txt
14484T>C,...particularly if they harbor either m.3460G>A or m.14484T>C. 2-deoxy-d-ribose-induced apoptotic respo...,31,386,Middle_East_Afr_J_Ophthalmol_2011_Jan-Mar_18(1)_17-23.txt
4216T>C,"...ns, which have been associated with LHON (e.g., m.4216T>C, m.13708G>A, m.15257G>A). These substituti...",34,785,Middle_East_Afr_J_Ophthalmol_2011_Jan-Mar_18(1)_17-23.txt
13708G>A,"...ave been associated with LHON (e.g., m.4216T>C, m.13708G>A, m.15257G>A). These substitutions are als...",34,796,Middle_East_Afr_J_Ophthalmol_2011_Jan-Mar_18(1)_17-23.txt
15257G>A,"...ociated with LHON (e.g., m.4216T>C, m.13708G>A, m.15257G>A). These substitutions are also found in t...",34,808,Middle_East_Afr_J_Ophthalmol_2011_Jan-Mar_18(1)_17-23.txt
265T>C,...alysis showed that the proband has a homozygote c.265T>C (p.C89R) HJV mutation + a heterozygote c.88...,43,296,Middle_East_J_Dig_Dis_2014_Apr_6(2)_87-92.txt
884T>C,...c.265T>C (p.C89R) HJV mutation + a heterozygote c.884T>C (p.V295A) mutation of HFE. The affected pro...,43,344,Middle_East_J_Dig_Dis_2014_Apr_6(2)_87-92.txt
265T>C,"...ed proband’s sister presented with the same HJV c.265T>C (p.C89R) homozygote mutation. In addition, ...",43,438,Middle_East_J_Dig_Dis_2014_Apr_6(2)_87-92.txt
6C>G,"...gote mutation. In addition, we found the HJV c.98-6C>G polymorphic variant in both the sister and pr...",43,510,Middle_East_J_Dig_Dis_2014_Apr_6(2)_87-92.txt
265T>C,"...d that the proband, case III-9 was a homozygote c.265T>C (p.C89R) HJV mutation + a heterozygote c.88...",317,114,Middle_East_J_Dig_Dis_2014_Apr_6(2)_87-92.txt
884T>C,...c.265T>C (p.C89R) HJV mutation + a heterozygote c.884T>C (p.V295A) mutation for HFE. The latter muta...,317,162,Middle_East_J_Dig_Dis_2014_Apr_6(2)_87-92.txt
265T>C,"...ygote HJV mutation found in the proband, namely c.265T>C (p.C89R). Also HJV c.98-6C>G (rs56025621) p...",317,367,Middle_East_J_Dig_Dis_2014_Apr_6(2)_87-92.txt
6C>G,"... proband, namely c.265T>C (p.C89R). Also HJV c.98-6C>G (rs56025621) polymorphic variant was found in...",317,398,Middle_East_J_Dig_Dis_2014_Apr_6(2)_87-92.txt
884T>C,...1 and III- 5 were also heterozygous for the HFE c.884T>C (p.V295A) mutation. Both parents (II-10 and...,317,570,Middle_East_J_Dig_Dis_2014_Apr_6(2)_87-92.txt
265T>C,...(II-10 and II-11) were heterozygous for the HJV c.265T>C (p.C89R) mutation and the mother was also h...,317,660,Middle_East_J_Dig_Dis_2014_Apr_6(2)_87-92.txt
884T>C,...nd the mother was also heterozygous for the HFE c.884T>C (p.V295A) mutation (Figure 2),317,736,Middle_East_J_Dig_Dis_2014_Apr_6(2)_87-92.txt
265T>C,The HJV c.265T>C (p.C89R) mutation is a novel mutation and t...,336,11,Middle_East_J_Dig_Dis_2014_Apr_6(2)_87-92.txt
186C>T,"...notypes, compared to controls [11]. The SOD3 IVS1+186C>T polymorphism is associated with a significa...",22,539,Mol_Biol_Int_2013_Dec_16_2013_189237.txt
19G>C,"...version at the 19 position in the HMOX1 gene (the 19G>C-HMOX1 polymorphism, rs2071747) and a A → G t...",3,1606,Mol_Biol_Rep_2012_Mar_7_39(3)_2081-2087.txt
1444A>G,"... −42 + 1444 position in the HMOX2 gene (the −42 + 1444A>G-HMOX2 polymorphism, rs2270363) and its mod...",3,1722,Mol_Biol_Rep_2012_Mar_7_39(3)_2081-2087.txt
1444A>G,"...ence of dry AMD and the G/A genotype of the −42 + 1444A>G-HMOX2 polymorphism (odds ratio (OR) 2.72),...",3,2104,Mol_Biol_Rep_2012_Mar_7_39(3)_2081-2087.txt
19 G>C,...R 0.41). The G/C genotype and the C allele of the 19 G>C-HMOX1 polymorphism and the G/G genotype and...,3,2260,Mol_Biol_Rep_2012_Mar_7_39(3)_2081-2087.txt
1444A>G,...nd the G/G genotype and the G allele of the −42 + 1444A>G-HMOX2 polymorphism were associated with pr...,3,2337,Mol_Biol_Rep_2012_Mar_7_39(3)_2081-2087.txt
19 G>C,"...er hand, the G/G genotype and the G allele of the 19 G>C-HMOX1 polymorphism and the A/G genotype and...",3,2528,Mol_Biol_Rep_2012_Mar_7_39(3)_2081-2087.txt
1444A>G,...nd the A/G genotype and the A allele of the −42 + 1444A>G-HMOX2 polymorphism protected against AMD p...,3,2605,Mol_Biol_Rep_2012_Mar_7_39(3)_2081-2087.txt
19G>C,"..., 0.19, 0.34, 0.59, respectively). Therefore, the 19G>C-HMOX1 and the −42 + 1444A>G-HMOX2 polymorphi...",3,2724,Mol_Biol_Rep_2012_Mar_7_39(3)_2081-2087.txt
1444A>G,"...tively). Therefore, the 19G>C-HMOX1 and the −42 + 1444A>G-HMOX2 polymorphisms may be associated with...",3,2750,Mol_Biol_Rep_2012_Mar_7_39(3)_2081-2087.txt
19G>C,"...version at the 19 position in the HMOX1 gene (the 19G>C-HMOX1 polymorphism, rs2071747) and an A → G ...",18,331,Mol_Biol_Rep_2012_Mar_7_39(3)_2081-2087.txt
1444A>G,"... −42 + 1444 position in the HMOX2 gene (the −42 + 1444A>G-HMOX2 polymorphism, rs2270363) and AMD. We...",18,448,Mol_Biol_Rep_2012_Mar_7_39(3)_2081-2087.txt
19 G>C,...tion by some clinical and life-style factors. The 19 G>C-HMOX1 polymorphism is located in the coding...,18,606,Mol_Biol_Rep_2012_Mar_7_39(3)_2081-2087.txt
19G>C,...lele frequency ≥3% in an European population. The 19G>C-HMOX1 polymorphism is a non-synonymous mutat...,18,857,Mol_Biol_Rep_2012_Mar_7_39(3)_2081-2087.txt
19 G>C,The genotypes of the 19 G>C-HMOX1 polymorphism were determined by the a...,31,22,Mol_Biol_Rep_2012_Mar_7_39(3)_2081-2087.txt
1444A>G,... was used to determine the genotypes of the −42 + 1444A>G-HMOX2 polymorphism. PCR assay was performe...,33,139,Mol_Biol_Rep_2012_Mar_7_39(3)_2081-2087.txt
19G>C,The genotype and allele distributions of the 19G>C-HMOX1 and −42 + 1444A>G-HMOX2 polymorphisms ...,50,46,Mol_Biol_Rep_2012_Mar_7_39(3)_2081-2087.txt
1444A>G,...allele distributions of the 19G>C-HMOX1 and −42 + 1444A>G-HMOX2 polymorphisms in AMD patients and co...,50,68,Mol_Biol_Rep_2012_Mar_7_39(3)_2081-2087.txt
1444A>G,"... AMD occurrence and the G/A genotype of the −42 + 1444A>G-HMOX2 polymorphism was found, whereas the ...",50,571,Mol_Biol_Rep_2012_Mar_7_39(3)_2081-2087.txt
19G>C,...MD progression. The G/C genotype and the C of the 19G>C-HMOX1 polymorphism and the G/G genotype and ...,52,281,Mol_Biol_Rep_2012_Mar_7_39(3)_2081-2087.txt
1444A>G,...nd the G/G genotype and the G allele of the −42 + 1444A>G-HMOX2 polymorphism increased progression o...,52,357,Mol_Biol_Rep_2012_Mar_7_39(3)_2081-2087.txt
19G>C,"...hermore, the G/G genotype and the G allele of the 19G>C-HMOX1 polymorphism and the G/A genotype and ...",52,468,Mol_Biol_Rep_2012_Mar_7_39(3)_2081-2087.txt
19G>C,... progression of AMD and combined genotypes of the 19G>C-HMOX1 and −42 + 1444A>G-HMOX2 polymorphisms....,55,110,Mol_Biol_Rep_2012_Mar_7_39(3)_2081-2087.txt
1444A>G,...d combined genotypes of the 19G>C-HMOX1 and −42 + 1444A>G-HMOX2 polymorphisms. The distribution of c...,55,132,Mol_Biol_Rep_2012_Mar_7_39(3)_2081-2087.txt
19G>C,"...G/G–G/G genotype, whereas the G/G genotype of the 19G>C-HMOX1 polymorphism and the A/G genotype of t...",57,165,Mol_Biol_Rep_2012_Mar_7_39(3)_2081-2087.txt
1444A>G,...OX1 polymorphism and the A/G genotype of the 42 + 1444A>G-HMOX2 polymorphism were associated with a ...,57,223,Mol_Biol_Rep_2012_Mar_7_39(3)_2081-2087.txt
19G>C,The association between AMD and the 19G>C-HMOX1 and the −42 + 1444A>G-HMOX2 polymorphi...,60,37,Mol_Biol_Rep_2012_Mar_7_39(3)_2081-2087.txt
1444A>G,...ion between AMD and the 19G>C-HMOX1 and the −42 + 1444A>G-HMOX2 polymorphism was subjected to strati...,60,63,Mol_Biol_Rep_2012_Mar_7_39(3)_2081-2087.txt
1444A>G,"...atification analysis, but only data for the −42 + 1444A>G-HMOX2 are presented in Supplementary Table...",60,160,Mol_Biol_Rep_2012_Mar_7_39(3)_2081-2087.txt
19G>C,...nce of the G/C genotype and the C allele of the c.19G>C polymorphism of the HMOX1 gene increased the...,71,1214,Mol_Biol_Rep_2012_Mar_7_39(3)_2081-2087.txt
1444A>G,"...opulation [44, 45]. The other polymorphism, −42 + 1444A>G-HMOX2, is located in the 5′ flanking regio...",71,1472,Mol_Biol_Rep_2012_Mar_7_39(3)_2081-2087.txt
19G>C,"In summary, our results suggest that the 19G>C polymorphism of the HMOX1 gene and the −42 +...",73,42,Mol_Biol_Rep_2012_Mar_7_39(3)_2081-2087.txt
1444A>G,...9G>C polymorphism of the HMOX1 gene and the −42 + 1444A>G polymorphism of the HMOX2 gene may be asso...,73,93,Mol_Biol_Rep_2012_Mar_7_39(3)_2081-2087.txt
19G>C,"In conclusion, our findings suggest that the 19G>C-HMOX1 polymorphism and the −42 + 1444A>G-HMO...",76,46,Mol_Biol_Rep_2012_Mar_7_39(3)_2081-2087.txt
1444A>G,...t that the 19G>C-HMOX1 polymorphism and the −42 + 1444A>G-HMOX2 polymorphism may be linked with the ...,76,85,Mol_Biol_Rep_2012_Mar_7_39(3)_2081-2087.txt
1215T>C,"...ucleotide polymorphisms (SNPs) at nucleotides g. +1215T>C, g. +3377C>T, and g. +28625C>T were in lin...",3,1296,Mol_Biol_Rep_2013_Jan_17_40(1)_417-426.txt
3377C>T,"...ymorphisms (SNPs) at nucleotides g. +1215T>C, g. +3377C>T, and g. +28625C>T were in linkage disequil...",3,1309,Mol_Biol_Rep_2013_Jan_17_40(1)_417-426.txt
28625C>T,"... at nucleotides g. +1215T>C, g. +3377C>T, and g. +28625C>T were in linkage disequilibrium with each ...",3,1326,Mol_Biol_Rep_2013_Jan_17_40(1)_417-426.txt
1878C>T,... this study and shown in Table 2. The SNPs of g. +1878C>T and g. +7315C>T resulted in synonymous mut...,97,587,Mol_Biol_Rep_2013_Jan_17_40(1)_417-426.txt
7315C>T,...shown in Table 2. The SNPs of g. +1878C>T and g. +7315C>T resulted in synonymous mutations of Tyr626...,97,603,Mol_Biol_Rep_2013_Jan_17_40(1)_417-426.txt
7294C>T,"...nd Val2439Val, respectively, while the SNP of g. +7294C>T brought a missense mutation Arg2432Cys. In...",97,708,Mol_Biol_Rep_2013_Jan_17_40(1)_417-426.txt
7294C>T,... regions could alter gene expression. The SNP g. +7294C>T was a missense mutation Arg2432Cys. It is ...,264,158,Mol_Biol_Rep_2013_Jan_17_40(1)_417-426.txt
1843 C>T,... in the association studies were tested for the c.1843 C>T mutation in the ryanodine receptor gene a...,31,64,Mol_Biol_Rep_2016_Apr_13_43_517-526.txt
143T>C,"...ribed by [9, 27, 28]. CTSL was genotyped on the g.143T>C SNP (NCBI accession number rs 81212773); CT...",43,124,Mol_Biol_Rep_2016_Apr_13_43_517-526.txt
171G>A,... number rs 81212773); CTSS was genotyped on the g.171G>A SNP (NCBI accession number rs 331232519); C...,43,200,Mol_Biol_Rep_2016_Apr_13_43_517-526.txt
72A>C,"...number rs 331232519); CTSB was genotyped on the g.72A>C SNP (EMBL accession number AJ315558), and GH...",43,277,Mol_Biol_Rep_2016_Apr_13_43_517-526.txt
15G>A,...sualised using ethidium bromide (0.5 µg/µl CTSK g.15G>A SNP (NCBI accession number rs 337183461) and...,45,723,Mol_Biol_Rep_2016_Apr_13_43_517-526.txt
1987C>T,...P (NCBI accession number rs 337183461) and LEPR c.1987C>T SNP (db SNP accession number ss 262803826)...,45,781,Mol_Biol_Rep_2016_Apr_13_43_517-526.txt
72A>C,"...09 (Table 2). Major alleles were A for the CTSB g.72A>C SNP, C for the CTSL g.143C>T SNP and G for t...",87,302,Mol_Biol_Rep_2016_Apr_13_43_517-526.txt
143C>T,"...were A for the CTSB g.72A>C SNP, C for the CTSL g.143C>T SNP and G for the CTSK g.15G>A SNP. Consequ...",87,330,Mol_Biol_Rep_2016_Apr_13_43_517-526.txt
15G>A,"... C for the CTSL g.143C>T SNP and G for the CTSK g.15G>A SNP. Consequently, observed heterozygosity (...",87,362,Mol_Biol_Rep_2016_Apr_13_43_517-526.txt
72A>C,... were similar to those observed by [7] for CTSB g.72A>C in Italian Large White pigs (MAF = 0.06 for ...,87,910,Mol_Biol_Rep_2016_Apr_13_43_517-526.txt
1987C>T,...nd allele C was the most prevalent for the LEPR c.1987C>TSNP (allelic frequency of 0.67). A previous...,139,275,Mol_Biol_Rep_2016_Apr_13_43_517-526.txt
72A>C,"...lished any significant relationship between the g.72A>C CTSB polymorphism and total protein content,...",144,68,Mol_Biol_Rep_2016_Apr_13_43_517-526.txt
72A>C,...hanges in pH values [38].Table 3 Effect of CTSB g.72A>C SNP and CTSL g.143T>C SNP on meat quality tr...,144,1528,Mol_Biol_Rep_2016_Apr_13_43_517-526.txt
143T>C,...38].Table 3 Effect of CTSB g.72A>C SNP and CTSL g.143T>C SNP on meat quality traits. Data are presen...,144,1549,Mol_Biol_Rep_2016_Apr_13_43_517-526.txt
143C>T,"...ing results were obtained in our study on CTSL (g.143C>T genotype, Table 3). On this locus, the tota...",172,329,Mol_Biol_Rep_2016_Apr_13_43_517-526.txt
1987C>T,The g.1987C>T polymorphism in the LEPR gene also had sig...,240,7,Mol_Biol_Rep_2016_Apr_13_43_517-526.txt
1987C>T,...d water content [51].Table 6 Effect of LEPR SNP c.1987C>T mutation on meat quality trait,240,540,Mol_Biol_Rep_2016_Apr_13_43_517-526.txt
1987C>T,...erences reported in TT pigs (Table 5). The LEPR c.1987C>T mutation involves a L663F amino acid chang...,279,314,Mol_Biol_Rep_2016_Apr_13_43_517-526.txt
143C>T,... Brzobohaty L   The effect of missense mutation G.143C>T in the CTSL gene on production traits witho...,293,120,Mol_Biol_Rep_2016_Apr_13_43_517-526.txt
3072G>A,...insulin-like growth factor 2(IGF2) gene intron3-g.3072G>A polymorphism is not the only Sus scrofa  c...,295,155,Mol_Biol_Rep_2016_Apr_13_43_517-526.txt
4933C>T,"...ted iPSCs from a Dravet syndrome patient with a c.4933C>T substitution in SCN1A, which is predicted ...",7,60,Mol_Brain_2013_May_2_6_19.txt
4933C>T,"...d genomic DNA revealed an SCN1A point mutation, c.4933C>T [GenBank: NM_001165963.1] (Figure 1A) as f...",23,747,Mol_Brain_2013_May_2_6_19.txt
4933C>T,...ed cell material. Solid arrowheads point to the c.4933C>T substitution. (B) iPSC morphology and immu...,25,161,Mol_Brain_2013_May_2_6_19.txt
1163T>C,"... primary breast cancer. However, point mutations (1163T>C and 1544C>T) have, so far, only been detec...",15,345,Mol_Cancer_2010_Jul_1_9_173.txt
1544C>T,"...ast cancer. However, point mutations (1163T>C and 1544C>T) have, so far, only been detected in a sin...",15,357,Mol_Cancer_2010_Jul_1_9_173.txt
1731G>A,9.	m	57	-	-	c.1731G>A	-	+,83,15,Mol_Cancer_2014_Jan_24_13_11.txt
676C>T,10.	m	49	-	-	c.676C>T	-	+,85,16,Mol_Cancer_2014_Jan_24_13_11.txt
583A>T,11.	f	44	-	-	c.583A>T	-	+,87,16,Mol_Cancer_2014_Jan_24_13_11.txt
1408 G>C,"We found a missense mutation (c.1408 G>C, p.Glu470Gln) in one patient and a nonsen...",12,33,Mol_Cell_Pediatr_2015_Jul_1_2(Suppl_1)_A7.txt
1723G>T,"...ent and a nonsense mutation in another patient (c.1723G>T, p.Glu575*). None of these mutations were ...",12,117,Mol_Cell_Pediatr_2015_Jul_1_2(Suppl_1)_A7.txt
733G>A,"...dentified one single nucleotide polymorphismus (c.733G>A, p.Gly245Arg) homozygous in two and heteroz...",12,268,Mol_Cell_Pediatr_2015_Jul_1_2(Suppl_1)_A7.txt
3871C>T,"...ies. Here, we found two novel MYO15A mutations, c.3871C>T (p.L1291F) and c.5835T>G (p.Y1945X) in an ...",11,585,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
5835T>G,"...ovel MYO15A mutations, c.3871C>T (p.L1291F) and c.5835T>G (p.Y1945X) in an affected individual carry...",11,610,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
3871C>T,"...le gene, MYO15A, remained (Table 1). These were c.3871C>T (p.L 1291F) in exon 6 and c.5835T>G (p.Y19...",47,647,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
5835T>G,... These were c.3871C>T (p.L 1291F) in exon 6 and c.5835T>G (p.Y1945*) in exon 24 (Fig. 1C). The mothe...,47,683,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
3871C>T,...r of SB156-272 (SB156-328) was heterozygous for c.3871C>T (p.L1291F) and the father (SB156-327) was ...,47,783,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
5835T>G,...and the father (SB156-327) was heterozygous for c.5835T>G (p.Y1945*) (Figs. 1D and 1E). These two va...,47,852,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
3871C>T,"...n-2 analyses consistently identified the MYO15A c.3871C>T (p.L1291F) SNP as “damaging.” Furthermore,...",47,1078,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
3871C>T,...henylalanine at residue 1291 of myosin XVA. The c.3871C>T and c.5835T>G mutations resided in the myo...,47,1367,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
5835T>G,...t residue 1291 of myosin XVA. The c.3871C>T and c.5835T>G mutations resided in the myosin motor and ...,47,1381,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
3871C>T,"...ily in the motor domain, such as the p. L1291F (c.3871C>T) mutation identified in this study. The mo...",62,162,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
3871C>T,...he motor domain demonstrated how the p. L1291F (c.3871C>T) mutation altered the structure of the act...,62,674,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
5835T>G,"...tation found was a nonsense mutation: p.Y1945* (c.5835T>G). It resides in the IQ2 domain, which is h...",64,64,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
5835T>G,"...hanges (Bahler and Rhoads, 2002). The p.Y1945* (c.5835T>G) mutation is predicted to truncate the tra...",64,308,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
5835T>G,...). Therefore it seems likely that the p.Y1945* (c.5835T>G) mutation that results in a shorter protei...,64,720,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
3871C>T,...dy state response (ASSR) and segregation of the c.3871C>T and c.5835T>G variants of MYO15A in family...,79,82,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
5835T>G,...nse (ASSR) and segregation of the c.3871C>T and c.5835T>G variants of MYO15A in family SB156. (A) Ta...,79,96,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
3871C>T,...hs of age. (C) Sanger sequencing traces for the c.3871C>T (p.L1291F) + c.5835T>G (p.Y1945*) compound...,79,481,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
5835T>G,...equencing traces for the c.3871C>T (p.L1291F) + c.5835T>G (p.Y1945*) compound heterozygote (SB156-27...,79,504,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
5835T>G,...B156-272). (D) Sanger sequencing traces for the c.5835T>G carrier (SB156-327). (E) Sanger sequencing...,79,597,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
3871C>T,...B156-327). (E) Sanger sequencing traces for the c.3871C>T carrier (SB156-328). (F) Conservation of m...,79,665,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
3871C>T,... humans to zebrafish. (G) The sequence variants c.3871C>T and c.5835T>G reside in exon 6 (motor doma...,79,870,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
5835T>G,...rafish. (G) The sequence variants c.3871C>T and c.5835T>G reside in exon 6 (motor domain) and exon 2...,79,884,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
3871C> T,B156-272	MYO15A	NM_016239:exon6:c.3871C> T:p.Leu1291Phe	AR	17	C	T	60	100.00%	60	5.01...,90,35,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
5835T> G,NM_016239:exon24:c.5835T> G:p.Tyr1945*	AR	17	T	G	81	100.00%	60		Nonse...,91,20,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
867C>G,c.867C>G	p.Tyr289*	N-terminal	Homozygous	*Residual h...,95,3,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
867C>G,c.867C>G	p.Tyr289*	N-terminal	Homozygous	Profound	Ce...,96,3,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
3313G>T,c.3313G>T	p.Glu1105*	N-terminal	Homozygous	Severe to...,98,3,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
3685C>T,c.3685C>T	p.Gln1229*	Motor	Homozygous	Profound	Libur...,100,3,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
1G>T,"c.3756+1G>T			Homozygous	Profound	Liburd et al., 2001",101,8,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
3758C>T,c.3758C>T	p.Thr1253Ile	Motor	Homozygous	Severe to pr...,102,3,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
1G>A,"c.3866+1G>A			Homozygous	Severe to profound	Nal et al., 2...",103,8,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
3871C>T,c.3871C>T	p.Leu1291Phe	Motor	Heterozygous	Profound	T...,104,3,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
4176C>A,c.4176C>A	p.Tyr1392*	Motor	Homozygous	Severe to prof...,105,3,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
4198G>A,c.4198G>A	p.Val1400Met	Motor	Homozygous	Severe to pr...,106,3,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
4240G>A,c.4240G>A	p.Glu1414Lys		Homozygous	Profound	Brownste...,107,3,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
4351G>A,c.4351G>A	p.Asp1451Asn	Motor	Homozygous	Severe to pr...,109,3,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
4441T>C,c.4441T>C	p.Ser1481Pro	Motor	Homozygous	Severe to pr...,110,3,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
4669A>G,c.4669A>G	p.Lys1557Glu	Motor	Homozygous	Severe to pr...,111,3,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
4998C>A,c.4998C>A	p.Cys1666*	Motor	Homozygous	Severe to prof...,112,3,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
5189T>C,c.5189T>C	p.Leu1730Pro	Motor	Homozygous	Severe to pr...,114,3,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
5492G>T,c.5492G>T	p.Gly1831Val	Motor	Homozygous	Profound	Kal...,115,3,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
5835T>G,c.5835T>G	p.Tyr1945*	IQ 2	Heterozygous	Profound	This...,117,3,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
5913G>A,c.5913G>A			Heterozygous	Severe to profound	Gao et a...,118,3,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
6061C>T,c.6061C>T	p.Gln2021*		?	Severe to profound	Nal et al...,119,3,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
6217C>T,c.6217C>T	p.Pro2073Ser	MyTH4 1	Homozygous	Severe to ...,120,3,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
6340G>A,c.6340G>A	p.Val2114Met	MyTH4 1	Heterozygous	Severe t...,122,3,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
6371G>A,c.6371G>A	p.Arg2124Gln	MyTH4 1	Homozygous	Severe to ...,123,3,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
6437G>A,c.6437G>A	p.Arg2146Gln	MyTH4 1	Heterozygous	Severe t...,124,3,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
6614C>T,c.6614C>T	p.Thr2205Ile	MyTH4 1	Hemizygous	*Residual ...,125,3,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
6731G>A,c.6731G>A	p.Gly2244Glu		Homozygous	Severe to profoun...,126,3,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
6796G>A,c.6796G>A	p.Val2266Met		Homozygous	Severe to profoun...,127,3,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
9C>G,c.6956+9C>G			Heterozygous	Severe to profound	Yang et al....,128,8,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
9C>G,c.6956+9C>G			Heterozygous	Severe to profound	Yang et al....,129,8,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
3G>C,c.7395+3G>C			Homozygous	Severe to profound	Belguith et a...,130,8,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
8148G>T,c.8148G>T	p.Gln2716His		Homozygous	Profound	Liburd e...,131,3,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
8158G>C,c.8158G>C	p.Asp2720His		Homozygous	Severe to profoun...,132,3,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
8324G>A,c.8324G>A	p.Arg2775His		Heterozygous	Severe to profo...,133,3,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
8375T>C,c.8375T>C	p.Val2792Ala		Heterozygous	Severe to profo...,134,3,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
8767C>T,c.8767C>T	p.Arg2923*	SH3	Heterozygous	Severe to prof...,135,3,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
1G>C,"c.8968−1G>C			Homozygous	Profound	Kalay et al., 2007",137,8,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
1G>T,c.9229+1G>T			Homozygous	Severe to profound	Belguith et a...,138,8,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
9478C>T,c.9478C>T	p.Leu3160Phe	MyTH4 2	Homozygous	Severe to ...,139,3,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
10474C>T,c.10474C>T	p.Gln3492*	FERM	Homozygous	Severe to prof...,143,3,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
366G>A,"... which 3 (D85V, R175W & N372Y) are missense, 3 (c.366G>A, c.381G>A & c.384C>T) are in 5’UTR, 1 synon...",12,363,Mol_Cytogenet_2014_Jan_21_7(Suppl_1)_P32.txt
381G>A,"...D85V, R175W & N372Y) are missense, 3 (c.366G>A, c.381G>A & c.384C>T) are in 5’UTR, 1 synonymous chan...",12,373,Mol_Cytogenet_2014_Jan_21_7(Suppl_1)_P32.txt
384C>T,"... & N372Y) are missense, 3 (c.366G>A, c.381G>A & c.384C>T) are in 5’UTR, 1 synonymous change (c.682G>...",12,384,Mol_Cytogenet_2014_Jan_21_7(Suppl_1)_P32.txt
682G>T,"... & c.384C>T) are in 5’UTR, 1 synonymous change (c.682G>T) and 3 (c.947-20G>C, c.1140+14G>A & c.1289+...",12,429,Mol_Cytogenet_2014_Jan_21_7(Suppl_1)_P32.txt
20G>C,"...’UTR, 1 synonymous change (c.682G>T) and 3 (c.947-20G>C, c.1140+14G>A & c.1289+68G>A) are intronic v...",12,450,Mol_Cytogenet_2014_Jan_21_7(Suppl_1)_P32.txt
14G>A,"...mous change (c.682G>T) and 3 (c.947-20G>C, c.1140+14G>A & c.1289+68G>A) are intronic variants. In BM...",12,464,Mol_Cytogenet_2014_Jan_21_7(Suppl_1)_P32.txt
68G>A,"...682G>T) and 3 (c.947-20G>C, c.1140+14G>A & c.1289+68G>A) are intronic variants. In BMP4, 3 sequence ...",12,479,Mol_Cytogenet_2014_Jan_21_7(Suppl_1)_P32.txt
1695A>C,"...ariants are found, out of which only one novel (c.1695A>C) in 3’UTR region has been found in one ind...",12,580,Mol_Cytogenet_2014_Jan_21_7(Suppl_1)_P32.txt
1639G>A,"...genotyping of CYP450 2C9 (*2 and *3) and VKORC1 (−1639G>A), with a result produced in approximately ...",234,157,Mol_Diagn_Ther_2013_Jun_16_17(3)_165-184.txt
662C>T,...upGGATTCCG; p.Val19fs*24) and a point mutation (c.662C>T; p.Pro221Leu). The consanguineous parents c...,3,1457,Mol_Genet_Genomic_Med_2013_Jul_30_1(2)_113-117.txt
662C>T,...4) and a separate point mutation within exon 5 (c.662C>T; p.Pro221Leu). Neither mutation has been de...,10,624,Mol_Genet_Genomic_Med_2013_Jul_30_1(2)_113-117.txt
5G>A,...ing mutation was found in APC (NM_000038.4:c.1312+5G>A) and six heterozygous in GNAQ (NM_002072.2:c....,5,1030,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
1C>T,"...) and six heterozygous in GNAQ (NM_002072.2:c.735+1C>T), ABCC3 (NM_003786.3:c.1783-1G>A), KLHDC1 (NM...",5,1084,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
1G>A,"...M_002072.2:c.735+1C>T), ABCC3 (NM_003786.3:c.1783-1G>A), KLHDC1 (NM_172193.1:c.568-2A>G), HOOK1 (NM_...",5,1117,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
2A>G,"..._003786.3:c.1783-1G>A), KLHDC1 (NM_172193.1:c.568-2A>G), HOOK1 (NM_015888.4:c.1662-1G>A), SMAD9 (NM_...",5,1150,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
1G>A,"...M_172193.1:c.568-2A>G), HOOK1 (NM_015888.4:c.1662-1G>A), SMAD9 (NM_001127217.2:c.1004-1C>T), and DNA...",5,1183,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
1C>T,"...5888.4:c.1662-1G>A), SMAD9 (NM_001127217.2:c.1004-1C>T), and DNAH9 (NM_001372.3:c.10242+5G>A). Integ...",5,1219,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
5G>A,"...17.2:c.1004-1C>T), and DNAH9 (NM_001372.3:c.10242+5G>A). Integrating whole-exome and RNA sequencing ...",5,1257,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
5G>A,"... the intron between exon 10 and 11 of APC (c.1312+5G>A, OMIM# 611731, NM_000038, NCBI36.1 nomenclatu...",64,542,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
1C>T,"GNAQ	Ph+001	9,79599197,79599198,1,C/T	c.735+1C>T	23 (65)	8 (0)	35% (0%)	Donor lost",71,45,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
1G>A,"ABCC3	Ph+004	17,46100788,46100789,1,G/A	c.1783-1G>A	59 (36)	30 (0)	51% (1%)	Acceptor lost",72,48,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
2A>G,"KLHDC1	Ph+005	14,49265391,49265392,1,A/G	c.568-2A>G	93 (14)	48 (1)	52% (7%)	Acceptor lost",73,48,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
1C>T,"SMAD9	Ph-005	13,36325812,36325813,1,C/T	c.1004-1C>T	27 (16)	14 (0)	52% (0%)	Acceptor lost",74,48,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
1G>A,"HOOK1	Ph-006	1,60103421,60103422,1,G/A	c.1662-1G>A	186 (153)	87 (0)	47% (0%)	Acceptor lost",75,47,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
5G>A,"DNAH9	Ph-007	17,11715832,11715833,1,G/A	c.10242+5G>A	37 (43)	19 (0)	51% (0%)	Donor lost",76,49,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
1C>T,"... (OMIM# 600998) proto-oncogene (NM_002072.2:c.735+1C>T, NCBI36.1 nomenclature). The somatic variant ...",79,207,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
1C>T,"GNAQ	Ph+001	c.735+1C>T	1	1.00/–	0.997/–	2160	2843	32.938	22% wt RNA,...",84,19,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
1G>A,"ABCC3	Ph+004	c.1783-1G>A	1	0.91/–	0.390/–	5155	859	6.109	58% wt RNA, 3...",85,21,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
2A>G,KLHDC1	Ph+005	c.568-2A>G	1	0.93/–	0.946/–	2644	72	0.939	Low expression...,86,21,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
1C>T,SMAD9	Ph-005	c.1004-1C>T	1	0.98/–	0.988/–	5558	42	0.379	Low expression...,87,21,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
1G>A,"HOOK1	Ph-006	c.1662-1G>A	1	0.94/–	0.877/–	5861	344	3.767	58% wt RNA, 4...",88,21,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
5G>A,DNAH9	Ph-007	c.10242+5G>A	0.999	0.95/–	0.949/–	14087	0	0	Not expression...,89,22,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
1C>T,Figure 1 GNAQ (NM_002072.2:c.735+1C>T) splicing mutation near the 5’ donor splice s...,94,34,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
1G>A,...4 of ABCC3 (OMIM#604323) gene (NM_003786.3:c.1783-1G>A); it was present with a frequency of 51%. The...,100,178,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
2A>G,"... the KLHDC1 (OMIM#611281) gene (NM_172193.1:c.568-2A>G), near the 3’ acceptor splice site at positio...",102,92,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
1C>T,"...e SMAD9 (OMIM#603295) gene (NM_001127217.2:c.1004-1C>T), causing a loss of acceptor site. Despite th...",106,185,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
1G>A,"... of HOOK1 (OMIM# 607820) gene (NM_015888.4:c.1662-1G>A) with a frequency of 47% (Table 1, Fig. S5A a...",108,206,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
5G>A,...utation affected position +5 (NM_001372.3:c.10242+5G>A) of the donor splice site of DNAH9 (OMIM# 603...,112,70,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
5G>A,...our newly identified splicing variant. The c.1312+5G>A variation in APC was absent from dbSNP and CO...,119,372,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
4T>G,"...tations (0.6%). Of them, the transversion (c.1312+4T>G) and the transition (c.1312+2T>C) affected, r...",119,620,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
2T>C,"...sversion (c.1312+4T>G) and the transition (c.1312+2T>C) affected, respectively, position +4 (chr5:11...",119,653,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
1C>T,...splicing in GNAQ gene caused by NM_002072.2:c.735+1C>T mutation by RT-PCR. This analysis showed and ...,125,89,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
1C>T,The GNAQ (NM_002072.2:c.735+1C>T) variant has not been reported in literature ...,127,29,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
1G>A,...n retention in HOOK1 caused by NM_015888.4:c.1662-1G>A mutation was functionally validated by demons...,129,72,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
1G>A,"...ng aberrant mRNA. However, the NM_015888.4:c.1662-1G>A mutation has not been reported in literature....",129,353,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
5G>A,APC (NM_000038.4:c.1312+5G>A) splicing mutation detected by whole-exome se...,146,25,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
1G>A,Figure S3. (A) ABCC3 (NM_003786.3:c.1783-1G>A) splicing mutation near the 3’ acceptor splic...,150,42,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
2A>G,... somatic mutations. (A) KLHDC1 (NM_172193.1:c.568-2A>G) splicing mutation near the 3’ acceptor splic...,153,67,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
1C>T,...nger validation. (B) SMAD9 (NM_001127217.2:c.1004-1C>T) splicing mutation near the 3’ acceptor splic...,153,263,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
5G>A,...Sanger validation. (C) DNAH9 (NM_001372.3:c.10242+5G>A) splicing mutation near the 5’ donor site at ...,153,457,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
1G>A,Figure S5. (A) HOOK1 (NM_015888.4:c.1662-1G>A) splicing mutation near the 3’ acceptor splic...,155,42,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
1G>A,...as M  Balmana J  Diez O   The variants BRCA1 IVS6-1G>A and BRCA2 IVS15+1G>A lead to aberrant splicin...,186,87,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
1G>A,... O   The variants BRCA1 IVS6-1G>A and BRCA2 IVS15+1G>A lead to aberrant splicing of the transcripts ...,186,108,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
313G>C,...ene2/) for mutations affecting splice sites and c.313G>C,16,1750,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
1G>A,"...n order to analyze the effects of the CCM1:c.2025+1G>A splice site mutation, RNA was extracted from ...",19,52,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
1G>A,"...quence of CCM1 lacking human exon 18 (CCM1:c.2025+1G>A, CCM1:p.N607_K675del) was similarly fused to ...",22,268,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
313G>C,7	c.313G>C	p.G105R	f	Novel	12,36,5,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
406C>T,8	c.406C>T	p.Q136*	f	Novel	46,37,5,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
5G>A,IVS9	c.729+5G>A	p.Q201Rfs*23	f	Novel	44,39,12,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
1G>A,IVS9	c.730-1G>A	p.?	i	Davenport et al. (2001)	27,40,12,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
1G>A,IVS10	c.845+1G>A	p.?	i	Novel	36,42,13,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
1G>T,IVS10	c.845+1G>T	p.?	f	Novel	77,43,13,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
1093G>T,12	c.1093G>T	p.G365*	f	Novel	1,45,6,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
1G>A,IVS13	c.1255-1G>A	p.Y419Ffs*153	f	Cavé-Riant et al. (2002)	31,48,14,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
1267C>T,"14	c.1267C>T4	p.R423*	i/f	Cavé-Riant et al. (2002)	23,6...",50,6,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
1G>C,IVS14	c.1412-1G>C	p.?	i	Novel	26,52,14,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
1431T>A,15	c.1431T>A	p.Y477*	i	Novel	24,53,6,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
1G>A,IVS15	c.1564-1G>A	p.?	f	Novel	32,55,14,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
1619T>A,16	c.1619T>A	p.L540*	f	Novel	10,56,6,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
1678C>T,16	c.1678C>T	p.Q560*	f	Stahl et al. (2008)	8,58,6,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
1G>A,IVS18	c.2025+1G>A	p.N607_K675del3	f	Denier et al. (2004)	21,63,14,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
12A>G,IVS18	c.2026-12A>G	p.A676_Q714del3	f	Laberge-le Couteulx et al....,64,14,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
30G>A,"1	c.30G>A4	No transcript	i/f	Liquori et al. (2003)	16,...",67,5,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
103C>T,"5	c.103C>T4	p.R35*	i/f	Bergametti et al. (2005)	8,11,2...",72,5,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
1G>T,IVS6	c.269-1G>T	p.?	f	Novel	3,74,12,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
2A>G,IVS8	c.475-2A>G	p.A119Gfs*423	i	Novel	22,78,12,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
1G>C,"IVS9	c.558-1G>C4	p.?	i/f	Novel	11,36",79,12,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
2A>C,IVS9	c.558-2A>C	p.?	i	Novel	3,80,12,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
586C>T,10	c.586C>T	p.R196*	i	Bergametti et al. (2005)	17,81,6,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
598C>T,10	c.598C>T	p.Q200*	f	Schröder et al. (2014)	50,82,6,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
1G>A,The mutation c.2025+1G>A within CCM1 (CCM1:p.N607_K675del) was found i...,103,21,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
1G>A,...d out to be a heterozygous carrier of CCM1:c.2025+1G>A (Fig. 2B and C),103,548,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
1G>A,...quencing revealed the splice site mutation c.2025+1G>A within CCM1 likely resulting in skipping of e...,105,562,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
1G>A,CCM1:c.2025+1G>A affects a canonical splice site and is predic...,107,13,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
12A>G,"...e shown that the splice site mutation CCM1:c.2026-12A>G results in the deletion of entire exon 19, w...",107,685,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
1G>A,CCM1:c.2025+1G>A is predicted to cause a 69 amino acid deletio...,109,13,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
313G>C,The novel UV c.313G>C within the CCM1 gene was found in a 12-year...,116,16,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
313G>C,"...ithin exon 7 is also conceivable. However, CCM1:c.313G>C cannot be considered to be a disease-causin...",116,463,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
598C>T,...tion carriers: c.317delA (unpublished data) and c.598C>T (Schröder et al. 2014),125,1092,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
1G>A,"....g., 2 years for the proband carrying CCM1:c.2025+1G>A; Fig. 2) has previously been much earlier tha...",129,681,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
2219G>C,"...ions in this study, with two mutations in MFN2 (c.2219G>C, p.W740S; c.227T>C; p.L76P) comprising 8.7...",82,1051,Mol_Genet_Genomic_Med_2014_Nov_21_2(6)_522-529.txt
227T>C,"...with two mutations in MFN2 (c.2219G>C, p.W740S; c.227T>C; p.L76P) comprising 8.7%. Other frequent mu...",82,1071,Mol_Genet_Genomic_Med_2014_Nov_21_2(6)_522-529.txt
2860C>T,"...8.7%. Other frequent mutations included SH3TC2 (c.2860C>T; p.Arg954* [4.8%]), FIG4 (c.122T>C; p.Ile4...",82,1148,Mol_Genet_Genomic_Med_2014_Nov_21_2(6)_522-529.txt
122T>C,"...ded SH3TC2 (c.2860C>T; p.Arg954* [4.8%]), FIG4 (c.122T>C; p.Ile41Thr [4.3%]), and GJB1 (c.305A>G; p....",82,1184,Mol_Genet_Genomic_Med_2014_Nov_21_2(6)_522-529.txt
305A>G,"..., FIG4 (c.122T>C; p.Ile41Thr [4.3%]), and GJB1 (c.305A>G; p.Glu102Gly [2.5%]) (Table S6). The distri...",82,1224,Mol_Genet_Genomic_Med_2014_Nov_21_2(6)_522-529.txt
1505T>A,"...urthermore, F8 compound heterozygote mutations (c.1505T>A, p.Val502Asp and c.3279G>A, p.Met1093Ile) ...",12,201,Mol_Med_Rep_2014_Feb_4_9(2)_466-470.txt
3279G>A,"...erozygote mutations (c.1505T>A, p.Val502Asp and c.3279G>A, p.Met1093Ile) were identified using multi...",12,228,Mol_Med_Rep_2014_Feb_4_9(2)_466-470.txt
1505T>A,"...y reported mutation (15) was detected (exon 10, c.1505T>A, p.Val502Asp), and a novel unreported miss...",31,98,Mol_Med_Rep_2014_Feb_4_9(2)_466-470.txt
3279G>A,"...el unreported missense point mutation (exon 14, c.3279G>A, p.Met1093Ile) (Fig. 1)",31,180,Mol_Med_Rep_2014_Feb_4_9(2)_466-470.txt
1505T>A,...ng of exons 10 and 14. (A) Exon 10: NM_000132.3 c.1505T>A (p.Val502Asp). (B) Exon 14: NM_000132.3 c....,51,85,Mol_Med_Rep_2014_Feb_4_9(2)_466-470.txt
3279G>A,...1505T>A (p.Val502Asp). (B) Exon 14: NM_000132.3 c.3279G>A (p.Met1093Ile),51,135,Mol_Med_Rep_2014_Feb_4_9(2)_466-470.txt
2246G>T,...revealed a nucleotide alteration between G and T (2246G>T) in exon 15 in the two affected individual...,24,256,Mol_Med_Rep_2015_Aug_9_12(2)_1845-1849.txt
489C>T,Possible protective role of the 489C>T P2X7R polymorphism in Alzheimer’s disease ....,351,33,Mol_Pain_2016_May_12_12_1744806916646786.txt
677C>T,...ine level and methylenetetrahydrofolate reductase 677C>T genetic polymorphism in Japanese patients w...,243,134,Mol_Psychiatry_2013_Jan_31_18(1)_15-37.txt
677C>T,...oung IS  Folate/homocysteine phenotypes and MTHFR 677C>T genotypes are associated with serum levels ...,246,106,Mol_Psychiatry_2013_Jan_31_18(1)_15-37.txt
677C>T,... Methylenetetrahydrofolate reductase polymorphism 677C>T is associated with peripheral arterial dise...,254,114,Mol_Psychiatry_2013_Jan_31_18(1)_15-37.txt
677C>T,...b J Hunter DJ  Linkage disequilibrium between the 677C>T and 1298A>C polymorphisms in human methylen...,255,92,Mol_Psychiatry_2013_Jan_31_18(1)_15-37.txt
1298A>C,...DJ  Linkage disequilibrium between the 677C>T and 1298A>C polymorphisms in human methylenetetrahydro...,255,103,Mol_Psychiatry_2013_Jan_31_18(1)_15-37.txt
874 T>A,...VN Dias-Baptista IM Maniero VC Venturini J  IFNG +874 T>A single nucleotide polymorphism is associat...,463,88,Mol_Psychiatry_2013_Jan_31_18(1)_15-37.txt
415 T > C,"4	1 of 2	1 of 1	4q12:55,603,415 T > C	I924T	Neutral (0.86)",143,30,Mol_Psychiatry_2016_Mar_22_10_1038_mp_2016_24.txt
995 C > T,"4	1 of 2	1 of 1	15q23:72,638,995 C > T	M401I	Neutral (0.76)",151,31,Mol_Psychiatry_2016_Mar_22_10_1038_mp_2016_24.txt
774 A > C,"3	1 of 1	2 of 5	1p34.3:35,453,774 A > C	L970R	Deleterious (1)",159,32,Mol_Psychiatry_2016_Mar_22_10_1038_mp_2016_24.txt
369 G > C,"3	1 of 1	1 of 5	1p12:118,509,369 G > C	A2132G	Deleterious (1)",167,31,Mol_Psychiatry_2016_Mar_22_10_1038_mp_2016_24.txt
497 C > G,"3	0 of 1	2 of 5	6q25.3:160,201,497 C > G	D359H	Deleterious (0.99)",175,33,Mol_Psychiatry_2016_Mar_22_10_1038_mp_2016_24.txt
880 T > G,"3	1 of 1	1 of 5	7q22.1:99,794,880 T > G	I348S	Deleterious (1)",183,32,Mol_Psychiatry_2016_Mar_22_10_1038_mp_2016_24.txt
789 A > G,"3	1 of 1	1 of 5	12q24.31:124,086,789 A > G	M32V	Neutral (0.93)",201,35,Mol_Psychiatry_2016_Mar_22_10_1038_mp_2016_24.txt
466 C > G,"3	0 of 1	2 of 5	15q25.3:88,472,466 C > G	D697H	Deleterious (1)",209,33,Mol_Psychiatry_2016_Mar_22_10_1038_mp_2016_24.txt
839 A > G,"3	1 of 1	1 of 5	18q11.2:19,093,839 A > G	N1598S	Deleterious (1)",217,33,Mol_Psychiatry_2016_Mar_22_10_1038_mp_2016_24.txt
144 G > A,"3	0 of 1	3 of 5	19q13.32:45,211,144 G > A	A318T	Neutral (0.79)",225,34,Mol_Psychiatry_2016_Mar_22_10_1038_mp_2016_24.txt
130 C > G,"6	1 of 1	1 of 2	11q13.1:63,963,130 C > G	P173A	Neutral (0.97)",233,33,Mol_Psychiatry_2016_Mar_22_10_1038_mp_2016_24.txt
595 G > A,"6	1 of 1	1 of 2	11q13.4:70,644,595 G > A	A578V	Deleterious (1)",241,33,Mol_Psychiatry_2016_Mar_22_10_1038_mp_2016_24.txt
574 G > A,"796G6.2	6	0 of 1	2 of 2	14q32.31:102,198,574 G > A	W112*	n/a",249,42,Mol_Psychiatry_2016_Mar_22_10_1038_mp_2016_24.txt
588 G > A,"6	0 of 1	1 of 2	16q24.3:90,030,588 G > A	R399Q	n/a Deleterious (1)",257,33,Mol_Psychiatry_2016_Mar_22_10_1038_mp_2016_24.txt
525 C > G,"4	1 of 2	0 of 0	1q25.3:182,545,525 C > G	<splice>	n/a",265,33,Mol_Psychiatry_2016_Mar_22_10_1038_mp_2016_24.txt
916 T > C,"4	1 of 2	0 of 0	3q13.13:108,301,916 T > C	T89A	Neutral (0.85)",273,34,Mol_Psychiatry_2016_Mar_22_10_1038_mp_2016_24.txt
202 C > T,"4	1 of 2	0 of 0	15q14:34,331,202 C > T	G16S	Deleterious (1)",281,31,Mol_Psychiatry_2016_Mar_22_10_1038_mp_2016_24.txt
728 C > T,"4	1 of 2	0 of 0	Xq25:128,638,728 C > T	V384M	Deleterious (1)",289,31,Mol_Psychiatry_2016_Mar_22_10_1038_mp_2016_24.txt
113 G > A,"4	0 of 1	2 of 3	20p13:2,384,113 G > A	V354I	Deleterious",297,30,Mol_Psychiatry_2016_Mar_22_10_1038_mp_2016_24.txt
147 G > C,"4	0 of 1	2 of 3	5q23.1:118,835,147 G > C	D395H	Neutral (0.86)",306,33,Mol_Psychiatry_2016_Mar_22_10_1038_mp_2016_24.txt
217 C > T,"4	1 of 1	3 of 3	6q22.31:119,670,217 C > T	G5D	Neutral (0.87)",314,34,Mol_Psychiatry_2016_Mar_22_10_1038_mp_2016_24.txt
551 G >	S,"4	0 of 1	2 of 3	15q25.3:85,400,551 G >	S1063N	Deleterious",322,33,Mol_Psychiatry_2016_Mar_22_10_1038_mp_2016_24.txt
853 G > T,"2	1 of 2	2 of 3	10p13:13,534,853 G > T	P147T	Neutral (0.92)",331,31,Mol_Psychiatry_2016_Mar_22_10_1038_mp_2016_24.txt
576 T > A,"2	1 of 2	2 of 3	10q11.23:49,982,576 T > A	V876D	Deleterious (1)",339,34,Mol_Psychiatry_2016_Mar_22_10_1038_mp_2016_24.txt
319 G > A,"2	1 of 2	2 of 3	14q32.2:100,992,319 G > A	R405H	Deleterious (1)",347,34,Mol_Psychiatry_2016_Mar_22_10_1038_mp_2016_24.txt
787T > C,...nspecific alkaline phosphatase gene polymorphism (787T > C) associated with bone mineral density . B...,194,165,Mol_Ther_Methods_Clin_Dev_2016_Feb_3_3_15059.txt
574C>T,"...RS1 gene revealed five mutations in exon 6 like c.574C>T, c.583A>G, c.608C>T, c.617G>A, and c.637C>T...",15,72,Mol_Vis_2007_Apr_19_13_611-617.txt
583A>G,"...evealed five mutations in exon 6 like c.574C>T, c.583A>G, c.608C>T, c.617G>A, and c.637C>T, respecti...",15,82,Mol_Vis_2007_Apr_19_13_611-617.txt
608C>T,"...ve mutations in exon 6 like c.574C>T, c.583A>G, c.608C>T, c.617G>A, and c.637C>T, respectively, amon...",15,92,Mol_Vis_2007_Apr_19_13_611-617.txt
617G>A,"...ns in exon 6 like c.574C>T, c.583A>G, c.608C>T, c.617G>A, and c.637C>T, respectively, among them fou...",15,102,Mol_Vis_2007_Apr_19_13_611-617.txt
637C>T,"...ike c.574C>T, c.583A>G, c.608C>T, c.617G>A, and c.637C>T, respectively, among them four missense mut...",15,116,Mol_Vis_2007_Apr_19_13_611-617.txt
637C>T,.... RFLP analysis was carried out to identify the c.637C>T mutation using MSP1 restriction enzyme,55,445,Mol_Vis_2007_Apr_19_13_611-617.txt
574C>T,"...anges. Five genetic variations were identified: c.574C>T, c.583A>G, c.608C>T, c.617G>A, and c.637C>T...",58,202,Mol_Vis_2007_Apr_19_13_611-617.txt
583A>G,"...e genetic variations were identified: c.574C>T, c.583A>G, c.608C>T, c.617G>A, and c.637C>T. Two of t...",58,212,Mol_Vis_2007_Apr_19_13_611-617.txt
608C>T,"...variations were identified: c.574C>T, c.583A>G, c.608C>T, c.617G>A, and c.637C>T. Two of these, c.58...",58,222,Mol_Vis_2007_Apr_19_13_611-617.txt
617G>A,"... were identified: c.574C>T, c.583A>G, c.608C>T, c.617G>A, and c.637C>T. Two of these, c.583A>G and c...",58,232,Mol_Vis_2007_Apr_19_13_611-617.txt
637C>T,"...ed: c.574C>T, c.583A>G, c.608C>T, c.617G>A, and c.637C>T. Two of these, c.583A>G and c.617G>A, are n...",58,246,Mol_Vis_2007_Apr_19_13_611-617.txt
583A>G,"...c.608C>T, c.617G>A, and c.637C>T. Two of these, c.583A>G and c.617G>A, are novel. Similar to previou...",58,270,Mol_Vis_2007_Apr_19_13_611-617.txt
617G>A,"...17G>A, and c.637C>T. Two of these, c.583A>G and c.617G>A, are novel. Similar to previous reports, al...",58,283,Mol_Vis_2007_Apr_19_13_611-617.txt
574C>T,1	574C>T	Pro192Ser	6,62,3,Mol_Vis_2007_Apr_19_13_611-617.txt
583A>G,2	583A>G	Ile195Val*	6,63,3,Mol_Vis_2007_Apr_19_13_611-617.txt
608C>T,3	608C>T	Pro203Leu	6,64,3,Mol_Vis_2007_Apr_19_13_611-617.txt
617G>A,4	617G>A	Trp206X*	6,65,3,Mol_Vis_2007_Apr_19_13_611-617.txt
637C>T,5	637C>T	Arg213Trp	6,66,3,Mol_Vis_2007_Apr_19_13_611-617.txt
637C>T,6	637C>T	Arg213Trp	6,67,3,Mol_Vis_2007_Apr_19_13_611-617.txt
574C>T,Patient 1 with c.574C>T mutatio,80,18,Mol_Vis_2007_Apr_19_13_611-617.txt
574C>T,A c.574C>T mutation was found in a 10-year-old male. H...,81,5,Mol_Vis_2007_Apr_19_13_611-617.txt
583A>G,Patient 2 with c.583A>G novel genetic variatio,83,18,Mol_Vis_2007_Apr_19_13_611-617.txt
583A>G,A c.583A>G variation was identified in an 11-year-old ...,84,5,Mol_Vis_2007_Apr_19_13_611-617.txt
583A>G,"...temporal schisis. To the best of our knowledge, c.583A>G transition leading to the replacement of is...",84,346,Mol_Vis_2007_Apr_19_13_611-617.txt
608C>T,Patient 3 with c.608C>T mutatio,86,18,Mol_Vis_2007_Apr_19_13_611-617.txt
608C>T,A c.608C>T mutation was observed in a 20-year-old male...,87,5,Mol_Vis_2007_Apr_19_13_611-617.txt
617G>A,Patient 4 with c.617G>A novel nonsense variatio,89,18,Mol_Vis_2007_Apr_19_13_611-617.txt
617G>A,A c.617G>A nonsense mutation was found in a 10-year-ol...,90,5,Mol_Vis_2007_Apr_19_13_611-617.txt
617G>A,... analysis of RS1 and sequencing result showed a c.617G>A transition that resulted in a nonsense muta...,94,266,Mol_Vis_2007_Apr_19_13_611-617.txt
617G>A,"...ly pedigree of patient 4, who exhibited a novel c.617G>A mutation. The arrow indicates proband. The ...",96,135,Mol_Vis_2007_Apr_19_13_611-617.txt
617G>A,...: This sequence chromatogram compares the novel c.617G>A nonsense mutation with the sequence derived...,96,338,Mol_Vis_2007_Apr_19_13_611-617.txt
637C>T,Patient 5 with c.637C>T transitio,98,18,Mol_Vis_2007_Apr_19_13_611-617.txt
637C>T,A c.637C>T transition was observed in a 17-year-old ma...,99,5,Mol_Vis_2007_Apr_19_13_611-617.txt
637C>T,Patient 6 with c.637C>T transitio,103,18,Mol_Vis_2007_Apr_19_13_611-617.txt
637C>T,A c.637C>T transition mutation was also identified in ...,104,5,Mol_Vis_2007_Apr_19_13_611-617.txt
617G>A,"...e sporadic cases, and one novel genetic variant c.617G>A was identified in a family",107,918,Mol_Vis_2007_Apr_19_13_611-617.txt
617G>A,A c.617G>A novel nonsense mutation was identifiedin pa...,109,5,Mol_Vis_2007_Apr_19_13_611-617.txt
618G>A,...sense mutation involving a different nucleotide c.618G>A in the same codon was previously reported i...,109,543,Mol_Vis_2007_Apr_19_13_611-617.txt
583A>G,"Patient 2 was found to have a c.583A>G novel genetic variation, leading to the rep...",111,33,Mol_Vis_2007_Apr_19_13_611-617.txt
15C>T,"1	5'UTR-15C>T	2 ARRP (003-147, 003-185)	0",49,9,Mol_Vis_2007_Apr_5_13_588-593.txt
7A>C,"1	IVS1+7A>C	2 ARRP (003-069, 003-161)	0",50,8,Mol_Vis_2007_Apr_5_13_588-593.txt
13G>T,1	IVS1+13G>T	1 ARRP (003-178)	0,51,8,Mol_Vis_2007_Apr_5_13_588-593.txt
156C>G,1	5'UTR-156C>G	1 ARRP (003-182)	0,52,9,Mol_Vis_2007_Apr_5_13_588-593.txt
342G>A,"2b	Glu114Glu c.342G>A	4 ARRP (003-089, 003-197, 003-285, 003-371)...",53,16,Mol_Vis_2007_Apr_5_13_588-593.txt
3T>G,3	3'UTR+3T>G	1 ARRP (003-064)	0,55,9,Mol_Vis_2007_Apr_5_13_588-593.txt
1G>A,Intron 2	c.99+1G>A	Aberrant splicing	LCA/Early onset RP	Found in...,45,15,Mol_Vis_2008_Apr_21_14_675-682.txt
2T>C,Intron 7	c.718+2T>C	Aberrant splicing	Juvenile RP		 [16],48,16,Mol_Vis_2008_Apr_21_14_675-682.txt
5G>C,Intron 10	c.999+5G>C	Aberrant splicing	Juvenile RP		 [16],50,17,Mol_Vis_2008_Apr_21_14_675-682.txt
1102G>T,Exon 11	c.1102G>T	p.G368W	LCA		 [2],51,11,Mol_Vis_2008_Apr_21_14_675-682.txt
1145T>C,Exon 11	c.1145T>C	p.F382S	Early onset RP		 [19],52,11,Mol_Vis_2008_Apr_21_14_675-682.txt
1198C>T,Exon 12	c.1198C>T	p.R400W	LCA		 [2],53,11,Mol_Vis_2008_Apr_21_14_675-682.txt
1204G>T,Exon 12	c.1204G>T	p.E402X	LCA	Found in compound heterozygosi...,54,11,Mol_Vis_2008_Apr_21_14_675-682.txt
1G>A,...2X	LCA	Found in compound heterozygosity with c.99+1G>A	 [2],54,74,Mol_Vis_2008_Apr_21_14_675-682.txt
4A>G,"Intron 12	c.1224+4A>G, (IVS12+4A>G)	Aberrant splicing	RP	Found in h...",55,18,Mol_Vis_2008_Apr_21_14_675-682.txt
4A>G,"Intron 12	c.1224+4A>G, (IVS12+4A>G)	Aberrant splicing	RP	Found in heterozygosity...",55,31,Mol_Vis_2008_Apr_21_14_675-682.txt
1259G>C,Exon 13	c.1259G>C	p.R420P	Early onset RP	Found in compound h...,56,11,Mol_Vis_2008_Apr_21_14_675-682.txt
1376 T>A,Exon 14	c.1376 T>A	p.I459K	Early onset RP	Found in compound ...,57,11,Mol_Vis_2008_Apr_21_14_675-682.txt
1G>A,...set RP	Found in compound heterozygosity with c.99+1G>A	 [11],57,86,Mol_Vis_2008_Apr_21_14_675-682.txt
1381C>G,Exon 14	c.1381C>G	p.L461V	Juvenile RP		 [16],58,11,Mol_Vis_2008_Apr_21_14_675-682.txt
1472 T>C,Exon 14	c.1472 T>C	p.F491L	Early onset RP	Found in compound ...,59,11,Mol_Vis_2008_Apr_21_14_675-682.txt
1444C>T,Exon 14	c.1444C>T	p.R482W	Early onset RP	Found in compound h...,60,11,Mol_Vis_2008_Apr_21_14_675-682.txt
1502G>A,Exon 14	c.1502G>A	p.K489R	RP		 [18],61,11,Mol_Vis_2008_Apr_21_14_675-682.txt
1522 G>A,Exon 14	c.1522 G>A	p.A496T	RP	Found in heterozygosity; secon...,62,11,Mol_Vis_2008_Apr_21_14_675-682.txt
1G>A,"Intron 14	c.1495+1G>A, (IVS14+1G>A)	Aberrant splicing	Early onset R...",63,18,Mol_Vis_2008_Apr_21_14_675-682.txt
1G>A,"Intron 14	c.1495+1G>A, (IVS14+1G>A)	Aberrant splicing	Early onset RP		 [9,24]",63,31,Mol_Vis_2008_Apr_21_14_675-682.txt
6C>A,"Intron 14	c.1496-6C>A, (IVS14-6C>A)	Aberrant splicing	RP		 [18]",65,18,Mol_Vis_2008_Apr_21_14_675-682.txt
6C>A,"Intron 14	c.1496-6C>A, (IVS14-6C>A)	Aberrant splicing	RP		 [18]",65,31,Mol_Vis_2008_Apr_21_14_675-682.txt
1G>A,...nsT mutation or from a normal control. The c.1495+1G>A mutation was generated by site-directed mutag...,74,293,Mol_Vis_2008_Apr_21_14_675-682.txt
1G>A,"...utation identified in family TB13; and the c.1495+1G>A (IVS14+1G>A) mutation, which was previously i...",95,615,Mol_Vis_2008_Apr_21_14_675-682.txt
1G>A,"...tified in family TB13; and the c.1495+1G>A (IVS14+1G>A) mutation, which was previously identified in...",95,627,Mol_Vis_2008_Apr_21_14_675-682.txt
1G>A,...site of intron 14: c.1495+2_1495+3insT and c.1495+1G>A. Also shown are the locations of primers used...,99,422,Mol_Vis_2008_Apr_21_14_675-682.txt
1G>A,"...of TULP1 which have been reported to date, c.1495+1G>A (IVS14+1G>A) and c.1496–6C>A (IVS14–6C>A), af...",102,729,Mol_Vis_2008_Apr_21_14_675-682.txt
1G>A,"...ch have been reported to date, c.1495+1G>A (IVS14+1G>A) and c.1496–6C>A (IVS14–6C>A), affect the don...",102,741,Mol_Vis_2008_Apr_21_14_675-682.txt
6C>A,"...rted to date, c.1495+1G>A (IVS14+1G>A) and c.1496–6C>A (IVS14–6C>A), affect the donor and acceptor s...",102,758,Mol_Vis_2008_Apr_21_14_675-682.txt
6C>A,"..., c.1495+1G>A (IVS14+1G>A) and c.1496–6C>A (IVS14–6C>A), affect the donor and acceptor sites of intr...",102,770,Mol_Vis_2008_Apr_21_14_675-682.txt
575C>T,"...ies: six known and one novel missense mutation (c.575C>T, p.Pro192Leu), one insertion mutation (c.57...",15,1480,Mol_Vis_2008_Dec_12_14_2321-2332.txt
1G>C,"...ne frameshift, causing splice site mutation (c.78+1G>C) were detected. These mutations were absent i...",15,1615,Mol_Vis_2008_Dec_12_14_2321-2332.txt
1G>C,c.78+1G>C	splice site	frameshift→ truncated protein	int...,88,6,Mol_Vis_2008_Dec_12_14_2321-2332.txt
214G>A,c.214G>A	missense	p.Glu72Lys	exon 4	5	5	2	17.86,89,3,Mol_Vis_2008_Dec_12_14_2321-2332.txt
418G>A,c.418G>A	missense	p.Gly140Arg	exon 5	4	3	2	12.5%,90,3,Mol_Vis_2008_Dec_12_14_2321-2332.txt
421C>T,c.421C>T	missense	p.Arg141Cys	exon 5	6	6+1	3	21.42+1...,91,3,Mol_Vis_2008_Dec_12_14_2321-2332.txt
422G>A,c.422G>A	missense	p.Arg141His	exon 5	5	4	1	16.07,92,3,Mol_Vis_2008_Dec_12_14_2321-2332.txt
574C>T,c.574C>T	missense	p.Pro192Ser	exon 6	3	2	2	8.93,93,3,Mol_Vis_2008_Dec_12_14_2321-2332.txt
575C>T,c.575C>T *	missense	p.Pro192Leu	exon 6	-	1	1	1.79,94,3,Mol_Vis_2008_Dec_12_14_2321-2332.txt
625C>T,c.625C>T	missense	p.Arg209Cys	exon 6	3	1	1	7.14,96,3,Mol_Vis_2008_Dec_12_14_2321-2332.txt
421C>T,"...2 in family 4, who had two different mutations (c.421C>T, c.574C>T) in the RS1 gene, which resulted ...",98,502,Mol_Vis_2008_Dec_12_14_2321-2332.txt
574C>T,"...y 4, who had two different mutations (c.421C>T, c.574C>T) in the RS1 gene, which resulted in apparen...",98,512,Mol_Vis_2008_Dec_12_14_2321-2332.txt
214G>A,...photography of patient III:3 from family 3 with c.214G>A missense mutation in the RS1 gene. Huge fov...,100,67,Mol_Vis_2008_Dec_12_14_2321-2332.txt
421C>T,...e most commonly found mutation (23.21%) was the c.421C>T (p.Arg141Cys) missense mutation (exon 5). M...,121,752,Mol_Vis_2008_Dec_12_14_2321-2332.txt
575C>T,"...lar testing revealed a novel missense mutation (c.575C>T, p.Pro192Leu) in exon 6 of family 7. In add...",121,857,Mol_Vis_2008_Dec_12_14_2321-2332.txt
1G>C,...utations were found: a splice site mutation (c.78+1G>C) in intron 2 of family 2 (7.14%) and an inser...,121,1008,Mol_Vis_2008_Dec_12_14_2321-2332.txt
421C>T,"... two different mutations were found: a de novo (c.421C>T, Arg141Cys) mutation and a maternal inherit...",121,1198,Mol_Vis_2008_Dec_12_14_2321-2332.txt
574C>T,"...g141Cys) mutation and a maternal inherited one (c.574C>T, Pro192Ser). The pathogenic effects of thes...",121,1258,Mol_Vis_2008_Dec_12_14_2321-2332.txt
422G>A,"...worst BCVA belonged to two adjoining mutations (c.422G>A, c.421C>T). B: FT values change irrespectiv...",126,507,Mol_Vis_2008_Dec_12_14_2321-2332.txt
421C>T,"... belonged to two adjoining mutations (c.422G>A, c.421C>T). B: FT values change irrespectively of the...",126,517,Mol_Vis_2008_Dec_12_14_2321-2332.txt
421C>T,"Of the nine different mutations found, the c.421C>T missense mutation (exon 5) was detected mos...",147,46,Mol_Vis_2008_Dec_12_14_2321-2332.txt
421C>T,...ected most frequently. That a de novo mutation (c.421C>T) was found in patient II:2 of family 4 toge...,147,137,Mol_Vis_2008_Dec_12_14_2321-2332.txt
574C>T,"...with the already known disease-causing variant (c.574C>T, inherited from his mother), illustrates th...",147,242,Mol_Vis_2008_Dec_12_14_2321-2332.txt
575C>T,"...hlight the fact that a novel missense mutation (c.575C>T) was found in family 7. Although missense, ...",149,57,Mol_Vis_2008_Dec_12_14_2321-2332.txt
2A>G,... novel heterozygous splicing site mutation c.985 −2A>G in intron 9 was found in family F1. RT–PCR re...,17,275,Mol_Vis_2008_Dec_29_14_2451-2457.txt
2197C>T,...protein. A novel heterozygous nonsense mutation c.2197C>T(p.R733X)was detected in family F2,17,493,Mol_Vis_2008_Dec_29_14_2451-2457.txt
2A>G,...zygous mutations: a splicing site mutation c.985 −2A>G in family F1 and a nonsense mutation c.2197C>...,111,113,Mol_Vis_2008_Dec_29_14_2451-2457.txt
2197C>T,....985 −2A>G in family F1 and a nonsense mutation c.2197C>T (p.R733X) in family F2 (Figure 3). Using S...,111,157,Mol_Vis_2008_Dec_29_14_2451-2457.txt
2A>G,...ows the heterozygous splicing site mutation c.985–2A>G; B: Sequence shows the heterozygous nonsense ...,113,140,Mol_Vis_2008_Dec_29_14_2451-2457.txt
2197C>T,...quence shows the heterozygous nonsense mutation c.2197C>T (p. R733X). The 2 sequences given are in s...,113,201,Mol_Vis_2008_Dec_29_14_2451-2457.txt
2A>G,...ncing analysis for the splice site mutation c.985–2A>G. A: Ethidium bromide-agarose gel was loaded w...,117,83,Mol_Vis_2008_Dec_29_14_2451-2457.txt
2A>G,...a novel heterozygous splicing site mutation c.985–2A>G and a novel heterozygous nonsense mutation c....,120,172,Mol_Vis_2008_Dec_29_14_2451-2457.txt
2197C>T,...2A>G and a novel heterozygous nonsense mutation c.2197C>T (p.R733X). The 2 novel mutations cosegrega...,120,222,Mol_Vis_2008_Dec_29_14_2451-2457.txt
2A>G,...translation. The novel splice-site mutation c.985–2A>G detected in family F1 causes an in-frame skip...,122,646,Mol_Vis_2008_Dec_29_14_2451-2457.txt
1G>A,"...lettre et al. reported a recurrent mutation c.985–1G>A, which has a similar consequence [9,11]. This...",122,849,Mol_Vis_2008_Dec_29_14_2451-2457.txt
2A>G,...ed member of family F1 carried the mutation c.985–2A>G; he was also found to harbor the affected hap...,124,1069,Mol_Vis_2008_Dec_29_14_2451-2457.txt
2197C>T,The novel nonsense mutation c.2197C>T (p.R733X) detected in family F2 presumably...,126,31,Mol_Vis_2008_Dec_29_14_2451-2457.txt
2109C>T,"...ing pyrosequencing of an RT–PCR amplified cSNP (c.2109C>T) in OPA1, they found that mutant transcrip...",126,940,Mol_Vis_2008_Dec_29_14_2451-2457.txt
153236A>T,"...not previously reported, including g.64407delT, g.153236A>T, g.156743delTCTG, and g.162078delA. Eigh...",15,290,Mol_Vis_2009_Apr_17_15_771-777.txt
2196G>A,2	F2	2y	1.1	2 rc	Rb	1	g.2196G>A	R46K,95,25,Mol_Vis_2009_Apr_17_15_771-777.txt
2196G>A,3	F2	4 y 2 m	1.1	-	1 rc	1	g.2196G>A	R46K,96,29,Mol_Vis_2009_Apr_17_15_771-777.txt
2196G>A,4	F2	62 y	1.1	-	1 rc	1	g.2196G>A	R46K,97,26,Mol_Vis_2009_Apr_17_15_771-777.txt
65386C>T,6	F4	5 y 8 m	1.8	3 rc	1 rc	11	g.65386C>T	R358X,99,33,Mol_Vis_2009_Apr_17_15_771-777.txt
65386C>T,7	F4	8 m	1.8	2 rc	Rb	11	g.65386C>T	R358X,100,27,Mol_Vis_2009_Apr_17_15_771-777.txt
65386C>T,8	F4	30 y 8 m	1.8	1 rc	1 rc	11	g.65386C>T	R358X,101,34,Mol_Vis_2009_Apr_17_15_771-777.txt
73843C>T,9	S	6 y 10 m	-	1 rc	1Rb	13	g.73843C>T	Q436X,102,30,Mol_Vis_2009_Apr_17_15_771-777.txt
76430C>T,10	F5	35 y 10 m	1.4	1 rc	1 rc	14	g.76430C>T	R445X,103,36,Mol_Vis_2009_Apr_17_15_771-777.txt
153236A>T,11	S	39 y	-	2 rc	1 rc**	19	g.153236A>T*	K615X,104,30,Mol_Vis_2009_Apr_17_15_771-777.txt
160834G>C,13	F7	32 y 2 m	2	1 rc	2 rc	21	g.160834G>C	E737D,106,33,Mol_Vis_2009_Apr_17_15_771-777.txt
162237C>T,16	F9	8 y 9 m	1.3	7 rc	5 rc	23	g.162237C>T	R787X,109,34,Mol_Vis_2009_Apr_17_15_771-777.txt
162237C>T,17	F9	1 y10 m	1.3	Rb	1 rc	23	g.162237C>T	R787X,110,32,Mol_Vis_2009_Apr_17_15_771-777.txt
448G>A,...irect sequencing of RHO identified a homozygous c.448G>A mutation resulting in the p.Glu150Lys amino...,13,257,Mol_Vis_2009_Dec_3_15_2526-2534.txt
448G>A,"...in a consanguineous Indian family, a homozygous c.448G>A (p.Glu150Lys) mutation in exon 2 was report...",23,799,Mol_Vis_2009_Dec_3_15_2526-2534.txt
448G>A,"...sequencing of RHO resulted in identification of c.448G>A, a previously reported mutation in exon 2, ...",141,58,Mol_Vis_2009_Dec_3_15_2526-2534.txt
448G>A,...21-IV-1) showing the homozygous mutant sequence c.448G>A. B: Sequencing results of RP21-IV-7 showing...,143,166,Mol_Vis_2009_Dec_3_15_2526-2534.txt
448G>A,...g results of RP21-IV-7 showing the heterozygous c.448G>A sequence. C: Sequence trace of an unaffecte...,143,236,Mol_Vis_2009_Dec_3_15_2526-2534.txt
448G>A,To determine the frequency of the c.448G>A mutation in the general Pakistani populatio...,145,37,Mol_Vis_2009_Dec_3_15_2526-2534.txt
448G>A,"...le only one female, V-3, was homozygous for the c.448G>A mutation. Sequencing of the remaining exons...",145,953,Mol_Vis_2009_Dec_3_15_2526-2534.txt
448G>A,...ni RP cohort to determine the prevalence of the c.448G>A mutation. None of the affected individuals ...,147,184,Mol_Vis_2009_Dec_3_15_2526-2534.txt
448G>A,Founder effect analysis of the c.448G>A mutation in the two Pakistani families (RP2...,158,34,Mol_Vis_2009_Dec_3_15_2526-2534.txt
448G>A,"In this study, we identified the c.448G>A mutation in the RHO gene in two different c...",165,36,Mol_Vis_2009_Dec_3_15_2526-2534.txt
448G>A,"...ermining the population frequency, we found the c.448G>A mutation in the heterozygous state in one o...",165,272,Mol_Vis_2009_Dec_3_15_2526-2534.txt
448G>A,...es from our RP panel that were screened for the c.448G>A mutation. Further investigations of the fam...,165,451,Mol_Vis_2009_Dec_3_15_2526-2534.txt
448G>A,This c.448G>A mutation has previously been reported to ca...,167,8,Mol_Vis_2009_Dec_3_15_2526-2534.txt
38T>G,"...e polymorphisms (SNPs) in OPTN (M98K, R545Q, IVS5+38T>G, IVS8–53T>C, and IVS15+10G>A), one SNP in WD...",12,220,Mol_Vis_2009_Jan_16_15_89-98.txt
53T>C,"...sms (SNPs) in OPTN (M98K, R545Q, IVS5+38T>G, IVS8–53T>C, and IVS15+10G>A), one SNP in WDR36 (IVS5+30...",12,232,Mol_Vis_2009_Jan_16_15_89-98.txt
10G>A,"...N (M98K, R545Q, IVS5+38T>G, IVS8–53T>C, and IVS15+10G>A), one SNP in WDR36 (IVS5+30C>T) as well as t...",12,249,Mol_Vis_2009_Jan_16_15_89-98.txt
30C>T,"...8–53T>C, and IVS15+10G>A), one SNP in WDR36 (IVS5+30C>T) as well as the APOE promoter and ε2/ε3/ε4 p...",12,280,Mol_Vis_2009_Jan_16_15_89-98.txt
35A>G,"...ntified a best 6-factor model for POAG: MYOC IVS2+35A>G, OPTN Met98Lys, OPTN IVS5+38T>G, OPTN IVS8–5...",15,336,Mol_Vis_2009_Jan_16_15_89-98.txt
38T>G,"...r POAG: MYOC IVS2+35A>G, OPTN Met98Lys, OPTN IVS5+38T>G, OPTN IVS8–53T>C, WDR36 IVS5+30C>T, and APOE...",15,368,Mol_Vis_2009_Jan_16_15_89-98.txt
53T>C,"...+35A>G, OPTN Met98Lys, OPTN IVS5+38T>G, OPTN IVS8–53T>C, WDR36 IVS5+30C>T, and APOE −491A>T",15,385,Mol_Vis_2009_Jan_16_15_89-98.txt
30C>T,"...Lys, OPTN IVS5+38T>G, OPTN IVS8–53T>C, WDR36 IVS5+30C>T, and APOE −491A>T",15,403,Mol_Vis_2009_Jan_16_15_89-98.txt
491A>T,"...T>G, OPTN IVS8–53T>C, WDR36 IVS5+30C>T, and APOE −491A>T",15,420,Mol_Vis_2009_Jan_16_15_89-98.txt
603T>A,"...l be performed. Accordingly, five SNPs in OPTN (c.603T>A [M98K], c.1944G>A [R545Q], IVS5+38T>G, IVS8...",40,272,Mol_Vis_2009_Jan_16_15_89-98.txt
1944G>A,"...ccordingly, five SNPs in OPTN (c.603T>A [M98K], c.1944G>A [R545Q], IVS5+38T>G, IVS8–53T>C, and IVS15...",40,289,Mol_Vis_2009_Jan_16_15_89-98.txt
38T>G,"...in OPTN (c.603T>A [M98K], c.1944G>A [R545Q], IVS5+38T>G, IVS8–53T>C, and IVS15+10G>A) were selected,...",40,311,Mol_Vis_2009_Jan_16_15_89-98.txt
53T>C,"...03T>A [M98K], c.1944G>A [R545Q], IVS5+38T>G, IVS8–53T>C, and IVS15+10G>A) were selected, as they had...",40,323,Mol_Vis_2009_Jan_16_15_89-98.txt
10G>A,"...944G>A [R545Q], IVS5+38T>G, IVS8–53T>C, and IVS15+10G>A) were selected, as they had been found to ha...",40,340,Mol_Vis_2009_Jan_16_15_89-98.txt
30C>T,"...ol of our previous studies [3,16]. In WDR36, IVS5+30C>T had been found to be significantly associate...",40,597,Mol_Vis_2009_Jan_16_15_89-98.txt
491A>T,"...CTC CA-3′). In APOE, the promoter polymorphisms (−491A>T, −427T>C, and −219T>G) and the ε2/ε3/ε4 pol...",40,969,Mol_Vis_2009_Jan_16_15_89-98.txt
427T>C,"...). In APOE, the promoter polymorphisms (−491A>T, −427T>C, and −219T>G) and the ε2/ε3/ε4 polymorphism...",40,978,Mol_Vis_2009_Jan_16_15_89-98.txt
219T>G,"...he promoter polymorphisms (−491A>T, −427T>C, and −219T>G) and the ε2/ε3/ε4 polymorphisms in exon 4 (...",40,991,Mol_Vis_2009_Jan_16_15_89-98.txt
526C>T,...9T>G) and the ε2/ε3/ε4 polymorphisms in exon 4 (c.526C>T for ε2 and c.388T>C for ε4) were investigat...,40,1043,Mol_Vis_2009_Jan_16_15_89-98.txt
388T>C,...ε4 polymorphisms in exon 4 (c.526C>T for ε2 and c.388T>C for ε4) were investigated by the TaqMan gen...,40,1063,Mol_Vis_2009_Jan_16_15_89-98.txt
16G>T,"...level). Four variants (Gln161Arg, Gly183Ser, IVS1+16G>T, and Asn428Ser) were novel. They were detect...",53,355,Mol_Vis_2009_Jan_16_15_89-98.txt
126 T>C,Promoter	−126 T>C	-	0 (0)	1 (0.25)	0/0/176	0/1/199,59,11,Mol_Vis_2009_Jan_16_15_89-98.txt
83 G>A,Promoter	−83 G>A	-	16 (4.5)	30 (7.5)	2/12/162	3/24/173,60,11,Mol_Vis_2009_Jan_16_15_89-98.txt
34 G>C,Exon 1	c. 34 G>C	G12R*	3(0.85)	0 (0)	0/3/173	0/0/200,61,11,Mol_Vis_2009_Jan_16_15_89-98.txt
57 G>T,Exon 1	c. 57 G>T	Q19H	0 (0)	1 (0.25)	0/0/176	0/1//199,62,11,Mol_Vis_2009_Jan_16_15_89-98.txt
136 C>T,Exon 1	c. 136 C>T	R46X	2 (0.57)	3 (0.75)	0/2/174	0/3/197,63,11,Mol_Vis_2009_Jan_16_15_89-98.txt
158 T>C,Exon 1	c. 158 T>C	V53A*	1 (0.28)	0 (0)	0/1/175	0/0/200,64,11,Mol_Vis_2009_Jan_16_15_89-98.txt
227 G>A,Exon 1	c. 227 G>A	R76K	13 (3.69)	28 (7)	0/13/163	1/26/173,65,11,Mol_Vis_2009_Jan_16_15_89-98.txt
369 C>T,Exon 1	c. 369 C>T	T123T	2 (0.57)	1 (0.25)	0/2/174	0/1/199,66,11,Mol_Vis_2009_Jan_16_15_89-98.txt
482 A>G,Exon 1	c. 482 A>G	Q161R	0 (0)	1 (0.25)	0/0/176	0/1/199,67,11,Mol_Vis_2009_Jan_16_15_89-98.txt
547 G>A,Exon 1	c. 547 G>A	G183S	0 (0)	1 (0.25)	0/0/176	0/1/199,68,11,Mol_Vis_2009_Jan_16_15_89-98.txt
16 G>T,Intron 1	IVS1+16 G>T	-	0 (0)	1 (0.25)	0/0/176	0/1/199,69,15,Mol_Vis_2009_Jan_16_15_89-98.txt
611 C>T,Exon 2	c. 611 C>T	T204M	0 (0)	2 (0.5)	0/0/176	0/2/198,70,11,Mol_Vis_2009_Jan_16_15_89-98.txt
624 C>G,Exon 2	c. 624 C>G	D208E	1 (0.28)	3 (0.75)	0/1/175	0/3/197,71,11,Mol_Vis_2009_Jan_16_15_89-98.txt
35 A>G,Intron 2	IVS 2+35 A>G	-	69 (19.6)	84 (21)	9/51/116	7/70/123,72,16,Mol_Vis_2009_Jan_16_15_89-98.txt
172 C>A,Intron 2	IVS 2+172 C>A	-	4 (1.14)	1 (0.25)	0/4/172	0/1/199,73,16,Mol_Vis_2009_Jan_16_15_89-98.txt
864 C>T,Exon 3	c. 864 C>T	I288I	1 (0.28)	1 (0.25)	0/1/175	0/1/199,74,11,Mol_Vis_2009_Jan_16_15_89-98.txt
927 G>A,Exon 3	c. 927 G>A	Q309Q	0 (0)	1 (0.25)	0/0/176	0/1/199,75,11,Mol_Vis_2009_Jan_16_15_89-98.txt
1041 T>C,Exon 3	c. 1041 T>C	Y347Y	0 (0)	1 (0.25)	0/0/176	0/1/199,76,11,Mol_Vis_2009_Jan_16_15_89-98.txt
1058 C>T,Exon 3	c. 1058 C>T	T353I*	1 (0.28)	0 (0)	0/1/175	0/0/200,77,11,Mol_Vis_2009_Jan_16_15_89-98.txt
1283 A>G,Exon 3	c. 1283 A>G	N428S	0 (0)	1 (0.25)	0/0/176	0/1/199,78,11,Mol_Vis_2009_Jan_16_15_89-98.txt
1464 C>T,Exon 3	c. 1464 C>T	A488A	0 (0)	2 (0.5)	0/0/176	0/2/198,79,11,Mol_Vis_2009_Jan_16_15_89-98.txt
73 G>C,3′UTR	1515+73 G>C	-	3 (0.85)	1 (0.25)	0/3/173	0/1/199,80,12,Mol_Vis_2009_Jan_16_15_89-98.txt
38T>G,"...ic frequencies of OPTN (Met98Lys, Arg545Gln, IVS5+38T>G, IVS8–53T>C, and IVS15+10G>A) and WDR36 (IVS...",84,58,Mol_Vis_2009_Jan_16_15_89-98.txt
53T>C,"...es of OPTN (Met98Lys, Arg545Gln, IVS5+38T>G, IVS8–53T>C, and IVS15+10G>A) and WDR36 (IVS5+30C>T) fol...",84,70,Mol_Vis_2009_Jan_16_15_89-98.txt
10G>A,"...Lys, Arg545Gln, IVS5+38T>G, IVS8–53T>C, and IVS15+10G>A) and WDR36 (IVS5+30C>T) followed HWE in case...",84,87,Mol_Vis_2009_Jan_16_15_89-98.txt
30C>T,"...T>G, IVS8–53T>C, and IVS15+10G>A) and WDR36 (IVS5+30C>T) followed HWE in cases and controls. No sign...",84,110,Mol_Vis_2009_Jan_16_15_89-98.txt
603 T>A,OPTN	c.603 T>A	M98K	39 (11.08)	48 (12)	3/33/140	3/42/155,91,8,Mol_Vis_2009_Jan_16_15_89-98.txt
1944 G>A,OPTN	c.1944 G>A	R545Q	12 (3)	13 (3.25)	0/12/164	1/11/188,92,8,Mol_Vis_2009_Jan_16_15_89-98.txt
38 T>G,OPTN	IVS5+38 T>G	-	118 (33.5)	121 (30.25)	17/84/75	14/93/93,93,11,Mol_Vis_2009_Jan_16_15_89-98.txt
53 T>C,OPTN	IVS8 −53 T>C	-	27 (7.67)	24 (6)	1/25/150	1/22/177,94,12,Mol_Vis_2009_Jan_16_15_89-98.txt
10G>A,OPTN	IVS15+10G>A	-	8 (2.27)	7 (1.75)	0/8/168	0/7/193,95,12,Mol_Vis_2009_Jan_16_15_89-98.txt
30 C>T,WDR36	IVS 5+30 C>T	-	134 (38.1)	170 (42.5)	22/90/64	33/104/63,96,13,Mol_Vis_2009_Jan_16_15_89-98.txt
491A>T,"Genotypes of all the APOE polymorphisms, i.e., −491A>T, −427T>C, −219T>G, and the ε2/ε3/ε4 polymor...",100,49,Mol_Vis_2009_Jan_16_15_89-98.txt
427T>C,"...es of all the APOE polymorphisms, i.e., −491A>T, −427T>C, −219T>G, and the ε2/ε3/ε4 polymorphism, fo...",100,58,Mol_Vis_2009_Jan_16_15_89-98.txt
219T>G,"... the APOE polymorphisms, i.e., −491A>T, −427T>C, −219T>G, and the ε2/ε3/ε4 polymorphism, followed th...",100,67,Mol_Vis_2009_Jan_16_15_89-98.txt
491 A>T,−491 A>T	T	8 (2.3)	13 (3.25)	TT	0 (0)	0 (0),108,2,Mol_Vis_2009_Jan_16_15_89-98.txt
427 T>C,−427 T>C	C	25 (7.1)	36 (9.0)	CC	1 (0.6)	1 0.5 (0),111,2,Mol_Vis_2009_Jan_16_15_89-98.txt
219 T>G,−219 T>G	G	93 (26.4)	117 (29.25)	GG	10 (5.7)	15 (7....,114,2,Mol_Vis_2009_Jan_16_15_89-98.txt
83G>A,"...vealed one LD block, spanning from the promoter (−83G>A) to exon 1 (c.227G>A). Within this block, po...",126,75,Mol_Vis_2009_Jan_16_15_89-98.txt
227G>A,"... spanning from the promoter (−83G>A) to exon 1 (c.227G>A). Within this block, polymorphisms −83G>A a...",126,95,Mol_Vis_2009_Jan_16_15_89-98.txt
83G>A,"...n 1 (c.227G>A). Within this block, polymorphisms −83G>A and c.227G>A were the only two variants that...",126,138,Mol_Vis_2009_Jan_16_15_89-98.txt
227G>A,"...A). Within this block, polymorphisms −83G>A and c.227G>A were the only two variants that had a minor...",126,150,Mol_Vis_2009_Jan_16_15_89-98.txt
35A>G,...lotype A-A was not associated with glaucoma. IVS2+35A>G was the only other MYOC polymorphism that ha...,126,504,Mol_Vis_2009_Jan_16_15_89-98.txt
491A>T,"...), which are defined by the three promoter SNPs (−491A>T, −427T>C, and −219T>G), were not associated...",130,242,Mol_Vis_2009_Jan_16_15_89-98.txt
427T>C,"...are defined by the three promoter SNPs (−491A>T, −427T>C, and −219T>G), were not associated with POA...",130,251,Mol_Vis_2009_Jan_16_15_89-98.txt
219T>G,"...y the three promoter SNPs (−491A>T, −427T>C, and −219T>G), were not associated with POAG. When the ε...",130,264,Mol_Vis_2009_Jan_16_15_89-98.txt
526C>T,...ted with POAG. When the ε2/ε3/ε4 polymorphisms (c.526C>T and c.388T>C) were included in haplotype an...,130,339,Mol_Vis_2009_Jan_16_15_89-98.txt
388T>C,".... When the ε2/ε3/ε4 polymorphisms (c.526C>T and c.388T>C) were included in haplotype analysis, no co...",130,352,Mol_Vis_2009_Jan_16_15_89-98.txt
35 A>G,"...rom all four genes was identified, including IVS2+35 A>G in MYOC; Met98Lys, IVS5+38T>G, and IVS8–53T...",133,287,Mol_Vis_2009_Jan_16_15_89-98.txt
38T>G,"...ed, including IVS2+35 A>G in MYOC; Met98Lys, IVS5+38T>G, and IVS8–53T>C in OPTN; IVS5+30C>T in WDR36...",133,318,Mol_Vis_2009_Jan_16_15_89-98.txt
53T>C,"...S2+35 A>G in MYOC; Met98Lys, IVS5+38T>G, and IVS8–53T>C in OPTN; IVS5+30C>T in WDR36; and −491A>T in...",133,334,Mol_Vis_2009_Jan_16_15_89-98.txt
30C>T,"...et98Lys, IVS5+38T>G, and IVS8–53T>C in OPTN; IVS5+30C>T in WDR36; and −491A>T in APOE. The combinati...",133,354,Mol_Vis_2009_Jan_16_15_89-98.txt
491A>T,...and IVS8–53T>C in OPTN; IVS5+30C>T in WDR36; and −491A>T in APOE. The combination of these possibly ...,133,375,Mol_Vis_2009_Jan_16_15_89-98.txt
30C>T,"...el. The hierarchical cluster analysis placed IVS5+30C>T (WDR36), IVS8–53T>C (OPTN), and Met98Lys (OP...",133,759,Mol_Vis_2009_Jan_16_15_89-98.txt
53T>C,"... cluster analysis placed IVS5+30C>T (WDR36), IVS8–53T>C (OPTN), and Met98Lys (OPTN) on the same bran...",133,779,Mol_Vis_2009_Jan_16_15_89-98.txt
38T>G,...teraction effect on modulating risk of POAG. IVS5+38T>G (OPTN) and IVS2+35A>G (MYOC) were on another...,133,984,Mol_Vis_2009_Jan_16_15_89-98.txt
35A>G,"...dulating risk of POAG. IVS5+38T>G (OPTN) and IVS2+35A>G (MYOC) were on another branch, revealing an ...",133,1006,Mol_Vis_2009_Jan_16_15_89-98.txt
491A>T,"...r branch, revealing an interaction between them. −491A>T (APOE) was located on a different remote br...",133,1083,Mol_Vis_2009_Jan_16_15_89-98.txt
219T>G,−219T>G	43.61	0.999	5/10,137,2,Mol_Vis_2009_Jan_16_15_89-98.txt
53T>C,IVS8–53T>C and IVS5+30C>T	52.5	0.377	7/10,138,6,Mol_Vis_2009_Jan_16_15_89-98.txt
30C>T,IVS8–53T>C and IVS5+30C>T	52.5	0.377	7/10,138,21,Mol_Vis_2009_Jan_16_15_89-98.txt
35A>G,"IVS2+35A>G, IVS5+30C>T, and −219T>G	43.59	1.0	4/10",139,6,Mol_Vis_2009_Jan_16_15_89-98.txt
30C>T,"IVS2+35A>G, IVS5+30C>T, and −219T>G	43.59	1.0	4/10",139,18,Mol_Vis_2009_Jan_16_15_89-98.txt
219T>G,"IVS2+35A>G, IVS5+30C>T, and −219T>G	43.59	1.0	4/10",139,30,Mol_Vis_2009_Jan_16_15_89-98.txt
35A>G,"IVS2+35A>G, IVS5+30C>T, −219T>G, and 290C>T	47.53	0.945...",140,6,Mol_Vis_2009_Jan_16_15_89-98.txt
30C>T,"IVS2+35A>G, IVS5+30C>T, −219T>G, and 290C>T	47.53	0.945	9/10",140,18,Mol_Vis_2009_Jan_16_15_89-98.txt
219T>G,"IVS2+35A>G, IVS5+30C>T, −219T>G, and 290C>T	47.53	0.945	9/10",140,26,Mol_Vis_2009_Jan_16_15_89-98.txt
290C>T,"IVS2+35A>G, IVS5+30C>T, −219T>G, and 290C>T	47.53	0.945	9/10",140,38,Mol_Vis_2009_Jan_16_15_89-98.txt
30C>T,"A488A, IVS5+38, IVS5+30C>T, −427T>C, and −219T>G	49.16	0.623	10/10",141,22,Mol_Vis_2009_Jan_16_15_89-98.txt
427T>C,"A488A, IVS5+38, IVS5+30C>T, −427T>C, and −219T>G	49.16	0.623	10/10",141,30,Mol_Vis_2009_Jan_16_15_89-98.txt
219T>G,"A488A, IVS5+38, IVS5+30C>T, −427T>C, and −219T>G	49.16	0.623	10/10",141,43,Mol_Vis_2009_Jan_16_15_89-98.txt
35A>G,"IVS2+35A>G, M98K, IVS5+38T>G, IVS8–53T>C, IVS5+30C>T, a...",142,6,Mol_Vis_2009_Jan_16_15_89-98.txt
38T>G,"IVS2+35A>G, M98K, IVS5+38T>G, IVS8–53T>C, IVS5+30C>T, and −491A>T	55.14	0...",142,24,Mol_Vis_2009_Jan_16_15_89-98.txt
53T>C,"IVS2+35A>G, M98K, IVS5+38T>G, IVS8–53T>C, IVS5+30C>T, and −491A>T	55.14	0.0107	10/10",142,36,Mol_Vis_2009_Jan_16_15_89-98.txt
30C>T,"IVS2+35A>G, M98K, IVS5+38T>G, IVS8–53T>C, IVS5+30C>T, and −491A>T	55.14	0.0107	10/10",142,48,Mol_Vis_2009_Jan_16_15_89-98.txt
491A>T,"...G, M98K, IVS5+38T>G, IVS8–53T>C, IVS5+30C>T, and −491A>T	55.14	0.0107	10/10",142,60,Mol_Vis_2009_Jan_16_15_89-98.txt
16G>T,"...d four novel variants, Gln161Arg, Gly183Ser, IVS1+16G>T, and Asn428Ser, each in one control subject,...",148,198,Mol_Vis_2009_Jan_16_15_89-98.txt
83G>A,"...riants, the three common polymorphisms (MAF>1%), −83G>A, R76K, and IVS2+35A>G, were not statisticall...",148,1905,Mol_Vis_2009_Jan_16_15_89-98.txt
35A>G,"...on polymorphisms (MAF>1%), −83G>A, R76K, and IVS2+35A>G, were not statistically associated with POAG...",148,1927,Mol_Vis_2009_Jan_16_15_89-98.txt
83G>A,Promoter	−83G>A	-	37 (6.3)	16 (4.5)	0.26	50 (8.9)	30 (7.5)	0...,155,11,Mol_Vis_2009_Jan_16_15_89-98.txt
227 G>A,Exon 1	c. 227 G>A	R76K	38 (6.5)	13 (3.7)	0.07	51 (9.1)	28 (7...,156,11,Mol_Vis_2009_Jan_16_15_89-98.txt
35A>G,Intron 2	IVS2+35A>G	-	119 (20.2)	69 (19.6)	0.81	91 (16.2)	84 (21...,157,15,Mol_Vis_2009_Jan_16_15_89-98.txt
603 T>A,Exon 5	c.603 T>A	M98K	100 (17.0)	39 (11.1)	0.013	88 (15.7)	...,159,10,Mol_Vis_2009_Jan_16_15_89-98.txt
1944 G>A,Exon 16	c.1944 G>A	R545Q	21 (3.6)	12 (3.0)	0.9	19 (3.4)	13 (...,160,11,Mol_Vis_2009_Jan_16_15_89-98.txt
38T>G,Intron 5	IVS5+38T>G	-	73 (12.4)	118 (33.5)	3.8×10–15	29 (5.2)	12...,161,15,Mol_Vis_2009_Jan_16_15_89-98.txt
53T>C,Intron 8	IVS8–53T>C	-	21 (3.6)	27 (7.7)	0.006	12 (2.1)	24 (6.0)	...,162,15,Mol_Vis_2009_Jan_16_15_89-98.txt
10G>A,Intron 15	IVS15+10G>A	-	9 (1.5)	8 (2.3)	0.41	8 (1.4)	7 (1.75)	0.69...,163,17,Mol_Vis_2009_Jan_16_15_89-98.txt
491A>T,Promoter	−491A>T	-	28 (4.8)	8 (2.3)	0.054	15 (2.7)	13 (3.25)...,165,11,Mol_Vis_2009_Jan_16_15_89-98.txt
427 T>C,Promoter	−427 T>C	-	5 (0.9)	25 (7.1)	1.3×10–7	5 (0.9)	36 (9....,166,11,Mol_Vis_2009_Jan_16_15_89-98.txt
219 T>G,Promoter	−219 T>G	-	222 (37.8)	93 (26.4)	0.00037	187 (33.3)	...,167,11,Mol_Vis_2009_Jan_16_15_89-98.txt
10G>A,"...riant, Arg545Gln, and the intronic variant, IVS15+10G>A, also showed comparable allelic distribution...",171,1130,Mol_Vis_2009_Jan_16_15_89-98.txt
38T>G,"... among the two Chinese populations. However, IVS5+38T>G, which was significantly associated with POA...",171,1231,Mol_Vis_2009_Jan_16_15_89-98.txt
53T>C,"...2=111.8, p=4.0×10−26). Another intronic SNP, IVS8–53T>C, was also found to have higher allelic frequ...",171,1754,Mol_Vis_2009_Jan_16_15_89-98.txt
427T>C,"...in allelic distributions was also found for APOE −427T>C, which presented at significantly higher fr...",171,1981,Mol_Vis_2009_Jan_16_15_89-98.txt
30C>T,"...hinese POAG patients, only one SNP in WDR36, IVS5+30C>T, showed significant association with POAG, a...",173,207,Mol_Vis_2009_Jan_16_15_89-98.txt
491A>T,"...t al. [35] found the APOE promoter polymorphism, −491A>T, interacted with MYOC −1000C>G (MYOC.mt1) t...",175,1016,Mol_Vis_2009_Jan_16_15_89-98.txt
1000C>G,"...oter polymorphism, −491A>T, interacted with MYOC −1000C>G (MYOC.mt1) to increase IOP in POAG patient...",175,1046,Mol_Vis_2009_Jan_16_15_89-98.txt
83G>A,"...ctions for normal tension glaucoma (between MYOC −83G>A and the APOE ε2/ε3/ε4, MYOC IVS2+35A>G and A...",175,1471,Mol_Vis_2009_Jan_16_15_89-98.txt
35A>G,"...ween MYOC −83G>A and the APOE ε2/ε3/ε4, MYOC IVS2+35A>G and APOE −219T>G, as well as OPTN Arg545Gln ...",175,1510,Mol_Vis_2009_Jan_16_15_89-98.txt
219T>G,"... and the APOE ε2/ε3/ε4, MYOC IVS2+35A>G and APOE −219T>G, as well as OPTN Arg545Gln and APOE ε2/ε3/ε...",175,1526,Mol_Vis_2009_Jan_16_15_89-98.txt
10G>A,...s for POAG (between MYOC Thr353Ile and OPTN IVS15+10G>A and between OPTN IVS5+38T>G and APOE −491A>T...,175,1658,Mol_Vis_2009_Jan_16_15_89-98.txt
38T>G,"...353Ile and OPTN IVS15+10G>A and between OPTN IVS5+38T>G and APOE −491A>T). In this present study, a ...",175,1686,Mol_Vis_2009_Jan_16_15_89-98.txt
491A>T,"...IVS15+10G>A and between OPTN IVS5+38T>G and APOE −491A>T). In this present study, a best interaction...",175,1702,Mol_Vis_2009_Jan_16_15_89-98.txt
30C>T,"... interaction dendrogram, the variants, WDR36 IVS5+30C>T and OPTN IVS8–53T>C, are expected to have a ...",175,2095,Mol_Vis_2009_Jan_16_15_89-98.txt
53T>C,"...ram, the variants, WDR36 IVS5+30C>T and OPTN IVS8–53T>C, are expected to have a strong synergistic i...",175,2115,Mol_Vis_2009_Jan_16_15_89-98.txt
38T>G,"...eraction with both. Similarly, variants OPTN IVS5+38T>G and MYOC IVS2+35A>G also have strong synergi...",175,2267,Mol_Vis_2009_Jan_16_15_89-98.txt
35A>G,"...Similarly, variants OPTN IVS5+38T>G and MYOC IVS2+35A>G also have strong synergistic interaction the...",175,2287,Mol_Vis_2009_Jan_16_15_89-98.txt
491A>T,"...ree variants in the first branch. Moreover, APOE −491A>T may have the least degree of interaction wi...",175,2436,Mol_Vis_2009_Jan_16_15_89-98.txt
34C>T,"...subjects. A heterozygous missense substitution, c.34C>T, in CRYAA, which is responsible for the R12C...",15,207,Mol_Vis_2009_Jun_4_15_1127-1138.txt
34C>T,"...ession vector, pcDNA6/myc-His (Invitrogen). The c.34C>T mutation was introduced by polymerase chain ...",222,224,Mol_Vis_2009_Jun_4_15_1127-1138.txt
34C>T,...ous C>T transition at the 34th coding position (c.34C>T) in exon 1 of CRYAA (NM_000394) was identifi...,290,436,Mol_Vis_2009_Jun_4_15_1127-1138.txt
34C>T,"...sults showed a substitution of C to T in CRYAA (c.34C>T), which led to a R12C amino acid change. In ...",292,105,Mol_Vis_2009_Jun_4_15_1127-1138.txt
34C>T,"...tudy, we first reported a heterozygous mutation c.34C>T in exon 1 of CRYAA in a Chinese family affec...",313,60,Mol_Vis_2009_Jun_4_15_1127-1138.txt
34C>T,"In conclusion, the c.34C>T mutation in CRYAA that leads to the R12C sub...",325,22,Mol_Vis_2009_Jun_4_15_1127-1138.txt
413C>G,A de novo heterozygous c.413C>G p.S138X stop mutation was identified in a s...,31,26,Mol_Vis_2009_Nov_21_15_2442-2447.txt
674A>G,c.674A>G	p.Asn225Ser	CPHD	[22],52,3,Mol_Vis_2009_Nov_21_15_2442-2447.txt
674A>G,c.674A>G	p.Asn225Ser	CPHD	[22],53,3,Mol_Vis_2009_Nov_21_15_2442-2447.txt
93C>G,c.93C>G	p.Tyr31X	Microphthalmia	[20],56,3,Mol_Vis_2009_Nov_21_15_2442-2447.txt
289C>T,c.289C>T	p.Gln97X	Extreme microphthalmia	[20],59,3,Mol_Vis_2009_Nov_21_15_2442-2447.txt
289C>T,c.289C>T	p.Gln97X	Inferior iris coloboma OD/ retinal...,60,3,Mol_Vis_2009_Nov_21_15_2442-2447.txt
265C>G,c.265C>G	p.Arg89Gly	bilateral microphthalmia	[11],65,3,Mol_Vis_2009_Nov_21_15_2442-2447.txt
537T>A,c.537T>A	p.Tyr179X	severe microphthalmia and colobom...,67,3,Mol_Vis_2009_Nov_21_15_2442-2447.txt
537T>A,"c.537T>A	p.Tyr179X	bilateral mild microphthalmia, re...",68,3,Mol_Vis_2009_Nov_21_15_2442-2447.txt
295C>T,c.295C>T	p.Gln99X	bilateral anopthalmia	[11],70,3,Mol_Vis_2009_Nov_21_15_2442-2447.txt
397C>A,c.397C>A	p.Pro133Thr	bilateral microphthalmia	[11],71,3,Mol_Vis_2009_Nov_21_15_2442-2447.txt
400C>G,c.400C>G	p.Pro134Ala	anophthalmia OS/ OD normal	[11]...,72,3,Mol_Vis_2009_Nov_21_15_2442-2447.txt
718C>T,...s17] and c.475delC [p.R159fs47]) and one known (c.718C>T [p.R240X]) PAX6 mutations in the affected m...,13,422,Mol_Vis_2009_Oct_17_15_2074-2083.txt
30579567C>T,"I-1	9	g.30579567C>T	R240X	absent pineal gland, optic chias...",48,9,Mol_Vis_2009_Oct_17_15_2074-2083.txt
30579567C>T,II-1	9	g.30579567C>T	R240X	NA	3m	NA	no	no	normal,49,10,Mol_Vis_2009_Oct_17_15_2074-2083.txt
718C>T,"...ase [17]. In Family 3, the previously described c.718C>T (p.R240X) nonsense mutation in exon 9 [2,18...",86,791,Mol_Vis_2009_Oct_17_15_2074-2083.txt
529C>T,"...recurrent mutation in SOX2; one other mutation, c.529C>T, has been noted in three unrelated families...",56,1701,Mol_Vis_2010_Apr_28_16_768-773.txt
453G>A,...onserved with only one synonymous polymorphism (c.453G>A) observed in our patient group (also seen i...,70,722,Mol_Vis_2010_Apr_28_16_768-773.txt
543G>A,SNX5 (NM_152227)	c.543G>A	p.Glu181Glu	rs2273448	Y (hetero) Score=25	Y...,80,20,Mol_Vis_2010_Dec_18_16_2829-2838.txt
98T>A,SNORD17 (NR_003045)	98T>A	Non-coding microRNA	rs753213	N	Y(hetero) Sco...,81,21,Mol_Vis_2010_Dec_18_16_2829-2838.txt
43A>T,C20orf72 (NM_018152)	c.43A>T	p.Ser15Cys	rs11551768	Y (hetero) Score=18	N	...,82,24,Mol_Vis_2010_Dec_18_16_2829-2838.txt
794C>T, 	c.794C>T	p.Thr265Ile	-	N	Y (hetero) Score=2**	N	Y (h...,83,5,Mol_Vis_2010_Dec_18_16_2829-2838.txt
846T>C, 	c.846T>C	p.Asp282Asp	rs28455091	Y (hetero) Score=2*	...,84,5,Mol_Vis_2010_Dec_18_16_2829-2838.txt
347T>G,PTMAP3 (NG_001180)	c.347T>G	p.Val116Gly	-	N*	N*	Y (hetero)	Y (hetero),85,22,Mol_Vis_2010_Dec_18_16_2829-2838.txt
348C>G, 	c.348C>G	p.Val116Val	-	N*	N*	Y (homo)	Y (homo),86,5,Mol_Vis_2010_Dec_18_16_2829-2838.txt
362C>G, 	c.362C>G	p.Thr121Arg	-	N*	N*	Y (homo)	Y (homo),87,5,Mol_Vis_2010_Dec_18_16_2829-2838.txt
415T>C, 	c.415T>C	p.Leu139Leu	-	N*	N*	Y (homo)	Y (homo),88,5,Mol_Vis_2010_Dec_18_16_2829-2838.txt
553T>C, 	c.553T>C	p.Cys185Arg	rs3748493	N*	N*	Y (hetero)	Y (h...,89,5,Mol_Vis_2010_Dec_18_16_2829-2838.txt
843C>T, 	c.843C>T	p.Cys281Cys	rs3748492	N*	Y (homo) Score=4**...,90,5,Mol_Vis_2010_Dec_18_16_2829-2838.txt
327C>A,OVOL2 (NM_021220)	c.327C>A	p.Thr109Thr	rs6111803	Y (hetero) Score=17	N...,92,21,Mol_Vis_2010_Dec_18_16_2829-2838.txt
1199T>G,CSRP2BP (NM_020536)	c.1199T>G	p.Val400Gly	rs1205193	Y (homo) Score=23	Y ...,95,23,Mol_Vis_2010_Dec_18_16_2829-2838.txt
1437C>T, 	c.1437C>T	p.Pro479Pro	rs1205194	N	N	N	N,96,5,Mol_Vis_2010_Dec_18_16_2829-2838.txt
1499C>T, 	c.1499C>T	p.Ala500Val	rs41276418	Y (hetero) Score=25...,97,5,Mol_Vis_2010_Dec_18_16_2829-2838.txt
2223T>C, 	c.2223T>C	p.Pro741Pro	rs2747404	Y (homo) Score=25	Y ...,98,5,Mol_Vis_2010_Dec_18_16_2829-2838.txt
89T>C,MGC44328 (NM_001004344)	c.89T>C	p.Leu30Pro	rs1883938	Y (homo) Score=27	Y (ho...,101,27,Mol_Vis_2010_Dec_18_16_2829-2838.txt
40T>C,C20orf12 (NM_018152)	c.40T>C	p.Leu14Leu	rs6035051	Y (hetero) Score=25	Y (...,102,24,Mol_Vis_2010_Dec_18_16_2829-2838.txt
801T>C, 	c.801T>C	p.Cys267Cys	rs6035042	Y (homo) Score=29	Y (...,103,5,Mol_Vis_2010_Dec_18_16_2829-2838.txt
1410G>C, 	c.1410G>C	p.Leu470Leu	rs6075337	Y (homo) Score=26	Y ...,104,5,Mol_Vis_2010_Dec_18_16_2829-2838.txt
840A>G,POLR3F (NM_006466)	c.840A>G	p.Thr280Thr	rs1055171	Y (homo) Score=26	Y (...,106,22,Mol_Vis_2010_Dec_18_16_2829-2838.txt
136C>G,RPS19P1 (NG_001295)	c.136C>G	p.Pro46Ala	rs2009092	Y (hetero) Score=12	Y ...,109,23,Mol_Vis_2010_Dec_18_16_2829-2838.txt
167G>A, 	c.167G>A	p.Arg56Gln	-	N*	N*	Y (hetero)	N,110,5,Mol_Vis_2010_Dec_18_16_2829-2838.txt
490G>A,SEC23B (NM_032985)	c.490G>A	p.Val164Met	rs36023150	N	N	N	N,111,22,Mol_Vis_2010_Dec_18_16_2829-2838.txt
1198T>C, 	c.1198T>C	p.Phe400Leu	-	N	Y (hetero) Score=8	N	Y(het...,112,5,Mol_Vis_2010_Dec_18_16_2829-2838.txt
1276G>A, 	c.1276G>A	p.Val426Ile	-	N	N	N	N,113,5,Mol_Vis_2010_Dec_18_16_2829-2838.txt
1467C>G, 	c.1467C>G	p.His489Gln	rs2273526	N	Y (hetero) Score=2...,114,5,Mol_Vis_2010_Dec_18_16_2829-2838.txt
48A>G,LOC388789 (XM_939954)	c.48A>G	p.Arg16Arg	rs12624935	N*	N*	N	Y (hetero),115,25,Mol_Vis_2010_Dec_18_16_2829-2838.txt
447A>C,DUXAP7 (NG_004846)	c.447A>C	p.Gln149His	rs6132094	N*	N*	Y (hetero)	Y (h...,117,22,Mol_Vis_2010_Dec_18_16_2829-2838.txt
664A>G, 	c.664A>G	p.Thr222Ala	rs6081271	N*	N*	Y (homo)	Y (hom...,118,5,Mol_Vis_2010_Dec_18_16_2829-2838.txt
665C>T, 	c.665C>T	p.Thr222Ile	rs6081270	N*	N*	Y (hetero)	Y (h...,119,5,Mol_Vis_2010_Dec_18_16_2829-2838.txt
716T>A, 	c.716T>A	p.Ile239Lys	-	N*	N*	Y (hetero)	Y (hetero),120,5,Mol_Vis_2010_Dec_18_16_2829-2838.txt
943G>C, 	c.943G>C	p.Val315Leu	rs6132093	N*	N*	Y (hetero)	Y (h...,126,5,Mol_Vis_2010_Dec_18_16_2829-2838.txt
1124T>C, 	c.1124T>C	p.Val375Ala	rs6081268	N*	N*	Y (hetero)	Y (...,127,5,Mol_Vis_2010_Dec_18_16_2829-2838.txt
1156C>T, 	c.1156C>T	p.Pro386Ser	rs6075382	N*	N*	Y (hetero)	Y (...,128,5,Mol_Vis_2010_Dec_18_16_2829-2838.txt
274C>T,LOC100132358 (NC_000020)	c.274C>T	p.Gln92X	rs6081369	Y (hetero) Score=24	Y (h...,129,28,Mol_Vis_2010_Dec_18_16_2829-2838.txt
172C>T,LOC100270804	172C>T	p.Pro58Ser	rs41309831	Y (hetero) Score=13	N...,131,14,Mol_Vis_2010_Dec_18_16_2829-2838.txt
543G>T,c.543G>T	p.Gly181Gly	rs7262320	Y (hetero) Score=26	N...,132,4,Mol_Vis_2010_Dec_18_16_2829-2838.txt
1343G>A,1343G>A	p.Arg448Arg	rs80046336	Y (hetero) Score=22...,134,2,Mol_Vis_2010_Dec_18_16_2829-2838.txt
138C>G,LOC100128496 (XM_001725705)	c.138C>G	p.Leu46Leu	rs56743271	Y (hetero) Score=19	N...,136,31,Mol_Vis_2010_Dec_18_16_2829-2838.txt
255C>T,C20orf79 (NM_178483)	c.255C>T	p.Thr85Thr	rs1053834	Y (hetero) Score=25	N	...,137,24,Mol_Vis_2010_Dec_18_16_2829-2838.txt
295C>T,c.295C>T	p.Pro99Ser	rs1053839	Y (hetero) Score=20	N	...,138,4,Mol_Vis_2010_Dec_18_16_2829-2838.txt
163G>A,c.163G>A	p.Val55Ile	rs1569767	N	Y (hetero) Score=17	...,140,4,Mol_Vis_2010_Dec_18_16_2829-2838.txt
369G>A,c.369G>A	p.Ala123Ala	rs3790261	Y (Hetero) Score=26	Y...,141,4,Mol_Vis_2010_Dec_18_16_2829-2838.txt
639G>A,c.639G>A	p.Leu213Leu	rs3790278	Y (homo) Score=30	Y (...,142,4,Mol_Vis_2010_Dec_18_16_2829-2838.txt
654T>C,c.654T>C	p.Ile218Ile	rs3790279	Y (homo) Score=26	Y (...,143,4,Mol_Vis_2010_Dec_18_16_2829-2838.txt
846T>C,...hile two variants (c.52_54delCGC in SLC24A3 and c.846T>C in C20orf72) were not reported due to insuf...,153,587,Mol_Vis_2010_Dec_18_16_2829-2838.txt
1410 G>C,...and NGS was the identification of the known SNP c.1410 G>C (rs6075337) in C20orf12 in the heterozygo...,158,986,Mol_Vis_2010_Dec_18_16_2829-2838.txt
846T>C,"...onal screening criterion, with the exception of c.846T>C in C20orf72 (inadequate coverage, 4 reads)....",168,1298,Mol_Vis_2010_Dec_18_16_2829-2838.txt
846T>C,...g regions of the 13 known genes. Two variants (c. 846T>C in C20orf72 and c.843C>T in PTMAP3) that we...,168,1671,Mol_Vis_2010_Dec_18_16_2829-2838.txt
843C>T,... genes. Two variants (c. 846T>C in C20orf72 and c.843C>T in PTMAP3) that were identified by Sanger s...,168,1696,Mol_Vis_2010_Dec_18_16_2829-2838.txt
1702G>C,"Two novel mutations, c.(1702G>C and 1706T>A; p.Arg514Pro and Phe515Leu) in...",13,25,Mol_Vis_2010_Feb_15_16_224-230.txt
1706T>A,"Two novel mutations, c.(1702G>C and 1706T>A; p.Arg514Pro and Phe515Leu) in TGFBI were ...",13,37,Mol_Vis_2010_Feb_15_16_224-230.txt
531C>T,"...fied in Family 1. Two known hotspot mutations, c. 531C>T (p. Arg124Cys) and c.1876A>G (p.His572Arg),...",13,143,Mol_Vis_2010_Feb_15_16_224-230.txt
1876A>G,"...hotspot mutations, c. 531C>T (p. Arg124Cys) and c.1876A>G (p.His572Arg), were revealed in Family 2 a...",13,171,Mol_Vis_2010_Feb_15_16_224-230.txt
1702G>C,...not detect gross structural changes. Mutations c.(1702G>C and 1706T>A; p.Arg514Pro and Phe515Leu) an...,13,577,Mol_Vis_2010_Feb_15_16_224-230.txt
1706T>A,...ross structural changes. Mutations c.(1702G>C and 1706T>A; p.Arg514Pro and Phe515Leu) and the c. 531...,13,589,Mol_Vis_2010_Feb_15_16_224-230.txt
531C>T,...nd 1706T>A; p.Arg514Pro and Phe515Leu) and the c. 531C>T (p. Arg124Cys) were present in the corneas ...,13,636,Mol_Vis_2010_Feb_15_16_224-230.txt
1702G>C,"The novel mutations c.(1702G>C and 1706T>A; p.Arg514Pro and Phe515Leu), c...",16,24,Mol_Vis_2010_Feb_15_16_224-230.txt
1706T>A,"The novel mutations c.(1702G>C and 1706T>A; p.Arg514Pro and Phe515Leu), c. 531C>T (p....",16,36,Mol_Vis_2010_Feb_15_16_224-230.txt
531C>T,"...02G>C and 1706T>A; p.Arg514Pro and Phe515Leu), c. 531C>T (p. Arg124Cys), c.1876A>G (p.His572Arg) in ...",16,76,Mol_Vis_2010_Feb_15_16_224-230.txt
1876A>G,"...14Pro and Phe515Leu), c. 531C>T (p. Arg124Cys), c.1876A>G (p.His572Arg) in TGFBI were responsible fo...",16,101,Mol_Vis_2010_Feb_15_16_224-230.txt
1702G>C,...sponsible for LCD in the 3 families. Mutations c.(1702G>C and 1706T>A) (p.Arg514Pro and Phe515Leu) a...,16,189,Mol_Vis_2010_Feb_15_16_224-230.txt
1706T>A,...r LCD in the 3 families. Mutations c.(1702G>C and 1706T>A) (p.Arg514Pro and Phe515Leu) and the c. 53...,16,201,Mol_Vis_2010_Feb_15_16_224-230.txt
531C>T,...d 1706T>A) (p.Arg514Pro and Phe515Leu) and the c. 531C>T (p. Arg124Cys) were associated with more se...,16,249,Mol_Vis_2010_Feb_15_16_224-230.txt
1702G>C,"...the TGFBI locus markers D5S816, D5S393, and the c.1702G>C and c.1706T>A variants in Family 1",32,784,Mol_Vis_2010_Feb_15_16_224-230.txt
1706T>A,"...s markers D5S816, D5S393, and the c.1702G>C and c.1706T>A variants in Family 1",32,798,Mol_Vis_2010_Feb_15_16_224-230.txt
1702G>C,"...ree families. In Family 1, two novel mutations, c.1702G>C and 1706T>A (p.Arg514Pro and Phe515Leu), i...",61,127,Mol_Vis_2010_Feb_15_16_224-230.txt
1706T>A,".... In Family 1, two novel mutations, c.1702G>C and 1706T>A (p.Arg514Pro and Phe515Leu), in exon 11 of...",61,139,Mol_Vis_2010_Feb_15_16_224-230.txt
531C>T,"... IV-3). In Family 2, a known hotspot mutation, c. 531C>T (p. Arg124Cys), in exon 4 was detected (Fig...",61,418,Mol_Vis_2010_Feb_15_16_224-230.txt
1876A>G,"...d (Figure 7). A recently reported mutation [8], c.1876A>G (p.His572Arg), in exon 13 was identified i...",61,512,Mol_Vis_2010_Feb_15_16_224-230.txt
1702G>C,...6 Sequencing results of the two novel mutations c.1702G>C and 1706T>A (p.Arg514Pro and Phe515Leu) of...,63,58,Mol_Vis_2010_Feb_15_16_224-230.txt
1706T>A,... results of the two novel mutations c.1702G>C and 1706T>A (p.Arg514Pro and Phe515Leu) of TGFBI in Fa...,63,70,Mol_Vis_2010_Feb_15_16_224-230.txt
531C>T,"...equencing results of the heterozygote mutation c. 531C>T (p. Arg124Cys) of TGFBI in Family 2, and th...",65,61,Mol_Vis_2010_Feb_15_16_224-230.txt
1876A>G,"...equencing results of the heterozygote mutations c.1876A>G (p.His572Arg) of TGFBI in Family 3, and th...",67,61,Mol_Vis_2010_Feb_15_16_224-230.txt
1702G>C,"...served c.1702G and c.1706T, suggesting that the c.1702G>C and 1706T>A substitutions were not polymor...",69,124,Mol_Vis_2010_Feb_15_16_224-230.txt
1706T>A,"...2G and c.1706T, suggesting that the c.1702G>C and 1706T>A substitutions were not polymorphisms. Owin...",69,136,Mol_Vis_2010_Feb_15_16_224-230.txt
1702G>C,...e TGFBI locus markers D5S816 and D5S393 and the c.1702G>C and 1706T>A variants could not conclusivel...,69,296,Mol_Vis_2010_Feb_15_16_224-230.txt
1706T>A,...s markers D5S816 and D5S393 and the c.1702G>C and 1706T>A variants could not conclusively identify p...,69,308,Mol_Vis_2010_Feb_15_16_224-230.txt
1702G>C,... their late 20s. This indicates that mutations c.(1702G>C and 1706T>A) (p.Arg514Pro and Phe515Leu) a...,77,216,Mol_Vis_2010_Feb_15_16_224-230.txt
1706T>A,...20s. This indicates that mutations c.(1702G>C and 1706T>A) (p.Arg514Pro and Phe515Leu) and c. 531C>T...,77,228,Mol_Vis_2010_Feb_15_16_224-230.txt
531C>T,...C and 1706T>A) (p.Arg514Pro and Phe515Leu) and c. 531C>T (p. Arg124Cys) have more phenotypic effects...,77,272,Mol_Vis_2010_Feb_15_16_224-230.txt
1876A>G,...Cys) have more phenotypic effects. The mutation c.1876A>G (p.His572Arg) is also identified in Family...,77,339,Mol_Vis_2010_Feb_15_16_224-230.txt
1876A>G,...on in the affected eye [8]. This indicates that c.1876A>G may be particularly associated with the re...,77,1001,Mol_Vis_2010_Feb_15_16_224-230.txt
1702G>C,"...ects. In this present study, 2 novel mutations, c.1702G>C and 1706T>A (p.Arg514Pro and Phe515Leu), a...",81,353,Mol_Vis_2010_Feb_15_16_224-230.txt
1706T>A,"...s present study, 2 novel mutations, c.1702G>C and 1706T>A (p.Arg514Pro and Phe515Leu), are identifie...",81,365,Mol_Vis_2010_Feb_15_16_224-230.txt
34T>C,"... the RP1 protein. The other three variants (c.787+34T>C, p.I408L and p.L2015L) were considered benig...",15,301,Mol_Vis_2010_Jul_15_16_1353-1360.txt
34T>C,Intron 3	c.787+34T>C	/	Novel	20090	0/190,53,16,Mol_Vis_2010_Jul_15_16_1353-1360.txt
1222A>C,Exon 4	c.1222A>C	p.I408L	Novel	20090	0/190,54,10,Mol_Vis_2010_Jul_15_16_1353-1360.txt
2116G>C,Exon 4	c.2116G>C *	p.G706R	 [26]	20121	1/190,55,10,Mol_Vis_2010_Jul_15_16_1353-1360.txt
2615G>A,Exon 4	c.2615G>A	p.R872H	rs444772	43/55	130/190,56,10,Mol_Vis_2010_Jul_15_16_1353-1360.txt
2953A>T,Exon 4	c.2953A>T	p.N985Y	rs2293869	20149	27/190,57,10,Mol_Vis_2010_Jul_15_16_1353-1360.txt
3024G>A,Exon 4	c.3024G>A	p.Q1008Q	 [26]	20090	1/190,58,10,Mol_Vis_2010_Jul_15_16_1353-1360.txt
4108A>G,Exon 4	c.4108A>G	p.K1370E	Novel	20090	0/190,59,10,Mol_Vis_2010_Jul_15_16_1353-1360.txt
4955G>T,Exon 4	c.4955G>T	p.R1652L	Novel	20090	0/190,60,10,Mol_Vis_2010_Jul_15_16_1353-1360.txt
5008G>A,Exon 4	c.5008G>A	p.A1670T	rs446227	44/55	106/190,61,10,Mol_Vis_2010_Jul_15_16_1353-1360.txt
5071T>C,Exon 4	c.5071T>C	p.S1691P	rs414352	44/55	106/190,62,10,Mol_Vis_2010_Jul_15_16_1353-1360.txt
5175A>G,Exon 4	c.5175A>G	p.Q1725Q	rs441800	44/55	106/190,63,10,Mol_Vis_2010_Jul_15_16_1353-1360.txt
6045A>G,Exon 4	c.6045A>G	p.L2015L	Novel	20090	0/190,64,10,Mol_Vis_2010_Jul_15_16_1353-1360.txt
6098G>A,Exon 4	c.6098G>A	p.C2033Y	rs61739567	20149	27/190,65,10,Mol_Vis_2010_Jul_15_16_1353-1360.txt
6542C>T,Exon 4 (3′UTR)	c.6542C>T	/	 [26]	20149	2/190,66,18,Mol_Vis_2010_Jul_15_16_1353-1360.txt
6542C>T,"...ariants, three of which (p.G706R, p.Q1008Q, and c.6542C>T) occurred in both the case and control sub...",69,82,Mol_Vis_2010_Jul_15_16_1353-1360.txt
34T>C,"...f China. Two of them (p.L2015L and intronic c.787+34T>C) did not lead to amino acid change, while th...",69,286,Mol_Vis_2010_Jul_15_16_1353-1360.txt
1222A>C,Exon 4	c.1222A>C	p.I408L	adRP	F	56	0/552	Borderline	1.234	T...,76,10,Mol_Vis_2010_Jul_15_16_1353-1360.txt
4108A>G,Exon 4	c.4108A>G	p.K1370E	sRP	F	61	0/552	Potentially damagi...,77,10,Mol_Vis_2010_Jul_15_16_1353-1360.txt
4955G>T,Exon 4	c.4955G>T	p.R1652L	sRP	F	50	0/552	Possibly damaging	...,78,10,Mol_Vis_2010_Jul_15_16_1353-1360.txt
1118C>T,p.T373I*	c.1118C>T	Pakistan	ARRP	[18],105,12,Mol_Vis_2010_Jul_15_16_1353-1360.txt
2005G>A,p.A669T	c.2005G>A	Pakistan	ARRP	[18],107,11,Mol_Vis_2010_Jul_15_16_1353-1360.txt
2951A>G,p.D984G	c.2951A>G	Chinese	ADRP	[21],108,11,Mol_Vis_2010_Jul_15_16_1353-1360.txt
2954A>T,p.N985Y	c.2954A>T	Chinese	ADRP	[39],109,11,Mol_Vis_2010_Jul_15_16_1353-1360.txt
4108A>G,p.K1370E	c.4108A>G	Chinese	SRP	Present Study,110,12,Mol_Vis_2010_Jul_15_16_1353-1360.txt
4955G>T,p.R1652L	c.4955G>T	Chinese	SRP	Present Study,111,12,Mol_Vis_2010_Jul_15_16_1353-1360.txt
5423T>C,p.L1808P	c.5423T>C	U.S.A.	ADRP	[16],112,12,Mol_Vis_2010_Jul_15_16_1353-1360.txt
319G>A,... of the candidate genes detected a heterozygous c.319G>A change in the coding region of the major in...,15,276,Mol_Vis_2010_Mar_25_16_534-539.txt
319G>A,"...ed a heterozygous change, G>A, at position 319 (c.319G>A) in MIP in all of the affected individuals ...",46,127,Mol_Vis_2010_Mar_25_16_534-539.txt
319G>A,...s ADCC Chinese family. A heterozygous mutation (c.319G>A) in exon 1 of MIP (black triangles) is show...,48,147,Mol_Vis_2010_Mar_25_16_534-539.txt
1 G>A,IVS3–1 G>A		AD	COOH-terminus	Snail-like	Chinese	[13],72,6,Mol_Vis_2010_Mar_25_16_534-539.txt
319G>A,...unction-forming interactions of AQP0. The novel c.319G>A transition results in the substitution of a...,75,493,Mol_Vis_2010_Mar_25_16_534-539.txt
266A>G,c266A>G	Q89R	FEVR; LBM; spinal osteoarthritis	Unkno...,29,2,Mol_Vis_2011_Apr_8_17_894-902.txt
331G>T,c331G>T	D111Y	HBM	Increase	Decreases Dkk1 and SOST ...,30,2,Mol_Vis_2011_Apr_8_17_894-902.txt
461G>T,c461G>T	R154M	HBM	Increase	Decreases SOST inhibitio...,31,2,Mol_Vis_2011_Apr_8_17_894-902.txt
511G>C,c511G>C	G171R	HBM	Increase	Decreases Dkk1 and SOST ...,32,2,Mol_Vis_2011_Apr_8_17_894-902.txt
512G>T,c512G>T	G171V	HBM	Increase	Decreases MESD binding; ...,33,2,Mol_Vis_2011_Apr_8_17_894-902.txt
593A>G,c593A>G	N198S	HBM	Increase	Decreases SOST inhibitio...,34,2,Mol_Vis_2011_Apr_8_17_894-902.txt
640G>A,c640G>A	A214T	HBM	Increase	Decreases Dkk1 and SOST ...,35,2,Mol_Vis_2011_Apr_8_17_894-902.txt
724G>A,c724G>A	A242T	HBM	Increase	Decreases Dkk1 and SOST ...,36,2,Mol_Vis_2011_Apr_8_17_894-902.txt
758C>T,c758C>T	T253I	HBM	Increase	Decreases Dkk1 and SOST ...,37,2,Mol_Vis_2011_Apr_8_17_894-902.txt
844A>G,c844A>G	M282V	HBM	Increase	Decreases Dkk1 and SOST ...,38,2,Mol_Vis_2011_Apr_8_17_894-902.txt
1330C>T,c1330C>T	R444C	FEVR	Decrease	Inhibits Norrin-FZD4 m...,39,2,Mol_Vis_2011_Apr_8_17_894-902.txt
1481G>A,c1481G>A	R494Q	OPPG	Decrease	Increases Dkk1 inhibit...,40,2,Mol_Vis_2011_Apr_8_17_894-902.txt
1564G>A,c1564G>A	A522T	FEVR	Decrease	Inhibits norrin-FZD4 m...,41,2,Mol_Vis_2011_Apr_8_17_894-902.txt
1708C>T,c1708C>T	R570W	OPPG	Decrease	Increases Dkk1 inhibit...,42,2,Mol_Vis_2011_Apr_8_17_894-902.txt
3989C>T,c3989C>T	A1330V	FEVR	Decrease	Inhibits norrin-FZD4 ...,43,2,Mol_Vis_2011_Apr_8_17_894-902.txt
4574T>C,c4574T>C#	V1525A#	BMD#	Decrease	Unknown	[34],44,2,Mol_Vis_2011_Apr_8_17_894-902.txt
4619C>T,c4619C>T	T1540M	FEVR	Decrease	Inhibits norrin-FZD4 ...,45,2,Mol_Vis_2011_Apr_8_17_894-902.txt
4643G>T,c4643G>T	C1548F	FEVR	Decrease	Inhibits norrin-FZD4 ...,46,2,Mol_Vis_2011_Apr_8_17_894-902.txt
144 G>T,...variation (Figure 1). The Gln48His variation is a 144 G>T transversion which resulted in a non-conse...,89,126,Mol_Vis_2011_Dec_15_17_3243-3253.txt
3635G>A,...nce variation of Chinese families with mutation m.3635G>A and Leber hereditary optic neuropathy Bi R...,3,182,Mol_Vis_2012_Dec_30_18_3087-3094.txt
3460G>A,"...ee mitochondrial DNA (mtDNA) primary mutations (m.3460G>A, m.11778G>A, and m.14484T>C). In recent st...",4,138,Mol_Vis_2012_Dec_30_18_3087-3094.txt
11778G>A,"...drial DNA (mtDNA) primary mutations (m.3460G>A, m.11778G>A, and m.14484T>C). In recent studies, we a...",4,149,Mol_Vis_2012_Dec_30_18_3087-3094.txt
14484T>C,"...) primary mutations (m.3460G>A, m.11778G>A, and m.14484T>C). In recent studies, we and others have s...",4,165,Mol_Vis_2012_Dec_30_18_3087-3094.txt
3635G>A,"...studies, we and others have shown that mutation m.3635G>A is a primary LHON mutation, particularly i...",4,236,Mol_Vis_2012_Dec_30_18_3087-3094.txt
3635G>A,...ome sequence variation in Chinese patients with m.3635G>A and to identify potentially functional var...,4,434,Mol_Vis_2012_Dec_30_18_3087-3094.txt
3635G>A,...tentially functional variants cosegregated with m.3635G>A,4,510,Mol_Vis_2012_Dec_30_18_3087-3094.txt
3635G>A,...mes of five Chinese patients with LHON carrying m.3635G>A were determined. A phylogenetic tree was c...,7,74,Mol_Vis_2012_Dec_30_18_3087-3094.txt
3635G>A,"...b6 (Le834), which suggested multiple origins of m.3635G>A. Private variants m.12811T>C, m.14063T>C, ...",10,183,Mol_Vis_2012_Dec_30_18_3087-3094.txt
12811T>C,"...multiple origins of m.3635G>A. Private variants m.12811T>C, m.14063T>C, m.15237T>C, and m.9071C>T in...",10,211,Mol_Vis_2012_Dec_30_18_3087-3094.txt
14063T>C,"...gins of m.3635G>A. Private variants m.12811T>C, m.14063T>C, m.15237T>C, and m.9071C>T in these patie...",10,223,Mol_Vis_2012_Dec_30_18_3087-3094.txt
15237T>C,"...35G>A. Private variants m.12811T>C, m.14063T>C, m.15237T>C, and m.9071C>T in these patients were pre...",10,235,Mol_Vis_2012_Dec_30_18_3087-3094.txt
9071C>T,"...ariants m.12811T>C, m.14063T>C, m.15237T>C, and m.9071C>T in these patients were predicted to change...",10,251,Mol_Vis_2012_Dec_30_18_3087-3094.txt
3635G>A,Mutation m.3635G>A had multiple origins in Chinese patients w...,13,12,Mol_Vis_2012_Dec_30_18_3087-3094.txt
3635G>A,...tentially functional variants cosegregated with m.3635G>A,13,151,Mol_Vis_2012_Dec_30_18_3087-3094.txt
3460G>A,"...,2]. Three mitochondrial DNA (mtDNA) mutations (m.3460G>A in the MT-ND1 gene, m.11778G>A in the MT-N...",18,220,Mol_Vis_2012_Dec_30_18_3087-3094.txt
11778G>A,"...mtDNA) mutations (m.3460G>A in the MT-ND1 gene, m.11778G>A in the MT-ND4 gene, and m.14484T>C in the...",18,250,Mol_Vis_2012_Dec_30_18_3087-3094.txt
14484T>C,"...MT-ND1 gene, m.11778G>A in the MT-ND4 gene, and m.14484T>C in the MT-ND6 gene) are the main etiologi...",18,285,Mol_Vis_2012_Dec_30_18_3087-3094.txt
3635G>A,"...visional) pathogenic mutations (e.g., mutations m.3635G>A and m.10680G>A) in patients who present ty...",18,564,Mol_Vis_2012_Dec_30_18_3087-3094.txt
10680G>A,"...ogenic mutations (e.g., mutations m.3635G>A and m.10680G>A) in patients who present typical clinical...",18,578,Mol_Vis_2012_Dec_30_18_3087-3094.txt
3635G>A,Mutation m.3635G>A was first identified in a Russian family w...,20,12,Mol_Vis_2012_Dec_30_18_3087-3094.txt
3635G>A,"...f the MT-ND1 protein. In recent years, mutation m.3635G>A was occasionally reported in various Chine...",20,293,Mol_Vis_2012_Dec_30_18_3087-3094.txt
3635G>A,"...leton cases with LHON [5,7,8]. The frequency of m.3635G>A was found to be similar to that of m.3460G...",20,416,Mol_Vis_2012_Dec_30_18_3087-3094.txt
3460G>A,...of m.3635G>A was found to be similar to that of m.3460G>A in Chinese patients with LHON [8] and was ...,20,461,Mol_Vis_2012_Dec_30_18_3087-3094.txt
3635G>A,...uence variation in these patients with LHON and m.3635G>A has been conducted to date,20,672,Mol_Vis_2012_Dec_30_18_3087-3094.txt
3635G>A,"... genomes of five Chinese patients with LHON and m.3635G>A. We analyzed the new sequence data, togeth...",22,98,Mol_Vis_2012_Dec_30_18_3087-3094.txt
3635G>A,...r previously reported mtDNA sequences harboring m.3635G>A by using a phylogenetic approach. We aimed...,22,209,Mol_Vis_2012_Dec_30_18_3087-3094.txt
3635G>A,...netic approach. We aimed to learn the origin of m.3635G>A in Han Chinese and to identify potentially...,22,285,Mol_Vis_2012_Dec_30_18_3087-3094.txt
3635G>A,...unctional variants that may act in synergy with m.3635G>A. Our results suggested multiple origins of...,22,387,Mol_Vis_2012_Dec_30_18_3087-3094.txt
3635G>A,...5G>A. Our results suggested multiple origins of m.3635G>A in Han Chinese,22,440,Mol_Vis_2012_Dec_30_18_3087-3094.txt
3635G>A,"...3, EU807741.1, FJ969382.1, and FJ969383.1) with m.3635G>A [4,5,7], was conducted following the same ...",29,954,Mol_Vis_2012_Dec_30_18_3087-3094.txt
3635G>A,Though mutation m.3635G>A has been reported in several families with...,35,19,Mol_Vis_2012_Dec_30_18_3087-3094.txt
3635G>A,...me sequence variation in patients with LHON and m.3635G>A is needed to identify mtDNA mutations that...,35,249,Mol_Vis_2012_Dec_30_18_3087-3094.txt
3635G>A,"... mutations that enact a synergistic effect with m.3635G>A. In this study, five entire mtDNA genomes ...",35,334,Mol_Vis_2012_Dec_30_18_3087-3094.txt
3635G>A,... mtDNA genomes that had been reported to harbor m.3635G>A [8] were sequenced and were analyzed toget...,35,419,Mol_Vis_2012_Dec_30_18_3087-3094.txt
3635G>A,"...d four other previously reported sequences with m.3635G>A (Le1143, EU807741.1, FJ969382.1, and FJ969...",37,231,Mol_Vis_2012_Dec_30_18_3087-3094.txt
3635G>A,"...plogroup status, indicating multiple origins of m.3635G>A, similar to the other mtDNA pathogenic mut...",37,1081,Mol_Vis_2012_Dec_30_18_3087-3094.txt
3635G>A,"...5,21,28]. We further searched the occurrence of m.3635G>A in 15,859 complete or nearly complete mtDN...",37,1193,Mol_Vis_2012_Dec_30_18_3087-3094.txt
3635G>A,...l web server [24]. No other sequence containing m.3635G>A was identified (Table 1),37,1357,Mol_Vis_2012_Dec_30_18_3087-3094.txt
3635G>A,...tion tree of nine complete mtDNA sequences with m.3635G>A. The revised Cambridge Reference Sequence ...,39,81,Mol_Vis_2012_Dec_30_18_3087-3094.txt
3635G>A,...ivate variants in complete mtDNA sequences with m.3635G>A,41,88,Mol_Vis_2012_Dec_30_18_3087-3094.txt
3635G>A,Allg	m.3635G>A (p.S110N)	MT-ND1	No	Yes	No	4/15859	1	0.797...,43,8,Mol_Vis_2012_Dec_30_18_3087-3094.txt
5301A>G,"Le329, Le337	m.5301A>G (p.I278V)	MT-ND2	Yes	Yes	Yes (M6, D5, H1e1...",44,16,Mol_Vis_2012_Dec_30_18_3087-3094.txt
14063T>C, 	m.14063T>C (p.I576T)	MT-ND5	Yes	Yes	No	12/15859	0.25...,45,5,Mol_Vis_2012_Dec_30_18_3087-3094.txt
12811T>C," 	m.12811T>C (p.Y159H)	MT-ND5	Yes	Yes	Yes (H3h, A2h1, ...",46,5,Mol_Vis_2012_Dec_30_18_3087-3094.txt
15237T>C, 	m.15237T>C (p.I164T)	MT-CYB	Yes	No	No	2/15859	1	0.50...,47,5,Mol_Vis_2012_Dec_30_18_3087-3094.txt
5773G>A,"Le569	m.5773G>A	MT-TC	Yes	Yes	Yes (L0d3, A5a1a1, M13a, M24...",48,9,Mol_Vis_2012_Dec_30_18_3087-3094.txt
8551T>C,EU807741.1	m.8551T>C (p.F9L)	MT-ATP6	Yes	Yes	No	10/15859	1	0.74...,49,14,Mol_Vis_2012_Dec_30_18_3087-3094.txt
7868C>T,FJ969382.1	m.7868C>T (p.L95F)	MT-CO2	Yes	Yes	No	12/15859	0.15	0...,50,14,Mol_Vis_2012_Dec_30_18_3087-3094.txt
9071C>T, 	m.9071C>T (p.S182L)	MT-ATP6	Yes	Yes	Yes (H16c)	5/158...,51,5,Mol_Vis_2012_Dec_30_18_3087-3094.txt
12358A>G," 	m.12358A>G (p.T8A)	MT-ND5	Yes	Yes	Yes (B4e, P4a, N1a...",52,5,Mol_Vis_2012_Dec_30_18_3087-3094.txt
3421G>A,"FJ969383.1	m.3421G>A (p.V39I)	MT-ND1	Yes	Yes	Yes (D4n, HV1a3, W...",53,14,Mol_Vis_2012_Dec_30_18_3087-3094.txt
3635G>A,"...n 10 August, 2012 (e.g., both “G3635A mtDNA” and “3635G>A mtDNA” were queried). cThe haplogroup-spec...",54,285,Mol_Vis_2012_Dec_30_18_3087-3094.txt
3635G>A,...the variant is pathogenic. gAll samples contain m.3635G>A,54,1282,Mol_Vis_2012_Dec_30_18_3087-3094.txt
3635G>A,"... functional mutations could act in synergy with m.3635G>A, the non-synonymous, mitochondrial tRNA an...",56,240,Mol_Vis_2012_Dec_30_18_3087-3094.txt
3635G>A,"...membrane regions (Table 1 and Figure 2). Except m.3635G>A, a total of ten non-synonymous and mt tRNA...",56,537,Mol_Vis_2012_Dec_30_18_3087-3094.txt
5301A>G,...te variants were identified in Le329 and Le337 (m.5301A>G [MT-ND2: p.I278V]; m.14063T>C [MT-ND5: p.I...,56,643,Mol_Vis_2012_Dec_30_18_3087-3094.txt
14063T>C,...n Le329 and Le337 (m.5301A>G [MT-ND2: p.I278V]; m.14063T>C [MT-ND5: p.I576T]; m.12811T>C [MT-ND5: p....,56,672,Mol_Vis_2012_Dec_30_18_3087-3094.txt
12811T>C,...MT-ND2: p.I278V]; m.14063T>C [MT-ND5: p.I576T]; m.12811T>C [MT-ND5: p.Y159H] and m.15237T>C [MT-CYB:...,56,702,Mol_Vis_2012_Dec_30_18_3087-3094.txt
15237T>C,"...ND5: p.I576T]; m.12811T>C [MT-ND5: p.Y159H] and m.15237T>C [MT-CYB: p.I164T]), Le569 (m.5773G>A, [MT...",56,735,Mol_Vis_2012_Dec_30_18_3087-3094.txt
5773G>A,"...159H] and m.15237T>C [MT-CYB: p.I164T]), Le569 (m.5773G>A, [MT-TC]), EU807741.1 (m.8551T>C [MT-ATP6:...",56,773,Mol_Vis_2012_Dec_30_18_3087-3094.txt
8551T>C,"...164T]), Le569 (m.5773G>A, [MT-TC]), EU807741.1 (m.8551T>C [MT-ATP6: p.F9L]), FJ969382.1 (m.7868C>T [...",56,806,Mol_Vis_2012_Dec_30_18_3087-3094.txt
7868C>T,"...741.1 (m.8551T>C [MT-ATP6: p.F9L]), FJ969382.1 (m.7868C>T [MT-CO2: p.L95F]; m.9071C>T [MT-ATP6: p.S1...",56,847,Mol_Vis_2012_Dec_30_18_3087-3094.txt
9071C>T,"....F9L]), FJ969382.1 (m.7868C>T [MT-CO2: p.L95F]; m.9071C>T [MT-ATP6: p.S182L] and m.12358A>G [MT-ND5:...",56,875,Mol_Vis_2012_Dec_30_18_3087-3094.txt
12358A>G,"...-CO2: p.L95F]; m.9071C>T [MT-ATP6: p.S182L] and m.12358A>G [MT-ND5: p.T8A]), and FJ969383.1 (m.3421G...",56,908,Mol_Vis_2012_Dec_30_18_3087-3094.txt
3421G>A,"...nd m.12358A>G [MT-ND5: p.T8A]), and FJ969383.1 (m.3421G>A [MT-ND1: p.V39I]; Table 1). Employing stan...",56,953,Mol_Vis_2012_Dec_30_18_3087-3094.txt
12811T>C,...re predicted by the TMPRED program. A: Variants m.12811T>C (p.Y159H) and m.14063T>C (p.I576T) change...,58,195,Mol_Vis_2012_Dec_30_18_3087-3094.txt
14063T>C,...D program. A: Variants m.12811T>C (p.Y159H) and m.14063T>C (p.I576T) changed the structure of the me...,58,220,Mol_Vis_2012_Dec_30_18_3087-3094.txt
15237T>C,...anning region of the MT-ND5 protein. B: Variant m.15237T>C (p.I164T) changed the structure of the me...,58,329,Mol_Vis_2012_Dec_30_18_3087-3094.txt
9071C>T,...anning region of the MT-CYB protein. C: Variant m.9071C>T (p.S182L) changed the structure of the mem...,58,438,Mol_Vis_2012_Dec_30_18_3087-3094.txt
12811T>C,"...or “suspected” LHON-associated mutation, except m.12811T>C in family Le329 and sample Le337, which w...",60,113,Mol_Vis_2012_Dec_30_18_3087-3094.txt
14063T>C,"...potentially functional non-synonymous variants (m.14063T>C and m.15237T>C, Table 1, Figure 1). These...",60,499,Mol_Vis_2012_Dec_30_18_3087-3094.txt
15237T>C,"...ctional non-synonymous variants (m.14063T>C and m.15237T>C, Table 1, Figure 1). These two variants, ...",60,514,Mol_Vis_2012_Dec_30_18_3087-3094.txt
12811T>C,"...1, Figure 1). These two variants, together with m.12811T>C, showed the ability to change the structu...",60,580,Mol_Vis_2012_Dec_30_18_3087-3094.txt
3635G>A,"Among all LHON cases with m.3635G>A analyzed in this study, families EU807741....",62,29,Mol_Vis_2012_Dec_30_18_3087-3094.txt
8551T>C,"...4] contained one non-synonymous private variant m.8551T>C, but it did not change the MT-ATP6 protein...",62,254,Mol_Vis_2012_Dec_30_18_3087-3094.txt
7868C>T,"..., and high pathogenic score (Table 1). Mutation m.7868C>T was considered the reason for the high pen...",62,654,Mol_Vis_2012_Dec_30_18_3087-3094.txt
9071C>T,"...r potentially functional non-synonymous variant m.9071C>T in this lineage, with the ability to influ...",62,841,Mol_Vis_2012_Dec_30_18_3087-3094.txt
3635G>A,"..., indicating its potentially synergic role with m.3635G>A",62,996,Mol_Vis_2012_Dec_30_18_3087-3094.txt
5301A>G,"...mtDNA tree Build 14, 5 Apr 2012 [21-23]): e.g., m.5301A>G and m.12811T>C in sequences Le329 and Le33...",64,244,Mol_Vis_2012_Dec_30_18_3087-3094.txt
12811T>C,"...ld 14, 5 Apr 2012 [21-23]): e.g., m.5301A>G and m.12811T>C in sequences Le329 and Le337 are haplogro...",64,258,Mol_Vis_2012_Dec_30_18_3087-3094.txt
5773G>A,"...or haplogroups D5 and M7b1’2’4–8, respectively; m.5773G>A in sequence Le569 is a haplogroup-specific...",64,380,Mol_Vis_2012_Dec_30_18_3087-3094.txt
9071C>T,"...aplogroups, including A5a1a1, L0d3, and others; m.9071C>T and m.12358A>G in sequence FJ969382.1 are ...",64,499,Mol_Vis_2012_Dec_30_18_3087-3094.txt
12358A>G,"...cluding A5a1a1, L0d3, and others; m.9071C>T and m.12358A>G in sequence FJ969382.1 are haplogroup-spe...",64,513,Mol_Vis_2012_Dec_30_18_3087-3094.txt
3421G>A,"...for haplogroups H16c and B4e, respectively; and m.3421G>A in sequence FJ969383.1 is a haplogroup-spe...",64,628,Mol_Vis_2012_Dec_30_18_3087-3094.txt
12811T>C,"...HV1a3, and so on (Table 1). Except for variants m.12811T>C and m.9071C>T that have been discussed ab...",64,780,Mol_Vis_2012_Dec_30_18_3087-3094.txt
9071C>T,"...n (Table 1). Except for variants m.12811T>C and m.9071C>T that have been discussed above, these vari...",64,795,Mol_Vis_2012_Dec_30_18_3087-3094.txt
3635G>A,... excluding their potentially synergic role with m.3635G>A. Through analyzing all private variants in...,64,1120,Mol_Vis_2012_Dec_30_18_3087-3094.txt
3635G>A,...ome sequence variation in Chinese patients with m.3635G>A was comprehensively analyzed in this study...,66,84,Mol_Vis_2012_Dec_30_18_3087-3094.txt
3635G>A,...analyzed in this study. Our results showed that m.3635G>A arose independently in different mtDNA hap...,66,162,Mol_Vis_2012_Dec_30_18_3087-3094.txt
3635G>A,"...tDNA private variants in patients with LHON and m.3635G>A, we identified several variants that may a...",66,311,Mol_Vis_2012_Dec_30_18_3087-3094.txt
3635G>A,"...d several variants that may act in synergy with m.3635G>A. However, we used only the evolutionary co...",66,382,Mol_Vis_2012_Dec_30_18_3087-3094.txt
3635G>A,...  Zhang Q  Yao Y-G   Mitochondrial DNA mutation m.3635G>A may be associated with Leber hereditary op...,78,83,Mol_Vis_2012_Dec_30_18_3087-3094.txt
3635G>A,8 Jia X  Li S  Wang P  Guo X  Zhang Q   mtDNA m.3635G>A may be classified as a common primary muta...,79,49,Mol_Vis_2012_Dec_30_18_3087-3094.txt
10680G>A,...  Zhang Q  Yao Y-G   Mitochondrial DNA mutation m.10680G>A is associated with Leber hereditary optic...,80,76,Mol_Vis_2012_Dec_30_18_3087-3094.txt
14484T>C,... distribution in Chinese patients with LHON and m.14484T>C. PLoS ONE 2010 5 e13426 20976138,86,161,Mol_Vis_2012_Dec_30_18_3087-3094.txt
3460G>A,...r characterization of six Chinese families with m.3460G>A and Leber hereditary optic neuropathy. Neu...,99,123,Mol_Vis_2012_Dec_30_18_3087-3094.txt
471G>A,"...quencing of the candidate gene cluster showed a c.471G>A transition in exon 3 of CRYGC, which co-seg...",13,145,Mol_Vis_2012_Jul_11_18_1874-1880.txt
471G>A,...his study identified a disease-causing mutation c.471G>A in CRYGC in a Chinese family with cataracts...,16,52,Mol_Vis_2012_Jul_11_18_1874-1880.txt
471G>A,...residue to a stop codon (W157X). The transition c.471G>A was not found in any of the unaffected fami...,81,317,Mol_Vis_2012_Jul_11_18_1874-1880.txt
471G>A,...the COOH-terminus of γC-crystallin as result of c.471G>A mutation,90,295,Mol_Vis_2012_Jul_11_18_1874-1880.txt
471G>A,"In this study, we report a nonsense mutation (c.471G>A) in exon 3 of CRYGC resulting in autosomal ...",93,49,Mol_Vis_2012_Jul_11_18_1874-1880.txt
471G>A,"...e mutant transcripts of this nonsense mutation (c.471G>A, p.W157X) may escape the NMD pathway and th...",97,449,Mol_Vis_2012_Jul_11_18_1874-1880.txt
471G>A,"...GC. The mutation detected in our present study, c.471G>A, creates a premature stop codon (W157X) and...",97,1010,Mol_Vis_2012_Jul_11_18_1874-1880.txt
471G>A,"...s listed in Table 2 [21-27]. In addition to the c.471G>A mutation, the other phenotypes described in...",99,155,Mol_Vis_2012_Jul_11_18_1874-1880.txt
470G>A,"...G>A transition in the previous W157X report was c.470G>A (TGG→TAG) in CRYGC. However, in our paper, ...",99,833,Mol_Vis_2012_Jul_11_18_1874-1880.txt
471G>A,"...r, in our paper, the site of G>A transition was c.471G>A (TGG→TGA) in CRYGC (Table 2). The previous ...",99,916,Mol_Vis_2012_Jul_11_18_1874-1880.txt
471G>A,... The two families have different pedigrees. The c.471G>A transition in CRYGC is the first reported. ...,99,1124,Mol_Vis_2012_Jul_11_18_1874-1880.txt
470G>A,...oximately 9 mm. The previous W157X report was a c.470G>A transition and the clinical phenotype also ...,99,1326,Mol_Vis_2012_Jul_11_18_1874-1880.txt
13A>C,c.13A>C	T5P	GKM1	Coppock-like	[21],103,3,Mol_Vis_2012_Jul_11_18_1874-1880.txt
502C>T,c.502C>T	R168W	GKM4	Lamellar	[23],105,3,Mol_Vis_2012_Jul_11_18_1874-1880.txt
502C>T,c.502C>T	R168W	GKM4	Nuclear	[24],106,3,Mol_Vis_2012_Jul_11_18_1874-1880.txt
327C>A,c.327C>A	C109X	GKM3	Nuclear	[25],107,3,Mol_Vis_2012_Jul_11_18_1874-1880.txt
470G>A,c.470G>A	W157X	GKM4	Nuclear + Microcornea	[26],108,3,Mol_Vis_2012_Jul_11_18_1874-1880.txt
385G>T,c.385G>T	G129C	GKM4	Nuclear	[27],109,3,Mol_Vis_2012_Jul_11_18_1874-1880.txt
471G>A,c.471G>A	W157X	GKM4	Nuclear + Microcornea	Present st...,110,3,Mol_Vis_2012_Jul_11_18_1874-1880.txt
471G>A,"...esent study has identified a nonsense mutation (c.471G>A, p.W157X) in CRYGC associated with autosoma...",113,72,Mol_Vis_2012_Jul_11_18_1874-1880.txt
813C>A,"...e MF1 family, a heterozygous base substitution, c.813C>A, was detected in exon 8. This single base s...",93,159,Mol_Vis_2013_Apr_5_19_751-758.txt
1910G>A,"...). In the MF2 family, a heterozygous variation, c.1910G>A was found in exon 16, resulting in a cyste...",93,359,Mol_Vis_2013_Apr_5_19_751-758.txt
813C>A,...n the MF1 family were linked to a PTC mutation (c.813C>A) of the FBN1 gene. PTC mutations predict th...,98,593,Mol_Vis_2013_Apr_5_19_751-758.txt
813C>A,"...cay (NMD), therefore, the heterozygous mutation c.813C>A of FBN1 could cause haploinsufficiency of f...",98,1134,Mol_Vis_2013_Apr_5_19_751-758.txt
1910G>A,...ype was the consequence of a missense mutation (c.1910G>A) of the FBN1 gene. This mutation is locate...,100,318,Mol_Vis_2013_Apr_5_19_751-758.txt
700G>A,CA4	17–58235763	c.700G>A,34,19,Mol_Vis_2013_Mar_21_19_654-664.txt
15G>A,CRX	19–48342562	c.253–15G>A,35,23,Mol_Vis_2013_Mar_21_19_654-664.txt
641C>T,PRPH2	6–42672290	c.641C>T,38,20,Mol_Vis_2013_Mar_21_19_654-664.txt
11G>A,CRX	None (c.252+11G>A)	50	99	48	67	0*	-	0*	-	0*	-,82,17,Mol_Vis_2013_Mar_21_19_654-664.txt
313C>A,"...ncluding c.672_701dup30 (p.Ala224_Ala234dup10), c.313C>A (p.N105H), and c.430G>T (p.R144W). The c.67...",12,106,Mol_Vis_2013_Nov_16_19_2298-2305.txt
430G>T,"...(p.Ala224_Ala234dup10), c.313C>A (p.N105H), and c.430G>T (p.R144W). The c.672_701dup30 (p.Ala224_Ala...",12,130,Mol_Vis_2013_Nov_16_19_2298-2305.txt
313C>A,...ions of the polyalanine tract. The mutations of c.313C>A (p. N105H) and c.430G>T (p.R144W) are two n...,12,306,Mol_Vis_2013_Nov_16_19_2298-2305.txt
430G>T,...tract. The mutations of c.313C>A (p. N105H) and c.430G>T (p.R144W) are two novel missense mutations,12,330,Mol_Vis_2013_Nov_16_19_2298-2305.txt
313C>A,"...ncluding c.672_701dup30 (p.Ala224_Ala234dup10), c.313C>A (p. N105H), and c.430G>T (p.R144W; Figure 3...",53,168,Mol_Vis_2013_Nov_16_19_2298-2305.txt
430G>T,"...p.Ala224_Ala234dup10), c.313C>A (p. N105H), and c.430G>T (p.R144W; Figure 3). These mutations were a...",53,193,Mol_Vis_2013_Nov_16_19_2298-2305.txt
313C>A,...701dup30 (p.Ala224_Ala234dup10). B: Mutation of c.313C>A (p.N105H). C: Mutation of c.430G>T (p.R144W...,55,178,Mol_Vis_2013_Nov_16_19_2298-2305.txt
430G>T,... Mutation of c.313C>A (p.N105H). C: Mutation of c.430G>T (p.R144W). The upper panel is the chromatog...,55,213,Mol_Vis_2013_Nov_16_19_2298-2305.txt
313C>A,The heterozygous mutations of c.313C>A and c.430G>T were detected in family C and ...,65,33,Mol_Vis_2013_Nov_16_19_2298-2305.txt
430G>T,"The heterozygous mutations of c.313C>A and c.430G>T were detected in family C and D, respective...",65,46,Mol_Vis_2013_Nov_16_19_2298-2305.txt
313C>A,...in. These results suggest that the mutations of c.313C>A (p. N105H) and c.430G>T (p.R144W) are novel...,67,608,Mol_Vis_2013_Nov_16_19_2298-2305.txt
430G>T,...t that the mutations of c.313C>A (p. N105H) and c.430G>T (p.R144W) are novel mutations in the FOXL2 ...,67,632,Mol_Vis_2013_Nov_16_19_2298-2305.txt
313C>A,"...utations—c.672_701dup30 (p.Ala224_Ala234dup10), c.313C>A (p.N105H), and c.430G>T (p.R144W)—in the FO...",82,84,Mol_Vis_2013_Nov_16_19_2298-2305.txt
430G>T,"...(p.Ala224_Ala234dup10), c.313C>A (p.N105H), and c.430G>T (p.R144W)—in the FOXL2 gene in four Han Chi...",82,108,Mol_Vis_2013_Nov_16_19_2298-2305.txt
313C>A,"...ES type II, while the two missense mutations of c.313C>A and c.430G>T are novel mutations detected i...",82,300,Mol_Vis_2013_Nov_16_19_2298-2305.txt
430G>T,...hile the two missense mutations of c.313C>A and c.430G>T are novel mutations detected in the other t...,82,313,Mol_Vis_2013_Nov_16_19_2298-2305.txt
402C>G,...-associated somatic FOXL2 mutation p.Cys134Trp (c.402C>G). PLoS ONE 2010 5 e8789 20098707,106,275,Mol_Vis_2013_Nov_16_19_2298-2305.txt
4325T>C,"...ype 2A (USH2A) compound heterozygous mutations, c.4325T>C (p.F1442S) and c.15188T>G (p.L5063R), loca...",10,73,Mol_Vis_2013_Nov_7_19_2187-2195.txt
15188T>G,"...eterozygous mutations, c.4325T>C (p.F1442S) and c.15188T>G (p.L5063R), located in exons 20 and 70, r...",10,98,Mol_Vis_2013_Nov_7_19_2187-2195.txt
4325 T>C,"...gregation of the compound heterozygous changes, c.4325 T>C and c.15188 T>G within the USH2A gene in ...",57,127,Mol_Vis_2013_Nov_7_19_2187-2195.txt
15188 T>G,"...e compound heterozygous changes, c.4325 T>C and c.15188 T>G within the USH2A gene in all affected me...",57,142,Mol_Vis_2013_Nov_7_19_2187-2195.txt
4325T>C,...he USH2A gene at genomic positions 1:216363636 (c.4325T>C) and 1:215807910 (c.15188T>G). No other pa...,60,828,Mol_Vis_2013_Nov_7_19_2187-2195.txt
15188T>G,...itions 1:216363636 (c.4325T>C) and 1:215807910 (c.15188T>G). No other pathogenic mutations were foun...,60,856,Mol_Vis_2013_Nov_7_19_2187-2195.txt
4325T>C,...control individuals were screened for the USH2A c.4325T>C and c.15188T>G mutations. Sanger sequencin...,72,217,Mol_Vis_2013_Nov_7_19_2187-2195.txt
15188T>G,...duals were screened for the USH2A c.4325T>C and c.15188T>G mutations. Sanger sequencing confirmed co...,72,231,Mol_Vis_2013_Nov_7_19_2187-2195.txt
992A>C,"...with BCD include c.802_810del17insGC in exon 7, c.992A>C in exon 8, and c.1091–2A>G in an intronic, ...",22,515,Mol_Vis_2014_Dec_31_20_1806-1814.txt
2A>G,"...17insGC in exon 7, c.992A>C in exon 8, and c.1091–2A>G in an intronic, accounting for 83.3% of the m...",22,544,Mol_Vis_2014_Dec_31_20_1806-1814.txt
283G>A,"31	43/F	30	11	RE: —10.5	RE:20/200	c.283G>A, p.G95R+ c.1027T>G, p.Y343D﹡",46,37,Mol_Vis_2014_Dec_31_20_1806-1814.txt
1027T>G,"...3/F	30	11	RE: —10.5	RE:20/200	c.283G>A, p.G95R+ c.1027T>G, p.Y343D﹡",46,55,Mol_Vis_2014_Dec_31_20_1806-1814.txt
2T>G,"...1/F	55	55		RE:20/400	c.802–8_810del17insGC+ c.413+2T>G,del﹡",48,55,Mol_Vis_2014_Dec_31_20_1806-1814.txt
31C>T,"60	55/M	49	44	RE: —2.75	RE:20/200	c.31C>T, p.Q11X*+ c.31C>T, p.Q11X*",50,37,Mol_Vis_2014_Dec_31_20_1806-1814.txt
31C>T,"...5/M	49	44	RE: —2.75	RE:20/200	c.31C>T, p.Q11X*+ c.31C>T, p.Q11X*",50,55,Mol_Vis_2014_Dec_31_20_1806-1814.txt
31C>T,1	c.31C>T	p.Q11X	1/0	0/200	2/184	novel,66,5,Mol_Vis_2014_Dec_31_20_1806-1814.txt
64C>G,1	c.64C>G	p.L22V	1/4	ND	6/184	Reported,67,5,Mol_Vis_2014_Dec_31_20_1806-1814.txt
2A>G,2	c.215–2A>G	Splicing acceptor	2/0	ND	4/184	Reported,68,9,Mol_Vis_2014_Dec_31_20_1806-1814.txt
219T>A,2	c.219T>A	p.F73L	0/3	0/200	3/184	Reported,69,5,Mol_Vis_2014_Dec_31_20_1806-1814.txt
283G>A,2	c.283G>A	p.G95R	0/5	ND	5/184	Reported,70,5,Mol_Vis_2014_Dec_31_20_1806-1814.txt
2T>G,3	c.413+2T>G	Splicing acceptor	0/1	0/200	1/184	novel,71,9,Mol_Vis_2014_Dec_31_20_1806-1814.txt
732G>A,6	c.732G>A	p.W244X	0/1	ND	1/184	Reported,72,5,Mol_Vis_2014_Dec_31_20_1806-1814.txt
958C>T,7	c.958C>T	p.R320X	0/1	ND	1/184	Reported,75,5,Mol_Vis_2014_Dec_31_20_1806-1814.txt
992A>C,8	c.992A>C	p.H331P	0/22	ND	22/184	Reported,76,5,Mol_Vis_2014_Dec_31_20_1806-1814.txt
1027T>G,8	c.1027T>G	p.Y343D	0/1	0/200	1/184	novel,77,5,Mol_Vis_2014_Dec_31_20_1806-1814.txt
2A>G,9	c.1091–2A>G	Splicing acceptor	3/11	ND	17/184	Reported,79,10,Mol_Vis_2014_Dec_31_20_1806-1814.txt
1187C>T,9	c.1187C>T	p.P396L	0/2	ND	2/184	Reported,80,5,Mol_Vis_2014_Dec_31_20_1806-1814.txt
992A>G,"...n allele frequency of 52.7% (97/184), while the c.992A>G mutation accounted for 11.9% (22/184), and ...",82,129,Mol_Vis_2014_Dec_31_20_1806-1814.txt
2A>G,"...tion accounted for 11.9% (22/184), and the c.1091–2A>G accounted for 9.8% (17/184). Collectively, th...",82,190,Mol_Vis_2014_Dec_31_20_1806-1814.txt
1027T>G,"...nese control individuals. A missense mutation, c. 1027T>G, was identified in patient 31 (Figure 4A,B...",84,395,Mol_Vis_2014_Dec_31_20_1806-1814.txt
31C>T,"...Tyr343Asp). In patient 60, a nonsense mutation (c.31C>T) that converts a glutamine (CAG) into a prem...",84,554,Mol_Vis_2014_Dec_31_20_1806-1814.txt
2T >G,"...ne novel heterozygous splice-site mutation, c.413+2T >G, was detected in the 3′- acceptor in intron ...",84,1050,Mol_Vis_2014_Dec_31_20_1806-1814.txt
1027T>G,"...he heterozygous mutant single base-pair change (c.1027T>G,p.Y343D). B: Control (wild type, WT). C: T...",88,129,Mol_Vis_2014_Dec_31_20_1806-1814.txt
2T>G,"...: DNA-MT of the heterozygous splice change (c.413+2T>G). H: Control (WT). I: cDNA sequence, from the...",88,344,Mol_Vis_2014_Dec_31_20_1806-1814.txt
2T>G,...The cDNA of the heterozygous splice change (c.413+2T>G). The deletion is indicated with an arrow and...,88,484,Mol_Vis_2014_Dec_31_20_1806-1814.txt
992A>G,... high prevalence in the Chinese population. The c.992A>G and c.1091–2A>G mutations were also common ...,101,525,Mol_Vis_2014_Dec_31_20_1806-1814.txt
2A>G,"...n the Chinese population. The c.992A>G and c.1091–2A>G mutations were also common in this study, wit...",101,543,Mol_Vis_2014_Dec_31_20_1806-1814.txt
2T>G,"...at these four novel mutations, p.Tyr343Asp, c.413+2T>G, c.791delT, and p.Gln11X, segregated with the...",103,188,Mol_Vis_2014_Dec_31_20_1806-1814.txt
2T>G,"...ructure and function of CYP4V2, such as the c.413+2T>G mutation that was located in a splice site an...",103,411,Mol_Vis_2014_Dec_31_20_1806-1814.txt
2T>G,"...810del17insGC) and a novel splice mutation (c.413+2T>G), exhibited a late age of onset, rapid diseas...",107,115,Mol_Vis_2014_Dec_31_20_1806-1814.txt
768 G>T,"...y 1, the proband (age 23) was homozygote for the c768 G>T mutation. She was diagnosed with cone rod ...",10,59,Mol_Vis_2014_Jan_7_20_89-104.txt
768 G>T,... aunt (age 69) was compound heterozygote for the c768 G>T and c2894 A>G mutations and had autosomal ...,10,184,Mol_Vis_2014_Jan_7_20_89-104.txt
2894 A>G,...) was compound heterozygote for the c768 G>T and c2894 A>G mutations and had autosomal recessive ret...,10,197,Mol_Vis_2014_Jan_7_20_89-104.txt
768 G>T,"...of the proband were asymptomatic carriers of the c768 G>T mutation. In family 2, the proband (age 25...",10,367,Mol_Vis_2014_Jan_7_20_89-104.txt
5882 G>A,... were compound heterozygote for the c5917del and c5882 G>A mutations. The eldest sister (age 23) suf...,10,556,Mol_Vis_2014_Jan_7_20_89-104.txt
5882 G>A,... the youngest child (age 9; heterozygote for the c5882 G>A mutation) had a normal phenotype. In fami...,10,918,Mol_Vis_2014_Jan_7_20_89-104.txt
768 G>T,...e proband (age 43) was compound heterozygote for c768 G>T and c3113 C>T and had been diagnosed with ...,10,1026,Mol_Vis_2014_Jan_7_20_89-104.txt
3113 C>T,...e 43) was compound heterozygote for c768 G>T and c3113 C>T and had been diagnosed with STGD. Her son...,10,1039,Mol_Vis_2014_Jan_7_20_89-104.txt
768 G>T,"...GD. Her son (age 12), who was homozygote for the c768 G>T mutation, had wider scotomas with earlier ...",10,1128,Mol_Vis_2014_Jan_7_20_89-104.txt
768 G>T,...ge 45) was asymptomatic and heterozygote for the c768 G>T mutation. The patients with progressive di...,10,1401,Mol_Vis_2014_Jan_7_20_89-104.txt
768 G>T,1 Ia	c768 G>T	V256V/splice	c2894 A>G	N965S/missense	arRP...,75,7,Mol_Vis_2014_Jan_7_20_89-104.txt
2894 A>G,1 Ia	c768 G>T	V256V/splice	c2894 A>G	N965S/missense	arRP,75,29,Mol_Vis_2014_Jan_7_20_89-104.txt
768 G>T,1 Ib	c768 G>T	V256V/splice	─	─	NVP,76,7,Mol_Vis_2014_Jan_7_20_89-104.txt
768 G>T,1 Ic	c768 G>T	V256V/splice	─	─	NVP,77,7,Mol_Vis_2014_Jan_7_20_89-104.txt
768 G>T,1 IIa	c768 G>T	V256V/splice	c768 G>T	V256V/splice	CRD,78,8,Mol_Vis_2014_Jan_7_20_89-104.txt
768 G>T,1 IIa	c768 G>T	V256V/splice	c768 G>T	V256V/splice	CRD,78,30,Mol_Vis_2014_Jan_7_20_89-104.txt
5882 G>A,2 Ib	c5917 delG	V1973X/frameshift	c5882 G>A	G1961E/missense	STGD,80,36,Mol_Vis_2014_Jan_7_20_89-104.txt
5882 G>A,2 IIb	c5917 delG	V1973X/frameshift	c5882 G>A	G1961E/missense	STGD,82,37,Mol_Vis_2014_Jan_7_20_89-104.txt
5882 G>A,2 IIc	c5917 delG	V1973X/frameshift	c5882 G>A	G1961E/missense	STGD,83,37,Mol_Vis_2014_Jan_7_20_89-104.txt
5882 G>A,2 II d	c5882 G>A	G1961E/missense	─	─	NVP,84,9,Mol_Vis_2014_Jan_7_20_89-104.txt
768 G>T,3 Ia	c768 G>T	V256V/splice	c3113 C>T	A1038V/missense	STG...,85,7,Mol_Vis_2014_Jan_7_20_89-104.txt
3113 C>T,3 Ia	c768 G>T	V256V/splice	c3113 C>T	A1038V/missense	STGD,85,29,Mol_Vis_2014_Jan_7_20_89-104.txt
768 G>T,3 Ib	c768 G>T	V256V/splice	─	─	NVP,86,7,Mol_Vis_2014_Jan_7_20_89-104.txt
768 G>T,3 IIa	c768 G>T	V256V/splice	c768 G>T	V256V/splice	STGD,87,8,Mol_Vis_2014_Jan_7_20_89-104.txt
768 G>T,3 IIa	c768 G>T	V256V/splice	c768 G>T	V256V/splice	STGD,87,30,Mol_Vis_2014_Jan_7_20_89-104.txt
5882 G>A,... and harbored the same mutations (c5917 delG and c5882 G>A). The c5882 G>A mutation is mild [37] and...,172,215,Mol_Vis_2014_Jan_7_20_89-104.txt
5882 G>A,...e same mutations (c5917 delG and c5882 G>A). The c5882 G>A mutation is mild [37] and has previously ...,172,231,Mol_Vis_2014_Jan_7_20_89-104.txt
5882 G>A,"...onset for her. Family 2 is from Hungary, and the c5882 G>A mutation is common in Hungarian patients ...",172,651,Mol_Vis_2014_Jan_7_20_89-104.txt
5882 G>A,"...TGD [39]. In this and other [23,38] studies, the c5882 G>A mutation has been associated with reduced...",172,757,Mol_Vis_2014_Jan_7_20_89-104.txt
5882 G>A,"...d by other authors [8,23,38] in association with c5882 G>A. In one study [38], however, a combinatio...",172,1522,Mol_Vis_2014_Jan_7_20_89-104.txt
5882 G>A,"...>A. In one study [38], however, a combination of c5882 G>A and mutations other than c5917 delG gave ...",172,1578,Mol_Vis_2014_Jan_7_20_89-104.txt
5882 G>A,...nts 2Ib and 2IIa. The elder generation (with the c5882 G>A and c5917 delG mutations) showed similar ...,172,1946,Mol_Vis_2014_Jan_7_20_89-104.txt
3113 C>T,"...). Patient 3Ia was compound heterozygote for the c3113 C>T and c768 G>T mutations while her son, pat...",174,141,Mol_Vis_2014_Jan_7_20_89-104.txt
768 G>T,"... was compound heterozygote for the c3113 C>T and c768 G>T mutations while her son, patient 3IIa, was...",174,155,Mol_Vis_2014_Jan_7_20_89-104.txt
768 G>T,"... while her son, patient 3IIa, was homozygote for c768 G>T. Patient 3Ia seemed to have a milder condi...",174,222,Mol_Vis_2014_Jan_7_20_89-104.txt
3113 C>T,...on on OCT (Figure 8F compared to Figure 8B). The c3113 C>T mutation has previously most often been d...,174,580,Mol_Vis_2014_Jan_7_20_89-104.txt
1622 T>C,"...n described as a component of the complex allele c1622 T>C;c3113 C>T (L541P/A;A1038V) [11,25,38], bu...",174,677,Mol_Vis_2014_Jan_7_20_89-104.txt
3113 C>T,"...d as a component of the complex allele c1622 T>C;c3113 C>T (L541P/A;A1038V) [11,25,38], but it is al...",174,687,Mol_Vis_2014_Jan_7_20_89-104.txt
3113 C>T,"...in patient 3Ia, has also been described [8]. The c3113 C>T mutation is a mild or moderate mutation [...",174,971,Mol_Vis_2014_Jan_7_20_89-104.txt
768G>T,"The c768G>T mutation, however, is severe [11,25,37,42,4...",176,6,Mol_Vis_2014_Jan_7_20_89-104.txt
768G>T,".... Patients 1IIa and 3IIa were homozygote for the c768G>T mutation. Patient 1IIa, accordingly, had la...",176,179,Mol_Vis_2014_Jan_7_20_89-104.txt
768G>T,Patients with homozygote c768G>T and c5917 delG mutations seem to have worse...,178,27,Mol_Vis_2014_Jan_7_20_89-104.txt
768G>T,"... residual function of the ABCA4 protein [11,29]. c768G>T is a splice site mutation leading to loss o...",178,190,Mol_Vis_2014_Jan_7_20_89-104.txt
2894A>G,"...lso harbored the c768G>, but in combination with c2894A>G, had the most serious form of ABCA4 associ...",180,69,Mol_Vis_2014_Jan_7_20_89-104.txt
2894A>G,"...ciated retinal degeneration, a form of arRP. The c2894A>G also previously has been described in pati...",180,167,Mol_Vis_2014_Jan_7_20_89-104.txt
2588G>C,...p G  Wadelius C  Weber BH  Cremers FP   The ABCA4 2588G>C Stargardt mutation: single origin and incr...,239,339,Mol_Vis_2014_Jan_7_20_89-104.txt
1G>T,"...ied a homozygous novel splice-site mutation c.873+1G>T in a known WMS-like syndrome gene, ADAMTS17, ...",12,75,Mol_Vis_2014_Jun_12_20_790-796.txt
1G>T,"...e of the variants, the splice-site mutation c.873+1G>T in intron 5, was in a known WMS-like syndrome...",51,860,Mol_Vis_2014_Jun_12_20_790-796.txt
1G>T,ADAMTS17	NM_139057.2	c.873+1G>T	-	Disease causin,55,28,Mol_Vis_2014_Jun_12_20_790-796.txt
326G>A,CAMK1D	NM_020397.2	c.326G>A (p.R109Q)	Probably damagin,57,22,Mol_Vis_2014_Jun_12_20_790-796.txt
847G>A,PYROXD2	NM_032709.2	c.847G>A (p.V283I)	Probably damagin,61,23,Mol_Vis_2014_Jun_12_20_790-796.txt
2488G>A,SIPA1L3	NM_015073.1	c.2488G>A (p.E830K)	Possibly damagin,64,23,Mol_Vis_2014_Jun_12_20_790-796.txt
326G>A,...s of unknown significance in three other genes [c.326G>A (p.R109Q) in CAMK1D located on chromosome 1...,70,87,Mol_Vis_2014_Jun_12_20_790-796.txt
847G>A,"...p.R109Q) in CAMK1D located on chromosome 10p13, c.847G>A (p.V283I) in PYROXD2 located on chromosome ...",70,145,Mol_Vis_2014_Jun_12_20_790-796.txt
2488G>A,...I) in PYROXD2 located on chromosome 10q24.2 and c.2488G>A (p.E830K) in SIPA1L3 located on chromosome...,70,209,Mol_Vis_2014_Jun_12_20_790-796.txt
1G>A,"...mutations [c.2458_2459insG (p.E820Gfs*23), c.1721+1G>A and c.760C>T (p.Q254*)] in the ADAMTS17 gene ...",72,112,Mol_Vis_2014_Jun_12_20_790-796.txt
760C>T,"...c.2458_2459insG (p.E820Gfs*23), c.1721+1G>A and c.760C>T (p.Q254*)] in the ADAMTS17 gene in three Sa...",72,123,Mol_Vis_2014_Jun_12_20_790-796.txt
1 G>A,"...ly. Interestingly, a splice-site mutation, c.1473+1 G>A, in the ADAMTS17 gene has been reported to b...",72,391,Mol_Vis_2014_Jun_12_20_790-796.txt
1G>A,2	c.1721+1G>A	Intron 12	Splice site	Homozygous	Saudi Arabia...,90,10,Mol_Vis_2014_Jun_12_20_790-796.txt
760C>T,3	c.760C>,91,5,Mol_Vis_2014_Jun_12_20_790-796.txt
1G>T,6	c.873+1G>T	Intron 5	Splice site	Homozygous	Indian	Presen...,96,9,Mol_Vis_2014_Jun_12_20_790-796.txt
857C>T,...ations identified in TRPM1 was corrected to be c.[857C>T];[857C>T] p.(S286L),7,108,Mol_Vis_2014_Jun_2_20_780.txt
857C>T,...entified in TRPM1 was corrected to be c.[857C>T];[857C>T] p.(S286L),7,117,Mol_Vis_2014_Jun_2_20_780.txt
1184A>G,... cognitive defects. NGS identified a homozygous c.1184A>G mutation in the MKKS/BBS6 gene in both pat...,10,216,Mol_Vis_2016_Jan_24_22_73-81.txt
1184A>G,...red that both patients share a novel homozygous c.1184A>G missense mutation in the MKKS/BBS6 gene th...,24,238,Mol_Vis_2016_Jan_24_22_73-81.txt
1G>A,"...t homolog (EYS) gene, involving two novel (c.7228+1G>A and c.9248G>A) and three recurrent mutations ...",12,243,Mol_Vis_2016_Jun_16_22_646-657.txt
9248G>A,"...EYS) gene, involving two novel (c.7228+1G>A and c.9248G>A) and three recurrent mutations (c.4957dupA...",12,254,Mol_Vis_2016_Jun_16_22_646-657.txt
6416G>A,"...G>A) and three recurrent mutations (c.4957dupA, c.6416G>A and c.6557G>A), were found as RP causative...",12,308,Mol_Vis_2016_Jun_16_22_646-657.txt
6557G>A,"... recurrent mutations (c.4957dupA, c.6416G>A and c.6557G>A), were found as RP causative in the four f...",12,322,Mol_Vis_2016_Jun_16_22_646-657.txt
5093T>C,...tive in the four families. The missense variant c.5093T>C was determined to be a variant of unknown ...,12,404,Mol_Vis_2016_Jun_16_22_646-657.txt
6416G>A,...me allele with the reported pathogenic mutation c.6416G>A. The two novel variants were further confi...,12,568,Mol_Vis_2016_Jun_16_22_646-657.txt
6557G>A,...drogen bonds by the missense mutation p.G2186E (c.6557G>A) and elongation of its neighboring β-sheet...,12,885,Mol_Vis_2016_Jun_16_22_646-657.txt
9248G>A,"...of its neighboring β-sheet induced by p.G3083D (c.9248G>A), which could alter the tertiary structure...",12,959,Mol_Vis_2016_Jun_16_22_646-657.txt
6557G>A,"...lies. A homozygous recurrent missense mutation, c.6557G>A, was found carried by patient ARRP07-II:1 ...",45,693,Mol_Vis_2016_Jun_16_22_646-657.txt
6557G>A,"ARRP07	RPSP	6: 64,791,763	c.6557G>A	p.G2186E	missense	Hom	E32	DA (0.03)	PD (0....",68,29,Mol_Vis_2016_Jun_16_22_646-657.txt
5093T>C,"ARRP08	RP	6: 65,300,667	c.5093T>C	p.I1698T	missense	Het	E26	DA (0)	B (0.082)...",69,27,Mol_Vis_2016_Jun_16_22_646-657.txt
9248G>A,"6: 64,430,679	c.9248G>A	p.G3083D	missense	Het	E43	DA (0.02)	DA (0....",70,17,Mol_Vis_2016_Jun_16_22_646-657.txt
6416G>A,"6: 64,940,493	c.6416G>A	p.C2139Y	missense	Het	E31	DA (0)	PD (0.797...",71,17,Mol_Vis_2016_Jun_16_22_646-657.txt
6557G>A,"ARRP09	RPSP	6: 64,791,763	c.6557G>A	p.G2186E	missense	Het	E32	DA (0.03)	PD (0....",72,29,Mol_Vis_2016_Jun_16_22_646-657.txt
1 G>A,"6: 64,574,078	c.7228+1 G>A	p.A2410Gfs*4	splice site	Het	I36–37	NA	NA	NA...",73,22,Mol_Vis_2016_Jun_16_22_646-657.txt
1 G>A,"ARRP10	RP	6: 64,574,078	c.7228+1 G>A	p.A2410Gfs*4	splice site	Het	I36–37	NA	NA	NA...",74,32,Mol_Vis_2016_Jun_16_22_646-657.txt
5093T>C,"Biallelic EYS variants, c.[5093T>C; 6416G>A];[9248G>A], were found to be carr...",78,28,Mol_Vis_2016_Jun_16_22_646-657.txt
6416G>A,"Biallelic EYS variants, c.[5093T>C; 6416G>A];[9248G>A], were found to be carried by pa...",78,37,Mol_Vis_2016_Jun_16_22_646-657.txt
9248G>A,"Biallelic EYS variants, c.[5093T>C; 6416G>A];[9248G>A], were found to be carried by patient ARRP...",78,47,Mol_Vis_2016_Jun_16_22_646-657.txt
9248G>A,"...RP08-II:2 (Figure 1A,C–E). The missense variant c.9248G>A was novel, while c.5093T>C was determined ...",78,145,Mol_Vis_2016_Jun_16_22_646-657.txt
5093T>C,"...The missense variant c.9248G>A was novel, while c.5093T>C was determined as a variant of unknown sig...",78,172,Mol_Vis_2016_Jun_16_22_646-657.txt
6416G>A,...me allele with the reported pathogenic mutation c.6416G>A. The missense variant c.9248G>A would indu...,78,323,Mol_Vis_2016_Jun_16_22_646-657.txt
9248G>A,...ogenic mutation c.6416G>A. The missense variant c.9248G>A would induce a change from the neutral gly...,78,355,Mol_Vis_2016_Jun_16_22_646-657.txt
6416G>A,"...roperties (Figure 3D,E). The recurrent mutation c.6416G>A would lead to an amino acid change from th...",78,711,Mol_Vis_2016_Jun_16_22_646-657.txt
5093T>C,...iginal twist led by this mutation [24]. The VUS c.5093T>C would lead to the substitution from the hy...,78,980,Mol_Vis_2016_Jun_16_22_646-657.txt
6557G>A,"... patient ARRP08-II:2, biallelic EYS mutations, c.[6557G>A];[7228+1G>A], were found to be carried by ...",80,61,Mol_Vis_2016_Jun_16_22_646-657.txt
1G>A,"...-II:2, biallelic EYS mutations, c.[6557G>A];[7228+1G>A], were found to be carried by patient ARRP09-...",80,76,Mol_Vis_2016_Jun_16_22_646-657.txt
6557G>A,...be carried by patient ARRP09-II:1. The missense c.6557G>A was the same recurrent mutation carried by...,80,147,Mol_Vis_2016_Jun_16_22_646-657.txt
1G>A,...RP07-II:1. The novel splice-site variation c.7228+1G>A was predicted to abolish the regular splice d...,80,258,Mol_Vis_2016_Jun_16_22_646-657.txt
1G>A,...carried biallelic heterozygous c.[4957dupA];[7228+1G>A]. The first variant was a reported frameshift...,80,525,Mol_Vis_2016_Jun_16_22_646-657.txt
1G>A,"...*2 or cause NMD. The two novel variations, c.7228+1G>A and c.9248G>A, were further confirmed absent ...",80,686,Mol_Vis_2016_Jun_16_22_646-657.txt
9248G>A,"... NMD. The two novel variations, c.7228+1G>A and c.9248G>A, were further confirmed absent in the 100 ...",80,697,Mol_Vis_2016_Jun_16_22_646-657.txt
8012T>A,1*	c.[8012T>A];[704G>A]	p.[L2671*];[W235*]	F35–1	IRDs	43...,92,7,Mol_Vis_2016_Jun_16_22_646-657.txt
704G>A,1*	c.[8012T>A];[704G>A]	p.[L2671*];[W235*]	F35–1	IRDs	43/M	13	20/1...,92,17,Mol_Vis_2016_Jun_16_22_646-657.txt
490C>T,2#	c.[490C>T];[6416G>A]	p.[R614*];[C2139Y]	ARRP05-II:3	R...,93,7,Mol_Vis_2016_Jun_16_22_646-657.txt
6416G>A,2#	c.[490C>T];[6416G>A]	p.[R614*];[C2139Y]	ARRP05-II:3	RP	40/M	22...,93,16,Mol_Vis_2016_Jun_16_22_646-657.txt
490C>T,2#	c.[490C>T];[6416G>A]	p.[R614*];[C2139Y]	ARRP05-II:5	R...,94,7,Mol_Vis_2016_Jun_16_22_646-657.txt
6416G>A,2#	c.[490C>T];[6416G>A]	p.[R614*];[C2139Y]	ARRP05-II:5	RP	37/M	20...,94,16,Mol_Vis_2016_Jun_16_22_646-657.txt
490C>T,2#	c.[490C>T];[6416G>A]	p.[R614*];[C2139Y]	ARRP05-II:7	R...,95,7,Mol_Vis_2016_Jun_16_22_646-657.txt
6416G>A,2#	c.[490C>T];[6416G>A]	p.[R614*];[C2139Y]	ARRP05-II:7	RP	32/M	25...,95,16,Mol_Vis_2016_Jun_16_22_646-657.txt
7919G>A,2#	c.[7919G>A];[8861T>C]	p.[W2640*];[F2954S]	ARRP06-II:2...,96,7,Mol_Vis_2016_Jun_16_22_646-657.txt
8861T>C,2#	c.[7919G>A];[8861T>C]	p.[W2640*];[F2954S]	ARRP06-II:2	RP	54/M	1...,96,17,Mol_Vis_2016_Jun_16_22_646-657.txt
7919G>A,2#	c.[7919G>A];[8861T>C]	p.[W2640*];[F2954S]	ARRP06-II:4...,97,7,Mol_Vis_2016_Jun_16_22_646-657.txt
8861T>C,2#	c.[7919G>A];[8861T>C]	p.[W2640*];[F2954S]	ARRP06-II:4	RP	52/M	3...,97,17,Mol_Vis_2016_Jun_16_22_646-657.txt
7919G>A,2#	c.[7919G>A];[8861T>C]	p.[W2640*];[F2954S]	ARRP06-II:8...,98,7,Mol_Vis_2016_Jun_16_22_646-657.txt
8861T>C,2#	c.[7919G>A];[8861T>C]	p.[W2640*];[F2954S]	ARRP06-II:8	RP	49/F	3...,98,17,Mol_Vis_2016_Jun_16_22_646-657.txt
6557G>A,2#	c.[6557G>A],99,7,Mol_Vis_2016_Jun_16_22_646-657.txt
6416G>A,2#	c.[6416G>A];[8150delA]	p.[C2139Y];[NA]	W286–1	IRDs	43...,101,7,Mol_Vis_2016_Jun_16_22_646-657.txt
2510G>T,2#	c.[2510G>T];[8107G>T]	p.[C837F];[E2703*]	F11–1	IRDs	4...,102,7,Mol_Vis_2016_Jun_16_22_646-657.txt
8107G>T,2#	c.[2510G>T];[8107G>T]	p.[C837F];[E2703*]	F11–1	IRDs	48/M	41	20/...,102,17,Mol_Vis_2016_Jun_16_22_646-657.txt
7492G>C,2#	c.[7492G>C],103,7,Mol_Vis_2016_Jun_16_22_646-657.txt
6416G>A,2#	c.[6416G>A];[8392delG]	p.[C2139Y];[NA]	W86–1	IRDs	25/...,105,7,Mol_Vis_2016_Jun_16_22_646-657.txt
6416G>A,3$	c.[6416G>A];[6557G>A]	p.[C2139Y];[G2186E]	No.10-II:1	...,106,7,Mol_Vis_2016_Jun_16_22_646-657.txt
6557G>A,3$	c.[6416G>A];[6557G>A]	p.[C2139Y];[G2186E]	No.10-II:1	RP	49/F	42...,106,17,Mol_Vis_2016_Jun_16_22_646-657.txt
6416G>A,3$	c.[6416G>A];[6557G>A]	p.[C2139Y];[G2186E]	No.10-II:3	...,107,7,Mol_Vis_2016_Jun_16_22_646-657.txt
6557G>A,3$	c.[6416G>A];[6557G>A]	p.[C2139Y];[G2186E]	No.10-II:3	RP	45/M	36...,107,17,Mol_Vis_2016_Jun_16_22_646-657.txt
6416G>A,3$	c.[6416G>A];[6557G>A]	p.[C2139Y];[G2186E]	No.10-II:4	...,108,7,Mol_Vis_2016_Jun_16_22_646-657.txt
6557G>A,3$	c.[6416G>A];[6557G>A]	p.[C2139Y];[G2186E]	No.10-II:4	RP	35/F	20...,108,17,Mol_Vis_2016_Jun_16_22_646-657.txt
9368A>C,3$	c.[9368A>C];[6416G>A]	p.[N3123T];[C2139Y]	W5–1	IRDs	3...,109,7,Mol_Vis_2016_Jun_16_22_646-657.txt
6416G>A,3$	c.[9368A>C];[6416G>A]	p.[N3123T];[C2139Y]	W5–1	IRDs	34/M	14	20/...,109,17,Mol_Vis_2016_Jun_16_22_646-657.txt
7492G>C,3$	c.7492G>C (Hom)	p.A2498P (Hom)	W159–1	IRDs	34/M	20	2...,110,6,Mol_Vis_2016_Jun_16_22_646-657.txt
7609G>A,3$	c.[7609G>A];[7949C>T]	p.[A2537T];[S2650F]	W171–1	IRDs...,111,7,Mol_Vis_2016_Jun_16_22_646-657.txt
7949C>T,3$	c.[7609G>A];[7949C>T]	p.[A2537T];[S2650F]	W171–1	IRDs	37/F	20	F...,111,17,Mol_Vis_2016_Jun_16_22_646-657.txt
3489T>A,3$	c.[3489T>A];[2644T>C]	p.[N1163K];[F882L]	W13–1	IRDs	6...,112,7,Mol_Vis_2016_Jun_16_22_646-657.txt
2644T>C,3$	c.[3489T>A];[2644T>C]	p.[N1163K];[F882L]	W13–1	IRDs	63/M	41	20/...,112,17,Mol_Vis_2016_Jun_16_22_646-657.txt
6416G>A,3$	c.6416G>A (Hom)	p.C2139Y (Hom)	W75–1	IRDs	31/M	20	20...,113,6,Mol_Vis_2016_Jun_16_22_646-657.txt
1 G>A,"... carries a novel heterozygous EYS mutation c.7228+1 G>A, a splice-site variant that may eliminate th...",116,1305,Mol_Vis_2016_Jun_16_22_646-657.txt
5093T>C,"... of its neighboring β-sheet, and a missense VUS c.5093T>C colocalized in the same allele with the re...",118,686,Mol_Vis_2016_Jun_16_22_646-657.txt
1G>A,"... ARRP10-II:3, the same patient who carries c.7228+1G>A. This mutation has not been previously report...",118,912,Mol_Vis_2016_Jun_16_22_646-657.txt
148C>G,c.148C>G (p.His50Asp)	Damagin,80,3,Mol_Vis_2016_May_16_22_491-502.txt
170C>G,c.170C>G (p.Ser57*)	-	-	Reported [59]	OU:5	108 FR	0....,85,3,Mol_Vis_2016_May_16_22_491-502.txt
338G>A,Exon 3	c.338G>A (p.Gly113Asp)	Damaging 0	Probably damaging ...,86,10,Mol_Vis_2016_May_16_22_491-502.txt
362G>A,c.362G>A (p.Arg121Gln)	Damagin,87,3,Mol_Vis_2016_May_16_22_491-502.txt
376T>C,c.376T>C (p.Cys126Arg)	Damaging 0	Probably damaging ...,89,3,Mol_Vis_2016_May_16_22_491-502.txt
522T>C,".... Further, two novel variations in the 3′ UTR, c.*522T>C and c.*974C>G, were observed in two patient...",92,678,Mol_Vis_2016_May_16_22_491-502.txt
974C>G,"... novel variations in the 3′ UTR, c.*522T>C and c.*974C>G, were observed in two patients with disease...",92,692,Mol_Vis_2016_May_16_22_491-502.txt
34G>A,...cts on gefitinib toxicities were evaluated. ABCG2 34G>A was statistically associated with occurrence...,10,430,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
34G>A,...f the 32 patients with at least one variant ABCG2 34G>A allele (G/A and A/A) developed grade 2 or wo...,10,555,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
421C>A,...ween severe toxicities and polymorphisms of ABCG2 421C>A nor ABCB1 3435C>T. The results suggested th...,10,853,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
3435C>T,...ities and polymorphisms of ABCG2 421C>A nor ABCB1 3435C>T. The results suggested that ABCG2 34G>A wo...,10,870,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
34G>A,...r ABCB1 3435C>T. The results suggested that ABCG2 34G>A would be useful for predicting grade 2 or wo...,10,912,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
34G>A,"...se variants, two major functional variants, ABCG2 34G>A (rs2231137), resulting in a Val12Met substit...",22,214,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
421C>A,"...), resulting in a Val12Met substitution and ABCG2 421C>A (rs2231142), resulting in a Glu141Lys subst...",22,280,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
421C>A,...cells transfected with wild-type and mutant ABCG2 421C>A demonstrated that HEK293 cells transfected ...,23,102,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
3435C>T,...ransition at nucleotide position 3435 in exon 26 (3435C>T) (rs1045642).14) Although this transition ...,25,125,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
421C>A,ABCG2 421C>A polymorphism was statistically significantl...,28,7,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
421C>A,"...f the 16 patients with at least one variant ABCG2 421C>A allele developed grade 1 or 2 diarrhea, aga...",28,166,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
421C>A,"...aluated the association between three SNPs, ABCG2 421C>A, 34G>A and ABCB1 3435C>T polymorphisms and ...",32,255,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
34G>A,"...the association between three SNPs, ABCG2 421C>A, 34G>A and ABCB1 3435C>T polymorphisms and moderate...",32,263,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
3435C>T,"...between three SNPs, ABCG2 421C>A, 34G>A and ABCB1 3435C>T polymorphisms and moderate or severe toxic...",32,279,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
421C > A,"... GmbH, Hilden, Germany). The polymorphisms, ABCG2 421C > A and ABCB1 3435C > T were genotyped by the...",58,140,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
3435C > T,"...any). The polymorphisms, ABCG2 421C > A and ABCB1 3435C > T were genotyped by the TaqMan assay (Appl...",58,159,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
34G>A,...n 1.4.1 of Applied Biosystems. We sequenced ABCG2 34G>A after performing a single polymerase chain r...,58,363,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
34G>A,the primer Sequence (5’–3’) of ABCG2 34G>A (V12M,60,38,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
34G>A,"Genotyping of ABCG2 34G>A, ABCG2 421C>A and ABCB1 3435C>",75,21,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
421C>A,"Genotyping of ABCG2 34G>A, ABCG2 421C>A and ABCB1 3435C>",75,34,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
3435C>T,"Genotyping of ABCG2 34G>A, ABCG2 421C>A and ABCB1 3435C>",75,51,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
34G>A,"... in 28 (34%), and A/A alleles in 4 (5%) for ABCG2 34G>A. C/C alleles were found in 45 (54%) patients...",76,112,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
421C>A,"...s in 31 (38%), and A/A allele in 7 (8%) for ABCG2 421C>A. C/C alleles were found in 23 patients (28%...",76,224,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
3435C>T,"...n 44 (53%), and T/T alleles in 16 (19%) for ABCB1 3435C>T. The frequencies of the ABCG2 or ABCB1 var...",76,340,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
34G>A,ABCG2 34G>A	GG	GA	AA,80,7,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
421C>A,ABCG2 421C>A	CC	CA	AA,82,7,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
3435C>T,ABCB1 3435C>T	CC	CT	TT,84,7,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
34G>A,"...f moderate or severe toxicities and SNPs at ABCG2 34G>A, ABCG2 421C>A and ABCB1 3435C>T (Table 3–5)....",87,147,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
421C>A,"... severe toxicities and SNPs at ABCG2 34G>A, ABCG2 421C>A and ABCB1 3435C>T (Table 3–5). Statisticall...",87,160,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
3435C>T,"...s and SNPs at ABCG2 34G>A, ABCG2 421C>A and ABCB1 3435C>T (Table 3–5). Statistically significant ass...",87,177,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
34G>A,"...urrence of skin toxicity and ABCG2 polymorphisms, 34G>A; 13 (42%) of the 32 patients with at least o...",87,313,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
34G>A,"...f the 32 patients with at least one variant ABCG2 34G>A allele (G/A and A/A) developed skin rash, ag...",87,380,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
34G>A,...  Association between genetic polymorphisms ABCG2 34G>A and toxicit,89,58,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
421C>A,...4 Association between genetic polymorphisms ABCG2 421C>A and toxicit,104,57,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
3435C>T,...5 Association between genetic polymorphisms ABCB1 3435C>T and toxicit,119,57,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
34G>A,...l impact on gefitinib-induced toxicities of ABCG2 34G>A. Our results suggested that ABCG2 34G>A woul...,135,423,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
34G>A,... of ABCG2 34G>A. Our results suggested that ABCG2 34G>A would be useful for predicting grade 2 or wo...,135,463,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
34G>A,"...8) We also examined the association between ABCG2 34G>A and disease control, which means responses t...",137,602,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
34G>A,...g patients with at least one variant allele ABCG2 34G>A was significantly higher than in patients wi...,137,833,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
34G>A,Variant allele of ABCG2 34G>A caused apical plasma membrane dislocalizatio...,139,25,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
421C>A,...th skin rash or diarrhea and indicated that ABCG2 421C>A was statistically significantly associated ...,141,116,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
421C>A,...currence of diarrhea.17) The frequencies of ABCG2 421C>A are reported to be 20–40% in Asian populati...,141,227,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
421C>A,...lthough the allele frequency of the variant ABCG2 421C>A in our Japanese lung cancer population was ...,141,402,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
421C>A,...e unable to confirm the association between ABCG2 421C>A and diarrhea. Akasaka et al. also reported ...,141,543,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
421C>A,...ed that the allele frequency of the variant ABCG2 421C>A was higher and not associated with diarrhea...,141,640,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
421C>A,...ht be lower allele frequency of the variant ABCG2 421C>A in Caucasian populations compared with two ...,143,83,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
421C>A,"...e study, 14 patients had variant alleles of ABCG2 421C>A and seven patients developed diarrhea, whil...",143,222,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
421C>A,"...ssociation between genetic polymorphisms of ABCG2 421C>A and toxicities, although ABCG2 16702G>A was...",143,690,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
16702G>A,"...ms of ABCG2 421C>A and toxicities, although ABCG2 16702G>A was associated with grade 2 or more skin ...",143,728,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
3435C>T,ABCB1 3435C>T has been significantly associated with red...,145,7,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
3435C>T,"...ever, the determination of polymorphisms of ABCB1 3435C>T would not be useful for predicting moderat...",145,204,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
34G>A,"In summary, our study suggested that ABCG2 34G>A might be the predictor of skin toxicity in g...",147,44,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
3435C>T,"...ug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C>T affects mRNA stability. Pharmacogenet Geno...",165,111,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
106C>T,"...ethods). A heterozygous CTR9 nonsense mutation, c.106C>T; p.Q36X, was present in each half-sister (F...",19,143,Nat_Commun_2014_Aug_7_5_4398.txt
2T>C,...eterozygous essential splice-site mutation c.1194+2T>C was detected in both sisters and was inherite...,21,155,Nat_Commun_2014_Aug_7_5_4398.txt
3A>C,"...ified another exon 9 splice-site mutation, c.1194+3A>C, in Fam0484, which includes two cousins affec...",23,230,Nat_Commun_2014_Aug_7_5_4398.txt
3487A>T,"...A and identified a somatic truncating mutation, c.3487A>T; p.R1163X (Fig. 1b). While the phase of th...",25,331,Nat_Commun_2014_Aug_7_5_4398.txt
2T>C,... containing wild-type CTR9 sequence or the c.1194+2T>C mutation using a QIAprep Spin MiniPrep Kit (Q...,71,486,Nat_Commun_2014_Aug_7_5_4398.txt
2T>C,"...inigene splicing constructs containing the c.1194+2T>C mutation identified in Fam3727, showing monoa...",91,181,Nat_Commun_2014_Aug_7_5_4398.txt
3A>C,"...m0484 (proband 2), who is heterozygous for c.1194+3A>C, demonstrates that exon 9 is deleted on one a...",91,333,Nat_Commun_2014_Aug_7_5_4398.txt
2T>C,...peptide repeat domains (shaded boxes). The c.1194+2T>C and c.1194+3A>C splice-site mutations result ...,91,526,Nat_Commun_2014_Aug_7_5_4398.txt
3A>C,...omains (shaded boxes). The c.1194+2T>C and c.1194+3A>C splice-site mutations result in an in-frame d...,91,542,Nat_Commun_2014_Aug_7_5_4398.txt
75G>A,c.75G>A(p.=)	rs138850547	 	 	No effect	 	1,167,3,Nat_Commun_2014_Aug_7_5_4398.txt
303G>C,c.303G>C; p.Lys101Asn	 	Possibly damaging	Tolerated	...,168,3,Nat_Commun_2014_Aug_7_5_4398.txt
304A>G,c.304A>G; p.Asn102Asp	 	Benign	Tolerated	No effect	1...,169,3,Nat_Commun_2014_Aug_7_5_4398.txt
762T>C,c.762T>C(p.=)	rs116362368	 	 	No effect	1	 ,170,3,Nat_Commun_2014_Aug_7_5_4398.txt
921G>A,c.921G>A(p.=)	rs368868162	 	 	No effect	1	 ,171,3,Nat_Commun_2014_Aug_7_5_4398.txt
1233T>C,c.1233T>C(p.=)	rs143491141	 	 	No effect	1	 ,172,3,Nat_Commun_2014_Aug_7_5_4398.txt
1329G>T,c.1329G>T; p.Glu443Asp	 	Benign	Tolerated	No effect	...,173,3,Nat_Commun_2014_Aug_7_5_4398.txt
1461C>T,c.1461C>T(p.=)	 	 	 	No effect	Common	Common,174,3,Nat_Commun_2014_Aug_7_5_4398.txt
1494C>T,c.1494C>T(p.=)	rs7118399	 	 	No effect	Common	Common...,175,3,Nat_Commun_2014_Aug_7_5_4398.txt
3C>T,c.1687-3C>T	rs76650154	 	 	No effect	5	 ,176,8,Nat_Commun_2014_Aug_7_5_4398.txt
1800T>C,c.1800T>C(p.=)	rs199500868	 	 	No effect	1	 ,177,3,Nat_Commun_2014_Aug_7_5_4398.txt
4A>G,c.1873-4A>G	 	 	 	No effect	 	3,178,8,Nat_Commun_2014_Aug_7_5_4398.txt
2097C>T,c.2097C>T(p.=)	rs140813178	 	 	No effect	1	8,179,3,Nat_Commun_2014_Aug_7_5_4398.txt
4A>C,c.2372+4A>C	rs199735513	 	 	No effect	1	 ,180,8,Nat_Commun_2014_Aug_7_5_4398.txt
8T>C,c.2445-8T>C	 	 	 	No effect	 	1,181,8,Nat_Commun_2014_Aug_7_5_4398.txt
2487C>T,c.2487C>T(p.=)	 	 	 	No effect	 	1,182,3,Nat_Commun_2014_Aug_7_5_4398.txt
2516G>A,c.2516G>A; p.Arg839Gln	 	Benign	Tolerated	No effect	...,183,3,Nat_Commun_2014_Aug_7_5_4398.txt
2610G>A,c.2610G>A(p.=)	 	 	 	No effect	 	1,184,3,Nat_Commun_2014_Aug_7_5_4398.txt
2745A>G,c.2745A>G(p.=)	 	 	 	No effect	1	 ,185,3,Nat_Commun_2014_Aug_7_5_4398.txt
2897G>C,c.2897G>C; p.Gly966Ala	rs192522878	Benign	Tolerated	...,186,3,Nat_Commun_2014_Aug_7_5_4398.txt
2953C>T,c.2953C>T; p.Arg985Cys	 	Possibly damaging	Affect pr...,187,3,Nat_Commun_2014_Aug_7_5_4398.txt
3149A>G,c.3149A>G; p.Lys1050Arg	rs141131642	Benign	Tolerated...,189,3,Nat_Commun_2014_Aug_7_5_4398.txt
3154T>C,c.3154T>C; p.Cys1052Arg	rs35696189	Benign	Tolerated	...,190,3,Nat_Commun_2014_Aug_7_5_4398.txt
3195G>A,c.3195G>A(p.=)	rs34200650	 	 	No effect	1	 ,191,3,Nat_Commun_2014_Aug_7_5_4398.txt
3211G>A,c.3211G>A; p.Gly1071Ser	rs35766432	Benign	Tolerated	...,192,3,Nat_Commun_2014_Aug_7_5_4398.txt
3244G>A,c.3244G>A; p.Asp1082Asn	rs138871050	Benign	Tolerated...,193,3,Nat_Commun_2014_Aug_7_5_4398.txt
3284G>A,c.3284G>A; p.Arg1095Lys	rs141434094	Possibly damagin...,194,3,Nat_Commun_2014_Aug_7_5_4398.txt
3292G>A,c.3292G>A; p.Gly1098Ser	rs376210239	Benign	Tolerated...,195,3,Nat_Commun_2014_Aug_7_5_4398.txt
3402G>A,c.3402G>A(p.=)	rs147016884	 	 	No effect	1	1,196,3,Nat_Commun_2014_Aug_7_5_4398.txt
3449A>G,c.3449A>G; p.Glu1150Gly	rs35023148	Benign	Tolerated	...,197,3,Nat_Commun_2014_Aug_7_5_4398.txt
3512A>G,c.3512A>G; p.Asp1171Gly	 	Benign	Deleterious	No effe...,198,3,Nat_Commun_2014_Aug_7_5_4398.txt
896G>A,...hanges35. Albino rats carry a single SNP mutation 896G>A in exon 2 of the Tyr gene resulting in an A...,25,457,Nat_Commun_2014_Jun_26_5_4240.txt
3551T>C,"... both individuals, a missense change in SCN11A, c.3551T>C, p.V1184A (chr3:38913144A>G, hg19), was th...",20,1190,Nat_Commun_2015_Dec_8_6_10049.txt
38913144A>G,"...sense change in SCN11A, c.3551T>C, p.V1184A (chr3:38913144A>G, hg19), was the most likely candidate ...",20,1214,Nat_Commun_2015_Dec_8_6_10049.txt
3551T>C,...4139.2) in pcDNA3.1 was used as template15. The c.3551T>C (p.Val1184Ala) mutation was introduced by ...,67,75,Nat_Commun_2015_Dec_8_6_10049.txt
1G>A,"...ere heterozygous for changes in in-tron 12 (c.993+1G>A, c.993+3A>G) that are predicted to affect spl...",20,204,Nat_Commun_2015_Jun_16_6_7092.txt
3A>G,"...gous for changes in in-tron 12 (c.993+1G>A, c.993+3A>G) that are predicted to affect splicing (Table...",20,216,Nat_Commun_2015_Jun_16_6_7092.txt
1G>A,...t DYNC2LI1 is markedly reduced in R01-013A (c.993+1G>A; p.Leu117Val) and R07-628A (p.Trp124Ter; p.Le...,20,1342,Nat_Commun_2015_Jun_16_6_7092.txt
1G>A,R01-013A	0/1	c.993+1G>A	Intron 12	4.37			16.1		0.00008,148,20,Nat_Commun_2015_Jun_16_6_7092.txt
349C>G,0/1	c.349C>,149,7,Nat_Commun_2015_Jun_16_6_7092.txt
349C>G,R07-628A	0/1	c.349C>,151,16,Nat_Commun_2015_Jun_16_6_7092.txt
372G>A,0/1	c.372G>,153,7,Nat_Commun_2015_Jun_16_6_7092.txt
1000G>T,R03-303A	0/1	c.1000G>,155,16,Nat_Commun_2015_Jun_16_6_7092.txt
3A>G,0/1	c.993+3A>G	Intron 12	4.37			10.8,157,11,Nat_Commun_2015_Jun_16_6_7092.txt
13	C>T,1–2 K1	Pat	13	C>T	0	0	0.0008	2.57	Novel	—,195,12,Nat_Commun_2015_Nov_2_6_8718.txt
37	G>A,1–2 K1	Mat	37	G>A	0	0	0	2.63	Novel	—,196,12,Nat_Commun_2015_Nov_2_6_8718.txt
13	C>T,"3, K2	Pat	13	C>T	0	0	0.0008	2.57	Novel	—",197,11,Nat_Commun_2015_Nov_2_6_8718.txt
48	G>A,"3, K2	Mat	48	G>A	0	0	0	2.63	Novel	—",198,11,Nat_Commun_2015_Nov_2_6_8718.txt
16	G>A,"4–5, K3	Mat	16	G>A	0	0	0.0008	2.63	Novel	—",199,13,Nat_Commun_2015_Nov_2_6_8718.txt
51	G>A,"4–5, K3	Pat	51	G>A	0.0014	0	0	1.37	MOPD1	rs188343279",200,13,Nat_Commun_2015_Nov_2_6_8718.txt
8	C>T,"6, K4	Mat	8	C>T	0	0.0011	0	2.57	Novel	rs370715569",201,11,Nat_Commun_2015_Nov_2_6_8718.txt
118	T>C,"6, K4	Pat	118	T>C	0	0	0	2.12	Novel	—",202,11,Nat_Commun_2015_Nov_2_6_8718.txt
1861A>G,"...bstitution at position 1,861 of the coding DNA (c.1861A>G) and results in an amino-acid substitution...",17,1125,Nat_Commun_2016_Apr_15_7_11253.txt
1861A>G,"... As such, we have shown segregation of the CCNF c.1861A>G mutation in seven ALS patients from family...",17,1665,Nat_Commun_2016_Apr_15_7_11253.txt
1861A>G,...exome sequencing. (b) Sequence traces of WT and c.1861A>G mutation identified in family FALS10. (c) ...,110,369,Nat_Commun_2016_Apr_15_7_11253.txt
7A>G, p.S3G	7A>G	1	1/99 US FTLD-ALS	0/1038 US controls0/657 AU...,121,8,Nat_Commun_2016_Apr_15_7_11253.txt
290A>G, p.K97R	290A>G	4	1/159 UK FALS	0/897 UK controls0/967 AU c...,122,9,Nat_Commun_2016_Apr_15_7_11253.txt
585T>G, p.S195R	585T>G	6	1/30 SP FALS	0/967 AU control exomes	Abse...,123,10,Nat_Commun_2016_Apr_15_7_11253.txt
1525T>C, p.S509P	1525T>C	13	1/99 IT FALS1/168 CA SALS	0/361 CA cont...,124,10,Nat_Commun_2016_Apr_15_7_11253.txt
1861A>G, p.S621G	1861A>G	16	1/75 AU FALS	0/864 AU Sanger controls0/...,125,10,Nat_Commun_2016_Apr_15_7_11253.txt
2315T>C, p.I772T	2315T>C	17	1/159 UK FALS	0/897 UK controls0/967 AU...,126,10,Nat_Commun_2016_Apr_15_7_11253.txt
542C>T, p.T181I	542C>T	6	1/283 JA SALS	0/514 JA controls0/967 AU c...,129,10,Nat_Commun_2016_Apr_15_7_11253.txt
1175G>C, p.R392T	1175G>C	11	1/99 US FTLD	0/1038 US controls0/967 AU...,130,10,Nat_Commun_2016_Apr_15_7_11253.txt
1628C>T, p.T543I	1628C>T	15	1/283 JA SALS	0/514 JA controls0/967 AU...,131,10,Nat_Commun_2016_Apr_15_7_11253.txt
1870G>A, p.E624K	1870G>A	16	1/49 US SALS trios	0/801 AU Sanger cont...,132,10,Nat_Commun_2016_Apr_15_7_11253.txt
1G>C,"...published low-frequency variant in CARD9 (c.IVS11+1G>C) located on the donor site of exon 11, which ...",16,1245,Nat_Commun_2016_Aug_9_7_12342.txt
1G>C,"... and the splice disrupting CARD9 variant (c.IVS11+1G>C, MAF=0.58%, OR=0.29 (0.22–0.37))7, R179X exer...",42,809,Nat_Commun_2016_Aug_9_7_12342.txt
308G>A,"...InterLymph consortium, the variant allele for TNF-308G>A (rs1800629) and a TNF/LTA haplotype located...",21,353,Nat_Genet_2010_Aug_18_42(8)_661-664.txt
2A>G,"...o cause JATD. However, a similar genotype (c.2758-2A>G/P209L or C552X/P209L) leads to early-onset NP...",44,791,Nat_Genet_2011_Mar_23_43(3)_189-196.txt
3A>G,BBS	12620/V.15	N. European	c.2322+3A>G		0/440	0/356	BBS1: M390R hom,137,35,Nat_Genet_2011_Mar_23_43(3)_189-196.txt
3A>G,BBS	13881/VI.24	N. European	c.2322+3A>G		0/440	0/356	BBS2:L209fsX229 hom,138,36,Nat_Genet_2011_Mar_23_43(3)_189-196.txt
1G>T,...9L		0/440	0/356	BBS4: Q218fsX228 het; BBS4: c.151+1G>T het,140,76,Nat_Genet_2011_Mar_23_43(3)_189-196.txt
711G>T,BBS	10172/I.25	N. European	c.711G>T/Y255C		0/440	0/356	BBS10: C91fsX95 het; BBS...,145,30,Nat_Genet_2011_Mar_23_43(3)_189-196.txt
2 A>G,NPHP+	A34-II1	Portuguese	P209L	c.2758-2 A>G	0/440	0/440	0/356	0/356,153,39,Nat_Genet_2011_Mar_23_43(3)_189-196.txt
3C>G,NPHP+	F514	N. European	W150R	c.3264-3C>G	0/440	0/440	0/356	0/356,155,37,Nat_Genet_2011_Mar_23_43(3)_189-196.txt
3A>G,NPHP	F925-II1	N. European	c.2322+3A>G		0/440	0/356,157,34,Nat_Genet_2011_Mar_23_43(3)_189-196.txt
2931G>A,"...ementary Table 1) revealed a nonsense mutation, c.2931G>A (p.Trp977X), also in IGSF1 (Fig. 1c). B-II...",42,1217,Nat_Genet_2012_Dec_11_44(12)_1375-1381.txt
2931G>A,c.2931G>A	p.Trp977X	UK	4 wks	+	+	10.52	1.1/1.0 [0.55...,184,4,Nat_Genet_2012_Dec_11_44(12)_1375-1381.txt
2588C>T,c.2588C>T	p.Ser863Phe	NL	5 wks	+	+	27.52	11.8/38 [8....,233,4,Nat_Genet_2012_Dec_11_44(12)_1375-1381.txt
2839T>C,c.2839T>C	p.Cys947Arg	NL	6.5 yrs	+	+	18.36	22.7/22.7...,242,4,Nat_Genet_2012_Dec_11_44(12)_1375-1381.txt
3518G>A,c.3518G>A	p.Trp1173X	NL	14.1 yrs	+	+	16.69	19/17 [8-...,248,4,Nat_Genet_2012_Dec_11_44(12)_1375-1381.txt
2309G>A,c.2309G>A	p.Ser770Asn	IT	10.6 yrs	+	+	26.54	21.5/21....,257,4,Nat_Genet_2012_Dec_11_44(12)_1375-1381.txt
272T>C,"...stani families, we found a homozygous mutation (c.272T>C; p.Phe91Ser) of CIB2 (Figs. 1 and 2a; Suppl...",24,427,Nat_Genet_2012_Nov_30_44(11)_1265-1271.txt
297C>G,"...ile in two DFNB48 families (DEM4025, DEM4225) a c.297C>G (p.Cys99Trp) CIB2 mutation co-segregated wi...",24,547,Nat_Genet_2012_Nov_30_44(11)_1265-1271.txt
368T>C,"...es 1 and 2). In addition, a transition mutation c.368T>C (p.Ile123Thr) of CIB2 co-segregated with AR...",24,777,Nat_Genet_2012_Nov_30_44(11)_1265-1271.txt
272T>C,...related affected individuals homozygous for the c.272T>C and c.297C>G mutations and the flanking hap...,24,969,Nat_Genet_2012_Nov_30_44(11)_1265-1271.txt
297C>G,...ted individuals homozygous for the c.272T>C and c.297C>G mutations and the flanking haplotypes were ...,24,982,Nat_Genet_2012_Nov_30_44(11)_1265-1271.txt
192G>C,...DF117 (Fig. 1c) were found to be homozygous for c.192G>C (p.Glu64Asp) in CIB2. This new locus is des...,26,321,Nat_Genet_2012_Nov_30_44(11)_1265-1271.txt
192G>C,...le carriers have normal hearing. No carriers of c.192G>C and c.368T>C were found among 676 and 724 e...,26,577,Nat_Genet_2012_Nov_30_44(11)_1265-1271.txt
368T>C,...ave normal hearing. No carriers of c.192G>C and c.368T>C were found among 676 and 724 ethnically mat...,26,590,Nat_Genet_2012_Nov_30_44(11)_1265-1271.txt
272T>C,...ely (Supplementary Table 4). Heterozygosity for c.272T>C and c.297C>G was identified in one and five...,26,725,Nat_Genet_2012_Nov_30_44(11)_1265-1271.txt
297C>G,...ntary Table 4). Heterozygosity for c.272T>C and c.297C>G was identified in one and five representati...,26,738,Nat_Genet_2012_Nov_30_44(11)_1265-1271.txt
272T>C,"...2) at D15SA975 (78.56 Mb). CIB2 mutant alleles [c.272T>C (p.Phe91Ser), c.297C>G (p.Cys99Trp) and c.2...",118,601,Nat_Genet_2012_Nov_30_44(11)_1265-1271.txt
297C>G,"...b). CIB2 mutant alleles [c.272T>C (p.Phe91Ser), c.297C>G (p.Cys99Trp) and c.297C>G (p.Ile123Thr)] co...",118,624,Nat_Genet_2012_Nov_30_44(11)_1265-1271.txt
297C>G,"....272T>C (p.Phe91Ser), c.297C>G (p.Cys99Trp) and c.297C>G (p.Ile123Thr)] co-segregate with NSHI pheno...",118,650,Nat_Genet_2012_Nov_30_44(11)_1265-1271.txt
192G>C,... phenotype of family PKDF117 co-segregates with c.192G>C (p.Glu64Asp) mutation of CIB2. These four r...,118,822,Nat_Genet_2012_Nov_30_44(11)_1265-1271.txt
23508437A>G,"...nts (Supplementary Figure 2). This variant, chr10:23508437A>G, was located ~25kb downstream of PTF1A...",25,1254,Nat_Genet_2014_Jan_10_46(1)_61-64.txt
23508437A>G,"...h mutations in this element, 6 had the same chr10:23508437A>G mutation as part of a shared extended ...",27,518,Nat_Genet_2014_Jan_10_46(1)_61-64.txt
23508363A>G,"...t base substitution mutations: a homozygous chr10:23508363A>G mutation, a homozygous chr10:23508305A...",27,733,Nat_Genet_2014_Jan_10_46(1)_61-64.txt
23508305A>G,"...us chr10:23508363A>G mutation, a homozygous chr10:23508305A>G mutation and compound heterozygous chr...",27,774,Nat_Genet_2014_Jan_10_46(1)_61-64.txt
23508365A>G,...08305A>G mutation and compound heterozygous chr10:23508365A>G/chr10:23508446A>C mutations (Figure 2)...,27,827,Nat_Genet_2014_Jan_10_46(1)_61-64.txt
23508446A>C,...and compound heterozygous chr10:23508365A>G/chr10:23508446A>C mutations (Figure 2). In the tenth fam...,27,845,Nat_Genet_2014_Jan_10_46(1)_61-64.txt
437A>G,...aplotype analyses of additional families with the 437A>G mutation we also included 3 patients genoty...,67,443,Nat_Genet_2014_Jan_10_46(1)_61-64.txt
437A>G,...tween probands from each of the families with the 437A>G mutation. We only used SNPs that were prese...,69,188,Nat_Genet_2014_Jan_10_46(1)_61-64.txt
23508305A>G,"...g19 coordinates as labels (referring to positions 23508305A>G, 23508363A>G, 23508365A>G, 23508437A>G...",98,891,Nat_Genet_2014_Jan_10_46(1)_61-64.txt
23508363A>G,"...es as labels (referring to positions 23508305A>G, 23508363A>G, 23508365A>G, 23508437A>G and 23508446...",98,904,Nat_Genet_2014_Jan_10_46(1)_61-64.txt
23508365A>G,"...(referring to positions 23508305A>G, 23508363A>G, 23508365A>G, 23508437A>G and 23508446A>C on chromo...",98,917,Nat_Genet_2014_Jan_10_46(1)_61-64.txt
23508437A>G,"... positions 23508305A>G, 23508363A>G, 23508365A>G, 23508437A>G and 23508446A>C on chromosome 10 respe...",98,930,Nat_Genet_2014_Jan_10_46(1)_61-64.txt
23508446A>C,"...305A>G, 23508363A>G, 23508365A>G, 23508437A>G and 23508446A>C on chromosome 10 respectively)",98,946,Nat_Genet_2014_Jan_10_46(1)_61-64.txt
363 A>G,"...ntaining the wild type (WT) sequence, but not the 363 A>G mutation (MUT). The retardation signal was...",104,1158,Nat_Genet_2014_Jan_10_46(1)_61-64.txt
446 A>C,"...ntaining the wild type (WT) sequence, but not the 446 A>C mutation (MUT). The retardation signal was...",104,1751,Nat_Genet_2014_Jan_10_46(1)_61-64.txt
529 C>T,PARN	c.529 C>T	Gln177*	Novel	Novel	Novel	< 1st,99,8,Nat_Genet_2015_May_13_47(5)_512-517.txt
1262 A>G,PARN	c.1262 A>G	Lys421Arg	Novel	Novel	Novel	< 1st,103,8,Nat_Genet_2015_May_13_47(5)_512-517.txt
1451 C>T,RTEL1	c.1451 C>T	Pro484Leu	Novel	Novel	Novel	< 1st,107,9,Nat_Genet_2015_May_13_47(5)_512-517.txt
1940 C>T,RTEL1	c.1940 C>T	Pro647Leu	Novel	Novel	Novel	< 1st,108,9,Nat_Genet_2015_May_13_47(5)_512-517.txt
2005 C>T,RTEL1	c.2005 C>T	Gln693*	Novel	Novel	Novel	< 1st,109,9,Nat_Genet_2015_May_13_47(5)_512-517.txt
3371 A>C,RTEL1	c.3371 A>C	His1124Pro	Novel	Novel	Novel	< 1st,110,9,Nat_Genet_2015_May_13_47(5)_512-517.txt
553C>T,...us for the paternally derived nonsense p.Q185X (c.553C>T) mutation in exon 5 of HOIL1 (Fig. 1c),14,1560,Nat_Immunol_2012_Dec_28_13(12)_1178-1186.txt
553 C>T,"... encompassing TRIB3 and HOIL1, and the nonsense c.553 C>T, p.Q185X mutant allele in HOIL1. Pedigree ...",103,180,Nat_Immunol_2012_Dec_28_13(12)_1178-1186.txt
3G>A,".... RPS19 mutations in these two individuals were c.3G>A Met1Ile and c.185G>A Arg62Gln, respectively",33,1092,Nat_Med_2014_Jul_22_20(7)_748-753.txt
185G>A,"...n these two individuals were c.3G>A Met1Ile and c.185G>A Arg62Gln, respectively",33,1111,Nat_Med_2014_Jul_22_20(7)_748-753.txt
3059G>A,"... two heterozygous missense mutations - p.R1020K,c.3059G>A and p.L1872P,c.5615T>C. Both cases (PD2126...",29,209,Nature_2011_Jan_27_469(7331)_539-542.txt
5615T>C,"...nse mutations - p.R1020K,c.3059G>A and p.L1872P,c.5615T>C. Both cases (PD2126, PD2127) have a PBRM1 ...",29,232,Nature_2011_Jan_27_469(7331)_539-542.txt
2T>C,... The second trace is a normal control. The c.1376+2T>C mutation occurs 2 base pairs into intron 13 a...,18,168,NDT_Plus_2008_Jun_27_1(3)_171-175.txt
2 A > T,"Patient S3	Lung, left	KRAS G12 V; CDKN2A c.151-2 A > T	Lung, right	STK11 D194Y",100,48,Neoplasia_2016_Sep_20_18(9)_577-583.txt
1664C>T,1	13	1664C>T	Ser555Leu,91,6,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
2576T>C,22	2576T>C	Leu859Pro,94,4,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
363G>C,3	3	363G>C	Glu121Asp,95,5,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
626G>A,5	626G>A	Arg209Gln,96,3,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
1763C>T,4	14	1763C>T	Ala588Val,97,6,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
2893C>T,25	2893C>T	Gln965Xc,98,4,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
1195C>T,5a	10	Homozygous 1195C>T	Arg399Cys,99,18,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
497C>T,6	3	497C>T	Ala166Val,100,5,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
2576T>C,22	2576T>C	Leu859Pro,101,4,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
2221G>A,7	18	2221G>A	Gly741Arg,102,6,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
2981G>A,26	2981G>A	Cys994Tyr,103,4,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
2981G>A,26	2981G>A	Cys994Tyr,105,4,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
961C>T,9	7	961C>T	Arg321Trp,106,5,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
2221G>A,18	2221G>A	Gly741Arg,107,4,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
911C>T,10	7	911C>T	Thr304Met,108,6,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
1G>T,24	2883+1G>T	Intron 24 5′ splice site lost,109,9,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
1963C>T,11	16	1963C>T	Arg655Cys,110,7,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
1664C>T,12	13	1664C>T	Ser555Leu,112,7,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
2221G>A,18	2221G>A	Gly741Arg,113,4,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
2221G>A,13	18	2221G>A	Gly741Arg,114,7,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
1G>T,24	2883+1G>T	Intron 24 5′ splice site lost,115,9,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
2996A>G,14	26	2996A>G	Tyr999Cysc,116,7,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
3089A>G,26	3089A>G	Gln1030Arg,117,4,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
1145C>T,15	9	1145C>T	Thr382Met,118,6,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
2221G>A,18	2221G>A	Gly741Arg,119,4,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
710G>A,16	5	710G>A	Gly237Aspc,120,6,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
2576T>C,22	2576T>C	Leu859Pro,121,4,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
1196G>T,17b	10	1196G>T	Arg399Leuc,122,8,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
1G>T,14	1825+1G>T	Intron 14 5′ splice site lost,123,9,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
1196G>T,18b	10	1196G>T	Arg399Leuc,124,8,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
1G>T,14	1825+1G>T	Intron 14 5′ splice site lost,125,9,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
1G>T,24	2883+1G>T	Intron 24 5′ splice site lost,127,9,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
1390G>A,20	11	1390G>A	Ala464Thr,128,7,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
2576T>C,22	2576T>C	Leu859Pro,129,4,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
2221G>A,21	18	2221G>A	Gly741Arg,130,7,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
3053G>C,26	3053G>C	Arg1018Proc,131,4,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
1G>A,22	4	506-1G>A	Intron 3 3′ splice site lost,132,10,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
1763C>T,23	14	1763C>T	Ala588Val,134,7,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
2576T>C,22	2576T>C	Leu859Pro,135,4,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
1258G>A,24	10	1258G>A	Ala420Thrc,136,7,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
2947G>A,25	2947G>A	Val983Ilec,137,4,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
2965G>A,26	2965G>A	Gly989Arg,139,4,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
1315G>A,26	10	1315G>A	Gly439Ser,140,7,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
2221G>A,18	2221G>A	Gly741Arg,141,4,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
2221G>A,27	18	Homozygous 2221G>A	Gly741Arg,142,18,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
2221G>A,28	18	2221G>A	Gly741Arg,143,7,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
2981G>A,26	2981G>A	Cys994Tyr,144,4,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
1G>A,29	16	2037+1G>A	Intron 16 5′ splice site lost,145,12,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
3053G>A,26	3053G>A	Arg1018Gln,146,4,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
2221G>A,18	2221G>A	Gly741Arg,148,4,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
626G>A,31	5	626G>A	Arg209Gln,149,6,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
1763C>A,14	1763C>A	Ala588Gluc,150,4,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
2581C>T,32	22	2581C>T	Arg861Cys,151,7,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
2723T>C,23	2723T>C	Ile908Thrc,152,4,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
1351T>A,33	11	1351T>A	Ser451Thrc,153,7,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
2221G>A,18	2221G>A	Gly741Arg,154,4,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
1315G>A,34	10	1315G>A	Gly439Ser,155,7,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
1G>T,24	2883+1G>T	Intron 24 5′ splice site lost,156,9,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
2221G>A,35	18	Homozygous 2221G>A	Gly741Arg,157,18,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
626G>A,36	5	626G>A	Arg209Gln,158,6,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
2981G>A,26	2981G>A	Cys994Tyr,159,4,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
524A>C,"... Genetic association between bipolar disorder and 524A>C (Leu133Ile) polymorphism of CNR2 gene, enco...",164,90,Neural_Plast_2016_Dec_27_2016_9817089.txt
42C>T,The HTR3A polymorphism c. ‐42C>T is ass‐ociated with amygdala responsiveness ...,939,28,Neurogastroenterol_Motil_2016_Jun_11_28(6)_900-913.txt
16C>T,... Japan [7–11]. A single nucleotide substitution (–16C>T) in the 5′-untranslated region (UTR) of the ...,9,390,Neurogenetics_2010_Oct_28_11(4)_409-415.txt
16C>T,...da K Sakai H Hamanoue H Mizuguchi T Shimizu Y  A –16C>T substitution in the 5′ UTR of the puratrophi...,113,68,Neurogenetics_2010_Oct_28_11(4)_409-415.txt
3G>C,"...r splice site in intron 2 of the GYG1 gene (c.143+3G>C, p.Asp3Glufs*4), either in homozygous (in the...",542,525,Neurol_Genet_2015_Sep_24_1(3)_e21.txt
967C>G,...encing revealed a novel variant (chr 3: g.148.717.967C>G) that enhances a cryptic 5′ splice site in ...,542,899,Neurol_Genet_2015_Sep_24_1(3)_e21.txt
967C>G,...ows a single nucleotide variant (chr 3: g.148.717.967C>G) that enhances the 5′ splice site of this c...,545,1596,Neurol_Genet_2015_Sep_24_1(3)_e21.txt
143G>C,The c.143G>C homozygous mutation has been identified in ...,547,7,Neurol_Genet_2015_Sep_24_1(3)_e21.txt
1448T>C,...ic patients with the L444P/L444P GBA1 genotype (c.1448T>C) who were on ERT were included in this stu...,342,121,Neurol_Genet_2016_Feb_25_2(2)_e55.txt
1G>A,"...mutations in the GBA gene (c.84dupG (84GG), c.115+1G>A (IVS2+1G>A), c.1226A>G (p.N370S), c.1297G>T (...",342,609,Neurol_Genet_2016_Feb_25_2(2)_e55.txt
1G>A,"...n the GBA gene (c.84dupG (84GG), c.115+1G>A (IVS2+1G>A), c.1226A>G (p.N370S), c.1297G>T (p.V394L), c...",342,620,Neurol_Genet_2016_Feb_25_2(2)_e55.txt
1226A>G,"... gene (c.84dupG (84GG), c.115+1G>A (IVS2+1G>A), c.1226A>G (p.N370S), c.1297G>T (p.V394L), c.1342G>C ...",342,629,Neurol_Genet_2016_Feb_25_2(2)_e55.txt
1297G>T,"...), c.115+1G>A (IVS2+1G>A), c.1226A>G (p.N370S), c.1297G>T (p.V394L), c.1342G>C (p.D409H), c.1448T>C ...",342,650,Neurol_Genet_2016_Feb_25_2(2)_e55.txt
1342G>C,"...G>A), c.1226A>G (p.N370S), c.1297G>T (p.V394L), c.1342G>C (p.D409H), c.1448T>C (p.L444P), c.1504C>T ...",342,671,Neurol_Genet_2016_Feb_25_2(2)_e55.txt
1448T>C,"...70S), c.1297G>T (p.V394L), c.1342G>C (p.D409H), c.1448T>C (p.L444P), c.1504C>T (p.R463C), and c.1604...",342,692,Neurol_Genet_2016_Feb_25_2(2)_e55.txt
1504C>T,"...94L), c.1342G>C (p.D409H), c.1448T>C (p.L444P), c.1504C>T (p.R463C), and c.1604G>A (p.R496H)) and 2 ...",342,713,Neurol_Genet_2016_Feb_25_2(2)_e55.txt
1604G>A,"..., c.1448T>C (p.L444P), c.1504C>T (p.R463C), and c.1604G>A (p.R496H)) and 2 recombinant alleles (RecN...",342,738,Neurol_Genet_2016_Feb_25_2(2)_e55.txt
464G>A,"...hogenic due to a frameshift, and the mutations, c.464G>A (p.Arg155His) and c.902C>G (p.Ser301Cys), a...",1220,420,Neurol_Genet_2016_Oct_11_2(6)_e112.txt
902C>G,"..., and the mutations, c.464G>A (p.Arg155His) and c.902C>G (p.Ser301Cys), affect highly conserved site...",1220,447,Neurol_Genet_2016_Oct_11_2(6)_e112.txt
79G>C,...is can be attributed to the allele carrying the c.79G>C mutation because the c.859C>T mutation has b...,1230,141,Neurol_Genet_2016_Oct_11_2(6)_e112.txt
859C>T,...llele carrying the c.79G>C mutation because the c.859C>T mutation has been shown to yield no protein...,1230,170,Neurol_Genet_2016_Oct_11_2(6)_e112.txt
79G>C,"...has been shown to yield no protein, whereas the c.79G>C does.6 Patients had decreased α-dystroglycan...",1230,236,Neurol_Genet_2016_Oct_11_2(6)_e112.txt
79G>C,It has been suggested that the c.79G>C mutation leads to a mild phenotype of LGMD2T...,1232,34,Neurol_Genet_2016_Oct_11_2(6)_e112.txt
859C>T,...on leads to a mild phenotype of LGMD2T5 and the c.859C>T to a severe one.6 Three cases were compound...,1232,96,Neurol_Genet_2016_Oct_11_2(6)_e112.txt
1205G>A,"... of TUBA1A gene revealed a missense mutation of c.1205G>A, which was negative in both parents indica...",8,532,Neurol_Sci_2014_Feb_8_35(5)_801-803.txt
5540G>A,...9Case ReportClinical features of the pathogenic m.5540G>A mitochondrial transfer RNA tryptophan gene...,3,189,Neuromuscul_Disord_2016_Oct_26(10)_702-705.txt
5540G>A,• De novo m.5540G>A mtDNA mutation adds to its credentials as ...,6,13,Neuromuscul_Disord_2016_Oct_26(10)_702-705.txt
3243A>G,...ease. Whilst common point mutations such as the m.3243A>G mutation and three primary Leber hereditar...,18,585,Neuromuscul_Disord_2016_Oct_26(10)_702-705.txt
5540G>A,The m.5540G>A mutation in the mitochondrial (mt-) tRNATr...,20,7,Neuromuscul_Disord_2016_Oct_26(10)_702-705.txt
3243A>G,"Screens for common mtDNA mutations including m.3243A>G, m.8344A>G, m.8993T>C/G and m.13513G>A wer...",40,48,Neuromuscul_Disord_2016_Oct_26(10)_702-705.txt
8344A>G,"...for common mtDNA mutations including m.3243A>G, m.8344A>G, m.8993T>C/G and m.13513G>A were negative ...",40,59,Neuromuscul_Disord_2016_Oct_26(10)_702-705.txt
8993T>C,"...mtDNA mutations including m.3243A>G, m.8344A>G, m.8993T>C/G and m.13513G>A were negative whilst long...",40,70,Neuromuscul_Disord_2016_Oct_26(10)_702-705.txt
13513G>A,"...including m.3243A>G, m.8344A>G, m.8993T>C/G and m.13513G>A were negative whilst long-range PCR proto...",40,86,Neuromuscul_Disord_2016_Oct_26(10)_702-705.txt
5540G>A,...orted mutation in the mt-tRNATrp (MT-TW) gene – m.5540G>A. The mutation load was heteroplasmic and q...,40,354,Neuromuscul_Disord_2016_Oct_26(10)_702-705.txt
5540G>A,The m.5540G>A mutation was not detected in any samples (...,42,7,Neuromuscul_Disord_2016_Oct_26(10)_702-705.txt
5540G>A,...arboured the previously-described heteroplasmic m.5540G>A mutation and presented with a childhood-on...,45,88,Neuromuscul_Disord_2016_Oct_26(10)_702-705.txt
5540G>A,"... had a stroke. Furthermore, we believe that the m.5540G>A mutation has arisen de novo in our patient...",47,1179,Neuromuscul_Disord_2016_Oct_26(10)_702-705.txt
5540G>A,...n MT-TW pathogenic gene variants (including the m.5540G>A mutation) have been reported to occur as d...,49,448,Neuromuscul_Disord_2016_Oct_26(10)_702-705.txt
5540G>A,...aden the clinical phenotype associated with the m.5540G>A mutation which in our patient is likely to...,55,82,Neuromuscul_Disord_2016_Oct_26(10)_702-705.txt
5540G>A,... the proband (highlighted by an arrow) with the m.5540G>A mutation. Analysis of several samples from...,70,145,Neuromuscul_Disord_2016_Oct_26(10)_702-705.txt
5540G>A,...y-unaffected mother strongly suggested that the m.5540G>A mutation has arisen de novo. (B–D) A first...,70,269,Neuromuscul_Disord_2016_Oct_26(10)_702-705.txt
5540G>A,... and severe clinical course associated with the m.5540G>A mutation in Mol Genet Metab Rep 1 2014 61 ...,79,103,Neuromuscul_Disord_2016_Oct_26(10)_702-705.txt
2345 G>A,"...another novel mutation of CSF1R, a heterozygous c.2345 G>A (p.782 Arg>His) in exon 18, in a Japanese...",48,266,Neuropathol_Appl_Neurobiol_2013_Dec_29_39(7)_837-843.txt
782 Arg>His,"...l mutation of CSF1R, a heterozygous c.2345 G>A (p.782 Arg>His) in exon 18, in a Japanese family with...",48,278,Neuropathol_Appl_Neurobiol_2013_Dec_29_39(7)_837-843.txt
2080A>G,"...t eight missense mutations: M694V (p.Met694Val, c.2080A>G, rs61752717), M694I (p.Met694Ile, c.2082G>...",22,578,Neuropsychiatr_Dis_Treat_2016_Aug_29_12_2225-2232.txt
2082G>A,"...al, c.2080A>G, rs61752717), M694I (p.Met694Ile, c.2082G>A, rs28940578), M680I (p.Met680Ile, c.2040G>...",22,622,Neuropsychiatr_Dis_Treat_2016_Aug_29_12_2225-2232.txt
2040G>C,"...le, c.2082G>A, rs28940578), M680I (p.Met680Ile, c.2040G>C, rs28940580), V726A (p.Val726Ala, c.2177T>...",22,666,Neuropsychiatr_Dis_Treat_2016_Aug_29_12_2225-2232.txt
2177T>C,"...le, c.2040G>C, rs28940580), V726A (p.Val726Ala, c.2177T>C, rs28940579), R761H (p.Arg761His, c.2282G>...",22,710,Neuropsychiatr_Dis_Treat_2016_Aug_29_12_2225-2232.txt
2282G>A,"...la, c.2177T>C, rs28940579), R761H (p.Arg761His, c.2282G>A, rs104895097), and K695R (p.Lys695Arg, c.2...",22,754,Neuropsychiatr_Dis_Treat_2016_Aug_29_12_2225-2232.txt
2084A>G,"....2282G>A, rs104895097), and K695R (p.Lys695Arg, c.2084A>G, rs104895094) in exon 10; P369S (p.Pro369S...",22,803,Neuropsychiatr_Dis_Treat_2016_Aug_29_12_2225-2232.txt
1105C>T,"...G, rs104895094) in exon 10; P369S (p.Pro369Ser, c.1105C>T, rs11466023) in exon 3; and E148Q (p.Glu14...",22,859,Neuropsychiatr_Dis_Treat_2016_Aug_29_12_2225-2232.txt
442G>C,"... rs11466023) in exon 3; and E148Q (p.Glu148Gln, c.442G>C, rs3743930) in exon 2 of the MEFV gene. To ...",22,917,Neuropsychiatr_Dis_Treat_2016_Aug_29_12_2225-2232.txt
14A > G,...ranscribed from constructs carrying mutation IVS1-14A > G. (B) Splicing pattern of LIPC minigenes mu...,146,519,Nucleic_Acids_Res_2007_Oct_18_35(19)_6399-6413.txt
14A > G,...sulted from a disease-causing point mutation IVS1-14A > G that created a new AG dinucleotide downstr...,162,356,Nucleic_Acids_Res_2007_Oct_18_35(19)_6399-6413.txt
514 C > T,...used to test the hypothesis that the positions of 514 C > T and 231 G > A transitions were each dist...,55,388,Nucleic_Acids_Res_2007_Sep_22_35(17)_5717-5728.txt
231 G > A,...he hypothesis that the positions of 514 C > T and 231 G > A transitions were each distributed accord...,55,402,Nucleic_Acids_Res_2007_Sep_22_35(17)_5717-5728.txt
514 C > T,...nov one sample tests on the relative positions of 514 C > T and 231 G > A transitions from 1449 454-...,136,66,Nucleic_Acids_Res_2007_Sep_22_35(17)_5717-5728.txt
231 G > A,... tests on the relative positions of 514 C > T and 231 G > A transitions from 1449 454-derived Mammut...,136,80,Nucleic_Acids_Res_2007_Sep_22_35(17)_5717-5728.txt
514 C > T,...R amplification of 454-generated ssDNA molecules (514 C > T and 231 G > A). The plot comprises a box...,137,156,Nucleic_Acids_Res_2007_Sep_22_35(17)_5717-5728.txt
231 G > A,...n of 454-generated ssDNA molecules (514 C > T and 231 G > A). The plot comprises a box and whiskers....,137,170,Nucleic_Acids_Res_2007_Sep_22_35(17)_5717-5728.txt
24 G > A,... the single exception to the predicted pattern (1/24 G > A transitions) is due to a polymerase misin...,141,485,Nucleic_Acids_Res_2007_Sep_22_35(17)_5717-5728.txt
9A->G,"...e 9 edited adenosines were mutated to guanosines (9A->G) and a reporter with compensatory mutations,...",56,627,Nucleic_Acids_Res_2012_Oct_30_40(19)_9876-9886.txt
9A->G,"...s, restoring the base pairs in the intronic stem (9A->G+9U->C)",56,725,Nucleic_Acids_Res_2012_Oct_30_40(19)_9876-9886.txt
9U->C,...toring the base pairs in the intronic stem (9A->G+9U->C),56,731,Nucleic_Acids_Res_2012_Oct_30_40(19)_9876-9886.txt
6792C>G,...Baralle FE   The pathological splicing mutation c.6792C>G in NF1 exon 37 causes a change of tenancy ...,123,85,Nucleic_Acids_Res_2013_Nov_21_41(21)_9858-9869.txt
12201T>C,...ing the deafness-associated mitochondrial tRNAHis 12201T>C mutation. The destabilization of a highly...,3,1591,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
12201T>C,...a highly conserved base-pairing (5A-68U) by the m.12201T>C mutation alters structure and function of...,3,1683,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
1555A>G,"... non-syndromic deafness (1–3). In particular, the 1555A>G and 1494C>T mutations in the 12S rRNA gene...",8,420,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
1494C>T,"...ic deafness (1–3). In particular, the 1555A>G and 1494C>T mutations in the 12S rRNA gene have been a...",8,432,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
3243A>G,...tion associated with syndromic deafness was the m.3243A>G mutation in the tRNALeu(UUR) gene (8). The...,8,786,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
7445A>G,"...s-associated tRNA mutations were the tRNASer(UCN) 7445A>G, 7472insC, 7505T>C, 7510T>C and 7511T>C, t...",8,908,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
7505T>C,"...utations were the tRNASer(UCN) 7445A>G, 7472insC, 7505T>C, 7510T>C and 7511T>C, tRNAHis 12201T>C and...",8,927,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
7510T>C,"...were the tRNASer(UCN) 7445A>G, 7472insC, 7505T>C, 7510T>C and 7511T>C, tRNAHis 12201T>C and tRNAIle ...",8,936,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
7511T>C,"...ASer(UCN) 7445A>G, 7472insC, 7505T>C, 7510T>C and 7511T>C, tRNAHis 12201T>C and tRNAIle 4295A>G muta...",8,948,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
12201T>C,"..., 7472insC, 7505T>C, 7510T>C and 7511T>C, tRNAHis 12201T>C and tRNAIle 4295A>G mutations (2,9–14). T...",8,965,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
4295A>G,"...7510T>C and 7511T>C, tRNAHis 12201T>C and tRNAIle 4295A>G mutations (2,9–14). These mutations have s...",8,986,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
7445A>G,"...ide modification and aminoacylation (6,15). The m.7445A>G mutation altered the processing of the tRN...",8,1176,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
4295A>G,"...g of the tRNASer(UCN) precursor (16), while the m.4295A>G mutation may affect the nucleotide modific...",8,1264,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
7510T>C,"...anticodon of the tRNAIle (17). Furthermore, the m.7510T>C and m.7511T>C mutations disrupted the Wats...",8,1405,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
7511T>C,"...he tRNAIle (17). Furthermore, the m.7510T>C and m.7511T>C mutations disrupted the Watson–Crick base-...",8,1419,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
12201T>C,The m.12201T>C mutation in the tRNAHis gene was associat...,10,7,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
12201T>C,"...hinese pedigree (14). As shown in Figure 1, the m.12201T>C mutation is localized at a highly conserv...",10,177,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
12201T>C,...abilization of the base-pairing (5A-68U) by the m.12201T>C mutation altered the structure and functi...,10,409,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
12201T>C,"...her investigate the pathogenic mechanism of the m.12201T>C mutation in the Chinese family, cybrid ce...",10,908,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
12201T>C,...l tRNAHis. An arrow denotes the location of the m.12201T>C mutation,11,103,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
12201T>C,...tive (IV-11) of the Chinese family carrying the m.12201T>C mutation and one genetically unrelated Ch...,17,132,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
12201T>C,An analysis for the presence and level of the m.12201T>C mutation in the tRNAHis gene was carried ...,23,49,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
12201T>C,...ntly analyzed for the presence and level of the m.12201T>C mutation (14). The results confirmed the ...,51,556,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
12201T>C,To further examine whether the m.12201T>C mutation affects the stability of tRNAHis...,54,34,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
12201T>C,... from one affected subject (IV-11) carrying the m.12201T>C mutation and three cybrid cell lines deri...,55,568,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
12201T>C,...or uncharged tRNAHis in cell lines carrying the m.12201T>C mutation migrated slower than those of ce...,60,546,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
12201T>C,...and tRNAGly between the cell lines carrying the m.12201T>C mutation and cell lines lacking this muta...,60,783,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
12201T>C,"...slation occurred in the cell lines carrying the m.12201T>C mutation, a Western blot analysis was car...",66,116,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
7445A>G,...o previous studies with the deafness-associated m.7445A>G mutation in the precursor of tRNASer(UCN) ...,66,1377,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
12201T>C,...β-actin in three mutant cell lines carrying the m.12201T>C mutation and three control cell lines lac...,67,846,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
12201T>C,...β-actin in three mutant cell lines carrying the m.12201T>C mutation and three control cell lines lac...,67,1173,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
12201T>C,"To evaluate if the m.12201T>C mutation alters cellular bioenergetics, w...",72,22,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
12201T>C,...rived from three mutant cell lines carrying the m.12201T>C mutation and three control cell lines. As...,72,184,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
12201T>C,"...ls of the ΔΨm in the mutant cell lines carrying m.12201T>C mutation ranged from 14.2 and 21.4%, with...",84,512,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
12201T>C,...rived from three mutant cell lines carrying the m.12201T>C mutation and three control cell lines lac...,90,105,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
12201T>C,"...eneration in the mutant cell lines carrying the m.12201T>C mutation ranged from 126 and 145%, with a...",90,618,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
12201T>C,...thogenetic mechanism of the deafness-associated m.12201T>C mutation in the tRNAHis gene. The mutatio...,96,95,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
12201T>C,...destabilization of base-pairing (5A-68U) by the m.12201T>C mutation leads to the structural and func...,96,589,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
12201T>C,"... aminoacylation of mutant tRNAHis. In fact, the m.12201T>C mutation changed the conformation of tRNA...",96,793,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
15927G>A,"...wild-type molecule, as in the case of the tRNAThr 15927G>A mutation (24). However, the aminoacylatio...",96,982,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
3243A>G,"...lowering the level of the tRNA, as in the case of 3243A>G mutation in the tRNALeu(UUR) (25,39). In t...",96,1689,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
12201T>C,...ation in lymphoblastoid cell lines carrying the m.12201T>C mutation (14). These results strongly sup...,96,1917,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
12201T>C,... observed in the cybrid cell lines carrying the m.12201T>C mutation. It is likely that the altered t...,96,2317,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
7445A>G,...what was previously shown in cells carrying the m.7445A>G mutation in the precursor of tRNASer(UCN) ...,98,876,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
8344A>G,...rsor of tRNASer(UCN) (16) or the MERRF-associated 8344A>G mutation in tRNALys gene (40). The imprope...,98,955,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
7445A>G,"...lls carrying the deafness-associated tRNASer(UCN) 7445A>G, 7472insC and 7511T>C mutations (16,18,41)...",98,1612,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
7511T>C,"...ess-associated tRNASer(UCN) 7445A>G, 7472insC and 7511T>C mutations (16,18,41)",98,1634,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
12201T>C,The respiratory deficiency caused by the tRNAHis 12201T>C mutation results in decreased efficiency ...,100,50,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
12201T>C,...chondrial ATP production in cybrid carrying the m.12201T>C mutation was much lower than those in cel...,100,217,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
8344A>G,... those in cells carrying MERRF-associated tRNALys 8344A>G and MELAS-associated tRNALeu(UUR) 3243A>G ...,100,304,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
3243A>G,"...tRNALys 8344A>G and MELAS-associated tRNALeu(UUR) 3243A>G mutations (42,43). Alternatively, the redu...",100,346,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
12201T>C,... was observed in mutant cell lines carrying the m.12201T>C mutation. The defects in mitochondrial me...,100,1161,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
12201T>C,... production of ROS in mutant cells carrying the m.12201T>C mutation. The overproduction of ROS can e...,100,1534,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
12201T>C,...ll lines carrying the deafness-associated tRNAHis 12201T>C mutation. The m.12201T>C mutation alters ...,102,187,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
12201T>C,...fness-associated tRNAHis 12201T>C mutation. The m.12201T>C mutation alters the secondary structure a...,102,212,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
7510T>C,...c hearing impairment in a Spanish family with the 7510T>C mutation in the mitochondrial tRNASer(UCN)...,125,204,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
7505T>C,...ciated with the novel mitochondrial tRNASer(UCN)  7505T>C mutation in a Han Chinese family Mol. Gene...,127,184,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
3243A>G,... a metastable heteroplasmic segregation unit in m.3243A>G cybrid cells PLoS One 2012 7 e52080 232722...,179,246,Nucleic_Acids_Res_2015_Feb_27_43(4)_2177-2187.txt
80A>G,...05-02551ArticleThe Reduced Folate Carrier (RFC-1) 80A>G Polymorphism and Maternal Risk of Having a C...,3,136,Nutrients_2013_Jul_5_5(7)_2551-2563.txt
80A>G,...ns.org/licenses/by/3.0/).A common polymorphism (c.80A>G) in the gene coding for the reduced folate c...,3,1048,Nutrients_2013_Jul_5_5(7)_2551-2563.txt
80A>G,.... Present results suggest that the maternal RFC-1 80A>G polymorphism might be associated with an inc...,3,2196,Nutrients_2013_Jul_5_5(7)_2551-2563.txt
80A>G,...ate carrierSLC19A1RFC-1RFC1 A80G polymorphismRFC1 80A>G polymorphismDown Syndromematernal riskmeta-a...,5,62,Nutrients_2013_Jul_5_5(7)_2551-2563.txt
677C>T,... the methylenetetrahydrofolate reductase (MTHFR c.677C>T) and the methionine synthase reductase (MTR...,12,1035,Nutrients_2013_Jul_5_5(7)_2551-2563.txt
66A>G,...>T) and the methionine synthase reductase (MTRR c.66A>G) polymorphisms (both genes are involved in f...,12,1089,Nutrients_2013_Jul_5_5(7)_2551-2563.txt
80A>G,"..., Chango and coworkers [18] identified a common c.80A>G polymorphism in the gene coding for RFC-1 (S...",14,58,Nutrients_2013_Jul_5_5(7)_2551-2563.txt
677C>T,"...eased folate levels in combination with the MTHFR 677C>T one [18]. In 2006, we first suggested a con...",14,271,Nutrients_2013_Jul_5_5(7)_2551-2563.txt
80A>G,"...6, we first suggested a contribution of the RFC-1 80A>G polymorphism to the maternal risk of birth o...",14,344,Nutrients_2013_Jul_5_5(7)_2551-2563.txt
677C>T,...tion with maternal risk in combination with MTHFR 677C>T or MTHFR 1298A>C polymorphisms [19]. Subseq...,14,480,Nutrients_2013_Jul_5_5(7)_2551-2563.txt
1298A>C,...al risk in combination with MTHFR 677C>T or MTHFR 1298A>C polymorphisms [19]. Subsequent studies hav...,14,496,Nutrients_2013_Jul_5_5(7)_2551-2563.txt
80A>G,...observing an independent association of the RFC-1 80A>G polymorphism with the maternal risk of DS in...,14,633,Nutrients_2013_Jul_5_5(7)_2551-2563.txt
80A>G,"...d others failing to find any association of RFC-1 80A>G alone or combined [25,26,27]. Moreover, the ...",14,883,Nutrients_2013_Jul_5_5(7)_2551-2563.txt
80A>G,"...alone or combined [25,26,27]. Moreover, the RFC-1 80A>G polymorphism has been associated with reduce...",14,939,Nutrients_2013_Jul_5_5(7)_2551-2563.txt
80A>G,...erformed in 2009 to address the role of the RFC-1 80A>G polymorphism as a maternal risk factor for t...,16,176,Nutrients_2013_Jul_5_5(7)_2551-2563.txt
80A>G,...c association studies that investigated the RFC-1 80A>G polymorphism as a maternal risk factor for h...,16,799,Nutrients_2013_Jul_5_5(7)_2551-2563.txt
80A>G,"...guages, evaluating the association of the RFC-1 c.80A>G polymorphism and maternal risk for having a ...",20,1501,Nutrients_2013_Jul_5_5(7)_2551-2563.txt
80A>G,...ows allele and genotype distributions for RFC-1 c.80A>G in the selected studies. Deviations from Har...,22,218,Nutrients_2013_Jul_5_5(7)_2551-2563.txt
80A>G,...5-02551-t002_Table 2Table 2 Distribution of RFC-1 80A>G alleles and genotypes in Down Syndrome mothe...,53,62,Nutrients_2013_Jul_5_5(7)_2551-2563.txt
80A>G,...o examine the association of the maternal RFC-1 c.80A>G polymorphism with the risk of birth of a chi...,92,125,Nutrients_2013_Jul_5_5(7)_2551-2563.txt
80A>G,...used to examine the association between the RFC-1 80A>G polymorphism and maternal risk of birth of a...,97,346,Nutrients_2013_Jul_5_5(7)_2551-2563.txt
80A>G,...mates with 95% CI (fixed effects model) for RFC-1 80A>G recessive genetic model is shown in Figure 2...,99,111,Nutrients_2013_Jul_5_5(7)_2551-2563.txt
80A>G,...CI) forest plot for the association between RFC-1 80A>G polymorphism and maternal risk for a DS birt...,138,127,Nutrients_2013_Jul_5_5(7)_2551-2563.txt
80A>G,...ta-analysis suggest a possible role for the RFC-1 80A>G polymorphism in modulating maternal risk for...,141,76,Nutrients_2013_Jul_5_5(7)_2551-2563.txt
80A>G,...ms known to be in linkage disequilibrium with the 80A>G one have been associated with an increased r...,141,799,Nutrients_2013_Jul_5_5(7)_2551-2563.txt
66A>G,16. Amorim M.R.  Lima M.A.   MTRR 66A>G polymorphism as maternal risk factor for Dow...,175,35,Nutrients_2013_Jul_5_5(7)_2551-2563.txt
80G>A,...  Rosenblatt D.S.  Nicolas J.P.   A polymorphism (80G>A) in the reduced folate carrier gene and its ...,177,121,Nutrients_2013_Jul_5_5(7)_2551-2563.txt
80G>A,...ulty H.    The reduced folate carrier (SLC19A1) c.80G>A polymorphism is associated with red cell fol...,187,188,Nutrients_2013_Jul_5_5(7)_2551-2563.txt
385G>C,"...y one likely pathogenic variant in exon 7 (EYA4:c.385G>C, p.Gly129Arg) of sample H23 that converts a...",27,513,Oncogene_2014_Sep_4_33(36)_4464-4473.txt
385G>C,"...issense mutation in exon 7 was identified (EYA4:c.385G>C, p.Gly129Arg), which is shown along with wi...",93,236,Oncogene_2014_Sep_4_33(36)_4464-4473.txt
1047H>H,"...dentified. These were the missense mutation A>AG, 1047H>H/R in codon 3140, and the silent mutation C...",26,348,Oncol_Lett_2014_Jun_7_7(6)_2019-2022.txt
1025T>T,"...>H/R in codon 3140, and the silent mutation C>CT, 1025T>T in codon 3075 (Fig. 1). These samples were...",26,403,Oncol_Lett_2014_Jun_7_7(6)_2019-2022.txt
1047H>H,"...ts with GII and GIII tumors. The genetic changes, 1047H>H/R and 1025T>T, have already been reported ...",35,195,Oncol_Lett_2014_Jun_7_7(6)_2019-2022.txt
1025T>T,"...d GIII tumors. The genetic changes, 1047H>H/R and 1025T>T, have already been reported in the COSMIC ...",35,209,Oncol_Lett_2014_Jun_7_7(6)_2019-2022.txt
1047H>H,"...se (database ID 775 and 21451, respectively). The 1047H>H/R missense mutation is the most common mut...",35,356,Oncol_Lett_2014_Jun_7_7(6)_2019-2022.txt
1047H>H,"...utations. (A) GII meningioma sample with an A>AG, 1047H>H/R mutation in codon 3140. (B) GIII meningi...",44,124,Oncol_Lett_2014_Jun_7_7(6)_2019-2022.txt
1025T>T,"...don 3140. (B) GIII meningioma sample with a C>CT, 1025T>T silent mutation in codon 3075. PIK3CA, pho...",44,198,Oncol_Lett_2014_Jun_7_7(6)_2019-2022.txt
11614913 T>C,...[192-193]. Tian Tian et al. showed that the SNP rs11614913 T>C in the pre-miRNA region of miR-196a2 ...,203,197,Oncoscience_2014_Nov_15_1(11)_674-705.txt
34G>A,"1	63	M	R (asc)	5,0 cm	T3	Not tested	KRAS c.34G>A (p.G12S)	Reg Ascending LN & metachr Liver: K...",36,44,Oncoscience_2015_Feb_9_2(2)_125-130.txt
34G>A,...(p.G12S)	Reg Ascending LN & metachr Liver: KRAS c.34G>A (p.G12S)	None,36,100,Oncoscience_2015_Feb_9_2(2)_125-130.txt
35G>A,"L (desc)	2,5 cm	T3	Not tested	KRAS c.35G>A (p.G12D)",37,38,Oncoscience_2015_Feb_9_2(2)_125-130.txt
35G>A,"2	74	M	NS	5,8 cm	T3	No loss	KRAS c.35G>A (p.G12D)	Paraaortic LN & metachr Brain & met...",38,36,Oncoscience_2015_Feb_9_2(2)_125-130.txt
35G>A,...aaortic LN & metachr Brain & metachr Lung: KRAS c.35G>A	None,38,104,Oncoscience_2015_Feb_9_2(2)_125-130.txt
35G>T,"4	83	M	R (cecum)	10,0 cm	T3	MLH-1/PMS2	KRAS c.35G>T (p.G12V)	Reg LN WT	Multiple CBC, RCC",42,47,Oncoscience_2015_Feb_9_2(2)_125-130.txt
35G>A,"5	79	M	L (desc)	3,5 cm	T3	No loss	KRAS c.35G>A (p.G12D)	Synchr lung WT	Prostate Cancer",44,42,Oncoscience_2015_Feb_9_2(2)_125-130.txt
38G>A,"R (transv)	1,6 cm	T1	MSH2/MSH6	KRAS c.38G>A (p.G13D)",47,39,Oncoscience_2015_Feb_9_2(2)_125-130.txt
35G>T,7	63	F	R (asc)	Biopsy	NA	NA	KRAS c.35G>T (p.G12V)	liver (clinicaly)	None,48,36,Oncoscience_2015_Feb_9_2(2)_125-130.txt
35G>T,R (transv)	Biopsy	NA	NA	KRAS c.35G>T (p.G12V),49,32,Oncoscience_2015_Feb_9_2(2)_125-130.txt
182A>T,"8	69	M	L (desc)	5,5 cm	T3	NA	NRAS c.182A>T (p.Q61L)	Reg LN & synchr liver WT	None",50,37,Oncoscience_2015_Feb_9_2(2)_125-130.txt
35G>A,"...s, 77%). Three mutations were noted: 3 cases of c.35G>A in KRAS codon 12 (p.G12D), 3 cases of c.35G>...",57,288,Oncoscience_2015_Feb_9_2(2)_125-130.txt
35G>T,"...f c.35G>A in KRAS codon 12 (p.G12D), 3 cases of c.35G>T (p.G12V) in KRAS codon 12, and 1 case of c.3...",57,334,Oncoscience_2015_Feb_9_2(2)_125-130.txt
34G>A,"....35G>T (p.G12V) in KRAS codon 12, and 1 case of c.34G>A (p.G12S). A KRAS mutation in codon 13 (c.38G...",57,383,Oncoscience_2015_Feb_9_2(2)_125-130.txt
38G>A,"... c.34G>A (p.G12S). A KRAS mutation in codon 13 (c.38G>A [p.G13D]) was observed in 1 patient, and a N...",57,430,Oncoscience_2015_Feb_9_2(2)_125-130.txt
182A>T,"... in 1 patient, and a NRAS mutation in codon 61 (c.182A>T [p.Q61L]) detected in 1 patient. There were...",57,508,Oncoscience_2015_Feb_9_2(2)_125-130.txt
35G>A,"...patient 1) harbored a mutation in KRAS codon 12 c.35G>A (p.G12D) and c.34G>A (p.G12S), respectively....",59,423,Oncoscience_2015_Feb_9_2(2)_125-130.txt
34G>A,"... mutation in KRAS codon 12 c.35G>A (p.G12D) and c.34G>A (p.G12S), respectively. Of the 2 cases that ...",59,444,Oncoscience_2015_Feb_9_2(2)_125-130.txt
35G>T,"...d WT RAS in both lesions, and patient 7 had the c.35G>T KRAS mutation in both lesions",59,642,Oncoscience_2015_Feb_9_2(2)_125-130.txt
34G>A,...h the LN and liver metastases had the same KRAS c.34G>A (p.G12S) mutation. See Table 1 for RAS mutat...,61,513,Oncoscience_2015_Feb_9_2(2)_125-130.txt
395G>A,The wild-type human IDH1 and IDH1-R132H mutant (c.395G>A) were generously provided by Dr. Kun-Liang ...,148,51,Oncotarget_2014_Aug_16_5(17)_7342-7356.txt
2A>G,...utation S2215Y and FLT3 mutation splice site 1418+2A>G (Figure 1). mTOR acts downstream of multiple ...,52,682,Oncotarget_2014_Feb_21_5(10)_3012-3022.txt
2A>G,...horylation of ERK1 and 2 (Figure 2).[30] The 1418+2A>G splice site mutation seen in this tumor disru...,52,1297,Oncotarget_2014_Feb_21_5(10)_3012-3022.txt
2211A>G,"...ed bladder cancer tissues. We found three SNPs (c.2211A>G (5/31), c.3522A>T (14/31), c.4335A>G (4/31...",86,490,Oncotarget_2015_Apr_19_6(18)_16366-16378.txt
3522A>T,"...tissues. We found three SNPs (c.2211A>G (5/31), c.3522A>T (14/31), c.4335A>G (4/31)) (Figure 4, Supp...",86,508,Oncotarget_2015_Apr_19_6(18)_16366-16378.txt
4335A>G,"...hree SNPs (c.2211A>G (5/31), c.3522A>T (14/31), c.4335A>G (4/31)) (Figure 4, Supplement table 2), bu...",86,527,Oncotarget_2015_Apr_19_6(18)_16366-16378.txt
2211A>G,"...sequence analysis showed genetic alterations A. c.2211A>G, B. c.3522A>T and C. c.4335A>G respectivel...",89,58,Oncotarget_2015_Apr_19_6(18)_16366-16378.txt
3522A>T,"...sis showed genetic alterations A. c.2211A>G, B. c.3522A>T and C. c.4335A>G respectively",89,72,Oncotarget_2015_Apr_19_6(18)_16366-16378.txt
4335A>G,"...c alterations A. c.2211A>G, B. c.3522A>T and C. c.4335A>G respectively",89,89,Oncotarget_2015_Apr_19_6(18)_16366-16378.txt
531T > G, 131	p.Y177Ter (c.531T > G)		6,74,19,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
697C > T, 133	p.R233Ter (c.697C > T)		7,75,19,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
376G > A, 181	p.A126T (c.376G > A)		5,76,17,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
974T > G, 218	p.L325R (c.974T > G)		8,80,17,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
700C > T, 240	p.R234W (c.700C > T)		7,82,17,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
365T > A, 264	p.I122N (c.365T > A)		5,83,17,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
359G > A, 264	p.R130Q (c.359G > A),84,17,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
29G > T, 273	p.S10I (c.29G > T)		1,86,16,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
908C > A, 131	ERBB4: S303Y (c.908C > A)	ERBB4: N365T (c.1094A > C,103,22,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
1094A > C, 131	ERBB4: S303Y (c.908C > A)	ERBB4: N365T (c.1094A > C,103,48,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
694C > T,ERBB4: R232Ter (694C > T)*,104,17,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
1498A > T,KIT: T500S (c.1498A > T),105,17,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
1901G > A,KIT: R634Q (c.1901G > A)*,106,17,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
148G > A, 266	KIT: V50M (c.148G > A),107,19,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
2264T > C, 61	ERBB2: L755S (c.2264T > C) KIT: R49C (c.145C > T),109,21,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
145C > T, 61	ERBB2: L755S (c.2264T > C) KIT: R49C (c.145C > T),109,45,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
1918C > T, 85	FGFR3: R640W (1918C > T)	FGFR3: G697S (2089G > A)*,110,19,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
2089G > A, 85	FGFR3: R640W (1918C > T)	FGFR3: G697S (2089G > A)*,110,44,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
2588G > T, 252		EGFR: G863V (c.2588G > T)* ERBB2: V797M (c.2389G > A)*,111,22,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
2389G > A, 252		EGFR: G863V (c.2588G > T)* ERBB2: V797M (c.2389G > A)*,111,50,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
2470G > A, 264		PDGFRA: V824I (c.2470G > A)*,112,24,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
2258C > T, 276	EGFR: P753L (c.2258C > T),113,21,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
2477T > C,MSI-H23		PDGFRA: L826P (c.2477T > C),114,27,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
1172C > T,MSI-H24	FGFR3: A391V (c.1172C > T),115,25,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
1109G > A,MSI-H25		FGFR3: G370D (c.1109G > A)*,116,26,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
2777C > T,MSI-H29		ERBB4: T926M (c.2777C > T)* FGFR1: R148H (c.443G > A),117,26,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
443G > A,...-H29		ERBB4: T926M (c.2777C > T)* FGFR1: R148H (c.443G > A),117,54,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
501A>G,"...iously reported synonymous mutation, Ala167Ala (c.501A>G, rs71653621), in exon 7. No Ala167Ala carri...",3,1942,Open_Neurol_J_2011_Mar_22_5_8-11.txt
501A>G,"... identified the synonymous mutation, Ala167Ala (c.501A>G, rs71653621), in exon 7 of DJ-1 in two PD p...",27,69,Open_Neurol_J_2011_Mar_22_5_8-11.txt
501A>G,"...cing of exon 7 in DJ-1 including the Ala167Ala (c.501A>G, rs71653621) mutation using a reverse seque...",40,99,Open_Neurol_J_2011_Mar_22_5_8-11.txt
501A>G,"...) Heterozygous for the DJ-1 Mutation Ala167Ala (c.501A>G, rs71653621) in Exon",42,131,Open_Neurol_J_2011_Mar_22_5_8-11.txt
1361A>G,c.1361A>G (p.H454R)	c.571>A (p.E191K,166,3,Orphanet_J_Rare_Dis_2009_Feb_21_4_6.txt
550C>T,c.550C>T (p.R184W)	c.526G>A (p.A176T,167,3,Orphanet_J_Rare_Dis_2009_Feb_21_4_6.txt
526G>A,c.550C>T (p.R184W)	c.526G>A (p.A176T,167,22,Orphanet_J_Rare_Dis_2009_Feb_21_4_6.txt
1G>A,c.648+1G>A	c.1250A>G (p.N417S)	c. 212G>A (p.R71H),168,7,Orphanet_J_Rare_Dis_2009_Feb_21_4_6.txt
1250A>G,c.648+1G>A	c.1250A>G (p.N417S)	c. 212G>A (p.R71H),168,14,Orphanet_J_Rare_Dis_2009_Feb_21_4_6.txt
212G>A,c.648+1G>A	c.1250A>G (p.N417S)	c. 212G>A (p.R71H),168,35,Orphanet_J_Rare_Dis_2009_Feb_21_4_6.txt
1361 A>G,"...one of them corresponding to a severe mutation (c.1361 A>G and c.550C>T, respectively), the other be...",182,176,Orphanet_J_Rare_Dis_2009_Feb_21_4_6.txt
550C>T,"...responding to a severe mutation (c.1361 A>G and c.550C>T, respectively), the other being a mild muta...",182,191,Orphanet_J_Rare_Dis_2009_Feb_21_4_6.txt
571G>A,"...respectively), the other being a mild mutation (c.571G>A) [18]. In patients 4 and 5, only one hetero...",182,249,Orphanet_J_Rare_Dis_2009_Feb_21_4_6.txt
571G>A,"...carry two heterozygous mutations, one moderate (c.571G>A or c.526G>A), the other one severe (c.1361A...",209,76,Orphanet_J_Rare_Dis_2009_Feb_21_4_6.txt
526G>A,"...terozygous mutations, one moderate (c.571G>A or c.526G>A), the other one severe (c.1361A>G, c.550C>T...",209,88,Orphanet_J_Rare_Dis_2009_Feb_21_4_6.txt
1361A>G,"...e (c.571G>A or c.526G>A), the other one severe (c.1361A>G, c.550C>T or c.648+1G>A) [18]. This is a c...",209,121,Orphanet_J_Rare_Dis_2009_Feb_21_4_6.txt
550C>T,"... or c.526G>A), the other one severe (c.1361A>G, c.550C>T or c.648+1G>A) [18]. This is a common situa...",209,132,Orphanet_J_Rare_Dis_2009_Feb_21_4_6.txt
1G>A,"...he other one severe (c.1361A>G, c.550C>T or c.648+1G>A) [18]. This is a common situation in non-leth...",209,148,Orphanet_J_Rare_Dis_2009_Feb_21_4_6.txt
1250A>G,...e found heterozygotes for the missense mutation c.1250A>G and c.212G>A. These mutations have a domin...,209,421,Orphanet_J_Rare_Dis_2009_Feb_21_4_6.txt
212G>A,...zygotes for the missense mutation c.1250A>G and c.212G>A. These mutations have a dominant negative e...,209,435,Orphanet_J_Rare_Dis_2009_Feb_21_4_6.txt
1G>C,...compound heterozygous constellations (R277X/IVS34-1G>C and R277X/R1511X) in the thyroglobulin (TG) g...,573,153,Orphanet_J_Rare_Dis_2010_Jun_10_5_17.txt
1009G > A,"...e each found in two unrelated families (COL1A2, c.1009G > A in families Nos. 1 and 19; COL1A1, c.129...",92,1707,Orphanet_J_Rare_Dis_2011_Dec_29_6_88.txt
1G > A,"...09G > A in families Nos. 1 and 19; COL1A1, c.1299+1G > A in families Nos. 44 and 50; and COL1A1, c.7...",92,1759,Orphanet_J_Rare_Dis_2011_Dec_29_6_88.txt
769G > A,"...+1G > A in families Nos. 44 and 50; and COL1A1, c.769G > A in families Nos. 7 and 22). However, the ...",92,1808,Orphanet_J_Rare_Dis_2011_Dec_29_6_88.txt
769G > A,...ffected by the same underlying COL1A1 mutation (c.769G > A) were diagnosed with a hearing loss chara...,92,2069,Orphanet_J_Rare_Dis_2011_Dec_29_6_88.txt
70A-->G,...ir hypoplasia: ancient founder origin of the major70A-->G mutation of the untranslated RMRP Eur J Hu...,767,155,Orphanet_J_Rare_Dis_2011_May_19_6_26.txt
820C > T,c.820C > T	5	p.R274X	+	2	Present study,70,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
1518T > A,"c.1518T > A	8	p.Y506X	+	1	Bernal et al., 2005",72,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
3883C > T,"c.3883C > T	18	p.R1295X	+	1	Dreyer et al., 2000",74,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
4474G > T,"c.4474G > T	21	p.E1492X	+	2	Bernal et al., 2005",76,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
4645C > T,"c.4645C > T	22	p.R1549X	+	1	Baux et al., 2007",78,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
7854G > C,c.7854G > C	41	p.W2618X	+	1	Present study,80,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
9753T > A,c.9753T > A	50	p.C3251X	+	2	Present study,82,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
10102C > T,c.10102C > T	51	p.Q3368Xa	+	1	Present study,84,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
10759C > T,"c.10759C > T	55	p.Q3587X	+	2	Baux et al., 2007",86,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
11146C > T,c.11146C > T	57	p.Q3716X	+	1	Present study,88,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
14175G > A,c.14175G > A	65	P.W4725X	+	1	Present study,90,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
1G > T,c.1328 + 1G > T	IVS7	Ex7 splice defect	+	1	Present study,124,10,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
2A > G,"c.1841-2A > G	IVS10	Ex11 splice defect	+	2	Bernal et al.,...",126,8,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
2T > G,c.11548 + 2T > G	IVS59	Ex59 splice defect	+	1	Present study,128,11,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
2A > G,c.12067-2A > G	IVS61	Ex62 splice defect	+	4	Auslender et a...,130,9,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
1G > A,c.15053-1G > A	IVS69	Ex70 splice defect	+	1	Present study,132,9,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
373G > A,"c.373G > A	2	p.A125T	-	81	Dreyer et al., 2000",144,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
130G > A,c.130G > A	2	p.G44R	+	1	Present Study,146,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
688G > A,"c.688G > A	4	p.V230M	-	3	Dreyer et al., 2000",148,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
908G > A,"c.908G > A	6	p.R303He	UV3	1	Yan et al., 2009",150,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
1144G > A,c.1144G > A	7	p.V382Mb	UV3	1	Present Study,152,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
1434G > C,"c.1434G > C	8	p.E478D	-	4	Seyedahmadi et al., 2004",154,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
1663C > G,"c.1663C > G	10	p.L555V	-	2	Bernal et al., 2003",156,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
1931A > T,"c.1931A > T	11	p.D644V	-	6	Weston et al., 2000",158,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
2137G > C,"c.2137G > C	12	P.G713R	UV2	2	Dreyer et al., 2000",160,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
2276G > T,"c.2276G > T	13	p.C759F	+	3	Dreyer et al., 2000",162,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
2522C > A,"c.2522C > A	13	p.S841Y	UV2	1	Jaijo et al., 2009",164,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
4457G > A,"c.4457G > A	21	p.R1486K	-	75	Dreyer et al., 2000",166,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
4714C > T,"c.4714C > T	22	p.L1572F	-	7	Dreyer et al., 2008",168,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
4994T > C,"c.4994T > C	25	p.I1665T	-	31	Kaiserman et al., 2007",170,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
5975A > G,"c.5975A > G	30	p.Y1992Ce	UV3	1	McGee et al., 2010",172,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
6317T > C,"c.6317T > C	32	p.I2106T	-	117	Aller et al., 2006",174,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
6506T > C,"c.6506T > C	34	p.I2169T	-	85	Aller et al., 2006",176,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
6587G > C,"c.6587G > C	34	p.S2196T	UV2	2	Jaijo et al., 2009",178,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
6713A > C,"c.6713A > C	35	p.E2238A	-	1	Aller et al., 2006",180,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
6875G > A,"c.6875G > A	36	p.R2292H	-	2	Dreyer et al., 2008",182,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
7130A > G,c.7130A > G	38	p.N2377S	UV2	1	Present Study,184,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
7182C > A,c.7182C > A	38	p.N2394K	UV2	1	Present Study,186,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
7506G > A,"c.7506G > A	40	p.P2502P	-	11	Baux et al., 2008",188,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
7685T > C,"c.7685T > C	41	p.V2562A	-	1	Dreyer et al., 2008",190,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
7915T > C,"c.7915T > C	41	p.S2639P	UV2	3	McGee et al., 2010",192,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
8624G > A,"c.8624G > A	43	p.R2875Q	-	9	Aller et al., 2006",194,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
8656C > T,"c.8656C > T	43	p.L2886F	-	9	Aller et al., 2006",196,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
9262G > A,"c.9262G > A	47	p.E3088K	-	1	Dreyer et al., 2008",198,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
9296A > G,"c.9296A > G	47	p.N3099S	-	12	Aller et al., 2006",200,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
9343A > G,"c.9343A > G	47	p.T3115A	-	9	Dreyer et al., 2008",202,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
9430G > A,"c.9430G > A	48	p.D3144N	-	8	Aller et al., 2006",204,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
9595A > G,"c.9595A > G	49	p.N3199D	-	9	Baux et al., 2007",206,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
9799T > C,"c.9799T > C	50	p.C3267R	+	5	Aller et al., 2006",208,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
10073G > A,"c.10073G > A	51	p.C3358Y	+	1	McGee et al., 2010",210,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
10232A > C,"c.10232A > C	52	p.E3411A	-	94	Aller et al., 2006",212,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
10636G > A,c.10636G > A	54	p.G3546R	+	4	Present Study,214,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
11504C > T,c.11504C > T	59	p.T3835I	-	30	Present Study,216,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
11602A > G,"c.11602A > G	60	p.M3868V	-	34	Aller et al., 2006",218,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
11677C > A,"c.11677C > A	60	p.P3893T	-	2	Dreyer et al., 2008",220,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
11680A > G,c.11680A > G	60	p.N3894D	UV3	1	Present Study,222,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
12343C > T,"c.12343C > T	63	p.R4115C	-	2	van Wijk et al., 2004",224,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
14074G > A,"c.14074G > A	64	p.G4692Rc	UV2	1	McGee et al., 2010",226,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
14453C > T,"c.14453C > T	66	p.P4818L	+	1	Aller et al., 2006",228,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
14513G > A,"c.14513G > A	66	p.G4838E	-	1	McGee et al., 2010",230,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
14543G > A,"c.14543G > A	66	p.R4848Q	-	1	McGee et al., 2010",232,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
14761G > A,c.14761G > A	67	p.E4921K	UV2	1	Present Study,234,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
15076A > G,"c.15076A > G	70	p.K5026E	UV2	1	McGee et al., 2010",236,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
15091C > T,"c.15091C > T	70	p.R5031W	-	2	Dreyer et al., 2008",238,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
504A > G,"c.504A > G	3	p.T168T	-	75	Baux et al., 2008",254,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
1179A > G,"c.1179A > G	7	p.Q393Q	-	1	Aller, 2008",256,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
1419C > T,"c.1419C > T	8	p.T473T	-	36	Dreyer et al., 2000",258,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
2109T > C,"c.2109T > C	12	p.D703D	-	7	Weston et al., 2000",260,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
2256T > C,"c.2256T > C	13	p.H752H	-	3	Dreyer et al., 2008",262,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
3945T > C,c.3945T > C	18	p.N1315N	UV2	3	Present Study,264,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
4371G > A,"c.4371G > A	20	p.S1457S	-	1	Dreyer et al., 2000",266,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
5031C > A,"c.5031C > A	25	p.G1671G	-	22	Aller et al., 2006",268,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
5751C > T,"c.5751C > T	28	p.Y1917Y	UV2	1	McGee et al., 2010",270,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
7488A > G,c.7488A > G	40	p.E2496Eb	+	1	Present Study,272,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
7506G > A,"c.7506G > A	40	p.P2502P	-	11	McGee et al., 2010",274,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
11736G > A,"c.11736G > A	61	p.E3912E	-	2	Dreyer et al., 2008",276,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
11907A > T,"c.11907A > T	61	p.P3969P	-	2	Dreyer et al., 2008",278,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
11946A > T,"c.11946A > T	61	p.L3982L	-	29	Dreyer et al., 2008",280,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
12093C > T,"c.12093C > T	62	p.Y4031Y	-	1	Dreyer et al., 2008",282,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
12612A > G,"c.12612A > G	63	p.T4204T	-	129	Dreyer et al., 2008",284,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
12666A > G,"c.12666A > G	63	p.T4222T	-	58	Dreyer et al., 2008",286,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
13191G > A,"c.13191G > A	63	p.E4397E	-	23	Dreyer et al., 2008",288,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
14481C > T,"c.14481C > T	66	p.A4827A	-	1	McGee et al., 2010",290,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
14664G > A,c.14664G > A	67	p.T4888T	UV2	1	Present Study,292,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
2A > G,RP1310*	c.12067-2A > G/c.12067-2A > G		USHNC,306,17,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
2A > G,RP1310*	c.12067-2A > G/c.12067-2A > G		USHNC,306,32,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
2A > G,RP1625*	c.12067-2A > G/p.R274X	1976	USH2	25	Since infancy	NormalA	...,336,17,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
2A > G,RP1631	c.1841-2A > G/p.R274X	1976	USH2		Since infancy	NormalA	28...,338,15,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
1G > T,RP1558	p.R1549X/c.1328 + 1G > T	1933	USH2	43	Severe and progressive since 2...,342,26,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
2T > G,RP1667*	p.C759F/c.11548 + 2T > G	1954	USH2	15	Mild and slightly progressive	...,350,27,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
1G > A,RP1615	c.11566delA/c.15053-1G > A	1975	USH2	27	Moderate since infancy	NormalA...,360,28,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
52T > C,c.1328 + 52T > C	IVS7	-	3,378,10,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
61G > A,c.1841-61G > A	IVS10	-	11,380,8,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
32G > T,c.4627 + 32G > T	IVS21	UV2	1,382,10,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
18C > T,c.6485 + 18C > T	IVS33	UV2	1,384,10,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
54T > C,c.6486-54T > C	IVS33	UV2	2,386,8,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
43T > A,c.6486-43T > A	IVS33	UV2	1,388,8,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
29C > A,c.6657 + 29C > A	IVS34	UV2	1,390,10,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
18A > G,c.8681 + 18A > G	IVS43	UV2	1,392,10,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
53T > G,c.8681 + 53T > G	IVS43	UV2	1,394,10,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
118A > G,c.8681 + 118A > G	IVS43	UV2	1,396,10,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
52G > T,c.9056-52G > T	IVS45	UV	1,398,8,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
50A > G,c.9372-50A > G	IVS47	UV2	1,400,8,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
59G > A,c.9740-59G > A	IVS49	UV2	1,402,8,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
128A > G,c.9958 + 128A > G	IVS50	-	4,404,10,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
123T > C,c.10388-123T > C	IVS52	UV2	1,406,9,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
78A > G,c.13812-78A > G	IVS63	UV2	1,408,9,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
53T > C,c.14134-53T > C	IVS64	UV2	1,410,9,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
36G > C,c.14343 + 36G > C	IVS65	UV2	1,412,11,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
35T > A,c.15298-35T > A	IVS70	UV2	1,414,9,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
1153G > A,c.15298-1153G > A(g.798209G > A) d	IVS71	UV2	1,416,9,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
798209G > A,c.15298-1153G > A(g.798209G > A) d	IVS71	UV2	1,416,21,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
798209G > A,dThe intronic variant g.798209G > A affects the last nucleotide of the coc...,421,25,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
2A > G,"...n-Ashkenazi Jews. The splice-site variant c.12062-2A > G was detected in three patients, in homozygo...",473,512,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
26A>G,"...e mostly alternative splicing mutants (e.g., 3272-26A>G) which allow synthesis of some normal CFTR m...",9,675,Orphanet_J_Rare_Dis_2012_Nov_22_7(Suppl_2)_A19.txt
2A>T,...d a novel heterozygous splice site mutation c.622-2A>T (g.30100162 T>A) in two patients (Figure 1). ...,75,205,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
2A>T,...X6 in two MA patients. Splice site mutation c.622-2A>T (g.30100162 T>A) in two MA patients compared ...,77,92,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
2A>T,The mutation (c.622-2A>T) is situated in the canonical sequence of the...,79,21,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
2A>T,...n 5 or the use of cryptic splice sites. The c.622-2A>T mutation resides within the highly conserved ...,79,557,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
2A>T,"... splice site mutation site (g.30100162 T>A, c.622-2A>T in violet brackets and a line) and its conser...",81,207,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
30100401C>T,...exonic missense variants in exon 4 (rs56098093; g.30100401C>T; p.Gly162Ser) and exon 6 (rs201231713;...,83,164,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
30099890C>T,...00401C>T; p.Gly162Ser) and exon 6 (rs201231713; g.30099890C>T; p.Arg272Gln) were found in a higher f...,83,217,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
30102391G>A,g.30102391G>A	rs112565029	intron 2	CC: 107 (95.5%)	C...,89,3,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
6C>T,c.118+6C>T	 	 	CT: 5 (4.5%)	CT: 13 (6.5%),90,7,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
30100402G>A,g.30100402G>A	rs147485102	exon 4	CC: 111 (99.1%)	CC:...,92,3,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
30100401C>T,g.30100401C>T	rs56098093	exon 4	GG: 97 (86.6%)	GG: 1...,95,3,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
2A>T,c.622-2A>T	 	 	AT: 2 (1.8%)	AT: 0 (0%),99,7,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
30099890C>T,g.30099890C>T	rs201231713	exon 6	GG: 101 (90.2%)	GG:...,101,3,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
30098022G>A,g.30098022G>A	rs200310768	intron 7	CC: 109 (97.3%)	C...,104,3,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
6C>T,c.914-6C>T	 	 	CT: 3 (2.7%)	CT: 6 (3%),105,7,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
30097630C>T,g.30097630C>T	rs2289292	exon 9	GG: 32 (28.6%)	GG: 67...,107,3,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
35295505G>C,"...(Figure 5). One patient had a missense variant (g.35295505G>C; p.Cys4Ser) in exon 1, three patients ...",124,196,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
35300142C>A,...patients had the same missense variant in ex 5 (g.35300142C>A; p.Pro312His) and one patient had anot...,124,287,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
35300202C>G,...e patient had another missense variant in ex 5 (g.35300202C>G; p.Arg332Pro) (Table 3). None of the v...,124,369,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
35295505G>C,...ense variants found in five MA patients. A) The g.35295505G>C (p.Cys4Ser) variant in control and pat...,126,134,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
35300142C>A,"...Ser) variant in control and patient 223, B) the g.35300142C>A (p.Pro312His) in control and patients ...",126,203,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
35300202C>G,"...ontrol and patients 162, 237, and 97 and C) the g.35300202C>G (p.Arg332Pro) in control and patient 1...",126,283,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
35295505G>C,g.35295505G>C	-	exon 1	GG: 111 (99.1%)	GG: 180 (100%...,132,3,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
35300142C>A,g.35300142C>A	-	exon 5	CC: 109 (97.3%)	CC: 180 (100%...,135,3,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
35300202C>G,g.35300202C>G	TMP_ESP_17_35300202c	exon 5	CC: 111 (9...,138,3,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
2A>T,"...ing domain, the T-box [55]. We identified a c.622-2A>T splice site mutation in two patients (one wit...",156,504,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
3163A>G,"... model of NPC disease, Npc1 (nmf164) carrying a c.3163A>G mutation that results in an aspartate to g...",28,686,Orphanet_J_Rare_Dis_2013_Feb_21_8_34.txt
3182T>C,"...1 gene. The two affected siblings presented the c.3182T>C (P.I1061T)/c.3182T>C (p.I1061T) genotype, ...",44,337,Orphanet_J_Rare_Dis_2013_Feb_21_8_34.txt
3182T>C,"...ted siblings presented the c.3182T>C (P.I1061T)/c.3182T>C (p.I1061T) genotype, while the third unrel...",44,358,Orphanet_J_Rare_Dis_2013_Feb_21_8_34.txt
1G>C,... third unrelated NPC patient presented the c.2795+1G>C/c.3493G>A (p.V1165M) genotype. This study was...,44,446,Orphanet_J_Rare_Dis_2013_Feb_21_8_34.txt
3493G>A,...unrelated NPC patient presented the c.2795+1G>C/c.3493G>A (p.V1165M) genotype. This study was approv...,44,453,Orphanet_J_Rare_Dis_2013_Feb_21_8_34.txt
575G>A,"...ovel mutations (c.468_469delTC, c.799_800delCT, c.575G>A (p.Arg192Gln), c.751+5G>A and c.752-2A>G) w...",12,932,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
5G>A,"...TC, c.799_800delCT, c.575G>A (p.Arg192Gln), c.751+5G>A and c.752-2A>G) were identified",12,960,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
2A>G,"...lCT, c.575G>A (p.Arg192Gln), c.751+5G>A and c.752-2A>G) were identified",12,975,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
1G >T,"...maller T1 fibres	Low	19% of LLR	Pu, Me, Ico	c.240+1G >T, c.575G>A",48,130,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
575G>A,"... fibres	Low	19% of LLR	Pu, Me, Ico	c.240+1G >T, c.575G>A",48,139,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
5G>A,"...ow	37% of LLR	Mb, pons	c.312_320del10insAT, c.751+5G>A",49,144,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
2A>G,"... increased lipid	Low	UD	Dt, Cd, Mb, Me	Homo c.516-2A>G",51,139,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
2A>G,...20	Increased lipid	NA	NA	At 1y: normal	Homo c.516-2A>G,52,82,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
11T>G,"...X	NA	12% of LLR	Dt, dorsal BS, Cp, STh	Homo c.324-11T>G",53,152,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
2A>G,...UD	CT brain: GP and cerebellar atrophy	Homo c.516-2A>G,55,201,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
2A>G,...RF	10	6y 6 m	NA	NA	NA	CT brain: normal	Homo c.516-2A>G,56,133,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
2A>G,"...axia, RF	4	24 m	T1FP	Low	50% of LLR	NA	Homo c.516-2A>G",59,98,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
751C>T,"...ed lipid, T1FP	NA	7% of LLR	Mb, Dt, Cd, GP	Homo c.751C>T",60,154,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
688C>T,"...m	NA	NA	NA	Cd, Pu, BS	Homo c.312_320del10insAT, c.688C>T",61,112,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
11 T>G,"...rigonal regions, posterior limbs of IC	Homo c.324-11 T>G",62,222,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
11 T>G,"...DD, DR	15	Outcome unknown	NA	Low	NA	NA	Homo c.324-11 T>G",63,82,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
11T>G,"...ystic changes in Dt, BG and central WM	Homo c.324-11T>G",66,172,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
1G>A,...in cerebral hemispheres and cerebellum	Homo c.833+1G>A,68,206,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
704C>T,...Alive 16y	Reduced COX	Low	NA	At 1y: normal	Homo c.704C>T,70,210,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
1G>T,"...ey matter involvement of cerebellum, Mb, Pu	c.240+1G>T, c.574C>T",73,210,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
574C>T,"...r involvement of cerebellum, Mb, Pu	c.240+1G>T, c.574C>T",73,218,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
11T>G,"... Scp, Dt, Me, WM tracts of spinal cord	Homo c.324-11T>G",75,215,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
1G>T,"...cerebellar hemispheres	c.312_320del10insAT, c.240+1G>T",78,205,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
1G>T,"... COX	Normal	UD	CT brain: BG	c.845_846delCT, c.240+1G>T",79,106,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
751C >T,"...	Post mortem	12% of LLR	Th	c.312_320del10insAT, c.751C >T",87,195,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
688C>T,"...em	44% of LLR	CT brain: Pu	c.312_320del10insAT, c.688C>T",88,209,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
2A>G,"...duced COX	Low	NA	STh	c.312_320del10insAT, c. 752 -2A>G",89,162,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
1G>T,"...n = 5, 3 pedigrees) and the splice mutation c.240+1G>T which was observed in 5 individuals, all of w...",160,667,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
11T>G,...ad the novel c.799_800delCT mutation or the c.324-11T>G mutation. The c.516-2A>G mutation segregated...,160,923,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
2A>G,...T mutation or the c.324-11T>G mutation. The c.516-2A>G mutation segregated in two different Indian G...,160,949,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
11T>G,...d mixed Caucasian Asian parenthood [7]. The c.324-11T>G genotype was observed in 4 individuals from ...,160,1134,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
575G>A,"...enic mutations (c.468_469delTC, c.799_800delCT, c.575G>A (p.Arg192Gln), c.751+5G>A. and c.752-2A>G)",163,148,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
5G>A,"...TC, c.799_800delCT, c.575G>A (p.Arg192Gln), c.751+5G>A. and c.752-2A>G)",163,176,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
2A>G,"...CT, c.575G>A (p.Arg192Gln), c.751+5G>A. and c.752-2A>G)",163,192,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
5G>A,"... and died at 2 years. The novel splice site c.751+5G>A mutation, generating an aberrant transcript w...",167,221,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
5G>A,"...compound heterozygote (c.312_321del10insAT, c.751+5G>A). She had an atypical milder clinical course ...",167,447,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
575G>A,"...t 19 years of age. The novel missense mutation (c.575G>A, p.Arg192Gln) was found in a 12 year old fe...",167,840,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
2A>G,...d play the violin. The splice site mutation c.752-2A>G was found in a patient (case 37) of Australia...,167,1244,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
604G > C,...ngali pedigrees. Previous reports indicate that c.604G > C mutation has only been reported in Chines...,188,566,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
985A>G,"...uch as seizures, coma or even sudden death. The c.985A>G missense mutation on the ACADM gene (gene e...",22,218,Orphanet_J_Rare_Dis_2013_Mar_20_8_43.txt
985A>G,1	c.985A>G	c.199T>C	2.85	2.3	Normal	39	36	-	-	-	-	-	-	...,56,5,Orphanet_J_Rare_Dis_2013_Mar_20_8_43.txt
199T>C,1	c.985A>G	c.199T>C	2.85	2.3	Normal	39	36	-	-	-	-	-	-	-	-	-	-,56,14,Orphanet_J_Rare_Dis_2013_Mar_20_8_43.txt
985A>G,"2	c.985A>G	c.199T>C	0.67	2.7	DC, HG	44	29	58	-	-	-	-	-...",57,5,Orphanet_J_Rare_Dis_2013_Mar_20_8_43.txt
199T>C,"2	c.985A>G	c.199T>C	0.67	2.7	DC, HG	44	29	58	-	-	-	-	-	-	-	-	-",57,14,Orphanet_J_Rare_Dis_2013_Mar_20_8_43.txt
985A>G,"3	c.985A>G	c.199T>C	0.35	2.3	Trace N-HG, SG, DC	48	43	...",58,5,Orphanet_J_Rare_Dis_2013_Mar_20_8_43.txt
199T>C,"3	c.985A>G	c.199T>C	0.35	2.3	Trace N-HG, SG, DC	48	43	48	-	-	-	...",58,14,Orphanet_J_Rare_Dis_2013_Mar_20_8_43.txt
985A>G,4	c.985A>G	c.199T>C	0.74	2.8	Trace HG	36	34	44	10	18	4...,59,5,Orphanet_J_Rare_Dis_2013_Mar_20_8_43.txt
199T>C,4	c.985A>G	c.199T>C	0.74	2.8	Trace HG	36	34	44	10	18	4.5	1.1	5....,59,14,Orphanet_J_Rare_Dis_2013_Mar_20_8_43.txt
985A>G,5	c.985A>G	c.473A>G	0.39	2.3	Normal	38	25	39	6	18.5	2....,60,5,Orphanet_J_Rare_Dis_2013_Mar_20_8_43.txt
473A>G,5	c.985A>G	c.473A>G	0.39	2.3	Normal	38	25	39	6	18.5	2.8	0.3	0.8...,60,14,Orphanet_J_Rare_Dis_2013_Mar_20_8_43.txt
985A>G,"6	c.985A>G	c.734C>T	1.41	3.0	Trace DC, 5-OH-C, HG, SG	...",61,5,Orphanet_J_Rare_Dis_2013_Mar_20_8_43.txt
734C>T,"6	c.985A>G	c.734C>T	1.41	3.0	Trace DC, 5-OH-C, HG, SG	41	17	11	...",61,14,Orphanet_J_Rare_Dis_2013_Mar_20_8_43.txt
985A>G,"7	c.985A>G	c.928G>A	2.28	3.2	5-OH-H, trace HG	48	23	0	...",62,5,Orphanet_J_Rare_Dis_2013_Mar_20_8_43.txt
928G>A,"7	c.985A>G	c.928G>A	2.28	3.2	5-OH-H, trace HG	48	23	0	16	15	3.2...",62,14,Orphanet_J_Rare_Dis_2013_Mar_20_8_43.txt
985A>G,8	c.985A>G	Not found	0.70	1.3	Normal	28	-	-	25	18.5	4....,63,5,Orphanet_J_Rare_Dis_2013_Mar_20_8_43.txt
985A>G,9	c.985A>G	Not found	0.50	0.8	Normal	15	11	86	27	16.5	...,64,5,Orphanet_J_Rare_Dis_2013_Mar_20_8_43.txt
985A>G,"... was the younger sister of case 2, carrying the c.985A>G/c.199T>C ACADM genotype. Case 5 was identif...",70,143,Orphanet_J_Rare_Dis_2013_Mar_20_8_43.txt
199T>C,"...younger sister of case 2, carrying the c.985A>G/c.199T>C ACADM genotype. Case 5 was identified durin...",70,152,Orphanet_J_Rare_Dis_2013_Mar_20_8_43.txt
985A>G,"...sical ACADM genotypes, and from carriers of the c.985A>G mutation (i.e. siblings or parents of patie...",73,762,Orphanet_J_Rare_Dis_2013_Mar_20_8_43.txt
985A>G,"...y low birth weight [17], heterozygosity for the c.985A>G mutation [18], and the time at which NBS is...",106,784,Orphanet_J_Rare_Dis_2013_Mar_20_8_43.txt
985A>G,"...athways [22]. In combination with the classical c.985A>G ACADM mutation, theoretical candidate genes...",108,1201,Orphanet_J_Rare_Dis_2013_Mar_20_8_43.txt
617G>A,...terozygous for a recurrent activating mutation (c.617G>A; p.R206H) in the cytoplasmic GS (glycine-se...,21,86,Orphanet_J_Rare_Dis_2013_Sep_18_8_145.txt
571G>A,...ductase. We report two sisters homozygous for the 571G>A (E191K) DHCR24 mutation. Comparison of the ...,3,2096,Orphanet_J_Rare_Dis_2014_Jun_25_9_94.txt
571G>A,"...ified a homozygous DHCR24 mutation (NM_014762.3:c.571G>A; p.E191K), a recognized cause of desmostero...",26,113,Orphanet_J_Rare_Dis_2014_Jun_25_9_94.txt
571G>A,...sisters with the biallelic mutation NM_014762.3:c.571G>A in DHCR24. The recurrence of this mutation ...,31,66,Orphanet_J_Rare_Dis_2014_Jun_25_9_94.txt
571G>A,Mutation	c.[571G>A] + [571G>A] p.[E191K] + [E191K]	c.[571G>A] ...,45,13,Orphanet_J_Rare_Dis_2014_Jun_25_9_94.txt
571G>A,Mutation	c.[571G>A] + [571G>A] p.[E191K] + [E191K]	c.[571G>A] + [571G>A] ...,45,24,Orphanet_J_Rare_Dis_2014_Jun_25_9_94.txt
571G>A,...tion	c.[571G>A] + [571G>A] p.[E191K] + [E191K]	c.[571G>A] + [571G>A] p.[E191K] + [E191K]	c.[307C>T] ...,45,55,Orphanet_J_Rare_Dis_2014_Jun_25_9_94.txt
571G>A,...G>A] + [571G>A] p.[E191K] + [E191K]	c.[571G>A] + [571G>A] p.[E191K] + [E191K]	c.[307C>T] + [307C>T] ...,45,66,Orphanet_J_Rare_Dis_2014_Jun_25_9_94.txt
307C>T,...91K]	c.[571G>A] + [571G>A] p.[E191K] + [E191K]	c.[307C>T] + [307C>T] p.[R103C] + [R103C]	c.[281G>A] ...,45,97,Orphanet_J_Rare_Dis_2014_Jun_25_9_94.txt
307C>T,...G>A] + [571G>A] p.[E191K] + [E191K]	c.[307C>T] + [307C>T] p.[R103C] + [R103C]	c.[281G>A] + [1438G>A]...,45,108,Orphanet_J_Rare_Dis_2014_Jun_25_9_94.txt
281G>A,...91K]	c.[307C>T] + [307C>T] p.[R103C] + [R103C]	c.[281G>A] + [1438G>A] p.[R94H] + [E480K]	c.[1412A>C]...,45,139,Orphanet_J_Rare_Dis_2014_Jun_25_9_94.txt
1438G>A,...C>T] + [307C>T] p.[R103C] + [R103C]	c.[281G>A] + [1438G>A] p.[R94H] + [E480K]	c.[1412A>C] + [881A > ...,45,150,Orphanet_J_Rare_Dis_2014_Jun_25_9_94.txt
1412A>C,...03C]	c.[281G>A] + [1438G>A] p.[R94H] + [E480K]	c.[1412A>C] + [881A > C;918G>C] p.[Y471S] + [N294T; K...,45,181,Orphanet_J_Rare_Dis_2014_Jun_25_9_94.txt
918G>C,...38G>A] p.[R94H] + [E480K]	c.[1412A>C] + [881A > C;918G>C] p.[Y471S] + [N294T; K306N]	 ,45,202,Orphanet_J_Rare_Dis_2014_Jun_25_9_94.txt
613G>A,"1	CHILD syndrome	NSDHL: c.613G>A, p.G205S (heterozygous)	Yes",34,27,Orphanet_J_Rare_Dis_2014_Mar_7_9_33.txt
628C>T,"2	CHILD syndrome	NSDHL: c.628C>T, p.Q210X (heterozygous)	Yes",37,27,Orphanet_J_Rare_Dis_2014_Mar_7_9_33.txt
262C>T,"3	CHILD syndrome	NSDHL: c.262C>T, p.R88X (heterozygous)	Yes",40,27,Orphanet_J_Rare_Dis_2014_Mar_7_9_33.txt
527C>A,...tosomal recessive congenital ichthyosis	NIPAL4: c.527C>A; p.A176D (homozygous)	No,46,55,Orphanet_J_Rare_Dis_2014_Mar_7_9_33.txt
1516C>G,...ized to the chromosome 12 candidate region: The c.1516C>G (p.Arg506Gly) variant in SLC11A2 has been ...,115,234,Orphanet_J_Rare_Dis_2015_Feb_10_10_15.txt
53G>A,"...1A2 mutations cause ADNSHL. A missense variant, c.53G>A (p.Arg18His), was identified in CELA1 (chymo...",115,602,Orphanet_J_Rare_Dis_2015_Feb_10_10_15.txt
1202G>C,... candidate region on chromosome 20: The variant c.1202G>C (p.Arg401Pro) in GTPBP5 affects an evoluti...,117,122,Orphanet_J_Rare_Dis_2015_Feb_10_10_15.txt
1738A>C,"...8420, with an MAF of 0.04%. A variant in DIDO1 (c.1738A>C; p.Thr580Pro), also affects a non-conserve...",117,301,Orphanet_J_Rare_Dis_2015_Feb_10_10_15.txt
287C>G,"A nonsense mutation, c.287C>G (p.Ser96*), was found in both patients in S...",119,24,Orphanet_J_Rare_Dis_2015_Feb_10_10_15.txt
289C>T,"2		34,3	3		c.289C>T heterozygous de novo (both parents wildtype...",36,14,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
464G>A,"3		22,1			c.464G>A heterozygous de nov",37,13,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
961G>T,"4		31,8	2	0	c.961G>T heterozygous	p.Glu321",40,15,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
1G>C,"5		37,6	4		c.1065+1G>C heterozygous	IVS7+1G>C ds	Splice site mutatio...",42,19,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
1G>C,"5		37,6	4		c.1065+1G>C heterozygous	IVS7+1G>C ds	Splice site mutation",42,42,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
1G>T,"6		25,4	3	1	c.1065+1G>T heterozygous	IVS7+1G>T ds	Splice site mutatio...",43,20,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
1G>T,"6		25,4	3	1	c.1065+1G>T heterozygous	IVS7+1G>T ds	Splice site mutation",43,43,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
1087C>T,"7		17,1	4	1	c.1087C>T heterozygous	p.Gln363",44,15,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
1G>A,"10		57,0			c.2022+1G>A heterozygous	IVS13+1G>A ds	Splice site mutati...",48,19,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
1G>A,"10		57,0			c.2022+1G>A heterozygous	IVS13+1G>A ds	Splice site mutation",48,43,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
2T>G,"12		30,0	2	1	c.2565+2T>G heterozygous	IVS17+2T>G ds	Splice site mutati...",54,21,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
2T>G,"12		30,0	2	1	c.2565+2T>G heterozygous	IVS17+2T>G ds	Splice site mutation",54,45,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
3742C>T,"17		16,6	2	1	c.3742C>T heterozygous	p.Gln1248",62,16,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
4294C>T,"18		37,3	3	1	c.4294C>T heterozygous	p.Gln1432",64,16,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
2T>G,"20		1,7			c.4303+2T>G heterozygous	IVS25+2T>G ds	Splice site mutati...",67,18,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
2T>G,"20		1,7			c.4303+2T>G heterozygous	IVS25+2T>G ds	Splice site mutation",67,42,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
4576G>T,"21		18,0			c.4576G>T heterozygous	p.Gly1526",68,14,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
5686G>A,"30,7	1	0	c.5686G>A heterozygous paternal	p.Gly1896Arg/Splice	...",76,13,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
5686G>A,"28,9	3	1	c.5686G>A heterozygous paternal	p.Gly1896Arg/Splice	...",78,13,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
5686G>A,"62,2	2	0	c.5686G>A mosaicism	p.Gly1896Arg/Splice	Splicesitemu...",80,13,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
6321C>A,"25		47,0	2	1	c.6321C>A heterozygous	p.Cys2107",81,16,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
6898C>T,"26		17,8			c.6898C>T heterozygous	p.Gln2300",83,14,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
2A>G,"27		24,9	1	2	c.6908-2A>G heterozygous	IVS42-2A>G	Splice site mutation",85,21,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
2A>G,"27		24,9	1	2	c.6908-2A>G heterozygous	IVS42-2A>G	Splice site mutation",85,45,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
7115C>G,"31		21,7			c.7115C>G heterozygous	p.Ser2372",90,14,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
7255C>T,"34		1,0	4	2	c.7255C>T heterozygous	p.Arg2419",97,15,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
7714G>A,"36		7,9	4	1	c.7714G>A heterozygous; unclassified variant	p.Val25...",101,15,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
289C>T,... one of these two missense variants p.Pro97Ser (c.289C>T) the absence in both parental samples furth...,149,285,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
5686G>A,...otentially truncating FLNA splice site mutation c.5686G>A in mosaic state estimated to affect 40 to ...,156,143,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
986G>A,(NM_001605.2)	3	c.986G>A	p.Arg329His,141,20,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
2981C>T,(NM_000052.6)	1	c.2981C>T	p.Thr994Ile,144,20,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
263 A>G,(NM_032667.6)	2	c.263 A>G	p.Asn88Ser,147,20,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
269 C>T,(NM_032667.6)	1	c.269 C>T	p.Leu90Ser,150,20,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
1792 C>T,(NM_001376.4)	2	c.1792 C>T	p.Arg598Cys,156,20,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
1231G>A,(NM_000399.3)	1	c.1231G>A	p.Asp411Asn,159,20,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
1117C>T,(NM_006329.3)	1	c.1117C>T	p.Arg373Cys,162,20,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
1G>A,(NM_014845.5)	1	c.[498-1G>A];[122T>C],165,25,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
122T>C,(NM_014845.5)	1	c.[498-1G>A];[122T>C],165,32,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
793C>T,(NM_014845.5)	2	c.[793C>T];[122T>C]	p.[Arg265*];[Ile41Thr],168,21,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
122T>C,(NM_014845.5)	2	c.[793C>T];[122T>C]	p.[Arg265*];[Ile41Thr],168,30,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
715C>T,(NM_018972.2)	1	c.715C>T	p.Leu239Phe,171,20,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
88A>T,(NM_000166.5)	1	c.88A>T	p.Ile30Phe,174,20,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
622G>A,(NM_000166.5)	1	c.622G>A	p.Glu208Lys,180,20,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
212T>C,(NM_000166.5)	1	c.212T>C	p.Ile71Thr,183,20,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
110G>C,(NM_005340.5)	2	c.[110G>C];[110G>C]	p.[Arg37Pro];[Arg37Pro],189,21,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
110G>C,(NM_005340.5)	2	c.[110G>C];[110G>C]	p.[Arg37Pro];[Arg37Pro],189,30,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
21G>T,(NM_006308.2)	1	c.21G>T	p.Arg7Ser,195,20,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
383T>C,(NM_022489.3)	1	c.383T>C	p.Leu128Pro,198,20,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
233T>C,(NM_022489.3)	1	c.233T>C	p.Leu78Pro,201,20,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
334G>A,(NM_001136472.1)	1	c.334G>A	p.Gly112Ser,207,23,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
280 C>T,(NM_014874.3)	1	c.280 C>T	p.Arg94Trp,210,20,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
436 C>T,(NM_014874.3)	1	c.436 C>T	p.Leu146Phe,213,20,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
493 C>T,(NM_014874.3)	1	c.493 C>T	p.His165Tyr,216,20,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
701T>A,(NM_014874.3)	1	c.701T>A	p.Met234Lys,219,20,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
839G>A,(NM_014874.3)	1	c.839G>A	p.Arg280His,222,20,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
880C>T,(NM_014874.3)	1	c.880C>T	p.Arg294*,225,20,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
1081C>T,(NM_014874.3)	1	c.1081C>T	p.His361Tyr,228,20,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
1090 C>T,(NM_014874.3)	1	c.1090 C>T	p.Arg364Trp,231,20,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
1574A>G,(NM_014874.3)	1	c.1574A>G	p.Asn525Ser,234,20,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
442 C>T,(NM_001135242.1)	1	c.442 C>T	p.Arg148*,237,23,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
310T>G,(NM_006158.4)	1	c.310T>G	p.Phe104Val,240,20,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
1186G>A,(NM_006158.4)	1	c.1186G>A	p.Glu396Lys,243,20,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
124T>C,(NM_153322.1)	1	c.124T>C	p.Cys42Arg,246,20,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
1656G>T,(NM_015046.5)	1	c.[1656G>T(;)1658C>T]	p.[(Gln552His(;)Ser553Phe)],252,21,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
1658C>T,(NM_015046.5)	1	c.[1656G>T(;)1658C>T]	p.[(Gln552His(;)Ser553Phe)],252,31,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
134T>A,(NM_030962.3)	1	c.[134T>A];[c.134T>A]	p..[Ile45Asn];[Ile45Asn],255,21,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
134T>A,(NM_030962.3)	1	c.[134T>A];[c.134T>A]	p..[Ile45Asn];[Ile45Asn],255,32,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
2860C>T,(NM_024577.3)	1	c.[2860C>T];[c.279G>A]	p.[Arg954*];[Lys93Lys],261,21,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
279G>A,(NM_024577.3)	1	c.[2860C>T];[c.279G>A]	p.[Arg954*];[Lys93Lys],261,33,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
2860C>T,(NM_024577.3)	1	c.[2860C>T];[1447T>G]	p.[Arg954*];[Phe483Val],264,21,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
1447T>G,(NM_024577.3)	1	c.[2860C>T];[1447T>G]	p.[Arg954*];[Phe483Val],264,31,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
2860C>T,(NM_024577.3)	1	c.[2860C>T];[c.2812C>T]	p.[Arg954*];[His938Tyr],267,21,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
2812C>T,(NM_024577.3)	1	c.[2860C>T];[c.2812C>T]	p.[Arg954*];[His938Tyr],267,33,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
1144G>C,(NM_004863.3)	1	c.1144G>C	p.Gly382Arg,270,20,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
557G>A,(NM_021625.4)	1	c.557G>A	p.Arg186Gln,273,20,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
986G>A,AARS (NM_001605.2): c.986G>,289,23,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
986G>A,Mutation p.Arg329His (c.986G>A) was found in three families with IPN. This...,290,25,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
1792 C>T,DYNC1H1 (NM_001376.4): c.1792 C>,296,26,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
1792 C>T,A mutation p.Arg598Cys (c.1792 C>T) in DYNC1H1 gene was found in two origina...,297,27,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
442 C>T,NDRG1 (NM_001135242.1): c.442 C>,302,27,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
1656G>T,SETX (NM_015046.5): c.[1656G>T(;)1658C>T,307,24,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
1658C>T,SETX (NM_015046.5): c.[1656G>T(;)1658C>T,307,34,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
1656G>T,The mutation c.[1656G>T(;)1658C>T] in SETX gene was detected. It w...,310,17,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
1658C>T,The mutation c.[1656G>T(;)1658C>T] in SETX gene was detected. It was not det...,310,27,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
503 C>T,(NM_001605.2)	c.503 C>T	p.Pro168Leu	SIFT:,320,18,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
1540G>A,(NM_001003800.1)	c.1540G>A	p.Gly514Ser	SIFT:,326,21,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
487G>A,(NM_004082.4)	c.487G>A	p.Ala163Thr	SIFT:,332,18,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
890G>T,(NM_001005360)	c.890G>T	p.Arg297Leu	SIFT:,338,19,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
796C>T,(NM_001005360)	c.796C>T	p.Arg266Trp	SIFT:,344,19,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
125G>A,(NM_021629.3)	c.125G>A	p.Arg42Gln	SIFT:,350,18,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
3190A>G,(NM_002224.3)	c.3190A>G	p.Met1064Val	SIFT:,356,18,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
1298C>T,(NM_138361.5)	c.1298C>T	p.Ser433Leu	SIFT:,361,18,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
218A>G,(NM_001142386.2)	c.218A>G	p.Asn73Ser	SIFT:,366,21,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
5825T>C,(NM_015046.5)	c.5825T>C	p.Ile1942Thr	SIFT:,371,18,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
1656G>T,"...ETX (NM_015046.5):p.[(Gln552His(;)Ser553Phe)], c.[1656G>T(;)1658C>T",418,78,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
1658C>T,"...5046.5):p.[(Gln552His(;)Ser553Phe)], c.[1656G>T(;)1658C>T",418,88,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
3243A>G,...y all organs and cause significant morbidity. The 3243A>G mutation in the mitochondrial DNA is one o...,6,116,Oxf_Med_Case_Reports_2014_May_8_2014(2)_24-25.txt
3243A>G,...nally inherited diabetes and deafness (MIDD). The 3243A>G mutation in the MT-TL1 gene of the mitocho...,11,297,Oxf_Med_Case_Reports_2014_May_8_2014(2)_24-25.txt
3243A>G,...disease and was confirmed by demonstration of the 3243A>G transition in blood and urine. The heterop...,13,686,Oxf_Med_Case_Reports_2014_May_8_2014(2)_24-25.txt
3243A>G,The 3243A>G mtDNA mutation constitutes the most common...,19,5,Oxf_Med_Case_Reports_2014_May_8_2014(2)_24-25.txt
3243A>G,... diabetes and deafness (MIDD) associated with the 3243A>G mitochondrial point mutation Diabet Med 20...,23,169,Oxf_Med_Case_Reports_2014_May_8_2014(2)_24-25.txt
3243A>G,...s the best predictor of clinical outcome in the m.3243A>G mtDNA mutation Neurology 2009 72 568 9 192...,27,149,Oxf_Med_Case_Reports_2014_May_8_2014(2)_24-25.txt
229C>T,...7-7ResearchTopoisomerase IIβ Binding Protein 1 c.*229C>T (rs115160714) Gene Polymorphism and Endomet...,3,195,Pathol_Oncol_Res_2014_Dec_18_20(3)_597-602.txt
229C>T,...ańska E  Krześlak A    Association between the c.*229C>T polymorphism of the topoisomerase IIβ bindi...,186,69,Pathol_Oncol_Res_2014_Dec_18_20(3)_597-602.txt
446T>G,"...ase of an exon4 heterozygous nucleotide change, c.446T>G, leading to the missense amino acid substit...",15,256,Pediatr_Rheumatol_Online_J_2015_Sep_28_13(Suppl_1)_P57.txt
3H > A,C3H≠AJ≈B6	C3H > AJ ≈ B6	C3H < AJ ≈ B6,138,12,PeerJ_2016_Aug_9_4_e2318.txt
3H > A,"... = C3H) (Dhami, He & Schuchman, 2010), Hck (B6 > C3H > AJ) (Ernst et al., 2002), Gas5 (B6 > AJ = C3H...",179,1404,PeerJ_2016_Aug_9_4_e2318.txt
1474 A > G,...RC0022311) in pig KL intron 1 was renamed as KL g.1474 A > G according to the standard mutation nome...,81,236,PeerJ_2016_Jul_14_4_e2186.txt
1474 A > G,"...hematic diagram of KL promoter, MARC0022311 (KL g.1474 A > G) and OCT-1 binding site in intron 1. (B...",84,57,PeerJ_2016_Jul_14_4_e2186.txt
1474 A > G,...in vitro (Fig. 4A). We found the KL genotype at g.1474 A > G locus was AA in PK and ST cells by PCR-...,103,578,PeerJ_2016_Jul_14_4_e2186.txt
1474 A>G,... procine KL intron 1 containing MARC0022311 (KL g.1474 A>G,125,137,PeerJ_2016_Jul_14_4_e2186.txt
20209 C>T,...Deutsch V  Kulozik A  Ben-Tal O   The prothrombin 20209 C>T mutation in Jewish-Moroccan Caucasians: ...,174,118,Pflugers_Arch_2016_May_25_468_993-1012.txt
208T>C,...(P27). Genetic and sequencing analysis revealed a 208T>C transition causing an amino acid substituti...,7,520,Pharmacogenomics_J_2012_Feb_20_12(1)_30-44.txt
208T>C,"...rporation, Ann Arbor, MI, USA). A point mutation (208T>C) in the middle region of exon 3 (Genbank ac...",54,291,Pharmacogenomics_J_2012_Feb_20_12(1)_30-44.txt
208T>C,"In summary, a point mutation in the Cdh23 gene (208T>C) of C57BL/6J mice results in hearing loss a...",98,49,Pharmacogenomics_J_2012_Feb_20_12(1)_30-44.txt
2988 G>A,"..., and termination at 72°C for 2 min. ForCYP2D6*41(2988 G>A) detection, a separate short amplicon PCR...",25,771,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
31 G>A,"...2D6 detected by RETINA were as follows (Table 1): 31 G>A, 77 G>A, 100 C>T,124 G>A, 137_138 insT, 883...",27,73,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
77 G>A,"...cted by RETINA were as follows (Table 1): 31 G>A, 77 G>A, 100 C>T,124 G>A, 137_138 insT, 883 G>C, 10...",27,81,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
100 C>T,"...RETINA were as follows (Table 1): 31 G>A, 77 G>A, 100 C>T,124 G>A, 137_138 insT, 883 G>C, 1023 C>T,1...",27,89,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
124 G>A,"...ere as follows (Table 1): 31 G>A, 77 G>A, 100 C>T,124 G>A, 137_138 insT, 883 G>C, 1023 C>T,1659 G>A,...",27,97,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
883 G>C,"...): 31 G>A, 77 G>A, 100 C>T,124 G>A, 137_138 insT, 883 G>C, 1023 C>T,1659 G>A, 1707 delT, 1716 G>A, 1...",27,120,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
1023 C>T,"..., 77 G>A, 100 C>T,124 G>A, 137_138 insT, 883 G>C, 1023 C>T,1659 G>A, 1707 delT, 1716 G>A, 1758 G>T, ...",27,129,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
1659 G>A,"... 100 C>T,124 G>A, 137_138 insT, 883 G>C, 1023 C>T,1659 G>A, 1707 delT, 1716 G>A, 1758 G>T, 1863_1864...",27,138,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
1716 G>A,"..._138 insT, 883 G>C, 1023 C>T,1659 G>A, 1707 delT, 1716 G>A, 1758 G>T, 1863_1864ins(TTTCGCCCC)2,1846 ...",27,159,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
1758 G>T,"... 883 G>C, 1023 C>T,1659 G>A, 1707 delT, 1716 G>A, 1758 G>T, 1863_1864ins(TTTCGCCCC)2,1846 G>A, 1973_...",27,169,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
1846 G>A,"...elT, 1716 G>A, 1758 G>T, 1863_1864ins(TTTCGCCCC)2,1846 G>A, 1973_1974 insG, 2291 G>A, 2539_2542 del ...",27,204,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2291 G>A,"...863_1864ins(TTTCGCCCC)2,1846 G>A, 1973_1974 insG, 2291 G>A, 2539_2542 del AACT, 2549 delA, 2573_2574...",27,230,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2850 C>T,"...3_2574 insC, 2587_2590 delGACT, 2615_2617 delAAG, 2850 C>T, 2935 A>C, 2950 G>C, 2988 G>A, 3183 G>A, ...",27,324,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2935 A>C,"...C, 2587_2590 delGACT, 2615_2617 delAAG, 2850 C>T, 2935 A>C, 2950 G>C, 2988 G>A, 3183 G>A, 3201 C>T, ...",27,334,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2950 G>C,"...90 delGACT, 2615_2617 delAAG, 2850 C>T, 2935 A>C, 2950 G>C, 2988 G>A, 3183 G>A, 3201 C>T, 3259_3260 ...",27,344,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2988 G>A,"..., 2615_2617 delAAG, 2850 C>T, 2935 A>C, 2950 G>C, 2988 G>A, 3183 G>A, 3201 C>T, 3259_3260 insGT,4125...",27,354,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
3183 G>A,"...7 delAAG, 2850 C>T, 2935 A>C, 2950 G>C, 2988 G>A, 3183 G>A, 3201 C>T, 3259_3260 insGT,4125_4133 dup ...",27,364,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
3201 C>T,"...2850 C>T, 2935 A>C, 2950 G>C, 2988 G>A, 3183 G>A, 3201 C>T, 3259_3260 insGT,4125_4133 dup GTGCCCACT,...",27,374,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2988 G>A,"...g alleles were included in the genotyping assays: 2988 G>A (CYP2D6*41), 2850 C>T (CYP2D6*2), 2615_26...",34,63,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2850 C>T,"...d in the genotyping assays: 2988 G>A (CYP2D6*41), 2850 C>T (CYP2D6*2), 2615_2617 delAAG (CYP2D6*9), ...",34,85,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
1846 G>A,"...CYP2D6*9), 1863_1864 ins(TTTCGCCCC)2 (CYP2D6*40), 1846 G>A (CYP2D6*4), 1023 C>T (CYP2D6*17), 100 C>T...",34,174,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
1023 C>T,"...ins(TTTCGCCCC)2 (CYP2D6*40), 1846 G>A (CYP2D6*4), 1023 C>T (CYP2D6*17), 100 C>T (CYP2D6*10), 31 G>A ...",34,195,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
100 C>T,"...6*40), 1846 G>A (CYP2D6*4), 1023 C>T (CYP2D6*17), 100 C>T (CYP2D6*10), 31 G>A (CYP2D6*35), and 3189 ...",34,217,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
31 G>A,"...D6*4), 1023 C>T (CYP2D6*17), 100 C>T (CYP2D6*10), 31 G>A (CYP2D6*35), and 3189 G>A (CYP2D6*29)",34,238,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
3189 G>A,"...17), 100 C>T (CYP2D6*10), 31 G>A (CYP2D6*35), and 3189 G>A (CYP2D6*29)",34,262,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2850C>T,"...rphic among the 48 samples: 31 samples (65%)had a 2850C>T SNP, 13 (27%) had a100C>T SNP, 10 (21%) ha...",58,319,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
100C>T,"... 31 samples (65%)had a 2850C>T SNP, 13 (27%) had a100C>T SNP, 10 (21%) had a 1846G>A SNP, 9 (19%) ha...",58,346,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
1846G>A,"...C>T SNP, 13 (27%) had a100C>T SNP, 10 (21%) had a 1846G>A SNP, 9 (19%) had a 1023 C>T SNP, 9 (19%) h...",58,373,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
1023 C>T,"...>T SNP, 10 (21%) had a 1846G>A SNP, 9 (19%) had a 1023 C>T SNP, 9 (19%) had a 2988 G>A SNP, 3 (6%) h...",58,400,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2988 G>A,"...>A SNP, 9 (19%) had a 1023 C>T SNP, 9 (19%) had a 2988 G>A SNP, 3 (6%) had a 31 G>A SNP, 2 (4%) had ...",58,428,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
31 G>A,"...C>T SNP, 9 (19%) had a 2988 G>A SNP, 3 (6%) had a 31 G>A SNP, 2 (4%) had a 1716 G>A SNP, 2 (4%) had ...",58,455,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
1716 G>A,"...88 G>A SNP, 3 (6%) had a 31 G>A SNP, 2 (4%) had a 1716 G>A SNP, 2 (4%) had a 1659 G>A SNP, 2 (4%) ha...",58,480,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
1659 G>A,"... G>A SNP, 2 (4%) had a 1716 G>A SNP, 2 (4%) had a 1659 G>A SNP, 2 (4%) had a 3183 G>A SNP, 1 (2%) ha...",58,507,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
3183 G>A,"... G>A SNP, 2 (4%) had a 1659 G>A SNP, 2 (4%) had a 3183 G>A SNP, 1 (2%) had a 77 G>A SNP, 1 (2%) had ...",58,534,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
77 G>A,"... G>A SNP, 2 (4%) had a 3183 G>A SNP, 1 (2%) had a 77 G>A SNP, 1 (2%) had a 1863_1864ins(TTTCGCCCC)2 ...",58,561,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
1846G>A,...15_2617delAAG variant. Representative data of the 1846G>A and 100C>T SNP assays of the RETINA system...,58,689,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
100C>T,...G variant. Representative data of the 1846G>A and 100C>T SNP assays of the RETINA system for all 48 ...,58,701,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
31 G>A,"...er, only 9 were availablecommerciallyvia TaqMan® (31 G>A, 100C>T, 1023 C>T, 1846G>A, 1863_1864ins(TT...",60,255,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
100C>T,"... 9 were availablecommerciallyvia TaqMan® (31 G>A, 100C>T, 1023 C>T, 1846G>A, 1863_1864ins(TTTCGCCCC)...",60,263,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
1023 C>T,"...availablecommerciallyvia TaqMan® (31 G>A, 100C>T, 1023 C>T, 1846G>A, 1863_1864ins(TTTCGCCCC)2, 2615_...",60,271,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
1846G>A,"...ommerciallyvia TaqMan® (31 G>A, 100C>T, 1023 C>T, 1846G>A, 1863_1864ins(TTTCGCCCC)2, 2615_2617 delAA...",60,281,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2850C>T,"...46G>A, 1863_1864ins(TTTCGCCCC)2, 2615_2617 delAAG,2850C>T, 2988G>A, and 3183 G>A).We tested those 9T...",60,333,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2988G>A,"...63_1864ins(TTTCGCCCC)2, 2615_2617 delAAG,2850C>T, 2988G>A, and 3183 G>A).We tested those 9TaqMan® Dr...",60,342,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
3183 G>A,"...TCGCCCC)2, 2615_2617 delAAG,2850C>T, 2988G>A, and 3183 G>A).We tested those 9TaqMan® Drug Metabolism...",60,355,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
1846G>A,...een the two platforms. Representative data of the 1846G>A and 100 C>T SNPs from the TaqMan® Drug Met...,60,522,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
100 C>T,...platforms. Representative data of the 1846G>A and 100 C>T SNPs from the TaqMan® Drug Metabolism assa...,60,534,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
100C>T,"...attern in TaqMan® Drug Metabolism Genotyping assay100C>T, but not in the RETINA 100C>T assay.Further...",60,808,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
100C>T,"...ism Genotyping assay100C>T, but not in the RETINA 100C>T assay.Further CNV methods were applied to c...",60,838,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
31 G>A,"...overed by the RETINA system in our study, only 11(31 G>A, 100 C>T, 883 G>C, 1023 C>T, 1707 delT, 175...",73,289,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
100 C>T,"...y the RETINA system in our study, only 11(31 G>A, 100 C>T, 883 G>C, 1023 C>T, 1707 delT, 1758 G>T, 1...",73,297,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
883 G>C,"...INA system in our study, only 11(31 G>A, 100 C>T, 883 G>C, 1023 C>T, 1707 delT, 1758 G>T, 1846 G>A,2...",73,306,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
1023 C>T,"...m in our study, only 11(31 G>A, 100 C>T, 883 G>C, 1023 C>T, 1707 delT, 1758 G>T, 1846 G>A,2549 delA,...",73,315,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
1758 G>T,"...11(31 G>A, 100 C>T, 883 G>C, 1023 C>T, 1707 delT, 1758 G>T, 1846 G>A,2549 delA, , 2615_2617 del AAG,...",73,336,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
1846 G>A,"... 100 C>T, 883 G>C, 1023 C>T, 1707 delT, 1758 G>T, 1846 G>A,2549 delA, , 2615_2617 del AAG, , 2850 C>...",73,346,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2850 C>T,"...8 G>T, 1846 G>A,2549 delA, , 2615_2617 del AAG, , 2850 C>T, and 2988 G>A) were found within the 1000...",73,389,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2988 G>A,"...A,2549 delA, , 2615_2617 del AAG, , 2850 C>T, and 2988 G>A) were found within the 1000 Genomes data ...",73,403,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
31 G>A,"...anger sequencing by us. Similarly, in sample #41, 31 G>A heterozygous SNP was identified by the 1000...",75,198,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2850C>T,"...entified to be polymorphic: 29 samples (58%)had a 2850C>T SNP, 16 samples (32%) had a 1846G>A SNP, 1...",80,115,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
1846G>A,"...es (58%)had a 2850C>T SNP, 16 samples (32%) had a 1846G>A SNP, 15 samples (30%) had a100C>T SNP, 14 ...",80,151,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
100C>T,"...es (32%) had a 1846G>A SNP, 15 samples (30%) had a100C>T SNP, 14 samples (28%) had a 2988 G>A SNP, 5...",80,186,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2988 G>A,"...les (30%) had a100C>T SNP, 14 samples (28%) had a 2988 G>A SNP, 5 samples (10%) had a 31 G>A SNP, 4 ...",80,221,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
31 G>A,"...s (28%) had a 2988 G>A SNP, 5 samples (10%) had a 31 G>A SNP, 4 samples (8%) had a 1707delT variant,...",80,257,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2291G>A,"...(8%) had a 1707delT variant, 3 samples (6%) had a 2291G>A SNP, 2 samples (4%) had a 1023 C>T SNP, 2 ...",80,329,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
1023 C>T,"...ples (6%) had a 2291G>A SNP, 2 samples (4%) had a 1023 C>T SNP, 2 samples (4%) had a variant of gene...",80,363,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
1659 G>A,"...ersion with CYP2D7 in exon 9, 1 sample (2%) had a 1659 G>A SNP, 1 sample (2%) had a 3183 G>A SNP, an...",80,468,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
3183 G>A,"...mple (2%) had a 1659 G>A SNP, 1 sample (2%) had a 3183 G>A SNP, and 1 sample (2%) had a 2549 delA va...",80,502,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2291 G>A,"..., exon 9 conversion with CYP2D7 (*36 or *4N), and 2291 G>A (*59)",80,734,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
1846 G>A,"...f CYP2D6 gene, were found to carry a heterozygous 1846 G>A SNP, a heterozygous 100 C>T SNP, and a he...",86,137,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
100 C>T,"...carry a heterozygous 1846 G>A SNP, a heterozygous 100 C>T SNP, and a heterozygous variant of the CYP...",86,166,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
31 G>A,...d to identify CYP2D6*35 because they donot detect 31 G>A. Roche Amplichip had the best allele covera...,99,538,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2988G>A,"...ver,it doesnot include the defining CYP2D6*41 SNP 2988G>A and thus may misclassify some CYP2D6*2 all...",99,691,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
124 G>A,"...ip – our platform can detect ten additional loci (124 G>A [CYP2D6*12], 4142_4133 dupGTGCCCACT [CYP2D...",99,1599,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
77 G>A,"...4 insC [CYP2D6*21], 2587_2590 delGACT [CYP2D6*38],77 G>A[CYP2D6*43],1716 G>A [CYP2D6*45], 77 G>A and...",99,1715,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
1716 G>A,"..., 2587_2590 delGACT [CYP2D6*38],77 G>A[CYP2D6*43],1716 G>A [CYP2D6*45], 77 G>A and 1716 G>A [CYP2D6*...",99,1733,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
77 G>A,"...YP2D6*38],77 G>A[CYP2D6*43],1716 G>A [CYP2D6*45], 77 G>A and 1716 G>A [CYP2D6*46],3259_3260 insGT [C...",99,1755,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
1716 G>A,"...7 G>A[CYP2D6*43],1716 G>A [CYP2D6*45], 77 G>A and 1716 G>A [CYP2D6*46],3259_3260 insGT [CYP2D6*42], ...",99,1766,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
3201 C>T,"...1716 G>A [CYP2D6*46],3259_3260 insGT [CYP2D6*42], 3201 C>T [CYP2D6*56], and 2291 G>A [CYP2D6*59]). F...",99,1816,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2291 G>A,"...3260 insGT [CYP2D6*42], 3201 C>T [CYP2D6*56], and 2291 G>A [CYP2D6*59]). For the RETINA assays for w...",99,1842,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
1846 G>A,Examination of heterozygous 1846 G>A alleles by Sanger Sequencing in liver sam...,117,29,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
1846 G>A,...typing methods. Variation discrimination plots of 1846 G>A (upper panels; *4) and 100 C>T (lower pan...,126,100,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
100 C>T,...mination plots of 1846 G>A (upper panels; *4) and 100 C>T (lower panels: *10/*4) by mPCR RETINA (A) ...,126,132,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2850 C>T,*2	2850 C>T,137,4,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
100 C>T,"*4	100 C>T, 1846 G>A, (exon 9 converstion with CYP2D7...",139,4,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
1846 G>A,"*4	100 C>T, 1846 G>A, (exon 9 converstion with CYP2D7 for CYP2...",139,13,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2935 A>C,*7	2935 A>C,141,4,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
1758 G>T,"*8	1758 G>T, 2850 C>T",142,4,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2850 C>T,"*8	1758 G>T, 2850 C>T",142,14,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
100 C>T,*10	100 C>T,144,5,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
883 G>C,"*11	883 G>C, 2850 C>T",145,5,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2850 C>T,"*11	883 G>C, 2850 C>T",145,14,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
124 G>A,"*12	124 G>A, 2850 C>T",146,5,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2850 C>T,"*12	124 G>A, 2850 C>T",146,14,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
1023 C>T,"*17	1023 C>T, 2850 C>T",148,5,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2850 C>T,"*17	1023 C>T, 2850 C>T",148,15,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2850 C>T,"*19	2539_2542 delAACT, 2850 C>T",150,24,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2850 C>T,"*20	1973_1974 insG, 2850 C>T",151,21,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2850 C>T,"*21	2573_2574 insC, 2850 C>T",152,21,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
1659 G>A,"*29	1659 G>A, 3183 G>A, 2850 C>T",153,5,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
3183 G>A,"*29	1659 G>A, 3183 G>A, 2850 C>T",153,15,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2850 C>T,"*29	1659 G>A, 3183 G>A, 2850 C>T",153,25,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
31 G>A,"*35	31 G>A, 2850 C>T",154,5,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2850 C>T,"*35	31 G>A, 2850 C>T",154,13,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
100 C>T,"*36	100 C>T, exon 9 conversion with CYP2D7",155,5,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
1023 C>T,"*40	1023 C>T, 1863_1864 ins(TTTCGCCCC)2, 2850 C>T",157,5,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2850 C>T,"*40	1023 C>T, 1863_1864 ins(TTTCGCCCC)2, 2850 C>T",157,42,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2850 C>T,"*41	2850 C>T, 2988 G>A",158,5,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2988 G>A,"*41	2850 C>T, 2988 G>A",158,15,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2850 C>T,"*42	2850 C>T, 3259_3260 insGT",159,5,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
77 G>A,*43	77 G>A,160,5,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2950 G>C,*44	2950 G>C,161,5,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
1716 G>A,"*45	1716 G>A, 2850 C>T",162,5,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2850 C>T,"*45	1716 G>A, 2850 C>T",162,15,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
77 G>A,"*46	77 G>A, 1716 G>A, 2850 C>T",163,5,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
1716 G>A,"*46	77 G>A, 1716 G>A, 2850 C>T",163,13,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2850 C>T,"*46	77 G>A, 1716 G>A, 2850 C>T",163,23,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2850 C>T,"*56	2850 C>T, 3201 C>T",164,5,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
3201 C>T,"*56	2850 C>T, 3201 C>T",164,15,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2291 G>A,"*59	2291 G>A, 2850 C>T",165,5,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2850 C>T,"*59	2291 G>A, 2850 C>T",165,15,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
6986A>G,"...gle nucleotide polymorphisms CYP3A5*3(rs776746, g.6986A>G), CYP3A5*6 (rs10264272, g.14690 G>A) and C...",23,128,Pharmacogenomics_J_2015_Dec_15_10_1038_tpj_2015_87.txt
14690 G>A,"...5*3(rs776746, g.6986A>G), CYP3A5*6 (rs10264272, g.14690 G>A) and CYP3A5*7 (rs41303343, g.27131-27132...",23,162,Pharmacogenomics_J_2015_Dec_15_10_1038_tpj_2015_87.txt
1058C>T,"...is analysis.(60) In addition POR*28 (rs1057868, g.1058C>T) and CYP3A4*22 (rs35599367, g.15389 C>T) w...",23,359,Pharmacogenomics_J_2015_Dec_15_10_1038_tpj_2015_87.txt
15389 C>T,"...s1057868, g.1058C>T) and CYP3A4*22 (rs35599367, g.15389 C>T) were also evaluated based on data from ...",23,397,Pharmacogenomics_J_2015_Dec_15_10_1038_tpj_2015_87.txt
22 C>T,...de Loor H  van Schaik RH  Kuypers DR   The CYP3A4*22 C>T single nucleotide polymorphism is associate...,327,75,Pharmacogenomics_J_2015_Dec_15_10_1038_tpj_2015_87.txt
596C > T,"...earance in individuals carrying three variants (c.596C > T, c.602C > T, c.808G > T) of the SLC22A2 g...",32,642,Pharmgenomics_Pers_Med_2009_Sep_13_2_79-91.txt
602C > T,"...ndividuals carrying three variants (c.596C > T, c.602C > T, c.808G > T) of the SLC22A2 gene. One stu...",32,654,Pharmgenomics_Pers_Med_2009_Sep_13_2_79-91.txt
808G > T,"...arrying three variants (c.596C > T, c.602C > T, c.808G > T) of the SLC22A2 gene. One study was done ...",32,666,Pharmgenomics_Pers_Med_2009_Sep_13_2_79-91.txt
2289669G > A,...looked at one polymorphism of the SLC47A1 gene (rs2289669G > A) and the associated reduction in HbA1...,35,74,Pharmgenomics_Pers_Med_2009_Sep_13_2_79-91.txt
182V > V,"...esently, the rank of sensitivities to either SU (I182V > V59M > Q52R > I296L) may provide a general ...",50,1954,Pharmgenomics_Pers_Med_2009_Sep_13_2_79-91.txt
59M > Q,... the rank of sensitivities to either SU (I182V > V59M > Q52R > I296L) may provide a general dosing a...,50,1962,Pharmgenomics_Pers_Med_2009_Sep_13_2_79-91.txt
52R > I,...nk of sensitivities to either SU (I182V > V59M > Q52R > I296L) may provide a general dosing algorith...,50,1969,Pharmgenomics_Pers_Med_2009_Sep_13_2_79-91.txt
521T > C,...respect to nateglinide.56 Results showed that the 521T > C polymorphisms of SLCO1B1 does not alter t...,109,224,Pharmgenomics_Pers_Med_2009_Sep_13_2_79-91.txt
521T > C,...M4 metabolites were significantly affected by the 521T > C polymorphism.56 Individuals expressing th...,109,537,Pharmgenomics_Pers_Med_2009_Sep_13_2_79-91.txt
638G > A,"...er cytosols was then explored. When SULT1A1*1/*2 (638G > A) was examined, both fulvestrant (Figure 4...",62,123,Pharmgenomics_Pers_Med_2011_Nov_17_4_137-145.txt
638G > A,Figure 4 SULT1A1*1/*2 (638G > A) influence on the sulfation of fulvestran...,93,24,Pharmgenomics_Pers_Med_2011_Nov_17_4_137-145.txt
584C>T,EL	c.584C>T	Increased risk factor for developing severe...,179,6,Pharmgenomics_Pers_Med_2014_Dec_12_7_399-409.txt
1545 T>C,...ndians found an association between CYP1A2*1C and 1545 T>C polymorphisms and TD29. Fu et al found CY...,29,231,Pharmgenomics_Pers_Med_2014_Oct_13_7_317-328.txt
609 C>T,...for cellular damage and TD. Studies examining the 609 C>T polymorphism found the T allele is associa...,70,362,Pharmgenomics_Pers_Med_2014_Oct_13_7_317-328.txt
1545 C>T,... schizophrenia subjects: V. Association of CYP1A2 1545 C>T polymorphism Pharmacogenomics J 2007 7 5 ...,156,170,Pharmgenomics_Pers_Med_2014_Oct_13_7_317-328.txt
18492T>C,"...tation associated with low EFV concentrations was 18492T>C, and those associated with high EFV conce...",21,894,Pharmgenomics_Pers_Med_2015_Nov_5_8_163-170.txt
516G>T,"...hose associated with high EFV concentrations were 516G>T, 785A>G, and 21563C>T.8–1",21,959,Pharmgenomics_Pers_Med_2015_Nov_5_8_163-170.txt
785A>G,"...ociated with high EFV concentrations were 516G>T, 785A>G, and 21563C>T.8–1",21,967,Pharmgenomics_Pers_Med_2015_Nov_5_8_163-170.txt
21563C>T,"... high EFV concentrations were 516G>T, 785A>G, and 21563C>T.8–1",21,979,Pharmgenomics_Pers_Med_2015_Nov_5_8_163-170.txt
516G>T,"...tham, MA, USA) were used to genotype the CYP2B6 c.516G>T (assay ID C_7817765_60), c.64C>T (assay ID ...",41,107,Pharmgenomics_Pers_Med_2015_Nov_5_8_163-170.txt
64C>T,"...pe the CYP2B6 c.516G>T (assay ID C_7817765_60), c.64C>T (assay ID C_2818162_20), c.499C>G (assay ID ...",41,141,Pharmgenomics_Pers_Med_2015_Nov_5_8_163-170.txt
499C>G,"...C_7817765_60), c.64C>T (assay ID C_2818162_20), c.499C>G (assay ID C_2752377_10), c.1375A>G (assay I...",41,174,Pharmgenomics_Pers_Med_2015_Nov_5_8_163-170.txt
1375A>G,"..._2818162_20), c.499C>G (assay ID C_2752377_10), c.1375A>G (assay ID C_2741754_10), c.1459C>T (assay ...",41,208,Pharmgenomics_Pers_Med_2015_Nov_5_8_163-170.txt
1459C>T,"...2752377_10), c.1375A>G (assay ID C_2741754_10), c.1459C>T (assay ID C_30634242_40), g.3003T>C (assay...",41,243,Pharmgenomics_Pers_Med_2015_Nov_5_8_163-170.txt
3003T>C,"...741754_10), c.1459C>T (assay ID C_30634242_40), g.3003T>C (assay ID C_2818167_10), and g.21563C>T (a...",41,279,Pharmgenomics_Pers_Med_2015_Nov_5_8_163-170.txt
21563C>T,"...242_40), g.3003T>C (assay ID C_2818167_10), and g.21563C>T (assay ID C_22275631_10). The genotyping ...",41,318,Pharmgenomics_Pers_Med_2015_Nov_5_8_163-170.txt
785A>G,...say ID C_22275631_10). The genotyping of CYP2B6 c.785A>G was performed by custom TaqMan assays (Appl...,41,380,Pharmgenomics_Pers_Med_2015_Nov_5_8_163-170.txt
785A>G,"...f primers and probes were the following: CYP2B6 c.785A>G, TGGAGAAGCACCGTGAAACC (forward), TGGAGCAGGT...",41,512,Pharmgenomics_Pers_Med_2015_Nov_5_8_163-170.txt
21563C>T,"...*1/*4, and CYP2B6*1/*2 with heterozygous mutant g.21563C>T (CT). Of these, 51.0% were intermediate m...",74,256,Pharmgenomics_Pers_Med_2015_Nov_5_8_163-170.txt
18492T>C,"...P2B6*1/*6, CYP2B6*1/*2 with heterozygous mutant g.18492T>C (TC), CYP2B6*1/*5 with homozygous mutant ...",74,410,Pharmgenomics_Pers_Med_2015_Nov_5_8_163-170.txt
18492T>C,"...492T>C (TC), CYP2B6*1/*5 with homozygous mutant g.18492T>C (CC), CYP2B6*2/*4 with mutations, and CYP...",74,462,Pharmgenomics_Pers_Med_2015_Nov_5_8_163-170.txt
18492T>C,"...st patient had CYP2B6*6/*6+ heterozygous mutant g.18492T>C (TC), but the EFV level was normal (2.093...",76,361,Pharmgenomics_Pers_Med_2015_Nov_5_8_163-170.txt
18492T>C,...atient who had CYP2B6*6/*6+ heterozygous mutant g.18492T>C (TC) had normal EFV level. This might be ...,91,410,Pharmgenomics_Pers_Med_2015_Nov_5_8_163-170.txt
18492T>C,... normal EFV level. This might be explained by the 18492T>C mutation associated with low EFV concentr...,91,477,Pharmgenomics_Pers_Med_2015_Nov_5_8_163-170.txt
18492T>C,No mutation	18492T>C	21563C>T	Other,174,13,Pharmgenomics_Pers_Med_2015_Nov_5_8_163-170.txt
21563C>T,No mutation	18492T>C	21563C>T	Other,174,22,Pharmgenomics_Pers_Med_2015_Nov_5_8_163-170.txt
388T>C,"...he single‐nucleotide polymorphisms, NM_000041.2:c.388T>C (p.Cys130Arg; rs429358) and c.526C>T (p.Arg...",170,739,Physiol_Rep_2016_Apr_25_4(8)_e12733.txt
526C>T,...M_000041.2:c.388T>C (p.Cys130Arg; rs429358) and c.526C>T (p.Arg176Cys; rs7414) as follows: at nucleo...,170,776,Physiol_Rep_2016_Apr_25_4(8)_e12733.txt
720006	G->T,P5c1	chrII: 720006	G->T,57,13,PLoS_Biol_2015_May_26_13(5)_e1002155.txt
136355	G-> C,chrXIII: 136355	G-> C,60,11,PLoS_Biol_2015_May_26_13(5)_e1002155.txt
885153	T-> C,chrXIII: 885153	T-> C,63,11,PLoS_Biol_2015_May_26_13(5)_e1002155.txt
619455	G-> T,P6c1	chrXVI: 619455	G-> T	intergenic		1		ND,68,14,PLoS_Biol_2015_May_26_13(5)_e1002155.txt
1408563	G-> A,chrIV: 1408563	G-> A,69,9,PLoS_Biol_2015_May_26_13(5)_e1002155.txt
545020	C-> A,chrV: 545020	C-> A,72,8,PLoS_Biol_2015_May_26_13(5)_e1002155.txt
401803	G-> C,chrVIII: 401803	G-> C,75,11,PLoS_Biol_2015_May_26_13(5)_e1002155.txt
25655	G-> A,chrXIII: 25655	G-> A,78,11,PLoS_Biol_2015_May_26_13(5)_e1002155.txt
499172	C-> T,chrXIII: 499172	C-> T,81,11,PLoS_Biol_2015_May_26_13(5)_e1002155.txt
381852	G-> A,chrXIV: 381852	G-> A,84,10,PLoS_Biol_2015_May_26_13(5)_e1002155.txt
299460	C-> A,S8c2	chrXIV: 299460	C-> A,88,14,PLoS_Biol_2015_May_26_13(5)_e1002155.txt
47386	C-> G,chrIV: 47386	C-> G,91,9,PLoS_Biol_2015_May_26_13(5)_e1002155.txt
897313	G-> A,chrIV: 897313	G-> A,94,9,PLoS_Biol_2015_May_26_13(5)_e1002155.txt
188 D>V,"... Methods, S7A Fig.). As a result, we identified 3,188 D>V genes compared with 1,352 V>D genes (Fig. ...",115,428,PLoS_Comput_Biol_2015_Jan_23_11(1)_e1004032.txt
352 V>D,"...lt, we identified 3,188 D>V genes compared with 1,352 V>D genes (Fig. 7B). We next used RNA-Seq anal...",115,458,PLoS_Comput_Biol_2015_Jan_23_11(1)_e1004032.txt
467 D>V,"...erences in their expression (Fig. 7C), of which 1,467 D>V genes and 1,198 V>D genes satisfied our cr...",115,694,PLoS_Comput_Biol_2015_Jan_23_11(1)_e1004032.txt
198 V>D,"...ression (Fig. 7C), of which 1,467 D>V genes and 1,198 V>D genes satisfied our criteria of 20% more e...",115,714,PLoS_Comput_Biol_2015_Jan_23_11(1)_e1004032.txt
181G>A,"...ntified a noncoding nucleotide substitution, c.58+181G>A, in the first intron of the Tw allele of Ze...",5,1357,PLoS_Genet_2011_Sep_29_7(9)_e1002307.txt
181G>A,"...e of Zeb1 (Zeb1Tw). A knockin mouse model of c.58+181G>A recapitulated the Tw phenotype, whereas a w...",5,1450,PLoS_Genet_2011_Sep_29_7(9)_e1002307.txt
181G>A,"... not, confirming the mutation as pathogenic. c.58+181G>A does not affect splicing but disrupts a pre...",5,1578,PLoS_Genet_2011_Sep_29_7(9)_e1002307.txt
181G>A,...al region. A single nucleotide substitution (c.58+181G>A) was detected in the Tw allele in the regio...,61,230,PLoS_Genet_2011_Sep_29_7(9)_e1002307.txt
181G>A,...B) c.58+181G is evolutionarily conserved and c.58+181G>A disrupts a consensus binding sequence for t...,61,382,PLoS_Genet_2011_Sep_29_7(9)_e1002307.txt
181G>A,"...Figure 3B). We designated this Tw variant as c.58+181G>A, which was the only sequence variation we d...",67,917,PLoS_Genet_2011_Sep_29_7(9)_e1002307.txt
181G>A,"...Nsplice, GeneSplicer, Net2Gene) predict that c.58+181G>A does not affect splicing of the adjacent sp...",67,1187,PLoS_Genet_2011_Sep_29_7(9)_e1002307.txt
181G>A,...b1os cDNA transcripts confirmed no effect of c.58+181G>A on splicing,67,1357,PLoS_Genet_2011_Sep_29_7(9)_e1002307.txt
181G>A,c.58+181G>A disrupts a predicted site for Myb protein b...,70,6,PLoS_Genet_2011_Sep_29_7(9)_e1002307.txt
181G>A,"To confirm the pathogenic effect of c.58+181G>A, we generated two knockin mouse lines: KIA ...",82,42,PLoS_Genet_2011_Sep_29_7(9)_e1002307.txt
560A>C,"...the combination of two common variants in APOA1, −560A>C (MAF = 3.5%, tagging the haplotype-560A>C, ...",121,804,PLoS_Genet_2012_Nov_29_8(11)_e1003063.txt
560A>C,"...APOA1, −560A>C (MAF = 3.5%, tagging the haplotype-560A>C, −151C>T, *181A>G) and −310G>A (MAF = 16%),...",121,846,PLoS_Genet_2012_Nov_29_8(11)_e1003063.txt
151C>T,"...60A>C (MAF = 3.5%, tagging the haplotype-560A>C, −151C>T, *181A>G) and −310G>A (MAF = 16%), associat...",121,855,PLoS_Genet_2012_Nov_29_8(11)_e1003063.txt
181A>G,"...F = 3.5%, tagging the haplotype-560A>C, −151C>T, *181A>G) and −310G>A (MAF = 16%), associated with m...",121,864,PLoS_Genet_2012_Nov_29_8(11)_e1003063.txt
310G>A,"...ging the haplotype-560A>C, −151C>T, *181A>G) and −310G>A (MAF = 16%), associated with minor increase...",121,877,PLoS_Genet_2012_Nov_29_8(11)_e1003063.txt
560A>C,"...nts in the promoter and coding regions of APOA1 (−560A>C MAF = 3.5%, tagging the haplotype-560A>C, −...",172,76,PLoS_Genet_2012_Nov_29_8(11)_e1003063.txt
560A>C,"... APOA1 (−560A>C MAF = 3.5%, tagging the haplotype-560A>C, −151C>T, *181A>G, and −310G>A MAF = 16%) c...",172,117,PLoS_Genet_2012_Nov_29_8(11)_e1003063.txt
151C>T,"...560A>C MAF = 3.5%, tagging the haplotype-560A>C, −151C>T, *181A>G, and −310G>A MAF = 16%) contribute...",172,126,PLoS_Genet_2012_Nov_29_8(11)_e1003063.txt
181A>G,"...F = 3.5%, tagging the haplotype-560A>C, −151C>T, *181A>G, and −310G>A MAF = 16%) contributed 0.4% (R...",172,135,PLoS_Genet_2012_Nov_29_8(11)_e1003063.txt
310G>A,"...ging the haplotype-560A>C, −151C>T, *181A>G, and −310G>A MAF = 16%) contributed 0.4% (R2 = 0.004) to...",172,148,PLoS_Genet_2012_Nov_29_8(11)_e1003063.txt
2278C>T,"... and observed a heterozygous mutational change, c.2278C>T, in exon12 which generated a stop codon pr...",157,449,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
2278C>T,"...pact on splicing (Table S1). Significantly, the c.2278C>T mutational change was observed as a hetero...",157,771,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
2278C>T,...Selective quantitative amplification of the WT or 2278C>T ATRIP alleles. Primers located in ATRIP ex...,162,771,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
2278C>T,...e WT (c.2278C) (P1 and P3C) versus the mutated (c.2278C>T) (P2 and P3C) alleles. The WT PCR product ...,162,923,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
2278C>T,...es. The WT PCR product is shown in blue and the c.2278C>T PCR product in red. The exon 12 mutated al...,162,1000,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
2278C>T,...y (NMD). Cycleave-qPCR confirmed that the ATRIP c.2278C>T mutant allele was expressed exclusively in...,162,2001,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
2278C>T,"...t probes were used to distinguish the WT versus c.2278C>T allele (probe1 and probe2, respectively). ...",162,2239,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
2278C>T,...ve amplification of the WT and mutant products (c.2278C>T mutant as well as the mis-spliced product)...,164,138,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
2278C>T,"...P3C selectively amplify the mutated (maternal) c. 2278C>T allele (Figure 2C). As expected, the mutan...",164,530,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
2278C>T,"...>T allele (Figure 2C). As expected, the mutant (c.2278C>T)-allele-specific PCR product (right column...",164,585,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
2278C>T,...s (Figure 2C). The results also showed that the c.2278C>T and the WT (c.2278C) alleles were expresse...,164,892,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
2278C>T,"...led ‘mother’ in Figure 2C), suggesting that the c.2278C>T ATRIP mRNA is not subject to nonsense medi...",164,1090,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
2278C>T,"...n levels of the wild type (c.2278C) and mutant (c.2278C>T) alleles in the mother (Figure 2C, compare...",166,877,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
2278C>T,"...C would be equally derived from the c.2278C and c.2278C>T alleles, which have, therefore, been depic...",166,1095,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
2278C>T,"...er columns in Figure 2D). Similarly, the mutant c.2278C>T allele is likely to be expressed at an equ...",166,1257,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
2278C>T,"...eft hand panel in Figure 2D). Assuming that the c.2278C>T allele is fully inactivated (see below), t...",166,1625,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
2278C>T,...(probe 1) allele. We confirmed detection of the c.2278C>T allele exclusively in the patient and moth...,168,557,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
2278C>T,"...the mother, the wild type (c.2278C) and mutant (c.2278C>T) signals were detected at equal levels reg...",168,716,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
2278C>T,It is likely that ATRIP c.2278C>T causes an impacting mutational change sinc...,173,27,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
2278C>T,...e low ATRIP protein level in CV1720 cells). The c.2278C>T mutational change was introduced into ATRI...,173,600,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
2278C>T,...bserved in CV1720 cells following expression of c.2278C>T ATRIP cDNA (encoding R760* ATRIP). Surpris...,173,1113,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
2278C>T,"...ve low ATR and ATRIP expression. Significantly, c.2278C>T ATRIP cDNA was unable to rescue ATR–SS cel...",173,1445,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
2278C>T,...e to rescue ATR–SS cells. Finally expression of c.2278C>T ATRIP cDNA in WT cells did not affect G2/M...,173,1523,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
2278C>T,"...0* ATRIP can interact with ATR, HA-tagged WT or c.2278C>T (ATRIP R760*) cDNA was co-expressed with u...",180,226,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
2278C>T,...t after HA-R760* ATRIP expression (derived from c.2278C>T ATRIP cDNA) was substantially lower than a...,180,565,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
3477G>T,...ssion. Sequencing of ATR cDNA revealed the same c.3477G>T mutational change in both patients (Figure...,184,812,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
464C>G,"The second ATR mutation identified was c.6897+464C>G;p.Val2300Gly fs75*, which, surprisingly, wa...",189,47,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
2278C>T,... levels of the ATRIP–c.2278C (normal) and ATRIP–c.2278C>T (p.Arg760*) alleles in LBLs from patient C...,234,61,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
2278C>T,...bes that specifically recognize the c.2278C and c.2278C>T alleles were used for the assay. qPCR resu...,234,484,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
2278C>T,"...ged ATRIP cDNA expressing plasmids (wild type and 2278C>T ATRIP) together with ATR cDNA, followed by...",237,160,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
2278C>T,"...affected mother, CV1780, are heterozygous for a c.2278C>T mutational change in exon12 of ATRIP. The ...",263,206,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
2278C>T,...ATRIP. The father has a WT sequence at this site. 2278C>T generates a primary stop codon predicting ...,263,295,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
3477G>T,...served in ATR in patients 27-4BI and 19-8BI. A) c.3477G>T mutational change in patients 27-4BI and 1...,275,83,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
3477G>T,...19-8BI. RT-PCR sequencing revealed a heterozygous 3477G>T mutational change in both patients causing...,275,182,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
67334934 G>T,...NA (gDNA) as control. The polymorphic position g. 67334934 G>T was used to monitor differential expr...,26,1276,PLoS_Genet_2013_Jan_24_9(1)_e1003183.txt
67334934 G>T,...ion on the peaks for T and G are the T or G at g. 67334934 G>T. (F) Summary of the detection of diff...,26,1680,PLoS_Genet_2013_Jan_24_9(1)_e1003183.txt
67334934 G>T,We found a SNP (g.67334934 G>T) in exon 5 of SLCO1B3 gene by sequenc...,42,19,PLoS_Genet_2013_Jan_24_9(1)_e1003183.txt
67320217A>G,g.67320217A>,53,3,PLoS_Genet_2013_Jan_24_9(1)_e1003183.txt
67320779A>G,g.67320779A>,56,3,PLoS_Genet_2013_Jan_24_9(1)_e1003183.txt
67322980C>T,g.67322980C>,59,3,PLoS_Genet_2013_Jan_24_9(1)_e1003183.txt
67325964G>C,g.67325964G>,95,3,PLoS_Genet_2013_Jan_24_9(1)_e1003183.txt
67328567A>G,g.67328567A>,98,3,PLoS_Genet_2013_Jan_24_9(1)_e1003183.txt
67330251C>T,g.67330251C>,101,3,PLoS_Genet_2013_Jan_24_9(1)_e1003183.txt
67330635C>T,g.67330635C>,104,3,PLoS_Genet_2013_Jan_24_9(1)_e1003183.txt
67332494A>G,g.67332494A>,107,3,PLoS_Genet_2013_Jan_24_9(1)_e1003183.txt
67333488C>T,g.67333488C>,110,3,PLoS_Genet_2013_Jan_24_9(1)_e1003183.txt
67334934G>T,g.67334934G>,113,3,PLoS_Genet_2013_Jan_24_9(1)_e1003183.txt
67335932T>C,g.67335932T>,116,3,PLoS_Genet_2013_Jan_24_9(1)_e1003183.txt
67336084C>T,g.67336084C>,119,3,PLoS_Genet_2013_Jan_24_9(1)_e1003183.txt
67336453G>T,g.67336453G>,122,3,PLoS_Genet_2013_Jan_24_9(1)_e1003183.txt
67336599C>T,g.67336599C>,125,3,PLoS_Genet_2013_Jan_24_9(1)_e1003183.txt
67336867A>T,g.67336867A>,128,3,PLoS_Genet_2013_Jan_24_9(1)_e1003183.txt
67337145A>G,g.67337145A>,131,3,PLoS_Genet_2013_Jan_24_9(1)_e1003183.txt
67338442C>G,g.67338442C>,134,3,PLoS_Genet_2013_Jan_24_9(1)_e1003183.txt
67339003C>T,g.67339003C>,137,3,PLoS_Genet_2013_Jan_24_9(1)_e1003183.txt
67339848A>G,g.67339848A>,140,3,PLoS_Genet_2013_Jan_24_9(1)_e1003183.txt
67340370C>T,g.67340370C>,143,3,PLoS_Genet_2013_Jan_24_9(1)_e1003183.txt
67342640A>G,g.67342640A>,146,3,PLoS_Genet_2013_Jan_24_9(1)_e1003183.txt
67334934 G>T,...he 18 hexamers. A fragment containing the SNP (g. 67334934 G>T) in exon 5 was amplified with forward...,283,385,PLoS_Genet_2013_Jan_24_9(1)_e1003183.txt
67334934 G>T,... heterzygotes was scored by analyzing the SNP (g. 67334934 G>T) by pyrosequencing. A pyro-seq primer...,283,627,PLoS_Genet_2013_Jan_24_9(1)_e1003183.txt
21U>A,♂21U>A1258	♂Tg1258 with synthetic 21U RNA first nt ...,95,2,PLoS_Genet_2013_Mar_14_9(3)_e1003392.txt
21U>G,♂21U>G1258	♂Tg1258 with synthetic 21U RNA first nt ...,102,2,PLoS_Genet_2013_Mar_14_9(3)_e1003392.txt
21U>A,♀21U>A2502	♀Tg2502 with synthetic 21U RNA first nt ...,133,2,PLoS_Genet_2013_Mar_14_9(3)_e1003392.txt
21U>G,♀21U>G2502	♀Tg2502 with synthetic 21U RNA first nt ...,140,2,PLoS_Genet_2013_Mar_14_9(3)_e1003392.txt
21U>A,"... the first nucleotide of 21UR-synth to adenosine (21U>A transgenes) or guanosine (21U>G transgenes),...",238,516,PLoS_Genet_2013_Mar_14_9(3)_e1003392.txt
21U>G,"...nth to adenosine (21U>A transgenes) or guanosine (21U>G transgenes), such that the transgenes encode...",238,548,PLoS_Genet_2013_Mar_14_9(3)_e1003392.txt
21U>A,"...19(+)], xkIs12[♀Scram2502 cb-unc-119(+)], xkIs14[♂21U>A1258 cb-unc-119(+)], xkIs15[♂21U>G1258 cb-unc...",283,272,PLoS_Genet_2013_Mar_14_9(3)_e1003392.txt
21U>G,"...19(+)], xkIs14[♂21U>A1258 cb-unc-119(+)], xkIs15[♂21U>G1258 cb-unc-119(+)], xkIs16[♂Min1258 cb-unc-1...",283,306,PLoS_Genet_2013_Mar_14_9(3)_e1003392.txt
21U>A,"...-119(+)], xkIs16[♂Min1258 cb-unc-119(+)], xkIs17[♀21U>A2502 cb-unc-119(+)], xkIs18[♀21U>G2502 cb-unc...",283,372,PLoS_Genet_2013_Mar_14_9(3)_e1003392.txt
21U>G,"...19(+)], xkIs17[♀21U>A2502 cb-unc-119(+)], xkIs18[♀21U>G2502 cb-unc-119(+)], xkIs19[♀Min2502 cb-unc-1...",283,406,PLoS_Genet_2013_Mar_14_9(3)_e1003392.txt
0	G>C,Chr14:60974363	----	0.002	0	G>C	----	3.77,82,28,PLoS_Genet_2014_May_29_10(5)_e1004372.txt
0	C>T,Chr14:60974373	rs8004739	0.008	0	C>T	----	5.58,85,33,PLoS_Genet_2014_May_29_10(5)_e1004372.txt
002	C>T,Chr14:60974378	----	0	0.002	C>T	----	2.77,88,26,PLoS_Genet_2014_May_29_10(5)_e1004372.txt
002	C>A,Chr14:60974400	----	0.002	0.002	C>A	----	5.58,91,30,PLoS_Genet_2014_May_29_10(5)_e1004372.txt
0	A>G,Chr14:60974449	----	0.002	0	A>G	----	3.48,94,28,PLoS_Genet_2014_May_29_10(5)_e1004372.txt
002	G>C,Chr14:60976393	rs78954112	0	0.002	G>C	Glu93Gln	5.52,97,32,PLoS_Genet_2014_May_29_10(5)_e1004372.txt
002	G>A,Chr14:60976501	rs146737847	0.008	0.002	G>A	Glu129Lys	5.38,100,37,PLoS_Genet_2014_May_29_10(5)_e1004372.txt
37	A>C,Chr14:60976537	rs33912345	0.47	0.37	A>C	Asn141His	5.38,103,35,PLoS_Genet_2014_May_29_10(5)_e1004372.txt
002	T>G,Chr14:60977843	rs45549246	0.002	0.002	T>G	Leu205Arg	4.14,106,36,PLoS_Genet_2014_May_29_10(5)_e1004372.txt
0	C>T,Chr14:60977864	rs202029915	0.002	0	C>T	Thr212Met	2.36,109,35,PLoS_Genet_2014_May_29_10(5)_e1004372.txt
0	G>T,Chr14:60977954	rs139302405	0.002	0	G>T	Ser242Ile	5.19,112,35,PLoS_Genet_2014_May_29_10(5)_e1004372.txt
600 C>A,"...ee J , Kim CH , Lee S  (2014 ) The polymorphism (−600 C>A) of CpG methylation site at the promoter r...",1233,62,PLoS_Genet_2014_Nov_6_10(11)_e1004735.txt
3034T>C,"...nd was found to carry a de novo USP9X mutation (c.3034T>C, p.Ser1012Pro) at a highly conserved resid...",131,277,PLoS_Genet_2015_Mar_12_11(3)_e1005022.txt
5669G>A,"...l genotypes unavailable) harbored variant (T2587c.5669G>A, p.Gly1890Glu) a rare missense variant. Bo...",131,502,PLoS_Genet_2015_Mar_12_11(3)_e1005022.txt
17704	C>T,Q97Stop	17704	C>T	n/a	n/a	Severe	2.4	n/a	n/a	n/a,34,9,PLoS_Genet_2016_May_26_12(5)_e1006082.txt
17761	C>A,R116R	17761	C>A	5–7	3–6	Mild/Moderate	2.0	96±5	96±8	I,35,7,PLoS_Genet_2016_May_26_12(5)_e1006082.txt
17778	G>T,Q121H	17778	G>T	n/a	18	Mild	7.0	26±3	110±15	II,36,7,PLoS_Genet_2016_May_26_12(5)_e1006082.txt
17761	C>T,R116Stop	17761	C>T	<1–3	<1–1	Severe	7.0	n/a	n/a	n/a,37,10,PLoS_Genet_2016_May_26_12(5)_e1006082.txt
17736	G>A,V107V	17736	G>A	14–24	12–21	Mild	7.6	100±6	81±22	I,38,7,PLoS_Genet_2016_May_26_12(5)_e1006082.txt
17776	C>T,Q121Stop	17776	C>T	<1	<1	Severe	20.6	n/a	n/a	n/a,39,10,PLoS_Genet_2016_May_26_12(5)_e1006082.txt
17768	C>T,A118V	17768	C>T	n/a	25	Mild	22.2	17±1.6	92±7	II,40,7,PLoS_Genet_2016_May_26_12(5)_e1006082.txt
17761	C>G,*R116G	17761	C>G	n/a	n/a	n/a*	24.8	27±2	88±15	II,41,8,PLoS_Genet_2016_May_26_12(5)_e1006082.txt
17764	C>T,L117F	17764	C>T	n/a	<1	Severe	27.7	0	0	III,42,7,PLoS_Genet_2016_May_26_12(5)_e1006082.txt
17773	A>T,N120Y	17773	A>T	0.4	<1	Severe	56.7	n/a	n/a	n/a,43,7,PLoS_Genet_2016_May_26_12(5)_e1006082.txt
17756	G>T,G114V	17756	G>T	2	<1–1	Moderate/Severe	62.6	n/a	n/a	n/a,44,7,PLoS_Genet_2016_May_26_12(5)_e1006082.txt
17783	C>G,S123C	17783	C>G	n/a	15	Mild	69.5	n/a	n/a	n/a,45,7,PLoS_Genet_2016_May_26_12(5)_e1006082.txt
17756	G>C,G114A	17756	G>C	4–5	5–13	Mild/Moderate	71.3	n/a	n/a	n/a,46,7,PLoS_Genet_2016_May_26_12(5)_e1006082.txt
17704	C>G,Q97E	17704	C>G	<1	<1	Severe	75.3	63.5±5.8	5.9±2	n/a,47,6,PLoS_Genet_2016_May_26_12(5)_e1006082.txt
17704	C>A,Q97K	17704	C>A	n/a	<1	Severe	83.8	60±0.2	2.9±1	n/a,48,6,PLoS_Genet_2016_May_26_12(5)_e1006082.txt
17782	T>C,S123P	17782	T>C	n/a	<1	Severe	86.6	n/a	n/a	n/a,49,7,PLoS_Genet_2016_May_26_12(5)_e1006082.txt
17756	G>A,G114E	17756	G>A	8	4–7	Mild/Moderate	93.1	n/a	n/a	n/a,50,7,PLoS_Genet_2016_May_26_12(5)_e1006082.txt
866G>A,"... polymorphism in the promoter of this gene (UCP2 −866G>A) (rs659366) has been associated in some, bu...",11,546,PLoS_Med_2005_Dec_1_2(12)_e406.txt
676T>C,"...stigation were selected. Four promoter variants (−676T>C, −472T>C, −469C>G, −276C>T), and the non-sy...",47,205,PLoS_Negl_Trop_Dis_2015_Mar_25_9(3)_e0003647.txt
472T>C,"... were selected. Four promoter variants (−676T>C, −472T>C, −469C>G, −276C>T), and the non-synonymous ...",47,214,PLoS_Negl_Trop_Dis_2015_Mar_25_9(3)_e0003647.txt
469C>G,"...ected. Four promoter variants (−676T>C, −472T>C, −469C>G, −276C>T), and the non-synonymous (ns) subs...",47,223,PLoS_Negl_Trop_Dis_2015_Mar_25_9(3)_e0003647.txt
276C>T,"...ur promoter variants (−676T>C, −472T>C, −469C>G, −276C>T), and the non-synonymous (ns) substitution ...",47,232,PLoS_Negl_Trop_Dis_2015_Mar_25_9(3)_e0003647.txt
676T>C,"The four gene variants in the promoter region, −676T>C, −472T>C, −469C>G, −276C>T, and the non-syn...",60,49,PLoS_Negl_Trop_Dis_2015_Mar_25_9(3)_e0003647.txt
472T>C,"...r gene variants in the promoter region, −676T>C, −472T>C, −469C>G, −276C>T, and the non-synonymous s...",60,58,PLoS_Negl_Trop_Dis_2015_Mar_25_9(3)_e0003647.txt
469C>G,"...riants in the promoter region, −676T>C, −472T>C, −469C>G, −276C>T, and the non-synonymous substituti...",60,67,PLoS_Negl_Trop_Dis_2015_Mar_25_9(3)_e0003647.txt
276C>T,"... the promoter region, −676T>C, −472T>C, −469C>G, −276C>T, and the non-synonymous substitution p.R216...",60,76,PLoS_Negl_Trop_Dis_2015_Mar_25_9(3)_e0003647.txt
472T>C,"...Fig. 1). The other investigated COLEC11 variants −472T>C, −469C>G, −276C>T were not associated with ...",65,1291,PLoS_Negl_Trop_Dis_2015_Mar_25_9(3)_e0003647.txt
469C>G,"...The other investigated COLEC11 variants −472T>C, −469C>G, −276C>T were not associated with urinary s...",65,1300,PLoS_Negl_Trop_Dis_2015_Mar_25_9(3)_e0003647.txt
276C>T,"... investigated COLEC11 variants −472T>C, −469C>G, −276C>T were not associated with urinary schistosom...",65,1309,PLoS_Negl_Trop_Dis_2015_Mar_25_9(3)_e0003647.txt
472T>C,"...f the reconstructed COLEC11 haplotypes including −472T>C, −469C>G, −276C>T and +48912G>A are summari...",99,69,PLoS_Negl_Trop_Dis_2015_Mar_25_9(3)_e0003647.txt
469C>G,"...onstructed COLEC11 haplotypes including −472T>C, −469C>G, −276C>T and +48912G>A are summarized in Ta...",99,78,PLoS_Negl_Trop_Dis_2015_Mar_25_9(3)_e0003647.txt
276C>T,"...d COLEC11 haplotypes including −472T>C, −469C>G, −276C>T and +48912G>A are summarized in Table 2. Si...",99,87,PLoS_Negl_Trop_Dis_2015_Mar_25_9(3)_e0003647.txt
48912G>A,"...plotypes including −472T>C, −469C>G, −276C>T and +48912G>A are summarized in Table 2. Six haplotypes...",99,99,PLoS_Negl_Trop_Dis_2015_Mar_25_9(3)_e0003647.txt
871G>A,...ase (G6PD) mutations in Cambodia: G6PD Viangchan (871G>A) is the most common variant in the Cambodia...,267,151,PLoS_Negl_Trop_Dis_2015_Mar_6_9(3)_e0003602.txt
871G>A,"...haroen C , Nuchprayoon I  (2005 ) G6PD Viangchan (871G>A) is the most common G6PD-deficient variant ...",269,59,PLoS_Negl_Trop_Dis_2015_Mar_6_9(3)_e0003602.txt
1919A>T,"...cantly associated with higher CRP levels for SNPs 1919A>T and 4741G>C, but associated with lower CRP...",9,686,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
4741G>C,"...iated with higher CRP levels for SNPs 1919A>T and 4741G>C, but associated with lower CRP levels for ...",9,698,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
2667G>C,"...>C, but associated with lower CRP levels for SNPs 2667G>C and 3872C>T. SNP 2667G>C was individually ...",9,753,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
3872C>T,...ciated with lower CRP levels for SNPs 2667G>C and 3872C>T. SNP 2667G>C was individually associated w...,9,765,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
2667G>C,...ower CRP levels for SNPs 2667G>C and 3872C>T. SNP 2667G>C was individually associated with increased...,9,778,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
2667G>C,"... and of these, Zee et al.,[15] which included SNP 2667G>C, Casas et al.,[19] which included SNP 3014...",17,386,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
3014G>A,"...SNP 2667G>C, Casas et al.,[19] which included SNP 3014G>A, also examined associations with cardiovas...",17,432,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
1440C>T,"...tagSNPs polymorphic in EAs, included a triallelic 1440C>T>A (rs3091244) and a commonly studied rare ...",36,497,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
2667G>C,"...1440C>T>A (rs3091244) and a commonly studied rare 2667G>C. (2.) Additionally, we conducted a compreh...",36,547,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
4362G>C,"...ional SNPs with low minor allele frequency (MAF) [4362G>C and 5606G>T]. (3.) Finally, the Internatio...",36,808,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
5606G>T,"...ith low minor allele frequency (MAF) [4362G>C and 5606G>T]. (3.) Finally, the International HapMap P...",36,820,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
1919A>T,...ional HapMap Project[33] showed that two tagSNPs [1919A>T and 3872C>T] were sufficient to assess the...,36,906,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
3872C>T,... Project[33] showed that two tagSNPs [1919A>T and 3872C>T] were sufficient to assess the variation i...,36,918,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
3872C>T,"...however, previous LD analyses[9] showed that SNPs 3872C>T and 5237A>G together serve as a proxy so t...",36,1144,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
5237A>G,...vious LD analyses[9] showed that SNPs 3872C>T and 5237A>G together serve as a proxy so these two SNP...,36,1156,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
1919A>T,"... probes used were designed by Applied Biosystems: 1919A>T (rs1417938), 2667G>C (rs1800947), 3014G>A ...",38,325,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
2667G>C,"...igned by Applied Biosystems: 1919A>T (rs1417938), 2667G>C (rs1800947), 3014G>A (rs1130864), 3872C>T ...",38,346,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
3014G>A,"...ystems: 1919A>T (rs1417938), 2667G>C (rs1800947), 3014G>A (rs1130864), 3872C>T (rs1205), 4362A>T (rs...",38,367,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
3872C>T,"...17938), 2667G>C (rs1800947), 3014G>A (rs1130864), 3872C>T (rs1205), 4362A>T (rs3093080), 4741G>C (rs...",38,388,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
4362A>T,"...s1800947), 3014G>A (rs1130864), 3872C>T (rs1205), 4362A>T (rs3093080), 4741G>C (rs3093068), 5237A>G ...",38,406,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
4741G>C,"...s1130864), 3872C>T (rs1205), 4362A>T (rs3093080), 4741G>C (rs3093068), 5237A>G (rs2808630), and 5606...",38,427,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
5237A>G,"...s1205), 4362A>T (rs3093080), 4741G>C (rs3093068), 5237A>G (rs2808630), and 5606G>T (rs3093071). Repl...",38,448,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
5606G>T,"...0), 4741G>C (rs3093068), 5237A>G (rs2808630), and 5606G>T (rs3093071). Replicate quality control sam...",38,473,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
4362A>T,"...HPFS. Among NHS, the minor allele frequencies for 4362A>T (0.6% cases, 1.1% controls) and 5606G>T (1...",38,885,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
5606G>T,"...ncies for 4362A>T (0.6% cases, 1.1% controls) and 5606G>T (1% cases, 0.5% controls) were very low; t...",38,925,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
5237A>G,"...erved allele frequencies for all SNPs, except for 5237A>G among women (p = 0.03) and 4741G>C among m...",49,515,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
4741G>C,"...Ps, except for 5237A>G among women (p = 0.03) and 4741G>C among men (p = 0.001), were within Hardy-W...",49,550,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
1919A>T,...ol women and men (Table 3). The minor alleles for 1919A>T and 3014G>A were in high pairwise LD (r2>0...,49,799,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
3014G>A,"... men (Table 3). The minor alleles for 1919A>T and 3014G>A were in high pairwise LD (r2>0.95), wherea...",49,811,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
2667G>C,"...14G>A were in high pairwise LD (r2>0.95), whereas 2667G>C, 3872C>T, 4741G>C, and 5237A>G were not in...",49,863,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
3872C>T,"...e in high pairwise LD (r2>0.95), whereas 2667G>C, 3872C>T, 4741G>C, and 5237A>G were not in high LD ...",49,872,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
4741G>C,"... pairwise LD (r2>0.95), whereas 2667G>C, 3872C>T, 4741G>C, and 5237A>G were not in high LD (r2<0.30)...",49,881,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
5237A>G,"...(r2>0.95), whereas 2667G>C, 3872C>T, 4741G>C, and 5237A>G were not in high LD (r2<0.30)",49,894,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
1919A>T,1919A>T	rs1417938,76,1,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
2667G>C,2667G>C	rs1800947,82,1,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
3014G>A,3014G>A	rs1130864,88,1,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
3872C>T,3872C>T	rs1205,94,1,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
4741G>C,4741G>C	rs3093068,100,1,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
5237A>G,5237A>G	rs2808630,106,1,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
2667G>C,"Under the additive model, 2667G>C was associated with an increased risk of C...",130,27,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
2667G>C,"...men and men (Table 4). Under the same model, SNPs 2667G>C and 3872C>T were associated with 22–37% lo...",130,525,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
3872C>T,"...(Table 4). Under the same model, SNPs 2667G>C and 3872C>T were associated with 22–37% lower CRP leve...",130,537,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
4741G>C,"... associated with 22–37% lower CRP levels, whereas 4741G>C was associated with ∼40% higher CRP levels...",130,599,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
1919A>T,... was associated with ∼40% higher CRP levels. SNPs 1919A>T and 3014G>A were associated with approxima...,130,656,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
3014G>A,...ted with ∼40% higher CRP levels. SNPs 1919A>T and 3014G>A were associated with approximately 20% hig...,130,668,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
5237A>G,"...with approximately 20% higher CRP levels, whereas 5237A>G was not associated with CRP levels in eith...",130,742,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
1919A>T,1919A>T	236/466	0.90 (0.70–1.14)	0.37	1.22	0.009	2...,135,1,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
2667G>C,2667G>C	241/482	1.57 (1.01–2.44)	0.047	0.63	0.01	2...,136,1,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
3014G>A,3014G>A	237/467	0.88 (0.69–1.12)	0.28	1.15	0.08	24...,137,1,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
3872C>T,3872C>T	241/475	1.08 (0.85–1.37)	0.54	0.76	0.001	2...,138,1,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
4741G>C,4741G>C	238/470	1.22 (0.76–1.94)	0.42	1.38	0.006	2...,139,1,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
5237A>G,5237A>G	241/476	0.93 (0.72–1.19)	0.56	0.98	0.86	24...,140,1,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
1919A>T,...frequency ≥5% (Table 5). H1 with minor alleles of 1919A>T and 3014G>A and major alleles of all other...,148,99,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
3014G>A,"...% (Table 5). H1 with minor alleles of 1919A>T and 3014G>A and major alleles of all others, was the m...",148,111,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
5237A>G,"... in subsequent analyses. H2, with minor allele of 5237A>G, and H3, with minor allele of 3872C>T, had...",148,268,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
3872C>T,"...r allele of 5237A>G, and H3, with minor allele of 3872C>T, had estimated frequencies ranging from 25...",148,306,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
2667G>C,...and H4 may be attributable to the minor allele of 2667G>C,148,663,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
1919A>T,"1919A>T	[14], [20]		[23], [36]",193,1,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
2667G>C,"2667G>C	[21]	[14]–[16], [20], [23]	[13], [18]			[1...",194,1,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
3014G>A,"3014G>A	[13], [16], [19], [20], [22]		[18]			[19],...",195,1,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
3872C>T,"3872C>T		[16], [20], [22], [23]				[22]",196,1,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
4741G>C,"4741G>C	[22], [23], [37]					[22]",197,1,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
5237A>G,"5237A>G*			[18], [20], [21], [23]		[23]",198,1,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
717A>G,...as in high LD with another commonly reported SNP -717A>G (rs2794521),199,63,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
2667G>C,"...ting. Though the Rotterdam Study did not genotype 2667G>C, they reported four haplotypes significant...",203,334,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
3872C>T,"... with CRP levels in the Physicians' Health Study, 3872C>T individually was associated with lower CRP...",203,797,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
2667G>C,"...I 0.99–1.67).[23] Furthermore, the odds ratio for 2667G>C was suggestive of a 50% increase as well, ...",203,963,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
2667G>C,"...wider. Taken together, these results suggest that 2667G>C and 3872C>T, though associated with lower ...",203,1100,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
3872C>T,"... together, these results suggest that 2667G>C and 3872C>T, though associated with lower CRP levels, ...",203,1112,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
3872C>T,"...ctivity, and CRP levels.[17] The major alleles of 3872C>T and 5237A>G together serve as a proxy for ...",205,425,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
5237A>G,... CRP levels.[17] The major alleles of 3872C>T and 5237A>G together serve as a proxy for the triallel...,205,437,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
4216T > C,...istance and type 2 diabetes: an analysis of the m.4216T > C and m.4917A > G variants. Ann Hum Genet ...,170,203,PLoS_ONE_2008_Mar_12_3(3)_e1764.txt
4917A > G,... 2 diabetes: an analysis of the m.4216T > C and m.4917A > G variants. Ann Hum Genet 70 488 495 16759...,170,219,PLoS_ONE_2008_Mar_12_3(3)_e1764.txt
3787730 A>G,...am and downstream. Only one SNP in KCNE1 (LQT5; rs3787730 A>G; frequency allele A: 31.7%; β≈−1.6 ms/...,71,470,PLoS_One_2009_Jul_9_4(7)_e6138.txt
6 T>C,"...rent mutation sites (CD8 −AA, CD8/9 +G, and IVS I+6 T>C). The graphs are based on the quantified sig...",71,766,PLoS_ONE_2009_Mar_11_4(3)_e4808.txt
24 T>A,...eak signals for CD8-AA (Fig. 2B); separation of CD24 T>A heterozygotes and wild-type ratios was limi...,79,657,PLoS_ONE_2009_Mar_11_4(3)_e4808.txt
17 A>T,...terozygote samples; the heterozygote ratios for CD17 A>T samples were too low compared to the optima...,79,851,PLoS_ONE_2009_Mar_11_4(3)_e4808.txt
24T>A,...ing from 166 to 661 mM (Fig. 4). The probes for CD24T>A still gave poor separation of homozygote wil...,87,487,PLoS_ONE_2009_Mar_11_4(3)_e4808.txt
17A>T,"...erozygotes (Fig. 4), whereas the probe pair for CD17A>T resulted in low heterozygote ratios at all s...",87,602,PLoS_ONE_2009_Mar_11_4(3)_e4808.txt
17A>T,"...teria mentioned above, neither of the mutations CD17A>T or CD24T>A was genotyped to the fullest by t...",87,754,PLoS_ONE_2009_Mar_11_4(3)_e4808.txt
24T>A,"...oned above, neither of the mutations CD17A>T or CD24T>A was genotyped to the fullest by the Tm match...",87,765,PLoS_ONE_2009_Mar_11_4(3)_e4808.txt
17A>T,"...genotyping assays, the probes for the mutations CD17A>T and CD24T>A were redesigned (MSAW method iii...",89,74,PLoS_ONE_2009_Mar_11_4(3)_e4808.txt
24T>A,"...ssays, the probes for the mutations CD17A>T and CD24T>A were redesigned (MSAW method iii above). Com...",89,86,PLoS_ONE_2009_Mar_11_4(3)_e4808.txt
24T>A,"... initial set, the shorter probes for genotyping CD24T>A had a calculated Tm that was about 3°C lower...",89,226,PLoS_ONE_2009_Mar_11_4(3)_e4808.txt
17A>T,"...t was about 3°C lower, and the mutant probe for CD17A>T was truncated so that its signal would be lo...",89,305,PLoS_ONE_2009_Mar_11_4(3)_e4808.txt
24T>A,...he wild-type probe. Shorter probes for mutation CD24T>A resulted in heterozygote ratios of about 0.5...,89,444,PLoS_ONE_2009_Mar_11_4(3)_e4808.txt
17A>T,...C). Reducing the length of the mutant probe for CD17A>T resulted in a probe pair that fulfilled the ...,89,670,PLoS_ONE_2009_Mar_11_4(3)_e4808.txt
5C>Gal,"... Clones of follicle cells expressing YFP-Sans (Act5C>Gal4, UAS-YFP-Sans) labeled by YFP-Sans (green)...",63,290,PLoS_ONE_2009_Mar_9_4(3)_e4753.txt
5C>C,"...ns245 (this study), UAS-YFP-Sans (this study), Act5C>CD2>Gal4 [49], and ck13 [29]. Marked clones of ...",95,1268,PLoS_ONE_2009_Mar_9_4(3)_e4753.txt
2T>C,"...tations in the SBDS gene are 183–184TA>CT and 258+2T>C [4], [7], [9], [10], which are located in SBD...",17,490,PLoS_One_2009_Sep_17_4(9)_e7084.txt
2T>C,"...ery low, but correct residual splicing of the 258+2T>C SBDS transcript[11]–[13]. To date, there are ...",17,868,PLoS_One_2009_Sep_17_4(9)_e7084.txt
2T>C,...pression due correct residual splicing of the 258+2T>C SBDS transcript causing the C84fsX3 mutation ...,99,334,PLoS_One_2009_Sep_17_4(9)_e7084.txt
71G>A,...SNHL are presented in Fig 1. A heterozygous W24X (71G>A) mutation was identified in the GJB2 gene of...,28,774,PLoS_One_2010_Jul_26_5(7)_e11804.txt
1555A>G,... Fig 1A). Fig 1B depicts the homoplasmic mutation 1555A>G detected in the mitochondrial MTRNR1 gene ...,28,902,PLoS_One_2010_Jul_26_5(7)_e11804.txt
71G>A,....0011804.g001Figure 1 APEX detection of the W24X (71G>A) mutation in GJB2 and the 1555A>G mutation i...,30,71,PLoS_One_2010_Jul_26_5(7)_e11804.txt
1555A>G,...tion of the W24X (71G>A) mutation in GJB2 and the 1555A>G mutation in MTRNR1,30,103,PLoS_One_2010_Jul_26_5(7)_e11804.txt
1555A>G,... allele are detected. Row 3. Negative control. B) 1555A>G in MTRNR1. Row 1. Wild-type genotype for n...,31,421,PLoS_One_2010_Jul_26_5(7)_e11804.txt
1555A>G,... allele is detected in AS. Row 2. Homoplasmic for 1555A>G. S: the mutant G allele is present. AS: th...,31,631,PLoS_One_2010_Jul_26_5(7)_e11804.txt
2A>G,...n SLC26A4; two others carried splice variant IVS2-2A>G (of unknown clinical significance) in the pre...,33,866,PLoS_One_2010_Jul_26_5(7)_e11804.txt
2A>G,(GJB2; V27I*)/SLC26A4; 919-2A>G/919-2A>G	1	SLC26A4; IVS1-2A>G**/L236P	1	GJB2;...,38,28,PLoS_One_2010_Jul_26_5(7)_e11804.txt
2A>G,(GJB2; V27I*)/SLC26A4; 919-2A>G/919-2A>G	1	SLC26A4; IVS1-2A>G**/L236P	1	GJB2; 35delG	2...,38,37,PLoS_One_2010_Jul_26_5(7)_e11804.txt
2A>G,...V27I*)/SLC26A4; 919-2A>G/919-2A>G	1	SLC26A4; IVS1-2A>G**/L236P	1	GJB2; 35delG	2	GJB2; V27I*/V37I	1,38,58,PLoS_One_2010_Jul_26_5(7)_e11804.txt
1555A>G,GJB2; V27I*	13	(GJB2; V37I)/MTRNR1; 1555A>G†	1,40,41,PLoS_One_2010_Jul_26_5(7)_e11804.txt
2A>G,GJB2; V37I	3	SLC26A4; F335L/SLC26A5; IVS2-2A>G**	1,42,47,PLoS_One_2010_Jul_26_5(7)_e11804.txt
2A>G,GJB2; R127H*	2	SLC26A4; V609G/SLC26A5; IVS2-2A>G**	1,43,49,PLoS_One_2010_Jul_26_5(7)_e11804.txt
2A>G,SLC26A5; IVS2-2A>G**	2,51,19,PLoS_One_2010_Jul_26_5(7)_e11804.txt
2A>G,...TRNR1 genes of three others. Two carried the IVS2-2A>G splice variant in the SLC26A5 gene. A third i...,62,205,PLoS_One_2010_Jul_26_5(7)_e11804.txt
1555A>G,... gene. A third individual was homoplasmic for the 1555A>G mutation of the MTRNR1 gene that encodes t...,62,289,PLoS_One_2010_Jul_26_5(7)_e11804.txt
1555A>G,...lear SLC26A4 gene and one was homoplasmic for the 1555A>G substitution in the mitochondrial MTRNR1 g...,62,682,PLoS_One_2010_Jul_26_5(7)_e11804.txt
2A>G,... The array identified one SLC26A4 homozygous (919-2A>G/919-2A>G) and two compound heterozygous genot...,69,1287,PLoS_One_2010_Jul_26_5(7)_e11804.txt
2A>G,...y identified one SLC26A4 homozygous (919-2A>G/919-2A>G) and two compound heterozygous genotypes (N32...,69,1296,PLoS_One_2010_Jul_26_5(7)_e11804.txt
2A>G,"...ound heterozygous genotypes (N324Y/V609G and IVS1-2A>G/L236P). Of note, whereas L236P is a frequentl...",69,1364,PLoS_One_2010_Jul_26_5(7)_e11804.txt
2A>G,"...16% of Pendred disease-causing alleles [21], IVS1-2A>G is a rare splice variant, the clinical signif...",69,1509,PLoS_One_2010_Jul_26_5(7)_e11804.txt
2A>G,.... Four individuals were heterozygous for the IVS2-2A>G variant in SLC26A5. Similar to IVS1-2A>G in S...,69,2565,PLoS_One_2010_Jul_26_5(7)_e11804.txt
2A>G,"...the IVS2-2A>G variant in SLC26A5. Similar to IVS1-2A>G in SLC26A4, its clinical significance is unkn...",69,2606,PLoS_One_2010_Jul_26_5(7)_e11804.txt
1555A>G,"...ly, a single, homoplasmic mitochondrial mutation (1555A>G in the MTRNR1 gene) was identified. Both m...",69,3015,PLoS_One_2010_Jul_26_5(7)_e11804.txt
1555A>G,...n hot-spot regions associated with NSHL [26]. The 1555A>G mutation predisposes affected individuals ...,69,3164,PLoS_One_2010_Jul_26_5(7)_e11804.txt
2A>G,"...ira FA Alford RL  2005 High frequency of the IVS2-2A>G DNA sequence variation in SLC26A5, encoding t...",112,83,PLoS_One_2010_Jul_26_5(7)_e11804.txt
2A>G,...ük K Zordania R Joost K  2009 Splice variant IVS2-2A>G in the SLC26A5 (Prestin) gene in five Estonia...,113,76,PLoS_One_2010_Jul_26_5(7)_e11804.txt
341G>A,...(exon 3) of the RET protein (RETR114H mutation; c.341G>A according to NP_066124.1 and NM_020975.4 re...,21,296,PLoS_One_2010_Jun_2_5(6)_e10918.txt
341G>A,...represents the allele change from the wild type c.341G>A for RETR114H; T represents the high risk SN...,57,474,PLoS_One_2010_Jun_2_5(6)_e10918.txt
47A>G,"...males. However, two novel intronic variants, c.52-47A>G and c.105-179G>T, were identified in FMR1 (T...",66,153,PLoS_One_2010_Mar_5_5(3)_e9476.txt
179G>T,"...two novel intronic variants, c.52-47A>G and c.105-179G>T, were identified in FMR1 (Table 3). As an a...",66,169,PLoS_One_2010_Mar_5_5(3)_e9476.txt
47A>G,Intron 1	c.52-47A>G	0.01	1.27	1/51,70,15,PLoS_One_2010_Mar_5_5(3)_e9476.txt
179G>T,Intron 2	c.105-179G>T	0.01	1.06	1/51,71,16,PLoS_One_2010_Mar_5_5(3)_e9476.txt
623 G>A,GG	Irish-French Canadian	623 G>A	A97T	1	1	this report,35,26,PLoS_One_2010_May_21_5(5)_e10760.txt
639 A>G,F123	Italian	639 A>G	N102S	1	1	7,36,14,PLoS_One_2010_May_21_5(5)_e10760.txt
639 A>G,BB1	British	639 A>G	N102S	1	1	8,37,13,PLoS_One_2010_May_21_5(5)_e10760.txt
639 A>G,BB2	British	639 A>G	N102S	1	1	8,38,13,PLoS_One_2010_May_21_5(5)_e10760.txt
639 A>G,Q	American	639 A>G	N102S	1	1	8,39,12,PLoS_One_2010_May_21_5(5)_e10760.txt
639 A>G,U	American	639 A>G	N102S	1	1	8,40,12,PLoS_One_2010_May_21_5(5)_e10760.txt
639 A>G,Y	German	639 A>G	N102S	1	1	8,41,10,PLoS_One_2010_May_21_5(5)_e10760.txt
639 A>G,1	Irish	639 A>G	N102S	1	1	10,42,9,PLoS_One_2010_May_21_5(5)_e10760.txt
639 A>G,BB	Czechoslavakian	639 A>G	N102S	1	1	9,43,20,PLoS_One_2010_May_21_5(5)_e10760.txt
639 A>G,DD	Chinese-Taiwan	639 A>G	N102S	1	1	9,44,19,PLoS_One_2010_May_21_5(5)_e10760.txt
639 A>G,K	German	639 A>G	N102S	1	1	9,45,10,PLoS_One_2010_May_21_5(5)_e10760.txt
639 A>G,L	American	639 A>G	N102S	1	1	9,46,12,PLoS_One_2010_May_21_5(5)_e10760.txt
639 A>G,R	American	639 A>G	N102S	1	1	9,47,12,PLoS_One_2010_May_21_5(5)_e10760.txt
639 A>G,CC	Japan	639 A>G	N102S	1	1	this report,48,10,PLoS_One_2010_May_21_5(5)_e10760.txt
639 A>G,II	American	639 A>G	N102S	1	1	this report,49,13,PLoS_One_2010_May_21_5(5)_e10760.txt
639 A>G,KK	American	639 A>G	N102S	1	1	this report,50,13,PLoS_One_2010_May_21_5(5)_e10760.txt
639 A>G,MM	American	639 A>G	N102S	1	1	this report,51,13,PLoS_One_2010_May_21_5(5)_e10760.txt
639 A>G,N	German	639 A>G	N102S	1	1	this reporth,52,10,PLoS_One_2010_May_21_5(5)_e10760.txt
668 G>A,LL	French-British-CAf	668 G>A	D112N	1	1	this report,53,23,PLoS_One_2010_May_21_5(5)_e10760.txt
669 A>G,F122	Indian	669 A>G	D112G	1	1	7,54,13,PLoS_One_2010_May_21_5(5)_e10760.txt
687 A>G,H	American	687 A>G	D118G	1	1	9,55,12,PLoS_One_2010_May_21_5(5)_e10760.txt
689 A>G,F105	Spanish?-Canadian	689 A>G	R119G	1	1	7,56,24,PLoS_One_2010_May_21_5(5)_e10760.txt
689 A>G,3	African-American	689 A>G	R119G	1	1	10,57,20,PLoS_One_2010_May_21_5(5)_e10760.txt
695 C>G,2	Egyptian	695 C>G	L121V	1	1	10,58,12,PLoS_One_2010_May_21_5(5)_e10760.txt
695 C>T,BB3	British	695 C>T	L121F	1	1	9,59,13,PLoS_One_2010_May_21_5(5)_e10760.txt
695 C>T,O	American	695 C>T	L121F	1	1	9,60,12,PLoS_One_2010_May_21_5(5)_e10760.txt
999 T>A,AA	Native American	999 T>A	V122E	1	1	this report,61,20,PLoS_One_2010_May_21_5(5)_e10760.txt
999 T>G,F1	Finnish	999 T>G	V122G	1	1	this report,62,12,PLoS_One_2010_May_21_5(5)_e10760.txt
845 T>C,K1	German	845 T>C	S171P	1	2	9,63,11,PLoS_One_2010_May_21_5(5)_e10760.txt
855 A>G,Case 1	Japanese	855 A>Gg	Y174C	1	2	11,64,17,PLoS_One_2010_May_21_5(5)_e10760.txt
858 C>T,F115	Scottish	858 C>T	T175I	1	2	7,65,15,PLoS_One_2010_May_21_5(5)_e10760.txt
858 C>T,J	Hungarian-American	858 C>T	T175I	1	2	9,66,22,PLoS_One_2010_May_21_5(5)_e10760.txt
863 G>C,T	American	863 G>C	G177R	1	2	8,67,12,PLoS_One_2010_May_21_5(5)_e10760.txt
863 G>A,X	Chinese-Taiwan	863 G>A	G177R	1	2	9,68,18,PLoS_One_2010_May_21_5(5)_e10760.txt
863 G>A,Z	Kosovar	863 G>A	G177R	1	2	9,69,11,PLoS_One_2010_May_21_5(5)_e10760.txt
876 A>G,Case 4	Japanese	876 A>Gg	K181R	2	2	11,70,17,PLoS_One_2010_May_21_5(5)_e10760.txt
890 G>A,G	German-American	890 G>A	G186R	2	2	9,71,19,PLoS_One_2010_May_21_5(5)_e10760.txt
897 T>A,EE	Chinese-Taiwan	897 T>A	L188H	2	2	this report,72,19,PLoS_One_2010_May_21_5(5)_e10760.txt
1029 A>G,F118	Canadian	1029 A>G	N232S	2	3	7,73,15,PLoS_One_2010_May_21_5(5)_e10760.txt
1031 A>C,Case 6	Japanese	1031 A>Cg	N233H	2	3	11,74,17,PLoS_One_2010_May_21_5(5)_e10760.txt
1042 C>G,FF	African-American	1042 C>G	D236E	2	3	9,75,21,PLoS_One_2010_May_21_5(5)_e10760.txt
88F>C,...oss of function (hypomorphic mutant background or 88F>CF2-RNAi). We also observe repression of the A...,94,723,PLoS_One_2010_May_25_5(5)_e10713.txt
8C>T,"MVK (N = 19)	p.S52N(1)(2),c.371+8C>T(1)(2), p.S135L(1), p.S135S(1), p.D170D(1)(2),...",110,35,PLoS_One_2010_Nov_23_5(11)_e14096.txt
18A>G,"...)(2), p.S135L(1), p.S135S(1), p.D170D(1)(2),c.632−18A>G (1)(2), c.769-7_769-6dupT(1)*,c.885+24G>A(1)...",110,91,PLoS_One_2010_Nov_23_5(11)_e14096.txt
24G>A,"...),c.632−18A>G (1)(2), c.769-7_769-6dupT(1)*,c.885+24G>A(1)(2), p.G309S(1), p.S329N(1), p.V377I(1)(2)...",110,133,PLoS_One_2010_Nov_23_5(11)_e14096.txt
45T>C,"NLRP3 (N = 23)	c.278−45T>C(1), p.Y141Y(1)*, p.R168Q(3), p.V198M(1), p.T...",111,24,PLoS_One_2010_Nov_23_5(11)_e14096.txt
25C>T,"...(1), p.T587I(1), p.Q703K(1)(2), p.Y859C(1),c.3005+25C>T(1), p.T348M(1), p.L411L(3), p.S434S(1)(2), p...",111,198,PLoS_One_2010_Nov_23_5(11)_e14096.txt
1043C>T,...al retardation); 2) One patient with a p.T348M (c.1043C>T) mutation in NLRP3 in whom we performed al...,146,346,PLoS_One_2010_Nov_23_5(11)_e14096.txt
8938C>T,ALMS1 mutation*	c.[8938C>T]	c.[3425C>G]	c.[3425C>G]	c. [2164A>T],25,20,PLoS_One_2011_Apr_26_6(4)_e19081.txt
3425C>G,ALMS1 mutation*	c.[8938C>T]	c.[3425C>G]	c.[3425C>G]	c. [2164A>T],25,32,PLoS_One_2011_Apr_26_6(4)_e19081.txt
3425C>G,ALMS1 mutation*	c.[8938C>T]	c.[3425C>G]	c.[3425C>G]	c. [2164A>T],25,44,PLoS_One_2011_Apr_26_6(4)_e19081.txt
2164A>T,...mutation*	c.[8938C>T]	c.[3425C>G]	c.[3425C>G]	c. [2164A>T],25,57,PLoS_One_2011_Apr_26_6(4)_e19081.txt
8938C>T,+[8938C>T]	+[3425C>G]	+[3425C>G]	+[11313_11316delTAG...,26,4,PLoS_One_2011_Apr_26_6(4)_e19081.txt
3425C>G,+[8938C>T]	+[3425C>G]	+[3425C>G]	+[11313_11316delTAGA],26,15,PLoS_One_2011_Apr_26_6(4)_e19081.txt
3425C>G,+[8938C>T]	+[3425C>G]	+[3425C>G]	+[11313_11316delTAGA],26,26,PLoS_One_2011_Apr_26_6(4)_e19081.txt
820C>T,...d grandfather (P1) [6]. The same STAT1 variant (c.820C>T; p.Arg274Trp) was detected in all three ind...,20,213,PLoS_One_2011_Dec_14_6(12)_e29248.txt
866G>A,...elated Metabolic Traits: Focus on the Functional -866G>A Promoter Variant (rs659366). J Obes doi:10....,236,160,PLoS_One_2011_Dec_27_6(12)_e29650.txt
2832A>G,"...ore relaxed threshold of P = 0.05. The SNP CAST:c.2832A>G, which is not part of the Bovine SNP50 arr...",30,845,PLoS_One_2011_Dec_28_6(12)_e29601.txt
590C>T,"...between the polymorphisms of IL-4 gene promoter (−590C>T), IL-13 coding region (R130Q) and IL-16 gen...",229,197,PLoS_One_2011_Feb_28_6(2)_e16522.txt
295T>C,...3 coding region (R130Q) and IL-16 gene promoter (−295T>C) and allergic asthma.              Iran J A...,229,260,PLoS_One_2011_Feb_28_6(2)_e16522.txt
84G>A,... Dong X    2010 Lack of association between nNOS −84G>A polymorphism and risk of infantile hypertrop...,158,96,PLoS_One_2011_Jul_15_6(7)_e22035.txt
2T>C,"...ions are the consequence of 183–184 TA>CT and 258+2T>C genomic changes [5], [8]–[10]. These mutation...",10,335,PLoS_One_2011_Jun_13_6(6)_e20727.txt
3293A>G,...homozygous A-to-G nucleotide change in exon 22 (c.3293A>G) (Figure 1A). The mutation caused a glutam...,21,155,PLoS_One_2011_Jun_9_6(6)_e20854.txt
3293A>G,A. Mutation c.3293A>G (p.G1069R) in homozygous state in our prob...,24,15,PLoS_One_2011_Jun_9_6(6)_e20854.txt
77G>A,"...6G) and a variant in the 5′ untranslated region (−77G>A) have been found in the Soat1 gene, and indi...",82,1194,PLoS_One_2011_Oct_14_6(10)_e25344.txt
77G>A,"...en found in the Soat1 gene, and individuals with −77G>A variant have significantly higher plasma HDL...",82,1258,PLoS_One_2011_Oct_14_6(10)_e25344.txt
7331T>A,2	Atypical	c.7331T>A	p.L2444X	Nonsense			Novel,61,14,PLoS_One_2011_Sep_13_6(9)_e24511.txt
6193C>A,3	Atypical	c.6193C>A	p.R2065S	Missense			Novel,62,14,PLoS_One_2011_Sep_13_6(9)_e24511.txt
5G>C,5	Atypical	c.5210+5G>C		Splice site	Exon 23 skipping	Deterioration o...,64,19,PLoS_One_2011_Sep_13_6(9)_e24511.txt
7G>A,7	Typical	c.5405-7G>A		Splice site	Insertion of 5bp at cryptic acce...,66,18,PLoS_One_2011_Sep_13_6(9)_e24511.txt
1465C>T,9	Atypical	c.1465C>T	p.Q489X	Nonsense			(20),68,14,PLoS_One_2011_Sep_13_6(9)_e24511.txt
5G>C,...ults are shown in Table S3. One variation (c.5210+5G>C) was predicted as a loss of strength of nativ...,70,363,PLoS_One_2011_Sep_13_6(9)_e24511.txt
7G>A,... prediction programs. The other variation (c.5405-7G>A) resulted in appearance of a new cryptic spli...,70,495,PLoS_One_2011_Sep_13_6(9)_e24511.txt
5G>C,...rted the prediction results. The variation c.5210+5G>C caused exon skipping as a result of splice do...,72,179,PLoS_One_2011_Sep_13_6(9)_e24511.txt
7G>A,...ult of splice donor site deterioration and c.5405-7G>A introduced a 5-bp intronic sequence by activa...,72,263,PLoS_One_2011_Sep_13_6(9)_e24511.txt
5G>C,"...alysis of the novel splice site variation, c.5210+5G>C. For the c.5210+5G>C variation, exons 22 and ...",170,78,PLoS_One_2011_Sep_13_6(9)_e24511.txt
5G>C,"...plice site variation, c.5210+5G>C. For the c.5210+5G>C variation, exons 22 and 23 of CHD7 were intro...",170,99,PLoS_One_2011_Sep_13_6(9)_e24511.txt
7G>A,"...rapping analysis of splice site variation, c.5405-7G>A. For the c.5405-7G>A variation, exon 26 of CH...",176,68,PLoS_One_2011_Sep_13_6(9)_e24511.txt
7G>A,"...plice site variation, c.5405-7G>A. For the c.5405-7G>A variation, exon 26 of CHD7 was introduced int...",176,89,PLoS_One_2011_Sep_13_6(9)_e24511.txt
53T>T,...of the sleep episodes (Fig. 1D) was extended (αS>A53T>TP-αS). While the expression of wild type αS a...,25,1252,PLoS_One_2011_Sep_8_6(9)_e24701.txt
3243 A>G,...etes due to defects in mitochondrial DNA (mtDNA). 3243 A>G is the mutation most frequently associate...,5,425,PLoS_One_2012_Apr_19_7(4)_e34956.txt
3243A>G,"...ntified 33 diabetes-suspected mutations, 1/33 was 3243A>G. Most patients (91%) and their mothers had...",5,1139,PLoS_One_2012_Apr_19_7(4)_e34956.txt
3243A>G,...n. The whole mtDNA should be screened because the 3243A>G variant is not as frequent in children as ...,5,1900,PLoS_One_2012_Apr_19_7(4)_e34956.txt
3243A>G,"...D [1], [3]. Besides the frequently reported mtDNA 3243A>G mutation, whose functional significance ha...",8,678,PLoS_One_2012_Apr_19_7(4)_e34956.txt
9803A>G,CO3	9803A>G	syn				Novel Variant,50,6,PLoS_One_2012_Apr_19_7(4)_e34956.txt
9947G>A,CO3	9947G>Ae	syn				31,51,6,PLoS_One_2012_Apr_19_7(4)_e34956.txt
10373G>A,"41, 42, 43	ND3	10373G>A	syn				-",52,16,PLoS_One_2012_Apr_19_7(4)_e34956.txt
11447G>A,ND4	11447G>A	V230M	C	T/0.11	Benign	-,53,6,PLoS_One_2012_Apr_19_7(4)_e34956.txt
3243A>G,5	TL1	3243A>Ge					32,54,7,PLoS_One_2012_Apr_19_7(4)_e34956.txt
293T>C,6	HVII	293T>C					-,55,8,PLoS_One_2012_Apr_19_7(4)_e34956.txt
12346C>T,ND5	12346C>T	H4Y	N	T/0.17	Benign	-,56,6,PLoS_One_2012_Apr_19_7(4)_e34956.txt
15530 T>C,CYB	15530 T>C	syn				-,57,6,PLoS_One_2012_Apr_19_7(4)_e34956.txt
385A>G,7	HVII	385A>G					-,58,8,PLoS_One_2012_Apr_19_7(4)_e34956.txt
1664G>A,TV	1664G>A					-,59,5,PLoS_One_2012_Apr_19_7(4)_e34956.txt
5093T>C,ND2	5093T>C	syn				-,60,6,PLoS_One_2012_Apr_19_7(4)_e34956.txt
5300C>T,ND2	5300C>T	syn				Novel Variant,61,6,PLoS_One_2012_Apr_19_7(4)_e34956.txt
8562C>G,ATP8	8562C>G	P66R	N	T/0.44	Possibly Damaging	Novel Vari...,62,7,PLoS_One_2012_Apr_19_7(4)_e34956.txt
11928A>G,ND4	11928A>G	N390S	H	A/0.00	Benign	-,63,6,PLoS_One_2012_Apr_19_7(4)_e34956.txt
4086C>T,ND1	4086C>T	syn				33,64,6,PLoS_One_2012_Apr_19_7(4)_e34956.txt
13135G>A,9	ND5	13135G>A	A267T	N	T/0.50	Benign	34,65,7,PLoS_One_2012_Apr_19_7(4)_e34956.txt
4024A>G,ND1	4024A>G	T240A	N	T/0.12	Benign	-,67,6,PLoS_One_2012_Apr_19_7(4)_e34956.txt
14365C>T,ND6	14365C>T	V103M	C	A/0.01	Benign	-,68,6,PLoS_One_2012_Apr_19_7(4)_e34956.txt
14582A>G,ND6	14582A>G	V31A	N	T/1	Benign	-,69,6,PLoS_One_2012_Apr_19_7(4)_e34956.txt
16048G>A,HVI	16048G>A					-,70,6,PLoS_One_2012_Apr_19_7(4)_e34956.txt
9935T>C,14	CO3	9935T>C	syn				-,71,8,PLoS_One_2012_Apr_19_7(4)_e34956.txt
9548G>A,CO3	9548G>A	syn				36,72,6,PLoS_One_2012_Apr_19_7(4)_e34956.txt
10685G>A,ND4L	10685G>A	syn				-,73,7,PLoS_One_2012_Apr_19_7(4)_e34956.txt
16137A>G,HVI	16137A>G					-,74,6,PLoS_One_2012_Apr_19_7(4)_e34956.txt
16526G>A,HVI	16526G>A					-,75,6,PLoS_One_2012_Apr_19_7(4)_e34956.txt
951G>A,15	RNR1	951G>A					-,76,9,PLoS_One_2012_Apr_19_7(4)_e34956.txt
7762G>A,CO2	7762G>A	syn				-,77,6,PLoS_One_2012_Apr_19_7(4)_e34956.txt
11253 T>C,ND4	11253 T>Ce	I165T	C	A/0.01	Possibly Damaging	37,78,6,PLoS_One_2012_Apr_19_7(4)_e34956.txt
14002A>G,ND5	14002A>G	T556A	N	T/0.42	Benign	-,79,6,PLoS_One_2012_Apr_19_7(4)_e34956.txt
14502T>C,ND6	14502T>C	I58V	C	T/0.36	Benign	-,80,6,PLoS_One_2012_Apr_19_7(4)_e34956.txt
16354C>T,HVI	16354C>T					-,81,6,PLoS_One_2012_Apr_19_7(4)_e34956.txt
3243A>G,"The 3243A>G variant in tRNA leucine, which is the muta...",92,5,PLoS_One_2012_Apr_19_7(4)_e34956.txt
4024A>G,"...est frequencies occurred in complex I (46%) (ND1: 4024A>G, 4086C>T; ND2:5093T>C, 5300C>T; ND3: 10373...",92,676,PLoS_One_2012_Apr_19_7(4)_e34956.txt
4086C>T,"...encies occurred in complex I (46%) (ND1: 4024A>G, 4086C>T; ND2:5093T>C, 5300C>T; ND3: 10373G>A; ND4:...",92,685,PLoS_One_2012_Apr_19_7(4)_e34956.txt
5093T>C,"...ed in complex I (46%) (ND1: 4024A>G, 4086C>T; ND2:5093T>C, 5300C>T; ND3: 10373G>A; ND4: 11253T>C, 11...",92,698,PLoS_One_2012_Apr_19_7(4)_e34956.txt
5300C>T,"...plex I (46%) (ND1: 4024A>G, 4086C>T; ND2:5093T>C, 5300C>T; ND3: 10373G>A; ND4: 11253T>C, 11447G>A, 1...",92,707,PLoS_One_2012_Apr_19_7(4)_e34956.txt
10373G>A,"...ND1: 4024A>G, 4086C>T; ND2:5093T>C, 5300C>T; ND3: 10373G>A; ND4: 11253T>C, 11447G>A, 11928A>G; ND4L:...",92,721,PLoS_One_2012_Apr_19_7(4)_e34956.txt
11253T>C,"...086C>T; ND2:5093T>C, 5300C>T; ND3: 10373G>A; ND4: 11253T>C, 11447G>A, 11928A>G; ND4L:10685G>A; ND5:1...",92,736,PLoS_One_2012_Apr_19_7(4)_e34956.txt
11447G>A,"...2:5093T>C, 5300C>T; ND3: 10373G>A; ND4: 11253T>C, 11447G>A, 11928A>G; ND4L:10685G>A; ND5:12346C>T, 1...",92,746,PLoS_One_2012_Apr_19_7(4)_e34956.txt
11928A>G,"... 5300C>T; ND3: 10373G>A; ND4: 11253T>C, 11447G>A, 11928A>G; ND4L:10685G>A; ND5:12346C>T, 13135G>A, 1...",92,756,PLoS_One_2012_Apr_19_7(4)_e34956.txt
10685G>A,"...10373G>A; ND4: 11253T>C, 11447G>A, 11928A>G; ND4L:10685G>A; ND5:12346C>T, 13135G>A, 14002A>G; ND6:14...",92,771,PLoS_One_2012_Apr_19_7(4)_e34956.txt
12346C>T,"... 11253T>C, 11447G>A, 11928A>G; ND4L:10685G>A; ND5:12346C>T, 13135G>A, 14002A>G; ND6:14365C>T, 14502T...",92,785,PLoS_One_2012_Apr_19_7(4)_e34956.txt
13135G>A,"... 11447G>A, 11928A>G; ND4L:10685G>A; ND5:12346C>T, 13135G>A, 14002A>G; ND6:14365C>T, 14502T>C, 14582A...",92,795,PLoS_One_2012_Apr_19_7(4)_e34956.txt
14002A>G,"... 11928A>G; ND4L:10685G>A; ND5:12346C>T, 13135G>A, 14002A>G; ND6:14365C>T, 14502T>C, 14582A>G), in co...",92,805,PLoS_One_2012_Apr_19_7(4)_e34956.txt
14365C>T,"...L:10685G>A; ND5:12346C>T, 13135G>A, 14002A>G; ND6:14365C>T, 14502T>C, 14582A>G), in complex-IV (15%)...",92,819,PLoS_One_2012_Apr_19_7(4)_e34956.txt
14502T>C,"...; ND5:12346C>T, 13135G>A, 14002A>G; ND6:14365C>T, 14502T>C, 14582A>G), in complex-IV (15%) (CO2:7762...",92,829,PLoS_One_2012_Apr_19_7(4)_e34956.txt
14582A>G,"...6C>T, 13135G>A, 14002A>G; ND6:14365C>T, 14502T>C, 14582A>G), in complex-IV (15%) (CO2:7762G>A; CO3:9...",92,839,PLoS_One_2012_Apr_19_7(4)_e34956.txt
7762G>A,"...>T, 14502T>C, 14582A>G), in complex-IV (15%) (CO2:7762G>A; CO3:9803A>G, 9935T>C, 9947G>A, 9548G>A) o...",92,875,PLoS_One_2012_Apr_19_7(4)_e34956.txt
9803A>G,"... 14582A>G), in complex-IV (15%) (CO2:7762G>A; CO3:9803A>G, 9935T>C, 9947G>A, 9548G>A) of the respira...",92,888,PLoS_One_2012_Apr_19_7(4)_e34956.txt
9935T>C,"...), in complex-IV (15%) (CO2:7762G>A; CO3:9803A>G, 9935T>C, 9947G>A, 9548G>A) of the respiratory chai...",92,897,PLoS_One_2012_Apr_19_7(4)_e34956.txt
9947G>A,"...plex-IV (15%) (CO2:7762G>A; CO3:9803A>G, 9935T>C, 9947G>A, 9548G>A) of the respiratory chain enzymes...",92,906,PLoS_One_2012_Apr_19_7(4)_e34956.txt
9548G>A,"...15%) (CO2:7762G>A; CO3:9803A>G, 9935T>C, 9947G>A, 9548G>A) of the respiratory chain enzymes followed...",92,915,PLoS_One_2012_Apr_19_7(4)_e34956.txt
15530T>C,...y chain enzymes followed by complex III (3%) (CYB:15530T>C) and complex V (3%) (ATP8:8562C>G). Withi...,92,991,PLoS_One_2012_Apr_19_7(4)_e34956.txt
8562C>G,"... III (3%) (CYB:15530T>C) and complex V (3%) (ATP8:8562C>G). Within the non-coding region, the highes...",92,1026,PLoS_One_2012_Apr_19_7(4)_e34956.txt
16048G>A,"... mutation frequency was in the D-Loop (18%) (HVI: 16048G>A, 16137A>G, 16354C>T, 16526G>A; HVII:293T>...",92,1137,PLoS_One_2012_Apr_19_7(4)_e34956.txt
16137A>G,"...frequency was in the D-Loop (18%) (HVI: 16048G>A, 16137A>G, 16354C>T, 16526G>A; HVII:293T>C, 385A>G)...",92,1147,PLoS_One_2012_Apr_19_7(4)_e34956.txt
16354C>T,"...was in the D-Loop (18%) (HVI: 16048G>A, 16137A>G, 16354C>T, 16526G>A; HVII:293T>C, 385A>G), followed...",92,1157,PLoS_One_2012_Apr_19_7(4)_e34956.txt
16526G>A,"... D-Loop (18%) (HVI: 16048G>A, 16137A>G, 16354C>T, 16526G>A; HVII:293T>C, 385A>G), followed by RNRs (...",92,1167,PLoS_One_2012_Apr_19_7(4)_e34956.txt
293T>C,"...HVI: 16048G>A, 16137A>G, 16354C>T, 16526G>A; HVII:293T>C, 385A>G), followed by RNRs (951G>A, 960delC...",92,1182,PLoS_One_2012_Apr_19_7(4)_e34956.txt
385A>G,"...48G>A, 16137A>G, 16354C>T, 16526G>A; HVII:293T>C, 385A>G), followed by RNRs (951G>A, 960delC) and tR...",92,1190,PLoS_One_2012_Apr_19_7(4)_e34956.txt
951G>A,"...16526G>A; HVII:293T>C, 385A>G), followed by RNRs (951G>A, 960delC) and tRNAs (TV:1664G>A; TL1:3243A>...",92,1217,PLoS_One_2012_Apr_19_7(4)_e34956.txt
1664G>A,"... followed by RNRs (951G>A, 960delC) and tRNAs (TV:1664G>A; TL1:3243A>G) both 6%, and by the NC7 regi...",92,1248,PLoS_One_2012_Apr_19_7(4)_e34956.txt
3243A>G,"...RNRs (951G>A, 960delC) and tRNAs (TV:1664G>A; TL1:3243A>G) both 6%, and by the NC7 region (3%) (8289...",92,1261,PLoS_One_2012_Apr_19_7(4)_e34956.txt
3243A>G,"...s 2, 6, 9, 10 and 15). Patient 5 carried mutation 3243A>G and was not further investigated because t...",97,382,PLoS_One_2012_Apr_19_7(4)_e34956.txt
3243A>G,"...es [1], [20] started with the search for mutation 3243A>G in patients affected by both diabetes and ...",111,65,PLoS_One_2012_Apr_19_7(4)_e34956.txt
3243A>G,"...an previously reported, namely from 75% to 98% in 3243A>G-carriers with diabetes, with or without a ...",111,799,PLoS_One_2012_Apr_19_7(4)_e34956.txt
3243A>G,"...wer than the 86% reported in carriers of mutation 3243A>G [1], [20]. All our patients had DQ2 and/or...",113,121,PLoS_One_2012_Apr_19_7(4)_e34956.txt
3243A>G,"...hyroiditis, which has been previously reported in 3243A>G carriers in the presence of diabetes or ot...",113,879,PLoS_One_2012_Apr_19_7(4)_e34956.txt
3243A>G,"... heteroplasmy level of the mutations. In fact, in 3243A>G carriers with heteroplasmy levels of 34.5%...",115,378,PLoS_One_2012_Apr_19_7(4)_e34956.txt
3243A>G,...abetic patient (patient 5) who had a heteroplasmy 3243A>G level of 34%. The heteroplasmic level of t...,115,665,PLoS_One_2012_Apr_19_7(4)_e34956.txt
3243A>G,"...he concept that the heteroplasmy load in blood of 3243A>G declines with age [1], [28]",115,936,PLoS_One_2012_Apr_19_7(4)_e34956.txt
3243A>G,...sis of MIDD usually focuses on the search for the 3243A>G mutation in selected diabetic patients aff...,117,88,PLoS_One_2012_Apr_19_7(4)_e34956.txt
8562C>G,.... Only one of the four novel suspected mutations (8562C>G) detected in our population caused an amin...,117,864,PLoS_One_2012_Apr_19_7(4)_e34956.txt
3243A>G,"...ificance of these suspected mutations, apart from 3243A>G [4], has been scarcely investigated [7], [...",119,560,PLoS_One_2012_Apr_19_7(4)_e34956.txt
3243A>G,...include the study of the entire mtDNA because the 3243A>G variant is not as frequent in children as ...,121,264,PLoS_One_2012_Apr_19_7(4)_e34956.txt
3243A>G,...titative PCR (qRT-PCR) the level of heteroplasmic 3243A>G mutation detected in one patient and his m...,133,157,PLoS_One_2012_Apr_19_7(4)_e34956.txt
3243A>G,Figure S1 Detection of 3243A>G mitochondrial mutation by sequence analysi...,153,24,PLoS_One_2012_Apr_19_7(4)_e34956.txt
3243A>G,...nd from her mother (m5) showing the heteroplasmic 3243A>G mutation. Levels of heteroplasmy were high...,153,191,PLoS_One_2012_Apr_19_7(4)_e34956.txt
3243A>G,... diabetes and deafness (MIDD) associated with the 3243A>G mitochondrial point mutation. Diabet Med 2...,196,174,PLoS_One_2012_Apr_19_7(4)_e34956.txt
3380G>A,... I genes in MELAS: a novel heteroplasmic mutation 3380G>A in ND1 of mtDNA. Neuromuscul Disord 18 553...,231,149,PLoS_One_2012_Apr_19_7(4)_e34956.txt
7028C>T,...SBE)	7028	5′-ACACGACACGTAACTACGTTGTAGC-3′	7004F	m.7028C>T,61,72,PLoS_One_2012_Aug_28_7(8)_e44128.txt
14766C>T,...5′cgatcATGAGTGGTTAATTAATTTTATTAGGGTTA-3′	14798R	m.14766C>T,62,58,PLoS_One_2012_Aug_28_7(8)_e44128.txt
10398A>G,...5′-ataTATGAGTGACTACAAAAAGGATTAGA CTGA-3′	10368F	m.10398A>G,63,58,PLoS_One_2012_Aug_28_7(8)_e44128.txt
4580G>A,...(at)7TTTTTTACCTGAGTAGGCCTAGAAA TAAACAT-3′	4548F	m.4580G>A,64,60,PLoS_One_2012_Aug_28_7(8)_e44128.txt
12308A>G,...12308	5′-(tacg)5aCCATTGGTCTTAGGCCCCAA-3′	12288F	m.12308A>G,65,52,PLoS_One_2012_Aug_28_7(8)_e44128.txt
4216T>C,...4216	5′-cgCCACTCACCCTAGCATTACTTATATG A-3′	4189F	m.4216T>C,66,52,PLoS_One_2012_Aug_28_7(8)_e44128.txt
10034T>C,5′- TATTCCTAGAAGTGAGATGGT-3′	9902F 10526R	m.10034T>C	(−)AluI,68,45,PLoS_One_2012_Aug_28_7(8)_e44128.txt
1470T>C,...′ 5′- CCGTGCGAGAATAATGATGTATGC-3′	14430F 14686R	m.1470T>C	(+)AccI,70,94,PLoS_One_2012_Aug_28_7(8)_e44128.txt
8994G>A,5′-GTGTGAAAACGTAGGCTTG-3′	8900F 9172R	m.8994G>A	(−)HaeIII,73,41,PLoS_One_2012_Aug_28_7(8)_e44128.txt
10398A>G,...nucleotide localised at polymorphic site 10398 (m.10398A>G). Samples with the m.10398G allele were t...,83,250,PLoS_One_2012_Aug_28_7(8)_e44128.txt
10398A>G,"...I = [0.48–0.99], p<0.05, respectively). The SNP m.10398A>G causes a non-synonymous amino acid change...",138,651,PLoS_One_2012_Aug_28_7(8)_e44128.txt
4216T>C,"... is observed in haplogroups K, J and I. The SNP m.4216T>C is specific for the cluster JT and produce...",138,803,PLoS_One_2012_Aug_28_7(8)_e44128.txt
14766C>T,...e development of ischemia in our study. The SNP m.14766C>T causes the amino acid substitution of a t...,147,149,PLoS_One_2012_Aug_28_7(8)_e44128.txt
7028C>T,"... overrepresented in our study. However, the SNP m.7028C>T causes a synonymous amino acid change, the...",147,704,PLoS_One_2012_Aug_28_7(8)_e44128.txt
11016G>A,... reported haplogroup N9b specific polymorphisms m.11016G>A (p.Ser86Asn in NADH dehydrogenase 4) and ...,147,1278,PLoS_One_2012_Aug_28_7(8)_e44128.txt
13183A>G,...016G>A (p.Ser86Asn in NADH dehydrogenase 4) and m.13183A>G (p.Ile283Val in NADH dehydrogenase 5) con...,147,1330,PLoS_One_2012_Aug_28_7(8)_e44128.txt
15452C>A,"...utations affecting genes encoding cytochrome b (m.15452C>A), NADH dehydrogenase 1 (m.4216T>C) and NA...",147,1663,PLoS_One_2012_Aug_28_7(8)_e44128.txt
4216T>C,"...ytochrome b (m.15452C>A), NADH dehydrogenase 1 (m.4216T>C) and NADH dehydrogenase 5 (m.13708G>A). Al...",147,1698,PLoS_One_2012_Aug_28_7(8)_e44128.txt
13708G>A,...ogenase 1 (m.4216T>C) and NADH dehydrogenase 5 (m.13708G>A). All these gene products are involved in...,147,1735,PLoS_One_2012_Aug_28_7(8)_e44128.txt
295C>T,"...urthermore, a different study revealed that the m.295C>T polymorphism of haplogroup J increases the ...",147,1897,PLoS_One_2012_Aug_28_7(8)_e44128.txt
797G>A,"...d (E) A heterozygous missense mutation of p53 (C. 797G>A, P. Gly133Glu, arrows indicated) was identi...",27,609,PLoS_One_2012_Aug_28_7(8)_e44301.txt
797G>A,".... Both cell lines contained the same mutation (C. 797G>A, P. Gly133Glu) in exon 7 (Figure 1D, E), wh...",29,152,PLoS_One_2012_Aug_28_7(8)_e44301.txt
786G>C,"...us BACE1 polymorphism at codon 262 (NM_012104.3:c.786G>C, rs638405) with sporadic CJD (sCJD)",18,393,PLoS_One_2012_Aug_30_7(8)_e43926.txt
755C>G,...ndertaken for two different mutations of FGFR2 (c.755C>G encoding p.Ser252Trp and c.758C>G encoding ...,26,400,PLoS_One_2012_Aug_6_7(8)_e42382.txt
758C>G,"...ons of FGFR2 (c.755C>G encoding p.Ser252Trp and c.758C>G encoding p.Pro253Arg, both causing Apert sy...",26,434,PLoS_One_2012_Aug_6_7(8)_e42382.txt
2943T>C,"... causing Apert syndrome) and a mutation in RET (c.2943T>C, encoding p.Met918Thr and causing multiple...",26,517,PLoS_One_2012_Aug_6_7(8)_e42382.txt
1138G>A,...[23]. A conceptually similar study of the FGFR3 c.1138G>A achondroplasia mutation (encoding p.Gly380...,26,1648,PLoS_One_2012_Aug_6_7(8)_e42382.txt
336A>G,... Ching JC  So TM  Lai ST    2010 CD209 (DC-SIGN) -336A>G promoter polymorphism and severe acute resp...,263,69,PLoS_One_2012_Feb_27_7(2)_e32273.txt
1226 A>G,"...common mutation in type 1 GD occurs at position c.1226 A>G, causing an N370S amino acid change [13],...",16,207,PLoS_One_2012_Jan_17_7(1)_e29861.txt
31G>A,...d the first heterozygous intronic mutation (c.188-31G>A) in the INS gene causing neonatal diabetes i...,32,90,PLoS_One_2012_Jan_3_7(1)_e29205.txt
31G>A,...he potential effect on mRNA splicing of the c.188-31G>A mutation was analyzed using the splice site ...,71,52,PLoS_One_2012_Jan_3_7(1)_e29205.txt
330 A>G,"...nce and the United Kingdom, the missense mutation 330 A>G was independently identified in six famili...",141,945,PLoS_One_2012_Jul_11_7(7)_e40543.txt
330 A>G,...ilies studied shared a common ancestry with BRCA1 330 A>G being a founder mutation of Spanish/Galici...,141,1329,PLoS_One_2012_Jul_11_7(7)_e40543.txt
11573156 C>G,"...e functionality of two PLA2G2A non-coding SNPs, rs11573156 C>G and rs3767221 T>G where the rare alle...",7,274,PLoS_One_2012_Jul_17_7(7)_e41139.txt
3767221 T>G,"...two PLA2G2A non-coding SNPs, rs11573156 C>G and rs3767221 T>G where the rare alleles have been previ...",7,293,PLoS_One_2012_Jul_17_7(7)_e41139.txt
11573156 C >G,...a nuclear protein compared to the T-allele. For rs11573156 C >G there were no luciferase or EMSA all...,10,386,PLoS_One_2012_Jul_17_7(7)_e41139.txt
11573156 C>G,...ividuals homozygous for the common C allele for rs11573156 C>G (NC_000001.10:g20306146G>C) in the 5′...,24,386,PLoS_One_2012_Jul_17_7(7)_e41139.txt
20306146G>C,"...common C allele for rs11573156 C>G (NC_000001.10:g20306146G>C) in the 5′UTR of PLA2G2A (Figure 1), t...",24,414,PLoS_One_2012_Jul_17_7(7)_e41139.txt
3767221 T>G,"...levels (p = 1.9×10−14). For the second variant, rs3767221 T>G (NC_000001.10:g20301781A>C) in the 3′U...",24,567,PLoS_One_2012_Jul_17_7(7)_e41139.txt
20301781A>C,"... the second variant, rs3767221 T>G (NC_000001.10:g20301781A>C) in the 3′UTR (Figure 1), the opposite...",24,594,PLoS_One_2012_Jul_17_7(7)_e41139.txt
3767221 T>G,Rs3767221 T>G is Associated with Altered PLA2G2A Pro...,41,3,PLoS_One_2012_Jul_17_7(7)_e41139.txt
3767221 T>G,Results from the luciferase assays for rs3767221 T>G are shown in Figure 4. A significant d...,42,42,PLoS_One_2012_Jul_17_7(7)_e41139.txt
3767221 T >G,... 4 Luciferase Assay Activity Analysis Comparing rs3767221 T >G,44,90,PLoS_One_2012_Jul_17_7(7)_e41139.txt
11573156 C>G,Rs11573156 C>G is Associated with Alternative Splici...,52,3,PLoS_One_2012_Jul_17_7(7)_e41139.txt
11573156 C >G,... 6 Luciferase Assay Activity Analysis Comparing rs11573156 C >G,55,90,PLoS_One_2012_Jul_17_7(7)_e41139.txt
3767221 T>G,There is strong evidence to suggest that rs3767221 T>G in the 3′UTR of PLA2G2A is also functi...,88,44,PLoS_One_2012_Jul_17_7(7)_e41139.txt
3767221 T>G,"For rs3767221 T>G, a 303 bp fragment downstream of the P...",105,7,PLoS_One_2012_Jul_17_7(7)_e41139.txt
11573156 C>G,For rs11573156 C>G,124,7,PLoS_One_2012_Jul_17_7(7)_e41139.txt
3767221 T>G,For rs3767221 T>G,134,7,PLoS_One_2012_Jul_17_7(7)_e41139.txt
11573156 C>G,The effects of rs11573156 C>G on gene expression was assessed using...,159,18,PLoS_One_2012_Jul_17_7(7)_e41139.txt
11573156 C>G,Sequence Analysis of rs11573156 C>G and rs3767221 T>,166,24,PLoS_One_2012_Jul_17_7(7)_e41139.txt
3767221 T>G,Sequence Analysis of rs11573156 C>G and rs3767221 T>,166,43,PLoS_One_2012_Jul_17_7(7)_e41139.txt
61A>G,...0 Genetic polymorphism of epidermal growth factor 61A>G and cancer risk: a meta-analysis. Cancer Epi...,110,84,PLoS_One_2012_Jul_19_7(7)_e41470.txt
6T>C,"...teria. Among these, ERCC1 T262G [22], hMSH2 IVS12-6T>C [35], RRM1 C-524T [36], XPA A23G [24] and XRC...",149,619,PLoS_One_2012_Jun_26_7(6)_e38150.txt
6T>C,"... RRM1 C-524T. Besides, the results of hMSH2 IVS12-6T>C and XRCC1 T194C were inconsistent between dif...",149,966,PLoS_One_2012_Jun_26_7(6)_e38150.txt
2168G> A,...XJ  Zhou HH    2011 ABCC1 polymorphism Arg723Gln (2168G> A) is associated with lung cancer susceptib...,246,82,PLoS_One_2012_Jun_26_7(6)_e38150.txt
325C>T,212	337	no	n.a.	MT	exon1	325C>T	Q109X	exon1	325C>T	Q109X,25,26,PLoS_One_2012_Mar_20_7(3)_e33667.txt
325C>T,212	337	no	n.a.	MT	exon1	325C>T	Q109X	exon1	325C>T	Q109X,25,45,PLoS_One_2012_Mar_20_7(3)_e33667.txt
325C>T,212	340	no	n.a.	MT	exon1	325C>T	Q109X	exon1	325C>T	Q109X,26,26,PLoS_One_2012_Mar_20_7(3)_e33667.txt
325C>T,212	340	no	n.a.	MT	exon1	325C>T	Q109X	exon1	325C>T	Q109X,26,45,PLoS_One_2012_Mar_20_7(3)_e33667.txt
1068G>A,237	536	no	75.0	n.a.	exon1	1068G>A	V356X	exon3	1468C>T	R490X,27,28,PLoS_One_2012_Mar_20_7(3)_e33667.txt
1468C>T,237	536	no	75.0	n.a.	exon1	1068G>A	V356X	exon3	1468C>T	R490X,27,48,PLoS_One_2012_Mar_20_7(3)_e33667.txt
1468C>T,...no	44.2	MT	intron3	IVS3+2–5 (TAGG)del	DSS	intron3	1468C>T	R490X,28,59,PLoS_One_2012_Mar_20_7(3)_e33667.txt
4A>G,262	586	yes	n.a.	n.a.	intron5	IVS5 −4A>G	?	-	-	-,31,37,PLoS_One_2012_Mar_20_7(3)_e33667.txt
4A>G,162*	131	yes	n.a.	n.a.	intron 5	IVS5 −4A>G	?	-	-	-,32,39,PLoS_One_2012_Mar_20_7(3)_e33667.txt
4A>G,111	432	no	n.a.	n.a.	intron 5	IVS5 −4A>G	?	-	-	-,33,37,PLoS_One_2012_Mar_20_7(3)_e33667.txt
325C>T,"A homozygous c.325C>T transition, introducing a premature stop co...",37,16,PLoS_One_2012_Mar_20_7(3)_e33667.txt
1468C>T,"...naffected sisters did not carry the mutation. A c.1468C>T transition, resulting in R490X in exon 3, ...",37,249,PLoS_One_2012_Mar_20_7(3)_e33667.txt
1068G>A,"...proband from family #237, it was accompanied by c.1068G>A, resulting in W356X in exon 3. In two affe...",37,430,PLoS_One_2012_Mar_20_7(3)_e33667.txt
4A>G,Gene region	Intron3 (+2–5del)	Intron5 (−4A>G)	3′UTR (+195del11 bp),40,41,PLoS_One_2012_Mar_20_7(3)_e33667.txt
4A>G,...entified in the examined PCD patients were: IVS5 −4A>G and 3′UTR+(195–205)del. No SNPs were reported...,67,88,PLoS_One_2012_Mar_20_7(3)_e33667.txt
4A>G,"...d on the above observations, we assumed that IVS5-4A>G did not represent a causative PCD mutation. T...",67,1159,PLoS_One_2012_Mar_20_7(3)_e33667.txt
325C>T,"...le 4). As expected, two alleles carrying Q109X (c.325C>T) in homozygous siblings #337 and #340 had a...",72,318,PLoS_One_2012_Mar_20_7(3)_e33667.txt
14G>C,...have never been described before. A heterozygous −14G>C transversion in the 5′UTR was found in a sin...,125,241,PLoS_One_2012_Mar_20_7(3)_e33667.txt
52A>G,"...ontrol chromosomes. Two heterozygous transitions, 52A>G and 73G>A, were found in the 3′UTR, each in ...",125,480,PLoS_One_2012_Mar_20_7(3)_e33667.txt
73G>A,"...omosomes. Two heterozygous transitions, 52A>G and 73G>A, were found in the 3′UTR, each in one of two...",125,490,PLoS_One_2012_Mar_20_7(3)_e33667.txt
52A>G,...0-5p and 2). Verification of the possibility that 52A>G transition affected the level of RSPH9 expre...,127,778,PLoS_One_2012_Mar_20_7(3)_e33667.txt
52A>G,"...as not pursued further, given that a heterozygous 52A>G was found in only one patient with no other ...",127,943,PLoS_One_2012_Mar_20_7(3)_e33667.txt
20G>C,Gene region	5′UTR (−20G>C)	3′UTR (+52A>G and +73G>A),133,21,PLoS_One_2012_Mar_20_7(3)_e33667.txt
52A>G,Gene region	5′UTR (−20G>C)	3′UTR (+52A>G and +73G>A),133,36,PLoS_One_2012_Mar_20_7(3)_e33667.txt
73G>A,Gene region	5′UTR (−20G>C)	3′UTR (+52A>G and +73G>A),133,47,PLoS_One_2012_Mar_20_7(3)_e33667.txt
504C>T,"... of PCD cases among the Slavic people. Although c.504C>T (Q154X), reported earlier in four Pakistani...",155,153,PLoS_One_2012_Mar_20_7(3)_e33667.txt
1468C>T,...ackgrounds. Since the mutation results from the c.1468C>T transition at a fast-mutating CpG dinucleo...,157,731,PLoS_One_2012_Mar_20_7(3)_e33667.txt
325C>T,Number of chromosomes with 325C>T (Q109X)		1	0	2	0	3,173,28,PLoS_One_2012_Mar_20_7(3)_e33667.txt
1068G>A,Number of chromosomes with 1068G>A (W356X)		0	0	1	0	1,174,28,PLoS_One_2012_Mar_20_7(3)_e33667.txt
1468C>T,Number of chromosomes with 1468C>T (R490X)		1	0	2	0	3,175,28,PLoS_One_2012_Mar_20_7(3)_e33667.txt
460C>T,"The 460C>T (Q154X) mutation (rs118204041), found only ...",178,6,PLoS_One_2012_Mar_20_7(3)_e33667.txt
66G>A,"...ighted several associations including infant MTRR 66G>A genotype with DNA methylation (χ2 = 8.82, p ...",5,1800,PLoS_One_2012_Mar_30_7(3)_e33290.txt
677C>T,"...ylation (χ2 = 8.82, p = 0.003) and maternal MTHFR 677C>T genotype with IGF2 methylation (χ2 = 2.77, ...",5,1878,PLoS_One_2012_Mar_30_7(3)_e33290.txt
677C>T,...ne report suggests that maternal and infant MTHFR 677C>T does not affect cord blood methylation of t...,12,931,PLoS_One_2012_Mar_30_7(3)_e33290.txt
677C>T,"...ate transport and in one carbon metabolism (MTHFR 677C>T (rs1801133), MTHFR 1298A>C (rs1801131), MTR...",37,97,PLoS_One_2012_Mar_30_7(3)_e33290.txt
1298A>C,"...arbon metabolism (MTHFR 677C>T (rs1801133), MTHFR 1298A>C (rs1801131), MTRR 66G>A (rs1801394), FOLH1...",37,123,PLoS_One_2012_Mar_30_7(3)_e33290.txt
66G>A,"...7C>T (rs1801133), MTHFR 1298A>C (rs1801131), MTRR 66G>A (rs1801394), FOLH1 1561C>T (rs202676), CβS 6...",37,149,PLoS_One_2012_Mar_30_7(3)_e33290.txt
1561C>T,"...298A>C (rs1801131), MTRR 66G>A (rs1801394), FOLH1 1561C>T (rs202676), CβS 644 bp ins, RFC1 80G>A (rs...",37,174,PLoS_One_2012_Mar_30_7(3)_e33290.txt
80G>A,"...), FOLH1 1561C>T (rs202676), CβS 644 bp ins, RFC1 80G>A (rs1051266) and SHMT 1420C>T (rs1979277)) we...",37,215,PLoS_One_2012_Mar_30_7(3)_e33290.txt
1420C>T,"..., CβS 644 bp ins, RFC1 80G>A (rs1051266) and SHMT 1420C>T (rs1979277)) were determined using standar...",37,242,PLoS_One_2012_Mar_30_7(3)_e33290.txt
66 G>A,Univariate	Global	Infant MTRR 66 G>A*	307	−0.035	0.014	0.009	0.022	0.013	0.007	−...,80,31,PLoS_One_2012_Mar_30_7(3)_e33290.txt
66 G>A,Multipleł	Global	Infant MTRR 66 G>A*	117	−0.033	0.015	0.026	0.083	0.014	0.018	−...,82,30,PLoS_One_2012_Mar_30_7(3)_e33290.txt
66 G>A,Univariate	IGF2 Site 3	Infant MTRR 66 G>A*	382	−0.706	0.498	0.157	0.005	0.497	0.156	−...,88,36,PLoS_One_2012_Mar_30_7(3)_e33290.txt
677 C>T,Univariate	IGF2 Site 1	Maternal MTHFR 677 C>T‡	154	2.081	0.694	0.003	0.056	0.651	0.002	0...,90,39,PLoS_One_2012_Mar_30_7(3)_e33290.txt
66 G>A,Infant MTRR 66 G>A*		−0.251	0.636	0.694		0.654	0.702	−0.032,93,15,PLoS_One_2012_Mar_30_7(3)_e33290.txt
677 C>T,Maternal MTHFR 677 C>T‡		1.286	0.478	0.008		0.460	0.006	0.214,95,18,PLoS_One_2012_Mar_30_7(3)_e33290.txt
80G>A,Univariate	IGFBP3 Site 4	Infant RFC1 80G>A*	302	0.676	0.380	0.076	0.011	0.319	0.035	0.1...,97,38,PLoS_One_2012_Mar_30_7(3)_e33290.txt
1561C>T,Univariate	IGFBP3 Site 2	Maternal GCPII 1561C>T*	121	0.889	0.353	0.013	0.051	0.378	0.020	0...,98,41,PLoS_One_2012_Mar_30_7(3)_e33290.txt
66 G>A,Univariate	IGFBP3 Site 3	Maternal MTRR 66 G>AΦ	117	−0.810	0.497	0.106	0.023	0.207	2.000×1...,99,40,PLoS_One_2012_Mar_30_7(3)_e33290.txt
66 G>A,Univariate	IGFBP3 Mean	Maternal MTRR 66 G>AΦ	117	−0.655	0.570	0.253	0.011	0.283	0.022	−...,100,38,PLoS_One_2012_Mar_30_7(3)_e33290.txt
80G>A,Infant RFC1 80G>A*		0.273	0.268	0.311		0.274	0.321	0.099,102,15,PLoS_One_2012_Mar_30_7(3)_e33290.txt
1561C>T,Maternal GCPII 1561C>T*		0.247	0.272	0.366		0.300	0.411	0.090,103,18,PLoS_One_2012_Mar_30_7(3)_e33290.txt
66 G>A,Maternal MTRR 66 G>AΦ		−0.432	0.422	0.309		0.336	0.202	−0.096,104,17,PLoS_One_2012_Mar_30_7(3)_e33290.txt
80G>A,Univariate	ZNT5 Site 2	Infant RFC1 80G>A*	314	3.469	1.396	0.014	0.019	1.481	0.020	0.1...,108,36,PLoS_One_2012_Mar_30_7(3)_e33290.txt
1298A>C,Univariate	ZNT5 Site 3	Maternal MTHFR 1298A>C*	132	8.290	2.579	0.002	0.074	2.682	0.002	0...,109,39,PLoS_One_2012_Mar_30_7(3)_e33290.txt
66 G>A,Univariate	ZNT5 Site 5	Maternal MTRR 66 G>AΦ	104	−18.714	6.105	0.003	0.084	3.410	2.971×...,110,38,PLoS_One_2012_Mar_30_7(3)_e33290.txt
66G>A,"MTRR 66G>A	Global*	179	0.37*	0.32, 0.44	117	0.35*	0.30,...",128,6,PLoS_One_2012_Mar_30_7(3)_e33290.txt
66G>A,"MTRR 66G>A	IGF2 Site 3	198	50.88	47.69, 53.24	171	49.59...",129,6,PLoS_One_2012_Mar_30_7(3)_e33290.txt
80G>A,"RFC1 80G>A	IGFBP3 Site 4	94	6.98	6.33, 8.01	158	7.50	6....",131,6,PLoS_One_2012_Mar_30_7(3)_e33290.txt
80G>A,"RFC1 80G>A	ZNT5 Site2	111	92.50	84.50, 97.00	151	95.00	...",132,6,PLoS_One_2012_Mar_30_7(3)_e33290.txt
677C>T,"MTHFR 677C>T	IGF2 Site 1	49	43.10	40.37, 46.45	83	45.40	...",134,7,PLoS_One_2012_Mar_30_7(3)_e33290.txt
677C>T,"MTHFR 677C>T	IGF2 Site 2	51	50.46	48.37, 53.91	80	51.74	...",135,7,PLoS_One_2012_Mar_30_7(3)_e33290.txt
677C>T,"MTHFR 677C>T	IGF2 Mean	52	47.67	45.23, 51.00	86	49.28	46...",136,7,PLoS_One_2012_Mar_30_7(3)_e33290.txt
1298A>C,"MTHFR 1298A>C	ZNT5 Site3	60	92.25	75.00, 97.50	55	97.00	...",137,7,PLoS_One_2012_Mar_30_7(3)_e33290.txt
1561C>T,"GCPII/FOLHI 1561C>T	IGFBP3 Site 2	83	5.71	5.24, 6.51	35	6.00	5...",138,13,PLoS_One_2012_Mar_30_7(3)_e33290.txt
66G>A,"MTRR 66G>A	IGFBP3 Site 1	47	4.82	3.39, 5.78	59	5.04	4.4...",139,6,PLoS_One_2012_Mar_30_7(3)_e33290.txt
66G>A,"MTRR 66G>A	IGFBP3 Site 3	47	4.46	4.06, 4.94	60	4.53	4.1...",140,6,PLoS_One_2012_Mar_30_7(3)_e33290.txt
66G>A,"MTRR 66G>A	IGFBP3 Site 5	45	6.16	5.46, 6.83	58	6.93	5.9...",141,6,PLoS_One_2012_Mar_30_7(3)_e33290.txt
66G>A,"MTRR 66G>A	IGFBP3 Mean	47	5.58	5.13, 6.58	60	5.89	5.45,...",142,6,PLoS_One_2012_Mar_30_7(3)_e33290.txt
66G>A,"MTRR 66G>A	ZNT5 Site5	45	85.00	66.50, 93.50	51	76.00	66...",143,6,PLoS_One_2012_Mar_30_7(3)_e33290.txt
1561C>T,Φ SNP GCPII/FOLHI 1561C>T and CβS 644ins were tested under a dominan...,148,19,PLoS_One_2012_Mar_30_7(3)_e33290.txt
1561C>T,...t the ZNT5 site 5 locus. The maternal GCPII/FOLHI 1561C>T SNP had a low MAF so data were tested unde...,150,679,PLoS_One_2012_Mar_30_7(3)_e33290.txt
66A>G,"...y assess effect the relationship between the MTRR 66A>G variant and DNA methylation patterns, given ...",157,2352,PLoS_One_2012_Mar_30_7(3)_e33290.txt
66G>A,...et al (2010) [59] reported no effects of the MTRR 66G>A variant on p16INK4A hypermethylation in the ...,157,2540,PLoS_One_2012_Mar_30_7(3)_e33290.txt
66G>A,"...as inversely associated with carriage of the MTRR 66G>A variant [60]. In the present study, both vit...",157,2774,PLoS_One_2012_Mar_30_7(3)_e33290.txt
66G>A,...n of the effects of both vitamin B12 and the MTRR 66G>A genotype on one-carbon metabolism are warran...,157,3056,PLoS_One_2012_Mar_30_7(3)_e33290.txt
677C>T,...argest individual effect sizes (∼6–7%). The MTHFR 677C>T and 1298A>C variant were selected for inves...,161,191,PLoS_One_2012_Mar_30_7(3)_e33290.txt
1298A>C,...vidual effect sizes (∼6–7%). The MTHFR 677C>T and 1298A>C variant were selected for investigation be...,161,202,PLoS_One_2012_Mar_30_7(3)_e33290.txt
66G>A,"...enetic factors, specifically vitamin B12 the MTRR 66G>A SNP and MTHFR variants can influence infant ...",168,1330,PLoS_One_2012_Mar_30_7(3)_e33290.txt
2274223 A>G,"...ve found a single nucleotide polymorphism (SNP, rs2274223 A>G) in PLCE1 to be associated with risk o...",6,99,PLoS_One_2012_Mar_6_7(3)_e31932.txt
11187870 G>C,... another unreported potentially functional SNP (rs11187870 G>C) of PLCE1 in a hospital-based case-co...,6,315,PLoS_One_2012_Mar_6_7(3)_e31932.txt
2274223A>G,"...e reported a shared susceptible locus at 10q23 (rs2274223A>G, exon 26) in the PLCE1 gene associated ...",19,479,PLoS_One_2012_Mar_6_7(3)_e31932.txt
2274223A>G,"...st this hypothesis, in addition to the reported rs2274223A>G, we also selected another potentially f...",21,616,PLoS_One_2012_Mar_6_7(3)_e31932.txt
11187870G>C,...lso selected another potentially functional SNP rs11187870G>C in the 3′UTR miRNA binding site of PLC...,21,682,PLoS_One_2012_Mar_6_7(3)_e31932.txt
753724 G>T,"... novel SNPs revealed in GWAS of gastric cancer (rs753724 G>T, r2 = 0.823; rs11187842 C>T, r2 = 0.823...",21,978,PLoS_One_2012_Mar_6_7(3)_e31932.txt
11187842 C>T,"...AS of gastric cancer (rs753724 G>T, r2 = 0.823; rs11187842 C>T, r2 = 0.823; rs3781264 T>C, r2 = 0.82...",21,1004,PLoS_One_2012_Mar_6_7(3)_e31932.txt
3781264 T>C,"...24 G>T, r2 = 0.823; rs11187842 C>T, r2 = 0.823; rs3781264 T>C, r2 = 0.823) [14]. We further measured...",21,1032,PLoS_One_2012_Mar_6_7(3)_e31932.txt
2274223A>G,"...not shown). As a result, we genotyped two SNPs (rs2274223A>G and rs11187870G>C) of PLCE1 using genom...",28,874,PLoS_One_2012_Mar_6_7(3)_e31932.txt
11187870G>C,"...result, we genotyped two SNPs (rs2274223A>G and rs11187870G>C) of PLCE1 using genomic DNA isolated f...",28,891,PLoS_One_2012_Mar_6_7(3)_e31932.txt
2274223A>G,"...tially functional SNPs, one located in exon 26 (rs2274223A>G) and the other located in the 3′ UTR (r...",169,131,PLoS_One_2012_Mar_6_7(3)_e31932.txt
11187870G>C,"...274223A>G) and the other located in the 3′ UTR (rs11187870G>C) of PLCE1, with risk of gastric cancer...",169,182,PLoS_One_2012_Mar_6_7(3)_e31932.txt
2274223A>G,...rmed the reported association between the PLCE1 rs2274223A>G SNP and gastric cancer susceptibility [...,173,81,PLoS_One_2012_Mar_6_7(3)_e31932.txt
11187870G>C,"...hree published studies. In addition, the 3′ UTR rs11187870G>C SNP of PLCE1 was identified for the fi...",173,353,PLoS_One_2012_Mar_6_7(3)_e31932.txt
2274223A>G,"...cer, although this SNP is in incomplete LD with rs2274223A>G. It is likely that this SNP in the 3′UT...",173,513,PLoS_One_2012_Mar_6_7(3)_e31932.txt
765G>A,"rs10188090, c.2635−765G>A	GG vs AA/AG	1.13(0.24−5.44)	0.879	1.33(0.65...",57,20,PLoS_One_2012_May_18_7(5)_e36962.txt
118T>C,"rs3771280, c.1510+118T>C	TT vs CC/CT	1.99(0.47−8.39)	0.350	0.94(0.51...",59,19,PLoS_One_2012_May_18_7(5)_e36962.txt
12568A>G,"rs1428030, c.1341-12568A>G	GG vs AA/AG	0.90(0.48−1.69)	0.747	1.56(0....",63,19,PLoS_One_2012_May_18_7(5)_e36962.txt
639G>A,"rs5742938, c.-21+639G>A	AA vs GG/GA	2.29(0.67−7.79)	0.182",67,18,PLoS_One_2012_May_18_7(5)_e36962.txt
3331G>A,"rs13404927, c.699+3331G>A	AA vs GG/GA	0.56(0.23−1.38)	0.210	0.97(0.2...",71,19,PLoS_One_2012_May_18_7(5)_e36962.txt
191T>C,"rs13320360, c.546-191T>C	CC vs TT/CT	0.54(0.17−1.73)	0.299	7.16(0.49...",73,19,PLoS_One_2012_May_18_7(5)_e36962.txt
639G>A,...ed the risk for cancer. The intronic change c.-21+639G>A (rs5742938) has not been identified in asso...,182,352,PLoS_One_2012_May_18_7(5)_e36962.txt
380A>G,"...hree SNPs were selected (rs17217772, Asn127Ser, c.380A>G; rs10188090, c.2635-765G>A; and rs3771280, ...",204,890,PLoS_One_2012_May_18_7(5)_e36962.txt
765G>A,"...17217772, Asn127Ser, c.380A>G; rs10188090, c.2635-765G>A; and rs3771280, c.1510+118T>C), three in MS...",204,917,PLoS_One_2012_May_18_7(5)_e36962.txt
118T>C,"... rs10188090, c.2635-765G>A; and rs3771280, c.1510+118T>C), three in MSH3 (rs26279, Ala1045Thr, c.313...",204,947,PLoS_One_2012_May_18_7(5)_e36962.txt
3133G>A,"...10+118T>C), three in MSH3 (rs26279, Ala1045Thr, c.3133G>A; rs1428030, c.1341-12568A>G; and rs1805355...",204,994,PLoS_One_2012_May_18_7(5)_e36962.txt
12568A>G,"...rs26279, Ala1045Thr, c.3133G>A; rs1428030, c.1341-12568A>G; and rs1805355, Pro231Pro, c.693G>A), two...",204,1021,PLoS_One_2012_May_18_7(5)_e36962.txt
693G>A,"...030, c.1341-12568A>G; and rs1805355, Pro231Pro, c.693G>A), two in PMS1 (rs5742938, c. −21+639G>A; an...",204,1059,PLoS_One_2012_May_18_7(5)_e36962.txt
639G>A,"...231Pro, c.693G>A), two in PMS1 (rs5742938, c. −21+639G>A; and rs13404927, c.699+3331G>A), one in MLH...",204,1099,PLoS_One_2012_May_18_7(5)_e36962.txt
3331G>A,"... (rs5742938, c. −21+639G>A; and rs13404927, c.699+3331G>A), one in MLH1 (rs13320360, c.546-191T>C), ...",204,1129,PLoS_One_2012_May_18_7(5)_e36962.txt
191T>C,"...7, c.699+3331G>A), one in MLH1 (rs13320360, c.546-191T>C), and one in MLH3 (rs28756991, Arg797His, c...",204,1170,PLoS_One_2012_May_18_7(5)_e36962.txt
2390G>A,"...91T>C), and one in MLH3 (rs28756991, Arg797His, c.2390G>A). No polymorphisms were selected in MSH6 a...",204,1221,PLoS_One_2012_May_18_7(5)_e36962.txt
2A>G,"...und heterozygous c.802-8_810del17insGC and c.1091-2A>G mutations of the CYP4V2 gene, known as geneti...",5,1458,PLoS_One_2012_May_31_7(5)_e33673.txt
2A>G,"Mutation(s)	c.802-8_810del17insGC	c.1091-2A>G	c.802-8_810del17insGC, c.1091-2A>G	c.802-8_81...",76,42,PLoS_One_2012_May_31_7(5)_e33673.txt
2A>G,"...17insGC	c.1091-2A>G	c.802-8_810del17insGC, c.1091-2A>G	c.802-8_810del17insGC, c.1091-2A>G	c.802-8_81...",76,77,PLoS_One_2012_May_31_7(5)_e33673.txt
2A>G,"...7insGC, c.1091-2A>G	c.802-8_810del17insGC, c.1091-2A>G	c.802-8_810del17insGC, c.1091-2A>G	c.802-8_81...",76,112,PLoS_One_2012_May_31_7(5)_e33673.txt
2A>G,"...7insGC, c.1091-2A>G	c.802-8_810del17insGC, c.1091-2A>G	c.802-8_810del17insGC, c.1091-2A>G	c.802-8_81...",76,147,PLoS_One_2012_May_31_7(5)_e33673.txt
2A>G,"...7insGC, c.1091-2A>G	c.802-8_810del17insGC, c.1091-2A>G	c.802-8_810del17insGC	c.1091-2A>G	c.802-8_810...",76,182,PLoS_One_2012_May_31_7(5)_e33673.txt
2A>G,"...17insGC, c.1091-2A>G	c.802-8_810del17insGC	c.1091-2A>G	c.802-8_810del17insGC	–	–	c.802-8_810del17ins...",76,216,PLoS_One_2012_May_31_7(5)_e33673.txt
2A>G,....802-8_810del17insGC	c.802-8_810del17insGC	c.1091-2A>G,76,320,PLoS_One_2012_May_31_7(5)_e33673.txt
2A>G,"...us variants (Table 4). Heterozygous CYP4V2 c.1091-2A>G was one of the 26 variants, and was known to ...",83,907,PLoS_One_2012_May_31_7(5)_e33673.txt
2A>G,...ociationMutation	–	–	c.802-8_810del17insGC	c.1091-2A>G,90,62,PLoS_One_2012_May_31_7(5)_e33673.txt
775C>A,"...entified, including two non-synonymous variants c.775C>A and c.802-8_810del17insGC. The former was n...",91,350,PLoS_One_2012_May_31_7(5)_e33673.txt
2A>G,"...e two mutations, c.802-8_810del17insGC and c.1091-2A>G. Only patients were found to carry both mutat...",93,144,PLoS_One_2012_May_31_7(5)_e33673.txt
2A>G,...und heterozygous c.802-8_810del17insGC and c.1091-2A>G mutations of the CYP4V2 gene. c.802-8_810del1...,96,91,PLoS_One_2012_May_31_7(5)_e33673.txt
2A>G,"...0del17insGC was carried by the mother II2. c.1091-2A>G mutation was carried by II3, the brother of I...",96,186,PLoS_One_2012_May_31_7(5)_e33673.txt
7C>T,...n the fourth generation. Intronic variation c.802-7C>T is non-pathogenic,96,385,PLoS_One_2012_May_31_7(5)_e33673.txt
2A>G,...l analysis of exome sequencing showed that c.1091-2A>G in CYP4V2 was first carried by the 3 patients...,109,212,PLoS_One_2012_May_31_7(5)_e33673.txt
2A>G,... since only the four patients carried both c.1091-2A>G and c.802-8_810del17insGC in CYP4V2,109,982,PLoS_One_2012_May_31_7(5)_e33673.txt
2A>G,"...the mutations identified in this pedigree, c.1091-2A>G of CYP4V2 was predicted to disrupt the splici...",111,57,PLoS_One_2012_May_31_7(5)_e33673.txt
2298881C>A,"Three ERCC1 functional SNPs (rs2298881C>A, rs3212986C>A and rs11615G>A) and two X...",11,32,PLoS_One_2012_Nov_15_7(11)_e49308.txt
3212986C>A,"Three ERCC1 functional SNPs (rs2298881C>A, rs3212986C>A and rs11615G>A) and two XPF/ERCC4 funct...",11,46,PLoS_One_2012_Nov_15_7(11)_e49308.txt
11615G>A,"...functional SNPs (rs2298881C>A, rs3212986C>A and rs11615G>A) and two XPF/ERCC4 functional SNPs (rs227...",11,63,PLoS_One_2012_Nov_15_7(11)_e49308.txt
2276466C>G,... rs11615G>A) and two XPF/ERCC4 functional SNPs (rs2276466C>G and rs6498486A>C) were genotyped for 11...,11,110,PLoS_One_2012_Nov_15_7(11)_e49308.txt
6498486A>C,...two XPF/ERCC4 functional SNPs (rs2276466C>G and rs6498486A>C) were genotyped for 1125 gastric adenoc...,11,127,PLoS_One_2012_Nov_15_7(11)_e49308.txt
1800067G>A,"...studies have mainly focused on a functional SNP rs1800067G>A, and few case-control studies reported ...",26,493,PLoS_One_2012_Nov_15_7(11)_e49308.txt
2298881C>A,"...e published GWASs. For the ERCC1 gene, we chose rs2298881C>A that may affect the TFBS activity, in a...",82,438,PLoS_One_2012_Nov_15_7(11)_e49308.txt
3212986C>A,"...idely investigated potentially functional SNPs (rs3212986C>A and rs11615G>A, the former may be assoc...",82,560,PLoS_One_2012_Nov_15_7(11)_e49308.txt
11615G>A,"...d potentially functional SNPs (rs3212986C>A and rs11615G>A, the former may be associated with transc...",82,577,PLoS_One_2012_Nov_15_7(11)_e49308.txt
2276466C>G,"...vels alterations). For the ERCC4 gene, we chose rs2276466C>G and rs6498486A>C; the former may affect...",82,752,PLoS_One_2012_Nov_15_7(11)_e49308.txt
6498486A>C,".... For the ERCC4 gene, we chose rs2276466C>G and rs6498486A>C; the former may affect the miRNA bindin...",82,769,PLoS_One_2012_Nov_15_7(11)_e49308.txt
11615T>C,"...ished studies on associations between the ERCC1 rs11615T>C, rs3212986C>A and rs3212961A>C polymorphi...",176,986,PLoS_One_2012_Nov_15_7(11)_e49308.txt
3212986C>A,"...s on associations between the ERCC1 rs11615T>C, rs3212986C>A and rs3212961A>C polymorphisms and canc...",176,998,PLoS_One_2012_Nov_15_7(11)_e49308.txt
3212961A>C,"... between the ERCC1 rs11615T>C, rs3212986C>A and rs3212961A>C polymorphisms and cancer risk [16], onl...",176,1015,PLoS_One_2012_Nov_15_7(11)_e49308.txt
11615T>C,"...sk of gastric cancer, both of which studied the rs11615T>C only in a relatively small Italy populati...",176,1166,PLoS_One_2012_Nov_15_7(11)_e49308.txt
62093482C>T,.... [13] The result of that study revealed a SNP (rs62093482C>T) in the V30M TTR 3′ UTR of the Swedish...,31,175,PLoS_One_2012_Nov_19_7(11)_e49981.txt
4022T>C,"...y the following dysferlin mutations: homozygous c.4022T>C (patient 1), compound heterozygous c.855+1...",88,531,PLoS_One_2012_Nov_20_7(11)_e49603.txt
895G>A,"... (patient 1), compound heterozygous c.855+1delG/c.895G>A (patient 2)",88,588,PLoS_One_2012_Nov_20_7(11)_e49603.txt
895G>A,...from patients with LGMD2B: DYSF c.855+1delG and c.895G>A; p.G299R; homozygosity for DYSF c.4022T>C; ...,91,456,PLoS_One_2012_Nov_20_7(11)_e49603.txt
4022T>C,...lG and c.895G>A; p.G299R; homozygosity for DYSF c.4022T>C; p.L1341P. Muscle specimens were placed in...,91,497,PLoS_One_2012_Nov_20_7(11)_e49603.txt
895G>A,"...r. Steven Laval (Newcastle Upon Tyne, UK). DYSF c.895G>A leading to DYSF p.G299R and DYSF c.4022T>C ...",97,195,PLoS_One_2012_Nov_20_7(11)_e49603.txt
4022T>C,... DYSF c.895G>A leading to DYSF p.G299R and DYSF c.4022T>C leading to DYSF p.L1431P were cloned into ...,97,237,PLoS_One_2012_Nov_20_7(11)_e49603.txt
2R > S,"... conditions, when the matrix fulfills the formula 2R > S+T and T > R >P> S, the game can be defined ...",47,446,PLoS_One_2012_Nov_7_7(11)_e48794.txt
2R > S,"... conditions, when the matrix fulfills the formula 2R > S+T and T > R >P> S, the game can be defined ...",53,320,PLoS_One_2012_Nov_7_7(11)_e48794.txt
2578C>A,"...olymorphisms that may influence VEGF expression: −2578C>A (rs699947), −1154G>A (rs1570360), −634G>C ...",16,1033,PLoS_One_2012_Oct_12_7(10)_e47158.txt
1154G>A,"... influence VEGF expression: −2578C>A (rs699947), −1154G>A (rs1570360), −634G>C (rs2010963), and 936C...",16,1054,PLoS_One_2012_Oct_12_7(10)_e47158.txt
634G>C,"...sion: −2578C>A (rs699947), −1154G>A (rs1570360), −634G>C (rs2010963), and 936C>T (rs3025039) [26], [...",16,1076,PLoS_One_2012_Oct_12_7(10)_e47158.txt
936C>T,"...), −1154G>A (rs1570360), −634G>C (rs2010963), and 936C>T (rs3025039) [26], [27], [28]",16,1100,PLoS_One_2012_Oct_12_7(10)_e47158.txt
936C>T,"... region polymorphisms, the T allele of the common 936C>T polymorphism in the 3′-untranslated region ...",37,304,PLoS_One_2012_Oct_12_7(10)_e47158.txt
1154G>A,There was strong LD between −1154G>A (rs 1570460) and −634G>C (rs2010963) (D′ =...,40,30,PLoS_One_2012_Oct_12_7(10)_e47158.txt
634G>C,"... was strong LD between −1154G>A (rs 1570460) and −634G>C (rs2010963) (D′ = 0.92), −2578C>A (rs 69994...",40,56,PLoS_One_2012_Oct_12_7(10)_e47158.txt
2578C>A,"...rs 1570460) and −634G>C (rs2010963) (D′ = 0.92), −2578C>A (rs 699947)and 1154G>A (rs1570360) (D′ = 0...",40,89,PLoS_One_2012_Oct_12_7(10)_e47158.txt
1154G>A,"... (rs2010963) (D′ = 0.92), −2578C>A (rs 699947)and 1154G>A (rs1570360) (D′ = 0.89). There was strong ...",40,112,PLoS_One_2012_Oct_12_7(10)_e47158.txt
1719T>A,...1570360) (D′ = 0.89). There was strong LD between 1719T>A(rs1870377) and 1192G>A (rs2305948) (D′ = 0...,40,173,PLoS_One_2012_Oct_12_7(10)_e47158.txt
1192G>A,...here was strong LD between 1719T>A(rs1870377) and 1192G>A (rs2305948) (D′ = 0.79),40,196,PLoS_One_2012_Oct_12_7(10)_e47158.txt
2578C>A,"....0047158.t002Table 2 The frequencies of the VEGF −2578C>A, −1154G>A, −634G>C, and 936C>T polymorphis...",42,71,PLoS_One_2012_Oct_12_7(10)_e47158.txt
1154G>A,"...002Table 2 The frequencies of the VEGF −2578C>A, −1154G>A, −634G>C, and 936C>T polymorphisms between...",42,81,PLoS_One_2012_Oct_12_7(10)_e47158.txt
634G>C,"... The frequencies of the VEGF −2578C>A, −1154G>A, −634G>C, and 936C>T polymorphisms between control s...",42,91,PLoS_One_2012_Oct_12_7(10)_e47158.txt
936C>T,"...cies of the VEGF −2578C>A, −1154G>A, −634G>C, and 936C>T polymorphisms between control subjects and ...",42,103,PLoS_One_2012_Oct_12_7(10)_e47158.txt
2578C>A,VEGF −2578C>A,44,7,PLoS_One_2012_Oct_12_7(10)_e47158.txt
1154G>A,VEGF–1154G>A,50,6,PLoS_One_2012_Oct_12_7(10)_e47158.txt
634G>C,VEGF −634G>C,56,7,PLoS_One_2012_Oct_12_7(10)_e47158.txt
936C>T,VEGF 936C>T,62,6,PLoS_One_2012_Oct_12_7(10)_e47158.txt
2578C>A,"...tudy was to evaluate the frequencies of the VEGF −2578C>A, −1154G>A, −634G>C, and 936C>T and KDR −60...",70,222,PLoS_One_2012_Oct_12_7(10)_e47158.txt
1154G>A,"...o evaluate the frequencies of the VEGF −2578C>A, −1154G>A, −634G>C, and 936C>T and KDR −604T>C (rs20...",70,232,PLoS_One_2012_Oct_12_7(10)_e47158.txt
634G>C,"... the frequencies of the VEGF −2578C>A, −1154G>A, −634G>C, and 936C>T and KDR −604T>C (rs2071559), 11...",70,242,PLoS_One_2012_Oct_12_7(10)_e47158.txt
936C>T,"...cies of the VEGF −2578C>A, −1154G>A, −634G>C, and 936C>T and KDR −604T>C (rs2071559), 1192G>A (rs230...",70,254,PLoS_One_2012_Oct_12_7(10)_e47158.txt
604T>C,"... −2578C>A, −1154G>A, −634G>C, and 936C>T and KDR −604T>C (rs2071559), 1192G>A (rs2305948), and 1719T...",70,270,PLoS_One_2012_Oct_12_7(10)_e47158.txt
1192G>A,"... −634G>C, and 936C>T and KDR −604T>C (rs2071559), 1192G>A (rs2305948), and 1719T>A (rs1870377) polym...",70,290,PLoS_One_2012_Oct_12_7(10)_e47158.txt
1719T>A,"...KDR −604T>C (rs2071559), 1192G>A (rs2305948), and 1719T>A (rs1870377) polymorphisms in Korean patien...",70,315,PLoS_One_2012_Oct_12_7(10)_e47158.txt
604T>C,"...e.0047158.t003Table 3 The frequencies of the KDR −604T>C, 1192G>A, and 1719T>A polymorphisms between...",72,70,PLoS_One_2012_Oct_12_7(10)_e47158.txt
1192G>A,"...8.t003Table 3 The frequencies of the KDR −604T>C, 1192G>A, and 1719T>A polymorphisms between control...",72,78,PLoS_One_2012_Oct_12_7(10)_e47158.txt
1719T>A,"... The frequencies of the KDR −604T>C, 1192G>A, and 1719T>A polymorphisms between control subjects and...",72,91,PLoS_One_2012_Oct_12_7(10)_e47158.txt
604T>C,KDR −604T>C,74,6,PLoS_One_2012_Oct_12_7(10)_e47158.txt
1192G>A,KDR 1192G>A,80,5,PLoS_One_2012_Oct_12_7(10)_e47158.txt
1719T>A,KDR 1719T>A,86,5,PLoS_One_2012_Oct_12_7(10)_e47158.txt
2578C>A,VEGF −2578C>A,101,7,PLoS_One_2012_Oct_12_7(10)_e47158.txt
1154G>A,VEGF −1154G>A,107,7,PLoS_One_2012_Oct_12_7(10)_e47158.txt
634G>C,VEGF −634G>C,113,7,PLoS_One_2012_Oct_12_7(10)_e47158.txt
936C>T,VEGF 936C>T,119,6,PLoS_One_2012_Oct_12_7(10)_e47158.txt
604T>C,KDR −604T>C,132,6,PLoS_One_2012_Oct_12_7(10)_e47158.txt
1192G>A,KDR 1192G>A,138,5,PLoS_One_2012_Oct_12_7(10)_e47158.txt
1719T>A,KDR 1719T>A,144,5,PLoS_One_2012_Oct_12_7(10)_e47158.txt
2578C>A,VEGF −2578C>A,180,7,PLoS_One_2012_Oct_12_7(10)_e47158.txt
1154G>A,VEGF −1154G>A,186,7,PLoS_One_2012_Oct_12_7(10)_e47158.txt
634G>C,VEGF −634G>C,192,7,PLoS_One_2012_Oct_12_7(10)_e47158.txt
936C>T,VEGF 936C>T,198,6,PLoS_One_2012_Oct_12_7(10)_e47158.txt
604T>C,KDR −604T>C,204,6,PLoS_One_2012_Oct_12_7(10)_e47158.txt
1192G>A,KDR 1192G>A,210,5,PLoS_One_2012_Oct_12_7(10)_e47158.txt
1719T>A,KDR 1719T>A,216,5,PLoS_One_2012_Oct_12_7(10)_e47158.txt
2578C>A,"... HapMap database (www.hapmap.org) [33]. The VEGF -2578C>A, -1154G>A, -634G>C, and 936C>T polymorphis...",225,341,PLoS_One_2012_Oct_12_7(10)_e47158.txt
1154G>A,"...tabase (www.hapmap.org) [33]. The VEGF -2578C>A, -1154G>A, -634G>C, and 936C>T polymorphisms were an...",225,351,PLoS_One_2012_Oct_12_7(10)_e47158.txt
634G>C,"...w.hapmap.org) [33]. The VEGF -2578C>A, -1154G>A, -634G>C, and 936C>T polymorphisms were analyzed by ...",225,361,PLoS_One_2012_Oct_12_7(10)_e47158.txt
936C>T,"...) [33]. The VEGF -2578C>A, -1154G>A, -634G>C, and 936C>T polymorphisms were analyzed by polymerase c...",225,373,PLoS_One_2012_Oct_12_7(10)_e47158.txt
2578C>A,"We used following primers: VEGF −2578C>A polymorphism, forward 5′-GGA TGG GGC TGA C...",227,34,PLoS_One_2012_Oct_12_7(10)_e47158.txt
1154G>A,"...bp (C allele) or 326 bp (A allele) product; VEGF −1154G>A polymorphism, forward 5′-CGC GTG TCT CTG G...",227,214,PLoS_One_2012_Oct_12_7(10)_e47158.txt
634G>C,"...TTC AG-3′, that amplifies a 173 bp product; VEGF −634G>C polymorphism, forward 5′-CAG GTC ACT CAC TT...",227,367,PLoS_One_2012_Oct_12_7(10)_e47158.txt
936C>T,"...TCG-3′, that amplifies a 204 bp product; and VEGF 936C>T polymorphism, forward 5′-AAG GAA GAG GAG AC...",227,527,PLoS_One_2012_Oct_12_7(10)_e47158.txt
2578C>A,The VEGF −2578C>A and −634G>C polymorphisms were identified ...,229,11,PLoS_One_2012_Oct_12_7(10)_e47158.txt
634G>C,The VEGF −2578C>A and −634G>C polymorphisms were identified by digesting ...,229,24,PLoS_One_2012_Oct_12_7(10)_e47158.txt
1154G>A,"...New England Biolabs, Beverly, MA, USA). The VEGF −1154G>A polymorphism was identified by digesting t...",229,181,PLoS_One_2012_Oct_12_7(10)_e47158.txt
936C>T,...endonuclease MnlI (New England Biolabs). The VEGF 936C>T polymorphism was identified by digesting th...,229,317,PLoS_One_2012_Oct_12_7(10)_e47158.txt
2578C>A,"...yamoya patients and control subjects of the VEGF −2578C>A, −1154G>A, −634G>C, and 936C>T polymorphis...",244,194,PLoS_One_2012_Oct_12_7(10)_e47158.txt
1154G>A,"...ients and control subjects of the VEGF −2578C>A, −1154G>A, −634G>C, and 936C>T polymorphisms and the...",244,204,PLoS_One_2012_Oct_12_7(10)_e47158.txt
634G>C,"...control subjects of the VEGF −2578C>A, −1154G>A, −634G>C, and 936C>T polymorphisms and the KDR −604T...",244,214,PLoS_One_2012_Oct_12_7(10)_e47158.txt
936C>T,"...ects of the VEGF −2578C>A, −1154G>A, −634G>C, and 936C>T polymorphisms and the KDR −604T>C, 1192G>A,...",244,226,PLoS_One_2012_Oct_12_7(10)_e47158.txt
604T>C,"...A, −634G>C, and 936C>T polymorphisms and the KDR −604T>C, 1192G>A, and 1719T>A polymorphisms is show...",244,260,PLoS_One_2012_Oct_12_7(10)_e47158.txt
1192G>A,"...>C, and 936C>T polymorphisms and the KDR −604T>C, 1192G>A, and 1719T>A polymorphisms is shown in Tab...",244,268,PLoS_One_2012_Oct_12_7(10)_e47158.txt
1719T>A,"...T polymorphisms and the KDR −604T>C, 1192G>A, and 1719T>A polymorphisms is shown in Table 2. There w...",244,281,PLoS_One_2012_Oct_12_7(10)_e47158.txt
634G>C,... S1). Our results potentially implicate the VEGF −634G>C polymorphism in the development of collater...,250,412,PLoS_One_2012_Oct_12_7(10)_e47158.txt
634 G>C,"...ion, as suggested by the data in our study, VEGF −634 G>C may be a possible prognostic biomarker aft...",265,59,PLoS_One_2012_Oct_12_7(10)_e47158.txt
677C>T,"... Nagel D , Lohse P  (2006 ) Effects of the common 677C>T mutation of the 5,10-methylenetetrahydrofol...",235,91,PLoS_One_2012_Sep_26_7(9)_e46276.txt
18S > G,...otal RNA. The expression levels of the genes were 18S > GAPDH > RPS8 > > EF1alpha > PUB-2> TubB > Ac...,96,184,PLoS_One_2013_Apr_18_8(4)_e60740.txt
18S > G,The expression levels of the tested genes were 18S > GAPDH > RPS8 > > EF1alpha > PUB-2> TubB > Ac...,158,48,PLoS_One_2013_Apr_18_8(4)_e60740.txt
17L>A,...2 Mb and encompasses a core set of nine genes (MPV17L>ABCC6). This particular interval has shown to ...,157,260,PLoS_One_2013_Apr_18_8(4)_e61365.txt
1Y>A,"...(Y) did not influence export of the resulting PbCP1Y>AGFP fusion protein to the RBC cytosol, resembl...",42,479,PLoS_One_2013_Apr_26_8(4)_e61482.txt
1R>A,...ne residue abolished export of the respective PbCP1R>AGFP chimera and led to the accumulation of thi...,42,786,PLoS_One_2013_Apr_26_8(4)_e61482.txt
1L>A,"...chimera; in ∼40% of the expressing parasites, PbCP1L>AGFP was not exported and accumulated at the PP...",42,1368,PLoS_One_2013_Apr_26_8(4)_e61482.txt
1R>A,...e first PEXEL residue (R) abolished export of PbCP1R>AGFP and led to the accumulation of the respect...,46,69,PLoS_One_2013_Apr_26_8(4)_e61482.txt
1L>A,...ifferent phenotypes could be observed for the PbCP1L>AGFP mutant. Mutation of the last PEXEL residue...,46,221,PLoS_One_2013_Apr_26_8(4)_e61482.txt
1Y>A,...(Y) did not influence export of the resulting PbCP1Y>AGFP fusion protein to the RBC cytosol and the ...,46,322,PLoS_One_2013_Apr_26_8(4)_e61482.txt
436A>G,...identification of PD-specific SLC41A1 variants (c.436A>G resulting in p.K146E; c.1440A>G resulting i...,19,139,PLoS_One_2013_Aug_15_8(8)_e71096.txt
1440A>G,...LC41A1 variants (c.436A>G resulting in p.K146E; c.1440A>G resulting in p.P480P; and c.552+50G>A) in ...,19,170,PLoS_One_2013_Aug_15_8(8)_e71096.txt
50G>A,....K146E; c.1440A>G resulting in p.P480P; and c.552+50G>A) in the Chinese population [24] and of the v...,19,210,PLoS_One_2013_Aug_15_8(8)_e71096.txt
1049C>T,...1 carrying the amino acid substitution p.A350V (c.1049C>T) in one PD patient of Caucasian origin [23...,19,326,PLoS_One_2013_Aug_15_8(8)_e71096.txt
698G>T,"Furthermore, the null mutation c.698G>T resulting in skipping of exon 6 of SLC41A1 ...",21,34,PLoS_One_2013_Aug_15_8(8)_e71096.txt
1049C>T,...with an N-terminal HA-strep tag. Point mutation c.1049C>T (p.A350V) was introduced by PCR-site-direc...,27,338,PLoS_One_2013_Aug_15_8(8)_e71096.txt
1049C>T,...SH-HA-strep-SLC41A1 and pNTGSH-HA-strep-SLC41A1-c.1049C>T were separately electroporated into the Fl...,27,549,PLoS_One_2013_Aug_15_8(8)_e71096.txt
1049C>T,"...h transgenic variants of SLC41A1, namely wt and c.1049C>T, by the quantitative real time PCR (q-RT-P...",37,97,PLoS_One_2013_Aug_15_8(8)_e71096.txt
1049C>T,...Quantitative real time PCR analysis of SLC41A1-(c.1049C>T) expression in -tet and +tet cells. The dd...,75,366,PLoS_One_2013_Aug_15_8(8)_e71096.txt
1049C>T,...ignificantly higher amount of ∼14.25 fold (+tet c.1049C>T ddCt mean 144.9±34.62/-tet c.1049C>T ddCt ...,76,337,PLoS_One_2013_Aug_15_8(8)_e71096.txt
1049C>T,...fold (+tet c.1049C>T ddCt mean 144.9±34.62/-tet c.1049C>T ddCt mean 10.17±0.79; P = 1.84e-08) of the...,76,374,PLoS_One_2013_Aug_15_8(8)_e71096.txt
1049C>T,"...t mean 10.17±0.79; P = 1.84e-08) of the SLC41A1-c.1049C>T transcript was detected, when compared wit...",76,435,PLoS_One_2013_Aug_15_8(8)_e71096.txt
1049C>T,...ow whether the over-expression of wt SLC41A1 or c.1049C>T mutant could influence the expression of S...,76,709,PLoS_One_2013_Aug_15_8(8)_e71096.txt
738409 C>G,...merous recent studies have established that the rs738409 C>G polymorphism encoding for the PNPLA3 I1...,120,2645,PLoS_One_2013_Aug_19_8(8)_e71538.txt
14C>T,"...stic callus formation. The causative mutation, c.-14C>T in the 5'-untranslated region of IFITM5, was...",7,562,PLoS_One_2013_Aug_20_8(8)_e72337.txt
14C>T,"...ine. Recently, a recurrent mutation in IFITM5 (c.-14C>T) has been found to be responsible for OI typ...",16,495,PLoS_One_2013_Aug_20_8(8)_e72337.txt
14C>T,...ng candidate gene for IO type V. The mutation (c.-14C>T) was predicted to generate an in-frame trans...,69,743,PLoS_One_2013_Aug_20_8(8)_e72337.txt
14C>T,"...r sequencing, we identified the same mutation (c.-14C>T) in proband 4 (Figure 3). Furthermore, it wa...",69,961,PLoS_One_2013_Aug_20_8(8)_e72337.txt
14C>T,...f IFITM5 identified the identical heterozygous c.-14C>T mutation (black arrow) in all the affected p...,71,112,PLoS_One_2013_Aug_20_8(8)_e72337.txt
14C>T,...arch on the function of the specific mutation (c.-14C>T) may help us gain a better understanding of ...,84,1752,PLoS_One_2013_Aug_20_8(8)_e72337.txt
14C>T,...variability despite the presence of the IFITM5 c.-14C>T mutation in all patients . J Med Genet 50 : ...,121,174,PLoS_One_2013_Aug_20_8(8)_e72337.txt
751027 G>A,...ication cohort identified the strongest SNP BICF2P751027 G>A at g.22737570 bp (p = 6.3×10−05). The s...,98,325,PLoS_One_2013_Aug_7_8(8)_e70903.txt
1308530 T>C,...e entire study cohort was found for the SNP BICF2P1308530 T>C at g.22785650 bp for the T allele (p =...,98,452,PLoS_One_2013_Aug_7_8(8)_e70903.txt
308G>A,"..., gender and ethnicity matched controls for TNFA -308G>A, NFkB1 -94ATTG ins/del and NFKBIA (-826C>T ...",14,132,PLoS_One_2013_Dec_4_8(12)_e81999.txt
826C>T,"... TNFA -308G>A, NFkB1 -94ATTG ins/del and NFKBIA (-826C>T and 3’UTRA>G) polymorphisms using PCR alone...",14,175,PLoS_One_2013_Dec_4_8(12)_e81999.txt
826C>T,"...ed risk of ESCC in females. Haplotypes of NFKBIA -826C>T and 3’UTRA>G polymorphisms, C-826G3’UTR and...",18,238,PLoS_One_2013_Dec_4_8(12)_e81999.txt
826C>T,TNFA-308 and NFKBIA (-826C>T and 3’UTRA>G) polymorphisms may play role i...,21,23,PLoS_One_2013_Dec_4_8(12)_e81999.txt
308 G>A,...emiological studies exploring association of TNFA-308 G>A polymorphism with cancer risk are inconsis...,28,803,PLoS_One_2013_Dec_4_8(12)_e81999.txt
826 C>T,...NFKB1 (-94 ATTG ins/del; rs28720239) and NFKBIA (-826 C>T; rs2233406) and 3’UTR region of NFKBIA (3’...,30,1292,PLoS_One_2013_Dec_4_8(12)_e81999.txt
308 G>A,"...nt study, we investigated the association of TNFA-308 G>A, NFKB1 -94ATTG ins/del and NFKBIA (-826 C>...",30,1580,PLoS_One_2013_Dec_4_8(12)_e81999.txt
826 C>T,"... TNFA-308 G>A, NFKB1 -94ATTG ins/del and NFKBIA (-826 C>T and 3’UTR A>G) polymorphisms with suscepti...",30,1624,PLoS_One_2013_Dec_4_8(12)_e81999.txt
308 G>A,...d salting out method [31]. The genotyping of TNFA-308 G>A and NFKB1 -94ins/del ATTG polymorphisms we...,42,251,PLoS_One_2013_Dec_4_8(12)_e81999.txt
826 C>T,"...equences as described previously [32,33]. NFKBIA -826 C>T and 3’UTR A>G polymorphisms were genotyped...",42,406,PLoS_One_2013_Dec_4_8(12)_e81999.txt
308 G>A,"...ati Indian population in Hapmap database for TNFA-308 G>A polymorphism) and genetic effect of 2.0, t...",48,165,PLoS_One_2013_Dec_4_8(12)_e81999.txt
308 G>A,"Association of the TNFA-308 G>A, NFKB1 -94ATTG ins/del and NFKBIA (-826 C>...",89,25,PLoS_One_2013_Dec_4_8(12)_e81999.txt
826 C>T,"... TNFA-308 G>A, NFKB1 -94ATTG ins/del and NFKBIA (-826 C>T and 3’ UTR A>G) polymorphisms with overall...",89,69,PLoS_One_2013_Dec_4_8(12)_e81999.txt
308 G>A,... each case). When genotypic distribution of TNFA -308 G>A polymorphism was compared between cases an...,90,189,PLoS_One_2013_Dec_4_8(12)_e81999.txt
826 C>T,"...o associations of NFKB1 -94 ins/del, and NFKBIA (-826 C>T and 3’UTR A>G) polymorphisms were observed...",90,584,PLoS_One_2013_Dec_4_8(12)_e81999.txt
308 G>A,TNFA-308 G>A polymorphism,94,6,PLoS_One_2013_Dec_4_8(12)_e81999.txt
826 C>T,NFKBIA -826 C>T polymorphism,108,9,PLoS_One_2013_Dec_4_8(12)_e81999.txt
308 G>A,"...ion analysis showed no significant effect of TNFA-308 G>A, NFKB1 -94ATTG ins/del, NFKBIA (-826 C>T a...",125,90,PLoS_One_2013_Dec_4_8(12)_e81999.txt
826 C>T,"... of TNFA-308 G>A, NFKB1 -94ATTG ins/del, NFKBIA (-826 C>T and 3’UTR A>G) polymorphisms on the surviv...",125,131,PLoS_One_2013_Dec_4_8(12)_e81999.txt
308 G>A,TNFA -308 G>A polymorphism,130,7,PLoS_One_2013_Dec_4_8(12)_e81999.txt
826 C>T,NFKBIA -826 C>T polymorphism,140,9,PLoS_One_2013_Dec_4_8(12)_e81999.txt
308 G>A,TNFA-308 G>A polymorphism,174,7,PLoS_One_2013_Dec_4_8(12)_e81999.txt
826 C>T,NFKBIA -826 C>T polymorphism,180,10,PLoS_One_2013_Dec_4_8(12)_e81999.txt
308 G>A,TNFA -308 G>A polymorphis,198,7,PLoS_One_2013_Dec_4_8(12)_e81999.txt
826 C>T,NFKBIA -826 C>T polymorphis,209,9,PLoS_One_2013_Dec_4_8(12)_e81999.txt
308 G>A,"Association of the TNFA-308 G>A, NFKB1 -94ATTG ins/del and NFKBIA polymorp...",222,25,PLoS_One_2013_Dec_4_8(12)_e81999.txt
308 G>A,TNFA -308 G>A polymorphism,228,7,PLoS_One_2013_Dec_4_8(12)_e81999.txt
826 C>T,NFKBIA -826 C>T polymorphism,238,9,PLoS_One_2013_Dec_4_8(12)_e81999.txt
826 C>T,... disequilibrium (LD) analysis showed that NFKBIA -826 C>T and 3’UTR A>G polymorphisms were in modera...,254,58,PLoS_One_2013_Dec_4_8(12)_e81999.txt
308 G>A,"Combined risk genotype analysis of TNFA-308 G>A, NFKB1 -94ATTG ins/del and NFKBIA (-826 C>...",264,41,PLoS_One_2013_Dec_4_8(12)_e81999.txt
826 C>T,"... TNFA-308 G>A, NFKB1 -94ATTG ins/del and NFKBIA (-826 C>T and 3’UTR A>G) polymorphism",264,85,PLoS_One_2013_Dec_4_8(12)_e81999.txt
308 G>A,...northern Indian population. We observed that TNFA-308 G>A polymorphism was associated with enhanced ...,290,395,PLoS_One_2013_Dec_4_8(12)_e81999.txt
826 C>T,... role of either NFKB1 -94ATTG ins/del or NFKBIA (-826 C>T and 3’UTR A>G) polymorphisms in ESCC susce...,290,599,PLoS_One_2013_Dec_4_8(12)_e81999.txt
308 G>A,The MAF of TNFA -308 G>A polymorphism in present study was 7.1% whi...,292,18,PLoS_One_2013_Dec_4_8(12)_e81999.txt
308 G>A,...ies did not find independent association of TNFA -308 G>A polymorphism with susceptibility to gastro...,293,579,PLoS_One_2013_Dec_4_8(12)_e81999.txt
826C>T,"...ation of two functional polymorphisms in NFKBIA (-826C>T and 3’UTRA>G) with ESCC susceptibility, how...",295,1007,PLoS_One_2013_Dec_4_8(12)_e81999.txt
826 C>T,...ypes. Bioinformatics analysis showed that NFKBIA -826 C>T polymorphism may affect binding of transcr...,305,209,PLoS_One_2013_Dec_4_8(12)_e81999.txt
308 G>A,"...ry, our results suggest independent role of TNFA -308 G>A polymorphism and combined effect of TNFA a...",311,59,PLoS_One_2013_Dec_4_8(12)_e81999.txt
308 G>A,"Table S1 Details of genotyping methods of TNFA-308 G>A, NFKB1 -94ATTG ins/del and NFKBIA (-826 C>...",314,48,PLoS_One_2013_Dec_4_8(12)_e81999.txt
826 C>T,"... TNFA-308 G>A, NFKB1 -94ATTG ins/del and NFKBIA (-826 C>T and 3’UTR A>G) polymorphisms",314,92,PLoS_One_2013_Dec_4_8(12)_e81999.txt
308G>A,"...achan R , Mittal B  (2009 ) Association of TNFA (-308G>A) and IL-10 (-819C>T) promoter polymorphisms...",339,74,PLoS_One_2013_Dec_4_8(12)_e81999.txt
819C>T,...(2009 ) Association of TNFA (-308G>A) and IL-10 (-819C>T) promoter polymorphisms with risk of cervic...,339,94,PLoS_One_2013_Dec_4_8(12)_e81999.txt
174G>C,... Mittal B  (2008 ) Association of interleukin-6 (-174G>C) promoter polymorphism with risk of squamou...,366,98,PLoS_One_2013_Dec_4_8(12)_e81999.txt
19G>A,...ttal B  (2011 ) CASP8 -652 6N del and CASP8 IVS12-19G>A gene polymorphisms and susceptibility/progno...,380,101,PLoS_One_2013_Dec_4_8(12)_e81999.txt
31G>C,...1 ) Role of survivin gene promoter polymorphism (-31G>C) in susceptibility and survival of esophagea...,381,116,PLoS_One_2013_Dec_4_8(12)_e81999.txt
20210 G->A,...atient was heterozygous for the prothrombin gene G20210 G->A mutation. The Jak2 mutation was detecte...,112,734,PLoS_One_2013_Dec_5_8(12)_e81574.txt
6107C>A,"...(III-6). We found nonsense mutation in CACNA1A (c.6107C>A, exon 40, NM_001127221.1) in all three pat...",56,386,PLoS_One_2013_Feb_18_8(2)_e56362.txt
6107C>A,"...irmation of a heterozygous mutation in CACNA1A (c.6107C>A, NM_001127221.1, p.Tyr1957Ter, NP_00112069...",59,348,PLoS_One_2013_Feb_18_8(2)_e56362.txt
8850G>T,... pEGFP-C1 (DSS1) or pGEX-4T1 (BRCA2). The BRCA2 c.8850G>T (p.Lys2950Asn) variant was inserted by dir...,38,263,PLoS_One_2013_Feb_22_8(2)_e57173.txt
2T>G,IVS7+2T>G	c.441+2T>G	D	skipping of 62 bp at the3′-end o...,61,6,PLoS_One_2013_Feb_22_8(2)_e57173.txt
2T>G,IVS7+2T>G	c.441+2T>G	D	skipping of 62 bp at the3′-end of exon 7	r....,61,17,PLoS_One_2013_Feb_22_8(2)_e57173.txt
2T>A,IVS8+2T>Ac	c.547+2T>A	D	skipping of exon 8	r.[442_547de...,62,6,PLoS_One_2013_Feb_22_8(2)_e57173.txt
2T>A,IVS8+2T>Ac	c.547+2T>A	D	skipping of exon 8	r.[442_547del]	mono-alle...,62,18,PLoS_One_2013_Feb_22_8(2)_e57173.txt
1G>T,IVS16+1G>T	c.4986+1G>T	D	retention of 65 bp at the5′-end...,63,7,PLoS_One_2013_Feb_22_8(2)_e57173.txt
1G>T,IVS16+1G>T	c.4986+1G>T	D	retention of 65 bp at the5′-end of intron 1...,63,19,PLoS_One_2013_Feb_22_8(2)_e57173.txt
1G>A,IVS16−1G>A	c.4987−1G>A	A	skipping of exon 17	r.[4987_507...,64,7,PLoS_One_2013_Feb_22_8(2)_e57173.txt
1G>A,IVS16−1G>A	c.4987−1G>A	A	skipping of exon 17	r.[4987_5074del]	mono-a...,64,19,PLoS_One_2013_Feb_22_8(2)_e57173.txt
1G>A,IVS21+1G>A	c.5332+1G>A	D	skipping of exon 21	r.[5278_533...,66,7,PLoS_One_2013_Feb_22_8(2)_e57173.txt
1G>A,IVS21+1G>A	c.5332+1G>A	D	skipping of exon 21	r.[5278_5332del]	mono-a...,66,19,PLoS_One_2013_Feb_22_8(2)_e57173.txt
1G>A,IVS5+1G>A	c.475+1G>A	D	skipping of exon 5	r.[426_475del...,68,6,PLoS_One_2013_Feb_22_8(2)_e57173.txt
1G>A,IVS5+1G>A	c.475+1G>A	D	skipping of exon 5	r.[426_475del]	mono-alle...,68,17,PLoS_One_2013_Feb_22_8(2)_e57173.txt
2A>G,IVS5−2A>Gd	c.476−2A>G	A	skipping of exons 6;up-regulati...,69,6,PLoS_One_2013_Feb_22_8(2)_e57173.txt
2A>G,IVS5−2A>Gd	c.476−2A>G	A	skipping of exons 6;up-regulation of Δexons...,69,18,PLoS_One_2013_Feb_22_8(2)_e57173.txt
2A>T,IVS13−2A>Te*	c.7008−2A>T	A	skipping of exon 14;skipping ...,70,7,PLoS_One_2013_Feb_22_8(2)_e57173.txt
2A>T,IVS13−2A>Te*	c.7008−2A>T	A	skipping of exon 14;skipping of 10 bp at 5′...,70,21,PLoS_One_2013_Feb_22_8(2)_e57173.txt
1G>A,IVS21−1G>Af*	c.8755−1G>A	A	skipping of exon 22; skipping...,71,7,PLoS_One_2013_Feb_22_8(2)_e57173.txt
1G>A,IVS21−1G>Af*	c.8755−1G>A	A	skipping of exon 22; skipping of exon22+51 ...,71,21,PLoS_One_2013_Feb_22_8(2)_e57173.txt
331G>A,331G>Ac	c.212G>A	D	up-regulation of Δexon5q isofor...,92,1,PLoS_One_2013_Feb_22_8(2)_e57173.txt
212G>A,331G>Ac	c.212G>A	D	up-regulation of Δexon5q isoform	r.[191_2...,92,11,PLoS_One_2013_Feb_22_8(2)_e57173.txt
11T>G,IVS5−11T>Gd	c.213−11T>G	A	retention of 59 bp atthe 3′-e...,93,6,PLoS_One_2013_Feb_22_8(2)_e57173.txt
11T>G,IVS5−11T>Gd	c.213−11T>G	A	retention of 59 bp atthe 3′-end of intron ...,93,19,PLoS_One_2013_Feb_22_8(2)_e57173.txt
4A>G,IVS9−4A>G	c.594−4A>G	A	none	r.[ = ]	bi-allelic	none	p. ...,95,6,PLoS_One_2013_Feb_22_8(2)_e57173.txt
4A>G,IVS9−4A>G	c.594−4A>G	A	none	r.[ = ]	bi-allelic	none	p. = 	2,95,17,PLoS_One_2013_Feb_22_8(2)_e57173.txt
4216G>A,4216G>A	c.4097G>A	A	none	r.[4097g>a]	bi-allelic	aa...,96,1,PLoS_One_2013_Feb_22_8(2)_e57173.txt
4097G>A,4216G>A	c.4097G>A	A	none	r.[4097g>a]	bi-allelic	aa change at...,96,11,PLoS_One_2013_Feb_22_8(2)_e57173.txt
4603G>T,4603G>Te	c.4484G>T	D	skipping of exon 14	r.[4358_4...,97,1,PLoS_One_2013_Feb_22_8(2)_e57173.txt
4484G>T,4603G>Te	c.4484G>T	D	skipping of exon 14	r.[4358_4484del]	mon...,97,12,PLoS_One_2013_Feb_22_8(2)_e57173.txt
5G>A,IVS16+5G>A	c.4986+5G>A	D	retention of 65 bp atthe 5′-end...,98,7,PLoS_One_2013_Feb_22_8(2)_e57173.txt
5G>A,IVS16+5G>A	c.4986+5G>A	D	retention of 65 bp atthe 5′-end of intron 1...,98,19,PLoS_One_2013_Feb_22_8(2)_e57173.txt
5452A>G,5452A>Gf	c.5333A>G	A	none	r.[5333a>g]	bi-allelic	a...,99,1,PLoS_One_2013_Feb_22_8(2)_e57173.txt
5333A>G,5452A>Gf	c.5333A>G	A	none	r.[5333a>g]	bi-allelic	aa change at...,99,12,PLoS_One_2013_Feb_22_8(2)_e57173.txt
859G>A,859G>Ag*	c.631G>A	D	skipping of exon 7	r.[517_631d...,101,1,PLoS_One_2013_Feb_22_8(2)_e57173.txt
631G>A,859G>Ag*	c.631G>A	D	skipping of exon 7	r.[517_631del]	mono-al...,101,12,PLoS_One_2013_Feb_22_8(2)_e57173.txt
3G>C,IVS21+3G>Ch*	c.8754+3G>C	D	retention of 46 bp atthe 5′-e...,102,7,PLoS_One_2013_Feb_22_8(2)_e57173.txt
3G>C,IVS21+3G>Ch*	c.8754+3G>C	D	retention of 46 bp atthe 5′-end of intron 2...,102,21,PLoS_One_2013_Feb_22_8(2)_e57173.txt
9344C>T,9344C>Ti*	c.9116C>T	D	none	r.[9116c>u]	bi-allelic	...,103,1,PLoS_One_2013_Feb_22_8(2)_e57173.txt
9116C>T,9344C>Ti*	c.9116C>T	D	none	r.[9116c>u]	bi-allelic	aa change at...,103,13,PLoS_One_2013_Feb_22_8(2)_e57173.txt
9345G>A,9345G>Aj	c.9117G>A	D	skipping of exon 23	r.[8954_9...,104,1,PLoS_One_2013_Feb_22_8(2)_e57173.txt
9117G>A,9345G>Aj	c.9117G>A	D	skipping of exon 23	r.[8954_9117del]	mon...,104,12,PLoS_One_2013_Feb_22_8(2)_e57173.txt
2T>A,"... been already analyzed in previous studies (c.547+2T>A in BRCA1, and c.476−2A>G, c.7008−2A>T, c.8755...",125,104,PLoS_One_2013_Feb_22_8(2)_e57173.txt
2A>G,"... previous studies (c.547+2T>A in BRCA1, and c.476−2A>G, c.7008−2A>T, c.8755−1G>A and c.8954−1_8955de...",125,129,PLoS_One_2013_Feb_22_8(2)_e57173.txt
2A>T,"...dies (c.547+2T>A in BRCA1, and c.476−2A>G, c.7008−2A>T, c.8755−1G>A and c.8954−1_8955delGTTinsAA in ...",125,142,PLoS_One_2013_Feb_22_8(2)_e57173.txt
1G>A,"...T>A in BRCA1, and c.476−2A>G, c.7008−2A>T, c.8755−1G>A and c.8954−1_8955delGTTinsAA in BRCA2) [18], ...",125,155,PLoS_One_2013_Feb_22_8(2)_e57173.txt
2T>G,"...[43]–[45] and 6 not previously characterized (441+2T>G, c.4986+1G>T, c.4987−1G>A, c.5278−2delA, c.53...",125,261,PLoS_One_2013_Feb_22_8(2)_e57173.txt
1G>T,"... 6 not previously characterized (441+2T>G, c.4986+1G>T, c.4987−1G>A, c.5278−2delA, c.5332+1G>A in BR...",125,274,PLoS_One_2013_Feb_22_8(2)_e57173.txt
1G>A,"...usly characterized (441+2T>G, c.4986+1G>T, c.4987−1G>A, c.5278−2delA, c.5332+1G>A in BRCA1and c.475+...",125,287,PLoS_One_2013_Feb_22_8(2)_e57173.txt
1G>A,"...G, c.4986+1G>T, c.4987−1G>A, c.5278−2delA, c.5332+1G>A in BRCA1and c.475+1G>A in BRCA2). In particul...",125,314,PLoS_One_2013_Feb_22_8(2)_e57173.txt
1G>A,"...1G>A, c.5278−2delA, c.5332+1G>A in BRCA1and c.475+1G>A in BRCA2). In particular, BRCA1 c.547+2T>A, c...",125,337,PLoS_One_2013_Feb_22_8(2)_e57173.txt
2T>A,"... c.475+1G>A in BRCA2). In particular, BRCA1 c.547+2T>A, c.4987−1G>A and c.5332+1G>A caused the loss ...",125,380,PLoS_One_2013_Feb_22_8(2)_e57173.txt
1G>A,"...n BRCA2). In particular, BRCA1 c.547+2T>A, c.4987−1G>A and c.5332+1G>A caused the loss of the whole ...",125,393,PLoS_One_2013_Feb_22_8(2)_e57173.txt
1G>A,"...ticular, BRCA1 c.547+2T>A, c.4987−1G>A and c.5332+1G>A caused the loss of the whole exons 8, 17 and ...",125,409,PLoS_One_2013_Feb_22_8(2)_e57173.txt
1G>A,"...and 21, respectively (Fig. 1A–C), and BRCA2 c.475+1G>A resulted in the loss of exon 5 (Fig. 1D). In ...",125,505,PLoS_One_2013_Feb_22_8(2)_e57173.txt
2T>G,...s of exon 7 (62 bp at the 3′-end) for BRCA1 c.441+2T>G (Fig. 1E) and partial retention of intron 16 ...,125,678,PLoS_One_2013_Feb_22_8(2)_e57173.txt
1G>T,... intron 16 (65 bp at the 5′-end) for BRCA1 c.4986+1G>T (Fig. 1F). BRCA2 c.476−2A>G was found to give...,125,767,PLoS_One_2013_Feb_22_8(2)_e57173.txt
2A>G,...end) for BRCA1 c.4986+1G>T (Fig. 1F). BRCA2 c.476−2A>G was found to give rise to an abnormal transcr...,125,795,PLoS_One_2013_Feb_22_8(2)_e57173.txt
1G>A,"...at the 5′-end of exon 21) (Fig. 1H), BRCA2 c.8755−1G>A (one lacking exon 22 and another exon 22 plus...",125,1166,PLoS_One_2013_Feb_22_8(2)_e57173.txt
1G>A,"...-end of exon 23) (Fig. 1J). Notably, BRCA2 c.8755−1G>A and c.8954−1_8955delGTTinsAA mutations led to...",125,1392,PLoS_One_2013_Feb_22_8(2)_e57173.txt
2A>T,"...splice site in exon 23. Finally, the BRCA2 c.7008−2A>T variant was observed to give rise to 3 aberra...",125,1528,PLoS_One_2013_Feb_22_8(2)_e57173.txt
212G>A,"...s of group B included 6 already analyzed (BRCA1 c.212G>A, c.213−11T>G, and c.4484G>T, and BRCA2 c.63...",130,72,PLoS_One_2013_Feb_22_8(2)_e57173.txt
11T>G,"...ncluded 6 already analyzed (BRCA1 c.212G>A, c.213−11T>G, and c.4484G>T, and BRCA2 c.631G>A, c.8754+3...",130,86,PLoS_One_2013_Feb_22_8(2)_e57173.txt
4484G>T,"...eady analyzed (BRCA1 c.212G>A, c.213−11T>G, and c.4484G>T, and BRCA2 c.631G>A, c.8754+3G>C, and c.91...",130,99,PLoS_One_2013_Feb_22_8(2)_e57173.txt
631G>A,"...c.212G>A, c.213−11T>G, and c.4484G>T, and BRCA2 c.631G>A, c.8754+3G>C, and c.9117G>A) [11], [18], [1...",130,120,PLoS_One_2013_Feb_22_8(2)_e57173.txt
3G>C,"...−11T>G, and c.4484G>T, and BRCA2 c.631G>A, c.8754+3G>C, and c.9117G>A) [11], [18], [19], [21], [22],...",130,135,PLoS_One_2013_Feb_22_8(2)_e57173.txt
9117G>A,"...c.4484G>T, and BRCA2 c.631G>A, c.8754+3G>C, and c.9117G>A) [11], [18], [19], [21], [22], [26], [44]–...",130,147,PLoS_One_2013_Feb_22_8(2)_e57173.txt
5G>A,"...newly characterized (c.134+3_134+6delAAGT, c.4986+5G>A in BRCA1). Three mutations caused the skippin...",130,258,PLoS_One_2013_Feb_22_8(2)_e57173.txt
4484G>T,"...ns caused the skipping of an entire exon: BRCA1 c.4484G>T (exon 14) (Fig. 2A), BRCA2 c.631G>A (exon ...",130,337,PLoS_One_2013_Feb_22_8(2)_e57173.txt
631G>A,"...xon: BRCA1 c.4484G>T (exon 14) (Fig. 2A), BRCA2 c.631G>A (exon 7) (Fig. 2B) and BRCA2 c.9117G>A (exo...",130,374,PLoS_One_2013_Feb_22_8(2)_e57173.txt
9117G>A,"...A), BRCA2 c.631G>A (exon 7) (Fig. 2B) and BRCA2 c.9117G>A (exon 23) (Fig. 2C). Conversely, partial i...",130,412,PLoS_One_2013_Feb_22_8(2)_e57173.txt
11T>G,"...cryptic splice sites was observed for BRCA1 c.213−11T>G (59 bp at the 3′-end of intron 5) (Fig. 2D),...",130,558,PLoS_One_2013_Feb_22_8(2)_e57173.txt
5G>A,"...t the 3′-end of intron 5) (Fig. 2D), BRCA1 c.4986+5G>A (65 bp at the 5′-end of intron 16) (Fig. 2E),...",130,622,PLoS_One_2013_Feb_22_8(2)_e57173.txt
3G>C,"...end of intron 16) (Fig. 2E), and for BRCA2 c.8754+3G>C (46 bp at the 5′-end of intron 21) (Fig. 2F)....",130,694,PLoS_One_2013_Feb_22_8(2)_e57173.txt
212G>A,"...F). Finally, the BRCA1 c.134+3_134+6delAAGT and c.212G>A variants were associated with a relevant in...",130,791,PLoS_One_2013_Feb_22_8(2)_e57173.txt
2A>G,"...are reported in Table S2. In 2 cases, BRCA2 c.476−2A>G and c.8755−1G>A, cDNA sequence analyses revea...",135,406,PLoS_One_2013_Feb_22_8(2)_e57173.txt
1G>A,"...Table S2. In 2 cases, BRCA2 c.476−2A>G and c.8755−1G>A, cDNA sequence analyses revealed maintenance ...",135,422,PLoS_One_2013_Feb_22_8(2)_e57173.txt
1114C>A,...ce of the constitutional heterozygosity for the c.1114C>A SNP (exon 10; rs144848) and the c.9876G>A ...,135,519,PLoS_One_2013_Feb_22_8(2)_e57173.txt
9876G>A,"...r the c.1114C>A SNP (exon 10; rs144848) and the c.9876G>A synonymous change (exon 27), respectively ...",135,561,PLoS_One_2013_Feb_22_8(2)_e57173.txt
2A>G,"... A total of 23 clones were analyzed for the c.476−2A>G mutation. Of these, 20 (87%) carried the rs14...",135,913,PLoS_One_2013_Feb_22_8(2)_e57173.txt
1G>A,"... A allele. Of the 52 clones analyzed for the 8755−1G>A mutation, 47 (90%) carried the G allele and 5...",135,1042,PLoS_One_2013_Feb_22_8(2)_e57173.txt
1G>T,...e assessed for 2 intronic mutations (BRCA1 c.4986+1G>T and c.134+3_134+6delAAGT) due to the lack of ...,137,339,PLoS_One_2013_Feb_22_8(2)_e57173.txt
5333A>G,"...emaining 5 variants of group B, including BRCA1 c.5333A>G and BRCA2 c.9116C>T, already analyzed [20]...",139,94,PLoS_One_2013_Feb_22_8(2)_e57173.txt
9116C>T,"...of group B, including BRCA1 c.5333A>G and BRCA2 c.9116C>T, already analyzed [20]–[22] and BRCA1 c.54...",139,114,PLoS_One_2013_Feb_22_8(2)_e57173.txt
4A>G,"...y analyzed [20]–[22] and BRCA1 c.548−3delT, c.594−4A>G, c.4097G>A, not previously characterized. To ...",139,179,PLoS_One_2013_Feb_22_8(2)_e57173.txt
4097G>A,"...ed [20]–[22] and BRCA1 c.548−3delT, c.594−4A>G, c.4097G>A, not previously characterized. To account ...",139,187,PLoS_One_2013_Feb_22_8(2)_e57173.txt
212G>A,c.212G>A	YES	−100%; S (C)	−81.6%; S (C)	−100%; S (C)...,160,3,PLoS_One_2013_Feb_22_8(2)_e57173.txt
11T>G,c.213−11T>G	YES	−100%; S (C)	−100%; S (C)			−4.1%; S (C)...,161,7,PLoS_One_2013_Feb_22_8(2)_e57173.txt
4A>G,c.594−4A>G	NO	0.0%; NS (C)	+1.5; NS (C)	−1.6%; NS (C)	+1...,163,7,PLoS_One_2013_Feb_22_8(2)_e57173.txt
4097G>A,c.4097G>A	NO	−4.4%; NS (C)	−23.4%; NS (C)	−13.9%; S ...,164,3,PLoS_One_2013_Feb_22_8(2)_e57173.txt
4484G>T,c.4484G>T	YES	−13.4%; S (C)	−47.4%; S (C)	−9.8%; S (...,165,3,PLoS_One_2013_Feb_22_8(2)_e57173.txt
5G>A,c.4986+5G>A	YES	−100%; S (C)	−100%; S (C)	−100%; S (C)		−...,166,8,PLoS_One_2013_Feb_22_8(2)_e57173.txt
5333A>G,c.5333A>G	NO	+5.4%; NS (C)	+12.3%; NS (C)	+32.5%; NS...,167,3,PLoS_One_2013_Feb_22_8(2)_e57173.txt
631G>A,c.631G>A	YES	−100%; S (C)	−100%; S (C)	−100%; S (C)	...,169,3,PLoS_One_2013_Feb_22_8(2)_e57173.txt
3G>C,c.8754+3G>C	YES	−6.3%; S (C)	−31.5; S (C)	−35.5%; S (C)	−...,170,8,PLoS_One_2013_Feb_22_8(2)_e57173.txt
9116C>T,c.9116C>T	NO		−43.6%; S (D)	−100%; S (D)		0.0%; NS (...,171,3,PLoS_One_2013_Feb_22_8(2)_e57173.txt
9117G>A,c.9117G>A	YES		−100%; S (C)	−100%; S (C)		−14.7%; S ...,172,3,PLoS_One_2013_Feb_22_8(2)_e57173.txt
2A>T,...ed mutations (BRCA1 c.5278−2delA and BRCA2 c.7008−2A>T; c.8755−1G>A; c.8954−1_8955delGTTinsAA) of mo...,176,911,PLoS_One_2013_Feb_22_8(2)_e57173.txt
1G>A,...(BRCA1 c.5278−2delA and BRCA2 c.7008−2A>T; c.8755−1G>A; c.8954−1_8955delGTTinsAA) of more than one a...,176,924,PLoS_One_2013_Feb_22_8(2)_e57173.txt
212G>A,"...taining PTCs, 2 (BRCA1 c.134+3_134+6delAAGT and c.212G>A) to the up-regulation of naturally occurrin...",179,465,PLoS_One_2013_Feb_22_8(2)_e57173.txt
2A>G,"... above, we detected 2 such mutations (BRCA2 c.476−2A>G and c.8755−1G>A). However, quantitative analy...",181,1154,PLoS_One_2013_Feb_22_8(2)_e57173.txt
1G>A,"...ted 2 such mutations (BRCA2 c.476−2A>G and c.8755−1G>A). However, quantitative analyses indicated th...",181,1170,PLoS_One_2013_Feb_22_8(2)_e57173.txt
6853A>G,"... is supported by the observation that the BRCA2 c.6853A>G variant, resulting in increased exclusion ...",191,433,PLoS_One_2013_Feb_22_8(2)_e57173.txt
6853A>G,...CA2 revealed by a comprehensive analysis of the c.6853A>G (p.I2285V) variant . Hum Mutat 30 : 1543 –...,293,160,PLoS_One_2013_Feb_22_8(2)_e57173.txt
1 Ser->Ala,"... Tsirigotis D , et al (2008 ) Muscle-specific IRS-1 Ser->Ala transgenic mice are protected from fat-...",115,93,PLoS_One_2013_Jan_10_8(1)_e53557.txt
1G>C,M4166	II:1	F	20	17	c.1708-1G>C/Pro840Leu	Hepatic	Absent	Present	Present	Pres...,41,27,PLoS_One_2013_Jul_2_8(7)_e66526.txt
411C>A,"...luding 16 polymorphisms (7 novel polymorphisms: c.411C>A (p.Ser137Ser), c.2289C>T (p.Phe763Phe), c.2...",73,84,PLoS_One_2013_Jul_2_8(7)_e66526.txt
2289C>T,"...(7 novel polymorphisms: c.411C>A (p.Ser137Ser), c.2289C>T (p.Phe763Phe), c.2502C>G (p.Val834Val), c....",73,108,PLoS_One_2013_Jul_2_8(7)_e66526.txt
2502C>G,"....411C>A (p.Ser137Ser), c.2289C>T (p.Phe763Phe), c.2502C>G (p.Val834Val), c.3973C>T (p.Leu1325Leu), c...",73,133,PLoS_One_2013_Jul_2_8(7)_e66526.txt
3973C>T,"...2289C>T (p.Phe763Phe), c.2502C>G (p.Val834Val), c.3973C>T (p.Leu1325Leu), c.3999G>T (p.Leu1333Leu), ...",73,158,PLoS_One_2013_Jul_2_8(7)_e66526.txt
3999G>T,"...502C>G (p.Val834Val), c.3973C>T (p.Leu1325Leu), c.3999G>T (p.Leu1333Leu), IVS8+26A>G, and IVS8+27G>A...",73,184,PLoS_One_2013_Jul_2_8(7)_e66526.txt
26A>G,"...>T (p.Leu1325Leu), c.3999G>T (p.Leu1333Leu), IVS8+26A>G, and IVS8+27G>A), in the ATP7B gene were obs...",73,213,PLoS_One_2013_Jul_2_8(7)_e66526.txt
27G>A,"...), c.3999G>T (p.Leu1333Leu), IVS8+26A>G, and IVS8+27G>A), in the ATP7B gene were observed by screeni...",73,229,PLoS_One_2013_Jul_2_8(7)_e66526.txt
1G>C,"...utation (c.2659delG), one splice mutation (c.1708-1G>C) and 15 missense mutations (p.Val145Phe, p.Th...",73,501,PLoS_One_2013_Jul_2_8(7)_e66526.txt
11377 C>G,The common SNP -11377 C>G (rs266729) is located in the promoter re...,27,17,PLoS_One_2013_Jun_24_8(6)_e66808.txt
45T>G,"...iations between single-nucleotide polymorphisms (+45T>G, +276G>T, −11377C>G, −11391G>A) of adiponect...",201,120,PLoS_One_2013_Jun_24_8(6)_e66808.txt
276G>T,"...between single-nucleotide polymorphisms (+45T>G, +276G>T, −11377C>G, −11391G>A) of adiponectin gene ...",201,128,PLoS_One_2013_Jun_24_8(6)_e66808.txt
11377C>G,"...ingle-nucleotide polymorphisms (+45T>G, +276G>T, −11377C>G, −11391G>A) of adiponectin gene and type ...",201,137,PLoS_One_2013_Jun_24_8(6)_e66808.txt
11391G>A,"...otide polymorphisms (+45T>G, +276G>T, −11377C>G, −11391G>A) of adiponectin gene and type 2 diabetes ...",201,148,PLoS_One_2013_Jun_24_8(6)_e66808.txt
1A>G,...ed with HSCR and meningocele. + indicates EDNRB c.1A>G; * indicates EDN3 c.-248G>A,27,206,PLoS_One_2013_Jun_26_8(6)_e66631.txt
248G>A,...le. + indicates EDNRB c.1A>G; * indicates EDN3 c.-248G>A,27,232,PLoS_One_2013_Jun_26_8(6)_e66631.txt
249C>T,Exon 2	c.249C>T (rs73415876)	Y83Y	II-6,81,10,PLoS_One_2013_Jun_26_8(6)_e66631.txt
927T>C,"Exon 4	c.927T>C (rs139884)	H309H	II-6, II-4, III-6, III-7",82,10,PLoS_One_2013_Jun_26_8(6)_e66631.txt
1A>G,...f the complete CDS of the EDNRB gene revealed a c.1A>G heterozygous DNA change in the NM_000115.3 se...,86,63,PLoS_One_2013_Jun_26_8(6)_e66631.txt
1A>G,"...iduals (I-2, III-5, III-7) (Table 1; Figure 1). c.1A>G was passed down to the family members by the ...",86,306,PLoS_One_2013_Jun_26_8(6)_e66631.txt
238G>A,"..., Liu L , Gao T  (2007 ) TNF-alpha gene promoter -238G>A and -308G>A polymorphisms alter risk of pso...",180,76,PLoS_One_2013_May_23_8(5)_e64376.txt
308G>A,...o T  (2007 ) TNF-alpha gene promoter -238G>A and -308G>A polymorphisms alter risk of psoriasis vulga...,180,88,PLoS_One_2013_May_23_8(5)_e64376.txt
3757	S>F,...ccipital Gyrus/Fusiform Gyrus	−42	63	−10.80	15.33	3757	S>F,94,66,PLoS_One_2013_May_3_8(5)_e63220.txt
1515	S>F,Left Lateral Occipital Gyrus	48	72	−3.20	13.08	1515	S>F,95,48,PLoS_One_2013_May_3_8(5)_e63220.txt
1168	F>S,Bilateral Calcarine Sulcus	−1	89	4.20	12.78	1168	F>S,96,45,PLoS_One_2013_May_3_8(5)_e63220.txt
592	F>S,Right Lingual Gyrus	−5	83	−7.60	13.30	592	F>S,97,39,PLoS_One_2013_May_3_8(5)_e63220.txt
252	S>F,Left Fusiform Gyrus	38	52	−19.30	11.73	252	S>F,98,40,PLoS_One_2013_May_3_8(5)_e63220.txt
1554	N>R,...rontal Gyrus/Temporal Pole	35.8	−23.5	−16.1	13.35	1554	N>R,100,66,PLoS_One_2013_May_3_8(5)_e63220.txt
982	N>R,Right Lingual Gyrus	−18.4	77.6	−15.9	13.86	982	N>R,101,44,PLoS_One_2013_May_3_8(5)_e63220.txt
961	N>R,Left Superior Frontal Gyrus	9.1	−25.1	60.6	12.43	961	N>R,102,50,PLoS_One_2013_May_3_8(5)_e63220.txt
829	N>R,...gdala/Substantia Innominata	−14.1	0.2	−10.6	14.97	829	N>R,103,60,PLoS_One_2013_May_3_8(5)_e63220.txt
564	N>R,...ght Lateral Occipital Gyrus	−37.9	72.4	−9.8	11.97	564	N>R,104,53,PLoS_One_2013_May_3_8(5)_e63220.txt
527	N>R,Left Insula	44.3	−17.2	−2.8	13.50	527	N>R,105,35,PLoS_One_2013_May_3_8(5)_e63220.txt
507	N>R,Left Fusiform Gyrus	35	36.5	−21.6	13.92	507	N>R,106,41,PLoS_One_2013_May_3_8(5)_e63220.txt
411	N>R,...ight Middle Occipital Gyrus	−16.7	91.5	16.5	12.23	411	N>R,107,52,PLoS_One_2013_May_3_8(5)_e63220.txt
349	N>R,Left Amygdala	18.9	1.7	−11.8	16.10	349	N>R,108,36,PLoS_One_2013_May_3_8(5)_e63220.txt
347	N>R,...ight Inferior Temporal Gyrus	−48.1	68.8	0.8	11.92	347	N>R,109,52,PLoS_One_2013_May_3_8(5)_e63220.txt
305	N>R,...ight Superior Parietal Lobule	−26	61.5	56.5	13.62	305	N>R,110,52,PLoS_One_2013_May_3_8(5)_e63220.txt
290	N>R,Left Superior Frontal Gyrus	13.5	−54.4	31.8	12.18	290	N>R,111,51,PLoS_One_2013_May_3_8(5)_e63220.txt
255	N>R,Right Lingual Gyrus	−19.5	85.4	0.8	12.61	255	N>R,112,42,PLoS_One_2013_May_3_8(5)_e63220.txt
229	N>R,Left Posterior Cingulate	3.6	46.2	14.9	12.31	229	N>R,113,46,PLoS_One_2013_May_3_8(5)_e63220.txt
3460G>A,"...hree mitochondrial DNA (mtDNA) point mutations: m.3460G>A, m.11778G>A and m.14484T>C, all of which a...",7,505,PLoS_One_2013_May_7_8(5)_e63446.txt
11778G>A,"...ondrial DNA (mtDNA) point mutations: m.3460G>A, m.11778G>A and m.14484T>C, all of which affect criti...",7,516,PLoS_One_2013_May_7_8(5)_e63446.txt
14484T>C,"...DNA) point mutations: m.3460G>A, m.11778G>A and m.14484T>C, all of which affect critical complex I s...",7,531,PLoS_One_2013_May_7_8(5)_e63446.txt
11778G>A,"...eries of three affected patients harbouring the m.11778G>A mutation, we provide evidence suggesting ...",7,878,PLoS_One_2013_May_7_8(5)_e63446.txt
3460G>A,"... one of three common causative mtDNA mutations: m.3460G>A, m.11778G>A, and m.14484T>C [3]. An intrig...",12,393,PLoS_One_2013_May_7_8(5)_e63446.txt
11778G>A,"...ee common causative mtDNA mutations: m.3460G>A, m.11778G>A, and m.14484T>C [3]. An intriguing, and a...",12,404,PLoS_One_2013_May_7_8(5)_e63446.txt
14484T>C,"...ive mtDNA mutations: m.3460G>A, m.11778G>A, and m.14484T>C [3]. An intriguing, and as yet unexplaine...",12,420,PLoS_One_2013_May_7_8(5)_e63446.txt
11778G>A,"... series of three affected patients carrying the m.11778G>A mtDNA mutation, we provide evidence sugge...",12,1655,PLoS_One_2013_May_7_8(5)_e63446.txt
11778G>A,...entually revealed the presence of a homoplasmic m.11778G>A LHON mutation as the cause of this patien...,16,1465,PLoS_One_2013_May_7_8(5)_e63446.txt
11778G>A,...ted shortly after molecular confirmation of the m.11778G>A LHON mutation			Idebenone 300 mg tds – no...,33,88,PLoS_One_2013_May_7_8(5)_e63446.txt
11778G>A,...onfirmed by the identification of a homoplasmic m.11778G>A LHON mutation,39,1388,PLoS_One_2013_May_7_8(5)_e63446.txt
11778G>A,... the patient was found to harbour a homoplasmic m.11778G>A LHON mutation during his investigative wo...,45,1097,PLoS_One_2013_May_7_8(5)_e63446.txt
11778G>A,...gers for visual loss in these otherwise healthy m.11778G>A mutation carriers. Unilateral optic neuro...,51,414,PLoS_One_2013_May_7_8(5)_e63446.txt
14484T>C,"...ffected before the age of 20 years and with the m.14484T>C mutation, which carries the best prognosi...",53,508,PLoS_One_2013_May_7_8(5)_e63446.txt
11778G>A,"...efore unusual, especially in the context of the m.11778G>A mutation. Although no visual recovery occ...",53,770,PLoS_One_2013_May_7_8(5)_e63446.txt
3460G>A,"...r of one of three primary mtDNA LHON mutations (m.3460G>A, m.11778G>A, and m.14484T>C)	1 in 8,460	[3...",61,59,PLoS_One_2013_May_7_8(5)_e63446.txt
11778G>A,"... three primary mtDNA LHON mutations (m.3460G>A, m.11778G>A, and m.14484T>C)	1 in 8,460	[32]",61,70,PLoS_One_2013_May_7_8(5)_e63446.txt
14484T>C,"...tDNA LHON mutations (m.3460G>A, m.11778G>A, and m.14484T>C)	1 in 8,460	[32]",61,86,PLoS_One_2013_May_7_8(5)_e63446.txt
8590T>C,"..., Aherrahrou Z , et al (2005 ) Association of the 8590T>C polymorphism of CYP4A11 with hypertension ...",217,91,PLoS_One_2013_Nov_21_8(11)_e80072.txt
465G>C,"...ndicates that there is a heterozygous mutation (c.465G>C) in exon 6 of CRYBB2 (black triangles), whi...",55,193,PLoS_One_2013_Nov_28_8(11)_e81290.txt
321C>T,"...hich patients a sysnonimous variant of ATP6AP2, c.321C>T (p.D107D) and a resultant markedly increase...",119,144,PLoS_One_2013_Nov_4_8(11)_e78603.txt
345C>T,"..., another synonymous mutation in the same exon, c.345C>T (p.S115S), which also affects RNA splicing,...",119,290,PLoS_One_2013_Nov_4_8(11)_e78603.txt
10761T>C,...andidate gene sequencing identified a homozygous c10761T>C missense mutation resulting in an S3588P ...,24,655,PLoS_One_2013_Oct_15_8(10)_e76342.txt
10762T>C,...flanking sequences from genomic DNA identified a c10762T>C mutation causing a Ser3588Pro substitutio...,69,88,PLoS_One_2013_Oct_15_8(10)_e76342.txt
10762T>C,...matogram of Fras1 gene sequence identifying the c.10762T>C mutation in Fras1bfb/bfb mice. (B) Sequen...,72,59,PLoS_One_2013_Oct_15_8(10)_e76342.txt
217C>T,"...or a variant in RGS6: c.37del; p.Val13LeufsX11, c.217C>T; p.Leu73Phe, c.808G>T; p.Ala270Ser, or c.13...",99,386,PLoS_One_2013_Oct_29_8(10)_e76973.txt
808G>T,"...c.37del; p.Val13LeufsX11, c.217C>T; p.Leu73Phe, c.808G>T; p.Ala270Ser, or c.1382C>T; p.Ala461Val wer...",99,408,PLoS_One_2013_Oct_29_8(10)_e76973.txt
1382C>T,"...c.217C>T; p.Leu73Phe, c.808G>T; p.Ala270Ser, or c.1382C>T; p.Ala461Val were evaluated in parallel wi...",99,434,PLoS_One_2013_Oct_29_8(10)_e76973.txt
184C>T,"...L , Kay GW , et al (2006 ) A missense mutation (c.184C>T) in ovine CLN6 causes neuronal ceroid lipof...",159,102,PLoS_One_2013_Oct_4_8(10)_e75963.txt
293T > Jur,"...is and previous works: human myeloid K562 > 293T, 293T > Jurkat, human SupT1 > 293T, human lymphoid ...",81,609,PLoS_One_2013_Sep_10_8(9)_e74925.txt
4675C>T,NFKBIA rs2233409 g.4675C>T	−310 bp	CC CT TT	22 19 1	31 14 4	0.294,92,20,PLoS_One_2013_Sep_16_8(9)_e73926.txt
4091A>G,NFKBIA rs3138053g.4091A>G	−894 bp	AA AG GG	19 21 2	27 17 5	0.348,93,19,PLoS_One_2013_Sep_16_8(9)_e73926.txt
73666064A>T,"...th the Silver coat color [12,13]. One of these, g.73666064A>T is located in intron 9 and not within ...",47,759,PLoS_One_2013_Sep_23_8(9)_e75639.txt
73665304C>T,"...created as a result of the SNP. The second SNP, g.73665304C>T, is positioned 760 bp downstream of th...",47,1112,PLoS_One_2013_Sep_23_8(9)_e75639.txt
73665304C>T,The missense mutation g.73665304C>T in the cytoplasmic region of PMEL caus...,71,25,PLoS_One_2013_Sep_23_8(9)_e75639.txt
1268 T>C,...vels after treatment. We discovered that exon 9 c.1268 T>C and exon 8 c.1129 T>G compound heterozygo...,7,1024,PLoS_One_2014_Apr_10_9(4)_e94697.txt
1129 T>G,...We discovered that exon 9 c.1268 T>C and exon 8 c.1129 T>G compound heterozygous mutations in the LD...,7,1046,PLoS_One_2014_Apr_10_9(4)_e94697.txt
1129 T>G,"... father, respectively, in which the mutation of c.1129 T>G has not been reported previously. The mut...",7,1196,PLoS_One_2014_Apr_10_9(4)_e94697.txt
1129 G>T,"...h different mutations, respectively. The exon 8 c.1129 G>T and exon 9 c.1268 T>C mutations are depic...",24,164,PLoS_One_2014_Apr_10_9(4)_e94697.txt
1268 T>C,... respectively. The exon 8 c.1129 G>T and exon 9 c.1268 T>C mutations are depicted on the right,24,186,PLoS_One_2014_Apr_10_9(4)_e94697.txt
1129T>G,I-2	57	M	5.20	0.93	1.09	3.10	p.Cys356Gly (c.1129T>G),107,45,PLoS_One_2014_Apr_10_9(4)_e94697.txt
1268T>C,I-3	66	F	4.75	1.21	1.13	3.87	p.IIe402Thr (c.1268T>C),108,45,PLoS_One_2014_Apr_10_9(4)_e94697.txt
1129T>G,II-1	28	F	4.47	1.47	1.26	4.02	p.Cys356Gly (c.1129T>G),109,46,PLoS_One_2014_Apr_10_9(4)_e94697.txt
1268T>C,II-2	34	M	5.10	0.96	1.53	3.41	p.IIe402Thr (c.1268T>C),110,46,PLoS_One_2014_Apr_10_9(4)_e94697.txt
1268T>C,II-3	44	M	5.01	1.38	2.01	4.11	p.IIe402Thr (c.1268T>C),111,46,PLoS_One_2014_Apr_10_9(4)_e94697.txt
1268T>C,III-3	23	M	3.87	1.19	1.67	3.17	p.IIe402Thr (c.1268T>C),112,47,PLoS_One_2014_Apr_10_9(4)_e94697.txt
1130G>A,... [26]. The C356Y mutation (nucleotide change to c.1130G>A) was first reported by Ekstrom in 1998 [27...,119,664,PLoS_One_2014_Apr_10_9(4)_e94697.txt
1129T>G,"...], but the C356G mutation (nucleotide change to c.1129T>G) has not been reported previously. In this...",119,764,PLoS_One_2014_Apr_10_9(4)_e94697.txt
125 G>A,"...A and FY*B, differ by a single base substitution (125 G>A) resulting in the replacement at residue 4...",17,97,PLoS_One_2014_Apr_7_9(4)_e93782.txt
33T>C,"...sulting in the absence of DARC antigens on RBCs (-33T>C; FyES, erythrocyte-silent) [30]. Although mo...",17,480,PLoS_One_2014_Apr_7_9(4)_e93782.txt
33T>C,"...agment of DARC, comprising polymorphic positions −33T>C and 125G>A, was amplified by PCR using the f...",36,1416,PLoS_One_2014_Apr_7_9(4)_e93782.txt
125G>A,"...DARC, comprising polymorphic positions −33T>C and 125G>A, was amplified by PCR using the forward pri...",36,1426,PLoS_One_2014_Apr_7_9(4)_e93782.txt
793C>T,...ere identified. One recurrent mutation in MLH1 (c.793C>T) was also observed. 92.9% sensitivity for i...,14,224,PLoS_One_2014_Apr_7_9(4)_e94170.txt
793C>T,...or IHC and the hotspot mutation testing at MLH1 c.793C>T followed by comprehensive mutation scanning...,17,403,PLoS_One_2014_Apr_7_9(4)_e94170.txt
1779T>A,"...th non-hereditary origin, the mutation hotspot (c.1779T>A, p.V600E) of BRAF was scanned via HRM foll...",55,113,PLoS_One_2014_Apr_7_9(4)_e94170.txt
793C >T,"...stingly, one pathogenic point mutation in MLH1 (c.793C >T) leading to skipping of exon 10 occurred i...",73,555,PLoS_One_2014_Apr_7_9(4)_e94170.txt
1G>A,"MLH1/Intron 9	c.790+1G>A	Splicing change, skipping of exons 9 and 10	C...",80,21,PLoS_One_2014_Apr_7_9(4)_e94170.txt
793C>T,"MLH1/Exon 10	c.793C>T	Splicing change, skipping of exon 10	Chines...",81,16,PLoS_One_2014_Apr_7_9(4)_e94170.txt
2041G>A,MLH1/Exon 18	c.2041G>A	p.Ala681Thr	Chinese	1	1	Pathogenic	Dis cau...,85,16,PLoS_One_2014_Apr_7_9(4)_e94170.txt
508C>T,MSH2/Exon 3	c.508C>T	p.Gln170X	Chinese	1	1	Pathogenic	Dis causin...,87,15,PLoS_One_2014_Apr_7_9(4)_e94170.txt
1216C>T,MSH2/Exon 7	c.1216C>T	p. Arg406X	Malay	1	2	Pathogenic	Dis causin...,88,15,PLoS_One_2014_Apr_7_9(4)_e94170.txt
2041C>T,MSH2/Exon 13	c.2041C>T	p.Gln681X	Eurasian	1	1	No record	No record...,90,16,PLoS_One_2014_Apr_7_9(4)_e94170.txt
1G>A,MSH2/Intron 13	c.2210+1G>A	Skipping of exon 13	Chinese	1	1	Likely pathog...,91,23,PLoS_One_2014_Apr_7_9(4)_e94170.txt
1G>A,"51	MLH1/Intron 9, c.790+1G>A	Pathogenic	Lost	Normal	Normal	Lost	Yes	Yes",109,25,PLoS_One_2014_Apr_7_9(4)_e94170.txt
793C>T,"32	MLH1/Exon 10, c.793C>T, p.Arg265Cys	Pathogenic	Lost	Normal	Normal	...",110,20,PLoS_One_2014_Apr_7_9(4)_e94170.txt
508C>T,"21	MSH2/Exon 3, c.508C>T, p.Gln170X	Pathogenic	Normal	Lost	Equivocal...",116,19,PLoS_One_2014_Apr_7_9(4)_e94170.txt
2041C>T,"52	MSH2/Exon 13, c.2041C>T, p.Gln681X	Novel Pathogenic	Normal	Lost	Lo...",117,20,PLoS_One_2014_Apr_7_9(4)_e94170.txt
1G>A,"27	MSH2/Intron 13, c.2210+1G>A	Pathogenic, skipping of exon	Normal	Lost	Lost...",118,27,PLoS_One_2014_Apr_7_9(4)_e94170.txt
2041G>A,"393	MLH1/Exon 18, c.2041G>A, p.Ala681Thr	Pathogenic	Normal	Normal	Norm...",125,21,PLoS_One_2014_Apr_7_9(4)_e94170.txt
2042 C>T,"81	MLH1/Exon 18, c.2042 C>T, p.Ala681Val	Discrepancy by InSiGHT † and...",127,20,PLoS_One_2014_Apr_7_9(4)_e94170.txt
14G>A,"368	MLH1/Intron 13, c.1558+14G>A; PMS2/Intron 11, c.2006 +6 G>A	MLH1, probabl...",129,28,PLoS_One_2014_Apr_7_9(4)_e94170.txt
6 G>A,".../Intron 13, c.1558+14G>A; PMS2/Intron 11, c.2006 +6 G>A	MLH1, probably dis causing by HGMD criteria;...",129,59,PLoS_One_2014_Apr_7_9(4)_e94170.txt
1168C>T,"68	MSH2/Exon 7, c.1168C>T, p.Leu390Phe	Probably dis causing by HGMD ...",131,19,PLoS_One_2014_Apr_7_9(4)_e94170.txt
2246G>C,"8	MSH6/Exon 4, c.2246G>C, p.Gly749Ala	Novel VUS	Normal	Normal	Norma...",132,18,PLoS_One_2014_Apr_7_9(4)_e94170.txt
718 A>T,"409	PMS2/Exon 7, C.718 A>T, p.Ile240Phe	Novel VUS	Normal	Normal	Norma...",133,20,PLoS_One_2014_Apr_7_9(4)_e94170.txt
6G>A,"438	PMS2/Intron 11, c. 2006+6G>A	VUS	Normal	Normal	Normal	Normal	Inconclusive ...",134,29,PLoS_One_2014_Apr_7_9(4)_e94170.txt
793C>T,"...ogeneity observed, one recurrent mutation (MLH1 c.793C>T) was identified in five patients from three...",193,83,PLoS_One_2014_Apr_7_9(4)_e94170.txt
793C>T,"...e cohort, it is premature to conclude that MLH1 c.793C>T is also a founder mutation in Singapore due...",193,525,PLoS_One_2014_Apr_7_9(4)_e94170.txt
793C>T,...d the germline hotspot mutation testing at MLH1 c.793C>T. This is followed by thorough mutation scan...,203,996,PLoS_One_2014_Apr_7_9(4)_e94170.txt
803G>A,"...study, we identified a novel missense mutation (c.803G>A, p.R268Q) in the plasma membrane calcium AT...",7,581,PLoS_One_2014_Aug_13_9(8)_e104790.txt
803G>A,"..., and we identified a novel causative mutation, c.803G>A, p.R268Q in the PMCA4 gene",15,214,PLoS_One_2014_Aug_13_9(8)_e104790.txt
803G>A,"...hogenic SNVs (Table 2), the missense mutation, c. 803G>A, of PMCA4 gene had the highest pathogenic p...",63,75,PLoS_One_2014_Aug_13_9(8)_e104790.txt
803G>A,"We evaluated the impact of the mutation, c. 803G>A (p.R268Q), on PMCA4 protein structure (Fig....",78,45,PLoS_One_2014_Aug_13_9(8)_e104790.txt
418 G>C,...ical Research DesignNo Correlation between TIMP2 -418 G>C Polymorphism and Increased Risk of Cancer:...,3,650,PLoS_One_2014_Aug_19_9(8)_e88184.txt
418 G>C,...k of Cancer: Evidence from a Meta-Analysis TIMP2 -418 G>C Variant & Cancer Risk: Meta-AnalysisMandal...,3,738,PLoS_One_2014_Aug_19_9(8)_e88184.txt
418 G>C,...d studies based on the association between TIMP2 -418 G>C polymorphism and cancer risk are inconsist...,8,255,PLoS_One_2014_Aug_19_9(8)_e88184.txt
418 G>C,...evaluate the potential association between TIMP2 -418 G>C polymorphism and cancer risk,8,395,PLoS_One_2014_Aug_19_9(8)_e88184.txt
418 G>C,...cover all studies based on relationship of TIMP2 -418 G>C polymorphism and risk of cancer until Octo...,11,108,PLoS_One_2014_Aug_19_9(8)_e88184.txt
418 G>C,...ed no evidence of significant risk between TIMP2 -418 G>C polymorphism and cancer risk in any of the...,14,196,PLoS_One_2014_Aug_19_9(8)_e88184.txt
418 G>C,...he present meta-analysis suggests that the TIMP2 -418 G>C polymorphism may not be involved in predis...,17,52,PLoS_One_2014_Aug_19_9(8)_e88184.txt
418 G>C,...igate the possible association between the TIMP2 -418 G>C polymorphism and cancer susceptibility in ...,26,190,PLoS_One_2014_Aug_19_9(8)_e88184.txt
418 G>C,...-analysis to evaluate the overall association of -418 G>C polymorphism in risk/resistance to the dev...,26,750,PLoS_One_2014_Aug_19_9(8)_e88184.txt
418 G>C,"...a) must evaluated the association between TIMP2 (-418 G>C) polymorphism and risk of cancer, b) used ...",33,138,PLoS_One_2014_Aug_19_9(8)_e88184.txt
418 G>C,"...aluate the strength of association between TIMP2 -418 G>C polymorphism and cancer risk, pooled ORs a...",39,65,PLoS_One_2014_Aug_19_9(8)_e88184.txt
418 G>C,...088184.t001Table 1 Main characteristics of TIMP2 -418 G>C polymorphism included in this meta-analysi...,45,73,PLoS_One_2014_Aug_19_9(8)_e88184.txt
418 G>C,...8184.t002Table 2 Genotypic distribution of TIMP2 -418 G>C gene polymorphism,59,75,PLoS_One_2014_Aug_19_9(8)_e88184.txt
418 G>C,Association of TIMP2 -418 G>C polymorphism and overall cancer susceptibi...,87,23,PLoS_One_2014_Aug_19_9(8)_e88184.txt
418 G>C,...r appraisal of overall association between TIMP2 -418 G>C polymorphism and cancer risk. The pooled O...,88,167,PLoS_One_2014_Aug_19_9(8)_e88184.txt
418 G>C,... significant increased or decreased risk between -418 G>C polymorphism and cancer susceptibility in ...,88,302,PLoS_One_2014_Aug_19_9(8)_e88184.txt
418 G>C,...ORs on overall cancer risk associated with TIMP2 -418 G>C gene polymorphism,90,110,PLoS_One_2014_Aug_19_9(8)_e88184.txt
418 G>C,...ORs on overall cancer risk associated with TIMP2 -418 G>C gene polymorphism,93,110,PLoS_One_2014_Aug_19_9(8)_e88184.txt
418 G>C,...tudy investigating the association between TIMP2 -418 G>C gene polymorphism and overall cancer risk....,102,114,PLoS_One_2014_Aug_19_9(8)_e88184.txt
418 G>C,...in the meta-analysis. The results indicated that -418 G>C polymorphism is not significantly associat...,102,300,PLoS_One_2014_Aug_19_9(8)_e88184.txt
418 G>C,...bute the susceptibility to cancer risk and TIMP2 -418 G>C analyzed variant do not influence individu...,102,856,PLoS_One_2014_Aug_19_9(8)_e88184.txt
418 G>C,...eta-analysis evaluated the relationship of TIMP2 -418 G>C polymorphism with the risk of cancer and s...,109,300,PLoS_One_2014_Aug_19_9(8)_e88184.txt
418 G>C,... the risk of cancer and suggested that the TIMP2 -418 G>C polymorphism did not contribute increased ...,109,375,PLoS_One_2014_Aug_19_9(8)_e88184.txt
418 G>C,"...possible association. Here, we only analyzed the -418 G>C variant for cancer risk without considerin...",109,656,PLoS_One_2014_Aug_19_9(8)_e88184.txt
418 G>C,Figure S3 Sensitivity analysis of TIMP2 -418 G>C polymorphism,124,43,PLoS_One_2014_Aug_19_9(8)_e88184.txt
735C>T,...association of matrix metalloproteinase [MMP]-2 (-735C>T) and tissue inhibitor of metalloproteinase ...,158,113,PLoS_One_2014_Aug_19_9(8)_e88184.txt
418G>C,... tissue inhibitor of metalloproteinase [TIMP]-2 (-418G>C) gene polymorphisms with cervical cancer su...,158,174,PLoS_One_2014_Aug_19_9(8)_e88184.txt
280G>C,exon 3	c.280G>C	p.A94P	28	M	—	—	—	rs201350646,53,11,PLoS_One_2014_Aug_5_9(8)_e95453.txt
565A>T,c.565A>T	p.I189F	40	P	—	—	—	—,54,5,PLoS_One_2014_Aug_5_9(8)_e95453.txt
872C>T,c.872C>T	p.A291V	73	P	0.2	—	—	rs200459003,55,5,PLoS_One_2014_Aug_5_9(8)_e95453.txt
1334A>G,c.1334A>G	p.Y445C	35	—	—	—	—	—,56,5,PLoS_One_2014_Aug_5_9(8)_e95453.txt
889C>T,c.889C>T	p.P297S	66	M	—	—	1.7	rs79691946,59,5,PLoS_One_2014_Aug_5_9(8)_e95453.txt
583C>G,FOXC2	exon 1	c.583C>G	p.P195A	78	P	0.2	—	—	rs200751941,62,16,PLoS_One_2014_Aug_5_9(8)_e95453.txt
1331A>G,c.1331A>G	p.Q444R	34	—	0.2	0.14	—	rs147258453,63,5,PLoS_One_2014_Aug_5_9(8)_e95453.txt
543C>T,FOXH1	5'UTR	c.-543C>T	n/a	60	M	0.4	—		—,64,16,PLoS_One_2014_Aug_5_9(8)_e95453.txt
333T>C,c.-333T>C	n/a	76	P	0.6	—	—	rs147276162,65,6,PLoS_One_2014_Aug_5_9(8)_e95453.txt
338G>C,exon 3	c.338G>C	p.S113T	500	—	0.8	0.66	0.2	rs144830740,69,11,PLoS_One_2014_Aug_5_9(8)_e95453.txt
699G>A,GATA4	exon 2	c.699G>A	p.T233T	323	—	—	0.3	0.1	rs55788387,70,16,PLoS_One_2014_Aug_5_9(8)_e95453.txt
25G>A,intron 3-4	c.909+25G>A	n/a	507	—	0.9	0.72	0.003	rs147860174,71,19,PLoS_One_2014_Aug_5_9(8)_e95453.txt
1037C>T,exon 5	c.1037C>T	p.A346V	59	—	0.4	0.31	0.13	rs115372595,74,11,PLoS_One_2014_Aug_5_9(8)_e95453.txt
1164G>A,exon 6	c.1164G>A	p.A388A	315	M	—	0.03	—-	rs55968178,76,11,PLoS_One_2014_Aug_5_9(8)_e95453.txt
886G>A,c.*886G>A	n/a (3'UTR)	319	M	—	—	0.4	rs146304341,77,6,PLoS_One_2014_Aug_5_9(8)_e95453.txt
979G>C,c.*979G>C	n/a (3'UTR)	73	M	0.1	—	0.13	rs182365313,78,6,PLoS_One_2014_Aug_5_9(8)_e95453.txt
1012G>C,c.*1012G>C	n/a (3'UTR)	67	—	0.1	—	0.13	rs139566390,79,6,PLoS_One_2014_Aug_5_9(8)_e95453.txt
3C>T,ISL1	intron 2-3	c.219-3C>T	n/a	514	M	—	—	—	—,82,23,PLoS_One_2014_Aug_5_9(8)_e95453.txt
245A>G,3'UTR	c.*245A>G	n/a	44	M	—	—	—	—,83,11,PLoS_One_2014_Aug_5_9(8)_e95453.txt
651A>G,c.*651A>G	n/a	39	M	0.5	—	—	—,84,6,PLoS_One_2014_Aug_5_9(8)_e95453.txt
140T>C,BOP/SMYD	3'UTR	c.*140T>C	n/a	30	P	—	—	—	—,85,19,PLoS_One_2014_Aug_5_9(8)_e95453.txt
271C>T,c.*271C>T	n/a	330	P	0.1	—	—	—,86,6,PLoS_One_2014_Aug_5_9(8)_e95453.txt
699C>T,c.*699C>T	n/a	32	M	0.9	—	0.5	rs150572228,87,6,PLoS_One_2014_Aug_5_9(8)_e95453.txt
2435C>T,c.*2435C>T	n/a	28	P	—	—	—	rs142969860,88,6,PLoS_One_2014_Aug_5_9(8)_e95453.txt
81C>T,TBX20	exon 1	c.81C>T	p.G27G	325	M	—	0.01	—	rs113390069,89,16,PLoS_One_2014_Aug_5_9(8)_e95453.txt
364A>G,exon 2	c.364A>G	p.I122V	31	M	0.2	—	—	—,90,11,PLoS_One_2014_Aug_5_9(8)_e95453.txt
115G>A,TBX1	exon 3	c.115G>A	p.G39S	31	M	—	—	—	—,91,15,PLoS_One_2014_Aug_5_9(8)_e95453.txt
11C>T,exon 9a	c.*11C>T	n/a (3'UTR)	57	M	0.1	0.16	—	rs72646973,93,13,PLoS_One_2014_Aug_5_9(8)_e95453.txt
1074G>A,exon 9c	c.*1074G>A	n/a (3'UTR)	319	M	—	—	—	—,95,13,PLoS_One_2014_Aug_5_9(8)_e95453.txt
1037C>T,...as present in a single patient apart from GATA4 c.1037C>T (p.A346V) and c.*1012G>C; and FOXH1 c.-333...,98,219,PLoS_One_2014_Aug_5_9(8)_e95453.txt
1012G>C,...tient apart from GATA4 c.1037C>T (p.A346V) and c.*1012G>C; and FOXH1 c.-333T>C that were found in tw...,98,244,PLoS_One_2014_Aug_5_9(8)_e95453.txt
333T>C,"... c.1037C>T (p.A346V) and c.*1012G>C; and FOXH1 c.-333T>C that were found in two patients each, and t...",98,266,PLoS_One_2014_Aug_5_9(8)_e95453.txt
25G>A,"...n two patients each, and the intronic GATA4 c.909+25G>A that was found in 3 patients. We included th...",98,340,PLoS_One_2014_Aug_5_9(8)_e95453.txt
886G>A,...patients. The first patient carried both GATA4 c.*886G>A and TBX1 c.*1074G>A (both maternal in origi...,98,685,PLoS_One_2014_Aug_5_9(8)_e95453.txt
1074G>A,... patient carried both GATA4 c.*886G>A and TBX1 c.*1074G>A (both maternal in origin); the second carr...,98,704,PLoS_One_2014_Aug_5_9(8)_e95453.txt
271C>T,"...ernal in origin); the second carried BOP/SMYD1 c.*271C>T and TBX1 c.129_185del, p.P43_G61del PPPPRYD...",98,771,PLoS_One_2014_Aug_5_9(8)_e95453.txt
2435C>T,"...d in two patients. The first carried BOP/SMYD1 c.*2435C>T (paternal), HAND2 c.75_76insGCCGCC, p.A25_...",98,1107,PLoS_One_2014_Aug_5_9(8)_e95453.txt
280G>C,"...6insGCCGCC, p.A25_A26insAA (maternal) and FOXA2 c.280G>C, p.A94P (maternal). The second patient carr...",98,1189,PLoS_One_2014_Aug_5_9(8)_e95453.txt
979G>C,"...P (maternal). The second patient carried GATA4 c.*979G>C (maternal) FOXA2 c.872C>T, p.A291V (paterna...",98,1252,PLoS_One_2014_Aug_5_9(8)_e95453.txt
872C>T,"...atient carried GATA4 c.*979G>C (maternal) FOXA2 c.872C>T, p.A291V (paternal) and TBX1 c.*11C>T (mate...",98,1278,PLoS_One_2014_Aug_5_9(8)_e95453.txt
11C>T,"...l) FOXA2 c.872C>T, p.A291V (paternal) and TBX1 c.*11C>T (maternal). All variants were heterozygous. ...",98,1317,PLoS_One_2014_Aug_5_9(8)_e95453.txt
3C>T,The mutant minigene constructs for ISL1 c.219-3C>T and GATA4 c.699G>A p.T233T produced an RNA pr...,119,47,PLoS_One_2014_Aug_5_9(8)_e95453.txt
699G>A,...nigene constructs for ISL1 c.219-3C>T and GATA4 c.699G>A p.T233T produced an RNA profile identical t...,119,64,PLoS_One_2014_Aug_5_9(8)_e95453.txt
446G>T,"...n of NOTCH3, a novel missense mutation p.G149V (c.446G>T) was found. This mutation was not detected ...",7,1462,PLoS_One_2014_Aug_6_9(8)_e104533.txt
446G>T,...NOTCH3 mutation at the nucleotide position 446 (c.446G>T; p.G149V) in a Chinese family with CADASIL,15,103,PLoS_One_2014_Aug_6_9(8)_e104533.txt
446G>T,...s primers (Table 1) in wild type allele but not c.446G>T mutant allele of NOTCH3 gene,64,234,PLoS_One_2014_Aug_6_9(8)_e104533.txt
446G>T,...ith respect to the normal control (B). P.G149V (c.446G>T) was indicated with an arrow,76,731,PLoS_One_2014_Aug_6_9(8)_e104533.txt
446G>T,"... T transversion at the nucleotide position 446 (c.446G>T), resulting in a change of glycine (GGC) to...",81,198,PLoS_One_2014_Aug_6_9(8)_e104533.txt
446G>T,... pathogenic nucleotide change was detected. The c.446G>T change causes a loss of MscI restriction en...,81,443,PLoS_One_2014_Aug_6_9(8)_e104533.txt
446G>T,"... instead of T. By MscI enzyme, the heterozygous c.446G>T mutation was found in all the affected indi...",81,710,PLoS_One_2014_Aug_6_9(8)_e104533.txt
446G>T,"... been screened by MscI digestion, however, this c.446G>T mutation was not found in these individuals...",81,933,PLoS_One_2014_Aug_6_9(8)_e104533.txt
446G>T,...ese individuals. There was no report about this c.446G>T change in HGMD and the 1000 Genome project ...,81,1018,PLoS_One_2014_Aug_6_9(8)_e104533.txt
446G>T,"...domain. By genetic testing, we revealed a novel c.446G>T (p.G149V) mutation located in exon 4 of the...",91,863,PLoS_One_2014_Aug_6_9(8)_e104533.txt
445G>T,"...e phenotype of CADASIL. Similarly, the mutation c.445G>T (p.G149C) was reported in 5 individuals wit...",91,1498,PLoS_One_2014_Aug_6_9(8)_e104533.txt
131T>C,"...ing of the candidate GJA8 gene revealed a novel c.131T>C transition in exon 2, which cosegregated wi...",14,65,PLoS_One_2014_Dec_17_9(12)_e115406.txt
131T>C,"...e identified a novel heterozygous mutation, the c.131T>C (p.V44A) mutation, in exon2 of GJA8 in a Ch...",28,67,PLoS_One_2014_Dec_17_9(12)_e115406.txt
131T>C,...l. The black box shows a heterozygous mutation (c.131T>C) in exon 2. E: Conservation analysis of p.V...,73,570,PLoS_One_2014_Dec_17_9(12)_e115406.txt
131T>C,"... sequencing, we identified a novel heterozygous c.131T>C mutation in the GJA8 gene (RefSeq NM_005267...",76,61,PLoS_One_2014_Dec_17_9(12)_e115406.txt
131T>C,"In summary, we identified a novel heterozygous c.131T>C (p.V44A) mutation in GJA8 in a family of Ch...",116,50,PLoS_One_2014_Dec_17_9(12)_e115406.txt
1G>A,...ily with progressive childhood cataracts and IVS3+1G>A CRYBA3/A1 mutations . Mol Vis 16 :2347 –53 .2...,129,123,PLoS_One_2014_Dec_17_9(12)_e115406.txt
10K> Pis,...d in the following order: Pis-1≈Pis-V10K≈Pis-F1K/V10K> Pis-F2K/V10K> Pis-F6K/V10K,154,1007,PLoS_One_2014_Dec_4_9(12)_e114453.txt
10K> Pis,...wing order: Pis-1≈Pis-V10K≈Pis-F1K/V10K> Pis-F2K/V10K> Pis-F6K/V10K,154,1021,PLoS_One_2014_Dec_4_9(12)_e114453.txt
5G>A,...ions and the mRNA product from the mutation c.615+5G>A. This study aims to investigate the effect of...,8,297,PLoS_One_2014_Feb_21_9(2)_e89267.txt
5G>A,...and to explore the aberrant transcript from c.615+5G>A in the same CD infant,8,493,PLoS_One_2014_Feb_21_9(2)_e89267.txt
5G>A,...e patient proved a compound heterozygote of c.615+5G>A and a novel c.1064G>A (p.Arg355Gln) mutation....,11,130,PLoS_One_2014_Feb_21_9(2)_e89267.txt
1064G>A,...compound heterozygote of c.615+5G>A and a novel c.1064G>A (p.Arg355Gln) mutation. An aberrant transc...,11,149,PLoS_One_2014_Feb_21_9(2)_e89267.txt
5G>A,"...n number KJ128074), which was resulted from c.615+5G>A, was detected by RT-PCR and cDNA sequencing. ...",11,343,PLoS_One_2014_Feb_21_9(2)_e89267.txt
1064G>A,"...ormatic analyses of the novel missense mutation c.1064G>A, the growth abilities of three agc1Δ yeast...",11,455,PLoS_One_2014_Feb_21_9(2)_e89267.txt
5G>A,"...es supporting the splice-site nature of the c.615+5G>A mutation, and the novel c.1064G>A variation, ...",14,219,PLoS_One_2014_Feb_21_9(2)_e89267.txt
1064G>A,"...ature of the c.615+5G>A mutation, and the novel c.1064G>A variation, which proved a pathogenic mutat...",14,250,PLoS_One_2014_Feb_21_9(2)_e89267.txt
5G>A,"...he abnormal mRNA molecule from the mutation c.615+5G>A was not detected yet, making it obscure how t...",21,349,PLoS_One_2014_Feb_21_9(2)_e89267.txt
5G>A,"...long with the possible splice-site mutation c.615+5G>A. In this paper, by using an agc1Δ yeast model...",23,184,PLoS_One_2014_Feb_21_9(2)_e89267.txt
5G>A,...lood lymphocytes (PBLs) due to the mutation c.615+5G>A was also explored. We herein reported the cli...,23,390,PLoS_One_2014_Feb_21_9(2)_e89267.txt
5G>A,"...ons, i.e. c.851_854delGTAT, c.1638_1660dup, c.615+5G>A and IVS16ins3kb, were screened by PCR/LA-PCR ...",30,169,PLoS_One_2014_Feb_21_9(2)_e89267.txt
5G>A,...quenced to explore aberrant transcript with c.615+5G>A,40,917,PLoS_One_2014_Feb_21_9(2)_e89267.txt
5G>A,...fication the transcript from the allelewith c.615+5G>A,44,84,PLoS_One_2014_Feb_21_9(2)_e89267.txt
5G>A,...rozygote of a maternally-inherited mutation c.615+5G>A and a novel missense mutation c.1064G>A (p.Ar...,103,143,PLoS_One_2014_Feb_21_9(2)_e89267.txt
1064G>A,"...tation c.615+5G>A and a novel missense mutation c.1064G>A (p.Arg355Gln), which was inherited from hi...",103,180,PLoS_One_2014_Feb_21_9(2)_e89267.txt
5G>A,...n the left illustrated the screening of the c.615+5G>A mutation by mean of a PCR-RFLP approach. The ...,106,72,PLoS_One_2014_Feb_21_9(2)_e89267.txt
5G>A,...ent carried a maternally-inherited mutation c.615+5G>A. SLC25A13 gene sequencing results on the righ...,106,490,PLoS_One_2014_Feb_21_9(2)_e89267.txt
1064G>A,...e right demonstrated that the patient habored a c.1064G>A mutation which was inherited from his fath...,106,584,PLoS_One_2014_Feb_21_9(2)_e89267.txt
5G>A,...ipts from the SLC25A13 Allele Harboring the c.615+5G>A Mutatio,114,58,PLoS_One_2014_Feb_21_9(2)_e89267.txt
5G>A,"...) of SLC25A13 gene, along with the mutation c.615+5G>A, was retained in the 2292 bp product (Fig. 5B...",115,341,PLoS_One_2014_Feb_21_9(2)_e89267.txt
5G>A,...uct retained the entire intron 6 due to the c.615+5G>A mutation,118,412,PLoS_One_2014_Feb_21_9(2)_e89267.txt
1064G>A,...212 vector and the citrin variant with mutation c.1064G>A was named as pYX212-mutant. The growth abi...,124,73,PLoS_One_2014_Feb_21_9(2)_e89267.txt
5G>A,...Fig. 3) unveiled a compound heterozygote of c.615+5G>A and c.1064G>A (p.Arg355Gln). The former was a...,130,774,PLoS_One_2014_Feb_21_9(2)_e89267.txt
1064G>A,...eiled a compound heterozygote of c.615+5G>A and c.1064G>A (p.Arg355Gln). The former was a common SLC...,130,785,PLoS_One_2014_Feb_21_9(2)_e89267.txt
5G>A,Our study in this paper documented c.615+5G>A a real splice-site mutation that led to reten...,134,42,PLoS_One_2014_Feb_21_9(2)_e89267.txt
5G>A,...ation for intron 6 retention in cDNA due to c.615+5G>A in SLC25A13 gene. The retention may lead to p...,134,730,PLoS_One_2014_Feb_21_9(2)_e89267.txt
5G>A,"...e transcripts from the SLC25A13 allele with c.615+5G>A were degraded soon after transcription, makin...",134,1010,PLoS_One_2014_Feb_21_9(2)_e89267.txt
1064G>A,...n our study to analyzed the effect of the novel c.1064G>A mutation on AGC2 function of citrin protei...,137,222,PLoS_One_2014_Feb_21_9(2)_e89267.txt
1064G>A,"... of citrin protein. As illustrated in Figure 6, c.1064G>A caused complete loss of AGC2 function of c...",137,305,PLoS_One_2014_Feb_21_9(2)_e89267.txt
5G>A,...ely diagnosed as a compound heterozygote of c.615+5G>A and a novel c.1064G>A mutation by means of a ...,139,92,PLoS_One_2014_Feb_21_9(2)_e89267.txt
1064G>A,"...compound heterozygote of c.615+5G>A and a novel c.1064G>A mutation by means of a clinical, genetic, ...",139,111,PLoS_One_2014_Feb_21_9(2)_e89267.txt
5G>A,"...es supporting the splice-site nature of the c.615+5G>A mutation, and the novel c.1064G>A variation, ...",139,304,PLoS_One_2014_Feb_21_9(2)_e89267.txt
1064G>A,"...ature of the c.615+5G>A mutation, and the novel c.1064G>A variation, which proved a pathogenic mutat...",139,335,PLoS_One_2014_Feb_21_9(2)_e89267.txt
1236C>T,"...modulators. Several studies have associated ABCB1 1236C>T, 3435C>T, and 1199G>A with irinotecan conc...",16,867,PLoS_One_2014_Feb_25_9(2)_e89622.txt
3435C>T,"...s. Several studies have associated ABCB1 1236C>T, 3435C>T, and 1199G>A with irinotecan concentration...",16,876,PLoS_One_2014_Feb_25_9(2)_e89622.txt
1199G>A,"...udies have associated ABCB1 1236C>T, 3435C>T, and 1199G>A with irinotecan concentrations in patients...",16,889,PLoS_One_2014_Feb_25_9(2)_e89622.txt
1236C>T,"...dy that identified the functional effect of ABCB1 1236C>T, 2677G>T/A, and 3435C>T [27]. The variant ...",157,504,PLoS_One_2014_Feb_25_9(2)_e89622.txt
2677G>T,"...dentified the functional effect of ABCB1 1236C>T, 2677G>T/A, and 3435C>T [27]. The variant haplotype...",157,513,PLoS_One_2014_Feb_25_9(2)_e89622.txt
3435C>T,"...unctional effect of ABCB1 1236C>T, 2677G>T/A, and 3435C>T [27]. The variant haplotypes 1236T-2677A-3...",157,528,PLoS_One_2014_Feb_25_9(2)_e89622.txt
1G> C,"...xpressed at the mRNA level [syntenin>MPP1>4.1N, 4.1G> CASK, FAK] in human MCs [14]. The CADM1-bindin...",24,801,PLoS_One_2014_Jan_22_9(1)_e85980.txt
64E>V,...uctures' scores ordered from best to worst were: V64E>V64M>C61A>L16R>M49W>L58F,28,1344,PLoS_One_2014_Jan_23_9(1)_e86052.txt
64M>C,...es' scores ordered from best to worst were: V64E>V64M>C61A>L16R>M49W>L58F,28,1349,PLoS_One_2014_Jan_23_9(1)_e86052.txt
61A>L,...cores ordered from best to worst were: V64E>V64M>C61A>L16R>M49W>L58F,28,1354,PLoS_One_2014_Jan_23_9(1)_e86052.txt
16R>M,... ordered from best to worst were: V64E>V64M>C61A>L16R>M49W>L58F,28,1359,PLoS_One_2014_Jan_23_9(1)_e86052.txt
49W>L,...red from best to worst were: V64E>V64M>C61A>L16R>M49W>L58F,28,1364,PLoS_One_2014_Jan_23_9(1)_e86052.txt
49W>L,...ntial structures were in order of priority: L16R/M49W>L16R/M49W/L58F>L16R/L58F>M49W/L58F (see Table ...,124,1262,PLoS_One_2014_Jan_23_9(1)_e86052.txt
58F>L,...s were in order of priority: L16R/M49W>L16R/M49W/L58F>L16R/L58F>M49W/L58F (see Table 2). The program...,124,1277,PLoS_One_2014_Jan_23_9(1)_e86052.txt
58F>M,...order of priority: L16R/M49W>L16R/M49W/L58F>L16R/L58F>M49W/L58F (see Table 2). The program unequivoc...,124,1287,PLoS_One_2014_Jan_23_9(1)_e86052.txt
1G>A,"...ngiotensin I-converting enzyme (ACE) gene, c.3691+1G>A (IVS25+1G>A), causes a dramatic increase in c...",158,160,PLoS_One_2014_Jan_27_9(1)_e87484.txt
1G>A,"...-converting enzyme (ACE) gene, c.3691+1G>A (IVS25+1G>A), causes a dramatic increase in circulating A...",158,172,PLoS_One_2014_Jan_27_9(1)_e87484.txt
77T>C,"...countries. In China, Liu L et al. reported XRCC1 -77T>C may be a genetic determinant for developing ...",111,131,PLoS_One_2014_Jan_28_9(1)_e86086.txt
77T>C,"... L , Wu C , Zhang X , et al (2011 ) A functional -77T>C polymorphism in XRCC1 is associated with ris...",212,74,PLoS_One_2014_Jan_28_9(1)_e86086.txt
77T>C,"...C , Zhang X , Guo H , et al (2011 ) A functional -77T>C polymorphism in XRCC1 is associated with ris...",283,82,PLoS_One_2014_Jan_2_9(1)_e84532.txt
166G>A,"...tations have a recessive mode of inheritance, a c.166G>A (p.G56R) mutation in the NR2E3 gene is asso...",14,1335,PLoS_One_2014_Jan_31_9(1)_e87942.txt
10C>A,...91383391	G	G/T	0.017**	0.025	0.44	0.024	0.56	C	c.-10C>A		5′-ÚTR	1,91,67,PLoS_One_2014_Jul_14_9(7)_e102065.txt
43C>T,...rs3802829	G	G/A	0.093**	0.089	0.85	0.113	0.48	C	c.43C>T	p.Pro15Ser	missense	1	NH2-terminal region,92,64,PLoS_One_2014_Jul_14_9(7)_e102065.txt
70G>A,...7096918	C	C/T	0.083	0.069	0.52	0.081	0.93	G	c.170+70G>A		intron,93,67,PLoS_One_2014_Jul_14_9(7)_e102065.txt
20A>G,...0501986	T	T/C	0.480	0.495	0.71	0.492	0.81	A	c.171-20A>G		intron,94,67,PLoS_One_2014_Jul_14_9(7)_e102065.txt
888G>A,...74812	rs144891994	C	C/T	0 ∧	0.005	NA	0.008	NA	G	c.888G>A	p.Thr296Thr	synonymous	2	CCD,95,58,PLoS_One_2014_Jul_14_9(7)_e102065.txt
129C>T,...4542378	G	G/A	0.480	0.490	0.80	0.492	0.81	C	c.945+129C>T		intron,96,66,PLoS_One_2014_Jul_14_9(7)_e102065.txt
1211C>T,...s36111323	G	G/A	0.135**	0.165	0.24	0.156	0.52	C	c.1211C>T	p.Ala404Val	missense	4	linker region betwe...,97,65,PLoS_One_2014_Jul_14_9(7)_e102065.txt
1683T>C,...s12366144	A	A/G	0.250**	0.292	0.20	0.347	0.02	T	c.1683T>C	p.Asn561Asn	synonymous	6	linker region bet...,98,65,PLoS_One_2014_Jul_14_9(7)_e102065.txt
2115C>T,...	rs61743044	G	G/A	0.020	0.020	1.00	0.024	0.75	C	c.2115C>T	p.Tyr705Tyr	synonymous	8	linker region bet...,99,63,PLoS_One_2014_Jul_14_9(7)_e102065.txt
2142G>T,...931	rs144891994	C	C/A	0.008	0.005	0.66	0	0.32	G	c.2142G>T	p.Thr714Thr	synonymous	8	TMD 6,100,60,PLoS_One_2014_Jul_14_9(7)_e102065.txt
138C>T,...105083	G	G/A	0.263	0.238	0.47	0.266	0.93	C	c.2485-138C>T		intron,101,67,PLoS_One_2014_Jul_14_9(7)_e102065.txt
2529C>T,...	rs72984209	G	G/A	0.077	0.054	0.28	0.081	0.87	C	c.2529C>T	p.Phe843Phe	synonymous	11,102,63,PLoS_One_2014_Jul_14_9(7)_e102065.txt
2712G>A,...s12805398	C	C/T	0.140**	0.158	0.49	0.153	0.69	G	c.2712G>A	p.Gln904Gln	synonymous	13,103,65,PLoS_One_2014_Jul_14_9(7)_e102065.txt
888G>A,... Methods for definitions). These rare variants (c.888G>A and c.2142G>T) were both encountered once i...,117,246,PLoS_One_2014_Jul_14_9(7)_e102065.txt
2142G>T,...definitions). These rare variants (c.888G>A and c.2142G>T) were both encountered once in two differe...,117,259,PLoS_One_2014_Jul_14_9(7)_e102065.txt
10 C>A,"...ns, as well as one rare variant in the 5′-UTR (c1-10 C>A). The latter was present in 5 patients, all...",117,638,PLoS_One_2014_Jul_14_9(7)_e102065.txt
110 G>A,"...e distribution of a selected mutation (e.g. IVS I-110 G>A) as well as information (frequencies, orga...",130,1075,PLoS_One_2014_Jul_24_9(7)_e103020.txt
110 G>A,"...alassaemia in the Mediterranean population, IVS I-110 G>A, which is one of the best-studied mutation...",139,130,PLoS_One_2014_Jul_24_9(7)_e103020.txt
66493737C>T,...-association study confirms a sequence variant (g.66493737C>T) in the equine myostatin (MSTN) gene a...,232,134,PLoS_One_2014_Jun_23_9(6)_e100810.txt
2 Old > You,2 Old > Young; t-test =  independent two samples t...,68,1,PLoS_One_2014_Jun_9_9(6)_e99250.txt
829C>T,"...gs in ALL treatment, has been associated with SNP 829C>T near the miR-24 binding site in the 3′UTR o...",20,346,PLoS_One_2014_Mar_10_9(3)_e91261.txt
94C>A,"...A , Yusoff R , et al (2012 ) Polymorphism of ITPA 94C>A and risk of adverse effects among patients w...",255,99,PLoS_One_2014_Mar_10_9(3)_e91261.txt
5C>F,"...lip-out system [32]. Female flies with hs-flp; Act5C>FRT y FRT>GAL4, UAS-GFP were crossed with UAS-d...",49,99,PLoS_One_2014_Mar_31_9(3)_e93450.txt
3176352 G>C,...OncologyCancer PreventionCancer Risk Factorsp21 rs3176352 G>C and p73 rs1801173 C>T Polymorphisms Ar...,3,401,PLoS_One_2014_May_12_9(5)_e96958.txt
1801173 C>T,...ionCancer Risk Factorsp21 rs3176352 G>C and p73 rs1801173 C>T Polymorphisms Are Associated with an I...,3,423,PLoS_One_2014_May_12_9(5)_e96958.txt
3176352 G>C,"...k of ESCC. After Bonferroni correction, for p21 rs3176352 G>C, the pcorrect was still significant. F...",14,350,PLoS_One_2014_May_12_9(5)_e96958.txt
3176352 G>C,p21 rs3176352 G>C and p73 rs1801173 C>T SNPs are associa...,17,7,PLoS_One_2014_May_12_9(5)_e96958.txt
1801173 C>T,p21 rs3176352 G>C and p73 rs1801173 C>T SNPs are associated with increased ris...,17,29,PLoS_One_2014_May_12_9(5)_e96958.txt
1042522 G>C,...A repair genes expression [7]. Polymorphism p53 rs1042522 G>C has been associated with risk of numer...,24,475,PLoS_One_2014_May_12_9(5)_e96958.txt
3176352 G>C,"...rates of repeated analyses were 100% except p21 rs3176352 G>C (158/160, 98.75%). For all SNPs, minor...",51,405,PLoS_One_2014_May_12_9(5)_e96958.txt
2395655 G>A,Genotyped SNPs	p21 rs2395655 G>A	p21 rs1059234 C>T	p21 rs3176352 G>C	p2...,72,22,PLoS_One_2014_May_12_9(5)_e96958.txt
1059234 C>T,Genotyped SNPs	p21 rs2395655 G>A	p21 rs1059234 C>T	p21 rs3176352 G>C	p21 rs1801270 C>A	p2...,72,40,PLoS_One_2014_May_12_9(5)_e96958.txt
3176352 G>C,...ed SNPs	p21 rs2395655 G>A	p21 rs1059234 C>T	p21 rs3176352 G>C	p21 rs1801270 C>A	p21 rs762623 C>A	p53...,72,58,PLoS_One_2014_May_12_9(5)_e96958.txt
1801270 C>A,...655 G>A	p21 rs1059234 C>T	p21 rs3176352 G>C	p21 rs1801270 C>A	p21 rs762623 C>A	p53 rs1042522 G>C	TP5...,72,76,PLoS_One_2014_May_12_9(5)_e96958.txt
762623 C>A,...234 C>T	p21 rs3176352 G>C	p21 rs1801270 C>A	p21 rs762623 C>A	p53 rs1042522 G>C	TP53BP1 rs560191 G>C	...,72,94,PLoS_One_2014_May_12_9(5)_e96958.txt
1042522 G>C,...6352 G>C	p21 rs1801270 C>A	p21 rs762623 C>A	p53 rs1042522 G>C	TP53BP1 rs560191 G>C	p73 rs1801173C>T,72,111,PLoS_One_2014_May_12_9(5)_e96958.txt
560191 G>C,... C>A	p21 rs762623 C>A	p53 rs1042522 G>C	TP53BP1 rs560191 G>C	p73 rs1801173C>T,72,133,PLoS_One_2014_May_12_9(5)_e96958.txt
1801173C>T,... C>A	p53 rs1042522 G>C	TP53BP1 rs560191 G>C	p73 rs1801173C>T,72,150,PLoS_One_2014_May_12_9(5)_e96958.txt
1801173 C>T,"c MAF: minor allele frequency, p73 rs1801173 C>T MAF is in CHB+JPT population",91,38,PLoS_One_2014_May_12_9(5)_e96958.txt
2395655 G>A,p21 rs2395655 G>A,103,7,PLoS_One_2014_May_12_9(5)_e96958.txt
1059234 C>T,p21 rs1059234 C>T,110,7,PLoS_One_2014_May_12_9(5)_e96958.txt
3176352 G>C,p21 rs3176352 G>C,117,7,PLoS_One_2014_May_12_9(5)_e96958.txt
1801270 C>A,p21 rs1801270 C>A,124,7,PLoS_One_2014_May_12_9(5)_e96958.txt
762623 G>A,p21 rs762623 G>A,131,7,PLoS_One_2014_May_12_9(5)_e96958.txt
1042522 G>C,p53 rs1042522 G>C,138,7,PLoS_One_2014_May_12_9(5)_e96958.txt
560191 G>C,TP53BP1 rs560191 G>C,145,11,PLoS_One_2014_May_12_9(5)_e96958.txt
1801173 C>T,p73 rs1801173 C>T,152,7,PLoS_One_2014_May_12_9(5)_e96958.txt
3176352 G>C,p21 rs3176352 G>C and p73 rs1801173 C>T combinations				...,159,7,PLoS_One_2014_May_12_9(5)_e96958.txt
1801173 C>T,p21 rs3176352 G>C and p73 rs1801173 C>T combinations,159,29,PLoS_One_2014_May_12_9(5)_e96958.txt
3176352 G>C,"...rmed to correct the p value (pcorrect); for p21 rs3176352 G>C, the pcorrect = 0.096 for CC vs. GG af...",165,313,PLoS_One_2014_May_12_9(5)_e96958.txt
1801173 C>T,"...l., pcorrect = 0.0192 for CC vs. GG/GC. For p73 rs1801173 C>T, the pcorrect = 0.202 for CT vs. CC af...",165,438,PLoS_One_2014_May_12_9(5)_e96958.txt
2395655 G>A,"...istic regression analyses revealed that the p21 rs2395655 G>A, p21 rs1059234 C>T, p21 rs762623 C>A a...",169,373,PLoS_One_2014_May_12_9(5)_e96958.txt
1059234 C>T,"...alyses revealed that the p21 rs2395655 G>A, p21 rs1059234 C>T, p21 rs762623 C>A and p53 rs1042522 G>...",169,392,PLoS_One_2014_May_12_9(5)_e96958.txt
762623 C>A,"...t the p21 rs2395655 G>A, p21 rs1059234 C>T, p21 rs762623 C>A and p53 rs1042522 G>C polymorphisms wer...",169,411,PLoS_One_2014_May_12_9(5)_e96958.txt
1042522 G>C,"...>A, p21 rs1059234 C>T, p21 rs762623 C>A and p53 rs1042522 G>C polymorphisms were not associated with...",169,432,PLoS_One_2014_May_12_9(5)_e96958.txt
3176352 G>C,"...rection (number of mutiple test  = 32), for p21 rs3176352 G>C, the adjusted p = 0.096 for CC vs. GG,...",169,585,PLoS_One_2014_May_12_9(5)_e96958.txt
1801173 C>T,"..., adjusted p = 0.0192 for CC vs. GG/GC. For p73 rs1801173 C>T, the pcorrect = 0.202 for CT vs. CC af...",169,684,PLoS_One_2014_May_12_9(5)_e96958.txt
3176352 G>C,Stratification analyses on the p21 rs3176352 G>C and p73 rs1801173 C>T polymorphism and...,173,38,PLoS_One_2014_May_12_9(5)_e96958.txt
1801173 C>T,...ation analyses on the p21 rs3176352 G>C and p73 rs1801173 C>T polymorphism and the risk of ESC,173,60,PLoS_One_2014_May_12_9(5)_e96958.txt
3176352 G>C,To evaluate the effects of p21 rs3176352 G>C genotypes on ESCC risk according to di...,174,34,PLoS_One_2014_May_12_9(5)_e96958.txt
3176352 G>C,... increased risk of ESCC associated with the p21 rs3176352 G>C polymorphism was evident among all sub...,174,246,PLoS_One_2014_May_12_9(5)_e96958.txt
1801173 C>T,... decreased risk of ESCC associated with the p73 rs1801173 C>T polymorphism was evident among older p...,174,427,PLoS_One_2014_May_12_9(5)_e96958.txt
16 G>C,"P21 rs3176352 G/C (IVS2+16 G>C) is located in intron 2 of p21, 16 bp downs...",181,25,PLoS_One_2014_May_12_9(5)_e96958.txt
3176352 G>C,"Table S1 Stratified analyses between p21 rs3176352 G>C polymorphism and ESCC risk by sex, age...",192,44,PLoS_One_2014_May_12_9(5)_e96958.txt
1801173 C>T,"Table S2 Stratified analyses between p73 rs1801173 C>T polymorphism and ESCC risk by sex, age...",198,45,PLoS_One_2014_May_12_9(5)_e96958.txt
309G>T,"...eone M , et al (2009 ) The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breas...",217,107,PLoS_One_2014_May_12_9(5)_e96958.txt
11614913 T>C,"...iu S , Yin J , Wang L , et al (2013 ) MiR-196a2 rs11614913 T>C polymorphism and risk of esophageal c...",231,73,PLoS_One_2014_May_12_9(5)_e96958.txt
3212948 G>C,"Overall, this meta-analysis suggests that ERCC1 rs3212948 G>C, but not others, is a lung cancer risk...",20,51,PLoS_One_2014_May_19_9(5)_e97616.txt
17677A>C,"...ns of three other ERCC1 polymorphisms (rs3212961 (17677A>C), rs3212948 G>C, and rs2298881 C>A) with ...",25,2760,PLoS_One_2014_May_19_9(5)_e97616.txt
3212948 G>C,"...ther ERCC1 polymorphisms (rs3212961 (17677A>C), rs3212948 G>C, and rs2298881 C>A) with lung cancer r...",25,2773,PLoS_One_2014_May_19_9(5)_e97616.txt
2298881 C>A,"...hisms (rs3212961 (17677A>C), rs3212948 G>C, and rs2298881 C>A) with lung cancer risk have also gaine...",25,2792,PLoS_One_2014_May_19_9(5)_e97616.txt
11615 T>C,...	2004	mixed*	Denmark	Caucasian	PB	Real-time PCR	rs11615 T>C	0.313	252	266,51,56,PLoS_One_2014_May_19_9(5)_e97616.txt
11615 T>C,Zhou	2005	mixed	USA	Caucasian	PB	TaqMan	rs11615 T>C	0.541	1752	1358,52,43,PLoS_One_2014_May_19_9(5)_e97616.txt
3212986 C>A,rs3212986 C>A	0.985,53,10,PLoS_One_2014_May_19_9(5)_e97616.txt
3212948 G>C,Shen	2005	mixed	China	Asian	PB	real-time PCR	rs3212948 G>C	0.752	118	112,54,48,PLoS_One_2014_May_19_9(5)_e97616.txt
3212961 A>C,rs3212961 A>C	0.760,55,10,PLoS_One_2014_May_19_9(5)_e97616.txt
11615 T>C,Matullo	2006	mixed	European	Caucasian	PB	TaqMan	rs11615 T>C	0.156	116	1093,56,51,PLoS_One_2014_May_19_9(5)_e97616.txt
11615 T>C,...enolddiny	2006	NSCLC	Norway	Caucasian	PB	TaqMan	rs11615 T>C	0.670	260	213,57,53,PLoS_One_2014_May_19_9(5)_e97616.txt
3212986 C>A,rs3212986 C>A	0.088,58,10,PLoS_One_2014_May_19_9(5)_e97616.txt
3212961A>C,rs3212961A>C	0.025,59,10,PLoS_One_2014_May_19_9(5)_e97616.txt
2298881 C>A,Ma	2007	mixed	China	Chinese	HB	TaqMan	rs2298881 C>A	0.190	992	986,60,41,PLoS_One_2014_May_19_9(5)_e97616.txt
3212948 G>C,rs3212948 G>C	0.171,61,10,PLoS_One_2014_May_19_9(5)_e97616.txt
11615 T>C,Yu	2008	mixed	China	Chinese	PB	PCR-RFLP	rs11615 T>C	0.524	988	986,62,43,PLoS_One_2014_May_19_9(5)_e97616.txt
3212986 C>A,rs3212986 C>A	0.335,63,10,PLoS_One_2014_May_19_9(5)_e97616.txt
3212961 A>C,rs3212961 A>C	0.515,64,10,PLoS_One_2014_May_19_9(5)_e97616.txt
11615 T>C,Zhang	2008	mixed	China	Chinese	HB	TaqMan	rs11615 T>C	0.988	291	273,65,44,PLoS_One_2014_May_19_9(5)_e97616.txt
11615 T>C,Yin	2009	AC	China	Chinese	HB	PCR-RFLP	rs11615 T>C	0.980	285	285,66,41,PLoS_One_2014_May_19_9(5)_e97616.txt
11615 T>C,Deng	2011	mixed	China	Chinese	PB	Real-time PCR	rs11615 T>C	0.743	315	313,67,50,PLoS_One_2014_May_19_9(5)_e97616.txt
3212948 G>C,Jones	2011	mixed	USA	Caucasian	PB	TaqMan	rs3212948 G>C	0.848	427	737,68,44,PLoS_One_2014_May_19_9(5)_e97616.txt
11615 T>C,Yin	2011		China	Chinese	HB	LDR-PCR	rs11615 T>C	0.400	330	335,69,38,PLoS_One_2014_May_19_9(5)_e97616.txt
2298881 C>A,rs2298881 C>A	0.682,70,10,PLoS_One_2014_May_19_9(5)_e97616.txt
3212961 A>C,rs3212961 A>C	0.338,71,10,PLoS_One_2014_May_19_9(5)_e97616.txt
3212986 C>A,Kang	2011	mixed	China	Chinese	HB	PCR-RFLP	rs3212986 C>A	0.018	200	200,72,45,PLoS_One_2014_May_19_9(5)_e97616.txt
11615 T>C,Sakoda	2012	mixed	USA	Caucasian	PB	TaqMan	rs11615 T>C	0.013	744	1477,73,45,PLoS_One_2014_May_19_9(5)_e97616.txt
3212986 C>A,rs3212986 C>A	0.122,74,10,PLoS_One_2014_May_19_9(5)_e97616.txt
2298881 C>A,rs2298881 C>A	0.350,75,10,PLoS_One_2014_May_19_9(5)_e97616.txt
11615 T >C,Yin	2012	mixed	China	Chinese	HB	PCR-RFLP	rs11615 T >C	0.663	357	378,76,44,PLoS_One_2014_May_19_9(5)_e97616.txt
11615 T >C,...ma	2012	mixed	European	Caucasian	HB	HumanHap300	rs11615 T >C	0.185	2679	4226,77,54,PLoS_One_2014_May_19_9(5)_e97616.txt
3212986 C>A,rs3212986 C>A	0.732,79,10,PLoS_One_2014_May_19_9(5)_e97616.txt
2298881 C>A,rs2298881 C>A	0.787,80,10,PLoS_One_2014_May_19_9(5)_e97616.txt
11615 T>C,rs11615 T>,94,3,PLoS_One_2014_May_19_9(5)_e97616.txt
3212986 C>A,rs3212986 C>A,106,3,PLoS_One_2014_May_19_9(5)_e97616.txt
3212961 A>C,rs3212961 A>C,114,3,PLoS_One_2014_May_19_9(5)_e97616.txt
3212948 G>C,rs3212948 G>C,119,3,PLoS_One_2014_May_19_9(5)_e97616.txt
2298881 C>A,rs2298881 C>A,121,3,PLoS_One_2014_May_19_9(5)_e97616.txt
3212986 C>A,ERCC1 rs3212986 C>A polymorphis,134,9,PLoS_One_2014_May_19_9(5)_e97616.txt
3212961 A>C,ERCC1 rs3212961 A>C polymorphis,140,9,PLoS_One_2014_May_19_9(5)_e97616.txt
3212948 G>C,ERCC1 3212948 G>C polymorphis,143,7,PLoS_One_2014_May_19_9(5)_e97616.txt
3212948 G>C,"A tagSNP ERCC1 3212948 G>C, representing common genetic variation...",144,16,PLoS_One_2014_May_19_9(5)_e97616.txt
2298881 C>A,ERCC1 rs2298881 C>A polymorphis,146,9,PLoS_One_2014_May_19_9(5)_e97616.txt
31G > C,"...g Y , et al (2012 ) Association between survivin -31G > C promoter polymorphism and cancer risk: a m...",198,91,PLoS_One_2014_May_22_9(5)_e98022.txt
1123G>C,"..., et al (2007 ) The PTPN22 promoter polymorphism -1123G>C association cannot be distinguished from t...",189,105,PLoS_One_2014_May_9_9(5)_e96943.txt
1858C>T,...3G>C association cannot be distinguished from the 1858C>T association in a Norwegian rheumatoid arth...,189,158,PLoS_One_2014_May_9_9(5)_e96943.txt
1123G>C,"...J , et al (2012 ) A PTPN22 promoter polymorphism -1123G>C is associated with RA pathogenesis in Chin...",191,96,PLoS_One_2014_May_9_9(5)_e96943.txt
1123G > C,"...J, Li H, Gu D, Du W, Xue F, et al. (2012) PTPN22 -1123G > C polymorphism is associated with suscepti...",192,57,PLoS_One_2014_May_9_9(5)_e96943.txt
8126 T>C,...nd tumor suppressors. There is a TNFAIP2 3'-UTR rs8126 T>C genetic variant which has been proved to ...,8,245,PLoS_One_2014_Nov_10_9(11)_e109318.txt
8126 T>C,"...nterestingly, Liu et al identified a functional rs8126 T>C single nucleotide polymorphisms (SNP) wit...",25,729,PLoS_One_2014_Nov_10_9(11)_e109318.txt
8126 T>C,The rs8126 T>C polymorphism was genotyped through the PC...,34,7,PLoS_One_2014_Nov_10_9(11)_e109318.txt
8126 T>C,...variables and genotype distributions of TNFAIP2 rs8126 T>C polymorphism between ESCC patients and co...,41,82,PLoS_One_2014_Nov_10_9(11)_e109318.txt
8126 T>C,...equencies and genotype distributions of TNFAIP2 rs8126 T>C SNP in ESCC cases and controls are shown ...,69,60,PLoS_One_2014_Nov_10_9(11)_e109318.txt
8126 T>C,... cancerous esophagus tissues grouped by TNFAIP2 rs8126 T>C genotypes,91,141,PLoS_One_2014_Nov_10_9(11)_e109318.txt
8126 T>C,"...tudy, Liu et al firstly identified a functional rs8126 T>C SNP in HNSCC [15]. They demonstrated that...",99,66,PLoS_One_2014_Nov_10_9(11)_e109318.txt
8126 T> C,"...ang LE , et al (2013 ) The miR-184 binding-site rs8126 T> C polymorphism in TNFAIP2 is associated wi...",137,84,PLoS_One_2014_Nov_10_9(11)_e109318.txt
403G>A,"... YJ , Koh SJ , Kim JY , et al (2007 ) The RANTES -403G>A promoter polymorphism in Korean men: associ...",299,77,PLoS_One_2014_Nov_10_9(11)_e112279.txt
21086A>T,"...egion of HIF2A gene (rs11125070, NM_001430.4:c.27-21086A>T; minor allele frequency: 30.4% in phase I...",260,404,PLoS_One_2014_Nov_18_9(11)_e113513.txt
8939A>G,...able analyses. HIF2B rs12593988 (NM_014862.3:c.31+8939A>G) and HIF2A rs4953352 (NM_001430.4:c.27-849...,262,217,PLoS_One_2014_Nov_18_9(11)_e113513.txt
8490T>C,...31+8939A>G) and HIF2A rs4953352 (NM_001430.4:c.27-8490T>C) are both frequent polymorphisms (minor al...,262,264,PLoS_One_2014_Nov_18_9(11)_e113513.txt
124 G>A,...be accounted for by a gain-of-function mutation (-124 G>A) in the hTERT promoter region (Table S1 an...,45,814,PLoS_One_2014_Nov_6_9(11)_e112438.txt
124 G>A,"...cribed previously [27], and RMG-I cells harbor a -124 G>A mutation. The wild-type sequences of the c...",127,220,PLoS_One_2014_Nov_6_9(11)_e112438.txt
677C->T,"..., den HM , Blom HJ , Kapusta L  (2007 ) The MTHFR 677C->T polymorphism and the risk of congenital he...",295,68,PLoS_One_2014_Oct_2_9(10)_e108903.txt
468G>G,S11	M	33	–	Italy	GH	Macro	–	c.468G>GA(rs12721456)	–	c.105G>GA(rs2230350) c.987G>...,43,31,PLoS_One_2014_Oct_7_9(10)_e109897.txt
105G>G,...M	33	–	Italy	GH	Macro	–	c.468G>GA(rs12721456)	–	c.105G>GA(rs2230350) c.987G>GA(rs61758987),43,55,PLoS_One_2014_Oct_7_9(10)_e109897.txt
987G>G,...	–	c.468G>GA(rs12721456)	–	c.105G>GA(rs2230350) c.987G>GA(rs61758987),43,76,PLoS_One_2014_Oct_7_9(10)_e109897.txt
468G>G,S12	M	30	–	Italy	GH	Macro	–	c.468G>GA(rs12721456)	c.138C>CT(rs762707)	–,44,31,PLoS_One_2014_Oct_7_9(10)_e109897.txt
138C>C,...2	M	30	–	Italy	GH	Macro	–	c.468G>GA(rs12721456)	c.138C>CT(rs762707)	–,44,53,PLoS_One_2014_Oct_7_9(10)_e109897.txt
846T>T,S13	F	37	–	Italy	GH	Macro	–	c.846T>TC(rs10241877)	–	–,45,31,PLoS_One_2014_Oct_7_9(10)_e109897.txt
846T>T,S18	M	35	–	Italy	GH	Macro	–	c.846T>TC(rs10241877)	–	–,50,31,PLoS_One_2014_Oct_7_9(10)_e109897.txt
468G>G,S20	F	36	–	Italy	GH	Macro	–	c.468G>GA(rs12721456)	c.138C>CT(rs762707)	–,52,31,PLoS_One_2014_Oct_7_9(10)_e109897.txt
138C>C,...0	F	36	–	Italy	GH	Macro	–	c.468G>GA(rs12721456)	c.138C>CT(rs762707)	–,52,53,PLoS_One_2014_Oct_7_9(10)_e109897.txt
105G>G,S21	M	39	–	Italy	GH	Macro	–	–	–	(c.105G>GA)rs2230350,53,36,PLoS_One_2014_Oct_7_9(10)_e109897.txt
468G>G,S22	M	38	–	Italy	GH	Micro	–	c.468G>GA(rs12721456)	–	–,54,31,PLoS_One_2014_Oct_7_9(10)_e109897.txt
846T>T,S23	M	26	–	Finland	GH	NA	–	c.846T>TC (rs10241877)	–	–,55,30,PLoS_One_2014_Oct_7_9(10)_e109897.txt
846T>T,S25	M	23	–	Finland	GH/PRL	Macro	–	c.846T>TC(rs10241877)	–	–,57,37,PLoS_One_2014_Oct_7_9(10)_e109897.txt
846T>T,S26	F	43	–	Finland	GH	NA	–	c.846T>TC(rs10241877)	–	–,58,30,PLoS_One_2014_Oct_7_9(10)_e109897.txt
846T>T,S31	M	56	–	Finland	GH	NA	–	c.846T>TC(rs10241877)	–	–,63,30,PLoS_One_2014_Oct_7_9(10)_e109897.txt
138C>C,*F5	F	NA	36	Italy	PRL	NA	GH (aunt)	–	c.138C>CT(rs762707)	–,69,40,PLoS_One_2014_Oct_7_9(10)_e109897.txt
846T>T,*F8	M	36	–	Finland	GH	NA	GH (uncle)	c.846T>TC(rs10241877)	–	–,72,39,PLoS_One_2014_Oct_7_9(10)_e109897.txt
105G>G,F9	F	NA	59	Finland	GH	NA	PRL (niece)	–	–	(c.105G>GA)rs2230350,73,45,PLoS_One_2014_Oct_7_9(10)_e109897.txt
468G>G,*F10	M	NA	44	Italy	GH	NA	NFPA (niece)	c.468G>GA(rs12721456)	–	–,74,41,PLoS_One_2014_Oct_7_9(10)_e109897.txt
846T>T,F13	F	63	NA	Finland	GH	NA	ACTH (cousin)	c.846T>TC(rs10241877)	–	–,77,43,PLoS_One_2014_Oct_7_9(10)_e109897.txt
2243250 C>T,...ating a correlation between IL-4 polymorphisms (rs2243250 C>T) and susceptibility to HBV infection [...,158,652,PLoS_One_2014_Oct_8_9(10)_e110061.txt
3243A>G,...pe-specific manifestations of heteroplasmic mtDNA 3243A>G mutation in human induced pluripotent stem...,384,157,PLoS_One_2015_Dec_7_10(12)_e0144273.txt
118 A > G,"..., Kaasa S , Holthe M , Dale O , et al (2004 ) The 118 A > G polymorphism in the human mu-opioid rece...",265,74,PLoS_One_2015_Jan_23_10(1)_e0116885.txt
24B>Cbp,"... axonal branching (control: 5.9 +/- 0.27, n = 17; 24B>Cbp53E: 4.5 +/- 0.28, n = 13, vs. control: p<0...",83,1104,PLoS_One_2015_Jul_13_10(7)_e0132636.txt
24B>Cbp,"... +/- 0.5, n = 17, vs. control: p<0.05; Cbp53EMi22;24B>Cbp53E: 5.9 +/- 0.42, n = 16, vs. Cbp53EMi22;2...",83,1230,PLoS_One_2015_Jul_13_10(7)_e0132636.txt
24B>Cbp,"...Muscle expression: control: 2.9 +/- 0.13, n = 23; 24B>Cbp53E: 2.8 +/-0.19, n = 19, vs. control: p>0....",96,488,PLoS_One_2015_Jul_13_10(7)_e0132636.txt
24B>Cbp,"... +/-0.17, n = 21, vs. control: p<0.05; Cbp53EMi22;24B>Cbp53E: 2.6 +/- 0.16, n = 20, vs. Cbp53EMi22;2...",96,931,PLoS_One_2015_Jul_13_10(7)_e0132636.txt
001	O > S,"...g)	59.0	(8.0)	68.0	(9.1)	50.3	(7.8)	59.0	(7.5)	<0.001	O > SO, N > S",110,60,PLoS_One_2015_Jul_15_10(7)_e0132908.txt
001	O > S,"...2)	23.5	(2.2)	27.3	(2.9)	20.0	(2.0)	23.8	(2.1)	<0.001	O > SO, N > S",111,60,PLoS_One_2015_Jul_15_10(7)_e0132908.txt
001	O > S,...m)	82.3	(7.3)	91.0	(8.0)	75.3	(7.1)	86.1	(8.0)	<0.001	O > SO > N > S,112,73,PLoS_One_2015_Jul_15_10(7)_e0132908.txt
001	O > S,"...)	94.9	(5.0)	101.9	(6.6)	90.2	(5.0)	96.5	(4.9)	<0.001	O > SO, N > S",113,72,PLoS_One_2015_Jul_15_10(7)_e0132908.txt
1601G>A,"...Regarding the genetic factors, factor V Leiden (c.1601G>A, p.R534Q) and prothrombin G20210A mutation...",17,148,PLoS_One_2015_Jul_17_10(7)_e0133196.txt
586A>G,"...her researchers identified a missense mutation (c.586A>G, p.K196E) in the PS gene as a genetic risk ...",17,383,PLoS_One_2015_Jul_17_10(7)_e0133196.txt
479T>A,"...ciated with other CYP2A6 SNPs, e.g., rs1801272 (c.479T>A/p.L160H), with effect size of 0.68 CPD (N =...",176,509,PLoS_One_2015_Jul_1_10(7)_e0126113.txt
556G>A,...harbored a missense change in PRPH2 (NM_000322.4:c556G>A; p.Asp186Asn) [30] and the complete segrega...,97,66,PLoS_One_2015_Jul_21_10(7)_e0133624.txt
489C>A,"...ovel nucleotide change in C1QTNF5 (NM_015645.3: c.489C>A), leading to the missense mutation p.Ser163...",97,649,PLoS_One_2015_Jul_21_10(7)_e0133624.txt
556G>A,RP-0107	adRP	adCRD	PRPH2 c556G>A; p.Asp186Asn (NM_000322.4)	Kohl et al. 2012...,103,27,PLoS_One_2015_Jul_21_10(7)_e0133624.txt
489C>A,RP-0911	adRP + AMD	LORD	C1QTNF5 c. 489C>A; p.Ser163Arg (NM_015645.3)	Hayward C et al....,106,36,PLoS_One_2015_Jul_21_10(7)_e0133624.txt
08	A>C,"1.742, P = 0.08	A>C",173,21,PLoS_One_2015_Jul_21_10(7)_e0133762.txt
521C>G,"c.521C>G, p.P174T	c.949_950insC	-",18,3,PLoS_One_2015_Jul_29_10(7)_e0134748.txt
3860G>A,"...ngle nucleotide polymorphisms (SNPs) for CYP1A2 (-3860G>A, -3113G>A, -163C>A, 2159G>A, and 5347C>T),...",57,184,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
3113G>A,"...otide polymorphisms (SNPs) for CYP1A2 (-3860G>A, -3113G>A, -163C>A, 2159G>A, and 5347C>T), two for C...",57,194,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
163C>A,"...morphisms (SNPs) for CYP1A2 (-3860G>A, -3113G>A, -163C>A, 2159G>A, and 5347C>T), two for CYP2B6 (516...",57,204,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
2159G>A,"...s (SNPs) for CYP1A2 (-3860G>A, -3113G>A, -163C>A, 2159G>A, and 5347C>T), two for CYP2B6 (516 G>T and...",57,212,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
5347C>T,"...CYP1A2 (-3860G>A, -3113G>A, -163C>A, 2159G>A, and 5347C>T), two for CYP2B6 (516 G>T and 785 A>G), an...",57,225,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
516 G>T,"..., -163C>A, 2159G>A, and 5347C>T), two for CYP2B6 (516 G>T and 785 A>G), and four for CYP2E1 (-1293G>...",57,251,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
785 A>G,"...159G>A, and 5347C>T), two for CYP2B6 (516 G>T and 785 A>G), and four for CYP2E1 (-1293G>C, -352A>G, ...",57,263,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
1293G>C,"...P2B6 (516 G>T and 785 A>G), and four for CYP2E1 (-1293G>C, -352A>G, -333T>A, and 7632T>A) were detec...",57,295,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
352A>G,"...G>T and 785 A>G), and four for CYP2E1 (-1293G>C, -352A>G, -333T>A, and 7632T>A) were detected and th...",57,305,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
333T>A,"...85 A>G), and four for CYP2E1 (-1293G>C, -352A>G, -333T>A, and 7632T>A) were detected and the frequen...",57,314,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
7632T>A,"... four for CYP2E1 (-1293G>C, -352A>G, -333T>A, and 7632T>A) were detected and the frequencies were 11...",57,326,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
3860G>A,"...A2, 2B6, and 2E1 (Table 2). Five SNPs in CYP1A2 (-3860G>A, -3113G>A, -163C>A, 2159G>A, and 5347C>T) ...",94,144,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
3113G>A,"...nd 2E1 (Table 2). Five SNPs in CYP1A2 (-3860G>A, -3113G>A, -163C>A, 2159G>A, and 5347C>T) were used ...",94,154,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
163C>A,"...ble 2). Five SNPs in CYP1A2 (-3860G>A, -3113G>A, -163C>A, 2159G>A, and 5347C>T) were used in a corre...",94,164,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
2159G>A,"...Five SNPs in CYP1A2 (-3860G>A, -3113G>A, -163C>A, 2159G>A, and 5347C>T) were used in a correlation a...",94,172,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
5347C>T,"...CYP1A2 (-3860G>A, -3113G>A, -163C>A, 2159G>A, and 5347C>T) were used in a correlation analysis. Sign...",94,185,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
3860G>A,"...b5 contents correlated well with the Vmax of the -3860G>A mutant heterozygote. However, no correlati...",94,540,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
3860G>A,-3860G>A,99,3,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
163C>A,-163C>A,103,3,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
5347C>T,5347C>T,107,2,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
3113A>G,-3113A>G,111,3,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
2159G >A,2159G >A,114,2,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
516 G>T,516 G>T,119,2,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
785A>G,785A>G			-	-,123,2,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
1293G>C,-1293G>C,128,3,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
7632T>A,7632T>A,132,2,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
333T>A,-333T>A			-	-,136,3,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
352A>G,-352A>G,140,3,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
516 G>T,"...t b5 contents and Vmax and CLint of CYP2B6 516GG (516 G>T) and 785AA (785A>G) genotypes. However, th...",146,124,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
785A>G,"...ax and CLint of CYP2B6 516GG (516 G>T) and 785AA (785A>G) genotypes. However, the Km values of CYP2B...",146,144,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
1293G>C,"...hich was different from that of CYP1A2. For SNPs -1293G>C and 7632T>A of CYP2E1, the Vmax and CLint ...",146,321,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
7632T>A,"...ferent from that of CYP1A2. For SNPs -1293G>C and 7632T>A of CYP2E1, the Vmax and CLint of both the ...",146,333,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
333T>A,...contents and Vmax and/or CLint of CYP2E1 -333TT (-333T>A) and -352AA (-352A>G) genotypes were also o...,146,549,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
352A>G,".../or CLint of CYP2E1 -333TT (-333T>A) and -352AA (-352A>G) genotypes were also observed. However, for...",146,570,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
3860G>A,"...ke wild-type [14]. In the present study, 5 SNPs (-3860G>A, -3113G>A, -163C>A, 2159G>A, and 5347C>T) ...",161,1136,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
3113G>A,"...pe [14]. In the present study, 5 SNPs (-3860G>A, -3113G>A, -163C>A, 2159G>A, and 5347C>T) in CYP1A2 ...",161,1146,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
163C>A,"...n the present study, 5 SNPs (-3860G>A, -3113G>A, -163C>A, 2159G>A, and 5347C>T) in CYP1A2 were used ...",161,1156,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
2159G>A,"...esent study, 5 SNPs (-3860G>A, -3113G>A, -163C>A, 2159G>A, and 5347C>T) in CYP1A2 were used to asses...",161,1164,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
5347C>T,"...5 SNPs (-3860G>A, -3113G>A, -163C>A, 2159G>A, and 5347C>T) in CYP1A2 were used to assess the correla...",161,1177,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
3860G>A,... activities in HLM were rather interesting. SNPs -3860G>A and -3113G>A are located in the distal enh...,161,2107,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
3113G>A,...n HLM were rather interesting. SNPs -3860G>A and -3113G>A are located in the distal enhancer region ...,161,2120,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
163C>A,"... distal enhancer region of the CYP1A2 gene. Both -163C>A and 2159G>A are intronic mutations, whereas...",161,2196,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
2159G>A,"...ancer region of the CYP1A2 gene. Both -163C>A and 2159G>A are intronic mutations, whereas 5347C>T is...",161,2207,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
5347C>T,"...63C>A and 2159G>A are intronic mutations, whereas 5347C>T is a synonymous variant in exon 7 of CYP1A...",161,2247,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
3860G>A,"...ymous variant in exon 7 of CYP1A2 [34]. Although -3860G>A, -3113G>A, and -163C>A are considered to h...",161,2315,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
3113G>A,"...ant in exon 7 of CYP1A2 [34]. Although -3860G>A, -3113G>A, and -163C>A are considered to have a pote...",161,2325,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
163C>A,"...of CYP1A2 [34]. Although -3860G>A, -3113G>A, and -163C>A are considered to have a potential impact o...",161,2339,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
516G>T,SNPs 516G>T and 785A>G in CYP2B6 are exonic mutations a...,163,6,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
785A>G,SNPs 516G>T and 785A>G in CYP2B6 are exonic mutations associated w...,163,17,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
516G>T,"...H, K262R, respectively) [16,35]. In addition, SNP 516G>T can also lead to incorrect splicing of the ...",163,151,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
516 G>T,"...lint, negatively correlated with the Km of CYP2B6 516 G>T and 785 A>G wild-type genes. However, no a...",163,737,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
785 A>G,"...vely correlated with the Km of CYP2B6 516 G>T and 785 A>G wild-type genes. However, no association w...",163,749,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
516 G>T,"... AA wild-type. However, amino acid changes in the 516 G>T and 785 A>G variants may prevent the inter...",165,808,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
785 A>G,"...e. However, amino acid changes in the 516 G>T and 785 A>G variants may prevent the interaction of Cy...",165,820,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
1293G>C,"...[13]. None of the 4 SNPs assessed in this study (-1293G>C, -352A>G, -333T>A, and 7632T>A) had an eff...",167,207,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
352A>G,"... of the 4 SNPs assessed in this study (-1293G>C, -352A>G, -333T>A, and 7632T>A) had an effect on CYP...",167,217,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
333T>A,"... SNPs assessed in this study (-1293G>C, -352A>G, -333T>A, and 7632T>A) had an effect on CYP2E1 activ...",167,226,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
7632T>A,"...ed in this study (-1293G>C, -352A>G, -333T>A, and 7632T>A) had an effect on CYP2E1 activity. However...",167,238,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
1293G>C,...orrelated with the Vmax and CLint of CYP2E1 SNPs -1293G>C and 7632T>A wild-type homozygote and varia...,167,371,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
7632T>A,...th the Vmax and CLint of CYP2E1 SNPs -1293G>C and 7632T>A wild-type homozygote and variant heterozyg...,167,383,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
1293G>C,...t heterozygote. This tendency may be because the -1293G>C and 7632T>A mutations can link together to...,167,472,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
7632T>A,...te. This tendency may be because the -1293G>C and 7632T>A mutations can link together to construct a...,167,484,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
163C>A,...coffee consumption is associated with the CYP1A2 -163C>A polymorphism . Eur J Clin Pharmacol . 2010 ...,208,134,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
376C>T,"...s [10–15,20–27]. Recently, a nonsense mutation (c.376C>T) of LGR4, which abolishes the signal transd...",84,175,PLoS_One_2015_Mar_26_10(3)_e0119599.txt
12140G>A,"...moter single-nucleotide polymorphisms (SNPs) (SNP-12140G>A, SNP-11426A>G, SNP-11391G>A and SNP-11377...",7,1078,PLoS_One_2015_May_27_10(5)_e0127751.txt
11426A>G,"...ucleotide polymorphisms (SNPs) (SNP-12140G>A, SNP-11426A>G, SNP-11391G>A and SNP-11377C>G) with NSCL...",7,1092,PLoS_One_2015_May_27_10(5)_e0127751.txt
11391G>A,"...morphisms (SNPs) (SNP-12140G>A, SNP-11426A>G, SNP-11391G>A and SNP-11377C>G) with NSCLS risk. Additi...",7,1106,PLoS_One_2015_May_27_10(5)_e0127751.txt
11377C>G,"...(SNP-12140G>A, SNP-11426A>G, SNP-11391G>A and SNP-11377C>G) with NSCLS risk. Additionally, we constr...",7,1123,PLoS_One_2015_May_27_10(5)_e0127751.txt
12140G>A,"...sults showed that among these four SNPs, only SNP-12140G>A was associated with NSCLC risk(P<0.05). T...",7,1332,PLoS_One_2015_May_27_10(5)_e0127751.txt
12410G>A,...iation of two adiponectin gene promoter SNPs (SNP-12410G>A and SNP-11377C>G) with NSCLC risk in a Ha...,19,83,PLoS_One_2015_May_27_10(5)_e0127751.txt
11377C>G,...ponectin gene promoter SNPs (SNP-12410G>A and SNP-11377C>G) with NSCLC risk in a Han Chinese populat...,19,100,PLoS_One_2015_May_27_10(5)_e0127751.txt
12140G>A,"...inese population, and the results showed that SNP-12140G>A (rs266730) is associated with increased N...",19,187,PLoS_One_2015_May_27_10(5)_e0127751.txt
11426A>G,...ded two other adiponectin gene promoter SNPs (SNP-11426A>G and SNP-11391G>A) to evaluate the associa...,19,428,PLoS_One_2015_May_27_10(5)_e0127751.txt
11391G>A,...ponectin gene promoter SNPs (SNP-11426A>G and SNP-11391G>A) to evaluate the association of these fou...,19,445,PLoS_One_2015_May_27_10(5)_e0127751.txt
12140G>A,"...e four adiponectin gene promoter SNPs, namely,SNP-12140G>A (rs266730), SNP-11426A>G (rs16861194), SN...",19,540,PLoS_One_2015_May_27_10(5)_e0127751.txt
11426A>G,"...romoter SNPs, namely,SNP-12140G>A (rs266730), SNP-11426A>G (rs16861194), SNP-11391G>A (rs17200539) a...",19,565,PLoS_One_2015_May_27_10(5)_e0127751.txt
11391G>A,"...140G>A (rs266730), SNP-11426A>G (rs16861194), SNP-11391G>A (rs17200539) and SNP-11377C>G (rs266729),...",19,592,PLoS_One_2015_May_27_10(5)_e0127751.txt
11377C>G,"...G (rs16861194), SNP-11391G>A (rs17200539) and SNP-11377C>G (rs266729), and their haplotypes with NSC...",19,622,PLoS_One_2015_May_27_10(5)_e0127751.txt
12140G>A,"...ethod. Four adiponectin promoter SNPs, namely SNP-12140G>A (rs266730), SNP-11426A>G (rs16861194), SN...",29,149,PLoS_One_2015_May_27_10(5)_e0127751.txt
11426A>G,"...romoter SNPs, namely SNP-12140G>A (rs266730), SNP-11426A>G (rs16861194), SNP-11391G>A (rs17200539) a...",29,174,PLoS_One_2015_May_27_10(5)_e0127751.txt
11391G>A,"...140G>A (rs266730), SNP-11426A>G (rs16861194), SNP-11391G>A (rs17200539) and SNP-11377C>G (rs266729),...",29,201,PLoS_One_2015_May_27_10(5)_e0127751.txt
11377C>G,"...G (rs16861194), SNP-11391G>A (rs17200539) and SNP-11377C>G (rs266729), were genotyped using PCR ampl...",29,231,PLoS_One_2015_May_27_10(5)_e0127751.txt
12140G>A,"1.2 Association of adiponectin gene promoterSNP-12140G>A, SNP-11426A>G, SNP-11391G>A, and SNP-1137...",51,49,PLoS_One_2015_May_27_10(5)_e0127751.txt
11426A>G,"...ion of adiponectin gene promoterSNP-12140G>A, SNP-11426A>G, SNP-11391G>A, and SNP-11377C>G with NSCL...",51,63,PLoS_One_2015_May_27_10(5)_e0127751.txt
11391G>A,"...ctin gene promoterSNP-12140G>A, SNP-11426A>G, SNP-11391G>A, and SNP-11377C>G with NSCL",51,77,PLoS_One_2015_May_27_10(5)_e0127751.txt
11377C>G,"...SNP-12140G>A, SNP-11426A>G, SNP-11391G>A, and SNP-11377C>G with NSCL",51,95,PLoS_One_2015_May_27_10(5)_e0127751.txt
12140G>A,"The allele and genotype frequencies for SNP-12140G>A, SNP-11426A>G, SNP-11391G>A and SNP-11377...",52,45,PLoS_One_2015_May_27_10(5)_e0127751.txt
11426A>G,"...le and genotype frequencies for SNP-12140G>A, SNP-11426A>G, SNP-11391G>A and SNP-11377C>G in the NSC...",52,59,PLoS_One_2015_May_27_10(5)_e0127751.txt
11391G>A,"...e frequencies for SNP-12140G>A, SNP-11426A>G, SNP-11391G>A and SNP-11377C>G in the NSCLC and control...",52,73,PLoS_One_2015_May_27_10(5)_e0127751.txt
11377C>G,"... SNP-12140G>A, SNP-11426A>G, SNP-11391G>A and SNP-11377C>G in the NSCLC and control groups are liste...",52,90,PLoS_One_2015_May_27_10(5)_e0127751.txt
11391G>A,...CLC and control groups are listed in Table 2. SNP-11391G>A was found to be monomorphic(G allele) in ...,52,158,PLoS_One_2015_May_27_10(5)_e0127751.txt
12140G>A,"... control groups. The genotype frequencies for SNP-12140G>A, SNP-11426A>G and SNP-11377C>G were in HW...",52,276,PLoS_One_2015_May_27_10(5)_e0127751.txt
11426A>G,"...s. The genotype frequencies for SNP-12140G>A, SNP-11426A>G and SNP-11377C>G were in HWE for the NSCL...",52,290,PLoS_One_2015_May_27_10(5)_e0127751.txt
11377C>G,"...requencies for SNP-12140G>A, SNP-11426A>G and SNP-11377C>G were in HWE for the NSCLC and control gro...",52,307,PLoS_One_2015_May_27_10(5)_e0127751.txt
12140G>A,"...wever, the allele and genotype frequencies of SNP-12140G>A were significantly different in the NSCLC...",52,423,PLoS_One_2015_May_27_10(5)_e0127751.txt
12140G>A,"...11 and 0.046, respectively). The G allele for SNP-12140G>A occurred at a significantly higher freque...",52,551,PLoS_One_2015_May_27_10(5)_e0127751.txt
11426A>G,...094). The allele and genotype frequencies for SNP-11426A>G and SNP-11377C>G were not significantly d...,52,735,PLoS_One_2015_May_27_10(5)_e0127751.txt
11377C>G,...and genotype frequencies for SNP-11426A>G and SNP-11377C>G were not significantly different in the N...,52,752,PLoS_One_2015_May_27_10(5)_e0127751.txt
12140G>A,"...ison of genotypic and allelic distribution of SNP-12140G>A, SNP-11426A>G, SNP-11377C>G between NSCLC...",54,98,PLoS_One_2015_May_27_10(5)_e0127751.txt
11426A>G,"...pic and allelic distribution of SNP-12140G>A, SNP-11426A>G, SNP-11377C>G between NSCLC and control g...",54,112,PLoS_One_2015_May_27_10(5)_e0127751.txt
11377C>G,"...c distribution of SNP-12140G>A, SNP-11426A>G, SNP-11377C>G between NSCLC and control groups",54,126,PLoS_One_2015_May_27_10(5)_e0127751.txt
12140G>A,SNP-12140G>A	A/A(freq)	A/G(freq)	G/G(freq)		A(freq)	G(...,56,5,PLoS_One_2015_May_27_10(5)_e0127751.txt
11426A>G,SNP-11426A>G	A/A(freq)	A/G(freq)	G/G(freq)		A(freq)	G(...,59,5,PLoS_One_2015_May_27_10(5)_e0127751.txt
11377C>G,SNP-11377C>G	C/C(freq)	C/G(freq)	G/G(freq)		C(freq)	G(...,62,5,PLoS_One_2015_May_27_10(5)_e0127751.txt
12140G>A,"... inheritance analysis of adiponectin promoter SNP-12140G>A, SNP-11426A>G and SNP-11377C>",65,62,PLoS_One_2015_May_27_10(5)_e0127751.txt
11426A>G,"...nalysis of adiponectin promoter SNP-12140G>A, SNP-11426A>G and SNP-11377C>",65,76,PLoS_One_2015_May_27_10(5)_e0127751.txt
11377C>G,"...ectin promoter SNP-12140G>A, SNP-11426A>G and SNP-11377C>",65,93,PLoS_One_2015_May_27_10(5)_e0127751.txt
12140G>A,...ritance model with the lowest AIC and BIC for SNP-12140G>A and SNP-11426A>G was the log-additive mod...,66,482,PLoS_One_2015_May_27_10(5)_e0127751.txt
11426A>G,...h the lowest AIC and BIC for SNP-12140G>A and SNP-11426A>G was the log-additive model. The best fit ...,66,499,PLoS_One_2015_May_27_10(5)_e0127751.txt
11377C>G,...ritance model with the lowest AIC and BIC for SNP-11377C>G was the dominant and log-additive model. ...,66,603,PLoS_One_2015_May_27_10(5)_e0127751.txt
12140G>A,...netic models revealed that the GG genotype of SNP-12140G>A conferred more NSCLC risk in the log-addi...,66,731,PLoS_One_2015_May_27_10(5)_e0127751.txt
11426A>G,...dditive model. No significant differences for SNP-11426A>G and SNP-11377C>G were found between the N...,66,828,PLoS_One_2015_May_27_10(5)_e0127751.txt
11377C>G,... significant differences for SNP-11426A>G and SNP-11377C>G were found between the NSCLC and control ...,66,845,PLoS_One_2015_May_27_10(5)_e0127751.txt
12140G>A,... Different inheritance models analysis of the SNP-12140G>A in adiponectin gene promoter between NSCL...,68,91,PLoS_One_2015_May_27_10(5)_e0127751.txt
11426A>G,... Different inheritance models analysis of the SNP-11426A>G in adiponectin gene promoter between NSCL...,81,91,PLoS_One_2015_May_27_10(5)_e0127751.txt
11377C>G,... Different inheritance models analysis of the SNP-11377C>G in adiponectin gene promoter between NSCL...,94,91,PLoS_One_2015_May_27_10(5)_e0127751.txt
12140G>A,"...nd haplotype analysis of adiponectin promoter SNP-12140G>A, SNP-11426A>G and SNP-11377C>",107,84,PLoS_One_2015_May_27_10(5)_e0127751.txt
11426A>G,"...nalysis of adiponectin promoter SNP-12140G>A, SNP-11426A>G and SNP-11377C>",107,98,PLoS_One_2015_May_27_10(5)_e0127751.txt
11377C>G,"...ectin promoter SNP-12140G>A, SNP-11426A>G and SNP-11377C>",107,115,PLoS_One_2015_May_27_10(5)_e0127751.txt
12140G>A,"Significant LD (D') values between theSNP-12140G>A, SNP-11426A>G and SNP-11377C>G loci were ...",108,43,PLoS_One_2015_May_27_10(5)_e0127751.txt
11426A>G,"...icant LD (D') values between theSNP-12140G>A, SNP-11426A>G and SNP-11377C>G loci were found in all i...",108,57,PLoS_One_2015_May_27_10(5)_e0127751.txt
11377C>G,"...ues between theSNP-12140G>A, SNP-11426A>G and SNP-11377C>G loci were found in all individuals. The D...",108,74,PLoS_One_2015_May_27_10(5)_e0127751.txt
12140G>A,"...l individuals. The D' value was 0.899 between SNP-12140G>A and SNP-11426A>G, 0.857 between SNP-12140...",108,154,PLoS_One_2015_May_27_10(5)_e0127751.txt
11426A>G,"...e D' value was 0.899 between SNP-12140G>A and SNP-11426A>G, 0.857 between SNP-12140G>A and SNP-11377...",108,171,PLoS_One_2015_May_27_10(5)_e0127751.txt
12140G>A,"... SNP-12140G>A and SNP-11426A>G, 0.857 between SNP-12140G>A and SNP-11377C>G and 0.864 between SNP-11...",108,199,PLoS_One_2015_May_27_10(5)_e0127751.txt
11377C>G,"... SNP-11426A>G, 0.857 between SNP-12140G>A and SNP-11377C>G and 0.864 between SNP-11426A>G and SNP-11...",108,216,PLoS_One_2015_May_27_10(5)_e0127751.txt
11426A>G,"...P-12140G>A and SNP-11377C>G and 0.864 between SNP-11426A>G and SNP-11377C>G. Based on the LD result,...",108,247,PLoS_One_2015_May_27_10(5)_e0127751.txt
11377C>G,"...P-11377C>G and 0.864 between SNP-11426A>G and SNP-11377C>G. Based on the LD result, we calculated th...",108,264,PLoS_One_2015_May_27_10(5)_e0127751.txt
12140G>A,...nd Table 6 shows the estimated frequencies of SNP-12140G>A-SNP-11426A>G-SNP-11377C>G haplotypes with...,108,399,PLoS_One_2015_May_27_10(5)_e0127751.txt
11426A>G,...ows the estimated frequencies of SNP-12140G>A-SNP-11426A>G-SNP-11377C>G haplotypes with frequencies ...,108,412,PLoS_One_2015_May_27_10(5)_e0127751.txt
11377C>G,...ated frequencies of SNP-12140G>A-SNP-11426A>G-SNP-11377C>G haplotypes with frequencies of more than ...,108,425,PLoS_One_2015_May_27_10(5)_e0127751.txt
12140G>A,"....t006Table 6 Different haplotypes analysis of SNP-12140G>A, SNP-11426A>G, SNP-11377C>G in adiponecti...",110,79,PLoS_One_2015_May_27_10(5)_e0127751.txt
11426A>G,"...ifferent haplotypes analysis of SNP-12140G>A, SNP-11426A>G, SNP-11377C>G in adiponectin gene promote...",110,93,PLoS_One_2015_May_27_10(5)_e0127751.txt
11377C>G,"...types analysis of SNP-12140G>A, SNP-11426A>G, SNP-11377C>G in adiponectin gene promoter between NSCL...",110,107,PLoS_One_2015_May_27_10(5)_e0127751.txt
12140G>A,SNP-12140G>A	SNP-11426A>G	SNP-11377C>G	NSCLC[n(%)]	Con...,111,5,PLoS_One_2015_May_27_10(5)_e0127751.txt
11426A>G,SNP-12140G>A	SNP-11426A>G	SNP-11377C>G	NSCLC[n(%)]	Control[n(%)]	P ...,111,18,PLoS_One_2015_May_27_10(5)_e0127751.txt
11377C>G,SNP-12140G>A	SNP-11426A>G	SNP-11377C>G	NSCLC[n(%)]	Control[n(%)]	P value	P value...,111,31,PLoS_One_2015_May_27_10(5)_e0127751.txt
12140G>A,"... Association analysis of adiponectin promoter SNP-12140G>A, SNP-11426A>G, and SNP-11377C>G with diff...",120,54,PLoS_One_2015_May_27_10(5)_e0127751.txt
11426A>G,"...nalysis of adiponectin promoter SNP-12140G>A, SNP-11426A>G, and SNP-11377C>G with different patholog...",120,68,PLoS_One_2015_May_27_10(5)_e0127751.txt
11377C>G,"...ctin promoter SNP-12140G>A, SNP-11426A>G, and SNP-11377C>G with different pathologic stage",120,86,PLoS_One_2015_May_27_10(5)_e0127751.txt
12140G>A,"...ces in the allele and genotype frequencies forSNP-12140G>A, SNP-11426A>G and SNP-11377C>G between pa...",121,73,PLoS_One_2015_May_27_10(5)_e0127751.txt
11426A>G,"...ele and genotype frequencies forSNP-12140G>A, SNP-11426A>G and SNP-11377C>G between pathologic stage...",121,87,PLoS_One_2015_May_27_10(5)_e0127751.txt
11377C>G,"...frequencies forSNP-12140G>A, SNP-11426A>G and SNP-11377C>G between pathologic stages I+II and III+IV...",121,104,PLoS_One_2015_May_27_10(5)_e0127751.txt
12140G>A,"...ison of genotypic and allelic distribution of SNP-12140G>A, SNP-11426A>G, SNP-11377C>G between patho...",123,98,PLoS_One_2015_May_27_10(5)_e0127751.txt
11426A>G,"...pic and allelic distribution of SNP-12140G>A, SNP-11426A>G, SNP-11377C>G between pathologic stages I...",123,112,PLoS_One_2015_May_27_10(5)_e0127751.txt
11377C>G,"...c distribution of SNP-12140G>A, SNP-11426A>G, SNP-11377C>G between pathologic stages I+II and III+IV...",123,126,PLoS_One_2015_May_27_10(5)_e0127751.txt
12140G>A,SNP-12140G>A	A/A(freq)	A/G(freq)	G/G(freq)		A(freq)	G(...,125,5,PLoS_One_2015_May_27_10(5)_e0127751.txt
11426A>G,SNP-11426A>G	A/A(freq)	A/G(freq)	G/G(freq)		A(freq)	G(...,128,5,PLoS_One_2015_May_27_10(5)_e0127751.txt
11377C>G,SNP-11377C>G	C/C(freq)	C/G(freq)	G/G(freq)		C(freq)	G(...,131,5,PLoS_One_2015_May_27_10(5)_e0127751.txt
12140G>A,"... Association analysis of adiponectin promoter SNP-12140G>A, SNP-11426A>G, and SNP-11377C>G with aden...",134,54,PLoS_One_2015_May_27_10(5)_e0127751.txt
11426A>G,"...nalysis of adiponectin promoter SNP-12140G>A, SNP-11426A>G, and SNP-11377C>G with adenocarcinoma (AC...",134,68,PLoS_One_2015_May_27_10(5)_e0127751.txt
11377C>G,"...ctin promoter SNP-12140G>A, SNP-11426A>G, and SNP-11377C>G with adenocarcinoma (AC) and squamous cel...",134,86,PLoS_One_2015_May_27_10(5)_e0127751.txt
12140G>A,"...es in the allele and genotype frequencies for SNP-12140G>A, SNP-11426A>G and SNP-11377C>G between AC...",135,84,PLoS_One_2015_May_27_10(5)_e0127751.txt
11426A>G,"...le and genotype frequencies for SNP-12140G>A, SNP-11426A>G and SNP-11377C>G between AC and SCC(Table...",135,98,PLoS_One_2015_May_27_10(5)_e0127751.txt
11377C>G,"...requencies for SNP-12140G>A, SNP-11426A>G and SNP-11377C>G between AC and SCC(Table 8)",135,115,PLoS_One_2015_May_27_10(5)_e0127751.txt
12140G>A,"...ociation analysis of the adiponectin promoter SNP-12140G>A, SNP-11426A>G, SNP-11377C>G between adeno...",137,95,PLoS_One_2015_May_27_10(5)_e0127751.txt
11426A>G,"...sis of the adiponectin promoter SNP-12140G>A, SNP-11426A>G, SNP-11377C>G between adenocarcinoma (AC)...",137,109,PLoS_One_2015_May_27_10(5)_e0127751.txt
11377C>G,"...ponectin promoter SNP-12140G>A, SNP-11426A>G, SNP-11377C>G between adenocarcinoma (AC) and squamous ...",137,123,PLoS_One_2015_May_27_10(5)_e0127751.txt
12140 G>A,SNP-12140 G>A	A/A(freq)	A/G(freq)	G/G(freq)		A(freq)	G...,139,5,PLoS_One_2015_May_27_10(5)_e0127751.txt
11426 A>G,SNP-11426 A>G	A/A(freq)	A/G(freq)	G/G(freq)		A(freq)	G...,142,5,PLoS_One_2015_May_27_10(5)_e0127751.txt
11377 C>G,SNP-11377 C>G	C/C(freq)	C/G(freq)	G/G(freq)		C(freq)	G...,145,5,PLoS_One_2015_May_27_10(5)_e0127751.txt
11377C>G,"...i et al. failed to observe an association for SNP-11377C>G (rs266729), which is located in the adipo...",151,295,PLoS_One_2015_May_27_10(5)_e0127751.txt
11426A>G,"In 2009, Laumen et al. found that SNP-11426A>G, SNP-11391G>Aand SNP-11377C>G within the ...",153,39,PLoS_One_2015_May_27_10(5)_e0127751.txt
11391G>Aan,"... 2009, Laumen et al. found that SNP-11426A>G, SNP-11391G>Aand SNP-11377C>G within the adiponectin pr...",153,53,PLoS_One_2015_May_27_10(5)_e0127751.txt
11377C>G,"... al. found that SNP-11426A>G, SNP-11391G>Aand SNP-11377C>G within the adiponectin promoter were regu...",153,69,PLoS_One_2015_May_27_10(5)_e0127751.txt
12140G>A,...that the G allele of the adiponectin promoter SNP-12140G>A is a risk factor for NSCLC[23] and that i...,153,421,PLoS_One_2015_May_27_10(5)_e0127751.txt
12140G>A,...r for NSCLC[23] and that individuals with the SNP-12140G>A GG genotype have increased risk for NSCLC...,153,495,PLoS_One_2015_May_27_10(5)_e0127751.txt
11377C>G,"...ree adiponectin gene promoter SNPs, including SNP-11377C>G, were not correlated with NSCLC in the cu...",153,636,PLoS_One_2015_May_27_10(5)_e0127751.txt
11377C>G,...t al. reported that adiponectin gene promoter SNP-11377C>G is associated with colorectal cancer risk...,153,769,PLoS_One_2015_May_27_10(5)_e0127751.txt
11377C>G,... al. failed to observe an association between SNP-11377C>G and colorectal cancer risk in patients fr...,153,903,PLoS_One_2015_May_27_10(5)_e0127751.txt
11377C>G,"...with those of Cui et al. [30], indicated that SNP-11377C>G is not associated with NSCLC risk and sug...",153,1525,PLoS_One_2015_May_27_10(5)_e0127751.txt
11377C>G,...d suggested that the role of adiponectin gene SNP-11377C>G may be specific to the cancer type or eth...,153,1620,PLoS_One_2015_May_27_10(5)_e0127751.txt
12140G>A,"...er SNPs may be specific to the SNP site, e.g.,SNP-12140G>A maybe more important than SNP-11377C>G in...",153,1804,PLoS_One_2015_May_27_10(5)_e0127751.txt
11377C>G,"..., e.g.,SNP-12140G>A maybe more important than SNP-11377C>G in the Chinese population. Based on these...",153,1843,PLoS_One_2015_May_27_10(5)_e0127751.txt
12140G>A,"... Based on these results, we hypothesized that SNP-12140G>A may influence adiponectin promoter activi...",153,1928,PLoS_One_2015_May_27_10(5)_e0127751.txt
12140G>A,"...CLC risk. Unfortunately, to date, the role of SNP-12140G>A in adiponectin promoter activity and gene...",153,2093,PLoS_One_2015_May_27_10(5)_e0127751.txt
12140G>A,...ture. It was an interesting finding that only SNP-12140G>A was associated with NSCLC in our study. O...,153,2347,PLoS_One_2015_May_27_10(5)_e0127751.txt
12140G>A,...with NSCLC in our study. Our data showed that SNP-12140G>A just was partly in linkage disequilibrium...,153,2421,PLoS_One_2015_May_27_10(5)_e0127751.txt
11426A>G,"...ust was partly in linkage disequilibrium with SNP-11426A>G and SNP-11377C>G. Therefore, we assumed t...",153,2481,PLoS_One_2015_May_27_10(5)_e0127751.txt
11377C>G,"... linkage disequilibrium with SNP-11426A>G and SNP-11377C>G. Therefore, we assumed this could be poss...",153,2498,PLoS_One_2015_May_27_10(5)_e0127751.txt
12140G>A,...ble one of causes of the divergence that only SNP-12140G>A associated with NSCLC in this Han Chinese...,153,2599,PLoS_One_2015_May_27_10(5)_e0127751.txt
11426A>G,"...NSCLC in this Han Chinese population, but not SNP-11426A>G and SNP-11377C>G",153,2674,PLoS_One_2015_May_27_10(5)_e0127751.txt
11377C>G,"... Chinese population, but not SNP-11426A>G and SNP-11377C>G",153,2691,PLoS_One_2015_May_27_10(5)_e0127751.txt
12140G>A,"...ferences in allele and genotype frequency for SNP-12140G>A, SNP-11426A>G and SNP-11377C>G between AC...",155,105,PLoS_One_2015_May_27_10(5)_e0127751.txt
11426A>G,"...lele and genotype frequency for SNP-12140G>A, SNP-11426A>G and SNP-11377C>G between AC and SCC (Tabl...",155,119,PLoS_One_2015_May_27_10(5)_e0127751.txt
11377C>G,"... frequency for SNP-12140G>A, SNP-11426A>G and SNP-11377C>G between AC and SCC (Table 8). In addition...",155,136,PLoS_One_2015_May_27_10(5)_e0127751.txt
12140G>A,"...ferences in allele and genotype frequency for SNP-12140G>A, SNP-11426A>G and SNP-11377C>G between pa...",155,255,PLoS_One_2015_May_27_10(5)_e0127751.txt
11426A>G,"...lele and genotype frequency for SNP-12140G>A, SNP-11426A>G and SNP-11377C>G between pathologic stage...",155,269,PLoS_One_2015_May_27_10(5)_e0127751.txt
11377C>G,"... frequency for SNP-12140G>A, SNP-11426A>G and SNP-11377C>G between pathologic stages I+II and III+IV...",155,286,PLoS_One_2015_May_27_10(5)_e0127751.txt
12140G>A,"...ctin by subcutaneous adipose tissue [3].Thus, SNP-12140G>A may be merely a susceptibility factor for...",155,879,PLoS_One_2015_May_27_10(5)_e0127751.txt
12140G>A,"...tudy. The statistical power for the effect of SNP-12140G>A was calculated using PS software [28],and...",157,181,PLoS_One_2015_May_27_10(5)_e0127751.txt
12140G>A,"...an association study for adiponectin promoter SNP-12140G>A, SNP-11426A>G and SNP-11377C>G and NSCLC ...",160,79,PLoS_One_2015_May_27_10(5)_e0127751.txt
11426A>G,"... study for adiponectin promoter SNP-12140G>A, SNP-11426A>G and SNP-11377C>G and NSCLC in a Han Chine...",160,93,PLoS_One_2015_May_27_10(5)_e0127751.txt
11377C>G,"...ectin promoter SNP-12140G>A, SNP-11426A>G and SNP-11377C>G and NSCLC in a Han Chinese population and...",160,110,PLoS_One_2015_May_27_10(5)_e0127751.txt
12140G>A,...ese population and found that the G allele of SNP-12140G>A is a risk factor for NSCLC; individuals w...,160,192,PLoS_One_2015_May_27_10(5)_e0127751.txt
12140G>A,...a risk factor for NSCLC; individuals with the SNP-12140G>A GG genotype showed increased risk for NSC...,160,254,PLoS_One_2015_May_27_10(5)_e0127751.txt
448G>C,"...s revealed a missense mutation at position 448 (c.448G>C) of MIP, which resulted in the substitution...",7,988,PLoS_One_2015_May_6_10(5)_e0126679.txt
448G>C,"...ed a heterozygous change (G>C),at position 448 (c.448G>C) of MIP, which leads to the replacement of ...",60,98,PLoS_One_2015_May_6_10(5)_e0126679.txt
448G>C,"...cleotide change (black arrow) in exon 2 of MIP (c.448G>C), which leads to the replacement of asparti...",63,202,PLoS_One_2015_May_6_10(5)_e0126679.txt
448G>C,"MIP: c.448G>C, p.D150H		1.628	1.718	1.797	1.806",77,8,PLoS_One_2015_May_6_10(5)_e0126679.txt
6982C>T,"...s exon 3 deletion) or point mutations p.P2328S (c.6982C>T), p.T2538R (c.7613C>G), p.L4115F (c.12343C...",31,358,PLoS_One_2015_May_8_10(5)_e0125366.txt
7613C>G,"...point mutations p.P2328S (c.6982C>T), p.T2538R (c.7613C>G), p.L4115F (c.12343C>T), p.Q4201R (c.12602...",31,380,PLoS_One_2015_May_8_10(5)_e0125366.txt
12343C>T,"...8S (c.6982C>T), p.T2538R (c.7613C>G), p.L4115F (c.12343C>T), p.Q4201R (c.12602A>G) or p.V4653F (c.13...",31,402,PLoS_One_2015_May_8_10(5)_e0125366.txt
12602A>G,"...R (c.7613C>G), p.L4115F (c.12343C>T), p.Q4201R (c.12602A>G) or p.V4653F (c.13957G>T). Mutation nomen...",31,425,PLoS_One_2015_May_8_10(5)_e0125366.txt
13957G>T,"...c.12343C>T), p.Q4201R (c.12602A>G) or p.V4653F (c.13957G>T). Mutation nomenclature was based on RyR2...",31,450,PLoS_One_2015_May_8_10(5)_e0125366.txt
97V>A,"...n one RCUD patient. Thus, the mutation led to the 97V>A amino-acid change in the protein sequence. S...",157,139,PLoS_One_2015_May_8_10(5)_e0126555.txt
3140A>G,H1047R	3140A>G	112	11.1,66,8,PLoS_One_2015_Oct_9_10(10)_e0140293.txt
1633G>A,E545K	1633G>A	47	4.7,67,7,PLoS_One_2015_Oct_9_10(10)_e0140293.txt
1624G>A,E542K	1624G>A	38	3.8,68,7,PLoS_One_2015_Oct_9_10(10)_e0140293.txt
3140A>T,H1047L	3140A>T	27	2.7,69,8,PLoS_One_2015_Oct_9_10(10)_e0140293.txt
3140A>G,"H1047R,E542K	3140A>G,1624G>A	2	0.2",70,14,PLoS_One_2015_Oct_9_10(10)_e0140293.txt
1624G>A,"H1047R,E542K	3140A>G,1624G>A	2	0.2",70,22,PLoS_One_2015_Oct_9_10(10)_e0140293.txt
3140A>G,"H1047R,E545K	3140A>G,1633G>A	1	0.1",71,14,PLoS_One_2015_Oct_9_10(10)_e0140293.txt
1633G>A,"H1047R,E545K	3140A>G,1633G>A	1	0.1",71,22,PLoS_One_2015_Oct_9_10(10)_e0140293.txt
3139C>T,H1047Y	3139C>T	1	0.1,72,8,PLoS_One_2015_Oct_9_10(10)_e0140293.txt
3142T>C,H1047H	3142T>C	1	0.1,73,8,PLoS_One_2015_Oct_9_10(10)_e0140293.txt
3146G>A,G1049D	3146G>A	1	0.1,74,8,PLoS_One_2015_Oct_9_10(10)_e0140293.txt
3031C>T,P1011S	3031C>T	1	0.1,75,8,PLoS_One_2015_Oct_9_10(10)_e0140293.txt
3052G>A,D1018N	3052G>A	1	0.1,76,8,PLoS_One_2015_Oct_9_10(10)_e0140293.txt
3197C>T,A1066V	3197C>T hom	1	0.1,77,8,PLoS_One_2015_Oct_9_10(10)_e0140293.txt
3058G>A,"A1020T, H1047R, A1066T	3058G>A, 3140A>G, 3196G	1	0.1",78,24,PLoS_One_2015_Oct_9_10(10)_e0140293.txt
3140A>G,"A1020T, H1047R, A1066T	3058G>A, 3140A>G, 3196G	1	0.1",78,33,PLoS_One_2015_Oct_9_10(10)_e0140293.txt
3120G>A,"M1040I, p.A1066V	3120G>A, 3197C>T	1	0.1",79,18,PLoS_One_2015_Oct_9_10(10)_e0140293.txt
3197C>T,"M1040I, p.A1066V	3120G>A, 3197C>T	1	0.1",79,27,PLoS_One_2015_Oct_9_10(10)_e0140293.txt
2R > S,"... R > P > S. We further make the common assumption 2R > S + T > 2P, such that mutual cooperation is t...",25,371,PLoS_One_2015_Sep_1_10(9)_e0137435.txt
511 C>T,"..., clear trends of association were seen for IL1B -511 C>T and IL1RN 86bp VNTR in several of the cons...",9,1599,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
511 C>T,".... The presence of >1, ‘T’ (minor) allele of IL1B -511 C>T in a genotype seemed to provide protection...",9,1773,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
4845 G>T,"...ences in association statuses were seen for IL1A +4845 G>T, IL1B -511 C>T, IL1RN 86bp VNTR and IL1RN...",9,2828,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
511 C>T,"...tion statuses were seen for IL1A +4845 G>T, IL1B -511 C>T, IL1RN 86bp VNTR and IL1RN +8006 T>C for s...",9,2844,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
8006 T>C,"...45 G>T, IL1B -511 C>T, IL1RN 86bp VNTR and IL1RN +8006 T>C for select ancestral subgroups. The hints...",9,2880,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
511 C>T,...g to NIA in our case-control study for both IL1B -511 C>T and IL1RN 86bp VNTR were duly validated vi...,9,3026,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
511 C>T,"...hand, Mixed Ancestry (MA) subgroup carrying IL1B -511 C>T, IL1RN 86bp VNTR or IL1RN +8006 T>C polymo...",9,3309,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
8006 T>C,"...carrying IL1B -511 C>T, IL1RN 86bp VNTR or IL1RN +8006 T>C polymorphisms seemed to enjoy significant...",9,3344,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
511 C>T,"...eported lack of association of 3 SNPs (i.e. IL1B -511 C>T, IL1B+3954 C>T and IL1RN 86bp VNTR) residi...",15,1904,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
3954 C>T,"...f association of 3 SNPs (i.e. IL1B -511 C>T, IL1B+3954 C>T and IL1RN 86bp VNTR) residing in IL-1 gen...",15,1918,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
889 C>T,"...orth Indians (which examined only 1 SNP i.e. IL1A-889 C>T from this gene cluster), [11] no other ass...",15,2451,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
889 C>T,"...ymorphisms of the IL-1 gene cluster, namely: IL1A-889 C>T (rs1800587), IL1A+4845 G>T (rs17561), IL1B...",17,158,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
4845 G>T,"...e cluster, namely: IL1A-889 C>T (rs1800587), IL1A+4845 G>T (rs17561), IL1B-1903 C>T (rs1143627), IL1...",17,184,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
1903 C>T,"...89 C>T (rs1800587), IL1A+4845 G>T (rs17561), IL1B-1903 C>T (rs1143627), IL1B-3954 C>T (rs1143634), I...",17,209,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
3954 C>T,"...45 G>T (rs17561), IL1B-1903 C>T (rs1143627), IL1B-3954 C>T (rs1143634), IL1B-5887 C>T(rs1143633), IL...",17,236,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
5887 C>T,"... C>T (rs1143627), IL1B-3954 C>T (rs1143634), IL1B-5887 C>T(rs1143633), IL1B-511 C>T (rs16944), IL1RN...",17,263,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
511 C>T,"...4 C>T (rs1143634), IL1B-5887 C>T(rs1143633), IL1B-511 C>T (rs16944), IL1RN+9589 A>T (rs454078), IL1R...",17,289,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
9589 A>T,"...887 C>T(rs1143633), IL1B-511 C>T (rs16944), IL1RN+9589 A>T (rs454078), IL1RN+8006 T>C (rs419598), IL...",17,314,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
8006 T>C,"...1 C>T (rs16944), IL1RN+9589 A>T (rs454078), IL1RN+8006 T>C (rs419598), IL1RN+8061 C>T (rs423904), IL...",17,341,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
8061 C>T,"... A>T (rs454078), IL1RN+8006 T>C (rs419598), IL1RN+8061 C>T (rs423904), IL1RN+111000 T>C (rs315952) a...",17,368,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
111000 T>C,"... T>C (rs419598), IL1RN+8061 C>T (rs423904), IL1RN+111000 T>C (rs315952) and IL1RN 86bp VNTR (PMID 14...",17,395,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
511 C>T,"...sociation (p>0.0045), a couple of them i.e. IL1B -511 C>T and IL1RN 86bp VNTR certainly showed trend...",51,461,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
511 C>T,...he T (minor) allele and the TT genotype for IL1B -511 C>T polymorphism showed a promising trend towa...,51,608,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
511 C>T,...pe. The C (major) allele and CC genotype of IL1B -511 C>T thus automatically hinted to be involved w...,51,1012,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
111000 T>C,"...ing, published study for 3 IL1RN gene SNPs, viz. +111000 T>C, +8061 C>T and +9589 A>T, they were exc...",56,994,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
8061 C>T,"...d study for 3 IL1RN gene SNPs, viz. +111000 T>C, +8061 C>T and +9589 A>T, they were excluded from qu...",56,1007,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
9589 A>T,"...IL1RN gene SNPs, viz. +111000 T>C, +8061 C>T and +9589 A>T, they were excluded from quantitative syn...",56,1021,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
889 C>T,Interleukin-1 SNPs included- IL1A-889 C>T (rs1800587); IL1A+4845 G>T (rs17561); IL1B...,86,35,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
4845 G>T,...n-1 SNPs included- IL1A-889 C>T (rs1800587); IL1A+4845 G>T (rs17561); IL1B -511 C>T (rs16944); IL1B ...,86,61,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
511 C>T,...9 C>T (rs1800587); IL1A+4845 G>T (rs17561); IL1B -511 C>T (rs16944); IL1B -5887 C>T (rs1143633); IL1...,86,87,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
5887 C>T,...845 G>T (rs17561); IL1B -511 C>T (rs16944); IL1B -5887 C>T (rs1143633); IL1B -3954 C>T (rs1143634); ...,86,112,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
3954 C>T,... C>T (rs16944); IL1B -5887 C>T (rs1143633); IL1B -3954 C>T (rs1143634); IL1B -1903 C>T (rs1143627); ...,86,140,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
1903 C>T,...>T (rs1143633); IL1B -3954 C>T (rs1143634); IL1B -1903 C>T (rs1143627); IL1RN 86bp VNTR (PMID 145633...,86,168,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
8006 T>C,...1143627); IL1RN 86bp VNTR (PMID 14563376); IL1RN +8006 T>C (rs419598),86,230,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
889 C>T,Two variants of IL1A gene viz. -889 C>T and +4845 G>T were selected for meta-analy...,91,33,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
4845 G>T,Two variants of IL1A gene viz. -889 C>T and +4845 G>T were selected for meta-analysis. We inclu...,91,46,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
889 C>T,"...1, 25] to be used for quantitative synthesis for -889 C>T with a data of 1,306 subjects (605 cases a...",91,194,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
889 C>T,... heterogeneity. Lack of association with CAD for -889 C>T was however indicated by our pooled result...,91,418,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
889 C>T,"...7–0.57). No significant association with CAD for -889 C>T was detected either, for EA and NIA in our...",91,590,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
4845 G>T,"... studies (including ours’) fit for inclusion for +4845 G>T [26, 27] with a total sample size of 1,60...",91,884,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
4845 G>T,"...range = 0.34–0.90). Apart from the MEA, in which +4845 G>T polymorphism (in the dominant genetic mod...",91,1187,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
889 C>T,-889 C>T (rs1800587),97,2,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
4845 G>T,+4845 G>T (rs17561),105,2,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
511 C>T,-511 C>T (rs16944),115,2,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
1903 C>T,-1903 C>T (rs1143627),126,2,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
3954 C>T,-3954 C>T (rs1143634),134,2,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
5887 C>T,-5887 C>T (rs1143633),143,2,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
8006 T>C,+8006 T>C (rs419598),162,2,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
889 C>T,a Dominant genetic model: TT+CT vs. CC for A-889 C>T; TT+GT vs. GG for A+4845 G>T; TT+CT vs. CC...,175,46,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
4845 G>T,...l: TT+CT vs. CC for A-889 C>T; TT+GT vs. GG for A+4845 G>T; TT+CT vs. CC for B-511 C>T; TT+CT vs. CC...,175,74,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
511 C>T,...; TT+GT vs. GG for A+4845 G>T; TT+CT vs. CC for B-511 C>T; TT+CT vs. CC for B-1903 C>T; TT+CT vs. CC...,175,103,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
1903 C>T,...T; TT+CT vs. CC for B-511 C>T; TT+CT vs. CC for B-1903 C>T; TT+CT vs. CC for B-3954 C>T; TT+CT vs. C...,175,131,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
3954 C>T,...; TT+CT vs. CC for B-1903 C>T; TT+CT vs. CC for B-3954 C>T; TT+CT vs. CC for B-5887 C>T; 2/2+X/2 vs....,175,160,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
5887 C>T,...; TT+CT vs. CC for B-3954 C>T; TT+CT vs. CC for B-5887 C>T; 2/2+X/2 vs. X/X for RN 86bp VNTR (X = An...,175,189,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
8006 T>C,... other allele than allele 2); CC+CT vs. TT for RN+8006 T>C,175,290,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
889 C>T,b Recessive genetic model: TT vs. CT+CC for A-889 C>T; TT vs. CT+GG for A+4845 G>T; TT vs. CT+CC...,177,47,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
4845 G>T,...l: TT vs. CT+CC for A-889 C>T; TT vs. CT+GG for A+4845 G>T; TT vs. CT+CC for B-511 C>T; TT vs. CT+CC...,177,75,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
511 C>T,...; TT vs. CT+GG for A+4845 G>T; TT vs. CT+CC for B-511 C>T; TT vs. CT+CC for B-1903 C>T; TT vs. CT+CC...,177,104,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
1903 C>T,...T; TT vs. CT+CC for B-511 C>T; TT vs. CT+CC for B-1903 C>T; TT vs. CT+CC for B-3954 C>T; TT vs. CT+C...,177,132,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
3954 C>T,...; TT vs. CT+CC for B-1903 C>T; TT vs. CT+CC for B-3954 C>T; TT vs. CT+CC for B-5887 C>T; 2/2 vs. X/2...,177,161,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
5887 C>T,...; TT vs. CT+CC for B-3954 C>T; TT vs. CT+CC for B-5887 C>T; 2/2 vs. X/2+X/X for RN 86bp VNTR; CC vs....,177,190,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
8006 T>C,...vs. X/2+X/X for RN 86bp VNTR; CC vs. CT+TT for RN+8006 T>C,177,254,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
889 C>T,...llelic genetic model: Allele T vs. Allele C for A-889 C>T; Allele T vs. Allele G for A+4845 G>T; All...,179,54,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
4845 G>T,...lele C for A-889 C>T; Allele T vs. Allele G for A+4845 G>T; Allele T vs. Allele C for B-511 C>T; All...,179,91,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
511 C>T,...ele G for A+4845 G>T; Allele T vs. Allele C for B-511 C>T; Allele T vs. Allele C for B-1903 C>T; All...,179,129,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
1903 C>T,...lele C for B-511 C>T; Allele T vs. Allele C for B-1903 C>T; Allele T vs. Allele C for B-3954 C>T; Al...,179,166,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
3954 C>T,...ele C for B-1903 C>T; Allele T vs. Allele C for B-3954 C>T; Allele T vs. Allele C for B-5887 C>T; Al...,179,204,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
5887 C>T,...ele C for B-3954 C>T; Allele T vs. Allele C for B-5887 C>T; Allele 2 vs. Allele X for RN 86bp VNTR; ...,179,242,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
8006 T>C,... X for RN 86bp VNTR; Allele C vs. Allele T for RN+8006 T>C,179,321,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
4845 G>T,...t plots depicting meta-analysis results for IL1A +4845 G>T (rs17561) polymorphism,181,95,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
511 C>T,"A total of 4 SNPs from the IL1B gene, viz. -511 C>T, -5887 C>T, -3954 C>T and -1903 C>T, were ...",184,45,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
5887 C>T,"...tal of 4 SNPs from the IL1B gene, viz. -511 C>T, -5887 C>T, -3954 C>T and -1903 C>T, were selected f...",184,55,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
3954 C>T,"...Ps from the IL1B gene, viz. -511 C>T, -5887 C>T, -3954 C>T and -1903 C>T, were selected for the pres...",184,66,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
1903 C>T,"...1B gene, viz. -511 C>T, -5887 C>T, -3954 C>T and -1903 C>T, were selected for the present meta-analy...",184,80,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
511 C>T,"...rent studies (including ours’) were included for -511 C>T, with a total sample of 7,429 (4,376 cases...",184,198,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
511 C>T,...e effects for analysis. Protective effect of the -511 C>T polymorphism was seen more or less amongst...,184,882,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
511 C>T,...t plots depicting meta-analysis results for IL1B -511 C>T (rs16944) polymorphism,186,95,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
1903 C>T,"...present study, two studies[38] were included for -1903 C>T (total sample: 1,041 with 524 cases and 5...",189,65,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
3954 C>T,"...7 controls), 9 studies[25–27, 31, 32, 34–36] for -3954 C>T (total sample: 3,975 with 2,018 cases and...",189,166,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
5887 C>T,"... cases and 1,957 controls) and 2 studies[26] for -5887 C>T (total sample: 1,405 with 664 cases and 7...",189,256,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
1903 C>T,"...orementioned SNPs (p value range = 0.62–0.71 for -1903 C>T, p value range = 0.44–0.92 for -3954 C>T ...",189,592,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
3954 C>T,"....71 for -1903 C>T, p value range = 0.44–0.92 for -3954 C>T and p value range = 0.65–0.72 for -5887 C...",189,633,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
5887 C>T,"... for -3954 C>T and p value range = 0.65–0.72 for -5887 C>T). Additionally, none of the ancestral sub...",189,677,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
8006 T>C,"Two common polymorphisms, viz. 86bp VNTR and +8006 T>C, were selected for meta-analysis from the...",191,47,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
8006 T>C,"...[26, 42, 44] were included for meta-analysis for +8006 T>C with a total sample of 3,147 (1,512 cases...",196,63,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
8006 T>C,... as subgroup analysis. No hint of association of +8006 T>C polymorphism with CAD was deduced in the ...,196,281,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
8006 T>C,... plots depicting meta-analysis results for IL1RN +8006 T>C (rs419598) polymorphism,198,96,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
511 C>T,"...24] Using our preset criteria, only 4 SNPs viz. B-511 C>T, B-3954 C>T, RN86bp VNTR and RN+8006 T>C, ...",202,290,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
3954 C>T,"...ur preset criteria, only 4 SNPs viz. B-511 C>T, B-3954 C>T, RN86bp VNTR and RN+8006 T>C, qualified f...",202,301,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
8006 T>C,"...Ps viz. B-511 C>T, B-3954 C>T, RN86bp VNTR and RN+8006 T>C, qualified for publication bias assessmen...",202,330,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
511 C>T,"... S5 Fig displays all three funnel plots for IL1B -511 C>T and IL1B -3954 C>T, polymorphisms, whereas...",202,601,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
3954 C>T,"...ll three funnel plots for IL1B -511 C>T and IL1B -3954 C>T, polymorphisms, whereas S6 Fig displays a...",202,619,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
8006 T>C,...three funnel plots for IL1RN 86bp VNTR and IL1RN +8006 T>C polymorphisms. Each point in these plots ...,202,722,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
511 C>T,"...in groups of ≥ 5 studies). Only three SNPs viz. B-511 C>T, B-3954 C>T, RN86bp VNTR qualified for the...",205,199,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
3954 C>T,"...f ≥ 5 studies). Only three SNPs viz. B-511 C>T, B-3954 C>T, RN86bp VNTR qualified for the same. The ...",205,210,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
889 C>T,...ciation of both the studied IL1A gene SNPs (i.e. -889 C>T and +4845 G>T) with CAD. Neither of the po...,211,96,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
4845 G>T,...th the studied IL1A gene SNPs (i.e. -889 C>T and +4845 G>T) with CAD. Neither of the possible haplot...,211,109,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
889 C>T,"...nalysis deduced any significant associations for -889 C>T. Such result was expected, as none of the ...",211,315,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
889 C>T,...ry angioplasty (PTCA) has also been reported for -889 C>T which probably testifies its lack of assoc...,211,546,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
889 C>T,...] No published data reporting the association of -889 C>T polymorphism with levels of systemic/cardi...,211,673,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
4845 G>T,...terners) has reported significant association of +4845 G>T with CAD in a relatively small sample siz...,213,93,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
4845 G>T,...EA. Clear evidence indicating non-association of +4845 G>T polymorphism with levels of systemic infl...,213,428,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
511 C>T,"... the association tests for all 4 IL1B SNPs (i.e. -511 C>T, -1903 C>T, -3954 C>T and -5887 C>T), in t...",218,67,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
1903 C>T,"...iation tests for all 4 IL1B SNPs (i.e. -511 C>T, -1903 C>T, -3954 C>T and -5887 C>T), in the present...",218,77,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
3954 C>T,"...s for all 4 IL1B SNPs (i.e. -511 C>T, -1903 C>T, -3954 C>T and -5887 C>T), in the present case-contr...",218,88,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
5887 C>T,"...1B SNPs (i.e. -511 C>T, -1903 C>T, -3954 C>T and -5887 C>T), in the present case-control study yield...",218,102,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
511 C>T,...ds suggesting possible association were seen for -511 C>T. Congruent with the results of our case-co...,218,275,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
511 C>T,"...of our case-control study, subgroup analysis for -511 C>T hinted associations for certain ancestral ...",218,361,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
511 C>T,"... failed to report any significant association of -511 C>T with CAD. However, similar to the associat...",218,954,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
511 C>T,"...y been established,[47] the protective nature of -511 C>T polymorphism seen against CAD, probably su...",218,1531,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
511C>T,... 49] Further explanation of the link between the -511C>T genotypes and coronary thrombosis has been ...,218,1881,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
1903 C>T,"Lack of associations for -1903 C>T, -3954 C>T and -5887 C>T with CAD, as see...",220,27,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
3954 C>T,"Lack of associations for -1903 C>T, -3954 C>T and -5887 C>T with CAD, as seen in our ca...",220,38,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
5887 C>T,"...ack of associations for -1903 C>T, -3954 C>T and -5887 C>T with CAD, as seen in our case-control stu...",220,52,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
3954 C>T,"...5–27, 31, 32, 34–36, 38] Lack of association for -3954 C>T polymorphism with CAD has even been attes...",220,378,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
9589 A>T,"...out of 5 selected IL1RN gene polymorphisms (i.e. +9589 A>T, +8006 T>C, +8061 C>T and +111000 T>C) in...",225,171,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
8006 T>C,"...lected IL1RN gene polymorphisms (i.e. +9589 A>T, +8006 T>C, +8061 C>T and +111000 T>C) in our presen...",225,182,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
8061 C>T,"...N gene polymorphisms (i.e. +9589 A>T, +8006 T>C, +8061 C>T and +111000 T>C) in our present case-cont...",225,193,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
111000 T>C,"...phisms (i.e. +9589 A>T, +8006 T>C, +8061 C>T and +111000 T>C) in our present case-control study. Ass...",225,207,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
8006 T>C,"...s although validated the lack of association for +8006 T>C in the pooled analysis, but discovered si...",227,67,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
4845 G>T,"...residing in the IL-1 gene cluster (i.e. for IL1A +4845 G>T, IL1B -511 C>T, IL1RN +8006 T>C and IL1RN...",229,326,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
511 C>T,"...IL-1 gene cluster (i.e. for IL1A +4845 G>T, IL1B -511 C>T, IL1RN +8006 T>C and IL1RN 86bp VNTR) whic...",229,342,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
8006 T>C,"...r (i.e. for IL1A +4845 G>T, IL1B -511 C>T, IL1RN +8006 T>C and IL1RN 86bp VNTR) which duly qualifies...",229,358,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
511C>T,...s hinting association with the disease (i.e. IL1B-511C>T and ILIRN 86bp VNTR) have previously been t...,231,419,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
511 T>C,...ssociation for at least a couple of them (viz. B -511 T>C and RN 86bp VNTR). While the presence of >...,234,254,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
4845 G>T,"...ngst studied ancestral groups were seen for IL1A +4845 G>T, IL1B -511 C>T, IL1RN 86bp VNTR and IL1RN...",236,322,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
511 C>T,"...estral groups were seen for IL1A +4845 G>T, IL1B -511 C>T, IL1RN 86bp VNTR and IL1RN +8006 T>C. The ...",236,338,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
8006 T>C,"...45 G>T, IL1B -511 C>T, IL1RN 86bp VNTR and IL1RN +8006 T>C. The hints of associations deduced for su...",236,374,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
511 C>T,...g to NIA in our case-control study for both IL1B -511 C>T and IL1RN 86bp VNTR were duly validated vi...,236,489,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
511 C>T,"...is. On the other hand, MA subgroup carrying IL1B -511 C>T, IL1RN 86bp VNTR and IL1RN +8006 T>C polym...",236,640,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
8006 T>C,"...arrying IL1B -511 C>T, IL1RN 86bp VNTR and IL1RN +8006 T>C polymorphisms seemed to enjoy significant...",236,676,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
889 C>T,...t plots depicting meta-analysis results for IL1A -889 C>T (rs1800587) polymorphism,254,64,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
5887C>T,...t plots depicting meta-analysis results for IL1B -5887C>T (rs1143633) polymorphism,261,64,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
3954 C>T,...t plots depicting meta-analysis results for IL1B -3954 C>T (rs1143634) polymorphism,268,64,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
1903C>T,...t plots depicting meta-analysis results for IL1B -1903C>T (rs1143627) polymorphism,275,64,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
511 C>T,...r’s estimates for dominant genetic model of IL1B -511 C>T polymorphism. Panel B: Begg’s funnel plot ...,283,282,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
511 C>T,...’s estimates for recessive genetic model of IL1B -511 C>T polymorphism. Panel C: Begg’s funnel plot ...,283,392,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
511 C>T,...er’s estimates for allelic genetic model of IL1B -511 C>T polymorphism. Panel D: Begg’s funnel plot ...,283,500,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
3954 C>T,...r’s estimates for dominant genetic model of IL1B -3954 C>T polymorphism. Panel E: Begg’s funnel plot...,283,609,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
3954 C>T,...’s estimates for recessive genetic model of IL1B -3954 C>T polymorphism. Panel F: Begg’s funnel plot...,283,720,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
3954 C>T,...er’s estimates for allelic genetic model of IL1B -3954 C>T polymorphism. Abbreviations- EA: European...,283,829,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
8006 T>C,...’s estimates for dominant genetic model of IL1RN +8006 T>C polymorphism. Panel E: Begg’s funnel plot...,290,616,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
8006 T>C,...s estimates for recessive genetic model of IL1RN +8006 T>C polymorphism. Panel F: Begg’s funnel plot...,290,728,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
8006 T>C,...r’s estimates for allelic genetic model of IL1RN +8006 T>C polymorphism. Abbreviations- EA: European...,290,838,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
677C>T,MTHFR 677C>T polymorphism increases the male infertility...,353,7,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
2168A>G,"...ons in three genes associated with HL. Mutation c.2168A>G (SLC26A4) was found in one family, a novel...",7,1135,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
1111G>C,"...26A4) was found in one family, a novel mutation c.1111G>C (OTOF) was revealed in another family, and...",7,1197,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
5254G>A,"...F) was revealed in another family, and mutation c.5254G>A (RAI1) was found in two families. Sanger s...",7,1259,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
5254G>A,"...ciation of homozygosity for discovered variants c.5254G>A (RAI1), c.1111C>G (OTOF), and c.2168A>G (S...",7,1643,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
1111C>G,"...osity for discovered variants c.5254G>A (RAI1), c.1111C>G (OTOF), and c.2168A>G (SLC26A4) with HL in...",7,1661,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
2168A>G,"...ariants c.5254G>A (RAI1), c.1111C>G (OTOF), and c.2168A>G (SLC26A4) with HL in Altaian patients. Loc...",7,1683,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
5254G>A,...rome. Presumed association of RAI1 gene variant c.5254G>A with isolated HL needs to be proved by fur...,7,2094,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
5254G>A,...viduals heterozygous or homozygous for mutation c.5254G>A (RAI1). Primers and PCR conditions are ava...,36,231,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
5254G>A,...nd S1 Fig. A novel homozygous missense mutation c.5254G>A (p.Gly1752Arg) in gene RAI1 (retinoic acid...,44,185,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
1111C>G,"...8 and F40; a novel homozygous missense mutation c.1111C>G (p.Gly371Arg) in gene OTOF (otoferlin, MIM...",44,364,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
2168A>G,...a previously known homozygous missense mutation c.2168A>G (p.His723Arg) was found in gene SLC26A4 (p...,44,528,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
5254G>A,Nucleotide change (Amino acid change)	c.5254G>A (p.Gly1752Arg) *	c.1111C>G (p.Gly371Arg) *...,63,41,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
1111C>G,... (Amino acid change)	c.5254G>A (p.Gly1752Arg) *	c.1111C>G (p.Gly371Arg) *	c.2168A>G (p.His723Arg),63,68,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
2168A>G,...4G>A (p.Gly1752Arg) *	c.1111C>G (p.Gly371Arg) *	c.2168A>G (p.His723Arg),63,94,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
5254G>A,Variant c.5254G>A (p.Gly1752Arg) in the RAI1 gen,78,11,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
5254G>A,Cosegregation of homozygosity for mutation c.5254G>A in the RAI1 gene with congenital bilateral...,79,46,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
5254G>A,...al.pone.0153841.g001Fig 1 Identification of the c.5254G>A (p.Gly1752Arg) mutation in the RAI1 gene i...,81,64,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
5254G>A,"...n families F18, F37, F42, and F43 with mutation c.5254G>A (p.Gly1752Arg) in the RAI1 gene. (B) Valid...",82,121,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
5254G>A,...Gly1752Arg) in the RAI1 gene. (B) Validation of c.5254G>A by Sanger sequencing. WES was performed fo...,82,182,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
5254G>A,"...dividuals is marked by grey symbols. M—mutation c.5254G>A (p.Gly1752Arg), wt—wild type",82,419,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
5254G>A,Affected members from families F38 and F40 with c.5254G>A (RAI1) were originally examined in 2002. A...,84,51,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
5254G>A,...leep disturbances in the patients with mutation c.5254G>A. All patients have not shown evident intel...,84,780,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
5254G>A,... Mother in family F38 (38-I-1) heterozygous for c.5254G>A (Fig 1) had no hearing complaints during f...,84,1263,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
5254G>A,Mutation c.5254G>A was also found in additional five patients...,86,12,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
5254G>A,"..., F42, and F43 (Fig 1). Subjects homozygous for c.5254G>A (42-II-1 and 43-III-1) had congenital prof...",86,158,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
5254G>A,"...und sensorineural HL. Subjects heterozygous for c.5254G>A (18-II-1, 37-II-1, and 43-II-2) had varyin...",86,259,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
5254G>A,...is media. None of additional five patients with c.5254G>A demonstrated any signs or symptoms consist...,86,700,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
5254G>A,"...ing Altaians four individuals were heterozygous c.5254G>A carriers (4/120, 3.33%)",86,862,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
5254G>A,...dditional deleterious variants in compound with c.5254G>A in affected heterozygotes for c.5254G>A an...,88,72,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
5254G>A,...nd with c.5254G>A in affected heterozygotes for c.5254G>A and to evaluate the RAI1 allelic variation...,88,112,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
5254G>A,"...nd to evaluate the RAI1 allelic variations with c.5254G>A, we sequenced the RAI1 gene coding region ...",88,171,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
5254G>A,...n 13 individuals homozygous or heterozygous for c.5254G>A. These individuals included four affected ...,88,349,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
5254G>A,"...II-3, 38-II-1) (see Fig 1), and two carriers of c.5254G>A from Altaian controls whose DNAs were avai...",88,637,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
5254G>A,...rious RAI1 variants were found in compound with c.5254G>A in affected heterozygotes for c.5254G>A (1...,88,829,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
5254G>A,"...nd with c.5254G>A in affected heterozygotes for c.5254G>A (18-II-1, 37-II-1, 38-I-1, and 43-II-2). V...",88,869,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
5254G>A,...lesmut: C-A-Q13[CAG CAA (CAG)10 del(CAG) CAA]-G-c.5254G>A was observed in all c.5254G>A homozygote w...,88,1207,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
5254G>A,...0 del(CAG) CAA]-G-c.5254G>A was observed in all c.5254G>A homozygote which was suggested as the comm...,88,1237,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
5254G>A,"...s suggested as the common allelic haplotype for c.5254G>A. For all c.5254G>A heterozygotes, the hapl...",88,1314,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
5254G>A,"...common allelic haplotype for c.5254G>A. For all c.5254G>A heterozygotes, the haplotypes were reconst...",88,1333,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
5254G>A,...3 Table). All studied individuals with mutation c.5254G>A share a specific allelemut: C-A-Q13[CAG CA...,88,1750,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
5254G>A,...elemut: C-A-Q13[CAG CAA (CAG)10 del(CAG) CAA]-G-c.5254G>A suggesting the common origin of c.5254G>A ...,88,1828,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
5254G>A,...AA]-G-c.5254G>A suggesting the common origin of c.5254G>A in Altaians,88,1870,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
5254G>A,Mutation c.5254G>A was found only in Cx26-negative patients o...,90,12,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
5254G>A,"...f Altaian ethnicity. For accurate estimation of c.5254G>A allelic frequency, we also screened this m...",90,112,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
5254G>A,...an patients with HL. Nobody from this group had c.5254G>A. We compared frequency of c.5254G>A in a t...,90,242,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
5254G>A,...s group had c.5254G>A. We compared frequency of c.5254G>A in a total sample of Altaian patients (0.1...,90,278,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
5254G>A,...ound significantly (p<10−5) higher frequency of c.5254G>A in Altaian patients. To avoid probable bia...,90,484,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
5254G>A,"... (n = 74) by pedigree analysis and compared the c.5254G>A frequency in this group (0.081, 12/148 chr...",90,707,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
5254G>A,"...e control sample. Again, a statistically higher c.5254G>A frequency (p = 0.0026) was observed among ...",90,841,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
5254G>A,...ion supports a presumed association of mutation c.5254G>A (RAI1) with HL,90,973,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
1111C>G,Variant c.1111C>G (p.Gly371Arg) in the OTOF gen,92,11,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
1111C>G,We found a novel mutation c.1111C>G (p.Gly371Arg) in the OTOF gene in two sibl...,93,29,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
1111C>G,...erns of HL [3]. Segregation of homozygosity for c.1111C>G with HL was confirmed by Sanger sequencing...,93,379,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
1111C>G,"...er wt/wt (54–1 and 54-II-1) or heterozygous for c.1111C>G (54-I-1, 54-II-4, 54-II-7, and 54-III-1)",93,572,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
1111C>G,...al.pone.0153841.g002Fig 2 Identification of the c.1111C>G (p.Gly371Arg) mutation in the OTOF gene an...,95,64,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
2168A>G,...(p.Gly371Arg) mutation in the OTOF gene and the c.2168A>G (p.His723Arg) mutation in the SLC26A4 gene...,95,122,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
1111C>G,...together with related family F24) with mutation c.1111C>G (p.Gly371Arg) in the OTOF gene denoted as ...,96,96,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
1111C>G,...n the OTOF gene denoted as M. (B) Validation of c.1111C>G by Sanger sequencing. (C) Pedigree of the ...,96,169,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
2168A>G,...C) Pedigree of the WES family F53 with mutation c.2168A>G (p.His723Arg) in the SLC26A4 gene which is...,96,250,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
2168A>G,...4 gene which is denoted as M. (D) Validation of c.2168A>G by Sanger sequencing. WES was performed fo...,96,335,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
1111C>G,...6-negative patients revealed heterozygosity for c.1111C>G in individual 24-II-2 with prelingual prof...,98,81,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
1111C>G,...ssociated with the presence of a single copy of c.1111C>G: the only individual 24-II-2 out of seven ...,98,391,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
1111C>G,"...e only individual 24-II-2 out of seven detected c.1111C>G heterozygotes (24-I-2, 24-II-2, 24-II-1, 5...",98,452,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
1111C>G,"..., 54-II-4, 54-II-7, 54-III-1,) was affected and c.1111C>G was absent in his relatives 24–1 (with con...",98,557,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
1111C>G,"...ate HL). On the other hand, all homozygotes for c.1111C>G (54-II-2, 54-II-3, 54-II-5, 54-II-6) were ...",98,701,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
1111C>G,...anch F24 of combined pedigree F24-F54. Mutation c.1111C>G was not found among 120 normal hearing Alt...,98,933,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
2168A>G,Variant c.2168A>G (p.His723Arg) in gene SLC26A,100,11,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
2168A>G,Homozygous mutation c.2168A>G (p.His723Arg) in gene SLC26A4 was found in...,101,23,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
2168A>G,...bsequent Sanger sequencing confirmed homozygous c.2168A>G in his affected sister (53-II-2) and heter...,101,209,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
2168A>G,... his affected sister (53-II-2) and heterozygous c.2168A>G state in their normal hearing mother (53-I...,101,269,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
2168A>G,"...Mondini dysplasia) [23,24]. Both homozygous for c.2168A>G siblings (53-II-1 and 53-II-2, born in 198...",103,470,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
2168A>G,... bone computed tomography examination. Mutation c.2168A>G was found neither in other Cx26-negative p...,103,834,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
5254G>A,"... RAI1 missence mutation detected in this study, c.5254G>A, with isolated HL in Altaian patients. Thi...",114,112,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
5254G>A,...on 1752 in the C-terminal part of RAI1. Variant c.5254G>A has been predicted ‘possibly damaging’ by ...,114,473,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
5254G>A,"... of the NGS annotations pipelines. All detected c.5254G>A homozygotes (in total, 10 patients from 6 ...",114,884,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
5254G>A,... allelic mutation in RAI1 gene in four affected c.5254G>A heterozygous individuals (from total 20 de...,114,1201,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
5254G>A,...deed detected significantly higher frequency of c.5254G>A in Altaian patients compared with Altaian ...,114,1636,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
5254G>A,"...ntrols. In addition, high prevalence of variant c.5254G>A in the Altaians is probably due to founder...",114,1738,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
5254G>A,...elemut: C-A-Q13[CAG CAA (CAG)10 del(CAG) CAA]-G-c.5254G>A was shared by all studied carriers of c.52...,114,1913,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
5254G>A,...c.5254G>A was shared by all studied carriers of c.5254G>A that supports the common origin of c.5254G...,114,1961,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
5254G>A,...of c.5254G>A that supports the common origin of c.5254G>A in Altaians,114,2006,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
3650G>A,"... RAI1 protein with missense mutations p.R1217Q (c.3650G>A), p.Q1389R (c.4166A>G), p.Q1562R (c.4685A>...",116,1316,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
4166A>G,"...sense mutations p.R1217Q (c.3650G>A), p.Q1389R (c.4166A>G), p.Q1562R (c.4685A>G) and p.S1808N (c.542...",116,1338,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
4685A>G,"...7Q (c.3650G>A), p.Q1389R (c.4166A>G), p.Q1562R (c.4685A>G) and p.S1808N (c.5423G>A) (all are in C-te...",116,1360,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
5423G>A,"...(c.4166A>G), p.Q1562R (c.4685A>G) and p.S1808N (c.5423G>A) (all are in C-terminal half of the RAI1 p...",116,1385,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
4685A>G,...amino acid sequence between mutations p.Q1562R (c.4685A>G) and p.S1808N (c.5423G>A) studied by Carmo...,116,2181,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
5423G>A,...en mutations p.Q1562R (c.4685A>G) and p.S1808N (c.5423G>A) studied by Carmona-Mora et al [47] theref...,116,2206,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
5254G>A,...amilies; (ii) significantly higher frequency of c.5254G>A in patients compared with ethnically match...,118,295,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
1111C>G,...n genome databases) (Table 2) missense mutation c.1111C>G in exon 12 of OTOF leads to substitution G...,124,82,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
1194T>A,"...elinsC (p.G368AfsX2), c.1180dupG (p.E394GfsX6), c.1194T>A (p.D398E), and c.1236delC (p.E413NfsX90) l...",124,349,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
1111C>G,Variant c.1111C>G found in this study has been predicted ‘pr...,126,11,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
1111C>G,.... We also found segregation of homozygosity for c.1111C>G with recessive HL in Altaian family F54: a...,126,244,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
1111C>G,...>G with recessive HL in Altaian family F54: all c.1111C>G homozygous siblings from this family were ...,126,299,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
1111C>G,"...relatives were either wt/wt or heterozygous for c.1111C>G (Fig 2). Altogether, these data support pl...",126,438,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
1111C>G,...pport plausible association of homozygosity for c.1111C>G with recessive HL in Altaian patients. Thi...,126,530,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
1111C>G,... the combined pedigree F24-F54 (Fig 2) with one c.1111C>G copy (24-II-2) or without c.1111C>G (24–1 ...,126,696,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
1111C>G,...2) with one c.1111C>G copy (24-II-2) or without c.1111C>G (24–1 and 24-II-1). Presence of other dele...,126,732,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
1111C>G,...ce of other deleterious allele in compound with c.1111C>G seems unlikely in patient 24-II-2 due to a...,126,816,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
2168A>G,... mutations differs across populations. Mutation c.2168A>G (p.His723Arg) found in Altaian family F53 ...,128,412,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
5254G>A,"Distribution of all alleles with mutations c.5254G>A (RAI1), c.1111C>G (OTOF), and c.2168A>G (S...",130,46,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
1111C>G,"...of all alleles with mutations c.5254G>A (RAI1), c.1111C>G (OTOF), and c.2168A>G (SLC26A4) identified...",130,64,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
2168A>G,"...tations c.5254G>A (RAI1), c.1111C>G (OTOF), and c.2168A>G (SLC26A4) identified in Altaian patients, ...",130,86,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
5254G>A,...ancestral Altaian clans’ lands. Accumulation of c.5254G>A (RAI1) in two neighboring north-western di...,130,726,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
1111C>G,...nally occupied these territories. Prevalence of c.1111C>G (OTOF) is restricted to one extended Altai...,130,924,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
2168A>G,"...rn district of the Altai Republic, and mutation c.2168A>G (SLC26A4) was found in the only Altaian fa...",130,1063,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
5254G>A,"....pone.0153841.g003Fig 3 Prevalence of mutations c.5254G>A (RAI1), c.1111C>G (OTOF), and c.2168A>G (S...",132,66,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
1111C>G,"...Fig 3 Prevalence of mutations c.5254G>A (RAI1), c.1111C>G (OTOF), and c.2168A>G (SLC26A4) on the ter...",132,84,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
2168A>G,"...tations c.5254G>A (RAI1), c.1111C>G (OTOF), and c.2168A>G (SLC26A4) on the territory of the Altai Re...",132,106,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
5254G>A,"... fully or half-colored circle, correspondingly: c.5254G>A (RAI1)–by red; c.1111C>G (OTOF)–by blue; c...",133,146,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
1111C>G,"...rcle, correspondingly: c.5254G>A (RAI1)–by red; c.1111C>G (OTOF)–by blue; c.2168A>G (SLC26A4)–by gre...",133,171,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
2168A>G,...254G>A (RAI1)–by red; c.1111C>G (OTOF)–by blue; c.2168A>G (SLC26A4)–by green. (B) Distribution of st...,133,197,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
5254G>A,"...ciation of homozygosity for identified variants c.5254G>A (RAI1), c.1111C>G (OTOF), and c.2168A>G (S...",136,405,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
1111C>G,"...osity for identified variants c.5254G>A (RAI1), c.1111C>G (OTOF), and c.2168A>G (SLC26A4) with HL in...",136,423,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
2168A>G,"...ariants c.5254G>A (RAI1), c.1111C>G (OTOF), and c.2168A>G (SLC26A4) with HL in Altaian patients. Loc...",136,445,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
5254G>A,...rome. Presumed association of RAI1 gene variant c.5254G>A with isolated HL needs to be proved by fur...,136,844,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
5254G>A,... in individuals homozygous and heterozygous for c.5254G>A,164,133,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
47388990T>C,...001734.1:p.Asn98Ser; genomic code: NC_000002.11:g.47388990T>C; cDNA code: NM_001743.4:c.293A>G),37,1933,PLoS_One_2016_Apr_21_11(4)_e0153851.txt
293A>G,...000002.11:g.47388990T>C; cDNA code: NM_001743.4:c.293A>G),37,1971,PLoS_One_2016_Apr_21_11(4)_e0153851.txt
293A>G,"...ociated to CPVT in the literature, the variant (c.293A>G, named as Asn97Ser in the literature) was d...",61,100,PLoS_One_2016_Apr_21_11(4)_e0153851.txt
938C>A,...rganellesCell MembranesMembrane ProteinsThe BCL2 -938C>A Promoter Polymorphism Is Associated with Ri...,3,1216,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
938C>A,"...unctional single nucleotide polymorphism (SNP) c.-938C>A (rs2279115), located in the promoter region...",7,721,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
938C>A,...p = 0.004). These results indicate that the BCL2 -938C>A polymorphism influences the occurrence and ...,7,1343,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
938C>A,...rs a functional single nucleotide polymorphism c.-938C>A (rs2279115) [13]. Alleles of this polymorph...,17,93,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
938C>A,"...in different tumor tissues [15–18]. Furthermore, -938C>A genotypes have an impact on risk [19, 20], ...",17,456,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
938C>A,"...ve effects of polymorphisms, among them the BCL2 -938C>A polymorphism, in a preliminary study compri...",19,83,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
938C>A,"...th regard to time to aseptic loosening. However, -938C>A genotype distribution of aseptic loosening ...",19,293,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
938C>A,...or might be an indicator of a risk modulation by -938C>A genotypes. To answer this question we perfo...,19,598,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
938C>A,... manufacturer’s protocols. Genotypes of the BCL2 -938C>A polymorphism were determined by Slowdown PC...,26,179,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
938C>A,"...valuate the time to loosening, dependent on BCL2 -938C>A genotype. The impact of age, BMI, and BCL2 ...",29,555,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
938C>A,"...38C>A genotype. The impact of age, BMI, and BCL2 -938C>A genotype as prognostic factors for time to ...",29,606,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
938C>A,Clinical characteristics and BCL2 -938C>A genotype,32,36,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
938C>A,Clinical characteristics and -938C>A genotype distributions of patients with pri...,33,31,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
938C>A,...he 231 patients with primary THA revealed a BCL2 -938C>A genotype distribution with 81 patients carr...,33,226,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
938C>A,...ts and 42 CC genotype carriers. Determination of -938C>A genotypes in 234 patients with aseptic loos...,33,371,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
938C>A,...nical characteristics were analyzed dependent on -938C>A genotypes in both groups. None of the varia...,33,767,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
938C>A,...variables was significantly associated with BCL2 -938C>A genotypes. To control for differences in cl...,33,862,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
938C>A,BCL2 -938C>A genotype,36,9,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
938C>A,Risk for aseptic loosening and BCL2 -938C>A genotype,61,38,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
938C>A,"To determine a putative impact of the BCL2 -938C>A polymorphism on risk for aseptic loosening,...",62,45,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
938C>A,10.1371/journal.pone.0149528.t002Table 2 BCL2 -938C>A Genotype Distribution,64,48,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
938C>A,Time to aseptic loosening and BCL2 -938C>A genotype,83,37,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
938C>A,...otypes to further analyze the impact of the BCL2 -938C>A polymorphism on aseptic loosening. Median t...,84,161,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
938C>A,"... statistically significant association with BCL2 -938C>A genotypes, whereas AA homozygous patients h...",84,294,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
938C>A,BCL2 -938C>A genotype,87,9,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
938C>A,...r curve showed a significant association of BCL2 -938C>A genotypes with time to aseptic loosening (p...,94,62,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
938C>A,... Despite correcting for these variables the BCL2 -938C>A polymorphism remained a significant factor ...,94,516,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
938C>A,"...er-curves. (A) patients (n = 234), based on BCL2 -938C>A genotype. (B) patients (n = 234) based on B...",97,127,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
938C>A,...A genotype. (B) patients (n = 234) based on BCL2 -938C>A CC+CA and AA genotype,97,182,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
938C>A,BCL2 -938C>A,102,7,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
938C>A,BCL2 -938C>A,108,7,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
938C>A,"...oosening analysis, individual comparison of BCL2 -938C>A genotypes showed similar curve progression ...",117,103,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
938C>A,...ents. Our goal was to determine whether the BCL2 -938C>A polymorphism influences the course and occu...,120,574,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
938C>A,...ening of THA. Our results indicate that the BCL2 -938C>A polymorphism has a relevant impact on asept...,120,696,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
938C>A,We observed that BCL2 -938C>A genotype distributions of aseptic loosening...,122,24,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
938C>A,...us and heterozygous for the C allele of the BCL2 -938C>A polymorphism,122,1441,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
938C>A,"...l these players interact with regard to the BCL2 -938C>A genotype on the cellular level. Therefore, ...",124,1682,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
938C>A,"In summary, our work revealed the BCL2 -938C>A polymorphism as a putative molecular marker...",126,41,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
938C>A,...pe of the regulatory BCL2 promoter polymorphism (-938C>A) with better 2-year survival in patients wi...,160,79,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
938C>A,Regulatory BCL2 promoter polymorphism (-938C>A) is associated with adverse outcome in pati...,163,41,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
938C>A,...ype of the regulatory BCL2 promoter polymorphism (938C>A) is associated with a favorable outcome in ...,166,63,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
938C>A,The regulatory BCL2 promoter polymorphism (-938C>A) is associated with relapse and survival of...,168,45,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
938C > A,BCL-2 (-938C > A) polymorphism is associated with breast c...,177,9,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
938 C > A,"... , Eggert A , Schulte JH , Bachmann HS . The BCL2-938 C > A promoter polymorphism is associated with...",184,96,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
938C>A,BCL2-938C>A and CALCA-1786T>C polymorphisms in aseptic ...,188,6,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
1786T>C,BCL2-938C>A and CALCA-1786T>C polymorphisms in aseptic loosened total hi...,188,23,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
2A>G,"...ity: CYP21A2 deletion, large gene conversion, IV2-2A>G, p.G110Efs, exon 6 cluster (p.I236N, p.V237E,...",57,358,PLoS_One_2016_Feb_5_11(2)_e0148548.txt
1399G>A,The c.1399G>A mutation in exon 7 of POLG produces an ala...,15,7,PLoS_One_2016_Jan_6_11(1)_e0145500.txt
1399G>A,...nge at nucleotide position (np) 1399 in exon 7 (c.1399G>A; p.A467T) in all four individuals,93,534,PLoS_One_2016_Jan_6_11(1)_e0145500.txt
13528A>G,"...oplasmic in the patient’s muscle and blood, the m.13528A>G mutation was heteroplasmic in the patient...",190,464,PLoS_One_2016_Jan_6_11(1)_e0145500.txt
1555A>G,"Hearing in 44–45 year olds with m.1555A>G, a genetic mutation predisposing to aminog...",220,35,PLoS_One_2016_Jan_6_11(1)_e0145500.txt
225C>A,... described previously. A novel de novo variant (c.225C>A; p.Tyr75*) was identified in the PAX6 gene ...,14,149,PLoS_One_2016_Jul_27_11(7)_e0160016.txt
649C>T,"...ds with aniridia. In addition, a known variant (c.649C>T; p.Arg217*) in PAX6 segregated in a family ...",14,272,PLoS_One_2016_Jul_27_11(7)_e0160016.txt
454T>C,"...n the FOXC1 gene, a novel heterozygous variant (c.454T>C; p.Trp152Arg) segregated with the disease i...",14,388,PLoS_One_2016_Jul_27_11(7)_e0160016.txt
225C>A,...h eyes. A novel heterozygous nonsense mutation (c.225C>A; p.Tyr75*) in the PAX6 gene was identified ...,41,361,PLoS_One_2016_Jul_27_11(7)_e0160016.txt
225C>A,...) Pedigree and segregation of a novel mutation (c.225C>A; p.Tyr75*) in the PAX6 gene. (B). Clinical ...,44,53,PLoS_One_2016_Jul_27_11(7)_e0160016.txt
225C>A,The same variation (c.225C>A; p.Tyr75*) was identified in another unrela...,46,23,PLoS_One_2016_Jul_27_11(7)_e0160016.txt
649C>T,...he right eye. A heterozygous nonsense mutation (c.649C>T; p.Arg217*) in the PAX6 gene was detected i...,48,467,PLoS_One_2016_Jul_27_11(7)_e0160016.txt
649C>T,...segregation of a previously described mutation (c.649C>T; p.Arg217*) in the PAX6 gene. (b). DNA sequ...,51,68,PLoS_One_2016_Jul_27_11(7)_e0160016.txt
649C>T,...A sequence chromatogram of PAX6 for the variant c.649C>T,51,162,PLoS_One_2016_Jul_27_11(7)_e0160016.txt
454T>C,...ical characteristics. A novel missense variant (c.454T>C; p.Trp152Arg) was identified in the FOXC1 g...,54,456,PLoS_One_2016_Jul_27_11(7)_e0160016.txt
454T>C,...e and segregation of a novel missense mutation (c.454T>C; p.Trp152Arg) in the FOXC1 gene. (B). Syste...,57,62,PLoS_One_2016_Jul_27_11(7)_e0160016.txt
225C>A,...roband with aniridia. A novel de novo mutation (c.225C>A; p.Tyr75*) was identified in the PAX6 gene ...,69,133,PLoS_One_2016_Jul_27_11(7)_e0160016.txt
649C>T,"...a. In addition, a previously reported mutation (c.649C>T; p.Arg217*) was identified in the PAX6 gene...",69,329,PLoS_One_2016_Jul_27_11(7)_e0160016.txt
454T>C,"...ies with ARS: a heterozygous missense mutation (c.454T>C; p.Trp152Arg), and a homozygous in-frame de...",73,134,PLoS_One_2016_Jul_27_11(7)_e0160016.txt
1	G > A,nde-1/vang-1	zy1	G > A	atttgcaaGGC CAG AAG	splice acceptor,55,16,PLoS_One_2016_Jun_14_11(6)_e0157537.txt
2	G > A,zy2	G > A	TTC ACA TGA ATT GTC	406Wstop,56,3,PLoS_One_2016_Jun_14_11(6)_e0157537.txt
10	G > A,zy10	G > A	GGA AGA CGataaatgtt	splice donor,57,3,PLoS_One_2016_Jun_14_11(6)_e0157537.txt
18	C > T,zy18	C > T	GCA CCG TAG CTC ATC	Q19stop,59,3,PLoS_One_2016_Jun_14_11(6)_e0157537.txt
19	G > A,zy19	G > A	tcttacaaGTT CAT GCC	splice acceptor,60,3,PLoS_One_2016_Jun_14_11(6)_e0157537.txt
12	C > T,nde-3/dsh-1	zy12	C > T	GTC AAA TAG CAA CCA	Q64stop,61,15,PLoS_One_2016_Jun_14_11(6)_e0157537.txt
7	G > A,nde-4/fntb-1	zy7	G > A	ATG CTT AAA GAG TAC	E321K,62,16,PLoS_One_2016_Jun_14_11(6)_e0157537.txt
20	G > A,zy20	G > A	TGC TAC AAC TTC TGG	S289N,63,3,PLoS_One_2016_Jun_14_11(6)_e0157537.txt
21	C > T,zy21	C > T	ATG GAA TGA GAA GGC	R305stop,64,3,PLoS_One_2016_Jun_14_11(6)_e0157537.txt
23	G > A,zy23	G > A	CAC GGA GAA TAC ACT	G238E,65,3,PLoS_One_2016_Jun_14_11(6)_e0157537.txt
24	G > A,zy24	G > A	TGG ATG TAC TAC TGG	C92Y,66,3,PLoS_One_2016_Jun_14_11(6)_e0157537.txt
946G>A,"ATP1A3	19	NM_152296.3	[c.946G>A, p.Gly316Ser]	A/G	G/G	G/G	G/G	G/G",60,26,PLoS_One_2016_Mar_18_11(3)_e0151429.txt
1444G>A,"UBQLN4	1	NM_020131.3	[c.1444G>A, p.Glu482Lys]	A/G	G/G	G/G	G/G	G/G",61,25,PLoS_One_2016_Mar_18_11(3)_e0151429.txt
1373C>A,"SRPK3	X	NM_014370.2	[c.1373C>A, p.Thr458Asn]	hemiA	A/C	hemi C	hemi C	C/C",63,24,PLoS_One_2016_Mar_18_11(3)_e0151429.txt
2A>G,"...family studies. The results identified LMNA c.357-2A>G, a novel heterozygous splice-site mutation as...",7,1877,PLoS_One_2016_May_16_11(5)_e0155421.txt
625G>A,1. ACADS	chr12:121176083	c.625G>A	Gly209Ser; splicing	rs1799958	18	26	Risk al...,82,28,PLoS_One_2016_May_16_11(5)_e0155421.txt
5T>C,3. CACNA1S	chr1:201044748	c.1828-5T>C	Splicing	rs1998721	25	22	-,84,34,PLoS_One_2016_May_16_11(5)_e0155421.txt
1616C>T,4. DMPKc	chr19:46274624	c.1616C>T	Thr544Met	rs146680240	0.9	1.3	-,85,27,PLoS_One_2016_May_16_11(5)_e0155421.txt
991A>G,5. FGA	chr4:155507590	c.991A>G	Thr331Ala	rs6050	33	25	Risk allele for thro...,86,25,PLoS_One_2016_May_16_11(5)_e0155421.txt
3337A>G,6. HCN4c	chr15:73615097	c.3337A>G	Met1113Val	rs142735148	nd	1.3	Mutation or ...,87,27,PLoS_One_2016_May_16_11(5)_e0155421.txt
4T>C,7. HFE	chr6:26091336	c.340+4T>C	Splicing	rs2071303	46	33	-,88,28,PLoS_One_2016_May_16_11(5)_e0155421.txt
53G>A,8. KCNJ10c	chr1:160012270	c.53G>A	Arg18Gln	rs115466046	0.5	1.6	Mutation or ris...,89,29,PLoS_One_2016_May_16_11(5)_e0155421.txt
284A>G,10. KCNK15	chr20:43378770	c.284A>G	Glu95Gly; splicing	rs1111032	40	50	-,91,29,PLoS_One_2016_May_16_11(5)_e0155421.txt
193G>A,11. KCNMB1	chr5:169810796	c.193G>A	Glu65Lys	rs11739136	9.8	10	Risk allele for ...,92,29,PLoS_One_2016_May_16_11(5)_e0155421.txt
2A>G,12. LMNAc	chr1:156100406	c.357-2A>G	Splicing	rs113610699	nd	nd	-,93,32,PLoS_One_2016_May_16_11(5)_e0155421.txt
1698C>T,13. LMNA	chr1:156107534	c.1698C>T	His566His; splicing	rs4641	20	25	-,94,27,PLoS_One_2016_May_16_11(5)_e0155421.txt
2686G>A,14. MYBPC3c	chr11:47357479	c.2686G>A	Val895Met	rs35078470	0.3	0.5	Mutation or m...,95,30,PLoS_One_2016_May_16_11(5)_e0155421.txt
732C>T,15. MYH7	chr14:23900794	c.732C>T	Phe244Phe; splicing	rs2069542	23	18	-,96,27,PLoS_One_2016_May_16_11(5)_e0155421.txt
2384G>A,16. PKP4c	chr2:159519581	c.2384G>A	Arg795Lys	rs139221917	0.1	0.1	-,97,28,PLoS_One_2016_May_16_11(5)_e0155421.txt
1673A>G,17. SCN5A	chr3:38645420	c.1673A>G	His558Arg	rs1805124	21	23	Risk allele or m...,98,27,PLoS_One_2016_May_16_11(5)_e0155421.txt
3C>A,18. SCN5A	chr3:38647642	c.1141-3C>A	Splicing	rs41312433	15	19	Risk allele for lon...,99,32,PLoS_One_2016_May_16_11(5)_e0155421.txt
2068C>T,19. TMPOc	chr12:98928103	c.2068C>T	Arg690Cys	rs17028450	0.1	0.1	Mutation for ...,100,28,PLoS_One_2016_May_16_11(5)_e0155421.txt
18053G>C,20. TTNc	chr2:179587949	c.18053G>C	Thr6018Ser	novel	nd	nd	-,101,27,PLoS_One_2016_May_16_11(5)_e0155421.txt
21332C>A,21. TTN	chr2:179582537	c.21332C>A	Ala7111Glu; splicing	rs2627043	39	20	-,102,26,PLoS_One_2016_May_16_11(5)_e0155421.txt
2A>G,"...2 and Fig 4). These results identified LMNA c.357-2A>G (p.N120Lfs*5) (NM_170707.3), a novel heterozy...",119,604,PLoS_One_2016_May_16_11(5)_e0155421.txt
2A>G,...r absence (-) of the DNA variant. Only LMNA c.357-2A>G (marked in gray) was present in all affected ...,125,396,PLoS_One_2016_May_16_11(5)_e0155421.txt
2A>G,....pone.0155421.g005Fig 5 Novel LMNA mutation c.357-2A>G (p.N120Lfs*5),127,66,PLoS_One_2016_May_16_11(5)_e0155421.txt
2A>G,...ected individuals and heterozygous mutation c.357-2A>G / c.357-2A for the proband and affected famil...,128,323,PLoS_One_2016_May_16_11(5)_e0155421.txt
2A>G,"... Normal (F): lane 2), proband with mutation c.357-2A>G (HET Mutation: lane 3), and non-family contro...",134,191,PLoS_One_2016_May_16_11(5)_e0155421.txt
1698C>T,...ariant located in exon 10 (rs4641: NM_1701707.3:c.1698C>T). These findings are consistent with the L...,136,434,PLoS_One_2016_May_16_11(5)_e0155421.txt
2A>G,...als (>60 years old). We found only the LMNA c.357-2A>G variant completely segregated with the phenot...,146,402,PLoS_One_2016_May_16_11(5)_e0155421.txt
2A>G,Lamin A/C and the predicted impact of LMNA c.357-2A>,154,50,PLoS_One_2016_May_16_11(5)_e0155421.txt
2A>G,"We report LMNA c.357-2A>G, a novel transition at the splice acceptor si...",157,22,PLoS_One_2016_May_16_11(5)_e0155421.txt
1G>T,"...tide in the same splice acceptor site, LMNA c.357-1G>T was reported in three patients with arrhythmi...",157,232,PLoS_One_2016_May_16_11(5)_e0155421.txt
1G>T,"...,32]. In a cohort of 324 DCM patients, LMNA c.357-1G>T was detected in one family that consisted of ...",157,345,PLoS_One_2016_May_16_11(5)_e0155421.txt
1G>T,"...ions (PVCs), and a pacemaker/ICD [31]. LMNA c.357-1G>T also was found in one French patient with spo...",157,640,PLoS_One_2016_May_16_11(5)_e0155421.txt
2A>G,...igate the molecular mechanism by which LMNA c.357-2A>G leads to adult-onset SSS and DCM in our famil...,159,60,PLoS_One_2016_May_16_11(5)_e0155421.txt
2A>G,...ele in mutant fibroblast. Although the LMNA c.357-2A>G mutation is predicted to result in transcript...,159,326,PLoS_One_2016_May_16_11(5)_e0155421.txt
1G>T,...with the RNA studies conducted for the LMNA c.357-1G>T family [31]. Since both mutations are at the ...,161,145,PLoS_One_2016_May_16_11(5)_e0155421.txt
1G>T,"...e at the same splice site, we expected LMNA c.357-1G>T and LMNA c.357-2A>G to both produce the same ...",161,236,PLoS_One_2016_May_16_11(5)_e0155421.txt
2A>G,"... site, we expected LMNA c.357-1G>T and LMNA c.357-2A>G to both produce the same aberrant products th...",161,256,PLoS_One_2016_May_16_11(5)_e0155421.txt
1G>T,"...ld be subject to NMD. However, for the LMNA c.357-1G>T, RNA studies showed skipping of exon 2 in the...",161,362,PLoS_One_2016_May_16_11(5)_e0155421.txt
1G>T,...cific differences: the RNA analysis of LMNA c.357-1G>T was performed in heart tissue compared to our...,163,130,PLoS_One_2016_May_16_11(5)_e0155421.txt
2192T>C,"In all subjects combined, 2 SNPs in TLR1 (−2192T>C, 1805G>T) were significantly associated wi...",114,44,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
1805G>T,"... all subjects combined, 2 SNPs in TLR1 (−2192T>C, 1805G>T) were significantly associated with Td (Ta...",114,53,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
597T>C,"...ssociated with Td (Table 2), and one SNP in TLR2 (597T>C) was significantly associated with BOP (Tab...",114,132,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
1805G>T,...ed with BOP (Table 3). One of the 2 SNPs in TLR1 (1805G>T) was significantly associated with Td in C...,114,216,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
7202G>A,"...ans (Table 2). In addition, another SNP in TLR1 (−7202G>A) and a SNP in TLR6 (−502T>C) were also sig...",114,322,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
502T>C,...nother SNP in TLR1 (−7202G>A) and a SNP in TLR6 (−502T>C) were also significantly associated with Td...,114,351,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
2192T>C,All samples	Td	TLR1	rs5743595	−2192T>C	-	C	Add	1.27	0.001a,118,32,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
7202G>A,rs5743551	−7202G>A	-	A	Add	-0.95	0.002,120,15,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
1805G>T,rs5743618	1805G>T	Ser602Ile	G	Add	-1.11	0.001a,121,14,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
1401G>A,TLR6	rs5743795	−1401G>A	-	A	Add	1.39	0.004,122,19,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
502T>C,Caucasian	Pg	TLR6	rs1039559	−502T>C	-	C	Add	-2.10	0.001a,124,30,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
7202G>A,Td	TLR1	rs5743551	−7202G>A	-	A	Add	-1.57	0.001a,125,21,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
1805G>T,rs5743618	1805G>T	Ser602Ile	G	Add	-1.56	<0.001a,126,14,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
1805G>T,African American	Td	TLR1	rs5743618	1805G>T	Ser602Ile	G	Add	-1.72	0.009,127,36,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
16934T>A,TLR2	rs4696480	−16934T>A	-	T	Dom	-1.37	0.006,128,19,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
745T>C,TLR6	rs5743810	745T>C	Ser249Pro	T	Add	-1.81	0.003,129,18,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
28A>G,TLR8	rs5744077	28A>G	Met10Val	G	Add	-1.74	0.003,130,18,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
645C>T,rs5744080	645C>T	His215His	C	Add	-1.37	0.008,131,14,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
1805G>T,Tf	TLR1	rs5743618	1805G>T	Ser602Ile	G	Dom	-1.51	0.002,132,20,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
3121T>C,TLR8	rs1548731	+3121T>C	-	T	Add	0.86	0.004,133,19,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
28A>G, 	 	 	rs5744077	28A>G	Met10Val	G	Add	-1.22	0.008,134,17,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
4224C>T,All samples	REC	TLR6	rs2381289	4224C>T	-	T	Dom	13.26	0.007,141,32,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
597T>C,BOP	TLR2	rs3804099	597T>C	Asn199Asn	T	Add	8.89	0.001a,142,21,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
1486C>T,TLR9	rs187084	−1486C>T	-	C	Add	-7.31	0.010,144,18,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
1607T>C,Caucasian	PPD	TLR4	rs10759932	−1607T>C	-	C	Dom	18.12	0.005,145,32,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
15607A>G,REC	TLR2	rs1898830	−15607A>G	-	G	Add	12.92	0.006,146,22,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
1174G>A,BOP	TLR9	rs352139	+1174G>A	-	A	Dom	20.57	0.004,148,21,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
1635G>A,rs352140	1635G>A	Pro545Pro	A	Add	-12.98	0.006,149,13,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
4224C>T,African American	REC	TLR6	rs2381289	4224C>T	-	T	Dom	19.66	0.005,150,37,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
597T>C, 	BOP	TLR2	rs3804099	597T>C	Asn199Asn	T	Dom	14.70	0.004,151,22,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
2192T>C,...nformation regarding the functional relevance of −2192T>C is limited. The −2192C allele may be prote...,170,388,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
7202G>A,...er stimulation with TLR1/2 ligand Pam3CSK4 [62]. −7202G>A and 1805G>T were functionally relevant in ...,170,775,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
1805G>T,"...on with TLR1/2 ligand Pam3CSK4 [62]. −7202G>A and 1805G>T were functionally relevant in sepsis, tube...",170,787,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
597T>C,"Most previous studies did not include 597T>C [12,19,22,23]. One study, conducted in 2 No...",174,39,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
597T>C,"...ymous SNP (Asn199Asn), the molecular mechanism of 597T>C is not clear. The 597T allele may have a ro...",174,242,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
597T>C,...lar symbiotic bacterium Wolbachia. It may be that 597T>C is in LD with a highly polymorphic (GT)n di...,174,512,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
597T>C,"... previously associated with PD [18]. In addition, 597T>C is in LD with a 22-bp insertion-deletion po...",174,727,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
597T>C,...evaluating the functional and clinical effects of 597T>C in further studies is highly relevant,174,1191,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
745T>C,... fact that it is in strong LD with non-synonymous 745T>C (−502C-745T) (S3 Table). Others have found ...,176,428,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
502T>C,"...th TLR1/6 lipopeptide ligands [74]. In addition, −502T>C is in strong LD with 4224C>T (S3 Table), lo...",176,839,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
4224C>T,"...s [74]. In addition, −502T>C is in strong LD with 4224C>T (S3 Table), located in the 3′-UTR. It is w...",176,867,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
7202G>A,"...ng the 5 significant SNPs in this study, 3 (TLR1 −7202G>A, 1805G>T; TLR6 −502T>C) were associated wi...",178,1353,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
1805G>T,"...significant SNPs in this study, 3 (TLR1 −7202G>A, 1805G>T; TLR6 −502T>C) were associated with HIV st...",178,1362,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
502T>C,"...s in this study, 3 (TLR1 −7202G>A, 1805G>T; TLR6 −502T>C) were associated with HIV status in our pre...",178,1377,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
13T>G,1	F	50	Proximal weakness LL + axial	IVS1-13T>G	c.1076-1G>C	251	Yes	47	N	N,107,42,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
1G>C,...50	Proximal weakness LL + axial	IVS1-13T>G	c.1076-1G>C	251	Yes	47	N	N,107,55,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
13T>G,...L and LL + axial + respiratory insufficiency	IVS1-13T>G IVS1-13T>G	c.2173C>T	779	Yes	39	Y	Y,108,77,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
13T>G,...axial + respiratory insufficiency	IVS1-13T>G IVS1-13T>G	c.2173C>T	779	Yes	39	Y	Y,108,88,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
2173C>T,...respiratory insufficiency	IVS1-13T>G IVS1-13T>G	c.2173C>T	779	Yes	39	Y	Y,108,96,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
13T>G,3	F	26	HyperCKemia	IVS1-13T>G	c.1889-1G>A	779	No	-	N	N,109,25,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
1G>A,3	F	26	HyperCKemia	IVS1-13T>G	c.1889-1G>A	779	No	-	N	N,109,38,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
13T>G,4	F	63	Proximal weakness LL + axial	IVS1-13T>G	c.2600_2604delinsA	311	Yes	59	N	N,110,42,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
13T>G,5	M	11	HyperCKemia	IVS1-13T>G	c.573C>A	276	No	-	N	N,111,25,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
573C>A,5	M	11	HyperCKemia	IVS1-13T>G	c.573C>A	276	No	-	N	N,111,33,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
13T>G,6	F	45	Proximal weakness LL	IVS1-13T>G	c.1532C>A	322	Yes	42	N	N,112,34,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
1532C>A,6	F	45	Proximal weakness LL	IVS1-13T>G	c.1532C>A	322	Yes	42	N	N,112,42,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
13T>G,7	F	51	Proximal weakness LL	IVS1-13T>G	c.236_246del	240	Yes	47	N	N,113,34,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
13T>G,8	M	66	Axial + respiratory insufficiency	IVS1-13T>G	c.1933G>T	406	No	-	N	N,114,47,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
1933G>T,...66	Axial + respiratory insufficiency	IVS1-13T>G	c.1933G>T	406	No	-	N	N,114,55,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
13T>G,9	F	59	Proximal weakness LL	IVS1-13T>G	c.1637A>G	341	Yes	52	N	N,115,34,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
1637A>G,9	F	59	Proximal weakness LL	IVS1-13T>G	c.1637A>G	341	Yes	52	N	N,115,42,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
13T>G,10	F	55	Proximal weakness LL	IVS1-13T>G	c.2173C>T	359	Yes	48	N	N,116,35,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
2173C>T,10	F	55	Proximal weakness LL	IVS1-13T>G	c.2173C>T	359	Yes	48	N	N,116,43,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
13T>G,...kness LL + axial + respiratory insufficiency	IVS1-13T>G	c.573C>A	606	Yes	39	N	Y,117,71,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
573C>A,... + axial + respiratory insufficiency	IVS1-13T>G	c.573C>A	606	Yes	39	N	Y,117,79,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
13T>G,...akness UL and LL + respiratory insufficiency	IVS1-13T>G	c.1637A>G	391	Yes	24	Y	Y,118,70,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
1637A>G,...L and LL + respiratory insufficiency	IVS1-13T>G	c.1637A>G	391	Yes	24	Y	Y,118,78,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
13T>G,13	F	46	Proximal weakness LL	IVS1-13T>G	C.1192dupC	396	Yes	39	N	N,119,35,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
2173C>T,...roximal weakness LL + respiratory insufficiency	c.2173C>T	c.2173C>T	508	Yes	45	N	Y,120,60,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
2173C>T,...akness LL + respiratory insufficiency	c.2173C>T	c.2173C>T	508	Yes	45	N	Y,120,70,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
13T>G,...imal weakness LL + respiratory insufficiency	IVS1-13T>G	c.1657C>T	709	Yes	45	N	Y,121,63,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
1657C>T,...kness LL + respiratory insufficiency	IVS1-13T>G	c.1657C>T	709	Yes	45	N	Y,121,71,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
13T>G,...akness UL and LL + respiratory insufficiency	IVS1-13T>G	c.1657C>T	458	Yes	46	N	Y,122,70,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
1657C>T,...L and LL + respiratory insufficiency	IVS1-13T>G	c.1657C>T	458	Yes	46	N	Y,122,78,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
13T>G,17	M	22	HyperCKemia	IVS1-13T>G	c.1781G>A	1268	No	-	N	N,123,26,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
1781G>A,17	M	22	HyperCKemia	IVS1-13T>G	c.1781G>A	1268	No	-	N	N,123,34,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
271G>A,18	M	49	HyperCKemia	c.271G>A	c.2510G>A	641	No	-	N	N,124,23,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
2510G>A,18	M	49	HyperCKemia	c.271G>A	c.2510G>A	641	No	-	N	N,124,32,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
13T>G,19	M	14	HyperCKemia	IVS1-13T>G	c.573C>A	660	No	-	N	N,125,26,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
573C>A,19	M	14	HyperCKemia	IVS1-13T>G	c.573C>A	660	No	-	N	N,125,34,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
1781G>A,...roximal weakness LL + respiratory insufficiency	c.1781G>A	c.1194+5G>A	68	Yes	64	N	N,126,60,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
5G>A,...s LL + respiratory insufficiency	c.1781G>A	c.1194+5G>A	68	Yes	64	N	N,126,75,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
13T>G,21	F	35	Proximal weakness LL	IVS1-13T>G	c.1A>T	355	Yes	29	N	N,127,35,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
1A>T,21	F	35	Proximal weakness LL	IVS1-13T>G	c.1A>T	355	Yes	29	N	N,127,43,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
13T>G,22	F	40	Proximal weakness LL	IVS1-13T>G	c.1889-1G>A	831	No	-	N	Y,128,35,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
1G>A,22	F	40	Proximal weakness LL	IVS1-13T>G	c.1889-1G>A	831	No	-	N	Y,128,48,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
1781G>A,...roximal weakness LL + respiratory insufficiency	c.1781G>A	c.1194+5G>A	907	Yes	45	N	N,129,60,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
5G>A,...s LL + respiratory insufficiency	c.1781G>A	c.1194+5G>A	907	Yes	45	N	N,129,75,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
13T>G,... UL + LL + axial + respiratory insufficiency	IVS1-13T>G	c.2481+102_2646+31del	430	Yes	57	N	Y,130,76,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
13T>G,25	M	8	HyperCKemia	IVS1-13T>G	c.1889-1G>A	1077	No	-	N	N,131,25,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
1G>A,25	M	8	HyperCKemia	IVS1-13T>G	c.1889-1G>A	1077	No	-	N	N,131,38,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
13T>G,...imal weakness LL + respiratory insufficiency	IVS1-13T>G	c.1447G>T	394	Yes	55	N	Y,132,63,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
1447G>T,...kness LL + respiratory insufficiency	IVS1-13T>G	c.1447G>T	394	Yes	55	N	Y,132,71,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
13T>G,27	M	46	Proximal weakness LL	IVS1-13T>G	c.1532 C>A	882	Yes	43	N	Y,133,35,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
1532 C>A,27	M	46	Proximal weakness LL	IVS1-13T>G	c.1532 C>A	882	Yes	43	N	Y,133,43,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
13T>G,28	M	51	Proximal weakness LL	IVS1-13T>G	c.1933G>T	952	Yes	51	N	Y,134,35,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
1933G>T,28	M	51	Proximal weakness LL	IVS1-13T>G	c.1933G>T	952	Yes	51	N	Y,134,43,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
13T>G,29	M	51	Proximal weakness LL	IVS1-13T>G	c.1933G>T	432	No	-	N	Y,135,35,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
1933G>T,29	M	51	Proximal weakness LL	IVS1-13T>G	c.1933G>T	432	No	-	N	Y,135,43,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
13T>G,30	M	43	Proximal weakness LL	IVS1-13T>G	c.1408_1410delinsTTT	317	Yes	43	N	N,136,35,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
13T>G,32	M	42	Proximal weakness UL + LL	IVS1-13T>G	c.655G>A	886	No	-	N	N,138,40,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
655G>A,32	M	42	Proximal weakness UL + LL	IVS1-13T>G	c.655G>A	886	No	-	N	N,138,48,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
13T>G,33	F	20	HyperCKemia	IVS1-13T>G	c.1551+1G>A	928	No	-	N	N,139,26,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
1G>A,33	F	20	HyperCKemia	IVS1-13T>G	c.1551+1G>A	928	No	-	N	N,139,39,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
13T>G,34	M	50	Proximal weakness LL	IVS1-13T>G	c.1637A>G	492	No	-	N	Y,140,35,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
1637A>G,34	M	50	Proximal weakness LL	IVS1-13T>G	c.1637A>G	492	No	-	N	Y,140,43,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
66G>A,ER23/23EK	c.66G>A (p.Glu22Glu)	rs6189	2.19%	2.98% (ss131753929...,129,13,PLoS_One_2016_Sep_20_11(9)_e0162437.txt
68G>A,c.68G>A (p.Arg23Lys)	rs6190		2.98% (ss1317539290)	2....,130,3,PLoS_One_2016_Sep_20_11(9)_e0162437.txt
1088A>G,N363S	c.1088A>G (p.Asn363Ser)	rs56149945 (former rs6195 or...,131,9,PLoS_One_2016_Sep_20_11(9)_e0162437.txt
646C>G,BclI	c.1184+646C>G (p.?)	rs41423247	32.8%	37.97% (ss1317539254...,132,13,PLoS_One_2016_Sep_20_11(9)_e0162437.txt
3833A>G,"...hat BclI, N363S, ER22/23EK and A3669G (rs6198, c.*3833A>G) did not influence the development of Cush...",192,794,PLoS_One_2016_Sep_20_11(9)_e0162437.txt
409	C>M,"MMSE	27.29±2.31	25.68±2.68	19.33±3.82	201.32*	2, 409	C>M>A",152,50,PLoS_One_2016_Sep_26_11(9)_e0163792.txt
409	C>M,"...ecall	21.47±4.06	17.15±4.39	10.91±3.71	111.87*	2, 409	C>M>A",153,67,PLoS_One_2016_Sep_26_11(9)_e0163792.txt
409	C>M,"...d recall	7.26±2.00	3.49±2.92	0.29±0.92	152.14*	2, 409	C>M>A",154,62,PLoS_One_2016_Sep_26_11(9)_e0163792.txt
409	C>M,"...cognition	9.46±1.68	7.42±2.42	3.70±2.87	104.73*	2,409	C>M>A",155,58,PLoS_One_2016_Sep_26_11(9)_e0163792.txt
403	C>M,"...T-copy	32.41±3.87	28.87±5.32	22.50±7.63	66.91*	2, 403	C>M>A",156,54,PLoS_One_2016_Sep_26_11(9)_e0163792.txt
409	C>M,"...-animal	17.40±4.14	12.86±3.75	8.84±4.31	80.74*	2, 409	C>M>A",157,54,PLoS_One_2016_Sep_26_11(9)_e0163792.txt
404	C>M,"...t items	18.97±5.32	14.46±5.84	8.33±4.57	61.57*	2, 404	C>M>A",158,65,PLoS_One_2016_Sep_26_11(9)_e0163792.txt
358	C>M,"... ㅇ, ㅅ	26.35±11.01	20.41±9.78	13.83±8.95	27.51*	2, 358	C>M>A",159,57,PLoS_One_2016_Sep_26_11(9)_e0163792.txt
354	C>M,"...ng)	88.30±17.91	70.41±23.45	40.73±24.30	63.86*	2, 354	C>M>A",161,85,PLoS_One_2016_Sep_26_11(9)_e0163792.txt
409	C>M,"K-BNT	48.15±8.09	40.48±9.97	28.70±11.22	63.33*	2, 409	C>M>A",162,51,PLoS_One_2016_Sep_26_11(9)_e0163792.txt
409	C>M,"...an-forward	6.07±1.51	5.63±1.40	4.91±1.45	6.44*	2, 409	C>M>A",163,59,PLoS_One_2016_Sep_26_11(9)_e0163792.txt
409	C>M,"...-backward	4.10±1.15	3.56±0.97	2.92±0.95	25.23*	2, 409	C>M>A",164,61,PLoS_One_2016_Sep_26_11(9)_e0163792.txt
409	C>M,"Recall	1.87±0.85	1.20±0.84	0.26±0.51	77.30*	2, 409	C>M>A",193,48,PLoS_One_2016_Sep_26_11(9)_e0163792.txt
409	C>M,"... score	14.43±1.32	13.37±1.58	8.91±2.54	230.62*	2, 409	C>M>A",194,56,PLoS_One_2016_Sep_26_11(9)_e0163792.txt
409	C>M,"Recall	1.87±0.85	1.20±0.84	0.26±0.51	77.30*	2, 409	C>M>A",208,48,PLoS_One_2016_Sep_26_11(9)_e0163792.txt
409	C>M,"...Score	27.26±2.66	25.71±2.35	19.39±3.94	205.00*	2, 409	C>M>A",212,57,PLoS_One_2016_Sep_26_11(9)_e0163792.txt
409	C>M,"Recall	1.87±0.85	1.20±0.84	0.26±0.51	77.30*	2, 409	C>M>A",226,48,PLoS_One_2016_Sep_26_11(9)_e0163792.txt
409	C>M,"... memory	10.46±3.50	7.15±3.21	3.34±1.80	109.96*	2, 409	C>M>A",230,56,PLoS_One_2016_Sep_26_11(9)_e0163792.txt
409	C>M,"...g speed	12.24±4.31	10.47±4.03	6.35±3.40	38.78*	2, 409	C>M>A",231,60,PLoS_One_2016_Sep_26_11(9)_e0163792.txt
409	C>M,"...Score	49.84±9.59	43.48±7.81	29.06±7.17	168.37*	2, 409	C>M>A",232,57,PLoS_One_2016_Sep_26_11(9)_e0163792.txt
407	C>M,"...37±1.58	10.71±1.86	8.13±2.28	6.00±1.53	161.69*	4, 407	C>MC>E>Mi>Mo",374,68,PLoS_One_2016_Sep_26_11(9)_e0163792.txt
407	C>M,"...±2.35	22.03±2.85	18.35±3.50	14.43±3.60	151.66*	4, 407	C>MC>E>Mi>Mo",375,70,PLoS_One_2016_Sep_26_11(9)_e0163792.txt
407	C>M,"...±7.81	33.14±5.78	27.71±6.45	19.29±5.68	105.77*	4, 407	C>MC>E>Mi = Mo",376,70,PLoS_One_2016_Sep_26_11(9)_e0163792.txt
149T>C,"..., Gazouli M . Association of the miR-146aC>G, miR-149T>C, and miR-196a2T>C polymorphisms with gastri...",160,120,PLoS_One_2016_Sep_29_11(9)_e0163626.txt
2T>C,"...ation of the miR-146aC>G, miR-149T>C, and miR-196a2T>C polymorphisms with gastric cancer risk and su...",160,140,PLoS_One_2016_Sep_29_11(9)_e0163626.txt
77C->G,...s W  Borns K  Windhagen A  Schwinzer R   2006 The 77C->G mutation in the human CD45 (PTPRC) gene lea...,240,65,PLoS_Pathog_2011_Dec_8_7(12)_e1002432.txt
58 G>A,...A transcript [11]. We hypothesized that the prfA -58 G>A mutation also inactivated the P2 promoter a...,66,1364,PLoS_Pathog_2016_Jul_14_12(7)_e1005741.txt
58 G>A,...he ΔP2 gshF::Tn double mutant and the ΔgshF prfA -58 G>A suppressor mutants all formed plaques appro...,66,1512,PLoS_Pathog_2016_Jul_14_12(7)_e1005741.txt
4S > C,"... efficiency increased in the order of HA > Ch > Ch4S > Ch6S, whereas acceptor efficiency increased i...",44,426,Proc_Jpn_Acad_Ser_B_Phys_Biol_Sci_2012_Jul_25_88(7)_327-344.txt
4S > C,"... efficiency increased in the order of HA > Ch > Ch4S > Ch6S. However, DS could not act as either a d...",44,503,Proc_Jpn_Acad_Ser_B_Phys_Biol_Sci_2012_Jul_25_88(7)_327-344.txt
1055T>G,...und homo-/heterozygous variants for [rs2229291; c.1055T>G (p.F352C)] and [rs1799821; c.1102G>A (p.V3...,56,928,Proc_Jpn_Acad_Ser_B_Phys_Biol_Sci_2015_Oct_9_91(8)_351-368.txt
1102G>A,...rs2229291; c.1055T>G (p.F352C)] and [rs1799821; c.1102G>A (p.V368I)] of CPT II and mitochondrial ene...,56,965,Proc_Jpn_Acad_Ser_B_Phys_Biol_Sci_2015_Oct_9_91(8)_351-368.txt
521T > C,"...al-time polymerase chain reaction (PCR) (SLCO1B1 +521T > C, VKORC1 -1639G>A, CYP2C19 +681G>A, +636G>...",3,1519,Res_Pharm_Sci_2016_May-Jun_11(3)_259-264.txt
1639G>A,"... chain reaction (PCR) (SLCO1B1 +521T > C, VKORC1 -1639G>A, CYP2C19 +681G>A, +636G>A, CYP2C9 +430С>T,...",3,1537,Res_Pharm_Sci_2016_May-Jun_11(3)_259-264.txt
681G>A,"...CR) (SLCO1B1 +521T > C, VKORC1 -1639G>A, CYP2C19 +681G>A, +636G>A, CYP2C9 +430С>T, +1075A>C). Genoty...",3,1555,Res_Pharm_Sci_2016_May-Jun_11(3)_259-264.txt
636G>A,"...1B1 +521T > C, VKORC1 -1639G>A, CYP2C19 +681G>A, +636G>A, CYP2C9 +430С>T, +1075A>C). Genotype freque...",3,1564,Res_Pharm_Sci_2016_May-Jun_11(3)_259-264.txt
1075A>C,"...39G>A, CYP2C19 +681G>A, +636G>A, CYP2C9 +430С>T, +1075A>C). Genotype frequencies of polymorphisms in...",3,1589,Res_Pharm_Sci_2016_May-Jun_11(3)_259-264.txt
521T > C,...enotype frequencies of the polymorphism SLCO1B1 + 521T > C between groups consisting of individuals ...,28,480,Res_Pharm_Sci_2016_May-Jun_11(3)_259-264.txt
681G > A,...parison of the frequencies of genotypes CYP2C19 + 681G > A polymorphism found a significant differen...,28,697,Res_Pharm_Sci_2016_May-Jun_11(3)_259-264.txt
636G > A,... frequency distribution of genotypes of CYP2C19 + 636G > A polymorphism found similar frequencies in...,32,70,Res_Pharm_Sci_2016_May-Jun_11(3)_259-264.txt
636G > A,...and the Chinese. The difference between CYP2C19 + 636G > A genotype frequencies among the Yakuts and...,32,192,Res_Pharm_Sci_2016_May-Jun_11(3)_259-264.txt
430C > T,...nt. The comparison of the frequencies of CYP2C9 + 430C > T genotypes found a statistically significa...,32,422,Res_Pharm_Sci_2016_May-Jun_11(3)_259-264.txt
1075A > C,...he Yakuts and the Russians. The study of CYP2C9 + 1075A > C polymorphisms in the groups established ...,32,771,Res_Pharm_Sci_2016_May-Jun_11(3)_259-264.txt
1639G > A,... difference detected in the polymorphism VKORC1 - 1639G > A between the Yakut and Chinese groups (χ2...,32,952,Res_Pharm_Sci_2016_May-Jun_11(3)_259-264.txt
681G > A,...f minor alleles of polymorphisms in the CYP2C19 + 681G > A and CYP2C9 + 430C > T in the sample we st...,35,656,Res_Pharm_Sci_2016_May-Jun_11(3)_259-264.txt
430C > T,...ymorphisms in the CYP2C19 + 681G > A and CYP2C9 + 430C > T in the sample we studied were somewhere i...,35,678,Res_Pharm_Sci_2016_May-Jun_11(3)_259-264.txt
521T>C,... LE  Uitterlinden AG  Klungel OH    The SLCO1B1 c.521T>C polymorphism is associated with dose decrea...,68,96,Res_Pharm_Sci_2016_May-Jun_11(3)_259-264.txt
403 G-->A,...RC Makki R Tavernier G Smilie FI Custovic A  The -403 G-->A promoter polymorphism in the RANTES gene...,340,106,Respir_Res_2003_Dec_4_4(1)_14.txt
2052 C>A,...quencing revealed the presence of the homozygous c2052 C>A and the heterozygous c2619 T>C polymorphi...,42,59,Respir_Res_2011_Aug_25_12(1)_115.txt
2619 T>C,...of the homozygous c2052 C>A and the heterozygous c2619 T>C polymorphisms. SFTPC sequencing showed th...,42,90,Respir_Res_2011_Aug_25_12(1)_115.txt
2772 A>G,...sequencing showed the presence of the homozygous c2772 A>G and c2643 C>G polymorphisms. ABCA3 sequen...,42,170,Respir_Res_2011_Aug_25_12(1)_115.txt
2643 C>G,...wed the presence of the homozygous c2772 A>G and c2643 C>G polymorphisms. ABCA3 sequencing showed a ...,42,184,Respir_Res_2011_Aug_25_12(1)_115.txt
3381 T>C,"...BCA3 sequencing showed a mono-allelic variation, c3381 T>C, leading to the aminoacidic sequence chan...",42,259,Respir_Res_2011_Aug_25_12(1)_115.txt
710 T > C,"...rmal AAT alleles are PI*M1 (rs6647; NM_000295.4:c.710 T > C; p.Val213Ala, mature protein), PI*M2 (rs...",28,381,Respir_Res_2014_Oct_7_15(1)_125.txt
374G > A,"... p.Val213Ala, mature protein), PI*M2 (rs709932; c.374G > A; p.Arg101His) and PI*M3 (rs1303; c.1200A ...",28,441,Respir_Res_2014_Oct_7_15(1)_125.txt
1200A > C,...32; c.374G > A; p.Arg101His) and PI*M3 (rs1303; c.1200A > C; p.Glu376Asp). The allelic frequency of ...,28,485,Respir_Res_2014_Oct_7_15(1)_125.txt
863A > T,...st common deficient alleles are PI*S (rs17580: c. 863A > T; p. Glu264Val) and PI*Z (rs28929474; c.10...,28,864,Respir_Res_2014_Oct_7_15(1)_125.txt
1096G > A,".... 863A > T; p. Glu264Val) and PI*Z (rs28929474; c.1096G > A; p.Glu342Lys), with a PI*S prevalence in...",28,912,Respir_Res_2014_Oct_7_15(1)_125.txt
1G > A,"Intron 1C, c.-5 + 1G > A. Splicing site variant, causing no expressi...",78,20,Respir_Res_2014_Oct_7_15(1)_125.txt
1G > A,"..., Santa Clara, CA) and primers for variant c.-5 + 1G > A (QOPorto) (F:5′ACTGACCTGGGACAGTGAATCATAAGTA...",120,242,Respir_Res_2014_Oct_7_15(1)_125.txt
1G > A,"...plice donor site of intron 1C (NM_000295.4:c.-5 + 1G > A), previously described as QOPorto splicing ...",138,285,Respir_Res_2014_Oct_7_15(1)_125.txt
1G > A,"...nerated by the wild type, c.-5 + 2dupT and c.-5 + 1G > A minigenes. Screenshots of Peak Scanner elec...",179,174,Respir_Res_2014_Oct_7_15(1)_125.txt
1G > A,"...12) generated by the wild type, or mutants c.-5 + 1G > A (QOPorto) and c.-5 + 2dupT (QOMadrid) minig...",179,539,Respir_Res_2014_Oct_7_15(1)_125.txt
1G > A,"Interestingly, mutations c.-5 + 1G > A and c.-5 + 2dupT triggered the elimination ...",183,33,Respir_Res_2014_Oct_7_15(1)_125.txt
1G > A,"...nerated six new ones, Tr10, Tr11 and Tr12 (c.-5 + 1G > A), and Tr3, Tr4 and Tr9 (c.-5 + 2dupT). The ...",183,205,Respir_Res_2014_Oct_7_15(1)_125.txt
1G > A,...2 transcript was significantly enriched in c.-5 + 1G > A (83.0% vs. 51.3% in wt) although other thre...,183,311,Respir_Res_2014_Oct_7_15(1)_125.txt
6Man > Man,"...ially recognizes terminal mannose residues (Manα1,6Man > Manα1,3Man > Manα1,2Man), whereas GNAmaize ...",233,193,Retrovirology_2011_Feb_11_8_10.txt
3Man > Man,"...zes terminal mannose residues (Manα1,6Man > Manα1,3Man > Manα1,2Man), whereas GNAmaize has poor, if ...",233,206,Retrovirology_2011_Feb_11_8_10.txt
33T>C,"...FY*B/FY*B in 158 (39.50%) samples. The mutation (-33T>C), which occurs in the GATA-box erythroid pro...",114,148,Rev_Bras_Hematol_Hemoter_2011_33(1)_21-25.txt
20A>T,...nce of a sickle hemoglobin (Hb S) mutation (HBB:c.20A>T). People with SCD can be homozygous for Hb S...,5,130,Rev_Bras_Hematol_Hemoter_2016_Jun_22_Jul-Sep_38(3)_190-192.txt
364G>C,...ubstitution of glutamic acid for glutamine (HBB:c.364G>C). This abnormal Hb is usually called Hb D-P...,9,369,Rev_Bras_Hematol_Hemoter_2016_Jun_22_Jul-Sep_38(3)_190-192.txt
67G>C,"...ns in the β-globin gene, such as Hb D-Iran (HBB:c.67G>C) and Hb D-Ibadan (HBB:c.263C>A). However, in...",13,111,Rev_Bras_Hematol_Hemoter_2016_Jun_22_Jul-Sep_38(3)_190-192.txt
263C>A,"...as Hb D-Iran (HBB:c.67G>C) and Hb D-Ibadan (HBB:c.263C>A). However, individuals with these mutations...",13,141,Rev_Bras_Hematol_Hemoter_2016_Jun_22_Jul-Sep_38(3)_190-192.txt
220G>A,Hb Korle-Bu (Hb KB) or Hb G-Accra (HBB:c.220G>A) is a frequent mutation in Sub-Saharan Afri...,15,42,Rev_Bras_Hematol_Hemoter_2016_Jun_22_Jul-Sep_38(3)_190-192.txt
20A>T,"...is termed Hb C-Harlem (or Hb C-Georgetown) (HBB:c.20A>T, HBB:c.220G>A), because it migrates to the p...",17,244,Rev_Bras_Hematol_Hemoter_2016_Jun_22_Jul-Sep_38(3)_190-192.txt
220G>A,"...C-Harlem (or Hb C-Georgetown) (HBB:c.20A>T, HBB:c.220G>A), because it migrates to the position of Hb...",17,257,Rev_Bras_Hematol_Hemoter_2016_Jun_22_Jul-Sep_38(3)_190-192.txt
237C>A,"...eyville-II [alpha78(EF7)Asn→Lys (alpha2); HbA2: c.237C>A]: incidence of 1:11,500 in a newborn screen...",55,151,Rev_Bras_Hematol_Hemoter_2016_Jun_22_Jul-Sep_38(3)_190-192.txt
181A>G,...rticleAssociation of Matrix Metalloproteinase-7 (-181A>G) Polymorphism with Risk of Esophageal Squam...,3,265,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
181A>G,Carriers for the MMP-7 (-181A>G) GG were associated with an increased risk ...,10,26,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
181A>G,"... recessive model, our results showed that MMP-7 (-181A>G) GG allele conferred significantly higher r...",10,237,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
181A>G,"...t risk factors for EC, the interaction of MMP-7 (-181A>G) genotypes with these factors did not furth...",10,599,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
181A>G,"In conclusion, our results show that MMP-7 (-181A>G) GG carriers are at a higher risk of esopha...",13,46,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
181A>G,Esophageal cancerKashmir valleyMMP-7 (–181A>G) polymorphis,15,40,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
181A>G,"...olymorphisms exist in the MMP-7 promoter region, -181A>G and –153C>T, which are known to modify the ...",21,118,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
153C>T,"... exist in the MMP-7 promoter region, -181A>G and –153C>T, which are known to modify the gene transcr...",21,130,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
181A>G,...revious studies have shown association of MMP-7 (-181A>G) (rs11568818) polymorphisms with esophageal...,21,254,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
181A>G,...as been carried out to evaluate the role of MMP7 -181A>G polymorphism in relation to higher prevalen...,21,424,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
181A>G,...sent study was to investigate the role of MMP-7 (–181A>G) (rs11568818) in conferring genetic suscept...,21,659,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
181A>G,The MMP-7 polymorphism (–181A>G) was genotyped in subjects by polymerase ch...,31,26,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
181A>G,... (PCR-RFLP). Primers for amplification of MMP-7 (–181A>G) were taken as described.[14] PCR products ...,31,179,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
181A>G,...erence. Observed genotype frequencies for MMP-7 (-181A>G) polymorphism (rs17878362) in controls were...,34,666,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
181A>G,...ical models to predict the association of MMP-7 (-181A>G) genotypes with susceptibility to EC. Assoc...,34,1031,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
181A>G,Association of genetic variant of MMP-7 (-181A>G) polymorphism with susceptibility to E,42,43,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
181A>G,The genotype frequencies of the MMP-7 (-181A>G) polymorphism among cases and controls are ...,43,41,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
181A>G,"...). In the present study, when we used the MMP 7 (-181A>G) AA genotype as reference, we found that in...",43,271,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
181A>G,"...reference, we found that individuals with MMP-7 (-181A>G) GG genotype were significantly associated ...",43,344,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
181A>G,"... recessive model, our results showed that MMP-7 (-181A>G) GG genotype conferred significantly increa...",43,597,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
181A>G,...requency distribution of genotypes and of MMP-7 (–181A>G) genotypes with risk of esophageal cance,45,60,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
181A>G,Association of MMP-7 (-181A>G) genotypes with tumor histopatholog,47,24,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
181A>G,"...hen tumor histopathologies were analyzed, MMP-7 (-181A>G) GG genotype was found to be significantly ...",48,52,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
181A>G,Table 3 Association of MMP-7 (–181A>G) genotypes with tumor histopathology and ri...,50,32,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
181A>G,Interaction of MMP-7 (-181A>G) genotypes with environmental factor,52,24,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
181A>G,... significant modulation of cancer risk by MMP-7 (-181A>G) genotypes with salted tea and smoking [Tab...,53,218,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
181A>G,Table 4 Interaction of MMP-7 (–181A>G) genotypes with salted te,55,32,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
181A>G,Table 5 Interaction of MMP-7 (–181A>G) genotypes with smokin,57,32,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
181A>G,"...esent study, we looked for the effect of MMP- 7 (-181A>G) promoter polymorphism on the genetic susce...",62,60,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
181A>G,"...nted results, we report an association of MMP-7 (-181A>G) GG genotype with increased EC risk at geno...",62,195,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
181A>G,...rted studies suggesting an association of MMP-7 (-181A>G) GG genotypes with an increased risk of var...,62,484,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
181A>G,...ssociations was found. The association of MMP-7 (-181A>G) polymorphism with cancer has been observed...,62,718,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
181A>G,...graphical differences in the influence of MMP-7 (-181A>G) on the susceptibility of various cancers,62,888,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
181A>G,"...ogical types of EC. In the present study, MMP-7 (-181A>G) GG genotype was significantly associated w...",64,139,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
181A>G,...s have also shown positive association of MMP-7 (-181A>G) GG with SCC.[15–1724] Wu et al.[33] have r...,64,305,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
181A>G,...tion of cancer risk due to interaction of MMP-7 (-181A>G) genotypes with smoking or salted tea consu...,70,1040,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
181A>G,...rt of genetic susceptibility of EC due to MMP-7 (-181A>G) gene polymorphism in the Kashmir valley. I...,72,299,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
181A>G,"... In conclusion, our data suggest that the MMP-7 (-181A>G) gene polymorphism may influence the suscep...",72,397,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
181A>G,... susceptibility to ESCC. Determination of MMP-7 (–181A>G) genotype may provide a useful genetic mark...,72,490,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
181A>G,27 Singh H  Jain M  Mittal B   MMP-7 (-181A>G) promoter polymorphisms and risk for cervic...,108,40,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
482G>A,...ygosity for a mutation in the GCDH-coding gene (c.482G>A;p.R161Q). This case alerts pediatricians to...,26,383,Saudi_Med_J_2015_Nov_36(11)_1269.txt
329A>G,...equencing detected a homozygous novel mutation (c.329A>G; p.Y110C) in the MUT gene in patient 1 and ...,3,1717,Saudi_Med_J_2015_Sep_36(9)_1110-1114.txt
2200C>T,... detected a novel homozygous nonsense mutation (c.2200C>T; p.Q734X) and a heterozygous in parents. T...,3,1952,Saudi_Med_J_2015_Sep_36(9)_1110-1114.txt
329A>G,"...n patient 1, we detected a homozygous mutation (c.329A>G;p.Y110C) and heterozygous in both his paren...",23,52,Saudi_Med_J_2015_Sep_36(9)_1110-1114.txt
2200C>T,"... 2, we detected a homozygous nonsense mutation (c.2200C>T;p.Q734X) in the patient and heterozygous i...",25,61,Saudi_Med_J_2015_Sep_36(9)_1110-1114.txt
329A>G,"...e presented in both patients. In patient 1, the c.329A>G;p.Y110C mutation is located in the alpha/be...",30,797,Saudi_Med_J_2015_Sep_36(9)_1110-1114.txt
2200C>T,"...main of the protein, whereas in patient 2, the (c.2200C>T;p.Q734X) is located in the cobalamin bindi...",30,918,Saudi_Med_J_2015_Sep_36(9)_1110-1114.txt
975T>G,...s (Fig. 1). Each additional LoF allele in CD36 (c.975T>G) had a lowering effect on octanoylcarnitine...,50,355,Sci_Adv_2016_Aug_31_2(8)_e1600800.txt
1G>T,... and each additional LoF allele in SLCO1B1 (c.481+1G>T) demonstrated an increasing effect on hexadec...,50,485,Sci_Adv_2016_Aug_31_2(8)_e1600800.txt
2T>A,... effect on hexadecanedioate levels. LRRC69 (c.933+2T>A) homozygous LoF status appeared to have a mar...,50,567,Sci_Adv_2016_Aug_31_2(8)_e1600800.txt
975T>G,...evels. (A) Octanoylcarnitine levels among CD36 (c.975T>G) LoF mutation carriers. (B) Decanoylcarniti...,53,147,Sci_Adv_2016_Aug_31_2(8)_e1600800.txt
975T>G,...riers. (B) Decanoylcarnitine levels among CD36 (c.975T>G) LoF mutation carriers. (C) Hexadecanedioat...,53,221,Sci_Adv_2016_Aug_31_2(8)_e1600800.txt
1G>T,... (C) Hexadecanedioate levels among SLCO1B1 (c.481+1G>T) LoF mutation carriers. (D) Deoxycarnitine le...,53,301,Sci_Adv_2016_Aug_31_2(8)_e1600800.txt
2T>A,...rs. (D) Deoxycarnitine levels among LRRC69 (c.933+2T>A) LoF mutation carriers,53,376,Sci_Adv_2016_Aug_31_2(8)_e1600800.txt
1G>T,"... We next genotyped the LoF site in SLCO1B1 (c.481+1G>T) among the entire ARIC participants (10,263 E...",57,732,Sci_Adv_2016_Aug_31_2(8)_e1600800.txt
975T>G,"...e purpose of replication, three LoF sites—CD36 (c.975T>G), SLCO1B1 (c.481+1G>T), and LRRC69 (c.933+2...",77,57,Sci_Adv_2016_Aug_31_2(8)_e1600800.txt
1G>T,"..., three LoF sites—CD36 (c.975T>G), SLCO1B1 (c.481+1G>T), and LRRC69 (c.933+2T>A), having both homozy...",77,81,Sci_Adv_2016_Aug_31_2(8)_e1600800.txt
2T>A,"....975T>G), SLCO1B1 (c.481+1G>T), and LRRC69 (c.933+2T>A), having both homozygous and heterozygous gen...",77,106,Sci_Adv_2016_Aug_31_2(8)_e1600800.txt
975T>G,"Three LoF sites—CD36 (c.975T>G), SLCO1B1 (c.481+1G>T), and LRRC69 (c.933+2...",86,25,Sci_Adv_2016_Aug_31_2(8)_e1600800.txt
1G>T,"Three LoF sites—CD36 (c.975T>G), SLCO1B1 (c.481+1G>T), and LRRC69 (c.933+2T>A), having both homozy...",86,49,Sci_Adv_2016_Aug_31_2(8)_e1600800.txt
2T>A,"....975T>G), SLCO1B1 (c.481+1G>T), and LRRC69 (c.933+2T>A), having both homozygous and heterozygous gen...",86,74,Sci_Adv_2016_Aug_31_2(8)_e1600800.txt
1799T > A,...both the normal and mutant alleles for the BRAF c.1799T > A mutation were calculated for three repre...,54,179,Sci_Rep_2013_Dec_13_3_3494.txt
1799T > A,"(A) The coverage of the c.1799T > A, p. V600E mutation in exon 15 of the BRA...",152,27,Sci_Rep_2013_Dec_13_3_3494.txt
1799T > A,"LOXIMV1	BRAF c.1799T > A, V600E	Yes	62%	Yes	58%",163,16,Sci_Rep_2013_Dec_13_3_3494.txt
1799T > A,"A2058	BRAF c.1799T > A, V600E	Yes	33%	Yes	29%",164,14,Sci_Rep_2013_Dec_13_3_3494.txt
335T > C," 	PTEN c.335T > C, L112Q	Yes	49%	Yes	45%",165,10,Sci_Rep_2013_Dec_13_3_3494.txt
1010 C > A," 	TP53 c.1010 C > A, V274F	Yes	100%	Yes	100%",167,10,Sci_Rep_2013_Dec_13_3_3494.txt
1799T > A,"HT144	BRAF c.1799T > A, V600E	Yes	100%	Yes	99%",168,14,Sci_Rep_2013_Dec_13_3_3494.txt
1799T > A,"SK-MEL28	BRAF c.1799T > A, V600E	Yes	100%	Yes	94%",169,17,Sci_Rep_2013_Dec_13_3_3494.txt
2257C > T," 	EGFR c.2257C > T, p.P753S	Yes	98%	Yes	99%",170,10,Sci_Rep_2013_Dec_13_3_3494.txt
624A > C," 	TP53 c.624A > C, L145R	Yes	97%	Yes	98%",171,10,Sci_Rep_2013_Dec_13_3_3494.txt
509G > A,"MeWo	CDKN2A 509G > A, R80X	Yes	100%	Yes	100%",172,13,Sci_Rep_2013_Dec_13_3_3494.txt
1139 G > A," 	TP53 c.1139 G > A, Q317X	Yes	50%	Yes	53%",173,10,Sci_Rep_2013_Dec_13_3_3494.txt
962 C > T," 	TP53 c.962 C > T, E258K	Yes	49%	Yes	52%",174,10,Sci_Rep_2013_Dec_13_3_3494.txt
4006 G > A," 	NF1 c.4006 G > A, Q1136X	Yes	100%	Yes	99%",175,9,Sci_Rep_2013_Dec_13_3_3494.txt
1799T > A,"BRAF	c.1799T > A, V600E (WM266-4, CO55-M1)",178,8,Sci_Rep_2013_Dec_13_3_3494.txt
1856A > G,"PTEN	c.1856A > G, T167A (SK-MEL28)",179,8,Sci_Rep_2013_Dec_13_3_3494.txt
1260T > G,"STK11	c.1260T > G, Y49D (A2058)",180,9,Sci_Rep_2013_Dec_13_3_3494.txt
882A > G,"ERBB4	c.882A > G, P294P (MeWo)",181,9,Sci_Rep_2013_Dec_13_3_3494.txt
1657G > A," 	c.1657G > A, S449F (MeWo)",182,5,Sci_Rep_2013_Dec_13_3_3494.txt
2609C > T," 	c.2609C > T, M766I (MeWo)",183,5,Sci_Rep_2013_Dec_13_3_3494.txt
8919 G > A,"ATM	c. 8919 G > A, W2845X (HT144)",184,8,Sci_Rep_2013_Dec_13_3_3494.txt
4643 C > T," 	c.4643 C > T, L1420F (MeWo)",185,5,Sci_Rep_2013_Dec_13_3_3494.txt
3520 C > T,"NF1	c.3520 C > T, Q1174X (LOXIMV1)",186,7,Sci_Rep_2013_Dec_13_3_3494.txt
901 C > T,"MAP2K1	c.901 C > T, P124S (A2058)",187,10,Sci_Rep_2013_Dec_13_3_3494.txt
3951T > G,"MAP3K5	c.3951T > G, p.D3590A (HT144)",188,10,Sci_Rep_2013_Dec_13_3_3494.txt
4169 G > A," 	c.4169 G > A, p.L1270F (MeWo)",189,5,Sci_Rep_2013_Dec_13_3_3494.txt
1127T > C,"MAP3K9	c.1127T > C, p.E376G (MeWo)",190,10,Sci_Rep_2013_Dec_13_3_3494.txt
1162 G > A," 	c.1162 G > A, p.P388S (MeWo)",191,5,Sci_Rep_2013_Dec_13_3_3494.txt
1678G > A," 	c.1678G > A, p.R560X (MeWo",192,5,Sci_Rep_2013_Dec_13_3_3494.txt
2R > T,"...low the following inequalities: T > R > P ≥ S and 2R > T + S. Here, 2R > T + S makes mutual cooperat...",18,1340,Sci_Rep_2014_Aug_29_4_6224.txt
2R > T,"...inequalities: T > R > P ≥ S and 2R > T + S. Here, 2R > T + S makes mutual cooperation the best outco...",18,1358,Sci_Rep_2014_Aug_29_4_6224.txt
2284C>T,"...ble 1). Interestingly, a single CNGB1 mutation (c.2284C>T) was detected in a homozygous state in 4 o...",18,476,Sci_Rep_2015_Aug_26_5_13187.txt
1349G>A,"... revealed a TULP1 homozygous nonsense mutation (c.1349G>A, p.W450*) which cosegregated with LCA in b...",25,370,Sci_Rep_2015_Aug_26_5_13187.txt
1494C>A,"...d identified a novel missense sequence variant (c.1494C>A, p.D498E) in the CNNM4 gene which is locat...",25,768,Sci_Rep_2015_Aug_26_5_13187.txt
1494C>A,...ed in the largest shared homozygous region. The c.1494C>A sequence change was absent in WES database...,25,868,Sci_Rep_2015_Aug_26_5_13187.txt
479G>A,"...in the largest homozygous region. This variant, c.479G>A, affects the last nucleotide of exon 5 and ...",30,535,Sci_Rep_2015_Aug_26_5_13187.txt
1087T>A,ADAM9	c.1087T>A	p.C363S	0	arRP	Iraqi Jew	MOL0827 MOL0838	—...,85,9,Sci_Rep_2015_Aug_26_5_13187.txt
211G>T,AIPL1	c.211G>T	p.V71F	8*10−6	arLCA	Mix Jew	MOL0113	—	Homoz...,86,9,Sci_Rep_2015_Aug_26_5_13187.txt
479G>A,BBS1	c.479G>A	p.R160Q	4*10−5	arRP	Arab Muslim	MOL0745	—	H...,87,8,Sci_Rep_2015_Aug_26_5_13187.txt
94C>T,CNGA1	c.94C>T	p.R32*	0	arRP	Moroccan Jew	MOL0927	—	Heteroz...,89,9,Sci_Rep_2015_Aug_26_5_13187.txt
1540C>T,CNGA1	c.1540C>T	p.R514*	0	arRP	Moroccan Jew	MOL0927	—	Hete...,90,9,Sci_Rep_2015_Aug_26_5_13187.txt
2284C>T,CNGB1	c.2284C>T	p.R762C	0	arRP	Buchara Jew	MOL0990	4	Homoz...,91,9,Sci_Rep_2015_Aug_26_5_13187.txt
2760G>A,CNGB1	c.2760G>A	p.W920*	8*10−6	arRP	Ashkenazi Jew	CHRD	—	H...,92,9,Sci_Rep_2015_Aug_26_5_13187.txt
1494C>A,CNNM4	c.1494C>A	p.D498E	0	ar Jalili syndrome	Druze	MOL0367...,93,9,Sci_Rep_2015_Aug_26_5_13187.txt
2950C>T,"C2ORF71	c.2950C>T	p.R984*	2*10−5	arRP	Jew (Iran, Turkey)	MOL...",95,11,Sci_Rep_2015_Aug_26_5_13187.txt
3289C>T,"C2ORF71	c.3289C>T	p.Q1097*	4*10−5	arRP	Jew (Iran, Turkey)	MO...",96,11,Sci_Rep_2015_Aug_26_5_13187.txt
2A>C,NR2E3	c.119-2A>C	 	8*10−6	arRP	Arab Muslim	MOL1266	1	Homozygou...,100,13,Sci_Rep_2015_Aug_26_5_13187.txt
1960C>T,PDE6A	c.1960C>T	p.Q654*	0	arRP	Arab Muslim	MOL0271	—	Homoz...,101,9,Sci_Rep_2015_Aug_26_5_13187.txt
1481C>T,PRPF3	c.1481C>T	p.T494M	0	adRP	Yemenite Jew	MOL0108	—	Hete...,102,9,Sci_Rep_2015_Aug_26_5_13187.txt
295C>A,RDH12	c.295C>A	p.L99I	7*10−5	arRP	Moroccan Jew Moroccan Je...,105,9,Sci_Rep_2015_Aug_26_5_13187.txt
377C>T,RDH12	c.377C>T	p.A126V	8*10−6	arRP	Arab Muslim	MOL1389	—	H...,106,9,Sci_Rep_2015_Aug_26_5_13187.txt
722A>T,RPE65	c.722A>T	p.H241L	0	arRP	Ashkenazi Jew	MOL0942	—	Homo...,107,9,Sci_Rep_2015_Aug_26_5_13187.txt
688G>T,RP1	c.688G>T	p.G230*	0	arRP	Yemenite Jew	MOL0181	1	Homoz...,108,7,Sci_Rep_2015_Aug_26_5_13187.txt
288T>A,SPATA7	c.288T>A	p.C96*	3*10−5	arLCA	Arab Muslim	MOL0758	—	H...,109,10,Sci_Rep_2015_Aug_26_5_13187.txt
542G>T,TSPAN12	c.542G>T	p.C181F	0	arFEVR	Beduin	MOL0513	—	Homozygou...,110,11,Sci_Rep_2015_Aug_26_5_13187.txt
6937G>T,USH2A	c.6937G>T	p.G2313C	1*10−4	arRP	Arab Muslim	MOL1234	—...,113,9,Sci_Rep_2015_Aug_26_5_13187.txt
2200G>A,CDH3	c.2200G>A	p.V734M	3*10−5	arRP	Druze	MOL1145	—	Homozy...,122,8,Sci_Rep_2015_Aug_26_5_13187.txt
1T>G,CDHR1	c.1T>G	p.M1L	0	arRP	Druze	MOL1275	—	Homozygous	 ,123,9,Sci_Rep_2015_Aug_26_5_13187.txt
227A>C,RPE65	c.227A>C	p.H76P	0	arRP	Arab Muslim	MOL1026	—	Homozyg...,124,9,Sci_Rep_2015_Aug_26_5_13187.txt
329A>G,RPE65	c.329A>G	p.D110G	0	arLCA	Arab Muslim	MOL0093	—	Homoz...,125,9,Sci_Rep_2015_Aug_26_5_13187.txt
1087T>A,ADAM9	c.1087T>A	p.C363S	Disease causing	1	0.00 Damaging	0	...,131,9,Sci_Rep_2015_Aug_26_5_13187.txt
2200G>A,CDH3	c.2200G>A	p.V734M	Disease causing	1	0.06 Tolerated	0...,132,8,Sci_Rep_2015_Aug_26_5_13187.txt
1T>G,CDHR1	c.1T>G	p.M1L	Disease causing	0	0.54 Tolerated	0	0	0,133,9,Sci_Rep_2015_Aug_26_5_13187.txt
1494C>A,CNNM4	c.1494C>A	p.D498E	Disease causing	1	0.00 Damaging	0	...,134,9,Sci_Rep_2015_Aug_26_5_13187.txt
227A>C,RPE65	c.227A>C	p.H76P	Disease causing	0.059	0.11 Tolerated...,135,9,Sci_Rep_2015_Aug_26_5_13187.txt
329A>G,RPE65	c.329A>G	p.D110G	Disease causing	0.998	0.31 Tolerate...,136,9,Sci_Rep_2015_Aug_26_5_13187.txt
6937G>T,USH2A	c.6937G>T	p.G2313C	Disease causing	1	0.00 Damaging	1...,137,9,Sci_Rep_2015_Aug_26_5_13187.txt
313A > G,Glutathione S-transferase P1 c.313A > G polymorphism could be useful in the predi...,287,32,Sci_Rep_2015_Sep_10_5_14000.txt
1G>A,...sential splice site variant CFH 1:196648924 (IVS6+1G>A) or missense variant rs139360826 (R175P). In ...,3,2889,Sci_Rep_2016_Aug_30_6_31531.txt
1G>A,...la. Members of Pedigree B carrying the CFH IVS6 + 1G>A variant had extensive extramacular drusen in ...,32,324,Sci_Rep_2016_Aug_30_6_31531.txt
1G>A,"...atabase who did not carry the CFH C192F, CFH IVS6+1G>A, or CFH R175P variants based on sequencing. O...",32,873,Sci_Rep_2016_Aug_30_6_31531.txt
1G>A,"... activity. Most splice site variants, like IVS6 + 1G>A in Pedigree B, lead to haploinsufficiency as ...",37,952,Sci_Rep_2016_Aug_30_6_31531.txt
1G>A,Pedigree B (CFH IVS6+1G>A),139,22,Sci_Rep_2016_Aug_30_6_31531.txt
1639G>A,. Association of VKORC1-1639G>A polymorphism with susceptibility to ossifi...,216,25,Sci_Rep_2016_Feb_12_6_21580.txt
8422G>A,...nd one pair of compound heterozygous mutations (c.8422G>A (p.A2808T) and c.7868G>A (p.G2623E)) (Tabl...,36,1190,Sci_Rep_2016_Jan_20_6_19432.txt
7868G>A,...eterozygous mutations (c.8422G>A (p.A2808T) and c.7868G>A (p.G2623E)) (Table 2) in the EYS gene (NM_...,36,1215,Sci_Rep_2016_Jan_20_6_19432.txt
1871G>A,... found a homozygous single-nucleotide mutation (c.1871G>A (p.S624L)) (Table 2) in ARRP-206. To confi...,36,1349,Sci_Rep_2016_Jan_20_6_19432.txt
7868G>A,"...ed that the parents were unaffected carriers of c.7868G>A (p.G2623E, father) and c.8422G>A (p.A2808T...",36,1639,Sci_Rep_2016_Jan_20_6_19432.txt
8422G>A,"...ed carriers of c.7868G>A (p.G2623E, father) and c.8422G>A (p.A2808T, mother) in family ARRP-49 and c...",36,1672,Sci_Rep_2016_Jan_20_6_19432.txt
1871G>A,"...422G>A (p.A2808T, mother) in family ARRP-49 and c.1871G>A (p.S624L, father) in family ARRP-206. The ...",36,1723,Sci_Rep_2016_Jan_20_6_19432.txt
8422G>A,"...ound a pair of compound heterozygous mutations, c.8422G>A (p.A2808T) and c.7868G>A (p.G2623E), in EY...",48,387,Sci_Rep_2016_Jan_20_6_19432.txt
7868G>A,"...eterozygous mutations, c.8422G>A (p.A2808T) and c.7868G>A (p.G2623E), in EYS in family ARRP-49. Both...",48,412,Sci_Rep_2016_Jan_20_6_19432.txt
8422G>T,... et al. reported the same heterozygous mutation c.8422G>T in a French RP patient18. This French RP p...,48,821,Sci_Rep_2016_Jan_20_6_19432.txt
3329C>G,...ch RP patient had another heterozygous mutation c.3329C>G18. The novel mutation p.G2623E in exon 40 ...,48,914,Sci_Rep_2016_Jan_20_6_19432.txt
1871G>A,...n family ARRP-49. The novel homozygous mutation c.1871G>A (p.S624L) in EYS is likely the causative m...,48,1282,Sci_Rep_2016_Jan_20_6_19432.txt
8388C>A,"...found two novel homozygous stop-gain mutations, c.8388C>A (p.Y2796X) and c.3024C>A (p.C1008X), respe...",52,96,Sci_Rep_2016_Jan_20_6_19432.txt
3024C>A,"...s stop-gain mutations, c.8388C>A (p.Y2796X) and c.3024C>A (p.C1008X), respectively, and these mutati...",52,121,Sci_Rep_2016_Jan_20_6_19432.txt
8422G>A,...he segregation of compound heterozygous changes c.8422G>A (MU1) and c.7868G>A (MU2). Genotypes are p...,76,60,Sci_Rep_2016_Jan_20_6_19432.txt
7868G>A,...mpound heterozygous changes c.8422G>A (MU1) and c.7868G>A (MU2). Genotypes are presented as follows:...,76,80,Sci_Rep_2016_Jan_20_6_19432.txt
1871G>A,... shows the segregation of a homozygous mutation c.1871G>A (MU3). The proband is indicated by an arro...,79,52,Sci_Rep_2016_Jan_20_6_19432.txt
8422G>A,ARRP-49	c.[8422G>A];[7868G>A]	50/M	32	NA	NA	PD/ODW/RR	PD/ODW/...,90,12,Sci_Rep_2016_Jan_20_6_19432.txt
7868G>A,ARRP-49	c.[8422G>A];[7868G>A]	50/M	32	NA	NA	PD/ODW/RR	PD/ODW/RR,90,22,Sci_Rep_2016_Jan_20_6_19432.txt
4606C>G,RP:S-10	c.[4606C>G];[5038A>G]	55/M	40	NA	NA	NA	NA,93,12,Sci_Rep_2016_Jan_20_6_19432.txt
5038A>G,RP:S-10	c.[4606C>G];[5038A>G]	55/M	40	NA	NA	NA	NA,93,22,Sci_Rep_2016_Jan_20_6_19432.txt
9059T>C,RP:S-14	c.[9059T>C]	14/M	0	R-a/b	R-a/b	PD/ODW	PD/ODW,94,12,Sci_Rep_2016_Jan_20_6_19432.txt
1418G>T,RP:S-18	c.[1418G>T];[2971C>T]	55/M	52	NA	NA	NA	NA,95,12,Sci_Rep_2016_Jan_20_6_19432.txt
2971C>T,RP:S-18	c.[1418G>T];[2971C>T]	55/M	52	NA	NA	NA	NA,95,22,Sci_Rep_2016_Jan_20_6_19432.txt
8388C>A,RP:S-22	c.[8388C>A]	38/M	13	NA	NA	NA	NA,96,12,Sci_Rep_2016_Jan_20_6_19432.txt
7187G>A,RP:S-34	c.[7187G>A]	44/F	14	NA	NA	NA	NA,97,12,Sci_Rep_2016_Jan_20_6_19432.txt
1G>A,RP:S-40	c.[2259+1G>A]	25/M	13	NA	NA	NA	NA,98,17,Sci_Rep_2016_Jan_20_6_19432.txt
3024C>A,RP:S-48	c.[3024C>A]	20/F	15	R-a/b	R-a/b	PD/ODW	PD/ODW,99,12,Sci_Rep_2016_Jan_20_6_19432.txt
8422G>A,ARRP-49	43	c.8422G>A	het	p.A2808T	missense	rs111991705	LamG	Tol...,104,14,Sci_Rep_2016_Jan_20_6_19432.txt
7868G>A,ARRP-49	40	c.7868G>A	het	p.G2623E	missense	novel	EGF	Damaging (...,105,14,Sci_Rep_2016_Jan_20_6_19432.txt
1871G>A,ARRP-206	12	c.1871G>A	hom	p.S624L	missense	novel	Unknown region	...,106,15,Sci_Rep_2016_Jan_20_6_19432.txt
4606C>G,RP:S-10	26	c.4606C>G	het	p.Q1536E	missense	novel	Unknown region...,108,14,Sci_Rep_2016_Jan_20_6_19432.txt
5038A>G,RP:S-10	26	c.5038A>G	het	p.N1680D	missense	novel	Unknown region...,109,14,Sci_Rep_2016_Jan_20_6_19432.txt
9059T>C,RP:S-14	43	c.9059T>C	hom	P.I3020T	missense	novel	LamG	Damaging ...,110,14,Sci_Rep_2016_Jan_20_6_19432.txt
1418G>T,RP:S-18	9	c.1418G>T	het	p.G473V	missense	novel	Unknown region	...,111,13,Sci_Rep_2016_Jan_20_6_19432.txt
2971C>T,RP:S-18	19	c.2971C>T	het	p.L991F	missense	novel	EGF	Tolerated (...,112,14,Sci_Rep_2016_Jan_20_6_19432.txt
8388C>A,RP:S-22	43	c.8388C>A	hom	p.Y2796X	stopgain	novel	LamG	NA/NA,113,14,Sci_Rep_2016_Jan_20_6_19432.txt
7187G>C,RP:S-34	36	c.7187G>C	hom	p.C2396S	missense	novel	EGF	Damaging (...,114,14,Sci_Rep_2016_Jan_20_6_19432.txt
1 G>A,RP:S-40	15	c.2259+1 G>A	hom	–	splicing	novel	–	NA/NA,115,19,Sci_Rep_2016_Jan_20_6_19432.txt
3024C>A,RP:S-48	20	c.3024C>A	hom	p.C1008X	stopgain	novel	EGF-CA	NA/N,116,14,Sci_Rep_2016_Jan_20_6_19432.txt
893G >A,. The MC4R c.893G >A mutation: A marker for growth and leanness...,232,14,Sci_Rep_2016_Jun_29_6_29039.txt
3584G>A,"...ereinafter, the patient carrying the c.1253del, c.3584G>A and c.5720+1G>A (r.5720_5721ins148) mutati...",15,235,Sci_Rep_2016_Mar_18_6_23213.txt
1G>A,"...ient carrying the c.1253del, c.3584G>A and c.5720+1G>A (r.5720_5721ins148) mutations will be identif...",15,254,Sci_Rep_2016_Mar_18_6_23213.txt
5572C>T,"...l be identified as #1; the patient carrying the c.5572C>T, c.6652G>T and c.7033C>T mutations will be...",15,342,Sci_Rep_2016_Mar_18_6_23213.txt
6652G>T,"...fied as #1; the patient carrying the c.5572C>T, c.6652G>T and c.7033C>T mutations will be identified...",15,353,Sci_Rep_2016_Mar_18_6_23213.txt
7033C>T,"...e patient carrying the c.5572C>T, c.6652G>T and c.7033C>T mutations will be identified as #2; the tw...",15,367,Sci_Rep_2016_Mar_18_6_23213.txt
2187C>A,...identified as #2; the two patients carrying the c.2187C>A homozygous mutations will be identified as...,15,443,Sci_Rep_2016_Mar_18_6_23213.txt
3584G>A,c.3584G>A	25	p.Arg1195AGln	Missense	Paternal,110,3,Sci_Rep_2016_Mar_18_6_23213.txt
1G>A,c.5720+1G>A (r.5720_5721ins148)	i35	p.Met1908*	Splice-sit...,111,8,Sci_Rep_2016_Mar_18_6_23213.txt
5572C>T,Patient 2 Milan (Italy)	c.5572C>T	#2	34	p.Arg1858*	Nonsense	Paternal,112,27,Sci_Rep_2016_Mar_18_6_23213.txt
6652G>T,c.6652G>T	41	p.Glu2218*	Nonsense	Paternal,113,3,Sci_Rep_2016_Mar_18_6_23213.txt
7033C>T,c.7033C>T	45	p.Arg2345Trp	Missense	Maternal,114,3,Sci_Rep_2016_Mar_18_6_23213.txt
2187C>A,Patients 3A and 3B Buenos Aires (Argentina)**	c.2187C>A	#3	16	p.Tyr729*	Nonsense	Maternal and Pate...,115,49,Sci_Rep_2016_Mar_18_6_23213.txt
417C > T,...lattice corneal dystrophy type I in patients with 417C > T (R124C) and 1762A > G (H572R) mutations i...,267,75,Sci_Rep_2016_Mar_31_6_23836.txt
1762A > G,...ophy type I in patients with 417C > T (R124C) and 1762A > G (H572R) mutations in TGFBI (BIGH3) . Mol...,267,96,Sci_Rep_2016_Mar_31_6_23836.txt
6986A>G,...ll liver samples were genotyped for the CYP3A5*3 (6986A>G) allele by allelic discrimination with a T...,100,52,Sci_Rep_2016_May_23_6_26544.txt
1 G>A,The analysis of the DEL type RHD*DEL8 (RHD IVS3+1 G>A) shows a surprising result: Körmöczi et al.1...,54,49,Sci_Rep_2016_Sep_1_6_32317.txt
809T>G,...D type 1	Low expression	Single missense mutationc.809T>G (V270G)	6,163,67,Sci_Rep_2016_Sep_1_6_32317.txt
1154G>C,...D type 2	Missense mutation (splice site affectedc.1154G>C (G385A))	3,164,60,Sci_Rep_2016_Sep_1_6_32317.txt
8C>G,RHD*weak D type 3	Single missense mutationc.8C>G (S3C)	5,165,45,Sci_Rep_2016_Sep_1_6_32317.txt
602C>G,"...	Very low expression	multiple missense mutationsc.602C>G (T201R),c.667T>G (F223V),c.819G>A,c.872C>G ...",166,80,Sci_Rep_2016_Sep_1_6_32317.txt
667T>G,"...ion	multiple missense mutationsc.602C>G (T201R),c.667T>G (F223V),c.819G>A,c.872C>G (P291R)	6",166,97,Sci_Rep_2016_Sep_1_6_32317.txt
819G>A,"...ense mutationsc.602C>G (T201R),c.667T>G (F223V),c.819G>A,c.872C>G (P291R)	6",166,114,Sci_Rep_2016_Sep_1_6_32317.txt
872C>G,"...tionsc.602C>G (T201R),c.667T>G (F223V),c.819G>A,c.872C>G (P291R)	6",166,123,Sci_Rep_2016_Sep_1_6_32317.txt
1G>A,RHD*DEL8 (IVS3+1G>A)	Splice site mutation	6,167,16,Sci_Rep_2016_Sep_1_6_32317.txt
710G > A,"...cifically, transient receptor potential ankyrin 1 710G > A (rs920829, E179K) was associated with the...",58,2770,Scientifica_(Cairo)_2013_Apr_2_2013_415279.txt
1911A > G,"...ion, and transient receptor potential vanilloid 1 1911A > G (rs8065080, I585V) was associated with c...",58,2906,Scientifica_(Cairo)_2013_Apr_2_2013_415279.txt
3435C > T,"...ted phenotypes. In addition to the aforementioned 3435C > T ABCB1 alleles, 1236C > T and 2677G > T/A...",68,874,Scientifica_(Cairo)_2013_Apr_2_2013_415279.txt
1236C > T,"...on to the aforementioned 3435C > T ABCB1 alleles, 1236C > T and 2677G > T/A protect against the resp...",68,899,Scientifica_(Cairo)_2013_Apr_2_2013_415279.txt
2677G > T,"...ementioned 3435C > T ABCB1 alleles, 1236C > T and 2677G > T/A protect against the respiratory depres...",68,913,Scientifica_(Cairo)_2013_Apr_2_2013_415279.txt
118A>G,...tsch J   The μ -opioid receptor gene polymorphism 118A>G depletes alfentanil-induced analgesia and p...,279,107,Scientifica_(Cairo)_2013_Apr_2_2013_415279.txt
118A>G,...h J   Meta-analysis of the relevance of the OPRM1 118A>G genetic variant for pain treatment Pain  20...,280,70,Scientifica_(Cairo)_2013_Apr_2_2013_415279.txt
826C>A,"For the FKRP gene, the c.826C>A (p. Leu276Ile) mutation is particularly com...",90,26,Semin_Pediatr_Neurol_2011_Dec_18(4)_277-288.txt
3243A>G,... and blastomere mutation load in a patient with m.3243A>G tRNALeu(UUR) point mutation Mitochondrion ...,94,137,Stem_Cells_2015_Mar_17_33(3)_639-645.txt
174G > C,...ntgomery H. E.  Sanders J.    Interleukin-6 gene -174G > C and -572G > C promoter polymorphisms are ...,142,69,Stem_Cells_Int_2015_May_28_2015_498328.txt
572G > C,...  Sanders J.    Interleukin-6 gene -174G > C and -572G > C promoter polymorphisms are strong predict...,142,83,Stem_Cells_Int_2015_May_28_2015_498328.txt
857C>T,"...061/2011/920584Research ArticleAssociation of TNF-857C>T, TNFRSF1A36A>G, and TNFRSF1B676T>G Polymorp...",3,144,Stroke_Res_Treat_2011_May_29_2011_920584.txt
36A>G,"...esearch ArticleAssociation of TNF-857C>T, TNFRSF1A36A>G, and TNFRSF1B676T>G Polymorphisms with Ische...",3,160,Stroke_Res_Treat_2011_May_29_2011_920584.txt
676T>G,"...ciation of TNF-857C>T, TNFRSF1A36A>G, and TNFRSF1B676T>G Polymorphisms with Ischemic Stroke in a Gre...",3,179,Stroke_Res_Treat_2011_May_29_2011_920584.txt
857C>T,"...t study was to determine any possible role of TNF-857C>T,TNFRSF1A36A>G, and TNFRSF1B676T>G polymorph...",23,211,Stroke_Res_Treat_2011_May_29_2011_920584.txt
36A>G,"...determine any possible role of TNF-857C>T,TNFRSF1A36A>G, and TNFRSF1B676T>G polymorphisms in risk fo...",23,226,Stroke_Res_Treat_2011_May_29_2011_920584.txt
676T>G,"...ble role of TNF-857C>T,TNFRSF1A36A>G, and TNFRSF1B676T>G polymorphisms in risk for stroke. Materials...",23,245,Stroke_Res_Treat_2011_May_29_2011_920584.txt
857C>T,"... ischemic stroke, we analyzed the role of the TNF-857C>T,  TNFRSF1A36A>G, and TNFRSF1B676T>G polymor...",30,147,Stroke_Res_Treat_2011_May_29_2011_920584.txt
36A>G,"... we analyzed the role of the TNF-857C>T,  TNFRSF1A36A>G, and TNFRSF1B676T>G polymorphisms in ischemi...",30,164,Stroke_Res_Treat_2011_May_29_2011_920584.txt
676T>G,"...le of the TNF-857C>T,  TNFRSF1A36A>G, and TNFRSF1B676T>G polymorphisms in ischemic stroke patients i...",30,183,Stroke_Res_Treat_2011_May_29_2011_920584.txt
857C>T,"...dard salt extraction procedure. Polymorphisms TNF-857C>T  (rs1799724),  TNFRSF1A36A>G  (rs767455),  ...",43,132,Stroke_Res_Treat_2011_May_29_2011_920584.txt
36A>G,".... Polymorphisms TNF-857C>T  (rs1799724),  TNFRSF1A36A>G  (rs767455),  and  TNFRSF1B676T>G   (rs10616...",43,162,Stroke_Res_Treat_2011_May_29_2011_920584.txt
676T>G,"...99724),  TNFRSF1A36A>G  (rs767455),  and  TNFRSF1B676T>G   (rs1061622)  were amplified using the fol...",43,195,Stroke_Res_Treat_2011_May_29_2011_920584.txt
857C>T,"...ruited in each group (cases and controls) for TNF-857C>T, 272 subjects for TNFRSF1A36A>G, and 85 sub...",46,657,Stroke_Res_Treat_2011_May_29_2011_920584.txt
36A>G,"...ontrols) for TNF-857C>T, 272 subjects for TNFRSF1A36A>G, and 85 subjects in each group for TNFRSF1B6...",46,690,Stroke_Res_Treat_2011_May_29_2011_920584.txt
676T>G,"...A36A>G, and 85 subjects in each group for TNFRSF1B676T>G polymorphism, if  the study power required ...",46,739,Stroke_Res_Treat_2011_May_29_2011_920584.txt
857C>T,"...nberg equilibrium in patients.  Regarding the TNF-857C>T polymorphism distribution, a high prevalenc...",51,242,Stroke_Res_Treat_2011_May_29_2011_920584.txt
36A>G,"...SF1B are summarized in Table 2. Regarding TNFRSF1A36A>G, a statistically significant difference was ...",53,136,Stroke_Res_Treat_2011_May_29_2011_920584.txt
676T>G,"...le (P = .009, OR = 1.48 (1.1–2)). For the TNFRSF1B676T>G, the TT genotype was more frequent in the s...",53,536,Stroke_Res_Treat_2011_May_29_2011_920584.txt
857C>T,"...nt study, we investigated the association of  TNF-857C>T,  TNFRSF1A36A>G, and TNFRSF1B676T>G polymor...",58,63,Stroke_Res_Treat_2011_May_29_2011_920584.txt
36A>G,"...stigated the association of  TNF-857C>T,  TNFRSF1A36A>G, and TNFRSF1B676T>G polymorphisms with ische...",58,80,Stroke_Res_Treat_2011_May_29_2011_920584.txt
676T>G,"...ation of  TNF-857C>T,  TNFRSF1A36A>G, and TNFRSF1B676T>G polymorphisms with ischemic stroke, under t...",58,99,Stroke_Res_Treat_2011_May_29_2011_920584.txt
857C>T,...cated on chromosome 6p21 encodes TNF-α.  The  TNF-857C>T polymorphism is a functional polymorphism t...,60,60,Stroke_Res_Treat_2011_May_29_2011_920584.txt
308G>A,... polymorphism. Most groups have worked on the TNF-308G>A  polymorphism with Pereira et al. suggestin...,60,304,Stroke_Res_Treat_2011_May_29_2011_920584.txt
308G>A,...phism with Pereira et al. suggesting that the TNF-308G>A polymorphism may play a role in ischemic st...,60,369,Stroke_Res_Treat_2011_May_29_2011_920584.txt
308G>A,"...f young Italian stroke patients, the A allele of −308G>A polymorphism exerted an independent effect ...",60,742,Stroke_Res_Treat_2011_May_29_2011_920584.txt
308G>A,"...recent study conducted by our group [10], the TNF-308G>A polymorphism is not in Hardy-Weinberg equil...",62,115,Stroke_Res_Treat_2011_May_29_2011_920584.txt
857C>T,...to exclude this polymorphism and focus on the TNF-857C>T polymorphism. Our study exerted that this o...,62,300,Stroke_Res_Treat_2011_May_29_2011_920584.txt
36A>G,...a gene located on chromosome 12p13.2. The TNFRSF1A36A>G polymorphism is a silent mutation in codon 1...,64,74,Stroke_Res_Treat_2011_May_29_2011_920584.txt
857C>T,...e power of our study is limited regarding the TNF-857C>T and the TNFRSF1A36A>G polymorphism. Regardi...,70,238,Stroke_Res_Treat_2011_May_29_2011_920584.txt
36A>G,... limited regarding the TNF-857C>T and the TNFRSF1A36A>G polymorphism. Regarding the TNFRSF1B676T>G p...,70,261,Stroke_Res_Treat_2011_May_29_2011_920584.txt
676T>G,"...TNFRSF1A36A>G polymorphism. Regarding the TNFRSF1B676T>G polymorphism, power analysis confirmed a so...",70,303,Stroke_Res_Treat_2011_May_29_2011_920584.txt
676T>G,...n criteria and the significant result for TNFRSF1B676T>G polymorphism,70,593,Stroke_Res_Treat_2011_May_29_2011_920584.txt
857C>T,"..., our results indicate a possible association of −857C>T polymorphism of TNF with stroke and are in ...",73,63,Stroke_Res_Treat_2011_May_29_2011_920584.txt
676T>G,"...B on ischemic stroke predisposition, with TNFRSF1B676T>G polymorphism showing the closest associatio...",73,260,Stroke_Res_Treat_2011_May_29_2011_920584.txt
857C>T,Polymorphisms	TNF-857C>T	TNFRSF1A36A>G	TNFRSF1B676T>G,92,19,Stroke_Res_Treat_2011_May_29_2011_920584.txt
36A>G,Polymorphisms	TNF-857C>T	TNFRSF1A36A>G	TNFRSF1B676T>G,92,34,Stroke_Res_Treat_2011_May_29_2011_920584.txt
676T>G,Polymorphisms	TNF-857C>T	TNFRSF1A36A>G	TNFRSF1B676T>G,92,48,Stroke_Res_Treat_2011_May_29_2011_920584.txt
315Ile>His,"... capacity being Tyr253Phe, Glu255Lys>wtBcr-Abl>Thr315Ile>His396Pro>Met351Thr (Griswold et al 2006; S...",186,202,Ther_Clin_Risk_Manag_2008_Feb_4(1)_163-187.txt
396Pro>Met,"...being Tyr253Phe, Glu255Lys>wtBcr-Abl>Thr315Ile>His396Pro>Met351Thr (Griswold et al 2006; Skaggs et a...",186,212,Ther_Clin_Risk_Manag_2008_Feb_4(1)_163-187.txt
420 C>T,"The 420 C>T substitution of CYP2C9*2, the 1075 A>C sub...",15,5,Thromb_J_2008_Jun_17_6_7.txt
1075 A>C,"The 420 C>T substitution of CYP2C9*2, the 1075 A>C substitution of CYP2C9*3 and the 1173 C>T...",15,43,Thromb_J_2008_Jun_17_6_7.txt
1173 C>T,"...*2, the 1075 A>C substitution of CYP2C9*3 and the 1173 C>T substitution of VKORC1 had minor allele f...",15,85,Thromb_J_2008_Jun_17_6_7.txt
1173 C>T,"... number AY587020), we selected one SNP (rs9934438/1173 C>T) localized in the first intron of VKORC1,...",38,147,Thromb_J_2008_Jun_17_6_7.txt
1173 C>T,"...pe distributions of CYP2C9*2, CYP2C9*3 and VKORC1 1173 C>T polymorphisms in 212 patients from the Os...",50,57,Thromb_J_2008_Jun_17_6_7.txt
1173 C>T,"....5%, respectively), whereas homozygotes of VKORC1 1173 C>T (T/T) was 13.2%. The frequencies of the t...",50,312,Thromb_J_2008_Jun_17_6_7.txt
1173 C>T,...und heterozygotes of CYP2C9*2/*3 was 0.9%. VKORC1 1173 C>T heterozygotes was 46.7%. Minor allele fre...,50,514,Thromb_J_2008_Jun_17_6_7.txt
1173 C>T,"Table 1 Genotype distributions of VKORC1 1173 C>T, CYP2C9*2 and CYP2C9*3 polymorphisms in t...",52,42,Thromb_J_2008_Jun_17_6_7.txt
1173 C>T,1173 C>T		36.6		40.5		36.1		33.0,58,1,Thromb_J_2008_Jun_17_6_7.txt
1173 C>T,"... warfarin doses for different genotypes of VKORC1 1173 C>T and CYP2C9 *1,*2 and *3. The box represen...",72,83,Thromb_J_2008_Jun_17_6_7.txt
1173C>T,"...quencies (MAF) of 37% for the VKORC1 polymorphism 1173C>T, 11% for the CYP2C9*2 and 6% for the CYP2C...",105,71,Thromb_J_2008_Jun_17_6_7.txt
1173C>T,...an CYP2C9 due to markedly higher frequency of the 1173C>T polymorphism than of the CYP2C9*2 and CYP2...,105,1306,Thromb_J_2008_Jun_17_6_7.txt
2255 C>T,...d a significant association between the rs2359612/2255 C>T VKORC1 polymorphism (a polymorphism found...,109,498,Thromb_J_2008_Jun_17_6_7.txt
1173 C>T,...e in strong linkage disequilibrium with rs9934438/1173 C>T) and the risk of coronary heart disease (...,109,603,Thromb_J_2008_Jun_17_6_7.txt
181C>A,"... found in one FTC. Two NRAS codon 61 mutations (c.181C>A, p.Q61K) were also found, one in FTC and on...",77,461,Thyroid_2016_Feb_1_26(2)_227-234.txt
845G--> A,...i VJ  Koziol JA  Ho NJ  Gelbart T   Penetrance of 845G--> A (C282Y) HFE hereditary haemochromatosis ...,249,71,Transl_Oncogenomics_2014_Dec_4_6_1-12.txt
12083G>A,"...many). CYP3A5-genotyping (rs776746; NG_007938.1:g.12083G>A, A=CYP3A5*1 and G=CYP3A5*3) was performed...",39,209,Transpl_Int_2013_Dec_15_26(12)_1198-1207.txt
678 C>A,"...A sequencing, which showed a nucleotide change at 678 C>A that does not lead to an amino acid change...",16,483,Turk_J_Haematol_2012_Jun_15_29(2)_204-205.txt
678 C>A,"...orted a new heterozygous MTHFR gene polymorphism (678 C>A), with an unusual melting point profile. A...",20,78,Turk_J_Haematol_2012_Jun_15_29(2)_204-205.txt
678C>A,"...oint profile. Although rare, the finding of MTHFR 678C>A polymorphism indicates that this might be t...",20,163,Turk_J_Haematol_2012_Jun_15_29(2)_204-205.txt
20209 C >T,9 Ozdag H  Egin Y  Akar N   Prothrombin gene 20209 C >T along with the first description of a h...,35,46,Turk_J_Haematol_2012_Jun_15_29(2)_204-205.txt
4 C >T,...ozygous polymorphism at the 3’ downstream region +4 C >T in the Turkish population Lab Hematol 2006 ...,35,148,Turk_J_Haematol_2012_Jun_15_29(2)_204-205.txt
11279G>A,"...s confirmed due to mutation in the TCIRG1 gene [g.11279G>A(IVS18+1) paternal allele, g.8280_9560del ...",15,105,Turk_J_Haematol_2014_Sep_5_31(3)_335-336.txt
321C > A,"...ons, heterozygous on the LCAT gene: (1) Exon 3, c.321C > A, Tyr83Stp, and (2) Exon 3 c.367C > T, Arg...",50,816,Vasc_Health_Risk_Manag_2012_Jun_5_8_357-361.txt
367C > T,"...1) Exon 3, c.321C > A, Tyr83Stp, and (2) Exon 3 c.367C > T, Arg99cys. These two mutations have been ...",50,853,Vasc_Health_Risk_Manag_2012_Jun_5_8_357-361.txt
183	N>D,183	N>D	F>S,79,1,Virol_J_2009_Nov_16_6_198.txt
189	E>K,189	E>K	S>L,81,1,Virol_J_2009_Nov_16_6_198.txt
202	R>H,202	R>H	R>W,83,1,Virol_J_2009_Nov_16_6_198.txt
226	R>K,226	R>K	L>F,91,1,Virol_J_2009_Nov_16_6_198.txt
271	A>V,271	A>V	A>T,95,1,Virol_J_2009_Nov_16_6_198.txt
327	N>D,327	N>D	S>F,99,1,Virol_J_2009_Nov_16_6_198.txt
361	A>E,361	A>E	A>S,103,1,Virol_J_2009_Nov_16_6_198.txt
383	I>M,383	I>M	no change,109,1,Virol_J_2009_Nov_16_6_198.txt
401	D>E,401	D>E	L>F,113,1,Virol_J_2009_Nov_16_6_198.txt
413	I>M,413	I>M	no change,117,1,Virol_J_2009_Nov_16_6_198.txt
456	L>I,456	L>I	R>M,127,1,Virol_J_2009_Nov_16_6_198.txt
459	I>V,459	I>V	I>T,129,1,Virol_J_2009_Nov_16_6_198.txt
522	L>F,522	L>F	R>K,133,1,Virol_J_2009_Nov_16_6_198.txt
538	N>I,538	N>I	L>I,135,1,Virol_J_2009_Nov_16_6_198.txt
616	L>I,616	L>I	V>F,137,1,Virol_J_2009_Nov_16_6_198.txt
668	S>L,668	S>L	no change	S>L,143,1,Virol_J_2009_Nov_16_6_198.txt
702	V>I,702	V>I	I>T	no change,145,1,Virol_J_2009_Nov_16_6_198.txt
703	I>A,703	I>A	T>A	no change,147,1,Virol_J_2009_Nov_16_6_198.txt
723	N>D,723	N>D	F>S	no change,149,1,Virol_J_2009_Nov_16_6_198.txt
169	S>N,169	S>N	no change,155,1,Virol_J_2009_Nov_16_6_198.txt
379	R>K,379	R>K	no change,165,1,Virol_J_2009_Nov_16_6_198.txt
538	M>V,538	M>V	I>T,173,1,Virol_J_2009_Nov_16_6_198.txt
625	K>R,625	K>R	F>S	N>D,177,1,Virol_J_2009_Nov_16_6_198.txt
661	P > L,661	P > L	G>S	L>F,179,1,Virol_J_2009_Nov_16_6_198.txt
677	K>N,677	K>N	Y>*	S>I,181,1,Virol_J_2009_Nov_16_6_198.txt
729		I>T,729		I>T	no change,183,1,Virol_J_2009_Nov_16_6_198.txt
780		Q>R,780		Q>R	no change,185,1,Virol_J_2009_Nov_16_6_198.txt
465T>C,"... determinants at 4 polymorphic sites, which were −465T>C, −413C>T, 314C>T and 939A>G in the HNMT gen...",7,88,World_Allergy_Organ_J_2012_Feb_17_5(Suppl_2)_S33a.txt
413C>T,"...ants at 4 polymorphic sites, which were −465T>C, −413C>T, 314C>T and 939A>G in the HNMT gene, and th...",7,97,World_Allergy_Organ_J_2012_Feb_17_5(Suppl_2)_S33a.txt
314C>T,"...4 polymorphic sites, which were −465T>C, −413C>T, 314C>T and 939A>G in the HNMT gene, and the functi...",7,105,World_Allergy_Organ_J_2012_Feb_17_5(Suppl_2)_S33a.txt
939A>G,"...ic sites, which were −465T>C, −413C>T, 314C>T and 939A>G in the HNMT gene, and the functional effect...",7,116,World_Allergy_Organ_J_2012_Feb_17_5(Suppl_2)_S33a.txt
939A>G,"...n the HNMT gene, and the functional effect of the 939A>G polymorphism was analyzed. The genotyping w...",7,174,World_Allergy_Organ_J_2012_Feb_17_5(Suppl_2)_S33a.txt
314C>T,...ns of the genotype and allele frequencies of HNMT 314C>T polymorphism were significantly associated ...,10,122,World_Allergy_Organ_J_2012_Feb_17_5(Suppl_2)_S33a.txt
939A>G,...h non-atopic eczema (P = 0.004) and those of HNMT 939A>G polymorphism were significantly associated ...,10,225,World_Allergy_Organ_J_2012_Feb_17_5(Suppl_2)_S33a.txt
654T>C,"... atopy groups (P = 0.048). However, those of HNMT 654T>C and 413C>T polymorphisms were not. In addit...",10,339,World_Allergy_Organ_J_2012_Feb_17_5(Suppl_2)_S33a.txt
413C>T,"...ps (P = 0.048). However, those of HNMT 654T>C and 413C>T polymorphisms were not. In addition, subjec...",10,350,World_Allergy_Organ_J_2012_Feb_17_5(Suppl_2)_S33a.txt
939A>G,... with the homozygous AA or heterozygous AG of the 939A>G polymorphism showed significantly higher Ig...,10,452,World_Allergy_Organ_J_2012_Feb_17_5(Suppl_2)_S33a.txt
2A>G,"...a heterozygous splice site mutation in TP53, IVS6-2A>G, and no other mutations in cancer-related gen...",22,979,Yale_J_Biol_Med_2015_Jun_1_88(2)_181-185.txt
2A>G,"... Her specific germline TP53 mutation, namely IVS6-2A>G, might be predicted to yield a mild phenotype...",32,738,Yale_J_Biol_Med_2015_Jun_1_88(2)_181-185.txt
47 T>C,"...SNPs) of the β2-adrenergic receptor gene (ADRB2; -47 T>C, 46 A>G, 79 C>G, 252 G>A, and 523 C>A) usin...",8,479,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
46 A>G,"... the β2-adrenergic receptor gene (ADRB2; -47 T>C, 46 A>G, 79 C>G, 252 G>A, and 523 C>A) using a sing...",8,487,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
79 C>G,"...adrenergic receptor gene (ADRB2; -47 T>C, 46 A>G, 79 C>G, 252 G>A, and 523 C>A) using a single-base ...",8,495,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
252 G>A,"...ic receptor gene (ADRB2; -47 T>C, 46 A>G, 79 C>G, 252 G>A, and 523 C>A) using a single-base extensio...",8,503,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
523 C>A,"...ene (ADRB2; -47 T>C, 46 A>G, 79 C>G, 252 G>A, and 523 C>A) using a single-base extension method",8,516,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
46 A>G,"...rameters. The haplotype of ADRB2 (GAA composed of 46 A>G, 252 G>A, and 523 C>A) was significantly as...",11,178,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
252 G>A,".... The haplotype of ADRB2 (GAA composed of 46 A>G, 252 G>A, and 523 C>A) was significantly associated...",11,186,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
523 C>A,"...pe of ADRB2 (GAA composed of 46 A>G, 252 G>A, and 523 C>A) was significantly associated with work-re...",11,199,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
46 A>G,"...reover, in subjects with the AG or GG genotype at 46 A>G and haplotype [GAA] of ADRB2, the prevalenc...",11,326,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
47 T>C,... extension 5'-CXCGCAGAGCXCCGCCGTGGGTCCGCC-3' for -47 T>C; forward 5'-CAGGAAACAGCTATGACCGCACATAACGGGC...,34,595,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
46 A>G,"...and extension 5'-ACGTCRTGGTCCGGCGCATGGCTTC-3' for 46 A>G; forward 5'-TTCTTGCTGGCACCCAAT-3', reverse ...",34,744,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
79C>G,"...nd extension 5'- TGCGCCGGACCACGXCGXCACGCAG-3' for 79C>G; forward 5'-CAACTACTTCATCACTTCACTGR-3', reve...",34,872,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
252 G>A,"...and extension 5'-CCTGTGCTGATCTGGTCATGGGCCT-3' for 252 G>A; and forward 5'-ATTGTGTCAGGCCTTACCTCR-3', ...",34,1007,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
523 C>A,...and extension 5'-CTTGCCCATTCAGATGCACTGGTAC-3' for 523 C>A,34,1144,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
47T>C,"... seconds. Melting processes were done at 55℃ for -47T>C, 46A>G, 79C>G, and 523C>A SNPs, at 50℃ for 2...",36,309,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
46A>G,"...s. Melting processes were done at 55℃ for -47T>C, 46A>G, 79C>G, and 523C>A SNPs, at 50℃ for 252G>A S...",36,316,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
79C>G,"...ing processes were done at 55℃ for -47T>C, 46A>G, 79C>G, and 523C>A SNPs, at 50℃ for 252G>A SNP for ...",36,323,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
523C>A,"...es were done at 55℃ for -47T>C, 46A>G, 79C>G, and 523C>A SNPs, at 50℃ for 252G>A SNP for 1 minute. E...",36,334,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
252G>A,"...-47T>C, 46A>G, 79C>G, and 523C>A SNPs, at 50℃ for 252G>A SNP for 1 minute. Extensions were done at 7...",36,358,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
46 A>G,"... USA), and three haplotype sets were derived from 46 A>G, 252 G>A, and 523 C>A of ADRB2 SNPs. Signif...",41,152,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
252 G>A,"...nd three haplotype sets were derived from 46 A>G, 252 G>A, and 523 C>A of ADRB2 SNPs. Significant de...",41,160,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
523 C>A,"...otype sets were derived from 46 A>G, 252 G>A, and 523 C>A of ADRB2 SNPs. Significant departures of t...",41,173,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
252 G>A,"...was higher in subjects with GA or AA genotypes of 252 G>A, or the CA or AA genotypes of 523 C>A (p<0...",52,177,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
523 C>A,"...enotypes of 252 G>A, or the CA or AA genotypes of 523 C>A (p<0.05, respectively). However, the stati...",52,215,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
252 G>A,"...sons. The results of power analysis were 0.56 for 252 G>A (effect size 0.11), and 0.61 for 523 C>A (...",52,393,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
523 C>A,"...0.56 for 252 G>A (effect size 0.11), and 0.61 for 523 C>A (effect size 0.15)",52,434,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
46 A>G,"... WRS. When the haplotype of ADRB2 was composed of 46 A>G, 252 G>A, and 523 C>A, the prevalence rate ...",54,106,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
252 G>A,"...en the haplotype of ADRB2 was composed of 46 A>G, 252 G>A, and 523 C>A, the prevalence rate of work-...",54,114,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
523 C>A,"...ype of ADRB2 was composed of 46 A>G, 252 G>A, and 523 C>A, the prevalence rate of work-related sympt...",54,127,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
46 A>G,"...nd 2. In subjects with AG or GG genotype of ADRB2 46 A>G, prevalence rates of serum-specific IgG1 an...",57,479,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
46 A>G,"... these, many have reported on the associations of 46 A>G polymorphisms and indicated that the Gly mu...",62,476,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
46 A>G,...an individuals with the Gly/Gly genotype of ADRB2 46 A>G have a greater bronchodilator response to t...,64,58,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
47 T>C,"...gard to other ADRB2 SNPs, polymorphisms at ADRB2 -47 T>C located in the β upstream peptide were repo...",66,58,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
523 C>A,...can patients with asthma.29 Polymorphism at ADRB2 523 C>A was also shown to be associated with the b...,66,229,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
46 A>G,"...Moreover, the subjects with the G allele at ADRB2 46 A>G had significantly higher prevalence rates o...",68,568,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
46 A>G,...est that workers with the AG/GG genotype of ADRB2 46 A>G are at a higher risk of generating wheat-sp...,68,1053,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
46A>G,"...r in relation to exposure, according to the ADRB2 46A>G polymorphism",79,146,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
46A>G,"...genotype of ADRB2. *The haplotype was composed of 46A>G, 252G>A, and 523C>A of the β2-adrenergic rec...",81,198,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
252G>A,"...e of ADRB2. *The haplotype was composed of 46A>G, 252G>A, and 523C>A of the β2-adrenergic receptor g...",81,205,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
523C>A,"...*The haplotype was composed of 46A>G, 252G>A, and 523C>A of the β2-adrenergic receptor genetic polym...",81,217,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
46A>G,"*The haplotype was composed of 46A>G, ADRB2 252G>A, and 523C>A β2-adrenergic rece...",99,32,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
252G>A,"*The haplotype was composed of 46A>G, ADRB2 252G>A, and 523C>A β2-adrenergic receptor polymorp...",99,45,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
523C>A,"...aplotype was composed of 46A>G, ADRB2 252G>A, and 523C>A β2-adrenergic receptor polymorphisms",99,57,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
769C>T,"...tion in Slovenian APS-1 population was p.R257* (c.769C>T) present in 63.3 % of pathological alleles,...",54,200,Zdr_Varst_2015_Mar_13_54(2)_112-118.txt
769C>T,...of Slovenian patients share the common p.R257* (c.769C>T) mutation (1). CMC was detected in all Slov...,59,401,Zdr_Varst_2015_Mar_13_54(2)_112-118.txt
769C>T,"..., British and Norwegian patients (23), p.R257* (c.769C>T) is present in more than 85 % of the Finnis...",69,247,Zdr_Varst_2015_Mar_13_54(2)_112-118.txt
769C>T,c.[769C>T];[769C>T],98,4,Zdr_Varst_2015_Mar_13_54(2)_112-118.txt
769C>T,c.[769C>T];[769C>T],98,13,Zdr_Varst_2015_Mar_13_54(2)_112-118.txt
769C>T,c.[769C>T];[769C>T],100,4,Zdr_Varst_2015_Mar_13_54(2)_112-118.txt
769C>T,c.[769C>T];[769C>T],100,13,Zdr_Varst_2015_Mar_13_54(2)_112-118.txt
769C>T,c.[769C>T];[769C>T],102,4,Zdr_Varst_2015_Mar_13_54(2)_112-118.txt
769C>T,c.[769C>T];[769C>T],102,13,Zdr_Varst_2015_Mar_13_54(2)_112-118.txt
769C>T,c.[769C>T];[769C>T],104,4,Zdr_Varst_2015_Mar_13_54(2)_112-118.txt
769C>T,c.[769C>T];[769C>T],104,13,Zdr_Varst_2015_Mar_13_54(2)_112-118.txt
769C>T,c.[769C>T];[769C>T],106,4,Zdr_Varst_2015_Mar_13_54(2)_112-118.txt
769C>T,c.[769C>T];[769C>T],106,13,Zdr_Varst_2015_Mar_13_54(2)_112-118.txt
769C>T,c.[769C>T];[47C>T],108,4,Zdr_Varst_2015_Mar_13_54(2)_112-118.txt
47C>T,c.[769C>T];[47C>T],108,13,Zdr_Varst_2015_Mar_13_54(2)_112-118.txt
769C>T,c.[769C>T];[47C>T],110,4,Zdr_Varst_2015_Mar_13_54(2)_112-118.txt
47C>T,c.[769C>T];[47C>T],110,13,Zdr_Varst_2015_Mar_13_54(2)_112-118.txt
769C>T,c.[769C>T];[21-43dup23],112,4,Zdr_Varst_2015_Mar_13_54(2)_112-118.txt
769C>T,c.[769C>T];[540delG],114,4,Zdr_Varst_2015_Mar_13_54(2)_112-118.txt
769C>T,c.[769C>T];[769C>T],116,4,Zdr_Varst_2015_Mar_13_54(2)_112-118.txt
769C>T,c.[769C>T];[769C>T],116,13,Zdr_Varst_2015_Mar_13_54(2)_112-118.txt
769C>T,c.[769C>T];[653-7_-5delCTC],118,4,Zdr_Varst_2015_Mar_13_54(2)_112-118.txt
769C>T,c.[769C>T];[769C>T],126,4,Zdr_Varst_2015_Mar_13_54(2)_112-118.txt
769C>T,c.[769C>T];[769C>T],126,13,Zdr_Varst_2015_Mar_13_54(2)_112-118.txt
